assays_ss_d,assays_ss_tst_tp,assays_dc_d,assays_crtd_b,assays_ss_tx_d,assays_ss_strn,assays_src_d,assays_dscrptn,assays_cll_d,assays_src_ss_d,assays_chmbl_d,assays_ss_sbclllr_frctn,assays_td,assays_ss_rgnsm,assays_ss_cll_tp,assays_vrnt_d,assays_rltnshp_tp,assays_cnfdnc_scr,assays_b_frmt,assays_tss_d
7524,In vivo,9866,Intermediate,10116.0,,1,Biodistribution in normal rat kidney in the presence of 0.005 M Gd/0.01 M lig at 2 hr,,,CHEMBL618647,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2113.0
7525,In vivo,9866,Intermediate,10116.0,,1,Biodistribution in normal rat kidney in the presence of 0.01 M Gd/0.05 M lig,,,CHEMBL618648,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2113.0
7526,In vivo,9866,Intermediate,10116.0,,1,Biodistribution in normal rat kidney in the presence of NAC Gd 0.01 M lig at 2 hr,,,CHEMBL618649,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2113.0
7527,In vivo,9866,Intermediate,10116.0,,1,Biodistribution in normal rat liver in the presence of 0.005 M Gd/0.01 M lig at 2 hr,,,CHEMBL618650,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
7528,In vivo,9866,Intermediate,10116.0,,1,Biodistribution in normal rat liver in the presence of 0.01 M Gd/0.05 M lig,,,CHEMBL618651,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
7529,In vivo,9866,Intermediate,10116.0,,1,Biodistribution in normal rat liver in the presence of NAC Gd 0.01 M lig at 2 hr,,,CHEMBL876497,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
7530,In vivo,9866,Intermediate,10116.0,,1,Biodistribution in normal rat lung in the presence of 0.005 M Gd/0.01 M lig at 2 hr,,,CHEMBL618652,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2048.0
7531,In vivo,9866,Intermediate,10116.0,,1,Biodistribution in normal rat lung in the presence of 0.01 M Gd/0.05 M lig,,,CHEMBL618653,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2048.0
7532,In vivo,9866,Intermediate,10116.0,,1,Biodistribution in normal rat lung in the presence of NAC Gd 0.01 M lig at 2 hr,,,CHEMBL618654,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2048.0
7533,,6351,Intermediate,10116.0,,1,Recovery rate from urine and bile was determined after iv administration at 20 mg/kg in rats; Not tested,,,CHEMBL618655,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7534,,1465,Intermediate,10116.0,,1,Compound was tested for solubility in water,,,CHEMBL618656,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7535,,5182,Intermediate,,,1,Solubility in phosphate buffered saline (1% DMSO) at pH 6.5 (24 hr equilibration),,,CHEMBL618657,,22229,,,,U,0,BAO_0000100,
7536,,17847,Intermediate,10116.0,,1,Solubility was determined,,,CHEMBL618658,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7537,,15339,Intermediate,10116.0,,1,solubility in water (ug/mL) at 37 degree C.,,,CHEMBL618659,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7538,,5202,Intermediate,10116.0,,1,First pass metabolism and metabolic bioavailability using rat hepatic microsomes,,,CHEMBL618660,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7539,,1088,Intermediate,10116.0,,1,In vitro stability relative to (+)-AJ76 in rat hepatocyte assay,,,CHEMBL618661,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7540,,3169,Intermediate,10116.0,,1,Half life in rats,,,CHEMBL873807,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7541,,5353,Intermediate,10116.0,,1,Half life in Dawley rat,,,CHEMBL618662,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7542,In vivo,2864,Intermediate,10116.0,,1,Half life period after 3 mg/kg iv administration,,,CHEMBL618663,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7543,In vivo,2864,Intermediate,10116.0,,1,Half life period after 3 mg/kg iv administration in rat,,,CHEMBL618664,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7544,In vivo,2864,Intermediate,10116.0,,1,Half life period after 3 mg/kg iv administration in the rat,,,CHEMBL618665,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7545,,6362,Intermediate,10116.0,,1,Half life period in female Sprague-Dawley rats,,,CHEMBL876498,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7546,,6249,Intermediate,10116.0,,1,Half life period in rat,,,CHEMBL618666,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7547,,3169,Intermediate,10116.0,,1,Half-life in rats was determined,,,CHEMBL620440,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7548,,3169,Intermediate,10116.0,,1,Half-life in rats with metabolic oxidation,,,CHEMBL620441,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7549,,3169,Intermediate,10116.0,,1,Half-life in rats,,,CHEMBL620442,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7550,In vivo,17260,Intermediate,10116.0,,1,T 1/2 at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,,,CHEMBL620443,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7551,In vivo,17260,Intermediate,10116.0,,1,T 1/2 at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,,,CHEMBL620444,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7552,In vivo,17260,Intermediate,10116.0,,1,T max at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,,,CHEMBL620445,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7553,In vivo,17260,Intermediate,10116.0,,1,T max at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,,,CHEMBL620446,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7554,,2879,Intermediate,10116.0,,1,Biological half-life measured in plasma of rat,,,CHEMBL620447,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
7555,,2879,Intermediate,10116.0,,1,Biological half-life measured in plasma of rat; 22-25,,,CHEMBL621129,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
7556,,2879,Intermediate,10116.0,,1,Biological half-life measured in plasma of rat; 9-16,,,CHEMBL621130,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
7557,In vivo,3184,Intermediate,10116.0,,1,Compound was evaluated for its half life when administered intravenously in rat,,,CHEMBL873808,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7558,In vivo,4891,Intermediate,10116.0,,1,Compound was evaluated for pharmacokinetic parameter percent bioavailability at 8 h,,,CHEMBL876598,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7559,In vivo,429,Intermediate,10116.0,,1,Evaluated for pharmacokinetic parameter half-life in rat at the dose 50 mg/kg,,,CHEMBL621131,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7560,In vivo,5656,Intermediate,10116.0,,1,Half life (T1/2) after oral administration in rat,,,CHEMBL621132,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7561,In vivo,4413,Intermediate,10116.0,,1,Half life of compound after iv administration of 20 mg/kg dose in rat,,,CHEMBL621133,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7562,In vivo,3598,Expert,10116.0,,1,Half life of compound determined in rat after iv administration at a dose of 10 mg/kg,,,CHEMBL621312,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7563,,17267,Intermediate,10116.0,,1,Half life of compound was determined in rat,,,CHEMBL621313,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7564,,4727,Intermediate,10116.0,,1,Half life of compound was determined in rat blood,,,CHEMBL621314,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
7565,In vivo,17651,Intermediate,10116.0,,1,Half life at 1 mg/kg was determined in rat,,,CHEMBL621315,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7566,In vivo,17651,Intermediate,10116.0,,1,Half life at 10 mg/kg was determined in rat,,,CHEMBL621316,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7567,,401,Intermediate,10116.0,,1,Half life in rats,,,CHEMBL621317,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7568,,4942,Intermediate,10116.0,,1,Half life in rats in hours,,,CHEMBL621318,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7569,In vivo,17735,Intermediate,10116.0,,1,Half life following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats was determined,,,CHEMBL621319,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7570,In vivo,6056,Intermediate,10116.0,,1,Half life was calculated at a single intravenous administration of 20 mg/kg in rat,,,CHEMBL621377,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7571,,5213,Intermediate,10116.0,,1,Half life was determined,,,CHEMBL621378,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7572,In vivo,6616,Intermediate,10116.0,,1,Half life after i.v. administration,,,CHEMBL876599,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7573,In vivo,5937,Intermediate,10116.0,,1,Half life in rat after intravenous administration at a concentration 0.5 mg/kg,,,CHEMBL621379,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7574,,5819,Intermediate,10116.0,,1,Half life in rat plasma,,,CHEMBL621380,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
7575,,5819,Intermediate,10116.0,,1,Half life in rat plasma; Not detected,,,CHEMBL621381,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
7576,,6803,Intermediate,10116.0,,1,Half life in rats,,,CHEMBL618515,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7577,In vivo,17804,Intermediate,10116.0,,1,Half life period of compound was determined after peroral administration,,,CHEMBL618516,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7578,In vivo,17804,Intermediate,10116.0,,1,Half life period of compound was determined at a dose of 3 mg/kg by intravenous administration,,,CHEMBL618517,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7579,,5948,Intermediate,10116.0,,1,Half life period in rat,,,CHEMBL618518,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7580,In vivo,1916,Intermediate,10116.0,,1,Half life period was evaluated against Sprague-Dawley rats at a dose of 15 mg/kg after iv administration,,,CHEMBL618519,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7581,In vivo,1916,Intermediate,10116.0,,1,Half life period was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration,,,CHEMBL618698,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7582,In vivo,1916,Intermediate,10116.0,,1,Half life period was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration; Not available,,,CHEMBL618862,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7583,In vivo,4890,Intermediate,10116.0,,1,Half life period was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,,,CHEMBL618863,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7584,In vivo,17764,Intermediate,10116.0,,1,Half life period was determined for compound after intravenous administration in rats at 24 uM/kg,,,CHEMBL618864,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7585,In vivo,4727,Intermediate,10116.0,,1,Half life time in rat the dose of 2 mg/kg,,,CHEMBL618865,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7586,In vivo,17509,Intermediate,10116.0,,1,Half-life 24 hr after 10 mg/kg iv administration in rats,,,CHEMBL618866,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7587,In vivo,17509,Intermediate,10116.0,,1,Half-life 24 hr after 2 mg/kg iv administration in rats,,,CHEMBL618867,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7588,,6597,Intermediate,10116.0,,1,Half-life consistent with the observed metabolic steady state in rats,,,CHEMBL875828,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7589,In vivo,17735,Intermediate,10116.0,,1,Half-life following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats was determined,,,CHEMBL618868,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7590,,6597,Intermediate,10116.0,,1,Half-life for oxidative metabolic stability was determined using male human,,,CHEMBL618869,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7591,In vivo,17670,Intermediate,10116.0,,1,"Half-life in fischer rats at 5 mg/kg dose, administered intravenously",,,CHEMBL618870,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7592,,1696,Intermediate,10116.0,,1,Half-life in rat plasma,,,CHEMBL618871,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
7593,,1742,Intermediate,10116.0,,1,Half-life in rat plasma was determined,,,CHEMBL618872,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
7594,,17800,Intermediate,10116.0,,1,Half-life in rats was determined,,,CHEMBL873816,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7595,,12923,Autocuration,,,1,Area under curve of acid 2a was determined by HPLC at a dosage of 54.5 mg/kg administered intragastrically by gavage method in dog,,,CHEMBL618873,,22224,,,,U,0,BAO_0000218,
7596,,11954,Autocuration,,,1,Area under curve after oral dose of 0.1 mg//kg,,,CHEMBL621602,,22224,,,,U,0,BAO_0000019,
7597,,11954,Autocuration,,,1,Area under curve after oral dose of 0.3 mg/kg,,,CHEMBL621603,,22224,,,,U,0,BAO_0000218,
7598,,11954,Autocuration,,,1,Area under curve after oral dose of 1 mg/kg,,,CHEMBL621604,,22224,,,,U,0,BAO_0000218,
7599,,11954,Autocuration,,,1,Area under curve after oral dose of 10 mg/kg,,,CHEMBL621605,,22224,,,,U,0,BAO_0000218,
7600,,11954,Autocuration,,,1,Area under curve after oral dose of 23.4 mg/kg,,,CHEMBL621606,,22224,,,,U,0,BAO_0000218,
7601,,11954,Autocuration,,,1,Area under curve after oral dose of 3 mg/kg,,,CHEMBL621607,,22224,,,,U,0,BAO_0000218,
7602,,11954,Autocuration,,,1,Area under curve after oral dose of 3.87 mg/kg,,,CHEMBL621608,,22224,,,,U,0,BAO_0000218,
7603,,5237,Autocuration,,,1,Area under curve was determined,,,CHEMBL621609,,22224,,,,U,0,BAO_0000019,
7604,,4026,Autocuration,,,1,Area under curve at a dose of 10 mg/kg,,,CHEMBL621610,,22224,,,,U,0,BAO_0000218,
7605,,5237,Intermediate,10116.0,,1,Area under curve was determined; ND=No data,,,CHEMBL621611,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7606,,14793,Intermediate,10116.0,,1,Area under curve was evaluated in rat brain when administered intraperitoneally at a dose of 10 mg/kg for 4 or 6 hours,,,CHEMBL621612,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7607,,14793,Intermediate,10116.0,,1,Area under curve was evaluated in rat brain when administered intraperitoneally at a dose of 10 mg/kg for infinite hours,,,CHEMBL622308,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7608,,14793,Intermediate,10116.0,,1,Area under curve was evaluated in rat brain when administered intravenously at a dose of 10 mg/kg for 4 or 6 hours,,,CHEMBL622309,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7609,,14793,Intermediate,10116.0,,1,Area under curve was evaluated in rat brain when administered intravenously at a dose of 10 mg/kg for infinite hours,,,CHEMBL622310,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7610,,14793,Intermediate,10116.0,,1,Area under curve was evaluated in rat brain when administered perorally at a dose of 100 mg/kg for 4 or 6 hours,,,CHEMBL622311,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7611,,14793,Intermediate,10116.0,,1,Area under curve was evaluated in rat brain when administered perorally at a dose of 100 mg/kg for infinite hours; Not calculated,,,CHEMBL622312,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7612,,14793,Intermediate,10116.0,,1,Area under curve was evaluated in rat brain when administered perorally at a dose of 10 mg/kg for 4 or 6 hours,,,CHEMBL622931,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7613,,14793,Intermediate,10116.0,,1,Area under curve was evaluated in rat brain when administered perorally at a dose of 10 mg/kg for infinite hours; Not calculated,,,CHEMBL622932,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7614,,14793,Intermediate,10116.0,,1,Area under curve was evaluated in rat plasma when administered intraperitoneally at a dose of 10 mg/kg for 4 or 6 hours,,,CHEMBL622736,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
7615,,14793,Intermediate,10116.0,,1,Area under curve was evaluated in rat plasma when administered intraperitoneally at a dose of 10 mg/kg for infinite hours,,,CHEMBL622737,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
7616,,14793,Intermediate,10116.0,,1,Area under curve was evaluated in rat plasma when administered intravenously at a dose of 10 mg/kg for 4 or 6 hours,,,CHEMBL622738,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
7617,,14793,Intermediate,10116.0,,1,Area under curve was evaluated in rat plasma when administered intravenously at a dose of 10 mg/kg for infinite hours,,,CHEMBL622739,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
7618,,14793,Intermediate,10116.0,,1,Area under curve was evaluated in rat plasma when administered perorally at a dose of 100 mg/kg for 4 or 6 hours,,,CHEMBL622740,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
7619,,14793,Intermediate,10116.0,,1,Area under curve was evaluated in rat plasma when administered perorally at a dose of 100 mg/kg for infinite hours,,,CHEMBL622741,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
7620,,14793,Intermediate,10116.0,,1,Area under curve was evaluated in rat plasma when administered perorally at a dose of 10 mg/kg for 4 or 6 hours,,,CHEMBL622742,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
7621,,14793,Intermediate,10116.0,,1,Area under curve was evaluated in rat plasma when administered perorally at a dose of 10 mg/kg for infinite hours,,,CHEMBL622743,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
7622,,11637,Intermediate,10090.0,,1,AUC in mice,,,CHEMBL622744,,50594,Mus musculus,,,N,1,BAO_0000218,1969.0
7623,,11149,Autocuration,,,1,Area under curve was measured from the graph obtained from concentration Vs time,,,CHEMBL624134,,22224,,,,U,0,BAO_0000019,
7624,,10016,Autocuration,,,1,Area under curve value of compound per hour after oral administration,,,CHEMBL624135,,22224,,,,U,0,BAO_0000019,
7625,,17796,Intermediate,10116.0,,1,Area under curve was determined after oral administration in rats,,,CHEMBL624136,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7626,,17796,Intermediate,10116.0,,1,Area under curve was determined after oral administration in rats; No data,,,CHEMBL624137,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7627,,17796,Intermediate,10116.0,,1,Area under curve was determined after oral administration in rats;No data,,,CHEMBL624320,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7628,,12923,Intermediate,9615.0,,1,Area under curve was determined by HPLC at a dosage of 2.27 mg/kg administered intravenously by bolus method in dog,,,CHEMBL624321,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
7629,,15372,Intermediate,10116.0,,1,Area under curve was determined for the compound after iv dose of 4.74 mg/kg in rats,,,CHEMBL624322,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7630,,15372,Intermediate,10116.0,,1,Area under curve was determined for the compound after iv dose of 5.06 in rats,,,CHEMBL624323,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7631,,15372,Intermediate,10116.0,,1,Area under curve was determined for the compound after iv dose of 5.10 mg/kg in rats,,,CHEMBL624324,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7632,,15372,Intermediate,10116.0,,1,Area under curve was determined for the compound after po dose of 5.01 mg/kg in rats,,,CHEMBL624325,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7633,,15372,Intermediate,10116.0,,1,Area under curve was determined for the compound after po dose of 5.03 mg/kg in rats,,,CHEMBL624326,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7634,,15372,Intermediate,10116.0,,1,Area under curve was determined for the compound after po dose of 5.22 mg/kg in rats,,,CHEMBL624327,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7635,,15372,Intermediate,10116.0,,1,Area under curve was determined for the compound after po dose of 5.46 mg/kg in rats,,,CHEMBL624328,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7636,,14169,Intermediate,9615.0,,1,Area under curve was determined in Dogs after peroral administration,,,CHEMBL627848,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
7637,,14169,Intermediate,10116.0,,1,Area under curve was determined in Rats after peroral administration,,,CHEMBL627849,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7638,,14258,Intermediate,10116.0,,1,Area under curve was determined in carotid blood of rat when administered intradermally,,,CHEMBL627850,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7639,,14258,Intermediate,10116.0,,1,Area under curve was determined in portal blood of rat when administered intradermally,,,CHEMBL627851,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7640,,15011,Intermediate,10090.0,,1,Area under curve was determined using 0.4% Methyl cellulose (MC) as vehicle. Compound was administered intravenously to nude mice at a dose of 25 mg/kg,,,CHEMBL627852,,50594,Mus musculus,,,N,1,BAO_0000218,
7641,,15011,Intermediate,10090.0,,1,Area under curve was determined using 0.4% Methyl cellulose (MC) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg,,,CHEMBL627853,,50594,Mus musculus,,,N,1,BAO_0000218,
7642,,15011,Intermediate,10090.0,,1,Area under curve was determined using 0.4% Methyl cellulose (MC) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg (micronized sample),,,CHEMBL627854,,50594,Mus musculus,,,N,1,BAO_0000218,
7643,,15011,Intermediate,10090.0,,1,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered intravenously to nude mice at a dose of 25 mg/kg,,,CHEMBL627855,,50594,Mus musculus,,,N,1,BAO_0000218,
7644,,15011,Intermediate,10090.0,,1,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered intravenously to nude mice at a dose of 25 mg/kg (run time 7 hr),,,CHEMBL627856,,50594,Mus musculus,,,N,1,BAO_0000218,
7645,,15011,Intermediate,10090.0,,1,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg,,,CHEMBL875339,,50594,Mus musculus,,,N,1,BAO_0000218,
7646,,15011,Intermediate,10090.0,,1,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg (Run time = 7 hr),,,CHEMBL627857,,50594,Mus musculus,,,N,1,BAO_0000218,
7647,In vivo,11195,Intermediate,10116.0,,1,Biodistribution of the radiolabeled compound (2-5 uCi) in rat spleen 65 mins after i.v. administration,,,CHEMBL627858,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2106.0
7648,,10130,Intermediate,10116.0,,1,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in blood; Expressed as percent dose/organ,,,CHEMBL627859,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
7649,,10130,Intermediate,10116.0,,1,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in brain; Expressed as percent dose/organ,,,CHEMBL627860,,50597,Rattus norvegicus,,,N,1,BAO_0000218,955.0
7650,,10130,Intermediate,10116.0,,1,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in heart; Expressed as percent dose/organ,,,CHEMBL627019,,50597,Rattus norvegicus,,,N,1,BAO_0000218,948.0
7651,,10130,Intermediate,10116.0,,1,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in liver; Expressed as percent dose/organ,,,CHEMBL627020,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
7652,,10130,Intermediate,10116.0,,1,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in lung; Expressed as percent dose/organ,,,CHEMBL627021,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2048.0
7653,,10130,Intermediate,10116.0,,1,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in muscle; Expressed as percent dose/organ,,,CHEMBL627022,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2385.0
7654,,10130,Intermediate,10116.0,,1,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in skin; Expressed as percent dose/organ,,,CHEMBL627023,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7655,,10130,Intermediate,10116.0,,1,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in spleen; Expressed as percent dose/organ,,,CHEMBL627024,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2106.0
7656,,10130,Intermediate,10116.0,,1,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in thyroid; Expressed as percent dose/organ,,,CHEMBL627025,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2046.0
7657,,10130,Intermediate,10116.0,,1,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in kidney; Expressed as percent dose/organ,,,CHEMBL627026,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2113.0
7658,,10130,Intermediate,10116.0,,1,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in blood; Expressed as percent dose/organ,,,CHEMBL627027,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
7659,,10130,Intermediate,10116.0,,1,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in brain; Expressed as percent dose/organ,,,CHEMBL627028,,50597,Rattus norvegicus,,,N,1,BAO_0000218,955.0
7660,,10130,Intermediate,10116.0,,1,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in heart; Expressed as percent dose/organ,,,CHEMBL627029,,50597,Rattus norvegicus,,,N,1,BAO_0000218,948.0
7661,,10130,Intermediate,10116.0,,1,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in kidney; Expressed as percent dose/organ,,,CHEMBL627030,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2113.0
7662,,10130,Intermediate,10116.0,,1,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in liver; Expressed as percent dose/organ,,,CHEMBL627031,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
7663,,10130,Intermediate,10116.0,,1,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in lung; Expressed as percent dose/organ,,,CHEMBL627032,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2048.0
7664,,10130,Intermediate,10116.0,,1,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in muscle; Expressed as percent dose/organ,,,CHEMBL627033,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2385.0
7665,,10130,Intermediate,10116.0,,1,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in skin; Expressed as percent dose/organ,,,CHEMBL627034,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7666,,10130,Intermediate,10116.0,,1,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in spleen; Expressed as percent dose/organ,,,CHEMBL627035,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2106.0
7667,,10130,Intermediate,10116.0,,1,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in thyroid; Expressed as percent dose/organ,,,CHEMBL627036,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2046.0
7668,,10130,Intermediate,10116.0,,1,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in blood; Expressed as percent dose/organ,,,CHEMBL875340,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
7669,,10130,Intermediate,10116.0,,1,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in heart; Expressed as percent dose/organ,,,CHEMBL627037,,50597,Rattus norvegicus,,,N,1,BAO_0000218,948.0
7670,,10130,Intermediate,10116.0,,1,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in kidney; Expressed as percent dose/organ,,,CHEMBL627038,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2113.0
7671,,10130,Intermediate,10116.0,,1,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in liver; Expressed as percent dose/organ,,,CHEMBL627039,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
7672,,10130,Intermediate,10116.0,,1,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in muscle; Expressed as percent dose/organ,,,CHEMBL627040,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2385.0
7673,,10130,Intermediate,10116.0,,1,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in spleen; Expressed as percent dose/organ,,,CHEMBL624663,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2106.0
7674,,10130,Intermediate,10116.0,,1,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in thyroid; Expressed as percent dose/organ,,,CHEMBL625963,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2046.0
7675,,10130,Intermediate,10116.0,,1,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in brain; Expressed as percent dose/organ,,,CHEMBL876799,,50597,Rattus norvegicus,,,N,1,BAO_0000218,955.0
7676,,10130,Intermediate,10116.0,,1,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in lung; Expressed as percent dose/organ,,,CHEMBL626133,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2048.0
7677,,10130,Intermediate,10116.0,,1,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in skin; Expressed as percent dose/organ,,,CHEMBL626134,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7678,,6295,Intermediate,10116.0,,1,In vivo concentration in rat liver exposure 8 hour after oral administration 50 mg/kg,,,CHEMBL626135,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7679,,6296,Intermediate,10116.0,,1,In vivo concentration in rat liver exposure 8 hour after oral administration 50 mg/kg,,,CHEMBL626136,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7680,,6296,Intermediate,10116.0,,1,In vivo concentration in rat liver exposure 8 hour after oral administration 50 mg/kg; Below detection limit,,,CHEMBL626137,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7681,,6295,Intermediate,10116.0,,1,In vivo concentration in rat plasma exposure at 8 hour after oral administration 50 mg/kg,,,CHEMBL626138,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7682,,6296,Intermediate,10116.0,,1,In vivo concentration in rat plasma exposure at 8 hour after oral administration 50 mg/kg,,,CHEMBL626139,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7683,In vivo,17260,Intermediate,10116.0,,1,C max at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,,,CHEMBL626140,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7684,In vivo,17260,Intermediate,10116.0,,1,C max at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,,,CHEMBL626141,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7685,,17686,Intermediate,10116.0,,1,C24h in rat p.o. at 20 mg/kg concentration,,,CHEMBL626142,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7686,In vivo,9866,Intermediate,10116.0,,1,Biodistribution in normal rat muscle in the presence of 0.005 M Gd/0.01 M lig at 2 hr,,,CHEMBL627930,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2385.0
7687,In vivo,9866,Intermediate,10116.0,,1,Biodistribution in normal rat muscle in the presence of 0.01 M Gd/0.05 M lig,,,CHEMBL627931,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2385.0
7688,In vivo,9866,Intermediate,10116.0,,1,Biodistribution in normal rat muscle in the presence of NAC Gd 0.01 M lig at 2 hr,,,CHEMBL627932,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2385.0
7689,In vivo,9866,Intermediate,10116.0,,1,Biodistribution in normal rat spleen in the presence of 0.005 M Gd/0.01 M lig at 2 hr,,,CHEMBL627933,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2106.0
7690,In vivo,9866,Intermediate,10116.0,,1,Biodistribution in normal rat spleen in the presence of 0.01 M Gd/0.05 M lig,,,CHEMBL627934,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2106.0
7691,In vivo,9866,Intermediate,10116.0,,1,Biodistribution in normal rat spleen in the presence of NAC Gd 0.01 M lig at 2 hr,,,CHEMBL627935,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2106.0
7692,In vivo,9866,Intermediate,10116.0,,1,Biodistribution in rat blood in the presence of 0.001 M/0.008 M GdDTPA-AEP,,,CHEMBL627936,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
7693,In vivo,9866,Intermediate,10116.0,,1,Biodistribution in rat blood in the presence of 0.01 M GdDTPA-BDP,,,CHEMBL627937,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
7694,In vivo,9866,Intermediate,10116.0,,1,Biodistribution in rat blood in the presence of 0.01 M/0.01 M GdDTPA-AEP,,,CHEMBL627938,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
7695,In vivo,9866,Intermediate,10116.0,,1,Biodistribution in rat blood in the presence of 0.05 M Gd/0.15 M lig,,,CHEMBL627939,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
7696,In vivo,9866,Intermediate,10116.0,,1,Biodistribution in rat blood in the presence of 0.05 M GdDTPA-BDP,,,CHEMBL627940,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
7697,In vivo,9866,Intermediate,10116.0,,1,Biodistribution in rat blood in the presence of 0.05 M/0.05 M GdDTPA-AEP,,,CHEMBL627941,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
7698,In vivo,9866,Intermediate,10116.0,,1,Biodistribution in rat blood in the presence of 0.05 M/0.08 M GdDTPA-HPDP,,,CHEMBL876800,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
7699,In vivo,9866,Intermediate,10116.0,,1,Biodistribution in rat blood in the presence of 0.10 M GdDTPA-BDP,,,CHEMBL627942,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
7700,In vivo,9866,Intermediate,10116.0,,1,Biodistribution in rat blood in the presence of 0.10 M/0.11 M GdDTPA-AEP,,,CHEMBL627943,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
7701,In vivo,9866,Intermediate,10116.0,,1,Biodistribution in rat blood in the presence of 50 Gd/kg at 15 min,,,CHEMBL627944,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
7702,In vivo,9866,Intermediate,10116.0,,1,Biodistribution in rat blood in the presence of 50 Gd/kg at 2 hr,,,CHEMBL627945,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
7703,In vivo,9866,Intermediate,10116.0,,1,Biodistribution in rat blood in the presence of 50 Gd/kg at 6 hr,,,CHEMBL628584,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
7704,In vivo,9866,Intermediate,10116.0,,1,Biodistribution in rat blood in the presence of GdDTPA at 15 min,,,CHEMBL628585,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
7705,In vivo,9866,Intermediate,10116.0,,1,Biodistribution in rat blood in the presence of GdDTPA at 1 hr,,,CHEMBL628586,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
7706,In vivo,9866,Intermediate,10116.0,,1,Biodistribution in rat blood in the presence of GdDTPA at 30 min,,,CHEMBL628587,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
7707,In vivo,9866,Intermediate,10116.0,,1,Biodistribution in rat blood in the presence of GdDTPA at 4 hr,,,CHEMBL628588,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
7708,In vivo,9866,Intermediate,10116.0,,1,Biodistribution in rat blood in the presence of GdDTPA-BDP at 15 min,,,CHEMBL628589,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
7709,In vivo,9866,Intermediate,10116.0,,1,Biodistribution in rat blood in the presence of GdDTPA-BDP at 30 min,,,CHEMBL625304,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
7710,In vivo,9866,Intermediate,10116.0,,1,Biodistribution in rat blood in the presence of GdDTPA-BDP at 4 hr,,,CHEMBL625305,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
7711,In vivo,9866,Intermediate,10116.0,,1,Biodistribution in rat blood in the presence of GdDTPA-BDPat 1 hr,,,CHEMBL625306,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
7712,In vivo,9866,Intermediate,10116.0,,1,Biodistribution in rat blood in the presence of GdDTPA-HPDP at 15 min,,,CHEMBL625307,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
7713,In vivo,9866,Intermediate,10116.0,,1,Biodistribution in rat blood in the presence of GdDTPA-HPDP at 30 min,,,CHEMBL625308,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
7714,In vivo,9866,Intermediate,10116.0,,1,Biodistribution in rat blood in the presence of GdDTPA-HPDP at 4 hr,,,CHEMBL627740,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
7715,In vivo,9866,Intermediate,10116.0,,1,Biodistribution in rat blood in the presence of GdDTPA-HPDPat 1 hr,,,CHEMBL627741,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
7716,In vivo,9866,Intermediate,10116.0,,1,Biodistribution in rat blood in the presence of NAC Gd/0.01 M GdDTPA-HPDP,,,CHEMBL627742,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
7717,In vivo,9866,Intermediate,10116.0,,1,Biodistribution in rat blood in the presence of NCA Gd/0.01 M lip,,,CHEMBL627743,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
7718,In vivo,9866,Intermediate,10116.0,,1,Biodistribution in rat blood in the presence of NCAGd/0.01 M lig,,,CHEMBL627744,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
7719,In vivo,9866,Intermediate,10116.0,,1,Biodistribution in rat bone in the presence of 0.01 M GdDTPA-BDP,,,CHEMBL627745,,50597,Rattus norvegicus,,,N,1,BAO_0000218,10000001.0
7720,In vivo,9866,Intermediate,10116.0,,1,Biodistribution in rat bone in the presence of 0.01 M/0.01 M GdDTPA-AEP,,,CHEMBL627746,,50597,Rattus norvegicus,,,N,1,BAO_0000218,10000001.0
7721,In vivo,9866,Intermediate,10116.0,,1,Biodistribution in rat bone in the presence of 0.01 M/0.08 M GdDTPA-AEP,,,CHEMBL627747,,50597,Rattus norvegicus,,,N,1,BAO_0000218,10000001.0
7722,In vivo,9866,Intermediate,10116.0,,1,Biodistribution in rat bone in the presence of 0.05 M Gd/0.15 M lig,,,CHEMBL876810,,50597,Rattus norvegicus,,,N,1,BAO_0000218,10000001.0
7723,In vivo,9866,Intermediate,10116.0,,1,Biodistribution in rat bone in the presence of 0.05 M GdDTPA-BDP,,,CHEMBL627748,,50597,Rattus norvegicus,,,N,1,BAO_0000218,10000001.0
7724,In vivo,9866,Intermediate,10116.0,,1,Biodistribution in rat bone in the presence of 0.05 M/0.05 M GdDTPA-AEP,,,CHEMBL627749,,50597,Rattus norvegicus,,,N,1,BAO_0000218,10000001.0
7725,In vivo,9866,Intermediate,10116.0,,1,Biodistribution in rat bone in the presence of 0.05 M/0.08 M GdDTPA-HPDP,,,CHEMBL627750,,50597,Rattus norvegicus,,,N,1,BAO_0000218,10000001.0
7726,In vivo,9866,Intermediate,10116.0,,1,Biodistribution in rat bone in the presence of 0.10 M GdDTPA-BDP,,,CHEMBL618728,,50597,Rattus norvegicus,,,N,1,BAO_0000218,10000001.0
7727,In vivo,9866,Intermediate,10116.0,,1,Biodistribution in rat bone in the presence of 0.10 M/0.11 M GdDTPA-AEP,,,CHEMBL618729,,50597,Rattus norvegicus,,,N,1,BAO_0000218,10000001.0
7728,In vivo,9866,Intermediate,10116.0,,1,Biodistribution in rat bone in the presence of GdDTPA at 15 min,,,CHEMBL618730,,50597,Rattus norvegicus,,,N,1,BAO_0000218,10000001.0
7729,In vivo,9866,Intermediate,10116.0,,1,Biodistribution in rat bone in the presence of GdDTPA at 1 hr,,,CHEMBL618731,,50597,Rattus norvegicus,,,N,1,BAO_0000218,10000001.0
7730,In vivo,9866,Intermediate,10116.0,,1,Biodistribution in rat bone in the presence of GdDTPA at 30 min,,,CHEMBL618732,,50597,Rattus norvegicus,,,N,1,BAO_0000218,10000001.0
7731,In vivo,9866,Intermediate,10116.0,,1,Biodistribution in rat bone in the presence of GdDTPA at 4 hr,,,CHEMBL618733,,50597,Rattus norvegicus,,,N,1,BAO_0000218,10000001.0
7732,In vivo,9866,Intermediate,10116.0,,1,Biodistribution in rat bone in the presence of GdDTPA-BDP at 15 min,,,CHEMBL618734,,50597,Rattus norvegicus,,,N,1,BAO_0000218,10000001.0
7733,In vivo,9866,Intermediate,10116.0,,1,Biodistribution in rat bone in the presence of GdDTPA-BDP at 1 hr,,,CHEMBL618735,,50597,Rattus norvegicus,,,N,1,BAO_0000218,10000001.0
7734,In vivo,9866,Intermediate,10116.0,,1,Biodistribution in rat bone in the presence of GdDTPA-BDP at 30 min,,,CHEMBL876602,,50597,Rattus norvegicus,,,N,1,BAO_0000218,10000001.0
7735,In vivo,9866,Intermediate,10116.0,,1,Biodistribution in rat bone in the presence of GdDTPA-BDP at 4 hr,,,CHEMBL618736,,50597,Rattus norvegicus,,,N,1,BAO_0000218,10000001.0
7736,In vivo,9866,Intermediate,10116.0,,1,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 15 min,,,CHEMBL618737,,50597,Rattus norvegicus,,,N,1,BAO_0000218,10000001.0
7737,In vivo,9866,Intermediate,10116.0,,1,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 1 hr,,,CHEMBL618738,,50597,Rattus norvegicus,,,N,1,BAO_0000218,10000001.0
7738,In vivo,9866,Intermediate,10116.0,,1,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 30 min,,,CHEMBL618739,,50597,Rattus norvegicus,,,N,1,BAO_0000218,10000001.0
7739,In vivo,9866,Intermediate,10116.0,,1,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 4 hr,,,CHEMBL618740,,50597,Rattus norvegicus,,,N,1,BAO_0000218,10000001.0
7740,In vivo,9866,Intermediate,10116.0,,1,Biodistribution in rat bone in the presence of NAC Gd/0.01 M GdDTPA-HPDP,,,CHEMBL618741,,50597,Rattus norvegicus,,,N,1,BAO_0000218,10000001.0
7741,In vivo,9866,Intermediate,10116.0,,1,Biodistribution in rat bone in the presence of NCA Gd/0.01 M lip,,,CHEMBL618742,,50597,Rattus norvegicus,,,N,1,BAO_0000218,10000001.0
7742,In vivo,9866,Intermediate,10116.0,,1,Biodistribution in rat bone in the presence of NCAGd/0.01 M lig,,,CHEMBL618743,,50597,Rattus norvegicus,,,N,1,BAO_0000218,10000001.0
7743,In vivo,17752,Intermediate,10116.0,,1,Half-life from rat plasma at a single oral dose of 25 mg/kg,,,CHEMBL618744,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
7744,,5610,Intermediate,10116.0,,1,Half-life in male rat,,,CHEMBL618745,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7745,In vivo,5939,Intermediate,10116.0,,1,Half-life in rat after peroral administration at 10 mg/kg concentration,,,CHEMBL620479,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7746,In vivo,5939,Intermediate,10116.0,,1,Half-life in rat after peroral administration at 5 mg/kg concentration,,,CHEMBL620480,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7747,In vivo,17771,Intermediate,10116.0,,1,Half-life in rat at a dose of 3 mg/kg,,,CHEMBL620481,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7748,,1974,Intermediate,10116.0,,1,Half-life was evaluated in rats,,,CHEMBL620482,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7749,,4239,Intermediate,10116.0,,1,Half-life was measured in rat,,,CHEMBL876603,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7750,In vivo,6681,Intermediate,10116.0,,1,Half-life period for the compound was determined in rats at 50 mg/kg dose,,,CHEMBL620483,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7751,In vivo,17752,Intermediate,10116.0,,1,Half-life period in rats after intravenous administration at 5 mg/kg,,,CHEMBL620484,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7752,In vivo,6046,Intermediate,10116.0,,1,Half-life period in rat at 10 mg/kg,,,CHEMBL620485,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7753,In vivo,6685,Intermediate,10116.0,,1,"Half-life period was determined in rats at 10 mg/kg, p.o. dose",,,CHEMBL620486,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7754,In vivo,6685,Intermediate,10116.0,,1,"Half-life period was determined in rats at 20 mg/kg, i.p. dose",,,CHEMBL620487,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7755,In vivo,6685,Intermediate,10116.0,,1,"Half-life period was determined in rats at 2 mg/kg, i.v. dose",,,CHEMBL620488,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7756,In vivo,4727,Intermediate,10116.0,,1,Half-life time in rat the dose of 2 mg/kg,,,CHEMBL620489,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7757,In vivo,1088,Intermediate,10116.0,,1,Half-life was estimated from the elimination phase of the oral [C] vs time curves in 4 rats,,,CHEMBL620490,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7758,In vivo,5610,Intermediate,10116.0,,1,In vivo activity against Staphylococcus aureus when administered orally for 1 hr in rat at a dose of 15 mg/kg,,,CHEMBL620491,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7759,In vivo,3032,Intermediate,10116.0,,1,"In vivo half life of compound in rat plasma after a oral dose of 10 mg/kg (in water, N=4)",,,CHEMBL876604,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
7760,In vivo,5199,Intermediate,10116.0,,1,Oral half life was determined,,,CHEMBL620492,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7761,In vivo,14941,Intermediate,10116.0,,1,"Pharmacokinetic Parameter, half life period measured in Female Wistar Rats at 100 mg/kg by po administration",,,CHEMBL620493,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7762,In vivo,4408,Intermediate,10116.0,,1,Pharmacokinetic property (t1/2) in rat,,,CHEMBL620494,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7763,,2552,Intermediate,10116.0,,1,Plasma elimination half-life was determined,,,CHEMBL620495,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
7764,In vivo,5199,Intermediate,10116.0,,1,Plasma elimination half-life was determined in female Sprague-Dawley rats following intravenous (iv) administration of drug (1 mg/kg).,,,CHEMBL620496,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
7765,In vivo,15662,Intermediate,10116.0,,1,Plasma half life was observed after intravenous administration in rat,,,CHEMBL620497,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
7766,,1465,Intermediate,10116.0,,1,Plasma half-life was determined,,,CHEMBL620498,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
7767,In vivo,1446,Intermediate,10116.0,,1,Plasma half-life following oral administration in Fisher rats,,,CHEMBL620499,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
7768,,6824,Intermediate,10116.0,,1,Plasma half-life in rat,,,CHEMBL620500,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
7769,In vivo,17533,Intermediate,10116.0,,1,Plasmatic Half-life after intravenous administration to rat,,,CHEMBL873809,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
7770,In vivo,5979,Intermediate,10116.0,,1,T1/2 (half life) of compound after 2 hr iv infusion of 8.4 mg/kg in three rat,,,CHEMBL620501,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7771,In vivo,4689,Intermediate,10116.0,,1,Terminal half life after intravenous administration (1 mg/kg) in rat,,,CHEMBL620502,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7772,In vivo,4689,Intermediate,10116.0,,1,Terminal half life in Rat at a oral dose of 5 mg/kg,,,CHEMBL620503,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7773,In vivo,2463,Intermediate,10116.0,,1,Terminal phase half-life was evaluated in vivo in rat at a dose of 5 mg/kg by intra venous administration,,,CHEMBL620504,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7774,In vivo,4883,Intermediate,10116.0,,1,Tested for half life value after intravenous administration at dose of 0.2 mg/kg in rat,,,CHEMBL876605,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7775,In vivo,4883,Intermediate,10116.0,,1,Tested for half life value after oral administration at dosage of 4 mg/kg in rat,,,CHEMBL620505,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7776,In vivo,15662,Intermediate,10116.0,,1,plasma half life was observed after intravenous administration in rat,,,CHEMBL873811,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
7777,In vivo,3598,Expert,10116.0,,1,Half life of compound determined in rat after iv administration at a dose of 10 mg/kg,,,CHEMBL624016,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7778,,4576,Intermediate,10116.0,,1,Half life of compound determined in rat,,,CHEMBL624017,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7779,,4576,Intermediate,10116.0,,1,Mean residence time determined in rat,,,CHEMBL624018,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7780,,4576,Intermediate,10116.0,,1,Plasma half life determined in rat,,,CHEMBL624019,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7781,In vivo,4910,Intermediate,10116.0,,1,Compound was evaluated for Tmax in brain after intravenous administration in male rats,,,CHEMBL624020,,50597,Rattus norvegicus,,,N,1,BAO_0000218,955.0
7782,In vivo,4891,Intermediate,10116.0,,1,Compound was evaluated for pharmacokinetic parameter maximum time period,,,CHEMBL624201,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7783,In vivo,429,Intermediate,10116.0,,1,Evaluated for pharmacokinetic parameter tmax in rat at the dose 50 mg/kg,,,CHEMBL872528,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7784,In vivo,5974,Intermediate,10116.0,,1,In vivo Tmax was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,,,CHEMBL624202,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7785,In vivo,5974,Intermediate,10116.0,,1,In vivo Tmax was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,,,CHEMBL624203,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7786,In vivo,5974,Intermediate,10116.0,,1,In vivo Tmax was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,,,CHEMBL624350,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7787,In vivo,5974,Intermediate,10116.0,,1,In vivo Tmax was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,,,CHEMBL621320,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7788,In vivo,17582,Intermediate,10116.0,,1,In vivo maximum time required for clearance of compound after oral (po) administration at a dose of 10 mg/kg was measured in rats,,,CHEMBL621321,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7789,,4026,Intermediate,10116.0,,1,Maximum time (Tmax) required to reach Cmax in rats,,,CHEMBL621322,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7790,In vivo,4890,Intermediate,10116.0,,1,Maximum time constant was determined after oral administration at a dose 10 mg/kg to male Sprague-Dawley rats,,,CHEMBL621323,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7791,In vivo,6571,Intermediate,10116.0,,1,Maximum time of clearance of compound in rats after peroral administration,,,CHEMBL621324,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7792,,4727,Intermediate,10116.0,,1,Maximum time at the dose of 2 mg/kg in rat,,,CHEMBL621325,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7793,In vivo,17651,Intermediate,10116.0,,1,Maximum time to achieve peak plasma concentration was determined in rat at 1 mg/kg,,,CHEMBL875837,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
7794,In vivo,17651,Intermediate,10116.0,,1,Maximum time to achieve peak plasma concentration was determined in rat at 10 mg/kg,,,CHEMBL621326,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
7795,In vivo,14465,Intermediate,10116.0,,1,Tmax in Guinea pig (PO dose),,,CHEMBL621327,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7796,In vivo,14941,Intermediate,10116.0,,1,"Pharmacokinetic Parameter, Tmax is the time at which maximum concentration (Cmax) is reached in Female Wistar Rats at 100 mg/kg by po administration",,,CHEMBL621328,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7797,In vivo,5960,Intermediate,10116.0,,1,Pharmacokinetic parameter (Tmax) in rat,,,CHEMBL621329,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7798,In vivo,5022,Intermediate,10116.0,,1,Pharmacokinetic parameter (Tmax) was estimated,,,CHEMBL621330,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7799,In vivo,4408,Intermediate,10116.0,,1,Pharmacokinetic property (Tmax) in rat,,,CHEMBL621331,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7800,In vivo,5983,Intermediate,10116.0,,1,Pharmacokinetic property (Tmax) was measured in rat at the dose of 0.32 mg/kg p.o.,,,CHEMBL621332,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7801,In vivo,4689,Intermediate,10116.0,,1,T max in Rat at a oral dose of 5 mg/kg,,,CHEMBL621333,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7802,In vivo,2792,Intermediate,10116.0,,1,T max was determined at 10 mg/kg po dose in rats,,,CHEMBL621334,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7803,,15011,Intermediate,10090.0,,1,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg (run time 7 hr),,,CHEMBL621335,,50594,Mus musculus,,,N,1,BAO_0000218,
7804,,14180,Intermediate,9615.0,,1,Area under curve was evaluated after intravenous injection of 1 mg/kg of compound in dogs,,,CHEMBL621336,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
7805,,14180,Intermediate,10116.0,,1,Area under curve was evaluated after intravenous injection of 1 mg/kg of compound in rats,,,CHEMBL621337,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7806,,14599,Intermediate,9615.0,,1,Area under curve was measured after i.v. administration into Beagle dog.,,,CHEMBL621338,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
7807,,14599,Intermediate,9615.0,,1,Area under curve was measured after iv administration into Beagle dog,,,CHEMBL875838,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
7808,,14599,Intermediate,9615.0,,1,Area under curve was measured after po administration into Beagle dog,,,CHEMBL621339,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
7809,,14599,Intermediate,9615.0,,1,Area under curve was measured after po administration into Beagle dog.,,,CHEMBL621340,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
7810,,15675,Autocuration,,,1,Area under curve was measured at peroral dose of 3 mg/kg,,,CHEMBL621341,,22224,,,,U,0,BAO_0000218,
7811,,12706,Autocuration,,,1,Area under curve was measured by using concentration Vs time,,,CHEMBL621342,,22224,,,,U,0,BAO_0000019,
7812,,12706,Autocuration,,,1,Area under curve was measured by using concentration Vs time; not tested,,,CHEMBL621343,,22224,,,,U,0,BAO_0000019,
7813,,9750,Intermediate,10090.0,,1,Area under curve(AUC) was measured in mice after oral administration (50 mg/kg),,,CHEMBL621344,,50594,Mus musculus,,,N,1,BAO_0000218,
7814,,9750,Intermediate,10090.0,,1,Area under curve(AUC) was measured in mice after oral administration.,,,CHEMBL621345,,50594,Mus musculus,,,N,1,BAO_0000218,
7815,,14691,Autocuration,,,1,Area under curve(AUC) value of the compound,,,CHEMBL621346,,22224,,,,U,0,BAO_0000019,
7816,,14691,Autocuration,,,1,Area under curve(AUC) value of the compound in dogs at 0.5 mg/kg dose upon oral administration,,,CHEMBL621347,,22224,,,,U,0,BAO_0000218,
7817,,14691,Intermediate,9615.0,,1,Area under curve(AUC) value of the compound in dogs at 1 mg/kg dose upon oral administration,,,CHEMBL621348,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
7818,,2939,Autocuration,,,1,Area under curve(carotid artery) was determined by the availability in blood,,,CHEMBL621349,,22224,,,,U,0,BAO_0000019,178.0
7819,,2939,Autocuration,,,1,Area under curve(carotid artery) was determined by the availability in blood; ND means no data,,,CHEMBL621350,,22224,,,,U,0,BAO_0000019,178.0
7820,,2939,Autocuration,,,1,Area under curve(carotid artery) was determined by the availability in blood; No data,,,CHEMBL875839,,22224,,,,U,0,BAO_0000019,178.0
7821,,2939,Autocuration,,,1,Area under curve(portal vein) was determined by the availability in blood,,,CHEMBL620211,,22224,,,,U,0,BAO_0000019,178.0
7822,,2939,Autocuration,,,1,Area under curve(portal vein) was determined by the availability in blood; ND means no data,,,CHEMBL620212,,22224,,,,U,0,BAO_0000019,178.0
7823,,2939,Autocuration,,,1,Area under curve(portal vein) was determined by the availability in blood; No data,,,CHEMBL620213,,22224,,,,U,0,BAO_0000019,178.0
7824,,9552,Intermediate,9544.0,,1,"Area under plasma concentration vs time curve observed in Rhesus monkeys after, iv administration of single 30 mg/kg dose",,,CHEMBL620214,,50797,Macaca mulatta,,,N,1,BAO_0000218,1969.0
7825,,9552,Intermediate,9544.0,,1,"Area under plasma concentration vs time curve observed in Rhesus monkeys after, iv administration of single 30 mg/kg dose",,,CHEMBL620215,,50797,Macaca mulatta,,,N,1,BAO_0000218,1969.0
7826,,9552,Intermediate,9544.0,,1,Area under plasma concentration vs time curve observed in Rhesus monkeys after oral administration of single 30 mg/kg dose,,,CHEMBL620216,,50797,Macaca mulatta,,,N,1,BAO_0000218,1969.0
7827,,9552,Intermediate,9615.0,,1,"Area under plasma concentration vs time curve observed in female mongrel dogs after, iv administration of single 15 mg/kg dose",,,CHEMBL620888,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,1969.0
7828,,9552,Intermediate,9615.0,,1,"Area under plasma concentration vs time curve observed in female mongrel dogs after, oral administration of single 15 mg/kg dose",,,CHEMBL620889,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,1969.0
7829,,9552,Autocuration,,,1,Area under plasma concentration vs time curve observed in rats for 0-3 h,,,CHEMBL620890,,22224,,,,U,0,BAO_0000019,1969.0
7830,,11911,Intermediate,10116.0,,1,Area under plasma time curve determined in male rat,,,CHEMBL620891,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
7831,,16618,Autocuration,,,1,Area under the MAP curve measured over 5 min.,,,CHEMBL620892,,22224,,,,U,0,BAO_0000019,
7832,,14387,Intermediate,10090.0,,1,Area under the concentration time curve (AUC) taken for 0-24 hr was measured when administered through iv route in mice,,,CHEMBL621079,,50594,Mus musculus,,,N,1,BAO_0000218,
7833,,14387,Intermediate,10090.0,,1,Area under the concentration time curve (AUC) taken for 0-24 hr was measured when administered through oral route in mice,,,CHEMBL621080,,50594,Mus musculus,,,N,1,BAO_0000218,
7834,,12836,Intermediate,9615.0,,1,Area under the concentration vs time curve in dog at 10 mg/kg oral dose,,,CHEMBL621081,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
7835,,12836,Intermediate,10026.0,,1,Area under the concentration vs time curve in hamster at 10 mg/kg oral dose,,,CHEMBL621082,,100712,Cricetinae,,,N,1,BAO_0000218,
7836,,12836,Intermediate,10116.0,,1,Area under the concentration vs time curve in rat at 10 mg/kg oral dose,,,CHEMBL621083,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7837,,14339,Intermediate,9615.0,,1,Area under the concentration-time curve from time zero to infinity after intravenous administration of 2.5 mg/kg in dogs,,,CHEMBL621084,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
7838,,14339,Intermediate,9615.0,,1,Area under the concentration-time curve from time zero to infinity in oral (5 mg/kg) fasted dogs,,,CHEMBL621085,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
7839,,14339,Intermediate,9615.0,,1,Area under the concentration-time curve from time zero to infinity in oral (5 mg/kg) fed dogs,,,CHEMBL621086,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
7840,,10524,Intermediate,9615.0,,1,Area under the concentration/ time determined against Bacillus subtilis ATCC 6633 after oral administration in dog(25 mg/kg),,,CHEMBL621087,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
7841,,9994,Intermediate,9615.0,,1,Area under the concentration/ time in plasma after oral administration in dog (25 mg/kg),,,CHEMBL622607,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
7842,,11325,Intermediate,9615.0,,1,Serum AUC in marmosets (IV dose),,,CHEMBL622608,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
7843,,12536,Autocuration,,,1,Area under the curve after intravenous administration at a dose of 10 umol/kg,,,CHEMBL624481,,22224,,,,U,0,BAO_0000019,
7844,,12536,Autocuration,,,1,Area under the curve after intravenous administration at a dose of 2 umol/kg,,,CHEMBL624482,,22224,,,,U,0,BAO_0000019,
7845,,12536,Autocuration,,,1,Area under the curve after intravenous administration at a dose of 4 umol/kg,,,CHEMBL624483,,22224,,,,U,0,BAO_0000019,
7846,,12536,Autocuration,,,1,Area under the curve after intravenous administration at a dose of 40 umol/kg,,,CHEMBL624484,,22224,,,,U,0,BAO_0000019,
7847,,12536,Autocuration,,,1,Area under the curve after intravenous administration at a dose of 5 umol/kg,,,CHEMBL624485,,22224,,,,U,0,BAO_0000019,
7848,,15556,Intermediate,10116.0,,1,Area under the curve for fumarate salt was evaluated in F344 Rats.,,,CHEMBL624486,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7849,,2809,Autocuration,,,1,Area under the curve for the compound was calculated.,,,CHEMBL624487,,22224,,,,U,0,BAO_0000019,
7850,,9511,Autocuration,,,1,Area under the curve in concentration/ time,,,CHEMBL624488,,22224,,,,U,0,BAO_0000019,
7851,,12818,Intermediate,10116.0,,1,Area under the curve administered intraintestinal in rats.,,,CHEMBL624489,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7852,,12818,Intermediate,10116.0,,1,Area under the curve administered intravenously in rats.,,,CHEMBL625184,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7853,,15118,Autocuration,,,1,Area under the curve during intravenous administration,,,CHEMBL625185,,22224,,,,U,0,BAO_0000019,
7854,,15118,Autocuration,,,1,Area under the curve during intravenous administration; Not determined,,,CHEMBL875954,,22224,,,,U,0,BAO_0000019,
7855,,15118,Autocuration,,,1,Area under the curve during systemic administration,,,CHEMBL625186,,22224,,,,U,0,BAO_0000019,
7856,,15118,Autocuration,,,1,Area under the curve during systemic administration; Not determined,,,CHEMBL625187,,22224,,,,U,0,BAO_0000019,
7857,,2632,Autocuration,,,1,Area under the curve was calculated for the compound.,,,CHEMBL625188,,22224,,,,U,0,BAO_0000019,
7858,,14346,Intermediate,9615.0,,1,Area under the curve was determined after intravenous administration of 1.8 mg/kg in male Beagle dogs,,,CHEMBL625189,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
7859,,14346,Intermediate,9615.0,,1,Area under the curve was determined after intravenous administration of 10 mg/kg in male Beagle dogs,,,CHEMBL625190,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
7860,,14346,Intermediate,10116.0,,1,Area under the curve was determined after intravenous administration of 2.5 mg/kg in male Dawley rats,,,CHEMBL621733,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7861,,14346,Intermediate,10116.0,,1,Area under the curve was determined after intravenous administration of 2.6 mg/kg in male Dawley rats,,,CHEMBL621734,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7862,,11149,Intermediate,10116.0,,1,C6h was measured as concentration obtained after 6 hr of oral administration in air pouch exudate after oral administration to male F344 rats,,,CHEMBL621735,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7863,,17796,Intermediate,10116.0,,1,Clearance of the drug was measured in the plasma of rat; No data,,,CHEMBL621736,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
7864,,5247,Intermediate,10116.0,,1,The pharmacokinetic parameter plasma clearance in vivo in rats,,,CHEMBL621737,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
7865,,4727,Intermediate,10116.0,,1,Plasma clearance at the dose of 2 mg/kg in rat,,,CHEMBL621738,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7866,In vivo,5654,Intermediate,10116.0,,1,CL (clearance) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,,,CHEMBL622806,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7867,In vivo,5654,Intermediate,10116.0,,1,CL (clearance) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,,,CHEMBL623519,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7868,In vivo,17260,Intermediate,10116.0,,1,CL at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,,,CHEMBL623520,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7869,In vivo,17065,Intermediate,10116.0,,1,Clearance measured after intravenous bolus administration of 50 mg/kg of compound to rats,,,CHEMBL623521,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7870,In vivo,17671,Intermediate,10116.0,,1,Clearance in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,,,CHEMBL623522,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7871,In vivo,6672,Intermediate,10116.0,,1,Clearance rate in rat,,,CHEMBL623523,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7872,In vivo,6673,Intermediate,10116.0,,1,Clearance rate in rat,,,CHEMBL623690,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7873,In vivo,5978,Intermediate,10116.0,,1,Clearance (Cl) of compound (10 mg/kg) after iv administration was determined in Sprague-Dawley rat,,,CHEMBL623691,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7874,In vivo,5978,Intermediate,10116.0,,1,Clearance (Cl) of compound (9.83 mg/kg) after iv administration was determined in Sprague-Dawley rat,,,CHEMBL623692,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7875,In vivo,5978,Intermediate,10116.0,,1,Clearance (Cl) of compound (9.84 mg/kg) after iv administration was determined in Sprague-Dawley rat,,,CHEMBL623693,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7876,In vivo,5978,Intermediate,10116.0,,1,Clearance (Cl) of compound (9.92 mg/kg) after iv administration was determined in Sprague-Dawley rat,,,CHEMBL623694,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7877,In vivo,4413,Intermediate,10116.0,,1,Clearance of compound after iv administration of 20 mg/kg dose in rat,,,CHEMBL623695,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7878,In vivo,2661,Intermediate,10116.0,,1,Compound was evaluated for clearance after treatment with iv dose of 1 mgkg to female wistar rats,,,CHEMBL623696,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7879,In vivo,2661,Intermediate,10116.0,,1,Compound was evaluated for clearance after treatment with iv dose of 1 mgkg to male wistar rats,,,CHEMBL623697,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7880,In vivo,5005,Intermediate,9544.0,,1,Compound was tested for its plasma clearance rate in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po,,,CHEMBL623698,,22224,Macaca mulatta,,,U,0,BAO_0000218,1969.0
7881,In vivo,5005,Intermediate,10116.0,,1,Compound was tested for its plasma clearance rate in Sprague Dawley rats,,,CHEMBL623699,,22224,Rattus norvegicus,,,U,0,BAO_0000218,1969.0
7882,In vivo,15765,Intermediate,10116.0,,1,Mean (%CV) PK parameters for CL(mL/min/kg).,,,CHEMBL623700,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7883,In vivo,3747,Intermediate,10116.0,,1,Pharmacokinetic studies were carried out to determine the clearance after administration at 20 mg/kg intravenously in rat,,,CHEMBL623701,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7884,In vivo,16366,Intermediate,10116.0,,1,Pharmacokinetic parameter plasma clearance was determined at when a dose of 1 mg/kg is administered,,,CHEMBL623702,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
7885,In vivo,4199,Intermediate,10116.0,,1,Plasma Clearance measured at steady-state following iv infusion at 0.6 mg/kg/h in rats,,,CHEMBL623703,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7886,In vivo,17267,Intermediate,10116.0,,1,Plasma clearance in rat was determined,,,CHEMBL623704,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7887,In vivo,6535,Intermediate,10116.0,,1,Plasma clearance in rat after administration of 2 mg/kg iv,,,CHEMBL623705,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7888,In vivo,6535,Intermediate,10116.0,,1,Plasma clearance in rat after administration of 2 mg/kg iv,,,CHEMBL623706,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7889,In vivo,5041,Intermediate,10116.0,,1,Plasma clearance was determined,,,CHEMBL623707,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7890,In vivo,5960,Intermediate,10116.0,,1,Plasma clearance in rat,,,CHEMBL623708,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7891,In vivo,5937,Intermediate,10116.0,,1,Plasma clearance in rat after intravenous administration at a concentration 0.5 mg/kg,,,CHEMBL623709,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7892,In vivo,5871,Intermediate,10116.0,,1,Plasma clearance in rat by iv administration,,,CHEMBL623710,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7893,In vivo,5874,Intermediate,10116.0,,1,Plasma clearance in rat by iv administration at a dose of 3 mg/kg,,,CHEMBL623711,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7894,In vivo,6504,Intermediate,10116.0,,1,Plasma clearance in rat p.o.,,,CHEMBL623712,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7895,In vivo,6803,Intermediate,10116.0,,1,Plasma clearance in rats,,,CHEMBL623713,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7896,In vivo,5041,Intermediate,10116.0,,1,Plasma clearance was determined; ND denotes no data,,,CHEMBL623714,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7897,In vivo,5041,Intermediate,10116.0,,1,Plasma clearance was determined; ND denotes not determined,,,CHEMBL623715,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7898,In vivo,1916,Intermediate,10116.0,,1,Plasma clearance was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after iv administration,,,CHEMBL623716,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7899,In vivo,5199,Intermediate,10116.0,,1,Plasma clearance was determined in female Sprague-Dawley rats following intravenous (iv) administration of drug (1 mg/kg).,,,CHEMBL622980,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7900,In vivo,16367,Intermediate,10116.0,,1,Plasma administration to rats,,,CHEMBL622981,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7901,In vivo,6362,Intermediate,10116.0,,1,Plasma clearance of the compound in female Sprague-Dawley rats,,,CHEMBL622982,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7902,In vivo,15662,Intermediate,10116.0,,1,Plasma clearance was observed after intravenous administration in rat,,,CHEMBL622983,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7903,In vivo,6215,Intermediate,10116.0,,1,Systemic clearance after intravenous administration (5.0 mg/kg) was determined in rat,,,CHEMBL622984,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7904,In vivo,1466,Intermediate,10116.0,,1,Tested for systemic clearance upon intravenous administration of 5.0 mg/Kg dose in rat,,,CHEMBL622985,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7905,In vivo,15662,Intermediate,10116.0,,1,plasma clearance was observed after intravenous administration in rat,,,CHEMBL623631,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
7906,In vivo,4723,Intermediate,10116.0,,1,In vivo CL/F determined,,,CHEMBL623632,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7907,In vivo,2792,Intermediate,10116.0,,1,Pharmacokinetic parameter plasma clearance was determined at 2 mg/kg i.v. dose in rats,,,CHEMBL623633,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
7908,In vivo,2792,Intermediate,10116.0,,1,Pharmacokinetic parameter plasma clearance was determined at 5 mg/kg i.v. dose in rats,,,CHEMBL623634,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
7909,In vivo,5213,Intermediate,10116.0,,1,Compound was tested for the lower blood clearance in rat,,,CHEMBL623635,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7910,In vivo,4687,Intermediate,10116.0,,1,Evaluated for the low clearance in rat (in vivo),,,CHEMBL621195,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7911,In vivo,3371,Intermediate,10116.0,,1,Pharmacokinetic property (CLb)of the compound was determined in rat,,,CHEMBL621196,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7912,In vivo,4690,Intermediate,10116.0,,1,Rapid clearance after intravenous administration in rat was determined,,,CHEMBL875287,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7913,In vivo,5702,Intermediate,10116.0,,1,Clearance measured in rat,,,CHEMBL621197,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7914,In vivo,740,Intermediate,10116.0,,1,Compound was evaluated for plasma clearance in rat,,,CHEMBL621198,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
7915,In vivo,4853,Intermediate,10116.0,,1,Low plasma clearance was calculated in rat,,,CHEMBL621199,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
7916,In vivo,5789,Intermediate,10116.0,,1,Pharmacokinetic property (Clp) in rat,,,CHEMBL621200,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7917,In vivo,4527,Intermediate,10116.0,,1,Plasma clearance in dog at a dose of 1 uM/kg in rat was determined,,,CHEMBL621201,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7918,In vivo,4527,Intermediate,10116.0,,1,Plasma clearance in rat at a dose of 10 uM/kg in rat was determined,,,CHEMBL621202,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7919,In vivo,6518,Intermediate,10116.0,,1,Plasma clearance after IV dosing at 0.5 mg/kg in rat,,,CHEMBL621203,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7920,In vivo,6518,Intermediate,10116.0,,1,Plasma clearance after IV dosing at 1 mg/kg in rat,,,CHEMBL621204,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7921,In vivo,9866,Intermediate,10116.0,,1,Biodistribution in rat heart in the presence of 0.01 M Gd/0.01 M GdDTPA-AEP,,,CHEMBL621205,,50597,Rattus norvegicus,,,N,1,BAO_0000218,948.0
7922,In vivo,9866,Intermediate,10116.0,,1,Biodistribution in rat heart in the presence of 0.01 M GdDTPA-BDP,,,CHEMBL621206,,50597,Rattus norvegicus,,,N,1,BAO_0000218,948.0
7923,In vivo,9866,Intermediate,10116.0,,1,Biodistribution in rat heart in the presence of 0.01 M/0.08 M GdDTPA-AEP,,,CHEMBL621207,,50597,Rattus norvegicus,,,N,1,BAO_0000218,948.0
7924,In vivo,9866,Intermediate,10116.0,,1,Biodistribution in rat heart in the presence of 0.05 M /0.05 M GdDTPA-AEP,,,CHEMBL621208,,50597,Rattus norvegicus,,,N,1,BAO_0000218,948.0
7925,In vivo,9866,Intermediate,10116.0,,1,Biodistribution in rat heart in the presence of 0.05 M Gd/0.15 M lig,,,CHEMBL621209,,50597,Rattus norvegicus,,,N,1,BAO_0000218,948.0
7926,In vivo,9866,Intermediate,10116.0,,1,Biodistribution in rat heart in the presence of 0.05 M GdDTPA-BDP,,,CHEMBL876484,,50597,Rattus norvegicus,,,N,1,BAO_0000218,948.0
7927,In vivo,9866,Intermediate,10116.0,,1,Biodistribution in rat heart in the presence of 0.05 M/0.08 M GdDTPA-HPDP,,,CHEMBL621210,,50597,Rattus norvegicus,,,N,1,BAO_0000218,948.0
7928,In vivo,9866,Intermediate,10116.0,,1,Biodistribution in rat heart in the presence of 0.10 M GdDTPA-BDP,,,CHEMBL621211,,50597,Rattus norvegicus,,,N,1,BAO_0000218,948.0
7929,In vivo,9866,Intermediate,10116.0,,1,Biodistribution in rat heart in the presence of 0.10 M/0.11 M GdDTPA-AEP,,,CHEMBL621212,,50597,Rattus norvegicus,,,N,1,BAO_0000218,948.0
7930,In vivo,9866,Intermediate,10116.0,,1,Biodistribution in rat heart in the presence of GdDTPA at 15 min,,,CHEMBL621213,,50597,Rattus norvegicus,,,N,1,BAO_0000218,948.0
7931,In vivo,9866,Intermediate,10116.0,,1,Biodistribution in rat heart in the presence of GdDTPA at 1 hr,,,CHEMBL621214,,50597,Rattus norvegicus,,,N,1,BAO_0000218,948.0
7932,In vivo,9866,Intermediate,10116.0,,1,Biodistribution in rat heart in the presence of GdDTPA at 30 min,,,CHEMBL621215,,50597,Rattus norvegicus,,,N,1,BAO_0000218,948.0
7933,In vivo,9866,Intermediate,10116.0,,1,Biodistribution in rat heart in the presence of GdDTPA at 4 hr,,,CHEMBL621216,,50597,Rattus norvegicus,,,N,1,BAO_0000218,948.0
7934,In vivo,9866,Intermediate,10116.0,,1,Biodistribution in rat heart in the presence of GdDTPA-BDP at 1 hr,,,CHEMBL621217,,50597,Rattus norvegicus,,,N,1,BAO_0000218,948.0
7935,In vivo,9866,Intermediate,10116.0,,1,Biodistribution in rat heart in the presence of GdDTPA-BDP at 30 min,,,CHEMBL621218,,50597,Rattus norvegicus,,,N,1,BAO_0000218,948.0
7936,In vivo,9866,Intermediate,10116.0,,1,Biodistribution in rat heart in the presence of GdDTPA-BDP at 4 hr,,,CHEMBL621219,,50597,Rattus norvegicus,,,N,1,BAO_0000218,948.0
7937,In vivo,9866,Intermediate,10116.0,,1,Biodistribution in rat heart in the presence of GdDTPA-BDPat 15 min,,,CHEMBL621220,,50597,Rattus norvegicus,,,N,1,BAO_0000218,948.0
7938,In vivo,9866,Intermediate,10116.0,,1,Biodistribution in rat heart in the presence of GdDTPA-HPDP at 1 hr,,,CHEMBL621221,,50597,Rattus norvegicus,,,N,1,BAO_0000218,948.0
7939,In vivo,9866,Intermediate,10116.0,,1,Biodistribution in rat heart in the presence of GdDTPA-HPDP at 30 min,,,CHEMBL621222,,50597,Rattus norvegicus,,,N,1,BAO_0000218,948.0
7940,In vivo,9866,Intermediate,10116.0,,1,Biodistribution in rat heart in the presence of GdDTPA-HPDP at 4 hr,,,CHEMBL621223,,50597,Rattus norvegicus,,,N,1,BAO_0000218,948.0
7941,In vivo,9866,Intermediate,10116.0,,1,Biodistribution in rat heart in the presence of GdDTPA-HPDPat 15 min,,,CHEMBL876485,,50597,Rattus norvegicus,,,N,1,BAO_0000218,948.0
7942,In vivo,9866,Intermediate,10116.0,,1,Biodistribution in rat heart in the presence of NAC Gd/0.01 M GdDTPA-HPDP,,,CHEMBL621224,,50597,Rattus norvegicus,,,N,1,BAO_0000218,948.0
7943,In vivo,9866,Intermediate,10116.0,,1,Biodistribution in rat heart in the presence of NCA Gd/0.01 M lip,,,CHEMBL621225,,50597,Rattus norvegicus,,,N,1,BAO_0000218,948.0
7944,In vivo,9866,Intermediate,10116.0,,1,Biodistribution in rat heart in the presence of NCAGd/0.01 M lig,,,CHEMBL621226,,50597,Rattus norvegicus,,,N,1,BAO_0000218,948.0
7945,In vivo,9866,Intermediate,10116.0,,1,Biodistribution in rat kidney in the presence of 0.01 M GdDTPA-BDP,,,CHEMBL621227,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2113.0
7946,In vivo,9866,Intermediate,10116.0,,1,Biodistribution in rat kidney in the presence of 0.01 M/0.01 M GdDTPA-AEP,,,CHEMBL621228,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2113.0
7947,In vivo,9866,Intermediate,10116.0,,1,Biodistribution in rat kidney in the presence of 0.01 M/0.08 M GdDTPA-AEP,,,CHEMBL621229,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2113.0
7948,In vivo,9866,Intermediate,10116.0,,1,Biodistribution in rat kidney in the presence of 0.05 M Gd/0.15 M lig,,,CHEMBL621230,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2113.0
7949,In vivo,9866,Intermediate,10116.0,,1,Biodistribution in rat kidney in the presence of 0.05 M GdDTPA-BDP; ND=No data,,,CHEMBL621231,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2113.0
7950,In vivo,9866,Intermediate,10116.0,,1,Biodistribution in rat kidney in the presence of 0.05 M/0.05 M GdDTPA-AEP,,,CHEMBL621232,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2113.0
7951,In vivo,9866,Intermediate,10116.0,,1,Biodistribution in rat kidney in the presence of 0.05 M/0.08 M GdDTPA-HPDP,,,CHEMBL621233,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2113.0
7952,In vivo,9866,Intermediate,10116.0,,1,Biodistribution in rat kidney in the presence of 0.10 M GdDTPA-BDP,,,CHEMBL621234,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2113.0
7953,In vivo,9866,Intermediate,10116.0,,1,Biodistribution in rat kidney in the presence of 0.10 M/0.11 M GdDTPA-AEP; ND=No data,,,CHEMBL621235,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2113.0
7954,In vivo,9866,Intermediate,10116.0,,1,Biodistribution in rat kidney in the presence of NAC Gd/0.01 M GdDTPA-HPDP,,,CHEMBL621236,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2113.0
7955,In vivo,9866,Intermediate,10116.0,,1,Biodistribution in rat kidney in the presence of NCA Gd/0.01 M lip,,,CHEMBL621237,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2113.0
7956,In vivo,9866,Intermediate,10116.0,,1,Biodistribution in rat kidney in the presence of NCAGd/0.01 M lig,,,CHEMBL876486,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2113.0
7957,In vivo,9866,Intermediate,10116.0,,1,Biodistribution in rat l. intestine in the presence of 0.01 M carrier at 1 hr,,,CHEMBL622436,,50597,Rattus norvegicus,,,N,1,BAO_0000218,160.0
7958,In vivo,9866,Intermediate,10116.0,,1,Biodistribution in rat l. intestine in the presence of 50 Gd/kg at 2 hr,,,CHEMBL622437,,50597,Rattus norvegicus,,,N,1,BAO_0000218,160.0
7959,In vivo,9866,Intermediate,10116.0,,1,Biodistribution in rat l. intestine in the presence of 50 Gd/kg at 6 hr,,,CHEMBL622438,,50597,Rattus norvegicus,,,N,1,BAO_0000218,160.0
7960,In vivo,9866,Intermediate,10116.0,,1,Biodistribution in rat liver by in the presence 50 Gd/kg at 15 min,,,CHEMBL622439,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
7961,In vivo,9866,Intermediate,10116.0,,1,Biodistribution in rat liver by in the presence of 0.05 M Gd/0.15 M lig,,,CHEMBL622440,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
7962,In vivo,9866,Intermediate,10116.0,,1,Biodistribution in rat liver by in the presence of NCAGd/0.01 M lig,,,CHEMBL622441,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
7963,In vivo,9866,Intermediate,10116.0,,1,Biodistribution in rat liver in the presence of 0.001 M/0.008 M GdDTPA-AEP,,,CHEMBL622442,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
7964,In vivo,9866,Intermediate,10116.0,,1,Biodistribution in rat liver in the presence of 0.01 M GdDTPA-BDP,,,CHEMBL622443,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
7965,In vivo,9866,Intermediate,10116.0,,1,Biodistribution in rat liver in the presence of 0.01 M/0.01 M GdDTPA-AEP,,,CHEMBL622444,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
7966,In vivo,9866,Intermediate,10116.0,,1,Biodistribution in rat liver in the presence of 0.05 M GdDTPA-BDP,,,CHEMBL622445,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
7967,In vivo,9866,Intermediate,10116.0,,1,Biodistribution in rat liver in the presence of 0.05 M/0.05 M GdDTPA-AEP,,,CHEMBL622446,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
7968,In vivo,9866,Intermediate,10116.0,,1,Biodistribution in rat liver in the presence of 0.05 M/0.08 M GdDTPA-HPDP,,,CHEMBL622447,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
7969,In vivo,9866,Intermediate,10116.0,,1,Biodistribution in rat liver in the presence of 0.10 M GdDTPA-BDP,,,CHEMBL622448,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
7970,In vivo,9866,Intermediate,10116.0,,1,Biodistribution in rat liver in the presence of 0.10 M/0.11 M GdDTPA-AEP; ND=No data,,,CHEMBL622449,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
7971,In vivo,9866,Intermediate,10116.0,,1,Biodistribution in rat liver in the presence of 50 Gd/kg at 2 hr,,,CHEMBL622450,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
7972,In vivo,9866,Intermediate,10116.0,,1,Biodistribution in rat liver in the presence of 50 Gd/kg at at 6 hr,,,CHEMBL622451,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
7973,In vivo,9866,Intermediate,10116.0,,1,Biodistribution in rat liver in the presence of GdDTPA at 15 min,,,CHEMBL622452,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
7974,In vivo,9866,Intermediate,10116.0,,1,Biodistribution in rat liver in the presence of GdDTPA at 1 hr,,,CHEMBL622453,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
7975,In vivo,9866,Intermediate,10116.0,,1,Biodistribution in rat liver in the presence of GdDTPA at 30 min,,,CHEMBL622454,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
7976,In vivo,9866,Intermediate,10116.0,,1,Biodistribution in rat liver in the presence of GdDTPA at 4 hr,,,CHEMBL622455,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
7977,In vivo,9866,Intermediate,10116.0,,1,Biodistribution in rat liver in the presence of GdDTPA-BDP at 15 min,,,CHEMBL876024,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
7978,In vivo,2792,Intermediate,10116.0,,1,T max was determined at 3 mg/kg po dose in rats,,,CHEMBL622456,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7979,In vivo,15078,Intermediate,10116.0,,1,"The Tmax value in female wistar rat at 100 mg/kg, p.o. dose",,,CHEMBL622457,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7980,In vivo,15078,Intermediate,10116.0,,1,"The Tmax value in male wistar rat at 100 mg/kg, p.o. dose",,,CHEMBL622458,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7981,,15022,Intermediate,10116.0,,1,The time to reach maximum concentration of compound was measured at the dose of 100 umol/kg,,,CHEMBL622459,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7982,,15022,Intermediate,10116.0,,1,The time to reach maximum concentration of compound was measured at the dose of 300 umol/kg,,,CHEMBL873343,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7983,,15022,Intermediate,10116.0,,1,The time to reach maximum concentration of compound was measured at the dose of 30 umol/kg,,,CHEMBL622460,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7984,,4576,Intermediate,10116.0,,1,Time for maximum plasma concentration determined in rat,,,CHEMBL622461,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
7985,In vivo,6681,Intermediate,10116.0,,1,Time for maximum plasma concentration reached by compound was determined in rats at 50 mg/kg dose,,,CHEMBL622462,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
7986,In vivo,16365,Intermediate,10116.0,,1,Time of maximum concentration of the drug when administered orally a dose of 10 mg/kg to a fasting rat,,,CHEMBL622463,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7987,In vivo,16365,Intermediate,10116.0,,1,Time of maximum concentration of the drug when administered orally a dose of 1 mg/kg to a fasting rat,,,CHEMBL622464,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7988,In vivo,16365,Intermediate,10116.0,,1,Time of maximum concentration of the drug when administered orally a dose of 30 mg/kg,,,CHEMBL622465,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7989,In vivo,16365,Intermediate,10116.0,,1,Time of maximum concentration of the drug when administered orally a dose of 3 mg/kg to a fasting rat,,,CHEMBL622466,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7990,In vivo,16365,Intermediate,10116.0,,1,Time of maximum concentration of the drug when administered orally at dose of 3 mg/kg,,,CHEMBL622467,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7991,,6824,Intermediate,10116.0,,1,Time of maximum plasma concentration in rat,,,CHEMBL622468,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
7992,,6685,Intermediate,10116.0,,1,"Time required by compound for reaching maximum plasma concentration was determined in rats at 10 mg/kg, p.o. dose",,,CHEMBL876025,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
7993,,6685,Intermediate,10116.0,,1,"Time required by compound for reaching maximum plasma concentration was determined in rats at 20 mg/kg, i.p. dose",,,CHEMBL622469,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
7994,,6685,Intermediate,10116.0,,1,"Time required by compound for reaching maximum plasma concentration was determined in rats at 2 mg/kg, i.v. dose; n/a: not applicable",,,CHEMBL622470,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
7995,In vivo,15662,Intermediate,10116.0,,1,Time required to reach maximum concentration (Cmax) after oral administration in rat,,,CHEMBL622471,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
7996,,1742,Intermediate,10116.0,,1,Time required to reach maximum concentration in rat plasma,,,CHEMBL622472,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
7997,In vivo,2774,Intermediate,10116.0,,1,Time taken by the compound to achieve maximum concentration in rat plasma at 30 mg/Kg upon oral administration.,,,CHEMBL622473,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
7998,In vivo,5199,Intermediate,10116.0,,1,Time taken by the compound to achieve maximum plasma concentration at a 1 mg/kg oral dose in female Sprague-Dawley rats,,,CHEMBL624282,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
7999,In vivo,12873,Intermediate,10116.0,,1,Time taken for maximum plasma concentration for the compound in solution form (formulation) was determined in rats at peroral dose of 5 mg/kg,,,CHEMBL624283,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
8000,In vivo,12873,Intermediate,10116.0,,1,Time taken for maximum plasma concentration for the compound in suspension form (formulation) was determined in rats at peroral dose of 5 mg/kg,,,CHEMBL624284,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
8001,In vivo,1916,Intermediate,10116.0,,1,Time taken to reach maximum concentration in plasma was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration,,,CHEMBL624285,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
8002,In vivo,16367,Intermediate,10116.0,,1,Time to reach Cmax after oral administration to rats,,,CHEMBL624286,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8003,In vivo,16366,Intermediate,10116.0,,1,Time to reach Cmax when a dose of 1 mg/kg is administered orally,,,CHEMBL624287,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8004,,216,Intermediate,10116.0,,1,Time to reach maximum concentration following oral administration of 200 mg/kg in rat; value ranges from 2-4,,,CHEMBL624288,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8005,In vivo,6410,Intermediate,10116.0,,1,Time to reach maximum plasma concentration was evaluated at an intravenous dose of 3 mg/kg; Not applicable,,,CHEMBL624289,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
8006,In vivo,6410,Intermediate,10116.0,,1,Time to reach maximum plasma concentration was evaluated at an oral dose of 30 mg/kg,,,CHEMBL873344,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
8007,In vivo,6215,Intermediate,10116.0,,1,Tmax after peroral administration (10 mg/kg) was determined in rat,,,CHEMBL619623,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8008,In vivo,3598,Expert,10116.0,,1,Tmax of compound determined in rat after iv administration at a dose of 10 mg/kg,,,CHEMBL621399,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8009,In vivo,4527,Intermediate,10116.0,,1,Tmax by oral administration at a dose of 100 uM/kg in rat was determined,,,CHEMBL621400,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8010,In vivo,17670,Intermediate,10116.0,,1,"Tmax in fischer rats at 5 mg/kg dose, administered intravenously",,,CHEMBL621401,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8011,,1465,Intermediate,10116.0,,1,Tmax was determined,,,CHEMBL621402,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8012,,2552,Intermediate,10116.0,,1,Tmax was determined,,,CHEMBL621403,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8013,In vivo,5656,Intermediate,10116.0,,1,Tmax after oral administration in rat,,,CHEMBL621121,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8014,In vivo,17764,Intermediate,10116.0,,1,Tmax after peroral administration in rats at 2.4 uM/kg,,,CHEMBL872525,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8015,,5610,Intermediate,10116.0,,1,Tmax in male rat,,,CHEMBL621122,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8016,In vivo,6046,Intermediate,10116.0,,1,Tmax in rat at 10 mg/kg,,,CHEMBL621123,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8017,In vivo,5874,Intermediate,10116.0,,1,Tmax in rat by po administration at a dose of 40 mg/kg,,,CHEMBL621124,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8018,,17596,Intermediate,10116.0,,1,Tmax in rats,,,CHEMBL621125,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8019,In vivo,17804,Intermediate,10116.0,,1,Tmax was measured in rats after peroral administration at 5 mg/kg,,,CHEMBL621126,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8020,In vivo,1908,Intermediate,10116.0,,1,Tmax value after oral dose at a dose of 10 mg/kg in rats.,,,CHEMBL621127,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8021,In vivo,2959,Intermediate,10116.0,,1,Tmax value after administration of 20 mg/Kg oral dose in rat,,,CHEMBL621128,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8022,In vivo,6757,Intermediate,10116.0,,1,Tmax value at a dose of 10 mg/kg in male SD rats,,,CHEMBL618263,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8023,In vivo,6757,Intermediate,10116.0,,1,Tmax value at a dose of 100 mg/kg in male SD rats,,,CHEMBL618264,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8024,In vivo,6757,Intermediate,10116.0,,1,Tmax value at a dose of 50 mg/kg in male SD rats,,,CHEMBL618265,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8025,In vivo,4186,Intermediate,10116.0,,1,Total concentration in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,,,CHEMBL618266,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
8026,In vivo,15662,Intermediate,10116.0,,1,time required to reach maximum concentration (Cmax) after oral administration in rat,,,CHEMBL618267,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8027,,429,Intermediate,10116.0,,1,Evaluated for pharmacokinetic parameter urine recovery in rat at the dose 50 mg/kg ( 0-24 hr ),,,CHEMBL618450,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
8028,,429,Intermediate,10116.0,,1,Evaluated for pharmacokinetic parameter urine recovery in rat at the dose 50 mg/kg (0-24 hr),,,CHEMBL618451,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
8029,,5546,Intermediate,10116.0,,1,Unbound plasma was determined in Sprague-Dawley rats at a dose of 1 mg/kg by iv administration,,,CHEMBL618452,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8030,,3173,Intermediate,10116.0,,1,Amount of urine output was measured in rat at a dose of 1 mg/kg/po,,,CHEMBL618453,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
8031,,3173,Intermediate,10116.0,,1,Amount of urine output was measured in rat at a dose of 10 mg/kg/po,,,CHEMBL618454,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
8032,,3173,Intermediate,10116.0,,1,Amount of urine output was measured in rat at a dose of 10 mg/kg/po; NT-Not tested,,,CHEMBL618455,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
8033,In vivo,4257,Intermediate,10116.0,,1,Volume of distribution was determined in rat after a 3 mg/kg of iv dose,,,CHEMBL618456,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8034,In vivo,6011,Intermediate,10116.0,,1,Compound distribution in rat tissues was determined,,,CHEMBL618457,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8035,In vivo,5472,Intermediate,10116.0,,1,Volume of distribution was evaluated in rat,,,CHEMBL618458,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8036,,14346,Intermediate,10116.0,,1,Area under the curve was determined after intravenous administration of 2.7 mg/kg in male Dawley rats,,,CHEMBL618459,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8037,,14346,Intermediate,10116.0,,1,Area under the curve was determined after intravenous administration of 2.8 mg/kg in male Dawley rats,,,CHEMBL876733,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8038,,14346,Intermediate,9615.0,,1,Area under the curve was determined after intravenous administration of 4.9 mg/kg in male Beagle dogs,,,CHEMBL618460,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
8039,,14346,Intermediate,10116.0,,1,Area under the curve was determined after intravenous administration of 5.1 mg/kg in male Dawley rats,,,CHEMBL618461,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8040,,15469,Autocuration,,,1,Area under the curve was determined after oral administration (300 uM/Kg),,,CHEMBL618462,,22224,,,,U,0,BAO_0000019,
8041,,14346,Intermediate,10116.0,,1,Area under the curve was determined after peroral administration of 5.0 mg/kg in male Dawley rats,,,CHEMBL618463,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8042,,14346,Intermediate,10116.0,,1,Area under the curve was determined after peroral administration of 5.1 mg/kg in mal Dawley rats,,,CHEMBL618464,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8043,,14346,Intermediate,10116.0,,1,Area under the curve was determined after peroral administration of 5.1 mg/kg in male Dawley rats,,,CHEMBL618465,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8044,,14346,Intermediate,10116.0,,1,Area under the curve was determined after peroral administration of 5.2 mg/kg in mal Dawley rats,,,CHEMBL618466,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8045,,14346,Intermediate,10116.0,,1,Area under the curve was determined after peroral administration of 5.2 mg/kg in male Dawley rats,,,CHEMBL618467,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8046,,15372,Intermediate,10116.0,,1,Area under the curve was determined for the compound after iv dose of 4.97 mg/kg in rats,,,CHEMBL618468,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8047,,12935,Intermediate,9615.0,,1,Area under the plasma concentration was determined in fasted Beagle dogs after peroral administration of 100 mg/kg,,,CHEMBL618469,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,1969.0
8048,,12935,Intermediate,9615.0,,1,Area under the plasma concentration was determined in fasted Beagle dogs after peroral administration of 20 mg/kg,,,CHEMBL618470,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,1969.0
8049,,14813,Autocuration,,,1,Plasma drug AUC in rat (PO dose),,,CHEMBL618471,,22224,,,,U,0,BAO_0000218,
8050,,15792,Intermediate,10090.0,,1,Area under the tumor growth curve (AUC) in the B-6 Melanoma Model in C57/b1 mice at the dose of 1 mg/kg.,,,CHEMBL618472,,50594,Mus musculus,,,N,1,BAO_0000218,
8051,,3579,Autocuration,,,1,Area under was determined at a dose of 30 mg/kg,,,CHEMBL618473,,22224,,,,U,0,BAO_0000218,
8052,,12487,Intermediate,9669.0,,1,Average area under curve for compound at 1 mg/kg dose intravenous administration to Ferret,,,CHEMBL621699,,50506,Mustela putorius furo,,,N,1,BAO_0000218,
8053,,12487,Intermediate,10116.0,,1,Average area under curve for the compound at 10 mg/kg dose after intraduodenal administration to rat,,,CHEMBL621700,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8054,,12487,Intermediate,10116.0,,1,Average area under curve for the compound at 1 mg/kg dose after intravenous administration to rat,,,CHEMBL621701,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8055,,12487,Intermediate,9669.0,,1,Average area under curve at 10 mg/kg dose after intraduodenal administration to Ferret,,,CHEMBL621702,,50506,Mustela putorius furo,,,N,1,BAO_0000218,
8056,,12487,Intermediate,9615.0,,1,Average area under curve at 10 mg/kg intraduodenal administration to salt depleted dog,,,CHEMBL621703,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
8057,,12487,Intermediate,9615.0,,1,Average area under curve at 1 mg/kg intravenous administration to salt depleted dog,,,CHEMBL621704,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
8058,,12902,Intermediate,10116.0,,1,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 1.0(pmol/g/h)",,,CHEMBL624259,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8059,,12902,Intermediate,10116.0,,1,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 2.0(pmol/g/h)",,,CHEMBL624260,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8060,,12902,Intermediate,10116.0,,1,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 4.0(pmol/g/h)",,,CHEMBL624430,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8061,,12902,Intermediate,10116.0,,1,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 5.0(pmol/g/h)",,,CHEMBL624431,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8062,,12902,Intermediate,10116.0,,1,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 54.0(pmol/g/h)",,,CHEMBL624432,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8063,,12902,Intermediate,10116.0,,1,"Bioavailability in male Sprague-Dawley rats, after the po administration at a dose of 10.0(pmol/g/h)",,,CHEMBL624433,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8064,,12902,Intermediate,10116.0,,1,"Bioavailability in male Sprague-Dawley rats, after the po administration at a dose of 20.0(pmol/g/h)",,,CHEMBL624434,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8065,,12902,Intermediate,10116.0,,1,"Bioavailability in male Sprague-Dawley rats, after the po administration at a dose of 40.0(pmol/g/h)",,,CHEMBL624435,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8066,,12745,Intermediate,10090.0,,1,Bioavailability in mouse brain after intravenous administration of 105.1 mg/kg of dose,,,CHEMBL618570,,50594,Mus musculus,,,N,1,BAO_0000218,
8067,,12745,Intermediate,10090.0,,1,Bioavailability in mouse brain after intravenous administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),,,CHEMBL618571,,50594,Mus musculus,,,N,1,BAO_0000218,
8068,,12745,Intermediate,10090.0,,1,Bioavailability in mouse brain after oral administration of 100 mg/kg of dose,,,CHEMBL618572,,50594,Mus musculus,,,N,1,BAO_0000218,
8069,,12745,Intermediate,10090.0,,1,Bioavailability in mouse brain after oral administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),,,CHEMBL618573,,50594,Mus musculus,,,N,1,BAO_0000218,
8070,,12745,Intermediate,10090.0,,1,Bioavailability in mouse serum after intravenous administration of 105.1 mg/kg of dose,,,CHEMBL619267,,50594,Mus musculus,,,N,1,BAO_0000218,
8071,,12745,Intermediate,10090.0,,1,Bioavailability in mouse serum after intravenous administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),,,CHEMBL619431,,50594,Mus musculus,,,N,1,BAO_0000218,
8072,,12745,Intermediate,10090.0,,1,Bioavailability in mouse serum after oral administration of 100 mg/kg of dose,,,CHEMBL619432,,50594,Mus musculus,,,N,1,BAO_0000218,
8073,,12745,Intermediate,10090.0,,1,Bioavailability in mouse serum after oral administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),,,CHEMBL619433,,50594,Mus musculus,,,N,1,BAO_0000218,
8074,,13298,Autocuration,,,1,AUC in mice after oral dose (50 mg/kg),,,CHEMBL619434,,22224,,,,U,0,BAO_0000218,1969.0
8075,,12226,Intermediate,10090.0,,1,Blood level after oral administration in mice (50 mg/kg) was determined by bioassay procedure and represent total activity present in the serum,,,CHEMBL619435,,50594,Mus musculus,,,N,1,BAO_0000218,1977.0
8076,,12634,Autocuration,,,1,AUC (0-4 hr) ug/ml/h,,,CHEMBL619436,,22224,,,,U,0,BAO_0000019,1969.0
8077,,14810,Intermediate,10116.0,,1,Compound at a dose of 10 mg/kg was orally administered to rats and Area under curve was reported,,,CHEMBL619437,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8078,,13889,Autocuration,,,1,Compound evaluated for AUC = Area under the nucleoside serum or brain concentration versus time curve after iv administration,,,CHEMBL619438,,22224,,,,U,0,BAO_0000218,
8079,,10018,Intermediate,10090.0,,1,Compound was evaluated for Area under curve in mice,,,CHEMBL619439,,50594,Mus musculus,,,N,1,BAO_0000218,
8080,,8758,Intermediate,10116.0,,1,Compound was evaluated for area under curve doses in rat at 100 mg/kg po,,,CHEMBL619440,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8081,,8758,Autocuration,,,1,Compound was evaluated for area under curve doses in rat at 100 mg/kg po,,,CHEMBL619441,,22224,,,,U,0,BAO_0000218,
8082,,8758,Intermediate,10116.0,,1,Compound was evaluated for area under curve doses in rat at 50 mg/kg po,,,CHEMBL619442,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8083,,2249,Autocuration,,,1,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 0.5 mpk on day 1,,,CHEMBL875156,,22224,,,,U,0,BAO_0000019,
8084,,2249,Autocuration,,,1,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 0.5 mpk on day 4,,,CHEMBL619443,,22224,,,,U,0,BAO_0000019,
8085,,2249,Autocuration,,,1,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 1.0 mpk on day 1,,,CHEMBL619444,,22224,,,,U,0,BAO_0000019,
8086,,2249,Autocuration,,,1,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 1.0 mpk on day 4,,,CHEMBL623464,,22224,,,,U,0,BAO_0000019,
8087,,15115,Intermediate,10090.0,,1,Compound was evaluated for area under curve when administered through oral route in mouse,,,CHEMBL623465,,50594,Mus musculus,,,N,1,BAO_0000218,
8088,In vivo,6518,Intermediate,10116.0,,1,Plasma clearance after oral administration at a dose of 2 mg/kg in rat; no data,,,CHEMBL623466,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8089,In vivo,6518,Intermediate,10116.0,,1,Plasma clearance after oral administration at a dose of 4 mg/kg in rat; no data,,,CHEMBL623467,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8090,In vivo,6249,Intermediate,10116.0,,1,Plasma clearance in rat,,,CHEMBL623468,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8091,In vivo,2463,Intermediate,10116.0,,1,Plasma clearance was evaluated in vivo in rat at a dose of 5 mg/kg by intra venous administration,,,CHEMBL622660,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8092,In vivo,4969,Intermediate,10116.0,,1,Plasma clearance rate in Sprague-Dawley rats,,,CHEMBL622661,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8093,In vivo,17720,Intermediate,10116.0,,1,CLtot at a dose of 4 mg/kg in Rat Plasma after iv administration,,,CHEMBL622662,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8094,In vivo,3457,Intermediate,10116.0,,1,Pharmacokinetic property (total body clearance) in rat,,,CHEMBL622663,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8095,In vivo,5983,Intermediate,10116.0,,1,Pharmacokinetic property (CLtot)of the compound was measured in rat at the dose of 0.32 mg/kg i.v.,,,CHEMBL622664,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8096,,6295,Intermediate,10116.0,,1,In vivo concentration in rat liver exposure 0-8 hour after oral administration 50 mg/kg,,,CHEMBL622665,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8097,,6296,Intermediate,10116.0,,1,In vivo concentration in rat liver exposure 0-8 hour after oral administration 50 mg/kg,,,CHEMBL622666,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8098,In vivo,17686,Intermediate,10116.0,,1,Cl in rat i.v. at 2 mg/kg concentration,,,CHEMBL621615,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8099,In vivo,17764,Intermediate,10116.0,,1,Clearance of compound after intravenous administration in rats at 24 uM/kg,,,CHEMBL621616,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8100,In vivo,5503,Intermediate,10116.0,,1,Clearance was determined,,,CHEMBL621617,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8101,In vivo,4368,Intermediate,10116.0,,1,Clearance by intravenous administration of 3.4 mg/kg in rat,,,CHEMBL621618,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8102,In vivo,6005,Intermediate,10116.0,,1,Clearance was evaluated after i.v. administration in rat at a dose of 1 mg/kg,,,CHEMBL621619,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8103,In vivo,5031,Intermediate,10116.0,,1,Clearance rate after i.v. administration in rats,,,CHEMBL621620,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8104,In vivo,4890,Intermediate,10116.0,,1,Clearance was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,,,CHEMBL621786,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8105,In vivo,5182,Intermediate,10116.0,,1,Clearance was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat,,,CHEMBL621787,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8106,In vivo,5979,Intermediate,10116.0,,1,Clearance (Cl) of compound after 2 h iv infusion of 8.4 mg/kg in three rat,,,CHEMBL621788,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8107,In vivo,5656,Intermediate,10116.0,,1,Clearance (Cl) after oral administration in rat,,,CHEMBL621789,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8108,In vivo,17804,Intermediate,10116.0,,1,Compound clearance in rats was measured after intravenous administration at 3 mg/kg,,,CHEMBL621790,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8109,In vivo,4839,Intermediate,10116.0,,1,Compound was tested for plasma clearance in rat,,,CHEMBL621791,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
8110,In vitro,5041,Intermediate,10116.0,,1,In vitro microsome metabolism clearance in rat was determined,,,CHEMBL621792,Microsomes,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8111,In vitro,5041,Intermediate,10116.0,,1,In vitro microsome metabolism clearance in rat was determined; ND denotes no data,,,CHEMBL621793,Microsomes,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8112,In vivo,5974,Intermediate,10116.0,,1,In vivo Clearance (Cl) was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,,,CHEMBL621794,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8113,In vivo,5496,Intermediate,10116.0,,1,In vivo plasma clearance was determined,,,CHEMBL621795,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
8114,In vivo,5739,Intermediate,10116.0,,1,Pharmacokinetic property (Clearance) for the compound (5 mg/kg iv) was determined in rats,,,CHEMBL621796,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8115,In vivo,5676,Intermediate,10116.0,,1,Pharmacokinetic property (Clearance) in rat hepatocyte i.v.,401.0,,CHEMBL621797,,50597,Rattus norvegicus,Hepatocyte,,N,1,BAO_0000218,2107.0
8116,In vivo,4239,Intermediate,10116.0,,1,Pharmacokinetic property (Plasma clearance) was measured in rat,,,CHEMBL621798,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8117,In vivo,5676,Intermediate,10116.0,,1,Pharmacokinetic property (clearance) in rat i.v.,,,CHEMBL621799,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8118,In vivo,1918,Intermediate,10116.0,,1,"Plasma Clearance was evaluated in rats, iv",,,CHEMBL621800,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8119,In vivo,17800,Intermediate,10116.0,,1,Plasma clearance (in vivo) in rats was determined,,,CHEMBL621801,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8120,In vivo,6056,Intermediate,10116.0,,1,Plasma clearance for the compound was calculated at a single intravenous administration of 20 mg/kg in rat,,,CHEMBL621802,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8121,In vivo,5496,Intermediate,10116.0,,1,Plasma clearance was determined,,,CHEMBL618596,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8122,In vivo,5939,Intermediate,10116.0,,1,Plasma clearance in rat after peroral administration at 10 mg/kg concentration,,,CHEMBL618597,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8123,In vivo,5939,Intermediate,10116.0,,1,Plasma clearance in rat after peroral administration at 5 mg/kg concentration,,,CHEMBL618598,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8124,In vivo,17752,Intermediate,10116.0,,1,Plasma clearance in rats,,,CHEMBL618599,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8125,In vivo,4576,Intermediate,10116.0,,1,Plasma clearance rate determined in rat,,,CHEMBL618600,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8126,In vivo,6011,Intermediate,10116.0,,1,Plasma clearance was determined in rat,,,CHEMBL618601,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8127,In vivo,5510,Intermediate,10116.0,,1,Plasma clearance was determined,,,CHEMBL618602,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8128,In vivo,5948,Intermediate,10116.0,,1,Plasma clearance value in rat,,,CHEMBL618603,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8129,Ex vivo,6125,Intermediate,10116.0,,1,Clearance rate constant using isolated perfused rat liver (IPRL) assay,,,CHEMBL618604,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
8130,In vivo,4839,Intermediate,10116.0,,1,Clearance in rat,,,CHEMBL618605,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8131,In vivo,17686,Intermediate,10116.0,,1,Total body clearance in rat i.v. at 2 mg/kg concentration,,,CHEMBL618606,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8132,In vivo,6571,Intermediate,10116.0,,1,Clearance of compound in rats after intravenous administration,,,CHEMBL618607,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8133,In vivo,3364,Intermediate,10116.0,,1,Clearance after iv administration to rats,,,CHEMBL618608,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8134,In vivo,13569,Intermediate,10116.0,,1,Clearance at an iv dose of 12 mg/Kg and po dose of 23 mg/Kg,,,CHEMBL618609,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8135,In vivo,13569,Intermediate,10116.0,,1,Clearance at an iv dose of 14 mg/Kg and po dose of 15 mg/Kg,,,CHEMBL618610,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8136,In vivo,13569,Intermediate,10116.0,,1,Clearance at an iv dose of 15 mg/Kg and po dose of 30 mg/Kg,,,CHEMBL618611,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8137,In vivo,13569,Intermediate,10116.0,,1,Clearance at an iv dose of 15 mg/Kg and po dose of 30.2 mg/Kg,,,CHEMBL618612,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8138,In vivo,13569,Intermediate,10116.0,,1,Clearance at an iv dose of 15.6 mg/Kg and po dose of 31.2 mg/Kg,,,CHEMBL618613,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8139,In vivo,13569,Intermediate,10116.0,,1,Clearance at an iv dose of 15.7 mg/Kg and po dose of 31.4 mg/Kg,,,CHEMBL621076,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8140,In vivo,13569,Intermediate,10116.0,,1,Clearance at an iv dose of 16 mg/Kg and po dose of 35 mg/Kg,,,CHEMBL621077,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8141,In vivo,17670,Intermediate,10116.0,,1,"Clearance in fischer rats at 5 mg/kg dose, administered intravenously",,,CHEMBL621078,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8142,In vivo,5970,Intermediate,10116.0,,1,Clearance in rat,,,CHEMBL621251,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8143,In vivo,6495,Intermediate,10116.0,,1,Clearance in rat after oral administration at 10 mg/kg,,,CHEMBL621252,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8144,In vivo,4590,Intermediate,10116.0,,1,Clearance in rat.,,,CHEMBL621253,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8145,In vivo,6193,Intermediate,10116.0,,1,Clearance rate following an oral dose of 20 mg/kg in rats,,,CHEMBL621254,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8146,In vivo,2832,Intermediate,10116.0,,1,Compound was evaluated for the rate of clearance in rat upon intravenous administration.,,,CHEMBL621255,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8147,In vivo,1052,Intermediate,10116.0,,1,Compound was tested for plasma clearance in rats after 5 mg/kg of intravenous dosing,,,CHEMBL621256,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
8148,In vivo,9866,Intermediate,10116.0,,1,Biodistribution in rat liver in the presence of GdDTPA-BDP at 1 hr,,,CHEMBL621257,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
8149,In vivo,9866,Intermediate,10116.0,,1,Biodistribution in rat liver in the presence of GdDTPA-BDP at 30 min,,,CHEMBL621258,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
8150,In vivo,9866,Intermediate,10116.0,,1,Biodistribution in rat liver in the presence of GdDTPA-BDP at 4 hr,,,CHEMBL621259,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
8151,In vivo,9866,Intermediate,10116.0,,1,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 15 min,,,CHEMBL621260,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
8152,In vivo,9866,Intermediate,10116.0,,1,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 1 hr,,,CHEMBL876494,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
8153,In vivo,9866,Intermediate,10116.0,,1,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 30 min,,,CHEMBL621261,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
8154,In vivo,9866,Intermediate,10116.0,,1,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 4 hr,,,CHEMBL621262,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
8155,In vivo,9866,Intermediate,10116.0,,1,Biodistribution in rat liver in the presence of NAC Gd/0.01 M GdDTPA-HPDP,,,CHEMBL621263,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
8156,In vivo,9866,Intermediate,10116.0,,1,Biodistribution in rat liver in the presence of NCA Gd/0.01 M lip,,,CHEMBL621264,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
8157,In vivo,9866,Intermediate,10116.0,,1,Biodistribution in rat muscle in the presence of 0.01 M GdDTPA-BDP,,,CHEMBL621265,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2385.0
8158,In vivo,9866,Intermediate,10116.0,,1,Biodistribution in rat muscle in the presence of 0.05 M Gd/0.15 M lig,,,CHEMBL621266,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2385.0
8159,In vivo,9866,Intermediate,10116.0,,1,Biodistribution in rat muscle in the presence of 0.05 M GdDTPA-BDP,,,CHEMBL621267,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2385.0
8160,In vivo,9866,Intermediate,10116.0,,1,Biodistribution in rat muscle in the presence of 0.10 M GdDTPA-BDP,,,CHEMBL621268,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2385.0
8161,In vivo,9866,Intermediate,10116.0,,1,Biodistribution in rat muscle in the presence of GdDTPA-BDP at 1 hr,,,CHEMBL621269,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2385.0
8162,In vivo,9866,Intermediate,10116.0,,1,Biodistribution in rat muscle in the presence of GdDTPA-BDP at 4 hr,,,CHEMBL621270,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2385.0
8163,In vivo,9866,Intermediate,10116.0,,1,Biodistribution in rat muscle in the presence of GdDTPA-BDPat 15 min,,,CHEMBL621271,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2385.0
8164,In vivo,9866,Intermediate,10116.0,,1,Biodistribution in rat muscle in the presence of GdDTPA-BDPat 30 min,,,CHEMBL621272,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2385.0
8165,In vivo,9866,Intermediate,10116.0,,1,Biodistribution in rat muscle in the presence of GdDTPA-HPDP at 1 hr,,,CHEMBL621273,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2385.0
8166,In vivo,9866,Intermediate,10116.0,,1,Biodistribution in rat muscle in the presence of GdDTPA-HPDP at 4 hr,,,CHEMBL621274,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2385.0
8167,In vivo,9866,Intermediate,10116.0,,1,Biodistribution in rat muscle in the presence of GdDTPA-HPDPat 15 min,,,CHEMBL876495,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2385.0
8168,In vivo,9866,Intermediate,10116.0,,1,Biodistribution in rat muscle in the presence of GdDTPA-HPDPat 30 min,,,CHEMBL621275,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2385.0
8169,In vivo,9866,Intermediate,10116.0,,1,Biodistribution in rat muscle in the presence of NCA Gd/0.01 M lip,,,CHEMBL621276,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2385.0
8170,In vivo,9866,Intermediate,10116.0,,1,Biodistribution in rat muscle in the presence of NCAGd/0.01 M lig,,,CHEMBL621277,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2385.0
8171,In vivo,9866,Intermediate,10116.0,,1,Biodistribution in rat s. intestine in the presence of 50 Gd/kg at 2 hr,,,CHEMBL621278,,50597,Rattus norvegicus,,,N,1,BAO_0000218,160.0
8172,In vivo,9866,Intermediate,10116.0,,1,Biodistribution in rat s. intestine in the presence of 50 Gd/kg at 6 hr,,,CHEMBL621279,,50597,Rattus norvegicus,,,N,1,BAO_0000218,160.0
8173,In vivo,9866,Intermediate,10116.0,,1,Biodistribution in rat s. intestine in the presence of NCA (No carrier added),,,CHEMBL621280,,50597,Rattus norvegicus,,,N,1,BAO_0000218,160.0
8174,In vivo,9866,Intermediate,10116.0,,1,Biodistribution in rat spleen in the presence of 0.01 M GdDTPA-BDP,,,CHEMBL621281,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2106.0
8175,In vivo,9866,Intermediate,10116.0,,1,Biodistribution in rat spleen in the presence of 0.05 M Gd/0.15 M lig; ND=No data,,,CHEMBL621282,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2106.0
8176,In vivo,9866,Intermediate,10116.0,,1,Biodistribution in rat spleen in the presence of 0.05 M GdDTPA-BDP; ND=No data,,,CHEMBL621283,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2106.0
8177,In vivo,9866,Intermediate,10116.0,,1,Biodistribution in rat spleen in the presence of 0.10 M GdDTPA-BDP,,,CHEMBL621284,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2106.0
8178,In vivo,9866,Intermediate,10116.0,,1,Biodistribution in rat spleen in the presence of 50 Gd/kg at 15 min,,,CHEMBL621285,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2106.0
8179,In vivo,9866,Intermediate,10116.0,,1,Biodistribution in rat spleen in the presence of 50 Gd/kg at 2 hr,,,CHEMBL621286,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2106.0
8180,In vivo,9866,Intermediate,10116.0,,1,Biodistribution in rat spleen in the presence of 50 Gd/kg at 6 hr,,,CHEMBL623220,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2106.0
8181,In vivo,9866,Intermediate,10116.0,,1,Biodistribution in rat spleen in the presence of NCA Gd/0.01 M lip,,,CHEMBL623221,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2106.0
8182,In vivo,9866,Intermediate,10116.0,,1,Biodistribution in rat spleen in the presence of NCAGd/0.01 M lig,,,CHEMBL876029,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2106.0
8183,In vivo,9866,Intermediate,10116.0,,1,Biodistribution in rat stomach in the presence of 50 Gd/kg at 15 min,,,CHEMBL623222,,50597,Rattus norvegicus,,,N,1,BAO_0000218,945.0
8184,In vivo,9866,Intermediate,10116.0,,1,Biodistribution in rat stomach in the presence of 50 Gd/kg at 2 hr,,,CHEMBL623223,,50597,Rattus norvegicus,,,N,1,BAO_0000218,945.0
8185,In vivo,9866,Intermediate,10116.0,,1,Biodistribution in rat stomach in the presence of 50 Gd/kg at 6 h; ND=No data,,,CHEMBL621445,,50597,Rattus norvegicus,,,N,1,BAO_0000218,945.0
8186,In vivo,13950,Intermediate,10116.0,,1,Biodistribution of [123I]-label in rat blood was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,,,CHEMBL621446,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
8187,In vivo,13950,Intermediate,10116.0,,1,Biodistribution of [123I]-label in rat blood was reported at 1 hr post injection. Value shown is %ID/g of tissue,,,CHEMBL621447,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
8188,In vivo,13950,Intermediate,10116.0,,1,Biodistribution of [123I]-label in rat blood was reported at 2 hr post injection. Value shown is %ID/g of tissue,,,CHEMBL619681,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
8189,In vivo,13950,Intermediate,10116.0,,1,Biodistribution of [123I]-label in rat blood was reported at 24 hr post injection. Value shown is %ID/g of tissue,,,CHEMBL619682,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
8190,In vivo,13950,Intermediate,10116.0,,1,Biodistribution of [123I]-label in rat blood was reported at 4 hr post injection. Value shown is %ID/g of tissue,,,CHEMBL619683,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
8191,In vivo,13950,Intermediate,10116.0,,1,Biodistribution of [123I]-label in rat brain was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,,,CHEMBL619684,,50597,Rattus norvegicus,,,N,1,BAO_0000218,955.0
8192,In vivo,13950,Intermediate,10116.0,,1,Biodistribution of [123I]-label in rat brain was reported at 1 hr post injection. Value shown is %ID/g of tissue,,,CHEMBL619685,,50597,Rattus norvegicus,,,N,1,BAO_0000218,955.0
8193,In vivo,13950,Intermediate,10116.0,,1,Biodistribution of [123I]-label in rat brain was reported at 2 hr post injection. Value shown is %ID/g of tissue,,,CHEMBL619686,,50597,Rattus norvegicus,,,N,1,BAO_0000218,955.0
8194,In vivo,13950,Intermediate,10116.0,,1,Biodistribution of [123I]-label in rat brain was reported at 24 hr post injection. Value shown is %ID/g of tissue,,,CHEMBL619687,,50597,Rattus norvegicus,,,N,1,BAO_0000218,955.0
8195,In vivo,13950,Intermediate,10116.0,,1,Biodistribution of [123I]-label in rat brain was reported at 4 hr post injection. Value shown is %ID/g of tissue,,,CHEMBL619688,,50597,Rattus norvegicus,,,N,1,BAO_0000218,955.0
8196,In vivo,13950,Intermediate,10116.0,,1,Biodistribution of [123I]-label in rat heart was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,,,CHEMBL619689,,50597,Rattus norvegicus,,,N,1,BAO_0000218,948.0
8197,In vivo,13950,Intermediate,10116.0,,1,Biodistribution of [123I]-label in rat heart was reported at 1 hr post injection. Value shown is %ID/g of tissue,,,CHEMBL619690,,50597,Rattus norvegicus,,,N,1,BAO_0000218,948.0
8198,In vivo,13950,Intermediate,10116.0,,1,Biodistribution of [123I]-label in rat heart was reported at 2 hr post injection. Value shown is %ID/g of tissue,,,CHEMBL619691,,50597,Rattus norvegicus,,,N,1,BAO_0000218,948.0
8199,In vivo,6062,Intermediate,10116.0,,1,Terminal phase volume of distribution was measured in rat after an iv dose of 1 mg/kg,,,CHEMBL619692,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8200,,3598,Expert,10116.0,,1,Apparent volume of the central plasma compartment (Vc) of compound determined in rat after iv administration at a dose of 10 mg/kg,,,CHEMBL619693,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8201,In vivo,1908,Intermediate,10116.0,,1,Vc value after IV dose at a dose of 5 mg/kg in rats.,,,CHEMBL619694,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8202,In vivo,17596,Intermediate,10116.0,,1,Apparent volume of distribution at 10 mg/kg in rat upon intravenous administration,,,CHEMBL619695,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8203,In vivo,4891,Intermediate,10116.0,,1,Compound was evaluated for pharmacokinetic parameter volume of distribution,,,CHEMBL619696,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8204,In vivo,740,Intermediate,10116.0,,1,Compound was evaluated for volume of distribution in rat,,,CHEMBL619697,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8205,In vivo,16366,Intermediate,10116.0,,1,Steady state volume distribution was determined; steady state(ss),,,CHEMBL619698,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8206,In vivo,3364,Intermediate,10116.0,,1,Steady state volume of distribution after iv administration to rats,,,CHEMBL619699,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8207,In vivo,2552,Intermediate,10116.0,,1,Steady state volume of distribution dosing at 3 mg/kg iv,,,CHEMBL619700,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8208,In vivo,406,Intermediate,10116.0,,1,The compound was evaluated for volume of distribution in rat,,,CHEMBL619701,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8209,In vivo,12500,Intermediate,10116.0,,1,The compound was tested for volume of distribution in rat,,,CHEMBL619702,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8210,In vivo,12500,Intermediate,10116.0,,1,The compound was tested for volume of distribution in rat at dose of 3-10 mgkg,,,CHEMBL620335,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8211,In vivo,5656,Intermediate,10116.0,,1,Volume distribution (VD) after oral administration in rat,,,CHEMBL620336,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8212,In vivo,17671,Intermediate,10116.0,,1,Volume distribution of compound in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,,,CHEMBL620337,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8213,In vivo,1094,Intermediate,10116.0,,1,Volume distribution in rat,,,CHEMBL620520,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8214,In vivo,5833,Intermediate,10116.0,,1,Volume distribution in rat,,,CHEMBL620521,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8215,In vivo,5939,Intermediate,10116.0,,1,Volume distribution in rat after peroral administration at 10 mg/kg,,,CHEMBL875825,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8216,In vivo,5939,Intermediate,10116.0,,1,Volume distribution in rat after peroral administration at 5 mg/kg,,,CHEMBL620522,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8217,In vivo,6005,Intermediate,10116.0,,1,Volume distribution was evaluated after i.v. administration in rat at a dose of 1 mg/kg,,,CHEMBL620523,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8218,In vivo,1696,Intermediate,10116.0,,1,Volume of distribution in rat.,,,CHEMBL620524,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8219,In vivo,6672,Intermediate,10116.0,,1,Volume of distribution in rat,,,CHEMBL620525,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8220,In vivo,6673,Intermediate,10116.0,,1,Volume of distribution in rat,,,CHEMBL620526,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8221,In vivo,5871,Intermediate,10116.0,,1,Volume of distribution in rat by iv administration,,,CHEMBL620527,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8222,In vivo,6803,Intermediate,10116.0,,1,Volume of distribution in rats,,,CHEMBL620528,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8223,In vivo,5199,Intermediate,10116.0,,1,Volume of distribution was determined in female Sprague-Dawley rats following intravenous (iv) administration of drug (1 mg/kg).,,,CHEMBL620529,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8224,,4727,Intermediate,10116.0,,1,Volume distribution at the dose of 2 mg/kg in rat,,,CHEMBL620530,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8225,In vivo,16367,Intermediate,10116.0,,1,Steady state volume of distribution was determined,,,CHEMBL620531,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8226,In vivo,5005,Intermediate,9544.0,,1,Compound was tested for its plasma volume distribution in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po,,,CHEMBL620532,,22224,Macaca mulatta,,,U,0,BAO_0000218,
8227,In vivo,5005,Intermediate,10116.0,,1,Compound was tested for its plasma volume distribution in Sprague Dawley rats,,,CHEMBL620533,,22224,Rattus norvegicus,,,U,0,BAO_0000218,
8228,In vivo,5005,Intermediate,10116.0,,1,Compound was tested for its plasma volume distribution in Sprague Dawley rats; ND is not determined,,,CHEMBL620534,,22224,Rattus norvegicus,,,U,0,BAO_0000218,
8229,In vivo,15765,Intermediate,10116.0,,1,Mean (%CV) PK parameters for Vdss(mL/kg).,,,CHEMBL620535,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8230,In vivo,2792,Intermediate,10116.0,,1,Pharmacokinetic parameter Vdss was determined at 2 mg/kg i.v. dose in rats,,,CHEMBL875826,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8231,In vivo,2792,Intermediate,10116.0,,1,Pharmacokinetic parameter Vdss was determined at 5 mg/kg i.v. dose in rats,,,CHEMBL620536,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8232,In vivo,5334,Intermediate,10116.0,,1,Pharmacokinetic parameter volume of distribution was reported after intravenous administration at a dose of 1 mg/kg in Sprague-Dawley rat,,,CHEMBL620537,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8233,In vivo,5334,Intermediate,10116.0,,1,Pharmacokinetic parameter volume of distribution was reported in Sprague-Dawley rat; ND=Not determined,,,CHEMBL618526,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8234,In vivo,5739,Intermediate,10116.0,,1,Pharmacokinetic property (Vdss) for the compound (5 mg/kg iv) was determined in rats,,,CHEMBL618527,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8235,In vivo,5789,Intermediate,10116.0,,1,Pharmacokinetic property (Vdss) in rat,,,CHEMBL618528,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8236,In vivo,4239,Intermediate,10116.0,,1,Pharmacokinetic property (vdss) was measured in rat,,,CHEMBL618529,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8237,In vivo,4709,Intermediate,10116.0,,1,Steady state volume of distribution for the compound after intravenous administration of 1 mg/kg in rat,,,CHEMBL618530,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8238,In vivo,6642,Intermediate,10116.0,,1,Volume of distribution in rat,,,CHEMBL618531,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8239,In vivo,5247,Intermediate,10116.0,,1,The pharmacokinetic parameter volume of distribution in vivo in rats,,,CHEMBL618532,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8240,In vivo,17720,Intermediate,10116.0,,1,Vdss at a dose of 4 mg/kg in Rat Plasma after iv administration,,,CHEMBL618533,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8241,In vivo,17686,Intermediate,10116.0,,1,Vdss in rat i.v. at 2 mg/kg concentration,,,CHEMBL618534,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8242,In vivo,4689,Intermediate,10116.0,,1,Volume distribution after intravenous administration (1 mg/kg) in rat,,,CHEMBL618535,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8243,In vivo,5654,Intermediate,10116.0,,1,Volume distribution of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,,,CHEMBL618536,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8244,In vivo,5654,Intermediate,10116.0,,1,Volume distribution of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,,,CHEMBL618537,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8245,In vivo,4527,Intermediate,10116.0,,1,Volume distribution at a dose of 10 uM/kg in rat was determined,,,CHEMBL618538,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8246,In vivo,4521,Intermediate,10116.0,,1,Volume distribution in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,,,CHEMBL618539,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8247,In vivo,6057,Intermediate,10116.0,,1,Volume distribution was calculated in rat,,,CHEMBL618540,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8248,In vivo,5510,Intermediate,10116.0,,1,Volume distribution was determined,,,CHEMBL618541,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8249,In vivo,2938,Intermediate,10116.0,,1,Volume of distribution after intravenous administration was evaluated in rat,,,CHEMBL618542,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8250,In vivo,6679,Intermediate,10116.0,,1,Volume of distribution at steady state was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,,,CHEMBL622544,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8251,In vivo,6685,Intermediate,10116.0,,1,"Volume of distribution at steady state was determined in rats at 10 mg/kg, p.o. dose; n/a: not applicable",,,CHEMBL622545,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8252,In vivo,6685,Intermediate,10116.0,,1,"Volume of distribution at steady state was determined in rats at 20 mg/kg, i.p. dose; n/a: not applicable",,,CHEMBL622546,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8253,In vivo,6685,Intermediate,10116.0,,1,"Volume of distribution at steady state was determined in rats at 2 mg/kg, i.v. dose",,,CHEMBL622547,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8254,In vivo,5145,Intermediate,10116.0,,1,Volume of distribution in steady state was determined in rat,,,CHEMBL622548,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8255,In vivo,6467,Intermediate,10116.0,,1,Volume of distribution in steady state was determined in rats at the dose of 1.0 mpk by i.v. administration,,,CHEMBL622549,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8256,In vivo,6467,Intermediate,10116.0,,1,Volume of distribution in steady state was determined in rats at the dose of 1.0 mpk by i.v. administration; ND= not determined,,,CHEMBL622550,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8257,,15115,Intermediate,10090.0,,1,Compound was evaluated for area under curve when administered through oral route to mouse,,,CHEMBL622551,,50594,Mus musculus,,,N,1,BAO_0000218,
8258,,8758,Intermediate,10116.0,,1,Compound was evaluated for area under curve doses in rat at 100 mg/kg po,,,CHEMBL622552,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8259,,8758,Intermediate,10116.0,,1,Compound was evaluated for area under curve doses in rat at 50 mg/kg po,,,CHEMBL622553,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8260,In vivo,8267,Autocuration,,,1,Compound was evaluated for its bioavailability after oral administration (100 mg) to Beagle dogs,,,CHEMBL622554,,22224,,,,U,0,BAO_0000218,
8261,,8267,Intermediate,9615.0,,1,Compound was evaluated for its bioavailability after oral administration (200 mg) to Beagle dogs,,,CHEMBL622555,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
8262,,14239,Intermediate,10090.0,,1,Compound was evaluated for the area under the concentration - time curve by administering intravenously at 25 mg/kg in mice,,,CHEMBL622556,,50594,Mus musculus,,,N,1,BAO_0000218,
8263,,14239,Intermediate,10090.0,,1,Compound was evaluated for the area under the concentration - time curve by administering orally at 25 mg/kg in mice,,,CHEMBL622557,,50594,Mus musculus,,,N,1,BAO_0000218,
8264,,10754,Intermediate,10090.0,,1,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration using Area under the time-concentration curve after 40 mg/kg intramuscular administration to mice,,,CHEMBL622558,,50594,Mus musculus,,,N,1,BAO_0000218,178.0
8265,,10754,Intermediate,10090.0,,1,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration using Area under the time-concentration curve after 40 mg/kg peroral administration to mice,,,CHEMBL622559,,50594,Mus musculus,,,N,1,BAO_0000218,178.0
8266,,10754,Intermediate,9615.0,,1,Compound was evaluated in vivo in for its concentration using Area under the time-concentration curve after 40 mg/kg peroral administration to dogs.,,,CHEMBL622560,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
8267,,14681,Intermediate,10116.0,,1,Compound was tested for area under concentration -time curve from time 0 to time infinity in three male Wistar rats at a single 5 mg/kg oral gavage dose,,,CHEMBL622561,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8268,,14681,Intermediate,10116.0,,1,Compound was tested for area under concentration -time curve from time 0 to time infinity in three male Wistar rats at a single 5 mg/kg oral gavage dose. ,,,CHEMBL622562,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8269,,14681,Intermediate,10116.0,,1,Compound was tested for area under concentration -time curve from time 0 to time of last detectable concentration in three male Wistar rats at a single 5 mg/kg oral gavage dose,,,CHEMBL622563,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8270,,13118,Autocuration,,,1,Concentration of compound in Central nervous system,,,CHEMBL622564,,22224,,,,U,0,BAO_0000019,
8271,,13118,Autocuration,,,1,Concentration of compound in Central nervous system; Not detectable,,,CHEMBL622565,,22224,,,,U,0,BAO_0000019,
8272,,13318,Intermediate,10090.0,,1,"Concentration of diester in the blood, following oral administration in mice",,,CHEMBL622566,,50594,Mus musculus,,,N,1,BAO_0000218,
8273,,13318,Intermediate,10090.0,,1,"Concentration of monoester in the blood, following oral administration in mice",,,CHEMBL624515,,50594,Mus musculus,,,N,1,BAO_0000218,
8274,,13318,Intermediate,10090.0,,1,Concentration of the 9-[2-(Phosphonomethoxy)ethoxy]adenine in the blood following oral administration in mice,,,CHEMBL624516,,50594,Mus musculus,,,N,1,BAO_0000218,
8275,,15692,Autocuration,,,1,Evaluated for Pharmacokinetic property: Area under the curve,,,CHEMBL624517,,22224,,,,U,0,BAO_0000019,
8276,,14839,Intermediate,10090.0,,1,In vivo antitumor efficacy expressed as plasma area under the curve 0.4 hr after a peroral dose of 25 mg/kg in nude mice,,,CHEMBL624518,,50594,Mus musculus,,,N,1,BAO_0000218,
8277,,14839,Intermediate,9541.0,,1,In vivo antitumor efficacy expressed as plasma area under the curve 0.4 hr after iv dose of 25 mg/kg in nude mice,,,CHEMBL624519,,100710,Macaca fascicularis,,,N,1,BAO_0000218,
8278,,14839,Intermediate,9541.0,,1,In vivo antitumor efficacy in cynomolgus monkeys 0-48 hr after iv dose of 5 mg/kg expressed as Area under the curve,,,CHEMBL624520,,100710,Macaca fascicularis,,,N,1,BAO_0000218,
8279,,14839,Intermediate,9541.0,,1,In vivo antitumor efficacy in cynomolgus monkeys 0-48 hr after peroral dose of 10 mg/kg expressed as Area under the curve,,,CHEMBL624521,,100710,Macaca fascicularis,,,N,1,BAO_0000218,
8280,,14839,Intermediate,9541.0,,1,In vivo antitumor efficacy in cynomolgus monkeys 0-48 hr after peroral dose of 5 mg/kg expressed as Area under the curve,,,CHEMBL624522,,100710,Macaca fascicularis,,,N,1,BAO_0000218,
8281,,14839,Intermediate,9541.0,,1,In vivo antitumor efficacy in cynomolgus monkeys 0-8 hours after peroral dose of 25 mg/kg expressed as Area under the curve,,,CHEMBL624523,,100710,Macaca fascicularis,,,N,1,BAO_0000218,
8282,,14839,Intermediate,9541.0,,1,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 10 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-8 hr)",,,CHEMBL624409,,100710,Macaca fascicularis,,,N,1,BAO_0000218,
8283,,14839,Intermediate,9541.0,,1,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined. (0-8 hr)",,,CHEMBL624410,,100710,Macaca fascicularis,,,N,1,BAO_0000218,
8284,,14839,Intermediate,9541.0,,1,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-8 hr)",,,CHEMBL624411,,100710,Macaca fascicularis,,,N,1,BAO_0000218,
8285,,14839,Intermediate,9541.0,,1,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as the micronised free base in corn oil, iv and the total drug exposure was determined. (0-8 hr)",,,CHEMBL623531,,100710,Macaca fascicularis,,,N,1,BAO_0000218,
8286,,14839,Intermediate,9541.0,,1,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as the micronised free base in corn oil, perorally and the total drug exposure was determined (0-8 hr)",,,CHEMBL623532,,100710,Macaca fascicularis,,,N,1,BAO_0000218,
8287,,14839,Intermediate,9541.0,,1,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 5 mg/kg, as HCl salt in saline solution, intravenously and the total drug exposure was determined (0-8 hr)",,,CHEMBL623533,,100710,Macaca fascicularis,,,N,1,BAO_0000218,
8288,,14839,Intermediate,9541.0,,1,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 5 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-8 hr)",,,CHEMBL623534,,100710,Macaca fascicularis,,,N,1,BAO_0000218,
8289,,14839,Intermediate,10090.0,,1,In vivo antitumor efficacy in nude mice 0-24 hr after intravenous dose of 25 mg/kg expressed as Area under the curve,,,CHEMBL623535,,50594,Mus musculus,,,N,1,BAO_0000218,
8290,,14839,Intermediate,10090.0,,1,In vivo antitumor efficacy in nude mice 0-24 hr after iperoral dose of 25 mg/kg expressed as Area under the curve,,,CHEMBL623536,,50594,Mus musculus,,,N,1,BAO_0000218,
8291,,14839,Intermediate,10090.0,,1,In vivo antitumor efficacy in nude mice 0-24 hr after iv dose of 25 mg/kg expressed as Area under the curve,,,CHEMBL623537,,50594,Mus musculus,,,N,1,BAO_0000218,
8292,,14839,Intermediate,10090.0,,1,In vivo antitumor efficacy in nude mice 0-24 hr after peroral dose of 25 mg/kg expressed as Area under the curve,,,CHEMBL623538,,50594,Mus musculus,,,N,1,BAO_0000218,
8293,,14839,Intermediate,10090.0,,1,In vivo antitumor efficacy in nude mice after peroral dose of 10 mg/kg expressed as Area under the curve,,,CHEMBL623539,,50594,Mus musculus,,,N,1,BAO_0000218,
8294,,14839,Intermediate,10090.0,,1,In vivo antitumor efficacy in nude mice after peroral dose of 25 mg/kg expressed as Area under the curve,,,CHEMBL623540,,50594,Mus musculus,,,N,1,BAO_0000218,
8295,,14839,Intermediate,10090.0,,1,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined.",,,CHEMBL623541,,50594,Mus musculus,,,N,1,BAO_0000218,
8296,,14839,Intermediate,10090.0,,1,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined. (0-24hr)",,,CHEMBL623542,,50594,Mus musculus,,,N,1,BAO_0000218,
8297,,14839,Intermediate,10090.0,,1,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined. (0-4 hr)",,,CHEMBL623543,,50594,Mus musculus,,,N,1,BAO_0000218,
8298,,14839,Intermediate,10090.0,,1,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined",,,CHEMBL623544,,50594,Mus musculus,,,N,1,BAO_0000218,
8299,,14839,Intermediate,10090.0,,1,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-24hr)",,,CHEMBL623545,,50594,Mus musculus,,,N,1,BAO_0000218,
8300,,14839,Intermediate,10090.0,,1,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-4 hr)",,,CHEMBL623546,,50594,Mus musculus,,,N,1,BAO_0000218,
8301,In vivo,5408,Intermediate,10116.0,,1,Evaluated for plasma clearance after iv administration of 5 mg/kg to male Sprague-Dawley rats,,,CHEMBL623547,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
8302,In vivo,6827,Intermediate,10116.0,,1,High i.v. clearance in Dawley rats,,,CHEMBL623548,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8303,In vitro,17538,Intermediate,10116.0,,1,In vitro clearance in rat liver microsomes,,,CHEMBL623549,Microsomes,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
8304,In vitro,6331,Intermediate,10116.0,,1,Intrinsic clearance in rat liver microsomes was determined,,,CHEMBL623550,Microsomes,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
8305,In vitro,5948,Intermediate,10116.0,,1,Intrinsic clearance in rat hepatocytes was determined,401.0,,CHEMBL875276,,50597,Rattus norvegicus,Hepatocyte,,N,1,BAO_0000218,2107.0
8306,In vivo,4026,Intermediate,10116.0,,1,Plasma Clearance was determined,,,CHEMBL621872,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8307,In vivo,6647,Intermediate,10116.0,,1,Plasma clearance after intravenous administration of 0.4 mg/kg of dose in rats was determined,,,CHEMBL621873,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8308,In vivo,1696,Intermediate,10116.0,,1,Plasma clearance in rat.,,,CHEMBL621874,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8309,In vivo,6597,Intermediate,10116.0,,1,Plasma clearance in rats,,,CHEMBL621875,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8310,In vivo,347,Intermediate,10116.0,,1,Plasma clearance was estimated from the AUC after 5 mg/kg intravenous dosing in rats,,,CHEMBL621876,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8311,In vivo,16423,Intermediate,10116.0,,1,Plasma clearance was evaluated after 10 uM/kg of intra arterial administration,,,CHEMBL621877,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8312,In vivo,2879,Intermediate,10116.0,,1,Plasma clearance was measured in rat,,,CHEMBL621878,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8313,In vivo,4883,Intermediate,10116.0,,1,Clearance after iv administration to Sprague-Dawley rat at dosage of 0.2 mg/kg,,,CHEMBL621879,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8314,In vivo,5328,Intermediate,10116.0,,1,"Tested for the plasma clearance in Dawley rat at a dose of 1 mg/kg intravenous, 2 mg/kg orally",,,CHEMBL621880,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
8315,In vivo,5160,Intermediate,10116.0,,1,The clearance rate in mature male rat at a intravenous dose of 3 mg/kg,,,CHEMBL621881,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8316,In vivo,17582,Intermediate,10116.0,,1,Total body clearance was evaluated for the compound after i.v. administration at a dose of 5 mg/kg was measured in rats,,,CHEMBL621882,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8317,In vivo,17651,Intermediate,10116.0,,1,Total clearance at 1 mg/kg was determined in rat,,,CHEMBL875283,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8318,In vivo,17651,Intermediate,10116.0,,1,Total clearance at 10 mg/kg was determined in rat,,,CHEMBL621883,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8319,In vivo,6596,Intermediate,10116.0,,1,Clearance in rat,,,CHEMBL621884,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8320,In vivo,4796,Intermediate,10116.0,,1,Plasma clearance rate determined in rats,,,CHEMBL621885,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8321,In vivo,6850,Intermediate,10116.0,,1,Clearance of compound in rat was evaluated,,,CHEMBL621886,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8322,In vivo,5932,Intermediate,10116.0,,1,Plasma concentration in rats after 7 hr at 30mg/kg oral dose,,,CHEMBL621887,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
8323,In vivo,3371,Intermediate,10116.0,,1,Pharmacokinetic property (blood clearance) in rat,,,CHEMBL621888,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8324,In vivo,2083,Intermediate,10116.0,,1,Plasma clearance in rat,,,CHEMBL621889,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8325,In vivo,4942,Intermediate,10116.0,,1,Plasma clearance in rats,,,CHEMBL621890,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8326,In vitro,6838,Intermediate,10116.0,,1,Intrinsic clearance of compound against NADPH-fortified rat liver microsomes,,,CHEMBL621891,Microsomes,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
8327,In vivo,5353,Intermediate,10116.0,,1,Clearance in Dawley rat,,,CHEMBL621892,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8328,In vivo,6641,Intermediate,10116.0,,1,Clearance rat,,,CHEMBL621893,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8329,In vivo,6641,Intermediate,10116.0,,1,Clearance rat (dosed at 0.5 mpk IV and 2.0 mpk po.),,,CHEMBL621894,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8330,In vivo,6641,Intermediate,10116.0,,1,Clearance rat; Not determined,,,CHEMBL621895,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8331,In vivo,6444,Intermediate,10116.0,,1,Clearance rate was determined in rat at a dose of 1 mpk i.v.,,,CHEMBL875284,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8332,In vivo,6444,Intermediate,10116.0,,1,Clearance rate was determined in rat at a dose of 1 mpk i.v.; ND means not determined,,,CHEMBL618699,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8333,In vivo,6444,Intermediate,10116.0,,1,Clearance rate was determined in rat at a dose of 1 mpk i.v.; ND=not determined,,,CHEMBL618700,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8334,In vivo,6211,Intermediate,10116.0,,1,Clearance was determined by iv administration (1.5 mg/kg) in fasted male Sprague-Dawley rats,,,CHEMBL618701,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8335,In vivo,12873,Intermediate,10116.0,,1,"Clearance in plasma calculated from Time-Course plasma concentrations in rats at a dose of 2.5 mg/kg, iv",,,CHEMBL876600,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
8336,In vivo,6570,Intermediate,10116.0,,1,Clearance of compound in rat after 1 mg/kg i.v. administration,,,CHEMBL618702,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8337,In vivo,3341,Intermediate,10116.0,,1,Compound was evaluated for Hepatic clearance in rat,,,CHEMBL618703,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8338,In vivo,4891,Intermediate,10116.0,,1,In vivo clearance after 5 mg/kg dose,,,CHEMBL618704,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8339,In vivo,1094,Intermediate,10116.0,,1,Compound was tested for plasma clearance in rats,,,CHEMBL618705,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
8340,In vivo,2938,Intermediate,10116.0,,1,Hepatic clearance after intravenous administration was evaluated in rat,,,CHEMBL618706,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8341,In vivo,17853,Intermediate,10116.0,,1,Lower clearance in rat (i.v.) at 0.5 mpk,,,CHEMBL618707,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8342,In vivo,6049,Intermediate,10116.0,,1,Pharmacokinetic parameter expressed as plasma clearance in rat,,,CHEMBL618708,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
8343,In vivo,5789,Intermediate,10116.0,,1,Pharmacokinetic property (Clp) in rat,,,CHEMBL618709,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8344,In vivo,4514,Intermediate,10116.0,,1,Plasma clearance in Sprague-Dawley rats,,,CHEMBL618710,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8345,In vivo,6448,Intermediate,10116.0,,1,Plasma clearance (Clp) in rat,,,CHEMBL618711,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8346,In vivo,6062,Intermediate,10116.0,,1,Plasma clearance for the compound was measured in rat after an iv dose of 1 mg/kg,,,CHEMBL618712,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8347,In vivo,5710,Intermediate,10116.0,,1,Plasma clearance in fasted male Sprague dawely rats on administration of 0.5 mg/Kg i.v. of the compound,,,CHEMBL618713,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8348,In vivo,4709,Intermediate,10116.0,,1,Plasma clearance after intravenous administration of 1 mg/kg in rat,,,CHEMBL618714,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8349,In vivo,4521,Intermediate,10116.0,,1,Plasma clearance in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,,,CHEMBL618715,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8350,In vivo,1742,Intermediate,10116.0,,1,Plasma clearance in rat was determined,,,CHEMBL618716,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8351,In vivo,6057,Intermediate,10116.0,,1,Plasma clearance measured in rat,,,CHEMBL876601,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8352,In vivo,6057,Intermediate,10116.0,,1,Plasma clearance was calculated in rat,,,CHEMBL618717,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8353,In vivo,5145,Intermediate,10116.0,,1,Plasma clearance in rat,,,CHEMBL618718,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8354,In vivo,5833,Intermediate,10116.0,,1,Plasma clearance in rat,,,CHEMBL618719,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8355,In vivo,6453,Intermediate,10116.0,,1,Plasma clearance in rat,,,CHEMBL618720,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8356,In vivo,6640,Intermediate,10116.0,,1,Plasma clearance in rat,,,CHEMBL618721,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8357,In vivo,6305,Intermediate,10116.0,,1,Plasma clearance in rats,,,CHEMBL621477,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8358,In vivo,6642,Intermediate,10116.0,,1,Plasma clearance in rat,,,CHEMBL621478,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8359,In vivo,5472,Intermediate,10116.0,,1,Plasma clearance was evaluated in rat,,,CHEMBL621479,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8360,In vivo,5472,Intermediate,10116.0,,1,Plasma clearance was evaluated in rat; Not tested,,,CHEMBL621480,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8361,In vivo,5144,Intermediate,10116.0,,1,Plasma clearance rate was determined for the compound in rat,,,CHEMBL621481,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8362,In vivo,6685,Intermediate,10116.0,,1,"Plasma clearance rate was determined in rats at 10mg/kg, p.o. dose; n/a: not applicable",,,CHEMBL621482,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8363,In vivo,6685,Intermediate,10116.0,,1,"Plasma clearance rate was determined in rats at 20 mg/kg, i.p. dose; n/a: not applicable",,,CHEMBL621483,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8364,In vivo,6685,Intermediate,10116.0,,1,"Plasma clearance rate was determined in rats at 2 mg/kg, i.v. dose",,,CHEMBL621484,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8365,In vivo,13950,Intermediate,10116.0,,1,Biodistribution of [123I]-label in rat heart was reported at 24 hr post injection. Value shown is %ID/g of tissue,,,CHEMBL621485,,50597,Rattus norvegicus,,,N,1,BAO_0000218,948.0
8366,In vivo,13950,Intermediate,10116.0,,1,Biodistribution of [123I]-label in rat heart was reported at 4 hr post injection. Value shown is %ID/g of tissue,,,CHEMBL621486,,50597,Rattus norvegicus,,,N,1,BAO_0000218,948.0
8367,In vivo,13950,Intermediate,10116.0,,1,Biodistribution of [123I]-label in rat intestine was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,,,CHEMBL621487,,50597,Rattus norvegicus,,,N,1,BAO_0000218,160.0
8368,In vivo,13950,Intermediate,10116.0,,1,Biodistribution of [123I]-label in rat intestine was reported at 1 hr post injection. Value shown is %ID/g of tissue,,,CHEMBL621488,,50597,Rattus norvegicus,,,N,1,BAO_0000218,160.0
8369,In vivo,13950,Intermediate,10116.0,,1,Biodistribution of [123I]-label in rat intestine was reported at 2 hr post injection. Value shown is %ID/g of tissue,,,CHEMBL621489,,50597,Rattus norvegicus,,,N,1,BAO_0000218,160.0
8370,In vivo,13950,Intermediate,10116.0,,1,Biodistribution of [123I]-label in rat intestine was reported at 24 hr post injection. Value shown is %ID/g of tissue,,,CHEMBL621490,,50597,Rattus norvegicus,,,N,1,BAO_0000218,160.0
8371,In vivo,13950,Intermediate,10116.0,,1,Biodistribution of [123I]-label in rat intestine was reported at 4 hr post injection. Value shown is %ID/g of tissue,,,CHEMBL621491,,50597,Rattus norvegicus,,,N,1,BAO_0000218,160.0
8372,In vivo,13950,Intermediate,10116.0,,1,Biodistribution of [123I]-label in rat kidneys was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,,,CHEMBL621492,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2113.0
8373,In vivo,13950,Intermediate,10116.0,,1,Biodistribution of [123I]-label in rat kidneys was reported at 1 h post injection. Value shown is %ID/g of tissue,,,CHEMBL621493,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2113.0
8374,In vivo,13950,Intermediate,10116.0,,1,Biodistribution of [123I]-label in rat kidneys was reported at 2 hr post injection. Value shown is %ID/g of tissue,,,CHEMBL621494,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2113.0
8375,In vivo,13950,Intermediate,10116.0,,1,Biodistribution of [123I]-label in rat kidneys was reported at 24 hr post injection. Value shown is %ID/g of tissue,,,CHEMBL621495,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2113.0
8376,In vivo,13950,Intermediate,10116.0,,1,Biodistribution of [123I]-label in rat kidneys was reported at 4 hr post injection. Value shown is %ID/g of tissue,,,CHEMBL621496,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2113.0
8377,In vivo,13950,Intermediate,10116.0,,1,Biodistribution of [123I]-label in rat liver was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,,,CHEMBL621497,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
8378,In vivo,13950,Intermediate,10116.0,,1,Biodistribution of [123I]-label in rat liver was reported at 1 hr post injection. Value shown is %ID/g of tissue,,,CHEMBL621498,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
8379,In vivo,13950,Intermediate,10116.0,,1,Biodistribution of [123I]-label in rat liver was reported at 2 hr post injection. Value shown is %ID/g of tissue,,,CHEMBL621499,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
8380,In vivo,13950,Intermediate,10116.0,,1,Biodistribution of [123I]-label in rat liver was reported at 24 h post injection. Value shown is %ID/g of tissue,,,CHEMBL618634,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
8381,In vivo,13950,Intermediate,10116.0,,1,Biodistribution of [123I]-label in rat liver was reported at 4 hr post injection. Value shown is %ID/g of tissue,,,CHEMBL618635,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
8382,In vivo,13950,Intermediate,10116.0,,1,Biodistribution of [123I]-label in rat lung was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,,,CHEMBL618636,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2048.0
8383,In vivo,13950,Intermediate,10116.0,,1,Biodistribution of [123I]-label in rat lung was reported at 1 hr post injection. Value shown is %ID/g of tissue,,,CHEMBL619737,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2048.0
8384,In vivo,13950,Intermediate,10116.0,,1,Biodistribution of [123I]-label in rat lung was reported at 2 hr post injection. Value shown is %ID/g of tissue,,,CHEMBL619738,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2048.0
8385,In vivo,13950,Intermediate,10116.0,,1,Biodistribution of [123I]-label in rat lung was reported at 24 hr post injection. Value shown is %ID/g of tissue,,,CHEMBL624329,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2048.0
8386,In vivo,13950,Intermediate,10116.0,,1,Biodistribution of [123I]-label in rat lung was reported at 4 hr post injection. Value shown is %ID/g of tissue,,,CHEMBL624330,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2048.0
8387,In vivo,13950,Intermediate,10116.0,,1,Biodistribution of [123I]-label in rat muscle was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,,,CHEMBL624331,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2385.0
8388,In vivo,13950,Intermediate,10116.0,,1,Biodistribution of [123I]-label in rat muscle was reported at 1 hr post injection. Value shown is %ID/g of tissue,,,CHEMBL624332,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2385.0
8389,In vivo,13950,Intermediate,10116.0,,1,Biodistribution of [123I]-label in rat muscle was reported at 2 hr post injection. Value shown is %ID/g of tissue,,,CHEMBL624333,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2385.0
8390,In vivo,13950,Intermediate,10116.0,,1,Biodistribution of [123I]-label in rat muscle was reported at 24 hr post injection. Value shown is %ID/g of tissue,,,CHEMBL624334,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2385.0
8391,In vivo,13950,Intermediate,10116.0,,1,Biodistribution of [123I]-label in rat muscle was reported at 4 hr post injection. Value shown is %ID/g of tissue,,,CHEMBL624335,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2385.0
8392,In vivo,13950,Intermediate,10116.0,,1,Biodistribution of [123I]-label in rat spleen was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,,,CHEMBL620016,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2106.0
8393,In vivo,13950,Intermediate,10116.0,,1,Biodistribution of [123I]-label in rat spleen was reported at 1 hr post injection. Value shown is %ID/g of tissue,,,CHEMBL620169,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2106.0
8394,In vivo,13950,Intermediate,10116.0,,1,Biodistribution of [123I]-label in rat spleen was reported at 2 hr post injection. Value shown is %ID/g of tissue,,,CHEMBL620170,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2106.0
8395,In vivo,13950,Intermediate,10116.0,,1,Biodistribution of [123I]-label in rat spleen was reported at 24 h post injection. Value shown is %ID/g of tissue,,,CHEMBL620171,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2106.0
8396,In vivo,13950,Intermediate,10116.0,,1,Biodistribution of [123I]-label in rat spleen was reported at 4 hr post injection. Value shown is %ID/g of tissue,,,CHEMBL620172,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2106.0
8397,In vivo,13950,Intermediate,10116.0,,1,Biodistribution of [123I]-label in rat stomach was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,,,CHEMBL620173,,50597,Rattus norvegicus,,,N,1,BAO_0000218,945.0
8398,In vivo,13950,Intermediate,10116.0,,1,Biodistribution of [123I]-label in rat stomach was reported at 1 h post injection. Value shown is %ID/g of tissue,,,CHEMBL620174,,50597,Rattus norvegicus,,,N,1,BAO_0000218,945.0
8399,In vivo,13950,Intermediate,10116.0,,1,Biodistribution of [123I]-label in rat stomach was reported at 2 hr post injection. Value shown is %ID/g of tissue,,,CHEMBL620175,,50597,Rattus norvegicus,,,N,1,BAO_0000218,945.0
8400,In vivo,13950,Intermediate,10116.0,,1,Biodistribution of [123I]-label in rat stomach was reported at 24 hr post injection. Value shown is %ID/g of tissue,,,CHEMBL620176,,50597,Rattus norvegicus,,,N,1,BAO_0000218,945.0
8401,In vivo,13950,Intermediate,10116.0,,1,Biodistribution of [123I]-label in rat stomach was reported at 4 hr post injection. Value shown is %ID/g of tissue,,,CHEMBL620177,,50597,Rattus norvegicus,,,N,1,BAO_0000218,945.0
8402,,13950,Intermediate,10116.0,,1,Distribution of [123I]-label in rat brain (cerebellum) was reported at 20 min post injection. Value shown is %ID/g of tissue,,,CHEMBL620178,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2037.0
8403,,13950,Intermediate,10116.0,,1,Distribution of [123I]-label in rat brain (cerebellum) was reported at 60 min post injection. Value shown is %ID/g of tissue,,,CHEMBL620179,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2037.0
8404,,13950,Intermediate,10116.0,,1,Distribution of [123I]-label in rat brain (diencephalon) was reported at 20 min post injection. Value shown is %ID/g of tissue,,,CHEMBL620180,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8405,In vivo,6570,Intermediate,10116.0,,1,Volume of distribution of compound in rat after 1 mg/kg i.v. administration,,,CHEMBL620181,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8406,In vivo,6571,Intermediate,10116.0,,1,Volume of distribution of compound in rats after intravenous administration,,,CHEMBL620182,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8407,In vivo,6453,Intermediate,10116.0,,1,Volume of distribution in rat,,,CHEMBL620183,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8408,In vivo,6444,Intermediate,10116.0,,1,Volume of distribution was determined in rat at a dose of 1 mpk i.v.,,,CHEMBL620184,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8409,In vivo,6444,Intermediate,10116.0,,1,Volume of distribution was determined in rat at a dose of 1 mpk i.v.; ND means not determined,,,CHEMBL620185,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8410,In vivo,6444,Intermediate,10116.0,,1,Volume of distribution was determined in rat at a dose of 1 mpk i.v.; ND=not determined,,,CHEMBL620186,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8411,In vivo,5353,Intermediate,10116.0,,1,Volume of distribution was determined in Dawley rat,,,CHEMBL620187,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8412,In vivo,5334,Intermediate,10116.0,,1,Volume of distribution was reported after oral administration at a dose of 2 mg/kg in Sprague-Dawley rat,,,CHEMBL620188,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8413,In vivo,5334,Intermediate,10116.0,,1,Volume of distribution was reported in Sprague-Dawley rat,,,CHEMBL620189,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8414,In vivo,6641,Intermediate,10116.0,,1,Volumes of distribution in rat after peroral administration,,,CHEMBL620190,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8415,In vivo,6641,Intermediate,10116.0,,1,Volumes of distribution in rat after po administration,,,CHEMBL620191,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8416,In vivo,6641,Intermediate,10116.0,,1,Volumes of distribution in rat after po administration; Not determined,,,CHEMBL620192,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8417,In vivo,5676,Intermediate,10116.0,,1,Pharmacokinetic property (Volume) in rat i.v.,,,CHEMBL620193,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8418,In vivo,6410,Intermediate,10116.0,,1,Apparent volume of distribution when 3 mg/Kg dose was administered intravenously,,,CHEMBL620194,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8419,In vivo,17670,Intermediate,10116.0,,1,"Volume distribution in fischer rats at 5 mg/kg dose, administered intravenously",,,CHEMBL876730,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8420,In vivo,6495,Intermediate,10116.0,,1,Volume distribution in rat after oral administration at 10 mg/kg,,,CHEMBL620195,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8421,In vivo,5408,Intermediate,10116.0,,1,Evaluated for Volume of distribution after iv administration of 5 mg/kg to male Sprague-Dawley rats,,,CHEMBL620196,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8422,In vivo,4883,Intermediate,10116.0,,1,Tested for volume of distribution after intravenous administration to Sprague-Dawley rat at dosage of 0.2 mg/kg,,,CHEMBL620197,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8423,In vivo,6647,Intermediate,10116.0,,1,Volume of distribution after oral administration of 6 mg/kg of dose in rats was determined,,,CHEMBL620198,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8424,In vivo,6495,Intermediate,10116.0,,1,Volume of distribution in rats,,,CHEMBL620199,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8425,In vivo,2661,Intermediate,10116.0,,1,Compound was evaluated for volume of distribution (steady state) after treatment with iv dose of 1 mgkg to female wistar rats,,,CHEMBL620200,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8426,In vivo,2661,Intermediate,10116.0,,1,Compound was evaluated for volume of distribution (steady state) after treatment with iv dose of 1 mgkg to male wistar rats,,,CHEMBL620201,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8427,In vivo,5974,Intermediate,10116.0,,1,In vivo Volume distribution (Vss) was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,,,CHEMBL620202,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8428,In vivo,5974,Intermediate,10116.0,,1,In vivo Volume distribution (Vss) was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,,,CHEMBL620203,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8429,In vivo,5974,Intermediate,10116.0,,1,In vivo Volume distribution (Vss) was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat;no value,,,CHEMBL620204,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8430,In vivo,5974,Intermediate,10116.0,,1,In vivo Volume distribution (Vss) was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,,,CHEMBL620205,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8431,In vivo,5960,Intermediate,10116.0,,1,Pharmacokinetic parameter (Vss) in rat,,,CHEMBL624664,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8432,In vivo,5676,Intermediate,10116.0,,1,Pharmacokinetic property (Volume) in rat i.v.,,,CHEMBL624665,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8433,,5948,Intermediate,10116.0,,1,Pharmacokinetic property (Vss) in rat,,,CHEMBL624666,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8434,In vivo,5979,Intermediate,10116.0,,1,Steady state volume distribution (Vss) of compound after 2 hr iv infusion of 8.4 mg/kg in three rat,,,CHEMBL624667,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8435,In vivo,5978,Intermediate,10116.0,,1,Steady state volume distribution (Vss) of compound after iv administration was determined in Sprague-Dawley rat,,,CHEMBL624668,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8436,In vivo,5978,Intermediate,10116.0,,1,Steady state volume distribution (Vss) of compound (10 mg/kg) after iv administration was determined in Sprague-Dawley rat,,,CHEMBL624669,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8437,In vivo,5978,Intermediate,10116.0,,1,Steady state volume distribution (Vss) of compound(9.83 mg/kg) after iv administration was determined in Sprague-Dawley rat,,,CHEMBL624670,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8438,In vivo,5978,Intermediate,10116.0,,1,Steady state volume distribution (Vss) of compound(9.84 mg/kg) after iv administration was determined in Sprague-Dawley rat,,,CHEMBL624671,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8439,In vivo,6448,Intermediate,10116.0,,1,Steady state volume distribution in rat,,,CHEMBL624672,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8440,In vivo,12873,Intermediate,10116.0,,1,"Steady state volume of distribution calculated from Time-Course plasma concentrations in rats at a dose of 2.5 mg/kg, iv.",,,CHEMBL624673,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
8441,In vivo,4576,Intermediate,10116.0,,1,Steady state volume of distribution determined in rat,,,CHEMBL624674,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8442,In vivo,17582,Intermediate,10116.0,,1,Steady-state volume of distribution was evaluated for the compound after i.v. administration at a dose of 5 mg/kg was measured in rats,,,CHEMBL624675,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8443,In vivo,1466,Intermediate,10116.0,,1,Tested for volume of distribution at steady state upon intravenous administration of 5.0 mg/Kg dose in rat,,,CHEMBL621728,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8444,,5182,Intermediate,10116.0,,1,Volume at steady state distribution by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat was determined,,,CHEMBL621729,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8445,,5182,Intermediate,10116.0,,1,Volume at steady state distribution by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat was determined; NC means not calculated,,,CHEMBL621730,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8446,In vivo,6535,Intermediate,10116.0,,1,Volume distribution in rat after administration of 2 mg/kg iv,,,CHEMBL621731,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8447,In vivo,6535,Intermediate,10116.0,,1,Volume distribution in rat after administration of 2 mg/kg iv,,,CHEMBL621732,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8448,In vivo,5041,Intermediate,10116.0,,1,Volume in steady state distribution value was determined,,,CHEMBL621908,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8449,In vivo,5041,Intermediate,10116.0,,1,Volume in steady state distribution value was determined; ND denotes no data,,,CHEMBL875347,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8450,In vivo,5041,Intermediate,10116.0,,1,Volume in steady state distribution value was determined; ND denotes not determined,,,CHEMBL621909,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8451,In vivo,17065,Intermediate,10116.0,,1,Volume of distribution at a steady state measured after intravenous bolus administration of 50 mg/kg of compound to rats,,,CHEMBL621910,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8452,In vivo,6597,Intermediate,10116.0,,1,Volume of distribution at steady state was evaluated in rats,,,CHEMBL621911,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8453,In vivo,15662,Intermediate,10116.0,,1,Volume of distribution at steady state was observed after intravenous administration in rat,,,CHEMBL621912,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8454,In vivo,6485,Intermediate,10116.0,,1,Volume of distribution in steady state was determined in rat,,,CHEMBL621913,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8455,In vivo,17655,Intermediate,10116.0,,1,Volume of distribution in steady state was determined in rat,,,CHEMBL621914,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8456,In vivo,6616,Intermediate,10116.0,,1,Volume of distribution after i.v. administration,,,CHEMBL621915,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8457,In vivo,1916,Intermediate,10116.0,,1,Volume of distribution was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after iv administration,,,CHEMBL621916,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8458,In vivo,16438,Intermediate,10090.0,,1,"Biodistribution of compound (oxidized form) in liver tissues, animals were sacrificed 60 minutes after dosing, in DMSO solution",,,CHEMBL621917,,50594,Mus musculus,,,N,1,BAO_0000218,2107.0
8459,In vivo,16438,Intermediate,10090.0,,1,"Biodistribution of compound (oxidized form) in liver tissues, animals were sacrificed 60 minutes after dosing, in DMSO sol.",,,CHEMBL621918,,50594,Mus musculus,,,N,1,BAO_0000218,2107.0
8460,In vivo,16438,Intermediate,10090.0,,1,Biodistribution of compound (oxidized form) in spleen tissue,,,CHEMBL621919,,50594,Mus musculus,,,N,1,BAO_0000218,2106.0
8461,In vivo,16438,Intermediate,10090.0,,1,"Biodistribution of compound (oxidized form) in spleen tissue, animals were sacrificed 10 minutes after dosing, in DMSO sol.",,,CHEMBL621920,,50594,Mus musculus,,,N,1,BAO_0000218,2106.0
8462,In vivo,16438,Intermediate,10090.0,,1,"Biodistribution of compound (oxidized form) in spleen tissue, animals were sacrificed 10 minutes after dosing, in DMSO solution",,,CHEMBL621921,,50594,Mus musculus,,,N,1,BAO_0000218,2106.0
8463,In vivo,16438,Intermediate,10090.0,,1,"Biodistribution of compound (oxidized form) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO",,,CHEMBL622401,,50594,Mus musculus,,,N,1,BAO_0000218,2106.0
8464,In vivo,16438,Intermediate,10090.0,,1,"Biodistribution of compound (oxidized form) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO sol.",,,CHEMBL875348,,50594,Mus musculus,,,N,1,BAO_0000218,2106.0
8465,In vivo,16438,Intermediate,10090.0,,1,"Biodistribution of compound (oxidized form) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO solution",,,CHEMBL622402,,50594,Mus musculus,,,N,1,BAO_0000218,2106.0
8466,In vivo,16438,Intermediate,10090.0,,1,Biodistribution of compound (total concentration of both oxidized and reduced forms) in blood,,,CHEMBL622403,,50594,Mus musculus,,,N,1,BAO_0000218,178.0
8467,In vivo,16438,Intermediate,10090.0,,1,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in blood tissues, animals were sacrificed 60 minutes after dosing, in DMSO",,,CHEMBL622404,,50594,Mus musculus,,,N,1,BAO_0000218,178.0
8468,In vivo,16438,Intermediate,10090.0,,1,Biodistribution of compound (total concentration of both oxidized and reduced forms) in brain tissues,,,CHEMBL622405,,50594,Mus musculus,,,N,1,BAO_0000218,955.0
8469,In vivo,16438,Intermediate,10090.0,,1,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in brain tissues, animals were sacrificed 10 minutes after dosing, in DMSO",,,CHEMBL622406,,50594,Mus musculus,,,N,1,BAO_0000218,955.0
8470,In vivo,16438,Intermediate,10090.0,,1,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in brain tissues, animals were sacrificed 60 minutes after dosing, in DMSO",,,CHEMBL622407,,50594,Mus musculus,,,N,1,BAO_0000218,955.0
8471,In vivo,16438,Intermediate,10090.0,,1,Biodistribution of compound (total concentration of both oxidized and reduced forms) in heart tissues,,,CHEMBL622408,,50594,Mus musculus,,,N,1,BAO_0000218,948.0
8472,In vivo,16438,Intermediate,10090.0,,1,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in heart tissues, animals were sacrificed 10 minutes after dosing, in DMSO",,,CHEMBL622409,,50594,Mus musculus,,,N,1,BAO_0000218,948.0
8473,In vivo,16438,Intermediate,10090.0,,1,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in heart tissues, animals were sacrificed 60 minutes after dosing, in DMSO",,,CHEMBL622410,,50594,Mus musculus,,,N,1,BAO_0000218,948.0
8474,In vivo,16438,Intermediate,10090.0,,1,Biodistribution of compound (total concentration of both oxidized and reduced forms) in kidney,,,CHEMBL622411,,50594,Mus musculus,,,N,1,BAO_0000218,2113.0
8475,In vivo,16438,Intermediate,10090.0,,1,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in kidney tissues, animals were sacrificed 60 minutes after dosing in DMSO",,,CHEMBL627864,,50594,Mus musculus,,,N,1,BAO_0000218,2113.0
8476,In vivo,16438,Intermediate,10090.0,,1,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in kidney tissues, animals were sacrificed 60 minutes after dosing, in DMSO",,,CHEMBL627865,,50594,Mus musculus,,,N,1,BAO_0000218,2113.0
8477,In vivo,16438,Intermediate,10090.0,,1,Biodistribution of compound (total concentration of both oxidized and reduced forms) in liver,,,CHEMBL627866,,50594,Mus musculus,,,N,1,BAO_0000218,2107.0
8478,In vivo,16438,Intermediate,10090.0,,1,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in liver tissues, animals were sacrificed 60 minutes after dosing, in DMSO",,,CHEMBL627751,,50594,Mus musculus,,,N,1,BAO_0000218,2107.0
8479,In vivo,16438,Intermediate,10090.0,,1,Biodistribution of compound (total concentration of both oxidized and reduced forms) in spleen,,,CHEMBL627752,,50594,Mus musculus,,,N,1,BAO_0000218,2106.0
8480,In vivo,16438,Intermediate,10090.0,,1,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in spleen tissues, animals were sacrificed 60 minutes after dosing in DMSO",,,CHEMBL627753,,50594,Mus musculus,,,N,1,BAO_0000218,2106.0
8481,In vivo,16438,Intermediate,10090.0,,1,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO",,,CHEMBL627754,,50594,Mus musculus,,,N,1,BAO_0000218,2106.0
8482,,12467,Intermediate,10090.0,,1,Cellular uptake kinetics of Porphycenes saturation cell level (cs) in SSK2 murine fibrosarcoma cells,,,CHEMBL627755,,50594,Mus musculus,,,N,1,BAO_0000218,
8483,In vivo,17208,Intermediate,10090.0,,1,Biodistribution of radioactivity in normal mice (ICR) brain after 1 hour of intravenous injection of [125I]-16(IMPY),,,CHEMBL627756,,50594,Mus musculus,,,N,1,BAO_0000218,955.0
8484,In vivo,17208,Intermediate,10090.0,,1,Biodistribution of radioactivity in normal mice (ICR) brain after 2 hours of intravenous injection of [125I]-16(IMPY),,,CHEMBL627757,,50594,Mus musculus,,,N,1,BAO_0000218,955.0
8485,In vivo,17208,Intermediate,10090.0,,1,Biodistribution of radioactivity in normal mice (ICR) brain after 2 minutes of intravenous injection of [125I]-16(IMPY),,,CHEMBL627758,,50594,Mus musculus,,,N,1,BAO_0000218,955.0
8486,In vivo,17208,Intermediate,10090.0,,1,Biodistribution of radioactivity in normal mice (ICR) brain after 24 hours of intravenous injection of [125I]-16(IMPY),,,CHEMBL627759,,50594,Mus musculus,,,N,1,BAO_0000218,955.0
8487,In vivo,17208,Intermediate,10090.0,,1,Biodistribution of radioactivity in normal mice (ICR) brain after 30 minutes of intravenous injection of [125I]-16(IMPY),,,CHEMBL627760,,50594,Mus musculus,,,N,1,BAO_0000218,955.0
8488,In vivo,17208,Intermediate,10090.0,,1,Biodistribution of radioactivity in normal mice (ICR) brain after 6 hours of intravenous injection of [125I]-16(IMPY),,,CHEMBL627761,,50594,Mus musculus,,,N,1,BAO_0000218,955.0
8489,In vivo,17208,Intermediate,10090.0,,1,Biodistribution of radioactivity in normal mice (ICR) heart after 1 hour of intravenous injection of [125I]-16(IMPY),,,CHEMBL876811,,50594,Mus musculus,,,N,1,BAO_0000218,948.0
8490,In vivo,17208,Intermediate,10090.0,,1,Biodistribution of radioactivity in normal mice (ICR) heart after 2 hours of intravenous injection of [125I]-16(IMPY),,,CHEMBL627762,,50594,Mus musculus,,,N,1,BAO_0000218,948.0
8491,In vivo,17208,Intermediate,10090.0,,1,Biodistribution of radioactivity in normal mice (ICR) heart after 2 minutes of intravenous injection of [125I]-16(IMPY),,,CHEMBL627763,,50594,Mus musculus,,,N,1,BAO_0000218,948.0
8492,In vivo,17208,Intermediate,10090.0,,1,Biodistribution of radioactivity in normal mice (ICR) heart after 24 hours of intravenous injection of [125I]-16(IMPY),,,CHEMBL627764,,50594,Mus musculus,,,N,1,BAO_0000218,948.0
8493,In vivo,17208,Intermediate,10090.0,,1,Biodistribution of radioactivity in normal mice (ICR) heart after 30 minutes of intravenous injection of [125I]-16(IMPY),,,CHEMBL627765,,50594,Mus musculus,,,N,1,BAO_0000218,948.0
8494,In vivo,17208,Intermediate,10090.0,,1,Biodistribution of radioactivity in normal mice (ICR) heart after 6 hours of intravenous injection of [125I]-16(IMPY),,,CHEMBL627766,,50594,Mus musculus,,,N,1,BAO_0000218,948.0
8495,In vivo,17208,Intermediate,10090.0,,1,Biodistribution of radioactivity in normal mice (ICR) kidney after 1 hour of intravenous injection of [125I]-16(IMPY),,,CHEMBL627767,,50594,Mus musculus,,,N,1,BAO_0000218,2113.0
8496,In vivo,17208,Intermediate,10090.0,,1,Biodistribution of radioactivity in normal mice (ICR) kidney after 2 hours of intravenous injection of [125I]-16(IMPY),,,CHEMBL627768,,50594,Mus musculus,,,N,1,BAO_0000218,2113.0
8497,In vivo,17208,Intermediate,10090.0,,1,Biodistribution of radioactivity in normal mice (ICR) kidney after 2 minutes of intravenous injection of [125I]-16(IMPY),,,CHEMBL628422,,50594,Mus musculus,,,N,1,BAO_0000218,2113.0
8498,In vivo,17208,Intermediate,10090.0,,1,Biodistribution of radioactivity in normal mice (ICR) kidney after 24 hours of intravenous injection of [125I]-16(IMPY),,,CHEMBL628423,,50594,Mus musculus,,,N,1,BAO_0000218,2113.0
8499,In vivo,5089,Intermediate,10116.0,,1,Plasma clearance value at intravenous dose of 1 mg/kg (2 mg/kg po (cassette dosing) in Dawley rat,,,CHEMBL628424,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8500,In vivo,5089,Intermediate,10116.0,,1,Plasma clearance value at intravenous dose of 1 mg/kg (2 mg/kg po (cassette dosing)) in Dawley rat,,,CHEMBL628425,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8501,In vivo,4257,Intermediate,10116.0,,1,Plasma clearance value was determined in rat after a 3 mg/kg of iv dose,,,CHEMBL628426,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8502,In vivo,6679,Intermediate,10116.0,,1,Plasma clearance was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,,,CHEMBL628427,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8503,In vivo,5546,Intermediate,10116.0,,1,Plasma clearance was determined in Sprague-Dawley rats at a dose of 1 mg/kg by iv administration,,,CHEMBL626938,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8504,In vivo,6141,Intermediate,10116.0,,1,Plasma clearance was evaluated at 1 mg/kg of iv administration in Sprague-Dawley rats,,,CHEMBL626939,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8505,In vivo,5334,Intermediate,10116.0,,1,Plasma clearance was reported after intravenous administration at a dose of 1 mg/kg in Sprague-Dawley rat,,,CHEMBL626940,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8506,In vivo,5334,Intermediate,10116.0,,1,Plasma clearance was reported after oral administration at a dose of 2 mg/kg in Sprague-Dawley rat,,,CHEMBL626941,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8507,In vivo,5334,Intermediate,10116.0,,1,Plasma clearance was reported in Sprague-Dawley rat,,,CHEMBL626942,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8508,In vivo,4689,Intermediate,10116.0,,1,Plasma clearance after intravenous administration (1 mg/kg) in rat,,,CHEMBL876812,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8509,In vivo,6848,Intermediate,10116.0,,1,Plasma clearance of compound in rats was evaluated,,,CHEMBL626943,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8510,In vivo,6848,Intermediate,10116.0,,1,Plasma clearance of compound in rats was evaluated; ND indicates not determined,,,CHEMBL626944,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8511,In vivo,6467,Intermediate,10116.0,,1,Plasma clearance in rats at the dose of 1.0 mpk by i.v. administration,,,CHEMBL626945,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8512,In vivo,6467,Intermediate,10116.0,,1,Plasma clearance in rats at the dose of 1.0 mpk by i.v. administration; ND= not determined,,,CHEMBL626946,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8513,In vivo,4956,Intermediate,10116.0,,1,Plasma clearance rate in Sprague-Dawley rats,,,CHEMBL626856,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8514,In vivo,5529,Intermediate,10116.0,,1,Plasma clearance was determined in rat after intravenous administration (0.5 mg/kg),,,CHEMBL626857,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8515,In vivo,406,Intermediate,10116.0,,1,The compound was evaluated for plasma clearance in rat,,,CHEMBL626858,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
8516,In vivo,17655,Intermediate,10116.0,,1,Total plasma clearance in rat,,,CHEMBL627018,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
8517,In vivo,3293,Intermediate,10116.0,,1,Absorption behavior was judged by the peak blood concentration determined after oral dose of 30 mg/kg in rats.,,,CHEMBL625331,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
8518,In vivo,4075,Intermediate,10116.0,,1,Blood level after a 10 mg/kg oral dose in rat expressed as Cmax was determined,,,CHEMBL625332,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
8519,In vivo,2792,Intermediate,10116.0,,1,C max was determined at 10 mg/kg po dose in rats,,,CHEMBL877590,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8520,In vivo,2792,Intermediate,10116.0,,1,C max was determined at 3 mg/kg po dose in rats,,,CHEMBL625333,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8521,In vivo,17594,Intermediate,10116.0,,1,Cmax after repeated oral dose of compound at 1 mg/kg in rats,,,CHEMBL625334,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8522,In vivo,17594,Intermediate,10116.0,,1,Cmax after single intravenous bolus of 1 mg/kg in rats,,,CHEMBL625335,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8523,In vivo,4762,Intermediate,10116.0,,1,Cmax of compound at 5 mg/kg after po administration was determined in rat,,,CHEMBL625336,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8524,In vivo,17509,Intermediate,10116.0,,1,Cmax 24 hr after 10 mg/kg oral administration in rats,,,CHEMBL625337,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8525,In vivo,17509,Intermediate,10116.0,,1,Cmax 24 hr after 2 mg/kg oral administration in rats,,,CHEMBL625338,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8526,In vivo,1466,Intermediate,10116.0,,1,Cmax in plasma was determined upon peroral administration of 10.0 mg/Kg dose in rat,,,CHEMBL625339,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
8527,In vivo,6535,Intermediate,10116.0,,1,Cmax in rat after administration of 2 mg/kg iv,,,CHEMBL625340,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8528,In vivo,6535,Intermediate,10116.0,,1,Cmax in rat after administration of 2 mg/kg iv,,,CHEMBL625341,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8529,In vivo,3169,Intermediate,10116.0,,1,Cmax in rats determined 6 hours after oral dosing of 20 mg/kg,,,CHEMBL622687,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8530,In vivo,6515,Intermediate,10116.0,,1,Cmax wa determined in rat plasma at 30 mg/kg after po administration,,,CHEMBL622688,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
8531,In vivo,11149,Intermediate,10116.0,,1,Cmax was calculated as maximum concentration reached in the blood after oral administration to male F344 rats,,,CHEMBL622689,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
8532,In vivo,11149,Intermediate,10116.0,,1,Cmax was calculated as maximum concentration reached in the blood in air pouch exudate after oral administration to male F344 rats,,,CHEMBL620295,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
8533,In vivo,17858,Intermediate,10116.0,,1,Cmax after 10 mg/kg oral administration in rat,,,CHEMBL620296,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8534,In vivo,6518,Intermediate,10116.0,,1,Cmax after IV dosing at 0.5 mg/kg in rat; no data,,,CHEMBL620297,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8535,In vivo,6518,Intermediate,10116.0,,1,Cmax after IV dosing at 1 mg/kg in rat; no data,,,CHEMBL620298,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8536,In vivo,4426,Intermediate,10116.0,,1,Cmax after oral administration at 20 mpk in rats,,,CHEMBL620299,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8537,In vivo,4426,Intermediate,10116.0,,1,Cmax after oral administration at 20 mpk in rats; Not performed.,,,CHEMBL620300,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8538,In vivo,4426,Intermediate,10116.0,,1,Cmax after oral administration at 20 mpk in rats d; Not performed.,,,CHEMBL620301,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8539,In vivo,5656,Intermediate,10116.0,,1,Cmax after oral administration in rat,,,CHEMBL620302,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8540,In vivo,6518,Intermediate,10116.0,,1,Cmax after oral administration at a dose of 2 mg/kg in rat,,,CHEMBL620303,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8541,In vivo,6518,Intermediate,10116.0,,1,Cmax after oral administration at a dose of 4 mg/kg in rat,,,CHEMBL620304,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8542,In vivo,6113,Intermediate,10116.0,,1,Cmax in rats after 20 mg/kg oral dose,,,CHEMBL620305,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8543,In vivo,17764,Intermediate,10116.0,,1,Cmax after peroral administration in rats at 2.4 uM/kg,,,CHEMBL620306,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8544,In vivo,4756,Intermediate,10116.0,,1,Cmax at the dose of 2 mg/Kg administered perorally in rats,,,CHEMBL620307,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8545,In vivo,4756,Intermediate,10116.0,,1,Cmax at the dose of 5 mg/Kg administered perorally in rats,,,CHEMBL620308,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8546,In vivo,6402,Intermediate,10116.0,,1,Cmax by administering at 20 mg/kg p.o. in rats,,,CHEMBL620309,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8547,In vivo,5610,Intermediate,10116.0,,1,Cmax in male rat,,,CHEMBL620310,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8548,In vivo,5207,Intermediate,10116.0,,1,Cmax in rat,,,CHEMBL620311,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8549,In vivo,6011,Intermediate,10116.0,,1,Cmax in rat,,,CHEMBL620312,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8550,In vivo,6504,Intermediate,10116.0,,1,Cmax in rat,,,CHEMBL620313,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8551,In vivo,6046,Intermediate,10116.0,,1,Cmax in rat at 10 mg/kg,,,CHEMBL620314,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8552,In vivo,6504,Intermediate,10116.0,,1,Cmax in rat at the dose of 1 mg/kg i.v.,,,CHEMBL620315,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8553,In vivo,5874,Intermediate,10116.0,,1,Cmax in rat by po administration at a dose of 40 mg/kg,,,CHEMBL620316,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8554,In vivo,17686,Intermediate,10116.0,,1,Cmax in rat p.o. at 20 mg/kg concentration,,,CHEMBL620317,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8555,In vivo,5836,Intermediate,10116.0,,1,Cmax in rats,,,CHEMBL620318,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8556,In vivo,17596,Intermediate,10116.0,,1,Cmax in rats,,,CHEMBL620319,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8557,In vivo,16423,Intermediate,10116.0,,1,Cmax was evaluated after 20 uM/kg of peroral administration,,,CHEMBL620320,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8558,In vivo,17804,Intermediate,10116.0,,1,Cmax was measured in rats after peroral administration at 3 mg/kg,,,CHEMBL620321,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8559,In vivo,1908,Intermediate,10116.0,,1,Cmax value after oral dose at a dose of 10 mg/kg in rats.,,,CHEMBL620322,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8560,,13950,Intermediate,10116.0,,1,Distribution of [123I]-label in rat brain (diencephalon) was reported at 60 min post injection. Value shown is %ID/g of tissue,,,CHEMBL620323,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8561,,13950,Intermediate,10116.0,,1,Distribution of [123I]-label in rat brain (frontal cortex) was reported at 20 min post injection. Value shown is %ID/g of tissue,,,CHEMBL620324,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1870.0
8562,,13950,Intermediate,10116.0,,1,Distribution of [123I]-label in rat brain (frontal cortex) was reported at 60 min post injection. Value shown is %ID/g of tissue,,,CHEMBL620325,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1870.0
8563,,13950,Intermediate,10116.0,,1,Distribution of [123I]-label in rat brain (hippocampus) was reported at 20 min post injection. Value shown is %ID/g of tissue,,,CHEMBL620326,,50597,Rattus norvegicus,,,N,1,BAO_0000218,10000000.0
8564,,13950,Intermediate,10116.0,,1,Distribution of [123I]-label in rat brain (hippocampus) was reported at 60 min post injection. Value shown is %ID/g of tissue,,,CHEMBL620327,,50597,Rattus norvegicus,,,N,1,BAO_0000218,10000000.0
8565,,13950,Intermediate,10116.0,,1,Distribution of [123I]-label in rat brain (medulla pons) was reported at 20 min post injection. Value shown is %ID/g of tissue,,,CHEMBL620328,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8566,,13950,Intermediate,10116.0,,1,Distribution of [123I]-label in rat brain (medulla pons) was reported at 60 min post injection. Value shown is %ID/g of tissue,,,CHEMBL620329,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8567,,13950,Intermediate,10116.0,,1,Distribution of [123I]-label in rat brain (midbrain) was reported at 20 min post injection. Value shown is %ID/g of tissue,,,CHEMBL620330,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1891.0
8568,,13950,Intermediate,10116.0,,1,Distribution of [123I]-label in rat brain (midbrain) was reported at 60 min post injection. Value shown is %ID/g of tissue,,,CHEMBL875286,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1891.0
8569,,13950,Intermediate,10116.0,,1,Distribution of [123I]-label in rat brain (posterior cortex) was reported at 20 min post injection. Value shown is %ID/g of tissue,,,CHEMBL620331,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8570,,13950,Intermediate,10116.0,,1,Distribution of [123I]-label in rat brain (posterior cortex) was reported at 60 min post injection. Value shown is %ID/g of tissue,,,CHEMBL620332,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8571,,13950,Intermediate,10116.0,,1,Distribution of [123I]-label in rat brain (striatum) was reported at 20 min post injection. Value shown is %ID/g of tissue,,,CHEMBL620333,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2435.0
8572,,13950,Intermediate,10116.0,,1,Distribution of [123I]-label in rat brain (striatum) was reported at 60 min post injection. Value shown is %ID/g of tissue,,,CHEMBL620334,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2435.0
8573,,16434,Intermediate,10116.0,,1,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,,CHEMBL621015,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
8574,,16434,Intermediate,10116.0,,1,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,,CHEMBL621016,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
8575,,16434,Intermediate,10116.0,,1,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,,CHEMBL621191,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
8576,,16434,Intermediate,10116.0,,1,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,,CHEMBL621192,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
8577,,16434,Intermediate,10116.0,,1,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,,CHEMBL621193,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
8578,,16434,Intermediate,10116.0,,1,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,,CHEMBL621194,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
8579,,16434,Intermediate,10116.0,,1,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,,CHEMBL624204,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
8580,,16434,Intermediate,10116.0,,1,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,,,CHEMBL624205,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
8581,,16435,Intermediate,10116.0,,1,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,,CHEMBL624206,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
8582,,16435,Intermediate,10116.0,,1,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,,CHEMBL624207,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
8583,,16435,Intermediate,10116.0,,1,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,,CHEMBL624208,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
8584,,16435,Intermediate,10116.0,,1,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,,CHEMBL624209,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
8585,,16435,Intermediate,10116.0,,1,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,,CHEMBL624210,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
8586,,16435,Intermediate,10116.0,,1,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,,CHEMBL624211,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
8587,,16435,Intermediate,10116.0,,1,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,,CHEMBL624212,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
8588,,16435,Intermediate,10116.0,,1,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,,CHEMBL624213,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
8589,,16434,Intermediate,10116.0,,1,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,,CHEMBL876611,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
8590,,16434,Intermediate,10116.0,,1,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,,,CHEMBL624214,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
8591,,16434,Intermediate,10116.0,,1,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,,CHEMBL624215,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
8592,,16435,Intermediate,10116.0,,1,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,,CHEMBL624216,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
8593,,16435,Intermediate,10116.0,,1,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,,CHEMBL624217,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
8594,,16435,Intermediate,10116.0,,1,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,,CHEMBL624218,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
8595,,16435,Intermediate,10116.0,,1,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,,CHEMBL624219,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
8596,,16435,Intermediate,10116.0,,1,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,,CHEMBL624220,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
8597,,16435,Intermediate,10116.0,,1,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,,CHEMBL624221,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
8598,,16434,Intermediate,10116.0,,1,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,,CHEMBL624222,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8599,,16434,Intermediate,10116.0,,1,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,,CHEMBL624223,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8600,,16434,Intermediate,10116.0,,1,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,,CHEMBL624224,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8601,,16434,Intermediate,10116.0,,1,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,,CHEMBL624225,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8602,In vivo,17764,Intermediate,10116.0,,1,Volume of solubility in solution after intravenous administration in rats at 24 uM/kg,,,CHEMBL622420,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8603,In vivo,5031,Intermediate,10116.0,,1,Volume of steady state distribution after i.v. administration in rats,,,CHEMBL622421,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8604,In vivo,6215,Intermediate,10116.0,,1,Vss after intravenous administration (5.0 mg/kg) was determined in rat,,,CHEMBL622422,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8605,In vivo,17671,Intermediate,10116.0,,1,Vss in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,,,CHEMBL622423,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8606,In vivo,17752,Intermediate,10116.0,,1,Vss was determined,,,CHEMBL622424,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8607,In vivo,6596,Intermediate,10116.0,,1,Vss in rat,,,CHEMBL622425,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8608,In vivo,16423,Intermediate,10116.0,,1,Vss was evaluated after 10 uM/kg of intra arterial administration,,,CHEMBL876612,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8609,In vivo,15662,Intermediate,10116.0,,1,volume of distribution at steady state was observed after intravenous administration in rat,,,CHEMBL622426,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8610,In vivo,6062,Intermediate,10116.0,,1,Volume of distribution was measured in rat after an iv dose of 1 mg/kg,,,CHEMBL622427,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8611,In vivo,5874,Intermediate,10116.0,,1,Pharmacokinetic (PK) parameter Vz in rat,,,CHEMBL622428,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8612,In vivo,4942,Intermediate,10116.0,,1,Volume distribution in rats,,,CHEMBL622429,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8613,In vivo,17796,Intermediate,10116.0,,1,Volume of distribution in rat; No data,,,CHEMBL622430,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8614,In vivo,4890,Intermediate,10116.0,,1,Volume of distribution was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,,,CHEMBL622431,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8615,,15765,Intermediate,10116.0,,1,% absorption predicted from in vitro rat ileum transport studies,,,CHEMBL622432,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2116.0
8616,In vivo,13569,Intermediate,10116.0,,1,Bioavailability at an iv dose of 12 mg/Kg and po dose of 23 mg/Kg,,,CHEMBL622433,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8617,In vivo,13569,Intermediate,10116.0,,1,Bioavailability at an iv dose of 14 mg/Kg and po dose of 15 mg/Kg,,,CHEMBL622434,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8618,In vivo,13569,Intermediate,10116.0,,1,Bioavailability at an iv dose of 14 mg/Kg and po dose of 28 mg/Kg,,,CHEMBL622435,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8619,In vivo,13569,Intermediate,10116.0,,1,Bioavailability (dose 15 mg/kg i.v. and 30 mg/kg p.o.),,,CHEMBL618748,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8620,In vivo,13569,Intermediate,10116.0,,1,Bioavailability at an iv dose of 15 mg/Kg and po dose of 30.2 mg/Kg,,,CHEMBL618749,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8621,In vivo,13569,Intermediate,10116.0,,1,Bioavailability at an iv dose of 15.6 mg/Kg and po dose of 31.2 mg/Kg,,,CHEMBL618750,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8622,In vivo,13569,Intermediate,10116.0,,1,Bioavailability at an iv dose of 15.7 mg/Kg and po dose of 31.4 mg/Kg,,,CHEMBL618751,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8623,In vivo,13569,Intermediate,10116.0,,1,Bioavailability at an iv dose of 16 mg/Kg and po dose of 35 mg/Kg,,,CHEMBL618752,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8624,In vivo,4576,Intermediate,10116.0,,1,Oral bioavailability in rat,,,CHEMBL618753,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8625,In vivo,750,Intermediate,10116.0,,1,Oral bioavailability estimated by measurement of the circulating plasma levels of BMS-183920 after intravenous and oral dosing to rats for 4 determinations,,,CHEMBL618754,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
8626,In vivo,750,Intermediate,10116.0,,1,Oral bioavailability in rat,,,CHEMBL618755,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8627,In vivo,4590,Intermediate,10116.0,,1,Oral bioavailability in rat,,,CHEMBL618756,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8628,In vivo,1716,Intermediate,10116.0,,1,Oral bioavailability in rat,,,CHEMBL618757,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8629,In vivo,1974,Intermediate,10116.0,,1,Bioavailability in rat,,,CHEMBL618758,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8630,In vivo,4502,Intermediate,10116.0,,1,Oral bioavailability in rat (dose 30 mg/kg),,,CHEMBL621088,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8631,,3371,Intermediate,10116.0,,1,Pharmacokinetic property (cLogP) in rat,,,CHEMBL621089,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8632,,9099,Intermediate,10116.0,,1,Hyperglycemic activity and change in blood glucose concentration was reported 2 hours after administration of 100 mg/Kg perorally,,,CHEMBL621090,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
8633,,9099,Intermediate,10116.0,,1,Hyperglycemic activity and change in blood glucose concentration was reported 4 hours after administration of 100 mg/Kg perorally,,,CHEMBL621091,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
8634,In vivo,4590,Intermediate,10116.0,,1,Clearance in rat.,,,CHEMBL876731,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8635,In vivo,3184,Intermediate,10116.0,,1,Compound was evaluated for its clearance when administered intravenously in rat,,,CHEMBL621092,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8636,In vivo,16456,Intermediate,10116.0,,1,Plasma clearance in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,,,CHEMBL621093,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8637,,4199,Intermediate,10116.0,,1,Blood: Brain distribution ratio is determined in rat,,,CHEMBL621094,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8638,,4199,Intermediate,10116.0,,1,Blood: Brain distribution ratio is determined in rat; NQ: non quantifable,,,CHEMBL621095,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8639,,4199,Intermediate,10116.0,,1,Blood: Brain distribution ratio is determined in rat; NQ:non quantifable,,,CHEMBL621096,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8640,In vivo,8677,Intermediate,10116.0,,1,"Biodistribution in Sprague-Dawley rat kidneys(2) 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,,CHEMBL621097,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2113.0
8641,,7449,Intermediate,10116.0,,1,Percent dose excreted in 0-48 hours administered ip to male rat,,,CHEMBL621098,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8642,,11977,Intermediate,10116.0,,1,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 120 minutes after an intravenous injection is given (average of 3 rats),,,CHEMBL621099,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2037.0
8643,,11977,Intermediate,10116.0,,1,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 2 minutes after an intravenous injection is given (average of 3 rats),,,CHEMBL621100,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2037.0
8644,,11977,Intermediate,10116.0,,1,Uptake of radioligand [125I]-FIDA1 by cerebellum in rat after 30 minutes after an intravenous injection is given (average of 2 rats),,,CHEMBL621101,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2037.0
8645,,11977,Intermediate,10116.0,,1,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 30 minutes after an intravenous injection is given (average of 3 rats),,,CHEMBL621102,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2037.0
8646,,11977,Intermediate,10116.0,,1,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 60 minutes after an intravenous injection is given (average of 3 rats),,,CHEMBL876732,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2037.0
8647,,11977,Intermediate,10116.0,,1,Uptake of radioligand [125I]-FIDA1 by cortex in rat after 120 minutes after an intravenous injection is given (average of 3 rats),,,CHEMBL621103,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8648,,11977,Intermediate,10116.0,,1,Uptake of radioligand [125I]FIDA1 by cortex in rat after 2 minutes after an intravenous injection is given (average of 3 rats),,,CHEMBL621104,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8649,,11977,Intermediate,10116.0,,1,Uptake of radioligand [125I]FIDA1 by cortex in rat after 30 minutes after an intravenous injection is given (average of 2 rats),,,CHEMBL621105,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8650,,11977,Intermediate,10116.0,,1,Uptake of radioligand [125I]-FIDA1 by cortex in rat after 30 minutes after an intravenous injection is given (average of 3 rats),,,CHEMBL621106,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8651,,11977,Intermediate,10116.0,,1,Uptake of radioligand [125I]FIDA1 by cortex in rat after 60 minutes after an intravenous injection is given (average of 3 rats),,,CHEMBL621107,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8652,,11977,Intermediate,10116.0,,1,Uptake of radioligand [125I]FIDA1 by hippo-campus in rat after 120 minutes after an intravenous injection is given (average of 3 rats),,,CHEMBL621108,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8653,,11977,Intermediate,10116.0,,1,Uptake of radioligand [125I]FIDA1 by hippo-campus in rat after 2 minutes after an intravenous injection is given (average of 3 rats),,,CHEMBL621109,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8654,In vivo,17208,Intermediate,10090.0,,1,Biodistribution of radioactivity in normal mice (ICR) kidney after 30 minutes of intravenous injection of [125I]-16(IMPY),,,CHEMBL621110,,50594,Mus musculus,,,N,1,BAO_0000218,2113.0
8655,In vivo,17208,Intermediate,10090.0,,1,Biodistribution of radioactivity in normal mice (ICR) kidney after 6 hours of intravenous injection of [125I]-16(IMPY),,,CHEMBL621111,,50594,Mus musculus,,,N,1,BAO_0000218,2113.0
8656,In vivo,17208,Intermediate,10090.0,,1,Biodistribution of radioactivity in normal mice (ICR) liver after 1 hour of intravenous injection of [125I]-16(IMPY),,,CHEMBL622541,,50594,Mus musculus,,,N,1,BAO_0000218,2107.0
8657,In vivo,17208,Intermediate,10090.0,,1,Biodistribution of radioactivity in normal mice (ICR) liver after 2 hours of intravenous injection of [125I]-16(IMPY),,,CHEMBL622542,,50594,Mus musculus,,,N,1,BAO_0000218,2107.0
8658,In vivo,17208,Intermediate,10090.0,,1,Biodistribution of radioactivity in normal mice (ICR) liver after 2 minutes of intravenous injection of [125I]-16(IMPY),,,CHEMBL622543,,50594,Mus musculus,,,N,1,BAO_0000218,2107.0
8659,In vivo,17208,Intermediate,10090.0,,1,Biodistribution of radioactivity in normal mice (ICR) liver after 24 hours of intravenous injection of [125I]-16(IMPY),,,CHEMBL624412,,50594,Mus musculus,,,N,1,BAO_0000218,2107.0
8660,In vivo,17208,Intermediate,10090.0,,1,Biodistribution of radioactivity in normal mice (ICR) liver after 30 minutes of intravenous injection of [125I]-16(IMPY),,,CHEMBL624413,,50594,Mus musculus,,,N,1,BAO_0000218,2107.0
8661,In vivo,17208,Intermediate,10090.0,,1,Biodistribution of radioactivity in normal mice (ICR) liver after 6 hours of intravenous injection of [125I]-16(IMPY),,,CHEMBL624414,,50594,Mus musculus,,,N,1,BAO_0000218,2107.0
8662,In vivo,17208,Intermediate,10090.0,,1,Biodistribution of radioactivity in normal mice (ICR) lung after 1 hour of intravenous injection of [125I]-16(IMPY),,,CHEMBL624415,,50594,Mus musculus,,,N,1,BAO_0000218,2048.0
8663,In vivo,17208,Intermediate,10090.0,,1,Biodistribution of radioactivity in normal mice (ICR) lung after 2 hours of intravenous injection of [125I]-16(IMPY),,,CHEMBL624416,,50594,Mus musculus,,,N,1,BAO_0000218,2048.0
8664,In vivo,17208,Intermediate,10090.0,,1,Biodistribution of radioactivity in normal mice (ICR) lung after 2 minutes of intravenous injection of [125I]-16(IMPY),,,CHEMBL624417,,50594,Mus musculus,,,N,1,BAO_0000218,2048.0
8665,In vivo,17208,Intermediate,10090.0,,1,Biodistribution of radioactivity in normal mice (ICR) lung after 24 hours of intravenous injection of [125I]-16(IMPY),,,CHEMBL624418,,50594,Mus musculus,,,N,1,BAO_0000218,2048.0
8666,In vivo,17208,Intermediate,10090.0,,1,Biodistribution of radioactivity in normal mice (ICR) lung after 30 minutes of intravenous injection of [125I]-16(IMPY),,,CHEMBL624419,,50594,Mus musculus,,,N,1,BAO_0000218,2048.0
8667,In vivo,17208,Intermediate,10090.0,,1,Biodistribution of radioactivity in normal mice (ICR) lung after 6 hours of intravenous injection of [125I]-16(IMPY),,,CHEMBL624420,,50594,Mus musculus,,,N,1,BAO_0000218,2048.0
8668,In vivo,17208,Intermediate,10090.0,,1,Biodistribution of radioactivity in normal mice (ICR) muscle after 1 hr of intravenous injection of [125I]-16(IMPY),,,CHEMBL624421,,50594,Mus musculus,,,N,1,BAO_0000218,2385.0
8669,In vivo,17208,Intermediate,10090.0,,1,Biodistribution of radioactivity in normal mice (ICR) muscle after 2 hours of intravenous injection of [125I]-16(IMPY),,,CHEMBL624422,,50594,Mus musculus,,,N,1,BAO_0000218,2385.0
8670,In vivo,17208,Intermediate,10090.0,,1,Biodistribution of radioactivity in normal mice (ICR) muscle after 2 minutes of intravenous injection of [125I]-16(IMPY),,,CHEMBL624423,,50594,Mus musculus,,,N,1,BAO_0000218,2385.0
8671,In vivo,17208,Intermediate,10090.0,,1,Biodistribution of radioactivity in normal mice (ICR) muscle after 24 hours of intravenous injection of [125I]-16(IMPY),,,CHEMBL625123,,50594,Mus musculus,,,N,1,BAO_0000218,2385.0
8672,In vivo,17208,Intermediate,10090.0,,1,Biodistribution of radioactivity in normal mice (ICR) muscle after 30 minutes of intravenous injection of [125I]-16(IMPY),,,CHEMBL625124,,50594,Mus musculus,,,N,1,BAO_0000218,2385.0
8673,In vivo,17208,Intermediate,10090.0,,1,Biodistribution of radioactivity in normal mice (ICR) muscle after 6 hours of intravenous injection of [125I]-16(IMPY),,,CHEMBL625125,,50594,Mus musculus,,,N,1,BAO_0000218,2385.0
8674,In vivo,17208,Intermediate,10090.0,,1,Biodistribution of radioactivity in normal mice (ICR) skin after 1 hour of intravenous injection of [125I]-16(IMPY),,,CHEMBL625126,,50594,Mus musculus,,,N,1,BAO_0000218,14.0
8675,In vivo,17208,Intermediate,10090.0,,1,Biodistribution of radioactivity in normal mice (ICR) skin after 2 hours of intravenous injection of [125I]-16(IMPY),,,CHEMBL626947,,50594,Mus musculus,,,N,1,BAO_0000218,14.0
8676,In vivo,17208,Intermediate,10090.0,,1,Biodistribution of radioactivity in normal mice (ICR) skin after 2 minutes of intravenous injection of [125I]-16(IMPY),,,CHEMBL626948,,50594,Mus musculus,,,N,1,BAO_0000218,14.0
8677,In vivo,17208,Intermediate,10090.0,,1,Biodistribution of radioactivity in normal mice (ICR) skin after 24 hours of intravenous injection of [125I]-16(IMPY),,,CHEMBL626949,,50594,Mus musculus,,,N,1,BAO_0000218,14.0
8678,In vivo,17208,Intermediate,10090.0,,1,Biodistribution of radioactivity in normal mice (ICR) skin after 30 minutes of intravenous injection of [125I]-16(IMPY),,,CHEMBL626950,,50594,Mus musculus,,,N,1,BAO_0000218,14.0
8679,In vivo,17208,Intermediate,10090.0,,1,Biodistribution of radioactivity in normal mice (ICR) skin after 6 hours of intravenous injection of [125I]-16(IMPY),,,CHEMBL626951,,50594,Mus musculus,,,N,1,BAO_0000218,14.0
8680,In vivo,17208,Intermediate,10090.0,,1,Biodistribution of radioactivity in normal mice (ICR) spleen after 1 hour of intravenous injection of [125I]-16(IMPY),,,CHEMBL626952,,50594,Mus musculus,,,N,1,BAO_0000218,2106.0
8681,In vivo,17208,Intermediate,10090.0,,1,Biodistribution of radioactivity in normal mice (ICR) spleen after 2 hours of intravenous injection of [125I]-16(IMPY),,,CHEMBL626953,,50594,Mus musculus,,,N,1,BAO_0000218,2106.0
8682,In vivo,17208,Intermediate,10090.0,,1,Biodistribution of radioactivity in normal mice (ICR) spleen after 2 minutes of intravenous injection of [125I]-16(IMPY),,,CHEMBL626954,,50594,Mus musculus,,,N,1,BAO_0000218,2106.0
8683,In vivo,17208,Intermediate,10090.0,,1,Biodistribution of radioactivity in normal mice (ICR) spleen after 24 hours of intravenous injection of [125I]-16(IMPY),,,CHEMBL626955,,50594,Mus musculus,,,N,1,BAO_0000218,2106.0
8684,In vivo,17208,Intermediate,10090.0,,1,Biodistribution of radioactivity in normal mice (ICR) spleen after 30 minutes of intravenous injection of [125I]-16(IMPY),,,CHEMBL626956,,50594,Mus musculus,,,N,1,BAO_0000218,2106.0
8685,In vivo,17208,Intermediate,10090.0,,1,Biodistribution of radioactivity in normal mice (ICR) spleen after 6 hours of intravenous injection of [125I]-16(IMPY),,,CHEMBL626957,,50594,Mus musculus,,,N,1,BAO_0000218,2106.0
8686,In vivo,17208,Intermediate,10090.0,,1,Biodistribution of radioactivity in normal mice blood after 1 hour of intravenous injection of [125I]-16(IMPY),,,CHEMBL626958,,50594,Mus musculus,,,N,1,BAO_0000218,178.0
8687,In vivo,17208,Intermediate,10090.0,,1,Biodistribution of radioactivity in normal mice blood after 2 hours of intravenous injection of [125I]-16(IMPY),,,CHEMBL626959,,50594,Mus musculus,,,N,1,BAO_0000218,178.0
8688,In vivo,17208,Intermediate,10090.0,,1,Biodistribution of radioactivity in normal mice blood after 2 minutes of intravenous injection of [125I]-16(IMPY),,,CHEMBL626960,,50594,Mus musculus,,,N,1,BAO_0000218,178.0
8689,In vivo,17208,Intermediate,10090.0,,1,Biodistribution of radioactivity in normal mice blood after 24 hours of intravenous injection of [125I]-16(IMPY),,,CHEMBL626961,,50594,Mus musculus,,,N,1,BAO_0000218,178.0
8690,In vivo,17208,Intermediate,10090.0,,1,Biodistribution of radioactivity in normal mice blood after 30 minutes of intravenous injection of [125I]-16(IMPY),,,CHEMBL627589,,50594,Mus musculus,,,N,1,BAO_0000218,178.0
8691,In vivo,17208,Intermediate,10090.0,,1,Biodistribution of radioactivity in normal mice blood after 6 hours of intravenous injection of [125I]-16(IMPY),,,CHEMBL627590,,50594,Mus musculus,,,N,1,BAO_0000218,178.0
8692,,3132,Intermediate,10090.0,,1,Time taken for EC90 was determined when tested in mouse,,,CHEMBL627591,,50594,Mus musculus,,,N,1,BAO_0000218,
8693,,3132,Intermediate,10090.0,,1,Time taken for EC90 was determined when tested in mouse at dose 25 mg/kg,,,CHEMBL627592,,50594,Mus musculus,,,N,1,BAO_0000218,
8694,In vivo,16597,Intermediate,10090.0,,1,At a dose 50 mg/kg (114 umol/kg) was administered intraperitoneally to mice and was evaluated for half life (T1/2),,,CHEMBL627593,,50594,Mus musculus,,,N,1,BAO_0000218,
8695,,5727,Intermediate,10090.0,,1,Half life in mice,,,CHEMBL627594,,50594,Mus musculus,,,N,1,BAO_0000218,
8696,In vivo,5302,Intermediate,10090.0,,1,Half life period in mouse after 10 mg/Kg dose,,,CHEMBL876813,,50594,Mus musculus,,,N,1,BAO_0000218,
8697,In vivo,5302,Intermediate,10090.0,,1,Half life period in mouse after 10 mg/kg dose,,,CHEMBL627595,,50594,Mus musculus,,,N,1,BAO_0000218,
8698,In vivo,6348,Intermediate,10090.0,,1,Half life was determined in mouse after 5 mg/kg (i.v.) and 6 mg/kg (p.o.) administration,,,CHEMBL627596,,50594,Mus musculus,,,N,1,BAO_0000218,
8699,In vivo,5964,Intermediate,10116.0,,1,Cmax value at 5 mg/kg po was determined in rat,,,CHEMBL627597,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8700,In vivo,6078,Intermediate,10116.0,,1,Cmax value evaluated in rat,,,CHEMBL627598,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8701,In vivo,5206,Intermediate,10116.0,,1,Cmax value was calculated by applying at a dose of 10 mg/Kg ip in rat brain,,,CHEMBL627599,,50597,Rattus norvegicus,,,N,1,BAO_0000218,955.0
8702,In vivo,2959,Intermediate,10116.0,,1,Cmax value after administration of 20 mg/Kg oral dose in rat,,,CHEMBL627600,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8703,In vivo,5964,Intermediate,10116.0,,1,Cmax value at 1 mg/kg po in rat,,,CHEMBL627601,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8704,In vivo,5964,Intermediate,10116.0,,1,Cmax value at 5 mg/kg po in rat,,,CHEMBL627776,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8705,In vivo,6757,Intermediate,10116.0,,1,Cmax value at a dose of 10 mg/kg in male SD rats,,,CHEMBL627777,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8706,In vivo,6757,Intermediate,10116.0,,1,Cmax value at a dose of 100 mg/kg in male SD rats,,,CHEMBL627778,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8707,In vivo,6757,Intermediate,10116.0,,1,Cmax value at a dose of 50 mg/kg in male SD rats,,,CHEMBL627779,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8708,In vivo,17617,Intermediate,10116.0,,1,Cmax value in rats at 10 mg/kg,,,CHEMBL876814,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8709,In vivo,1445,Intermediate,10116.0,,1,Cmax value was evaluated in rats at a dose of 20 mg/kg,,,CHEMBL627780,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8710,In vivo,6082,Intermediate,10116.0,,1,Cmax value was determined after peroral administration of 20 mg/kg in rat,,,CHEMBL627781,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8711,In vivo,1446,Intermediate,10116.0,,1,Cmax value was determined between 15 and 30 minutes post administration in fisher rats; value ranges from 200-500,,,CHEMBL627782,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8712,In vivo,5407,Intermediate,10116.0,,1,Compound was evaluated for its pharmacokinetic parameter maximum plasma concentration (Cmax) after oral administration to rats,,,CHEMBL627783,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
8713,In vivo,2690,Intermediate,10116.0,,1,Compound was evaluated for maximal plasma concentration in rat upon 5 mg/kg upon oral administration,,,CHEMBL627784,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
8714,In vivo,2661,Intermediate,10116.0,,1,Compound was evaluated for maximum concentration after treatment with oral dose of 2 mgkg to female wistar rats,,,CHEMBL627785,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8715,In vivo,2661,Intermediate,10116.0,,1,Compound was evaluated for maximum concentration after treatment with oral dose of 2 mgkg to male wistar rats,,,CHEMBL627786,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8716,In vivo,4891,Intermediate,10116.0,,1,Compound was evaluated for pharmacokinetic parameter maximum plasma concentration,,,CHEMBL627787,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
8717,In vivo,2807,Intermediate,10116.0,,1,Compound was evaluated for plasma concentration in rats when administered at 20 mg/kg in methocel at 0.5 hr,,,CHEMBL627788,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
8718,In vivo,2807,Intermediate,10116.0,,1,Compound was evaluated for plasma concentration in rats when administered at 20 mg/kg in methocel at 1 hr,,,CHEMBL626579,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
8719,In vivo,2807,Intermediate,10116.0,,1,Compound was evaluated for plasma concentration in rats when administered at 20 mg/kg in methocel at 2 hr,,,CHEMBL626580,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
8720,In vivo,3634,Intermediate,10116.0,,1,Compound was evaluated for the pharmacokinetic property in rats after an oral dose of 10 mg/kg,,,CHEMBL876815,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8721,In vivo,1881,Intermediate,10116.0,,1,Compound was tested for plasma concentration in rats when administered at 20 mg/kg in 1% methocel at 1 hr,,,CHEMBL626581,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
8722,In vivo,1881,Intermediate,10116.0,,1,Compound was tested for plasma concentration in rats when administered at 20 mg/kg in 1% methocel at 2 hr,,,CHEMBL626582,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
8723,In vivo,429,Intermediate,10116.0,,1,Evaluated for pharmacokinetic parameter Cmax in rat at the dose 50 mg/kg,,,CHEMBL626583,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8724,In vivo,5974,Intermediate,10116.0,,1,In vivo Cmax was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,,,CHEMBL626205,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8725,In vivo,5974,Intermediate,10116.0,,1,In vivo Cmax was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,,,CHEMBL626206,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8726,In vivo,5974,Intermediate,10116.0,,1,In vivo Cmax was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,,,CHEMBL626207,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8727,In vivo,5974,Intermediate,10116.0,,1,In vivo Cmax was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,,,CHEMBL623882,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8728,In vivo,17582,Intermediate,10116.0,,1,Maximal concentration in male Sprague-Dawley rats after 5 mg/kg intravenous dose,,,CHEMBL623883,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8729,In vivo,17582,Intermediate,10116.0,,1,Maximal concentration in male Sprague-Dawley rats after 10 mg/kg oral dose,,,CHEMBL623884,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8730,In vivo,3032,Intermediate,10116.0,,1,"In vivo maximum concentration of compound in rat plasma after a oral dose of 10 mg/kg (in water, N=4)",,,CHEMBL623885,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
8731,In vivo,6295,Intermediate,10116.0,,1,In vivo maximum concentration in rat plasma exposure after oral administration 50 mg/kg,,,CHEMBL623886,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
8732,In vivo,6619,Intermediate,10116.0,,1,Maximal concentration in rat was determined,,,CHEMBL623887,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8733,In vivo,6616,Intermediate,10116.0,,1,Maximal concentration after i.v. administration,,,CHEMBL623888,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8734,In vivo,3249,Intermediate,10116.0,,1,Maximal concentration (Cmax) in the rat plasma at a dose of 10 mg/kg,,,CHEMBL623889,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
8735,In vivo,17791,Intermediate,10116.0,,1,Maximal plasma concentration in rat after oral administration at 50 mg/kg,,,CHEMBL623890,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
8736,In vivo,17791,Intermediate,10116.0,,1,Cmax in rat plasma after oral dose (50 mg/Kg),,,CHEMBL623891,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
8737,In vivo,1360,Intermediate,10116.0,,1,Maximal plasma concentration was determined.,,,CHEMBL623892,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
8738,In vivo,2552,Intermediate,10116.0,,1,Maximal plasma drug concentration was determined,,,CHEMBL623893,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
8739,In vivo,6571,Intermediate,10116.0,,1,Maximal concentration in rats after peroral administration,,,CHEMBL877616,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8740,In vivo,6570,Intermediate,10116.0,,1,Maximum concentration in rat after 2 mg/kg peroral administration,,,CHEMBL623894,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8741,In vivo,6567,Intermediate,10116.0,,1,Maximum concentration in rat plasma after 5 mg/kg oral gavage,,,CHEMBL623895,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
8742,In vivo,3031,Intermediate,10116.0,,1,Maximum concentration of compound in rat was evaluated.,,,CHEMBL623896,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8743,In vivo,3436,Intermediate,10116.0,,1,Maximum concentration at 0.5 hr by peroral administration at a dose of 20 mg/kg in rats,,,CHEMBL623897,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8744,In vivo,3436,Intermediate,10116.0,,1,Maximum concentration at 2 hr by peroral administration at a dose of 20 mg/kg in rats,,,CHEMBL623898,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8745,In vivo,2083,Intermediate,10116.0,,1,Maximum concentration at 4 hr after administration of 5 mg/kg dose peroral in rat,,,CHEMBL623899,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8746,In vivo,3436,Intermediate,10116.0,,1,Maximum concentration at 4 hr by peroral administration at a dose of 20 mg/kg in rats,,,CHEMBL623900,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8747,In vivo,4527,Intermediate,10116.0,,1,Maximum concentration by oral administration at a dose of 100 uM/kg in rat was determined,,,CHEMBL623901,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8748,In vivo,1974,Intermediate,10116.0,,1,Maximum concentration was evaluated in rats,,,CHEMBL623902,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8749,In vivo,3307,Intermediate,10116.0,,1,Maximum concentration in CSF at 30 min following 24 mg/kg subcutaneous dose in rats,,,CHEMBL623903,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1359.0
8750,In vivo,3307,Intermediate,10116.0,,1,Maximum concentration in plasma at 30 min following 24 mg/kg subcutaneous dose in rats,,,CHEMBL623904,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
8751,In vivo,1916,Intermediate,10116.0,,1,Maximum concentration in plasma was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration,,,CHEMBL877617,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
8752,In vivo,1500,Intermediate,10116.0,,1,Maximum concentration in portal vein was determined at a concentration of 10 mg/kg in rats,,,CHEMBL623905,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8753,In vivo,1500,Intermediate,10116.0,,1,Maximum concentration in portal vein was determined at a concentration of 20 mg/kg in rats,,,CHEMBL623906,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8754,In vivo,4186,Intermediate,10116.0,,1,Maximum concentration in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,,,CHEMBL623907,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
8755,,16434,Intermediate,10116.0,,1,Radioactivity distribution in bone of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,,CHEMBL623908,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8756,,16434,Intermediate,10116.0,,1,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 30 min.,,,CHEMBL623909,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8757,,16434,Intermediate,10116.0,,1,Radioactivity distribution in bone of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,,CHEMBL623910,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8758,,16434,Intermediate,10116.0,,1,Radioactivity distribution in bone of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,,,CHEMBL623911,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8759,,16435,Intermediate,10116.0,,1,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,,CHEMBL623912,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8760,,16435,Intermediate,10116.0,,1,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,,CHEMBL624616,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8761,,16435,Intermediate,10116.0,,1,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,,CHEMBL624617,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8762,,16435,Intermediate,10116.0,,1,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,,CHEMBL624618,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8763,,16435,Intermediate,10116.0,,1,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,,CHEMBL624619,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8764,,16435,Intermediate,10116.0,,1,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,,CHEMBL624794,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8765,,16435,Intermediate,10116.0,,1,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,,CHEMBL624795,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8766,,16435,Intermediate,10116.0,,1,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,,CHEMBL623921,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8767,,16434,Intermediate,10116.0,,1,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,,CHEMBL623922,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8768,,16434,Intermediate,10116.0,,1,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,,,CHEMBL623923,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8769,,16434,Intermediate,10116.0,,1,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,,CHEMBL623924,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8770,,16435,Intermediate,10116.0,,1,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,,CHEMBL623925,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8771,,16435,Intermediate,10116.0,,1,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,,CHEMBL623926,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8772,,16435,Intermediate,10116.0,,1,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,,CHEMBL623927,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8773,,16435,Intermediate,10116.0,,1,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,,CHEMBL623928,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8774,,16435,Intermediate,10116.0,,1,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,,CHEMBL623929,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8775,,16435,Intermediate,10116.0,,1,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,,CHEMBL623930,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8776,,16434,Intermediate,10116.0,,1,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,,CHEMBL623931,,50597,Rattus norvegicus,,,N,1,BAO_0000218,955.0
8777,,16434,Intermediate,10116.0,,1,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,,CHEMBL622165,,50597,Rattus norvegicus,,,N,1,BAO_0000218,955.0
8778,,16434,Intermediate,10116.0,,1,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,,CHEMBL621249,,50597,Rattus norvegicus,,,N,1,BAO_0000218,955.0
8779,,16434,Intermediate,10116.0,,1,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,,CHEMBL621250,,50597,Rattus norvegicus,,,N,1,BAO_0000218,955.0
8780,,16434,Intermediate,10116.0,,1,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,,CHEMBL621448,,50597,Rattus norvegicus,,,N,1,BAO_0000218,955.0
8781,,16434,Intermediate,10116.0,,1,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,,CHEMBL621449,,50597,Rattus norvegicus,,,N,1,BAO_0000218,955.0
8782,,16434,Intermediate,10116.0,,1,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,,CHEMBL621450,,50597,Rattus norvegicus,,,N,1,BAO_0000218,955.0
8783,,16434,Intermediate,10116.0,,1,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,,,CHEMBL621451,,50597,Rattus norvegicus,,,N,1,BAO_0000218,955.0
8784,,16435,Intermediate,10116.0,,1,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,,CHEMBL621452,,50597,Rattus norvegicus,,,N,1,BAO_0000218,955.0
8785,,16435,Intermediate,10116.0,,1,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,,CHEMBL621453,,50597,Rattus norvegicus,,,N,1,BAO_0000218,955.0
8786,,16435,Intermediate,10116.0,,1,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,,CHEMBL621454,,50597,Rattus norvegicus,,,N,1,BAO_0000218,955.0
8787,,16435,Intermediate,10116.0,,1,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,,CHEMBL621455,,50597,Rattus norvegicus,,,N,1,BAO_0000218,955.0
8788,,16435,Intermediate,10116.0,,1,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,,CHEMBL621456,,50597,Rattus norvegicus,,,N,1,BAO_0000218,955.0
8789,,16435,Intermediate,10116.0,,1,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,,CHEMBL625145,,50597,Rattus norvegicus,,,N,1,BAO_0000218,955.0
8790,,16435,Intermediate,10116.0,,1,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,,CHEMBL875847,,50597,Rattus norvegicus,,,N,1,BAO_0000218,955.0
8791,,16435,Intermediate,10116.0,,1,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,,CHEMBL625146,,50597,Rattus norvegicus,,,N,1,BAO_0000218,955.0
8792,,16434,Intermediate,10116.0,,1,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,,CHEMBL625147,,50597,Rattus norvegicus,,,N,1,BAO_0000218,955.0
8793,,16434,Intermediate,10116.0,,1,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,,,CHEMBL625148,,50597,Rattus norvegicus,,,N,1,BAO_0000218,955.0
8794,,16434,Intermediate,10116.0,,1,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,,CHEMBL625149,,50597,Rattus norvegicus,,,N,1,BAO_0000218,955.0
8795,,16435,Intermediate,10116.0,,1,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,,CHEMBL625150,,50597,Rattus norvegicus,,,N,1,BAO_0000218,955.0
8796,,16435,Intermediate,10116.0,,1,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,,CHEMBL625151,,50597,Rattus norvegicus,,,N,1,BAO_0000218,955.0
8797,,16435,Intermediate,10116.0,,1,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,,CHEMBL625152,,50597,Rattus norvegicus,,,N,1,BAO_0000218,955.0
8798,,16435,Intermediate,10116.0,,1,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,,CHEMBL625153,,50597,Rattus norvegicus,,,N,1,BAO_0000218,955.0
8799,,16435,Intermediate,10116.0,,1,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,,CHEMBL625154,,50597,Rattus norvegicus,,,N,1,BAO_0000218,955.0
8800,,16435,Intermediate,10116.0,,1,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,,CHEMBL625155,,50597,Rattus norvegicus,,,N,1,BAO_0000218,955.0
8801,,11977,Intermediate,10116.0,,1,Uptake of radioligand [125I]FIDA1 by hippo-campus in rat after 30 minutes after an intravenous injection is given (average of 2 rats),,,CHEMBL625156,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8802,,11977,Intermediate,10116.0,,1,Uptake of radioligand [125I]-FIDA1 by hippo-campus in rat after 60 minutes after an intravenous injection is given (average of 3 rats),,,CHEMBL624354,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8803,,11977,Intermediate,10116.0,,1,Uptake of radioligand [125I]FIDA1 by hippocampus in rat after 120 minutes after an intravenous injection is given (average of 3 rats),,,CHEMBL624355,,50597,Rattus norvegicus,,,N,1,BAO_0000218,10000000.0
8804,,11977,Intermediate,10116.0,,1,Uptake of radioligand [125I]FIDA1 by hippocampus in rat after 2 minutes after an intravenous injection is given (average of 3 rats),,,CHEMBL624356,,50597,Rattus norvegicus,,,N,1,BAO_0000218,10000000.0
8805,,11977,Intermediate,10116.0,,1,Uptake of radioligand [125I]-FIDA1 by hippocampus in rat after 30 minutes after an intravenous injection is given (average of 3 rats),,,CHEMBL624357,,50597,Rattus norvegicus,,,N,1,BAO_0000218,10000000.0
8806,,11977,Intermediate,10116.0,,1,Uptake of radioligand [125I]FIDA1 by hippocampus in rat after 60 minutes after an intravenous injection is given (average of 3 rats),,,CHEMBL624358,,50597,Rattus norvegicus,,,N,1,BAO_0000218,10000000.0
8807,,11977,Intermediate,10116.0,,1,Uptake of radioligand [125I]FIDA1 by striatum in rat after 120 minutes after an intravenous injection is given (average of 3 rats),,,CHEMBL624359,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2435.0
8808,,11977,Intermediate,10116.0,,1,Uptake of radioligand [125I]FIDA1 by striatum in rat after 2 minutes after an intravenous injection is given (average of 3 rats),,,CHEMBL624360,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2435.0
8809,,11977,Intermediate,10116.0,,1,Uptake of radioligand [125I]FIDA1 by striatum in rat after 30 minutes after an intravenous injection is given (average of 2 rats),,,CHEMBL624361,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2435.0
8810,,11977,Intermediate,10116.0,,1,Uptake of radioligand [125I]FIDA1 by striatum in rat after 30 minutes after an intravenous injection is given (average of 3 rats),,,CHEMBL624362,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2435.0
8811,,11977,Intermediate,10116.0,,1,Uptake of radioligand [125I]FIDA1 by striatum in rat after 60 minutes after an intravenous injection is given (average of 3 rats),,,CHEMBL624363,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2435.0
8812,In vivo,11977,Intermediate,10116.0,,1,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 120 minutes after an intravenous injection is given (average of 3 rats),,,CHEMBL624364,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
8813,In vivo,11977,Intermediate,10116.0,,1,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 2 minutes after an intravenous injection is given (average of 3 rats),,,CHEMBL624365,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
8814,In vivo,11977,Intermediate,10116.0,,1,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 30 minutes after an intravenous injection is given (average of 3 rats),,,CHEMBL624366,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
8815,In vivo,11977,Intermediate,10116.0,,1,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 60 minutes after an intravenous injection is given (average of 3 rats),,,CHEMBL624367,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
8816,In vivo,11977,Intermediate,10116.0,,1,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 120 minutes after an intravenous injection is given (average of 3 rats),,,CHEMBL624368,,50597,Rattus norvegicus,,,N,1,BAO_0000218,955.0
8817,In vivo,11977,Intermediate,10116.0,,1,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 2 minutes after an intravenous injection is given (average of 3 rats),,,CHEMBL624369,,50597,Rattus norvegicus,,,N,1,BAO_0000218,955.0
8818,In vivo,11977,Intermediate,10116.0,,1,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 30 minutes after an intravenous injection is given (average of 2 rats),,,CHEMBL624370,,50597,Rattus norvegicus,,,N,1,BAO_0000218,955.0
8819,In vivo,11977,Intermediate,10116.0,,1,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 30 minutes after an intravenous injection is given (average of 3 rats),,,CHEMBL625069,,50597,Rattus norvegicus,,,N,1,BAO_0000218,955.0
8820,In vivo,11977,Intermediate,10116.0,,1,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 60 minutes after an intravenous injection is given (average of 3 rats),,,CHEMBL625070,,50597,Rattus norvegicus,,,N,1,BAO_0000218,955.0
8821,In vivo,11977,Intermediate,10116.0,,1,Biodistribution of radioligand [125I]-FIDA1 in heart of rat after 120 minutes after an intravenous injection is given (average of 3 rats),,,CHEMBL626051,,50597,Rattus norvegicus,,,N,1,BAO_0000218,948.0
8822,In vivo,11977,Intermediate,10116.0,,1,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 2 minutes after an intravenous injection is given (average of 3 rats),,,CHEMBL626052,,50597,Rattus norvegicus,,,N,1,BAO_0000218,948.0
8823,In vivo,11977,Intermediate,10116.0,,1,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 30 minutes after an intravenous injection is given (average of 2 rats),,,CHEMBL626053,,50597,Rattus norvegicus,,,N,1,BAO_0000218,948.0
8824,In vivo,11977,Intermediate,10116.0,,1,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 30 minutes after an intravenous injection is given (average of 3 rats),,,CHEMBL626054,,50597,Rattus norvegicus,,,N,1,BAO_0000218,948.0
8825,In vivo,11977,Intermediate,10116.0,,1,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 60 minutes after an intravenous injection is given (average of 3 rats),,,CHEMBL626055,,50597,Rattus norvegicus,,,N,1,BAO_0000218,948.0
8826,In vivo,11977,Intermediate,10116.0,,1,Biodistribution of radioligand [125I]FIDA1 in kidney of rat after 120 minutes after an intravenous injection is given (average of 3 rats),,,CHEMBL626056,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2113.0
8827,In vivo,11977,Intermediate,10116.0,,1,Biodistribution of radioligand [125I]-FIDA1 in kidney of rat after 2 minutes after an intravenous injection is given (average of 3 rats),,,CHEMBL626057,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2113.0
8828,In vivo,11977,Intermediate,10116.0,,1,Biodistribution of radioligand [125I]FIDA1 in kidney of rat after 30 minutes after an intravenous injection is given (average of 3 rats),,,CHEMBL625193,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2113.0
8829,In vivo,11977,Intermediate,10116.0,,1,Biodistribution of radioligand [125I]FIDA1 in kidney of rat after 60 minutes after an intravenous injection is given (average of 3 rats),,,CHEMBL625194,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2113.0
8830,In vivo,11977,Intermediate,10116.0,,1,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 120 minutes after an intravenous injection is given (average of 3 rats),,,CHEMBL625195,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
8831,In vivo,11977,Intermediate,10116.0,,1,Biodistribution of radioligand [125I]-FIDA1 in liver of rat after 2 minutes after an intravenous injection is given (average of 3 rats),,,CHEMBL625196,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
8832,In vivo,11977,Intermediate,10116.0,,1,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 30 minutes after an intravenous injection is given (average of 2 rats),,,CHEMBL625197,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
8833,In vivo,11977,Intermediate,10116.0,,1,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 30 minutes after an intravenous injection is given (average of 3 rats),,,CHEMBL625198,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
8834,In vivo,11977,Intermediate,10116.0,,1,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 60 minutes after an intravenous injection is given (average of 3 rats),,,CHEMBL627929,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
8835,In vivo,11977,Intermediate,10116.0,,1,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 120 minutes after an intravenous injection is given (average of 3 rats),,,CHEMBL627074,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2048.0
8836,In vivo,11977,Intermediate,10116.0,,1,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 2 minutes after an intravenous injection is given (average of 3 rats),,,CHEMBL627075,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2048.0
8837,In vivo,11977,Intermediate,10116.0,,1,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 30 minutes after an intravenous injection is given (average of 2 rats),,,CHEMBL627076,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2048.0
8838,In vivo,11977,Intermediate,10116.0,,1,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 30 minutes after an intravenous injection is given (average of 3 rats),,,CHEMBL627077,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2048.0
8839,In vivo,11977,Intermediate,10116.0,,1,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 60 minutes after an intravenous injection is given (average of 3 rats),,,CHEMBL627078,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2048.0
8840,In vivo,11977,Intermediate,10116.0,,1,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 120 minutes after an intravenous injection is given (average of 2 rats),,,CHEMBL627079,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2385.0
8841,In vivo,4573,Intermediate,10090.0,,1,Half life (t1/2) determined at a dose 10 mg/kg administered intraperitoneally to mice,,,CHEMBL873824,,50594,Mus musculus,,,N,1,BAO_0000218,
8842,In vivo,3132,Intermediate,10090.0,,1,Half life in mouse plasma was determined at dose 25 mg/kg,,,CHEMBL627080,,50594,Mus musculus,,,N,1,BAO_0000218,1969.0
8843,,17718,Intermediate,10090.0,,1,Half life was determined,,,CHEMBL627081,,50594,Mus musculus,,,N,1,BAO_0000218,
8844,In vivo,17728,Intermediate,10090.0,,1,Half life in BALB/C mice at the dose of 20 mg/kg by i.v. administration,,,CHEMBL627082,,50594,Mus musculus,,,N,1,BAO_0000218,
8845,In vivo,5961,Intermediate,10090.0,,1,Half-life in male mice after 1 mg/kg intravenous dose,,,CHEMBL627083,,50594,Mus musculus,,,N,1,BAO_0000218,
8847,,17731,Intermediate,10090.0,,1,Half life in mice plasma,,,CHEMBL627085,,50594,Mus musculus,,,N,1,BAO_0000218,1969.0
8848,,17592,Intermediate,10090.0,,1,Half life in mouse,,,CHEMBL627086,,50594,Mus musculus,,,N,1,BAO_0000218,
8849,In vivo,3132,Intermediate,10090.0,,1,Half life in mouse plasma at dose 25 mg/kg,,,CHEMBL627087,,50594,Mus musculus,,,N,1,BAO_0000218,1969.0
8850,In vivo,17729,Intermediate,10090.0,,1,Half life when injected i.p. in mice at a dose of 50 mg/kg was determined,,,CHEMBL627088,,50594,Mus musculus,,,N,1,BAO_0000218,
8851,In vivo,17729,Intermediate,10090.0,,1,Half life when injected intravenously in mice at a dose of 20 mg/kg was determined,,,CHEMBL627089,,50594,Mus musculus,,,N,1,BAO_0000218,
8852,In vivo,17729,Intermediate,10090.0,,1,Half life when injected perorally in mice at a dose of 50 mg/kg was determined,,,CHEMBL627090,,50594,Mus musculus,,,N,1,BAO_0000218,
8853,In vivo,3277,Intermediate,10090.0,,1,Half life was determined in mice at a single subcutaneous administration of 40 mg/kg (n=4),,,CHEMBL627091,,50594,Mus musculus,,,N,1,BAO_0000218,
8854,In vivo,3760,Intermediate,10090.0,,1,"Half life was evaluated at 5 mg/kg of compound dose, administered perorally in mice",,,CHEMBL627092,,50594,Mus musculus,,,N,1,BAO_0000218,
8855,In vivo,3760,Intermediate,10090.0,,1,"Half life was evaluated at 50 mg/kg of compound dose, administered perorally in mice",,,CHEMBL876785,,50594,Mus musculus,,,N,1,BAO_0000218,
8856,In vivo,2862,Intermediate,10090.0,,1,Half-life by iv administration in mouse,,,CHEMBL627093,,50594,Mus musculus,,,N,1,BAO_0000218,
8857,In vivo,2862,Intermediate,10090.0,,1,Half-life by oral administration in mouse,,,CHEMBL627094,,50594,Mus musculus,,,N,1,BAO_0000218,
8858,,5980,Intermediate,10090.0,,1,Half-life in mice,,,CHEMBL627095,,50594,Mus musculus,,,N,1,BAO_0000218,
8859,,6159,Intermediate,10090.0,,1,Half-life using mouse brain homogenate,,,CHEMBL627096,,50594,Mus musculus,,,N,1,BAO_0000218,955.0
8860,,6254,Intermediate,10090.0,,1,Half-life was measured in mice,,,CHEMBL627097,,50594,Mus musculus,,,N,1,BAO_0000218,
8861,In vivo,6062,Intermediate,10090.0,,1,Half-life was measured in mouse after an iv dose of 1 mg/kg,,,CHEMBL627098,,50594,Mus musculus,,,N,1,BAO_0000218,
8862,,1574,Intermediate,10090.0,,1,Half-life period was determined in mouse blood,,,CHEMBL627099,,50594,Mus musculus,,,N,1,BAO_0000218,178.0
8863,,56,Intermediate,10090.0,,1,"Half-times of inhibition of PEP in in an ex vivo enzyme studies, using mice brain",,,CHEMBL627100,,50594,Mus musculus,,,N,1,BAO_0000218,955.0
8864,,993,Intermediate,10090.0,,1,Plasma half life in mouse,,,CHEMBL627101,,50594,Mus musculus,,,N,1,BAO_0000218,1969.0
8865,,6652,Intermediate,10090.0,,1,Stability of the peptide in the presence of mouse serum,,,CHEMBL627102,,50594,Mus musculus,,,N,1,BAO_0000218,
8866,,17852,Intermediate,10090.0,,1,Terminal half life of compound was determined in mouse,,,CHEMBL627103,,50594,Mus musculus,,,N,1,BAO_0000218,
8867,In vivo,2675,Intermediate,10090.0,,1,Terminal half life was evaluated in mice after intravenous administration,,,CHEMBL627104,,50594,Mus musculus,,,N,1,BAO_0000218,
8868,In vivo,2675,Intermediate,10090.0,,1,Terminal half life was evaluated in mice after oral administration,,,CHEMBL627105,,50594,Mus musculus,,,N,1,BAO_0000218,
8869,,499,Intermediate,10090.0,,1,The compound was evaluated for half life (release of DOX) in mice at 37 degree Celsius at the pH 5.,,,CHEMBL876786,,50594,Mus musculus,,,N,1,BAO_0000218,
8870,,499,Intermediate,10090.0,,1,The compound was evaluated for half life (release of DOX) in mice at 37 degree Celsius at the pH 7.,,,CHEMBL873825,,50594,Mus musculus,,,N,1,BAO_0000218,
8871,,499,Intermediate,10090.0,,1,The compound was evaluated for half life (release of DOX) in mice at 37 degree Celsius at the pH 7; ND means no data,,,CHEMBL627106,,50594,Mus musculus,,,N,1,BAO_0000218,
8872,In vivo,14239,Intermediate,10090.0,,1,half life period is evaluated by administering intravenously at 25 mg/kg in mice,,,CHEMBL626336,,50594,Mus musculus,,,N,1,BAO_0000218,
8873,In vivo,5506,Intermediate,10090.0,,1,"Half life beta(2,4,6,8h) value was determined at a dose of 200 mg/kg (i.p.) in Mice",,,CHEMBL877462,,50594,Mus musculus,,,N,1,BAO_0000218,
8874,In vivo,5506,Intermediate,10090.0,,1,"Half life beta(2,4,6,8h) value was determined at a dose of 200 mg/kg (i.p.) in Mice; NC: not calculable",,,CHEMBL626337,,50594,Mus musculus,,,N,1,BAO_0000218,
8875,,17734,Intermediate,10090.0,,1,Half life after intraperitoneal administration of 100 mg/kg in mice,,,CHEMBL626338,,50594,Mus musculus,,,N,1,BAO_0000218,
8876,In vivo,17728,Intermediate,10090.0,,1,Half life in BALB/C mice at the dose of 20 mg/kg by i.p. administration,,,CHEMBL626339,,50594,Mus musculus,,,N,1,BAO_0000218,
8877,In vivo,17728,Intermediate,10090.0,,1,Half life in BALB/C mice at the dose of 20 mg/kg by i.v. administration,,,CHEMBL626340,,50594,Mus musculus,,,N,1,BAO_0000218,
8878,In vivo,17728,Intermediate,10090.0,,1,Half life in BALB/C mice at the dose of 20 mg/kg by p.o. administration,,,CHEMBL625377,,50594,Mus musculus,,,N,1,BAO_0000218,
8879,In vivo,17728,Intermediate,10090.0,,1,Half life in BALB/C mice at the dose of 50 mg/kg by i.p. administration,,,CHEMBL625378,,50594,Mus musculus,,,N,1,BAO_0000218,
8880,In vivo,17728,Intermediate,10090.0,,1,Half life in BALB/C mice at the dose of 50 mg/kg by p.o. administration,,,CHEMBL625379,,50594,Mus musculus,,,N,1,BAO_0000218,
8881,,14294,Autocuration,9823.0,,1,Metabolism of compound in mini pig S9 microsomes ('+''indicates <20% largest observed peak),,,CHEMBL625380,Microsomes,22224,Sus scrofa,,,U,0,BAO_0000251,
8882,,14294,Autocuration,9823.0,,1,Metabolism of compound in mini pig S9 microsomes ('++++' indicates largest observed peak),,,CHEMBL625381,Microsomes,22224,Sus scrofa,,,U,0,BAO_0000251,
8883,,6056,Autocuration,9823.0,,1,Stability to porcine renal DHP-I,,,CHEMBL625382,,22224,Sus scrofa,,,U,0,BAO_0000019,
8884,In vivo,1317,Autocuration,9823.0,,1,Compound was tested for its half-life period at an intravenous dose of 30 ug/kg,,,CHEMBL873828,,22224,Sus scrofa,,,U,0,BAO_0000218,
8885,In vivo,1317,Autocuration,9823.0,,1,Compound was tested for its half-life period at an intravenous dose of 3 ug/kg,,,CHEMBL625383,,22224,Sus scrofa,,,U,0,BAO_0000218,
8886,,5229,Autocuration,9823.0,,1,Half-life of the parent prodrug in porcine esterase solution,,,CHEMBL625384,,22224,Sus scrofa,,,U,0,BAO_0000019,
8887,,4231,Autocuration,9823.0,,1,"First order rate constant, k was determined in in pig liver Esterase",,,CHEMBL625385,,22224,Sus scrofa,,,U,0,BAO_0000019,
8888,,4231,Autocuration,9823.0,,1,Half life of the in pig liver Esterase,,,CHEMBL625386,,22224,Sus scrofa,,,U,0,BAO_0000221,2107.0
8889,,5318,Autocuration,9823.0,,1,Tested for half life period at 37 degree Celsius in PBS buffer at 11.8 pH containing porcine liver esterase,,,CHEMBL623571,,22224,Sus scrofa,,,U,0,BAO_0000221,2107.0
8890,,5318,Autocuration,9823.0,,1,Tested for half life period at 37 degree Celsius in PBS buffer at 7.3 pH containing porcine liver esterase,,,CHEMBL623572,,22224,Sus scrofa,,,U,0,BAO_0000221,2107.0
8891,,5318,Autocuration,9823.0,,1,Tested for half life period at 37 degree Celsius in PBS buffer at 7.3 pH in containing porcine liver esterase,,,CHEMBL623573,,22224,Sus scrofa,,,U,0,BAO_0000221,2107.0
8892,,3305,Autocuration,9823.0,,1,Compound was evaluated for esterase half-life (t 1/2) period using Pig Liver Esterase (PLE) assay,,,CHEMBL623574,,22224,Sus scrofa,,,U,0,BAO_0000221,2107.0
8893,,3305,Autocuration,9823.0,,1,Compound was evaluated for esterase half-life (t 1/2) period using Pig Liver Esterase (PLE) assay; ND is not determined,,,CHEMBL623575,,22224,Sus scrofa,,,U,0,BAO_0000221,2107.0
8894,,2842,Autocuration,9823.0,,1,Half-life in the presence of pig liver esterase(PLE) was evaluated.,,,CHEMBL623749,,22224,Sus scrofa,,,U,0,BAO_0000221,2107.0
8895,,2842,Autocuration,9823.0,,1,Half-life in the presence of pig liver esterase(PLE) was evaluated; Stable,,,CHEMBL623750,,22224,Sus scrofa,,,U,0,BAO_0000221,2107.0
8896,In vitro,889,Autocuration,9823.0,,1,Half-life in vitro in pig liver,,,CHEMBL623751,,22224,Sus scrofa,,,U,0,BAO_0000221,2107.0
8897,,1904,Autocuration,9823.0,,1,Half-life time was determined for esterase-catalyzed hydrolysis of the phenol ester bond in porcine liver esterase,,,CHEMBL623752,,22224,Sus scrofa,,,U,0,BAO_0000221,2107.0
8898,In vivo,4186,Intermediate,10116.0,,1,Maximum concentration in rat plasma after administration of 50 mg/kg dose through subcutaneous route,,,CHEMBL623753,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
8899,In vivo,2774,Intermediate,10116.0,,1,Maximum concentration in rat plasma at 30 mg/Kg upon oral administration.,,,CHEMBL623754,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
8900,In vivo,1742,Intermediate,10116.0,,1,Maximum concentration in rat plasma was determined,,,CHEMBL623755,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
8901,In vivo,3169,Intermediate,10116.0,,1,Maximum concentration in rats,,,CHEMBL623756,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8902,In vivo,3169,Intermediate,10116.0,,1,Maximum concentration in rats at 1-2 hours,,,CHEMBL623757,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8903,In vivo,2081,Intermediate,10116.0,,1,Maximum concentration in rats at 1 hr was determined when dosed at 20 mg/Kg perorally,,,CHEMBL623758,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8904,In vivo,3307,Intermediate,10116.0,,1,Maximum concentration in whole brain at 30 min following 24 mg/kg subcutaneous dose in rats,,,CHEMBL623759,,50597,Rattus norvegicus,,,N,1,BAO_0000218,955.0
8905,In vivo,4727,Intermediate,10116.0,,1,Maximum concentration at the dose of 2 mg/kg in rat,,,CHEMBL623760,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8906,In vivo,6597,Intermediate,10116.0,,1,Maximum concentration was evaluated in rats,,,CHEMBL623761,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8907,In vivo,16365,Intermediate,10116.0,,1,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 10 mg/kg to a fasting rat,,,CHEMBL623762,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
8908,In vivo,16365,Intermediate,10116.0,,1,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 1 mg/kg to a fasting rat,,,CHEMBL877594,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
8909,In vivo,16365,Intermediate,10116.0,,1,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 30 mg/kg,,,CHEMBL623763,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
8910,In vivo,16365,Intermediate,10116.0,,1,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 3 mg/kg,,,CHEMBL623764,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
8911,In vivo,16365,Intermediate,10116.0,,1,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 3 mg/kg to a fasting rat,,,CHEMBL623765,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
8912,In vivo,2591,Intermediate,10116.0,,1,Maximum concentration value was evaluated for high sustained blood levels in rat after 1 hr of administration,,,CHEMBL623766,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
8913,In vivo,2591,Intermediate,10116.0,,1,Maximum concentration value was evaluated for high sustained blood levels in rat after 2 hr of administration,,,CHEMBL623767,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
8914,In vivo,2591,Intermediate,10116.0,,1,Maximum concentration value was evaluated for high sustained blood levels in rat after 30 min of administration,,,CHEMBL623768,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
8915,In vivo,5978,Intermediate,10116.0,,1,Maximum plasma concentration (Cmax) of compound (19.2 mg/kg) after po administration was determined Sprague-Dawley rat,,,CHEMBL623769,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
8916,In vivo,5978,Intermediate,10116.0,,1,Maximum plasma concentration (Cmax) of compound (19.76 mg/kg) after po administration was determined Sprague-Dawley rat,,,CHEMBL623770,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
8917,In vivo,5978,Intermediate,10116.0,,1,Maximum plasma concentration (Cmax) of compound (20.73 mg/kg) after po administration was determined Sprague-Dawley rat,,,CHEMBL623771,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
8918,In vivo,5978,Intermediate,10116.0,,1,Maximum plasma concentration (Cmax) of compound (25 mg/kg) after po administration was determined Sprague-Dawley rat,,,CHEMBL623772,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
8919,In vivo,5978,Intermediate,10116.0,,1,Maximum plasma concentration (Cmax) of compound (9.83 mg/kg) after iv administration was determined Sprague-Dawley rat,,,CHEMBL623773,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
8920,In vivo,5978,Intermediate,10116.0,,1,Maximum plasma concentration (Cmax) of compound (9.84 mg/kg) after iv administration was determined Sprague-Dawley rat,,,CHEMBL623774,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
8921,In vivo,5978,Intermediate,10116.0,,1,Maximum plasma concentration (Cmax) of compound (9.92 mg/kg) after iv administration was determined Sprague-Dawley rat,,,CHEMBL623775,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
8922,In vivo,14465,Intermediate,10116.0,,1,Cmax in rat (PO dose),,,CHEMBL623776,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
8923,In vivo,4723,Intermediate,10116.0,,1,Maximum plasma concentration determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,,,CHEMBL622191,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
8924,In vivo,4723,Intermediate,10116.0,,1,Maximum plasma concentration determined after 3 mg/kg oral administration in potassium oxonate treated rats,,,CHEMBL622192,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
8925,In vivo,4576,Intermediate,10116.0,,1,Maximum plasma concentration determined in rat,,,CHEMBL622193,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
8926,In vivo,12873,Intermediate,10116.0,,1,Maximum plasma concentration for the compound in solution form (formulation) was determined in rats at peroral dose of 5 mg/kg,,,CHEMBL622194,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
8927,In vivo,12873,Intermediate,10116.0,,1,Maximum plasma concentration for the compound in suspension form (formulation) was determined in rats at peroral dose of 5 mg/kg,,,CHEMBL622195,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
8928,In vivo,6824,Intermediate,10116.0,,1,Maximum plasma concentration in rat,,,CHEMBL622196,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
8929,In vivo,17065,Intermediate,10116.0,,1,Maximum plasma concentration measured after intravenous bolus administration of 50 mg/kg of compound to rats,,,CHEMBL622197,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
8930,In vivo,2932,Intermediate,10116.0,,1,Maximum plasma concentration of compound present in rats at the dose of 37 mg/kg in 15 min,,,CHEMBL622198,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
8931,In vivo,2932,Intermediate,10116.0,,1,Maximum plasma concentration of compound present in rats at the dose of 38 mg/kg in 15 min,,,CHEMBL622199,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
8932,In vivo,2879,Intermediate,10116.0,,1,Maximum plasma concentration of compound was measured in rat,,,CHEMBL622200,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
8933,In vivo,2864,Intermediate,10116.0,,1,Maximum plasma concentration after 20 mg/kg oral administration in rat,,,CHEMBL622201,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
8934,In vivo,16367,Intermediate,10116.0,,1,Maximum plasma concentration after oral administration to rats,,,CHEMBL623990,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
8935,In vivo,17717,Intermediate,10116.0,,1,Maximum plasma concentration at a concentration of 15 mg/kg perorally in rats along with 100 mg/kg of compound 11,,,CHEMBL623991,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
8936,In vivo,17717,Intermediate,10116.0,,1,"Maximum plasma concentration at a concentration of 3 mg/kg in rats, intravenously",,,CHEMBL623992,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
8937,In vivo,17717,Intermediate,10116.0,,1,Maximum plasma concentration at a concentration of 60 mg/kg perorally in rats along with 100 mg/kg of compound 11,,,CHEMBL623993,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
8938,In vivo,17717,Intermediate,10116.0,,1,Maximum plasma concentration at a concentration of 60 mg/kg perorally in rats along with control,,,CHEMBL623994,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
8939,In vivo,17720,Intermediate,10116.0,,1,Maximum plasma concentration at a dose of 100 mg/kg in Rat Plasma after iv administration,,,CHEMBL623995,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
8940,In vivo,17720,Intermediate,10116.0,,1,Maximum plasma concentration at a dose of 4 mg/kg in Rat Plasma after iv administration,,,CHEMBL623996,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
8941,In vivo,17720,Intermediate,10116.0,,1,Maximum plasma concentration at a dose of 50 mg/kg in Rat Plasma after iv administration,,,CHEMBL623997,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
8942,In vivo,4516,Intermediate,10116.0,,1,Maximum plasma concentration dosed orally in rats,,,CHEMBL623998,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
8943,In vivo,4516,Intermediate,10116.0,,1,Maximum plasma concentration dosed orally in rats after 6 hours,,,CHEMBL623999,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
8944,In vivo,4516,Intermediate,10116.0,,1,Maximum plasma concentration dosed orally in rats after 6 hours; ND is not detected,,,CHEMBL624000,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
8945,In vivo,5199,Intermediate,10116.0,,1,Maximum plasma concentration at a 1 mg/kg oral dose in female Sprague-Dawley rats,,,CHEMBL624001,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
8946,In vivo,17538,Intermediate,10116.0,,1,Maximum plasma concentration in rat after po administration,,,CHEMBL624002,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
8947,In vivo,6685,Intermediate,10116.0,,1,"Maximum plasma concentration in rats at 10 mg/kg, p.o. dose",,,CHEMBL624003,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
8948,In vivo,6685,Intermediate,10116.0,,1,"Maximum plasma concentration in rats at 20mg/kg, i.p. dose",,,CHEMBL624004,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
8949,,16434,Intermediate,10116.0,,1,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,,CHEMBL624005,,50597,Rattus norvegicus,,,N,1,BAO_0000218,948.0
8950,,16434,Intermediate,10116.0,,1,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,,CHEMBL624006,,50597,Rattus norvegicus,,,N,1,BAO_0000218,948.0
8951,,16434,Intermediate,10116.0,,1,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,,CHEMBL624007,,50597,Rattus norvegicus,,,N,1,BAO_0000218,948.0
8952,,16434,Intermediate,10116.0,,1,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,,CHEMBL624008,,50597,Rattus norvegicus,,,N,1,BAO_0000218,948.0
8953,,16434,Intermediate,10116.0,,1,Radioactivity distribution in heart of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,,CHEMBL624009,,50597,Rattus norvegicus,,,N,1,BAO_0000218,948.0
8954,,16434,Intermediate,10116.0,,1,Radioactivity distribution in heart of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,,CHEMBL874387,,50597,Rattus norvegicus,,,N,1,BAO_0000218,948.0
8955,,16434,Intermediate,10116.0,,1,Radioactivity distribution in heart of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,,CHEMBL624010,,50597,Rattus norvegicus,,,N,1,BAO_0000218,948.0
8956,,16434,Intermediate,10116.0,,1,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min.,,,CHEMBL624011,,50597,Rattus norvegicus,,,N,1,BAO_0000218,948.0
8957,,16435,Intermediate,10116.0,,1,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,,CHEMBL624012,,50597,Rattus norvegicus,,,N,1,BAO_0000218,948.0
8958,,16435,Intermediate,10116.0,,1,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,,CHEMBL624013,,50597,Rattus norvegicus,,,N,1,BAO_0000218,948.0
8959,,16435,Intermediate,10116.0,,1,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,,CHEMBL624736,,50597,Rattus norvegicus,,,N,1,BAO_0000218,948.0
8960,,16435,Intermediate,10116.0,,1,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,,CHEMBL624737,,50597,Rattus norvegicus,,,N,1,BAO_0000218,948.0
8961,,16434,Intermediate,10116.0,,1,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,,CHEMBL624738,,50597,Rattus norvegicus,,,N,1,BAO_0000218,948.0
8962,,16434,Intermediate,10116.0,,1,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,,,CHEMBL624739,,50597,Rattus norvegicus,,,N,1,BAO_0000218,948.0
8963,,16434,Intermediate,10116.0,,1,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,,CHEMBL624740,,50597,Rattus norvegicus,,,N,1,BAO_0000218,948.0
8964,,16435,Intermediate,10116.0,,1,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,,CHEMBL624896,,50597,Rattus norvegicus,,,N,1,BAO_0000218,948.0
8965,,16435,Intermediate,10116.0,,1,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,,CHEMBL624897,,50597,Rattus norvegicus,,,N,1,BAO_0000218,948.0
8966,,16435,Intermediate,10116.0,,1,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,,CHEMBL624108,,50597,Rattus norvegicus,,,N,1,BAO_0000218,948.0
8967,,16435,Intermediate,10116.0,,1,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,,CHEMBL624109,,50597,Rattus norvegicus,,,N,1,BAO_0000218,948.0
8968,,16435,Intermediate,10116.0,,1,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,,CHEMBL624110,,50597,Rattus norvegicus,,,N,1,BAO_0000218,948.0
8969,,16435,Intermediate,10116.0,,1,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,,CHEMBL624111,,50597,Rattus norvegicus,,,N,1,BAO_0000218,948.0
8970,,16435,Intermediate,10116.0,,1,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,,CHEMBL624112,,50597,Rattus norvegicus,,,N,1,BAO_0000218,948.0
8971,,16435,Intermediate,10116.0,,1,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,,CHEMBL624113,,50597,Rattus norvegicus,,,N,1,BAO_0000218,948.0
8972,,16435,Intermediate,10116.0,,1,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,,CHEMBL619709,,50597,Rattus norvegicus,,,N,1,BAO_0000218,948.0
8973,,16435,Intermediate,10116.0,,1,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,,CHEMBL619710,,50597,Rattus norvegicus,,,N,1,BAO_0000218,948.0
8974,,16434,Intermediate,10116.0,,1,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,,CHEMBL619711,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2113.0
8975,,16434,Intermediate,10116.0,,1,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,,CHEMBL619712,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2113.0
8976,,16434,Intermediate,10116.0,,1,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,,CHEMBL619713,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2113.0
8977,,16434,Intermediate,10116.0,,1,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,,CHEMBL619714,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2113.0
8978,,16434,Intermediate,10116.0,,1,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,,CHEMBL619715,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2113.0
8979,,16434,Intermediate,10116.0,,1,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,,CHEMBL619716,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2113.0
8980,,16434,Intermediate,10116.0,,1,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,,CHEMBL619717,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2113.0
8981,,16434,Intermediate,10116.0,,1,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,,,CHEMBL619718,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2113.0
8982,,16435,Intermediate,10116.0,,1,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,,CHEMBL619719,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2113.0
8983,,16435,Intermediate,10116.0,,1,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,,CHEMBL875329,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2113.0
8984,,16435,Intermediate,10116.0,,1,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,,CHEMBL619720,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2113.0
8985,,16435,Intermediate,10116.0,,1,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,,CHEMBL619721,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2113.0
8986,,16435,Intermediate,10116.0,,1,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,,CHEMBL619722,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2113.0
8987,,16435,Intermediate,10116.0,,1,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,,CHEMBL619723,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2113.0
8988,,16435,Intermediate,10116.0,,1,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,,CHEMBL619724,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2113.0
8989,,16435,Intermediate,10116.0,,1,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,,CHEMBL619725,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2113.0
8990,,16434,Intermediate,10116.0,,1,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,,CHEMBL619726,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2113.0
8991,,16434,Intermediate,10116.0,,1,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,,,CHEMBL619727,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2113.0
8992,,16434,Intermediate,10116.0,,1,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,,CHEMBL619728,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2113.0
8993,,16435,Intermediate,10116.0,,1,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,,CHEMBL619729,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2113.0
8994,In vivo,11977,Intermediate,10116.0,,1,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 120 minutes after an intravenous injection is given (average of 3 rats),,,CHEMBL619730,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2385.0
8995,In vivo,11977,Intermediate,10116.0,,1,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 2 minutes after an intravenous injection is given (average of 3 rats),,,CHEMBL619731,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2385.0
8996,In vivo,11977,Intermediate,10116.0,,1,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 30 minutes after an intravenous injection is given (average of 2 rats),,,CHEMBL619732,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2385.0
8997,In vivo,11977,Intermediate,10116.0,,1,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 30 minutes after an intravenous injection is given (average of 3 rats),,,CHEMBL619733,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2385.0
8998,In vivo,11977,Intermediate,10116.0,,1,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 60 minutes after an intravenous injection is given (average of 3 rats),,,CHEMBL619734,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2385.0
8999,In vivo,11977,Intermediate,10116.0,,1,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 120 minutes after an intravenous injection is given (average of 3 rats),,,CHEMBL619735,,50597,Rattus norvegicus,,,N,1,BAO_0000218,14.0
9000,In vivo,11977,Intermediate,10116.0,,1,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 2 minutes after an intravenous injection is given (average of 3 rats),,,CHEMBL875330,,50597,Rattus norvegicus,,,N,1,BAO_0000218,14.0
9001,In vivo,11977,Intermediate,10116.0,,1,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 30 minutes after an intravenous injection is given (average of 2 rats),,,CHEMBL628465,,50597,Rattus norvegicus,,,N,1,BAO_0000218,14.0
9002,In vivo,11977,Intermediate,10116.0,,1,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 30 minutes after an intravenous injection is given (average of 3 rats),,,CHEMBL628466,,50597,Rattus norvegicus,,,N,1,BAO_0000218,14.0
9003,In vivo,11977,Intermediate,10116.0,,1,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 60 minutes after an intravenous injection is given (average of 3 rats),,,CHEMBL628467,,50597,Rattus norvegicus,,,N,1,BAO_0000218,14.0
9004,In vivo,11977,Intermediate,10116.0,,1,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 120 minutes after an intravenous injection is given (average of 3 rats),,,CHEMBL628468,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2106.0
9005,In vivo,11977,Intermediate,10116.0,,1,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 2 minutes after an intravenous injection is given (average of 3 rats),,,CHEMBL628469,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2106.0
9006,In vivo,11977,Intermediate,10116.0,,1,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 30 minutes after an intravenous injection is given (average of 2 rats),,,CHEMBL628470,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2106.0
9007,In vivo,11977,Intermediate,10116.0,,1,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 30 minutes after an intravenous injection is given (average of 3 rats),,,CHEMBL628471,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2106.0
9008,In vivo,11977,Intermediate,10116.0,,1,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 60 minutes after an intravenous injection is given (average of 3 rats),,,CHEMBL628472,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2106.0
9009,In vivo,11977,Intermediate,10116.0,,1,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 120 minutes after an intravenous injection is given (average of 3 rats),,,CHEMBL625191,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2046.0
9010,In vivo,11977,Intermediate,10116.0,,1,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 2 minutes after an intravenous injection is given (average of 3 rats),,,CHEMBL625192,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2046.0
9011,In vivo,11977,Intermediate,10116.0,,1,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 30 minutes after an intravenous injection is given (average of 2 rats),,,CHEMBL875337,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2046.0
9012,In vivo,11977,Intermediate,10116.0,,1,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 30 minutes after an intravenous injection is given (average of 3 rats),,,CHEMBL626341,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2046.0
9013,In vivo,11977,Intermediate,10116.0,,1,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 60 minutes after an intravenous injection is given (average of 3 rats),,,CHEMBL626342,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2046.0
9014,In vivo,11977,Intermediate,10116.0,,1,Biodistribution of radioligand [125I]-FIDA1 in liver of rat after 2 minutes after an intravenous injection is given (average of 3 rats),,,CHEMBL621943,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
9015,,3748,Intermediate,10116.0,,1,Half life in rats,,,CHEMBL621944,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9016,,15765,Intermediate,10116.0,,1,Mean percent inhibition of joint damage reduction in fasted rats at 35 mg/kg administered orally twice daily,,,CHEMBL621945,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9017,,4871,Intermediate,10116.0,,1,Compound was evaluated for rate of clearance by using IPRL (Isolated Perfused Rat Liver),,,CHEMBL621946,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9018,,4871,Intermediate,10116.0,,1,Compound was evaluated for rate of clearance by using IPRL (Isolated Perfused Rat Liver); ND=Not determined,,,CHEMBL621947,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9019,,4872,Intermediate,10116.0,,1,Compound was evaluated for rate of clearance in IPRL (Isolated Perfused Rat Liver),,,CHEMBL621948,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9020,,4872,Intermediate,10116.0,,1,Compound was evaluated for rate of clearance in IPRL (Isolated Perfused Rat Liver); ND=Not determined,,,CHEMBL621949,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9021,,5413,Intermediate,10116.0,,1,Rate constant (k) of clearance from isolated perfused rat liver (IPRL),,,CHEMBL621950,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9022,,5413,Intermediate,10116.0,,1,Tested for rate of clearance from isolated perfused rat liver (IPRL) and expressed in terms of rate constant (k); not determined,,,CHEMBL621951,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9023,In vivo,15272,Intermediate,10116.0,,1,Maximal blood concentration after oral administration of a 30 uM/kg dose of compound,,,CHEMBL621952,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
9024,,4689,Intermediate,10116.0,,1,Stability (%) in rat liver microsomes,,,CHEMBL621953,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
9025,,6057,Intermediate,10116.0,,1,Area under curve was calculated after intravenous administration,,,CHEMBL621954,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9026,,6057,Intermediate,10116.0,,1,Area under the curve was calculated after iv administration in rat,,,CHEMBL621955,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9027,,6057,Intermediate,10116.0,,1,Area under the curve was calculated in rat after peroral administration,,,CHEMBL621956,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9028,,6211,Intermediate,10116.0,,1,Dose-normalized AUC was determined by po administration (10 mg/kg) in fasted male Sprague-Dawley rats,,,CHEMBL621957,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9029,,5710,Intermediate,10116.0,,1,Dose-normalized AUC measured in fasted male Sprague dawely rats when the compound was administered at a peroral dose of 2 mg/Kg,,,CHEMBL621958,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9030,,5710,Intermediate,10116.0,,1,Dose-normalized AUC measured in fasted male Sprague dawely rats when the compound was administered at a peroral of 2 mg/Kg,,,CHEMBL621959,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9031,,17853,Intermediate,10116.0,,1,Dose-normalized area under curve in rat (i.v.) at 0.5 mpk,,,CHEMBL621960,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9032,,17853,Intermediate,10116.0,,1,Dose-normalized area under curve in rat (p.o.) at 2.0 mpk,,,CHEMBL621961,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9033,,15765,Intermediate,10116.0,,1,p value of the compound,,,CHEMBL621962,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9034,,15765,Intermediate,10116.0,,1,p value of the compound,,,CHEMBL876787,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9035,,15765,Intermediate,10116.0,,1,p value of the compound,,,CHEMBL621963,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9036,,6175,Intermediate,10116.0,,1,pH of the gastric juice (Control value = 1.42+/-0.02) of stomach content of pylorus ligated rats was measured (10 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),,,CHEMBL622637,,50597,Rattus norvegicus,,,N,1,BAO_0000218,945.0
9037,,6175,Intermediate,10116.0,,1,pH of the gastric juice (Control value = 1.42+/-0.02) of stomach content of pylorus ligated rats was measured (20 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),,,CHEMBL622638,,50597,Rattus norvegicus,,,N,1,BAO_0000218,945.0
9038,,6175,Intermediate,10116.0,,1,pH of the gastric juice (Control value = 1.42+/-0.02) of stomach content of pylorus ligated rats was measured (5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),,,CHEMBL626561,,50597,Rattus norvegicus,,,N,1,BAO_0000218,945.0
9039,,7991,Autocuration,9986.0,,1,Negative log of minimum effective dose (moles per kilogram) in rabbits (hypnotic),,,CHEMBL626562,,22224,Oryctolagus cuniculus,,,U,0,BAO_0000019,
9040,,429,Autocuration,9986.0,,1,Evaluated for pharmacokinetic parameter area under curve in rabbit at the dose 20 mg/kg ( 0-4 hr ),,,CHEMBL626563,,22224,Oryctolagus cuniculus,,,U,0,BAO_0000218,
9041,,429,Autocuration,9986.0,,1,Evaluated for pharmacokinetic parameter area under curve in rabbit at the dose 20 mg/kg (0-4 hr ),,,CHEMBL626564,,22224,Oryctolagus cuniculus,,,U,0,BAO_0000218,
9042,In vivo,6253,Autocuration,9986.0,,1,Clearance was measured at the concentration of 1.11 mg/kg in rabbit blood sample,,,CHEMBL626565,,22224,Oryctolagus cuniculus,,,U,0,BAO_0000218,
9043,In vivo,6253,Autocuration,9986.0,,1,Clearance was measured at the concentration of 2.0 mg/kg in rabbit blood sample,,,CHEMBL626566,,22224,Oryctolagus cuniculus,,,U,0,BAO_0000218,
9044,In vivo,3615,Autocuration,9986.0,,1,Clearance rate in rabbits,,,CHEMBL626567,,22224,Oryctolagus cuniculus,,,U,0,BAO_0000218,
9045,In vivo,4059,Autocuration,9986.0,,1,Plasma clearance was determined in rabbit at a dose of 5 mg/kg/h administered i.v.,,,CHEMBL626568,,22224,Oryctolagus cuniculus,,,U,0,BAO_0000218,
9046,In vivo,5124,Autocuration,9986.0,,1,Clearance in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 4.9 mg/kg,,,CHEMBL626569,,22224,Oryctolagus cuniculus,,,U,0,BAO_0000218,
9047,In vivo,5124,Autocuration,9986.0,,1,Clearance in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 5 mg/kg,,,CHEMBL626570,,22224,Oryctolagus cuniculus,,,U,0,BAO_0000218,
9048,In vivo,5124,Autocuration,9986.0,,1,Clearance in male New Zealand white rabbits after i.v. administration at 2.0 mg/kg,,,CHEMBL626571,,22224,Oryctolagus cuniculus,,,U,0,BAO_0000218,
9049,In vivo,429,Autocuration,9986.0,,1,Evaluated for pharmacokinetic parameter Cmax in rabbit at the dose 20 mg/kg,,,CHEMBL626572,,22224,Oryctolagus cuniculus,,,U,0,BAO_0000218,
9050,In vivo,4059,Autocuration,9986.0,,1,Maximum plasma concentration was determined in rabbit at a dose of 5 mg/kg/h administered i.v.,,,CHEMBL626573,,22224,Oryctolagus cuniculus,,,U,0,BAO_0000218,1969.0
9051,,9659,Autocuration,9986.0,,1,Oxidation by dutch rabbit liver microsomes in presence of NADPH/O2,,,CHEMBL626574,Microsomes,22224,Oryctolagus cuniculus,,,U,0,BAO_0000251,2107.0
9052,,9659,Autocuration,9986.0,,1,Oxidation by dutch rabbit liver microsomes in presence of cumene hydroperoxide,,,CHEMBL626575,Microsomes,22224,Oryctolagus cuniculus,,,U,0,BAO_0000251,2107.0
9053,,3639,Autocuration,9986.0,,1,Dose at which bioavailability of intravenously administered compound was tested in rabbit,,,CHEMBL626576,,22224,Oryctolagus cuniculus,,,U,0,BAO_0000218,
9054,,3639,Autocuration,9986.0,,1,Dose at which bioavailability of perorally administered compound was tested in rabbit,,,CHEMBL626577,,22224,Oryctolagus cuniculus,,,U,0,BAO_0000218,
9055,In vivo,3639,Autocuration,9986.0,,1,The compound was tested for its bioavailability in rabbit (by oral dosage).,,,CHEMBL626578,,22224,Oryctolagus cuniculus,,,U,0,BAO_0000218,
9056,In vivo,5124,Autocuration,9986.0,,1,Mean retention time in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 4.9 mg/kg,,,CHEMBL625263,,22224,Oryctolagus cuniculus,,,U,0,BAO_0000218,
9057,In vivo,5124,Autocuration,9986.0,,1,Mean retention time in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 5 mg/kg,,,CHEMBL625264,,22224,Oryctolagus cuniculus,,,U,0,BAO_0000218,
9058,In vivo,5124,Autocuration,9986.0,,1,Mean retention time in male New Zealand white rabbits after i.v. administration at 2.0 mg/kg,,,CHEMBL625265,,22224,Oryctolagus cuniculus,,,U,0,BAO_0000218,
9059,,14294,Autocuration,9986.0,,1,Metabolism of compound in rabbit S9 microsomes ('+''indicates <20% largest observed peak),,,CHEMBL625266,Microsomes,22224,Oryctolagus cuniculus,,,U,0,BAO_0000251,
9060,,14294,Autocuration,9986.0,,1,Metabolism of compound in rabbit S9 microsomes ('++++' indicates largest observed peak),,,CHEMBL876796,Microsomes,22224,Oryctolagus cuniculus,,,U,0,BAO_0000251,
9061,In vivo,429,Autocuration,9986.0,,1,Evaluated for pharmacokinetic parameter half-life in rabbit at the dose 20 mg/kg,,,CHEMBL625267,,22224,Oryctolagus cuniculus,,,U,0,BAO_0000218,
9062,In vivo,5124,Autocuration,9986.0,,1,Plasma half-life in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 4.9 mg/kg,,,CHEMBL625268,,22224,Oryctolagus cuniculus,,,U,0,BAO_0000218,1969.0
9063,In vivo,5124,Autocuration,9986.0,,1,Plasma half-life in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 5 mg/kg,,,CHEMBL625269,,22224,Oryctolagus cuniculus,,,U,0,BAO_0000218,1969.0
9064,In vivo,5124,Autocuration,9986.0,,1,Plasma half-life in male New Zealand white rabbits after i.v. administration at 2.0 mg/kg,,,CHEMBL624689,,22224,Oryctolagus cuniculus,,,U,0,BAO_0000218,1969.0
9065,In vivo,429,Autocuration,9986.0,,1,Evaluated for pharmacokinetic parameter tmax in rabbit at the dose 20 mg/kg,,,CHEMBL624690,,22224,Oryctolagus cuniculus,,,U,0,BAO_0000218,
9066,,429,Autocuration,9986.0,,1,Evaluated for pharmacokinetic parameter urine recovery in rabbit at the dose 20 mg/kg ( 0-24 hr ),,,CHEMBL624691,,22224,Oryctolagus cuniculus,,,U,0,BAO_0000218,1088.0
9067,,429,Autocuration,9986.0,,1,Evaluated for pharmacokinetic parameter urine recovery in rabbit at the dose 20 mg/kg (0-24 hr),,,CHEMBL624692,,22224,Oryctolagus cuniculus,,,U,0,BAO_0000218,1088.0
9068,In vivo,4059,Autocuration,9986.0,,1,The compound was evaluated for volume of distribution in rabbit at a dose of 5 mg/kg/h administered i.v.,,,CHEMBL624693,,22224,Oryctolagus cuniculus,,,U,0,BAO_0000218,
9069,In vivo,4137,Autocuration,9986.0,,1,Volume of distribution after intravenous administration of 1 mg/kg/h in dog,,,CHEMBL624694,,22224,Oryctolagus cuniculus,,,U,0,BAO_0000218,
9070,In vitro,11672,Autocuration,9986.0,,1,In vitro Biological half-life in crude homogenate of rabbit renal cortex,,,CHEMBL877596,,22224,Oryctolagus cuniculus,,,U,0,BAO_0000221,
9071,,12886,Autocuration,9986.0,,1,Time within which only 10% of the drug was degraded,,,CHEMBL624695,,22224,Oryctolagus cuniculus,,,U,0,BAO_0000019,
9072,,3853,Autocuration,9986.0,,1,Half life period in rabbit liver homogenate,,,CHEMBL624696,,22224,Oryctolagus cuniculus,,,U,0,BAO_0000221,2107.0
9073,,3615,Autocuration,9986.0,,1,Half life value in rabbits,,,CHEMBL624697,,22224,Oryctolagus cuniculus,,,U,0,BAO_0000019,
9074,In vivo,6253,Autocuration,9986.0,,1,Half-life was measured at the concentration of 1.11 mg/kg in rabbit blood sample,,,CHEMBL624698,,22224,Oryctolagus cuniculus,,,U,0,BAO_0000218,178.0
9075,In vivo,6253,Autocuration,9986.0,,1,Half-life was measured at the concentration of 2.0 mg/kg in rabbit blood sample,,,CHEMBL624699,,22224,Oryctolagus cuniculus,,,U,0,BAO_0000218,178.0
9076,In vivo,6077,Autocuration,9986.0,,1,Half-life period in rabbits following intravenous administration at 2 mg/kg,,,CHEMBL624700,,22224,Oryctolagus cuniculus,,,U,0,BAO_0000218,
9077,,17617,Intermediate,10116.0,,1,AUC 0-8 hr value in rats at 10 mg/kg,,,CHEMBL622903,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
9078,,17594,Intermediate,10116.0,,1,AUC after administration at 2000 mg/kg/day in rats,,,CHEMBL622904,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
9079,,6149,Intermediate,10116.0,,1,AUC of compound for a 2 mpk po dose of the sodium salt in rats.,,,CHEMBL622905,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
9080,,17260,Intermediate,10116.0,,1,AUC at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,,,CHEMBL622906,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
9081,,17260,Intermediate,10116.0,,1,AUC at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,,,CHEMBL622907,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
9082,,6644,Intermediate,10116.0,,1,AUC in rat after oral administration at 10.5 mg/kg dose,,,CHEMBL622908,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
9083,,6644,Intermediate,10116.0,,1,AUC in rat after oral administration at 11.2 mg/kg dose,,,CHEMBL622909,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
9084,,6644,Intermediate,10116.0,,1,AUC in rat after oral administration at 9.7 mg/kg dose,,,CHEMBL622910,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
9085,,6495,Intermediate,10116.0,,1,AUC in rat brain after oral administration at 10 mg/kg,,,CHEMBL622911,,50597,Rattus norvegicus,,,N,1,BAO_0000218,955.0
9086,,6504,Intermediate,10116.0,,1,AUC in rat p.o.,,,CHEMBL622912,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
9087,,17686,Intermediate,10116.0,,1,AUC in rat p.o. at 20 mg/kg concentration,,,CHEMBL622913,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
9088,,6495,Intermediate,10116.0,,1,AUC in rat plasma after oral administration at 10 mg/kg,,,CHEMBL622914,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
9089,,216,Intermediate,10116.0,,1,AUC in rats,,,CHEMBL622915,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
9090,,1908,Intermediate,10116.0,,1,AUC value after IV dose at a dose of 5 mg/kg in rats.,,,CHEMBL622916,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
9091,,1908,Intermediate,10116.0,,1,AUC value after oral dose at a dose of 10 mg/kg in rats.,,,CHEMBL622917,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
9092,In vivo,6685,Intermediate,10116.0,,1,"Maximum plasma concentration in rats at 2 mg/kg, i.v. dose; n/a: not applicable",,,CHEMBL622918,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
9093,In vivo,216,Intermediate,10116.0,,1,Maximum plasma concentration in rats when a oral dose of 200 mg/kg was given,,,CHEMBL622919,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
9094,In vivo,6049,Intermediate,10116.0,,1,Maximum plasma concentration was evaluated in rat,,,CHEMBL622920,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
9095,In vivo,2463,Intermediate,10116.0,,1,Maximum plasma concentration was evaluated in vivo in rat at a dose of 5 mg/kg by oral administration,,,CHEMBL622921,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
9096,In vivo,6679,Intermediate,10116.0,,1,Maximum plasma concentration reached by compound was determined after 2 mg/kg (p.o.) administration,,,CHEMBL622922,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
9097,In vivo,6681,Intermediate,10116.0,,1,Maximum plasma concentration reached by compound was determined in rats at 50 mg/kg dose,,,CHEMBL622923,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
9098,In vivo,4890,Intermediate,10116.0,,1,Maximum plasma concentration was determined after oral administration at a dose 10 mg/kg to male Sprague-Dawley rats,,,CHEMBL877604,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
9099,In vivo,6410,Intermediate,10116.0,,1,Maximum plasma concentration was evaluated in rats at an intravenous dose of 3 mg/kg,,,CHEMBL622924,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
9100,In vivo,6410,Intermediate,10116.0,,1,Maximum plasma concentration was evaluated in rats at an oral dose of 30 mg/kg,,,CHEMBL622925,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
9101,In vivo,16366,Intermediate,10116.0,,1,Maximum plasma concentration was measured when a dose of 1 mg/kg is administered orally,,,CHEMBL622926,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
9102,In vivo,6227,Intermediate,10116.0,,1,Maximum plasma concentration (Cmax) in rat (in vivo) at a dose of 10 mg/kg,,,CHEMBL623625,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
9103,In vivo,3598,Expert,10116.0,,1,Maximum plasma drug concentration of compound determined in rat after iv administration at a dose of 10 mg/kg,,,CHEMBL623626,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
9104,In vivo,1465,Intermediate,10116.0,,1,Maximum plasma drug concentration was determined,,,CHEMBL623627,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
9105,In vivo,4368,Intermediate,10116.0,,1,Maximum concentration by intravenous administration of 3.4 mg/kg in rat,,,CHEMBL623628,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9106,In vivo,15662,Intermediate,10116.0,,1,Mean peak plasma concentration was observed after intravenous administration in rat,,,CHEMBL623629,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
9107,In vivo,15662,Intermediate,10116.0,,1,Mean peak plasma concentration was observed after oral administration in rat,,,CHEMBL623630,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
9108,In vivo,5355,Intermediate,10116.0,,1,Peak concentration (Cmax) at a dose of 10 mg/kg in rats,,,CHEMBL623804,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9109,In vivo,5355,Intermediate,10116.0,,1,Peak concentration (Cmax) at a dose of 20 mg/kg in rats,,,CHEMBL623805,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9110,In vivo,1567,Intermediate,10116.0,,1,Peak oral plasma concentration was determined in rats by oral administration,,,CHEMBL623806,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
9111,In vivo,4026,Intermediate,10116.0,,1,Peak plasma concentration (Cmax) was determined,,,CHEMBL623807,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
9112,In vivo,6193,Intermediate,10116.0,,1,Peak plasma concentration (Cmax) following an oral dose of 20 mg/kg in rats,,,CHEMBL623808,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
9113,In vivo,4026,Intermediate,10116.0,,1,Peak plasma concentration (Cmax) in rats,,,CHEMBL623809,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
9114,In vivo,6485,Intermediate,10116.0,,1,Peak plasma concentration at 1 mg/kg peroral administration,,,CHEMBL623810,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
9115,In vivo,17655,Intermediate,10116.0,,1,Peak plasma concentration in rat,,,CHEMBL623811,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
9116,In vivo,14941,Intermediate,10116.0,,1,"Pharmacokinetic Parameter, Cmax is observed maximum plasma concentration in Female Wistar Rats at 100 mg/kg by po administration",,,CHEMBL623812,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
9117,In vivo,5394,Intermediate,10116.0,,1,Pharmacokinetic parameter Cmax was measured after administration into rat at 10 mg/kg,,,CHEMBL877605,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9118,In vivo,4408,Intermediate,10116.0,,1,Pharmacokinetic property (Cmax) in rat,,,CHEMBL623813,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9119,In vivo,5983,Intermediate,10116.0,,1,Pharmacokinetic property (Cmax) was measured in rat at the dose of 0.32 mg/kg p.o.,,,CHEMBL623814,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9120,In vivo,4878,Intermediate,10116.0,,1,Cmax in rat after 3mg/kg oral dose,,,CHEMBL623815,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9121,In vivo,5862,Intermediate,10116.0,Sprague-Dawley,1,Clearance in Sprague-Dawley rats after 2mg/kg oral dose,,,CHEMBL623816,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9122,In vivo,4517,Intermediate,10116.0,,1,Cmax in rats after 20 mg/kg oral dose,,,CHEMBL623145,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9123,In vivo,5932,Intermediate,10116.0,,1,Cmax in rat plasma after 30mg/kg oral dose,,,CHEMBL623146,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
9124,In vivo,5436,Intermediate,10116.0,,1,Plasma concentration after oral administration of 100 mg/kg to rats,,,CHEMBL623147,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
9125,In vivo,4910,Intermediate,10116.0,,1,Tested for concentration in brain after intravenous administration (4.7 mg/kg) to male rats,,,CHEMBL623042,,50597,Rattus norvegicus,,,N,1,BAO_0000218,955.0
9126,In vivo,4950,Intermediate,10116.0,,1,Tested for the Cmax in rat at 10 mg/kg per orally,,,CHEMBL623043,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9127,In vivo,15078,Intermediate,10116.0,,1,"The Cmax value in female wistar rat at 100 mg/kg, p.o. dose",,,CHEMBL623044,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9128,In vivo,15078,Intermediate,10116.0,,1,"The Cmax value in male wistar rat at 100 mg/kg, p.o. dose",,,CHEMBL623045,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9129,In vivo,3360,Intermediate,10116.0,,1,Bioavailability as oral Cmax in rats at 30 mins,,,CHEMBL623046,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9130,In vivo,3360,Intermediate,10116.0,,1,Bioavailability as oral Cmax in rats at 6hr,,,CHEMBL623226,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9131,In vivo,15022,Intermediate,10116.0,,1,The maximum concentration of compound was measured at the dose of 100 umol/kg,,,CHEMBL623227,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9132,In vivo,15022,Intermediate,10116.0,,1,The maximum concentration of compound was measured at the dose of 300 umol/kg,,,CHEMBL623228,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9133,In vivo,15022,Intermediate,10116.0,,1,The maximum concentration of compound was measured at the dose of 30 umol/kg,,,CHEMBL623229,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9134,In vivo,5160,Intermediate,10116.0,,1,The maximum plasma levels for the compounds were determined by LC-MS.,,,CHEMBL623230,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
9135,In vivo,15662,Intermediate,10116.0,,1,mean peak plasma concentration was observed after intravenous administration in rat,,,CHEMBL623231,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
9136,In vivo,15662,Intermediate,10116.0,,1,mean peak plasma concentration was observed after oral administration in rat,,,CHEMBL623232,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
9137,,4709,Intermediate,10116.0,,1,Concentration in the plasma after intravenous administration of 1 mg/kg in rat,,,CHEMBL623233,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9138,,3535,Intermediate,10116.0,,1,Concentration in plasma (portal) following oral dose in rats at 0.25 hr,,,CHEMBL623234,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9139,,3535,Intermediate,10116.0,,1,Concentration in plasma (portal) following oral dose in rats at 1 hr,,,CHEMBL623235,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9140,,3535,Intermediate,10116.0,,1,Concentration in plasma (portal) following oral dose in rats at 2 hr,,,CHEMBL623236,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9141,,3535,Intermediate,10116.0,,1,Concentration in plasma (systemic) following oral dose in rats at 0.25 hr,,,CHEMBL623237,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9142,,3535,Intermediate,10116.0,,1,Concentration in plasma (systemic) following oral dose in rats at 1 hr,,,CHEMBL623238,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9143,,3535,Intermediate,10116.0,,1,Concentration in plasma (systemic) following oral dose in rats at 2 hr,,,CHEMBL623239,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9144,In vivo,5005,Intermediate,10116.0,,1,Compound was evaluated for the plasma concentration in rats versus time curves (AUC) in vivo,,,CHEMBL623240,,22224,Rattus norvegicus,,,U,0,BAO_0000218,1969.0
9145,,6326,Intermediate,10116.0,,1,"Concentration (30 mg/kg, p.o.) in rat hypothalamus after 2 hours",,,CHEMBL623241,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1898.0
9146,,6326,Intermediate,10116.0,,1,"Concentration (30 mg/kg, p.o.) in rat hypothalamus after 6 hours",,,CHEMBL623242,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1898.0
9147,,6326,Intermediate,10116.0,,1,"Concentration (30 mg/kg, p.o.) in rat plasma after 2 hours",,,CHEMBL874394,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9148,,6326,Intermediate,10116.0,,1,"Concentration (30 mg/kg, p.o.) in rat plasma after 6 hours",,,CHEMBL623243,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9149,,17411,Intermediate,10116.0,,1,Kidney concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,,,CHEMBL623244,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9150,,16435,Intermediate,10116.0,,1,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,,CHEMBL623245,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2113.0
9151,,16435,Intermediate,10116.0,,1,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,,CHEMBL623246,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2113.0
9152,,16435,Intermediate,10116.0,,1,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,,CHEMBL623247,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2113.0
9153,,16435,Intermediate,10116.0,,1,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,,CHEMBL623248,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2113.0
9154,,16435,Intermediate,10116.0,,1,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,,CHEMBL623249,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2113.0
9155,,16434,Intermediate,10116.0,,1,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,,CHEMBL625072,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
9156,,16434,Intermediate,10116.0,,1,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,,CHEMBL625073,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
9157,,16434,Intermediate,10116.0,,1,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,,CHEMBL625074,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
9158,,16434,Intermediate,10116.0,,1,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,,CHEMBL625075,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
9159,,16434,Intermediate,10116.0,,1,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 120 min.,,,CHEMBL625076,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
9160,,16434,Intermediate,10116.0,,1,Radioactivity distribution in liver of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,,CHEMBL625077,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
9161,,16434,Intermediate,10116.0,,1,Radioactivity distribution in liver of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,,CHEMBL625078,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
9162,,16434,Intermediate,10116.0,,1,Radioactivity distribution in liver of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,,,CHEMBL874395,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
9163,,16435,Intermediate,10116.0,,1,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,,CHEMBL625079,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
9164,,16435,Intermediate,10116.0,,1,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,,CHEMBL625080,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
9165,,16435,Intermediate,10116.0,,1,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,,CHEMBL625081,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
9166,,16435,Intermediate,10116.0,,1,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,,CHEMBL625082,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
9167,,16435,Intermediate,10116.0,,1,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,,CHEMBL625083,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
9168,,16435,Intermediate,10116.0,,1,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,,CHEMBL625084,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
9169,,16435,Intermediate,10116.0,,1,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,,CHEMBL625085,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
9170,,16435,Intermediate,10116.0,,1,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,,CHEMBL625086,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
9171,,16434,Intermediate,10116.0,,1,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,,CHEMBL625087,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
9172,,16434,Intermediate,10116.0,,1,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,,,CHEMBL625088,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
9173,,16434,Intermediate,10116.0,,1,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,,CHEMBL622205,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
9174,,16435,Intermediate,10116.0,,1,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,,CHEMBL622206,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
9175,,16435,Intermediate,10116.0,,1,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,,CHEMBL622207,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
9176,,16435,Intermediate,10116.0,,1,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,,CHEMBL622366,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
9177,,16435,Intermediate,10116.0,,1,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,,CHEMBL622367,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
9178,,16435,Intermediate,10116.0,,1,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,,CHEMBL875331,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
9179,,16435,Intermediate,10116.0,,1,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,,CHEMBL622368,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
9180,,16434,Intermediate,10116.0,,1,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,,CHEMBL622369,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2048.0
9181,,16434,Intermediate,10116.0,,1,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,,CHEMBL622370,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2048.0
9182,,16434,Intermediate,10116.0,,1,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,,CHEMBL622371,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2048.0
9183,,16434,Intermediate,10116.0,,1,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,,CHEMBL622372,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2048.0
9184,,16434,Intermediate,10116.0,,1,Radioactivity distribution in lung of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,,CHEMBL622373,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2048.0
9185,,16434,Intermediate,10116.0,,1,Radioactivity distribution in lung of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,,CHEMBL622374,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2048.0
9186,,16434,Intermediate,10116.0,,1,Radioactivity distribution in lung of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,,CHEMBL622375,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2048.0
9187,,16434,Intermediate,10116.0,,1,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min.,,,CHEMBL622376,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2048.0
9188,,16435,Intermediate,10116.0,,1,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,,CHEMBL622377,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2048.0
9189,,16435,Intermediate,10116.0,,1,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,,CHEMBL622378,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2048.0
9190,,16435,Intermediate,10116.0,,1,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,,CHEMBL622379,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2048.0
9191,,16435,Intermediate,10116.0,,1,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,,CHEMBL622380,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2048.0
9192,,16435,Intermediate,10116.0,,1,Radioactivity distribution in lung of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,,CHEMBL622381,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2048.0
9193,,16435,Intermediate,10116.0,,1,Radioactivity distribution in lung of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,,CHEMBL622382,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2048.0
9194,,16434,Intermediate,10116.0,,1,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 120 min,,,CHEMBL622383,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2048.0
9195,,6175,Intermediate,10116.0,,1,pH of the gastric juice (Control value = 1.44+/-0.01) of stomach content of pylorus ligated rats was measured ( 5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),,,CHEMBL875332,,50597,Rattus norvegicus,,,N,1,BAO_0000218,945.0
9196,,6175,Intermediate,10116.0,,1,pH of the gastric juice (Control value = 1.44+/-0.01) of stomach content of pylorus ligated rats was measured (10 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),,,CHEMBL622384,,50597,Rattus norvegicus,,,N,1,BAO_0000218,945.0
9197,,6175,Intermediate,10116.0,,1,pH of the gastric juice (control value = 1.39+/-0.02) of stomach content of pylorus ligated rats was measured (2.5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),,,CHEMBL622385,,50597,Rattus norvegicus,,,N,1,BAO_0000218,945.0
9198,,6175,Intermediate,10116.0,,1,pH of the gastric juice (control value = 1.39+/-0.02) of stomach content of pylorus ligated rats was measured (5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),,,CHEMBL622386,,50597,Rattus norvegicus,,,N,1,BAO_0000218,945.0
9199,,10839,Intermediate,10116.0,,1,The compound was tested for the plasma binding in rat,,,CHEMBL622387,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9200,,16459,Intermediate,10116.0,,1,"Plasma concentration after intravenous aministration at 1hr, (1 mg/kg, n=3)",,,CHEMBL622388,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9201,,16459,Intermediate,10116.0,,1,"Plasma concentration after intravenous aministration at 30 min. (1 mg/kg, n=3)",,,CHEMBL622389,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9202,,16459,Intermediate,10116.0,,1,"Plasma concentration after intravenous aministration at 60 min. (1 mg/kg, n=3)",,,CHEMBL622390,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9203,,16459,Intermediate,10116.0,,1,Plasma concentration after oral aministration at 1 hr. (10 mg/kg),,,CHEMBL622391,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9204,,16459,Intermediate,10116.0,,1,Plasma concentration after oral aministration at 2 hr. (10 mg/kg),,,CHEMBL622392,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9205,,16459,Intermediate,10116.0,,1,Plasma concentration after oral aministration at 4 hr. (10 mg/kg),,,CHEMBL622393,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9206,,3278,Intermediate,10116.0,,1,Plasma level at 2 hr after administration of the compound,,,CHEMBL622394,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9207,,3278,Intermediate,10116.0,,1,plasma level at 2 hr after administration of the compound,,,CHEMBL622395,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9208,,4684,Intermediate,10116.0,,1,Stability in rat serum measured as % recovery at 1 min,,,CHEMBL622396,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1977.0
9209,,4684,Intermediate,10116.0,,1,Stability in rat serum measured as % recovery at 10 min,,,CHEMBL624894,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1977.0
9210,,4684,Intermediate,10116.0,,1,Stability in rat serum measured as % recovery at 10 mins,,,CHEMBL624895,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1977.0
9211,,4684,Intermediate,10116.0,,1,Stability in rat serum measured as % recovery at 2 hr,,,CHEMBL624058,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1977.0
9212,,4684,Intermediate,10116.0,,1,Stability in rat serum measured as % recovery at 3 min,,,CHEMBL624059,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1977.0
9213,,4684,Intermediate,10116.0,,1,Stability in rat serum measured as % recovery at 3 mins,,,CHEMBL624060,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1977.0
9214,,4684,Intermediate,10116.0,,1,Stability in rat serum measured as % recovery at 5 min,,,CHEMBL624061,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1977.0
9215,,4684,Intermediate,10116.0,,1,Stability in rat serum measured as % recovery at 5 mins,,,CHEMBL624062,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1977.0
9216,In vivo,16456,Intermediate,10116.0,,1,Alpha-elimination half-life in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,,,CHEMBL624063,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9217,In vivo,16456,Intermediate,10116.0,,1,Beta-elimination half-life in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,,,CHEMBL624064,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9218,,723,Intermediate,10116.0,,1,Half life in plasma was determined against ovariectomized rats; t 1/2 (h) is short in plasma,,,CHEMBL624065,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
9219,,723,Intermediate,10116.0,,1,Half life in plasma was determined against ovariectomized rats; t1/2 is longer in plasma.,,,CHEMBL624066,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
9220,In vivo,5160,Intermediate,10116.0,,1,Half life tested in mature male rat at a dose of 30 mg/kg,,,CHEMBL877490,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9221,In vivo,4709,Intermediate,10116.0,,1,Half life after intravenous administration of 1 mg/kg in rat,,,CHEMBL874442,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9222,In vivo,5633,Intermediate,10116.0,,1,Half life period after administration (30 mg/kg) in rat,,,CHEMBL626890,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9223,In vivo,5302,Intermediate,10116.0,,1,Half life period in rat after 5 mg/Kg dose,,,CHEMBL626891,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9224,In vivo,5302,Intermediate,10116.0,,1,Half life period in rat after 5 mg/kg dose,,,CHEMBL626892,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9225,,17791,Intermediate,10116.0,,1,Half life period was determined,,,CHEMBL626893,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9226,,17791,Intermediate,10116.0,,1,Half life period was evaluated in rat,,,CHEMBL626894,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9227,,17791,Intermediate,10116.0,,1,Half life period was evaluated in rat; 0.5-1.0,,,CHEMBL626895,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9228,,17791,Intermediate,10116.0,,1,Half life period was evaluated in rat; 5.9-7.5,,,CHEMBL626896,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9229,,14512,Intermediate,10116.0,,1,Half-life in rat plasma,,,CHEMBL626897,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
9230,,6230,Intermediate,10116.0,,1,Half-life time in rat was determined,,,CHEMBL626898,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9231,In vivo,3364,Intermediate,10116.0,,1,Terminal half-life after iv administration to rats,,,CHEMBL626899,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9232,In vivo,6874,Intermediate,10116.0,,1,Tested for iv terminal half-life dosed as a solution in male Han Wistar rats,,,CHEMBL626900,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9233,,857,Intermediate,10116.0,,1,Time required to return to 50% inhibition of pressor response after AI-challenge in normotensive rats at 0.5 umol/kg,,,CHEMBL626901,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9234,In vivo,858,Intermediate,10116.0,,1,Time required to return to 50% inhibition of pressor response after AI-challenge in normotensive rats at 0.5 umol/kg (iv),,,CHEMBL626902,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9235,In vivo,858,Intermediate,10116.0,,1,Time required to return to 50% inhibition of pressor response after AI-challenge in normotensive rats at 5 umol/kg (iv),,,CHEMBL626903,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9236,In vivo,5355,Intermediate,10116.0,,1,Time for peak concentration (tmax) at a dose of 10 mg/kg in rats,,,CHEMBL874443,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9237,In vivo,5355,Intermediate,10116.0,,1,Time for peak concentration (tmax) at a dose of 20 mg/kg in rats,,,CHEMBL626904,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9238,,6305,Intermediate,10116.0,,1,Half life in rats,,,CHEMBL626905,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9239,In vivo,13501,Intermediate,10116.0,,1,Apparent Half life was determined from the linear portion of the log plasma concentration-time profile after oral administration of compound 18 at a dose of 4 mg/kg to rat,,,CHEMBL873830,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
9240,In vivo,17594,Intermediate,10116.0,,1,Apparent half-life after single intravenous bolus of 1 mg/kg in rats,,,CHEMBL626906,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9241,In vivo,4186,Intermediate,10116.0,,1,Apparent terminal elimination half-life in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,,,CHEMBL631076,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
9242,,2932,Intermediate,10116.0,,1,Biological half-life was measured in plasma of rats,,,CHEMBL631077,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
9243,In vivo,17065,Intermediate,10116.0,,1,Circulatory half life measured after intravenous bolus administration of 50 mg/kg of compound to rats,,,CHEMBL631078,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9244,In vivo,15765,Intermediate,10116.0,,1,Compound demonstarted an oral bioavailability of 6% with the half-life time as given in rats.,,,CHEMBL631079,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9245,In vivo,2713,Intermediate,10116.0,,1,Compound was evaluated for half life (t1/2) upon intravenous administration of 1 mg/Kg in rats,,,CHEMBL631080,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9246,In vivo,2661,Intermediate,10116.0,,1,Compound was evaluated for half life after treatment with iv dose of 1 mgkg to female wistar rats,,,CHEMBL631081,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9247,In vivo,2661,Intermediate,10116.0,,1,Compound was evaluated for half life after treatment with iv dose of 1 mgkg to male wistar rats,,,CHEMBL631239,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9248,,740,Intermediate,10116.0,,1,Compound was evaluated for plasma half life in rat,,,CHEMBL631240,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
9249,,6597,Intermediate,10116.0,,1,AUC value at a dose of 5 mg/kg (p.o.) in rats,,,CHEMBL631241,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
9250,,2959,Intermediate,10116.0,,1,AUC value after administration of 20 mg/Kg oral dose in rat,,,CHEMBL631242,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
9251,,17594,Intermediate,10116.0,,1,AUC0-24 after repeated oral dose of compound at 1 mg/kg in rats,,,CHEMBL631243,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
9252,,17596,Intermediate,10116.0,,1,AUC0-96 after administration at 50 mg/kg,,,CHEMBL874444,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
9253,,17594,Intermediate,10116.0,,1,AUC0-infinity after single intravenous bolus of 1 mg/kg in rats,,,CHEMBL631244,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
9254,,3293,Intermediate,10116.0,,1,"Absorption behavior was judged by the area under the curve, determined after oral dose of 30 mg/kg in rats.",,,CHEMBL631245,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9255,,6757,Intermediate,10116.0,,1,Area under curve (0-24 hr) at a dose of 10 mg/kg in male SD rats,,,CHEMBL627162,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9256,,6757,Intermediate,10116.0,,1,Area under curve (0-24 hr) at a dose of 100 mg/kg in male SD rats,,,CHEMBL627163,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9257,,6757,Intermediate,10116.0,,1,Area under curve (0-24 hr) at a dose of 50 mg/kg in male SD rats,,,CHEMBL627164,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9258,,5979,Intermediate,10116.0,,1,Area under curve (AUC) at a dose 1 mg/kg was determined in rat kidney,,,CHEMBL627165,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2113.0
9259,,5979,Intermediate,10116.0,,1,Area under curve (AUC) at a dose 1 mg/kg was determined in rat liver,,,CHEMBL627166,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9260,,5979,Intermediate,10116.0,,1,Area under curve (AUC) at a dose 1 mg/kg was determined in rat lung,,,CHEMBL627167,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9261,,4026,Intermediate,10116.0,,1,Area under curve (AUC) at a dose of 30 mg/kg in rats,,,CHEMBL627822,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9262,,5355,Intermediate,10116.0,,1,Area under curve (AUC) was calculated using trapezoidal rule at a dose of 20 mg/kg in rats,,,CHEMBL627823,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9263,,5355,Intermediate,10116.0,,1,Area under curve (AUC) was calculated using trapezoidal rule. at a dose of 10 mg/kg in rats,,,CHEMBL627824,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9264,,5355,Intermediate,10116.0,,1,Area under curve (AUC) was calculated using trapezoidal rule at a dose of 20 mg/kg in rats,,,CHEMBL627825,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9265,,5633,Intermediate,10116.0,,1,Area under curve (AUC0-24 h) after administration (30 mg/kg) in rat,,,CHEMBL627826,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9266,,1716,Intermediate,10116.0,,1,Area under curve (Pharmacokinetic property) was determined,,,CHEMBL627827,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9267,,1716,Intermediate,10116.0,,1,Area under curve (Pharmacokinetic property) of the compound; Not determined,,,CHEMBL627828,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9268,,4689,Intermediate,10116.0,,1,Area under curve after intravenous administration (1 mg/kg) in rat,,,CHEMBL627829,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9269,,4527,Intermediate,10116.0,,1,Area under curve by intravenous administration at a dose of 10 uM/kg in rat was determined,,,CHEMBL627830,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9270,,4527,Intermediate,10116.0,,1,Area under curve by oral administration at a dose of 100 uM/kg in rat was determined,,,CHEMBL627831,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9271,,15662,Intermediate,10116.0,,1,Area under curve in male SD rats was observed after oral administration in rat,,,CHEMBL627832,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9272,,4413,Intermediate,10116.0,,1,Area under curve of compound after iv administration of 20 mg/kg dose in rat,,,CHEMBL627833,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9273,,3598,Expert,10116.0,,1,Area under curve of compound determined in rat after iv administration at a dose of 10 mg/kg,,,CHEMBL627834,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9274,,3598,Expert,10116.0,,1,Area under curve of compound from zero time to infinity determined in rat after iv administration at a dose of 10 mg/kg,,,CHEMBL628004,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9275,,5964,Intermediate,10116.0,,1,Area under curve at 5 mg/kg po was determined in rat,,,CHEMBL628005,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9276,,4689,Intermediate,10116.0,,1,Area under curve in Rat at a oral dose of 5 mg/kg,,,CHEMBL628006,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9277,,4186,Intermediate,10116.0,,1,Area under curve in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,,,CHEMBL628007,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9278,,5510,Intermediate,10116.0,,1,Area under curve was determined,,,CHEMBL625676,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9279,,17858,Intermediate,10116.0,,1,Area under curve after 10 mg/kg oral administration in rat at 0-24 hr,,,CHEMBL631309,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9280,,17804,Intermediate,10116.0,,1,Area under curve after intravenous administration at 3 mg/kg,,,CHEMBL631310,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9281,,6106,Intermediate,10116.0,,1,Area under curve after peroral administration at 10 mg/kg in rat for 0-6 h,,,CHEMBL631311,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9282,,5964,Intermediate,10116.0,,1,Area under curve at 4 hr in rat,,,CHEMBL631312,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9283,,4026,Intermediate,10116.0,,1,Area under curve at a dose of 30 mg/kg,,,CHEMBL631313,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9284,,4756,Intermediate,10116.0,,1,Area under curve at the dose of 2 mg/Kg administered perorally in rats,,,CHEMBL631314,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9285,,4756,Intermediate,10116.0,,1,Area under curve at the dose of 5 mg/Kg administered perorally in rats,,,CHEMBL631315,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9286,,5862,Intermediate,10116.0,,1,Area under curve for a 2-mpk po dose in SD rats,,,CHEMBL631316,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9287,,5862,Intermediate,10116.0,,1,Area under curve in SD rats,,,CHEMBL631317,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9288,,6644,Intermediate,10116.0,,1,Area under curve in rat after oral administration at 13 mg/kg dose,,,CHEMBL874471,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9289,,5871,Intermediate,10116.0,,1,Area under curve in rat by po administration at 0-24 hr,,,CHEMBL631318,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9290,,5919,Intermediate,10116.0,,1,Area under curve in rat plasma,,,CHEMBL631319,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
9291,,5939,Intermediate,10116.0,,1,Area under curve in rat plasma for 0-4 hr after peroral administration at 10 mg/kg,,,CHEMBL631320,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9292,,5939,Intermediate,10116.0,,1,Area under curve in rat plasma for 0-4 hr after peroral administration at 5 mg/kg,,,CHEMBL631321,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9293,,10,Intermediate,10116.0,,1,Area under curve was evaluated in rat at 3 mg/kg dose administered intravenously,,,CHEMBL631322,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9294,,11149,Intermediate,10116.0,,1,Area under curve was measured from the graph obtained from concentration Vs time after oral administration to male F344 rats,,,CHEMBL631323,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9295,,5302,Intermediate,10116.0,,1,Area under curve value in rat at a dose of 5 mg/kg,,,CHEMBL631324,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9296,,17796,Intermediate,10116.0,,1,Area under curve was determined after oral administration in rats,,,CHEMBL631325,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9297,,4890,Intermediate,10116.0,,1,Area under curve was determined after oral administration at a dose 10 mg/kg to male Sprague-Dawley rats,,,CHEMBL631326,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9298,,6011,Intermediate,10116.0,,1,Area under curve was determined after peroral administration in rat,,,CHEMBL631327,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9299,,5375,Intermediate,10116.0,,1,Area under curve was determined at a dose 30 mpk administered orally.,,,CHEMBL631328,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9300,,17764,Intermediate,10116.0,,1,Area under curve was determined for compound after intravenous administration in rats at 24 uM/kg,,,CHEMBL631329,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9301,,4368,Intermediate,10116.0,,1,Area under curve was determined for the compound by intravenous administration of 3.4 mg/kg in rat,,,CHEMBL627217,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9302,,5610,Intermediate,10116.0,,1,Area under curve was determined in male rat,,,CHEMBL626352,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9303,,5833,Intermediate,10116.0,,1,Area under curve was determined in rat after PO administration,,,CHEMBL626353,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9304,,4257,Intermediate,10116.0,,1,Area under curve was determined in rat after a 3 mg/kg of oral dose,,,CHEMBL626354,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9305,,5937,Intermediate,10116.0,,1,Area under curve was determined in rat after oral administration at a concentration 1 mg/kg,,,CHEMBL626355,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9306,,5932,Intermediate,10116.0,,1,Area under curve was determined in rat after oral administration at a concentration 30 mg/kg,,,CHEMBL626356,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9307,,5932,Intermediate,10116.0,,1,Area under curve was determined in rat after oral administration at a concentration 30 mg/kg; NA= Not active,,,CHEMBL626357,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9308,,17411,Intermediate,10116.0,,1,Liver concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,,,CHEMBL626358,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9309,,17411,Intermediate,10116.0,,1,Lung concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,,,CHEMBL626359,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9310,,17771,Intermediate,10116.0,,1,Peak plasma concentration in rat at a dose of 3 mg/kg,,,CHEMBL626360,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
9311,,1628,Intermediate,10116.0,,1,Plasma concentration at 2 hr in rats was evaluated.,,,CHEMBL626361,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9312,,1628,Intermediate,10116.0,,1,Plasma concentration at 2 hr in rats was evaluated; Not available,,,CHEMBL626362,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9313,,17411,Intermediate,10116.0,,1,Serum concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,,,CHEMBL626363,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9314,,4910,Intermediate,10116.0,,1,Tested for concentration in brain after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,,,CHEMBL626970,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9315,,4910,Intermediate,10116.0,,1,Tested for concentration in brain after 2 hrs of intravenous administration (5 mg/kg) to male rats,,,CHEMBL626971,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9316,,4910,Intermediate,10116.0,,1,Tested for plasma concentration after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,,,CHEMBL626972,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
9317,,4910,Intermediate,10116.0,,1,Tested for plasma concentration after 2 hrs of intravenous administration (5 mg/kg) to male rats,,,CHEMBL626973,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
9318,,4910,Intermediate,10116.0,,1,Tested for plasma concentration in the after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,,,CHEMBL626974,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
9319,,4910,Intermediate,10116.0,,1,Tested for plasma concentration in the after 2 hrs of intravenous administration (5 mg/kg) to male rats,,,CHEMBL874592,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
9320,,5510,Intermediate,10116.0,,1,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C,,,CHEMBL626975,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9321,,5510,Intermediate,10116.0,,1,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C; Converted to an unknown compound,,,CHEMBL626976,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9322,,5510,Intermediate,10116.0,,1,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C; Not determined,,,CHEMBL626977,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9323,,5510,Intermediate,10116.0,,1,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C; Not tested,,,CHEMBL626978,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9324,,16427,Intermediate,10116.0,,1,PK study was carried to determine the relative absorption ranking in rat.,,,CHEMBL626979,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9325,In vivo,4689,Intermediate,10116.0,,1,Maximum plasma concentration in Rat at a oral dose of 5 mg/kg,,,CHEMBL626980,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
9326,,11450,Intermediate,10116.0,,1,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.57-0.75 % dose/g",,,CHEMBL626981,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
9327,,11450,Intermediate,10116.0,,1,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.06-0.63 % dose/g",,,CHEMBL626982,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
9328,,11450,Intermediate,10116.0,,1,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.40-0.55 % dose/g",,,CHEMBL626983,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
9329,,11450,Intermediate,10116.0,,1,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.28-0.37% dose/g",,,CHEMBL622522,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
9330,,11450,Intermediate,10116.0,,1,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.56-0.74 % dose/g",,,CHEMBL622523,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
9331,,11450,Intermediate,10116.0,,1,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from % dose/g",,,CHEMBL622524,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
9332,,11450,Intermediate,10116.0,,1,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 2.20-2.85 % dose/g",,,CHEMBL622525,,50597,Rattus norvegicus,,,N,1,BAO_0000218,955.0
9333,,11450,Intermediate,10116.0,,1,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.16-1.76 % dose/g",,,CHEMBL622526,,50597,Rattus norvegicus,,,N,1,BAO_0000218,955.0
9334,,11450,Intermediate,10116.0,,1,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.96-3.72 % dose/g",,,CHEMBL619849,,50597,Rattus norvegicus,,,N,1,BAO_0000218,955.0
9335,,11450,Intermediate,10116.0,,1,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 2.57-3.59 % dose/g",,,CHEMBL619850,,50597,Rattus norvegicus,,,N,1,BAO_0000218,955.0
9336,,11450,Intermediate,10116.0,,1,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.36-1.53 % dose/g",,,CHEMBL623864,,50597,Rattus norvegicus,,,N,1,BAO_0000218,955.0
9337,,11450,Intermediate,10116.0,,1,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.81-1.08 % dose/g",,,CHEMBL623865,,50597,Rattus norvegicus,,,N,1,BAO_0000218,955.0
9338,,11450,Intermediate,10116.0,,1,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.84-0.98 % dose/g",,,CHEMBL623866,,50597,Rattus norvegicus,,,N,1,BAO_0000218,948.0
9339,,11450,Intermediate,10116.0,,1,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.06-0.53 % dose/g",,,CHEMBL623867,,50597,Rattus norvegicus,,,N,1,BAO_0000218,948.0
9340,,11450,Intermediate,10116.0,,1,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.22-1.48 % dose/g",,,CHEMBL877615,,50597,Rattus norvegicus,,,N,1,BAO_0000218,948.0
9341,,11450,Intermediate,10116.0,,1,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.85-1.13 % dose/g",,,CHEMBL623868,,50597,Rattus norvegicus,,,N,1,BAO_0000218,948.0
9342,,11450,Intermediate,10116.0,,1,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.55-0.63 % dose/g",,,CHEMBL623869,,50597,Rattus norvegicus,,,N,1,BAO_0000218,948.0
9343,,11450,Intermediate,10116.0,,1,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.33-0.42 % dose/g",,,CHEMBL623870,,50597,Rattus norvegicus,,,N,1,BAO_0000218,948.0
9344,,16434,Intermediate,10116.0,,1,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min,,,CHEMBL623871,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2048.0
9345,,16434,Intermediate,10116.0,,1,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,,CHEMBL623872,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2048.0
9346,,16435,Intermediate,10116.0,,1,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,,CHEMBL622129,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2048.0
9347,,16435,Intermediate,10116.0,,1,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,,CHEMBL622130,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2048.0
9348,,16435,Intermediate,10116.0,,1,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,,CHEMBL622131,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2048.0
9349,,16435,Intermediate,10116.0,,1,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,,CHEMBL622132,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2048.0
9350,,16435,Intermediate,10116.0,,1,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,,CHEMBL622133,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2048.0
9351,,16435,Intermediate,10116.0,,1,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,,CHEMBL622134,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2048.0
9352,,16435,Intermediate,10116.0,,1,Radioactivity distribution in lungs of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,,CHEMBL622135,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2048.0
9353,,16435,Intermediate,10116.0,,1,Radioactivity distribution in lungs of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,,CHEMBL622136,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2048.0
9354,,16434,Intermediate,10116.0,,1,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,,CHEMBL622137,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2385.0
9355,,16434,Intermediate,10116.0,,1,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,,CHEMBL622138,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2385.0
9356,,16434,Intermediate,10116.0,,1,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,,CHEMBL623017,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2385.0
9357,,16434,Intermediate,10116.0,,1,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,,CHEMBL623018,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2385.0
9358,,16434,Intermediate,10116.0,,1,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,,CHEMBL623019,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2385.0
9359,,16434,Intermediate,10116.0,,1,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,,CHEMBL623020,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2385.0
9360,,16434,Intermediate,10116.0,,1,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min.,,,CHEMBL623021,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2385.0
9361,,16434,Intermediate,10116.0,,1,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min.,,,CHEMBL623022,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2385.0
9362,,16435,Intermediate,10116.0,,1,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,,CHEMBL623023,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2385.0
9363,,16435,Intermediate,10116.0,,1,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,,CHEMBL623024,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2385.0
9364,,16435,Intermediate,10116.0,,1,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,,CHEMBL623025,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2385.0
9365,,16435,Intermediate,10116.0,,1,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,,CHEMBL620545,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2385.0
9366,,16435,Intermediate,10116.0,,1,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,,CHEMBL620546,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2385.0
9367,,16435,Intermediate,10116.0,,1,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,,CHEMBL620547,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2385.0
9368,,16435,Intermediate,10116.0,,1,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,,CHEMBL620548,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2385.0
9369,,16435,Intermediate,10116.0,,1,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,,CHEMBL620549,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2385.0
9370,,16434,Intermediate,10116.0,,1,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,,CHEMBL620550,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2385.0
9371,,16434,Intermediate,10116.0,,1,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min,,,CHEMBL620551,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2385.0
9372,,16434,Intermediate,10116.0,,1,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,,CHEMBL620552,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2385.0
9373,,16435,Intermediate,10116.0,,1,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,,CHEMBL620553,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2385.0
9374,,16435,Intermediate,10116.0,,1,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,,CHEMBL620554,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2385.0
9375,,16435,Intermediate,10116.0,,1,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,,CHEMBL875845,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2385.0
9376,,16435,Intermediate,10116.0,,1,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,,CHEMBL620555,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2385.0
9377,,16435,Intermediate,10116.0,,1,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,,CHEMBL620556,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2385.0
9378,,16435,Intermediate,10116.0,,1,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,,CHEMBL620557,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2385.0
9379,,16434,Intermediate,10116.0,,1,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,,CHEMBL620558,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9380,,16434,Intermediate,10116.0,,1,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,,CHEMBL620559,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9381,,16434,Intermediate,10116.0,,1,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,,CHEMBL622939,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9382,,16434,Intermediate,10116.0,,1,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,,CHEMBL622940,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9383,,16434,Intermediate,10116.0,,1,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,,CHEMBL622941,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9384,,16434,Intermediate,10116.0,,1,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,,CHEMBL622942,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9385,,16434,Intermediate,10116.0,,1,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,,CHEMBL622943,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9386,,16434,Intermediate,10116.0,,1,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,,,CHEMBL622944,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9387,,16435,Intermediate,10116.0,,1,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,,CHEMBL622945,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9388,,16435,Intermediate,10116.0,,1,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,,CHEMBL622946,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9389,,3341,Intermediate,10116.0,,1,Compound was evaluated for terminal half life in rat,,,CHEMBL622947,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9390,In vivo,3634,Intermediate,10116.0,,1,Compound was evaluated in vivo in rat for the plasma half-life at a iv dose of 3 mg/kg and oral dose of 10 mg/kg and experiment by using concentration vs time curve,,,CHEMBL622948,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
9391,In vivo,3634,Intermediate,10116.0,,1,Compound was evaluated in vivo in rat for the plasma half-life at a oral dose of 20 mg/kg experiment by using concentration vs time curve,,,CHEMBL622949,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
9392,,4839,Intermediate,10116.0,,1,Compound was tested for its half life in rat,,,CHEMBL622950,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9393,In vivo,5005,Intermediate,9544.0,,1,Compound was tested for its plasma half life in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po; ND is not determined.,,,CHEMBL622951,,22224,Macaca mulatta,,,U,0,BAO_0000218,1969.0
9394,,5005,Intermediate,10116.0,,1,Compound was tested for its plasma half life in Sprague Dawley rats,,,CHEMBL622952,,22224,Rattus norvegicus,,,U,0,BAO_0000366,1969.0
9395,,5005,Intermediate,10116.0,,1,Compound was tested for its plasma half life in Sprague Dawley rats; ND is not determined,,,CHEMBL622953,,22224,Rattus norvegicus,,,U,0,BAO_0000366,1969.0
9396,,1094,Intermediate,10116.0,,1,Compound was tested for plasma half-life period in rat,,,CHEMBL873818,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
9397,In vivo,5031,Intermediate,10116.0,,1,Elimination half life after i.v. administration of compound in rats,,,CHEMBL622954,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9398,In vivo,6518,Intermediate,10116.0,,1,Elimination half-life after IV dosing at 0.5 mg/kg in rat,,,CHEMBL622955,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9399,In vivo,6518,Intermediate,10116.0,,1,Elimination half-life after IV dosing at 1 mg/kg in rat,,,CHEMBL875229,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9400,In vivo,6518,Intermediate,10116.0,,1,Elimination half-life after oral administration at a dose of 2 mg/kg in rat,,,CHEMBL622956,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9401,In vivo,6518,Intermediate,10116.0,,1,Elimination half-life after oral administration at a dose of 4 mg/kg in rat,,,CHEMBL622957,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9402,In vivo,5408,Intermediate,10116.0,,1,Evaluated for half-life after iv administration of 1 mg/kg to male Sprague-Dawley rats in brain; not determined,,,CHEMBL622958,,50597,Rattus norvegicus,,,N,1,BAO_0000218,955.0
9403,In vivo,5408,Intermediate,10116.0,,1,Evaluated for half-life after iv administration of 1 mg/kg to male Sprague-Dawley rats in plasma,,,CHEMBL622959,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
9404,In vivo,5408,Intermediate,10116.0,,1,Evaluated for half-life after iv administration of 5 mg/kg to male Sprague-Dawley rats in brain,,,CHEMBL622960,,50597,Rattus norvegicus,,,N,1,BAO_0000218,955.0
9405,In vivo,5408,Intermediate,10116.0,,1,Evaluated for half-life after iv administration of 5 mg/kg to male Sprague-Dawley rats in plasma,,,CHEMBL622961,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
9406,In vivo,4687,Intermediate,10116.0,,1,Evaluated for the half life in rat (in vivo),,,CHEMBL622962,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9407,,6640,Intermediate,10116.0,,1,Hafl life in rat,,,CHEMBL622963,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9408,,6640,Intermediate,10116.0,,1,Hafl life rat,,,CHEMBL622964,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9409,,6641,Intermediate,10116.0,,1,Hafl life rat,,,CHEMBL622965,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9410,,6640,Intermediate,10116.0,,1,Hafl life rat; Not determined,,,CHEMBL622966,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9411,,6641,Intermediate,10116.0,,1,Hafl life rat; Not determined,,,CHEMBL622967,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9412,In vivo,17411,Intermediate,10116.0,,1,Half life in kidney was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,,,CHEMBL622968,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2113.0
9413,In vivo,17411,Intermediate,10116.0,,1,Half life in liver was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,,,CHEMBL622969,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
9414,In vivo,17411,Intermediate,10116.0,,1,Half life in lung was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,,,CHEMBL875327,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2048.0
9415,In vivo,6570,Intermediate,10116.0,,1,Half life in rat after 1 mg/kg i.v. administration,,,CHEMBL628638,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9416,In vivo,6570,Intermediate,10116.0,,1,Half life in rat after 2 mg/kg peroral administration,,,CHEMBL628639,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9417,In vivo,17411,Intermediate,10116.0,,1,Half life in serum was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,,,CHEMBL625840,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9418,In vivo,4722,Intermediate,10116.0,,1,Half life of 10 mg/kg oral dose determined in rats,,,CHEMBL625841,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9419,In vivo,5978,Intermediate,10116.0,,1,Half life of compound (10 mg/kg) after iv administration was determined in Sprague-Dawley rat,,,CHEMBL625842,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9420,In vivo,5978,Intermediate,10116.0,,1,Half life of compound (19.2 mg/kg) after po administration was determined in Sprague-Dawley rat,,,CHEMBL625843,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9421,In vivo,5978,Intermediate,10116.0,,1,Half life of compound (20.73 mg/kg) after po administration was determined in Sprague-Dawley rat,,,CHEMBL625844,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9422,In vivo,5978,Intermediate,10116.0,,1,Half life of compound (25 mg/kg) after po administration was determined in Sprague-Dawley rat,,,CHEMBL873822,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9423,In vivo,5978,Intermediate,10116.0,,1,Half life of compound (9.83 mg/kg) after iv administration was determined in Sprague-Dawley rat,,,CHEMBL625845,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9424,In vivo,5978,Intermediate,10116.0,,1,Half life of compound (9.84 mg/kg) after iv administration was determined in Sprague-Dawley rat,,,CHEMBL627059,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9425,In vivo,5978,Intermediate,10116.0,,1,Half life of compound (9.84 mg/kg) after po administration was determined in Sprague-Dawley rat,,,CHEMBL627060,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9426,In vivo,5978,Intermediate,10116.0,,1,Half life of compound (9.92 mg/kg) after iv administration was determined in Sprague-Dawley rat,,,CHEMBL627061,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9427,In vivo,4762,Intermediate,10116.0,,1,Half life of compound at 5 mg/kg after po administration was determined in rat,,,CHEMBL627709,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9428,In vivo,5327,Intermediate,10116.0,,1,Half life of compound determined after intravenous administration to rat,,,CHEMBL627710,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9429,,4847,Intermediate,10116.0,,1,Half life of compound was determined in rat,,,CHEMBL627711,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9430,In vivo,17720,Intermediate,10116.0,,1,Half life at a dose of 4 mg/kg in Rat Plasma after iv administration,,,CHEMBL627712,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
9431,In vivo,4723,Intermediate,10116.0,,1,Half life determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,,,CHEMBL627713,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9432,In vivo,4723,Intermediate,10116.0,,1,Half life determined after 3 mg/kg oral administration in potassium oxonate treated rats,,,CHEMBL627714,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9433,In vivo,4256,Intermediate,9541.0,,1,Half life determined after intravenous administration at a dose of 3 mg/kg in cynomolgus monkey,,,CHEMBL627889,,22224,Macaca fascicularis,,,U,0,BAO_0000218,
9434,In vivo,4256,Intermediate,10116.0,,1,Half life determined in rat by intravenous administration,,,CHEMBL627890,,22224,Rattus norvegicus,,,U,0,BAO_0000218,
9435,In vivo,4722,Intermediate,10116.0,,1,Half life determined in rats after iv administration,,,CHEMBL627891,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9436,In vivo,6535,Intermediate,10116.0,,1,Half life in rat plasma after administration of 2 mg/kg iv,,,CHEMBL627892,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
9437,In vivo,6535,Intermediate,10116.0,,1,Half life in rat plasma after administration of 2 mg/kg iv,,,CHEMBL627893,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
9438,,1435,Intermediate,10116.0,,1,Half life in rat plasma was determined,,,CHEMBL627894,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
9439,,1435,Intermediate,10116.0,,1,Half life in rat plasma was determined; NA means not applicable,,,CHEMBL627895,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
9440,,5206,Intermediate,10116.0,,1,Half life in rat was tested,,,CHEMBL627896,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9441,,6080,Intermediate,10116.0,,1,Half life measured in rat plasma,,,CHEMBL627897,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
9442,,4449,Intermediate,10116.0,,1,Half life recorded in rats,,,CHEMBL627898,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9443,,6057,Intermediate,10116.0,,1,Half life was calculated,,,CHEMBL627899,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9444,,6057,Intermediate,10116.0,,1,Half life was calculated in rat,,,CHEMBL873823,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9445,,3747,Intermediate,10116.0,,1,Half life was determined,,,CHEMBL627900,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9446,In vivo,17858,Intermediate,10116.0,,1,Half life after 10 mg/kg oral administration in rat,,,CHEMBL627901,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9447,In vivo,16365,Intermediate,10116.0,,1,Half life after administering orally a dose of 10 mg/kg to a fasting rat,,,CHEMBL627902,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9448,In vivo,16365,Intermediate,10116.0,,1,Half life after administering orally a dose of 30 mg/kg,,,CHEMBL627903,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9449,,5031,Intermediate,10116.0,,1,Area under the curve (Concentration) was determined for the compound as AUC with limits 0-8 after i.v. administration in rats,,,CHEMBL627904,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9450,,4722,Intermediate,10116.0,,1,Area under the curve determined under pharmacokinetic behavior of the 10 mg/kg oral dose of compound for 0-6 hours,,,CHEMBL627905,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9451,,6078,Intermediate,10116.0,,1,Area under the curve for the compound calculated from 0-24 hr after intravenous administration at a dose of 10 mg/kg in rat,,,CHEMBL627906,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9452,,6078,Intermediate,10116.0,,1,Area under the curve for the compound calculated from 0-24 hr after oral administration at a dose of 10 mg/kg in rat,,,CHEMBL627907,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9453,,6078,Intermediate,10116.0,,1,Area under the curve for the compound calculated from 0-6 hr after oral administration at a dose of 10 mg/kg,,,CHEMBL876783,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9454,,6078,Intermediate,10116.0,,1,Area under the curve for the compound calculated from 0-6 hr after oral administration at a dose of 10 mg/kg; activity was not determined,,,CHEMBL627908,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9455,,17065,Intermediate,10116.0,,1,Area under the curve measured after intravenous bolus administration of 50 mg/kg of compound to rats,,,CHEMBL627909,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9456,,1353,Intermediate,10116.0,,1,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats,,,CHEMBL627910,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9457,,1353,Intermediate,10116.0,,1,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(0-1),,,CHEMBL627911,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9458,,1353,Intermediate,10116.0,,1,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(0-2),,,CHEMBL627912,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9459,,1353,Intermediate,10116.0,,1,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(0-5),,,CHEMBL627913,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9460,,1353,Intermediate,10116.0,,1,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(5-10),,,CHEMBL627914,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9461,,16423,Intermediate,10116.0,,1,Area under the curve was evaluated after 10 uM/kg of intra arterial administration,,,CHEMBL627915,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9462,,16423,Intermediate,10116.0,,1,Area under the curve was evaluated after 20 uM/kg of peroral administration,,,CHEMBL627916,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9463,,6062,Intermediate,10116.0,,1,Area under the curve was measured in rat after an iv dose of 1 mg/kg,,,CHEMBL627917,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9464,,6056,Intermediate,10116.0,,1,Area under the curve was calculated for the compound at a single intravenous administration of 20 mg/kg in rat,,,CHEMBL627918,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9465,,5182,Intermediate,10116.0,,1,Area under the curve was determined by administering the compound at a dose of 1 mg/kg intravenously in male wistar rat,,,CHEMBL627919,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9466,,6410,Intermediate,10116.0,,1,Area under the curve was evaluated at an intravenous dose of 3 mg/kg,,,CHEMBL627920,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9467,,6410,Intermediate,10116.0,,1,Area under the curve was evaluated at an oral dose of 30 mg/kg,,,CHEMBL627921,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9468,,4723,Intermediate,10116.0,,1,Area under the effect time curves from time 0-24 hr determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,,,CHEMBL627922,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9469,,4723,Intermediate,10116.0,,1,Area under the effect time curves from time 0-24 hr determined after 3 mg/kg oral administration in potassium oxonate treated rats,,,CHEMBL876784,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9470,,4723,Intermediate,10116.0,,1,Area under the effect time curves from time 0-6 hr determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,,,CHEMBL627923,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9471,,4723,Intermediate,10116.0,,1,Area under the effect time curves from time 0-6 hr determined after 3 mg/kg oral administration in potassium oxonate treated rats,,,CHEMBL626208,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9472,,4723,Intermediate,10116.0,,1,Area under the effect time curves from time 0-infinity hr determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,,,CHEMBL626209,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9473,,4723,Intermediate,10116.0,,1,Area under the effect time curves from time 0-infinity hr determined after 3 mg/kg oral administration in potassium oxonate treated rats,,,CHEMBL626210,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9474,,2463,Intermediate,10116.0,,1,Area under the plasma concentration curve was evaluated in vivo in rat at a dose of 5 mg/kg by oral administration,,,CHEMBL627994,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
9475,,4709,Intermediate,10116.0,,1,Bioavailability from area under the curve at time 0 to infinity after intravenous administration of 1 mg/kg in rat,,,CHEMBL627995,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9476,,4075,Intermediate,10116.0,,1,Blood level after a 10 mg/kg oral dose in rat expressed as AUC was determined,,,CHEMBL627996,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9477,,5394,Intermediate,10116.0,,1,Compound at a dose 10 mg/kg was administered orally to rat and the pharmacokinetic parameter area under curve (AUC) was measured,,,CHEMBL627997,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9478,,2661,Intermediate,10116.0,,1,Compound was evaluated for AUC after treatment with iv dose of 1 mgkg to female wistar rats,,,CHEMBL627998,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9479,,2661,Intermediate,10116.0,,1,Compound was evaluated for AUC after treatment with iv dose of 1 mgkg to male wistar rats,,,CHEMBL628640,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9480,,2661,Intermediate,10116.0,,1,Compound was evaluated for AUC after treatment with oral dose of 2 mgkg to female wistar rats,,,CHEMBL628641,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9481,,2661,Intermediate,10116.0,,1,Compound was evaluated for AUC after treatment with oral dose of 2 mgkg to male wistar rats,,,CHEMBL628642,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9482,,17791,Intermediate,10116.0,,1,Compound was evaluated for area under the curve expressed as (h*ug/ml),,,CHEMBL628643,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9483,,2591,Intermediate,10116.0,,1,Compound was tested for area under curve in rat,,,CHEMBL628644,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9484,,6567,Intermediate,10116.0,,1,Concentration in rat plasma after 5 mg/kg oral gavage for 8 hours,,,CHEMBL628645,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9485,,6211,Intermediate,10116.0,,1,Dose-normalized AUC was determined by po administration (10 mg/kg) in fasted male Sprague-Dawley rats,,,CHEMBL628646,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9486,,5529,Intermediate,10116.0,,1,Dose-normalized AUC was determined in rat after peroral administration (2 mg/kg),,,CHEMBL628647,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9487,,5408,Intermediate,10116.0,,1,Evaluated for AUC after iv administration of 1 mg/kg to male Sprague-Dawley rats in brain; not determined,,,CHEMBL628648,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9488,,5408,Intermediate,10116.0,,1,Evaluated for AUC after iv administration of 1 mg/kg to male Sprague-Dawley rats in plasma,,,CHEMBL625358,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9489,,5408,Intermediate,10116.0,,1,Evaluated for AUC after iv administration of 5 mg/kg to male Sprague-Dawley rats in brain,,,CHEMBL625359,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9490,,5408,Intermediate,10116.0,,1,Evaluated for AUC after iv administration of 5 mg/kg to male Sprague-Dawley rats in plasma,,,CHEMBL625360,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9491,,429,Intermediate,10116.0,,1,Evaluated for pharmacokinetic parameter area under curve in rat at the dose 50 mg/kg ( 0-8 hr ),,,CHEMBL625361,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9492,,429,Intermediate,10116.0,,1,Evaluated for pharmacokinetic parameter area under curve in rat at the dose 50 mg/kg (0-8 hr ),,,CHEMBL625362,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9493,,429,Intermediate,10116.0,,1,Evaluated for pharmacokinetic parameter area under curve in rat at the dose 50 mg/kg (0-8 hr),,,CHEMBL625363,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9494,,4796,Intermediate,10116.0,,1,Hepatic portal AUC was determined by pharmacokinetic study conducted in portal vein cannulated rats,,,CHEMBL625364,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9495,,5974,Intermediate,10116.0,,1,In vivo Area under curve (AUC) was determined after intravenous administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,,,CHEMBL625365,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9496,,5974,Intermediate,10116.0,,1,In vivo Area under curve (AUC) was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,,,CHEMBL625366,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9497,,5974,Intermediate,10116.0,,1,In vivo Area under curve (AUC) was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,,,CHEMBL625367,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9498,,11450,Intermediate,10116.0,,1,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.98-2.56 % dose/g",,,CHEMBL625368,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2113.0
9499,,11450,Intermediate,10116.0,,1,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.15-1.43 % dose/g",,,CHEMBL625369,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2113.0
9500,,11450,Intermediate,10116.0,,1,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 3.43-4.52 % dose/g",,,CHEMBL625370,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2113.0
9501,,11450,Intermediate,10116.0,,1,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 2.12-3.14 % dose/g",,,CHEMBL625371,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2113.0
9502,,11450,Intermediate,10116.0,,1,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.40-1.60 % dose/g",,,CHEMBL625372,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2113.0
9503,,11450,Intermediate,10116.0,,1,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.74-0.85 % dose/g",,,CHEMBL625373,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2113.0
9504,,11450,Intermediate,10116.0,,1,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.31-1.45 % dose/g",,,CHEMBL625374,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
9505,,11450,Intermediate,10116.0,,1,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.08-0.90 % dose/g",,,CHEMBL877593,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
9506,,11450,Intermediate,10116.0,,1,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 2.02-2.78 % dose/g",,,CHEMBL625375,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
9507,,11450,Intermediate,10116.0,,1,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 1.64-2.38 % dose/g",,,CHEMBL625376,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
9508,,11450,Intermediate,10116.0,,1,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.95-1.07 % dose/g",,,CHEMBL621973,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
9509,,11450,Intermediate,10116.0,,1,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.61-0.81 % dose/g",,,CHEMBL621974,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
9510,,11450,Intermediate,10116.0,,1,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 5.01-7.13 % dose/g",,,CHEMBL621975,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2048.0
9511,,11450,Intermediate,10116.0,,1,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.51-3.71 % dose/g",,,CHEMBL622166,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2048.0
9512,,11450,Intermediate,10116.0,,1,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 10.84-13.77 % dose/g",,,CHEMBL622167,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2048.0
9513,,11450,Intermediate,10116.0,,1,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 5.92-8.51% dose/g",,,CHEMBL622168,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2048.0
9514,,11450,Intermediate,10116.0,,1,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 3.37-3.94 % dose/g",,,CHEMBL622169,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2048.0
9515,,11450,Intermediate,10116.0,,1,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 1.87-2.12 % dose/g",,,CHEMBL622170,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2048.0
9516,,11450,Intermediate,10116.0,,1,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 37.97-75.23 % dose/g",,,CHEMBL622171,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2046.0
9517,,11450,Intermediate,10116.0,,1,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 5.03-36.88 % dose/g",,,CHEMBL622172,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2046.0
9518,,11450,Intermediate,10116.0,,1,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 13.20-17.31 % dose/g",,,CHEMBL622173,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2046.0
9519,,11450,Intermediate,10116.0,,1,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 7.87-16.51 % dose/g",,,CHEMBL622174,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2046.0
9520,,11450,Intermediate,10116.0,,1,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 81.37-166.09 % dose/g",,,CHEMBL622175,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2046.0
9521,,11450,Intermediate,10116.0,,1,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 31.90-39.98 % dose/g",,,CHEMBL622176,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2046.0
9522,,11450,Intermediate,10116.0,,1,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.41-0.83 % dose/g",,,CHEMBL622177,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2046.0
9523,,11450,Intermediate,10116.0,,1,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.05-0.38 % dose/g",,,CHEMBL622178,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2046.0
9524,,11450,Intermediate,10116.0,,1,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.16-0.20 % dose/g",,,CHEMBL622179,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2046.0
9525,,11450,Intermediate,10116.0,,1,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.08-0.17 % dose/g",,,CHEMBL622180,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2046.0
9526,,16435,Intermediate,10116.0,,1,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,,CHEMBL622181,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9527,,16435,Intermediate,10116.0,,1,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,,CHEMBL622182,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9528,,16435,Intermediate,10116.0,,1,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,,CHEMBL622183,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9529,,16435,Intermediate,10116.0,,1,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,,CHEMBL622184,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9530,,16435,Intermediate,10116.0,,1,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,,CHEMBL622185,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9531,,16435,Intermediate,10116.0,,1,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,,CHEMBL622186,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9532,,16434,Intermediate,10116.0,,1,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,,CHEMBL622187,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9533,,16434,Intermediate,10116.0,,1,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min,,,CHEMBL625002,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9534,,16434,Intermediate,10116.0,,1,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min,,,CHEMBL622090,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9535,,16435,Intermediate,10116.0,,1,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,,CHEMBL622091,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9536,,16435,Intermediate,10116.0,,1,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,,CHEMBL622092,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9537,,16435,Intermediate,10116.0,,1,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,,CHEMBL622093,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9538,,16435,Intermediate,10116.0,,1,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,,CHEMBL622094,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9539,,16435,Intermediate,10116.0,,1,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,,CHEMBL622095,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9540,,16435,Intermediate,10116.0,,1,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,,CHEMBL622264,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9541,,16434,Intermediate,10116.0,,1,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,,CHEMBL622265,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2106.0
9542,,16434,Intermediate,10116.0,,1,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,,CHEMBL622266,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2106.0
9543,,16434,Intermediate,10116.0,,1,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,,CHEMBL622267,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2106.0
9544,,16434,Intermediate,10116.0,,1,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,,CHEMBL622268,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2106.0
9545,,16434,Intermediate,10116.0,,1,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,,CHEMBL622269,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2106.0
9546,,16434,Intermediate,10116.0,,1,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,,CHEMBL625071,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2106.0
9547,,16434,Intermediate,10116.0,,1,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,,CHEMBL621621,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2106.0
9548,,16434,Intermediate,10116.0,,1,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,,,CHEMBL621622,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2106.0
9549,,16435,Intermediate,10116.0,,1,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,,CHEMBL621623,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2106.0
9550,,16435,Intermediate,10116.0,,1,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,,CHEMBL621624,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2106.0
9551,,16435,Intermediate,10116.0,,1,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,,CHEMBL621625,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2106.0
9552,,16435,Intermediate,10116.0,,1,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,,CHEMBL621626,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2106.0
9553,,16435,Intermediate,10116.0,,1,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,,CHEMBL621627,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2106.0
9554,,16435,Intermediate,10116.0,,1,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,,CHEMBL621628,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2106.0
9555,,16435,Intermediate,10116.0,,1,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,,CHEMBL875328,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2106.0
9556,,16435,Intermediate,10116.0,,1,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,,CHEMBL621629,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2106.0
9557,,16434,Intermediate,10116.0,,1,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,,CHEMBL621630,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2106.0
9558,,16434,Intermediate,10116.0,,1,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,,,CHEMBL621631,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2106.0
9559,,16434,Intermediate,10116.0,,1,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,,CHEMBL621632,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2106.0
9560,,16435,Intermediate,10116.0,,1,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,,CHEMBL621633,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2106.0
9561,,16435,Intermediate,10116.0,,1,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,,CHEMBL621634,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2106.0
9562,,16435,Intermediate,10116.0,,1,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,,CHEMBL621635,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2106.0
9563,,16435,Intermediate,10116.0,,1,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,,CHEMBL621636,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2106.0
9564,,16435,Intermediate,10116.0,,1,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,,CHEMBL621637,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2106.0
9565,,16435,Intermediate,10116.0,,1,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,,CHEMBL621638,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2106.0
9566,,16434,Intermediate,10116.0,,1,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,,CHEMBL618883,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9567,,16434,Intermediate,10116.0,,1,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,,CHEMBL618884,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9568,,16434,Intermediate,10116.0,,1,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,,CHEMBL628627,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9569,,16434,Intermediate,10116.0,,1,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,,CHEMBL628628,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9570,,16434,Intermediate,10116.0,,1,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,,CHEMBL628629,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9571,In vivo,16365,Intermediate,10116.0,,1,Half life after administering orally a dose of 3 mg/kg,,,CHEMBL628630,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9572,In vivo,16365,Intermediate,10116.0,,1,Half life after administering orally a dose of 3 mg/kg to a fasting rat,,,CHEMBL628631,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9573,In vivo,16365,Intermediate,10116.0,,1,Half life after administering intravenously a dose of 1 mg/kg,,,CHEMBL628632,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9574,In vivo,526,Intermediate,10116.0,,1,Half life after oral dosing in rats,,,CHEMBL628633,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9575,In vivo,16365,Intermediate,10116.0,,1,Half life after the administered orally a dose of 1 mg/kg to a fasting rat,,,CHEMBL628634,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9576,In vivo,4368,Intermediate,10116.0,,1,Half life by intravenous administration of 3.4 mg/kg in rat,,,CHEMBL627789,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9577,,3371,Intermediate,10116.0,,1,Half life in rat,,,CHEMBL627790,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9578,,6448,Intermediate,10116.0,,1,Half life in rat,,,CHEMBL627791,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9579,,6453,Intermediate,10116.0,,1,Half life in rat,,,CHEMBL627792,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9580,In vivo,4353,Intermediate,10116.0,,1,Half life in rat after intravenous administration of the compound,,,CHEMBL627793,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9581,In vivo,4353,Intermediate,10116.0,,1,Half life in rat after intravenous administration of the compound; nf:unable to estimate plasma elimination half life,,,CHEMBL627794,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
9582,In vivo,4353,Intermediate,10116.0,,1,Half life in rat after po administration of the compound,,,CHEMBL627795,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9583,In vivo,4353,Intermediate,10116.0,,1,Half life in rat after po administration of the compound; ND means Not determined,,,CHEMBL627796,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9584,In vivo,4353,Intermediate,10116.0,,1,Half life in rat after po administration of the compound; nf: unable to estimate plasma elimination half life,,,CHEMBL875335,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
9585,In vivo,4353,Intermediate,10116.0,,1,Half life in rat after po administration of the compound; nf:unable to estimate plasma elimination half life,,,CHEMBL627797,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
9586,In vivo,5789,Intermediate,10116.0,,1,Half life in rat i.v.,,,CHEMBL627798,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9587,In vivo,17686,Intermediate,10116.0,,1,Half life in rat i.v. at 2 mg/kg concentration,,,CHEMBL627799,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9588,,6495,Intermediate,10116.0,,1,Half life in rats,,,CHEMBL627800,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9589,In vivo,484,Intermediate,10116.0,,1,Half life in rats after intravenous administration,,,CHEMBL627801,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9590,In vivo,6467,Intermediate,10116.0,,1,Half life in rats at the dose of 1.0 mpk by i.v. administration,,,CHEMBL627802,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9591,,6642,Expert,10116.0,,1,Half life in rat,,,CHEMBL627803,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9592,In vivo,16367,Intermediate,10116.0,,1,Half life was evaluated after intravenous administration to rats,,,CHEMBL873820,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9593,,1369,Intermediate,10116.0,,1,Half life was evaluated by addition of 2 mM of 2-mercaptoethanol for inactivation of semicarbazide-sensitive amine oxidase (SSAO),,,CHEMBL627804,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9594,,5472,Intermediate,10116.0,,1,Half life was evaluated in rat,,,CHEMBL627805,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9595,,6049,Intermediate,10116.0,,1,Half life was evaluated in rat,,,CHEMBL627806,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9596,,5472,Intermediate,10116.0,,1,Half life was evaluated in rat; Not tested,,,CHEMBL627107,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9597,In vivo,16366,Intermediate,10116.0,,1,Half life was evaluated when a dose of 1 mg/kg was administered intravenously to rats,,,CHEMBL627108,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9598,In vivo,11149,Intermediate,10116.0,,1,Half life was measured as time taken to reach the half of the initial dose in air pouch exudate after oral administration to male F344 rats,,,CHEMBL627109,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9599,In vivo,11149,Intermediate,10116.0,,1,Half life was measured as time taken to reach the half of the initial dose in the blood after oral administration to male F344 rats,,,CHEMBL627110,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
9600,In vivo,2891,Intermediate,9443.0,,1,Half life was measured in monkey at dose of 10 mg/kg by po administration,,,CHEMBL627111,,22224,Primates,,,U,0,BAO_0000218,
9601,In vivo,2891,Intermediate,9443.0,,1,Half life was measured in monkey at dose of 10 mg/kg by po administration,,,CHEMBL627112,,22224,Primates,,,U,0,BAO_0000218,
9602,In vivo,2891,Intermediate,10116.0,,1,Half life was measured in rat at dose of 30 mg/kg by iv administration,,,CHEMBL627113,,22224,Rattus norvegicus,,,U,0,BAO_0000218,
9603,In vivo,2891,Intermediate,10116.0,,1,Half life was measured in rat at dose of 30 mg/kg by po administration,,,CHEMBL627114,,22224,Rattus norvegicus,,,U,0,BAO_0000218,
9604,,4026,Intermediate,10116.0,,1,Half life (t1/2) was determined,,,CHEMBL627115,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9605,,4527,Intermediate,10116.0,,1,Half life period at a dose of 10 uM/kg in rat was determined,,,CHEMBL627116,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9606,In vivo,4527,Intermediate,10116.0,,1,Half life period by oral administration at a dose of 100 uM/kg in rat was determined; ND is not determined,,,CHEMBL627117,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9607,,5503,Intermediate,10116.0,,1,Half life period was determined,,,CHEMBL627118,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9608,In vivo,4426,Intermediate,10116.0,,1,Half life period after intravenous administration at 20 mpk in rats,,,CHEMBL627119,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9609,In vivo,4426,Intermediate,10116.0,,1,Half life period after intravenous administration at 20 mpk in rats; Not performed.,,,CHEMBL627120,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9610,In vivo,6109,Intermediate,10116.0,,1,Half life period after intravenous administration in rat,,,CHEMBL626922,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9611,In vivo,5654,Intermediate,10116.0,,1,Half life period as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,,,CHEMBL626923,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9612,In vivo,5654,Intermediate,10116.0,,1,Half life period as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,,,CHEMBL626924,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9613,,4755,Intermediate,10116.0,,1,Half life period in 80% rat plasma at 37 degree Centigrade,,,CHEMBL626925,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
9614,,5862,Intermediate,10116.0,,1,Half life period in SD rats,,,CHEMBL626926,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9615,,1515,Intermediate,10116.0,,1,Half life period in human plasma at 25 degree Celsius temperature (pH 7.4),,,CHEMBL626927,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
9616,,1515,Intermediate,10116.0,,1,Half life period in human plasma at 37 degree Celsius temperature (pH 7.4),,,CHEMBL626928,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
9617,,1515,Intermediate,10116.0,,1,Half life period in human plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,,,CHEMBL626929,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
9618,,1515,Intermediate,10116.0,,1,Half life period in human plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,,,CHEMBL626930,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
9619,,5960,Intermediate,10116.0,,1,Half life period in rat,,,CHEMBL626931,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9620,,6103,Intermediate,10116.0,,1,Half life period in rat,,,CHEMBL626932,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9621,,6317,Intermediate,10116.0,,1,Half life period in rat,,,CHEMBL626933,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9622,In vivo,6644,Intermediate,10116.0,,1,Half life period in rat after oral administration at 10.5 mg/kg dose,,,CHEMBL873826,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9623,In vivo,6644,Intermediate,10116.0,,1,Half life period in rat after oral administration at 11.2 mg/kg dose,,,CHEMBL626934,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9624,In vivo,6644,Intermediate,10116.0,,1,Half life period in rat after oral administration at 13 mg/kg dose,,,CHEMBL626935,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9625,In vivo,6644,Intermediate,10116.0,,1,Half life period in rat after oral administration at 9.7 mg/kg dose,,,CHEMBL626936,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9626,,5974,Intermediate,10116.0,,1,In vivo Area under curve (AUC) was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,,,CHEMBL626937,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9627,,6295,Intermediate,10116.0,,1,In vivo area under curve in rat plasma exposure after oral administration 50 mg/kg,,,CHEMBL625906,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9628,,6296,Intermediate,10116.0,,1,In vivo area under curve in rat plasma exposure after oral administration 50 mg/kg,,,CHEMBL625907,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9629,,16427,Intermediate,10116.0,,1,PK study was carried to determine AUC (area under curve) value in rat,,,CHEMBL625908,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9630,,16367,Intermediate,10116.0,,1,Pharmacokinetic parameter AUC after intravenous administration to rats,,,CHEMBL625909,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9631,,16367,Intermediate,10116.0,,1,Pharmacokinetic parameter AUC after oral administration to rats,,,CHEMBL625910,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9632,,16365,Intermediate,10116.0,,1,Pharmacokinetic parameter AUC was evaluated intravenous administration of 3 mg/kg,,,CHEMBL625911,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9633,,16365,Intermediate,10116.0,,1,Pharmacokinetic parameter AUC was evaluated when a dose of 10 mg/kg is administered orally to a fasting rat,,,CHEMBL625912,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9634,,16365,Intermediate,10116.0,,1,Pharmacokinetic parameter AUC was evaluated when a dose of 1 mg/kg is administered orally to a fasting rat,,,CHEMBL626538,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9635,,16365,Intermediate,10116.0,,1,Pharmacokinetic parameter AUC was evaluated when a dose of 30 mg/kg is administered orally,,,CHEMBL876794,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9636,,16365,Intermediate,10116.0,,1,Pharmacokinetic parameter AUC was evaluated when a dose of 3 mg/kg is administered orally,,,CHEMBL626539,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9637,,16365,Intermediate,10116.0,,1,Pharmacokinetic parameter AUC was evaluated when a dose of 3 mg/kg is administered orally to a fasting rat,,,CHEMBL626540,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9638,,5394,Intermediate,10116.0,,1,Pharmacokinetic parameter area under curve (AUC) was measured after administration into monkey at 3 mg/kg,,,CHEMBL626541,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9639,,5394,Intermediate,10116.0,,1,Pharmacokinetic parameter area under curve (AUC) was measured after administration into rat at 10 mg/kg,,,CHEMBL626542,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9640,,2792,Intermediate,10116.0,,1,Pharmacokinetic parameter area under curve was determined at 10 mg/kg po dose in rats,,,CHEMBL626543,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9641,,2792,Intermediate,10116.0,,1,Pharmacokinetic parameter area under curve was determined at 2 mg/kg i.v. dose in rats,,,CHEMBL626544,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9642,,2792,Intermediate,10116.0,,1,Pharmacokinetic parameter area under curve was determined at 3 mg/kg po dose in rats,,,CHEMBL626545,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9643,,2792,Intermediate,10116.0,,1,Pharmacokinetic parameter area under curve was determined at 5 mg/kg i.v. dose in rats,,,CHEMBL626546,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9644,,5334,Intermediate,10116.0,,1,Pharmacokinetic parameter area under curve was reported,,,CHEMBL626547,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9645,,4408,Intermediate,10116.0,,1,Pharmacokinetic property (AUC) in rat,,,CHEMBL626548,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9646,,5983,Intermediate,10116.0,,1,Pharmacokinetic property (AUC) was measured in rat at the dose of 0.32 mg/kg p.o.,,,CHEMBL626549,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9647,,4397,Intermediate,10116.0,,1,Pharmacokinetic property at the dose of 10 mg/kg (20% HPbetaCD) concentration in rat (0 to 6 hr) p.o.,,,CHEMBL626550,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9648,,4397,Intermediate,10116.0,,1,Pharmacokinetic property at the dose of 10 mg/kg (20% HPbetaCD) concentration in rat (0 to 6 hr) p.o.; Not tested,,,CHEMBL626551,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9649,,5491,Intermediate,10116.0,,1,Pharmacokinetic property was determined,,,CHEMBL623777,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9650,,5491,Intermediate,10116.0,,1,Pharmacokinetic property when administered intravenously in rat at 2 mg/kg,,,CHEMBL623778,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9651,,5491,Intermediate,10116.0,,1,Pharmacokinetic property when administered intravenously in rat at 2 mg/kg; Not tested,,,CHEMBL623779,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9652,,4199,Intermediate,10116.0,,1,Pharmacokinetic property( plasma concentration) was determined upon 10 mg/kg in 1% methylcellulose peroral administration in rats,,,CHEMBL623780,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
9653,,4199,Intermediate,10116.0,,1,Pharmacokinetic property( plasma concentration) was determined upon 2 mg/kg in 1% methylcellulose peroral administration in rats,,,CHEMBL622015,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
9654,,4199,Intermediate,10116.0,,1,Pharmacokinetic property( plasma concentration) was determined upon 3 mg/kg in 1% methylcellulose peroral administration in rats,,,CHEMBL622016,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
9655,,5173,Intermediate,10116.0,,1,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 0.25 h",,,CHEMBL622017,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9656,,5173,Intermediate,10116.0,,1,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 0.5 h",,,CHEMBL622018,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9657,,5173,Intermediate,10116.0,,1,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 1 h",,,CHEMBL622019,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9658,,5173,Intermediate,10116.0,,1,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 2 h",,,CHEMBL622020,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9659,,16366,Intermediate,10116.0,,1,Pharmacokinetic parameter AUC was determined when a dose of 1 mg/kg was administered intravenously,,,CHEMBL622021,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9660,,16366,Intermediate,10116.0,,1,Pharmacokinetic parameter AUC was determined when a dose of 1 mg/kg was administered orally,,,CHEMBL622022,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9661,,5327,Intermediate,10116.0,,1,Plasma concentration expressed as area under curve after intravenous administration was determined in rat,,,CHEMBL622023,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9662,,6681,Intermediate,10116.0,,1,Plasma concentration for the compound was determined in rats at 50 mg/kg dose,,,CHEMBL622024,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9663,,12873,Intermediate,10116.0,,1,Plasma concentration was calculated in rats at a peroral dose of 5 mg/kg of solution (formulation of compound),,,CHEMBL622693,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9664,,12873,Intermediate,10116.0,,1,Plasma concentration was calculated in rats at a peroral dose of 5 mg/kg of suspension (formulation of compound),,,CHEMBL622694,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9665,,6685,Intermediate,10116.0,,1,"Plasma concentration was determined in rats at 10 mg/kg, p.o. dose",,,CHEMBL622695,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9666,,6685,Intermediate,10116.0,,1,"Plasma concentration was determined in rats at 20 mg/kg, i.p. dose",,,CHEMBL622696,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9667,,6685,Intermediate,10116.0,,1,"Plasma concentration was determined in rats at 2 mg/kg, i.v. dose",,,CHEMBL622697,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9668,,6619,Intermediate,10116.0,,1,"Reduction in area under curve was determined in fa/fa Zucker rats by oral glucose tolerance test following a single i.p. dose (20 mg/kg, 30 min pre-treatment)",,,CHEMBL622874,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9669,,6619,Intermediate,10116.0,,1,"Reduction in area under curve was determined in fa/fa Zucker rats by oral glucose tolerance test following a single i.p. dose (30 mg/kg, 30 min pre-treatment)",,,CHEMBL622875,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9670,,10363,Intermediate,10116.0,,1,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 30 mg/kg; Not significant,,,CHEMBL622876,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9671,,4796,Intermediate,10116.0,,1,Systemic AUC was determined by pharmacokinetic study conducted in portal vein cannulated rats,,,CHEMBL622877,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9672,,4910,Intermediate,10116.0,,1,Tested for concentration in brain after intravenous administration (4.7 mg/kg) to male rats,,,CHEMBL622878,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9673,,4910,Intermediate,10116.0,,1,Tested for plasma concentration after intravenous administration (4.7 mg/kg) to male rats,,,CHEMBL622879,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
9674,,4839,Intermediate,10116.0,,1,Tested for the pharmacokinetic parameter in rat and expressed as area under curve,,,CHEMBL877602,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9675,,15078,Intermediate,10116.0,,1,"The AUC(0-infinitive) value in female wistar rat at 100 mg/kg, p.o. dose",,,CHEMBL622880,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9676,,15078,Intermediate,10116.0,,1,"The AUC(0-infinitive) value in male wistar rat at 100 mg/kg, p.o. dose",,,CHEMBL622881,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9677,,15078,Intermediate,10116.0,,1,"The AUC(0-t)value in female wistar rat at 100 mg/kg, p.o. dose",,,CHEMBL622882,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9678,,15078,Intermediate,10116.0,,1,"The AUC(0-t)value in male wistar rat at 100 mg/kg, p.o. dose",,,CHEMBL622883,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9679,,11450,Intermediate,10116.0,,1,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 2.16-2.39% dose/g",,,CHEMBL622884,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2046.0
9680,,11450,Intermediate,10116.0,,1,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.99-1.40 % dose/g",,,CHEMBL622885,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2046.0
9681,,8151,Intermediate,10116.0,,1,Antidiuretic activity expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg.,,,CHEMBL622886,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9682,,8151,Intermediate,10116.0,,1,Antidiuretic activity expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,,,CHEMBL622887,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9683,,8151,Intermediate,10116.0,,1,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 100 mg/Kg,,,CHEMBL622888,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
9684,In vivo,8677,Intermediate,10116.0,,1,"Biodistribution in Sprague-Dawley rat blood 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,,CHEMBL622889,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
9685,In vivo,8677,Intermediate,10116.0,,1,"Biodistribution in Sprague-Dawley rat blood 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,,CHEMBL622890,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
9686,In vivo,8677,Intermediate,10116.0,,1,"Biodistribution in Sprague-Dawley rat blood 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,,CHEMBL622891,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
9687,In vivo,8677,Intermediate,10116.0,,1,"Biodistribution in Sprague-Dawley rat blood 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,,CHEMBL877603,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
9688,In vivo,8677,Intermediate,10116.0,,1,"Biodistribution in Sprague-Dawley rat brain 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,,CHEMBL622892,,50597,Rattus norvegicus,,,N,1,BAO_0000218,955.0
9689,In vivo,8677,Intermediate,10116.0,,1,"Biodistribution in Sprague-Dawley rat brain 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,,CHEMBL622893,,50597,Rattus norvegicus,,,N,1,BAO_0000218,955.0
9690,In vivo,8677,Intermediate,10116.0,,1,"Biodistribution in Sprague-Dawley rat brain 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,,CHEMBL622894,,50597,Rattus norvegicus,,,N,1,BAO_0000218,955.0
9691,In vivo,8677,Intermediate,10116.0,,1,"Biodistribution in Sprague-Dawley rat brain 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,,CHEMBL622895,,50597,Rattus norvegicus,,,N,1,BAO_0000218,955.0
9692,In vivo,8677,Intermediate,10116.0,,1,Biodistribution in Sprague-Dawley rat brain 2 minutes after intravenous administration.,,,CHEMBL622896,,50597,Rattus norvegicus,,,N,1,BAO_0000218,955.0
9693,In vivo,8677,Intermediate,10116.0,,1,"Biodistribution in Sprague-Dawley rat heart 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,,CHEMBL622897,,50597,Rattus norvegicus,,,N,1,BAO_0000218,948.0
9694,In vivo,8677,Intermediate,10116.0,,1,"Biodistribution in Sprague-Dawley rat heart 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,,CHEMBL622898,,50597,Rattus norvegicus,,,N,1,BAO_0000218,948.0
9695,In vivo,8677,Intermediate,10116.0,,1,"Biodistribution in Sprague-Dawley rat heart 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,,CHEMBL622899,,50597,Rattus norvegicus,,,N,1,BAO_0000218,948.0
9696,In vivo,8677,Intermediate,10116.0,,1,"Biodistribution in Sprague-Dawley rat kidneys(2) 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,,CHEMBL622900,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2113.0
9697,In vivo,8677,Intermediate,10116.0,,1,"Biodistribution in Sprague-Dawley rat kidneys(2) 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,,CHEMBL624114,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2113.0
9698,In vivo,8677,Intermediate,10116.0,,1,"Biodistribution in Sprague-Dawley rat kidneys(2) 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,,CHEMBL624115,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2113.0
9699,In vivo,8677,Intermediate,10116.0,,1,"Biodistribution in Sprague-Dawley rat kidneys(2) 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,,CHEMBL624116,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2113.0
9700,In vivo,8677,Intermediate,10116.0,,1,"Biodistribution in Sprague-Dawley rat liver 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,,CHEMBL624117,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
9701,In vivo,8677,Intermediate,10116.0,,1,"Biodistribution in Sprague-Dawley rat liver 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,,CHEMBL624118,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
9702,In vivo,8677,Intermediate,10116.0,,1,"Biodistribution in Sprague-Dawley rat liver 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,,CHEMBL624119,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
9703,In vivo,8677,Intermediate,10116.0,,1,"Biodistribution in Sprague-Dawley rat liver 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,,CHEMBL624120,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
9704,In vivo,8677,Intermediate,10116.0,,1,"Biodistribution in Sprague-Dawley rat lungs(2) 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,,CHEMBL624121,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2048.0
9705,In vivo,8677,Intermediate,10116.0,,1,"Biodistribution in Sprague-Dawley rat lungs(2) 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,,CHEMBL624122,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2048.0
9706,In vivo,8677,Intermediate,10116.0,,1,"Biodistribution in Sprague-Dawley rat lungs(2) 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,,CHEMBL624123,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2048.0
9707,In vivo,8677,Intermediate,10116.0,,1,"Biodistribution in Sprague-Dawley rat lungs(2) 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,,CHEMBL624124,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2048.0
9708,In vivo,8677,Intermediate,10116.0,,1,"Biodistribution in Sprague-Dawley rat muscle 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,,CHEMBL624125,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2385.0
9709,In vivo,8677,Intermediate,10116.0,,1,"Biodistribution in Sprague-Dawley rat muscle 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,,CHEMBL624126,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2385.0
9710,In vivo,8677,Intermediate,10116.0,,1,"Biodistribution in Sprague-Dawley rat muscle 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,,CHEMBL624127,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2385.0
9711,In vivo,8677,Intermediate,10116.0,,1,"Biodistribution in Sprague-Dawley rat muscle 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,,CHEMBL624128,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2385.0
9712,In vivo,8677,Intermediate,10116.0,,1,"Biodistribution in Sprague-Dawley rat skin 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,,CHEMBL624129,,50597,Rattus norvegicus,,,N,1,BAO_0000218,14.0
9713,In vivo,8677,Intermediate,10116.0,,1,"Biodistribution in Sprague-Dawley rat skin 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,,CHEMBL624130,,50597,Rattus norvegicus,,,N,1,BAO_0000218,14.0
9714,In vivo,8677,Intermediate,10116.0,,1,"Biodistribution in Sprague-Dawley rat skin 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,,CHEMBL622340,,50597,Rattus norvegicus,,,N,1,BAO_0000218,14.0
9715,In vivo,8677,Intermediate,10116.0,,1,"Biodistribution in Sprague-Dawley rat skin 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,,CHEMBL622341,,50597,Rattus norvegicus,,,N,1,BAO_0000218,14.0
9716,In vivo,8677,Intermediate,10116.0,,1,"Biodistribution in Sprague-Dawley rat small intestine 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,,CHEMBL622342,,50597,Rattus norvegicus,,,N,1,BAO_0000218,160.0
9717,In vivo,8677,Intermediate,10116.0,,1,"Biodistribution in Sprague-Dawley rat small intestine 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,,CHEMBL622343,,50597,Rattus norvegicus,,,N,1,BAO_0000218,160.0
9718,In vivo,8677,Intermediate,10116.0,,1,"Biodistribution in Sprague-Dawley rat small intestine 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,,CHEMBL622344,,50597,Rattus norvegicus,,,N,1,BAO_0000218,160.0
9719,In vivo,8677,Intermediate,10116.0,,1,"Biodistribution in Sprague-Dawley rat small intestine 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,,CHEMBL622345,,50597,Rattus norvegicus,,,N,1,BAO_0000218,160.0
9720,In vivo,8677,Intermediate,10116.0,,1,"Biodistribution in Sprague-Dawley rat spleen 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,,CHEMBL622346,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2106.0
9721,In vivo,8677,Intermediate,10116.0,,1,"Biodistribution in Sprague-Dawley rat spleen 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,,CHEMBL622347,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2106.0
9722,In vivo,8677,Intermediate,10116.0,,1,"Biodistribution in Sprague-Dawley rat spleen 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,,CHEMBL622348,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2106.0
9723,In vivo,8677,Intermediate,10116.0,,1,"Biodistribution in Sprague-Dawley rat spleen 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,,CHEMBL622349,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2106.0
9724,,16434,Intermediate,10116.0,,1,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,,CHEMBL622350,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9725,,16434,Intermediate,10116.0,,1,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,,CHEMBL622351,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9726,,16434,Intermediate,10116.0,,1,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,,,CHEMBL622352,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9727,,16435,Intermediate,10116.0,,1,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,,CHEMBL622353,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9728,,16435,Intermediate,10116.0,,1,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,,CHEMBL622354,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9729,,16435,Intermediate,10116.0,,1,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,,CHEMBL622355,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9730,,16435,Intermediate,10116.0,,1,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,,CHEMBL622356,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9731,,16435,Intermediate,10116.0,,1,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,,CHEMBL622357,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9732,,16435,Intermediate,10116.0,,1,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,,CHEMBL622358,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9733,,16435,Intermediate,10116.0,,1,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,,CHEMBL622359,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9734,,16435,Intermediate,10116.0,,1,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,,CHEMBL874393,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9735,,16434,Intermediate,10116.0,,1,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,,CHEMBL622872,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9736,,16434,Intermediate,10116.0,,1,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,,,CHEMBL622873,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9737,,16434,Intermediate,10116.0,,1,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,,CHEMBL623047,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9738,,16435,Intermediate,10116.0,,1,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,,CHEMBL623048,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9739,,16435,Intermediate,10116.0,,1,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,,CHEMBL623049,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9740,,16435,Intermediate,10116.0,,1,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,,CHEMBL623050,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9741,,16435,Intermediate,10116.0,,1,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,,CHEMBL623051,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9742,,16435,Intermediate,10116.0,,1,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,,CHEMBL623052,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9743,,16435,Intermediate,10116.0,,1,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,,CHEMBL626343,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9744,,16434,Intermediate,10116.0,,1,Radioactivity distribution in tumor of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,,CHEMBL626344,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9745,,16434,Intermediate,10116.0,,1,Radioactivity distribution in tumor of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,,CHEMBL626345,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9746,,16434,Intermediate,10116.0,,1,Radioactivity distribution in tumor of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,,CHEMBL626346,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9747,,16434,Intermediate,10116.0,,1,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,,CHEMBL626347,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9748,,16434,Intermediate,10116.0,,1,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,,,CHEMBL626348,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9749,,16434,Intermediate,10116.0,,1,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,,CHEMBL626349,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9750,,16435,Intermediate,10116.0,,1,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,,CHEMBL626350,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9751,,16435,Intermediate,10116.0,,1,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,,CHEMBL626351,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9752,,16435,Intermediate,10116.0,,1,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,,CHEMBL627650,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9753,,16435,Intermediate,10116.0,,1,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,,CHEMBL627651,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9754,,16435,Intermediate,10116.0,,1,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,,CHEMBL627652,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9755,,16435,Intermediate,10116.0,,1,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,,CHEMBL627653,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9756,,13091,Intermediate,10116.0,,1,Tissue biodistribution into estrogen-primed immature female rat blood at 1 hr blocked time interval,,,CHEMBL627654,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9757,,13091,Intermediate,10116.0,,1,Tissue biodistribution into estrogen-primed immature female rat blood at 1 hr low time interval,,,CHEMBL627835,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9758,,13091,Intermediate,10116.0,,1,Tissue biodistribution into estrogen-primed immature female rat blood at 1 hr time interval,,,CHEMBL627836,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9759,,13091,Intermediate,10116.0,,1,Tissue biodistribution into estrogen-primed immature female rat blood at 3 hr time interval,,,CHEMBL627837,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9760,,13091,Intermediate,10116.0,,1,Tissue biodistribution into estrogen-primed immature female rat bone at 1 hr blocked time interval,,,CHEMBL627838,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9761,,13091,Intermediate,10116.0,,1,Tissue biodistribution into estrogen-primed immature female rat bone at 1 hr low time interval,,,CHEMBL875338,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9762,,13091,Intermediate,10116.0,,1,Tissue biodistribution into estrogen-primed immature female rat bone at 1 hr time interval,,,CHEMBL627839,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9763,,13091,Intermediate,10116.0,,1,Tissue biodistribution into estrogen-primed immature female rat bone at 3 hr time interval,,,CHEMBL627840,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9764,,13091,Intermediate,10116.0,,1,Tissue biodistribution into estrogen-primed immature female rat brain at 1 hr blocked time interval,,,CHEMBL627841,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9765,,13091,Intermediate,10116.0,,1,Tissue biodistribution into estrogen-primed immature female rat brain at 1 hr low time interval,,,CHEMBL627842,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9766,,13091,Intermediate,10116.0,,1,Tissue biodistribution into estrogen-primed immature female rat brain at 1 hr time interval,,,CHEMBL627843,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9767,,13091,Intermediate,10116.0,,1,Tissue biodistribution into estrogen-primed immature female rat brain at 3 hr time interval,,,CHEMBL627844,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9768,,13091,Intermediate,10116.0,,1,Tissue biodistribution into estrogen-primed immature female rat fat at 1 hr blocked time interval,,,CHEMBL627845,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9769,In vivo,5874,Intermediate,10116.0,,1,Half life period in rat by iv administration at a dose of 3 mg/kg,,,CHEMBL627846,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9770,,1515,Intermediate,10116.0,,1,Half life period in rat plasma at 25 degree Centigrade temperature (pH 7.4),,,CHEMBL627847,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
9771,,1515,Intermediate,10116.0,,1,Half life period in rat plasma at 37 degree Celsius temperature (pH 7.4),,,CHEMBL873821,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
9772,,1515,Intermediate,10116.0,,1,Half life period in rat plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,,,CHEMBL626079,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
9773,,1515,Intermediate,10116.0,,1,Half life period in rat plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,,,CHEMBL626080,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
9774,,5491,Intermediate,10116.0,,1,Half life period was evaluated in rat plasma,,,CHEMBL626081,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
9775,,5491,Intermediate,10116.0,,1,Half life period was evaluated in rat plasma; Not tested,,,CHEMBL875344,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
9776,,1918,Intermediate,10116.0,,1,Half life period was evaluated in rats,,,CHEMBL626082,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9777,In vivo,1918,Intermediate,10116.0,,1,"Half life period was evaluated in rats, iv",,,CHEMBL626250,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9778,In vivo,6113,Intermediate,10116.0,,1,Half life period after intravenous administration at 5 mg/kg in rat,,,CHEMBL626251,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9779,In vivo,5546,Intermediate,10116.0,,1,Half life period was determined in Sprague-Dawley rats at a dose of 1 mg/kg by iv administration,,,CHEMBL626252,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9780,In vivo,5553,Intermediate,10116.0,,1,Half life period was determined in rat after iv administration at a dose of 5 mg/kg,,,CHEMBL626253,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9781,,4188,Intermediate,10116.0,,1,Half life stability of compound was evaluated in rat plasma,,,CHEMBL626254,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
9782,In vivo,6215,Intermediate,10116.0,,1,Half life time after intravenous administration (5.0 mg/kg) was determined in rat,,,CHEMBL626255,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9783,In vivo,6141,Intermediate,10116.0,,1,Half life time was evaluated at 1 mg/kg of iv administration in Sprague-Dawley rats,,,CHEMBL626256,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9784,In vivo,5182,Intermediate,10116.0,,1,Half life was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat,,,CHEMBL626257,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9785,In vivo,5182,Intermediate,10116.0,,1,Half life was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat; NC means not calculated,,,CHEMBL626258,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9786,In vivo,5710,Intermediate,10116.0,,1,Half life was measured in fasted male administration of compound 0.5 mg/Kg i.v.,,,CHEMBL626259,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9787,In vivo,5789,Intermediate,10116.0,,1,Half in rat i.v.,,,CHEMBL626260,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9788,In vivo,6011,Intermediate,10116.0,,1,Half period in rat after intravenous administration,,,CHEMBL875345,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9789,In vivo,17594,Intermediate,10116.0,,1,Half-life after repeated oral dose of compound at 1 mg/kg in rats,,,CHEMBL626261,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9790,In vitro,12357,Intermediate,10116.0,,1,Half-life measured in in vitro Cathepsin B assay in rat liver,,,CHEMBL626262,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
9791,,5210,Intermediate,10116.0,,1,Half-life of compound was determined in rats,,,CHEMBL626263,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9792,In vivo,17596,Intermediate,10116.0,,1,Half-life at 10 mg/kg in rat upon intravenous administration,,,CHEMBL625270,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9793,,6672,Intermediate,10116.0,,1,Half-life determined in rat,,,CHEMBL625271,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9794,,6673,Intermediate,10116.0,,1,Half-life determined in rat,,,CHEMBL625272,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9795,In vivo,4910,Intermediate,10116.0,,1,Half-life in brain after intravenous administration (4.7 mg/kg) to male rats,,,CHEMBL625273,,50597,Rattus norvegicus,,,N,1,BAO_0000218,955.0
9796,,3741,Intermediate,10116.0,,1,"Half-life in chemical and enzymatic hydrolysis, in 80% rat plasma",,,CHEMBL625274,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
9797,In vivo,17671,Intermediate,10116.0,,1,Half-life in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,,,CHEMBL625275,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9798,In vivo,4910,Intermediate,10116.0,,1,Half-life in plasma after intravenous administration (4.7 mg/kg) to male rats,,,CHEMBL625276,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
9799,,17537,Intermediate,10116.0,,1,Half-life in rat plasma,,,CHEMBL625277,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
9800,,4965,Intermediate,10116.0,,1,Half-life in rat plasma was determined,,,CHEMBL625278,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
9801,,17537,Intermediate,10116.0,,1,Half-life in rat plasma; Not tested,,,CHEMBL625279,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
9802,,6124,Intermediate,10116.0,,1,Half-life in rat serum,,,CHEMBL625280,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1977.0
9803,,6124,Intermediate,10116.0,,1,Half-life in rat serum; na is not available,,,CHEMBL876797,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1977.0
9804,,6078,Intermediate,10116.0,,1,Half-life was calculated in rat,,,CHEMBL625281,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9805,,17668,Intermediate,10116.0,,1,Half-life was calculated in rat plasma,,,CHEMBL873827,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
9806,,3185,Intermediate,10116.0,,1,Half-life was determined,,,CHEMBL625282,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9807,,4883,Intermediate,10116.0,,1,Half-life was determined,,,CHEMBL625283,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9808,In vivo,2959,Intermediate,10116.0,,1,Half-life after administration of 20 mg/Kg oral dose in rat,,,CHEMBL625284,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9809,In vivo,4029,Intermediate,10116.0,,1,Half-life after administration of 3.2 mg/kg intravenously in male rat,,,CHEMBL625285,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9810,In vivo,4029,Intermediate,10116.0,,1,Half-life after intravenous administration in female rat,,,CHEMBL625286,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9811,In vivo,4029,Intermediate,10116.0,,1,Half-life after intravenous administration in male rat,,,CHEMBL625287,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9812,In vivo,6180,Intermediate,10116.0,,1,Half-life after intravenous dose in rat,,,CHEMBL625288,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9813,,1557,Intermediate,10116.0,,1,Half-life in a rat liver homogenate preparation,,,CHEMBL625289,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
9814,,12500,Intermediate,10116.0,,1,Half-life in plasma of rat,,,CHEMBL625290,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
9815,,12500,Intermediate,10116.0,,1,Half-life in plasma of rat at dose of 3-10 mgkg,,,CHEMBL876798,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
9816,,5064,Intermediate,10116.0,,1,Half-life in rat,,,CHEMBL625291,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9817,,5145,Intermediate,10116.0,,1,Half-life in rat,,,CHEMBL625292,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9818,,5147,Intermediate,10116.0,,1,Half-life in rat,,,CHEMBL625293,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9819,,5833,Intermediate,10116.0,,1,Half-life in rat,,,CHEMBL622832,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9820,,6596,Intermediate,10116.0,,1,Half-life in rat,,,CHEMBL622833,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9821,,17655,Intermediate,10116.0,,1,Half-life in rat,,,CHEMBL622834,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9822,In vivo,6495,Intermediate,10116.0,,1,Half-life in rat after oral administration at 10 mg/kg,,,CHEMBL622835,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9823,In vivo,17538,Intermediate,10116.0,,1,Half-life in rat after po administration at a dose of 10 mg/kg,,,CHEMBL622836,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9824,In vivo,17538,Intermediate,10116.0,,1,Half-life in rat after po administration at a dose of 10 mg/kg; nd is not determined,,,CHEMBL622837,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9825,In vivo,10,Intermediate,10116.0,,1,Half-life in rat at 3 mg/kg dose administered intravenously,,,CHEMBL622838,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9826,,17669,Intermediate,10116.0,,1,Half-life in rat brain homogenate,,,CHEMBL622839,,50597,Rattus norvegicus,,,N,1,BAO_0000218,955.0
9827,,17065,Intermediate,10116.0,,1,Half-life in rat plasma,,,CHEMBL622840,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
9828,,4333,Intermediate,10116.0,,1,Half-life in rats,,,CHEMBL622841,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9829,,6827,Intermediate,10116.0,,1,Half-life in Dawley rats,,,CHEMBL622842,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9830,In vitro,889,Intermediate,10116.0,,1,Half-life in vitro in rat plasma,,,CHEMBL622843,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
9831,In vitro,889,Intermediate,10116.0,,1,Half-life in vitro in rat plasma; No detectable degradation over 2 hr; no detectable degradation over 2 hours,,,CHEMBL622844,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
9832,,3747,Intermediate,10116.0,,1,"The area under concentration-time curve(AUC) was determined at 20 mg/kg of compound dose, administered intravenously in rat",,,CHEMBL622845,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9833,,15022,Intermediate,10116.0,,1,The area under the curve of compound was measured at the dose of 100 umol/kg,,,CHEMBL622846,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9834,,15022,Intermediate,10116.0,,1,The area under the curve of compound was measured at the dose of 300 umol/kg,,,CHEMBL622847,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9835,,15022,Intermediate,10116.0,,1,The area under the curve of compound was measured at the dose of 30 umol/kg,,,CHEMBL622848,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9836,In vivo,3360,Intermediate,10116.0,,1,Bioavailability as oral AUC in rats,,,CHEMBL622849,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9837,,5334,Intermediate,10116.0,,1,The plasma concentration versus time curve (AUC) was determined,,,CHEMBL622850,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
9838,,17411,Intermediate,10116.0,,1,Total concentration in kidney was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,,,CHEMBL876807,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9839,,17411,Intermediate,10116.0,,1,Total concentration in liver was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,,,CHEMBL622851,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9840,,17411,Intermediate,10116.0,,1,Total concentration in lung was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,,,CHEMBL622852,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9841,,6570,Intermediate,10116.0,,1,Total concentration in rat after 1 mg/kg i.v. administration in 24 hours,,,CHEMBL622853,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9842,,6570,Intermediate,10116.0,,1,Total concentration in rat after 2 mg/kg peroral administration in 24 hours,,,CHEMBL622854,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9843,,17411,Intermediate,10116.0,,1,Total concentration in serum was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,,,CHEMBL622855,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9844,,14941,Intermediate,10116.0,,1,"Pharmacokinetic Parameter, AUC (0-infinity) is the area under the plasma concentration versus time curve extrapolated to infinity in Female Wistar Rats at 100 mg/kg by po administration",,,CHEMBL622856,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
9845,,14941,Intermediate,10116.0,,1,"Pharmacokinetic Parameter, AUC (0-t) is the area under the plasma concentration versus time curve in Female Wistar Rats at 100 mg/kg by po administration",,,CHEMBL622857,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
9846,,17538,Intermediate,10116.0,,1,AUC in rat after po administration at a dose of 10 mg/kg,,,CHEMBL622858,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
9847,,17752,Intermediate,10116.0,,1,Area under the plasma concentration-time curve in rats after oral administration at 25 mg/kg,,,CHEMBL622859,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
9848,,17509,Intermediate,10116.0,,1,Area under curve value 24 hr after 10 mg/kg iv administration in rats,,,CHEMBL622860,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9849,,17509,Intermediate,10116.0,,1,Area under curve value 24 hr after 10 mg/kg oral administration in rats,,,CHEMBL622861,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9850,,17509,Intermediate,10116.0,,1,Area under curve value 24 hr after 2 mg/kg iv administration in rats,,,CHEMBL622862,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9851,,17509,Intermediate,10116.0,,1,Area under curve value 24 hr after 2 mg/kg oral administration in rats,,,CHEMBL622863,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9852,,17509,Intermediate,10116.0,,1,Area under curve value 6 hr after po administration in rat,,,CHEMBL623817,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9853,,17717,Intermediate,10116.0,,1,Area under the curve at a concentration of 15 mg/kg perorally in rats along with 100 mg/kg of compound 11,,,CHEMBL623818,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9854,,17717,Intermediate,10116.0,,1,"Area under the curve at a concentration of 3 mg/kg in rats, intravenously",,,CHEMBL623819,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9855,,17717,Intermediate,10116.0,,1,Area under the curve at a concentration of 60 mg/kg perorally in rats along with 100 mg/kg of compound 11,,,CHEMBL623820,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9856,,17717,Intermediate,10116.0,,1,Area under the curve at a concentration of 60 mg/kg perorally in rats along with control,,,CHEMBL623821,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9857,,6642,Intermediate,10116.0,,1,AUC normalized for dose (AUCN) in rat,,,CHEMBL623822,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
9858,,6640,Intermediate,10116.0,,1,Area under curve in rat after p.o. administration,,,CHEMBL623823,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9859,,6641,Intermediate,10116.0,,1,Area under curve in rat after p.o. administration,,,CHEMBL623824,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9860,,6641,Intermediate,10116.0,,1,Area under curve in rat after p.o. administration; Not determined,,,CHEMBL623825,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9861,,6641,Intermediate,10116.0,,1,Area under curve in rat after peroral administration,,,CHEMBL622070,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9862,,3603,Intermediate,10116.0,,1,Area under curve (carotid artery) value of the compound,,,CHEMBL622071,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9863,,3550,Intermediate,10116.0,,1,Bioavailability expressed as the area under curve of rat carotid artery,,,CHEMBL622072,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9864,,15662,Intermediate,10116.0,,1,Area under curve in male SD rats was observed after intravenous administration in rat,,,CHEMBL622073,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9865,,17720,Intermediate,10116.0,,1,Area under curve of the compound was determined,,,CHEMBL622074,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9866,,5407,Intermediate,10116.0,,1,Compound was evaluated for its pharmacokinetic parameter maximum area under curve AUCmax,,,CHEMBL622075,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9867,,17752,Intermediate,10116.0,,1,Area under the plasma concentration-time curve in rats after oral administration at 20 mg/kg,,,CHEMBL622076,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
9868,,17752,Intermediate,10116.0,,1,Area under the plasma concentration-time curve in rats following oral administration at 20 mg/kg,,,CHEMBL622077,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
9869,,3603,Intermediate,10116.0,,1,Area under curve (portal vein) value of the compound,,,CHEMBL622078,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9870,,3550,Intermediate,10116.0,,1,Bioavailability expressed as the area under curve of rat portal vein,,,CHEMBL622079,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9871,,17655,Intermediate,10116.0,,1,Area Under plasma concentration time curve in rat upon peroral administration,,,CHEMBL622080,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
9872,,17582,Intermediate,10116.0,,1,In vivo area under curve was determined for the compound after i.v. administration at a dose of 5 mg/kg in rats,,,CHEMBL877612,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9873,,17582,Intermediate,10116.0,,1,In vivo area under curve was determined for the compound after oral (po) administration at a dose of 10 mg/kg in rats,,,CHEMBL622081,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9874,,17791,Intermediate,10116.0,,1,Compound was evaluated for oral bioavailability in rats,,,CHEMBL622082,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9875,,17791,Intermediate,10116.0,,1,Compound was evaluated for oral bioavailability in rats after iv administration,,,CHEMBL622083,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9876,,17791,Intermediate,10116.0,,1,Compound was evaluated for oral bioavailability in rats; 30-80,,,CHEMBL622084,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9877,,17791,Intermediate,10116.0,,1,Compound was evaluated for oral bioavailability in rats; 50-60,,,CHEMBL622085,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9878,,17791,Intermediate,10116.0,,1,Compound was evaluated for oral bioavailability in rats; no data,,,CHEMBL622086,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9879,,17791,Intermediate,10116.0,,1,Compound was evaluated for oral bioavailability in rats; peptide,,,CHEMBL622087,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9880,,7768,Intermediate,10116.0,,1,"Distribution of radioactivity in blood of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.03-0.03",,,CHEMBL622088,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
9881,,7768,Intermediate,10116.0,,1,"Distribution of radioactivity in blood of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range-0.9-1.03",,,CHEMBL622089,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
9882,,7768,Intermediate,10116.0,,1,"Distribution of radioactivity in blood of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range = 0.88-1.15",,,CHEMBL623685,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
9883,,7768,Intermediate,10116.0,,1,"Distribution of radioactivity in blood of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range = 0.71-0.87",,,CHEMBL623686,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
9884,In vivo,8677,Intermediate,10116.0,,1,"Biodistribution in Sprague-Dawley rat stomach 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,,CHEMBL623687,,50597,Rattus norvegicus,,,N,1,BAO_0000218,945.0
9885,In vivo,8677,Intermediate,10116.0,,1,"Biodistribution in Sprague-Dawley rat stomach 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,,CHEMBL623688,,50597,Rattus norvegicus,,,N,1,BAO_0000218,945.0
9886,In vivo,8677,Intermediate,10116.0,,1,"Biodistribution in Sprague-Dawley rat stomach 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,,CHEMBL623689,,50597,Rattus norvegicus,,,N,1,BAO_0000218,945.0
9887,In vivo,8677,Intermediate,10116.0,,1,"Biodistribution in Sprague-Dawley rat stomach 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,,CHEMBL622485,,50597,Rattus norvegicus,,,N,1,BAO_0000218,945.0
9888,In vivo,8677,Intermediate,10116.0,,1,"Biodistribution in Sprague-Dawley rat thyroid 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,,CHEMBL622486,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2046.0
9889,In vivo,8677,Intermediate,10116.0,,1,"Biodistribution in Sprague-Dawley rat thyroid 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,,CHEMBL877613,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2046.0
9890,In vivo,8677,Intermediate,10116.0,,1,"Biodistribution in Sprague-Dawley rat thyroid 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,,CHEMBL622487,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2046.0
9891,In vivo,8677,Intermediate,10116.0,,1,"Biodistribution in Sprague-Dawley rat thyroid 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,,CHEMBL622488,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2046.0
9892,In vivo,8677,Intermediate,10116.0,,1,"Biodistribution in Sprague-Dawley rats heart 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,,CHEMBL622489,,50597,Rattus norvegicus,,,N,1,BAO_0000218,948.0
9893,,6899,Intermediate,10116.0,,1,Compound was evaluated for percent dimer tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine,,,CHEMBL622490,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
9894,,6899,Intermediate,10116.0,,1,Compound was evaluated for percent dimer tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine; na - not available,,,CHEMBL622491,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
9895,,6899,Intermediate,10116.0,,1,Compound was evaluated for percent dose tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in liver,,,CHEMBL622492,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
9896,,6899,Intermediate,10116.0,,1,Compound was evaluated for percent thiol tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine,,,CHEMBL622493,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
9897,,6899,Intermediate,10116.0,,1,Compound was evaluated for percent thiol tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine; na - not available,,,CHEMBL622494,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
9898,,8677,Intermediate,10116.0,,1,"Compound was evaluated for the biodistribution in Sprague-Dawley rats in muscle 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,,CHEMBL622495,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2385.0
9899,,6899,Intermediate,10116.0,,1,Compound was evaluated for tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in rat kidney,,,CHEMBL622496,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9900,,6899,Intermediate,10116.0,,1,Compound was evaluated for tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine,,,CHEMBL622497,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
9901,,2189,Intermediate,10116.0,,1,Percent of radioactive dose in urine and faeces excreted in 0-24 hr by rats,,,CHEMBL622498,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9902,,2189,Intermediate,10116.0,,1,Percent of radioactive dose in urine and feces excreted in 0-24 hr by rats,,,CHEMBL624918,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
9903,,2189,Intermediate,10116.0,,1,Percent of radioactive dose in urine and feces excreted in 0-24 hr by rats; NA is <10% inhibition at 1 uM for binding data,,,CHEMBL624919,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
9904,In vivo,10839,Intermediate,10116.0,,1,Biodistribution of compound in rat blood after 5 min of administration,,,CHEMBL624920,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
9905,In vivo,10839,Intermediate,10116.0,,1,Biodistribution of compound in rat blood after 5 min of administration.,,,CHEMBL624921,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
9906,In vivo,10839,Intermediate,10116.0,,1,Biodistribution of compound in rat brain after 5 min of administration,,,CHEMBL624922,,50597,Rattus norvegicus,,,N,1,BAO_0000218,955.0
9907,In vivo,10839,Intermediate,10116.0,,1,Biodistribution of compound in rat heart after 5 min of administration,,,CHEMBL624923,,50597,Rattus norvegicus,,,N,1,BAO_0000218,948.0
9908,In vivo,10839,Intermediate,10116.0,,1,Biodistribution of compound in rat heart after 5 min of administration.,,,CHEMBL624924,,50597,Rattus norvegicus,,,N,1,BAO_0000218,948.0
9909,In vivo,10839,Intermediate,10116.0,,1,Biodistribution of compound in rat kidney after 5 min of administration,,,CHEMBL624925,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2113.0
9910,In vivo,10839,Intermediate,10116.0,,1,Biodistribution of compound in rat kidney after 5 min of administration.,,,CHEMBL624926,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2113.0
9911,In vivo,10839,Intermediate,10116.0,,1,Biodistribution of compound in rat liver after 5 min of administration,,,CHEMBL624927,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
9912,In vivo,10839,Intermediate,10116.0,,1,Biodistribution of compound in rat liver after 5 min of administration.,,,CHEMBL874402,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
9913,In vivo,10839,Intermediate,10116.0,,1,Biodistribution of compound in rat lung after 5 min of administration,,,CHEMBL624928,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2048.0
9914,In vivo,10839,Intermediate,10116.0,,1,Biodistribution of compound in rat lung after 5 min of administration.,,,CHEMBL624929,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2048.0
9915,In vivo,10839,Intermediate,10116.0,,1,Biodistribution of compound in rat muscle after 5 min of administration,,,CHEMBL624930,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2385.0
9916,In vivo,10839,Intermediate,10116.0,,1,Biodistribution of compound in rat muscle after 5 min of administration.,,,CHEMBL624931,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2385.0
9917,,4043,Intermediate,10116.0,,1,In vivo heart distribution of free doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,,CHEMBL624932,,50597,Rattus norvegicus,,,N,1,BAO_0000218,948.0
9918,,4043,Intermediate,10116.0,,1,In vivo heart distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,,CHEMBL624933,,50597,Rattus norvegicus,,,N,1,BAO_0000218,948.0
9919,,4043,Intermediate,10116.0,,1,In vivo liver distribution of free doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,,CHEMBL624934,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
9920,,4043,Intermediate,10116.0,,1,In vivo liver distribution of total doxorubicin after 6 h intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,,CHEMBL624935,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
9921,,4043,Intermediate,10116.0,,1,In vivo plasma distribution of free doxorubicin after 6 h intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,,CHEMBL624936,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9922,,4043,Intermediate,10116.0,,1,In vivo plasma distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,,CHEMBL624937,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9923,,4043,Intermediate,10116.0,,1,In vivo spleen distribution of free doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,,CHEMBL624938,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2106.0
9924,,4043,Intermediate,10116.0,,1,In vivo spleen distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,,CHEMBL624939,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2106.0
9925,,4043,Intermediate,10116.0,,1,In vivo tumor distribution of free doxorubicin after 6 h intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,,CHEMBL624940,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9926,,4043,Intermediate,10116.0,,1,In vivo tumor distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,,CHEMBL874403,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9927,,1446,Intermediate,10116.0,,1,Compound was tested for the duration that the plasma drug concentrations remained above the IC95,,,CHEMBL624941,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9928,,9971,Intermediate,10116.0,,1,Dose required to lower urine osmolality to 300 mOsm/kg in rat,,,CHEMBL624942,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
9929,,9971,Intermediate,10116.0,,1,Dose required to lower urine osmolality to 300 mOsm/kg in rat; NT=Not tested,,,CHEMBL624943,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
9930,In vivo,5765,Intermediate,10116.0,,1,% Bioavailability after 1 day of the drug administration in rats,,,CHEMBL624944,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9931,In vivo,5765,Intermediate,10116.0,,1,% Bioavailability after 4 day of the drug administration in rats,,,CHEMBL624945,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9932,In vivo,4257,Intermediate,10116.0,,1,Absolute bioavailability was evaluated in rat,,,CHEMBL624946,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9933,,13091,Intermediate,10116.0,,1,Tissue biodistribution into estrogen-primed immature female rat fat at 1 hr low time interval,,,CHEMBL624947,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9934,,13091,Intermediate,10116.0,,1,Tissue biodistribution into estrogen-primed immature female rat fat at 1 hr time interval,,,CHEMBL624948,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9935,,13091,Intermediate,10116.0,,1,Tissue biodistribution into estrogen-primed immature female rat fat at 3 hr time interval,,,CHEMBL624949,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9936,,13091,Intermediate,10116.0,,1,Tissue biodistribution into estrogen-primed immature female rat kidney at 1 hr blocked time interval,,,CHEMBL622025,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2113.0
9937,,13091,Intermediate,10116.0,,1,Tissue biodistribution into estrogen-primed immature female rat kidney at 1 hr low time interval,,,CHEMBL622026,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2113.0
9938,,13091,Intermediate,10116.0,,1,Tissue biodistribution into estrogen-primed immature female rat kidney at 1 hr time interval,,,CHEMBL622027,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2113.0
9939,,13091,Intermediate,10116.0,,1,Tissue biodistribution into estrogen-primed immature female rat kidney at 3 hr time interval,,,CHEMBL622028,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2113.0
9940,,13091,Intermediate,10116.0,,1,Tissue biodistribution into estrogen-primed immature female rat liver at 1 hr blocked time interval,,,CHEMBL622029,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
9941,,13091,Intermediate,10116.0,,1,Tissue biodistribution into estrogen-primed immature female rat liver at 1 hr low time interval,,,CHEMBL622208,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
9942,,13091,Intermediate,10116.0,,1,Tissue biodistribution into estrogen-primed immature female rat liver at 1 hr time interval,,,CHEMBL622209,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
9943,,13091,Intermediate,10116.0,,1,Tissue biodistribution into estrogen-primed immature female rat liver at 3 hr time interval,,,CHEMBL622210,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
9944,,13091,Intermediate,10116.0,,1,Tissue biodistribution into estrogen-primed immature female rat lung at 1 hr blocked time interval,,,CHEMBL622211,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9945,,13091,Intermediate,10116.0,,1,Tissue biodistribution into estrogen-primed immature female rat lung at 1 hr low time interval,,,CHEMBL622212,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9946,,13091,Intermediate,10116.0,,1,Tissue biodistribution into estrogen-primed immature female rat lung at 1 hr time interval,,,CHEMBL622213,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9947,,13091,Intermediate,10116.0,,1,Tissue biodistribution into estrogen-primed immature female rat lung at 3 hr time interval,,,CHEMBL874404,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9948,,13091,Intermediate,10116.0,,1,Tissue biodistribution into estrogen-primed immature female rat muscle at 1 hr blocked time interval,,,CHEMBL620452,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2385.0
9949,,13091,Intermediate,10116.0,,1,Tissue biodistribution into estrogen-primed immature female rat muscle at 1 hr low time interval,,,CHEMBL620453,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2385.0
9950,,13091,Intermediate,10116.0,,1,Tissue biodistribution into estrogen-primed immature female rat muscle at 1 hr time interval,,,CHEMBL620454,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2385.0
9951,,13091,Intermediate,10116.0,,1,Tissue biodistribution into estrogen-primed immature female rat muscle at 3 hr time interval,,,CHEMBL624067,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2385.0
9952,,13091,Intermediate,10116.0,,1,Tissue biodistribution into estrogen-primed immature female rat ovaries at 1 hr blocked time interval,,,CHEMBL624068,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9953,,13091,Intermediate,10116.0,,1,Tissue biodistribution into estrogen-primed immature female rat ovaries at 1 hr low time interval,,,CHEMBL624069,,50597,Rattus norvegicus,,,N,1,BAO_0000218,992.0
9954,,13091,Intermediate,10116.0,,1,Tissue biodistribution into estrogen-primed immature female rat ovaries at 1 hr time interval,,,CHEMBL624070,,50597,Rattus norvegicus,,,N,1,BAO_0000218,992.0
9955,,13091,Intermediate,10116.0,,1,Tissue biodistribution into estrogen-primed immature female rat ovaries at 3 hr time interval,,,CHEMBL624071,,50597,Rattus norvegicus,,,N,1,BAO_0000218,992.0
9956,,13091,Intermediate,10116.0,,1,Tissue biodistribution into estrogen-primed immature female rat uterus at 1 hr blocked time interval,,,CHEMBL624072,,50597,Rattus norvegicus,,,N,1,BAO_0000218,995.0
9957,,13091,Intermediate,10116.0,,1,Tissue biodistribution into estrogen-primed immature female rat uterus at 1 hr low time interval,,,CHEMBL624073,,50597,Rattus norvegicus,,,N,1,BAO_0000218,995.0
9958,,13091,Intermediate,10116.0,,1,Tissue biodistribution into estrogen-primed immature female rat uterus at 1 hr time interval,,,CHEMBL624788,,50597,Rattus norvegicus,,,N,1,BAO_0000218,995.0
9959,,13091,Intermediate,10116.0,,1,Tissue biodistribution into estrogen-primed immature female rat uterus at 3 hr time interval,,,CHEMBL624789,,50597,Rattus norvegicus,,,N,1,BAO_0000218,995.0
9960,,13091,Intermediate,10116.0,,1,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 1 hr blocked time interval,,,CHEMBL624790,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9961,,13091,Intermediate,10116.0,,1,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 1 hr low time interval,,,CHEMBL624791,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9962,,13091,Intermediate,10116.0,,1,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 1 hr time interval,,,CHEMBL624792,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9963,,13091,Intermediate,10116.0,,1,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 3 hr time interval,,,CHEMBL624793,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9964,,13091,Intermediate,10116.0,,1,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 1 hr blocked time interval,,,CHEMBL877491,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2385.0
9965,,13091,Intermediate,10116.0,,1,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 1 hr low time interval,,,CHEMBL624957,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2385.0
9966,,13091,Intermediate,10116.0,,1,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 1 hr time interval,,,CHEMBL624958,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2385.0
9967,,13091,Intermediate,10116.0,,1,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 3 hr time interval,,,CHEMBL624959,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2385.0
9968,,11977,Intermediate,10116.0,,1,Dissociation constant was determined,,,CHEMBL624960,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9969,,14941,Intermediate,10116.0,,1,"Pharmacokinetic Parameter, Kel is elimination rate constant in Female Wistar Rats at 100 mg/kg by po administration",,,CHEMBL624961,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9970,,15078,Intermediate,10116.0,,1,"The Kel value in female wistar rat at 100 mg/kg, p.o. dose",,,CHEMBL624962,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9971,,15078,Intermediate,10116.0,,1,"The Kel value in male wistar rat at 100 mg/kg, p.o. dose",,,CHEMBL624963,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9972,,4755,Intermediate,10116.0,,1,Observed rate constant in 80% rat plasma at 37 degree Centigrade,,,CHEMBL624964,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9973,,589,Intermediate,10116.0,,1,LogP value was evaluated in the in situ rat gut perfusion assay,,,CHEMBL624965,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9974,In vivo,17582,Intermediate,10116.0,,1,In vivo retention time was evaluated for the compound after i.v. administration at a dose of 5 mg/kg was measured in rats,,,CHEMBL624966,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9975,In vivo,5031,Intermediate,10116.0,,1,Mean residence time (Pharmacokinetic property) after i.v. administration in rats,,,CHEMBL624967,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9976,In vivo,17764,Intermediate,10116.0,,1,Mean-residence time of compound after intravenous administration in rats at 24 uM/kg,,,CHEMBL624968,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9977,,17720,Intermediate,10116.0,,1,Mean residence time at a dose of 4 mg/kg in Rat Plasma after iv administration,,,CHEMBL624969,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9978,,2862,Expert,10116.0,,1,Streptococcal cell wall-washed arthritis model in rats at 10.0 mg/kg peroral dose,,,CHEMBL624970,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9979,,16423,Intermediate,10116.0,,1,Half-life was evaluated after 10 uM/kg of intra arterial administration,,,CHEMBL624971,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9980,In vivo,16423,Intermediate,10116.0,,1,Half-life was evaluated after 20 uM/kg of peroral administration,,,CHEMBL624972,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9981,In vivo,6005,Intermediate,10116.0,,1,Half-life was evaluated after i.v. administration in rat at a dose of 1 mg/kg,,,CHEMBL624973,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9982,,2938,Intermediate,10116.0,,1,Half-life was evaluated in plasma of rat,,,CHEMBL624974,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
9983,In vivo,6410,Intermediate,10116.0,,1,Half-life was evaluated in rats at an intravenous dose of 3 mg/kg,,,CHEMBL624975,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9984,In vivo,6410,Intermediate,10116.0,,1,Half-life was evaluated in rats at an oral dose of 30 mg/kg,,,CHEMBL877492,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9985,In vivo,6062,Intermediate,10116.0,,1,Half-life was measured in rat after an iv dose of 1 mg/kg,,,CHEMBL624976,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9986,In vivo,6571,Intermediate,10116.0,,1,Half-life period of compound in rats after peroral administration,,,CHEMBL624977,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9987,,3136,Intermediate,10116.0,,1,Half-life period of compound was measured in rat plasma.,,,CHEMBL626848,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
9988,,3136,Intermediate,10116.0,,1,Half-life period of compound was measured in rat plasma; ND is not determined,,,CHEMBL626849,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
9989,,3136,Intermediate,10116.0,,1,Half-life period of compound was measured in rat plasma; not determined,,,CHEMBL626850,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
9990,In vivo,4521,Intermediate,10116.0,,1,Half-life period in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,,,CHEMBL626851,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9991,In vivo,5871,Intermediate,10116.0,,1,Half-life period in rat by iv administration,,,CHEMBL626852,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9992,In vivo,6077,Intermediate,10116.0,,1,Half-life period in rats following intravenous administration at 2 mg/kg,,,CHEMBL626853,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9993,In vivo,6679,Intermediate,10116.0,,1,Half-life period was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,,,CHEMBL626854,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9994,,5144,Intermediate,10116.0,,1,Half-life period was determined for the compound in rat,,,CHEMBL627486,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9995,In vivo,4498,Intermediate,10116.0,,1,"Half-life period was evaluated in rat, after administering 1 mg/kg intravenously",,,CHEMBL627487,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9996,In vivo,4498,Intermediate,10116.0,,1,"Half-life period was evaluated in rat, after administering 10 mg/kg orally",,,CHEMBL627488,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9997,In vivo,1908,Intermediate,10116.0,,1,Half-life value after IV dose at a dose of 5 mg/kg in rats.,,,CHEMBL627489,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9998,In vivo,6211,Intermediate,10116.0,,1,Half-life was determined by iv administration (1.5 mg/kg) in fasted male Sprague-Dawley rats,,,CHEMBL627490,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
9999,In vivo,5529,Intermediate,10116.0,,1,Half-life was determined in rat after intravenous administration (0.5 mg/kg),,,CHEMBL873829,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10000,In vivo,6444,Intermediate,10116.0,,1,Half-life was determined in rat at a dose of 1 mpk i.v.,,,CHEMBL627655,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10001,In vivo,6444,Intermediate,10116.0,,1,Half-life was determined in rat at a dose of 1 mpk i.v.; ND means not determined,,,CHEMBL625994,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10002,In vivo,6444,Intermediate,10116.0,,1,Half-life was determined in rat at a dose of 1 mpk i.v.; ND=not determined,,,CHEMBL625995,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10003,,5207,Intermediate,10116.0,,1,Half-life in rat,,,CHEMBL625996,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10004,In vitro,530,Intermediate,10116.0,,1,In vitro half life in rat plasma,,,CHEMBL625850,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
10005,In vitro,1116,Intermediate,10116.0,,1,"In vitro half life at 1.5 -5.6ug/mL, 37 degree C in rat plasma",,,CHEMBL625851,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
10006,In vitro,3219,Intermediate,10116.0,,1,In vitro half life in rat,,,CHEMBL625852,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10007,In vivo,6109,Intermediate,10116.0,,1,In vivo half life period after intravenous administration in rat,,,CHEMBL625853,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10008,In vivo,17582,Intermediate,10116.0,,1,In vivo half-life period for compound after i.v. administration at a dose of 5 mg/kg was measured in rats,,,CHEMBL625854,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10009,In vivo,17582,Intermediate,10116.0,,1,In vivo half-life period for compound after oral (po) administration at a dose of 10 mg/kg was measured in rats,,,CHEMBL874450,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10010,In vivo,5974,Intermediate,10116.0,,1,In vivo t1/2 was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,,,CHEMBL625855,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10011,In vivo,5974,Intermediate,10116.0,,1,In vivo t1/2 was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,,,CHEMBL625856,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10012,In vivo,5974,Intermediate,10116.0,,1,In vivo t1/2 was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,,,CHEMBL625857,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10013,In vivo,5974,Intermediate,10116.0,,1,In vivo t1/2 was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,,,CHEMBL873831,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10014,In vivo,17853,Intermediate,10116.0,,1,Longer half-life in rat (i.v.) at 0.5 mpk,,,CHEMBL625858,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10015,In vivo,17853,Intermediate,10116.0,,1,Longer half-life in rat (p.o.) at 2.0 mpk,,,CHEMBL625859,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10016,,3457,Intermediate,10116.0,,1,Pharmacokinetic property (half life) in rat,,,CHEMBL625860,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10017,In vivo,2792,Intermediate,10116.0,,1,Pharmacokinetic parameter half-life was determined at 10 mg/kg po dose in rats,,,CHEMBL625861,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10018,In vivo,2792,Intermediate,10116.0,,1,Pharmacokinetic parameter half-life was determined at 2 mg/kg i.v. dose in rats,,,CHEMBL625862,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10019,In vivo,2792,Intermediate,10116.0,,1,Pharmacokinetic parameter half-life was determined at 3 mg/kg po dose in rats,,,CHEMBL625863,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10020,In vivo,2792,Intermediate,10116.0,,1,Pharmacokinetic parameter half-life was determined at 5 mg/kg i.v. dose in rats,,,CHEMBL625864,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10021,In vivo,5739,Intermediate,10116.0,,1,Pharmacokinetic property (t1/2) for the compound (5 mg/kg iv) was determined in rats,,,CHEMBL625865,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10022,In vivo,15765,Intermediate,10116.0,,1,Pharmacokinetic half time was determined intravenously in rats.,,,CHEMBL625866,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10023,In vivo,6567,Intermediate,10116.0,,1,Plasma half life in rat after 5 mg/kg oral gavage; 6-8 hours,,,CHEMBL625867,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
10024,,2448,Intermediate,10116.0,,1,Plasma half life of hydrolysis of the compound,,,CHEMBL625868,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
10025,In vivo,5423,Intermediate,10116.0,,1,Plasma half life was reported after a intravenous dose of 1 mg/kg in Dawley rat,,,CHEMBL625869,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
10026,,4853,Intermediate,10116.0,,1,Plasma half life period was calculated in rat,,,CHEMBL874451,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
10027,,4514,Intermediate,10116.0,,1,Plasma half-life in Sprague-Dawley rats,,,CHEMBL625870,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
10028,,4514,Intermediate,10116.0,,1,Plasma half-life in Sprague-Dawley rats; Not determined,,,CHEMBL625871,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
10029,,1500,Intermediate,10116.0,,1,Plasma half-life in rats,,,CHEMBL625872,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
10030,,1500,Intermediate,10116.0,,1,Plasma half-life in rats; <MQL,,,CHEMBL625873,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
10031,,5334,Intermediate,10116.0,,1,Plasma half-life period (0-8 h) was determined,,,CHEMBL625874,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
10032,,5334,Intermediate,10116.0,,1,Plasma half-life period (0-8 h) was determined in Sprague-Dawley rat,,,CHEMBL625875,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
10033,In vivo,5334,Intermediate,10116.0,,1,Plasma half-life period (0-8 h) was reported after intravenous administration at a dose of 1 mg/kg in Sprague-Dawley rat,,,CHEMBL625876,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
10034,In vivo,5334,Intermediate,10116.0,,1,Plasma half-life period (0-8 h) was reported after oral administration at a dose of 2 mg/kg in Sprague-Dawley rat,,,CHEMBL631258,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
10035,,4956,Intermediate,10116.0,,1,Plasma half-life was determined in Sprague-Dawley rats after 0-8 h administration of the compound,,,CHEMBL631259,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
10036,,4956,Intermediate,10116.0,,1,Plasma half-life was determined in Sprague-Dawley rats after 0-8 hr administration of the compound; Not determined,,,CHEMBL631260,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
10037,,7768,Intermediate,10116.0,,1,"Distribution of radioactivity in blood of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range = 0.68-1.03",,,CHEMBL631261,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
10038,,7768,Intermediate,10116.0,,1,"Distribution of radioactivity in blood of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.45-0.48",,,CHEMBL631262,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
10039,,7768,Intermediate,10116.0,,1,"Distribution of radioactivity in blood of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range-0.81-1",,,CHEMBL631263,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
10040,,7768,Intermediate,10116.0,,1,"Distribution of radioactivity in brain tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.007-0.008",,,CHEMBL631264,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10041,,7768,Intermediate,10116.0,,1,"Distribution of radioactivity in brain tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.18-0.22",,,CHEMBL631265,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10042,,7768,Intermediate,10116.0,,1,"Distribution of radioactivity in brain tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.77-0.97",,,CHEMBL631266,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10043,,7768,Intermediate,10116.0,,1,"Distribution of radioactivity in brain tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.08-0.13",,,CHEMBL631267,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10044,,7768,Intermediate,10116.0,,1,"Distribution of radioactivity in brain tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.25-0.37",,,CHEMBL631268,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10045,,7768,Intermediate,10116.0,,1,"Distribution of radioactivity in brain tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.03-0.04",,,CHEMBL631269,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10046,,7768,Intermediate,10116.0,,1,"Distribution of radioactivity in brain tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.74-0.94",,,CHEMBL631270,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10047,,7768,Intermediate,10116.0,,1,"Distribution of radioactivity in heart tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.02-0.02",,,CHEMBL631271,,50597,Rattus norvegicus,,,N,1,BAO_0000218,948.0
10048,,7768,Intermediate,10116.0,,1,"Distribution of radioactivity in heart tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.5-0.63",,,CHEMBL631272,,50597,Rattus norvegicus,,,N,1,BAO_0000218,948.0
10049,,7768,Intermediate,10116.0,,1,"Distribution of radioactivity in heart tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 1.35-1.55",,,CHEMBL631273,,50597,Rattus norvegicus,,,N,1,BAO_0000218,948.0
10050,,7768,Intermediate,10116.0,,1,"Distribution of radioactivity in heart tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.24-0.38",,,CHEMBL631274,,50597,Rattus norvegicus,,,N,1,BAO_0000218,948.0
10051,,7768,Intermediate,10116.0,,1,"Distribution of radioactivity in heart tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.55-0.82",,,CHEMBL631275,,50597,Rattus norvegicus,,,N,1,BAO_0000218,948.0
10052,,7768,Intermediate,10116.0,,1,"Distribution of radioactivity in heart tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.16-0.2",,,CHEMBL626984,,50597,Rattus norvegicus,,,N,1,BAO_0000218,948.0
10053,,7768,Intermediate,10116.0,,1,"Distribution of radioactivity in heart tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 1.13-1.29",,,CHEMBL626985,,50597,Rattus norvegicus,,,N,1,BAO_0000218,948.0
10054,,7768,Intermediate,10116.0,,1,"Distribution of radioactivity in liver tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.02-0.02",,,CHEMBL626986,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
10055,,7768,Intermediate,10116.0,,1,"Distribution of radioactivity in liver tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.71-0.93",,,CHEMBL626987,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
10056,,7768,Intermediate,10116.0,,1,"Distribution of radioactivity in liver tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 2.91-3.53",,,CHEMBL626988,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
10057,,7768,Intermediate,10116.0,,1,"Distribution of radioactivity in liver tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.42-0.62",,,CHEMBL626989,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
10058,,7768,Intermediate,10116.0,,1,"Distribution of radioactivity in liver tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.97-1.41",,,CHEMBL626990,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
10059,,7768,Intermediate,10116.0,,1,"Distribution of radioactivity in liver tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.19-0.23",,,CHEMBL626991,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
10060,,7768,Intermediate,10116.0,,1,"Distribution of radioactivity in liver tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 2.49-2.82",,,CHEMBL626992,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
10061,,7768,Intermediate,10116.0,,1,"Distribution of radioactivity in lung tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.02-0.03",,,CHEMBL626993,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2048.0
10062,,7768,Intermediate,10116.0,,1,"Distribution of radioactivity in lung tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.66-0.77",,,CHEMBL874593,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2048.0
10063,,7768,Intermediate,10116.0,,1,"Distribution of radioactivity in lung tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 1.17-1.42",,,CHEMBL626994,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2048.0
10064,,7768,Intermediate,10116.0,,1,"Distribution of radioactivity in lung tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.47-0.58",,,CHEMBL626995,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2048.0
10065,,7768,Intermediate,10116.0,,1,"Distribution of radioactivity in lung tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.65-0.87",,,CHEMBL626190,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2048.0
10066,,7768,Intermediate,10116.0,,1,"Distribution of radioactivity in lung tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.28-0.31",,,CHEMBL626191,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2048.0
10067,,7768,Intermediate,10116.0,,1,"Distribution of radioactivity in lung tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.98-1.22",,,CHEMBL626364,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2048.0
10068,,7768,Intermediate,10116.0,,1,"Distribution of radioactivity in thyroid tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 406-499",,,CHEMBL626365,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2046.0
10069,,7768,Intermediate,10116.0,,1,"Distribution of radioactivity in thyroid tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 53.0-96",,,CHEMBL626366,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2046.0
10070,,7768,Intermediate,10116.0,,1,"Distribution of radioactivity in thyroid tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 6.65-8.0.8",,,CHEMBL626367,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2046.0
10071,,7768,Intermediate,10116.0,,1,"Distribution of radioactivity in thyroid tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 92-159",,,CHEMBL626368,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2046.0
10072,,7768,Intermediate,10116.0,,1,"Distribution of radioactivity in thyroid tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 18.74-30.84",,,CHEMBL626369,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2046.0
10073,,7768,Intermediate,10116.0,,1,"Distribution of radioactivity in thyroid tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 156-207",,,CHEMBL626370,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2046.0
10074,In vivo,4498,Intermediate,10116.0,,1,"Bioavailability (F) was evaluated in rat, after administering 1 mg/kg intravenously",,,CHEMBL626371,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10075,In vivo,4498,Intermediate,10116.0,,1,"Bioavailability (F) was evaluated in rat, after administering 10 mg/kg orally",,,CHEMBL626372,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10076,In vivo,3603,Intermediate,10116.0,,1,Bioavailability after a dose of 10 mg/kg p.o.,,,CHEMBL626373,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10077,In vivo,6215,Intermediate,10116.0,,1,Bioavailability after peroral administration (10 mg/kg) was determined in rat,,,CHEMBL626374,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10078,In vivo,5710,Intermediate,10116.0,,1,Bioavailability in fasted male administration of 2 mg/Kg of compound p.o.,,,CHEMBL626375,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10079,In vivo,5710,Intermediate,10116.0,,1,Oral bioavailability in rat (Sprague-Dawley) (fasted male) (dose 2 mg/kg),,,CHEMBL626376,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10080,In vivo,5676,Intermediate,10116.0,,1,Bioavailability in rat po was determined,,,CHEMBL626377,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10081,In vivo,17667,Intermediate,10116.0,,1,Bioavailability of compound at 10 mg/kg in rat after oral administration,,,CHEMBL626378,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10082,In vivo,17667,Intermediate,10116.0,,1,Bioavailability of compound at 3 mg/kg in rat after i.v. administration,,,CHEMBL626379,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10083,In vivo,6848,Intermediate,10116.0,,1,Bioavailability in rat (dose 1 mg/kg i.v. and 2 mg/kg p.o.),,,CHEMBL626380,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10084,In vivo,6848,Intermediate,10116.0,,1,Bioavailability in rat (dose 1 mg/kg i.v. and 2 mg/kg p.o.),,,CHEMBL626381,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10085,In vivo,17267,Intermediate,10116.0,,1,Bioavailability in rat,,,CHEMBL626382,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10086,In vivo,6362,Intermediate,10116.0,,1,Bioavailability in rat (Sprague-Dawley) (female),,,CHEMBL626383,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10087,In vivo,17671,Intermediate,10116.0,,1,Bioavailability in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,,,CHEMBL874652,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10088,In vivo,17671,Intermediate,10116.0,,1,Bioavailability in rat (Sprague-Dawley) (male) (dose 10-20 mg/kg),,,CHEMBL626384,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10089,In vivo,4333,Intermediate,10116.0,,1,Bioavailability in rat (Sprague-Dawley) (male) (dose 1 mg/kg i.v. and 3 mg/kg p.o.) measured from 0.3 to 6 hr,,,CHEMBL626385,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10090,In vivo,6077,Intermediate,10116.0,,1,Bioavailability in rat at an oral dose of 2 mg/kg,,,CHEMBL626386,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10091,In vivo,3278,Intermediate,10116.0,,1,Bioavailability in rat,,,CHEMBL626387,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10092,In vivo,5964,Intermediate,10116.0,,1,Bioavailability in rat,,,CHEMBL626388,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10093,In vivo,4884,Intermediate,10116.0,,1,Bioavailability in rat,,,CHEMBL626389,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10094,In vivo,4905,Intermediate,10116.0,,1,Bioavailability in rat,,,CHEMBL626390,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10095,In vivo,4884,Intermediate,10116.0,,1,Bioavailability in rat was reported at the dose of 6 mg/kg in 25% PEG-300,,,CHEMBL626391,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10096,In vivo,6850,Intermediate,10116.0,,1,Bioavailability in rat,,,CHEMBL626392,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10097,In vivo,2864,Intermediate,10116.0,,1,Oral bioavailability in rat,,,CHEMBL626393,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10098,In vivo,5780,Intermediate,10116.0,,1,Bioavailability was determined in rat,,,CHEMBL623026,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10099,In vivo,1465,Intermediate,10116.0,,1,Bioavailability,,,CHEMBL623027,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10100,In vivo,5199,Intermediate,10116.0,,1,Bioavailability,,,CHEMBL623028,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10101,In vivo,5765,Intermediate,10116.0,,1,Bioavailability in rat after 1 day dosing,,,CHEMBL623029,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10102,In vivo,5765,Intermediate,10116.0,,1,Bioavailability in rat after 4 day dosing,,,CHEMBL623030,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10103,In vivo,6518,Intermediate,10116.0,,1,Bioavailability after IV dosing at 0.5 mg/kg in rat; no data,,,CHEMBL623031,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10104,In vivo,6518,Intermediate,10116.0,,1,Bioavailability after IV dosing at 1 mg/kg in rat; no data,,,CHEMBL623032,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10105,In vivo,6518,Intermediate,10116.0,,1,Bioavailability after oral administration at a dose of 2 mg/kg in rat,,,CHEMBL623033,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10106,In vivo,6518,Intermediate,10116.0,,1,Bioavailability after oral administration at a dose of 4 mg/kg in rat,,,CHEMBL623034,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10107,In vivo,2083,Intermediate,10116.0,,1,Bioavailability at 4 hr after administration of 5 mg/kg dose peroral in rat,,,CHEMBL623035,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10108,In vivo,17260,Intermediate,10116.0,,1,Bioavailability at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,,,CHEMBL623036,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10109,In vivo,4956,Intermediate,10116.0,,1,Bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v. and 2 mg/kg p.o.),,,CHEMBL623037,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10110,In vivo,4368,Intermediate,10116.0,,1,Bioavailability by intravenous administration of 3.4 mg/kg in rat,,,CHEMBL623038,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10111,In vivo,17752,Intermediate,10116.0,,1,Bioavailability from rat plasma at a single oral dose of 25 mg/kg,,,CHEMBL874385,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
10112,In vivo,1446,Intermediate,10116.0,,1,Bioavailability in rat (Fisher) (fasted),,,CHEMBL623039,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10113,In vivo,2891,Intermediate,9443.0,,1,Bioavailability in monkey after po administration of 10 mg/kg dose,,,CHEMBL623040,,22224,Primates,,,U,0,BAO_0000218,
10114,In vivo,2891,Intermediate,9443.0,,1,Oral bioavailability in monkey (dose 10 mg/kg),,,CHEMBL623041,,22224,Primates,,,U,0,BAO_0000218,
10115,In vivo,6672,Intermediate,10116.0,,1,Bioavailability in rat,,,CHEMBL623741,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10116,In vivo,6673,Intermediate,10116.0,,1,Bioavailability in rat,,,CHEMBL623742,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10117,In vivo,17655,Intermediate,10116.0,,1,Bioavailability in rat,,,CHEMBL623743,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10118,In vivo,17796,Intermediate,10116.0,,1,Bioavailability in rat,,,CHEMBL623744,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10119,In vivo,17853,Intermediate,10116.0,,1,Bioavailability in rat (dose 2.0 mg/kg p.o.),,,CHEMBL623745,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10120,In vivo,4521,Intermediate,10116.0,,1,Bioavailability in rat (dose 5 mg/kg p.o. and 1 mg/kg i.v.),,,CHEMBL623746,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10121,In vivo,4940,Intermediate,10116.0,,1,Oral bioavailability in rat (dose 5 mg/kg p.o.),,,CHEMBL623747,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10122,In vivo,2891,Intermediate,10116.0,,1,Bioavailability in rat after po administration of 30 mg/kg dose,,,CHEMBL623748,,22224,Rattus norvegicus,,,U,0,BAO_0000218,
10123,In vivo,2891,Intermediate,10116.0,,1,Bioavailability in rat after po administration of 30 mg/kg dose,,,CHEMBL623916,,22224,Rattus norvegicus,,,U,0,BAO_0000218,
10124,In vivo,4521,Intermediate,10116.0,,1,Bioavailability in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,,,CHEMBL623917,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10125,In vivo,17686,Intermediate,10116.0,,1,Bioavailability in rat (dose 2 mg/kg i.v.),,,CHEMBL623918,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10126,In vivo,17796,Intermediate,10116.0,,1,Bioavailability in rat,,,CHEMBL874386,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10127,In vivo,17796,Intermediate,10116.0,,1,Bioavailability in rat; Only traces detected in rat plasma,,,CHEMBL623919,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
10128,In vivo,5064,Intermediate,10116.0,,1,Bioavailability in rat,,,CHEMBL623920,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10129,In vivo,5147,Intermediate,10116.0,,1,Bioavailability upon oral administration of compound,,,CHEMBL623148,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10130,In vivo,1916,Intermediate,10116.0,,1,Oral bioavailability in rat (Sprague-Dawley) (dose 15 mg/kg),,,CHEMBL623149,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10131,In vivo,6049,Intermediate,10116.0,,1,Bioavailability in rat,,,CHEMBL623150,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10132,In vivo,1445,Intermediate,10116.0,,1,"Bioavailability was evaluated in rats at a dose of 20 mg/kg, under fasting state",,,CHEMBL623151,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10133,In vivo,1445,Intermediate,10116.0,,1,"Bioavailability was evaluated in rats at a dose of 20 mg/kg, under fed state",,,CHEMBL623152,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10134,,2862,Expert,10116.0,,1,Streptococcal cell wall-washed arthritis model in rats at 3.0 mg/kg peroral dose,,,CHEMBL623153,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10135,,2862,Expert,10116.0,,1,Streptococcal cell wall-washed arthritis model in rats at 30.0 mg/kg peroral dose,,,CHEMBL623154,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10136,,4194,Intermediate,10116.0,,1,In vitro and metabolic stability was determined,,,CHEMBL623155,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10137,,4194,Intermediate,10116.0,,1,In vitro metabolic stability in rat hepatocytes,,,CHEMBL623156,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10138,,5486,Intermediate,10116.0,,1,In vitro metabolic stability in rat was measured as pmol/min/mg/protein,,,CHEMBL623157,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10139,In vitro,17582,Intermediate,10116.0,,1,Metabolic rate for compound was observed in rat hepatocytes,401.0,,CHEMBL623158,,50597,Rattus norvegicus,Hepatocyte,,N,1,BAO_0000218,2107.0
10140,,5600,Intermediate,10116.0,,1,In vitro metabolic stability determined after 30 min of incubation in rat hepatic microsomes,,,CHEMBL623159,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10141,,14294,Intermediate,10116.0,,1,Metabolism of compound in rat S9 microsomes ('+''indicates <20% largest observed peak),,,CHEMBL874390,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10142,,14294,Intermediate,10116.0,,1,Metabolism of compound in rat S9 microsomes ('++++' indicates largest observed peak),,,CHEMBL623160,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10143,,14294,Intermediate,10116.0,,1,Metabolism of compound in rat S9 microsomes; Trace,,,CHEMBL623161,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10144,,17847,Intermediate,10116.0,,1,Metabolism was measured as percent loss at 4 hr in rat hepatocytes,,,CHEMBL623162,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10145,,11020,Intermediate,10116.0,,1,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex 5-HIAA,,,CHEMBL623163,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10146,,11020,Intermediate,10116.0,,1,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex 5-HT,,,CHEMBL623164,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10147,,11020,Intermediate,10116.0,,1,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex DA,,,CHEMBL623165,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10148,,11020,Intermediate,10116.0,,1,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex DOPAC,,,CHEMBL623166,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10149,,11020,Intermediate,10116.0,,1,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex HVA,,,CHEMBL624983,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10150,,11020,Intermediate,10116.0,,1,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex NE,,,CHEMBL624984,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10151,,11020,Intermediate,10116.0,,1,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Hippocampus 5-HIAA,,,CHEMBL624985,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10152,,11020,Intermediate,10116.0,,1,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus 5-HT,,,CHEMBL622970,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10153,,11020,Intermediate,10116.0,,1,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DA; below level of detection,,,CHEMBL622971,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10154,,11020,Intermediate,10116.0,,1,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DA; below the levels of detection,,,CHEMBL622972,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10155,,11020,Intermediate,10116.0,,1,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DOPAC; below level of detection,,,CHEMBL622973,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10156,,11020,Intermediate,10116.0,,1,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DOPAC; below the levels of detection,,,CHEMBL622974,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10157,,11020,Intermediate,10116.0,,1,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus HVA; below level of detection,,,CHEMBL622975,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10158,,11020,Intermediate,10116.0,,1,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus HVA; below the levels of detection,,,CHEMBL622976,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10159,,11020,Intermediate,10116.0,,1,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus NE,,,CHEMBL622977,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10160,,11020,Intermediate,10116.0,,1,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex 5-HIAA,,,CHEMBL624351,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10161,,11020,Intermediate,10116.0,,1,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex 5-HT,,,CHEMBL624352,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10162,,11020,Intermediate,10116.0,,1,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex DA,,,CHEMBL624353,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10163,,11020,Intermediate,10116.0,,1,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex DOPAC,,,CHEMBL622397,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10164,,11020,Intermediate,10116.0,,1,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex HVA,,,CHEMBL622398,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10165,,11020,Intermediate,10116.0,,1,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex NE,,,CHEMBL622399,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10166,,11020,Intermediate,10116.0,,1,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex DA,,,CHEMBL622400,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10167,,11020,Intermediate,10116.0,,1,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus 5-HIAA,,,CHEMBL628428,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10168,,11020,Intermediate,10116.0,,1,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus 5-HT,,,CHEMBL628590,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10169,,11020,Intermediate,10116.0,,1,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DA; below level of detection,,,CHEMBL628591,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10170,,11020,Intermediate,10116.0,,1,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DA; below the levels of detection,,,CHEMBL628592,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10171,,11020,Intermediate,10116.0,,1,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DOPAC; below level of detection,,,CHEMBL628593,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10172,,11020,Intermediate,10116.0,,1,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DOPAC; below the levels of detection,,,CHEMBL875333,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10173,,11020,Intermediate,10116.0,,1,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus HVA; below level of detection,,,CHEMBL628594,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10174,,4969,Intermediate,10116.0,,1,Plasma half-life was determined in Sprague-Dawley rats after 0-8 hr of administration,,,CHEMBL628595,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
10175,,6737,Intermediate,10116.0,,1,Stability in rat plasma was determined,,,CHEMBL628596,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
10176,,6737,Intermediate,10116.0,,1,Stability in rat plasma was determined; ND= no data,,,CHEMBL628597,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
10177,,5089,Intermediate,10116.0,,1,Tested for plasma half life period in rat (0-8 hr),,,CHEMBL628598,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
10178,,5089,Intermediate,10116.0,,1,Tested for plasma half life period in rat (0-8 hr); Not determined,,,CHEMBL628599,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
10179,In vivo,1466,Intermediate,10116.0,,1,Tested for t1/2 upon intravenous administration of 5.0 mg/Kg dose in rat,,,CHEMBL628600,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10180,In vivo,1466,Intermediate,10116.0,,1,Tested for t1/2 upon peroral administration of 10.0 mg/Kg dose in rat,,,CHEMBL628601,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10181,,4950,Intermediate,10116.0,,1,Tested for the half life in rat,,,CHEMBL628602,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10182,In vitro,2412,Intermediate,10116.0,,1,Tested in vitro for the time for half reactivation against rat small intestinal glucoamylase,,,CHEMBL628603,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10183,In vitro,2412,Intermediate,10116.0,,1,Tested in vitro for the time for half reactivation against rat small intestinal glucoamylase; ND=Not determined,,,CHEMBL628604,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10184,In vitro,2412,Intermediate,10116.0,,1,Tested in vitro for the time for half reactivation against rat small intestinal isomaltase,,,CHEMBL628605,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10185,In vitro,2412,Intermediate,10116.0,,1,Tested in vitro for the time for half reactivation against rat small intestinal isomaltase; ND=Not determined,,,CHEMBL628606,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10186,In vitro,2412,Intermediate,10116.0,,1,Tested in vitro for the time for half reactivation against rat small intestinal sucrase,,,CHEMBL628607,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10187,,15022,Intermediate,10116.0,,1,The biological half life the compound was measured at the dose of 100 umol/kg,,,CHEMBL628608,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10188,,15022,Intermediate,10116.0,,1,The biological half life the compound was measured at the dose of 30 umol/kg,,,CHEMBL628609,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10189,,406,Intermediate,10116.0,,1,The compound was evaluated for plasma half life period in rat,,,CHEMBL628610,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
10190,In vivo,15078,Intermediate,10116.0,,1,"The half life value in female wistar rat at 100 mg/kg, p.o. dose",,,CHEMBL873819,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10191,In vivo,15078,Intermediate,10116.0,,1,"The half life value in male wistar rat at 100 mg/kg, p.o. dose",,,CHEMBL628611,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10192,In vivo,5247,Intermediate,10116.0,,1,The pharmacokinetic parameter half-life period in vivo in rats,,,CHEMBL628612,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10193,In vivo,5041,Intermediate,10116.0,,1,"The pharmacokinetic property, Half-life was determined",,,CHEMBL628613,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10194,In vivo,5041,Intermediate,10116.0,,1,"The pharmacokinetic property, Half-life in rat in vivo",,,CHEMBL628614,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10195,In vivo,5041,Intermediate,10116.0,,1,"The pharmacokinetic property, Half-life was determined; ND denotes no data",,,CHEMBL628615,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10196,In vivo,5041,Intermediate,10116.0,,1,"The pharmacokinetic property, Half-life was determined; ND denotes not determined",,,CHEMBL628616,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10197,,3918,Intermediate,10116.0,,1,The plasma half life period in rats,,,CHEMBL627924,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
10198,,2906,Intermediate,10116.0,,1,The release rate of the free drug from the substrate in rat liver lysosomal preparation by rat liver lysosomal assay,,,CHEMBL627925,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
10199,In vivo,6467,Intermediate,10116.0,,1,half life in rats at the dose of 1.0 mpk by i.v. administration; ND= not determined,,,CHEMBL627926,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10200,,5510,Intermediate,10116.0,,1,t1/2 (apparent elimination)of the compound was determined,,,CHEMBL627927,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10201,,3788,Intermediate,10116.0,,1,t1/2 value in rat,,,CHEMBL627928,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10202,,17796,Intermediate,10116.0,,1,Half life in rat,,,CHEMBL627539,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10203,In vivo,12873,Intermediate,10116.0,,1,"Half life period calculated from Time-Course plasma concentrations in rats at a dose of 2.5 mg/kg, iv",,,CHEMBL876790,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
10204,In vivo,5983,Intermediate,10116.0,,1,Pharmacokinetic property (t1/2beta) was measured in rat at the dose of 0.32 mg/kg i.v.,,,CHEMBL858186,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10205,,15765,Intermediate,10116.0,,1,Half-life period in fasted rats,,,CHEMBL627540,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10206,In vivo,2661,Intermediate,10116.0,,1,Compound was evaluated for maximum time to reach Cmax after treatment with oral dose of 2 mgkg to female wistar rats,,,CHEMBL627541,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10207,In vivo,2661,Intermediate,10116.0,,1,Compound was evaluated for maximum time to reach Cmax after treatment with oral dose of 2 mgkg to male wistar rats,,,CHEMBL627715,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10208,In vivo,429,Intermediate,10116.0,,1,Evaluated for pharmacokinetic parameter tmax in rat at the dose 50 mg/kg,,,CHEMBL627716,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10209,,17655,Intermediate,10116.0,,1,Maximum time required to achieve Cmax was determined in rat,,,CHEMBL627717,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10210,In vivo,17717,Intermediate,10116.0,,1,Time calculated to reach Cmax at a concentration of 15 mg/kg perorally in rats along with 100 mg/kg of compound 11,,,CHEMBL627718,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10211,In vivo,17717,Intermediate,10116.0,,1,Time calculated to reach Cmax at a concentration of 60 mg/kg perorally in rats along with 100 mg/kg of compound 11,,,CHEMBL627719,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10212,In vivo,17717,Intermediate,10116.0,,1,Time calculated to reach Cmax at a concentration of 60 mg/kg perorally in rats along with control,,,CHEMBL627720,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10213,In vivo,6570,Intermediate,10116.0,,1,Time to reach maximum concentration in rat after 2 mg/kg peroral administration,,,CHEMBL627721,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10214,In vivo,6570,Intermediate,10116.0,,1,Time to reach maximum concentration in rat after 2 mg/kg peroral administration; 4-6,,,CHEMBL627722,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10215,In vivo,5978,Intermediate,10116.0,,1,Tmax of compound (19.2 mg/kg) after po administration was determined in Sprague-Dawley rat,,,CHEMBL627723,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10216,In vivo,5978,Intermediate,10116.0,,1,Tmax of compound (19.76 mg/kg) after po administration was determined in Sprague-Dawley rat,,,CHEMBL626058,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10217,In vivo,5978,Intermediate,10116.0,,1,Tmax of compound (20.73 mg/kg) after po administration was determined in Sprague-Dawley rat,,,CHEMBL626059,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10218,In vivo,5978,Intermediate,10116.0,,1,Tmax of compound (25 mg/kg) after po administration was determined in Sprague-Dawley rat,,,CHEMBL626060,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10219,In vivo,17720,Intermediate,10116.0,,1,Tmax at a dose of 4 mg/kg in Rat Plasma after iv administration,,,CHEMBL626061,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
10220,In vivo,4723,Intermediate,10116.0,,1,Tmax determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,,,CHEMBL876791,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10221,In vivo,4723,Intermediate,10116.0,,1,Tmax determined after 3 mg/kg oral administration in potassium oxonate treated rats,,,CHEMBL626062,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10222,In vivo,4756,Intermediate,10116.0,,1,Tmax at the dose of 2 mg/Kg administered perorally in rats,,,CHEMBL626063,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10223,In vivo,4756,Intermediate,10116.0,,1,Tmax at the dose of 5 mg/Kg administered perorally in rats,,,CHEMBL626064,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10224,In vivo,17720,Intermediate,10116.0,,1,tmax at a dose of 100 mg/kg in Rat Plasma after iv administration,,,CHEMBL626065,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
10225,In vivo,17720,Intermediate,10116.0,,1,tmax at a dose of 50 mg/kg in Rat Plasma after iv administration,,,CHEMBL626066,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
10226,In vivo,1466,Intermediate,10116.0,,1,tmax upon peroral administration of 10.0 mg/Kg dose in rat,,,CHEMBL626067,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10227,,7449,Intermediate,10116.0,,1,Percent total excretion of 3-(thiomethyl)acetaminophen glucuronide,,,CHEMBL626068,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10228,,7449,Intermediate,10116.0,,1,Percent total excretion of 3-(thiomethyl)acetaminophen sulfate,,,CHEMBL626069,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10229,,7449,Intermediate,10116.0,,1,Percent total excretion of 3-methoxyacetaminophen glucuronide,,,CHEMBL626070,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10230,,7449,Intermediate,10116.0,,1,Percent total excretion of N-methoxyacetaminophen glucuronide,,,CHEMBL626071,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10231,,7449,Intermediate,10116.0,,1,Percent total excretion of N-methoxyacetaminophen sulfate,,,CHEMBL626072,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10232,,7449,Intermediate,10116.0,,1,Percent total excretion of acetaminophen,,,CHEMBL626073,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10233,,7768,Intermediate,10116.0,,1,"Distribution of radioactivity in thyroid tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 6.19-7.22",,,CHEMBL626741,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2046.0
10234,,17655,Intermediate,10116.0,,1,"Percent instability was measured by Rat S9 liver slice metabolism assay, in vitro",,,CHEMBL626742,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10235,,17735,Intermediate,10116.0,,1,Plasma clearance following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats,,,CHEMBL626743,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10236,,5960,Intermediate,10116.0,,1,Plasma concentration at 4 hr after 30 mg/kg post dosing in rat using HPLC/MS,,,CHEMBL876792,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10237,,17735,Intermediate,10116.0,,1,Volume of distribution following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats was determined,,,CHEMBL626744,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10238,,7116,Intermediate,10116.0,,1,Compound was tested for antidiuretic activity in rats,,,CHEMBL626745,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10239,In vivo,4878,Intermediate,10116.0,,1,AUC in rat after 3mg/kg oral dose,,,CHEMBL626746,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
10240,,5939,Intermediate,10116.0,,1,Ratio in brain to that of rat plasma for 2 hr after peroral administration at 10 mg/kg,,,CHEMBL626747,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10241,,5939,Intermediate,10116.0,,1,Ratio in brain to that of rat plasma for 2 hr after peroral administration at 5 mg/kg,,,CHEMBL626748,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10242,,16367,Intermediate,10116.0,,1,Bioavailability administered orally at a dose of 10 mg/kg to rats,,,CHEMBL626749,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10243,,16366,Intermediate,10116.0,,1,Oral Bioavailability was determined,,,CHEMBL626750,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10244,,4426,Intermediate,10116.0,,1,Oral bioavailability in rat,,,CHEMBL626751,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10245,,4426,Intermediate,10116.0,,1,Oral bioavailability in rat; Not performed.,,,CHEMBL626913,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10246,,5041,Intermediate,10116.0,,1,Bioavailability,,,CHEMBL626914,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10247,,5041,Intermediate,10116.0,,1,Bioavailability was determined; ND denotes no data,,,CHEMBL626915,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10248,,1500,Intermediate,10116.0,,1,Biliary excretion when administered intravenously at a dose of 2.5 mg/kg in rats,,,CHEMBL626916,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10249,,1500,Intermediate,10116.0,,1,Biliary excretion when administered intravenously at a dose of 5 mg/kg in rats,,,CHEMBL626917,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10250,,17409,Intermediate,10116.0,,1,Binding towards rat plasma protein at 10 uM,,,CHEMBL626918,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10251,,17409,Intermediate,10116.0,,1,Binding towards rat plasma protein at 100 uM,,,CHEMBL626919,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10252,In vivo,2959,Intermediate,10116.0,,1,Bioavailability in rat (dose 20 mg/kg p.o.),,,CHEMBL626920,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10253,In vivo,13501,Intermediate,10116.0,,1,Bioavailability was determined after oral administration of compound 18 at a dose of 4 mg/kg to rat,,,CHEMBL621976,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10254,In vivo,6567,Intermediate,10116.0,,1,Bioavailability in rat after 5 mg/kg oral gavage,,,CHEMBL877599,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10255,In vivo,6571,Intermediate,10116.0,,1,Bioavailability in rat,,,CHEMBL621977,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10256,In vivo,6715,Intermediate,10116.0,,1,Bioavailability in rat (dose 1 mg/kg i.v.),,,CHEMBL621978,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10257,In vivo,6715,Intermediate,10116.0,,1,Bioavailability in rat (dose 3 mg/kg p.o.),,,CHEMBL621979,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10258,In vivo,2932,Intermediate,10116.0,,1,Oral bioavailability in rat,,,CHEMBL621980,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10259,In vivo,4171,Intermediate,10116.0,,1,Bioavailability of the compound in rats after administration of 30 mg/kg,,,CHEMBL621981,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10260,In vivo,17509,Intermediate,10116.0,,1,Bioavailability after administration of 10 mg/kg in rats,,,CHEMBL621982,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10261,In vivo,17509,Intermediate,10116.0,,1,Bioavailability after administration of 2 mg/kg in rats,,,CHEMBL882953,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10262,In vivo,4527,Intermediate,10116.0,,1,Bioavailability by oral administration at a dose of 100 uM/kg in rat was determined,,,CHEMBL621983,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10263,In vivo,4026,Intermediate,10116.0,,1,Bioavailability in dogs was determined; high,,,CHEMBL621984,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10264,In vivo,6659,Intermediate,10116.0,,1,Bioavailability in monkey after intravenous administration at 1 mpk,,,CHEMBL621985,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10265,In vivo,6659,Intermediate,10116.0,,1,Bioavailability in monkey after peroral administration at 10 mpk,,,CHEMBL621986,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10266,In vivo,6659,Intermediate,10116.0,,1,Bioavailability in rat after intravenous administration at 1 mpk,,,CHEMBL621987,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10267,In vivo,6659,Intermediate,10116.0,,1,Bioavailability in rat after intravenous administration at 2 mpk,,,CHEMBL877600,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10268,In vivo,6659,Intermediate,10116.0,,1,Bioavailability in rat after peroral administration at 30 mpk,,,CHEMBL621988,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10269,In vivo,6659,Intermediate,10116.0,,1,Bioavailability in rat after peroral administration at at 100 mpk,,,CHEMBL621989,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10270,In vivo,6597,Intermediate,10116.0,,1,Bioavailability in rats was evaluated,,,CHEMBL621990,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10271,In vivo,1202,Intermediate,10116.0,,1,Bioavailability was calculated after an intravenous dose of 0.3 mg/Kg in rats after 6 hr,,,CHEMBL621991,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10272,In vivo,1202,Intermediate,10116.0,,1,Bioavailability was calculated after an intravenous dose of 1 mg/Kg in rats after 6 hr,,,CHEMBL621992,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10273,In vivo,1202,Intermediate,10116.0,,1,Bioavailability was calculated after peroral dose of 3.0 mg/Kg in rats after 4 hr,,,CHEMBL621993,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10274,In vivo,1202,Intermediate,10116.0,,1,Bioavailability was calculated after peroral dose of 3.0 mg/Kg in rats after 6 hr,,,CHEMBL621994,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10275,In vivo,5207,Intermediate,10116.0,,1,Bioavailability in rat,,,CHEMBL621995,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10276,In vivo,5970,Intermediate,10116.0,,1,Bioavailability in rat,,,CHEMBL621996,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10277,In vivo,17538,Intermediate,10116.0,,1,Oral bioavailability in rat (dose 10 mg/kg),,,CHEMBL621997,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10278,In vivo,17538,Intermediate,10116.0,,1,Bioavailability in rat after po administration at a dose of 10 mg/kg; nd is not determined,,,CHEMBL621998,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10279,In vivo,1466,Intermediate,10116.0,,1,Bioavailability upon peroral administration of 10.0 mg/Kg dose in rat,,,CHEMBL621999,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10280,In vivo,2879,Intermediate,10116.0,,1,Oral bioavailability in rat,,,CHEMBL622000,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10281,In vivo,2879,Intermediate,10116.0,,1,Bioavailability was measured in rat after oral administration; 2-4,,,CHEMBL622001,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10282,In vivo,2879,Intermediate,10116.0,,1,Bioavailability was measured in rat after oral administration; 3-7,,,CHEMBL622002,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10283,In vivo,3777,Intermediate,10116.0,,1,Bioavailability in rat (intraduodenal administration),,,CHEMBL622003,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10284,In vivo,3777,Intermediate,10116.0,,1,Bioavailability in rat (intraduodenal administration),,,CHEMBL877601,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10285,In vivo,3777,Intermediate,10116.0,,1,Oral bioavailability in rat,,,CHEMBL624871,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10286,In vivo,3777,Intermediate,10116.0,,1,Oral bioavailability in rat,,,CHEMBL622004,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10287,In vivo,5423,Intermediate,10116.0,,1,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg p.o.),,,CHEMBL882954,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10288,In vivo,16365,Intermediate,10116.0,,1,Bioavailability was evaluated when a dose of 3 mg/kg was administered orally,,,CHEMBL622005,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10289,In vivo,16365,Intermediate,10116.0,,1,Bioavailability was evaluated when a dose of 3 mg/kg was administered orally to a fasting rat,,,CHEMBL622006,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10290,In vivo,4239,Intermediate,10116.0,,1,Bioavailability was measured in rat,,,CHEMBL622007,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10291,In vivo,5438,Intermediate,10116.0,,1,Bioavailability was reported,,,CHEMBL622008,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10292,In vivo,5334,Intermediate,10116.0,,1,Bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),,,CHEMBL622009,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10293,In vivo,5334,Intermediate,10116.0,,1,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),,,CHEMBL622010,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10294,In vivo,4199,Intermediate,10116.0,,1,Bioavailability was determined upon 10 mg/kg in 1% methylcellulose peroral administration in rats,,,CHEMBL622011,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10295,In vivo,4199,Intermediate,10116.0,,1,Bioavailability in rat (dose 2 mg/kg in 1% methylcellulose p.o.),,,CHEMBL622012,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10296,In vivo,4199,Intermediate,10116.0,,1,Bioavailability in rat (dose 3 mg/kg in 1% methylcellulose ),,,CHEMBL622013,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10297,In vivo,4890,Intermediate,10116.0,,1,Bioavailability was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,,,CHEMBL622014,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10298,In vivo,2792,Intermediate,10116.0,,1,Bioavailability was determined at 3 mg/kg po dose in rats,,,CHEMBL624749,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10299,In vivo,5529,Intermediate,10116.0,,1,Oral bioavailability in rat (dose 2 mg/kg),,,CHEMBL624750,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10300,In vivo,6685,Intermediate,10116.0,,1,"Bioavailability was determined in rats at 10 mg/kg, p.o. dose",,,CHEMBL624751,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10301,In vivo,6685,Intermediate,10116.0,,1,"Bioavailability was determined in rats at 20 mg/kg, i.p. dose; n/a: not applicable",,,CHEMBL624752,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10302,In vivo,6685,Intermediate,10116.0,,1,"Bioavailability was determined in rats at 2 mg/kg, i.v. dose; n/a: not applicable",,,CHEMBL624753,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10303,In vivo,6005,Intermediate,10116.0,,1,Bioavailability was evaluated in rat after peroral administration at a dose of 1 mg/kg,,,CHEMBL624754,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10304,In vivo,6410,Intermediate,10116.0,,1,Bioavailability was evaluated in rats at an intravenous dose of 3 mg/kg; Not applicable,,,CHEMBL624755,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10305,In vivo,6410,Intermediate,10116.0,,1,Bioavailability was evaluated in rats at an oral dose of 30 mg/kg,,,CHEMBL624756,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10306,In vivo,6103,Intermediate,10116.0,,1,Bioavailability in rat,,,CHEMBL624757,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10307,In vivo,6410,Intermediate,10116.0,,1,Bioavailability was evaluated in rats at an intravenous dose of 3 mg/kg; Not applicable,,,CHEMBL624758,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10308,In vivo,6410,Intermediate,10116.0,,1,Bioavailability was evaluated in rats at an oral dose of 30 mg/kg,,,CHEMBL622270,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10309,In vivo,5353,Intermediate,10116.0,,1,Bioavailability in rat (Sprague-Dawley),,,CHEMBL622271,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10310,In vivo,4727,Intermediate,10116.0,,1,Bioavailability in rat at the dose of 2 mg/kg,,,CHEMBL622272,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10311,In vivo,17804,Intermediate,10116.0,,1,Oral bioavailability in rat,,,CHEMBL622273,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10312,In vivo,5809,Intermediate,10116.0,,1,Bioavailability in rat (cannulated) (dose 2 mg/kg),,,CHEMBL622274,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10313,In vivo,17804,Intermediate,10116.0,,1,Bioavailability value of compound in rats was determined after peroral administration,,,CHEMBL622275,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10314,In vivo,3634,Intermediate,10116.0,,1,Oral bioavailability in rat (dose 20 mg/kg),,,CHEMBL622276,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10315,In vivo,3341,Intermediate,10116.0,,1,Oral bioavailability in rat,,,CHEMBL622277,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10316,In vivo,2690,Intermediate,10116.0,,1,Oral bioavailability in rat (dose 5 mg/kg),,,CHEMBL622278,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10317,In vivo,3184,Intermediate,10116.0,,1,Oral bioavailability in rat,,,CHEMBL622279,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10318,In vivo,740,Intermediate,10116.0,,1,Oral bioavailability in rat,,,CHEMBL622280,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10319,In vivo,1806,Intermediate,10116.0,,1,Compound was evaluated for oral bioavailability in rats; 15-27 %,,,CHEMBL624083,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10320,In vivo,4891,Intermediate,10116.0,,1,Compound was evaluated for pharmacokinetic parameter percent bioavailability at 18 h,,,CHEMBL624084,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10321,In vivo,3634,Intermediate,10116.0,,1,Compound was evaluated for pharmacokinetic property in rats after an oral dose of 10 mg/kg and the value was reported as oral bioavailability (F),,,CHEMBL624085,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10322,In vivo,64,Intermediate,10116.0,,1,Compound was tested for bioavailability in rats,,,CHEMBL624086,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10323,In vivo,4839,Intermediate,10116.0,,1,Bioavailability in rat,,,CHEMBL624087,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10324,In vivo,1094,Intermediate,10116.0,,1,Oral bioavailability in rat,,,CHEMBL624088,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10325,In vivo,5005,Intermediate,9544.0,,1,Compound was tested for oral bioavailability in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po.,,,CHEMBL624089,,22224,Macaca mulatta,,,U,0,BAO_0000218,
10326,In vivo,5005,Intermediate,10116.0,,1,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v. and 2 mg/kg p.o.),,,CHEMBL624090,,22224,Rattus norvegicus,,,U,0,BAO_0000218,
10327,In vivo,4687,Intermediate,10116.0,,1,Evaluated for the bioavailability in rat (in vivo),,,CHEMBL624091,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10328,In vivo,17804,Intermediate,10116.0,,1,F value of compound in rats was determined after peroral administration,,,CHEMBL624092,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10329,In vivo,5974,Intermediate,10116.0,,1,In vivo Oral bioavailability (F)was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,,,CHEMBL624093,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10330,In vivo,5974,Intermediate,10116.0,,1,In vivo Oral bioavailability (F)was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,,,CHEMBL624094,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10331,In vivo,5974,Intermediate,10116.0,,1,In vivo Oral bioavailability (F)was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,,,CHEMBL624095,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10332,In vivo,5974,Intermediate,10116.0,,1,In vivo Oral bioavailability (F)was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,,,CHEMBL624096,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10333,In vivo,1088,Intermediate,10116.0,,1,"In vivo percent of absolute bioavailability obtained from blood plasma levels analyzed by means of GC/MS (dose 5 uM/kg i.v. and 40 uM/kg, p.o.)",,,CHEMBL624097,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10334,In vivo,1742,Intermediate,10116.0,,1,Maximum fall in carotid flow in rat,,,CHEMBL624098,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10335,In vivo,4689,Intermediate,10116.0,,1,Oral Bioavailability after intravenous administration (1 mg/kg) in rat,,,CHEMBL874392,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10336,In vivo,2463,Intermediate,10116.0,,1,Oral bioavailability in rat (dose 5 mg/kg),,,CHEMBL624099,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10337,In vivo,5654,Intermediate,10116.0,,1,Oral bioavailability (F%) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,,,CHEMBL624100,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10338,In vivo,5654,Intermediate,10116.0,,1,Oral bioavailability (F%) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,,,CHEMBL624101,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10339,In vivo,6874,Intermediate,10116.0,,1,Oral bioavailability in rat (male Wistar),,,CHEMBL624102,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10340,In vivo,5633,Intermediate,10116.0,,1,Oral bioavailability after administration (30 mg/kg) in rat; good,,,CHEMBL624103,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10341,In vivo,5496,Intermediate,10116.0,,1,Oral bioavailability at the dose of 2 mg/kg in rat,,,CHEMBL624104,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10342,In vivo,2358,Intermediate,10116.0,,1,Oral bioavailability determined in rats,,,CHEMBL624105,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10343,In vivo,16456,Intermediate,10116.0,,1,Oral bioavailability in rat (Sprague-Dawley) (male) (dose 50 mg/kg p.o.),,,CHEMBL624106,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10344,In vivo,5302,Intermediate,10116.0,,1,Oral bioavailability in rat (dose single 10 mg/kg),,,CHEMBL624107,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10345,In vivo,5302,Intermediate,10116.0,,1,Oral bioavailability in rat (dose single 10 mg/kg),,,CHEMBL623943,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10346,In vivo,5302,Intermediate,10116.0,,1,Oral bioavailability in rat (dose 5 mg/kg,,,CHEMBL623944,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10347,,11020,Intermediate,10116.0,,1,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus HVA; below the levels of detection,,,CHEMBL623945,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10348,,11020,Intermediate,10116.0,,1,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus NE,,,CHEMBL623946,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10349,,11020,Intermediate,10116.0,,1,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex 5-HIAA,,,CHEMBL623947,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10350,,11020,Intermediate,10116.0,,1,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex 5-HT,,,CHEMBL623948,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10351,,11020,Intermediate,10116.0,,1,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex DA,,,CHEMBL623949,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10352,,11020,Intermediate,10116.0,,1,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex DOPAC,,,CHEMBL623950,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10353,,11020,Intermediate,10116.0,,1,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex HVA,,,CHEMBL874398,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10354,,11020,Intermediate,10116.0,,1,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex NE,,,CHEMBL623951,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10355,,11020,Intermediate,10116.0,,1,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus 5-HIAA,,,CHEMBL623952,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10356,,11020,Intermediate,10116.0,,1,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus 5-HT,,,CHEMBL623953,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10357,,11020,Intermediate,10116.0,,1,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DA; below level of detection,,,CHEMBL623954,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10358,,11020,Intermediate,10116.0,,1,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DA; below the levels of detection,,,CHEMBL623955,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10359,,11020,Intermediate,10116.0,,1,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DOPAC; below level of detection,,,CHEMBL623956,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10360,,11020,Intermediate,10116.0,,1,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DOPAC; below the levels of detection,,,CHEMBL627807,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10361,,11020,Intermediate,10116.0,,1,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus HVA; below level of detection,,,CHEMBL627808,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10362,,11020,Intermediate,10116.0,,1,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus HVA; below the levels of detection,,,CHEMBL627809,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10363,,11020,Intermediate,10116.0,,1,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus NE,,,CHEMBL627810,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10364,,11020,Intermediate,10116.0,,1,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex 5-HIAA",,,CHEMBL627811,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10365,,11020,Intermediate,10116.0,,1,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex 5-HT",,,CHEMBL627812,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10366,,11020,Intermediate,10116.0,,1,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex DA",,,CHEMBL627813,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10367,,11020,Intermediate,10116.0,,1,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex DOPAC",,,CHEMBL627814,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10368,,11020,Intermediate,10116.0,,1,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex HVA",,,CHEMBL875336,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10369,,11020,Intermediate,10116.0,,1,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex NE",,,CHEMBL627815,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10370,,11020,Intermediate,10116.0,,1,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus 5-HIAA",,,CHEMBL627816,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10371,,11020,Intermediate,10116.0,,1,"Momoamine and metabolic levels observed at 3 h postdrug against, at a dose of 20 mg/kg Hippocampus 5-HT",,,CHEMBL627817,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10372,,11020,Intermediate,10116.0,,1,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus DA; below the levels of detection",,,CHEMBL627818,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10373,,11020,Intermediate,10116.0,,1,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus DOPAC; below the levels of detection",,,CHEMBL627819,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10374,,11020,Intermediate,10116.0,,1,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus HVA; below the levels of detection",,,CHEMBL627820,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10375,,11020,Intermediate,10116.0,,1,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus NE",,,CHEMBL627821,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10376,,11020,Intermediate,10116.0,,1,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex 5-HIAA,,,CHEMBL628464,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10377,,11020,Intermediate,10116.0,,1,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex 5-HT,,,CHEMBL626239,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10378,,11020,Intermediate,10116.0,,1,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex DA,,,CHEMBL626240,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10379,,11020,Intermediate,10116.0,,1,Momoamine and metabolic levels observed at 3 h postdrug against at a dose of 20 mg/kg Frontal cortex DOPAC,,,CHEMBL626241,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10380,,11020,Intermediate,10116.0,,1,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex HVA,,,CHEMBL626242,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10381,,11020,Intermediate,10116.0,,1,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex NE,,,CHEMBL626243,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10382,,11020,Intermediate,10116.0,,1,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus 5-HIAA,,,CHEMBL626244,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10383,,11020,Intermediate,10116.0,,1,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus 5-HT; below level of detection,,,CHEMBL626907,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10384,,11020,Intermediate,10116.0,,1,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus DA; below level of detection,,,CHEMBL626908,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10385,,11020,Intermediate,10116.0,,1,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus DOPAC; below level of detection,,,CHEMBL626909,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10386,,11020,Intermediate,10116.0,,1,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus HVA; below level of detection,,,CHEMBL626910,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10387,,7449,Intermediate,10116.0,,1,Percent total excretion of acetaminophen cysteine conjugate,,,CHEMBL875342,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10388,,7449,Intermediate,10116.0,,1,Percent total excretion of acetaminophen glucuronide,,,CHEMBL626911,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10389,,7449,Intermediate,10116.0,,1,Percent total excretion of acetaminophen sulfate,,,CHEMBL626912,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10390,,7449,Intermediate,10116.0,,1,Percent total excretion of acetaminophen-mercapturic acid,,,CHEMBL627065,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10391,,3172,Intermediate,10116.0,,1,Amount of urine output was measured in rat at a dose of 10 mg/kg administered orally,,,CHEMBL627066,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
10392,In vivo,16456,Intermediate,10116.0,,1,Volume of distribution in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,,,CHEMBL627067,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10393,In vivo,10839,Autocuration,8656.0,,1,Biodistribution of compound in rat muscle after 5 min of administration,,,CHEMBL627068,,22224,ratrat,,,U,0,BAO_0000218,2385.0
10394,In vivo,10839,Autocuration,8656.0,,1,Biodistribution of compound in rat muscle after 5 min of administration.,,,CHEMBL627069,,22224,ratrat,,,U,0,BAO_0000218,2385.0
10395,In vivo,5334,Autocuration,9940.0,,1,Plasma clearance was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),,,CHEMBL627070,,22224,Ovis aries,,,U,0,BAO_0000218,
10396,In vivo,5334,Autocuration,9940.0,,1,Plasma clearance was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),,,CHEMBL627071,,22224,Ovis aries,,,U,0,BAO_0000218,
10397,In vivo,5334,Autocuration,9940.0,,1,Bioavailability was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),,,CHEMBL627072,,22224,Ovis aries,,,U,0,BAO_0000218,
10398,In vivo,5334,Autocuration,9940.0,,1,Bioavailability was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),,,CHEMBL627073,,22224,Ovis aries,,,U,0,BAO_0000218,
10399,In vivo,5334,Autocuration,9940.0,,1,Volume of distribution was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),,,CHEMBL625387,,22224,Ovis aries,,,U,0,BAO_0000218,
10400,In vivo,5334,Autocuration,9940.0,,1,Volume of distribution was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),,,CHEMBL625388,,22224,Ovis aries,,,U,0,BAO_0000218,
10401,In vivo,5334,Autocuration,9940.0,,1,Plasma half-life period (0-8 h) was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),,,CHEMBL625389,,22224,Ovis aries,,,U,0,BAO_0000218,1969.0
10402,In vivo,5334,Autocuration,9940.0,,1,Plasma half-life period (0-8 h) was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),,,CHEMBL875343,,22224,Ovis aries,,,U,0,BAO_0000218,1969.0
10403,,1735,Intermediate,8570.0,,1,Biological half life period of compound was measured against snake venom phosphodiesterase (SVPDE),,,CHEMBL876795,,50497,Serpentes,,,N,1,BAO_0000218,
10404,,1469,Intermediate,8570.0,,1,Half life (t) of enzymatic phosphodiester hydrolysis of compound towards snake venom (SV-PDE) at a concentration of 4 microg,,,CHEMBL626552,,50497,Serpentes,,,N,1,BAO_0000218,
10405,,1336,Intermediate,8570.0,,1,Enzymatic stability was assessed with snake venom phosphodiesterase (SV PDE) exonuclase,,,CHEMBL626553,,50497,Serpentes,,,N,1,BAO_0000218,
10406,,12403,Autocuration,9606.0,,1,The human biological plasma half life of the compound,,,CHEMBL626554,,22224,Homo sapiens,,,U,0,BAO_0000366,1969.0
10407,,8151,Intermediate,10116.0,,1,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 100 mg/Kg,,,CHEMBL626555,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
10408,,8004,Intermediate,10116.0,,1,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 120 min after iv administration compound,,,CHEMBL626556,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10409,,8004,Intermediate,10116.0,,1,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 15 after iv administration of compound,,,CHEMBL626557,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10410,,8004,Intermediate,10116.0,,1,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 240 min after iv administration compound,,,CHEMBL626558,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10411,,8004,Intermediate,10116.0,,1,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 30 min after iv administration of compound,,,CHEMBL626559,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10412,,8004,Intermediate,10116.0,,1,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 5 min after iv administration of compound,,,CHEMBL626560,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10413,,8004,Intermediate,10116.0,,1,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 60 min after iv administration of compound,,,CHEMBL876803,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10414,,8004,Intermediate,10116.0,,1,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 120 min after iv administration compound,,,CHEMBL627964,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10415,,8004,Intermediate,10116.0,,1,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 15 min after iv administration of compound,,,CHEMBL627965,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10416,,8004,Intermediate,10116.0,,1,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 240 min after iv administration compound,,,CHEMBL627966,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10417,,8004,Intermediate,10116.0,,1,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 30 min after iv administration of compound,,,CHEMBL627967,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10418,,8004,Intermediate,10116.0,,1,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 5 min after iv administration of compound,,,CHEMBL627968,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10419,,8004,Intermediate,10116.0,,1,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 60 min after iv administration of compound,,,CHEMBL627969,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10420,,8004,Intermediate,10116.0,,1,Distribution of Se-75 activity in Liver of female Sprague-Dawley Rat 5 min after iv administration of compound,,,CHEMBL627970,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10421,,8004,Intermediate,10116.0,,1,Distribution of Se-75 activity in blood of female Sprague-Dawley Rat 120 min after iv administration of compound,,,CHEMBL627971,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
10422,,8004,Intermediate,10116.0,,1,Distribution of Se-75 activity in blood of female Sprague-Dawley Rat 240 min after iv administration of compound,,,CHEMBL627972,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
10423,,15917,Expert,9606.0,,1,Dissociation constant against binding to human cyclophilin A,,,CHEMBL856029,,180,Homo sapiens,,,D,9,BAO_0000357,
10424,,12396,Expert,9913.0,,1,Michaelis-Menten constant for inhibitory activity against bovine liver glyoxalase II,,,CHEMBL627973,,11591,Bos taurus,,,H,8,BAO_0000019,
10425,,7065,Autocuration,,,1,-Log C was determined by performing the electroshock minimum test,,,CHEMBL627974,,22224,,,,U,0,BAO_0000019,
10426,,7065,Autocuration,,,1,-Log C was determined by performing the foot shock test,,,CHEMBL627975,,22224,,,,U,0,BAO_0000019,
10427,,7065,Autocuration,,,1,-Log C was determined by performing the incl screen test,,,CHEMBL627976,,22224,,,,U,0,BAO_0000019,
10428,,7065,Autocuration,,,1,-Log C was determined by performing the maximum electroshock test,,,CHEMBL627977,,22224,,,,U,0,BAO_0000019,
10429,,7065,Autocuration,,,1,-Log C was determined by performing the pentylenetetrazole test,,,CHEMBL627978,,22224,,,,U,0,BAO_0000019,
10430,,12415,Autocuration,,,1,Tested for experimental arotinoid inhibitory dose,,,CHEMBL627979,,22224,,,,U,0,BAO_0000019,
10431,,10256,Autocuration,,,1,Negative log transformed activity,,,CHEMBL876804,,22224,,,,U,0,BAO_0000019,
10432,,7991,Autocuration,,,1,"Negative log of Langmuir's alpha constant (-log alpha), which is inversely proportional to the effective binding constant (protein binding)",,,CHEMBL627980,,22224,,,,U,0,BAO_0000019,
10433,,14342,Intermediate,10141.0,,1,Dissociation constant was evaluated on guinea pig bladder at M3 muscarinic receptor,,,CHEMBL627981,,50512,Cavia porcellus,,,N,1,BAO_0000218,
10434,,14342,Intermediate,10141.0,,1,Dissociation constant was evaluated on guinea pig heart (force) at M2 muscarinic receptor,,,CHEMBL627982,,50512,Cavia porcellus,,,N,1,BAO_0000218,
10435,,14342,Intermediate,10141.0,,1,Dissociation constant was evaluated on guinea pig heart (rate) at M2 muscarinic receptor,,,CHEMBL627983,,50512,Cavia porcellus,,,N,1,BAO_0000218,
10436,,14342,Intermediate,10141.0,,1,Dissociation constant was evaluated on guinea pig ileum at M3 muscarinic receptor,,,CHEMBL627984,,50512,Cavia porcellus,,,N,1,BAO_0000218,2116.0
10437,,6047,Autocuration,,,1,Solubility in water was determined; values expressed as -log,,,CHEMBL627985,,22229,,,,U,0,BAO_0000100,
10438,,17269,Autocuration,,,1,Ratio of Kcat to that of Km was determined,,,CHEMBL627986,,22224,,,,U,0,BAO_0000019,
10439,,10026,Autocuration,,,1,Observed first order rate constant,,,CHEMBL627987,,22224,,,,U,0,BAO_0000019,
10440,,14583,Autocuration,,,1,Fraction of 88Y (%) released from chelate after incubation in serum for 15 hours,,,CHEMBL627988,,22224,,,,U,0,BAO_0000019,
10441,In vivo,2661,Intermediate,10116.0,,1,Compound was evaluated for bioavailability after treatment with oral dose of 2 mgkg to female wistar rats,,,CHEMBL627989,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10442,In vivo,2661,Intermediate,10116.0,,1,Compound was evaluated for bioavailability after treatment with oral dose of 2 mgkg to male wistar rats,,,CHEMBL627990,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10443,In vivo,4029,Intermediate,10116.0,,1,Oral Bioavailability after administration of 10 mg/kg in male rat,,,CHEMBL876805,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10444,In vivo,17735,Intermediate,10116.0,,1,Oral bioavailability in rat (dose 10 mg/kg i.v. and 50 mg/kg p.o.),,,CHEMBL627991,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10445,In vivo,4576,Intermediate,10116.0,,1,Oral bioavailability in rat,,,CHEMBL627992,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10446,In vivo,17582,Intermediate,10116.0,,1,Oral bioavailability after oral (po) administration at a dose of 10 mg/kg was measured in rats,,,CHEMBL627993,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10447,In vivo,17651,Intermediate,10116.0,,1,Oral bioavailability at 1 mg/kg was determined in rat,,,CHEMBL622817,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10448,In vivo,17651,Intermediate,10116.0,,1,Oral bioavailability at 10 mg/kg was determined in rat,,,CHEMBL622818,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10449,In vivo,17670,Intermediate,10116.0,,1,"Oral bioavailability in fischer rats at 30 mg/kg dose, administered perorally",,,CHEMBL622819,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10450,In vivo,5045,Intermediate,10116.0,,1,Oral bioavailability in rat,,,CHEMBL872267,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10451,In vivo,1696,Intermediate,10116.0,,1,Oral bioavailability in rat,,,CHEMBL622820,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10452,In vivo,17764,Intermediate,10116.0,,1,Oral bioavailability after intravenous administration in rats at 24 uM/kg,,,CHEMBL622821,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10453,In vivo,6448,Intermediate,10116.0,,1,Oral bioavailability in rat,,,CHEMBL622822,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10454,In vivo,6596,Intermediate,10116.0,,1,Oral bioavailability in rat,,,CHEMBL622823,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10455,In vivo,17547,Intermediate,10116.0,,1,Oral bioavailability in rat,,,CHEMBL622824,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10456,In vivo,17771,Intermediate,10116.0,,1,Oral bioavailability in rat at a dose of 3 mg/kg,,,CHEMBL622825,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10457,In vivo,6495,Intermediate,10116.0,,1,Oral bioavailability in rat after oral administration at 10 mg/kg,,,CHEMBL622901,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10458,In vivo,4558,Intermediate,10116.0,,1,Oral bioavailability in rat,,,CHEMBL622902,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10459,In vivo,17596,Intermediate,10116.0,,1,Oral bioavailability in rat,,,CHEMBL621844,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10460,In vivo,6827,Intermediate,10116.0,,1,Oral bioavailability in Dawley rats,,,CHEMBL621845,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10461,In vivo,4026,Intermediate,10116.0,,1,Oral bioavailability,,,CHEMBL621846,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10462,In vivo,10,Intermediate,10116.0,,1,Oral bioavailability in rat (dose 30 mg/kg),,,CHEMBL621847,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10463,In vivo,17717,Intermediate,10116.0,,1,Bioavailability in rat at a concentration of 15 mg/kg perorally in rat along with 100 mg/kg 11,,,CHEMBL877609,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10464,In vivo,17717,Intermediate,10116.0,,1,Bioavailability in rat (dose 3 mg/kg i.v.),,,CHEMBL621848,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10465,In vivo,17717,Intermediate,10116.0,,1,Bioavailability in rat at a concentration of 60 mg/kg perorally in rat along with 100 mg/kg 11,,,CHEMBL621849,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10466,In vivo,17717,Intermediate,10116.0,,1,Oral bioavailability in rat (dose 60 mg/kg p.o.),,,CHEMBL622030,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10467,In vivo,4796,Intermediate,10116.0,,1,Percent oral bioavailability determined in rats,,,CHEMBL622031,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10468,In vivo,4883,Intermediate,10116.0,,1,Tested for percent bioavailability after oral administration to Sprague-Dawley rat at dosage of 0.2 mg/kg,,,CHEMBL622032,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10469,In vivo,2137,Intermediate,10116.0,,1,The compound was evaluated for bioavailability in rats; 32-51,,,CHEMBL622033,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10470,In vivo,2959,Intermediate,10116.0,,1,Bioavailability in rat (dose 20 mg/kg p.o.),,,CHEMBL622034,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10471,In vivo,1361,Intermediate,10116.0,,1,Oral bioavailability in rat,,,CHEMBL622035,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10472,In vivo,4727,Intermediate,10116.0,,1,Bioavailability percent in rat at the dose of 2 mg/kg,,,CHEMBL882966,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10473,In vivo,16423,Intermediate,10116.0,,1,Bioavailability was evaluated after 20 uM/kg of peroral administration,,,CHEMBL622036,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10474,In vivo,5206,Intermediate,10116.0,,1,Oral bioavailability in rat,,,CHEMBL622037,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10475,In vivo,6448,Intermediate,10116.0,,1,Oral bioavailability in rat,,,CHEMBL622038,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10476,In vivo,17723,Intermediate,10116.0,,1,Bioavailability in rats,,,CHEMBL622039,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10477,In vivo,17738,Intermediate,10116.0,,1,Biodistribution of radiolabeled compound in rat blood after 24 hr postinjection activity expressed as %ID/Organ,,,CHEMBL622040,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
10478,In vivo,17738,Intermediate,10116.0,,1,Biodistribution of radiolabeled compound in rat blood after 24 hr activity expressed as %ID/Organ,,,CHEMBL622041,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
10479,In vivo,17738,Intermediate,10116.0,,1,Biodistribution of radiolabeled compound in rat blood after 2 hr activity expressed as %ID/Organ,,,CHEMBL622042,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
10480,In vivo,17738,Intermediate,10116.0,,1,Biodistribution of radiolabeled compound in rat blood after 30 min activity expressed as %ID/Organ,,,CHEMBL622043,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
10481,In vivo,17738,Intermediate,10116.0,,1,Biodistribution of radiolabeled compound in rat blood after 5 min activity expressed as %ID/Organ,,,CHEMBL622044,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
10482,In vivo,17738,Intermediate,10116.0,,1,Biodistribution of radiolabeled compound in rat bone after 24 hr activity expressed as %ID/Organ,,,CHEMBL622045,,50597,Rattus norvegicus,,,N,1,BAO_0000218,10000001.0
10483,In vivo,17738,Intermediate,10116.0,,1,Biodistribution of radiolabeled compound in rat bone after 2 hr activity expressed as %ID/Organ,,,CHEMBL622046,,50597,Rattus norvegicus,,,N,1,BAO_0000218,10000001.0
10484,In vivo,17738,Intermediate,10116.0,,1,Biodistribution of radiolabeled compound in rat bone after 30 min activity expressed as %ID/Organ,,,CHEMBL622047,,50597,Rattus norvegicus,,,N,1,BAO_0000218,10000001.0
10485,In vivo,17738,Intermediate,10116.0,,1,Biodistribution of radiolabeled compound in rat bone after 5 min activity expressed as %ID/Organ,,,CHEMBL877610,,50597,Rattus norvegicus,,,N,1,BAO_0000218,10000001.0
10486,In vivo,17738,Intermediate,10116.0,,1,Biodistribution of radiolabeled compound in rat brain after 24 hr activity expressed as %ID/Organ,,,CHEMBL622048,,50597,Rattus norvegicus,,,N,1,BAO_0000218,955.0
10487,In vivo,17738,Intermediate,10116.0,,1,Biodistribution of radiolabeled compound in rat brain after 2 hr activity expressed as %ID/Organ,,,CHEMBL622049,,50597,Rattus norvegicus,,,N,1,BAO_0000218,955.0
10488,In vivo,17738,Intermediate,10116.0,,1,Biodistribution of radiolabeled compound in rat brain after 30 min activity expressed as %ID/Organ,,,CHEMBL622050,,50597,Rattus norvegicus,,,N,1,BAO_0000218,955.0
10489,In vivo,17738,Intermediate,10116.0,,1,Biodistribution of radiolabeled compound in rat brain after 5 min activity expressed as %ID/Organ,,,CHEMBL622051,,50597,Rattus norvegicus,,,N,1,BAO_0000218,955.0
10490,In vivo,17738,Intermediate,10116.0,,1,Biodistribution of radiolabeled compound in rat fat after 24 hr activity expressed as %ID/Organ,,,CHEMBL622052,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10491,In vivo,17738,Intermediate,10116.0,,1,Biodistribution of radiolabeled compound in rat fat after 2 hr activity expressed as %ID/Organ,,,CHEMBL622053,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10492,In vivo,17738,Intermediate,10116.0,,1,Biodistribution of radiolabeled compound in rat fat after 30 min activity expressed as %ID/Organ,,,CHEMBL622054,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10493,In vivo,17738,Intermediate,10116.0,,1,Biodistribution of radiolabeled compound in rat fat after 5 min activity expressed as %ID/Organ,,,CHEMBL622055,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10494,In vivo,5237,Intermediate,10116.0,,1,Oral bioavailability in rats was determined; High,,,CHEMBL622056,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10495,In vivo,5503,Intermediate,10116.0,,1,Oral bioavailability in the rat was determined,,,CHEMBL622057,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10496,In vivo,15765,Intermediate,10116.0,,1,Oral bioavailability measured by the ratio of intravenous to oral area under concentration.,,,CHEMBL628008,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10497,In vivo,15660,Intermediate,10116.0,,1,Oral bioavailability in rat (dose 10 mg/kg p.o. and 3 mg/kg i.v.),,,CHEMBL622058,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10498,In vivo,5978,Intermediate,10116.0,,1,Oral bioavailability of compound (19.2 mg/kg) after po administration was determined in Sprague-Dawley rat,,,CHEMBL622059,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10499,In vivo,5978,Intermediate,10116.0,,1,Oral bioavailability of compound (19.76 mg/kg) after po administration was determined in Sprague-Dawley rat,,,CHEMBL622060,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10500,In vivo,5978,Intermediate,10116.0,,1,Oral bioavailability of compound (20.73 mg/kg) after po administration was determined in Sprague-Dawley rat,,,CHEMBL622061,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10501,In vivo,5978,Intermediate,10116.0,,1,Oral bioavailability of compound (25 mg/kg) after po administration was determined in Sprague-Dawley rat,,,CHEMBL622062,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10502,In vivo,5656,Intermediate,10116.0,,1,Oral bioavailability of compound at a dose of 20 mg/kg was determined after oral administration in rat,,,CHEMBL622063,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10503,In vivo,3598,Expert,10116.0,,1,Oral bioavailability of compound determined in rat after iv administration at a dose of 10 mg/kg,,,CHEMBL877611,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10504,In vivo,4216,Intermediate,10116.0,,1,Oral bioavailability of compound in Sprague Dawley rats,,,CHEMBL622064,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10505,In vivo,17839,Intermediate,10116.0,,1,Oral bioavailability of compound in rat,,,CHEMBL622065,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10506,In vivo,6570,Intermediate,10116.0,,1,Oral bioavailability in rat (dose 2 mg/kg),,,CHEMBL622066,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10507,In vivo,5334,Intermediate,10116.0,,1,Oral bioavailability of compound in rat was determined,,,CHEMBL622067,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10508,In vivo,6886,Intermediate,10116.0,,1,Oral bioavailability of compound in rats,,,CHEMBL622068,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10509,In vivo,5210,Intermediate,10116.0,,1,Oral bioavailability of compound was determined in rats,,,CHEMBL622069,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10510,In vivo,4170,Intermediate,10116.0,,1,Oral bioavailability at a dose of 30 mg/kg in rats,,,CHEMBL624796,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10511,In vivo,6028,Intermediate,10116.0,,1,Oral bioavailability in rat (dose 10 mg/kg),,,CHEMBL624797,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10512,In vivo,6028,Intermediate,10116.0,,1,Oral bioavailability in rat (dose 10 mg/kg),,,CHEMBL623053,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10513,In vivo,6078,Intermediate,10116.0,,1,Oral bioavailability evaluated in rat,,,CHEMBL623054,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10514,In vivo,6168,Intermediate,10116.0,,1,Oral bioavailability in fasted rat,,,CHEMBL623055,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10515,In vivo,6168,Intermediate,10116.0,,1,Oral bioavailability in fed rat,,,CHEMBL623056,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10516,In vivo,5160,Intermediate,10116.0,,1,Oral bioavailability in rat (mature male) (dose 30 mg/kg),,,CHEMBL623057,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10517,In vivo,6057,Intermediate,10116.0,,1,Oral bioavailability in rat,,,CHEMBL623058,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10518,In vivo,6535,Intermediate,10116.0,,1,Oral bioavailability in rat (dose 10 mg/kg p.o.),,,CHEMBL623059,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10519,In vivo,6535,Intermediate,10116.0,,1,Oral bioavailability in rat after administration of 10 mg/kg po,,,CHEMBL623060,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10520,In vivo,4194,Intermediate,10116.0,,1,Oral bioavailability in rat,,,CHEMBL623061,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10521,In vivo,6230,Intermediate,10116.0,,1,Oral bioavailability in rat,,,CHEMBL623062,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10522,In vivo,6619,Intermediate,10116.0,,1,Oral bioavailability in rat,,,CHEMBL623063,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10523,In vivo,17607,Intermediate,10116.0,,1,Oral bioavailability in rat,,,CHEMBL623064,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10524,In vivo,4942,Intermediate,10116.0,,1,Oral bioavailability in ratrs,,,CHEMBL623065,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10525,In vivo,4942,Intermediate,10116.0,,1,Oral bioavailability in rat,,,CHEMBL623066,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10526,In vivo,6646,Intermediate,10116.0,,1,Oral bioavailability in rat,,,CHEMBL623067,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10527,In vivo,5237,Intermediate,10116.0,,1,Oral bioavailability in rats was determined; High,,,CHEMBL623068,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10528,In vivo,6646,Intermediate,10116.0,,1,Oral bioavailability in rat,,,CHEMBL623069,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10529,In vivo,4449,Intermediate,10116.0,,1,Oral bioavailability in rat,,,CHEMBL623070,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10530,In vivo,6057,Intermediate,10116.0,,1,Oral bioavailability was calculated in rat,,,CHEMBL623071,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10531,In vivo,2552,Intermediate,10116.0,,1,Oral bioavailability,,,CHEMBL623072,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10532,In vivo,5496,Intermediate,10116.0,,1,Oral bioavailability,,,CHEMBL623073,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10533,In vivo,6484,Intermediate,10116.0,,1,Oral bioavailability,,,CHEMBL623074,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10534,In vivo,6485,Intermediate,10116.0,,1,Oral bioavailability,,,CHEMBL623075,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10535,In vivo,6616,Intermediate,10116.0,,1,Oral bioavailability after i.v. administration,,,CHEMBL623076,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10536,In vivo,4969,Intermediate,10116.0,,1,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),,,CHEMBL623077,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10537,In vivo,5862,Intermediate,10116.0,,1,Oral bioavailability in rat (Sprague-Dawley),,,CHEMBL623078,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10538,In vivo,4514,Intermediate,10116.0,,1,Oral bioavailability in Sprague-Dawley rats,,,CHEMBL623079,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10539,In vivo,4514,Intermediate,10116.0,,1,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),,,CHEMBL623080,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10540,In vivo,4514,Intermediate,10116.0,,1,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),,,CHEMBL623081,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10541,In vivo,5546,Intermediate,10116.0,,1,Oral bioavailability in Sprague-Dawley rats at a dose of 2 mg/kg by po administration,,,CHEMBL623082,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10542,In vivo,6168,Intermediate,10116.0,,1,Oral bioavailability in fasted rat,,,CHEMBL874400,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10543,In vivo,6168,Intermediate,10116.0,,1,Oral bioavailability in fed rat,,,CHEMBL623083,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10544,In vivo,3624,Intermediate,10116.0,,1,Oral bioavailability in rat,,,CHEMBL623084,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10545,In vivo,5213,Intermediate,10116.0,,1,Oral bioavailability in rat,,,CHEMBL623085,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10546,In vivo,5496,Intermediate,10116.0,,1,Oral bioavailability in rat,,,CHEMBL623086,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10547,In vivo,5553,Intermediate,10116.0,,1,Oral bioavailability in rat,,,CHEMBL623087,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10548,In vivo,5833,Intermediate,10116.0,,1,Oral bioavailability in rat,,,CHEMBL623088,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10549,In vivo,5836,Intermediate,10116.0,,1,Oral bioavailability in rat,,,CHEMBL623089,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10550,In vivo,5865,Intermediate,10116.0,,1,Oral bioavailability in rat,,,CHEMBL623090,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10551,In vivo,5960,Intermediate,10116.0,,1,Oral bioavailability in rat,,,CHEMBL623091,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10552,In vivo,6249,Intermediate,10116.0,,1,Oral bioavailability in rat,,,CHEMBL623092,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10553,In vivo,6448,Intermediate,10116.0,,1,Oral bioavailability in rat,,,CHEMBL623093,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10554,In vivo,6453,Intermediate,10116.0,,1,Oral bioavailability in rat,,,CHEMBL874401,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10555,In vivo,6640,Intermediate,10116.0,,1,Oral bioavailability in rat,,,CHEMBL623094,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10556,In vivo,17607,Intermediate,10116.0,,1,Oral bioavailability in rat,,,CHEMBL623095,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10557,In vivo,5939,Intermediate,10116.0,,1,Oral bioavailability in rat after peroral administration at 10 mg/kg,,,CHEMBL623096,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10558,In vivo,5939,Intermediate,10116.0,,1,Oral bioavailability in rat after peroral administration at 5 mg/kg,,,CHEMBL624913,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10559,In vivo,6281,Intermediate,10116.0,,1,Oral bioavailability in rat (dose 2.8 mg/kg p.o.),,,CHEMBL624914,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10560,In vivo,5874,Intermediate,10116.0,,1,Oral bioavailability in rat by po administration at a dose of 40 mg/kg,,,CHEMBL624915,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10561,In vivo,5213,Intermediate,10116.0,,1,Oral bioavailability in rat; Not measured,,,CHEMBL624916,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10562,In vivo,4964,Intermediate,10116.0,,1,Oral bioavailability in rat,,,CHEMBL624917,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10563,,11020,Intermediate,10116.0,,1,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus NE,,,CHEMBL625157,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10564,,6251,Intermediate,10116.0,,1,In vitro metabolic potential in rat liver microsomes,,,CHEMBL625158,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
10565,In vivo,1568,Intermediate,10116.0,,1,"Oral availability was tested for plasma levels at a dose of 40 mg/kg, after 6 hr of in fed fisher rats.",,,CHEMBL625159,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10566,In vivo,3032,Intermediate,10116.0,,1,"In vivo percentage mean absolute bioavailability of compound in rat after an oral dose of 10 mg/kg (in water, N=4)",,,CHEMBL625160,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10567,In vivo,3748,Intermediate,10116.0,,1,Oral bioavailability of intravenously administered compound (3 mg/kg) was tested in rats,,,CHEMBL625161,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10568,In vivo,401,Intermediate,10116.0,,1,Oral bioavailability in rat,,,CHEMBL625162,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10569,In vivo,6512,Intermediate,10116.0,,1,Oral bioavailability in rat,,,CHEMBL625163,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10570,In vivo,17617,Intermediate,10116.0,,1,Oral bioavailability in rats at 10 mg/kg,,,CHEMBL625164,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10571,In vivo,6679,Intermediate,10116.0,,1,Oral bioavailability was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,,,CHEMBL625165,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10572,In vivo,6742,Intermediate,10116.0,,1,Oral bioavailability in rat,,,CHEMBL625166,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10573,,589,Intermediate,10116.0,,1,Tested for effective permeability across the rat intestinal membrane using mass balance analysis,,,CHEMBL625167,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10574,,589,Intermediate,10116.0,,1,Tested for effective permeability across the rat intestinal membrane using mass balance analysis at 0.01 mM concentration,,,CHEMBL625168,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10575,In vivo,3185,Intermediate,10116.0,,1,Plasma clearance of the compound,,,CHEMBL625169,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10576,In vivo,17596,Intermediate,10116.0,,1,Plasma clearance at 10 mg/kg in rat upon intravenous administration,,,CHEMBL626264,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10577,In vivo,2713,Intermediate,10116.0,,1,Plasma clearance upon intravenous administration of 1 mg/Kg in rats,,,CHEMBL626265,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10578,In vivo,12500,Intermediate,10116.0,,1,The compound was tested for plasma clearance in rat,,,CHEMBL626266,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
10579,In vivo,12500,Intermediate,10116.0,,1,The compound was tested for plasma clearance in rat at dose of 3-10 mgkg,,,CHEMBL626267,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
10580,,2713,Intermediate,10116.0,,1,Plasma concentration upon oral administration of 1 mg/Kg in rats,,,CHEMBL626268,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10581,,1446,Intermediate,10116.0,,1,Peak plasma level between 0.5 and 1.0 hour in Dawley rats; value ranges from 1021-2551,,,CHEMBL626269,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10582,,6227,Intermediate,10116.0,,1,Plasma level after intravenous administration in rat model of FeCl3-induced carotid thrombosis,,,CHEMBL626270,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10583,,4709,Intermediate,10116.0,,1,Plasma protein binding was determined after intravenous administration of 1 mg/kg in rat,,,CHEMBL626271,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10584,,5510,Intermediate,10116.0,,1,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1",,,CHEMBL626272,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10585,,5510,Intermediate,10116.0,,1,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1; Not determined",,,CHEMBL626273,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10586,,5510,Intermediate,10116.0,,1,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1; Not determined",,,CHEMBL875346,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10587,,5510,Intermediate,10116.0,,1,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1; Not stable",,,CHEMBL626274,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10588,,4514,Intermediate,10116.0,,1,Compound was tested for protein binding in rat plasma,,,CHEMBL626275,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10589,,2713,Intermediate,10116.0,,1,Compound was evaluated for absorption of radioligand following oral administration to bile duct cannulated rat. ,,,CHEMBL624646,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10590,,2713,Intermediate,10116.0,,1,Compound was evaluated for absorption of radioligand upon oral administration to bile duct cannulated rats,,,CHEMBL624647,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10591,,5340,Intermediate,10116.0,,1,In vitro metabolism in rat liver microsomes was evaluated to determine diminishing of glucuronidation rate,,,CHEMBL624648,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
10592,,12058,Intermediate,10116.0,,1,Area under curve ratio was determined (po/iv) in rat,,,CHEMBL624649,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10593,,11195,Intermediate,10116.0,,1,Blood by brain ratio of the radiolabeled compound (2-5 uCi) in rat 15 mins after i.v. administration,,,CHEMBL624650,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10594,,11195,Intermediate,10116.0,,1,Blood by brain ratio of the radiolabeled compound (2-5 uCi) in rat 2 mins after i.v. administration,,,CHEMBL624651,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10595,,11195,Intermediate,10116.0,,1,Blood by brain ratio of the radiolabeled compound (2-5 uCi) in rat 65 mins after i.v. administration,,,CHEMBL624652,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10596,,6495,Intermediate,10116.0,,1,Compound was tested for brain/plasma ratio after oral administration at 10 mg/kg,,,CHEMBL624653,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10597,,6078,Intermediate,10116.0,,1,Ratio of AUCbrain to AUCplasma,,,CHEMBL624654,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10598,,5656,Intermediate,10116.0,,1,Ratio of brain to plasma,,,CHEMBL624655,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10599,,4910,Intermediate,10116.0,,1,Ratio of the AUC values of brain and plasma after intravenous administration (4.7 mg/kg) to male rats was evaluated,,,CHEMBL624656,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10600,,4910,Intermediate,10116.0,,1,Ratio in brain and plasma after 0.25 hrs of intravenous administration (5 mg/kg) to male rats was evaluated,,,CHEMBL624657,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10601,,4910,Intermediate,10116.0,,1,Ratio in brain and plasma after 2 hrs of intravenous administration (5 mg/kg) to male rats was evaluated,,,CHEMBL624658,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10602,,10130,Intermediate,10116.0,,1,Selectivity ratio for biodistribution in brain and blood of rats after 15 minutes; Expressed as percent dose/gram ratio,,,CHEMBL624659,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10603,,10130,Intermediate,10116.0,,1,Selectivity ratio for biodistribution in brain and blood of rats after 2 minutes; Expressed as percent dose/gram ratio,,,CHEMBL624660,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10604,,10130,Intermediate,10116.0,,1,Selectivity ratio for biodistribution in brain and blood of rats after 60 minutes; Expressed as percent dose/gram ratio,,,CHEMBL624661,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10605,,5213,Intermediate,10116.0,,1,Steady state brain :blood ratio was determined,,,CHEMBL624662,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10606,,4910,Intermediate,10116.0,,1,Tested for ratio in brain and plasma after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,,,CHEMBL625199,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10607,,4910,Intermediate,10116.0,,1,Tested for ratio in brain and plasma after 0.25 hrs of intravenous administration (5 mg/kg) to male rats; ND = not determined,,,CHEMBL625200,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10608,,4910,Intermediate,10116.0,,1,Tested for ratio in brain and plasma after 2 hrs of intravenous administration (5 mg/kg) to male rats,,,CHEMBL625201,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10609,,4910,Intermediate,10116.0,,1,Tested for ratio in brain and plasma after 2 hrs of intravenous administration (5 mg/kg) to male rats; ND = not determined,,,CHEMBL625202,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10610,,2083,Intermediate,10116.0,,1,Percentage recovery after 3h incubation with rat hapatocytes was determined,,,CHEMBL625203,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10611,,2082,Intermediate,10116.0,,1,Percentage recovery in rat hepatic microsomal fractions under oxidative conditions after 1 hour,,,CHEMBL625204,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10612,,2082,Intermediate,10116.0,,1,Percentage recovery in rhesus monkey hepatic microsomal fractions under oxidative conditions after 1 hour,,,CHEMBL625205,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10613,,6351,Intermediate,10116.0,,1,Recovery rate from urine and bile was determined after iv administration at 20 mg/kg in rats,,,CHEMBL625206,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10614,,14583,Autocuration,,,1,"Fraction of 88Y (%) released from chelate after incubation in serum for 15 hours; not measured, No site available for protein conjugation.",,,CHEMBL625207,,22224,,,,U,0,BAO_0000019,
10615,,14583,Autocuration,,,1,Fraction of 88Y (%) released from chelate after incubation in serum for 15 hours; not measured.,,,CHEMBL625208,,22224,,,,U,0,BAO_0000019,
10616,,4608,Intermediate,9606.0,,1,In vivo absorption in Caco-2 cell line monolayers was determined,495.0,,CHEMBL625209,,50587,Homo sapiens,Caco-2,,N,1,BAO_0000218,
10617,,13668,Autocuration,,,1,Calculated partition coefficient (clogP),,,CHEMBL625210,,22229,,,,U,0,BAO_0000100,
10618,,5669,Intermediate,10116.0,,1,Area under curve was determine after peroral administration at 10 mpk in Rat,,,CHEMBL625211,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10619,,5669,Intermediate,9544.0,,1,Area under curve was determine after peroral administration at 10 mpk in Rhesus,,,CHEMBL625212,,50797,Macaca mulatta,,,N,1,BAO_0000218,
10620,,5669,Intermediate,10116.0,,1,Area under curve was determine after peroral administration at 160 mpk in Rat,,,CHEMBL625213,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10621,,5669,Intermediate,10116.0,,1,Area under curve was determine after peroral administration at 20 mpk in Rat,,,CHEMBL625214,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10622,,5669,Intermediate,10116.0,,1,Area under curve was determine after peroral administration at 50 mpk in Rat,,,CHEMBL874542,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10623,,6472,Autocuration,,,1,Calculated partition coefficient (clogP) (AlogP),,,CHEMBL625215,,22229,,,,U,0,BAO_0000100,
10624,,15106,Autocuration,,,1,Activated partial thromboplastin time measured,,,CHEMBL625216,,22224,,,,U,0,BAO_0000019,
10625,,15207,Autocuration,,,1,Compound was evaluated for the aqueous solubility (AS) in mg/mL (Measured in 0.2 M phosphate buffer of pH 7.4),,,CHEMBL625217,,22224,,,,U,0,BAO_0000100,
10626,,15207,Autocuration,,,1,Compound was evaluated for the aqueous solubility (AS) in mg/mL (Measured in 0.2 M phosphate buffer of pH 7.4); ND=Not determined (AS mg/mL),,,CHEMBL625218,,22224,,,,U,0,BAO_0000100,
10627,,13941,Intermediate,9615.0,,1,AUC (Area under curve) was determined after intravenous administration at a dose 1 mg/kg in dog,,,CHEMBL622864,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,1969.0
10628,,13941,Intermediate,10116.0,,1,AUC (Area under curve) was determined after intravenous administration at a dose 2 mg/kg in rat.,,,CHEMBL622865,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
10629,,13941,Intermediate,10116.0,,1,AUC (Area under curve) was determined after peroral administration at a dose 10 mg/kg in rat.,,,CHEMBL622866,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
10630,,13941,Intermediate,9615.0,,1,AUC (Area under curve) was determined after peroral administration at a dose 5 mg/kg in dog,,,CHEMBL622867,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,1969.0
10631,,15240,Intermediate,10141.0,,1,AUC (ng h/mL) value after oral administration of 10 mg/kg in guinea pig.,,,CHEMBL876808,,50512,Cavia porcellus,,,N,1,BAO_0000218,1969.0
10632,,10655,Autocuration,,,1,AUC in brain,,,CHEMBL627725,,22224,,,,U,0,BAO_0000019,955.0
10633,,10655,Autocuration,,,1,AUC in serum,,,CHEMBL627726,,22224,,,,U,0,BAO_0000019,1977.0
10634,,6504,Autocuration,,,1,AUC was determined,,,CHEMBL627727,,22224,,,,U,0,BAO_0000019,1969.0
10635,,10615,Autocuration,,,1,AUC of the compound.,,,CHEMBL627728,,22224,,,,U,0,BAO_0000019,1969.0
10636,,10353,Autocuration,,,1,AUC value (0-4 hr),,,CHEMBL627729,,22224,,,,U,0,BAO_0000019,1969.0
10637,,14907,Autocuration,,,1,"AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 150 uMol/kg,",,,CHEMBL627730,,22224,,,,U,0,BAO_0000019,1969.0
10638,,14907,Autocuration,,,1,AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 300 uMol/kg,,,CHEMBL627731,,22224,,,,U,0,BAO_0000019,1969.0
10639,,14907,Autocuration,,,1,"AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 300 uMol/kg,",,,CHEMBL627732,,22224,,,,U,0,BAO_0000019,1969.0
10640,,14907,Autocuration,,,1,"AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 700 uMol/kg,",,,CHEMBL627733,,22224,,,,U,0,BAO_0000019,1969.0
10641,,16359,Intermediate,10116.0,,1,AUC(area under curve) was determined after intravenous administration in rats,,,CHEMBL627734,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
10642,,16359,Intermediate,10116.0,,1,AUC(area under curve) was determined after oral administration in rats,,,CHEMBL627735,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
10643,,15240,Intermediate,10141.0,,1,AUC(ng h/mL)values after oral administration of 10 mg/kg in guinea pig.,,,CHEMBL627736,,50512,Cavia porcellus,,,N,1,BAO_0000218,1969.0
10644,,15240,Intermediate,10116.0,,1,AUC(ng h/mL)values after oral administration of 10 mg/kg in rat.,,,CHEMBL876809,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
10645,,15469,Autocuration,,,1,Area Under Curve after oral dosing of 100 uM/Kg,,,CHEMBL627737,,22224,,,,U,0,BAO_0000019,
10646,,15469,Autocuration,,,1,Area Under Curve after oral dosing of 30 uM/Kg,,,CHEMBL627738,,22224,,,,U,0,BAO_0000019,
10647,,13520,Autocuration,,,1,Area Under Curve was measured by ploting the graph between concentration verses time,,,CHEMBL627739,,22224,,,,U,0,BAO_0000019,
10648,,17025,Intermediate,9615.0,,1,Area under concentration-time curve of compound was determined in dog at 25 mg/kg orally,,,CHEMBL626143,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
10649,,17025,Autocuration,314293.0,,1,Area under concentration-time curve of compound was determined in monkey at 25 mg/kg orally,,,CHEMBL626144,,22224,Simiiformes,,,U,0,BAO_0000218,
10650,,17025,Intermediate,9986.0,,1,Area under concentration-time curve of compound was determined in rabbit at 25 mg/kg orally,,,CHEMBL626145,,50592,Oryctolagus cuniculus,,,N,1,BAO_0000218,
10651,,17025,Intermediate,10116.0,,1,Area under concentration-time curve of compound was determined in rat at 25 mg/kg orally,,,CHEMBL626146,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10652,,12032,Intermediate,10116.0,,1,Area under curve (AUC) is the drug concentrations in blood samples of rats with arterial catheters at 5 min and 12 hr plotted against time,,,CHEMBL626147,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
10653,,10291,Autocuration,,,1,Area under curve (AUC) was determined,,,CHEMBL626148,,22224,,,,U,0,BAO_0000019,
10654,,5767,Autocuration,,,1,Area under curve (AUC) following ip administration at 1 mg/kg,,,CHEMBL626149,,22224,,,,U,0,BAO_0000218,
10655,,1434,Autocuration,,,1,Area under curve (AUC) was determined; ND is Not determined,,,CHEMBL626150,,22224,,,,U,0,BAO_0000019,
10656,,14925,Intermediate,9615.0,,1,Area under curve (AUC) was determined in dogs fed after intravenous administration of 25 mg/kg of the compound,,,CHEMBL626151,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
10657,,14925,Intermediate,9615.0,,1,Area under curve (AUC) was determined in dogs fed after oral administration of 25 mg/kg of the compound,,,CHEMBL626152,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
10658,,14925,Intermediate,9615.0,,1,Area under curve (AUC) was determined in fasted dogs after oral administration of 25 mg/kg of the compound,,,CHEMBL626153,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
10659,,1434,Autocuration,,,1,Area under curve (AUR) was determined,,,CHEMBL626154,,22224,,,,U,0,BAO_0000019,
10660,,11883,Autocuration,,,1,Area under curve at 1 uM/dg administered intravenously,,,CHEMBL626155,,22224,,,,U,0,BAO_0000019,
10661,,11883,Autocuration,,,1,Area under curve at 10 uM/dg administered perorally,,,CHEMBL626156,,22224,,,,U,0,BAO_0000019,
10662,,11883,Autocuration,,,1,Area under curve at 2 uM/dg administered intravenously,,,CHEMBL626157,,22224,,,,U,0,BAO_0000019,
10663,,11883,Autocuration,,,1,Area under curve at 20 uM/dg administered perorally,,,CHEMBL626158,,22224,,,,U,0,BAO_0000019,
10664,,15233,Intermediate,9615.0,,1,Area under curve at a peroral dose of 3 mg/kg in dog,,,CHEMBL626159,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
10665,,15233,Intermediate,10116.0,,1,Area under curve at a peroral dose of 3 mg/kg in rat,,,CHEMBL626160,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10666,,15233,Intermediate,9615.0,,1,Area under curve at an iv dose of 1 mg/kg in dog,,,CHEMBL626161,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
10667,,15233,Intermediate,10116.0,,1,Area under curve at an iv dose of 1 mg/kg in rat,,,CHEMBL626162,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10668,,12978,Autocuration,,,1,Area under curve gives the effective duration for the angiotensin II antagonist effect of the compound.,,,CHEMBL626163,,22224,,,,U,0,BAO_0000019,
10669,,12978,Autocuration,,,1,Area under curve gives the effective duration for the angiotensin II antagonist effect.,,,CHEMBL626164,,22224,,,,U,0,BAO_0000019,
10670,,11355,Intermediate,10090.0,,1,Area under curve measured as conc vs time after intravenous administration to mice.,,,CHEMBL626165,,50594,Mus musculus,,,N,1,BAO_0000218,
10671,,11355,Intermediate,10090.0,,1,Area under curve measured as conc vs time after peroral administration to mice.,,,CHEMBL626166,,50594,Mus musculus,,,N,1,BAO_0000218,
10672,,12923,Intermediate,9615.0,,1,Area under curve of acid 2a was determined by HPLC at a dosage of 2.27 mg/kg administered intravenously by bolus method in dog,,,CHEMBL626167,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
10673,,12923,Intermediate,9615.0,,1,Area under curve of acid 2a was determined by HPLC at a dosage of 5.45 mg/kg administered intragastrically by capsule method in dog,,,CHEMBL626168,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
10674,,12923,Intermediate,9615.0,,1,Area under curve of acid 2a was determined by HPLC at a dosage of 5.45 mg/kg administered intragastrically by gavage method in dog,,,CHEMBL877463,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
10675,,12923,Intermediate,9615.0,,1,Area under curve of acid 2a was determined by HPLC at a dosage of 54.5 mg/kg administered intragastrically by capsule method in dog,,,CHEMBL626169,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
10676,In vivo,17738,Intermediate,10116.0,,1,Biodistribution of radiolabeled compound in rat heart after 24 hr activity expressed as %ID/Organ,,,CHEMBL626170,,50597,Rattus norvegicus,,,N,1,BAO_0000218,948.0
10677,In vivo,17738,Intermediate,10116.0,,1,Biodistribution of radiolabeled compound in rat heart after 2 hr activity expressed as %ID/Organ,,,CHEMBL626171,,50597,Rattus norvegicus,,,N,1,BAO_0000218,948.0
10678,In vivo,17738,Intermediate,10116.0,,1,Biodistribution of radiolabeled compound in rat heart after 30 min activity expressed as %ID/Organ,,,CHEMBL626172,,50597,Rattus norvegicus,,,N,1,BAO_0000218,948.0
10679,In vivo,17738,Intermediate,10116.0,,1,Biodistribution of radiolabeled compound in rat heart after 5 min activity expressed as %ID/Organ,,,CHEMBL626173,,50597,Rattus norvegicus,,,N,1,BAO_0000218,948.0
10680,In vivo,17738,Intermediate,10116.0,,1,Biodistribution of radiolabeled compound in rat kidney after 24 hr postinjection activity expressed as %ID/Organ,,,CHEMBL626174,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2113.0
10681,In vivo,17738,Intermediate,10116.0,,1,Biodistribution of radiolabeled compound in rat kidney after 24 hr activity expressed as %ID/Organ,,,CHEMBL626175,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2113.0
10682,In vivo,17738,Intermediate,10116.0,,1,Biodistribution of radiolabeled compound in rat kidney after 2 hr activity expressed as %ID/Organ,,,CHEMBL626176,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2113.0
10683,In vivo,17738,Intermediate,10116.0,,1,Biodistribution of radiolabeled compound in rat kidney after 30 min activity expressed as %ID/Organ,,,CHEMBL626177,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2113.0
10684,In vivo,17738,Intermediate,10116.0,,1,Biodistribution of radiolabeled compound in rat kidney after 5 min activity expressed as %ID/Organ,,,CHEMBL622499,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2113.0
10685,In vivo,17738,Intermediate,10116.0,,1,Biodistribution of radiolabeled compound in rat liver after 24 hr postinjection activity expressed as %ID/Organ,,,CHEMBL622500,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
10686,In vivo,17738,Intermediate,10116.0,,1,Biodistribution of radiolabeled compound in rat liver after 24 hr activity expressed as %ID/Organ,,,CHEMBL622501,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
10687,In vivo,17738,Intermediate,10116.0,,1,Biodistribution of radiolabeled compound in rat liver after 2 hr activity expressed as %ID/Organ,,,CHEMBL622502,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
10688,In vivo,17738,Intermediate,10116.0,,1,Biodistribution of radiolabeled compound in rat liver after 30 min activity expressed as %ID/Organ,,,CHEMBL622503,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
10689,In vivo,17738,Intermediate,10116.0,,1,Biodistribution of radiolabeled compound in rat liver after 5 min activity expressed as %ID/Organ,,,CHEMBL877614,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
10690,In vivo,17738,Intermediate,10116.0,,1,Biodistribution of radiolabeled compound in rat lung after 24 hr activity expressed as %ID/Organ,,,CHEMBL624839,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2048.0
10691,In vivo,17738,Intermediate,10116.0,,1,Biodistribution of radiolabeled compound in rat lung after 2 hr activity expressed as %ID/Organ,,,CHEMBL624840,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2048.0
10692,In vivo,17738,Intermediate,10116.0,,1,Biodistribution of radiolabeled compound in rat lung after 30 min activity expressed as %ID/Organ,,,CHEMBL624841,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2048.0
10693,In vivo,17738,Intermediate,10116.0,,1,Biodistribution of radiolabeled compound in rat lung after 5 min activity expressed as %ID/Organ,,,CHEMBL624842,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2048.0
10694,In vivo,17738,Intermediate,10116.0,,1,Biodistribution of radiolabeled compound in rat muscle after 24 hr activity expressed as %ID/Organ,,,CHEMBL624843,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2385.0
10695,In vivo,17738,Intermediate,10116.0,,1,Biodistribution of radiolabeled compound in rat muscle after 2 hr activity expressed as %ID/Organ,,,CHEMBL624844,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2385.0
10696,In vivo,17738,Intermediate,10116.0,,1,Biodistribution of radiolabeled compound in rat muscle after 30 min activity expressed as %ID/Organ,,,CHEMBL624845,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2385.0
10697,In vivo,17738,Intermediate,10116.0,,1,Biodistribution of radiolabeled compound in rat muscle after 5 min activity expressed as %ID/Organ,,,CHEMBL621904,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2385.0
10698,In vivo,11195,Intermediate,10116.0,,1,Biodistribution of the radiolabeled compound (2-5 uCi) in rat blood 15 mins after i.v. administration,,,CHEMBL621905,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
10699,In vivo,11195,Intermediate,10116.0,,1,Biodistribution of the radiolabeled compound (2-5 uCi) in rat blood 2 mins after i.v. administration,,,CHEMBL874382,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
10700,In vivo,11195,Intermediate,10116.0,,1,Biodistribution of the radiolabeled compound (2-5 uCi) in rat blood 65 mins after i.v. administration,,,CHEMBL621906,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
10701,In vivo,11195,Intermediate,10116.0,,1,Biodistribution of the radiolabeled compound (2-5 uCi) in rat brain 15 mins after i.v. administration,,,CHEMBL621907,,50597,Rattus norvegicus,,,N,1,BAO_0000218,955.0
10702,In vivo,11195,Intermediate,10116.0,,1,Biodistribution of the radiolabeled compound (2-5 uCi) in rat brain 2 mins after i.v. administration,,,CHEMBL622096,,50597,Rattus norvegicus,,,N,1,BAO_0000218,955.0
10703,In vivo,11195,Intermediate,10116.0,,1,Biodistribution of the radiolabeled compound (2-5 uCi) in rat brain 65 mins after i.v. administration,,,CHEMBL622097,,50597,Rattus norvegicus,,,N,1,BAO_0000218,955.0
10704,In vivo,11195,Intermediate,10116.0,,1,Biodistribution of the radiolabeled compound (2-5 uCi) in rat heart 15 mins after i.v. administration,,,CHEMBL622098,,50597,Rattus norvegicus,,,N,1,BAO_0000218,948.0
10705,In vivo,11195,Intermediate,10116.0,,1,Biodistribution of the radiolabeled compound (2-5 uCi) in rat heart 2 mins after i.v. administration,,,CHEMBL622099,,50597,Rattus norvegicus,,,N,1,BAO_0000218,948.0
10706,In vivo,11195,Intermediate,10116.0,,1,Biodistribution of the radiolabeled compound (2-5 uCi) in rat heart 65 mins after i.v. administration,,,CHEMBL622100,,50597,Rattus norvegicus,,,N,1,BAO_0000218,948.0
10707,In vivo,11195,Intermediate,10116.0,,1,Biodistribution of the radiolabeled compound (2-5 uCi) in rat kidney 15 mins after i.v. administration,,,CHEMBL622101,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2113.0
10708,In vivo,11195,Intermediate,10116.0,,1,Biodistribution of the radiolabeled compound (2-5 uCi) in rat kidney 2 mins after i.v. administration,,,CHEMBL622102,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2113.0
10709,In vivo,11195,Intermediate,10116.0,,1,Biodistribution of the radiolabeled compound (2-5 uCi) in rat kidney 65 mins after i.v. administration,,,CHEMBL622103,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2113.0
10710,In vivo,11195,Intermediate,10116.0,,1,Biodistribution of the radiolabeled compound (2-5 uCi) in rat liver 15 mins after i.v. administration,,,CHEMBL622104,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
10711,In vivo,11195,Intermediate,10116.0,,1,Biodistribution of the radiolabeled compound (2-5 uCi) in rat liver 2 mins after i.v. administration,,,CHEMBL622105,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
10712,In vivo,11195,Intermediate,10116.0,,1,Biodistribution of the radiolabeled compound (2-5 uCi) in rat liver 65 mins after i.v. administration,,,CHEMBL622106,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
10713,In vivo,11195,Intermediate,10116.0,,1,Biodistribution of the radiolabeled compound (2-5 uCi) in rat lung 15 mins after i.v. administration,,,CHEMBL622107,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2048.0
10714,In vivo,11195,Intermediate,10116.0,,1,Biodistribution of the radiolabeled compound (2-5 uCi) in rat lung 2 mins after i.v. administration,,,CHEMBL622108,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2048.0
10715,In vivo,11195,Intermediate,10116.0,,1,Biodistribution of the radiolabeled compound (2-5 uCi) in rat lung 65 mins after i.v. administration,,,CHEMBL622109,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2048.0
10716,In vivo,11195,Intermediate,10116.0,,1,Biodistribution of the radiolabeled compound (2-5 uCi) in rat muscle 15 mins after i.v. administration,,,CHEMBL622110,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2385.0
10717,In vivo,11195,Intermediate,10116.0,,1,Biodistribution of the radiolabeled compound (2-5 uCi) in rat muscle 2 mins after i.v. administration,,,CHEMBL622111,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2385.0
10718,In vivo,11195,Intermediate,10116.0,,1,Biodistribution of the radiolabeled compound (2-5 uCi) in rat muscle 65 mins after i.v. administration,,,CHEMBL874383,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2385.0
10719,In vivo,11195,Intermediate,10116.0,,1,Biodistribution of the radiolabeled compound (2-5 uCi) in rat skin 15 mins after i.v. administration,,,CHEMBL622112,,50597,Rattus norvegicus,,,N,1,BAO_0000218,14.0
10720,In vivo,11195,Intermediate,10116.0,,1,Biodistribution of the radiolabeled compound (2-5 uCi) in rat skin 2 mins after i.v. administration,,,CHEMBL622113,,50597,Rattus norvegicus,,,N,1,BAO_0000218,14.0
10721,In vivo,11195,Intermediate,10116.0,,1,Biodistribution of the radiolabeled compound (2-5 uCi) in rat skin 65 mins after i.v. administration,,,CHEMBL622114,,50597,Rattus norvegicus,,,N,1,BAO_0000218,14.0
10722,In vivo,11195,Intermediate,10116.0,,1,Biodistribution of the radiolabeled compound (2-5 uCi) in rat spleen 15 mins after i.v. administration,,,CHEMBL622115,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2106.0
10723,In vivo,11195,Intermediate,10116.0,,1,Biodistribution of the radiolabeled compound (2-5 uCi) in rat spleen 2 mins after i.v. administration,,,CHEMBL622116,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2106.0
10724,In vivo,6193,Intermediate,10116.0,,1,Oral bioavailability in rat,,,CHEMBL622117,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10725,In vivo,6803,Intermediate,10116.0,,1,Oral bioavailability in rat,,,CHEMBL622118,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10726,In vivo,6647,Intermediate,10116.0,,1,Oral bioavailability in rats at 6 mg/kg,,,CHEMBL622119,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10727,In vivo,6647,Intermediate,10116.0,,1,Oral bioavailability in rat (dose 6 mg/kg),,,CHEMBL622120,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10728,In vivo,6647,Intermediate,10116.0,,1,Oral bioavailability in rats at 6 mg/kg dose; Not tested,,,CHEMBL622121,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10729,In vivo,6640,Intermediate,10116.0,,1,Oral bioavailability in rat,,,CHEMBL622122,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10730,In vivo,6641,Intermediate,10116.0,,1,Oral bioavailability in rat,,,CHEMBL622123,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10731,In vivo,6641,Intermediate,10116.0,,1,Oral bioavailability in rat,,,CHEMBL622124,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10732,In vivo,6642,Intermediate,10116.0,,1,Bioavailability in rat,,,CHEMBL622125,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10733,In vivo,5472,Intermediate,10116.0,,1,Oral bioavailability,,,CHEMBL622126,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10734,In vivo,6141,Intermediate,10116.0,,1,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),,,CHEMBL620455,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10735,In vivo,4390,Intermediate,10116.0,,1,Oral bioavailability in rat,,,CHEMBL620456,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10736,In vivo,5472,Intermediate,10116.0,,1,Oral bioavailability in rat,,,CHEMBL620457,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10737,In vivo,5472,Intermediate,10116.0,,1,Oral bioavailability was evaluated; Not tested,,,CHEMBL620458,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10738,In vivo,5438,Intermediate,10116.0,,1,Oral bioavailability,,,CHEMBL620459,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10739,In vivo,4883,Intermediate,10116.0,,1,Oral bioavailability in rat by oral dosing,,,CHEMBL620460,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10740,In vivo,1908,Intermediate,10116.0,,1,Oral bioavailability in rat (dose 10 mg/kg p.o.),,,CHEMBL620461,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10741,In vivo,4853,Intermediate,10116.0,,1,Oral bioavailability in rat (Sprague-Dawley),,,CHEMBL620462,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10742,In vivo,4853,Intermediate,10116.0,,1,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),,,CHEMBL620463,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10743,In vivo,4853,Intermediate,10116.0,,1,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),,,CHEMBL620464,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10744,In vivo,4853,Intermediate,10116.0,,1,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),,,CHEMBL620465,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10745,In vivo,4853,Intermediate,10116.0,,1,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg p.o.),,,CHEMBL620466,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10746,In vivo,4853,Intermediate,10116.0,,1,Oral bioavailability was calculated in Spragun Dawley rat at oral dosage of 1 mg/kg,,,CHEMBL620467,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10747,In vivo,4853,Intermediate,10116.0,,1,Oral bioavailability was calculated in Spragun Dawley rat at oral dosage of 2 mg/kg,,,CHEMBL620468,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10748,In vivo,12873,Intermediate,10116.0,,1,Oral bioavailability was calculated in rats using an average of the intravenous AUC at peroral dose of 5 mgkg in solution form,,,CHEMBL620469,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10749,In vivo,12873,Intermediate,10116.0,,1,Oral bioavailability was calculated in rats using an average of the intravenous AUC at peroral dose of 5 mgkg in suspension form,,,CHEMBL620470,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10750,In vivo,3169,Intermediate,10116.0,,1,Oral bioavailability in rat,,,CHEMBL620471,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10751,In vivo,6305,Intermediate,10116.0,,1,Oral bioavailability in rat,,,CHEMBL620472,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10752,In vivo,4762,Intermediate,10116.0,,1,Oral bioavailability of compound at 5 mg/kg after po administration was determined in rat,,,CHEMBL620473,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10753,In vivo,17847,Intermediate,10116.0,,1,Oral bioavailability in rat,,,CHEMBL620474,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10754,In vivo,6211,Intermediate,10116.0,,1,Oral bioavailability in rat (Sprague-Dawley) (fasted male) (dose 10 mg/kg),,,CHEMBL620475,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10755,In vivo,6011,Intermediate,10116.0,,1,Oral bioavailability in rat,,,CHEMBL620476,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10756,In vivo,6317,Intermediate,10116.0,,1,Oral bioavailability in rat,,,CHEMBL620477,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10757,In vivo,6644,Intermediate,10116.0,,1,Oral bioavailability in rat after oral administration at 10.5 mg/kg dose,,,CHEMBL620478,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10758,In vivo,6644,Intermediate,10116.0,,1,Oral bioavailability in rat after oral administration at 11.2 mg/kg dose,,,CHEMBL618768,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10759,In vivo,6644,Intermediate,10116.0,,1,Oral bioavailability in rat after oral administration at 13 mg/kg dose,,,CHEMBL618769,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10760,In vivo,6644,Intermediate,10116.0,,1,Oral bioavailability in rat after oral administration at 9.7 mg/kg dose,,,CHEMBL618770,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10761,In vivo,6113,Intermediate,10116.0,,1,Oral bioavailability (dose 20 mg/kg p.o.),,,CHEMBL618771,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10762,In vivo,5937,Intermediate,10116.0,,1,Oral bioavailability was determined in rat after oral administration at a concentration 1 mg/kg,,,CHEMBL618772,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10763,In vivo,5711,Intermediate,10116.0,,1,Oral bioavailability in rat at 10 mg/kg of the compound,,,CHEMBL618773,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10764,In vivo,17717,Intermediate,10116.0,,1,Bioavailability in rat at a concentration of 15 mg/kg perorally in rat along with 100 mg/kg 11,,,CHEMBL875842,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10765,In vivo,17717,Intermediate,10116.0,,1,Bioavailability in rat (dose 3 mg/kg i.v.),,,CHEMBL618774,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10766,In vivo,17717,Intermediate,10116.0,,1,Bioavailability in rat at a concentration of 60 mg/kg perorally in rat along with 100 mg/kg 11,,,CHEMBL618775,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10767,In vivo,17717,Intermediate,10116.0,,1,Oral bioavailability in rat (dose 60 mg/kg p.o.),,,CHEMBL618776,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10768,In vivo,4722,Intermediate,10116.0,,1,Percent bioavailability (F) in rats after iv administration,,,CHEMBL618777,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10769,In vivo,4722,Intermediate,10116.0,,1,Percent bioavailability (F) in rats after oral dose of 10 mg/kg,,,CHEMBL618778,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10770,In vivo,4353,Intermediate,10116.0,,1,Bioavailability in rat (dose 5 uM/kg p.o.),,,CHEMBL618779,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10771,In vivo,15662,Intermediate,10116.0,,1,Oral bioavailability,,,CHEMBL618780,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10772,In vivo,4756,Intermediate,10116.0,,1,Bioavailability in rat (dose 2 mg/kg p.o.),,,CHEMBL618781,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10773,In vivo,4756,Intermediate,10116.0,,1,Percent bioavailability at the dose of 5 mg/Kg administered perorally in rats,,,CHEMBL618782,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10774,In vivo,3436,Intermediate,10116.0,,1,Oral bioavailability in rat (dose 20 mg/kg),,,CHEMBL618783,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10775,In vivo,17800,Intermediate,10116.0,,1,Oral bioavailability in rat,,,CHEMBL618784,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10776,In vivo,15762,Intermediate,10116.0,,1,Percent oral bioavailability evaluated in rat,,,CHEMBL618785,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10777,In vivo,5089,Intermediate,10116.0,,1,Oral bioavailability in rat,,,CHEMBL618786,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10778,In vivo,5089,Intermediate,10116.0,,1,Percent oral bioavailability in rat; Not determined,,,CHEMBL618787,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10779,In vivo,3185,Intermediate,10116.0,,1,Oral bioavailability in rat,,,CHEMBL618788,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10780,In vivo,5145,Intermediate,10116.0,,1,Bioavailability in rat,,,CHEMBL618789,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10781,In vivo,3457,Intermediate,10116.0,,1,Pharmacokinetic property (oral bioavailability) in rat (dose given as a solution),,,CHEMBL618790,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10782,In vivo,3457,Intermediate,10116.0,,1,Pharmacokinetic property (oral bioavailability) in rat (dose given as a suspension),,,CHEMBL618791,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10783,In vivo,5983,Intermediate,10116.0,,1,Pharmacokinetic property (F) was measured in rat at the dose of 0.32 mg/kg,,,CHEMBL875843,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10784,In vivo,5739,Intermediate,10116.0,,1,Oral bioavailability in rat (dose 20 mg/kg p.o.),,,CHEMBL618792,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10785,In vivo,3579,Intermediate,10116.0,,1,Cmax at a dose of 30 mg/kg in rat,,,CHEMBL623395,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10786,In vivo,17788,Autocuration,314293.0,,1,Cmax in monkeys at a dose of 1 mg/kg,,,CHEMBL623396,,22224,Simiiformes,,,U,0,BAO_0000218,
10787,In vivo,14956,Intermediate,10116.0,,1,Cmax in rat,,,CHEMBL623397,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10788,In vivo,17788,Intermediate,10116.0,,1,Cmax in rats at a dose of 1 mg/kg,,,CHEMBL623398,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10789,In vivo,9750,Intermediate,10090.0,,1,Cmax was measured in mice after an oral dose of 50 mg/kg.,,,CHEMBL623399,,50594,Mus musculus,,,N,1,BAO_0000218,
10790,In vivo,12767,Autocuration,,,1,"Cmax value at a dose of 12.7 uM/kg, po",,,CHEMBL623400,,22224,,,,U,0,BAO_0000218,
10791,In vivo,12767,Autocuration,,,1,"Cmax value at a dose of 6.3 uM/kg, iv",,,CHEMBL623401,,22224,,,,U,0,BAO_0000218,
10792,In vivo,12767,Autocuration,,,1,"Cmax value at a dose of 7.1 uM/kg, iv",,,CHEMBL623402,,22224,,,,U,0,BAO_0000218,
10793,In vivo,12703,Autocuration,,,1,Cmax value of compound was determined after 1 hr,,,CHEMBL623403,,22224,,,,U,0,BAO_0000218,
10794,In vivo,15778,Autocuration,,,1,Cmax value of the compound,,,CHEMBL623404,,22224,,,,U,0,BAO_0000218,
10795,In vivo,12818,Intermediate,10116.0,,1,Cmax value administered intraintestinal in rats.,,,CHEMBL625997,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10796,In vivo,14964,Intermediate,10116.0,,1,Cmax value administered perorally was determined in rat; Not determined,,,CHEMBL625998,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10797,In vivo,15808,Autocuration,,,1,Cmax value at the dose of 2.3 mg/kg,,,CHEMBL625999,,22224,,,,U,0,BAO_0000218,
10798,In vivo,15808,Autocuration,,,1,Cmax value at the dose of 5 mg/kg,,,CHEMBL626000,,22224,,,,U,0,BAO_0000218,
10799,In vivo,15778,Autocuration,,,1,Cmax value in the period of 8 hr after dosing. ,,,CHEMBL626001,,22224,,,,U,0,BAO_0000218,
10800,In vivo,3715,Autocuration,,,1,Cmax value at a oral dose of 20 mg/kg; Not tested,,,CHEMBL626002,,22224,,,,U,0,BAO_0000218,
10801,In vivo,3715,Autocuration,,,1,Cmax value at a oral dose of 20 mg/kg,,,CHEMBL626003,,22224,,,,U,0,BAO_0000218,
10802,In vivo,1446,Intermediate,10116.0,,1,Cmax value was determined between 15 and 30 minutes post administration in fisher rats; value ranges from 200-500,,,CHEMBL626004,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10803,In vivo,15240,Intermediate,10141.0,,1,Cmax(ng /mL)values after oral administration of 10 mg/kg in guinea pig.,,,CHEMBL626005,,50512,Cavia porcellus,,,N,1,BAO_0000218,
10804,In vivo,15240,Intermediate,10116.0,,1,Cmax(ng /mL)values after oral administration of 10 mg/kg in rat.,,,CHEMBL626006,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10805,In vivo,14810,Intermediate,10116.0,,1,Compound at a dose of 10 mg/kg was orally administered to rats and maximum plasma concentration was reported,,,CHEMBL626007,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
10806,In vivo,14239,Intermediate,10090.0,,1,Compound was evaluated for maximum plasma concentration by administering orally at 25 mg/kg in mice,,,CHEMBL626008,,50594,Mus musculus,,,N,1,BAO_0000218,1969.0
10807,In vivo,12555,Intermediate,9615.0,,1,Compound was evaluated for maximum plasma concentration levels in dogs for the orally delivered compound in 0.05 M citric acid,,,CHEMBL626009,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,2107.0
10808,In vivo,10754,Intermediate,9615.0,,1,Compound was evaluated in vivo for its concentration after a peroral administration 40 mg/kg in dogs.,,,CHEMBL626010,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
10809,In vivo,10754,Intermediate,10090.0,,1,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after a intramuscular administration 40 mg/kg in mice,,,CHEMBL626011,,50594,Mus musculus,,,N,1,BAO_0000218,178.0
10810,In vivo,10754,Intermediate,10090.0,,1,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after a peroral administration 40 mg/kg in mice,,,CHEMBL626012,,50594,Mus musculus,,,N,1,BAO_0000218,178.0
10811,In vivo,10754,Intermediate,10090.0,,1,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after a peroral administration of 40 mg/kg in mice,,,CHEMBL626013,,50594,Mus musculus,,,N,1,BAO_0000218,178.0
10812,In vivo,10754,Intermediate,10090.0,,1,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after an intramuscular administration of 40 mg/kg in mice,,,CHEMBL626014,,50594,Mus musculus,,,N,1,BAO_0000218,178.0
10813,In vivo,10754,Intermediate,10090.0,,1,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after an intramuscular administration of 40 mg/kg in mice.,,,CHEMBL877496,,50594,Mus musculus,,,N,1,BAO_0000218,178.0
10814,In vivo,14600,Intermediate,9615.0,,1,Compound was tested Growth Hormone(GH) release after 0.5 mg/kg administration (Po) in Beagle dogs,,,CHEMBL626015,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
10815,In vivo,14600,Intermediate,9615.0,,1,Compound was tested Growth Hormone(GH) release after 10 mg/kg administration (Po) in Beagle dogs,,,CHEMBL626016,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
10816,In vivo,14600,Intermediate,9615.0,,1,Compound was tested Growth Hormone(GH) release after 2.5 mg/kg administration (Po) in Beagle dogs,,,CHEMBL626017,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
10817,In vivo,13543,Intermediate,9615.0,,1,Bioavailability as maximal plasma concentration in dogs,,,CHEMBL626018,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,1969.0
10818,In vivo,13543,Intermediate,9615.0,,1,Bioavailability as maximal plasma concentration in dogs,,,CHEMBL626692,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,1969.0
10819,In vivo,13543,Intermediate,10116.0,,1,Bioavailability as maximal plasma concentration in rats,,,CHEMBL626693,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
10820,In vivo,13543,Autocuration,10116.0,,1,Bioavailability as maximal plasma concentration in rats,,,CHEMBL626694,,22224,Rattus norvegicus,,,U,0,BAO_0000218,1969.0
10821,In vivo,14600,Intermediate,9615.0,,1,Compound was tested for maximum blood concentration after 0.5 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,,,CHEMBL626695,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,178.0
10822,In vivo,14600,Intermediate,9615.0,,1,Compound was tested for maximum blood concentration after 10 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,,,CHEMBL626696,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,178.0
10823,In vivo,14600,Intermediate,9615.0,,1,Compound was tested for maximum blood concentration after 2.5 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,,,CHEMBL626697,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,178.0
10824,In vivo,14600,Intermediate,9615.0,,1,Compound was tested for maximum concentration in blood after 0.5 mg/kg administration (Po) in Beagle dogs; nd = Not Detectable,,,CHEMBL626859,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,178.0
10825,In vivo,14600,Intermediate,9615.0,,1,Compound was tested for maximum concentration in blood after 10 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,,,CHEMBL626860,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,178.0
10826,In vivo,14600,Intermediate,9615.0,,1,Compound was tested for maximum concentration in blood after 2.5 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,,,CHEMBL626861,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,178.0
10827,In vivo,14681,Intermediate,10116.0,,1,Compound was tested for maximum observed concentration in three male Wistar rats at a single 5 mg/kg oral gavage dose,,,CHEMBL626296,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10828,In vivo,15905,Autocuration,,,1,Compound was tested for the max. conc. when administered perorally(po) 30 mg/kg,,,CHEMBL626297,,22224,,,,U,0,BAO_0000218,
10829,In vivo,15905,Autocuration,,,1,Compound was tested for the max. plasma conc. when administered intraperitoneally (ip) 30 mg/kg.,,,CHEMBL626298,,22224,,,,U,0,BAO_0000218,1969.0
10830,In vivo,13304,Intermediate,10116.0,,1,"Drug plasma level in rat was determined on the last day of dosing at 1,2,4.8 and 24 hr and ED50 was evaluated",,,CHEMBL626299,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
10831,In vivo,15137,Intermediate,10116.0,,1,Effect of ip administration of compound on plasma concentration of allo-pregnanolone (AP) in rats after 30 min.,,,CHEMBL626300,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
10832,In vivo,15137,Intermediate,10116.0,,1,Effect of ip administration of compound on plasma concentration of allotetrahydrodeoxy corticosterone(THDOC) in rats after 30 min.,,,CHEMBL626301,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
10833,In vivo,15137,Intermediate,10116.0,,1,Effect of ip administration of compound on plasma concentration of corticosterone (CTS) in rats after 30 min.,,,CHEMBL626962,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
10834,In vivo,15137,Intermediate,10116.0,,1,Effect of ip administration of compound on plasma concentration of pregnenolone (PRE) in rats after 30 min.,,,CHEMBL626963,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
10835,In vivo,15137,Intermediate,10116.0,,1,Effect of ip administration of compound on plasma concentration of progesterone (PRO) in rats after 30 min.,,,CHEMBL626964,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
10836,In vivo,14839,Intermediate,9541.0,,1,In vivo antitumor efficacy expressed as maximum plasma concentration 0.4 hr after a peroral dose of 25 mg/kg in cynomolgus monkeys,,,CHEMBL626965,,100710,Macaca fascicularis,,,N,1,BAO_0000218,1969.0
10837,In vivo,14839,Intermediate,10090.0,,1,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,,,CHEMBL626966,,50594,Mus musculus,,,N,1,BAO_0000218,1969.0
10838,In vivo,14839,Intermediate,10090.0,,1,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,,,CHEMBL626967,,50594,Mus musculus,,,N,1,BAO_0000218,1969.0
10839,In vivo,14839,Intermediate,9541.0,,1,In vivo antitumor efficacy expressed as maximum plasma concentration after a peroral dose of 10 mg/kg in cynomolgus monkeys,,,CHEMBL626968,,100710,Macaca fascicularis,,,N,1,BAO_0000218,1969.0
10840,,8418,Intermediate,10116.0,,1,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.89-1.24,,,CHEMBL626969,,50597,Rattus norvegicus,,,N,1,BAO_0000218,948.0
10841,,8418,Intermediate,10116.0,,1,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 2.24-2.58,,,CHEMBL627126,,50597,Rattus norvegicus,,,N,1,BAO_0000218,948.0
10842,,8418,Intermediate,10116.0,,1,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.24-0.28,,,CHEMBL631276,,50597,Rattus norvegicus,,,N,1,BAO_0000218,948.0
10843,,8418,Intermediate,10116.0,,1,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.52-0.62,,,CHEMBL631277,,50597,Rattus norvegicus,,,N,1,BAO_0000218,948.0
10844,,8418,Intermediate,10116.0,,1,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.68-0.84,,,CHEMBL631278,,50597,Rattus norvegicus,,,N,1,BAO_0000218,948.0
10845,,8418,Intermediate,10116.0,,1,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.75-1.03,,,CHEMBL874457,,50597,Rattus norvegicus,,,N,1,BAO_0000218,948.0
10846,,8418,Intermediate,10116.0,,1,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.96-2.46,,,CHEMBL631279,,50597,Rattus norvegicus,,,N,1,BAO_0000218,948.0
10847,,8418,Intermediate,10116.0,,1,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.36-0.42,,,CHEMBL631280,,50597,Rattus norvegicus,,,N,1,BAO_0000218,948.0
10848,,8418,Intermediate,10116.0,,1,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.58-0.82,,,CHEMBL631281,,50597,Rattus norvegicus,,,N,1,BAO_0000218,948.0
10849,,8418,Intermediate,10116.0,,1,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.24-1.46,,,CHEMBL631968,,50597,Rattus norvegicus,,,N,1,BAO_0000218,948.0
10850,,8418,Intermediate,10116.0,,1,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 2.36-3.96,,,CHEMBL631969,,50597,Rattus norvegicus,,,N,1,BAO_0000218,948.0
10851,,8418,Intermediate,10116.0,,1,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.24-0.29,,,CHEMBL631970,,50597,Rattus norvegicus,,,N,1,BAO_0000218,948.0
10852,,8418,Intermediate,10116.0,,1,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.39-0.74,,,CHEMBL631971,,50597,Rattus norvegicus,,,N,1,BAO_0000218,948.0
10853,,8418,Intermediate,10116.0,,1,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.79-0.85,,,CHEMBL631972,,50597,Rattus norvegicus,,,N,1,BAO_0000218,948.0
10854,,8418,Intermediate,10116.0,,1,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.64-0.86,,,CHEMBL630435,,50597,Rattus norvegicus,,,N,1,BAO_0000218,948.0
10855,,8418,Intermediate,10116.0,,1,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 1.68-2.23,,,CHEMBL630436,,50597,Rattus norvegicus,,,N,1,BAO_0000218,948.0
10856,,8418,Intermediate,10116.0,,1,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.19-0.23,,,CHEMBL630437,,50597,Rattus norvegicus,,,N,1,BAO_0000218,948.0
10857,,8418,Intermediate,10116.0,,1,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.22-0.29,,,CHEMBL630438,,50597,Rattus norvegicus,,,N,1,BAO_0000218,948.0
10858,,8418,Intermediate,10116.0,,1,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.58-0.75,,,CHEMBL630439,,50597,Rattus norvegicus,,,N,1,BAO_0000218,948.0
10859,,8418,Intermediate,10116.0,,1,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.42-1.82,,,CHEMBL630440,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2113.0
10860,,8418,Intermediate,10116.0,,1,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 2.24-3.12,,,CHEMBL630441,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2113.0
10861,,8418,Intermediate,10116.0,,1,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.62-0.92,,,CHEMBL630442,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2113.0
10862,,8418,Intermediate,10116.0,,1,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 1.12-2.04,,,CHEMBL625234,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2113.0
10863,,8418,Intermediate,10116.0,,1,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 1.59-2.03,,,CHEMBL625235,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2113.0
10864,,8418,Intermediate,10116.0,,1,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.14-1.4,,,CHEMBL625236,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2113.0
10865,,8418,Intermediate,10116.0,,1,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.56-1.83,,,CHEMBL625237,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2113.0
10866,,8418,Intermediate,10116.0,,1,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.58-0.73,,,CHEMBL626125,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2113.0
10867,,8418,Intermediate,10116.0,,1,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 1.67-2.11,,,CHEMBL626126,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2113.0
10868,,8418,Intermediate,10116.0,,1,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.64-3.43,,,CHEMBL626127,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2113.0
10869,,8418,Intermediate,10116.0,,1,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 3.18-4.74,,,CHEMBL626128,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2113.0
10870,,8418,Intermediate,10116.0,,1,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.62-1.13,,,CHEMBL626129,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2113.0
10871,,8418,Intermediate,10116.0,,1,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 1.73-2.64,,,CHEMBL626130,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2113.0
10872,,8418,Intermediate,10116.0,,1,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 13.02-19.07,,,CHEMBL626131,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2113.0
10873,,8418,Intermediate,10116.0,,1,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.89-1.19,,,CHEMBL626132,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2113.0
10874,,8418,Intermediate,10116.0,,1,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 1.17-1.48,,,CHEMBL626752,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2113.0
10875,,8418,Intermediate,10116.0,,1,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.48-0.72,,,CHEMBL626753,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2113.0
10876,,8418,Intermediate,10116.0,,1,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.49-0.57,,,CHEMBL626754,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2113.0
10877,,8418,Intermediate,10116.0,,1,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.99-1.24,,,CHEMBL626755,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2113.0
10878,,8418,Intermediate,10116.0,,1,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.23-1.78,,,CHEMBL626756,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
10879,,8418,Intermediate,10116.0,,1,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 2.43-2.92,,,CHEMBL626757,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
10880,,8418,Intermediate,10116.0,,1,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.81-1.18,,,CHEMBL626758,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
10881,,8418,Intermediate,10116.0,,1,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 1.37-1.74,,,CHEMBL626759,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
10882,,8418,Intermediate,10116.0,,1,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 4.01-4.81,,,CHEMBL626760,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
10883,,6996,Intermediate,9615.0,,1,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5.4 mg/kg after ip administration ( 0-6 hr),,,CHEMBL626394,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
10884,,6996,Intermediate,9615.0,,1,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration,,,CHEMBL626395,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
10885,,6996,Intermediate,9615.0,,1,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration (0-6 hr),,,CHEMBL626396,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
10886,,6996,Intermediate,9615.0,,1,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration ( 0 - 6 hr),,,CHEMBL626397,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
10887,,6996,Intermediate,9615.0,,1,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration ( 0-6 hr ),,,CHEMBL626398,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
10888,,6996,Intermediate,9615.0,,1,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration ( 0-6 hr),,,CHEMBL626399,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
10889,,6996,Intermediate,10116.0,,1,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration,,,CHEMBL874653,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10890,,6996,Intermediate,10116.0,,1,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),,,CHEMBL626400,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10891,,6996,Intermediate,10116.0,,1,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration (0-5 hr),,,CHEMBL626401,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10892,,6996,Intermediate,10116.0,,1,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0 - 5 hr),,,CHEMBL626402,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10893,,6996,Intermediate,10116.0,,1,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr ),,,CHEMBL626403,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10894,,6996,Intermediate,10116.0,,1,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),,,CHEMBL626404,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10895,,6996,Intermediate,10116.0,,1,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration,,,CHEMBL626405,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10896,,6996,Intermediate,10116.0,,1,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),,,CHEMBL625529,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10897,,6996,Intermediate,10116.0,,1,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration (0-5 hr),,,CHEMBL625530,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10898,,6996,Intermediate,10116.0,,1,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0 - 5 hr),,,CHEMBL625531,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10899,,6996,Intermediate,10116.0,,1,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr ),,,CHEMBL625532,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10900,,6996,Intermediate,10116.0,,1,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),,,CHEMBL625533,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10901,,6996,Intermediate,10116.0,,1,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration,,,CHEMBL875474,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10902,,6996,Intermediate,10116.0,,1,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),,,CHEMBL625534,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10903,,6996,Intermediate,10116.0,,1,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration (0-5 hr),,,CHEMBL625535,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10904,,6996,Intermediate,10116.0,,1,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0 - 5 hr),,,CHEMBL625536,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10905,,6996,Intermediate,10116.0,,1,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr ),,,CHEMBL625537,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10906,,6996,Intermediate,10116.0,,1,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),,,CHEMBL625538,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10907,,6996,Intermediate,10116.0,,1,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration,,,CHEMBL625539,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10908,,6996,Intermediate,10116.0,,1,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),,,CHEMBL625540,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10909,,6996,Intermediate,10116.0,,1,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration (0-5 hr),,,CHEMBL625541,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10910,,6996,Intermediate,10116.0,,1,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0 - 5 hr),,,CHEMBL625542,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10911,,6996,Intermediate,10116.0,,1,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr ),,,CHEMBL625543,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10912,,6996,Intermediate,10116.0,,1,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),,,CHEMBL625544,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10913,,6996,Intermediate,9615.0,,1,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.312 mg/kg after ip administration,,,CHEMBL625545,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
10914,,6996,Intermediate,9615.0,,1,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.3 mg/kg after ip administration (0-6 hr),,,CHEMBL625546,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
10915,,6996,Intermediate,9615.0,,1,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.625 mg/kg after ip administration,,,CHEMBL625547,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
10916,,6996,Intermediate,9615.0,,1,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.6 mg/kg after ip administration ( 0-6 hr),,,CHEMBL625548,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
10917,,6996,Intermediate,9615.0,,1,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1.8 mg/kg after ip administration ( 0-6 hr),,,CHEMBL625549,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
10918,,6996,Intermediate,9615.0,,1,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 10 mg/kg after ip administration (0-6 hr),,,CHEMBL625550,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
10919,,6996,Intermediate,9615.0,,1,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 10 mg/kg after ip administration ( 0-6 hr),,,CHEMBL625551,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
10920,,6996,Intermediate,9615.0,,1,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 16.2 mg/kg after ip administration ( 0-6 hr),,,CHEMBL875475,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
10921,,6996,Intermediate,9615.0,,1,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr),,,CHEMBL625552,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
10922,,6996,Intermediate,9615.0,,1,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration (0-6 hr),,,CHEMBL625553,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
10923,,6996,Intermediate,9615.0,,1,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration ( 0 - 6 hr),,,CHEMBL625554,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
10924,,6996,Intermediate,9615.0,,1,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr ),,,CHEMBL625555,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
10925,,6996,Intermediate,9615.0,,1,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 20 mg/kg after ip administration ( 0-6 hr),,,CHEMBL625556,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
10926,,6996,Intermediate,9615.0,,1,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 2 mg/kg after ip administration,,,CHEMBL624986,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
10927,,6996,Intermediate,9615.0,,1,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 2 mg/kg after ip administration (0-6 hr),,,CHEMBL624987,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
10928,,6996,Intermediate,9615.0,,1,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 2 mg/kg after ip administration ( 0 - 6 hr),,,CHEMBL624988,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
10929,In vivo,9025,Intermediate,9615.0,,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3 range; -2/-14,,,CHEMBL624989,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,1637.0
10930,In vivo,9025,Intermediate,9615.0,,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3 range; -4/-4,,,CHEMBL624990,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,1637.0
10931,In vivo,9025,Intermediate,9615.0,,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3 range; 4/7,,,CHEMBL874391,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,1637.0
10932,In vivo,9025,Intermediate,9615.0,,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3/10 range; -3/0/4,,,CHEMBL624991,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,1637.0
10933,In vivo,9025,Intermediate,9615.0,,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; -6/0,,,CHEMBL624992,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,1637.0
10934,In vivo,9025,Intermediate,9615.0,,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 10/31,,,CHEMBL624993,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,1637.0
10935,In vivo,9025,Intermediate,9615.0,,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 11/-19,,,CHEMBL624994,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,1637.0
10936,In vivo,9025,Intermediate,9615.0,,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 14/6,,,CHEMBL624995,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,1637.0
10937,In vivo,9025,Intermediate,9615.0,,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 19/25,,,CHEMBL624996,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,1637.0
10938,In vivo,9025,Intermediate,9615.0,,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 19/3,,,CHEMBL624997,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,1637.0
10939,In vivo,9025,Intermediate,9615.0,,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 2/16,,,CHEMBL624998,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,1637.0
10940,In vivo,9025,Intermediate,9615.0,,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 6/2,,,CHEMBL624999,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,1637.0
10941,In vivo,9025,Intermediate,9615.0,,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 7/26,,,CHEMBL882955,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,1637.0
10942,In vivo,9025,Intermediate,9615.0,,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 8/49,,,CHEMBL625000,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,1637.0
10943,In vivo,9025,Intermediate,9615.0,,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 8/8,,,CHEMBL625001,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,1637.0
10944,In vivo,9025,Intermediate,9615.0,,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 9/-18,,,CHEMBL625089,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,1637.0
10945,In vivo,9025,Intermediate,9615.0,,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/60 range; 13/23,,,CHEMBL625090,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,1637.0
10946,In vivo,9025,Intermediate,9615.0,,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 3 range,,,CHEMBL625091,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,1637.0
10947,In vivo,9025,Intermediate,9615.0,,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 3/10 range; -7/-11,,,CHEMBL625092,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,1637.0
10948,In vivo,9025,Intermediate,9615.0,,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a of 1/3 dose range; 6/-7,,,CHEMBL625093,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,1637.0
10949,In vivo,9025,Intermediate,9615.0,,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a of 10/30 dose range; -13/19,,,CHEMBL625094,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,1637.0
10950,In vivo,9025,Intermediate,9615.0,,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a of 3/10 dose range; 30/47,,,CHEMBL625095,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,1637.0
10951,In vivo,2249,Intermediate,9615.0,,1,Compound was evaluated for its bioavailability in the dogs,,,CHEMBL625096,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
10952,In vivo,2249,Intermediate,10116.0,,1,Compound was evaluated for its bioavailability in the rats,,,CHEMBL625097,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10953,In vivo,17515,Autocuration,,,1,Compound was evaluated for oral bioavailability,,,CHEMBL882956,,22224,,,,U,0,BAO_0000218,
10954,In vivo,14541,Intermediate,10116.0,,1,Compound was evaluated for percentage of Oral bioavailability in rats,,,CHEMBL625098,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10955,In vivo,12797,Autocuration,10141.0,,1,Bioavailability in guinea pig,,,CHEMBL625099,,22224,Cavia porcellus,,,U,0,BAO_0000218,
10956,In vivo,12797,Intermediate,10116.0,,1,Compound was evaluated for the oral bioavailability in rat,,,CHEMBL625100,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10957,In vivo,12797,Intermediate,9615.0,,1,Compound was evaluated for the oral bioavailability in dog,,,CHEMBL625101,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
10958,In vivo,12797,Intermediate,10116.0,,1,Compound was evaluated for the oral bioavailability in rat,,,CHEMBL874396,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10959,In vivo,11727,Autocuration,9615.0,,1,Bioavailability in dog (dosed i.v.),,,CHEMBL625102,,22224,Canis lupus familiaris,,,U,0,BAO_0000218,
10960,In vivo,13249,Intermediate,9615.0,,1,Compound was tested for in vivo bioavailability in dog,,,CHEMBL625103,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
10961,In vivo,13249,Intermediate,10026.0,,1,Compound was tested for in vivo bioavailability in hamsters,,,CHEMBL625104,,100712,Cricetinae,,,N,1,BAO_0000218,
10962,In vivo,13249,Autocuration,314293.0,,1,Compound was tested for in vivo bioavailability in monkey,,,CHEMBL625105,,22224,Simiiformes,,,U,0,BAO_0000218,
10963,In vivo,13249,Intermediate,10116.0,,1,Compound was tested for in vivo bioavailability in rat,,,CHEMBL625106,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10964,In vivo,9552,Autocuration,10090.0,,1,Oral bioavailability in mouse,,,CHEMBL625107,,22224,Mus musculus,,,U,0,BAO_0000218,
10965,In vivo,9552,Intermediate,10090.0,,1,Compound was tested for percent of oral bioavailability in mice; 56-74,,,CHEMBL625108,,50594,Mus musculus,,,N,1,BAO_0000218,
10966,In vivo,14839,Autocuration,10090.0,,1,Oral bioavailability in mouse (nude) (dose of 25 mg/kg),,,CHEMBL625109,,22224,Mus musculus,,,U,0,BAO_0000218,
10967,In vivo,14839,Autocuration,9541.0,,1,Bioavailability in cynomolgus monkey (dose 25 mg/kg i.v.),,,CHEMBL625110,,22224,Macaca fascicularis,,,U,0,BAO_0000218,
10968,In vivo,14839,Autocuration,9541.0,,1,Bioavailability in cynomolgus monkey (dose 5 mg/kg i.v.),,,CHEMBL625111,,22224,Macaca fascicularis,,,U,0,BAO_0000218,
10969,In vivo,14839,Intermediate,10090.0,,1,Oral bioavailability in mouse (nude) (dose 25 mg/kg i.v.),,,CHEMBL625112,,50594,Mus musculus,,,N,1,BAO_0000218,
10970,In vivo,14839,Intermediate,10090.0,,1,Oral bioavailability in nude mice,,,CHEMBL875334,,50594,Mus musculus,,,N,1,BAO_0000218,
10971,In vivo,11219,Autocuration,9443.0,,1,Bioavailability in monkey (i.d. dosing),,,CHEMBL628617,,22224,Primates,,,U,0,BAO_0000218,
10972,In vivo,9552,Autocuration,10116.0,,1,Bioavailability in rat,,,CHEMBL628618,,22224,Rattus norvegicus,,,U,0,BAO_0000218,
10973,In vivo,11732,Autocuration,,,1,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 10%,,,CHEMBL628619,,22224,,,,U,0,BAO_0000218,
10974,In vivo,11732,Autocuration,,,1,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 20%,,,CHEMBL628620,,22224,,,,U,0,BAO_0000218,
10975,In vivo,14839,Intermediate,9541.0,,1,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 10 mg/kg, as HCl salt in saline solution, perorally and the maximum drug concentration was determined",,,CHEMBL628621,,100710,Macaca fascicularis,,,N,1,BAO_0000218,
10976,In vivo,14839,Intermediate,9541.0,,1,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the maximum drug concentration was determined",,,CHEMBL628622,,100710,Macaca fascicularis,,,N,1,BAO_0000218,
10977,In vivo,14839,Intermediate,9541.0,,1,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 5 mg/kg, as HCl salt in saline solution, perorally and the maximum drug concentration was determined",,,CHEMBL628623,,100710,Macaca fascicularis,,,N,1,BAO_0000218,
10978,In vivo,14839,Intermediate,9541.0,,1,Maximal plasma concentration in cynomolgus monkeys after 10 mg/kg oral dose,,,CHEMBL628624,,100710,Macaca fascicularis,,,N,1,BAO_0000218,1969.0
10979,In vivo,14839,Intermediate,10090.0,,1,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,,,CHEMBL628625,,50594,Mus musculus,,,N,1,BAO_0000218,1969.0
10980,In vivo,14839,Intermediate,9541.0,,1,Maximal plasma concentration in cynomolgus monkeys after 5 mg/kg oral dose,,,CHEMBL628626,,100710,Macaca fascicularis,,,N,1,BAO_0000218,1969.0
10981,In vivo,14839,Intermediate,10090.0,,1,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,,,CHEMBL627041,,50594,Mus musculus,,,N,1,BAO_0000218,1969.0
10982,In vivo,14839,Intermediate,10090.0,,1,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,,,CHEMBL627042,,50594,Mus musculus,,,N,1,BAO_0000218,1969.0
10983,In vivo,14839,Intermediate,10090.0,,1,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,,,CHEMBL627043,,50594,Mus musculus,,,N,1,BAO_0000218,1969.0
10984,In vivo,13932,Autocuration,,,1,In vivo evaluation of maximum plasma concentration at a dose of 10 mg/kg,,,CHEMBL627044,,22224,,,,U,0,BAO_0000218,1969.0
10985,In vivo,11637,Intermediate,10090.0,,1,Cmax in mouse plasma,,,CHEMBL627045,,50594,Mus musculus,,,N,1,BAO_0000218,1969.0
10986,In vivo,11637,Autocuration,,,1,Max plasma concentration was measured by 40 mg/kg dose of peroral administration.,,,CHEMBL627046,,22224,,,,U,0,BAO_0000218,1969.0
10987,In vivo,13960,Intermediate,10116.0,,1,Maximal plasma concentration in rat,,,CHEMBL627047,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
10988,In vivo,15905,Intermediate,10116.0,,1,Maximal plasma level when administered 1 mg/kg perorally (po) in rat,,,CHEMBL627048,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
10989,In vivo,14062,Intermediate,10116.0,,1,Maximum concentration at an intraduodenal dose of 5.2 mg/kg in rat,,,CHEMBL627049,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10990,In vivo,14062,Intermediate,10116.0,,1,Maximum concentration at an intraduodenal dose of 6.6 mg/kg in rat,,,CHEMBL627050,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10991,In vivo,14062,Intermediate,10116.0,,1,Maximum concentration at an intravenous dose of 5.5 mg/kg in rat,,,CHEMBL627051,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10992,In vivo,14062,Intermediate,10116.0,,1,Maximum concentration at an intravenous dose of 6.5 mg/kg in rat,,,CHEMBL627052,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10993,In vivo,14062,Intermediate,10116.0,,1,Maximum concentration at an peroral dose of 6.2 mg/kg in rat,,,CHEMBL627053,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10994,In vivo,14062,Intermediate,10116.0,,1,Maximum concentration at an peroral dose of 6.3 mg/kg in rat,,,CHEMBL627054,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
10995,In vivo,15011,Intermediate,10090.0,,1,Maximum concentration (Cmax) using 0.4% Methyl cellulose (MC) as vehicle. compound was administered intravenously to nude mice at a dose of 25 mg/kg,,,CHEMBL627055,,50594,Mus musculus,,,N,1,BAO_0000218,
10996,In vivo,15011,Intermediate,10090.0,,1,Maximum concentration (Cmax) using 0.4% Methyl cellulose (MC) as vehicle. compound was administered orally to nude mice at a dose of 25 mg/kg,,,CHEMBL627056,,50594,Mus musculus,,,N,1,BAO_0000218,
10997,In vivo,15011,Intermediate,10090.0,,1,Maximum concentration (Cmax) using 0.4% Methyl cellulose (MC) as vehicle. compound was administered orally to nude mice at a dose of 25 mg/kg (micronized sample),,,CHEMBL627057,,50594,Mus musculus,,,N,1,BAO_0000218,
10998,In vivo,15011,Intermediate,10090.0,,1,Maximum concentration (Cmax) using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. compound was administered intravenously to nude mice at a dose of 25 mg/kg,,,CHEMBL627058,,50594,Mus musculus,,,N,1,BAO_0000218,
10999,In vivo,15011,Intermediate,10090.0,,1,Maximum concentration (Cmax) using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. compound was administered orally to nude mice at a dose of 25 mg/kg,,,CHEMBL626211,,50594,Mus musculus,,,N,1,BAO_0000218,
11000,In vivo,10291,Autocuration,,,1,Maximum Concentration of the compound.,,,CHEMBL626212,,22224,,,,U,0,BAO_0000218,
11001,In vivo,14599,Intermediate,9615.0,,1,Maximum Concentration was measured after iv administration into Beagle dog,,,CHEMBL626213,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
11002,In vivo,14599,Intermediate,9615.0,,1,Maximum Concentration was measured after iv administration into Beagle dog.,,,CHEMBL626214,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
11003,In vivo,14599,Intermediate,9615.0,,1,Maximum Concentration was measured after po administration into Beagle dog,,,CHEMBL626215,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
11004,In vivo,14599,Intermediate,9615.0,,1,Maximum Concentration was measured after po administration into Beagle dog.,,,CHEMBL626216,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
11005,In vivo,12767,Autocuration,,,1,Maximum blood level reached after an dose of 10.6 uM/kg intravenously,,,CHEMBL626217,,22224,,,,U,0,BAO_0000218,178.0
11006,In vivo,12767,Autocuration,,,1,Maximum blood level reached after an iv dose of 12.2 uM/kg,,,CHEMBL626218,,22224,,,,U,0,BAO_0000218,178.0
11007,In vivo,12767,Autocuration,,,1,Maximum blood level reached after an oral dose 14.7 uM/kg oral route,,,CHEMBL626219,,22224,,,,U,0,BAO_0000218,178.0
11008,In vivo,12767,Autocuration,,,1,Maximum blood level reached after an oral dose of 14.7 uM/kg intravenous route,,,CHEMBL626220,,22224,,,,U,0,BAO_0000218,178.0
11009,In vivo,12767,Autocuration,,,1,Maximum blood level reached after an oral dose of 5.0 mg/kg,,,CHEMBL626221,,22224,,,,U,0,BAO_0000218,178.0
11010,In vivo,12767,Autocuration,,,1,Maximum blood level reached at dose of 10.6 uM/kg orally,,,CHEMBL626222,,22224,,,,U,0,BAO_0000218,178.0
11011,In vivo,14706,Intermediate,10141.0,,1,Maximum concentration (Cmax) in guinea pigs at 2 mg/kg after oral administration,,,CHEMBL626223,,50512,Cavia porcellus,,,N,1,BAO_0000218,
11012,In vivo,14706,Intermediate,10141.0,,1,Maximum concentration (Cmax) in guinea pigs at 3 mg/kg after oral administration,,,CHEMBL626224,,50512,Cavia porcellus,,,N,1,BAO_0000218,
11013,In vivo,14793,Intermediate,10116.0,,1,Maximum concentration achieved in rat brain when administered intraperitoneally at a dose of 10 mg/kg,,,CHEMBL626225,,50597,Rattus norvegicus,,,N,1,BAO_0000218,955.0
11014,In vivo,14793,Intermediate,10116.0,,1,Maximum concentration achieved in rat brain when administered intravenously at a dose of 10 mg/kg,,,CHEMBL626226,,50597,Rattus norvegicus,,,N,1,BAO_0000218,955.0
11015,In vivo,14793,Intermediate,10116.0,,1,Maximum concentration achieved in rat brain when administered perorally at a dose of 100 mg/kg,,,CHEMBL626227,,50597,Rattus norvegicus,,,N,1,BAO_0000218,955.0
11016,In vivo,14793,Intermediate,10116.0,,1,Maximum concentration achieved in rat brain when administered perorally at a dose of 10 mg/kg,,,CHEMBL626228,,50597,Rattus norvegicus,,,N,1,BAO_0000218,955.0
11017,In vivo,14793,Intermediate,10116.0,,1,Maximum concentration achieved in rat plasma when administered intraperitoneally at a dose of 10 mg/kg,,,CHEMBL626229,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11018,In vivo,14793,Intermediate,10116.0,,1,Maximum concentration achieved in rat plasma when administered intravenously at a dose of 10 mg/kg,,,CHEMBL626921,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11019,In vivo,14793,Intermediate,10116.0,,1,Maximum concentration achieved in rat plasma when administered perorally at a dose of 100 mg/kg,,,CHEMBL876793,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11020,In vivo,14793,Intermediate,10116.0,,1,Maximum concentration achieved in rat plasma when administered perorally at a dose of 10 mg/kg,,,CHEMBL625309,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11021,In vivo,10524,Intermediate,1423.0,,1,Maximum concentration determined against Bacillus subtilis ATCC 6633 after oral administration in dog(25 mg/kg),,,CHEMBL625310,,50278,Bacillus subtilis,,,N,1,BAO_0000218,
11022,In vivo,11871,Autocuration,314293.0,,1,Maximum concentration determined in monkeys dosed intravenously with 30 mg/kg,,,CHEMBL625311,,22224,Simiiformes,,,U,0,BAO_0000218,
11023,In vivo,11871,Intermediate,10116.0,,1,Maximum concentration determined in rats dosed intravenously with 20 mg/kg,,,CHEMBL625312,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11024,In vivo,3437,Autocuration,,,1,Maximum concentration for the bioavailability at a dose of 20 mg/kg administered orally,,,CHEMBL625313,,22224,,,,U,0,BAO_0000218,
11025,In vivo,12038,Intermediate,10090.0,,1,Maximum concentration in male CD-1 mice after sc administration of 20 mg/kg,,,CHEMBL625314,,50594,Mus musculus,,,N,1,BAO_0000218,
11026,In vivo,12038,Intermediate,10116.0,,1,Maximum concentration in male rats after iv administration of 20 mg/kg,,,CHEMBL625315,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11027,,8418,Intermediate,10116.0,,1,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.06-1.29,,,CHEMBL625316,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
11028,,8418,Intermediate,10116.0,,1,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.77-2.08,,,CHEMBL625317,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
11029,,8418,Intermediate,10116.0,,1,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.54-0.89,,,CHEMBL625318,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
11030,,8418,Intermediate,10116.0,,1,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 1.57-1.66,,,CHEMBL625319,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
11031,,8418,Intermediate,10116.0,,1,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.06-2.71,,,CHEMBL625320,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
11032,,8418,Intermediate,10116.0,,1,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 2.98-3.22,,,CHEMBL625321,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
11033,,8418,Intermediate,10116.0,,1,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.73-1.45,,,CHEMBL625322,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
11034,,8418,Intermediate,10116.0,,1,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 1.03-1.31,,,CHEMBL876801,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
11035,,8418,Intermediate,10116.0,,1,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 6.76-10.44,,,CHEMBL625323,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
11036,,8418,Intermediate,10116.0,,1,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.47-1.17,,,CHEMBL625324,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
11037,,8418,Intermediate,10116.0,,1,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 1.12-1.44,,,CHEMBL625325,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
11038,,8418,Intermediate,10116.0,,1,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.38-0.57,,,CHEMBL625326,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
11039,,8418,Intermediate,10116.0,,1,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.75-1.14,,,CHEMBL625327,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
11040,,8418,Intermediate,10116.0,,1,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 1.36-1.74,,,CHEMBL625328,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
11041,,8418,Intermediate,10116.0,,1,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.05-1.5,,,CHEMBL625329,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2048.0
11042,,8418,Intermediate,10116.0,,1,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 3.10-3.77,,,CHEMBL625330,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2048.0
11043,,8418,Intermediate,10116.0,,1,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.4-0.54,,,CHEMBL627774,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2048.0
11044,,8418,Intermediate,10116.0,,1,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.58-0.86,,,CHEMBL627775,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2048.0
11045,,8418,Intermediate,10116.0,,1,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.77-0.86,,,CHEMBL627949,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2048.0
11046,,8418,Intermediate,10116.0,,1,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.86-1.13,,,CHEMBL627950,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2048.0
11047,,8418,Intermediate,10116.0,,1,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 2.26-2.89,,,CHEMBL627951,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2048.0
11048,,8418,Intermediate,10116.0,,1,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.54-0.7,,,CHEMBL627952,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2048.0
11049,,8418,Intermediate,10116.0,,1,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.6-0.66,,,CHEMBL627953,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2048.0
11050,,8418,Intermediate,10116.0,,1,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.35-1.74,,,CHEMBL627954,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2048.0
11051,,8418,Intermediate,10116.0,,1,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 3.62-7.08,,,CHEMBL627955,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2048.0
11052,,8418,Intermediate,10116.0,,1,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.47-0.56,,,CHEMBL627956,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2048.0
11053,,8418,Intermediate,10116.0,,1,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.54-1.07,,,CHEMBL876802,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2048.0
11054,,8418,Intermediate,10116.0,,1,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.76-0.91,,,CHEMBL627957,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2048.0
11055,,8418,Intermediate,10116.0,,1,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.61-0.86,,,CHEMBL627958,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2048.0
11056,,8418,Intermediate,10116.0,,1,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 2.11-3.79,,,CHEMBL627959,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2048.0
11057,,8418,Intermediate,10116.0,,1,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.3-0.36,,,CHEMBL627960,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2048.0
11058,,8418,Intermediate,10116.0,,1,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.36-0.44,,,CHEMBL627961,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2048.0
11059,,8418,Intermediate,10116.0,,1,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.5-0.65,,,CHEMBL627962,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2048.0
11060,,9796,Intermediate,10116.0,,1,Distribution of radiolabeled compound in intestinal contents of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,,,CHEMBL627963,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11061,,9796,Intermediate,10116.0,,1,Distribution of radiolabeled compound in intestinal contents of rat 1 hr after ip administration of dose; fmol equivalents per 100 mg,,,CHEMBL624759,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11062,,9796,Intermediate,10116.0,,1,Distribution of radiolabeled compound in intestinal contents of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,,,CHEMBL624760,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11063,,9796,Intermediate,10116.0,,1,Distribution of radiolabeled compound in intestinal contents of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,,,CHEMBL624761,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11064,,9796,Intermediate,10116.0,,1,Distribution of radiolabeled compound in intestinal contents of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,,,CHEMBL877607,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11065,,9796,Intermediate,10116.0,,1,Distribution of radiolabeled compound in liver of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,,,CHEMBL624762,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
11066,,9796,Intermediate,10116.0,,1,Distribution of radiolabeled compound in liver of rat 1 hr after ip administration of dose; fmol equivalents per 100 mg,,,CHEMBL624763,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
11067,,9796,Intermediate,10116.0,,1,Distribution of radiolabeled compound in liver of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,,,CHEMBL624764,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
11068,,9796,Intermediate,10116.0,,1,Distribution of radiolabeled compound in liver of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,,,CHEMBL624765,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
11069,,9796,Intermediate,10116.0,,1,Distribution of radiolabeled compound in liver of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,,,CHEMBL624766,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
11070,,6996,Intermediate,9615.0,,1,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5.4 mg/kg after ip administration ( 0-6 hr),,,CHEMBL624767,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
11071,,6996,Intermediate,9615.0,,1,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration,,,CHEMBL624768,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
11072,,6996,Intermediate,9615.0,,1,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration (0-6 hr),,,CHEMBL624769,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
11073,,6996,Intermediate,9615.0,,1,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration ( 0 - 6 hr),,,CHEMBL624770,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
11074,,6996,Intermediate,9615.0,,1,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr ),,,CHEMBL624771,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
11075,,6996,Intermediate,9615.0,,1,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr),,,CHEMBL624772,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
11076,,6996,Intermediate,10116.0,,1,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration,,,CHEMBL624773,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11077,,6996,Intermediate,10116.0,,1,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),,,CHEMBL624774,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11078,,6996,Intermediate,10116.0,,1,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration (0-5 hr),,,CHEMBL624775,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11079,,6996,Intermediate,10116.0,,1,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0 - 5 hr),,,CHEMBL624776,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11080,,6996,Intermediate,10116.0,,1,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr ),,,CHEMBL624777,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11081,,6996,Intermediate,10116.0,,1,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),,,CHEMBL624778,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11082,,6996,Intermediate,10116.0,,1,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration,,,CHEMBL624779,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11083,,6996,Intermediate,10116.0,,1,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0 - 5 hr),,,CHEMBL624780,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11084,,6996,Intermediate,10116.0,,1,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr ),,,CHEMBL624781,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11085,,6996,Intermediate,10116.0,,1,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),,,CHEMBL877608,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11086,,6996,Intermediate,10116.0,,1,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration (0-5 hr),,,CHEMBL624782,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11087,,6996,Intermediate,10116.0,,1,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),,,CHEMBL624783,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11088,,6996,Intermediate,10116.0,,1,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration,,,CHEMBL624784,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11089,,6996,Intermediate,10116.0,,1,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),,,CHEMBL624785,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11090,,6996,Intermediate,10116.0,,1,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration (0-5 hr),,,CHEMBL624786,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11091,,6996,Intermediate,10116.0,,1,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr ),,,CHEMBL624787,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11092,,6996,Intermediate,10116.0,,1,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),,,CHEMBL628676,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11093,,6996,Intermediate,10116.0,,1,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration,,,CHEMBL621842,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11094,,6996,Intermediate,10116.0,,1,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),,,CHEMBL621843,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11095,,6996,Intermediate,10116.0,,1,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration (0-5 hr),,,CHEMBL623873,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11096,,6996,Intermediate,10116.0,,1,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0 - 5 hr),,,CHEMBL623874,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11097,,6996,Intermediate,10116.0,,1,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr ),,,CHEMBL623875,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11098,,6996,Intermediate,10116.0,,1,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),,,CHEMBL623876,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11099,,6996,Intermediate,9615.0,,1,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.312 mg/kg after ip administration,,,CHEMBL623877,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
11100,,6996,Intermediate,9615.0,,1,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.3 mg/kg after ip administration (0-6 hr),,,CHEMBL623878,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
11101,,6996,Intermediate,9615.0,,1,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.625 mg/kg after ip administration,,,CHEMBL623879,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
11102,,6996,Intermediate,9615.0,,1,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.6 mg/kg after ip administration ( 0-6 hr),,,CHEMBL623880,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
11103,,6996,Intermediate,9615.0,,1,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1.8 mg/kg after ip administration ( 0-6 hr),,,CHEMBL623881,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
11104,,6996,Intermediate,9615.0,,1,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 10 mg/kg after ip administration (0-6 hr),,,CHEMBL623957,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
11105,,6996,Intermediate,9615.0,,1,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 10 mg/kg after ip administration ( 0-6 hr),,,CHEMBL623958,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
11106,,6996,Intermediate,9615.0,,1,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 16.2 mg/kg after ip administration ( 0-6 hr),,,CHEMBL623959,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
11107,,6996,Intermediate,9615.0,,1,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr),,,CHEMBL623960,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
11108,,6996,Intermediate,9615.0,,1,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration (0-6 hr),,,CHEMBL623961,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
11109,,6996,Intermediate,9615.0,,1,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration ( 0 - 6 hr),,,CHEMBL623962,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
11110,,6996,Intermediate,9615.0,,1,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr ),,,CHEMBL624676,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
11111,,6996,Intermediate,9615.0,,1,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 20 mg/kg after ip administration ( 0-6 hr),,,CHEMBL624677,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
11112,,6996,Intermediate,9615.0,,1,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 2 mg/kg after ip administration,,,CHEMBL624678,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
11113,,6996,Intermediate,9615.0,,1,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 2 mg/kg after ip administration (0-6 hr),,,CHEMBL624679,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
11114,,6996,Intermediate,9615.0,,1,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 2 mg/kg after ip administration ( 0 - 6 hr),,,CHEMBL624680,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
11115,In vivo,11732,Autocuration,,,1,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 27%,,,CHEMBL624849,,22224,,,,U,0,BAO_0000218,
11116,In vivo,11732,Autocuration,,,1,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 4%,,,CHEMBL624850,,22224,,,,U,0,BAO_0000218,
11117,In vivo,11732,Autocuration,,,1,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 54%,,,CHEMBL874399,,22224,,,,U,0,BAO_0000218,
11118,In vivo,11732,Autocuration,,,1,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 72%,,,CHEMBL624851,,22224,,,,U,0,BAO_0000218,
11119,In vivo,11732,Autocuration,,,1,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 76%,,,CHEMBL624852,,22224,,,,U,0,BAO_0000218,
11120,In vivo,13359,Autocuration,10116.0,,1,Oral bioavailability in rat (dose 10 mg/kg),,,CHEMBL624853,,22224,Rattus norvegicus,,,U,0,BAO_0000218,
11121,In vivo,16618,Autocuration,10116.0,,1,Oral bioavailability in rat (Sprague-Dawley),,,CHEMBL624854,,22224,Rattus norvegicus,,,U,0,BAO_0000218,
11122,In vivo,13960,Autocuration,10116.0,,1,Oral bioavailability in rat,,,CHEMBL624855,,22224,Rattus norvegicus,,,U,0,BAO_0000218,
11123,In vivo,13917,Autocuration,10116.0,,1,Oral bioavailability in rats was determined in vivo,,,CHEMBL624856,,22224,Rattus norvegicus,,,U,0,BAO_0000218,
11124,In vivo,14266,Autocuration,9615.0,,1,Oral bioavailability in dog,,,CHEMBL882957,,22224,Canis lupus familiaris,,,U,0,BAO_0000218,
11125,In vivo,12359,Autocuration,314293.0,,1,Oral bioavailability of compound in monkey,,,CHEMBL624857,,22224,Simiiformes,,,U,0,BAO_0000218,
11126,In vivo,12359,Intermediate,10116.0,,1,Oral bioavailability of compound in rat,,,CHEMBL622202,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11127,In vivo,12359,Autocuration,10116.0,,1,Bioavailability in rat of PMEA prodrug,,,CHEMBL622203,,22224,Rattus norvegicus,,,U,0,BAO_0000218,
11128,In vivo,12359,Intermediate,10116.0,,1,Oral bioavailability of compound was evaluated relative to that of PMEA in rat; Not determined due to lack of solubility,,,CHEMBL625522,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11129,In vivo,10791,Autocuration,9544.0,,1,Serum conc at 3 hours following 25 mg/kg dose,,,CHEMBL622868,,22224,Macaca mulatta,,,U,0,BAO_0000218,
11130,In vivo,10791,Autocuration,9544.0,,1,Urine conc 0-5 hours following 25 mg/kg dose,,,CHEMBL622869,,22224,Macaca mulatta,,,U,0,BAO_0000218,1088.0
11131,In vivo,10791,Autocuration,9544.0,,1,Urine conc 0-24 hours following 25 mg/kg dose,,,CHEMBL622870,,22224,Macaca mulatta,,,U,0,BAO_0000218,1088.0
11132,In vivo,138,Autocuration,9534.0,,1,Oral bioavailability in African green monkeys; 20-25,,,CHEMBL622871,,22224,Chlorocebus aethiops,,,U,0,BAO_0000218,
11133,In vivo,14521,Intermediate,9541.0,,1,Oral bioavailability in cynomolgus monkey.,,,CHEMBL620560,,100710,Macaca fascicularis,,,N,1,BAO_0000218,
11134,In vivo,13953,Autocuration,9615.0,,1,Oral bioavailability in dog,,,CHEMBL620561,,22224,Canis lupus familiaris,,,U,0,BAO_0000218,
11135,In vivo,12836,Intermediate,9615.0,,1,Oral bioavailability in dog at 10 mg/kg oral dose,,,CHEMBL620562,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
11136,In vivo,12836,Intermediate,10026.0,,1,Oral bioavailability in hamster at 10 mg/kg oral dose,,,CHEMBL620563,,100712,Cricetinae,,,N,1,BAO_0000218,
11137,In vivo,12836,Intermediate,10116.0,,1,Oral bioavailability in rat at 10 mg/kg oral dose,,,CHEMBL620564,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11138,In vivo,14521,Autocuration,10116.0,,1,Oral bioavailability in rat,,,CHEMBL872265,,22224,Rattus norvegicus,,,U,0,BAO_0000218,
11139,In vivo,13953,Autocuration,10116.0,,1,Oral bioavailability in rat,,,CHEMBL620565,,22224,Rattus norvegicus,,,U,0,BAO_0000218,
11140,In vivo,6799,Autocuration,9347.0,,1,Oral bioavailability,,,CHEMBL620566,,22224,Eutheria,,,U,0,BAO_0000218,
11141,In vivo,11311,Autocuration,,,1,Oral bioavailability was determined; range 49-102%,,,CHEMBL620567,,22224,,,,U,0,BAO_0000218,
11142,In vivo,4013,Intermediate,9615.0,,1,Oral bioavailability was determined in dogs,,,CHEMBL620568,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
11143,In vivo,4013,Autocuration,10116.0,,1,Oral bioavailability in rat,,,CHEMBL620569,,22224,Rattus norvegicus,,,U,0,BAO_0000218,
11144,In vivo,17591,Autocuration,9347.0,,1,Oral bioavailability,,,CHEMBL620570,,22224,Eutheria,,,U,0,BAO_0000218,
11145,In vivo,17591,Autocuration,,,1,Oral bioavailability was determined; Not orally available,,,CHEMBL620571,,22224,,,,U,0,BAO_0000218,
11146,In vivo,15011,Intermediate,10090.0,,1,Percent bioavailability was administered by using 0.4% Methyl cellulose (MC) as vehicle to nude mice at a dose of 25 mg/kg (micronized sample),,,CHEMBL620572,,50594,Mus musculus,,,N,1,BAO_0000218,
11147,In vivo,15011,Autocuration,10090.0,,1,Bioavailability in mouse (nude) (dose 0.4% Methylcellulose (MC) as vehicle 25 mg/kg),,,CHEMBL620573,,22224,Mus musculus,,,U,0,BAO_0000218,
11148,In vivo,15011,Autocuration,10090.0,,1,Bioavailability in mouse (nude) using 20% aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle 25 mg/kg,,,CHEMBL620574,,22224,Mus musculus,,,U,0,BAO_0000218,
11149,In vivo,9552,Autocuration,9544.0,,1,Oral bioavailability in Rhesus monkey,,,CHEMBL620575,,22224,Macaca mulatta,,,U,0,BAO_0000218,
11150,In vivo,9552,Autocuration,9615.0,,1,Oral bioavailability in dog (female mongrel),,,CHEMBL620576,,22224,Canis lupus familiaris,,,U,0,BAO_0000218,
11151,In vivo,3639,Autocuration,,,1,Percent oral bioavailability of perorally administered compound (30 mg/kg) was tested,,,CHEMBL875846,,22224,,,,U,0,BAO_0000218,
11152,In vivo,13397,Autocuration,9615.0,,1,Oral bioavailability in dog,,,CHEMBL620577,,22224,Canis lupus familiaris,,,U,0,BAO_0000218,
11153,In vivo,3031,Autocuration,,,1,Percentage Bioavailability was evaluated.,,,CHEMBL620578,,22224,,,,U,0,BAO_0000218,
11154,In vivo,12818,Autocuration,10116.0,,1,Bioavailability in rat administered i.d.,,,CHEMBL620579,,22224,Rattus norvegicus,,,U,0,BAO_0000218,
11155,In vivo,4847,Autocuration,9347.0,,1,Bioavailability,,,CHEMBL621248,,22224,Eutheria,,,U,0,BAO_0000218,
11156,In vivo,12421,Autocuration,9615.0,,1,Bioavailability in dog (male Beagle) i.v. administration,,,CHEMBL625390,,22224,Canis lupus familiaris,,,U,0,BAO_0000218,
11157,In vivo,11966,Autocuration,10116.0,,1,"Bioavailability in rat (dose 20 mg/kg p.o. in 1% methocel, and 5 mg/kg i.v. in PEG400)",,,CHEMBL625391,,22224,Rattus norvegicus,,,U,0,BAO_0000218,
11158,In vivo,11218,Autocuration,9443.0,,1,Bioavailability in monkey (dose 10 mg/kg i.d. or 0.3 mg/kg i.v.),,,CHEMBL872266,,22224,Primates,,,U,0,BAO_0000218,
11159,In vivo,13129,Autocuration,10116.0,,1,Oral bioavailability in rat (Sprague-Dawley) (male),,,CHEMBL625392,,22224,Rattus norvegicus,,,U,0,BAO_0000218,
11160,In vivo,12350,Intermediate,10116.0,,1,The oral bioavailability was measured on rats after oral administration,,,CHEMBL625393,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11161,In vivo,2231,Intermediate,10116.0,,1,Bioavailability was evaluated in rat at an intravenous dose of 3 mg/kg and peroral dose of 5 mg/kg,,,CHEMBL625394,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11162,In vivo,2231,Intermediate,9544.0,,1,Bioavailability was evaluated in rhesus monkey at an intravenous dose of 1 mg/kg and peroral dose of 1 mg/kg,,,CHEMBL625395,,50797,Macaca mulatta,,,N,1,BAO_0000218,
11163,In vivo,12187,Autocuration,10116.0,,1,Bioavailability in rat (dose 10 mg/kg i.d.),,,CHEMBL625396,,22224,Rattus norvegicus,,,U,0,BAO_0000218,
11164,In vivo,12421,Autocuration,9615.0,,1,Bioavailability in dog (male Beagle) i.v. administration,,,CHEMBL625397,,22224,Canis lupus familiaris,,,U,0,BAO_0000218,
11165,In vivo,13256,Intermediate,10090.0,,1,Biodistribution in CD-1 mice was determined after 1 minute in Striatum(expressed as percent injected dose per gram normalized to a 25 g mouse),,,CHEMBL625398,,50594,Mus musculus,,,N,1,BAO_0000218,
11166,In vivo,13256,Intermediate,10090.0,,1,Biodistribution in CD-1 mice was determined after 1 minute in blood(expressed as percent injected dose per gram normalized to a 25 g mouse),,,CHEMBL625399,,50594,Mus musculus,,,N,1,BAO_0000218,178.0
11167,In vivo,13256,Intermediate,10090.0,,1,Biodistribution in CD-1 mice was determined after 1 minute in cerebellum(expressed as percent injected dose per gram normalized to a 25 g mouse),,,CHEMBL626074,,50594,Mus musculus,,,N,1,BAO_0000218,2037.0
11168,In vivo,13256,Intermediate,10090.0,,1,Biodistribution in CD-1 mice was determined after 1 minute in cortex(expressed as percent injected dose per gram normalized to a 25 g mouse),,,CHEMBL626075,,50594,Mus musculus,,,N,1,BAO_0000218,
11169,In vivo,2231,Intermediate,10116.0,,1,Maximum concentration in plasma (Cmax) was evaluated in rat at an intravenous dose of 3 mg/kg and peroral dose of 5 mg/kg,,,CHEMBL626076,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
11170,In vivo,2231,Intermediate,9544.0,,1,Maximum concentration in plasma (Cmax) was evaluated in rhesus monkey at an intravenous dose of 1 mg/kg and peroral dose of 1 mg/kg,,,CHEMBL626077,,50797,Macaca mulatta,,,N,1,BAO_0000218,1969.0
11171,In vivo,12178,Intermediate,10116.0,,1,Maximum concentration in whole blood recorded in the period 0-24 hr postdose of 1 mg/kg in rat (normalized to a 1 mg/kg dose),,,CHEMBL626078,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
11172,In vivo,12178,Autocuration,,,1,Maximum concentration in whole blood recorded in the period 0-24 hr postdose of 2.5 mg/kg in rat (normalized to a 1 mg/kg dose),,,CHEMBL625846,,22224,,,,U,0,BAO_0000218,178.0
11173,In vivo,12178,Autocuration,,,1,Maximum concentration in whole blood recorded in the period 0-24 hr postdose of 5.0 mg/kg GP (normalized to a 1 mg/kg dose),,,CHEMBL625847,,22224,,,,U,0,BAO_0000218,178.0
11174,In vivo,15633,Expert,10116.0,,1,Maximum concentration observed in rats at an oral dose of 50 mg/kg,,,CHEMBL625848,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11175,In vivo,14258,Intermediate,10116.0,,1,Maximum concentration of compound in plasma administered orally to rats,,,CHEMBL625849,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
11176,In vivo,14224,Intermediate,9615.0,,1,"Maximum concentration (10 mg/kg, orally) in plasma of dogs",,,CHEMBL626023,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,1969.0
11177,In vivo,14224,Intermediate,9615.0,,1,"Maximum concentration (10 mg/kg, perorally) in plasma of dogs",,,CHEMBL626024,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,1969.0
11178,In vivo,14224,Intermediate,9615.0,,1,"Maximum concentration (5 mg/kg, intravenously) in plasma of dogs",,,CHEMBL626025,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,1969.0
11179,In vivo,5566,Autocuration,,,1,Maximum concentration after 10 mg/kg by oral administration,,,CHEMBL626026,,22224,,,,U,0,BAO_0000218,
11180,In vivo,16935,Autocuration,,,1,Maximum concentration at a dose of 1.5 mg/kg,,,CHEMBL626027,,22224,,,,U,0,BAO_0000218,
11181,In vivo,16935,Autocuration,,,1,Maximum concentration at a dose of 2.0 mg/kg,,,CHEMBL626028,,22224,,,,U,0,BAO_0000218,
11182,In vivo,14224,Intermediate,9615.0,,1,Maximum concentration in dog plasma,,,CHEMBL626029,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,1969.0
11183,In vivo,12536,Autocuration,,,1,Maximum concentration in plasma after administration of 10 umol/kg dose perorally,,,CHEMBL626030,,22224,,,,U,0,BAO_0000218,1969.0
11184,In vivo,12536,Autocuration,,,1,Maximum concentration in plasma after administration of 2 umol/kg dose intravenously,,,CHEMBL626031,,22224,,,,U,0,BAO_0000218,1969.0
11185,In vivo,12536,Autocuration,,,1,Maximum concentration in plasma after administration of 4 umol/kg dose intravenously,,,CHEMBL626032,,22224,,,,U,0,BAO_0000218,1969.0
11186,In vivo,12536,Autocuration,,,1,Maximum concentration in plasma after administration of 40 umol/kg dose perorally,,,CHEMBL626033,,22224,,,,U,0,BAO_0000218,1969.0
11187,In vivo,12536,Autocuration,,,1,Maximum concentration in plasma after administration of 5 umol/kg dose intravenously,,,CHEMBL626034,,22224,,,,U,0,BAO_0000218,1969.0
11188,In vivo,9994,Intermediate,9615.0,,1,Maximum concentration in plasma after oral administration in dog (25 mg/kg),,,CHEMBL626035,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,1969.0
11189,In vivo,1434,Autocuration,,,1,Maximum concentration in plasma at Tmax,,,CHEMBL626036,,22224,,,,U,0,BAO_0000218,1969.0
11190,In vivo,12836,Expert,9615.0,,1,Maximum concentration in plasma recorded 0-6 hr post dose in dog at 10 mg/kg oral dose,,,CHEMBL626037,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,1969.0
11191,In vivo,12836,Intermediate,10026.0,,1,Maximum concentration in plasma recorded in the period 0-6 hr post dose in hamster at 10 mg/kg oral dose,,,CHEMBL626038,,100712,Cricetinae,,,N,1,BAO_0000218,1969.0
11192,In vivo,12836,Intermediate,10116.0,,1,Maximum concentration in plasma recorded in the period 0-6 hr post dose in rat at 10 mg/kg oral dose,,,CHEMBL626039,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
11193,In vivo,12545,Intermediate,10116.0,,1,Maximum concentration in plasma was determined by oral administration to rats at 20 mg/kg,,,CHEMBL626040,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
11194,In vivo,13856,Intermediate,9986.0,,1,Maximum concentration present in the rabbit plasma following peroral administration of 10 mg/kg,,,CHEMBL626041,,50592,Oryctolagus cuniculus,,,N,1,BAO_0000218,1969.0
11195,In vivo,3550,Autocuration,,,1,Maximum concentration was calculated,,,CHEMBL626042,,22224,,,,U,0,BAO_0000218,
11196,In vivo,2632,Autocuration,,,1,Maximum concentration was calculated.,,,CHEMBL626043,,22224,,,,U,0,BAO_0000218,
11197,In vivo,5566,Autocuration,,,1,Maximum concentration at a peroral dose of 10 mg/kg,,,CHEMBL626044,,22224,,,,U,0,BAO_0000218,
11198,In vivo,11883,Autocuration,,,1,Maximum concentration of the drug at 10 uM/dg administered perorally,,,CHEMBL626045,,22224,,,,U,0,BAO_0000218,
11199,In vivo,11883,Autocuration,,,1,Maximum concentration of the drug at 2 uM/dg administered intravenously,,,CHEMBL626046,,22224,,,,U,0,BAO_0000218,
11200,In vivo,14122,Intermediate,9615.0,,1,"Maximum concentration of the unchanged compound in dog plasma, recorded in the period 0-6 hr post dose.",,,CHEMBL626047,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,1969.0
11201,In vivo,14122,Intermediate,10026.0,,1,"Maximum concentration of the unchanged compound in hamster plasma, recorded in the period 0-6 hr post dose.",,,CHEMBL626048,,100712,Cricetinae,,,N,1,BAO_0000218,1969.0
11202,In vivo,14122,Intermediate,10116.0,,1,"Maximum concentration of the unchanged compound in rat plasma, recorded in the period 0-6 hr post dose.",,,CHEMBL626049,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
11203,In vivo,12542,Intermediate,10116.0,,1,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in anesthetized rat at 60 mg/kg oral dose,,,CHEMBL626050,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
11204,In vivo,12542,Intermediate,9615.0,,1,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in dog at 5 mg/kg oral dose,,,CHEMBL874541,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,1969.0
11205,In vivo,12542,Intermediate,10026.0,,1,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in hamster at 40 mg/kg oral dose,,,CHEMBL622826,,100712,Cricetinae,,,N,1,BAO_0000218,1969.0
11206,In vivo,12542,Intermediate,10026.0,,1,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose to hamster at 40 mg/kg oral dose,,,CHEMBL622827,,100712,Cricetinae,,,N,1,BAO_0000218,1969.0
11207,In vivo,12542,Intermediate,10116.0,,1,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in anesthetized rat at 25 mg/kg oral dose,,,CHEMBL622828,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
11208,In vivo,14080,Intermediate,10116.0,,1,Maximum concentration of unchanged drug in rat plasma in the period 0-24 hr after dosing,,,CHEMBL622829,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
11209,In vivo,11911,Intermediate,10116.0,,1,Maximum concentration reached following intravenous administration in male rat,,,CHEMBL876806,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11210,In vivo,13204,Intermediate,9615.0,,1,Maximum concentration was determined in an aqueous sodium hydroxide solution adjusted to pH 10 at 10 mg/kg dosage administered perorally in dog,,,CHEMBL622830,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
11211,In vivo,13204,Intermediate,10116.0,,1,Maximum concentration was determined in an aqueous sodium hydroxide solution adjusted to pH 10 at 5 mg/kg dosage administered perorally in rats,,,CHEMBL622831,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11212,In vivo,14346,Intermediate,9615.0,,1,Maximum concentration was measured after peroral administration of 10 mg/kg of drug in male Beagle dogs,,,CHEMBL626794,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
11213,In vivo,14346,Intermediate,10116.0,,1,Maximum concentration was measured after peroral administration of 5.0 mg/kg of drug in male Dawley rats,,,CHEMBL626795,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11214,In vivo,14346,Intermediate,10116.0,,1,Maximum concentration was measured after peroral administration of 5.1 mg/kg of drug in male Dawley rats,,,CHEMBL626796,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11215,In vivo,14346,Intermediate,10116.0,,1,Maximum concentration was measured after peroral administration of 5.2 mg/kg of drug in male Dawley rats,,,CHEMBL626797,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11216,In vivo,14127,Intermediate,10116.0,,1,Maximum drug concentration is determined after oral dosing in rats.,,,CHEMBL626798,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11217,In vivo,14339,Intermediate,9615.0,,1,Maximum observed concentration in oral (5 mg/kg) fasted dogs,,,CHEMBL626799,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
11218,In vivo,14339,Intermediate,9615.0,,1,Maximum observed concentration in oral (5 mg/kg) fed dogs,,,CHEMBL626800,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
11219,In vivo,13494,Autocuration,,,1,Maximum plasma concentration,,,CHEMBL626801,,22224,,,,U,0,BAO_0000218,1969.0
11220,In vivo,14925,Intermediate,10116.0,,1,Maximum plasma concentration (Cmax) was determined in rats after intraduodenal administration of the drug,,,CHEMBL876816,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
11221,In vivo,14474,Intermediate,10116.0,,1,Maximum plasma concentration following oral administration of 26.3 mg/kg in rats,,,CHEMBL626802,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
11222,In vivo,14474,Intermediate,9615.0,,1,Maximum plasma concentration following oral administration of 3.8 mg/kg in Beagle dog,,,CHEMBL626803,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,1969.0
11223,In vivo,13917,Autocuration,,,1,Maximum plasma concentration following oral administration of 30 umol/kg,,,CHEMBL626804,,22224,,,,U,0,BAO_0000218,1969.0
11224,,9796,Intermediate,10116.0,,1,Distribution of radiolabeled compound in plasma of rat 1 hr after ip administration of dose,,,CHEMBL626805,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
11225,,9796,Intermediate,10116.0,,1,Distribution of radiolabeled compound in plasma of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,,,CHEMBL626309,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
11226,,9796,Intermediate,10116.0,,1,Distribution of radiolabeled compound in plasma of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,,,CHEMBL626310,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
11227,,9796,Intermediate,10116.0,,1,Distribution of radiolabeled compound in plasma of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,,,CHEMBL626311,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
11228,,9796,Intermediate,10116.0,,1,Distribution of radiolabeled compound in plasma of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,,,CHEMBL626312,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
11229,,9796,Intermediate,10116.0,,1,Distribution of radiolabeled compound in uterus of rat 1 hr after ip administration of dose; fmol equivalents per 100 mg,,,CHEMBL626313,,50597,Rattus norvegicus,,,N,1,BAO_0000218,995.0
11230,,9796,Intermediate,10116.0,,1,Distribution of radiolabeled compound in uterus of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,,,CHEMBL626314,,50597,Rattus norvegicus,,,N,1,BAO_0000218,995.0
11231,,9796,Intermediate,10116.0,,1,Distribution of radiolabeled compound in uterus of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,,,CHEMBL626315,,50597,Rattus norvegicus,,,N,1,BAO_0000218,995.0
11232,,9796,Intermediate,10116.0,,1,Distribution of radiolabeled compound in uterus of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,,,CHEMBL626316,,50597,Rattus norvegicus,,,N,1,BAO_0000218,995.0
11233,,9796,Intermediate,10116.0,,1,Distribution of radiolabeled compound in uterus of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,,,CHEMBL626317,,50597,Rattus norvegicus,,,N,1,BAO_0000218,995.0
11234,,8363,Intermediate,10116.0,,1,Distribution of rat erythrocytes for tube 2 on rate of aging in 2 mL of cell suspension; Minus (-),,,CHEMBL626318,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11235,,8363,Intermediate,10116.0,,1,Distribution of rat erythrocytes for tube 2 on rate of aging in 2 mL of cell suspension; Plus (+),,,CHEMBL626319,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11236,,8363,Intermediate,10116.0,,1,Distribution of rat erythrocytes for tube 3 on rate of aging in 2 mL of cell suspension; Minus (-),,,CHEMBL626320,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11237,,8363,Intermediate,10116.0,,1,Distribution of rat erythrocytes for tube 3 on rate of aging in 2 mL of cell suspension; Plus (+),,,CHEMBL875053,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11238,,8363,Intermediate,10116.0,,1,Distribution of rat erythrocytes for tube 4 on rate of aging in 2 mL of cell suspension; Minus (-),,,CHEMBL626321,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11239,,8363,Intermediate,10116.0,,1,Distribution of rat erythrocytes for tube 4 on rate of aging in 2 mL of cell suspension; Plus (+),,,CHEMBL626322,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11240,,8363,Intermediate,10116.0,,1,Distribution of rat erythrocytes for tube 5 on rate of aging in 2 mL of cell suspension; Minus (-),,,CHEMBL626323,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11241,,8363,Intermediate,10116.0,,1,Distribution of rat erythrocytes for tube 5 on rate of aging in 2 mL of cell suspension; Plus (+),,,CHEMBL626324,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11242,,8363,Intermediate,10116.0,,1,Distribution of rat erythrocytes for tube 6 on rate of aging in 2 mL of cell suspension; Minus (-),,,CHEMBL626325,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11243,,8363,Intermediate,10116.0,,1,Distribution of rat erythrocytes for tube 6 on rate of aging in 2 mL of cell suspension; Plus (+),,,CHEMBL626326,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11244,,8363,Intermediate,10116.0,,1,Distribution of rat erythrocytes for tube 7 on rate of aging in 2 mL of cell suspension; Plus (+),,,CHEMBL626327,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11245,,8363,Intermediate,10116.0,,1,Distribution of rat erythrocytes for tube 1 on rate of aging in 2 mL of cell suspension; Minus (-),,,CHEMBL626328,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11246,,8684,Intermediate,10116.0,,1,"Distribution in blood of rat 5 min after intravenous administration, injected dose/gm",,,CHEMBL626329,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
11247,,8684,Intermediate,10116.0,,1,"Distribution in blood of rat, 15 min after intravenous administration, injected dose/gm",,,CHEMBL626330,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
11248,,8684,Intermediate,10116.0,,1,"Distribution in blood of rat, 1 hr after intravenous administration, injected dose/gm",,,CHEMBL626331,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
11249,,8684,Intermediate,10116.0,,1,"Distribution in blood of rat, 2 hr after intravenous administration, injected dose/gm",,,CHEMBL626332,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
11250,,8684,Intermediate,10116.0,,1,"Distribution in blood of rat, 30 min after intravenous administration, injected dose/gm",,,CHEMBL626333,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
11251,,8684,Intermediate,10116.0,,1,"Distribution in blood of rat, 4 hr after intravenous administration, injected dose/gm",,,CHEMBL626334,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
11252,,8684,Intermediate,10116.0,,1,"Distribution in blood of rat, 6 hr after intravenous administration, injected dose/gm",,,CHEMBL626335,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
11253,,8684,Intermediate,10116.0,,1,"Distribution in blood of rat, 8 hr after intravenous administration, injected dose/gm",,,CHEMBL624798,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
11254,,8684,Intermediate,10116.0,,1,"Distribution in brain of rat, 15 min after intravenous administered, injected dose/gm",,,CHEMBL624799,,50597,Rattus norvegicus,,,N,1,BAO_0000218,955.0
11255,,8684,Intermediate,10116.0,,1,"Distribution in brain of rat, 1 hr after intravenous administered, injected dose/gm",,,CHEMBL624800,,50597,Rattus norvegicus,,,N,1,BAO_0000218,955.0
11256,,8684,Intermediate,10116.0,,1,"Distribution in brain of rat, 2 hr after intravenous administered, injected dose/gm",,,CHEMBL624801,,50597,Rattus norvegicus,,,N,1,BAO_0000218,955.0
11257,,8684,Intermediate,10116.0,,1,"Distribution in brain of rat, 30 min after intravenous administered, injected dose/gm",,,CHEMBL624802,,50597,Rattus norvegicus,,,N,1,BAO_0000218,955.0
11258,,8684,Intermediate,10116.0,,1,"Distribution in brain of rat, 4 hr after intravenous administered, injected dose/gm",,,CHEMBL624803,,50597,Rattus norvegicus,,,N,1,BAO_0000218,955.0
11259,,8684,Intermediate,10116.0,,1,"Distribution in brain of rat, 5 min after intravenous administered, injected dose/gm",,,CHEMBL624804,,50597,Rattus norvegicus,,,N,1,BAO_0000218,955.0
11260,,8684,Intermediate,10116.0,,1,"Distribution in brain of rat, 6 hr after intravenous administered, injected dose/gm",,,CHEMBL624805,,50597,Rattus norvegicus,,,N,1,BAO_0000218,955.0
11261,,8684,Intermediate,10116.0,,1,"Distribution in brain of rat, 8 hr after intravenous administered, injected dose/gm",,,CHEMBL624806,,50597,Rattus norvegicus,,,N,1,BAO_0000218,955.0
11262,,8684,Intermediate,10116.0,,1,"Distribution in rat fat 15 min after intravenous administration, injected dose/gm",,,CHEMBL624807,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11263,,8684,Intermediate,10116.0,,1,"Distribution in rat fat 1 hr after intravenous administration, injected dose/gm",,,CHEMBL624808,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11264,,8684,Intermediate,10116.0,,1,"Distribution in rat fat 2 hr after intravenous administration, injected dose/gm",,,CHEMBL624809,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11265,,8684,Intermediate,10116.0,,1,"Distribution in rat fat 30 min after intravenous administration, injected dose/gm",,,CHEMBL624810,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11266,,8684,Intermediate,10116.0,,1,"Distribution in rat fat 4 hr after intravenous administration, injected dose/gm",,,CHEMBL877618,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11267,,8684,Intermediate,10116.0,,1,"Distribution in rat fat 5 min after intravenous administration, injected dose/gm",,,CHEMBL624811,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11268,,8684,Intermediate,10116.0,,1,"Distribution in rat fat 6 hr after intravenous administration, injected dose/gm",,,CHEMBL624812,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11269,,8684,Intermediate,10116.0,,1,"Distribution in rat fat 8 hr after intravenous administration, injected dose/gm",,,CHEMBL624813,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11270,,8684,Intermediate,10116.0,,1,"Distribution in rat heart 15 min after intravenous administration, injected dose/gm",,,CHEMBL624814,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11271,,8684,Intermediate,10116.0,,1,"Distribution in rat heart 1 hr after intravenous administration, injected dose/gm",,,CHEMBL624815,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11272,,8684,Intermediate,10116.0,,1,"Distribution in rat heart 2 hr after intravenous administration, injected dose/gm",,,CHEMBL624816,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11273,,8684,Intermediate,10116.0,,1,"Distribution in rat heart 30 min after intravenous administration, injected dose/gm",,,CHEMBL624817,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11274,,6996,Intermediate,9615.0,,1,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5.4 mg/kg after ip administration ( 0-6 hr),,,CHEMBL624818,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
11275,,6996,Intermediate,9615.0,,1,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration,,,CHEMBL624819,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
11276,,6996,Intermediate,9615.0,,1,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration (0-6 hr),,,CHEMBL624820,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
11277,,6996,Intermediate,9615.0,,1,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration ( 0 - 6 hr),,,CHEMBL624821,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
11278,,6996,Intermediate,9615.0,,1,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr ),,,CHEMBL624822,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
11279,,6996,Intermediate,9615.0,,1,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr),,,CHEMBL624823,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
11280,,15599,Intermediate,562.0,,1,Observed diffusion coefficient in organic solvent for Escherichia coli,,,CHEMBL624824,,50212,Escherichia coli,,,N,1,BAO_0000218,
11281,,9614,Intermediate,10116.0,,1,"Concentration of compound in blood of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",,,CHEMBL624825,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
11282,,9614,Intermediate,10116.0,,1,"Concentration of compound in blood of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",,,CHEMBL624826,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
11283,,9614,Intermediate,10116.0,,1,"Concentration of compound in left atrium of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",,,CHEMBL876817,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2081.0
11284,,9614,Intermediate,10116.0,,1,"Concentration of compound in left atrium of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",,,CHEMBL624827,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2081.0
11285,,9614,Intermediate,10116.0,,1,"Concentration of compound in left ventricle of of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",,,CHEMBL624828,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11286,,9614,Intermediate,10116.0,,1,"Concentration of compound in left ventricle of of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",,,CHEMBL624829,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11287,,9614,Intermediate,10116.0,,1,"Concentration of compound in liver of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",,,CHEMBL624830,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
11288,,9614,Intermediate,10116.0,,1,"Concentration of compound in liver of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",,,CHEMBL624831,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
11289,,9614,Intermediate,10116.0,,1,"Concentration of compound in right atrium of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",,,CHEMBL624832,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2081.0
11290,,9614,Intermediate,10116.0,,1,"Concentration of compound in right atrium of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",,,CHEMBL624833,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2081.0
11291,,9614,Intermediate,10116.0,,1,"Concentration of compound in right ventricle of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",,,CHEMBL624834,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11292,,9614,Intermediate,10116.0,,1,"Concentration of compound in right ventricle of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",,,CHEMBL624835,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11293,,9614,Intermediate,10116.0,,1,"Concentration of compound in spleen of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",,,CHEMBL624836,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2106.0
11294,,9614,Intermediate,10116.0,,1,"Concentration of compound in spleen of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",,,CHEMBL624837,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2106.0
11295,,9071,Intermediate,10116.0,,1,Distribution of radioactivity of radiolabeled compound in blood of female rats 30 minutes after intravenous administration,,,CHEMBL624838,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
11296,,9071,Intermediate,10116.0,,1,Distribution of radioactivity of radiolabeled compound in blood of female rats 5 minutes after intravenous administration,,,CHEMBL622188,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
11297,,9071,Intermediate,10116.0,,1,Distribution of radioactivity of radiolabeled compound in heart of female rats 30 minutes after intravenous administration,,,CHEMBL622189,,50597,Rattus norvegicus,,,N,1,BAO_0000218,948.0
11298,,9071,Intermediate,10116.0,,1,Distribution of radioactivity of radiolabeled compound in heart of female rats 30 minutes after intravenous administration at,,,CHEMBL622190,,50597,Rattus norvegicus,,,N,1,BAO_0000218,948.0
11299,,9071,Intermediate,10116.0,,1,Distribution of radioactivity of radiolabeled compound in heart of female rats 5 minutes after intravenous administration,,,CHEMBL625170,,50597,Rattus norvegicus,,,N,1,BAO_0000218,948.0
11300,,9071,Intermediate,10116.0,,1,Distribution of radioactivity of radiolabeled compound in kidney of female rats 30 minutes after intravenous administration,,,CHEMBL625171,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2113.0
11301,,9071,Intermediate,10116.0,,1,Distribution of radioactivity of radiolabeled compound in kidney of female rats 30 minutes after intravenous administration,,,CHEMBL625172,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2113.0
11302,,9071,Intermediate,10116.0,,1,Distribution of radioactivity of radiolabeled compound in kidney of female rats 5 minutes after intravenous administration,,,CHEMBL625173,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2113.0
11303,,9071,Intermediate,10116.0,,1,Distribution of radioactivity of radiolabeled compound in liver of female rats 30 minutes after intravenous administration,,,CHEMBL625174,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
11304,,9071,Intermediate,10116.0,,1,Distribution of radioactivity of radiolabeled compound in liver of female rats 5 minutes after intravenous administration,,,CHEMBL625175,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
11305,,9071,Intermediate,10116.0,,1,Distribution of radioactivity of radiolabeled compound in liver of female rats 5 minutes after intravenous administration at,,,CHEMBL625176,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
11306,,9071,Intermediate,10116.0,,1,Distribution of radioactivity of radiolabeled compound in lung of female rats 30 minutes after intravenous administration,,,CHEMBL625177,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2048.0
11307,,9071,Intermediate,10116.0,,1,Distribution of radioactivity of radiolabeled compound in lung of female rats 5 minutes after intravenous administration,,,CHEMBL625178,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2048.0
11308,,9071,Intermediate,10116.0,,1,Distribution of radioactivity of radiolabeled compound in lung of female rats 5 minutes after intravenous administration at,,,CHEMBL625179,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2048.0
11309,,9071,Intermediate,10116.0,,1,Distribution of radioactivity of radiolabeled compound in lung of female rats 30 minutes after intravenous administration,,,CHEMBL625180,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2048.0
11310,,10677,Autocuration,,,1,"Original dose appeared in the bile as unchanged compound, which was eliminated at a fairly constant rate over the first 4 hr following the iv administration",,,CHEMBL625181,,22224,,,,U,0,BAO_0000218,
11311,,9750,Intermediate,10090.0,,1,Percentage of dose recovered after 0-6 hr in the urine of mice was measured.,,,CHEMBL625182,,50594,Mus musculus,,,N,1,BAO_0000218,1088.0
11312,,8319,Intermediate,10116.0,,1,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat blood as Percent of injected dose per gram in the organ,,,CHEMBL625183,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11313,,8319,Intermediate,10116.0,,1,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose in the total organ,,,CHEMBL875848,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11314,,8319,Intermediate,10116.0,,1,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose per gram in the organ,,,CHEMBL622260,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11315,,8319,Intermediate,10116.0,,1,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose in the total organ,,,CHEMBL622261,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11316,,8319,Intermediate,10116.0,,1,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose per gram in the organ,,,CHEMBL622262,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11317,,8319,Intermediate,10116.0,,1,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose in the total organ,,,CHEMBL622263,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2113.0
11318,,8319,Intermediate,10116.0,,1,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,,,CHEMBL622418,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2113.0
11319,,8319,Intermediate,10116.0,,1,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose in the total organ,,,CHEMBL622419,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
11320,In vivo,13256,Intermediate,10090.0,,1,Biodistribution in CD-1 mice was determined after 1 minute in femur(expressed as percent injected dose per gram normalized to a 25 g mouse),,,CHEMBL623388,,50594,Mus musculus,,,N,1,BAO_0000218,
11321,In vivo,13256,Intermediate,10090.0,,1,Biodistribution in CD-1 mice was determined after 1 minute in liver(expressed as percent injected dose per gram normalized to a 25 g mouse),,,CHEMBL623389,,50594,Mus musculus,,,N,1,BAO_0000218,2107.0
11322,In vivo,13256,Intermediate,10090.0,,1,Biodistribution in CD-1 mice was determined after 1 minute in lung(expressed as percent injected dose per gram normalized to a 25 g mouse),,,CHEMBL623390,,50594,Mus musculus,,,N,1,BAO_0000218,
11323,In vivo,13256,Intermediate,10090.0,,1,Biodistribution in CD-1 mice was determined after 120 minutes in Striatum(expressed as percent injected dose per gram normalized to a 25 g mouse),,,CHEMBL623391,,50594,Mus musculus,,,N,1,BAO_0000218,
11324,In vivo,13256,Intermediate,10090.0,,1,Biodistribution in CD-1 mice was determined after 120 minutes in blood(expressed as percent injected dose per gram normalized to a 25 g mouse),,,CHEMBL623392,,50594,Mus musculus,,,N,1,BAO_0000218,178.0
11325,In vivo,13256,Intermediate,10090.0,,1,Biodistribution in CD-1 mice was determined after 120 minutes in cerebellum(expressed as percent injected dose per gram normalized to a 25 g mouse),,,CHEMBL623393,,50594,Mus musculus,,,N,1,BAO_0000218,2037.0
11326,In vivo,13256,Intermediate,10090.0,,1,Biodistribution in CD-1 mice was determined after 120 minutes in cortex(expressed as percent injected dose per gram normalized to a 25 g mouse),,,CHEMBL623394,,50594,Mus musculus,,,N,1,BAO_0000218,
11327,In vivo,13256,Intermediate,10090.0,,1,Biodistribution in CD-1 mice was determined after 120 minutes in femur(expressed as percent injected dose per gram normalized to a 25 g mouse),,,CHEMBL618885,,50594,Mus musculus,,,N,1,BAO_0000218,
11328,In vivo,13256,Intermediate,10090.0,,1,Biodistribution in CD-1 mice was determined after 120 minutes in liver(expressed as percent injected dose per gram normalized to a 25 g mouse),,,CHEMBL618886,,50594,Mus musculus,,,N,1,BAO_0000218,2107.0
11329,In vivo,13256,Intermediate,10090.0,,1,Biodistribution in CD-1 mice was determined after 120 minutes in lung(expressed as percent injected dose per gram normalized to a 25 g mouse),,,CHEMBL618887,,50594,Mus musculus,,,N,1,BAO_0000218,
11330,In vivo,13256,Intermediate,10090.0,,1,Biodistribution in CD-1 mice was determined after 30 minutes in Striatum (expressed as percent injected dose per gram normalized to a 25 g mouse),,,CHEMBL619535,,50594,Mus musculus,,,N,1,BAO_0000218,
11331,In vivo,13256,Intermediate,10090.0,,1,Biodistribution in CD-1 mice was determined after 30 minutes in blood (expressed as percent injected dose per gram normalized to a 25 g mouse),,,CHEMBL619536,,50594,Mus musculus,,,N,1,BAO_0000218,178.0
11332,In vivo,13256,Intermediate,10090.0,,1,Biodistribution in CD-1 mice was determined after 30 minutes in cerebellum (expressed as percent injected dose per gram normalized to a 25 g mouse),,,CHEMBL619537,,50594,Mus musculus,,,N,1,BAO_0000218,2037.0
11333,In vivo,13256,Intermediate,10090.0,,1,Biodistribution in CD-1 mice was determined after 30 minutes in cortex (expressed as percent injected dose per gram normalized to a 25 g mouse),,,CHEMBL619705,,50594,Mus musculus,,,N,1,BAO_0000218,
11334,In vivo,13256,Intermediate,10090.0,,1,Biodistribution in CD-1 mice was determined after 30 minutes in femur (expressed as percent injected dose per gram normalized to a 25 g mouse),,,CHEMBL619706,,50594,Mus musculus,,,N,1,BAO_0000218,
11335,In vivo,13256,Intermediate,10090.0,,1,Biodistribution in CD-1 mice was determined after 30 minutes in liver (expressed as percent injected dose per gram normalized to a 25 g mouse),,,CHEMBL619707,,50594,Mus musculus,,,N,1,BAO_0000218,2107.0
11336,In vivo,13256,Intermediate,10090.0,,1,Biodistribution in CD-1 mice was determined after 30 minutes in lung (expressed as percent injected dose per gram normalized to a 25 g mouse),,,CHEMBL619708,,50594,Mus musculus,,,N,1,BAO_0000218,
11337,In vivo,13256,Intermediate,10090.0,,1,Biodistribution in CD-1 mice was determined after 5 minute in Striatum(expressed as percent injected dose per gram normalized to a 25 g mouse),,,CHEMBL625219,,50594,Mus musculus,,,N,1,BAO_0000218,
11338,In vivo,13256,Intermediate,10090.0,,1,Biodistribution in CD-1 mice was determined after 5 minute in blood(expressed as percent injected dose per gram normalized to a 25 g mouse),,,CHEMBL625220,,50594,Mus musculus,,,N,1,BAO_0000218,178.0
11339,In vivo,13256,Intermediate,10090.0,,1,Biodistribution in CD-1 mice was determined after 5 minute in cerebellum(expressed as percent injected dose per gram normalized to a 25 g mouse),,,CHEMBL625221,,50594,Mus musculus,,,N,1,BAO_0000218,2037.0
11340,In vivo,13256,Intermediate,10090.0,,1,Biodistribution in CD-1 mice was determined after 5 minute in cortex(expressed as percent injected dose per gram normalized to a 25 g mouse),,,CHEMBL625222,,50594,Mus musculus,,,N,1,BAO_0000218,
11341,In vivo,13256,Intermediate,10090.0,,1,Biodistribution in CD-1 mice was determined after 5 minute in femur(expressed as percent injected dose per gram normalized to a 25 g mouse),,,CHEMBL625223,,50594,Mus musculus,,,N,1,BAO_0000218,
11342,In vivo,13256,Intermediate,10090.0,,1,Biodistribution in CD-1 mice was determined after 5 minute in liver(expressed as percent injected dose per gram normalized to a 25 g mouse),,,CHEMBL625224,,50594,Mus musculus,,,N,1,BAO_0000218,2107.0
11343,In vivo,13256,Intermediate,10090.0,,1,Biodistribution in CD-1 mice was determined after 5 minute in lung(expressed as percent injected dose per gram normalized to a 25 g mouse),,,CHEMBL625225,,50594,Mus musculus,,,N,1,BAO_0000218,
11344,In vivo,8829,Intermediate,10116.0,,1,Biodistribution in Rat blood after 24 hours of iv administration,,,CHEMBL625226,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
11345,In vivo,8829,Intermediate,10116.0,,1,Biodistribution in Rat blood after 24 hours of iv administration; per g of tissue,,,CHEMBL625227,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
11346,In vivo,8829,Intermediate,10116.0,,1,Biodistribution in Rat blood after 30 minutes of iv administration,,,CHEMBL625228,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
11347,In vivo,8829,Intermediate,10116.0,,1,Biodistribution in Rat blood after 30 minutes of iv administration; per g of tissue,,,CHEMBL875354,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
11348,In vivo,8829,Intermediate,10116.0,,1,Biodistribution in Rat blood after 5 minutes of iv administration,,,CHEMBL625229,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
11349,In vivo,8829,Intermediate,10116.0,,1,Biodistribution in Rat blood after 5 minutes of iv administration; per g of tissue,,,CHEMBL625230,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
11350,In vivo,8829,Intermediate,10116.0,,1,Biodistribution in Rat heart after 24 hours of iv administration,,,CHEMBL625231,,50597,Rattus norvegicus,,,N,1,BAO_0000218,948.0
11351,In vivo,8829,Intermediate,10116.0,,1,Biodistribution in Rat heart after 24 hours of iv administration; per g of tissue,,,CHEMBL625900,,50597,Rattus norvegicus,,,N,1,BAO_0000218,948.0
11352,In vivo,8829,Intermediate,10116.0,,1,Biodistribution in Rat heart after 30 minutes of iv administration,,,CHEMBL625901,,50597,Rattus norvegicus,,,N,1,BAO_0000218,948.0
11353,In vivo,8829,Intermediate,10116.0,,1,Biodistribution in Rat heart after 30 minutes of iv administration; per g of tissue,,,CHEMBL625902,,50597,Rattus norvegicus,,,N,1,BAO_0000218,948.0
11354,In vivo,8829,Intermediate,10116.0,,1,Biodistribution in Rat heart after 5 minutes of iv administration,,,CHEMBL625903,,50597,Rattus norvegicus,,,N,1,BAO_0000218,948.0
11355,In vivo,8829,Intermediate,10116.0,,1,Biodistribution in Rat heart after 5 minutes of iv administration; per g of tissue,,,CHEMBL625904,,50597,Rattus norvegicus,,,N,1,BAO_0000218,948.0
11356,In vivo,8829,Intermediate,10116.0,,1,Biodistribution in Rat liver after 24 hours of iv administration,,,CHEMBL625905,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
11357,In vivo,8829,Intermediate,10116.0,,1,Biodistribution in Rat liver after 24 hours of iv administration; per g of tissue,,,CHEMBL627861,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
11358,In vivo,8829,Intermediate,10116.0,,1,Biodistribution in Rat liver after 30 minutes of iv administration,,,CHEMBL627862,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
11359,In vivo,8829,Intermediate,10116.0,,1,Biodistribution in Rat liver after 30 minutes of iv administration; per g of tissue,,,CHEMBL627863,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
11360,In vivo,8829,Intermediate,10116.0,,1,Biodistribution in Rat liver after 30 minutes of iv administration,,,CHEMBL627769,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
11361,In vivo,13249,Intermediate,9615.0,,1,Maximum plasma concentration in Beagle dogs at oral dose of 20 mg/kg and an intravenous dose of 5 mg/kg was administered,,,CHEMBL627770,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,1969.0
11362,In vivo,13622,Intermediate,9541.0,,1,Cmax in cynomolgus monkey (PO dose),,,CHEMBL627771,,100710,Macaca fascicularis,,,N,1,BAO_0000218,
11363,In vivo,13622,Intermediate,10116.0,,1,Cmax in rat (PO dose),,,CHEMBL627772,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11364,In vivo,13622,Intermediate,10116.0,,1,Cmax in rat (PO dose),,,CHEMBL627773,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11365,In vivo,13494,Intermediate,10116.0,,1,Maximum plasma concentration in rats after an oral dose of 5 mg/kg,,,CHEMBL621922,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
11366,In vivo,12170,Intermediate,10116.0,,1,Cmax in rat plasma after oral dose (10 mg/kg),,,CHEMBL621923,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
11367,In vivo,12170,Autocuration,,,1,Cmax in plasma after oral dose (10 mg/kg),,,CHEMBL621924,,22224,,,,U,0,BAO_0000218,1969.0
11368,In vivo,17025,Intermediate,9615.0,,1,Maximum plasma concentration of compound was determined in dog at 25 mg/kg orally,,,CHEMBL621925,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,1969.0
11369,In vivo,17025,Autocuration,314293.0,,1,Maximum plasma concentration of compound was determined in monkey at 25 mg/kg orally,,,CHEMBL621926,,22224,Simiiformes,,,U,0,BAO_0000218,1969.0
11370,In vivo,17025,Intermediate,9986.0,,1,Maximum plasma concentration of compound was determined in rabbit at 25 mg/kg orally,,,CHEMBL621927,,50592,Oryctolagus cuniculus,,,N,1,BAO_0000218,1969.0
11371,In vivo,17025,Intermediate,10116.0,,1,Maximum plasma concentration of compound was determined in rat at 25 mg/kg orally,,,CHEMBL621928,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
11372,In vivo,14187,Intermediate,10116.0,,1,Maximum plasma concentration after p.o. (10 mpk) administration in rats.,,,CHEMBL621929,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
11373,In vivo,14816,Intermediate,10090.0,,1,Maximum plasma concentration (Cmax) after p.o. administration of 200 mg/kg in mice,,,CHEMBL621930,,50594,Mus musculus,,,N,1,BAO_0000218,1969.0
11374,In vivo,17820,Intermediate,10116.0,,1,Maximum plasma concentration after oral dosing in rat,,,CHEMBL621931,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
11375,In vivo,14380,Autocuration,,,1,Maximum plasma concentration evaluated in 100% PEG solution at a dose of 20 mg/kg orally,,,CHEMBL621932,,22224,,,,U,0,BAO_0000218,1969.0
11376,In vivo,14380,Autocuration,,,1,Maximum plasma concentration evaluated in HP-beta-CD solution at a dose of 20 mg/kg orally,,,CHEMBL621933,,22224,,,,U,0,BAO_0000218,1969.0
11377,In vivo,14691,Intermediate,9615.0,,1,Maximum plasma concentration in dogs at 0.5 mg/kg dose upon oral administration,,,CHEMBL621934,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,1969.0
11378,In vivo,14691,Intermediate,9615.0,,1,Maximum plasma concentration in dogs at 1 mg/kg dose upon oral administration,,,CHEMBL621935,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,1969.0
11379,In vivo,13375,Intermediate,10116.0,,1,Maximum plasma concentration in rat upon oral administration of 40 mg/kg,,,CHEMBL621936,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
11380,In vivo,6236,Autocuration,,,1,Maximum plasma concentration was determined,,,CHEMBL621937,,22224,,,,U,0,BAO_0000218,1969.0
11381,In vivo,14380,Autocuration,,,1,Maximum plasma concentration was evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,,,CHEMBL621938,,22224,,,,U,0,BAO_0000218,1969.0
11382,In vivo,14380,Autocuration,,,1,Maximum plasma concentration was evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,,,CHEMBL621939,,22224,,,,U,0,BAO_0000218,1969.0
11383,In vivo,14380,Autocuration,,,1,Maximum plasma concentration was evaluated in 10% of PEG suspension at a dose of 20 mg/kg orally,,,CHEMBL621940,,22224,,,,U,0,BAO_0000218,1969.0
11384,In vivo,14380,Autocuration,,,1,Maximum plasma concentration was evaluated in 100% of PEG solution at a dose of 20 mg/kg orally,,,CHEMBL621941,,22224,,,,U,0,BAO_0000218,1969.0
11385,In vivo,14380,Autocuration,,,1,Maximum plasma concentration was evaluated in DMA:H2O solution at a dose of 20 mg/kg orally,,,CHEMBL621942,,22224,,,,U,0,BAO_0000218,1969.0
11386,In vivo,14380,Autocuration,,,1,Maximum plasma concentration was evaluated in HP-beta-CD solution at a dose of 20 mg/kg orally,,,CHEMBL626178,,22224,,,,U,0,BAO_0000218,1969.0
11387,In vivo,14380,Autocuration,,,1,Maximum plasma concentration was evaluated in Hp-beta-CD solution at a dose of 20 mg/kg orally,,,CHEMBL626179,,22224,,,,U,0,BAO_0000218,1969.0
11388,In vivo,14380,Autocuration,,,1,Maximum plasma concentration was evaluated in saline solution at a dose of 20 mg/kg orally,,,CHEMBL626180,,22224,,,,U,0,BAO_0000218,1969.0
11389,In vivo,13622,Intermediate,10116.0,,1,Plasma Cmax in rat (PO dose),,,CHEMBL626181,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
11390,In vivo,15372,Intermediate,10116.0,,1,Maximum serum concentration after po dose of 5.22 mg/kg in rats,,,CHEMBL626182,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11391,In vivo,15372,Intermediate,10116.0,,1,Maximum serum concentration after po dose of 5.46 mg/kg in rats,,,CHEMBL626183,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11392,In vivo,15372,Intermediate,10116.0,,1,Maximum serum concentration was determined for the compound after po dose of 5.01 mg/kg in rats,,,CHEMBL626184,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11393,In vivo,15372,Intermediate,10116.0,,1,Maximum serum concentration was determined for the compound after po dose of 5.03 mg/kg in rats,,,CHEMBL626185,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11394,In vivo,14925,Intermediate,9615.0,,1,Maximum plasma concentration (Cmax) was determined in dogs fed after oral administration of 25 mg/kg of the compound.,,,CHEMBL626186,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,1969.0
11395,In vivo,14925,Intermediate,9615.0,,1,Maximum plasma concentration (Cmax) was determined in fasted dogs after oral administration of 25 mg/kg of the compound.,,,CHEMBL877589,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,1969.0
11396,In vivo,11883,Autocuration,,,1,Maximum concentration of the drug at 1 uM/dg administered intravenously,,,CHEMBL626187,,22224,,,,U,0,BAO_0000218,
11397,In vivo,11883,Autocuration,,,1,Maximum concentration of the drug at 20 uM/dg administered perorally,,,CHEMBL626188,,22224,,,,U,0,BAO_0000218,
11398,In vivo,13391,Autocuration,,,1,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg,,,CHEMBL626189,,22224,,,,U,0,BAO_0000218,
11399,In vivo,13391,Autocuration,,,1,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg; b = No compound detectable in blood above the detection limit of 0.1 uM,,,CHEMBL626855,,22224,,,,U,0,BAO_0000218,178.0
11400,In vivo,13391,Autocuration,,,1,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg; b denotes No compound detectable in blood above the detection limit of 0.1 uM,,,CHEMBL623781,,22224,,,,U,0,BAO_0000218,178.0
11401,In vivo,13391,Autocuration,,,1,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg;b = No compound detectable in blood above the detection limit of 0.1 uM,,,CHEMBL623782,,22224,,,,U,0,BAO_0000218,178.0
11402,In vivo,16360,Intermediate,10116.0,,1,Oral absorption expressed as peak plasma conc (Cmax) after oral dosing of 50 mg/kg in rat,,,CHEMBL623783,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
11403,In vivo,3673,Intermediate,9615.0,,1,Cmax in dog plasma after 1mg/kg oral dose,,,CHEMBL623784,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,1969.0
11404,In vivo,14431,Intermediate,9615.0,,1,Bioavailability as maximal plasma concentration in dogs after 2.5 mg/kg oral dose,,,CHEMBL623785,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,1969.0
11405,In vivo,14431,Intermediate,10116.0,,1,Bioavailability as maximal plasma concentration in rats after 10 mg/kg oral dose,,,CHEMBL623786,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
11406,In vivo,14964,Intermediate,10116.0,,1,Oral maximum concentration in rat,,,CHEMBL623787,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11407,In vivo,14964,Intermediate,10116.0,,1,Oral maximum concentration in rat,,,CHEMBL623788,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11408,In vivo,14209,Intermediate,10090.0,,1,Oral plasma concentration in mice at 100 mg/kg dosage within 4-hr time frame.,,,CHEMBL623789,,50594,Mus musculus,,,N,1,BAO_0000218,1969.0
11409,In vivo,11355,Intermediate,10090.0,,1,Peak concentration in blood after intravenous administration to mice,,,CHEMBL623790,,50594,Mus musculus,,,N,1,BAO_0000218,178.0
11410,In vivo,11355,Intermediate,10090.0,,1,Peak concentration in blood after peroral administration to mice,,,CHEMBL623791,,50594,Mus musculus,,,N,1,BAO_0000218,178.0
11411,In vivo,11966,Intermediate,10116.0,,1,Peak concentration in rat plasma was determined,,,CHEMBL623792,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
11412,In vivo,8918,Autocuration,314293.0,,1,Peak plasma concentration expresses the ability of compound for the release of L-Dopa in the plasma of monkey after oral administration of 0.05 mmol/kg,,,CHEMBL623793,,22224,Simiiformes,,,U,0,BAO_0000218,1969.0
11413,In vivo,8918,Intermediate,10090.0,,1,Peak plasma concentration expresses the ability of compound for the release of L-Dopa in the plasma of mouse after oral administration of 0.05 mmol/kg,,,CHEMBL623794,,50594,Mus musculus,,,N,1,BAO_0000218,1969.0
11414,In vivo,8918,Intermediate,10116.0,,1,Peak plasma concentration expresses the ability of compound for the release of L-Dopa in the plasma of rat after oral administration of 0.05 mmol/kg,,,CHEMBL623795,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
11415,,8684,Intermediate,10116.0,,1,"Distribution in rat heart 4 hr after intravenous administration, injected dose/gm",,,CHEMBL623796,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11416,,8684,Intermediate,10116.0,,1,"Distribution in rat heart 5 min after intravenous administration, injected dose/gm",,,CHEMBL623797,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11417,,8684,Intermediate,10116.0,,1,"Distribution in rat heart 6 hr after intravenous administration, injected dose/gm",,,CHEMBL623798,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11418,,8684,Intermediate,10116.0,,1,"Distribution in rat heart 8 hr after intravenous administration, injected dose/gm",,,CHEMBL623799,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11419,,8684,Intermediate,10116.0,,1,"Distribution in rat intestine 15 min after intravenous administration, injected dose/gm",,,CHEMBL624490,,50597,Rattus norvegicus,,,N,1,BAO_0000218,160.0
11420,,8684,Intermediate,10116.0,,1,"Distribution in rat intestine 1 hr after intravenous administration, injected dose/gm",,,CHEMBL624491,,50597,Rattus norvegicus,,,N,1,BAO_0000218,160.0
11421,,8684,Intermediate,10116.0,,1,"Distribution in rat intestine 2 hr after intravenous administration, injected dose/gm",,,CHEMBL624492,,50597,Rattus norvegicus,,,N,1,BAO_0000218,160.0
11422,,8684,Intermediate,10116.0,,1,"Distribution in rat intestine 30 min after intravenous administration, injected dose/gm",,,CHEMBL624493,,50597,Rattus norvegicus,,,N,1,BAO_0000218,160.0
11423,,8684,Intermediate,10116.0,,1,"Distribution in rat intestine 4 hr after intravenous administration, injected dose/gm",,,CHEMBL877595,,50597,Rattus norvegicus,,,N,1,BAO_0000218,160.0
11424,,8684,Intermediate,10116.0,,1,"Distribution in rat intestine 5 min after intravenous administration, injected dose/gm",,,CHEMBL624494,,50597,Rattus norvegicus,,,N,1,BAO_0000218,160.0
11425,,8684,Intermediate,10116.0,,1,"Distribution in rat intestine 6 hr after intravenous administration, injected dose/gm",,,CHEMBL624495,,50597,Rattus norvegicus,,,N,1,BAO_0000218,160.0
11426,,8684,Intermediate,10116.0,,1,"Distribution in rat intestine 8 hr after intravenous administration, injected dose/gm",,,CHEMBL624681,,50597,Rattus norvegicus,,,N,1,BAO_0000218,160.0
11427,,8684,Intermediate,10116.0,,1,"Distribution in rat kidney, 15 min after intravenous administration, injected dose/gm",,,CHEMBL624682,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11428,,8684,Intermediate,10116.0,,1,"Distribution in rat kidney, 1 hr after intravenous administration, injected dose/gm",,,CHEMBL624683,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11429,,8684,Intermediate,10116.0,,1,"Distribution in rat kidney, 2 hr after intravenous administration, injected dose/gm",,,CHEMBL624684,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11430,,8684,Intermediate,10116.0,,1,"Distribution in rat kidney, 30 min after intravenous administration, injected dose/gm",,,CHEMBL624685,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11431,,8684,Intermediate,10116.0,,1,"Distribution in rat kidney, 4 hr after intravenous administration, injected dose/gm",,,CHEMBL624686,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11432,,8684,Intermediate,10116.0,,1,"Distribution in rat kidney, 5 min after intravenous administration, injected dose/gm",,,CHEMBL624687,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11433,,8684,Intermediate,10116.0,,1,"Distribution in rat kidney, 6 hr after intravenous administration, injected dose/gm",,,CHEMBL624688,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11434,,8684,Intermediate,10116.0,,1,"Distribution in rat kidney, 8 hr after intravenous administration, injected dose/gm",,,CHEMBL627161,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11435,,8684,Intermediate,10116.0,,1,"Distribution in rat liver 15 min after intravenous administration, injected dose/gm",,,CHEMBL622127,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11436,,8684,Intermediate,10116.0,,1,"Distribution in rat liver 1 hr after intravenous administration, injected dose/gm",,,CHEMBL622128,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11437,,8684,Intermediate,10116.0,,1,"Distribution in rat liver 2 hr after intravenous administration, injected dose/gm",,,CHEMBL874384,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11438,,8684,Intermediate,10116.0,,1,"Distribution in rat liver 30 min after intravenous administration, injected dose/gm",,,CHEMBL624898,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11439,,8684,Intermediate,10116.0,,1,"Distribution in rat liver 4 hr after intravenous administration, injected dose/gm",,,CHEMBL624899,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11440,,8684,Intermediate,10116.0,,1,"Distribution in rat liver 5 min after intravenous administration, injected dose/gm",,,CHEMBL624900,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11441,,8684,Intermediate,10116.0,,1,"Distribution in rat liver 6 hr after intravenous administration, injected dose/gm",,,CHEMBL624901,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11442,,8684,Intermediate,10116.0,,1,"Distribution in rat liver 8 hr after intravenous administration, injected dose/gm",,,CHEMBL624902,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11443,,8684,Intermediate,10116.0,,1,"Distribution in rat lungs 15 min after intravenous administration, injected dose/gm",,,CHEMBL624903,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11444,,8684,Intermediate,10116.0,,1,"Distribution in rat lungs 1 hr after intravenous administration, injected dose/gm",,,CHEMBL624904,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11445,,8684,Intermediate,10116.0,,1,"Distribution in rat lungs 2 hr after intravenous administration, injected dose/gm",,,CHEMBL624905,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11446,,8684,Intermediate,10116.0,,1,"Distribution in rat lungs 30 min after intravenous administration, injected dose/gm",,,CHEMBL624906,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11447,,8684,Intermediate,10116.0,,1,"Distribution in rat lungs 4 hr after intravenous administration, injected dose/gm",,,CHEMBL624907,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11448,,8684,Intermediate,10116.0,,1,"Distribution in rat lungs 5 min after intravenous administration, injected dose/gm",,,CHEMBL624908,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11449,,8684,Intermediate,10116.0,,1,"Distribution in rat lungs 6 hr after intravenous administration, injected dose/gm",,,CHEMBL624909,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11450,,8684,Intermediate,10116.0,,1,"Distribution in rat lungs 8 hr after intravenous administration, injected dose/gm",,,CHEMBL624910,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11451,,8684,Intermediate,10116.0,,1,"Distribution in rat muscle 15 min after intravenous administration, injected dose/gm",,,CHEMBL624911,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2385.0
11452,,8684,Intermediate,10116.0,,1,"Distribution in rat muscle 1 hr after intravenous administration, injected dose/gm",,,CHEMBL874388,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2385.0
11453,,8684,Intermediate,10116.0,,1,"Distribution in rat muscle 2 hr after intravenous administration, injected dose/gm",,,CHEMBL624912,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2385.0
11454,,8684,Intermediate,10116.0,,1,"Distribution in rat muscle 30 min after intravenous administration, injected dose/gm",,,CHEMBL622930,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2385.0
11455,,8684,Intermediate,10116.0,,1,"Distribution in rat muscle 4 hr after intravenous administration, injected dose/gm",,,CHEMBL623121,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2385.0
11456,,8684,Intermediate,10116.0,,1,"Distribution in rat muscle 5 min after intravenous administration, injected dose/gm",,,CHEMBL623122,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2385.0
11457,,8684,Intermediate,10116.0,,1,"Distribution in rat muscle 6 hr after intravenous administration, injected dose/gm",,,CHEMBL623123,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2385.0
11458,,8684,Intermediate,10116.0,,1,"Distribution in rat muscle 8 hr after intravenous administration, injected dose/gm",,,CHEMBL623124,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2385.0
11459,,8684,Intermediate,10116.0,,1,"Distribution in rat pancreas 15 min after intravenous administration, injected dose/gm",,,CHEMBL623125,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11460,,8684,Intermediate,10116.0,,1,"Distribution in rat pancreas 1 hr after intravenous administration, injected dose/gm",,,CHEMBL623126,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11461,,8684,Intermediate,10116.0,,1,"Distribution in rat pancreas 2 hr after intravenous administration, injected dose/gm",,,CHEMBL623127,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11462,,8684,Intermediate,10116.0,,1,"Distribution in rat pancreas 30 min after intravenous administration, injected dose/gm",,,CHEMBL623128,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11463,,8684,Intermediate,10116.0,,1,"Distribution in rat pancreas 4 hr after intravenous administration, injected dose/gm",,,CHEMBL623129,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11464,,8684,Intermediate,10116.0,,1,"Distribution in rat pancreas 5 min after intravenous administration, injected dose/gm",,,CHEMBL623130,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11465,,8684,Intermediate,10116.0,,1,"Distribution in rat pancreas 6 hr after intravenous administration, injected dose/gm",,,CHEMBL623131,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11466,,8684,Intermediate,10116.0,,1,"Distribution in rat pancreas 8 hr after intravenous administration, injected dose/gm",,,CHEMBL623132,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11467,,8319,Intermediate,10116.0,,1,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose per gram in the organ,,,CHEMBL623133,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
11468,,8319,Intermediate,10116.0,,1,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat lung as Percent of injected dose per gram in the organ,,,CHEMBL623134,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11469,,8319,Intermediate,10116.0,,1,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat blood as Percent of injected dose per gram in the organ,,,CHEMBL874389,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11470,,8319,Intermediate,10116.0,,1,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose in the total organ,,,CHEMBL623135,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11471,,8319,Intermediate,10116.0,,1,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose per gram in the organ,,,CHEMBL623136,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11472,,8319,Intermediate,10116.0,,1,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose in the total organ,,,CHEMBL623137,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11473,,8319,Intermediate,10116.0,,1,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose per gram in the organ,,,CHEMBL623138,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11474,,8319,Intermediate,10116.0,,1,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose in the total organ,,,CHEMBL623139,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2113.0
11475,,8319,Intermediate,10116.0,,1,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,,,CHEMBL623140,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2113.0
11476,,8319,Intermediate,10116.0,,1,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose in the total organ,,,CHEMBL623141,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
11477,,8319,Intermediate,10116.0,,1,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose per gram in the organ,,,CHEMBL623142,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
11478,,8319,Intermediate,10116.0,,1,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat lung as Percent of injected dose per gram in the organ,,,CHEMBL623143,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11479,,14571,Intermediate,10090.0,,1,The total amount of penciclovir recovered in the urine over a 48-h period was determined by HPLC using a C18 reversed-phase column in mouse.,,,CHEMBL623144,,50594,Mus musculus,,,N,1,BAO_0000218,1088.0
11480,,14571,Intermediate,10116.0,,1,The total amount of penciclovir recovered in the urine over a 48-h period was determined by HPLC using a C18 reversed-phase column in rat.,,,CHEMBL623405,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
11481,,8319,Intermediate,10116.0,,1,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat blood as Percent of injected dose per gram in the organ,,,CHEMBL624074,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11482,,8319,Intermediate,10116.0,,1,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose in the total organ,,,CHEMBL624075,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11483,,8319,Intermediate,10116.0,,1,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose per gram in the organ,,,CHEMBL624076,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11484,,8319,Intermediate,10116.0,,1,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose in the total organ,,,CHEMBL624077,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11485,,8319,Intermediate,10116.0,,1,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose per gram in the organ,,,CHEMBL624078,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11486,,8319,Intermediate,10116.0,,1,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose in the total organ,,,CHEMBL624079,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2113.0
11487,,8319,Intermediate,10116.0,,1,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,,,CHEMBL624261,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2113.0
11488,,8319,Intermediate,10116.0,,1,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose in the total organ,,,CHEMBL624262,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11489,,8319,Intermediate,10116.0,,1,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose per gram in the organ,,,CHEMBL624263,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11490,,8319,Intermediate,10116.0,,1,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat lung as Percent of injected dose per gram in the organ,,,CHEMBL624264,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11491,,8319,Intermediate,10116.0,,1,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat blood as Percent of injected dose per gram in the organ,,,CHEMBL624265,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11492,,8319,Intermediate,10116.0,,1,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose in the total organ,,,CHEMBL624266,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11493,,8319,Intermediate,10116.0,,1,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose per gram in the organ,,,CHEMBL624267,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11494,,8319,Intermediate,10116.0,,1,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose in the total organ,,,CHEMBL624268,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11495,,8319,Intermediate,10116.0,,1,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose per gram in the organ,,,CHEMBL875227,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11496,,8319,Intermediate,10116.0,,1,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose in the total organ,,,CHEMBL624269,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2113.0
11497,,8319,Intermediate,10116.0,,1,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,,,CHEMBL624270,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2113.0
11498,,8319,Intermediate,10116.0,,1,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose in the total organ,,,CHEMBL624271,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11499,,8319,Intermediate,10116.0,,1,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose per gram in the organ,,,CHEMBL624272,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11500,,8319,Intermediate,10116.0,,1,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat lung as Percent of injected dose per gram in the organ,,,CHEMBL624273,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11501,,12064,Intermediate,10116.0,,1,Urinary excretion in rat after 0-4 hours of oral administration at 50 mg/kg,,,CHEMBL624274,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
11502,,12064,Intermediate,10116.0,,1,Urinary excretion in rat after 4-8 hours of oral administration at 50 mg/kg,,,CHEMBL624275,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
11503,,12064,Intermediate,10116.0,,1,Urinary excretion in rat after 8-24 hours of oral administration at 50 mg/kg,,,CHEMBL624276,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
11504,,12038,Intermediate,10116.0,,1,Urinary recovery expressed as percentage dose in male rats after iv administration of 20 mg/kg,,,CHEMBL624277,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
11505,,14314,Autocuration,,,1,% dose converted to 2-amino-5-chlorophenyl sulfate,,,CHEMBL624278,,22224,,,,U,0,BAO_0000019,
11506,,14314,Autocuration,,,1,% dose converted to 4-(S-amino-N-{[(4-chlorophenyl)amino]carbonyl}sulfonimidoyl)benzoic acid (compound 41),,,CHEMBL624279,,22224,,,,U,0,BAO_0000019,
11507,,11488,Intermediate,10116.0,,1,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 0-24 hr",,,CHEMBL624280,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1988.0
11508,,11488,Intermediate,10116.0,,1,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 24-48 hr",,,CHEMBL624281,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1988.0
11509,,11488,Intermediate,10116.0,,1,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 0-24 hr",,,CHEMBL622933,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1988.0
11510,,11488,Intermediate,10116.0,,1,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 24-48 hr",,,CHEMBL622934,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1988.0
11511,In vivo,8829,Intermediate,10116.0,,1,Biodistribution in Rat liver after 30 minutes of iv administration; per g of tissue,,,CHEMBL622935,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
11512,In vivo,8829,Intermediate,10116.0,,1,Biodistribution in Rat liver after 5 minutes of iv administration,,,CHEMBL622936,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
11513,In vivo,8829,Intermediate,10116.0,,1,Biodistribution in Rat liver after 5 minutes of iv administration; per g of tissue,,,CHEMBL875228,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
11514,In vivo,8829,Intermediate,10116.0,,1,Biodistribution in Rat lung after 24 hours of iv administration,,,CHEMBL622937,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2048.0
11515,In vivo,8829,Intermediate,10116.0,,1,Biodistribution in Rat lung after 24 hours of iv administration; per g of tissue,,,CHEMBL622938,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2048.0
11516,In vivo,8829,Intermediate,10116.0,,1,Biodistribution in Rat lung after 30 minutes of iv administration,,,CHEMBL619736,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2048.0
11517,In vivo,8829,Intermediate,10116.0,,1,Biodistribution in Rat lung after 30 minutes of iv administration; per g of tissue,,,CHEMBL625117,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2048.0
11518,In vivo,8829,Intermediate,10116.0,,1,Biodistribution in Rat lung after 5 minutes of iv administration,,,CHEMBL625118,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2048.0
11519,In vivo,8829,Intermediate,10116.0,,1,Biodistribution in Rat lung after 5 minutes of iv administration; per g of tissue,,,CHEMBL625119,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2048.0
11520,In vivo,14972,Intermediate,10116.0,,1,"Biodistribution in rat cerebellum, expressed as percent I.D./g tissue",,,CHEMBL625120,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2037.0
11521,In vivo,14972,Intermediate,10116.0,,1,"Biodistribution in rat superior coliculus, expressed as percent I.D./g tissue",,,CHEMBL625121,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11522,In vivo,14972,Intermediate,10116.0,,1,"Biodistribution in rat thalamus, expressed as percent I.D./g tissue",,,CHEMBL625122,,50597,Rattus norvegicus,,,N,1,BAO_0000218,10000006.0
11523,In vivo,14608,Intermediate,10116.0,,1,Biodistribution was measured in blood of rat by injecting the radiolabeled compound intravenously and the value measured after 2 min,,,CHEMBL622204,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
11524,In vivo,14608,Intermediate,10116.0,,1,Biodistribution was measured in blood of rat by injecting the radiolabeled compound intravenously and the value measured after 30 min,,,CHEMBL877503,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
11525,In vivo,14608,Intermediate,10116.0,,1,Biodistribution was measured in blood of rat by injecting the radiolabeled compound intravenously and the value measured after 60 min,,,CHEMBL627127,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
11526,In vivo,14608,Autocuration,,,1,Biodistribution was measured in hippocampus region(HP/CB) by injecting the radiolabeled compound intravenously and the value measured after 2 min,,,CHEMBL627128,,22224,,,,U,0,BAO_0000218,10000000.0
11527,In vivo,14608,Autocuration,,,1,Biodistribution was measured in hippocampus region(HP/CB) by injecting the radiolabeled compound intravenously and the value measured after 30 min,,,CHEMBL627129,,22224,,,,U,0,BAO_0000218,10000000.0
11528,In vivo,14608,Autocuration,,,1,Biodistribution was measured in hippocampus region(HP/CB) by injecting the radiolabeled compound intravenously and the value measured after 60 min,,,CHEMBL627130,,22224,,,,U,0,BAO_0000218,10000000.0
11529,In vivo,14608,Intermediate,10116.0,,1,Biodistribution was measured in rat brain by injecting the radiolabeled compound intravenously and the value measured after 2 min,,,CHEMBL627131,,50597,Rattus norvegicus,,,N,1,BAO_0000218,955.0
11530,In vivo,14608,Intermediate,10116.0,,1,Biodistribution was measured in rat brain by injecting the radiolabeled compound intravenously and the value measured after 30 min,,,CHEMBL627132,,50597,Rattus norvegicus,,,N,1,BAO_0000218,955.0
11531,In vivo,14608,Intermediate,10116.0,,1,Biodistribution was measured in rat brain by injecting the radiolabeled compound intravenously and the value measured after 60 min,,,CHEMBL627133,,50597,Rattus norvegicus,,,N,1,BAO_0000218,955.0
11532,In vivo,14608,Intermediate,10116.0,,1,Biodistribution was measured in rat cerebellum by injecting the radiolabeled compound intravenously and the value measured after 2 min,,,CHEMBL627134,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2037.0
11533,In vivo,14608,Intermediate,10116.0,,1,Biodistribution was measured in rat cerebellum by injecting the radiolabeled compound intravenously and the value measured after 30 min,,,CHEMBL627135,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2037.0
11534,In vivo,14608,Intermediate,10116.0,,1,Biodistribution was measured in rat cerebellum by injecting the radiolabeled compound intravenously and the value measured after 60 min,,,CHEMBL627136,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2037.0
11535,In vivo,14608,Intermediate,10116.0,,1,Biodistribution was measured in rat cortex by injecting the radiolabeled compound intravenously and the value measured after 2 min,,,CHEMBL628435,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11536,In vivo,14608,Intermediate,10116.0,,1,Biodistribution was measured in rat cortex by injecting the radiolabeled compound intravenously and the value measured after 30 min,,,CHEMBL628436,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11537,In vivo,14608,Intermediate,10116.0,,1,Biodistribution was measured in rat cortex by injecting the radiolabeled compound intravenously and the value measured after 60 min,,,CHEMBL628437,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11538,In vivo,14608,Intermediate,10116.0,,1,Biodistribution was measured in rat heart by injecting the radiolabeled compound intravenously and the value measured after 2 min,,,CHEMBL628438,,50597,Rattus norvegicus,,,N,1,BAO_0000218,948.0
11539,In vivo,14608,Intermediate,10116.0,,1,Biodistribution was measured in rat heart by injecting the radiolabeled compound intravenously and the value measured after 30 min,,,CHEMBL628439,,50597,Rattus norvegicus,,,N,1,BAO_0000218,948.0
11540,In vivo,14608,Intermediate,10116.0,,1,Biodistribution was measured in rat heart by injecting the radiolabeled compound intravenously and the value measured after 60 min,,,CHEMBL628440,,50597,Rattus norvegicus,,,N,1,BAO_0000218,948.0
11541,In vivo,14608,Intermediate,10116.0,,1,Biodistribution was measured in rat hippocampus by injecting the radiolabeled compound intravenously and the value measured after 2 min,,,CHEMBL628441,,50597,Rattus norvegicus,,,N,1,BAO_0000218,10000000.0
11542,In vivo,14608,Intermediate,10116.0,,1,Biodistribution was measured in rat hippocampus by injecting the radiolabeled compound intravenously and the value measured after 30 min,,,CHEMBL628442,,50597,Rattus norvegicus,,,N,1,BAO_0000218,10000000.0
11543,In vivo,14608,Intermediate,10116.0,,1,Biodistribution was measured in rat hippocampus by injecting the radiolabeled compound intravenously and the value measured after 60 min,,,CHEMBL628443,,50597,Rattus norvegicus,,,N,1,BAO_0000218,10000000.0
11544,In vivo,14608,Intermediate,10116.0,,1,Biodistribution was measured in rat kidney by injecting the radiolabeled compound intravenously and the value measured after 2 min,,,CHEMBL628444,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2113.0
11545,In vivo,14608,Intermediate,10116.0,,1,Biodistribution was measured in rat kidney by injecting the radiolabeled compound intravenously and the value measured after 30 min,,,CHEMBL628445,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2113.0
11546,In vivo,14608,Intermediate,10116.0,,1,Biodistribution was measured in rat kidney by injecting the radiolabeled compound intravenously and the value measured after 60 min,,,CHEMBL877504,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2113.0
11547,In vivo,14608,Intermediate,10116.0,,1,Biodistribution was measured in rat liver by injecting the radiolabeled compound intravenously and the value measured after 2 min,,,CHEMBL628446,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
11548,In vivo,14608,Intermediate,10116.0,,1,Biodistribution was measured in rat liver by injecting the radiolabeled compound intravenously and the value measured after 30 min,,,CHEMBL626874,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
11549,In vivo,14608,Intermediate,10116.0,,1,Biodistribution was measured in rat liver by injecting the radiolabeled compound intravenously and the value measured after 60 min,,,CHEMBL626875,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
11550,In vivo,14608,Intermediate,10116.0,,1,Biodistribution was measured in rat lung by injecting the radiolabeled compound intravenously and the value measured after 2 min,,,CHEMBL626876,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2048.0
11551,In vivo,14608,Intermediate,10116.0,,1,Biodistribution was measured in rat lung by injecting the radiolabeled compound intravenously and the value measured after 30 min,,,CHEMBL626877,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2048.0
11552,In vivo,14608,Intermediate,10116.0,,1,Biodistribution was measured in rat lung by injecting the radiolabeled compound intravenously and the value measured after 60 min,,,CHEMBL626878,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2048.0
11553,In vivo,14608,Intermediate,10116.0,,1,Biodistribution was measured in rat muscle by injecting the radiolabeled compound intravenously and the value measured after 2 min,,,CHEMBL626879,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2385.0
11554,In vivo,8918,Autocuration,314293.0,,1,Peak plasma concentration expresses the ability of compound for the release of dopamine in the plasma of monkey after oral administration of 0.05 mmol/kg,,,CHEMBL626880,,22224,Simiiformes,,,U,0,BAO_0000218,1969.0
11555,In vivo,8918,Intermediate,10090.0,,1,Peak plasma concentration expresses the ability of compound for the release of dopamine in the plasma of mouse after oral administration of 0.05 mmol/kg,,,CHEMBL626881,,50594,Mus musculus,,,N,1,BAO_0000218,1969.0
11556,In vivo,8918,Intermediate,10116.0,,1,Peak plasma concentration expresses the ability of compound for the release of dopamine in the plasma of rat after oral administration of 0.05 mmol/kg,,,CHEMBL626882,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
11557,In vivo,14470,Intermediate,9615.0,,1,Peak plasma concentration was measured in dogs,,,CHEMBL626883,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,1969.0
11558,In vivo,14393,Intermediate,10116.0,,1,Pharmacokinetic Parameter (Cmax) was evaluated at 10 mg/kg (p.o.) in Wistar rats,,,CHEMBL626884,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11559,In vivo,14886,Intermediate,10116.0,,1,Pharmacokinetic parameter (Cmax ) was evaluated in Spargue-Dawley rat when given intravenously at dose 15 mg/kg,,,CHEMBL626885,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11560,In vivo,14886,Intermediate,10116.0,,1,Pharmacokinetic parameter (Cmax ) was evaluated in Spargue-Dawley rat when given peroral at dose 30 mg/kg,,,CHEMBL626886,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11561,In vivo,14886,Intermediate,10116.0,,1,Pharmacokinetic parameter (Cmax ) was evaluated in Spargue-Dawley rat when given peroral at dose 80 mg/kg,,,CHEMBL626887,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11562,In vivo,14393,Intermediate,10116.0,,1,Pharmacokinetic parameter (Cmax) was evaluated at 10 mg/kg (p.o.) in Wistar rats,,,CHEMBL626888,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11563,In vivo,13465,Intermediate,9615.0,,1,Pharmacokinetic parameter Cmax determined after intravenous administration of 15 mg/kg to dog,,,CHEMBL626889,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
11564,In vivo,13465,Autocuration,314293.0,,1,Pharmacokinetic parameter Cmax determined after intravenous administration of 25 mg/kg to monkey,,,CHEMBL626761,,22224,Simiiformes,,,U,0,BAO_0000218,
11565,In vivo,13465,Intermediate,9615.0,,1,Pharmacokinetic parameter Cmax determined after intravenous administration of 30 mg/kg abd antacid (CaCO3 dosed orally 10 min prior to and 60 min postdosing) to dog,,,CHEMBL626762,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
11566,In vivo,13465,Intermediate,9615.0,,1,Pharmacokinetic parameter Cmax determined after intravenous administration of 30 mg/kg to dog,,,CHEMBL626763,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
11567,In vivo,13465,Intermediate,10116.0,,1,Pharmacokinetic parameter Cmax determined after intravenous administration of 50 mg/kg to rat,,,CHEMBL626764,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11568,In vivo,13465,Intermediate,10116.0,,1,Pharmacokinetic parameter Cmax determined after intravenous administration of 60 mg/kg to rat,,,CHEMBL626765,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11569,In vivo,13465,Intermediate,9615.0,,1,Pharmacokinetic parameter Cmax determined after oral administration of 50 mg/kg to dog,,,CHEMBL626766,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
11570,In vivo,13465,Intermediate,10116.0,,1,Pharmacokinetic parameter Cmax determined after oral administration of 50 mg/kg to rat,,,CHEMBL626767,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11571,In vivo,13465,Intermediate,10116.0,,1,Pharmacokinetic parameter Cmax determined after oral administration of 50 mg/kg to rat; No levels,,,CHEMBL626768,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11572,In vivo,13465,Intermediate,9615.0,,1,Pharmacokinetic parameter Cmax determined after peroral administration of 15 mg/kg to dog,,,CHEMBL626769,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
11573,In vivo,13465,Intermediate,9615.0,,1,Pharmacokinetic parameter Cmax determined after peroral administration of 25 mg/kg to dog,,,CHEMBL874463,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
11574,In vivo,13465,Autocuration,314293.0,,1,Pharmacokinetic parameter Cmax determined after peroral administration of 25 mg/kg to monkey,,,CHEMBL626770,,22224,Simiiformes,,,U,0,BAO_0000218,
11575,In vivo,13465,Autocuration,314293.0,,1,Pharmacokinetic parameter Cmax determined after peroral administration of 25 mg/kg to monkey; No levels,,,CHEMBL626771,,22224,Simiiformes,,,U,0,BAO_0000218,
11576,In vivo,13465,Intermediate,10116.0,,1,Pharmacokinetic parameter Cmax determined after peroral administration of 50 mg/kg to rat,,,CHEMBL626772,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11577,In vivo,14731,Intermediate,9541.0,,1,Pharmacokinetic parameter Cmax for the compound was evaluated in nude cynomolgus monkeys after oral administration. ,,,CHEMBL626773,,100710,Macaca fascicularis,,,N,1,BAO_0000218,
11578,In vivo,14731,Intermediate,10090.0,,1,Pharmacokinetic parameter Cmax for the compound was evaluated in nude mice after oral administration. ,,,CHEMBL626774,,50594,Mus musculus,,,N,1,BAO_0000218,
11579,In vivo,13376,Intermediate,9615.0,,1,Pharmacokinetic parameter Cmax has been determined in fed Beagle dogs at a dose of 375 mg/kg,,,CHEMBL626775,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
11580,In vivo,13376,Intermediate,9615.0,,1,Pharmacokinetic parameter Cmax has been determined in fed Beagle dogs at a dose of 500 mg/kg,,,CHEMBL626776,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
11581,In vivo,14443,Intermediate,10116.0,,1,Maximum concentration (Cmax) in rat when administered orally,,,CHEMBL626777,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11582,In vivo,13465,Autocuration,314293.0,,1,Maximal concentration in monkey plasma after 25 mg/kg oral dose,,,CHEMBL626778,,22224,Simiiformes,,,U,0,BAO_0000218,1969.0
11583,In vivo,16359,Autocuration,10116.0,,1,"Mean Cmax in rats after 5 mg/kg oral dose, range (0.17-0.20)",,,CHEMBL626779,,22224,Rattus norvegicus,,,U,0,BAO_0000218,
11584,In vivo,16359,Autocuration,10116.0,,1,"Mean Cmax in rats after 5 mg/kg oral dose, range (0.4-0.8)",,,CHEMBL626780,,22224,Rattus norvegicus,,,U,0,BAO_0000218,
11585,In vivo,15618,Autocuration,,,1,Cmax in rat plasma after single 5 mg/kg oral cassette gavage dose,,,CHEMBL626781,,22224,,,,U,0,BAO_0000218,1969.0
11586,In vivo,14554,Intermediate,10116.0,,1,Pharmacokinetic profile Cmax was evaluated in rats,,,CHEMBL632164,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11587,In vivo,11537,Intermediate,9615.0,,1,Pharmacokinetic property(Cmax- maximum concentration) after oral administration in dog (25 mg/kg),,,CHEMBL632165,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
11588,In vivo,11537,Intermediate,10090.0,,1,Pharmacokinetic property(Cmax- maximum concentration) after oral administration in mice (50 mg/kg),,,CHEMBL632166,,50594,Mus musculus,,,N,1,BAO_0000218,
11589,In vivo,11537,Intermediate,9615.0,,1,Pharmacokinetic property(Cmax- maximum concentration) after oral administration to dog (25 mg/kg),,,CHEMBL632167,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
11590,In vivo,11537,Intermediate,10090.0,,1,Pharmacokinetic property(Cmax- maximum concentration) after oral administration to mice (50 mg/kg),,,CHEMBL632168,,50594,Mus musculus,,,N,1,BAO_0000218,
11591,In vivo,2021,Autocuration,10116.0,,1,Cmax in rat plasma,,,CHEMBL632169,,22224,Rattus norvegicus,,,U,0,BAO_0000218,1969.0
11592,In vivo,5932,Intermediate,9615.0,,1,Cmax in dog plasma after 30mg/kg oral dose,,,CHEMBL632170,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,1969.0
11593,In vivo,5932,Intermediate,10116.0,,1,Cmax in rat plasma after 30mg/kg oral dose,,,CHEMBL632171,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
11594,In vivo,17320,Intermediate,10116.0,,1,Plasma level in rats at 30 mg/kg,,,CHEMBL632172,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
11595,In vivo,15831,Intermediate,10090.0,,1,Tested for maximum plasma concentration in mice,,,CHEMBL632173,,50594,Mus musculus,,,N,1,BAO_0000218,1969.0
11596,In vivo,15078,Intermediate,10116.0,,1,"The Cmax value in female wistar rat at 100 mg/kg, p.o. dose",,,CHEMBL632174,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11597,In vivo,14941,Intermediate,10116.0,,1,The Cmax values in female wistar rats.,,,CHEMBL632175,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11598,In vivo,15343,Intermediate,9615.0,,1,The Peak plasma concentration was measured in dogs after oral administration of 1 mg/kg dose,,,CHEMBL632176,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,1969.0
11599,In vivo,15343,Intermediate,10116.0,,1,The Peak plasma concentration was measured in rats after oral administration of 1 mg/kg dose,,,CHEMBL632177,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
11600,In vivo,14856,Intermediate,10116.0,,1,The compound tested for maximum observed plasma concentration in rats and is expressed in microgram/mL.,,,CHEMBL632178,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
11601,In vivo,13129,Intermediate,10116.0,,1,The compound was tested for Cmax value pharmacokinetic parameter in the male Sprague-Dawley rat.,,,CHEMBL632179,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11602,In vivo,13098,Intermediate,10116.0,,1,The compound was tested for maximum blood level reached in rats at 15.9 uM/kg after peroral administration.,,,CHEMBL632180,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
11603,In vivo,13098,Intermediate,10116.0,,1,The compound was tested for maximum blood level reached in rats at 15.9 uM/Kg after intravenous administration.,,,CHEMBL632181,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
11604,In vivo,13098,Intermediate,10116.0,,1,The compound was tested for maximum blood level reached in rats at 15.9 uM/Kg after peroral administration.,,,CHEMBL632182,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
11605,In vivo,15478,Autocuration,10090.0,,1,The maximum concentration observed (Cmax) in the blood sample at indicated time point (tmax) at a dose 50 mg/Kg administered orally in mice.,,,CHEMBL632183,,22224,Mus musculus,,,U,0,BAO_0000218,178.0
11606,In vivo,15341,Intermediate,9615.0,,1,The maximum concentration of the compound was measured in dog at dose 5 mg/kg after peroral administration.,,,CHEMBL632184,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
11607,In vivo,15341,Intermediate,10116.0,,1,The maximum concentration of the compound was measured in rat at dose 1 mg/kg after peroral administration.,,,CHEMBL874470,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11608,,8684,Intermediate,10116.0,,1,"Distribution in rat skin 15 min after intravenous administration, injected dose/gm",,,CHEMBL631302,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11609,,8684,Intermediate,10116.0,,1,"Distribution in rat skin 1 hr after intravenous administration, injected dose/gm",,,CHEMBL631303,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11610,,8684,Intermediate,10116.0,,1,"Distribution in rat skin 2 hr after intravenous administration, injected dose/gm",,,CHEMBL631304,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11611,,8684,Intermediate,10116.0,,1,"Distribution in rat skin 30 min after intravenous administration, injected dose/gm",,,CHEMBL631305,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11612,,8684,Intermediate,10116.0,,1,"Distribution in rat skin 4 hr after intravenous administration, injected dose/gm",,,CHEMBL631306,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11613,,8684,Intermediate,10116.0,,1,"Distribution in rat skin 5 min after intravenous administration, injected dose/gm",,,CHEMBL631307,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11614,,8684,Intermediate,10116.0,,1,"Distribution in rat skin 6 hr after intravenous administration, injected dose/gm",,,CHEMBL631308,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11615,,8684,Intermediate,10116.0,,1,"Distribution in rat skin 8 hr after intravenous administration, injected dose/gm",,,CHEMBL625557,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11616,,8684,Intermediate,10116.0,,1,"Distribution in rat spleen 15 min after intravenous administration, injected dose/gm",,,CHEMBL625558,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2106.0
11617,,8684,Intermediate,10116.0,,1,"Distribution in rat spleen 1 hr after intravenous administration, injected dose/gm",,,CHEMBL625559,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2106.0
11618,,8684,Intermediate,10116.0,,1,"Distribution in rat spleen 2 hr after intravenous administration, injected dose/gm",,,CHEMBL625560,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2106.0
11619,,8684,Intermediate,10116.0,,1,"Distribution in rat spleen 30 min after intravenous administration, injected dose/gm",,,CHEMBL625561,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2106.0
11620,,8684,Intermediate,10116.0,,1,"Distribution in rat spleen 4 hr after intravenous administration, injected dose/gm",,,CHEMBL625562,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2106.0
11621,,8684,Intermediate,10116.0,,1,"Distribution in rat spleen 5 min after intravenous administration, injected dose/gm",,,CHEMBL875320,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2106.0
11622,,8684,Intermediate,10116.0,,1,"Distribution in rat spleen 6 hr after intravenous administration, injected dose/gm",,,CHEMBL625563,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2106.0
11623,,8684,Intermediate,10116.0,,1,"Distribution in rat spleen 8 hr after intravenous administration, injected dose/gm",,,CHEMBL625564,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2106.0
11624,,8684,Intermediate,10116.0,,1,"Distribution in rat uterus 15 min after intravenous administration, injected dose/gm",,,CHEMBL625565,,50597,Rattus norvegicus,,,N,1,BAO_0000218,995.0
11625,,8684,Intermediate,10116.0,,1,"Distribution in rat uterus 1 hr after intravenous administration, injected dose/gm",,,CHEMBL625566,,50597,Rattus norvegicus,,,N,1,BAO_0000218,995.0
11626,,8684,Intermediate,10116.0,,1,"Distribution in rat uterus 2 hr after intravenous administration, injected dose/gm",,,CHEMBL625567,,50597,Rattus norvegicus,,,N,1,BAO_0000218,995.0
11627,,8684,Intermediate,10116.0,,1,"Distribution in rat uterus 30 min after intravenous administration, injected dose/gm",,,CHEMBL625568,,50597,Rattus norvegicus,,,N,1,BAO_0000218,995.0
11628,,8684,Intermediate,10116.0,,1,"Distribution in rat uterus 4 hr after intravenous administration, injected dose/gm",,,CHEMBL628217,,50597,Rattus norvegicus,,,N,1,BAO_0000218,995.0
11629,,8684,Intermediate,10116.0,,1,"Distribution in rat uterus 5 min after intravenous administration, injected dose/gm",,,CHEMBL628218,,50597,Rattus norvegicus,,,N,1,BAO_0000218,995.0
11630,,8684,Intermediate,10116.0,,1,"Distribution in rat uterus 6 hr after intravenous administration, injected dose/gm",,,CHEMBL628219,,50597,Rattus norvegicus,,,N,1,BAO_0000218,995.0
11631,,8684,Intermediate,10116.0,,1,"Distribution in rat uterus 8 hr after intravenous administration, injected dose/gm",,,CHEMBL628220,,50597,Rattus norvegicus,,,N,1,BAO_0000218,995.0
11632,,8926,Autocuration,,,1,Distribution in the blood after 120 min of intravenous administration,,,CHEMBL628221,,22224,,,,U,0,BAO_0000019,
11633,,8926,Autocuration,,,1,Distribution in the blood after 15 min of intravenous administration,,,CHEMBL628222,,22224,,,,U,0,BAO_0000019,
11634,,8926,Autocuration,,,1,Distribution in the blood after 30 min of intravenous administration,,,CHEMBL628223,,22224,,,,U,0,BAO_0000019,
11635,,8926,Autocuration,,,1,Distribution in the blood after 5 min of intravenous administration,,,CHEMBL628224,,22224,,,,U,0,BAO_0000019,
11636,,8926,Autocuration,,,1,Distribution in the blood after 60 min of intravenous administration,,,CHEMBL628225,,22224,,,,U,0,BAO_0000019,
11637,,8926,Autocuration,,,1,Distribution in the blood after 90 min of intravenous administration,,,CHEMBL628226,,22224,,,,U,0,BAO_0000019,
11638,,8926,Autocuration,,,1,Distribution in the bone after 120 min of intravenous administration,,,CHEMBL628227,,22224,,,,U,0,BAO_0000019,
11639,,8926,Autocuration,,,1,Distribution in the bone after 15 min of intravenous administration,,,CHEMBL875481,,22224,,,,U,0,BAO_0000019,
11640,,8926,Autocuration,,,1,Distribution in the bone after 30 min of intravenous administration,,,CHEMBL628228,,22224,,,,U,0,BAO_0000019,
11641,,8926,Autocuration,,,1,Distribution in the bone after 5 min of intravenous administration,,,CHEMBL628229,,22224,,,,U,0,BAO_0000019,
11642,,8926,Autocuration,,,1,Distribution in the bone after 60 min of intravenous administration,,,CHEMBL628230,,22224,,,,U,0,BAO_0000019,
11643,,8926,Autocuration,,,1,Distribution in the bone after 90 min of intravenous administration,,,CHEMBL628231,,22224,,,,U,0,BAO_0000019,
11644,,8926,Autocuration,,,1,Distribution in the heart after 120 min of intravenous administration,,,CHEMBL628232,,22224,,,,U,0,BAO_0000019,
11645,,8926,Autocuration,,,1,Distribution in the heart after 15 min of intravenous administration,,,CHEMBL628233,,22224,,,,U,0,BAO_0000019,
11646,,8926,Autocuration,,,1,Distribution in the heart after 30 min of intravenous administration,,,CHEMBL628234,,22224,,,,U,0,BAO_0000019,
11647,,8926,Autocuration,,,1,Distribution in the heart after 5 min of intravenous administration,,,CHEMBL628235,,22224,,,,U,0,BAO_0000019,
11648,,8926,Autocuration,,,1,Distribution in the heart after 60 min of intravenous administration,,,CHEMBL628236,,22224,,,,U,0,BAO_0000019,
11649,,8926,Autocuration,,,1,Distribution in the heart after 90 min of intravenous administration,,,CHEMBL628237,,22224,,,,U,0,BAO_0000019,
11650,,8926,Autocuration,,,1,Distribution in the kidneys after 120 min of intravenous administration,,,CHEMBL628238,,22224,,,,U,0,BAO_0000019,
11651,,8926,Autocuration,,,1,Distribution in the kidneys after 15 min of intravenous administration,,,CHEMBL628239,,22224,,,,U,0,BAO_0000019,
11652,,8926,Autocuration,,,1,Distribution in the kidneys after 30 min of intravenous administration,,,CHEMBL628240,,22224,,,,U,0,BAO_0000019,
11653,,8926,Autocuration,,,1,Distribution in the kidneys after 5 min of intravenous administration,,,CHEMBL628241,,22224,,,,U,0,BAO_0000019,
11654,,8926,Autocuration,,,1,Distribution in the kidneys after 60 min of intravenous administration,,,CHEMBL628242,,22224,,,,U,0,BAO_0000019,
11655,,8926,Autocuration,,,1,Distribution in the kidneys after 90 min of intravenous administration,,,CHEMBL875482,,22224,,,,U,0,BAO_0000019,
11656,,8926,Autocuration,,,1,Distribution in the liver after 120 min of intravenous administration,,,CHEMBL628243,,22224,,,,U,0,BAO_0000019,
11657,,8926,Autocuration,,,1,Distribution in the liver after 15 min of intravenous administration,,,CHEMBL628244,,22224,,,,U,0,BAO_0000019,
11658,,8926,Autocuration,,,1,Distribution in the liver after 30 min of intravenous administration,,,CHEMBL628245,,22224,,,,U,0,BAO_0000019,
11659,,8926,Autocuration,,,1,Distribution in the liver after 5 min of intravenous administration,,,CHEMBL628246,,22224,,,,U,0,BAO_0000019,
11660,,8926,Autocuration,,,1,Distribution in the liver after 60 min of intravenous administration,,,CHEMBL628247,,22224,,,,U,0,BAO_0000019,
11661,,8926,Autocuration,,,1,Distribution in the liver after 90 min of intravenous administration,,,CHEMBL628248,,22224,,,,U,0,BAO_0000019,
11662,,8926,Autocuration,,,1,Distribution in the lung after 120 min of intravenous administration,,,CHEMBL628249,,22224,,,,U,0,BAO_0000019,
11663,,14839,Intermediate,10090.0,,1,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in solution, iv and the total drug exposure was determined. (0-24hr)",,,CHEMBL625452,,50594,Mus musculus,,,N,1,BAO_0000218,
11664,,14839,Intermediate,10090.0,,1,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in solution, perorally and the total drug exposure was determined (0-24hr)",,,CHEMBL625453,,50594,Mus musculus,,,N,1,BAO_0000218,
11665,,14839,Intermediate,10090.0,,1,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, micronized free base in 20% HPbetaCD, iv and the total drug exposure was determined. (0-24hr)",,,CHEMBL625454,,50594,Mus musculus,,,N,1,BAO_0000218,
11666,,14839,Intermediate,10090.0,,1,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, micronized free base in 20% HPbetaCD, perorally and the total drug exposure was determined (0-24hr)",,,CHEMBL623844,,50594,Mus musculus,,,N,1,BAO_0000218,
11667,,12178,Intermediate,10116.0,,1,Integrated area under the blood concentration vs time curve for the period 0-24 hr postdose of 1 mg/kg (normalized to a 1 mg/kg dose) in rat,,,CHEMBL623845,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11668,,12178,Intermediate,10116.0,,1,Integrated area under the blood concentration vs time curve for the period 0-24 hr postdose of 2.5 mg/kg (normalized to a 1 mg/kg dose) in rat,,,CHEMBL623846,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11669,,12178,Autocuration,,,1,Integrated area under the blood concentration vs time curve for the period 0-24 hr postdose of 5.0 mg/kg (normalized to a 1 mg/kg dose) GP,,,CHEMBL623847,,22224,,,,U,0,BAO_0000218,
11670,,12186,Intermediate,9541.0,,1,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from portal circulation in salt-depleted cynomolgus monkeys using HPLC assay,,,CHEMBL623848,,100710,Macaca fascicularis,,,N,1,BAO_0000218,
11671,,12186,Intermediate,9541.0,,1,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from portal circulation in salt-depleted cynomolgus monkeys using renin inhibition assay,,,CHEMBL623849,,100710,Macaca fascicularis,,,N,1,BAO_0000218,
11672,,12186,Intermediate,9541.0,,1,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using HPLC assay,,,CHEMBL623850,,100710,Macaca fascicularis,,,N,1,BAO_0000218,
11673,,12186,Intermediate,9541.0,,1,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using renin inhibition assay,,,CHEMBL623851,,100710,Macaca fascicularis,,,N,1,BAO_0000218,
11674,,12187,Autocuration,314293.0,,1,Integrated area under the plasma drug level-time curve was determined in portal circulation after intraduodenal dose of 10 mg/kg in monkey,,,CHEMBL623852,,22224,Simiiformes,,,U,0,BAO_0000218,
11675,,12187,Intermediate,9669.0,,1,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret,,,CHEMBL624551,,50506,Mustela putorius furo,,,N,1,BAO_0000218,
11676,,12187,Intermediate,9669.0,,1,"Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret, determined by renin inhibition assay",,,CHEMBL624552,,50506,Mustela putorius furo,,,N,1,BAO_0000218,
11677,,12187,Autocuration,314293.0,,1,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey,,,CHEMBL624553,,22224,Simiiformes,,,U,0,BAO_0000218,
11678,,12187,Autocuration,314293.0,,1,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey determined by renin inhibition assay,,,CHEMBL624554,,22224,Simiiformes,,,U,0,BAO_0000218,
11679,,12187,Intermediate,10116.0,,1,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat,,,CHEMBL624555,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11680,,12187,Intermediate,10116.0,,1,"Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat, determined by renin inhibition assay",,,CHEMBL624741,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11681,,14122,Intermediate,9615.0,,1,"Intravenous integrated area under the concentration vs time curve, for compound in dog plasma",,,CHEMBL624742,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
11682,,14122,Intermediate,10026.0,,1,"Intravenous integrated area under the concentration vs time curve, for compound in hamster plasma",,,CHEMBL624743,,100712,Cricetinae,,,N,1,BAO_0000218,
11683,,14122,Intermediate,10116.0,,1,"Intravenous integrated area under the concentration vs time curve, for compound in rat plasma",,,CHEMBL877606,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11684,,13391,Autocuration,,,1,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg,,,CHEMBL624744,,22224,,,,U,0,BAO_0000218,
11685,,13391,Autocuration,,,1,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg; b = No compound detectable in blood above the detection limit of 0.1 uM,,,CHEMBL624745,,22224,,,,U,0,BAO_0000218,178.0
11686,,13391,Autocuration,,,1,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg; b denotes No compound detectable in blood above the detection limit of 0.1 uM,,,CHEMBL624746,,22224,,,,U,0,BAO_0000218,178.0
11687,,13391,Autocuration,,,1,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg;b = No compound detectable in blood above the detection limit of 0.1 uM,,,CHEMBL624747,,22224,,,,U,0,BAO_0000218,178.0
11688,,16360,Autocuration,,,1,Oral absorption expressed as Area under curve was determined,,,CHEMBL624748,,22224,,,,U,0,BAO_0000019,
11689,,3673,Intermediate,9615.0,,1,Oral absorption kinetics (AUC) was determined after administration of compound orally at 1 mg/kg in dogs,,,CHEMBL622504,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
11690,,14122,Intermediate,9615.0,,1,"Oral integrated area under the concentration vs time curve, for compound in dog plasma",,,CHEMBL622505,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
11691,,14122,Intermediate,10026.0,,1,"Oral integrated area under the concentration vs time curve, for compound in hamster plasma",,,CHEMBL622506,,100712,Cricetinae,,,N,1,BAO_0000218,
11692,,14122,Intermediate,10026.0,,1,"Oral integrated area under the concentration vs time curve, for compound in hamster plasma",,,CHEMBL622507,,100712,Cricetinae,,,N,1,BAO_0000218,
11693,,14122,Intermediate,10116.0,,1,"Oral integrated area under the concentration vs time curve, for compound in rat plasma",,,CHEMBL622508,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11694,,13889,Autocuration,,,1,Pharmacokinetic parameter AUC in mice following a single dose intravenous administration of the compound,,,CHEMBL622509,,22224,,,,U,0,BAO_0000019,
11695,,14393,Intermediate,10116.0,,1,Pharmacokinetic Parameter [Area under curve (AUC)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,,,CHEMBL622510,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11696,,17279,Intermediate,10116.0,,1,Pharmacokinetic parameter (AUC) was determined after administering 1 mg/kg of compound intravenously in rat no.3 belonging to phenotype EM (extensive metabolizer),,,CHEMBL622511,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11697,,14548,Intermediate,9541.0,,1,Pharmacokinetic parameter AUC calculated in cynomolgus monkey when the compound was administered intravenously at 0.5 mg/kg concentration,,,CHEMBL622512,,100710,Macaca fascicularis,,,N,1,BAO_0000218,
11698,,14548,Intermediate,9541.0,,1,Pharmacokinetic parameter AUC calculated in cynomolgus monkey when the compound was administered intravenously at 1 mg/kg concentration,,,CHEMBL622513,,100710,Macaca fascicularis,,,N,1,BAO_0000218,
11699,,14548,Intermediate,9541.0,,1,Pharmacokinetic parameter AUC calculated in cynomolgus monkey when the compound was administered po at 5 mg/kg concentration,,,CHEMBL622514,,100710,Macaca fascicularis,,,N,1,BAO_0000218,
11700,,14548,Intermediate,9615.0,,1,Pharmacokinetic parameter AUC calculated in dog when the compound was administered intravenously at 2 mg/kg concentration,,,CHEMBL622515,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
11701,,14548,Intermediate,9615.0,,1,Pharmacokinetic parameter AUC calculated in dog when the compound was administered po at 5 mg/kg concentration,,,CHEMBL622516,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
11702,,14548,Intermediate,10116.0,,1,Pharmacokinetic parameter AUC calculated in rat when the compound was administered intravenously at 5 mg/kg concentration,,,CHEMBL622517,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11703,,14548,Intermediate,10116.0,,1,Pharmacokinetic parameter AUC calculated in rat when the compound was administered po at 12 mg/kg concentration,,,CHEMBL622518,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11704,,14548,Intermediate,10116.0,,1,Pharmacokinetic parameter AUC calculated in rat when the compound was administered po at 20 mg/kg concentration,,,CHEMBL622519,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11705,In vivo,14608,Intermediate,10116.0,,1,Biodistribution was measured in rat muscle by injecting the radiolabeled compound intravenously and the value measured after 30 min,,,CHEMBL622520,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2385.0
11706,In vivo,14608,Intermediate,10116.0,,1,Biodistribution was measured in rat muscle by injecting the radiolabeled compound intravenously and the value measured after 60 min,,,CHEMBL622521,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2385.0
11707,In vivo,14608,Intermediate,10090.0,,1,Biodistribution was measured in rat skin by injecting the radiolabeled compound intravenously and the value measured after 2 min,,,CHEMBL625113,,50594,Mus musculus,,,N,1,BAO_0000218,14.0
11708,In vivo,14608,Intermediate,10116.0,,1,Biodistribution was measured in rat skin by injecting the radiolabeled compound intravenously and the value measured after 30 min,,,CHEMBL625114,,50597,Rattus norvegicus,,,N,1,BAO_0000218,14.0
11709,In vivo,14608,Intermediate,10116.0,,1,Biodistribution was measured in rat skin by injecting the radiolabeled compound intravenously and the value measured after 60 min,,,CHEMBL874397,,50597,Rattus norvegicus,,,N,1,BAO_0000218,14.0
11710,In vivo,14608,Intermediate,10116.0,,1,Biodistribution was measured in rat spleen by injecting the radiolabeled compound intravenously and the value measured after 2 min,,,CHEMBL625115,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2106.0
11711,In vivo,14608,Intermediate,10116.0,,1,Biodistribution was measured in rat spleen by injecting the radiolabeled compound intravenously and the value measured after 30 min,,,CHEMBL625116,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2106.0
11712,In vivo,14608,Intermediate,10116.0,,1,Biodistribution was measured in rat spleen by injecting the radiolabeled compound intravenously and the value measured after 60 min,,,CHEMBL623932,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2106.0
11713,In vivo,14608,Intermediate,10116.0,,1,Biodistribution was measured in rat striatum by injecting the radiolabeled compound intravenously and the value measured after 2 min,,,CHEMBL623933,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2435.0
11714,In vivo,14608,Intermediate,10116.0,,1,Biodistribution was measured in rat striatum by injecting the radiolabeled compound intravenously and the value measured after 30 min,,,CHEMBL623934,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2435.0
11715,In vivo,14608,Intermediate,10116.0,,1,Biodistribution was measured in rat striatum by injecting the radiolabeled compound intravenously and the value measured after 60 min,,,CHEMBL623935,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2435.0
11716,In vivo,14608,Intermediate,10116.0,,1,Biodistribution was measured in rat thyroid by injecting the radiolabeled compound intravenously and the value measured after 2 min,,,CHEMBL623936,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2046.0
11717,In vivo,14608,Intermediate,10116.0,,1,Biodistribution was measured in rat thyroid by injecting the radiolabeled compound intravenously and the value measured after 30 min,,,CHEMBL623937,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2046.0
11718,In vivo,14608,Intermediate,10116.0,,1,Biodistribution was measured in rat thyroid by injecting the radiolabeled compound intravenously and the value measured after 60 min,,,CHEMBL623938,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2046.0
11719,,15383,Intermediate,10090.0,,1,In vivo biodistribution in mice blood bearing intracerebral GL261 gliomas at the dose of 30 ug/day,,,CHEMBL623939,,50594,Mus musculus,,,N,1,BAO_0000218,
11720,,15383,Intermediate,10090.0,,1,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 10 ug/g,,,CHEMBL623940,,50594,Mus musculus,,,N,1,BAO_0000218,
11721,,15383,Intermediate,10090.0,,1,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 20 ug/g,,,CHEMBL623941,,50594,Mus musculus,,,N,1,BAO_0000218,
11722,,15383,Intermediate,10090.0,,1,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,,CHEMBL627216,,50594,Mus musculus,,,N,1,BAO_0000218,
11723,,15383,Intermediate,10090.0,,1,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,,CHEMBL623942,,50594,Mus musculus,,,N,1,BAO_0000218,
11724,,15383,Intermediate,10090.0,,1,In vivo biodistribution in mice brain bearing intracerebral GL261 gliomas at the dose of 30 ug/day,,,CHEMBL618793,,50594,Mus musculus,,,N,1,BAO_0000218,955.0
11725,,15383,Intermediate,10090.0,,1,In vivo biodistribution in mice brain bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,,CHEMBL618794,,50594,Mus musculus,,,N,1,BAO_0000218,955.0
11726,,15383,Intermediate,10090.0,,1,In vivo biodistribution in mice brain bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,,CHEMBL618795,,50594,Mus musculus,,,N,1,BAO_0000218,955.0
11727,,15383,Intermediate,10090.0,,1,In vivo biodistribution in mice eyes bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,,CHEMBL618796,,50594,Mus musculus,,,N,1,BAO_0000218,
11728,,15383,Intermediate,10090.0,,1,In vivo biodistribution in mice eyes bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,,CHEMBL618797,,50594,Mus musculus,,,N,1,BAO_0000218,
11729,,15383,Intermediate,10090.0,,1,In vivo biodistribution in mice kidney bearing intracerebral GL261 gliomas at the dose of 10 microg of boron/g/day,,,CHEMBL618798,,50594,Mus musculus,,,N,1,BAO_0000218,2113.0
11730,,15383,Intermediate,10090.0,,1,In vivo biodistribution in mice kidney bearing intracerebral GL261 gliomas at the dose of 30 ug/day,,,CHEMBL618799,,50594,Mus musculus,,,N,1,BAO_0000218,2113.0
11731,,15383,Intermediate,10090.0,,1,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 10 ug/g,,,CHEMBL618800,,50594,Mus musculus,,,N,1,BAO_0000218,2113.0
11732,,15383,Intermediate,10090.0,,1,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 20 ug/g,,,CHEMBL618801,,50594,Mus musculus,,,N,1,BAO_0000218,2113.0
11733,,15383,Intermediate,10090.0,,1,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,,CHEMBL618802,,50594,Mus musculus,,,N,1,BAO_0000218,2113.0
11734,,15383,Intermediate,10090.0,,1,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,,CHEMBL618803,,50594,Mus musculus,,,N,1,BAO_0000218,2113.0
11735,,15383,Intermediate,10090.0,,1,In vivo biodistribution in mice liver bearing intracerebral GL261 gliomas at the dose of 10 microg of boron/g/day,,,CHEMBL618804,,50594,Mus musculus,,,N,1,BAO_0000218,2107.0
11736,,15383,Intermediate,10090.0,,1,In vivo biodistribution in mice liver bearing intracerebral GL261 gliomas at the dose of 30 ug/day,,,CHEMBL618805,,50594,Mus musculus,,,N,1,BAO_0000218,2107.0
11737,,15383,Intermediate,10090.0,,1,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 10 ug/g,,,CHEMBL618806,,50594,Mus musculus,,,N,1,BAO_0000218,2107.0
11738,,15383,Intermediate,10090.0,,1,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 20 ug/g,,,CHEMBL618807,,50594,Mus musculus,,,N,1,BAO_0000218,2107.0
11739,,15383,Intermediate,10090.0,,1,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,,CHEMBL618808,,50594,Mus musculus,,,N,1,BAO_0000218,2107.0
11740,,15383,Intermediate,10090.0,,1,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,,CHEMBL618809,,50594,Mus musculus,,,N,1,BAO_0000218,2107.0
11741,,15383,Intermediate,10090.0,,1,In vivo biodistribution in mice muscle bearing intracerebral GL261 gliomas at the dose of 30 ug/day,,,CHEMBL618810,,50594,Mus musculus,,,N,1,BAO_0000218,2385.0
11742,,15383,Intermediate,10090.0,,1,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 10 ug/g,,,CHEMBL618811,,50594,Mus musculus,,,N,1,BAO_0000218,2385.0
11743,,15383,Intermediate,10090.0,,1,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 20 ug/g,,,CHEMBL875844,,50594,Mus musculus,,,N,1,BAO_0000218,2385.0
11744,,15383,Intermediate,10090.0,,1,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,,CHEMBL618812,,50594,Mus musculus,,,N,1,BAO_0000218,2385.0
11745,,15383,Intermediate,10090.0,,1,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,,CHEMBL618813,,50594,Mus musculus,,,N,1,BAO_0000218,2385.0
11746,,15383,Intermediate,10090.0,,1,In vivo biodistribution in mice skin bearing intracerebral GL261 gliomas at the dose of 30 ug/day,,,CHEMBL618814,,50594,Mus musculus,,,N,1,BAO_0000218,
11747,,15383,Intermediate,10090.0,,1,In vivo biodistribution in mice skin bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,,CHEMBL618815,,50594,Mus musculus,,,N,1,BAO_0000218,
11748,,15383,Intermediate,10090.0,,1,In vivo biodistribution in mice skin bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,,CHEMBL618816,,50594,Mus musculus,,,N,1,BAO_0000218,
11749,,15383,Intermediate,10090.0,,1,In vivo biodistribution in mice skin by pump bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,,CHEMBL618817,,50594,Mus musculus,,,N,1,BAO_0000218,
11750,,15383,Intermediate,10090.0,,1,In vivo biodistribution in mice skin by pump bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,,CHEMBL620544,,50594,Mus musculus,,,N,1,BAO_0000218,
11751,In vivo,15341,Intermediate,10116.0,,1,The maximum concentration of the compound was measured in rat at dose 30 mg/kg after intraperitoneal administration.,,,CHEMBL626230,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11752,In vivo,15341,Intermediate,10116.0,,1,The maximum concentration of the compound was measured in rat at dose 30 mg/kg after intravenous administration.,,,CHEMBL626231,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11753,In vivo,15341,Intermediate,10116.0,,1,The maximum concentration of the compound was measured in rat at dose 30 mg/kg after peroral administration.,,,CHEMBL626232,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11754,In vivo,14906,Intermediate,9615.0,,1,The maximum plasma concentration (Cmax) is the observed peak plasma concentration after an oral dose on dog.,,,CHEMBL626233,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,1969.0
11755,In vivo,14906,Intermediate,10116.0,,1,The maximum plasma concentration (Cmax) is the observed peak plasma concentration after an oral dose on rat,,,CHEMBL626234,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
11756,In vivo,14906,Intermediate,10116.0,,1,The maximum plasma concentration (Cmax) is the observed peak plasma concentration after an oral dose on rat.,,,CHEMBL875341,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
11757,In vivo,14215,Intermediate,9606.0,,1,The maximum plasma concentration (100 mg/kg) administered orally in human,,,CHEMBL626235,,50587,Homo sapiens,,,N,1,BAO_0000218,1969.0
11758,In vivo,14215,Autocuration,9481.0,,1,The maximum plasma concentration (12.5 mg/kg) administered intravenously in marmoset,,,CHEMBL626236,,22224,Callithrix,,,U,0,BAO_0000218,1969.0
11759,In vivo,14215,Autocuration,314293.0,,1,The maximum plasma concentration (12.5 mg/kg) administered intravenously in monkey,,,CHEMBL626237,,22224,Simiiformes,,,U,0,BAO_0000218,1969.0
11760,In vivo,14215,Intermediate,9615.0,,1,The maximum plasma concentration (15 mg/kg) administered intravenously in dog,,,CHEMBL626238,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,1969.0
11761,In vivo,14215,Intermediate,9606.0,,1,The maximum plasma concentration (200 mg/kg) administered orally in human,,,CHEMBL622412,,50587,Homo sapiens,,,N,1,BAO_0000218,1969.0
11762,In vivo,14215,Intermediate,10116.0,,1,The maximum plasma concentration (25 mg/kg) administered intravenously in rat,,,CHEMBL623114,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
11763,In vivo,14215,Autocuration,9481.0,,1,The maximum plasma concentration (25 mg/kg) administered orally in marmoset,,,CHEMBL623115,,22224,Callithrix,,,U,0,BAO_0000218,1969.0
11764,In vivo,14215,Autocuration,314293.0,,1,The maximum plasma concentration (25 mg/kg) administered orally in monkey,,,CHEMBL623116,,22224,Simiiformes,,,U,0,BAO_0000218,1969.0
11765,In vivo,14215,Autocuration,9615.0,,1,The maximum plasma concentration (30 mg/kg) administered orally in dog,,,CHEMBL623117,,22224,Canis lupus familiaris,,,U,0,BAO_0000218,1969.0
11766,In vivo,14215,Intermediate,9606.0,,1,The maximum plasma concentration (400 mg/kg) administered orally in human,,,CHEMBL623118,,50587,Homo sapiens,,,N,1,BAO_0000218,1969.0
11767,In vivo,14215,Intermediate,10116.0,,1,The maximum plasma concentration (50 mg/kg) administered orally in fasted rat,,,CHEMBL623119,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
11768,In vivo,14215,Intermediate,10116.0,,1,The maximum plasma concentration (50 mg/kg) administered orally in rat,,,CHEMBL623120,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
11769,In vivo,14215,Intermediate,9606.0,,1,The maximum plasma concentration (800 mg/kg) administered orally in human,,,CHEMBL623286,,50587,Homo sapiens,,,N,1,BAO_0000218,1969.0
11770,In vivo,14067,Intermediate,10116.0,,1,The maximum plasma concentration was measured on rats,,,CHEMBL623287,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
11771,In vivo,12350,Intermediate,10116.0,,1,The maximum plasma concentration was measured on rats after oral administration,,,CHEMBL623288,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
11772,In vivo,14813,Intermediate,10116.0,,1,Plasma drug Cmax in rat (PO dose),,,CHEMBL623289,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
11773,In vivo,12536,Autocuration,,,1,Time taken to reach maximum concentration after administration of 2 umol/kg dose intravenously,,,CHEMBL623290,,22224,,,,U,0,BAO_0000218,
11774,In vivo,14169,Intermediate,9615.0,,1,maximum Plasma concentration in Dog was determined after Peroral administration,,,CHEMBL623291,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,1969.0
11775,In vivo,14169,Intermediate,10116.0,,1,maximum Plasma concentration in Rats was determined after Peroral administration,,,CHEMBL623292,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
11776,In vivo,15604,Intermediate,9615.0,,1,maximum concentration in plasma in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in dog,,,CHEMBL623293,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,1969.0
11777,In vivo,15604,Autocuration,314293.0,,1,maximum concentration in plasma in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in monkey,,,CHEMBL623294,,22224,Simiiformes,,,U,0,BAO_0000218,1969.0
11778,In vivo,15604,Intermediate,10116.0,,1,maximum concentration in plasma in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in rat,,,CHEMBL623295,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
11779,In vivo,14387,Intermediate,10090.0,,1,maximum concentration was measured when administered through oral route in mice,,,CHEMBL623296,,50594,Mus musculus,,,N,1,BAO_0000218,
11780,,15115,Intermediate,10090.0,,1,Compound was evaluated for Cmax/Tmax when administered through oral route in mouse; Value is 0.93/1,,,CHEMBL875349,,50594,Mus musculus,,,N,1,BAO_0000218,
11781,,15115,Autocuration,314293.0,,1,Compound was evaluated for Cmax/Tmax when administered through oral route to mouse; Value is 0.34/1,,,CHEMBL623297,,22224,Simiiformes,,,U,0,BAO_0000019,
11782,,15115,Autocuration,314293.0,,1,Compound was evaluated for Cmax/Tmax when administered through oral route to mouse; Value is 0.81/1.6,,,CHEMBL623298,,22224,Simiiformes,,,U,0,BAO_0000019,
11783,,15115,Autocuration,314293.0,,1,Compound was evaluated for Cmax/Tmax when administered through oral route to mouse; Value is 1.1/1.3,,,CHEMBL623299,,22224,Simiiformes,,,U,0,BAO_0000019,
11784,,16359,Intermediate,10116.0,,1,Pharmacokinetic parameter was evaluated in rats,,,CHEMBL623300,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11785,,12829,Intermediate,10090.0,,1,Plasma concentration at time-0 was measured in mice at 100 mg/kg after intraperitoneal administration with 90% DMSO as vehicle,,,CHEMBL623301,,50594,Mus musculus,,,N,1,BAO_0000218,
11786,,12829,Intermediate,10090.0,,1,Plasma concentration at time-0 was measured in mice at 100 mg/kg after intraperitoneal administration with saline(pH=11.4) as vehicle,,,CHEMBL623302,,50594,Mus musculus,,,N,1,BAO_0000218,
11787,,12829,Intermediate,10090.0,,1,Plasma concentration at time-0 was measured in mice at 120 mg/kg after intraperitoneal administration with 90% DMSO as vehicle,,,CHEMBL623303,,50594,Mus musculus,,,N,1,BAO_0000218,
11788,,12829,Intermediate,10090.0,,1,Plasma concentration at time-0 was measured in mice at 40 mg/kg after intravenous administration with saline(pH=11.4) as vehicle,,,CHEMBL623304,,50594,Mus musculus,,,N,1,BAO_0000218,
11789,,12829,Intermediate,10090.0,,1,Plasma concentration at time-0 was measured in mice at 40 mg/kg after intravenous administration with 90% DMSO as vehicle,,,CHEMBL623305,,50594,Mus musculus,,,N,1,BAO_0000218,
11790,,15137,Intermediate,10116.0,,1,Effect of ip administration of compound on plasma concentration of allo-pregnanolone (AP) in rats(Cerebral Cortex) after 30 min.,,,CHEMBL623306,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
11791,,15137,Intermediate,10116.0,,1,Effect of ip administration of compound on plasma concentration of allotetrahydrodeoxy corticosterone(THDOC) in rats(Cerebral Cortex) after 30 min.,,,CHEMBL623307,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
11792,,15137,Intermediate,10116.0,,1,Effect of ip administration of compound on plasma concentration of pregnenolone (PRE) in rats(Cerebral Cortex) after 30 min.,,,CHEMBL623308,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
11793,,15137,Intermediate,10090.0,,1,Effect of ip administration of compound on plasma concentration of progesterone (PRO) in rats(Cerebral Cortex) after 30 min.,,,CHEMBL623309,,50594,Mus musculus,,,N,1,BAO_0000218,1969.0
11794,,13509,Intermediate,10090.0,,1,Plasma Concentration after 120 min of oral administration to mice,,,CHEMBL623310,,50594,Mus musculus,,,N,1,BAO_0000218,
11795,,13509,Intermediate,10090.0,,1,Plasma Concentration after 30 min of oral administration to mice,,,CHEMBL623311,,50594,Mus musculus,,,N,1,BAO_0000218,
11796,,13509,Intermediate,9541.0,,1,Plasma Concentration after 60 min of oral administration to mice,,,CHEMBL623312,,100710,Macaca fascicularis,,,N,1,BAO_0000218,
11797,,13509,Intermediate,10090.0,,1,Plasma Concentration after 60 min of oral administration to mice; Not determined,,,CHEMBL875350,,50594,Mus musculus,,,N,1,BAO_0000218,
11798,,13509,Intermediate,10090.0,,1,Plasma Concentration after 90 min of oral administration to mice,,,CHEMBL628635,,50594,Mus musculus,,,N,1,BAO_0000218,
11799,,12064,Intermediate,10116.0,,1,Plasma concentration level in rat after 1 hour of oral administration at 50 mg/kg,,,CHEMBL628636,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11800,,12064,Intermediate,10116.0,,1,Plasma concentration level in rat after 15 hours of oral administration at 50 mg/kg,,,CHEMBL628637,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11801,,12064,Intermediate,10116.0,,1,Plasma concentration level in rat after 4 hours of oral administration at 50 mg/kg,,,CHEMBL628058,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11802,,10677,Intermediate,10116.0,,1,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 0-1 hr time,,,CHEMBL628059,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11803,,10677,Intermediate,10116.0,,1,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 1-2 hr time,,,CHEMBL628060,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11804,,8926,Autocuration,,,1,Distribution in the lung after 15 min of intravenous administration,,,CHEMBL628061,,22224,,,,U,0,BAO_0000019,
11805,,8926,Autocuration,,,1,Distribution in the lung after 30 min of intravenous administration,,,CHEMBL628062,,22224,,,,U,0,BAO_0000019,
11806,,8926,Autocuration,,,1,Distribution in the lung after 5 min of intravenous administration,,,CHEMBL628063,,22224,,,,U,0,BAO_0000019,
11807,,8926,Autocuration,,,1,Distribution in the lung after 60 min of intravenous administration,,,CHEMBL628064,,22224,,,,U,0,BAO_0000019,
11808,,8926,Autocuration,,,1,Distribution in the lung after 90 min of intravenous administration,,,CHEMBL628065,,22224,,,,U,0,BAO_0000019,
11809,,8926,Autocuration,,,1,Distribution in the muscle after 120 min of intravenous administration,,,CHEMBL628066,,22224,,,,U,0,BAO_0000019,2385.0
11810,,8926,Autocuration,,,1,Distribution in the muscle after 15 min of intravenous administration,,,CHEMBL628067,,22224,,,,U,0,BAO_0000019,2385.0
11811,,8926,Intermediate,10090.0,,1,Distribution in the muscle after 30 min of intravenous administration,,,CHEMBL874646,,50594,Mus musculus,,,N,1,BAO_0000218,2385.0
11812,,8926,Autocuration,,,1,Distribution in the muscle after 5 min of intravenous administration,,,CHEMBL628068,,22224,,,,U,0,BAO_0000019,2385.0
11813,,8926,Autocuration,,,1,Distribution in the muscle after 60 min of intravenous administration,,,CHEMBL628069,,22224,,,,U,0,BAO_0000019,2385.0
11814,,8926,Autocuration,,,1,Distribution in the muscle after 90 min of intravenous administration,,,CHEMBL628070,,22224,,,,U,0,BAO_0000019,2385.0
11815,,8926,Autocuration,,,1,Distribution in the spleen after 120 min of intravenous administration,,,CHEMBL628071,,22224,,,,U,0,BAO_0000019,2106.0
11816,,8926,Autocuration,,,1,Distribution in the spleen after 15 min of intravenous administration,,,CHEMBL628072,,22224,,,,U,0,BAO_0000019,2106.0
11817,,8926,Autocuration,,,1,Distribution in the spleen after 30 min of intravenous administration,,,CHEMBL628073,,22224,,,,U,0,BAO_0000019,2106.0
11818,,8926,Autocuration,,,1,Distribution in the spleen after 5 min of intravenous administration,,,CHEMBL628074,,22224,,,,U,0,BAO_0000019,2106.0
11819,,8926,Autocuration,,,1,Distribution in the spleen after 60 min of intravenous administration,,,CHEMBL628075,,22224,,,,U,0,BAO_0000019,2106.0
11820,,8926,Autocuration,,,1,Distribution in the spleen after 90 min of intravenous administration,,,CHEMBL628076,,22224,,,,U,0,BAO_0000019,2106.0
11821,,7570,Intermediate,10116.0,,1,Evaluated for distribution at 0.5 hr after intravenous administration in adrenal cortex of female Sprague Dawley rats,,,CHEMBL628077,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1235.0
11822,,7570,Intermediate,10116.0,,1,Evaluated for distribution at 0.5 hr after intravenous administration in blood of female Sprague Dawley rats,,,CHEMBL628078,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
11823,,7570,Intermediate,10116.0,,1,Evaluated for distribution at 0.5 hr after intravenous administration in liver of female Sprague Dawley rats,,,CHEMBL628079,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
11824,,7570,Intermediate,10116.0,,1,Evaluated for distribution at 0.5 hr after intravenous administration in ovary of female Sprague Dawley rats,,,CHEMBL628080,,50597,Rattus norvegicus,,,N,1,BAO_0000218,992.0
11825,,7570,Intermediate,10116.0,,1,Evaluated for distribution at 0.5 hr after intravenous administration in thyroid of female Sprague Dawley rats,,,CHEMBL628081,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2046.0
11826,,7570,Intermediate,10116.0,,1,Evaluated for distribution at 24 hours after intravenous administration in adrenal cortex of female Sprague Dawley rats,,,CHEMBL628082,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1235.0
11827,,7570,Intermediate,10116.0,,1,Evaluated for distribution at 24 hours after intravenous administration in blood of female Sprague Dawley rats,,,CHEMBL874647,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
11828,,7570,Intermediate,10116.0,,1,Evaluated for distribution at 24 hours after intravenous administration in liver of female Sprague Dawley rats,,,CHEMBL626406,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
11829,,7570,Intermediate,10116.0,,1,Evaluated for distribution at 24 hours after intravenous administration in ovary of female Sprague Dawley rats,,,CHEMBL626407,,50597,Rattus norvegicus,,,N,1,BAO_0000218,992.0
11830,,7570,Intermediate,10116.0,,1,Evaluated for distribution at 24 hours after intravenous administration in thyroid of female Sprague Dawley rats,,,CHEMBL626408,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2046.0
11831,,8608,Intermediate,10116.0,,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.07-0.09",,,CHEMBL626409,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
11832,,8608,Intermediate,10116.0,,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.10-0.13",,,CHEMBL626410,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
11833,,8608,Intermediate,10116.0,,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.18-0.24",,,CHEMBL626411,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
11834,,8608,Intermediate,10116.0,,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.19-0.24",,,CHEMBL626412,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
11835,,8608,Intermediate,10116.0,,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.22-0.32",,,CHEMBL626413,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
11836,,8608,Intermediate,10116.0,,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.25-0.32",,,CHEMBL626414,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
11837,,8608,Intermediate,10116.0,,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.10-0.14",,,CHEMBL626415,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
11838,,8608,Intermediate,10116.0,,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.25-0.34",,,CHEMBL626416,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
11839,,8608,Intermediate,10116.0,,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.27-0.33",,,CHEMBL627062,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
11840,,8608,Intermediate,10116.0,,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.32-0.46",,,CHEMBL627063,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
11841,,8608,Intermediate,10116.0,,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.40-0.45",,,CHEMBL627064,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
11842,,8608,Intermediate,10116.0,,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.44-0.52",,,CHEMBL627227,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
11843,,8608,Intermediate,10116.0,,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.08-0.09",,,CHEMBL627228,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
11844,,8608,Intermediate,10116.0,,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.12-0.14",,,CHEMBL627229,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
11845,,8608,Intermediate,10116.0,,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.13-0.15",,,CHEMBL625792,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
11846,,8608,Intermediate,10116.0,,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.15-0.20",,,CHEMBL625793,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
11847,,8608,Intermediate,10116.0,,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.15-0.23",,,CHEMBL625794,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
11848,,8608,Intermediate,10116.0,,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.16-0.21",,,CHEMBL625795,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
11849,,13792,Intermediate,10090.0,,1,Pharmacokinetic parameter AUC for the compound after intravenous administration into BALB/c Mice in plasma samples.,,,CHEMBL625796,,50594,Mus musculus,,,N,1,BAO_0000218,
11850,,13376,Intermediate,9615.0,,1,Pharmacokinetic parameter AUC has been determined in fed Beagle dogs at a dose of 375 mg/kg,,,CHEMBL625797,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
11851,,13376,Intermediate,9615.0,,1,Pharmacokinetic parameter AUC has been determined in fed Beagle dogs at a dose of 500 mg/kg,,,CHEMBL625798,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
11852,,14380,Autocuration,,,1,Pharmacokinetic parameter AUC evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,,,CHEMBL875613,,22224,,,,U,0,BAO_0000218,
11853,,14380,Autocuration,,,1,Pharmacokinetic parameter AUC was evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,,,CHEMBL625799,,22224,,,,U,0,BAO_0000218,
11854,,14380,Autocuration,,,1,Pharmacokinetic parameter AUC was evaluated in 10% PEG suspension at a dose of 20 mg/kg orally,,,CHEMBL625800,,22224,,,,U,0,BAO_0000218,
11855,,14380,Autocuration,,,1,Pharmacokinetic parameter AUC was evaluated in 100% PEG solution at a dose of 20 mg/kg orally,,,CHEMBL625801,,22224,,,,U,0,BAO_0000218,
11856,,14380,Autocuration,,,1,Pharmacokinetic parameter AUC was evaluated in DMA:H2O solution at a dose of 20 mg/kg orally,,,CHEMBL625802,,22224,,,,U,0,BAO_0000218,
11857,,14380,Autocuration,,,1,Pharmacokinetic parameter AUC was evaluated in HP-beta-CD solution at a dose of 20 mg/kg orally,,,CHEMBL625803,,22224,,,,U,0,BAO_0000218,
11858,,14380,Autocuration,,,1,Pharmacokinetic parameter AUC was evaluated in Hp-beta-CD solution,,,CHEMBL625804,,22224,,,,U,0,BAO_0000019,
11859,,14380,Autocuration,,,1,Pharmacokinetic parameter AUC was evaluated in saline solution at a dose of 20 mg/kg orally,,,CHEMBL622530,,22224,,,,U,0,BAO_0000218,
11860,,13701,Intermediate,10090.0,,1,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice brain; AUC (mM.h); not detected,,,CHEMBL622531,,50594,Mus musculus,,,N,1,BAO_0000218,
11861,,13701,Intermediate,10090.0,,1,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice serum; AUC (mM.h),,,CHEMBL622532,,50594,Mus musculus,,,N,1,BAO_0000218,
11862,,13701,Intermediate,10090.0,,1,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h),,,CHEMBL623176,,50594,Mus musculus,,,N,1,BAO_0000218,
11863,,13701,Intermediate,10090.0,,1,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice brain; AUC (mM.h),,,CHEMBL623177,,50594,Mus musculus,,,N,1,BAO_0000218,
11864,,13701,Intermediate,10090.0,,1,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice serum; AUC (mM.h),,,CHEMBL623178,,50594,Mus musculus,,,N,1,BAO_0000218,
11865,,13701,Intermediate,10090.0,,1,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration using FMAddA as substrate in mice brain; AUC 0-r (mM.h); not detected,,,CHEMBL623179,,50594,Mus musculus,,,N,1,BAO_0000218,
11866,,13701,Intermediate,10090.0,,1,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice brain; AUC (mM.h),,,CHEMBL623180,,50594,Mus musculus,,,N,1,BAO_0000218,
11867,,13701,Intermediate,10090.0,,1,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice brain; AUC 0-r (mM.h),,,CHEMBL623181,,50594,Mus musculus,,,N,1,BAO_0000218,
11868,,13701,Intermediate,10090.0,,1,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h),,,CHEMBL624131,,50594,Mus musculus,,,N,1,BAO_0000218,
11869,,13701,Intermediate,10090.0,,1,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration using 2`-F-ara-ddI as substrate in mice serum; AUC (mM.h),,,CHEMBL624132,,50594,Mus musculus,,,N,1,BAO_0000218,
11870,,13701,Intermediate,10090.0,,1,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by oral administration in mice serum; AUC 0-r (mM.h),,,CHEMBL624133,,50594,Mus musculus,,,N,1,BAO_0000218,
11871,,13701,Intermediate,10090.0,,1,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h).,,,CHEMBL624846,,50594,Mus musculus,,,N,1,BAO_0000218,
11872,,13701,Intermediate,10090.0,,1,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by oral administration in mice serum.; AUC 0-r (mM.h),,,CHEMBL624847,,50594,Mus musculus,,,N,1,BAO_0000218,
11873,,13701,Intermediate,10090.0,,1,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice brain; AUC 0-r (mM.h),,,CHEMBL624848,,50594,Mus musculus,,,N,1,BAO_0000218,
11874,,13701,Intermediate,10090.0,,1,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice serum; AUC (mM.h),,,CHEMBL625012,,50594,Mus musculus,,,N,1,BAO_0000218,
11875,,13701,Intermediate,10090.0,,1,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h),,,CHEMBL625013,,50594,Mus musculus,,,N,1,BAO_0000218,
11876,,13701,Intermediate,10090.0,,1,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice brain; AUC 0-r (mM.h); not detected,,,CHEMBL625014,,50594,Mus musculus,,,N,1,BAO_0000218,
11877,,13701,Intermediate,10090.0,,1,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice serum; AUC (mM.h),,,CHEMBL625015,,50594,Mus musculus,,,N,1,BAO_0000218,
11878,,13701,Intermediate,10090.0,,1,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice serum; AUC 0-r (mM.h),,,CHEMBL625016,,50594,Mus musculus,,,N,1,BAO_0000218,
11879,,13701,Intermediate,10090.0,,1,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral in mice brain; AUC (mM.h); not detected,,,CHEMBL625017,,50594,Mus musculus,,,N,1,BAO_0000218,
11880,,13701,Intermediate,10090.0,,1,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice brain; AUC 0-r (mM.h),,,CHEMBL625018,,50594,Mus musculus,,,N,1,BAO_0000218,
11881,,13701,Intermediate,10090.0,,1,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration mice serum.; AUC 0-r (mM.h),,,CHEMBL625019,,50594,Mus musculus,,,N,1,BAO_0000218,
11882,,13701,Intermediate,10090.0,,1,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice brain.; AUC 0-r (mM.h),,,CHEMBL625020,,50594,Mus musculus,,,N,1,BAO_0000218,
11883,,13701,Intermediate,10090.0,,1,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice serum.,,,CHEMBL625021,,50594,Mus musculus,,,N,1,BAO_0000218,
11884,,14393,Intermediate,10116.0,,1,Pharmacokinetic parameter [area under curve (AUC)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,,,CHEMBL625022,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11885,,14731,Intermediate,10090.0,,1,Pharmacokinetic parameter area under the curve (0-24 hr) for the compound was evaluated in nude mice after oral administration. ,,,CHEMBL625023,,50594,Mus musculus,,,N,1,BAO_0000218,
11886,,14731,Intermediate,9541.0,,1,Pharmacokinetic parameter area under the curve (0-48 h) for the compound was evaluated in nude cynomolgus monkeys after oral administration,,,CHEMBL625024,,100710,Macaca fascicularis,,,N,1,BAO_0000218,
11887,,14731,Intermediate,9541.0,,1,Pharmacokinetic parameter area under the curve (0-48 h) for the compound was evaluated in nude cynomolgus monkeys after oral administration. ,,,CHEMBL627626,,100710,Macaca fascicularis,,,N,1,BAO_0000218,
11888,,13758,Autocuration,,,1,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered intravenously in brain,,,CHEMBL627627,,22224,,,,U,0,BAO_0000218,955.0
11889,,13758,Autocuration,,,1,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered intravenously in serum,,,CHEMBL627628,,22224,,,,U,0,BAO_0000218,1977.0
11890,,13758,Autocuration,,,1,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered orally in brain,,,CHEMBL627629,,22224,,,,U,0,BAO_0000218,955.0
11891,,13758,Autocuration,,,1,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered orally in serum,,,CHEMBL627630,,22224,,,,U,0,BAO_0000218,1977.0
11892,,16359,Autocuration,,,1,Pharmacokinetic parameter was evaluated which is represented as AUC when administered 5 mg/Kg orally; range (0.19-0.35),,,CHEMBL627631,,22224,,,,U,0,BAO_0000019,
11893,,16359,Autocuration,,,1,Pharmacokinetic parameter was evaluated which is represented as AUC when administered 5 mg/kg intravenously; range (2.1-2.3),,,CHEMBL629515,,22224,,,,U,0,BAO_0000218,
11894,,15383,Intermediate,10090.0,,1,In vivo biodistribution in mice spleen bearing intracerebral GL261 gliomas at the dose of 30 ug/day,,,CHEMBL629516,,50594,Mus musculus,,,N,1,BAO_0000218,2106.0
11895,,15383,Intermediate,10090.0,,1,In vivo biodistribution in mice spleen bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,,CHEMBL629517,,50594,Mus musculus,,,N,1,BAO_0000218,2106.0
11896,,15383,Intermediate,10090.0,,1,In vivo biodistribution in mice spleen bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,,CHEMBL629518,,50594,Mus musculus,,,N,1,BAO_0000218,2106.0
11897,,15383,Intermediate,10090.0,,1,In vivo biodistribution in mice tumor bearing intracerebral GL261 gliomas at the dose of 30 ug/day,,,CHEMBL877499,,50594,Mus musculus,,,N,1,BAO_0000218,
11898,,15383,Intermediate,10090.0,,1,In vivo biodistribution in mice tumor bearing subcutaneous B16 melanomas at the dose of 20 ug/g,,,CHEMBL629519,,50594,Mus musculus,,,N,1,BAO_0000218,
11899,,15383,Intermediate,10090.0,,1,In vivo biodistribution in mice tumor bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,,CHEMBL629520,,50594,Mus musculus,,,N,1,BAO_0000218,
11900,,15383,Intermediate,10090.0,,1,In vivo biodistribution in mice tumor bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,,CHEMBL629521,,50594,Mus musculus,,,N,1,BAO_0000218,
11901,,14439,Intermediate,10090.0,,1,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Heart (H) and Blood (B),,,CHEMBL629522,,50594,Mus musculus,,,N,1,BAO_0000218,
11902,,14439,Intermediate,10090.0,,1,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Heart (H) and Lung (L),,,CHEMBL629523,,50594,Mus musculus,,,N,1,BAO_0000218,
11903,,14439,Intermediate,10090.0,,1,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Tumor (T) and Muscle (M),,,CHEMBL629524,,50594,Mus musculus,,,N,1,BAO_0000218,
11904,,14439,Intermediate,10090.0,,1,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Tumor (T) and blood (B),,,CHEMBL629525,,50594,Mus musculus,,,N,1,BAO_0000218,
11905,,14439,Intermediate,10090.0,,1,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Heart (H) and Blood (B),,,CHEMBL629526,,50594,Mus musculus,,,N,1,BAO_0000218,
11906,,14439,Intermediate,10090.0,,1,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Heart (H) and Lung (L),,,CHEMBL629527,,50594,Mus musculus,,,N,1,BAO_0000218,
11907,,14439,Intermediate,10090.0,,1,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Tumor (T) and Muscle (M),,,CHEMBL629528,,50594,Mus musculus,,,N,1,BAO_0000218,
11908,,14439,Intermediate,10090.0,,1,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Tumor (T) and blood (B),,,CHEMBL629529,,50594,Mus musculus,,,N,1,BAO_0000218,
11909,,14439,Intermediate,10090.0,,1,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Heart (H) and Blood (B),,,CHEMBL629530,,50594,Mus musculus,,,N,1,BAO_0000218,
11910,,14439,Intermediate,10090.0,,1,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Heart (H) and Lung (L),,,CHEMBL629531,,50594,Mus musculus,,,N,1,BAO_0000218,
11911,,14439,Intermediate,10090.0,,1,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Tumor (T) and Muscle (M),,,CHEMBL628656,,50594,Mus musculus,,,N,1,BAO_0000218,
11912,,14439,Intermediate,10090.0,,1,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Tumor (T) and blood (B),,,CHEMBL628657,,50594,Mus musculus,,,N,1,BAO_0000218,
11913,In vivo,13751,Intermediate,10116.0,,1,"Biodistribution in abdominal Dawley rat after 30min, expressed as percent injected dose/g",,,CHEMBL628658,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11914,In vivo,13751,Intermediate,10116.0,,1,"Biodistribution in abdominal of mature female Dawley rat after 10min, expressed as percent injected dose/g",,,CHEMBL628659,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11915,In vivo,13751,Intermediate,10116.0,,1,"Biodistribution in abdominal of mature female Dawley rat after 15min, expressed as percent injected dose/g",,,CHEMBL877500,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11916,In vivo,13751,Intermediate,10116.0,,1,"Biodistribution in abdominal of mature female Dawley rat after 1h, expressed as percent injected dose/g",,,CHEMBL628660,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11917,In vivo,13751,Intermediate,10116.0,,1,"Biodistribution in abdominal of mature female Dawley rat after 3 h, expressed as percent injected dose/g",,,CHEMBL628661,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11918,In vivo,13751,Intermediate,10116.0,,1,"Biodistribution in abdominal of mature female Dawley rat after 30min, expressed as percent injected dose/g",,,CHEMBL628662,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11919,In vivo,13751,Intermediate,10116.0,,1,"Biodistribution in abdominal of mature female Dawley rat after 45min, expressed as percent injected dose/g",,,CHEMBL628663,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11920,In vivo,13751,Intermediate,10116.0,,1,"Biodistribution in abdominal of mature female Dawley rat after 5min, expressed as percent injected dose/g",,,CHEMBL628664,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11921,In vivo,13751,Intermediate,10116.0,,1,"Biodistribution in blood of mature female Dawley rat after 10min, expressed as percent injected dose/g",,,CHEMBL628665,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
11922,In vivo,13751,Intermediate,10116.0,,1,"Biodistribution in blood of mature female Dawley rat after 15min, expressed as percent injected dose/g",,,CHEMBL628666,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
11923,In vivo,13751,Intermediate,10116.0,,1,"Biodistribution in blood of mature female Dawley rat after 1h, expressed as percent injected dose/g",,,CHEMBL628667,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
11924,In vivo,13751,Intermediate,10116.0,,1,"Biodistribution in blood of mature female Dawley rat after 3 h, expressed as percent injected dose/g",,,CHEMBL628668,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
11925,In vivo,13751,Intermediate,10116.0,,1,"Biodistribution in blood of mature female Dawley rat after 30min, expressed as percent injected dose/g",,,CHEMBL628669,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
11926,In vivo,13751,Intermediate,10116.0,,1,"Biodistribution in blood of mature female Dawley rat after 45min, expressed as percent injected dose/g",,,CHEMBL628670,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
11927,In vivo,13751,Intermediate,10116.0,,1,"Biodistribution in blood of mature female Dawley rat after 5min, expressed as percent injected dose/g",,,CHEMBL628671,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
11928,In vivo,13751,Intermediate,10116.0,,1,"Biodistribution in bone of mature female Dawley rat after 10min, expressed as percent injected dose/g",,,CHEMBL628672,,50597,Rattus norvegicus,,,N,1,BAO_0000218,10000001.0
11929,In vivo,13751,Intermediate,10116.0,,1,"Biodistribution in bone of mature female Dawley rat after 1h, expressed as percent injected dose/g",,,CHEMBL630300,,50597,Rattus norvegicus,,,N,1,BAO_0000218,10000001.0
11930,In vivo,13751,Intermediate,10116.0,,1,"Biodistribution in bone of mature female Dawley rat after 3 h, expressed as percent injected dose/g",,,CHEMBL629787,,50597,Rattus norvegicus,,,N,1,BAO_0000218,10000001.0
11931,In vivo,13751,Intermediate,10116.0,,1,"Biodistribution in bone of mature female Dawley rat after 30min, expressed as percent injected dose/g",,,CHEMBL629788,,50597,Rattus norvegicus,,,N,1,BAO_0000218,10000001.0
11932,In vivo,13751,Intermediate,10116.0,,1,"Biodistribution in brain of mature female Dawley rat after 10min, expressed as percent injected dose/g",,,CHEMBL629789,,50597,Rattus norvegicus,,,N,1,BAO_0000218,955.0
11933,In vivo,13751,Intermediate,10116.0,,1,"Biodistribution in brain of mature female Dawley rat after 15min, expressed as percent injected dose/g",,,CHEMBL629790,,50597,Rattus norvegicus,,,N,1,BAO_0000218,955.0
11934,In vivo,13751,Intermediate,10116.0,,1,"Biodistribution in brain of mature female Dawley rat after 1h, expressed as percent injected dose/g",,,CHEMBL629791,,50597,Rattus norvegicus,,,N,1,BAO_0000218,955.0
11935,In vivo,13751,Intermediate,10116.0,,1,"Biodistribution in brain of mature female Dawley rat after 3 h, expressed as percent injected dose/g",,,CHEMBL629792,,50597,Rattus norvegicus,,,N,1,BAO_0000218,955.0
11936,In vivo,13751,Intermediate,10116.0,,1,"Biodistribution in brain of mature female Dawley rat after 30min, expressed as percent injected dose/g",,,CHEMBL629793,,50597,Rattus norvegicus,,,N,1,BAO_0000218,955.0
11937,In vivo,13751,Intermediate,10116.0,,1,"Biodistribution in brain of mature female Dawley rat after 45min, expressed as percent injected dose/g",,,CHEMBL629794,,50597,Rattus norvegicus,,,N,1,BAO_0000218,955.0
11938,,10677,Intermediate,10116.0,,1,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 2-3 hr time,,,CHEMBL874459,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11939,,10677,Intermediate,10116.0,,1,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 3-4 hr time,,,CHEMBL629795,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11940,,10677,Intermediate,10116.0,,1,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 4-5 hr time,,,CHEMBL629796,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11941,,10677,Intermediate,10116.0,,1,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 5-6 hr time,,,CHEMBL629797,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11942,,10677,Intermediate,10116.0,,1,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 6-24 h time,,,CHEMBL629798,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11943,In vivo,10911,Intermediate,10116.0,,1,Biodistribution studied in the adrenals of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,,CHEMBL629799,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2369.0
11944,In vivo,10911,Intermediate,10116.0,,1,Biodistribution studied in the adrenals of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,,CHEMBL629800,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2369.0
11945,In vivo,10911,Intermediate,10116.0,,1,Biodistribution studied in the adrenals of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,,CHEMBL629801,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2369.0
11946,In vivo,10911,Intermediate,10116.0,,1,Biodistribution studied in the adrenals of immature Fischer female rats at 5 hour,,,CHEMBL629802,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2369.0
11947,In vivo,10911,Intermediate,10116.0,,1,Biodistribution studied in the adrenals of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,,CHEMBL629803,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2369.0
11948,In vivo,10911,Intermediate,10116.0,,1,Biodistribution studied in the blood of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,,CHEMBL629804,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
11949,In vivo,10911,Intermediate,10116.0,,1,Biodistribution studied in the blood of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,,CHEMBL629805,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
11950,In vivo,10911,Intermediate,10116.0,,1,Biodistribution studied in the blood of immature Fischer female rats at 2 hou; activity is expressed as inductive dose / gram,,,CHEMBL629806,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
11951,In vivo,10911,Intermediate,10116.0,,1,Biodistribution studied in the blood of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,,CHEMBL629807,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
11952,In vivo,10911,Intermediate,10116.0,,1,Biodistribution studied in the blood of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,,CHEMBL629808,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
11953,In vivo,10911,Intermediate,10116.0,,1,Biodistribution studied in the brain of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,,CHEMBL629809,,50597,Rattus norvegicus,,,N,1,BAO_0000218,955.0
11954,In vivo,10911,Intermediate,10116.0,,1,Biodistribution studied in the brain of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,,CHEMBL629810,,50597,Rattus norvegicus,,,N,1,BAO_0000218,955.0
11955,In vivo,10911,Intermediate,10116.0,,1,Biodistribution studied in the brain of immature Fischer female rats at 2 hou; activity is expressed as inductive dose / gram,,,CHEMBL629811,,50597,Rattus norvegicus,,,N,1,BAO_0000218,955.0
11956,In vivo,10911,Intermediate,10116.0,,1,Biodistribution studied in the brain of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,,CHEMBL629812,,50597,Rattus norvegicus,,,N,1,BAO_0000218,955.0
11957,In vivo,10911,Intermediate,10116.0,,1,Biodistribution studied in the brain of immature Fischer female rats at 5 hou; activity is expressed as inductive dose / gram,,,CHEMBL629813,,50597,Rattus norvegicus,,,N,1,BAO_0000218,955.0
11958,In vivo,10911,Intermediate,10116.0,,1,Biodistribution studied in the brain of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,,CHEMBL874460,,50597,Rattus norvegicus,,,N,1,BAO_0000218,955.0
11959,In vivo,10911,Intermediate,10116.0,,1,Biodistribution studied in the fat of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,,CHEMBL629814,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11960,In vivo,10911,Intermediate,10116.0,,1,Biodistribution studied in the fat of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,,CHEMBL629815,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11961,In vivo,10911,Intermediate,10116.0,,1,Biodistribution studied in the fat of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,,CHEMBL629816,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11962,In vivo,10911,Intermediate,10116.0,,1,Biodistribution studied in the fat of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,,CHEMBL629817,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11963,In vivo,10911,Intermediate,10116.0,,1,Biodistribution studied in the kidneys of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,,CHEMBL626643,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2113.0
11964,In vivo,10911,Intermediate,10116.0,,1,Biodistribution studied in the kidneys of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,,CHEMBL626644,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2113.0
11965,In vivo,10911,Intermediate,10116.0,,1,Biodistribution studied in the kidneys of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,,CHEMBL626806,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2113.0
11966,In vivo,10911,Intermediate,10116.0,,1,Biodistribution studied in the kidneys of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,,CHEMBL626807,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2113.0
11967,In vivo,10911,Intermediate,10116.0,,1,Biodistribution studied in the liver of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,,CHEMBL627261,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
11968,In vivo,10911,Intermediate,10116.0,,1,Biodistribution studied in the liver of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,,CHEMBL627262,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
11969,In vivo,10911,Intermediate,10116.0,,1,Biodistribution studied in the liver of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,,CHEMBL627263,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
11970,In vivo,10911,Intermediate,10116.0,,1,Biodistribution studied in the liver of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,,CHEMBL627264,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
11971,In vivo,10911,Intermediate,10116.0,,1,Biodistribution studied in the lungs of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,,CHEMBL627265,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2048.0
11972,In vivo,10911,Intermediate,10116.0,,1,Biodistribution studied in the lungs of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,,CHEMBL627266,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2048.0
11973,In vivo,10911,Intermediate,10116.0,,1,Biodistribution studied in the lungs of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,,CHEMBL627267,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2048.0
11974,In vivo,10911,Intermediate,10116.0,,1,Biodistribution studied in the lungs of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,,CHEMBL627268,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2048.0
11975,In vivo,10911,Intermediate,10116.0,,1,Biodistribution studied in the muscle of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,,CHEMBL627269,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2385.0
11976,In vivo,10911,Intermediate,10116.0,,1,Biodistribution studied in the muscle of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,,CHEMBL627270,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2385.0
11977,,8608,Intermediate,10116.0,,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 0.95-1.44",,,CHEMBL627271,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11978,,8608,Intermediate,10116.0,,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 1.39-2.43",,,CHEMBL627946,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11979,,8608,Intermediate,10116.0,,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 2.47-2.96",,,CHEMBL875472,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11980,,8608,Intermediate,10116.0,,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 2.67-3.69",,,CHEMBL627947,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11981,,8608,Intermediate,10116.0,,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 2.67-4.31",,,CHEMBL627948,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11982,,8608,Intermediate,10116.0,,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 3.17-4.70",,,CHEMBL628113,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11983,,8608,Intermediate,10116.0,,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration.; dose/g, range 2.20-2.97",,,CHEMBL628114,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11984,,8608,Intermediate,10116.0,,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 0.90-1.46",,,CHEMBL628115,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11985,,8608,Intermediate,10116.0,,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 2.72-3.52",,,CHEMBL628116,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11986,,8608,Intermediate,10116.0,,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 2.78-3.62",,,CHEMBL628117,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11987,,8608,Intermediate,10116.0,,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 2.82-3.86",,,CHEMBL628118,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11988,,8608,Intermediate,10116.0,,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 3.80-5.74",,,CHEMBL628119,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11989,,8608,Intermediate,10116.0,,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 1.05-1.57",,,CHEMBL628120,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11990,,8608,Intermediate,10116.0,,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 1.93-3.58",,,CHEMBL628121,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11991,,8608,Intermediate,10116.0,,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 2.88-4.32",,,CHEMBL628122,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11992,,8608,Intermediate,10116.0,,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 3-3.70",,,CHEMBL627297,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11993,,8608,Intermediate,10116.0,,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 3.21-3.92",,,CHEMBL627298,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11994,,8608,Intermediate,10116.0,,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 3.51-5.44",,,CHEMBL627299,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11995,,8608,Intermediate,10116.0,,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 0.24-0.31",,,CHEMBL627300,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11996,,8608,Intermediate,10116.0,,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 10.5-14.4",,,CHEMBL627301,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11997,,8608,Intermediate,10116.0,,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 6.28-7.41",,,CHEMBL627302,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11998,,8608,Intermediate,10116.0,,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 6.47-10.2",,,CHEMBL627303,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
11999,,8608,Intermediate,10116.0,,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 7.21-7.95",,,CHEMBL627304,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
12000,,8608,Intermediate,10116.0,,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 8.28-10.72",,,CHEMBL627305,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
12001,,8608,Intermediate,10116.0,,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 1.04-2.56",,,CHEMBL627306,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
12002,,8608,Intermediate,10116.0,,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 10.7-16.9",,,CHEMBL623982,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
12003,,8608,Intermediate,10116.0,,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 11.7-14.6",,,CHEMBL623983,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
12004,,8608,Intermediate,10116.0,,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 14.4-20.1",,,CHEMBL623984,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
12005,,8608,Intermediate,10116.0,,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 4.78-9.72",,,CHEMBL623985,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
12006,,8608,Intermediate,10116.0,,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 9.87-11.9",,,CHEMBL623986,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
12007,,8608,Intermediate,10116.0,,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 0.17-0.25",,,CHEMBL623987,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
12008,,8608,Intermediate,10116.0,,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 3.33-4.68",,,CHEMBL623988,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
12009,,8608,Intermediate,10116.0,,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 4.59-8.81",,,CHEMBL623989,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
12010,,8608,Intermediate,10116.0,,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 4.62-5.60",,,CHEMBL622215,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
12011,,8608,Intermediate,10116.0,,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 5.02-6.57",,,CHEMBL622216,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
12012,,8608,Intermediate,10116.0,,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 5.67-8.41",,,CHEMBL877481,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
12013,,16359,Autocuration,,,1,Pharmacokinetic parameter was evaluated which is represented as AUC when administered orally a dose of 5 mg/kg; range (4.2-8.8),,,CHEMBL622217,,22224,,,,U,0,BAO_0000218,
12014,,13701,Intermediate,10090.0,,1,Pharmacokinetic parameters was measured at 55 mg/kg dose by oral administration in mice serum.; AUC 0-r (mM.h),,,CHEMBL622218,,50594,Mus musculus,,,N,1,BAO_0000218,
12015,,14554,Intermediate,10116.0,,1,Pharmacokinetic profile AUC was evaluated in rats,,,CHEMBL622219,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
12016,,6241,Autocuration,,,1,Pharmacokinetic property (Area under curve),,,CHEMBL622220,,22224,,,,U,0,BAO_0000019,
12017,,11537,Intermediate,9615.0,,1,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration in dog (25 mg/kg).",,,CHEMBL622221,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
12018,,11537,Intermediate,10090.0,,1,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration in mice (50 mg/kg).",,,CHEMBL622222,,50594,Mus musculus,,,N,1,BAO_0000218,
12019,,11537,Intermediate,9615.0,,1,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration to dog (25 mg/kg).",,,CHEMBL622223,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
12020,,11537,Intermediate,10090.0,,1,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration to mice (50 mg/kg).",,,CHEMBL622224,,50594,Mus musculus,,,N,1,BAO_0000218,
12021,,13118,Autocuration,,,1,Plasma concentration (AUC) was determined,,,CHEMBL622225,,22224,,,,U,0,BAO_0000019,
12022,,13118,Autocuration,,,1,Plasma concentration (AUC) was determined; Not detectable,,,CHEMBL622226,,22224,,,,U,0,BAO_0000019,
12023,,9562,Intermediate,10141.0,,1,Prolongation of time to collapse in guinea pig treated with aerosolized histamine was measured in vivo as area under curve (AUC),,,CHEMBL624154,,50512,Cavia porcellus,,,N,1,BAO_0000218,
12024,,10363,Intermediate,10116.0,,1,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 30 mg/kg,,,CHEMBL624155,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
12025,,10363,Intermediate,10116.0,,1,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 30 mg/kg; Not significant,,,CHEMBL624156,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
12026,,10363,Intermediate,10116.0,,1,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 60 mg/kg,,,CHEMBL624157,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
12027,,10363,Intermediate,10116.0,,1,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 7.5 mg/kg,,,CHEMBL624158,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
12028,,12504,Intermediate,10116.0,,1,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 1,,,CHEMBL624159,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
12029,,12504,Intermediate,10116.0,,1,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 2,,,CHEMBL624160,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
12030,,12504,Intermediate,10116.0,,1,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 3,,,CHEMBL624161,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
12031,,12504,Intermediate,10116.0,,1,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 4,,,CHEMBL624162,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
12032,,13317,Intermediate,9615.0,,1,Tested for pharmacokinetic parameter in fasted Beagle dogs (Area Under Curve value) iv administration.,,,CHEMBL624163,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
12033,,15078,Intermediate,10116.0,,1,"The AUC(0-infinitive) value in female wistar rat at 100 mg/kg, p.o. dose",,,CHEMBL624164,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
12034,,14941,Intermediate,10116.0,,1,The AUC(0-infinity) values in female wistar rats.,,,CHEMBL624165,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
12035,,15078,Intermediate,10116.0,,1,"The AUC(0-t)value in female wistar rat at 100 mg/kg, p.o. dose",,,CHEMBL624166,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
12036,,15078,Intermediate,10116.0,,1,"The AUC(0-t)value in female wistar rat at 100 mg/kg, p.o. dose in mice",,,CHEMBL624167,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
12037,,14941,Intermediate,10116.0,,1,The AUC(0-t)values in female wistar rats.,,,CHEMBL624168,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
12038,,14067,Intermediate,10116.0,,1,The Area under the concentration time curve of compound was measured on rats,,,CHEMBL624169,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
12039,,14215,Intermediate,9606.0,,1,The area under curve (100 mg/kg) administered orally in humans,,,CHEMBL624170,,50587,Homo sapiens,,,N,1,BAO_0000218,
12040,,14215,Autocuration,9481.0,,1,The area under curve (12.5 mg/kg) administered intravenously in marmoset,,,CHEMBL624171,,22224,Callithrix,,,U,0,BAO_0000218,
12041,,14215,Autocuration,314293.0,,1,The area under curve (12.5 mg/kg) administered intravenously in monkey,,,CHEMBL624172,,22224,Simiiformes,,,U,0,BAO_0000218,
12042,,14215,Intermediate,9615.0,,1,The area under curve (15 mg/kg) administered intravenously in dog,,,CHEMBL624173,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
12043,,14215,Intermediate,9606.0,,1,The area under curve (200 mg/kg) administered orally in humans,,,CHEMBL877488,,50587,Homo sapiens,,,N,1,BAO_0000218,
12044,,14215,Intermediate,10116.0,,1,The area under curve (25 mg/kg) administered intravenously in rat,,,CHEMBL624174,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
12045,,14215,Autocuration,9481.0,,1,The area under curve (25 mg/kg) administered orally in marmoset,,,CHEMBL624175,,22224,Callithrix,,,U,0,BAO_0000218,
12046,,14215,Autocuration,314293.0,,1,The area under curve (25 mg/kg) administered orally in monkey,,,CHEMBL624176,,22224,Simiiformes,,,U,0,BAO_0000218,
12047,,14215,Intermediate,9615.0,,1,The area under curve (30 mg/kg) administered orally in dog,,,CHEMBL624177,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
12048,,14215,Intermediate,9606.0,,1,The area under curve (400 mg/kg) administered orally in humans,,,CHEMBL624178,,50587,Homo sapiens,,,N,1,BAO_0000218,
12049,,14215,Intermediate,10116.0,,1,The area under curve (50 mg/kg) administered orally in fasted rat,,,CHEMBL624179,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
12050,,14215,Intermediate,10116.0,,1,The area under curve (50 mg/kg) administered orally in rat,,,CHEMBL627689,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
12051,,14215,Intermediate,9606.0,,1,The area under curve (800 mg/kg) administered orally in humans,,,CHEMBL627690,,50587,Homo sapiens,,,N,1,BAO_0000218,
12052,,11324,Autocuration,,,1,The compound was evaluated for area under the curve,,,CHEMBL627691,,22224,,,,U,0,BAO_0000019,
12053,,11324,Autocuration,9481.0,,1,The compound was evaluated for area under the curve in marmosets,,,CHEMBL627692,,22224,Callithrix,,,U,0,BAO_0000019,
12054,,11324,Autocuration,9481.0,,1,The compound was evaluated for area under the curve in marmosets,,,CHEMBL627693,,22224,Callithrix,,,U,0,BAO_0000019,
12055,,13875,Intermediate,10116.0,,1,The compound was tested for the area of the change in MABP versus time curve at dose 30 mg/kg (po) in conscious spontaneously hypertensive rat,,,CHEMBL627694,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
12056,,13875,Intermediate,10116.0,,1,The compound was tested for the area of the change in MABP versus time curve at dose 10 mg/kg (po) in conscious spontaneously hypertensive rat,,,CHEMBL627695,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
12057,,13875,Autocuration,,,1,The compound was tested for the area of the change in MABP versus time curve at dose 10 mg/kg (po),,,CHEMBL627696,,22224,,,,U,0,BAO_0000218,
12058,,13875,Intermediate,10116.0,,1,The compound was tested for the area of the change in MABP versus time curve at dose 30 mg/kg (po) in conscious spontaneously hypertensive rat,,,CHEMBL627697,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
12059,,13875,Intermediate,10116.0,,1,The compound was tested for the area of the change in MABP versus time curve at dose 30 mg/kg (po) in conscious spontaneously hypertensive rat,,,CHEMBL627698,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
12060,,13875,Intermediate,10116.0,,1,The compound was tested for the area of the change in MABP versus time curve at dose 5 mg/kg (po) in conscious spontaneously hypertensive rat,,,CHEMBL627699,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
12061,,13807,Intermediate,10116.0,,1,Total absorption was estimated by area under curve (AUC) after intravenous administration in rat,,,CHEMBL627700,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
12062,,14127,Intermediate,10116.0,,1,Total drug exposure is determined after oral dosing in rats.,,,CHEMBL627701,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
12063,,15116,Autocuration,,,1,Total drug exposure (5 mg/kg) when administered intravenously,,,CHEMBL627702,,22224,,,,U,0,BAO_0000218,
12064,,15116,Autocuration,,,1,Total drug exposure (5 mg/kg) when administered orally,,,CHEMBL627703,,22224,,,,U,0,BAO_0000218,
12065,,15604,Autocuration,314293.0,,1,area under curve in preclinical species was measured after Intravenous administration at the given dose (0.01 mg/kg) in monkey,,,CHEMBL626873,,22224,Simiiformes,,,U,0,BAO_0000218,
12066,,15604,Intermediate,10116.0,,1,area under curve in preclinical species was measured after Intravenous administration at the given dose (0.05 mg/kg) in rat,,,CHEMBL629583,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
12067,,15604,Intermediate,9615.0,,1,area under curve in preclinical species was measured after Intravenous administration at the given dose (0.1 mg/kg) in dog,,,CHEMBL629584,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
12068,,15604,Intermediate,9615.0,,1,area under curve in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in dog,,,CHEMBL629585,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
12069,In vivo,13751,Intermediate,10116.0,,1,"Biodistribution in brain of mature female Dawley rat after 5min, expressed as percent injected dose/g",,,CHEMBL629586,,50597,Rattus norvegicus,,,N,1,BAO_0000218,955.0
12070,In vivo,13751,Intermediate,10116.0,,1,"Biodistribution in brain of mature female Dawley rat after 30min, expressed as percent injected dose/g",,,CHEMBL629587,,50597,Rattus norvegicus,,,N,1,BAO_0000218,955.0
12071,In vivo,13751,Intermediate,10116.0,,1,"Biodistribution in fat of mature female Dawley rat after 10min, expressed as percent injected dose/g",,,CHEMBL629588,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
12072,In vivo,13751,Intermediate,10116.0,,1,"Biodistribution in fat of mature female Dawley rat after 15min, expressed as percent injected dose/g",,,CHEMBL629589,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
12073,In vivo,13751,Intermediate,10116.0,,1,"Biodistribution in fat of mature female Dawley rat after 1h, expressed as percent injected dose/g",,,CHEMBL629590,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
12074,In vivo,13751,Intermediate,10116.0,,1,"Biodistribution in fat of mature female Dawley rat after 3 h, expressed as percent injected dose/g",,,CHEMBL629591,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
12075,In vivo,13751,Intermediate,10116.0,,1,"Biodistribution in fat of mature female Dawley rat after 30min, expressed as percent injected dose/g",,,CHEMBL629592,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
12076,In vivo,13751,Intermediate,10116.0,,1,"Biodistribution in fat of mature female Dawley rat after 45min, expressed as percent injected dose/g",,,CHEMBL629593,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
12077,In vivo,13751,Intermediate,10116.0,,1,"Biodistribution in fat of mature female Dawley rat after 5min, expressed as percent injected dose/g",,,CHEMBL629594,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
12078,In vivo,13751,Intermediate,10116.0,,1,"Biodistribution in heart of mature female Dawley rat after 10min, expressed as percent injected dose/g",,,CHEMBL629595,,50597,Rattus norvegicus,,,N,1,BAO_0000218,948.0
12079,In vivo,13751,Intermediate,10116.0,,1,"Biodistribution in heart of mature female Dawley rat after 15min, expressed as percent injected dose/g",,,CHEMBL630290,,50597,Rattus norvegicus,,,N,1,BAO_0000218,948.0
12080,In vivo,13751,Intermediate,10116.0,,1,"Biodistribution in heart of mature female Dawley rat after 1h, expressed as percent injected dose/g",,,CHEMBL627137,,50597,Rattus norvegicus,,,N,1,BAO_0000218,948.0
12081,In vivo,13751,Intermediate,10116.0,,1,"Biodistribution in heart of mature female Dawley rat after 3 h, expressed as percent injected dose/g",,,CHEMBL627138,,50597,Rattus norvegicus,,,N,1,BAO_0000218,948.0
12082,In vivo,13751,Intermediate,10116.0,,1,"Biodistribution in heart of mature female Dawley rat after 30min, expressed as percent injected dose/g",,,CHEMBL627139,,50597,Rattus norvegicus,,,N,1,BAO_0000218,948.0
12083,In vivo,13751,Intermediate,10116.0,,1,"Biodistribution in heart of mature female Dawley rat after 45min, expressed as percent injected dose/g",,,CHEMBL627140,,50597,Rattus norvegicus,,,N,1,BAO_0000218,948.0
12084,In vivo,13751,Intermediate,10116.0,,1,"Biodistribution in heart of mature female Dawley rat after 5min, expressed as percent injected dose/g",,,CHEMBL627141,,50597,Rattus norvegicus,,,N,1,BAO_0000218,948.0
12085,In vivo,13751,Intermediate,10116.0,,1,"Biodistribution in kidney of mature female Dawley rat after 10min, expressed as percent injected dose/g",,,CHEMBL627142,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2113.0
12086,In vivo,13751,Intermediate,10116.0,,1,"Biodistribution in kidney of mature female Dawley rat after 15min, expressed as percent injected dose/g",,,CHEMBL627143,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2113.0
12087,In vivo,13751,Intermediate,10116.0,,1,"Biodistribution in kidney of mature female Dawley rat after 1h, expressed as percent injected dose/g",,,CHEMBL874449,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2113.0
12088,In vivo,13751,Intermediate,10116.0,,1,"Biodistribution in kidney of mature female Dawley rat after 3 h, expressed as percent injected dose/g",,,CHEMBL627144,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2113.0
12089,In vivo,13751,Intermediate,10116.0,,1,"Biodistribution in kidney of mature female Dawley rat after 30min, expressed as percent injected dose/g",,,CHEMBL627145,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2113.0
12090,In vivo,13751,Intermediate,10116.0,,1,"Biodistribution in kidney of mature female Dawley rat after 45min, expressed as percent injected dose/g",,,CHEMBL627146,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2113.0
12091,In vivo,13751,Intermediate,10116.0,,1,"Biodistribution in kidney of mature female Dawley rat after 5min, expressed as percent injected dose/g",,,CHEMBL627147,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2113.0
12092,In vivo,13751,Intermediate,10116.0,,1,"Biodistribution in liver of mature female Dawley rat after 10min, expressed as percent injected dose/g",,,CHEMBL627148,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
12093,In vivo,13751,Intermediate,10116.0,,1,"Biodistribution in lung of mature female Dawley rat after 10min, expressed as percent injected dose/g",,,CHEMBL627149,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2048.0
12094,In vivo,13751,Intermediate,10116.0,,1,"Biodistribution in lung of mature female Dawley rat after 15min, expressed as percent injected dose/g",,,CHEMBL632160,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2048.0
12095,In vivo,13751,Intermediate,10116.0,,1,"Biodistribution in lung of mature female Dawley rat after 1h, expressed as percent injected dose/g",,,CHEMBL632161,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2048.0
12096,In vivo,13751,Intermediate,10116.0,,1,"Biodistribution in lung of mature female Dawley rat after 3 h, expressed as percent injected dose/g",,,CHEMBL632162,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2048.0
12097,In vivo,13751,Intermediate,10116.0,,1,"Biodistribution in lung of mature female Dawley rat after 30min, expressed as percent injected dose/g",,,CHEMBL632163,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2048.0
12098,In vivo,13751,Intermediate,10116.0,,1,"Biodistribution in lung of mature female Dawley rat after 45min, expressed as percent injected dose/g",,,CHEMBL874469,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2048.0
12099,In vivo,13751,Intermediate,10116.0,,1,"Biodistribution in lung of mature female Dawley rat after 5min, expressed as percent injected dose/g",,,CHEMBL627182,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2048.0
12100,In vivo,13751,Intermediate,10116.0,,1,"Biodistribution in muscle of mature female Dawley rat after 10min, expressed as percent injected dose/g",,,CHEMBL627183,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2385.0
12101,In vivo,13751,Intermediate,10116.0,,1,"Biodistribution in muscle of mature female Dawley rat after 15min, expressed as percent injected dose/g",,,CHEMBL627184,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2385.0
12102,In vivo,13751,Intermediate,10116.0,,1,"Biodistribution in muscle of mature female Dawley rat after 1h, expressed as percent injected dose/g",,,CHEMBL627185,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2385.0
12103,In vivo,13751,Intermediate,10116.0,,1,"Biodistribution in muscle of mature female Dawley rat after 3 h, expressed as percent injected dose/g",,,CHEMBL627186,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2385.0
12104,In vivo,13751,Intermediate,10116.0,,1,"Biodistribution in muscle of mature female Dawley rat after 30min, expressed as percent injected dose/g",,,CHEMBL627187,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2385.0
12105,In vivo,13751,Intermediate,10116.0,,1,"Biodistribution in muscle of mature female Dawley rat after 45min, expressed as percent injected dose/g",,,CHEMBL627188,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2385.0
12106,In vivo,13751,Intermediate,10116.0,,1,"Biodistribution in muscle of mature female Dawley rat after 5min, expressed as percent injected dose/g",,,CHEMBL627189,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2385.0
12107,In vivo,13751,Intermediate,10116.0,,1,"Biodistribution inl ilver of mature female Dawley rat after 30min, expressed as percent injected dose/g",,,CHEMBL627190,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
12108,In vivo,13751,Intermediate,10116.0,,1,"Biodistribution inl iver of mature female Dawley rat after 15min, expressed as percent injected dose/g",,,CHEMBL627191,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
12109,In vivo,13751,Intermediate,10116.0,,1,"Biodistribution inl iver of mature female Dawley rat after 3 h, expressed as percent injected dose/g",,,CHEMBL627192,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
12110,In vivo,13751,Intermediate,10116.0,,1,"Biodistribution inl iver of mature female Dawley rat after 5min, expressed as percent injected dose/g",,,CHEMBL627193,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
12111,In vivo,10911,Intermediate,10116.0,,1,Biodistribution studied in the muscle of immature Fischer female rats at 2 hou; activity is expressed as inductive dose / gram,,,CHEMBL874590,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2385.0
12112,In vivo,10911,Intermediate,10116.0,,1,Biodistribution studied in the muscle of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,,CHEMBL627194,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2385.0
12113,In vivo,10911,Intermediate,10116.0,,1,Biodistribution studied in the muscle of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,,CHEMBL627195,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2385.0
12114,In vivo,10911,Intermediate,10116.0,,1,Biodistribution studied in the ovaries of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,,CHEMBL627196,,50597,Rattus norvegicus,,,N,1,BAO_0000218,992.0
12115,In vivo,10911,Intermediate,10116.0,,1,Biodistribution studied in the ovaries of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,,CHEMBL627197,,50597,Rattus norvegicus,,,N,1,BAO_0000218,992.0
12116,In vivo,10911,Intermediate,10116.0,,1,Biodistribution studied in the ovaries of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,,CHEMBL627198,,50597,Rattus norvegicus,,,N,1,BAO_0000218,992.0
12117,In vivo,10911,Intermediate,10116.0,,1,Biodistribution studied in the ovaries of immature Fischer female rats at 5 hour,,,CHEMBL627199,,50597,Rattus norvegicus,,,N,1,BAO_0000218,992.0
12118,In vivo,10911,Intermediate,10116.0,,1,Biodistribution studied in the ovaries of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,,CHEMBL627200,,50597,Rattus norvegicus,,,N,1,BAO_0000218,992.0
12119,In vivo,10911,Intermediate,10116.0,,1,Biodistribution studied in the plasma of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,,CHEMBL627201,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
12120,In vivo,10911,Intermediate,10116.0,,1,Biodistribution studied in the plasma of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,,CHEMBL627202,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
12121,In vivo,10911,Intermediate,10116.0,,1,Biodistribution studied in the plasma of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,,CHEMBL627203,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
12122,In vivo,10911,Intermediate,10116.0,,1,Biodistribution studied in the plasma of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,,CHEMBL627204,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
12123,In vivo,10911,Intermediate,10116.0,,1,Biodistribution studied in the spleen of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,,CHEMBL627205,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2106.0
12124,In vivo,10911,Intermediate,10116.0,,1,Biodistribution studied in the spleen of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,,CHEMBL627206,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2106.0
12125,In vivo,10911,Intermediate,10116.0,,1,Biodistribution studied in the spleen of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,,CHEMBL627207,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2106.0
12126,In vivo,10911,Intermediate,10116.0,,1,Biodistribution studied in the spleen of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,,CHEMBL627208,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2106.0
12127,In vivo,10911,Intermediate,10116.0,,1,Biodistribution studied in the thyroid of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,,CHEMBL627209,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2046.0
12128,In vivo,10911,Intermediate,10116.0,,1,Biodistribution studied in the thyroid of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,,CHEMBL627210,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2046.0
12129,In vivo,10911,Intermediate,10116.0,,1,Biodistribution studied in the thyroid of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,,CHEMBL627211,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2046.0
12130,In vivo,10911,Intermediate,10116.0,,1,Biodistribution studied in the thyroid of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,,CHEMBL627212,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2046.0
12131,In vivo,10911,Intermediate,10116.0,,1,Biodistribution studied in the uterus of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,,CHEMBL627213,,50597,Rattus norvegicus,,,N,1,BAO_0000218,995.0
12132,In vivo,10911,Intermediate,10116.0,,1,Biodistribution studied in the uterus of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,,CHEMBL626599,,50597,Rattus norvegicus,,,N,1,BAO_0000218,995.0
12133,In vivo,10911,Intermediate,10116.0,,1,Biodistribution studied in the uterus of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,,CHEMBL626600,,50597,Rattus norvegicus,,,N,1,BAO_0000218,995.0
12134,In vivo,10911,Intermediate,10116.0,,1,Biodistribution studied in the uterus of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,,CHEMBL626601,,50597,Rattus norvegicus,,,N,1,BAO_0000218,995.0
12135,,8081,Autocuration,,,1,C(f=2) is the concentration at which the half life (t1/2) in the time course of inhibition of BChE by DFP increased by twofold in the presence of compound,,,CHEMBL627484,,22224,,,,U,0,BAO_0000019,
12136,,17248,Intermediate,9541.0,,1,Compound was tested for plasma concentration in CM-monkeys 7 hours after oral administration (50 mg/kg),,,CHEMBL627485,,100710,Macaca fascicularis,,,N,1,BAO_0000218,1969.0
12137,,17248,Intermediate,9541.0,,1,Compound was tested for plasma concentration in CM-monkeys 7 hours after oral administration (50 mg/kg); Not applicable,,,CHEMBL628147,,100710,Macaca fascicularis,,,N,1,BAO_0000218,1969.0
12138,,17248,Intermediate,9541.0,,1,Compound was tested for plasma concentration in CM-monkeys 7 hours after oral administration (50 mg/kg); Not determined,,,CHEMBL628148,,100710,Macaca fascicularis,,,N,1,BAO_0000218,1969.0
12139,,17248,Intermediate,9615.0,,1,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg),,,CHEMBL628149,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,1969.0
12140,,17248,Intermediate,9615.0,,1,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg) in experiment 1,,,CHEMBL628150,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,1969.0
12141,,17248,Intermediate,9615.0,,1,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg) in experiment 2,,,CHEMBL628318,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,1969.0
12142,,17248,Intermediate,9615.0,,1,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg); Not applicable,,,CHEMBL628319,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,1969.0
12143,,15592,Intermediate,9615.0,,1,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 )",,,CHEMBL875609,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
12144,,7040,Autocuration,,,1,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 10,,,CHEMBL628320,,22224,,,,U,0,BAO_0000019,
12145,,7040,Autocuration,,,1,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 10.5,,,CHEMBL628321,,22224,,,,U,0,BAO_0000019,
12146,,7040,Autocuration,,,1,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 6.8,,,CHEMBL628322,,22224,,,,U,0,BAO_0000019,
12147,,7040,Autocuration,,,1,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 7.2,,,CHEMBL628323,,22224,,,,U,0,BAO_0000019,
12148,,7040,Autocuration,,,1,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 7.6,,,CHEMBL628324,,22224,,,,U,0,BAO_0000019,
12149,,7040,Autocuration,,,1,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 8.2,,,CHEMBL628325,,22224,,,,U,0,BAO_0000019,
12150,,7040,Autocuration,,,1,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 9.6,,,CHEMBL628326,,22224,,,,U,0,BAO_0000019,
12151,,9614,Intermediate,9615.0,,1,"Concentration of compound in adrenal medulla of dog 2, after administering intravenously",,,CHEMBL628327,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,1236.0
12152,,9614,Intermediate,9615.0,,1,"Concentration of compound in adrenal medulla of dog1, after administering intravenously",,,CHEMBL628328,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,1236.0
12153,,9614,Intermediate,9615.0,,1,"Concentration of compound in blood of dog 1, after administering intravenously",,,CHEMBL628329,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,178.0
12154,,8608,Intermediate,10116.0,,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration.; dose/g, range 0.23-0.29",,,CHEMBL628330,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
12155,,8608,Intermediate,10116.0,,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 0.22-0.30",,,CHEMBL628331,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
12156,,8608,Intermediate,10116.0,,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 0.55-0.71",,,CHEMBL628332,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
12157,,8608,Intermediate,10116.0,,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 0.57-0.72",,,CHEMBL628333,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
12158,,8608,Intermediate,10116.0,,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 1.51-2.23",,,CHEMBL628334,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
12159,,8608,Intermediate,10116.0,,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 2.30-3.12",,,CHEMBL628335,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
12160,,8608,Intermediate,10116.0,,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 0.93-1.20",,,CHEMBL628336,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
12161,,8608,Intermediate,10116.0,,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 1.04-2.56",,,CHEMBL628337,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
12162,,8608,Intermediate,10116.0,,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 1.06-1.70",,,CHEMBL628338,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
12163,,8608,Intermediate,10116.0,,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 1.26-2.45",,,CHEMBL875610,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
12164,,8608,Intermediate,10116.0,,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 3.12-4.56",,,CHEMBL628339,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
12165,,8608,Intermediate,10116.0,,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 4.12-6.30",,,CHEMBL628340,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
12166,,8608,Intermediate,10116.0,,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.14-0.19",,,CHEMBL628341,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
12167,,8608,Intermediate,10116.0,,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.15-0.19",,,CHEMBL622214,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
12168,,8608,Intermediate,10116.0,,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.24-0.30",,,CHEMBL623167,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
12169,,8608,Intermediate,10116.0,,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.44-0.54",,,CHEMBL623168,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
12170,,8608,Intermediate,10116.0,,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.73-1.19",,,CHEMBL623169,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
12171,,8608,Intermediate,10116.0,,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 1.08-2.31",,,CHEMBL623170,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
12172,,8608,Intermediate,10116.0,,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration.; dose/g, range 0.34-0.47",,,CHEMBL627224,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2048.0
12173,,8608,Intermediate,10116.0,,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 0.83-1.21",,,CHEMBL875634,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2048.0
12174,,8608,Intermediate,10116.0,,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 0.91-1.74",,,CHEMBL627225,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2048.0
12175,,8608,Intermediate,10116.0,,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 0.99-1.23",,,CHEMBL627226,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2048.0
12176,,8608,Intermediate,10116.0,,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 1.07-1.30",,,CHEMBL626083,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2048.0
12177,,8608,Intermediate,10116.0,,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 1.12-1.39",,,CHEMBL626084,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2048.0
12178,,8608,Intermediate,10116.0,,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 0.51-0.66",,,CHEMBL626085,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2048.0
12179,,8608,Intermediate,10116.0,,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 0.95-1.49",,,CHEMBL626086,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2048.0
12180,,8608,Intermediate,10116.0,,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 0.96-1.35",,,CHEMBL626087,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2048.0
12181,,8608,Intermediate,10116.0,,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 1.18-1.44",,,CHEMBL626088,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2048.0
12182,,8608,Intermediate,10116.0,,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 1.20-1.52",,,CHEMBL626089,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2048.0
12183,,8608,Intermediate,10116.0,,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 1.41-2.17",,,CHEMBL626090,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2048.0
12184,,8608,Intermediate,10116.0,,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.28-0.33",,,CHEMBL626091,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2048.0
12185,,8608,Intermediate,10116.0,,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.81-1.13",,,CHEMBL626092,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2048.0
12186,,8608,Intermediate,10116.0,,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.83-2.11",,,CHEMBL626093,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2048.0
12187,,8608,Intermediate,10116.0,,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.94-1.36",,,CHEMBL626094,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2048.0
12188,,8608,Intermediate,10116.0,,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.97-1.54",,,CHEMBL626095,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2048.0
12189,,8608,Intermediate,10116.0,,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 1.07-1.26",,,CHEMBL626096,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2048.0
12190,,15604,Autocuration,314293.0,,1,area under curve in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in monkey,,,CHEMBL626097,,22224,Simiiformes,,,U,0,BAO_0000218,
12191,,15604,Intermediate,10116.0,,1,area under curve in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in rat,,,CHEMBL626098,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
12192,,1806,Autocuration,,,1,compound was evaluated for area under the plasma concentration vs. time curve at different dose 27.5 mg/kg DMP323 equiv,,,CHEMBL626099,,22224,,,,U,0,BAO_0000218,1969.0
12193,,1806,Autocuration,,,1,compound was evaluated for area under the plasma concentration vs. time curve at different dose 7.7 mg/kg DMP323 equiv,,,CHEMBL626100,,22224,,,,U,0,BAO_0000218,1969.0
12194,,17237,Intermediate,9615.0,,1,AUC 0-inf in dog,,,CHEMBL626101,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,1969.0
12195,,17237,Intermediate,10141.0,,1,AUC 0-inf in guinea pig,,,CHEMBL626102,,50512,Cavia porcellus,,,N,1,BAO_0000218,1969.0
12196,,17237,Intermediate,9615.0,,1,AUC 0-t in dog,,,CHEMBL626103,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,1969.0
12197,,17237,Intermediate,10141.0,,1,AUC 0-t in guinea pig,,,CHEMBL628391,,50512,Cavia porcellus,,,N,1,BAO_0000218,1969.0
12198,,15194,Intermediate,10116.0,,1,The compound was tested for brain to plasma partition in rat,,,CHEMBL628392,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
12199,,15194,Intermediate,10116.0,,1,The compound was tested for brain to plasma partition in rat.,,,CHEMBL628393,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
12200,,8787,Autocuration,,,1,Area under curve was determined for 0-6 hr duration using dihydralazine as reference drug for the peak blood pressure,,,CHEMBL628394,,22224,,,,U,0,BAO_0000019,178.0
12201,,17025,Intermediate,9615.0,,1,Area under concentration-time curve of compound was determined in dog at 5 mg/kg intravenously admn.,,,CHEMBL628395,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
12202,,17025,Autocuration,314293.0,,1,Area under concentration-time curve of compound was determined in monkey at 5 mg/kg intravenously admn.,,,CHEMBL628396,,22224,Simiiformes,,,U,0,BAO_0000218,
12203,,17025,Intermediate,9986.0,,1,Area under concentration-time curve of compound was determined in rabbit at 5 mg/kg intravenously admn.,,,CHEMBL628397,,50592,Oryctolagus cuniculus,,,N,1,BAO_0000218,
12204,,17025,Intermediate,10116.0,,1,Area under concentration-time curve of compound was determined in rat at 5 mg/kg intravenously admn.,,,CHEMBL628398,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
12205,,4236,Intermediate,9544.0,,1,Area under curve obtained at a dose of 10 mg/kg when administered orally to rhesus monkey,,,CHEMBL628399,,50797,Macaca mulatta,,,N,1,BAO_0000218,
12206,,15343,Intermediate,9615.0,,1,The Plasma area under the compound concentration -time curve was measured in dogs after oral administration of 1 mg/kg dose,,,CHEMBL628400,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
12207,,15343,Intermediate,10116.0,,1,The Plasma area under the compound concentration -time curve was measured in rats after oral administration of 1 mg/kg dose,,,CHEMBL874907,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
12208,,17720,Autocuration,,,1,Area under curve of the compound was determined,,,CHEMBL628401,,22224,,,,U,0,BAO_0000019,
12209,,17788,Autocuration,314293.0,,1,AUC in monkeys at a dose of 1 mg/kg,,,CHEMBL628402,,22224,Simiiformes,,,U,0,BAO_0000218,1969.0
12210,,17788,Intermediate,10116.0,,1,AUC in rats at a dose of 1 mg/kg,,,CHEMBL628403,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
12211,,8778,Autocuration,,,1,Compound was evaluated for the overall absorbance loss at pH of 2,,,CHEMBL628404,,22224,,,,U,0,BAO_0000019,
12212,,8778,Autocuration,,,1,Compound was evaluated for the overall absorbance loss at pH of 4,,,CHEMBL628405,,22224,,,,U,0,BAO_0000019,
12213,,8778,Autocuration,,,1,Compound was evaluated for the overall absorbance loss at pH of 7,,,CHEMBL628406,,22224,,,,U,0,BAO_0000019,
12214,,2249,Intermediate,10116.0,,1,Compound was evaluated for its absorption in the rats,,,CHEMBL628407,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
12215,,8881,Intermediate,10116.0,,1,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of 0.1 mmol/kg of body weight per mole of pro drug,,,CHEMBL628408,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
12216,,8881,Intermediate,10116.0,,1,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of 0.1 mmol/kg of body weight.,,,CHEMBL629171,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
12217,,8881,Intermediate,10116.0,,1,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of 0.1 mmol/kg of body weight per mole of pro drug,,,CHEMBL629172,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
12218,,8881,Intermediate,10116.0,,1,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of per moiety tranexamic acid,,,CHEMBL629173,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
12219,,15286,Intermediate,10116.0,,1,In vitro percent permeability into rat ileum,,,CHEMBL629174,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
12220,,15286,Intermediate,10116.0,,1,In vitro percent permeability into rat ileum; Range is 10-17,,,CHEMBL629175,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
12221,,15286,Intermediate,10116.0,,1,In vitro percent permeability into rat ileum; Range is 10-18,,,CHEMBL629176,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
12222,,15286,Intermediate,10116.0,,1,In vitro percent permeability into rat ileum; Range is 10-19,,,CHEMBL629177,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
12223,,15286,Intermediate,10116.0,,1,In vitro percent permeability into rat ileum; Range is 12-15,,,CHEMBL629178,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
12224,,15286,Intermediate,10116.0,,1,In vitro percent permeability into rat ileum; Range is 13-19,,,CHEMBL631869,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
12225,,15286,Intermediate,10116.0,,1,In vitro percent permeability into rat ileum; Range is 14-17,,,CHEMBL631870,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
12226,,15286,Intermediate,10116.0,,1,In vitro percent permeability into rat ileum; Range is 15-18,,,CHEMBL631871,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
12227,,15286,Intermediate,10116.0,,1,In vitro percent permeability into rat ileum; Range is 2-5,,,CHEMBL631872,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
12228,,15286,Autocuration,,,1,In vitro percent permeability into rat ileum; Range is 23-42,,,CHEMBL875775,,22224,,,,U,0,BAO_0000221,2116.0
12229,,15286,Intermediate,10116.0,,1,In vitro percent permeability into rat ileum; Range is 28-36,,,CHEMBL631873,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
12230,,15286,Intermediate,10116.0,,1,In vitro percent permeability into rat ileum; Range is 29-35,,,CHEMBL631874,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
12231,,15286,Intermediate,10116.0,,1,In vitro percent permeability into rat ileum; Range is 46-66,,,CHEMBL631875,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
12232,,15286,Intermediate,10116.0,,1,In vitro percent permeability into rat ileum; Range is 50-68,,,CHEMBL631876,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
12233,,15286,Intermediate,10116.0,,1,In vitro percent permeability into rat ileum; Range is 78-81,,,CHEMBL631877,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
12234,,15286,Intermediate,10116.0,,1,In vitro percent permeability into rat ileum; insol indicates not soluble in aqueous buffer,,,CHEMBL631878,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
12235,,15286,Intermediate,10116.0,,1,In vitro percent permeability into rat ileum; nd indicates not detected,,,CHEMBL631879,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
12236,,15286,Intermediate,10116.0,,1,In vitro percent permeability into rat ileum; nt indicates not detected,,,CHEMBL631880,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
12237,,15286,Intermediate,10116.0,,1,In vitro percent permeability into rat ileum; nt indicates not tested,,,CHEMBL631881,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
12238,,13770,Intermediate,10116.0,,1,Compound was tested for oral absorption in bile-duct cannulated rats,,,CHEMBL631882,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
12239,,13770,Intermediate,10116.0,,1,Compound was tested for oral absorption in bile-duct cannulated rats.,,,CHEMBL630749,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
12240,,5202,Intermediate,9606.0,,1,Oral absorption using Caco-2 cell monolayers.,,,CHEMBL630750,,50587,Homo sapiens,,,N,1,BAO_0000218,
12241,,14920,Intermediate,9606.0,,1,Percent of the drug absorbed after administration to humans was determined,,,CHEMBL630253,,50587,Homo sapiens,,,N,1,BAO_0000218,
12242,,14103,Intermediate,10116.0,,1,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 120 minutes.,,,CHEMBL630254,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
12243,,14103,Intermediate,10116.0,,1,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 15 minutes.,,,CHEMBL630255,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
12244,,14103,Intermediate,10116.0,,1,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 180 minutes.,,,CHEMBL630256,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
12245,In vivo,13751,Intermediate,10116.0,,1,"Biodistribution inl liver of mature female Dawley rat after 1h, expressed as percent injected dose/g",,,CHEMBL875781,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
12246,In vivo,13751,Intermediate,10116.0,,1,"Biodistribution inl liver of mature female Dawley rat after 30min, expressed as percent injected dose/g",,,CHEMBL630257,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
12247,In vivo,13751,Intermediate,10116.0,,1,"Biodistribution inl liver of mature female Dawley rat after 45min, expressed as percent injected dose/g",,,CHEMBL630258,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
12248,,15807,Intermediate,10116.0,,1,"Distribution of radioactivity in rat blood after 2 minutes of iv administration at the dose of 10.05-0.07 gram of tissue, expressed as percent injected dose per gram of tissue",,,CHEMBL630259,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
12249,,15807,Intermediate,10116.0,,1,"Distribution of radioactivity in rat striatum after 5 minutes of iv administration at the dose of 1.89-3.73 g of tissue, expressed as percent injected dose per gram of tissue",,,CHEMBL630260,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2435.0
12250,,15807,Intermediate,10116.0,,1,"Distribution of radioactivity in rat striatum after 5 minutes of iv administration at the dose of 3.44-4.80 g of tissue, expressed as percent injected dose per gram of tissue",,,CHEMBL630261,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2435.0
12251,,14950,Intermediate,10116.0,,1,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat and 5-alpha-DHT was reported,,,CHEMBL630262,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
12252,,14950,Intermediate,10116.0,,1,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat blood at 1 hour time,,,CHEMBL630263,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
12253,,14950,Intermediate,10116.0,,1,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat blood at 2 hours time,,,CHEMBL630264,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
12254,,14950,Intermediate,10116.0,,1,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat fat at 0.5 hours time,,,CHEMBL630265,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
12255,,14950,Intermediate,10116.0,,1,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat fat at 4 hours time,,,CHEMBL630266,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
12256,,14950,Intermediate,10116.0,,1,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat kidney at 0.5 hours time,,,CHEMBL630267,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2113.0
12257,,14950,Intermediate,10116.0,,1,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat kidney at 4 hours time,,,CHEMBL630268,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2113.0
12258,,14950,Intermediate,10116.0,,1,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat liver at 1 hour time,,,CHEMBL630269,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
12259,,14950,Intermediate,10116.0,,1,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat liver at 2 hours time,,,CHEMBL630270,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
12260,,14950,Intermediate,10116.0,,1,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat lung at 1 hour time,,,CHEMBL630141,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2048.0
12261,,14950,Intermediate,10116.0,,1,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat lung at 2 hours time,,,CHEMBL630142,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2048.0
12262,,14950,Intermediate,10116.0,,1,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat muscle at 0.5 hours time,,,CHEMBL630143,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2385.0
12263,,14950,Intermediate,10116.0,,1,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat muscle at 4 hours time,,,CHEMBL630144,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2385.0
12264,,14950,Intermediate,10116.0,,1,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate at 0.5 hours time,,,CHEMBL630145,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2367.0
12265,,14950,Intermediate,10116.0,,1,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate at 4 hours time,,,CHEMBL630146,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2367.0
12266,,14950,Intermediate,10116.0,,1,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate/blood,,,CHEMBL630147,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
12267,,14950,Intermediate,10116.0,,1,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate/blood at 1 hours time,,,CHEMBL630148,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
12268,,14950,Intermediate,10116.0,,1,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate/blood at 2 hours time,,,CHEMBL630149,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
12269,,14950,Intermediate,10116.0,,1,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat spleen at 1 hour time,,,CHEMBL630150,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2106.0
12270,,14950,Intermediate,10116.0,,1,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat spleen at 2 hours time,,,CHEMBL630151,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2106.0
12271,,14950,Intermediate,10116.0,,1,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat thyroid at 0.5 hours time,,,CHEMBL632031,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2046.0
12272,,14950,Intermediate,10116.0,,1,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat thyroid at 4 hours time,,,CHEMBL632032,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2046.0
12273,,14950,Intermediate,10116.0,,1,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat fat at 1 hour time,,,CHEMBL632033,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
12274,,14950,Intermediate,10116.0,,1,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat kidney at 1 hour time,,,CHEMBL632034,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
12275,,14950,Intermediate,10116.0,,1,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat muscle at 1 hour time,,,CHEMBL632035,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2385.0
12276,,14950,Intermediate,10116.0,,1,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat prostrateat 1 hour time,,,CHEMBL632036,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
12277,,14950,Intermediate,10116.0,,1,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat thyroid at 1 hour time,,,CHEMBL632037,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2046.0
12278,,8631,Intermediate,10116.0,,1,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 10 minutes,,,CHEMBL632038,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
12279,,8631,Intermediate,10116.0,,1,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 15 minutes,,,CHEMBL632039,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
12280,,8631,Intermediate,10116.0,,1,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 20 minutes,,,CHEMBL632040,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
12281,,8631,Intermediate,10116.0,,1,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 30 minutes,,,CHEMBL632041,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
12282,,9614,Intermediate,9615.0,,1,"Concentration of compound in blood of dog 2, after administering intravenously",,,CHEMBL632042,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,178.0
12283,,9614,Intermediate,9615.0,,1,"Concentration of compound in left ventricle of dog 1, after administering intravenously",,,CHEMBL632043,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
12284,,9614,Intermediate,9615.0,,1,"Concentration of compound in left ventricle of dog 2, after administering intravenously",,,CHEMBL632044,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
12285,,9614,Intermediate,9615.0,,1,"Concentration of compound in liver of dog 1, after administering intravenously",,,CHEMBL632045,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,2107.0
12286,,9614,Intermediate,9615.0,,1,"Concentration of compound in liver of dog 2, after administering intravenously",,,CHEMBL632046,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,2107.0
12287,,9614,Intermediate,9615.0,,1,"Concentration of compound in lung of dog 1, after administering intravenously",,,CHEMBL632047,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,2048.0
12288,,9614,Intermediate,9615.0,,1,"Concentration of compound in lung of dog 2, after administering intravenously",,,CHEMBL632048,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,2048.0
12289,,9614,Intermediate,9615.0,,1,"Concentration of compound in muscle of dog 1, after administering intravenously",,,CHEMBL632049,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,2385.0
12290,,9614,Intermediate,9615.0,,1,"Concentration of compound in muscle of dog 2, after administering intravenously",,,CHEMBL876418,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,2385.0
12291,,9614,Intermediate,9615.0,,1,"Concentration of compound in spleen of dog 1,after administering intravenously",,,CHEMBL632050,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,2106.0
12292,,9614,Intermediate,9615.0,,1,"Concentration of compound in spleen of dog 2, after administering intravenously",,,CHEMBL632051,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,2106.0
12293,,10353,Autocuration,,,1,Concentration of liberated compound in serum after 120 min at the dose of 50 mg/kg (po).,,,CHEMBL632052,,22224,,,,U,0,BAO_0000218,
12294,,10353,Autocuration,,,1,Concentration of liberated compound in serum after 240 min at the dose of 50 mg/kg (po).,,,CHEMBL632053,,22224,,,,U,0,BAO_0000218,
12295,,10353,Autocuration,,,1,Concentration of liberated compound in serum after 30 min at the dose of 50 mg/kg (po).,,,CHEMBL632054,,22224,,,,U,0,BAO_0000218,
12296,,10353,Autocuration,,,1,Concentration of liberated compound in serum after 30 min at the dose of 50 mg/kg (po).,,,CHEMBL632055,,22224,,,,U,0,BAO_0000218,
12297,,10353,Autocuration,,,1,Concentration of liberated compound in serum after 60 min at the dose of 50 mg/kg (po).,,,CHEMBL631181,,22224,,,,U,0,BAO_0000218,
12298,,9196,Autocuration,,,1,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous after 1.5 hr,,,CHEMBL631182,,22224,,,,U,0,BAO_0000218,
12299,,9196,Autocuration,,,1,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.5 hr,,,CHEMBL631183,,22224,,,,U,0,BAO_0000218,
12300,,9196,Autocuration,,,1,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,,,CHEMBL631184,,22224,,,,U,0,BAO_0000218,
12301,,9196,Autocuration,,,1,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,,,CHEMBL629774,,22224,,,,U,0,BAO_0000218,
12302,,9196,Autocuration,,,1,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,,,CHEMBL629775,,22224,,,,U,0,BAO_0000218,
12303,,9196,Autocuration,,,1,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,,,CHEMBL876549,,22224,,,,U,0,BAO_0000218,
12304,,9196,Autocuration,,,1,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,,,CHEMBL628172,,22224,,,,U,0,BAO_0000218,
12305,,9196,Autocuration,,,1,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr,,,CHEMBL628173,,22224,,,,U,0,BAO_0000218,
12306,,9196,Autocuration,,,1,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous after 1.5 hr,,,CHEMBL628174,,22224,,,,U,0,BAO_0000218,
12307,,9196,Autocuration,,,1,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage a after 4.0 hr,,,CHEMBL628175,,22224,,,,U,0,BAO_0000218,
12308,,9196,Autocuration,,,1,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 0.5 hr,,,CHEMBL628176,,22224,,,,U,0,BAO_0000218,
12309,,9196,Autocuration,,,1,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.0 hr,,,CHEMBL628177,,22224,,,,U,0,BAO_0000218,
12310,,9196,Autocuration,,,1,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,,,CHEMBL628178,,22224,,,,U,0,BAO_0000218,
12311,,9196,Autocuration,,,1,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr,,,CHEMBL628179,,22224,,,,U,0,BAO_0000218,
12312,,9196,Autocuration,,,1,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg i intravenous dosage after 1.0 hr; insufficient gastric juice produced,,,CHEMBL628180,,22224,,,,U,0,BAO_0000218,
12313,,9196,Autocuration,,,1,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage a after 2.5 hr,,,CHEMBL628181,,22224,,,,U,0,BAO_0000218,
12314,,9196,Autocuration,,,1,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,,,CHEMBL628182,,22224,,,,U,0,BAO_0000218,
12315,,9196,Autocuration,,,1,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,,,CHEMBL628183,,22224,,,,U,0,BAO_0000218,
12316,,9196,Autocuration,,,1,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr; ND means not determined,,,CHEMBL628184,,22224,,,,U,0,BAO_0000218,
12317,,9196,Autocuration,,,1,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,,,CHEMBL628185,,22224,,,,U,0,BAO_0000218,
12318,,9196,Autocuration,,,1,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,,,CHEMBL875617,,22224,,,,U,0,BAO_0000218,
12319,,9196,Autocuration,,,1,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr; ND means not determined,,,CHEMBL628186,,22224,,,,U,0,BAO_0000218,
12320,,9196,Autocuration,,,1,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,,,CHEMBL628187,,22224,,,,U,0,BAO_0000218,
12321,,9196,Autocuration,,,1,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 0.5 hr,,,CHEMBL628188,,22224,,,,U,0,BAO_0000218,
12322,,9196,Autocuration,,,1,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.0 hr,,,CHEMBL628189,,22224,,,,U,0,BAO_0000218,
12323,,9196,Autocuration,,,1,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.5 hr; ND means not determined,,,CHEMBL628190,,22224,,,,U,0,BAO_0000218,
12324,,9196,Autocuration,,,1,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.0 hr,,,CHEMBL628191,,22224,,,,U,0,BAO_0000218,
12325,,9196,Autocuration,,,1,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.5 hr; ND means not determined,,,CHEMBL626513,,22224,,,,U,0,BAO_0000218,
12326,,8608,Intermediate,10116.0,,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 19-24",,,CHEMBL626514,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2046.0
12327,,8608,Intermediate,10116.0,,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 26-40",,,CHEMBL626515,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2046.0
12328,,8608,Intermediate,10116.0,,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 29-44",,,CHEMBL626516,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2046.0
12329,,8608,Intermediate,10116.0,,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 32-42",,,CHEMBL626517,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2046.0
12330,,8608,Intermediate,10116.0,,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 33-60",,,CHEMBL626518,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2046.0
12331,,8608,Intermediate,10116.0,,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 4-7",,,CHEMBL626519,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2046.0
12332,,8608,Intermediate,10116.0,,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 13-18",,,CHEMBL626520,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2046.0
12333,,8608,Intermediate,10116.0,,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 16-32",,,CHEMBL626521,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2046.0
12334,,8608,Intermediate,10116.0,,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 22-25",,,CHEMBL626522,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2046.0
12335,,8608,Intermediate,10116.0,,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 26-49",,,CHEMBL626523,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2046.0
12336,,8608,Intermediate,10116.0,,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 29-36",,,CHEMBL626524,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2046.0
12337,,8608,Intermediate,10116.0,,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 5-8",,,CHEMBL626688,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2046.0
12338,,8608,Intermediate,10116.0,,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 26-42",,,CHEMBL626689,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2046.0
12339,,8608,Intermediate,10116.0,,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 30-53",,,CHEMBL626690,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2046.0
12340,,8608,Intermediate,10116.0,,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 32-43",,,CHEMBL626691,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2046.0
12341,,8608,Intermediate,10116.0,,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 35-53",,,CHEMBL627319,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2046.0
12342,,8608,Intermediate,10116.0,,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 5-12",,,CHEMBL624052,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2046.0
12343,,8608,Intermediate,10116.0,,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 55-102",,,CHEMBL624053,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2046.0
12344,,8085,Intermediate,10116.0,,1,In vivo distribution of the drug in plasma was determined at 1 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,,,CHEMBL624054,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
12345,,8085,Intermediate,10116.0,,1,In vivo distribution of the drug in plasma was determined at 2 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,,,CHEMBL624055,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
12346,,8085,Intermediate,10116.0,,1,In vivo distribution of the drug in plasma was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,,,CHEMBL624056,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
12347,,8085,Intermediate,10116.0,,1,In vivo distribution of the drug in uterus was determined at 1 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,,,CHEMBL624057,,50597,Rattus norvegicus,,,N,1,BAO_0000218,995.0
12348,,8085,Intermediate,10116.0,,1,In vivo distribution of the drug in uterus was determined at 2 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,,,CHEMBL622281,,50597,Rattus norvegicus,,,N,1,BAO_0000218,995.0
12349,,8085,Intermediate,10116.0,,1,In vivo distribution of the drug in uterus was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,,,CHEMBL622282,,50597,Rattus norvegicus,,,N,1,BAO_0000218,995.0
12350,,8085,Intermediate,10116.0,,1,In vivo distribution of the drug in uterus/plasma was determined at 1 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,,,CHEMBL622283,,50597,Rattus norvegicus,,,N,1,BAO_0000218,995.0
12351,,8085,Intermediate,10116.0,,1,In vivo distribution of the drug in uterus/plasma was determined at 2 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,,,CHEMBL622284,,50597,Rattus norvegicus,,,N,1,BAO_0000218,995.0
12352,,8085,Intermediate,10116.0,,1,In vivo distribution of the drug in uterus/plasma was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,,,CHEMBL622285,,50597,Rattus norvegicus,,,N,1,BAO_0000218,995.0
12353,,8085,Intermediate,10116.0,,1,In vivo distribution of the drug in uterus/plasma was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,,,CHEMBL622286,,50597,Rattus norvegicus,,,N,1,BAO_0000218,995.0
12354,,7657,Autocuration,,,1,Distribution coefficient (D %) between octanol and buffer of pH 7.4,,,CHEMBL622287,,22224,,,,U,0,BAO_0000100,
12355,,8935,Intermediate,10090.0,,1,Partition coefficient (logD7.4),,,CHEMBL622288,,50594,Mus musculus,,,N,1,BAO_0000218,
12356,,13792,Intermediate,10090.0,,1,"Percentage of radioactivity in P1 subregion in mouse brain that contains nuclei and cell debris, after Jugular Vein Injection",,,CHEMBL622289,,50594,Mus musculus,,,N,1,BAO_0000218,
12357,,13792,Intermediate,10090.0,,1,"Percentage of radioactivity in P2 subregion in mouse brain that contains myelin fragments, synaptosomes (pinched-nerve endings), and mitochondria after Jugular Vein Injection",,,CHEMBL622290,,50594,Mus musculus,,,N,1,BAO_0000218,955.0
12358,,13792,Intermediate,10090.0,,1,Percentage of radioactivity in P3 subregion in mouse brain that contains microsomal fraction after Jugular Vein Injection,,,CHEMBL622291,,50594,Mus musculus,,,N,1,BAO_0000218,
12359,,13792,Intermediate,10090.0,,1,Percentage of radioactivity in S3 which is the soluble fraction in mouse brain after Jugular Vein Injection,,,CHEMBL622292,,50594,Mus musculus,,,N,1,BAO_0000218,955.0
12360,,13792,Intermediate,10090.0,,1,"Percentage of total protein recovered in P1 subregion in mouse brain that contains nuclei and cell debris, after Jugular Vein Injection",,,CHEMBL622293,,50594,Mus musculus,,,N,1,BAO_0000218,
12361,,13792,Intermediate,10090.0,,1,"Percentage of total protein recovered in P2 subregion in mouse brain that contains myelin fragments, synaptosomes (pinched-nerve endings), and mitochondria after Jugular Vein Injection",,,CHEMBL622294,,50594,Mus musculus,,,N,1,BAO_0000218,955.0
12362,,13792,Intermediate,10090.0,,1,Percentage of total protein recovered in P3 subregion in mouse brain that contains microsomal fraction after Jugular Vein Injection,,,CHEMBL622295,,50594,Mus musculus,,,N,1,BAO_0000218,
12363,,13792,Intermediate,10116.0,,1,Percentage of total protein recovered in S3 which is the soluble fraction in mouse brain after Jugular Vein Injection,,,CHEMBL622296,,50597,Rattus norvegicus,,,N,1,BAO_0000218,955.0
12364,,14103,Intermediate,10116.0,,1,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 2 minutes.,,,CHEMBL874409,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
12365,,14103,Intermediate,10116.0,,1,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 240 minutes.,,,CHEMBL622297,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
12366,,14103,Intermediate,10116.0,,1,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 30 minutes.,,,CHEMBL622298,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
12367,,14103,Intermediate,10116.0,,1,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 45 minutes.,,,CHEMBL622299,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
12368,,14103,Intermediate,10116.0,,1,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 5 minutes.,,,CHEMBL622300,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
12369,,14103,Intermediate,10116.0,,1,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 60 minutes.,,,CHEMBL622301,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
12370,,14103,Intermediate,10116.0,,1,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 90 minutes.,,,CHEMBL622302,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
12371,,14103,Intermediate,10116.0,,1,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 120 minutes.,,,CHEMBL622303,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
12372,,14103,Intermediate,10116.0,,1,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 15 minutes.,,,CHEMBL622304,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
12373,,14103,Intermediate,10116.0,,1,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 15 minutes;nd=not determined,,,CHEMBL622305,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
12374,,14103,Intermediate,10116.0,,1,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 180 minutes.,,,CHEMBL622306,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
12375,,14103,Intermediate,10116.0,,1,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 2 minutes;nd=not determined,,,CHEMBL626864,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
12376,,14103,Intermediate,10116.0,,1,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 240 minutes.,,,CHEMBL626865,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
12377,,14103,Intermediate,10116.0,,1,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 240 minutes;nd=not determined,,,CHEMBL626866,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
12378,,14103,Intermediate,10116.0,,1,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 30 minutes.,,,CHEMBL626867,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
12379,,14103,Intermediate,10116.0,,1,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 45 minutes.,,,CHEMBL626868,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
12380,,14103,Intermediate,10116.0,,1,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 45 minutes;nd=not determined,,,CHEMBL626869,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
12381,,14103,Intermediate,10116.0,,1,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 5 minutes.,,,CHEMBL626870,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
12382,,14103,Intermediate,10116.0,,1,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 5 minutes;nd=not determined,,,CHEMBL626871,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
12383,,14103,Intermediate,10116.0,,1,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 60 minutes.,,,CHEMBL626872,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
12384,,14103,Intermediate,10116.0,,1,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 90 minutes.,,,CHEMBL632185,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
12385,,14103,Intermediate,10116.0,,1,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 90 minutes;nd=not determined,,,CHEMBL632186,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
12386,,12904,Autocuration,,,1,Amount of acetic acid produced by the compound,,,CHEMBL629310,,22224,,,,U,0,BAO_0000019,
12387,,12904,Autocuration,,,1,Apparent first-order rate of solvolysis for the bipinnatin-A(A4) was determined,,,CHEMBL629311,,22224,,,,U,0,BAO_0000019,
12388,,9663,Intermediate,10116.0,,1,Log of (Cbrain/Cblood) in rats,,,CHEMBL629312,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
12389,,7652,Autocuration,,,1,Compound in absence of MPM cell homogenate at pH 3 to isolate compound 4 (ng),,,CHEMBL629313,,22224,,,,U,0,BAO_0000221,
12390,,7652,Autocuration,,,1,Compound in absence of MPM cell homogenate at pH 4.5 to isolate compound 4 (ng),,,CHEMBL629314,,22224,,,,U,0,BAO_0000221,
12391,,7652,Autocuration,,,1,Compound in absence of MPM cell homogenate at pH 7 to isolate compound 4 (ng),,,CHEMBL629315,,22224,,,,U,0,BAO_0000221,
12392,,7652,Autocuration,,,1,Compound in presence of MPM cells and in absence of inactivator at pH 8 to isolate compound 4 (ng),,,CHEMBL629316,,22224,,,,U,0,BAO_0000219,
12393,,7652,Autocuration,,,1,Compound treated in absence of MPM cell homogenate at pH 4.5 to isolate compound 4 (ng),,,CHEMBL629317,,22224,,,,U,0,BAO_0000221,
12394,,7652,Autocuration,,,1,Compound treated with MPM cell homogenate at pH 3 to isolate compound 4 (ng),,,CHEMBL629318,,22224,,,,U,0,BAO_0000019,
12395,,7652,Autocuration,,,1,Compound treated with MPM cell homogenate at pH 3.5 to isolate compound 4 (ng),,,CHEMBL877497,,22224,,,,U,0,BAO_0000019,
12396,,7652,Autocuration,,,1,Compound treated with MPM cell homogenate at pH 4 to isolate compound 4 (ng),,,CHEMBL629319,,22224,,,,U,0,BAO_0000019,
12397,,7652,Autocuration,,,1,Compound treated with MPM cell homogenate at pH 4.5 to isolate compound 4 (ng),,,CHEMBL629320,,22224,,,,U,0,BAO_0000019,
12398,,7652,Autocuration,,,1,Compound treated with MPM cell homogenate at pH 5 to isolate compound 4 (ng),,,CHEMBL629496,,22224,,,,U,0,BAO_0000019,
12399,,7652,Autocuration,,,1,Compound treated with MPM cell homogenate at pH 5.5 to isolate compound 4 (ng),,,CHEMBL629497,,22224,,,,U,0,BAO_0000019,
12400,,7652,Autocuration,,,1,Compound treated with MPM cell homogenate at pH 6 to isolate compound 4 (ng),,,CHEMBL629498,,22224,,,,U,0,BAO_0000019,
12401,,7652,Autocuration,,,1,Compound treated with MPM cell homogenate at pH 6.5 to isolate compound 4 (ng),,,CHEMBL629499,,22224,,,,U,0,BAO_0000019,
12402,,7652,Autocuration,,,1,Compound treated with MPM cell homogenate at pH 7 to isolate compound 4 (ng),,,CHEMBL629500,,22224,,,,U,0,BAO_0000019,
12403,,7652,Autocuration,,,1,Compound treated with MPM cell homogenate at pH 7.5 to isolate compound 4 (ng),,,CHEMBL629501,,22224,,,,U,0,BAO_0000019,
12404,,7652,Autocuration,,,1,Compound treated with MPM cell homogenate at pH 8 to isolate compound 4 (ng),,,CHEMBL629502,,22224,,,,U,0,BAO_0000019,
12405,In vivo,8267,Autocuration,,,1,Compound was evaluated for its urinary recovery after oral administration (100 mg) to Beagle dogs,,,CHEMBL629503,,22224,,,,U,0,BAO_0000218,
12406,,8267,Intermediate,9615.0,,1,Compound was evaluated for its urinary recovery after oral administration (200 mg) to Beagle dogs,,,CHEMBL629504,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
12407,,14479,Autocuration,,,1,Compound was evaluated for the rate of degradation by Carboxypeptidase A.,,,CHEMBL629505,,22224,,,,U,0,BAO_0000019,
12408,,17515,Autocuration,,,1,Compound was evaluated for total body clearance,,,CHEMBL629506,,22224,,,,U,0,BAO_0000019,
12409,,17515,Autocuration,,,1,Compound was evaluated for volume of distribution at steady state,,,CHEMBL629507,,22224,,,,U,0,BAO_0000019,
12410,,8142,Autocuration,,,1,Compound was tested for hydrolysis by acetylcholinesterase and the kinetic constant KOH- was reported.,,,CHEMBL877498,,22224,,,,U,0,BAO_0000019,
12411,,14849,Autocuration,,,1,Percentage of the diamine which is monoprotonated at pH 7.4,,,CHEMBL629508,,22224,,,,U,0,BAO_0000019,
12412,,7653,Autocuration,,,1,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells,,,CHEMBL629509,,22224,,,,U,0,BAO_0000019,
12413,,8631,Intermediate,10116.0,,1,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 5 minutes,,,CHEMBL629510,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
12414,,8631,Intermediate,10116.0,,1,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 minutes,,,CHEMBL629511,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
12415,,8631,Intermediate,10116.0,,1,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,,,CHEMBL629512,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
12416,,8631,Intermediate,10116.0,,1,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,,,CHEMBL629513,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
12417,,8631,Intermediate,10116.0,,1,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 30 minutes,,,CHEMBL629514,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
12418,,8631,Intermediate,10116.0,,1,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,,,CHEMBL628447,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
12419,,8631,Intermediate,10116.0,,1,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 10 minutes,,,CHEMBL628448,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
12420,,8631,Intermediate,10116.0,,1,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 15 minutes,,,CHEMBL628449,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
12421,,8631,Intermediate,10116.0,,1,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 20 minutes,,,CHEMBL631119,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
12422,,8631,Intermediate,10116.0,,1,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 30 minutes,,,CHEMBL631120,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
12423,,8631,Intermediate,10116.0,,1,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 5 minutes,,,CHEMBL631121,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
12424,,8631,Intermediate,10116.0,,1,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 min,,,CHEMBL874458,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
12425,,8631,Intermediate,10116.0,,1,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,,,CHEMBL631122,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
12426,,8631,Intermediate,10116.0,,1,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,,,CHEMBL631123,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
12427,,8631,Intermediate,10116.0,,1,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,,,CHEMBL631124,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
12428,,8631,Intermediate,10116.0,,1,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 minutes,,,CHEMBL631125,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
12429,,8631,Intermediate,10116.0,,1,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,,,CHEMBL631290,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
12430,,8631,Intermediate,10116.0,,1,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,,,CHEMBL631291,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
12431,,8631,Intermediate,10116.0,,1,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,,,CHEMBL631292,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
12432,,8631,Intermediate,10116.0,,1,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 minutes,,,CHEMBL631293,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
12433,,8631,Intermediate,10116.0,,1,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,,,CHEMBL631294,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
12434,,8631,Intermediate,10116.0,,1,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,,,CHEMBL631295,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
12435,,8631,Intermediate,10116.0,,1,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 30 minutes,,,CHEMBL631296,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
12436,,8631,Intermediate,10116.0,,1,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,,,CHEMBL631297,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
12437,,10263,Autocuration,,,1,Maximum biodistribution (Bmax) was determined.,,,CHEMBL631298,,22224,,,,U,0,BAO_0000218,
12438,,12364,Intermediate,10090.0,,1,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 1.5625 (mg/kg) intravenous dose in 6 mice,,,CHEMBL631299,,50594,Mus musculus,,,N,1,BAO_0000218,
12439,,12364,Intermediate,10090.0,,1,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 10 (mg/kg) intravenous dose in 6 mice,,,CHEMBL631300,,50594,Mus musculus,,,N,1,BAO_0000218,
12440,,12364,Intermediate,10090.0,,1,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 3.125 (mg/kg) intravenous dose in 6 mice,,,CHEMBL631301,,50594,Mus musculus,,,N,1,BAO_0000218,
12441,,12364,Intermediate,10090.0,,1,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 6.25 (mg/kg) intravenous dose in 6 mice,,,CHEMBL630291,,50594,Mus musculus,,,N,1,BAO_0000218,
12442,,14793,Autocuration,,,1,Brain concentration after 0.25 hr at a dose of 10 mg/kg when administered intraperitoneally,,,CHEMBL630292,,22224,,,,U,0,BAO_0000218,
12443,,14793,Autocuration,,,1,Brain concentration after 0.25 h at a dose of 10 mg/kg when administered intravenously,,,CHEMBL630293,,22224,,,,U,0,BAO_0000218,
12444,,14793,Autocuration,,,1,Brain concentration after 0.5 h at a dose of 100 mg/kg when administered perorally,,,CHEMBL630294,,22224,,,,U,0,BAO_0000218,
12445,,14793,Autocuration,,,1,Brain concentration after 0.5 h at a dose of 10 mg/kg when administered intraperitoneally,,,CHEMBL630295,,22224,,,,U,0,BAO_0000218,
12446,,14793,Autocuration,,,1,Brain concentration after 0.5 hr at a dose of 10 mg/kg when administered intravenously,,,CHEMBL630296,,22224,,,,U,0,BAO_0000218,
12447,,14793,Autocuration,,,1,Brain concentration after 0.5 hr at a dose of 10 mg/kg when administered perorally,,,CHEMBL626782,,22224,,,,U,0,BAO_0000218,
12448,,14793,Autocuration,,,1,Brain concentration after 1 hr at a dose of 100 mg/kg when administered perorally,,,CHEMBL626783,,22224,,,,U,0,BAO_0000218,
12449,,14793,Autocuration,,,1,Brain concentration after 1 hr at a dose of 10 mg/kg when administered intraperitoneally,,,CHEMBL626784,,22224,,,,U,0,BAO_0000218,
12450,,14793,Autocuration,,,1,Brain concentration after 1 hr at a dose of 10 mg/kg when administered intravenously,,,CHEMBL626785,,22224,,,,U,0,BAO_0000218,
12451,,14793,Autocuration,,,1,Brain concentration after 1 hr at a dose of 10 mg/kg when administered perorally,,,CHEMBL626786,,22224,,,,U,0,BAO_0000218,
12452,,9196,Autocuration,,,1,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,,,CHEMBL626787,,22224,,,,U,0,BAO_0000218,
12453,,9196,Autocuration,,,1,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr; ND means not determined,,,CHEMBL626788,,22224,,,,U,0,BAO_0000218,
12454,,9196,Autocuration,,,1,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 4.0 hr,,,CHEMBL625927,,22224,,,,U,0,BAO_0000218,
12455,,8374,Intermediate,10116.0,,1,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,,CHEMBL625928,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
12456,,8374,Intermediate,10116.0,,1,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg; ND is Not Detected,,,CHEMBL625929,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
12457,,8374,Intermediate,10116.0,,1,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg; ND is Not Detected.,,,CHEMBL625930,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
12458,,8374,Intermediate,10116.0,,1,"Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound, Compound was found to be in trace amount.",,,CHEMBL625931,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
12459,,8374,Intermediate,10116.0,,1,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound; ND is Not Detected.,,,CHEMBL627230,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
12460,,8374,Intermediate,10116.0,,1,Concentration 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,,CHEMBL627231,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
12461,,8374,Intermediate,10116.0,,1,Concentration 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,,,CHEMBL627232,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
12462,,8374,Intermediate,10116.0,,1,Concentration 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected.,,,CHEMBL627233,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
12463,,8374,Intermediate,10116.0,,1,Concentration 5a detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,,CHEMBL875470,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
12464,,8374,Intermediate,10116.0,,1,Concentration 5a detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,,CHEMBL627234,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
12465,,8374,Intermediate,10116.0,,1,Concentration 5b detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,,CHEMBL627235,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
12466,,8374,Intermediate,10116.0,,1,Concentration 5b detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,,CHEMBL627236,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
12467,,8374,Intermediate,10116.0,,1,Concentration 5c detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,,CHEMBL627237,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
12468,,8374,Intermediate,10116.0,,1,Concentration 5c detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,,CHEMBL627238,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
12469,,8374,Intermediate,10116.0,,1,Concentration 5d detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,,CHEMBL627239,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
12470,,8374,Intermediate,10116.0,,1,Concentration 5d detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,,CHEMBL627240,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
12471,,8374,Intermediate,10116.0,,1,Concentration 5e detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,,CHEMBL627241,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
12472,,8374,Intermediate,10116.0,,1,Concentration 5e detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,,CHEMBL627242,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
12473,,8374,Intermediate,10116.0,,1,Concentration 5f detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound; ND is Not Detected,,,CHEMBL627243,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
12474,,8374,Intermediate,10116.0,,1,Concentration 5f detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,,,CHEMBL627244,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
12475,,8374,Intermediate,10116.0,,1,Concentration 6a detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,,CHEMBL627245,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
12476,,8374,Intermediate,10116.0,,1,Concentration 6a detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,,CHEMBL627246,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
12477,,8374,Intermediate,10116.0,,1,Concentration 6c detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,,CHEMBL627247,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
12478,,8374,Intermediate,10116.0,,1,Concentration 6c detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,,CHEMBL627248,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
12479,,8374,Intermediate,10116.0,,1,Concentration 6d detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,,CHEMBL627249,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
12480,,8374,Intermediate,10116.0,,1,Concentration 6d detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,,CHEMBL625569,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
12481,,8374,Intermediate,10116.0,,1,Concentration 6e detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,,CHEMBL625570,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
12482,,8374,Intermediate,10116.0,,1,Concentration 6e detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,,CHEMBL625571,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
12483,,8374,Intermediate,10116.0,,1,Concentration 6f detected in blood of rat 1 hr after an oral dose of 200 mg/kg; ND is Not Detected,,,CHEMBL625572,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
12484,,8374,Intermediate,10116.0,,1,Concentration 6f detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,,,CHEMBL625573,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
12485,,8374,Intermediate,10116.0,,1,Concentration detected in blood of rat 1 hr after an oral dose of 200 mg/kg,,,CHEMBL625574,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
12486,,8374,Intermediate,10116.0,,1,Concentration detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,,,CHEMBL626245,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
12487,,8374,Intermediate,10116.0,,1,Concentration detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,,CHEMBL626246,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
12488,,9196,Autocuration,,,1,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,,,CHEMBL626247,,22224,,,,U,0,BAO_0000218,
12489,,9196,Autocuration,,,1,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,,,CHEMBL626248,,22224,,,,U,0,BAO_0000218,
12490,,9196,Autocuration,,,1,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.5 hr,,,CHEMBL626249,,22224,,,,U,0,BAO_0000218,
12491,,9196,Autocuration,,,1,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,,,CHEMBL626420,,22224,,,,U,0,BAO_0000218,
12492,,9196,Autocuration,,,1,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.5 hr,,,CHEMBL626421,,22224,,,,U,0,BAO_0000218,
12493,,9196,Autocuration,,,1,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr,,,CHEMBL626422,,22224,,,,U,0,BAO_0000218,
12494,,9196,Autocuration,,,1,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,,,CHEMBL626423,,22224,,,,U,0,BAO_0000218,
12495,,9196,Autocuration,,,1,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,,,CHEMBL626424,,22224,,,,U,0,BAO_0000218,
12496,,12023,Intermediate,9615.0,,1,Volume of distribution in Beagles dog at a dose of 1 mg/kg given intravenously,,,CHEMBL626425,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
12497,,12023,Intermediate,10116.0,,1,Volume of distribution in CD rat at a dose of 5 mg/kg given intravenously,,,CHEMBL875476,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
12498,,12023,Intermediate,9541.0,,1,Volume of distribution in Cynomolgus monkey at a dose of 5 mg/kg given intravenously,,,CHEMBL626426,,100710,Macaca fascicularis,,,N,1,BAO_0000218,
12499,,10580,Autocuration,,,1,Distribution coefficient and iron(III) complex was measured at an aqueous phase buffered at pH 7.4 and octanol,,,CHEMBL626427,,22224,,,,U,0,BAO_0000100,
12500,,10580,Autocuration,,,1,Distribution coefficient was measured at an aqueous phase buffered at pH 7.4 and octanol,,,CHEMBL626428,,22224,,,,U,0,BAO_0000100,
12501,,16032,Autocuration,,,1,Iron clearance was stimulated by the compound was expressed as % distribution of excreted Fe in bile by subcutaneous dose of 150 umol/kg,,,CHEMBL626429,,22224,,,,U,0,BAO_0000019,
12502,,16032,Autocuration,,,1,Iron clearance was stimulated by the compound was expressed as % distribution of excreted Fe in urine by subcutaneous dose of 150 umol/kg,,,CHEMBL625025,,22224,,,,U,0,BAO_0000019,1088.0
12503,,8594,Intermediate,10116.0,,1,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,,,CHEMBL625026,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
12504,,8594,Intermediate,10116.0,,1,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,,,CHEMBL625027,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
12505,,8594,Intermediate,10116.0,,1,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,,,CHEMBL874410,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
12506,,8594,Intermediate,10116.0,,1,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,,,CHEMBL625028,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
12507,,8594,Intermediate,10116.0,,1,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,,,CHEMBL625029,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
12508,,8594,Intermediate,10116.0,,1,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,,,CHEMBL625030,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
12509,,8594,Intermediate,10116.0,,1,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,,,CHEMBL625031,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
12510,,8594,Intermediate,10116.0,,1,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,,,CHEMBL625032,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
12511,,8594,Intermediate,10116.0,,1,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,,,CHEMBL625033,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
12512,,8594,Intermediate,10116.0,,1,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,,,CHEMBL625034,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
12513,,8594,Intermediate,10116.0,,1,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,,,CHEMBL624872,,50597,Rattus norvegicus,,,N,1,BAO_0000218,948.0
12514,,8594,Intermediate,10116.0,,1,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,,,CHEMBL624873,,50597,Rattus norvegicus,,,N,1,BAO_0000218,948.0
12515,,8594,Intermediate,10116.0,,1,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,,,CHEMBL624874,,50597,Rattus norvegicus,,,N,1,BAO_0000218,948.0
12516,,8594,Intermediate,10116.0,,1,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,,,CHEMBL624875,,50597,Rattus norvegicus,,,N,1,BAO_0000218,948.0
12517,,8594,Intermediate,10116.0,,1,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,,,CHEMBL624876,,50597,Rattus norvegicus,,,N,1,BAO_0000218,948.0
12518,,8594,Intermediate,10116.0,,1,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,,,CHEMBL624877,,50597,Rattus norvegicus,,,N,1,BAO_0000218,948.0
12519,,8594,Intermediate,10116.0,,1,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,,,CHEMBL624878,,50597,Rattus norvegicus,,,N,1,BAO_0000218,948.0
12520,,8594,Intermediate,10116.0,,1,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,,,CHEMBL624879,,50597,Rattus norvegicus,,,N,1,BAO_0000218,948.0
12521,,8594,Intermediate,10116.0,,1,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,,,CHEMBL624880,,50597,Rattus norvegicus,,,N,1,BAO_0000218,948.0
12522,,8594,Intermediate,10116.0,,1,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 10 min (radiolabeled with [125I]-,,,CHEMBL624881,,50597,Rattus norvegicus,,,N,1,BAO_0000218,948.0
12523,,8594,Intermediate,10116.0,,1,"Concentration was measured in heart tissue of unfasted Fischer 344 rats, administered intravenous, after 5 minute (radiolabeled with [125I]-",,,CHEMBL624882,,50597,Rattus norvegicus,,,N,1,BAO_0000218,948.0
12524,,8594,Intermediate,10116.0,,1,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,,,CHEMBL624883,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2113.0
12525,,8594,Intermediate,10116.0,,1,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,,,CHEMBL624884,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2113.0
12526,,8594,Intermediate,10116.0,,1,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,,,CHEMBL624885,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2113.0
12527,,8594,Intermediate,10116.0,,1,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,,,CHEMBL624886,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2113.0
12528,,8594,Intermediate,10116.0,,1,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,,,CHEMBL624887,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2113.0
12529,,8594,Intermediate,10116.0,,1,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,,,CHEMBL624888,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2113.0
12530,,8594,Intermediate,10116.0,,1,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,,,CHEMBL624889,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2113.0
12531,,8594,Intermediate,10116.0,,1,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,,,CHEMBL624890,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2113.0
12532,,8594,Intermediate,10116.0,,1,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,,,CHEMBL621964,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2113.0
12533,,8594,Intermediate,10116.0,,1,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,,,CHEMBL621965,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2113.0
12534,,8594,Intermediate,10116.0,,1,Concentration was measured in liver tissue f unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,,,CHEMBL621966,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
12535,,8594,Intermediate,10116.0,,1,Concentration was measured in liver tissue f unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,,,CHEMBL621967,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
12536,,8594,Intermediate,10116.0,,1,Concentration was measured in liver tissue f unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,,,CHEMBL622164,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
12537,,7653,Autocuration,,,1,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; acid insoluble (nucleic acids),,,CHEMBL623097,,22224,,,,U,0,BAO_0000019,
12538,,7653,Autocuration,,,1,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; acid insoluble (protein),,,CHEMBL623098,,22224,,,,U,0,BAO_0000019,
12539,,7653,Autocuration,,,1,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; acid soluble,,,CHEMBL623099,,22224,,,,U,0,BAO_0000019,
12540,,7653,Autocuration,,,1,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; total uptake,,,CHEMBL623100,,22224,,,,U,0,BAO_0000019,
12541,,9104,Intermediate,10116.0,,1,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated Number of new tumors observed",,,CHEMBL628673,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
12542,,9104,Intermediate,10116.0,,1,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated complete percent remission indicates tumor not palpable.",,,CHEMBL628674,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
12543,,9104,Intermediate,10116.0,,1,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated number of tumors at the beginning of the test.",,,CHEMBL628675,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
12544,,9104,Intermediate,10116.0,,1,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated of percent static tumors indicates size of tumor 51-150% of the initial size",,,CHEMBL627644,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
12545,,9104,Intermediate,10116.0,,1,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated partial percent remission indicates reduction of initial tumor size <=50%.",,,CHEMBL627645,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
12546,,9104,Intermediate,10116.0,,1,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated percent progress in tumor size indicates >150% of the initial size",,,CHEMBL627646,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
12547,,9104,Intermediate,10116.0,,1,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated percent static tumors indicates size of tumor 51-150% of the initial size",,,CHEMBL627647,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
12548,,9104,Intermediate,10116.0,,1,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated percent tumor area measured as the average on the 28th day of therapy.",,,CHEMBL627648,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
12549,,12902,Intermediate,10116.0,,1,Free level in rat plasma,,,CHEMBL627649,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
12550,,6614,Autocuration,,,1,Level reaching in blood plasma of rat or human was determined,,,CHEMBL628313,,22224,,,,U,0,BAO_0000019,
12551,,9663,Intermediate,10116.0,,1,Log (Cbrain/Cblood) in rats,,,CHEMBL628314,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
12552,,17658,Autocuration,,,1,Mean percentage of compound transport through P-glycoprotein; expressed as p-glycoprotein affinity,,,CHEMBL628315,,22224,,,,U,0,BAO_0000019,
12553,,17658,Autocuration,,,1,Mean percentage of compound transport through membrane; expressed as membrane transport,,,CHEMBL628316,,22224,,,,U,0,BAO_0000019,
12554,,14314,Autocuration,,,1,Metabolic breakdown to the o-sulfate of p-chloroaniline (2-amino-5-chlorophenyl sulfate) by giving 100 mg/kg oral doses of the compound,,,CHEMBL628317,,22224,,,,U,0,BAO_0000218,
12555,,7385,Autocuration,,,1,Michaelis-Menten constant was measured in the inactivation of HPK; Km x 10 e5,,,CHEMBL628473,,22224,,,,U,0,BAO_0000019,
12556,,7385,Autocuration,,,1,"Michaelis-Menten constant was measured in the inactivation of HPK; Km x 10 e5, ND=Not determined",,,CHEMBL628474,,22224,,,,U,0,BAO_0000019,
12557,,7385,Autocuration,,,1,Michaelis-Menten constant was measured in the inactivation of trypsin; Km x 10 e5,,,CHEMBL628475,,22224,,,,U,0,BAO_0000019,
12558,,1329,Autocuration,,,1,Net water uptake by a carrier mediated transport (%cm) mechanism,,,CHEMBL628476,,22224,,,,U,0,BAO_0000019,
12559,,12187,Autocuration,314293.0,,1,Peak concentration was determined in portal circulation after intraduodenal dose of 10 mg/kg in monkey,,,CHEMBL628477,,22224,Simiiformes,,,U,0,BAO_0000218,
12560,,12187,Intermediate,9669.0,,1,Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret,,,CHEMBL628478,,50506,Mustela putorius furo,,,N,1,BAO_0000218,
12561,,12187,Intermediate,9669.0,,1,"Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret, determined by renin inhibition assay",,,CHEMBL628479,,50506,Mustela putorius furo,,,N,1,BAO_0000218,
12562,,12187,Autocuration,314293.0,,1,Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey,,,CHEMBL628480,,22224,Simiiformes,,,U,0,BAO_0000218,
12563,,12187,Autocuration,314293.0,,1,"Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey, determined by renin inhibition assay",,,CHEMBL628481,,22224,Simiiformes,,,U,0,BAO_0000218,
12564,,12187,Intermediate,10116.0,,1,Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat,,,CHEMBL628482,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
12565,,12187,Intermediate,10116.0,,1,"Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat, determined by renin inhibition assay",,,CHEMBL628483,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
12566,,9278,Intermediate,10116.0,,1,"Peak plasma concentration at a dose of 10 mg/kg, ip route in rat suspended in carboxymethyl cellulose (CMC);ND is defined as no-data.",,,CHEMBL628484,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
12567,,9278,Intermediate,10116.0,,1,"Peak plasma concentration at a dose of 100 mg/kg, os route in rat suspended in carboxymethyl cellulose (CMC)",,,CHEMBL628485,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
12568,,9278,Intermediate,9541.0,,1,"Peak plasma concentration at a dose of 20 mg/kg, oral route in monkey (Macaca fascicularis) suspended in carboxymethyl cellulose (CMC);Range is between (5.5-6)",,,CHEMBL628486,,100710,Macaca fascicularis,,,N,1,BAO_0000218,1969.0
12569,,9278,Intermediate,9606.0,,1,"Peak plasma concentration at a dose of 200 mg/kg, oral route in human",,,CHEMBL628487,,50587,Homo sapiens,,,N,1,BAO_0000218,1969.0
12570,,9278,Intermediate,10116.0,,1,"Peak plasma concentration at a dose of 25 mg/kg, ip route in rat suspended in carboxymethyl cellulose (CMC);ND is defined as no-data.",,,CHEMBL628488,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
12571,,9278,Intermediate,10116.0,,1,"Peak plasma concentration at a dose of 25 mg/kg, os route in rat suspended in carboxymethyl cellulose (CMC)",,,CHEMBL628489,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
12572,,9278,Intermediate,10116.0,,1,"Peak plasma concentration at a dose of 50 mg/kg, os route in rat suspended in carboxymethyl cellulose (CMC)",,,CHEMBL628490,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
12573,,12186,Intermediate,9541.0,,1,Peak plasma drug level after intraduodenal administration at a dose 10 mg/kg from portal circulation in salt-depleted cynomolgus monkeys using HPLC assay,,,CHEMBL628491,,100710,Macaca fascicularis,,,N,1,BAO_0000218,
12574,,12186,Intermediate,9541.0,,1,Peak plasma drug level after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using HPLC assay,,,CHEMBL877507,,100710,Macaca fascicularis,,,N,1,BAO_0000218,
12575,,12186,Autocuration,,,1,Peak plasma drug level after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using renin inhibition assay,,,CHEMBL628492,,22224,,,,U,0,BAO_0000218,
12576,,12041,Autocuration,314293.0,,1,% metabolized in monkey S-9 after 2 hours (10 ug/mL),,,CHEMBL628493,,22224,Simiiformes,,,U,0,BAO_0000019,
12577,,12041,Autocuration,314293.0,,1,% metabolized in monkey S-9 after 2 hours (1 ug/ml),,,CHEMBL628494,,22224,Simiiformes,,,U,0,BAO_0000019,
12578,,12041,Autocuration,314293.0,,1,% metabolized in monkey S-9 after 2 hours (10 ug/ml),,,CHEMBL628495,,22224,Simiiformes,,,U,0,BAO_0000019,
12579,,6737,Intermediate,9606.0,,1,Permeability in Caco-2 assay at 10E-6,,,CHEMBL628496,,50587,Homo sapiens,,,N,1,BAO_0000218,
12580,,13758,Autocuration,,,1,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered intravenously in brain,,,CHEMBL628497,,22224,,,,U,0,BAO_0000218,955.0
12581,,13758,Autocuration,,,1,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered orally in brain,,,CHEMBL628498,,22224,,,,U,0,BAO_0000218,955.0
12582,,5676,Autocuration,,,1,Plasma protein binding was determined,,,CHEMBL628499,,22224,,,,U,0,BAO_0000019,
12583,,14793,Autocuration,,,1,Brain concentration after 2 hr at a dose of 100 mg/kg when administered perorally,,,CHEMBL627656,,22224,,,,U,0,BAO_0000218,
12584,,14793,Autocuration,,,1,Brain concentration after 2 hr at a dose of 10 mg/kg when administered intraperitoneally,,,CHEMBL627657,,22224,,,,U,0,BAO_0000218,
12585,,14793,Autocuration,,,1,Brain concentration after 2 hr at a dose of 10 mg/kg when administered intravenously,,,CHEMBL626808,,22224,,,,U,0,BAO_0000218,
12586,,14793,Autocuration,,,1,Brain concentration after 2 hr at a dose of 10 mg/kg when administered perorally,,,CHEMBL626809,,22224,,,,U,0,BAO_0000218,
12587,,14793,Autocuration,,,1,Brain concentration after 4 hr at a dose of 100 mg/kg when administered perorally,,,CHEMBL626810,,22224,,,,U,0,BAO_0000218,
12588,,14793,Autocuration,,,1,Brain concentration after 4 hr at a dose of 10 mg/kg when administered intraperitoneally,,,CHEMBL626811,,22224,,,,U,0,BAO_0000218,
12589,,14793,Autocuration,,,1,Brain concentration after 4 hr at a dose of 10 mg/kg when administered intravenously,,,CHEMBL874465,,22224,,,,U,0,BAO_0000218,
12590,,14793,Autocuration,,,1,Brain concentration after 4 hr at a dose of 10 mg/kg when administered perorally,,,CHEMBL626812,,22224,,,,U,0,BAO_0000218,
12591,,14793,Autocuration,,,1,Brain concentration after 6 hr at a dose of 100 mg/kg when administered perorally,,,CHEMBL626813,,22224,,,,U,0,BAO_0000218,
12592,,14793,Autocuration,,,1,Brain concentration after 6 hr at a dose of 10 mg/kg when administered perorally,,,CHEMBL626814,,22224,,,,U,0,BAO_0000218,
12593,,14000,Autocuration,,,1,Bullaticin index relates the IC50 values by normalizing to the value of bullatacin for easy comparison.,,,CHEMBL626815,,22224,,,,U,0,BAO_0000019,
12594,,5948,Autocuration,,,1,Partition coefficient (logP),,,CHEMBL628566,,22224,,,,U,0,BAO_0000019,
12595,,13824,Autocuration,,,1,Calculated partition coefficient (clogP) (CLOGP3 V3.4),,,CHEMBL628567,,22229,,,,U,0,BAO_0000100,
12596,,10778,Autocuration,,,1,Calculated partition coefficient (clogP),,,CHEMBL628568,,22229,,,,U,0,BAO_0000100,
12597,In vivo,17237,Intermediate,9615.0,,1,C max in dog,,,CHEMBL628569,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
12598,In vivo,17237,Intermediate,10141.0,,1,C max in guinea pig,,,CHEMBL628570,,50512,Cavia porcellus,,,N,1,BAO_0000218,
12599,In vivo,2809,Autocuration,,,1,C max value was evaluated,,,CHEMBL628571,,22224,,,,U,0,BAO_0000218,
12600,In vivo,11954,Autocuration,,,1,Cmax value after oral dose of 0.1 mg//kg,,,CHEMBL628572,,22224,,,,U,0,BAO_0000218,
12601,In vivo,11954,Autocuration,,,1,Cmax value after oral dose of 0.3 mg/kg,,,CHEMBL628573,,22224,,,,U,0,BAO_0000218,
12602,In vivo,11954,Autocuration,,,1,Cmax value after oral dose of 1 mg/kg,,,CHEMBL628574,,22224,,,,U,0,BAO_0000218,
12603,In vivo,11954,Autocuration,,,1,Cmax value after oral dose of 10 mg/kg,,,CHEMBL628575,,22224,,,,U,0,BAO_0000218,
12604,In vivo,11954,Autocuration,,,1,Cmax value after oral dose of 23.4 mg/kg,,,CHEMBL628576,,22224,,,,U,0,BAO_0000218,
12605,In vivo,11954,Autocuration,,,1,Cmax value after oral dose of 3 mg/kg,,,CHEMBL628577,,22224,,,,U,0,BAO_0000218,
12606,In vivo,11954,Autocuration,,,1,Cmax value after oral dose of 3.87 mg/kg,,,CHEMBL628578,,22224,,,,U,0,BAO_0000218,
12607,In vivo,12768,Intermediate,9615.0,,1,Cmax value in female Beagle dogs,,,CHEMBL874466,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
12608,In vivo,12768,Intermediate,10116.0,,1,Cmax value in male rats,,,CHEMBL628579,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
12609,In vivo,12780,Intermediate,10116.0,,1,Cmax value in rat plasma when administered 20 mg/kg perorally,,,CHEMBL628580,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
12610,In vivo,15592,Intermediate,9615.0,,1,Maximal plasma concentration in dogs at 10mg/kg oral dose 0.05M citric acid,,,CHEMBL628581,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,1969.0
12611,In vivo,15592,Intermediate,9615.0,,1,Maximal plasma concentration in dogs at 10mg/kg oral dose 0.05M citric acid,,,CHEMBL628582,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,1969.0
12612,,17025,Intermediate,9615.0,,1,Peak concentration of compound at Time = 0 was determined in dog at 5 mg/kg intravenously admn.,,,CHEMBL628583,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
12613,,17025,Autocuration,314293.0,,1,Peak concentration of compound at Time = 0 was determined in monkey at 5 mg/kg intravenously admn.,,,CHEMBL625782,,22224,Simiiformes,,,U,0,BAO_0000218,
12614,,17025,Intermediate,9986.0,,1,Peak concentration of compound at Time = 0 was determined in rabbit at 5 mg/kg intravenously admn.,,,CHEMBL625783,,50592,Oryctolagus cuniculus,,,N,1,BAO_0000218,
12615,,17025,Intermediate,10116.0,,1,Peak concentration of compound at Time = 0 was determined in rat at 5 mg/kg intravenously admn.,,,CHEMBL625784,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
12616,,4236,Intermediate,9544.0,,1,Total plasma concentration at 24 hr at a dose of 10 mg/kg when administered orally to rhesus monkey,,,CHEMBL625785,,50797,Macaca mulatta,,,N,1,BAO_0000218,1969.0
12617,,15791,Intermediate,10116.0,,1,C5min (nM) value was determined in rats after intravenous dose of 5 mg/kg,,,CHEMBL625786,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
12618,,11149,Autocuration,,,1,C6h was measured as concentration obtained after 6 hr of oral administration in air pouch exudate,,,CHEMBL874467,,22224,,,,U,0,BAO_0000019,
12619,,15592,Intermediate,9615.0,,1,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 )",,,CHEMBL625787,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
12620,,15778,Intermediate,12721.0,,1,cytotoxicity against HIV protease enzyme.,,,CHEMBL625964,,50677,Human immunodeficiency virus,,,N,1,BAO_0000218,
12621,,12745,Intermediate,10090.0,,1,Apparent clearance in mice after intravenous administration of 105.1 mg/kg of dose,,,CHEMBL625965,,50594,Mus musculus,,,N,1,BAO_0000218,
12622,,12745,Intermediate,10090.0,,1,Apparent clearance in mice after oral administration of 100 mg/kg of dose,,,CHEMBL625966,,50594,Mus musculus,,,N,1,BAO_0000218,
12623,In vivo,13941,Intermediate,9615.0,,1,The plasma clearance in dog.,,,CHEMBL625967,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,1969.0
12624,In vivo,13941,Intermediate,10116.0,,1,The plasma clearance in rat.,,,CHEMBL625968,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
12625,In vivo,16449,Intermediate,10116.0,,1,Clearance from plasma in male Sprague-Dawley rats,,,CHEMBL625969,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
12626,In vivo,16449,Intermediate,9541.0,,1,Clearance from plasma in male cynomolgus monkeys,,,CHEMBL625970,,100710,Macaca fascicularis,,,N,1,BAO_0000218,1969.0
12627,In vivo,14224,Intermediate,9615.0,,1,"Clearance of compound (5 mg/kg, intravenously), in dog plasma",,,CHEMBL625971,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,1969.0
12628,In vivo,14224,Intermediate,9615.0,,1,Clearance of compound in dog plasma,,,CHEMBL625972,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,1969.0
12629,In vivo,14224,Intermediate,9606.0,,1,Clearance of compound in human plasma,,,CHEMBL625973,,50587,Homo sapiens,,,N,1,BAO_0000218,1969.0
12630,In vivo,14317,Intermediate,9615.0,,1,Clearance of compound when administered intravenously as a mixture (five-in-one dose) to a single dog.,,,CHEMBL625974,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
12631,In vivo,14317,Intermediate,9615.0,,1,Clearance of compound when administered intravenously as an individual dose to a single dog.,,,CHEMBL625975,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
12632,In vivo,14224,Intermediate,9615.0,,1,"Clearance (10 mg/kg, intravenously) in dog plasma",,,CHEMBL625976,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,1969.0
12633,In vivo,17237,Intermediate,9615.0,,1,Clearance value in dog,,,CHEMBL625977,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
12634,In vivo,17237,Intermediate,10141.0,,1,Clearance value in guinea pig,,,CHEMBL625978,,50512,Cavia porcellus,,,N,1,BAO_0000218,
12635,In vivo,14187,Intermediate,10116.0,,1,Clearance values in rats after iv administration.,,,CHEMBL874468,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
12636,In vivo,4806,Autocuration,,,1,Compound was tested for plasma clearance on administered orally as aqueous solutions at 1 mpk and by iv at 0.2 mpk,,,CHEMBL625421,,22224,,,,U,0,BAO_0000218,1969.0
12637,In vivo,15025,Intermediate,9986.0,,1,In vivo clearance (5 mg/kg) was determined in rabbits,,,CHEMBL625422,,50592,Oryctolagus cuniculus,,,N,1,BAO_0000218,
12638,In vivo,13197,Intermediate,10116.0,,1,Plasma Clearance rate was determined for the compound in rats,,,CHEMBL625423,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
12639,In vivo,13197,Autocuration,9520.0,,1,Plasma Clearance rate was determined for the compound in squirrel monkeys,,,CHEMBL625424,,22224,Saimiri,,,U,0,BAO_0000218,
12640,In vivo,13960,Intermediate,10116.0,,1,Plasma clearance in rat,,,CHEMBL625425,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
12641,In vivo,17820,Autocuration,,,1,Plasma clearance of the compound,,,CHEMBL625426,,22224,,,,U,0,BAO_0000218,
12642,In vivo,14706,Intermediate,10141.0,,1,Plasma clearance in guinea pigs at 2 mg/kg after iv administration,,,CHEMBL625427,,50512,Cavia porcellus,,,N,1,BAO_0000218,
12643,In vivo,14706,Intermediate,10141.0,,1,Plasma clearance in guinea pigs at 3 mg/kg after iv administration,,,CHEMBL625428,,50512,Cavia porcellus,,,N,1,BAO_0000218,
12644,In vivo,6504,Autocuration,,,1,Plasma clearance was determined,,,CHEMBL625429,,22224,,,,U,0,BAO_0000218,
12645,In vivo,14925,Intermediate,9615.0,,1,Plasma clearance rate (CL) was determined in dogs after intravenous administration of 25 mg/kg of the compound.,,,CHEMBL625430,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
12646,In vivo,13197,Intermediate,10116.0,,1,Plasma clearance rate was determined for the compound in rats,,,CHEMBL625431,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
12647,In vivo,13197,Autocuration,9520.0,,1,Plasma clearance rate was determined for the compound in squirrel monkeys,,,CHEMBL627307,,22224,Saimiri,,,U,0,BAO_0000218,
12648,In vivo,3437,Autocuration,,,1,Slow clearance (CL) was determined,,,CHEMBL627308,,22224,,,,U,0,BAO_0000218,
12649,,9196,Autocuration,,,1,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 0.5 hr,,,CHEMBL627309,,22224,,,,U,0,BAO_0000218,
12650,,9196,Autocuration,,,1,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.0 hr; insufficient gastric juice produced,,,CHEMBL627310,,22224,,,,U,0,BAO_0000218,
12651,,9196,Autocuration,,,1,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.5 hr,,,CHEMBL627311,,22224,,,,U,0,BAO_0000218,
12652,,9196,Autocuration,,,1,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.0 hr,,,CHEMBL627312,,22224,,,,U,0,BAO_0000218,
12653,,9196,Autocuration,,,1,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.5 hr,,,CHEMBL627313,,22224,,,,U,0,BAO_0000218,
12654,,9196,Autocuration,,,1,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr,,,CHEMBL627314,,22224,,,,U,0,BAO_0000218,
12655,,9196,Autocuration,,,1,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 4.0 hr,,,CHEMBL627315,,22224,,,,U,0,BAO_0000218,
12656,,9196,Autocuration,,,1,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,,,CHEMBL627316,,22224,,,,U,0,BAO_0000218,
12657,,9196,Autocuration,,,1,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,,,CHEMBL627317,,22224,,,,U,0,BAO_0000218,
12658,,9196,Autocuration,,,1,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,,,CHEMBL627318,,22224,,,,U,0,BAO_0000218,
12659,,9196,Autocuration,,,1,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.5 hr,,,CHEMBL627999,,22224,,,,U,0,BAO_0000218,
12660,,9196,Autocuration,,,1,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,,,CHEMBL628000,,22224,,,,U,0,BAO_0000218,
12661,,9196,Autocuration,,,1,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.5 hr,,,CHEMBL628001,,22224,,,,U,0,BAO_0000218,
12662,,9196,Autocuration,,,1,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,,,CHEMBL628002,,22224,,,,U,0,BAO_0000218,
12663,,9196,Autocuration,,,1,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr,,,CHEMBL625610,,22224,,,,U,0,BAO_0000218,
12664,,9196,Autocuration,,,1,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,,,CHEMBL625611,,22224,,,,U,0,BAO_0000218,
12665,,9196,Autocuration,,,1,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.0 hr,,,CHEMBL625612,,22224,,,,U,0,BAO_0000218,
12666,,9196,Autocuration,,,1,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.5 hr,,,CHEMBL625613,,22224,,,,U,0,BAO_0000218,
12667,,9196,Autocuration,,,1,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,,,CHEMBL875479,,22224,,,,U,0,BAO_0000218,
12668,,9196,Autocuration,,,1,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr,,,CHEMBL625614,,22224,,,,U,0,BAO_0000218,
12669,,9196,Autocuration,,,1,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 4.0 hr,,,CHEMBL625615,,22224,,,,U,0,BAO_0000218,
12670,,9196,Autocuration,,,1,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.5 hr,,,CHEMBL626302,,22224,,,,U,0,BAO_0000218,
12671,,8374,Intermediate,10116.0,,1,Cumulative concentration 6b and compound 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,,CHEMBL626303,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
12672,,8374,Intermediate,10116.0,,1,Cumulative concentration 6b and compound 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,,CHEMBL627420,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
12673,,13477,Intermediate,10116.0,,1,Degradation of compound in incubations at 25 uM with normal rat liver microsomes after 1 hour relative to initial concentration of 1 uM,,,CHEMBL627421,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
12674,,13477,Intermediate,10116.0,,1,Degradation of compound in incubations at 25 uM with normal rat liver microsomes after 24 hour relative to initial concentration of 1 uM,,,CHEMBL625695,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
12675,,13477,Intermediate,10116.0,,1,Degradation of compound in incubations at 25 uM with normal rat liver microsomes after 4 hour relative to initial concentration of 1 uM,,,CHEMBL625696,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
12676,,10009,Intermediate,10090.0,,1,Distribution of compound in mice brain was measured after 1 hr,,,CHEMBL875606,,50594,Mus musculus,,,N,1,BAO_0000218,955.0
12677,,10009,Intermediate,10090.0,,1,Distribution of compound in mice brain was measured after 24 hr r,,,CHEMBL625697,,50594,Mus musculus,,,N,1,BAO_0000218,955.0
12678,,10009,Intermediate,10090.0,,1,Distribution of compound in mice brain was measured after 2 hr,,,CHEMBL625698,,50594,Mus musculus,,,N,1,BAO_0000218,955.0
12679,,10009,Intermediate,10090.0,,1,Distribution of compound in mice brain was measured after 3 hr,,,CHEMBL625699,,50594,Mus musculus,,,N,1,BAO_0000218,955.0
12680,,10009,Intermediate,10090.0,,1,Distribution of compound in mice brain was measured after 6 hr,,,CHEMBL625700,,50594,Mus musculus,,,N,1,BAO_0000218,955.0
12681,,10009,Intermediate,10090.0,,1,Distribution of compound in mice liver was measured after 1 hr,,,CHEMBL625701,,50594,Mus musculus,,,N,1,BAO_0000218,
12682,,10009,Intermediate,10090.0,,1,Distribution of compound in mice liver was measured after 24 hr; b=Undetected,,,CHEMBL625702,,50594,Mus musculus,,,N,1,BAO_0000218,
12683,,10009,Intermediate,10090.0,,1,Distribution of compound in mice liver was measured after 2 hr,,,CHEMBL625703,,50594,Mus musculus,,,N,1,BAO_0000218,
12684,,10009,Intermediate,10090.0,,1,Distribution of compound in mice liver was measured after 3 hr,,,CHEMBL625704,,50594,Mus musculus,,,N,1,BAO_0000218,
12685,,10009,Intermediate,10090.0,,1,Distribution of compound in mice liver was measured after 6 hr,,,CHEMBL625705,,50594,Mus musculus,,,N,1,BAO_0000218,
12686,,8170,Intermediate,9615.0,,1,Distribution in dog adrenal medulla 30 min after administration.,,,CHEMBL625706,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,1236.0
12687,,8170,Intermediate,9615.0,,1,Distribution in dog adrenal medulla 72 hours after administration.,,,CHEMBL625707,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,1236.0
12688,,8170,Intermediate,9615.0,,1,Distribution in female dog Ovary 24 hours after administration.,,,CHEMBL625708,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
12689,,8170,Intermediate,9615.0,,1,Distribution in female dog Ovary 72 hours after administration.,,,CHEMBL625709,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
12690,,8170,Intermediate,9615.0,,1,Distribution in female dog adipose 24 hours after administration.,,,CHEMBL624180,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
12691,,8170,Intermediate,9615.0,,1,Distribution in female dog adipose 72 hours after administration.,,,CHEMBL624181,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
12692,,8170,Intermediate,9615.0,,1,Distribution in female dog adrenal cortex 72 hours after administration.,,,CHEMBL624182,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,1235.0
12693,,8170,Intermediate,9615.0,,1,Distribution in female dog adrenal cortex 72 hours after administration.,,,CHEMBL624183,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,1235.0
12694,,8594,Intermediate,10116.0,,1,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,,,CHEMBL624184,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
12695,,8594,Intermediate,10116.0,,1,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,,,CHEMBL877489,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
12696,,8594,Intermediate,10116.0,,1,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,,,CHEMBL624185,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
12697,,8594,Intermediate,10116.0,,1,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,,,CHEMBL624186,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
12698,,8594,Intermediate,10116.0,,1,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,,,CHEMBL624187,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
12699,,8594,Intermediate,10116.0,,1,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,,,CHEMBL624188,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
12700,,8594,Intermediate,10116.0,,1,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,,,CHEMBL624189,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2048.0
12701,,8594,Intermediate,10116.0,,1,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,,,CHEMBL624190,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2048.0
12702,,8594,Intermediate,10116.0,,1,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,,,CHEMBL624191,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2048.0
12703,,8594,Intermediate,10116.0,,1,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,,,CHEMBL624192,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2048.0
12704,,8594,Intermediate,10116.0,,1,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,,,CHEMBL624193,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2048.0
12705,,8594,Intermediate,10116.0,,1,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,,,CHEMBL624194,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2048.0
12706,,8594,Intermediate,10116.0,,1,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,,,CHEMBL624891,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2048.0
12707,,8594,Intermediate,10116.0,,1,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,,,CHEMBL624892,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2048.0
12708,,8594,Intermediate,10116.0,,1,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,,,CHEMBL624893,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2048.0
12709,,8594,Intermediate,10116.0,,1,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,,,CHEMBL627632,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2048.0
12710,,8594,Intermediate,10116.0,,1,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,,,CHEMBL627633,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
12711,,8594,Intermediate,10116.0,,1,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,,,CHEMBL627634,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
12712,,8594,Intermediate,10116.0,,1,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,,,CHEMBL627635,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
12713,,8594,Intermediate,10116.0,,1,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,,,CHEMBL627636,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
12714,,8594,Intermediate,10116.0,,1,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,,,CHEMBL626816,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
12715,,8594,Intermediate,10116.0,,1,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,,,CHEMBL626817,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
12716,,8594,Intermediate,10116.0,,1,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,,,CHEMBL626818,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
12717,,8594,Intermediate,10116.0,,1,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,,,CHEMBL626819,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
12718,,8594,Intermediate,10116.0,,1,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,,,CHEMBL626820,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
12719,,8594,Intermediate,10116.0,,1,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,,,CHEMBL626821,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
12720,,8594,Intermediate,10116.0,,1,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,,,CHEMBL626822,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2046.0
12721,,8594,Intermediate,10116.0,,1,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,,,CHEMBL626823,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2046.0
12722,,8594,Intermediate,10116.0,,1,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,,,CHEMBL626824,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2046.0
12723,,8594,Intermediate,10116.0,,1,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,,,CHEMBL626825,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2046.0
12724,,8594,Intermediate,10116.0,,1,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,,,CHEMBL626826,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2046.0
12725,,8594,Intermediate,10116.0,,1,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,,,CHEMBL626827,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2046.0
12726,,8594,Intermediate,10116.0,,1,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,,,CHEMBL626828,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2046.0
12727,,8594,Intermediate,10116.0,,1,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,,,CHEMBL626829,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2046.0
12728,,8594,Intermediate,10116.0,,1,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,,,CHEMBL626830,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2046.0
12729,,8594,Intermediate,10116.0,,1,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,,,CHEMBL627150,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
12730,,8594,Intermediate,10116.0,,1,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,,,CHEMBL627151,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
12731,,8594,Intermediate,10116.0,,1,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,,,CHEMBL627152,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
12732,,8594,Intermediate,10116.0,,1,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,,,CHEMBL627153,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
12733,,12904,Autocuration,,,1,Rate of acetate production by the compound was determined,,,CHEMBL627154,,22224,,,,U,0,BAO_0000019,
12734,,12904,Autocuration,,,1,Rate of acetate production by the compound was determined; Not determined,,,CHEMBL627155,,22224,,,,U,0,BAO_0000019,
12735,,3730,Autocuration,,,1,Rate of hydrolysis of nitrocefin by compound was evaluated in water,,,CHEMBL627156,,22224,,,,U,0,BAO_0000019,
12736,,3627,Autocuration,,,1,Reductive elimination of leaving group was determined at pH 7.4; expressed as loss of parent,,,CHEMBL627157,,22224,,,,U,0,BAO_0000019,
12737,,13799,Intermediate,9986.0,,1,Relative concentration of compound (70 mg/Kg) in brain compared to concentration in plasma (160 ug/mL) at the time of tissue collection from rabbit; relative concentration,,,CHEMBL627158,,50592,Oryctolagus cuniculus,,,N,1,BAO_0000218,
12738,,13799,Intermediate,9986.0,,1,Relative concentration of compound (70 mg/Kg) in lung compared to concentration in plasma (160 ug/mL) at the time of tissue collection from rabbit; relative concentration,,,CHEMBL627159,,50592,Oryctolagus cuniculus,,,N,1,BAO_0000218,1969.0
12739,,13799,Intermediate,10090.0,,1,Relative concentration of compound in brain compared to concentration in plasma (0.4 ug/mL) at the time of tissue collection from mice; relative concentration,,,CHEMBL627160,,50594,Mus musculus,,,N,1,BAO_0000218,
12740,,13799,Intermediate,10116.0,,1,Relative concentration of compound in brain compared to concentration in plasma (3.5 ug/mL) at the time of tissue collection from mice; relative concentration,,,CHEMBL628540,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
12741,,13799,Intermediate,10116.0,,1,Relative concentration of compound in lung compared to concentration in plasma (0.4 ug/mL) at the time of tissue collection from mice; relative concentration,,,CHEMBL628541,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
12742,,13799,Intermediate,10116.0,,1,Relative concentration of compound in lung compared to concentration in plasma (3.5 ug/mL) at the time of tissue collection from mice; relative concentration,,,CHEMBL628542,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
12743,,6629,Autocuration,,,1,Solubility after at a pH 1.2,,,CHEMBL628543,,22229,,,,U,0,BAO_0000100,
12744,,6629,Autocuration,,,1,Solubility after at pH 1.2,,,CHEMBL628544,,22229,,,,U,0,BAO_0000100,
12745,,6629,Autocuration,,,1,Solubility after injection of water,,,CHEMBL628545,,22229,,,,U,0,BAO_0000100,
12746,,14000,Autocuration,,,1,Statistical significance of IC 50 values; Expressed as R value,,,CHEMBL628546,,22224,,,,U,0,BAO_0000019,
12747,,8267,Autocuration,,,1,Systemic availability with respect to methyldopa was determined,,,CHEMBL874455,,22224,,,,U,0,BAO_0000019,
12748,,13799,Intermediate,10116.0,,1,Tissue distribution of the in rat brain relative to plasma concentration of 1 ug/kg; relative concentration,,,CHEMBL628547,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
12749,,13799,Intermediate,10116.0,,1,Tissue distribution of the in rat lung relative to plasma concentration of 1 ug/kg; relative concentration,,,CHEMBL628548,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
12750,,7132,Intermediate,9986.0,,1,"100 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit 1 lung, and radioactivity content in feces was estimated",,,CHEMBL628549,,50592,Oryctolagus cuniculus,,,N,1,BAO_0000218,1988.0
12751,,7132,Intermediate,9986.0,,1,"100 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit 1 liver, and radioactivity content in feces was estimated",,,CHEMBL628550,,50592,Oryctolagus cuniculus,,,N,1,BAO_0000218,1988.0
12752,,7132,Intermediate,9986.0,,1,"100 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit3, and radioactivity content in feces was estimated at total hours",,,CHEMBL628551,,50592,Oryctolagus cuniculus,,,N,1,BAO_0000218,1988.0
12753,,7132,Intermediate,9986.0,,1,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit1, and radioactivity content in urine was estimated at 0-2 hr",,,CHEMBL628552,,50592,Oryctolagus cuniculus,,,N,1,BAO_0000218,1088.0
12754,,7132,Intermediate,9986.0,,1,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 0-24 hr",,,CHEMBL628553,,50592,Oryctolagus cuniculus,,,N,1,BAO_0000218,1088.0
12755,,7132,Intermediate,9986.0,,1,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 0-48 hr",,,CHEMBL628554,,50592,Oryctolagus cuniculus,,,N,1,BAO_0000218,1088.0
12756,,7132,Intermediate,9986.0,,1,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 24-48 h",,,CHEMBL628555,,50592,Oryctolagus cuniculus,,,N,1,BAO_0000218,1088.0
12757,,7132,Intermediate,9986.0,,1,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 48-72 h",,,CHEMBL628556,,50592,Oryctolagus cuniculus,,,N,1,BAO_0000218,1088.0
12758,,7132,Intermediate,9986.0,,1,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit kidney, and radioactivity content in feces was estimated",,,CHEMBL628557,,50592,Oryctolagus cuniculus,,,N,1,BAO_0000218,2113.0
12759,,7132,Intermediate,9986.0,,1,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated",,,CHEMBL628558,,50592,Oryctolagus cuniculus,,,N,1,BAO_0000218,1988.0
12760,,7132,Intermediate,9986.0,,1,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 1 lung, and radioactivity content in feces was estimated at",,,CHEMBL628559,,50592,Oryctolagus cuniculus,,,N,1,BAO_0000218,1988.0
12761,,7132,Intermediate,9986.0,,1,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit1plasma, and radioactivity content in feces was estimated",,,CHEMBL628560,,50592,Oryctolagus cuniculus,,,N,1,BAO_0000218,1988.0
12762,,7132,Intermediate,9986.0,,1,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at total hours",,,CHEMBL874456,,50592,Oryctolagus cuniculus,,,N,1,BAO_0000218,1088.0
12763,,7132,Intermediate,9986.0,,1,"200 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit4, and radioactivity content in feces was estimated at 0-48 hr",,,CHEMBL628561,,50592,Oryctolagus cuniculus,,,N,1,BAO_0000218,1988.0
12764,,7132,Intermediate,9986.0,,1,"200 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit4, and radioactivity content in feces was estimated at total hours",,,CHEMBL628562,,50592,Oryctolagus cuniculus,,,N,1,BAO_0000218,1988.0
12765,,7132,Intermediate,9986.0,,1,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit2, and radioactivity content in urine was estimated at 0-4 hr",,,CHEMBL628563,,50592,Oryctolagus cuniculus,,,N,1,BAO_0000218,1088.0
12766,,7132,Intermediate,9986.0,,1,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at",,,CHEMBL628564,,50592,Oryctolagus cuniculus,,,N,1,BAO_0000218,1088.0
12767,,7132,Intermediate,9986.0,,1,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at 24-48 h",,,CHEMBL628565,,50592,Oryctolagus cuniculus,,,N,1,BAO_0000218,1088.0
12768,,7132,Intermediate,9986.0,,1,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at 48-72 h",,,CHEMBL631248,,50592,Oryctolagus cuniculus,,,N,1,BAO_0000218,1088.0
12769,,7132,Intermediate,9986.0,,1,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at total hours",,,CHEMBL631249,,50592,Oryctolagus cuniculus,,,N,1,BAO_0000218,1088.0
12770,,7132,Intermediate,9986.0,,1,"200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 kidney, and radioactivity content in feces was estimated",,,CHEMBL627214,,50592,Oryctolagus cuniculus,,,N,1,BAO_0000218,2113.0
12771,,7132,Intermediate,9986.0,,1,"200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 liver, and radioactivity content in feces was estimated",,,CHEMBL874591,,50592,Oryctolagus cuniculus,,,N,1,BAO_0000218,1988.0
12772,,7132,Intermediate,9986.0,,1,"200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 lung, and radioactivity content in feces was estimated",,,CHEMBL627215,,50592,Oryctolagus cuniculus,,,N,1,BAO_0000218,1988.0
12773,,7132,Intermediate,9986.0,,1,200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 plasma and radioactivity content in feces was estimated,,,CHEMBL625471,,50592,Oryctolagus cuniculus,,,N,1,BAO_0000218,1988.0
12774,,7132,Intermediate,9986.0,,1,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 1,,,CHEMBL625472,,50592,Oryctolagus cuniculus,,,N,1,BAO_0000218,
12775,,7132,Intermediate,9986.0,,1,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 3 by Gas-liquid chromatographic analysis,,,CHEMBL625473,,50592,Oryctolagus cuniculus,,,N,1,BAO_0000218,
12776,In vivo,13317,Intermediate,9615.0,,1,Tested for pharmacokinetic parameter in fasted Beagle dogs (Clearance value of the compound) iv administration.,,,CHEMBL625474,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
12777,In vivo,15341,Intermediate,9615.0,,1,The clearance was measured in dog at dose 5 mg/kg after intravenous administration.,,,CHEMBL625475,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
12778,In vivo,15341,Intermediate,10116.0,,1,The clearance was measured in rat at dose 12 mg/kg after intravenous administration.,,,CHEMBL625476,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
12779,In vivo,15341,Intermediate,10116.0,,1,The clearance was measured in rat at dose 1 mg/kg after intravenous administration.,,,CHEMBL625477,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
12780,In vivo,15341,Intermediate,10116.0,,1,The clearance was measured in rat at dose 30 mg/kg after intravenous administration.,,,CHEMBL625478,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
12781,In vitro,12801,Intermediate,10116.0,,1,The compound was evaluated for clearance value in rat isolated esophageal tunica muscularis mucose,,,CHEMBL625479,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
12782,In vitro,12801,Intermediate,10116.0,,1,The compound was evaluated for the value in rat isolated esophageal tunica muscularis mucose,,,CHEMBL625480,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
12783,In vivo,14856,Intermediate,10116.0,,1,The compound was tested for systemic plasma clearance(CL) in rats and is expressed in mL/min/kg.,,,CHEMBL625481,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
12784,In vivo,14062,Intermediate,10116.0,,1,Total body clearance at an intravenous dose of 5.2 mg/kg in rat,,,CHEMBL625482,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
12785,In vivo,14062,Intermediate,10116.0,,1,Total body clearance at an intravenous dose of 5.5 mg/kg in rat,,,CHEMBL625483,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
12786,In vivo,14062,Intermediate,10116.0,,1,Total body clearance at an intravenous dose of 6.3 mg/kg in rat,,,CHEMBL625484,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
12787,In vivo,14062,Intermediate,10116.0,,1,Total body clearance at an intravenous dose of 6.5 mg/kg in rat,,,CHEMBL625485,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
12788,In vivo,14346,Intermediate,9615.0,,1,Total plasma clearance value was obtained after intravenous administration of 1.8 mg/kg of drug in male Beagle dogs,,,CHEMBL625486,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,1969.0
12789,In vivo,14346,Intermediate,10116.0,,1,Total plasma clearance value was obtained after intravenous administration of 2.5 mg/kg of drug in male Dawley rats,,,CHEMBL625487,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
12790,In vivo,14346,Intermediate,10116.0,,1,Total plasma clearance value was obtained after intravenous administration of 2.6 mg/kg of drug in male Dawley rats,,,CHEMBL625488,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
12791,In vivo,14346,Intermediate,10116.0,,1,Total plasma clearance value was obtained after intravenous administration of 2.7 mg/kg of drug in male Dawley rats,,,CHEMBL625489,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
12792,In vivo,14346,Intermediate,10116.0,,1,Total plasma clearance value was obtained after intravenous administration of 2.8 mg/kg of drug in male Dawley rats,,,CHEMBL625490,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
12793,In vivo,14346,Intermediate,9615.0,,1,Total plasma clearance value was obtained after intravenous administration of 4.9 mg/kg of drug in male Beagle dogs,,,CHEMBL625491,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,1969.0
12794,In vivo,14346,Intermediate,10116.0,,1,Total plasma clearance value was obtained after intravenous administration of 5.1 mg/kg of drug in male Dawley rats,,,CHEMBL625492,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
12795,In vivo,15711,Intermediate,9606.0,,1,plasma clearance in human,,,CHEMBL625493,,50587,Homo sapiens,,,N,1,BAO_0000218,1969.0
12796,In vivo,14886,Intermediate,10116.0,,1,Pharmacokinetic parameter (CL/F ) was evaluated in Spargue-Dawley rat when given intravenously at dose 15 mg/kg,,,CHEMBL625494,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
12797,In vivo,14886,Intermediate,10116.0,,1,Pharmacokinetic parameter (CL/F ) was evaluated in Spargue-Dawley rat when given peroral at dose 30 mg/kg,,,CHEMBL625495,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
12798,In vivo,14886,Intermediate,10116.0,,1,Pharmacokinetic parameter (CL/F) was evaluated in Spargue-Dawley rat when given peroral at dose 80 mg/kg,,,CHEMBL625496,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
12799,,4115,Autocuration,,,1,1-Octanol/water partition coefficient measured at 7.4,,,CHEMBL625497,,22229,,,,U,0,BAO_0000100,
12800,,13733,Autocuration,,,1,Calculated partition coefficient (clogP),,,CHEMBL625498,,22229,,,,U,0,BAO_0000100,
12801,,12102,Autocuration,,,1,Partition coefficient (logP),,,CHEMBL625499,,22224,,,,U,0,BAO_0000019,
12802,,12676,Autocuration,,,1,Calculated partition coefficient (clogP),,,CHEMBL625500,,22229,,,,U,0,BAO_0000100,
12803,,13733,Autocuration,,,1,Calculated partition coefficient (clogP),,,CHEMBL625501,,22229,,,,U,0,BAO_0000100,
12804,,13740,Autocuration,,,1,Calculated partition coefficient (clogP),,,CHEMBL625502,,22229,,,,U,0,BAO_0000100,
12805,,12766,Autocuration,,,1,Calculated partition coefficient (clogP) (relative to BAY K 8644),,,CHEMBL625503,,22229,,,,U,0,BAO_0000100,
12806,,2764,Autocuration,,,1,Calculated partition coefficient (clogP),,,CHEMBL625504,,22229,,,,U,0,BAO_0000100,
12807,,12355,Autocuration,,,1,Calculated partition coefficient (clogP),,,CHEMBL625505,,22229,,,,U,0,BAO_0000100,
12808,,11314,Autocuration,,,1,Calculated partition coefficient of the compound,,,CHEMBL625506,,22229,,,,U,0,BAO_0000100,
12809,,12706,Autocuration,,,1,Partition coefficient (logP),,,CHEMBL625507,,22224,,,,U,0,BAO_0000019,
12810,,12645,Autocuration,,,1,Calculated partition coefficient (clogP),,,CHEMBL625508,,22229,,,,U,0,BAO_0000100,
12811,,13668,Autocuration,,,1,Calculated partition coefficient (clogP),,,CHEMBL625509,,22229,,,,U,0,BAO_0000100,
12812,,12819,Autocuration,,,1,Calculated partition coefficient (clogP),,,CHEMBL625510,,22229,,,,U,0,BAO_0000100,
12813,,13668,Autocuration,,,1,Calculated partition coefficient (clogP),,,CHEMBL883125,,22229,,,,U,0,BAO_0000100,
12814,,13017,Autocuration,,,1,Calculated partition coefficient (clogP),,,CHEMBL625511,,22229,,,,U,0,BAO_0000100,
12815,,2448,Autocuration,,,1,Partition coefficient of the compound,,,CHEMBL874650,,22224,,,,U,0,BAO_0000019,
12816,,11526,Autocuration,,,1,Partition coefficient of the compound,,,CHEMBL625512,,22224,,,,U,0,BAO_0000019,
12817,,12426,Autocuration,,,1,Partition coefficient of compound was determined,,,CHEMBL625513,,22224,,,,U,0,BAO_0000019,
12818,,2448,Autocuration,,,1,Partition coefficient was determined,,,CHEMBL625514,,22224,,,,U,0,BAO_0000019,
12819,,12001,Autocuration,,,1,Calculated partition coefficient (clogP),,,CHEMBL625515,,22229,,,,U,0,BAO_0000100,
12820,,12426,Autocuration,,,1,partition coefficient of compound was determined,,,CHEMBL625516,,22229,,,,U,0,BAO_0000100,
12821,In vivo,13204,Intermediate,9615.0,,1,The total body administered intravenously in dog,,,CHEMBL625517,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
12822,In vivo,13204,Intermediate,10116.0,,1,The total body administered intravenously in rats,,,CHEMBL625518,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
12823,,13889,Intermediate,10090.0,,1,Time taken for the administration to female NIH mice weighing 25-30 g.,,,CHEMBL625519,,50594,Mus musculus,,,N,1,BAO_0000218,
12824,,13889,Autocuration,,,1,Time taken for the administration,,,CHEMBL625520,,22224,,,,U,0,BAO_0000019,
12825,In vivo,17025,Intermediate,9615.0,,1,Total clearance of compound was determined in dog at 5 mg/kg intravenously admn.,,,CHEMBL874651,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
12826,In vivo,17025,Autocuration,314293.0,,1,Total clearance of compound was determined in monkey at 5 mg/kg intravenously admn.,,,CHEMBL625521,,22224,Simiiformes,,,U,0,BAO_0000218,
12827,In vivo,17025,Intermediate,9986.0,,1,Total clearance of compound was determined in rabbit at 5 mg/kg intravenously admn.,,,CHEMBL623171,,50592,Oryctolagus cuniculus,,,N,1,BAO_0000218,
12828,In vivo,17025,Intermediate,10116.0,,1,Total clearance of compound was determined in rat at 5 mg/kg intravenously admn.,,,CHEMBL623853,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
12829,,15067,Autocuration,,,1,Plasma clearance for the compound was determined.,,,CHEMBL623854,,22224,,,,U,0,BAO_0000019,
12830,,3091,Autocuration,,,1,CLog P value of the compound,,,CHEMBL874405,,22224,,,,U,0,BAO_0000100,
12831,,15592,Autocuration,,,1,Calculated partition coefficient (clogP),,,CHEMBL623855,,22229,,,,U,0,BAO_0000100,
12832,,14738,Autocuration,,,1,Calculated partition coefficient (clogP),,,CHEMBL623856,,22229,,,,U,0,BAO_0000100,
12833,,14738,Autocuration,,,1,ClogP value of the compound; nd ='no data',,,CHEMBL623857,,22224,,,,U,0,BAO_0000100,
12834,,14738,Autocuration,,,1,ClogP value of the compound; nd ='not determined',,,CHEMBL623858,,22224,,,,U,0,BAO_0000100,
12835,,6076,Autocuration,,,1,CLog P was determined,,,CHEMBL623859,,22224,,,,U,0,BAO_0000100,
12836,,17840,Autocuration,,,1,Calculated partition coefficient (clogP),,,CHEMBL839829,,22229,,,,U,0,BAO_0000100,
12837,,13589,Autocuration,,,1,CLogP was calculated,,,CHEMBL623860,,22224,,,,U,0,BAO_0000019,
12838,,17655,Autocuration,,,1,CLogP value was determined,,,CHEMBL623861,,22224,,,,U,0,BAO_0000019,
12839,,5867,Autocuration,,,1,CLogP value was evaluated using http://esc.syrres.com/interkow/kowdemo.htm.,,,CHEMBL623862,,22224,,,,U,0,BAO_0000019,
12840,,5867,Autocuration,,,1,Calculated partition coefficient (clogP),,,CHEMBL874406,,22229,,,,U,0,BAO_0000100,
12841,,10783,Autocuration,,,1,Calculated partition coefficient (clogP),,,CHEMBL623863,,22229,,,,U,0,BAO_0000100,
12842,,14849,Autocuration,,,1,Calculated partition coefficient (clogP),,,CHEMBL624021,,22229,,,,U,0,BAO_0000100,
12843,,8170,Intermediate,9615.0,,1,Distribution in female dog adrenal medulla 24 hours after administration.,,,CHEMBL624022,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,1236.0
12844,,8170,Intermediate,9615.0,,1,Distribution in female dog adrenal medulla 72 hours after administration.,,,CHEMBL624023,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,1236.0
12845,,8170,Intermediate,9615.0,,1,Distribution in female dog bile 24 hours after administration.,,,CHEMBL624024,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
12846,,8170,Intermediate,9615.0,,1,Distribution in female dog bile 72 hr after administration.,,,CHEMBL624025,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
12847,,8170,Intermediate,9615.0,,1,Distribution in female dog blood 24 hours after administration.,,,CHEMBL624026,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
12848,,8170,Intermediate,9615.0,,1,Distribution in female dog blood 72 hours after administration.,,,CHEMBL624027,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
12849,,8170,Intermediate,9615.0,,1,Distribution in female dog heart 24 hours after administration.,,,CHEMBL624028,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
12850,,8170,Intermediate,9615.0,,1,Distribution in female dog heart 72 hours after administration.,,,CHEMBL624029,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
12851,,8170,Intermediate,9615.0,,1,Distribution in female dog kidney 24 hours after administration.,,,CHEMBL624030,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
12852,,8170,Intermediate,9615.0,,1,Distribution in female dog kidney 72 hours after administration.,,,CHEMBL624031,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
12853,,8170,Intermediate,9615.0,,1,Distribution in female dog large intestine 24 hours after administration.,,,CHEMBL624032,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,160.0
12854,,8170,Intermediate,9615.0,,1,Distribution in female dog large intestine 72 hours after administration.,,,CHEMBL874407,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,160.0
12855,,8170,Intermediate,9615.0,,1,Distribution in female dog liver 24 hours after administration.,,,CHEMBL624033,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
12856,,8170,Intermediate,9615.0,,1,Distribution in female dog liver 72 hours after administration.,,,CHEMBL624034,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
12857,,8170,Intermediate,9615.0,,1,Distribution in female dog lung 24 hours after administration.,,,CHEMBL624035,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
12858,,8170,Intermediate,9615.0,,1,Distribution in female dog lung 72 hours after administration.,,,CHEMBL624036,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
12859,,8170,Intermediate,9615.0,,1,Distribution in female dog muscle 24 hours after administration.,,,CHEMBL624037,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,2385.0
12860,,8170,Intermediate,9615.0,,1,Distribution in female dog muscle 72 hours after administration.,,,CHEMBL624038,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,2385.0
12861,,8170,Intermediate,9615.0,,1,Distribution in female dog pancreas 24 hours after administration.,,,CHEMBL624039,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
12862,,8170,Intermediate,9615.0,,1,Distribution in female dog pancreas 72 hours after administration.,,,CHEMBL624040,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
12863,,8170,Intermediate,9615.0,,1,Distribution in female dog small intestine 24 hours after administration.,,,CHEMBL624041,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,160.0
12864,,8170,Intermediate,9615.0,,1,Distribution in female dog small intestine 72 hours after administration.,,,CHEMBL624042,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,160.0
12865,,8170,Intermediate,9615.0,,1,Distribution in female dog spleen 24 hours after administration.,,,CHEMBL624043,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,2106.0
12866,,8170,Intermediate,9615.0,,1,Distribution in female dog spleen 72 hours after administration.,,,CHEMBL624044,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,2106.0
12867,,8170,Intermediate,9615.0,,1,Distribution in female dog stomach 24 hours after administration.,,,CHEMBL624045,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,945.0
12868,,8170,Intermediate,9615.0,,1,Distribution in female dog stomach 72 hours after administration.,,,CHEMBL624046,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,945.0
12869,,8170,Intermediate,9615.0,,1,Distribution in female dog thyroid 24 hours after administration.,,,CHEMBL624047,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,2046.0
12870,,8170,Intermediate,9615.0,,1,Distribution in female dog thyroid 72 hours after administration.,,,CHEMBL624048,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,2046.0
12871,,8170,Intermediate,9615.0,,1,Distribution in female dog urine 24 hours after administration.,,,CHEMBL874408,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,1088.0
12872,,8170,Intermediate,9615.0,,1,Distribution in female dog urine 72 hr after administration.,,,CHEMBL624049,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,1088.0
12873,,14283,Autocuration,,,1,Mean plasma concentration measured 1 h following an oral dose of 30 mg/kg,,,CHEMBL624050,,22224,,,,U,0,BAO_0000218,1969.0
12874,,5623,Autocuration,,,1,Plasma concentration at 7 hr after intravenous dosing,,,CHEMBL624051,,22224,,,,U,0,BAO_0000019,
12875,,13477,Intermediate,10116.0,,1,Plasma concentration of 3 mg/kg iv after 0.25 hr in rats,,,CHEMBL623278,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
12876,,13477,Intermediate,10116.0,,1,Plasma concentration of 3 mg/kg iv after 0.5 hr in rats,,,CHEMBL623279,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
12877,,13477,Intermediate,10116.0,,1,Plasma concentration of 3 mg/kg iv after 1 hr in rats,,,CHEMBL623280,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
12878,,13477,Intermediate,10116.0,,1,Plasma concentration of 3 mg/kg iv after 2 hr in rats,,,CHEMBL623963,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
12879,,13477,Intermediate,10116.0,,1,Plasma concentration of 3 mg/kg iv after 4 hr in rats,,,CHEMBL623964,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
12880,,13477,Intermediate,10116.0,,1,Plasma concentration of 3 mg/kg iv after 6 hr in rats,,,CHEMBL623965,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
12881,,13477,Intermediate,10116.0,,1,Plasma concentration of 3 mg/kg po after 0.083 hr in rats,,,CHEMBL623966,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
12882,,13477,Intermediate,10116.0,,1,Plasma concentration after 3 mg/kg peroral dosing in rat at 0.083 h,,,CHEMBL874415,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
12883,,13477,Intermediate,10116.0,,1,Plasma concentration after 3 mg/kg peroral dosing in rat at 0.25 hr,,,CHEMBL623967,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
12884,,13477,Intermediate,10116.0,,1,Plasma concentration after 3 mg/kg peroral dosing in rat at 0.5 hr,,,CHEMBL623968,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
12885,,13477,Intermediate,10116.0,,1,Plasma concentration after 3 mg/kg peroral dosing in rat at 1 hr,,,CHEMBL623969,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
12886,,13477,Intermediate,10116.0,,1,Plasma concentration after 3 mg/kg peroral dosing in rat at 2 hr,,,CHEMBL628409,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
12887,,13477,Intermediate,10116.0,,1,Plasma concentration after 3 mg/kg peroral dosing in rat at 4 hr,,,CHEMBL628410,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
12888,,13477,Intermediate,10116.0,,1,Plasma concentration after 3 mg/kg peroral dosing in rat at 6 hr,,,CHEMBL628411,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
12889,,13477,Intermediate,10116.0,,1,Plasma concentration after 3 mg/kg peroral dosing in rat at 8 hr,,,CHEMBL628412,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
12890,,12553,Autocuration,,,1,Tested for the highest concentration at which toxicity was not observed or the concentration which provided the highest number of net grain counts,,,CHEMBL628413,,22224,,,,U,0,BAO_0000019,
12891,,14548,Autocuration,,,1,The concentration in plasmat; Not determined,,,CHEMBL628414,,22224,,,,U,0,BAO_0000019,1969.0
12892,,14393,Intermediate,10116.0,,1,Tissue level at 10 mg/kg/po in wistar rats in blood,,,CHEMBL628415,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
12893,,14393,Intermediate,10116.0,,1,Tissue level at 10 mg/kg/po in wistar rats in brown fat,,,CHEMBL628416,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
12894,,14393,Intermediate,10116.0,,1,Tissue level at 10 mg/kg/po in wistar rats in heart,,,CHEMBL628417,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
12895,,14393,Intermediate,10116.0,,1,Tissue level at 10 mg/kg/po in wistar rats in liver,,,CHEMBL874908,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
12896,,14393,Intermediate,10116.0,,1,Tissue level at 10 mg/kg/po in wistar rats in plasma,,,CHEMBL628418,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
12897,,14393,Intermediate,10116.0,,1,Tissue level at 10 mg/kg/po in wistar rats in skeletal muscle,,,CHEMBL628419,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2385.0
12898,,14393,Intermediate,10116.0,,1,Tissue level at 10 mg/kg/po in wistar rats in subcutaneous fat,,,CHEMBL628420,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
12899,,1629,Autocuration,,,1,Water solubility at 37 degree C.,,,CHEMBL628421,,22224,,,,U,0,BAO_0000019,
12900,,8194,Autocuration,,,1,Solubility of 10 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 13.5 hr,,,CHEMBL626726,,22229,,,,U,0,BAO_0000100,
12901,,8194,Autocuration,,,1,Solubility of 10 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 4.0 hr,,,CHEMBL626727,,22229,,,,U,0,BAO_0000100,
12902,,8594,Intermediate,10116.0,,1,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,,,CHEMBL626728,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
12903,,8594,Intermediate,10116.0,,1,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,,,CHEMBL626729,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
12904,,8594,Intermediate,10116.0,,1,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,,,CHEMBL626730,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
12905,,8594,Intermediate,10116.0,,1,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,,,CHEMBL626731,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
12906,,8594,Intermediate,10116.0,,1,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,,,CHEMBL626732,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
12907,,8594,Intermediate,10116.0,,1,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,,,CHEMBL626733,,50597,Rattus norvegicus,,,N,1,BAO_0000218,948.0
12908,,8594,Intermediate,10116.0,,1,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,,,CHEMBL626734,,50597,Rattus norvegicus,,,N,1,BAO_0000218,948.0
12909,,8594,Intermediate,10116.0,,1,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,,,CHEMBL626735,,50597,Rattus norvegicus,,,N,1,BAO_0000218,948.0
12910,,8594,Intermediate,10116.0,,1,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,,,CHEMBL874909,,50597,Rattus norvegicus,,,N,1,BAO_0000218,948.0
12911,,8594,Intermediate,10116.0,,1,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,,,CHEMBL626736,,50597,Rattus norvegicus,,,N,1,BAO_0000218,948.0
12912,,8594,Intermediate,10116.0,,1,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,,,CHEMBL626737,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2113.0
12913,,8594,Intermediate,10116.0,,1,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,,,CHEMBL630999,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2113.0
12914,,8594,Intermediate,10116.0,,1,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,,,CHEMBL631000,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2113.0
12915,,8594,Intermediate,10116.0,,1,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,,,CHEMBL631001,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2113.0
12916,,8594,Intermediate,10116.0,,1,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,,,CHEMBL631002,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2113.0
12917,,8594,Intermediate,10116.0,,1,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,,,CHEMBL631003,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
12918,,8594,Intermediate,10116.0,,1,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,,,CHEMBL631004,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
12919,,8594,Intermediate,10116.0,,1,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,,,CHEMBL631005,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
12920,,8594,Intermediate,10116.0,,1,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,,,CHEMBL631006,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
12921,,8594,Intermediate,10116.0,,1,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,,,CHEMBL631007,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
12922,,8594,Intermediate,10116.0,,1,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,,,CHEMBL631008,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2048.0
12923,,8594,Intermediate,10116.0,,1,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,,,CHEMBL631009,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2048.0
12924,,8594,Intermediate,10116.0,,1,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,,,CHEMBL631010,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2048.0
12925,,8594,Intermediate,10116.0,,1,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,,,CHEMBL631011,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2048.0
12926,,8594,Intermediate,10116.0,,1,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,,,CHEMBL631012,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2048.0
12927,,8594,Intermediate,10116.0,,1,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,,,CHEMBL630271,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2046.0
12928,,8594,Intermediate,10116.0,,1,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,,,CHEMBL630272,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2046.0
12929,,8594,Intermediate,10116.0,,1,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,,,CHEMBL630273,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2046.0
12930,,8594,Intermediate,10116.0,,1,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,,,CHEMBL630274,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2046.0
12931,,8594,Intermediate,10116.0,,1,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,,,CHEMBL630275,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2046.0
12932,,8594,Intermediate,10116.0,,1,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 15 minutes (radiolabeled with [125I]-,,,CHEMBL875782,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
12933,,8594,Intermediate,10116.0,,1,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 2 minutes (radiolabeled with [125I]-,,,CHEMBL630276,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
12934,,8594,Intermediate,10116.0,,1,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 30 minutes (radiolabeled with [125I]-,,,CHEMBL630277,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
12935,,8594,Intermediate,10116.0,,1,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 5 minutes (radiolabeled with [125I]-,,,CHEMBL630278,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
12936,,8594,Intermediate,10116.0,,1,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 60 minutes (radiolabeled with [125I]-,,,CHEMBL630279,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
12937,,8151,Autocuration,,,1,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 10 mg/Kg,,,CHEMBL630280,,22224,,,,U,0,BAO_0000019,
12938,,8151,Autocuration,,,1,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,,,CHEMBL630281,,22224,,,,U,0,BAO_0000019,
12939,,7132,Intermediate,9986.0,,1,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 4 by Gas-liquid chromatographic analysis,,,CHEMBL630282,,50592,Oryctolagus cuniculus,,,N,1,BAO_0000218,
12940,,7132,Intermediate,9986.0,,1,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 2,,,CHEMBL630283,,50592,Oryctolagus cuniculus,,,N,1,BAO_0000218,
12941,,5797,Autocuration,,,1,Alkylating activity (0.1 mM) was determined at pH 7.4; expressed as OD (540n m)/mM of drug),,,CHEMBL630284,,22224,,,,U,0,BAO_0000019,
12942,,7849,Autocuration,,,1,Alkylating activity was determined,,,CHEMBL630285,,22224,,,,U,0,BAO_0000019,
12943,,14220,Autocuration,,,1,Amount of metabolites in the microsomal medium after 90 min incubation of BTCP (500 uM),,,CHEMBL630286,Microsomes,22224,,,,U,0,BAO_0000251,
12944,,8650,Intermediate,9986.0,,1,"Formation of metabolite by rabbit liver microsomal preparation in absence of NADPH, at 2 hours",,,CHEMBL630069,,50592,Oryctolagus cuniculus,,,N,1,BAO_0000218,
12945,,8650,Intermediate,9986.0,,1,"Formation of metabolite by rabbit liver microsomal preparation in presence of Co-O2 (90:10),at 2 hour",,,CHEMBL630070,,50592,Oryctolagus cuniculus,,,N,1,BAO_0000218,
12946,,8650,Intermediate,9986.0,,1,"Formation of metabolite by rabbit liver microsomal preparation in presence of N2,at 2 hour",,,CHEMBL630071,,50592,Oryctolagus cuniculus,,,N,1,BAO_0000218,
12947,,8650,Intermediate,9986.0,,1,"Formation of metabolite by rabbit liver microsomal preparation in presence of NADPH, at 2 hours",,,CHEMBL630072,,50592,Oryctolagus cuniculus,,,N,1,BAO_0000218,
12948,,8650,Intermediate,9986.0,,1,"Formation of metabolite by rabbit liver microsomal preparation in presence of SKF525A,at 2 hour",,,CHEMBL875110,,50592,Oryctolagus cuniculus,,,N,1,BAO_0000218,
12949,,7116,Intermediate,10116.0,,1,Compound was tested for antidiuretic activity in rats,,,CHEMBL630073,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
12950,,14131,Autocuration,,,1,Compound was tested for inactivation kinetic values,,,CHEMBL630074,,22224,,,,U,0,BAO_0000019,
12951,In vivo,7415,Autocuration,,,1,Compound was evaluated for the average apparent volume of distribution when administered through intravenous route,,,CHEMBL630075,,22224,,,,U,0,BAO_0000218,
12952,,13178,Autocuration,,,1,Dissociation rate calculated from the first-order equation using the t1/2 value,,,CHEMBL630076,,22224,,,,U,0,BAO_0000019,
12953,,8815,Autocuration,,,1,Compound was evaluated for pKa by titration of the compounds in 1:2 methyl alcohol and water,,,CHEMBL630077,,22229,,,,U,0,BAO_0000100,
12954,,1450,Autocuration,,,1,Aqueous solubility was measured,,,CHEMBL630078,,22229,,,,U,0,BAO_0000100,
12955,,1450,Autocuration,,,1,Aqueous solubility was measured at a pH 4,,,CHEMBL630079,,22229,,,,U,0,BAO_0000100,
12956,,1450,Autocuration,,,1,Aqueous solubility (pH 7),,,CHEMBL630080,,22229,,,,U,0,BAO_0000100,
12957,,1450,Autocuration,,,1,Aqueous solubility was measured at a pH 9,,,CHEMBL630081,,22229,,,,U,0,BAO_0000100,
12958,,12711,Autocuration,,,1,"Aqueous solubilities were determined by dissolving an crystalline hemisulfate and dichloride salts, respectively in water and adding acetate to pH 5.0, concentrations are expressed in free base equivalents",,,CHEMBL630082,,22224,,,,U,0,BAO_0000019,
12959,,12711,Autocuration,,,1,"Aqueous solubilities were determined by dissolving an crystalline hemisulfate and dichloride salts, respectively in water and adding acetate to pH 5.0, concentrations are expressed in free base equivalents.",,,CHEMBL630083,,22224,,,,U,0,BAO_0000019,
12960,,12711,Autocuration,,,1,"Aqueous solubilities were determined by dissolving an crystalline hemisulfate and dichloride salts, respectively in water and adding acetate to pH 5.0, concentrations are expressed in free base equivalents.",,,CHEMBL630084,,22224,,,,U,0,BAO_0000019,
12961,,15032,Autocuration,,,1,Aqueous solubility of the compound,,,CHEMBL629198,,22229,,,,U,0,BAO_0000100,
12962,,9964,Autocuration,,,1,Aqueous solubility at 37 degree Celsius at pH 7.38,,,CHEMBL629199,,22229,,,,U,0,BAO_0000100,
12963,,14962,Autocuration,,,1,Aqueous solubility in pH 7.4 phosphate buffer,,,CHEMBL629200,,22229,,,,U,0,BAO_0000100,
12964,,12487,Intermediate,9615.0,,1,Mean arterial pressure response following 10 mg/kg intraduodenal administration to salt depleted dog,,,CHEMBL629201,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
12965,,12487,Intermediate,9615.0,,1,Mean arterial pressure response following 1 mg/kg intravenous administration to salt depleted dog,,,CHEMBL629202,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
12966,,10026,Intermediate,9606.0,,1,Percentage of aspirin formed during hydrolysis in 10% human plasma at pH 7.4 at 37 degrees celsius,,,CHEMBL875111,,50587,Homo sapiens,,,N,1,BAO_0000218,
12967,,10026,Intermediate,9606.0,,1,Percentage of aspirin formed during hydrolysis in undiluted human plasma at pH 7.4 at 37 degrees celsius,,,CHEMBL629203,,50587,Homo sapiens,,,N,1,BAO_0000218,
12968,,10026,Intermediate,9606.0,,1,The percentage of aspirin formed during hydrolysis in 100% human plasma at pH 7.4 at 37 degrees celsius,,,CHEMBL629204,,50587,Homo sapiens,,,N,1,BAO_0000218,
12969,,10026,Intermediate,9606.0,,1,The percentage of aspirin formed during hydrolysis in 20% human plasma at pH 7.4 at 37 degrees celsius,,,CHEMBL629205,,50587,Homo sapiens,,,N,1,BAO_0000218,
12970,,10026,Intermediate,9606.0,,1,The percentage of aspirin formed during hydrolysis in 60% human plasma at pH 7.4 at 37 degrees celsius,,,CHEMBL629206,,50587,Homo sapiens,,,N,1,BAO_0000218,
12971,,10026,Autocuration,,,1,The percentage of aspirin formed during hydrolysis in 80% human plasma at pH 7.4 at 37 degrees celsius,,,CHEMBL631185,,22224,,,,U,0,BAO_0000019,
12972,,7415,Intermediate,10116.0,,1,Compound was evaluated for the average bile flow rat in rats,,,CHEMBL631186,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
12973,,17025,Intermediate,9986.0,,1,"Effect of compound on cartilage in surgically induced osteoarthritis (OA) model in rabbit at 15 mg/kg, value are relative to activity of RS-130830 (7.9+/-1.5) at 25 mg/kg",,,CHEMBL631187,,50592,Oryctolagus cuniculus,,,N,1,BAO_0000218,
12974,,17025,Intermediate,9986.0,,1,"Effect of compound on cartilage in surgically induced osteoarthritis (OA) model in rabbit at 25 mg/kg, value are relative to activity of RS-130830 (7.9+/-1.5) at 25 mg/kg",,,CHEMBL631188,,50592,Oryctolagus cuniculus,,,N,1,BAO_0000218,
12975,,10184,Autocuration,,,1,Average half life period was determined,,,CHEMBL876419,,22224,,,,U,0,BAO_0000019,
12976,,10184,Autocuration,,,1,Average half life period was determined,,,CHEMBL631189,,22224,,,,U,0,BAO_0000019,
12977,,8613,Intermediate,10298.0,,1,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 0.8 mg/kg per day.,,,CHEMBL631190,,50602,Human herpesvirus 1,,,N,1,BAO_0000218,
12978,,8613,Intermediate,10298.0,,1,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 0.8 mg/kg per day.,,,CHEMBL631191,,50602,Human herpesvirus 1,,,N,1,BAO_0000218,
12979,,8613,Intermediate,10298.0,,1,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 12.5 mg/kg per day.,,,CHEMBL631192,,50602,Human herpesvirus 1,,,N,1,BAO_0000218,
12980,,8613,Intermediate,10298.0,,1,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 3.1 mg/kg per day.,,,CHEMBL632400,,50602,Human herpesvirus 1,,,N,1,BAO_0000218,
12981,,8613,Intermediate,10298.0,,1,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day.,,,CHEMBL630564,,50602,Human herpesvirus 1,,,N,1,BAO_0000218,
12982,,8613,Intermediate,10298.0,,1,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day.,,,CHEMBL630565,,50602,Human herpesvirus 1,,,N,1,BAO_0000218,
12983,,8613,Intermediate,10298.0,,1,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.02 mg/kg per day.,,,CHEMBL630566,,50602,Human herpesvirus 1,,,N,1,BAO_0000218,
12984,,8613,Intermediate,10298.0,,1,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.06 mg/kg per day.,,,CHEMBL631229,,50602,Human herpesvirus 1,,,N,1,BAO_0000218,
12985,,8613,Intermediate,10298.0,,1,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.25 mg/kg per day.,,,CHEMBL631230,,50602,Human herpesvirus 1,,,N,1,BAO_0000218,
12986,,6030,Autocuration,,,1,Calculated partition coefficient (clogP),,,CHEMBL876428,,22229,,,,U,0,BAO_0000100,
12987,,6147,Autocuration,,,1,Calculated partition coefficient (clogP),,,CHEMBL631231,,22229,,,,U,0,BAO_0000100,
12988,,14556,Autocuration,,,1,Calculated partition coefficient (clogP) (MacLogP),,,CHEMBL631232,,22229,,,,U,0,BAO_0000100,
12989,,768,Autocuration,,,1,Hydrophilicity was determined,,,CHEMBL631233,,22224,,,,U,0,BAO_0000019,
12990,,14452,Autocuration,,,1,Calculated partition coefficient (clogP),,,CHEMBL631234,,22229,,,,U,0,BAO_0000100,
12991,,5237,Autocuration,,,1,Increased absorption was determined,,,CHEMBL883126,,22224,,,,U,0,BAO_0000019,
12992,,14378,Autocuration,,,1,Lipophilicity value was evaluated,,,CHEMBL631235,,22224,,,,U,0,BAO_0000100,
12993,,14418,Autocuration,,,1,Log P value of the compound.,,,CHEMBL631236,,22224,,,,U,0,BAO_0000100,
12994,,5249,Autocuration,,,1,Partition coefficient of compound was determined,,,CHEMBL631237,,22224,,,,U,0,BAO_0000019,
12995,,14621,Autocuration,,,1,Calculated partition coefficient (clogP),,,CHEMBL631238,,22229,,,,U,0,BAO_0000100,
12996,,12542,Autocuration,,,1,Calculated partition coefficient (clogP),,,CHEMBL876429,,22229,,,,U,0,BAO_0000100,
12997,,12542,Autocuration,,,1,Partition coefficient was measured by medchem software; Not calculated,,,CHEMBL631414,,22224,,,,U,0,BAO_0000019,
12998,,12542,Autocuration,,,1,Partition coefficient was measured by octanol-water using standard shake-flask method,,,CHEMBL631415,,22224,,,,U,0,BAO_0000100,
12999,,15462,Autocuration,,,1,Calculated partition coefficient (clogP),,,CHEMBL631416,,22229,,,,U,0,BAO_0000100,
13000,,14884,Autocuration,,,1,Partition coefficient (logP),,,CHEMBL631417,,22224,,,,U,0,BAO_0000019,
13001,,16526,Autocuration,,,1,Calculated partition coefficient (clogP),,,CHEMBL631418,,22229,,,,U,0,BAO_0000100,
13002,,13693,Autocuration,,,1,The Octanol/Water partition coefficient CLogP,,,CHEMBL631419,,22229,,,,U,0,BAO_0000100,
13003,,13693,Autocuration,,,1,The pharmacokinetic parameter C Log p was reported,,,CHEMBL631420,,22224,,,,U,0,BAO_0000019,
13004,,13779,Autocuration,,,1,Calculated partition coefficient (clogP),,,CHEMBL631421,,22229,,,,U,0,BAO_0000100,
13005,,14772,Autocuration,,,1,Calculated partition coefficient (clogP),,,CHEMBL631422,,22229,,,,U,0,BAO_0000100,
13006,,14393,Autocuration,,,1,Calculated partition coefficient (clogP),,,CHEMBL631423,,22229,,,,U,0,BAO_0000100,
13007,In vivo,14793,Intermediate,10116.0,,1,Clearance rate in rat plasma when administered intraperitoneally at a dose of 10 mg/kg,,,CHEMBL876430,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
13008,In vivo,14793,Intermediate,10116.0,,1,Clearance rate in rat plasma when administered intravenously at a dose of 10 mg/kg,,,CHEMBL631424,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
13009,In vivo,13744,Intermediate,9615.0,,1,Compound was administered intravenously in dog to evaluate plasma clearance values,,,CHEMBL631425,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,1969.0
13010,In vivo,13744,Autocuration,314293.0,,1,Compound was administered intravenously in monkey to evaluate plasma clearance values,,,CHEMBL631426,,22224,Simiiformes,,,U,0,BAO_0000218,1969.0
13011,In vivo,13744,Intermediate,10090.0,,1,Compound was administered intravenously in mouse to evaluate plasma clearance values,,,CHEMBL631427,,50594,Mus musculus,,,N,1,BAO_0000218,1969.0
13012,In vivo,13207,Intermediate,9615.0,,1,Compound was evaluated in vivo for plasma clearance in dog after intravenous dose at 2 mg/Kg,,,CHEMBL631428,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,1969.0
13013,In vitro,5669,Intermediate,9544.0,,1,Intrinsic clearance in Rhesus liver microsome,,,CHEMBL631429,Microsomes,50797,Macaca mulatta,,,N,1,BAO_0000218,2107.0
13014,In vitro,5669,Intermediate,9615.0,,1,Intrinsic clearance in dog liver microsome,,,CHEMBL631430,Microsomes,50588,Canis lupus familiaris,,,N,1,BAO_0000218,2107.0
13015,In vitro,5669,Intermediate,10116.0,,1,Intrinsic clearance in rat liver microsome,,,CHEMBL631431,Microsomes,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
13016,In vivo,4853,Intermediate,9544.0,,1,Low plasma clearance was calculated in rhesus monkey,,,CHEMBL631432,,50797,Macaca mulatta,,,N,1,BAO_0000218,1969.0
13017,In vivo,16452,Intermediate,9615.0,,1,Pharmacokinetic data at 0.5 mg/kg dose given to dogs intravenously.,,,CHEMBL631433,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
13018,In vivo,11954,Autocuration,,,1,Plasma clearance after intravenous dose of 0.3 mg/kg,,,CHEMBL631434,,22224,,,,U,0,BAO_0000218,
13019,In vivo,11954,Autocuration,,,1,Plasma clearance after intravenous dose of 1 mg/kg,,,CHEMBL631435,,22224,,,,U,0,BAO_0000218,
13020,In vivo,11954,Autocuration,,,1,Plasma clearance after intravenous dose of 3 mg/kg,,,CHEMBL631436,,22224,,,,U,0,BAO_0000218,
13021,In vivo,11954,Autocuration,,,1,Plasma clearance after intravenous dose of 3.87 mg/kg,,,CHEMBL631437,,22224,,,,U,0,BAO_0000218,
13022,In vivo,5669,Intermediate,10116.0,,1,Plasma clearance after peroral administration at 10 mpk in Rat,,,CHEMBL631438,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13023,In vivo,5669,Intermediate,9544.0,,1,Plasma clearance after peroral administration at 10 mpk in Rhesus,,,CHEMBL876431,,50797,Macaca mulatta,,,N,1,BAO_0000218,
13024,In vivo,5669,Intermediate,9615.0,,1,Plasma clearance after peroral administration at 10 mpk in dog,,,CHEMBL631439,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
13025,In vivo,13662,Intermediate,10116.0,,1,Totla clearance of compound reported after 5 mg/kg i.v. dose in rat,,,CHEMBL631440,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13026,,8272,Autocuration,,,1,Compound was evaluated for physico-chemical property of Critical micellar concentration (CMC),,,CHEMBL631441,,22224,,,,U,0,BAO_0000019,
13027,,13410,Autocuration,,,1,Critical Micellar concentration was determined,,,CHEMBL631442,,22224,,,,U,0,BAO_0000019,
13028,,13410,Autocuration,,,1,Critical Micellar concentration of the compound. was determined,,,CHEMBL626525,,22224,,,,U,0,BAO_0000019,
13029,,12628,Autocuration,,,1,Critical micelle concentration determined from the plots of the fluorescence intensity as a function of compound concentration,,,CHEMBL627168,,22224,,,,U,0,BAO_0000019,
13030,,9675,Autocuration,,,1,Critical micellar concentration was measured in water by the dye solubilization method,,,CHEMBL875618,,22224,,,,U,0,BAO_0000019,
13031,,12628,Autocuration,,,1,Hydrolysis turn over determined from the plots of the fluorescence assay quantified by HPLC,,,CHEMBL626612,,22224,,,,U,0,BAO_0000019,
13032,,12766,Autocuration,,,1,CMR value (relative to BAY K 8644),,,CHEMBL626613,,22224,,,,U,0,BAO_0000019,
13033,,7849,Autocuration,,,1,Carbamoylating activity was determined,,,CHEMBL626614,,22224,,,,U,0,BAO_0000019,
13034,,12187,Autocuration,314293.0,,1,Hypotension peak is percentage change from predose baseline pressure observed after intraduodenal dose of 10 mg/kg in monkey,,,CHEMBL626615,,22224,Simiiformes,,,U,0,BAO_0000218,
13035,,2040,Autocuration,,,1,Compound was evaluated for induced thermal stabilization for compound: DNA ratio of 1:10 at 0.1 to 0.2 degrees Centigrade.,,,CHEMBL626616,,22224,,,,U,0,BAO_0000019,
13036,,2040,Autocuration,,,1,Compound was evaluated for induced thermal stabilization for compound: DNA ratio of 1:5 at 0.1 to 0.2 degrees Centigrade.,,,CHEMBL626617,,22224,,,,U,0,BAO_0000019,
13037,In vivo,14180,Intermediate,9615.0,,1,Clearance from dog plasma after intravenous injection of 1 mg/kg of compound,,,CHEMBL626618,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,1969.0
13038,In vivo,14180,Intermediate,10116.0,,1,Clearance from rat plasma after intravenous injection of 1 mg/kg of compound,,,CHEMBL626619,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
13039,In vivo,14474,Intermediate,9615.0,,1,"Clearance rate at 0.46 mg/kg, iv, in dogs",,,CHEMBL626620,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
13040,In vivo,14474,Intermediate,10116.0,,1,"Clearance rate at 5.5 mg/kg, iv, in rat",,,CHEMBL626621,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13041,In vivo,14548,Intermediate,9541.0,,1,Pharmacokinetic parameter Cl calculated in cynomolgus monkey when the compound was administered intravenously at 1 mg/kg concentration,,,CHEMBL626622,,100710,Macaca fascicularis,,,N,1,BAO_0000218,
13042,In vivo,14548,Intermediate,9541.0,,1,Pharmacokinetic parameter Cl calculated in cynomolgus monkey when the compound was administered intravenously at 0.5 mg/kg concentration,,,CHEMBL626623,,100710,Macaca fascicularis,,,N,1,BAO_0000218,
13043,In vivo,14548,Intermediate,9615.0,,1,Pharmacokinetic parameter Cl calculated in dog when the compound was administered intravenously at 2 mg/kg concentration,,,CHEMBL626624,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
13044,In vivo,14548,Intermediate,10116.0,,1,Pharmacokinetic parameter Cl calculated in rat when the compound was administered intravenously at 5 mg/kg concentration,,,CHEMBL626625,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13045,Ex vivo,6125,Intermediate,10116.0,,1,Clearance rate constant using isolated perfused rat liver (IPRL) assay,,,CHEMBL626626,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
13046,In vivo,6874,Autocuration,,,1,Tested for the total clearance of the compound,,,CHEMBL626627,,22224,,,,U,0,BAO_0000218,
13047,In vivo,15343,Intermediate,9615.0,,1,The clearance was measured in dogs after intravenous administration of 1 mg/kg dose,,,CHEMBL626628,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
13048,In vivo,6236,Autocuration,,,1,Total body clearance was determined,,,CHEMBL626629,,22224,,,,U,0,BAO_0000218,
13049,,11510,Intermediate,10116.0,,1,Mean Chlorine excretion in rats when compound administered at 0 mg/kg po and vehicle dosed at 0 umol/kg,,,CHEMBL626630,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13050,,11510,Intermediate,10116.0,,1,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 30.23 umol/kg,,,CHEMBL626631,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13051,,8194,Autocuration,,,1,Solubility of 10 mg compound in aqueous buffer at pH 7.3 and 37 degree Centigrade after 8.0 hr,,,CHEMBL626632,,22229,,,,U,0,BAO_0000100,
13052,,8194,Autocuration,,,1,Solubility of 150 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 4.0 hr,,,CHEMBL626633,,22229,,,,U,0,BAO_0000100,
13053,,8194,Autocuration,,,1,Solubility of 150 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 8.0 hr,,,CHEMBL626634,,22229,,,,U,0,BAO_0000100,
13054,,8194,Autocuration,,,1,Solubility of 20 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 13.5 hr,,,CHEMBL626635,,22229,,,,U,0,BAO_0000100,
13055,,8194,Autocuration,,,1,Solubility of 20 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 4.0 hr,,,CHEMBL626636,,22229,,,,U,0,BAO_0000100,
13056,,8194,Autocuration,,,1,Solubility of 20 mg compound in aqueous buffer at pH 7.3 and 37 degree Centigrade after 8.0 hr,,,CHEMBL626637,,22229,,,,U,0,BAO_0000100,
13057,,13273,Intermediate,4754.0,,1,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 10.9 uM/Kg/day),,,CHEMBL626638,,50339,Pneumocystis carinii,,,N,1,BAO_0000218,
13058,,13273,Intermediate,4754.0,,1,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 2.3 uM/Kg/day,,,CHEMBL626639,,50339,Pneumocystis carinii,,,N,1,BAO_0000218,
13059,,13273,Intermediate,4754.0,,1,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 23.3 uM/Kg/day,,,CHEMBL626640,,50339,Pneumocystis carinii,,,N,1,BAO_0000218,
13060,,13273,Intermediate,4754.0,,1,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 4.8 uM/Kg/day,,,CHEMBL626641,,50339,Pneumocystis carinii,,,N,1,BAO_0000218,
13061,,13273,Intermediate,4754.0,,1,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 9.2 uM/Kg/day,,,CHEMBL627272,,50339,Pneumocystis carinii,,,N,1,BAO_0000218,
13062,,13273,Intermediate,4754.0,,1,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted uM/Kg/day,,,CHEMBL627273,,50339,Pneumocystis carinii,,,N,1,BAO_0000218,
13063,,13273,Intermediate,4754.0,,1,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 0.027 (uM/kg/day),,,CHEMBL627441,,50339,Pneumocystis carinii,,,N,1,BAO_0000218,
13064,,13273,Intermediate,4754.0,,1,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 0.27 (uM/kg/day),,,CHEMBL628355,,50339,Pneumocystis carinii,,,N,1,BAO_0000218,
13065,,13273,Intermediate,4754.0,,1,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 13.3 (uM/kg/day),,,CHEMBL628356,,50339,Pneumocystis carinii,,,N,1,BAO_0000218,
13066,,13273,Intermediate,4754.0,,1,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 2.7 (uM/kg/day),,,CHEMBL628357,,50339,Pneumocystis carinii,,,N,1,BAO_0000218,
13067,,13273,Intermediate,4754.0,,1,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 22.1 (uM/kg/day),,,CHEMBL628358,,50339,Pneumocystis carinii,,,N,1,BAO_0000218,
13068,,13273,Intermediate,4754.0,,1,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 66.3 (uM/kg/day),,,CHEMBL622307,,50339,Pneumocystis carinii,,,N,1,BAO_0000218,
13069,,13118,Autocuration,,,1,Conversion rate by hydrolysis of compound in plasma after 2 hr at a pH of 1.0,,,CHEMBL622527,,22224,,,,U,0,BAO_0000019,
13070,,13118,Autocuration,,,1,Conversion rate by hydrolysis of compound in plasma after 2 hr at a pH of 1.0; Not detectable,,,CHEMBL622528,,22224,,,,U,0,BAO_0000019,
13071,,13118,Autocuration,,,1,Conversion rate by hydrolysis of compound in plasma after 4 hr at a pH of 7.4,,,CHEMBL622529,,22224,,,,U,0,BAO_0000019,
13072,,13118,Autocuration,,,1,Conversion rate by hydrolysis of compound in plasma after 4 hr at a pH of 7.4; Not detectable,,,CHEMBL622992,,22224,,,,U,0,BAO_0000019,
13073,,13118,Autocuration,,,1,Conversion rate by hydrolysis of compound in plasma after 6 hr. ,,,CHEMBL622993,,22224,,,,U,0,BAO_0000019,
13074,,13118,Autocuration,,,1,Conversion rate by hydrolysis of compound in plasma after 6 h; Not detectable,,,CHEMBL622994,,22224,,,,U,0,BAO_0000019,
13075,,10633,Intermediate,10116.0,,1,"In vitro rate constant, correlation coefficient for the conversion to progesterone in rat liver homogenate",,,CHEMBL622995,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13076,,10633,Intermediate,10116.0,,1,"In vitro rate constant, correlation coefficient for the conversion to progesterone in whole rat blood.",,,CHEMBL622996,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13077,,10633,Intermediate,10116.0,,1,"In vitro rate constant, correlation coefficient for the disappearance in rat liver homogenate",,,CHEMBL622997,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13078,,10633,Intermediate,10116.0,,1,"In vitro rate constant, correlation coefficient for the disappearance in rat brain homogenate",,,CHEMBL622998,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13079,,5767,Autocuration,,,1,Cp max following ip administration at 1 mg/kg,,,CHEMBL622999,,22224,,,,U,0,BAO_0000218,
13080,In vivo,3302,Autocuration,,,1,Maximum concentration in plasma was reported at 0.5 hour,,,CHEMBL623000,,22224,,,,U,0,BAO_0000218,1969.0
13081,In vivo,3302,Autocuration,,,1,Maximum concentration in plasma was reported at 2 hour,,,CHEMBL623001,,22224,,,,U,0,BAO_0000218,1969.0
13082,,12467,Intermediate,10090.0,,1,Cellular uptake kinetics of Porphycenes saturation cell level (cs) in SSK3 murine fibrosarcoma cells,,,CHEMBL623002,,50594,Mus musculus,,,N,1,BAO_0000218,
13083,,11778,Autocuration,,,1,Aqueous solubility in 25 mM N-glycyl-glycine and 10 mM MgSO4 (pH 7.8),,,CHEMBL623003,,22229,,,,U,0,BAO_0000100,
13084,,4321,Autocuration,,,1,Steady state concentration was evaluated,,,CHEMBL623004,,22224,,,,U,0,BAO_0000019,
13085,,14884,Autocuration,,,1,Partition coefficient (logP),,,CHEMBL623005,,22224,,,,U,0,BAO_0000019,
13086,,15234,Autocuration,,,1,Partition coefficient (logD7.4),,,CHEMBL623006,,22224,,,,U,0,BAO_0000019,
13087,In vivo,14198,Intermediate,10116.0,,1,Biodistribution of {18]Fluoro-CGP 12388 (60 minutes post injection) in liver of male wistar rats,,,CHEMBL623007,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
13088,In vivo,14198,Intermediate,10116.0,,1,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in bone of male wistar rats,,,CHEMBL623008,,50597,Rattus norvegicus,,,N,1,BAO_0000218,10000001.0
13089,In vivo,14198,Intermediate,10116.0,,1,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in cerebellum of male wistar rats,,,CHEMBL876654,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2037.0
13090,In vivo,14198,Intermediate,10116.0,,1,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in cortex of male wistar rats,,,CHEMBL623009,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13091,In vivo,14198,Intermediate,10116.0,,1,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in fat of male wistar rats,,,CHEMBL623010,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13092,In vivo,14198,Intermediate,10116.0,,1,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in heart of male wistar rats,,,CHEMBL623011,,50597,Rattus norvegicus,,,N,1,BAO_0000218,948.0
13093,In vivo,14198,Intermediate,10116.0,,1,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in intestine of male wistar rats,,,CHEMBL623012,,50597,Rattus norvegicus,,,N,1,BAO_0000218,160.0
13094,,8151,Autocuration,,,1,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 25 mg/Kg,,,CHEMBL623013,,22224,,,,U,0,BAO_0000019,
13095,,8151,Autocuration,,,1,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli euivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,,,CHEMBL623014,,22224,,,,U,0,BAO_0000019,
13096,,8151,Autocuration,,,1,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 10 mg/Kg,,,CHEMBL623015,,22224,,,,U,0,BAO_0000019,1088.0
13097,,8151,Autocuration,,,1,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 100 mg/Kg,,,CHEMBL623016,,22224,,,,U,0,BAO_0000019,1088.0
13098,,8151,Autocuration,,,1,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 25 mg/Kg,,,CHEMBL624858,,22224,,,,U,0,BAO_0000019,1088.0
13099,,8151,Intermediate,10116.0,,1,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 10 mg/Kg.,,,CHEMBL624859,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13100,,8151,Intermediate,10116.0,,1,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,,,CHEMBL624860,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13101,,8151,Intermediate,10116.0,,1,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg.,,,CHEMBL624861,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13102,,8151,Intermediate,10116.0,,1,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 25 mg/Kg,,,CHEMBL624862,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13103,,8151,Intermediate,10116.0,,1,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 25 mg/Kg.,,,CHEMBL624863,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13104,,8151,Intermediate,10116.0,,1,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli euivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg.,,,CHEMBL876655,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13105,,6996,Intermediate,9615.0,,1,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog,,,CHEMBL624864,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
13106,,6996,Intermediate,9615.0,,1,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 0-99,,,CHEMBL624865,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
13107,,6996,Intermediate,9615.0,,1,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-249,,,CHEMBL624866,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
13108,,6996,Expert,9615.0,,1,Salidiuretic activity in dog following i.v. dosing at 5 mg/kg,,,CHEMBL624867,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
13109,,6996,Intermediate,9615.0,,1,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 400-599,,,CHEMBL624868,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
13110,,6996,Intermediate,9615.0,,1,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 600- 799,,,CHEMBL628450,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
13111,,6996,Intermediate,9615.0,,1,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 600-799,,,CHEMBL628451,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
13112,,6996,Intermediate,9615.0,,1,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 800-899,,,CHEMBL628452,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
13113,,6996,Intermediate,9615.0,,1,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-249,,,CHEMBL628453,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
13114,,6996,Intermediate,9615.0,,1,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; act above 5 mg/kg,,,CHEMBL628454,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
13115,,6996,Intermediate,9615.0,,1,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog,,,CHEMBL628455,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
13116,,6996,Intermediate,9615.0,,1,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 0-99,,,CHEMBL628456,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
13117,,6996,Intermediate,9615.0,,1,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-249,,,CHEMBL628457,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
13118,,6996,Intermediate,9615.0,,1,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-299,,,CHEMBL877505,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
13119,,6996,Intermediate,9615.0,,1,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 250-399,,,CHEMBL628458,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
13120,,6996,Intermediate,9615.0,,1,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 400-599,,,CHEMBL628459,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
13121,,6996,Intermediate,9615.0,,1,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 600-799,,,CHEMBL628460,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
13122,,6996,Intermediate,9615.0,,1,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 800-899,,,CHEMBL628461,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
13123,,6996,Autocuration,,,1,"Evaluated for salidiuretic activity measured as sodium ion excretion in Rat, administered orally at a dose of 16.5 mg/kg",,,CHEMBL628462,,22224,,,,U,0,BAO_0000218,
13124,,6996,Intermediate,9615.0,,1,Compound administered orally at a dose of 1 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,,,CHEMBL628463,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
13125,,6996,Expert,10116.0,,1,"Evaluated for salidiuretic activity measured as sodium ion excretion in Rat, administered orally at a dose of 50 mg/kg",,,CHEMBL625666,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13126,,6996,Autocuration,,,1,Compound administered orally at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,,,CHEMBL625667,,22224,,,,U,0,BAO_0000218,
13127,,6996,Expert,10116.0,,1,Compound administered orally at a dose of 81 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,,,CHEMBL625668,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13128,,6996,Intermediate,10116.0,,1,Compound administered orally was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,,,CHEMBL625669,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13129,,7114,Autocuration,,,1,Compound was tested for diuretic activity in potassium content of the 3-h sample was measured by flame photometry,,,CHEMBL625670,,22224,,,,U,0,BAO_0000019,
13130,,7114,Intermediate,10116.0,,1,Compound was tested for diuretic activity in potassium content of the 3-h sample was measured by flame photometry in rat,,,CHEMBL625671,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13131,,8613,Intermediate,10298.0,,1,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 1 mg/kg per day.,,,CHEMBL625672,,50602,Human herpesvirus 1,,,N,1,BAO_0000218,
13132,,8613,Intermediate,10298.0,,1,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 0.8 mg/kg administered subcutaneously,,,CHEMBL625673,,50602,Human herpesvirus 1,,,N,1,BAO_0000218,
13133,,8613,Intermediate,10298.0,,1,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 0.8 mg/kg administered subcutaneously.,,,CHEMBL625674,,50602,Human herpesvirus 1,,,N,1,BAO_0000218,
13134,,8613,Intermediate,10298.0,,1,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered subcutaneously,,,CHEMBL625675,,50602,Human herpesvirus 1,,,N,1,BAO_0000218,
13135,,8613,Intermediate,10298.0,,1,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered subcutaneously.,,,CHEMBL627637,,50602,Human herpesvirus 1,,,N,1,BAO_0000218,
13136,,8613,Intermediate,10298.0,,1,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered orally.,,,CHEMBL627638,,50602,Human herpesvirus 1,,,N,1,BAO_0000218,
13137,,8613,Intermediate,10298.0,,1,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 3.1 mg/kg administered subcutaneously,,,CHEMBL627639,,50602,Human herpesvirus 1,,,N,1,BAO_0000218,
13138,,8613,Intermediate,10298.0,,1,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 3.1 mg/kg administered subcutaneously.,,,CHEMBL627640,,50602,Human herpesvirus 1,,,N,1,BAO_0000218,
13139,,8613,Intermediate,10298.0,,1,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 3.1 mg/kg administered orally.,,,CHEMBL627641,,50602,Human herpesvirus 1,,,N,1,BAO_0000218,
13140,,8613,Intermediate,10298.0,,1,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 50 mg/kg administered orally.,,,CHEMBL627642,,50602,Human herpesvirus 1,,,N,1,BAO_0000218,
13141,,8613,Intermediate,10298.0,,1,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 50 mg/kg administered orally.,,,CHEMBL877506,,50602,Human herpesvirus 1,,,N,1,BAO_0000218,
13142,,8613,Intermediate,10090.0,,1,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered subcutaneously.,,,CHEMBL627275,,50594,Mus musculus,,,N,1,BAO_0000218,
13143,,11219,Intermediate,9669.0,,1,"Average area under curve value dosed at 0.3 mg/kg, iv in ferrets.",,,CHEMBL627643,,50506,Mustela putorius furo,,,N,1,BAO_0000218,
13144,,11219,Intermediate,9669.0,,1,"Average area under curve value dosed at 10 mg/kg, id in ferrets.",,,CHEMBL631246,,50506,Mustela putorius furo,,,N,1,BAO_0000218,
13145,,11219,Intermediate,9669.0,,1,"Average area under curve value dosed at 10 mg/kg, id in ferrets.",,,CHEMBL631247,,50506,Mustela putorius furo,,,N,1,BAO_0000218,
13146,,11219,Intermediate,9669.0,,1,Average peak plasma drug concentration after id dose of 10 mg/kg in ferrets(Plasma samples collected from portal blood).,,,CHEMBL629532,,50506,Mustela putorius furo,,,N,1,BAO_0000218,
13147,,11219,Intermediate,9669.0,,1,Average peak plasma drug concentration after id dose of 10 mg/kg in ferrets(Plasma samples collected from arterial blood).,,,CHEMBL629533,,50506,Mustela putorius furo,,,N,1,BAO_0000218,
13148,,11219,Intermediate,9669.0,,1,Average peak plasma drug concentration after id dose of 10 mg/kg in ferrets(Plasma samples collected from portal blood).,,,CHEMBL629534,,50506,Mustela putorius furo,,,N,1,BAO_0000218,
13149,,11219,Intermediate,9669.0,,1,Average peak plasma drug concentration after iv dose of 0.3 mg/kg in ferrets.,,,CHEMBL629535,,50506,Mustela putorius furo,,,N,1,BAO_0000218,
13150,,14837,Autocuration,,,1,Pharmacokinetic parameter :drug bound to plasma was reported,,,CHEMBL625932,,22224,,,,U,0,BAO_0000019,
13151,,14837,Autocuration,,,1,compound was evaluated for drug bound in plasma,,,CHEMBL625933,,22224,,,,U,0,BAO_0000019,
13152,,15343,Intermediate,10116.0,,1,The Brain concentration compared to plasma concentration in rats after oral administration of 1 mg/kg dose,,,CHEMBL625934,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13153,,13761,Autocuration,9347.0,,1,Bioavailability,,,CHEMBL625935,,22224,Eutheria,,,U,0,BAO_0000218,
13154,,14810,Intermediate,10116.0,,1,Compound at a dose of 10 mg/kg was orally administered to rats and Bioavailability was reported,,,CHEMBL625936,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13155,,14810,Intermediate,10116.0,,1,Compound at a dose of 10 mg/kg was orally administered to rats and Bioavailability was reported; Not tested,,,CHEMBL625937,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13156,,13249,Intermediate,9615.0,,1,Oral bioavailability in Beagle dogs at oral dose of 20 mg/kg and an intravenous dose of 5 mg/kg was administered,,,CHEMBL625938,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
13157,,9267,Intermediate,10116.0,,1,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-1 hr after the treatment.,,,CHEMBL625939,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1970.0
13158,,9267,Intermediate,10116.0,,1,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-2 hr after the treatment.,,,CHEMBL625940,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1970.0
13159,,9267,Intermediate,10116.0,,1,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-3 hr after the treatment.,,,CHEMBL874464,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1970.0
13160,,9267,Intermediate,10116.0,,1,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-4 hr after the treatment.,,,CHEMBL625941,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1970.0
13161,,9267,Intermediate,10116.0,,1,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-5 hr after the treatment.,,,CHEMBL625942,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1970.0
13162,,9267,Intermediate,10116.0,,1,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-6 hr after the treatment.,,,CHEMBL625943,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1970.0
13163,,15549,Intermediate,9606.0,,1,In vitro protein binding in human serum at 5 ug/ml,,,CHEMBL625944,,50587,Homo sapiens,,,N,1,BAO_0000218,1977.0
13164,,10929,Autocuration,,,1,Serum protein binding ability was measured,,,CHEMBL625945,,22224,,,,U,0,BAO_0000019,
13165,,15444,Autocuration,,,1,The ability binding to plasma (Binding classified based on injection of compound at 80 concentration.),,,CHEMBL625946,,22224,,,,U,0,BAO_0000019,
13166,In vivo,12860,Autocuration,9615.0,,1,Oral bioavailability in dog,,,CHEMBL625947,,22224,Canis lupus familiaris,,,U,0,BAO_0000218,
13167,In vivo,12170,Intermediate,10116.0,,1,% bioavailability in rat after oral dose (10 mg/kg) 0 - 6 h.,,,CHEMBL625948,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13168,In vivo,15173,Autocuration,,,1,Absolute oral bioavailability at an iv dose of 14 mg/kg,,,CHEMBL625949,,22224,,,,U,0,BAO_0000218,
13169,In vivo,15173,Autocuration,,,1,Absolute oral bioavailability at an iv dose of 15.2 mg/kg,,,CHEMBL625950,,22224,,,,U,0,BAO_0000218,
13170,In vivo,15173,Autocuration,9347.0,,1,Oral bioavailability (dose 15 mg/kg i.v.),,,CHEMBL625951,,22224,Eutheria,,,U,0,BAO_0000218,
13171,In vivo,15173,Autocuration,,,1,Absolute oral bioavailability at an peroral dose of 15 mg/kg orally.,,,CHEMBL625952,,22224,,,,U,0,BAO_0000218,
13172,In vivo,15173,Autocuration,,,1,Absolute oral bioavailability at an peroral dose of 30 mg/kg orally,,,CHEMBL625953,,22224,,,,U,0,BAO_0000218,
13173,In vivo,15173,Autocuration,,,1,Absolute oral bioavailability at an peroral dose of 30.2 mg/kg orally.,,,CHEMBL625954,,22224,,,,U,0,BAO_0000218,
13174,In vivo,15173,Autocuration,,,1,Absolute oral bioavailability at an peroral dose of 30.3 mg/kg orally.,,,CHEMBL882959,,22224,,,,U,0,BAO_0000218,
13175,In vivo,11767,Intermediate,9615.0,,1,Apparent bioavailability in dogs at 15 mg/kg in an iv vs po dosing regimen,,,CHEMBL625955,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
13176,In vivo,11219,Autocuration,9669.0,,1,Bioavailability in ferret,,,CHEMBL625956,,22224,Mustela putorius furo,,,U,0,BAO_0000218,
13177,In vivo,12186,Intermediate,9541.0,,1,Bioavailability after intraduodenal administration at a dose 10 mg/kg in cynomolgus monkeys using renin inhibition assay,,,CHEMBL625957,,100710,Macaca fascicularis,,,N,1,BAO_0000218,
13178,,11510,Intermediate,10116.0,,1,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 33.59 umol/kg,,,CHEMBL625958,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13179,,11510,Intermediate,10116.0,,1,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 37.13 umol/kg,,,CHEMBL625959,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13180,,11510,Intermediate,10116.0,,1,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 39.48 umol/kg,,,CHEMBL626642,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13181,,11510,Intermediate,10116.0,,1,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 483.72 umol/kg,,,CHEMBL631330,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13182,,11510,Intermediate,10116.0,,1,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg,,,CHEMBL631331,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13183,,11510,Intermediate,10116.0,,1,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg; Not determined,,,CHEMBL631332,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13184,,11510,Intermediate,10116.0,,1,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 631.76 umol/kg,,,CHEMBL631333,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13185,,11510,Intermediate,10116.0,,1,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 7.56 umol/kg,,,CHEMBL632018,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13186,,11510,Intermediate,10116.0,,1,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 8.4 umol/kg,,,CHEMBL632019,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13187,,11510,Intermediate,10116.0,,1,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.28 umol/kg,,,CHEMBL632020,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13188,,11510,Intermediate,10116.0,,1,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.87 umol/kg,,,CHEMBL632021,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13189,,11510,Intermediate,10116.0,,1,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 60.46 umol/kg,,,CHEMBL632022,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13190,,11510,Intermediate,10116.0,,1,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 67.18 umol/kg,,,CHEMBL632023,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13191,,11510,Intermediate,10116.0,,1,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 74.26 umol/kg,,,CHEMBL632024,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13192,,11510,Intermediate,10116.0,,1,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 78.97 umol/kg,,,CHEMBL874472,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13193,,11510,Intermediate,10116.0,,1,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 120.93 umol/kg,,,CHEMBL632025,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13194,,11510,Intermediate,10116.0,,1,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 134.35 umol/kg,,,CHEMBL632026,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13195,,11510,Intermediate,10116.0,,1,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 148.52 umol/kg,,,CHEMBL632027,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13196,,11510,Intermediate,10116.0,,1,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 157.94 umol/kg,,,CHEMBL632028,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13197,,11510,Intermediate,10116.0,,1,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 15.12 umol/kg,,,CHEMBL626430,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13198,,11510,Intermediate,10116.0,,1,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 16.79 umol/kg,,,CHEMBL626431,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13199,,11510,Intermediate,10116.0,,1,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 18.56 umol/kg,,,CHEMBL626432,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13200,,11510,Intermediate,10116.0,,1,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 19.74 umol/kg,,,CHEMBL626433,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13201,,11510,Intermediate,10116.0,,1,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 241.86 umol/kg,,,CHEMBL626434,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13202,,11510,Intermediate,10116.0,,1,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 268.71 umol/kg,,,CHEMBL627280,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13203,,11510,Intermediate,10116.0,,1,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 297.03 umol/kg,,,CHEMBL627281,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13204,,11510,Intermediate,10116.0,,1,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 315.88 umol/kg,,,CHEMBL627282,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13205,,7199,Autocuration,,,1,Total body clearance was measured at given dose,,,CHEMBL627283,,22224,,,,U,0,BAO_0000019,
13206,,7199,Autocuration,,,1,Total body clearance was measured at given dose.,,,CHEMBL627284,,22224,,,,U,0,BAO_0000218,
13207,,7095,Intermediate,10116.0,,1,Metabolic clearance from the body in rat,,,CHEMBL627285,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13208,In vivo,7095,Autocuration,,,1,Renal clearance from the body,,,CHEMBL627286,,22224,,,,U,0,BAO_0000218,
13209,In vivo,7095,Intermediate,10116.0,,1,Renal clearance from the body in rat,,,CHEMBL875477,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13210,In vivo,12528,Intermediate,10116.0,,1,Tested for pharmacokinetic parameter to calculate the total body clearance at a dosage of 12 mg/kg in rat,,,CHEMBL627287,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13211,In vivo,12528,Intermediate,9615.0,,1,Tested for pharmacokinetic parameter to calculate the total body clearance at a dosage of 2.5 mg/kg in dog,,,CHEMBL627288,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
13212,,7095,Intermediate,10116.0,,1,Total clearance from the body in rat,,,CHEMBL627289,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13213,In vivo,14223,Intermediate,10116.0,,1,Clearance into cortex from rat plasma or PBS,,,CHEMBL627290,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
13214,In vivo,13569,Autocuration,,,1,Clearance at an iv dose of 15 mg/Kg and po dose of 120 mg/Kg,,,CHEMBL627291,,22224,,,,U,0,BAO_0000218,
13215,In vivo,13569,Autocuration,,,1,Clearance at an iv dose of 15 mg/Kg and po dose of 240 mg/Kg,,,CHEMBL627292,,22224,,,,U,0,BAO_0000218,
13216,In vivo,13569,Autocuration,,,1,Clearance at an iv dose of 15 mg/Kg and po dose of 29.1 mg/Kg,,,CHEMBL627293,,22224,,,,U,0,BAO_0000218,
13217,In vivo,13569,Autocuration,,,1,Clearance at an iv dose of 15 mg/Kg and po dose of 30 mg/Kg,,,CHEMBL627294,,22224,,,,U,0,BAO_0000218,
13218,In vivo,13569,Autocuration,,,1,Clearance at an iv dose of 15 mg/Kg and po dose of 60 mg/Kg,,,CHEMBL875478,,22224,,,,U,0,BAO_0000218,
13219,In vivo,13979,Autocuration,,,1,Clearance was determined,,,CHEMBL627295,,22224,,,,U,0,BAO_0000218,
13220,In vivo,14315,Intermediate,10090.0,,1,Clearance was measured in mouse after administration of compound 20 mg/kg intravenously,,,CHEMBL627296,,50594,Mus musculus,,,N,1,BAO_0000218,
13221,In vivo,14315,Intermediate,9986.0,,1,Clearance was measured in rabbit after administration of compound 20 mg/kg intravenously,,,CHEMBL626119,,50592,Oryctolagus cuniculus,,,N,1,BAO_0000218,
13222,In vivo,14315,Intermediate,10116.0,,1,Clearance was measured in rat after administration of compound 20 mg/kg intravenously,,,CHEMBL626120,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13223,In vivo,12174,Intermediate,10116.0,,1,Clearance in rat after iv dose (100 ug/kg),,,CHEMBL626121,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13224,In vivo,12797,Autocuration,10141.0,,1,Clearance in guinea pig,,,CHEMBL626122,,22224,Cavia porcellus,,,U,0,BAO_0000218,
13225,In vivo,12797,Intermediate,10116.0,,1,Compound was evaluated for clearance in rat,,,CHEMBL626123,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13226,In vivo,12797,Intermediate,9615.0,,1,Compound was evaluated for the clearance in dog,,,CHEMBL623456,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
13227,In vivo,12797,Intermediate,10116.0,,1,Compound was evaluated for the clearance in rat,,,CHEMBL623457,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13228,In vivo,11500,Intermediate,10116.0,,1,Compound was tested in vivo for clearance after iv administration in the rat,,,CHEMBL623458,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13229,In vivo,15173,Autocuration,,,1,IV clearance determined at an iv dose of 14 mg/kg,,,CHEMBL623459,,22224,,,,U,0,BAO_0000218,
13230,In vivo,15173,Autocuration,,,1,IV clearance determined at an iv dose of 15.2 mg/kg,,,CHEMBL875484,,22224,,,,U,0,BAO_0000218,
13231,In vivo,15173,Autocuration,,,1,IV clearance determined at an iv dose of 15 mg/kg,,,CHEMBL623460,,22224,,,,U,0,BAO_0000218,
13232,In vivo,15173,Autocuration,,,1,IV clearance determined at an peroral dose of 30 mg/kg.,,,CHEMBL623461,,22224,,,,U,0,BAO_0000218,
13233,In vivo,15173,Autocuration,,,1,IV clearance determined at an peroral dose of 30.2 mg/kg.,,,CHEMBL623462,,22224,,,,U,0,BAO_0000218,
13234,In vivo,15173,Autocuration,,,1,IV clearance determined at an peroral dose of 30.3 mg/kg.,,,CHEMBL627386,,22224,,,,U,0,BAO_0000218,
13235,In vivo,14198,Intermediate,10116.0,,1,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in kidney of male wistar rats,,,CHEMBL627387,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2113.0
13236,In vivo,14198,Intermediate,10116.0,,1,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in liver of male wistar rats,,,CHEMBL627388,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
13237,In vivo,14198,Intermediate,10116.0,,1,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in lung of male wistar rats,,,CHEMBL627389,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2048.0
13238,In vivo,14198,Intermediate,10116.0,,1,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in muscle of male wistar rats,,,CHEMBL627390,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2385.0
13239,In vivo,14198,Intermediate,10116.0,,1,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in plasma of male wistar rats,,,CHEMBL627391,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
13240,In vivo,14198,Intermediate,10116.0,,1,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in red blood cells of male wistar rats,,,CHEMBL627392,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13241,In vivo,14198,Intermediate,10116.0,,1,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in spleen of male wistar rats,,,CHEMBL627393,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2106.0
13242,In vivo,14198,Intermediate,10116.0,,1,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in trachea of male wistar rats,,,CHEMBL627394,,50597,Rattus norvegicus,,,N,1,BAO_0000218,3126.0
13243,In vivo,14198,Intermediate,10116.0,,1,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in bone of male wistar rats,,,CHEMBL627395,,50597,Rattus norvegicus,,,N,1,BAO_0000218,10000001.0
13244,In vivo,14198,Intermediate,10116.0,,1,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in cerebellum of male wistar rats,,,CHEMBL875485,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2037.0
13245,In vivo,14198,Intermediate,10116.0,,1,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in cortex of male wistar rats,,,CHEMBL627396,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13246,In vivo,14198,Intermediate,10116.0,,1,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in fat of male wistar rats,,,CHEMBL627397,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13247,In vivo,14198,Intermediate,10116.0,,1,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in heart of male wistar rats,,,CHEMBL627398,,50597,Rattus norvegicus,,,N,1,BAO_0000218,948.0
13248,In vivo,14198,Intermediate,10116.0,,1,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in intestine bone of male wistar rats,,,CHEMBL627399,,50597,Rattus norvegicus,,,N,1,BAO_0000218,10000001.0
13249,In vivo,14198,Intermediate,10116.0,,1,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in kidney of male wistar rats,,,CHEMBL627400,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2113.0
13250,In vivo,14198,Intermediate,10116.0,,1,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in liver of male wistar rats,,,CHEMBL627401,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
13251,In vivo,14198,Intermediate,10116.0,,1,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in lung of male wistar rats,,,CHEMBL627402,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2048.0
13252,In vivo,14198,Intermediate,10116.0,,1,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in muscle of male wistar rats,,,CHEMBL627403,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2385.0
13253,In vivo,14198,Intermediate,10116.0,,1,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in plasma of male wistar rats,,,CHEMBL627404,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
13254,In vivo,14198,Intermediate,10116.0,,1,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in red blood cells of male wistar rats,,,CHEMBL623101,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13255,In vivo,14198,Intermediate,10116.0,,1,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in spleen of male wistar rats,,,CHEMBL877480,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2106.0
13256,In vivo,14198,Intermediate,10116.0,,1,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in trachea of male wistar rats,,,CHEMBL623102,,50597,Rattus norvegicus,,,N,1,BAO_0000218,3126.0
13257,In vivo,14198,Intermediate,10116.0,,1,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in bone of male wistar rats,,,CHEMBL623103,,50597,Rattus norvegicus,,,N,1,BAO_0000218,10000001.0
13258,In vivo,14198,Intermediate,10116.0,,1,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in cerebellum of male wistar rats,,,CHEMBL623104,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2037.0
13259,In vivo,14198,Intermediate,10116.0,,1,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in cortex of male wistar rats,,,CHEMBL623105,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13260,In vivo,14198,Intermediate,10116.0,,1,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in fat of male wistar rats,,,CHEMBL623106,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13261,In vivo,14198,Intermediate,10116.0,,1,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in heart of male wistar rats,,,CHEMBL623107,,50597,Rattus norvegicus,,,N,1,BAO_0000218,948.0
13262,In vivo,14198,Intermediate,10116.0,,1,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in intestine of male wistar rats,,,CHEMBL623108,,50597,Rattus norvegicus,,,N,1,BAO_0000218,160.0
13263,In vivo,14198,Intermediate,10116.0,,1,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in kidney of male wistar rats,,,CHEMBL623109,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2113.0
13264,In vivo,14198,Intermediate,10116.0,,1,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in liver of male wistar rats,,,CHEMBL623110,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
13265,In vivo,14198,Intermediate,10116.0,,1,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in lung of male wistar rats,,,CHEMBL623111,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2048.0
13266,In vivo,14198,Intermediate,10116.0,,1,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in muscle of male wistar rats,,,CHEMBL625060,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2385.0
13267,In vivo,14198,Intermediate,10116.0,,1,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in plasma of male wistar rats,,,CHEMBL625061,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
13268,In vivo,14198,Intermediate,10116.0,,1,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in red blood cells of male wistar rats,,,CHEMBL625062,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13269,In vivo,14198,Intermediate,10116.0,,1,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in spleen of male wistar rats,,,CHEMBL625063,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2106.0
13270,In vivo,14198,Intermediate,10116.0,,1,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in trachea of male wistar rats,,,CHEMBL625064,,50597,Rattus norvegicus,,,N,1,BAO_0000218,3126.0
13271,In vivo,14198,Intermediate,10116.0,,1,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in bone of male wistar rats,,,CHEMBL625065,,50597,Rattus norvegicus,,,N,1,BAO_0000218,10000001.0
13272,In vivo,14198,Intermediate,10116.0,,1,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in cerebellum of male wistar rats,,,CHEMBL625066,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2037.0
13273,In vivo,14198,Intermediate,10116.0,,1,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in cortex of male wistar rats,,,CHEMBL625067,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13274,In vivo,14198,Intermediate,10116.0,,1,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in fat of male wistar rats,,,CHEMBL625068,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13275,In vivo,14198,Intermediate,10116.0,,1,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in heart of male wistar rats,,,CHEMBL622159,,50597,Rattus norvegicus,,,N,1,BAO_0000218,948.0
13276,In vivo,14198,Intermediate,10116.0,,1,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in intestine of male wistar rats,,,CHEMBL622160,,50597,Rattus norvegicus,,,N,1,BAO_0000218,160.0
13277,In vivo,14198,Intermediate,10116.0,,1,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in kidney of male wistar rats,,,CHEMBL622161,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2113.0
13278,In vivo,14198,Intermediate,10116.0,,1,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in lung of male wistar rats,,,CHEMBL622162,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2048.0
13279,In vivo,14198,Intermediate,10116.0,,1,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in muscle of male wistar rats,,,CHEMBL622163,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2385.0
13280,In vivo,14198,Intermediate,10116.0,,1,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in plasma of male wistar rats,,,CHEMBL622313,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
13281,In vivo,14198,Intermediate,10116.0,,1,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in red blood cells of male wistar rats,,,CHEMBL622314,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13282,In vivo,14198,Intermediate,10116.0,,1,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in spleen of male wistar rats,,,CHEMBL622315,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2106.0
13283,In vivo,14198,Intermediate,10116.0,,1,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in trachea of male wistar rats,,,CHEMBL622316,,50597,Rattus norvegicus,,,N,1,BAO_0000218,3126.0
13284,,15599,Intermediate,562.0,,1,Normal diffusion coefficient in water for Escherichia coli,,,CHEMBL877486,,50212,Escherichia coli,,,N,1,BAO_0000218,
13285,,8204,Autocuration,,,1,Average max percent decrease in RVR (renal vascular resistance) was determined,,,CHEMBL622317,,22224,,,,U,0,BAO_0000019,
13286,,8204,Autocuration,,,1,Average max percent decrease in RVR (renal vascular resistance) was determined.,,,CHEMBL622318,,22224,,,,U,0,BAO_0000019,
13287,,6154,Autocuration,,,1,In vitro stability to pepsin promoting hydrolysis after 1 hr incubation time,,,CHEMBL622319,,22224,,,,U,0,BAO_0000019,
13288,,6154,Autocuration,,,1,In vitro stability to pepsin promoting hydrolysis after 2 hr incubation time,,,CHEMBL622320,,22224,,,,U,0,BAO_0000019,
13289,,6154,Autocuration,,,1,In vitro stability to pepsin promoting hydrolysis after 64h incubation time,,,CHEMBL622321,,22224,,,,U,0,BAO_0000019,
13290,,6154,Autocuration,,,1,In vitro stability to pepsin promoting hydrolysis after 84 hr incubation time,,,CHEMBL622322,,22224,,,,U,0,BAO_0000019,
13291,,7114,Autocuration,,,1,Compound was tested for diuretic activity in sodium content of the 3-h sample was measured by flame photometry,,,CHEMBL622323,,22224,,,,U,0,BAO_0000019,
13292,,7114,Intermediate,10116.0,,1,Compound was tested for diuretic activity in sodium content of the 3-h sample was measured by flame photometry in rat,,,CHEMBL622324,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13293,,8133,Intermediate,9615.0,,1,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 0.03mg/kg, po",,,CHEMBL622325,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,1088.0
13294,,8133,Intermediate,9615.0,,1,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 1.0 mg/kg, po",,,CHEMBL622326,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,1088.0
13295,,8133,Intermediate,9615.0,,1,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 10.0 mg/kg, po",,,CHEMBL877487,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,1088.0
13296,,8133,Intermediate,9615.0,,1,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 1 mg/kg, po",,,CHEMBL622327,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,1088.0
13297,,8133,Intermediate,9615.0,,1,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 3.0 mg/kg, po",,,CHEMBL622328,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,1088.0
13298,,8133,Intermediate,9615.0,,1,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 30 mg/kg, po",,,CHEMBL622329,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,1088.0
13299,,8133,Intermediate,9615.0,,1,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 0.1 mg/kg, po",,,CHEMBL622330,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,1088.0
13300,,8133,Intermediate,9615.0,,1,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 0.3mg/kg, po",,,CHEMBL622331,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,1088.0
13301,,8133,Intermediate,9615.0,,1,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 10mg/kg, po",,,CHEMBL622332,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,1088.0
13302,,8133,Intermediate,9615.0,,1,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 3 mg/kg, po",,,CHEMBL622333,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,1088.0
13303,,8133,Autocuration,314293.0,,1,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded monkey at 100 mg/kg, po",,,CHEMBL627658,,22224,Simiiformes,,,U,0,BAO_0000218,1088.0
13304,,8133,Autocuration,314293.0,,1,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded monkey at 10mg/kg, po",,,CHEMBL630428,,22224,Simiiformes,,,U,0,BAO_0000218,1088.0
13305,,8133,Autocuration,314293.0,,1,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded monkey at 1 mg/kg, po",,,CHEMBL630429,,22224,Simiiformes,,,U,0,BAO_0000218,1088.0
13306,,8133,Autocuration,314293.0,,1,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded monkey at 30 mg/kg, po",,,CHEMBL630430,,22224,Simiiformes,,,U,0,BAO_0000218,1088.0
13307,,8133,Autocuration,314293.0,,1,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded monkey at 3 mg/kg, po",,,CHEMBL630431,,22224,Simiiformes,,,U,0,BAO_0000218,1088.0
13308,,8133,Intermediate,10116.0,,1,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 0.1 mg/kg, po",,,CHEMBL630432,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
13309,,8133,Intermediate,10116.0,,1,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 0.3mg/kg, po",,,CHEMBL630433,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
13310,,8133,Intermediate,10116.0,,1,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 1.0mg/kg, po",,,CHEMBL630434,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
13311,,8133,Intermediate,10116.0,,1,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 10.0mg/kg, po",,,CHEMBL629372,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
13312,,8133,Intermediate,10116.0,,1,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 100.0mg/kg, po",,,CHEMBL629553,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
13313,,8133,Intermediate,10116.0,,1,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 2.1 mg/kg, po",,,CHEMBL629554,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
13314,,8133,Intermediate,10116.0,,1,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 20.8mg/kg, po",,,CHEMBL874447,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
13315,,8133,Intermediate,10116.0,,1,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 207.6mg/kg, po",,,CHEMBL629555,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
13316,,8133,Intermediate,10116.0,,1,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 3.0mg/kg, po",,,CHEMBL629556,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
13317,,8133,Intermediate,10116.0,,1,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded rats at 30.0 mg/kg, po",,,CHEMBL629557,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
13318,,8133,Intermediate,10116.0,,1,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 6.9mg/kg, po",,,CHEMBL629558,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
13319,,8133,Intermediate,10116.0,,1,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 69.2mg/kg, po",,,CHEMBL629559,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
13320,,8133,Intermediate,10116.0,,1,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 691.9mg/kg, po",,,CHEMBL629560,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
13321,,8133,Intermediate,9615.0,,1,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.03mg/kg, po",,,CHEMBL629561,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,1088.0
13322,,8133,Intermediate,9615.0,,1,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.1 mg/kg, po",,,CHEMBL629562,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,1088.0
13323,,8133,Intermediate,9615.0,,1,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.3mg/kg, po",,,CHEMBL629563,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,1088.0
13324,,8133,Intermediate,9615.0,,1,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded dogs at 1.0 mg/kg, po",,,CHEMBL629564,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,1088.0
13325,,8133,Intermediate,9615.0,,1,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 10.0mg/kg, po",,,CHEMBL629565,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,1088.0
13326,,8133,Intermediate,9615.0,,1,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 10mg/kg, po",,,CHEMBL629566,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,1088.0
13327,,8133,Intermediate,9615.0,,1,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded dogs at 1 mg/kg, po",,,CHEMBL629567,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,1088.0
13328,,8133,Intermediate,9615.0,,1,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 3.0mg/kg, po",,,CHEMBL629568,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,1088.0
13329,,8133,Intermediate,9615.0,,1,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 30mg/kg, po",,,CHEMBL629569,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,1088.0
13330,,8133,Intermediate,9615.0,,1,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 3mg/kg, po",,,CHEMBL629570,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,1088.0
13331,,8133,Autocuration,314293.0,,1,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 100 mg/kg, po",,,CHEMBL629571,,22224,Simiiformes,,,U,0,BAO_0000218,1088.0
13332,In vivo,12170,Autocuration,10116.0,,1,% bioavailability in rat after oral dose (10 mg/kg) 0 - 6 h.,,,CHEMBL629572,,22224,Rattus norvegicus,,,U,0,BAO_0000218,
13333,In vivo,12170,Autocuration,10116.0,,1,% bioavailability in rat after oral dose (10 mg/kg) 0 - 6 h.,,,CHEMBL629573,,22224,Rattus norvegicus,,,U,0,BAO_0000218,
13334,In vivo,4985,Autocuration,9347.0,,1,Bioavailability (dose 20 mg/kg),,,CHEMBL629574,,22224,Eutheria,,,U,0,BAO_0000218,
13335,In vivo,15145,Autocuration,9615.0,,1,Bioavailability in dog,,,CHEMBL629575,,22224,Canis lupus familiaris,,,U,0,BAO_0000218,
13336,In vivo,14080,Autocuration,10116.0,,1,Bioavailability in rat (Sprague-Dawley) (male),,,CHEMBL874448,,22224,Rattus norvegicus,,,U,0,BAO_0000218,
13337,In vivo,11219,Autocuration,9443.0,,1,Bioavailability in monkey (dose 10 mg/kg i.d.),,,CHEMBL629576,,22224,Primates,,,U,0,BAO_0000218,
13338,In vivo,15145,Autocuration,10116.0,,1,Bioavailability in rat,,,CHEMBL629577,,22224,Rattus norvegicus,,,U,0,BAO_0000218,
13339,In vivo,15145,Autocuration,10116.0,,1,Bioavailability in rat,,,CHEMBL629578,,22224,Rattus norvegicus,,,U,0,BAO_0000218,
13340,In vivo,1202,Autocuration,9615.0,,1,Bioavailability in dog (dose 3.0 mg/kg p.o.),,,CHEMBL629579,,22224,Canis lupus familiaris,,,U,0,BAO_0000218,
13341,In vivo,1202,Autocuration,9615.0,,1,Bioavailability in dog (dose of 1.0 mg/kg i.v.) 0.5 hr,,,CHEMBL882958,,22224,Canis lupus familiaris,,,U,0,BAO_0000218,
13342,In vivo,1202,Intermediate,9598.0,,1,Bioavailability was calculated after peroral dose of 10 mg/Kg in chimp,,,CHEMBL629580,,50505,Pan troglodytes,,,N,1,BAO_0000218,
13343,In vivo,4026,Autocuration,9347.0,,1,Bioavailability,,,CHEMBL629581,,22224,Eutheria,,,U,0,BAO_0000218,
13344,In vivo,1492,Autocuration,9520.0,,1,Bioavailability in squirrel monkey,,,CHEMBL629582,,22224,Saimiri,,,U,0,BAO_0000218,
13345,In vivo,12793,Intermediate,9615.0,,1,Bioavailability was evaluated in dog,,,CHEMBL628522,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
13346,In vivo,12793,Intermediate,10026.0,,1,Bioavailability was evaluated in hamster,,,CHEMBL625432,,100712,Cricetinae,,,N,1,BAO_0000218,
13347,In vivo,12793,Autocuration,10116.0,,1,Bioavailability in rat,,,CHEMBL625433,,22224,Rattus norvegicus,,,U,0,BAO_0000218,
13348,In vivo,14793,Intermediate,10116.0,,1,Bioavailability was evaluated in rat plasma when administered intraperitoneally at a dose of 10 mg/kg,,,CHEMBL625434,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
13349,In vivo,14793,Intermediate,10116.0,,1,Bioavailability was evaluated in rat plasma when administered intravenously at a dose of 10 mg/kg; <Tr>,,,CHEMBL625435,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
13350,In vivo,14793,Autocuration,10116.0,,1,Bioavailability in rat (dose 10 mg/kg p.o.),,,CHEMBL625436,,22224,Rattus norvegicus,,,U,0,BAO_0000218,
13351,In vivo,14731,Intermediate,9541.0,,1,Bioavailability was measured in cynomolgus monkeys.,,,CHEMBL874588,,100710,Macaca fascicularis,,,N,1,BAO_0000218,
13352,In vivo,14731,Intermediate,10090.0,,1,Bioavailability was measured in nude mice.,,,CHEMBL625437,,50594,Mus musculus,,,N,1,BAO_0000218,
13353,In vivo,12187,Autocuration,9669.0,,1,Bioavailability in ferret (dose 10 mg/kg i.d.),,,CHEMBL625438,,22224,Mustela putorius furo,,,U,0,BAO_0000218,
13354,In vivo,12187,Autocuration,314293.0,,1,Bioavailability was determined after intraduodenal dose of 10 mg/kg in monkey (compared to 0.3 mg/kg intravenous dose),,,CHEMBL625439,,22224,Simiiformes,,,U,0,BAO_0000218,
13355,In vivo,12187,Autocuration,314293.0,,1,"Bioavailability was determined after intraduodenal dose of 10 mg/kg in monkey (compared to 0.3 mg/kg intravenous dose), determined by renin inhibition assay",,,CHEMBL625440,,22224,Simiiformes,,,U,0,BAO_0000218,
13356,In vivo,12187,Autocuration,314293.0,,1,Bioavailability was determined after intraduodenal dose of 10 mg/kg in monkey (compared to 1 mg/kg intravenous dose),,,CHEMBL625441,,22224,Simiiformes,,,U,0,BAO_0000218,
13357,In vivo,12187,Autocuration,10116.0,,1,Bioavailability in rat (dose 10 mg/kg i.d.),,,CHEMBL625442,,22224,Rattus norvegicus,,,U,0,BAO_0000218,
13358,In vivo,12187,Intermediate,10116.0,,1,"Bioavailability was determined after intraduodenal dose of 10 mg/kg in rat, determined by renin inhibition assay",,,CHEMBL625443,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13359,In vivo,17431,Autocuration,,,1,Bioavailability was determined; extremely poor,,,CHEMBL625444,,22224,,,,U,0,BAO_0000218,
13360,In vivo,13318,Intermediate,10090.0,,1,% bioavailability in mice after oral administration of prodrug,,,CHEMBL625445,,50594,Mus musculus,,,N,1,BAO_0000218,
13361,In vivo,9025,Intermediate,9615.0,,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose 10/30 range (low/high); -21/-5,,,CHEMBL625446,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
13362,In vivo,9025,Intermediate,9615.0,,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3 range (low/high); -2/6,,,CHEMBL882960,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
13363,In vivo,9025,Intermediate,9615.0,,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3 range (low/high); -4/-14,,,CHEMBL625447,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
13364,In vivo,9025,Intermediate,9615.0,,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3 range (low/high); -5/-12,,,CHEMBL625448,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
13365,In vivo,9025,Intermediate,9615.0,,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3/10 range (low/high); -1/-7/-11,,,CHEMBL625449,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
13366,In vivo,9025,Intermediate,9615.0,,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high),,,CHEMBL874589,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
13367,In vivo,9025,Intermediate,9615.0,,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -1/-9,,,CHEMBL625450,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
13368,In vivo,9025,Intermediate,9615.0,,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -11/-28,,,CHEMBL625451,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
13369,In vivo,9025,Intermediate,9615.0,,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -13/-29,,,CHEMBL626584,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
13370,In vivo,9025,Intermediate,9615.0,,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -13/30,,,CHEMBL626585,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
13371,In vivo,9025,Intermediate,9615.0,,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -16/-18,,,CHEMBL626586,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
13372,In vivo,9025,Intermediate,9615.0,,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -16/-35,,,CHEMBL626587,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
13373,In vivo,9025,Intermediate,9615.0,,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -19/-50,,,CHEMBL626588,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
13374,In vivo,9025,Intermediate,9615.0,,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -21/-29,,,CHEMBL626589,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
13375,In vivo,9025,Intermediate,9615.0,,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -24/-56,,,CHEMBL626590,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
13376,In vivo,9025,Intermediate,9615.0,,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -25/-33,,,CHEMBL626591,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
13377,In vivo,9025,Intermediate,9615.0,,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -3/-13,,,CHEMBL627181,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
13378,In vivo,9025,Intermediate,9615.0,,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -5/-47,,,CHEMBL628083,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
13379,In vivo,15173,Autocuration,,,1,IV clearance determined at an peroral dose of 15 mg/kg.,,,CHEMBL628084,,22224,,,,U,0,BAO_0000218,
13380,In vivo,7732,Expert,102285.0,,1,Mouse oral clearance was measured against Hymenolepiasis nana.,,,CHEMBL628085,,50064,Hymenolepis nana,,,N,1,BAO_0000218,
13381,In vivo,7732,Expert,6339.0,,1,Mouse oral clearance was measured against Nematospiroides dubius,,,CHEMBL628086,,50545,Heligmosomoides polygyrus,,,N,1,BAO_0000218,
13382,In vivo,7732,Autocuration,,,1,Mouse oral clearance was measured against N. dubius; NT is Not Tested,,,CHEMBL628087,,22224,,,,U,0,BAO_0000218,
13383,In vivo,7732,Intermediate,10090.0,,1,Mouse oral clearance was measured against N. nana; NT is Not Tested,,,CHEMBL628088,,50594,Mus musculus,,,N,1,BAO_0000218,
13384,In vivo,7732,Autocuration,,,1,Mouse oral clearance was measured against N. nana; NT is Not Tested,,,CHEMBL628089,,22224,,,,U,0,BAO_0000218,
13385,In vivo,8328,Autocuration,,,1,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 10 J/cm e2 ultraviolet-A radiation,,,CHEMBL628090,,22224,,,,U,0,BAO_0000218,
13386,In vivo,8328,Autocuration,,,1,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 6 J/cm e2 ultraviolet-A radiation,,,CHEMBL628091,,22224,,,,U,0,BAO_0000218,
13387,In vivo,8328,Autocuration,,,1,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 8 J/cm e2 ultraviolet-A radiation,,,CHEMBL628092,,22224,,,,U,0,BAO_0000218,
13388,In vivo,8328,Autocuration,,,1,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 9 J/cm e2 ultraviolet-A radiation,,,CHEMBL628093,,22224,,,,U,0,BAO_0000218,
13389,In vivo,8328,Autocuration,,,1,Percentage of clearance of psoriatic lesions by the compound at dose of 10 J/cm e2 ultraviolet-A radiation,,,CHEMBL875607,,22224,,,,U,0,BAO_0000218,
13390,In vivo,8328,Autocuration,,,1,Percentage of clearance of psoriatic lesions by the compound at dose of 4 J/cm e2 ultraviolet-A radiation,,,CHEMBL625710,,22224,,,,U,0,BAO_0000218,
13391,In vivo,8328,Autocuration,,,1,Percentage of clearance of psoriatic lesions by the compound at dose of 6 J/cm e2 ultraviolet-A radiation,,,CHEMBL625711,,22224,,,,U,0,BAO_0000218,
13392,In vivo,8328,Autocuration,,,1,Percentage of clearance of psoriatic lesions by the compound at dose of 8 J/cm e2 ultraviolet-A radiation,,,CHEMBL625712,,22224,,,,U,0,BAO_0000218,
13393,In vivo,8328,Autocuration,,,1,Percentage of clearance of psoriatic lesions by the compound at dose of 9 J/cm e2 ultraviolet-A radiation,,,CHEMBL625713,,22224,,,,U,0,BAO_0000218,
13394,In vivo,13376,Intermediate,9615.0,,1,Pharmacokinetic parameter clearance was determined in fed Beagle dogs after iv administration of 1.5 mg/kg,,,CHEMBL625714,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
13395,In vivo,13477,Intermediate,9544.0,,1,Plasma clearance after intravenous administration dosing (30 mg/kg) in Rhesus monkey,,,CHEMBL625715,,50797,Macaca mulatta,,,N,1,BAO_0000218,
13396,In vivo,13477,Intermediate,10116.0,,1,Plasma clearance after intravenous administration dosing (30 mg/kg) in rat,,,CHEMBL625716,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13397,In vivo,13477,Intermediate,10116.0,,1,Plasma clearance after intravenous administration iv dosing of 3 mg/kg in rat,,,CHEMBL625717,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13398,In vivo,13313,Intermediate,10116.0,,1,Plasma clearance was determined for the compound in rats,,,CHEMBL625718,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13399,In vivo,12504,Intermediate,10116.0,,1,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 1,,,CHEMBL625719,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13400,In vivo,12504,Intermediate,10116.0,,1,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 2,,,CHEMBL625720,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13401,In vivo,12504,Intermediate,10116.0,,1,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 3,,,CHEMBL625721,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13402,In vivo,12504,Intermediate,10116.0,,1,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 4,,,CHEMBL625722,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13403,In vivo,13129,Intermediate,10116.0,,1,The compound was tested for systemic clearance pharmacokinetic parameter in the male Sprague-Dawley rat.,,,CHEMBL625723,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13404,In vivo,7732,Intermediate,6339.0,,1,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.0125 concentration of diet.,,,CHEMBL625724,,50545,Heligmosomoides polygyrus,,,N,1,BAO_0000218,
13405,In vivo,7732,Intermediate,6339.0,,1,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.025 concentration of diet.,,,CHEMBL625725,,50545,Heligmosomoides polygyrus,,,N,1,BAO_0000218,
13406,In vivo,7732,Intermediate,6339.0,,1,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.05 concentration of diet.,,,CHEMBL625726,,50545,Heligmosomoides polygyrus,,,N,1,BAO_0000218,
13407,In vivo,7732,Intermediate,6339.0,,1,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.1 concentration of diet.,,,CHEMBL875608,,50545,Heligmosomoides polygyrus,,,N,1,BAO_0000218,
13408,In vivo,7732,Intermediate,6339.0,,1,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.2 concentration of diet.,,,CHEMBL625727,,50545,Heligmosomoides polygyrus,,,N,1,BAO_0000218,
13409,In vivo,9278,Autocuration,10116.0,,1,Urinary clearance was determined in rat at 100 mg/kg os dosage;ND is defined as no-data.,,,CHEMBL625728,,22224,Rattus norvegicus,,,U,0,BAO_0000218,1088.0
13410,In vivo,9278,Autocuration,10116.0,,1,Total clearance was determined in rat at 10 mg/kg intraperitoneal dosage,,,CHEMBL625729,,22224,Rattus norvegicus,,,U,0,BAO_0000218,
13411,In vivo,9278,Autocuration,10116.0,,1,Total clearance was determined in rat at 25 mg/kg os dosage;ND is defined as no-data.,,,CHEMBL625730,,22224,Rattus norvegicus,,,U,0,BAO_0000218,
13412,In vivo,9278,Autocuration,10116.0,,1,Urinary clearance was determined in rat at 10 mg/kg intraperitoneal dosage,,,CHEMBL625731,,22224,Rattus norvegicus,,,U,0,BAO_0000218,1088.0
13413,In vivo,9278,Autocuration,10116.0,,1,Urinary clearance was determined in rat at 25 mg/kg os dosage,,,CHEMBL626417,,22224,Rattus norvegicus,,,U,0,BAO_0000218,1088.0
13414,In vivo,9278,Intermediate,9606.0,,1,Urinary clearance was determined at 100 mg/kg oral dosage in human,,,CHEMBL626418,,50587,Homo sapiens,,,N,1,BAO_0000218,1088.0
13415,In vivo,9278,Intermediate,9615.0,,1,Urinary clearance was determined at 20 mg/kg oral dosage in dog(beagle);ND is defined as no-data.,,,CHEMBL626419,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,1088.0
13416,In vivo,5932,Intermediate,9615.0,,1,Plasma concentration in dogs after 2 hr at 30mg/kg oral dose,,,CHEMBL626592,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,1969.0
13417,In vivo,5932,Intermediate,10116.0,,1,Plasma concentration in rats after 7 hr at 30mg/kg oral dose,,,CHEMBL626593,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
13418,In vivo,5182,Intermediate,10116.0,,1,Clearance was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat,,,CHEMBL626594,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13419,In vivo,10499,Intermediate,9615.0,,1,Clearance rate in dogs,,,CHEMBL625035,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
13420,In vitro,6051,Autocuration,,,1,Compound was measured for intrinsic clearance,,,CHEMBL625036,,22224,,,,U,0,BAO_0000019,
13421,,17508,Autocuration,,,1,Calculated partition coefficient (clogP),,,CHEMBL625037,,22229,,,,U,0,BAO_0000100,
13422,,6228,Autocuration,,,1,Calculated partition coefficient (clogP),,,CHEMBL625038,,22229,,,,U,0,BAO_0000100,
13423,,6231,Autocuration,,,1,Calculated partition coefficient (clogP),,,CHEMBL625039,,22229,,,,U,0,BAO_0000100,
13424,,17740,Autocuration,,,1,Calculated partition coefficient (clogP),,,CHEMBL625040,,22229,,,,U,0,BAO_0000100,
13425,,6495,Autocuration,,,1,Calculated partition coefficient (clogP),,,CHEMBL625041,,22229,,,,U,0,BAO_0000100,
13426,,2171,Autocuration,,,1,Calculated partition coefficient (clogP),,,CHEMBL625042,,22229,,,,U,0,BAO_0000100,
13427,,3255,Autocuration,,,1,Partition coefficient of the compound,,,CHEMBL874411,,22224,,,,U,0,BAO_0000019,
13428,,6821,Autocuration,,,1,Permeability,,,CHEMBL625043,,22224,,,,U,0,BAO_0000019,
13429,,2685,Autocuration,,,1,Calculated partition coefficient (clogP),,,CHEMBL625044,,22229,,,,U,0,BAO_0000100,
13430,,17584,Autocuration,,,1,Partition coefficient (logD),,,CHEMBL625045,,22224,,,,U,0,BAO_0000019,
13431,,13824,Autocuration,,,1,Calculated partition coefficient (clogP) (CLOGP3 V3.4),,,CHEMBL625046,,22229,,,,U,0,BAO_0000100,
13432,,13824,Autocuration,,,1,Calculated partition coefficient (clogP) (CLOGP3 V3.4),,,CHEMBL625047,,22229,,,,U,0,BAO_0000100,
13433,,16479,Autocuration,,,1,Calculated partition coefficient (clogP),,,CHEMBL625048,,22229,,,,U,0,BAO_0000100,
13434,,11997,Autocuration,,,1,Calculated partition coefficient (clogP),,,CHEMBL625049,,22229,,,,U,0,BAO_0000100,
13435,,2988,Autocuration,,,1,Calculated logarithm of partition coefficient (P) was determined,,,CHEMBL625050,,22229,,,,U,0,BAO_0000100,
13436,,931,Autocuration,,,1,Calculated partition coefficient (clogP),,,CHEMBL625051,,22229,,,,U,0,BAO_0000100,
13437,,4381,Autocuration,,,1,Calculated partition coefficient (clogP),,,CHEMBL874412,,22229,,,,U,0,BAO_0000100,
13438,,4397,Autocuration,,,1,Calculated partition coefficient (clogP),,,CHEMBL625052,,22229,,,,U,0,BAO_0000100,
13439,,5889,Autocuration,,,1,Calculated partition coefficient (clogP),,,CHEMBL625053,,22229,,,,U,0,BAO_0000100,
13440,,6154,Autocuration,,,1,In vitro stability to pepsin promoting hydrolysis after 8 hr incubation time,,,CHEMBL623250,,22224,,,,U,0,BAO_0000019,
13441,,6154,Autocuration,,,1,In vitro stability to trypsin promoting hydrolysis after 1 hr incubation time,,,CHEMBL623251,,22224,,,,U,0,BAO_0000019,
13442,,6154,Autocuration,,,1,In vitro stability to trypsin promoting hydrolysis after 2 hr incubation time,,,CHEMBL623252,,22224,,,,U,0,BAO_0000019,
13443,,6154,Autocuration,,,1,In vitro stability to trypsin promoting hydrolysis after 64h incubation time,,,CHEMBL623253,,22224,,,,U,0,BAO_0000019,
13444,,6154,Autocuration,,,1,In vitro stability to trypsin promoting hydrolysis after 84 hr incubation time,,,CHEMBL623254,,22224,,,,U,0,BAO_0000019,
13445,,6154,Autocuration,,,1,In vitro stability to trypsin promoting hydrolysis after 8 hr incubation time,,,CHEMBL623255,,22224,,,,U,0,BAO_0000019,
13446,,6887,Autocuration,,,1,Percent degradation of compound at a pH of 1 over a 18 hr period,,,CHEMBL626831,,22224,,,,U,0,BAO_0000019,
13447,,6887,Autocuration,,,1,Percent degradation of compound at pH of 1 over an 18 hr period,,,CHEMBL877494,,22224,,,,U,0,BAO_0000019,
13448,,14116,Autocuration,,,1,Delta Logarithm of Partition Coefficient value was determined.,,,CHEMBL626832,,22224,,,,U,0,BAO_0000019,
13449,,11137,Autocuration,,,1,Delta logPoct-cyc,,,CHEMBL626833,,22224,,,,U,0,BAO_0000019,
13450,,7230,Autocuration,,,1,Lipophilicity estimated on reversed phase TLC,,,CHEMBL626834,,22224,,,,U,0,BAO_0000100,
13451,,15741,Autocuration,,,1,Delta Tm value ( Tmdrug-DNA )-TmDNA ) was obtained for the covalently cross-linked compound in the absence of formaldehyde using calf thymus DNA.,,,CHEMBL626835,,22224,,,,U,0,BAO_0000019,
13452,,9663,Autocuration,,,1,Delta logPoct-cyc,,,CHEMBL626836,,22224,,,,U,0,BAO_0000019,
13453,,9663,Autocuration,,,1,Change in logarithm of partition coefficient of the compound,,,CHEMBL626837,,22229,,,,U,0,BAO_0000100,
13454,,13807,Autocuration,,,1,Delta logD (pH 6.5),,,CHEMBL626838,,22224,,,,U,0,BAO_0000019,
13455,,13807,Autocuration,,,1,"Partition coefficient by standard shake-flask techniquesat 37 C, using octanol and cyclohexane",,,CHEMBL626839,,22224,,,,U,0,BAO_0000100,
13456,,17425,Autocuration,,,1,Oxygen pressure at which hemoglobin is 50% oxygenated; negative sign indicates that P50 of modified Hb is lower than that of unmodified Hb,,,CHEMBL626840,,22224,,,,U,0,BAO_0000019,
13457,,12143,Autocuration,,,1,Deoxyribose-damaging property as a measure of hydroxyl-radical formation (uM of malondialdehyde/mmol of deoxyribose released by 75 uM test compound),,,CHEMBL626841,,22224,,,,U,0,BAO_0000019,
13458,,12608,Autocuration,,,1,Peak depolarizations produced by injections of 100 micro M Ins p3 isomers in nine cells,,,CHEMBL626842,,22224,,,,U,0,BAO_0000219,
13459,,12608,Autocuration,,,1,Peak depolarizations produced by injections of 100 micro M Ins p3 isomers in six cells,,,CHEMBL626843,,22224,,,,U,0,BAO_0000219,
13460,,8649,Intermediate,10116.0,,1,Amount of deuterium retained was reported after normal workup in beta-naphthoflavone-treated male rats with the substrate rac 7-D,,,CHEMBL626844,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13461,,8649,Intermediate,10116.0,,1,Amount of deuterium retained was reported after normal workup in rats,,,CHEMBL877495,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13462,,8649,Intermediate,10116.0,,1,Amount of deuterium retained was reported after reincubation followed by normal workup in phenobarbital treated male rats,,,CHEMBL626845,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13463,,8649,Intermediate,10116.0,,1,Amount of deuterium retained was reported after reincubation followed by normal workup in phenobarbital treated male rats with rac 8-D,,,CHEMBL626846,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13464,,8649,Intermediate,10116.0,,1,Compound incubated with microsomal preparations from beta-naphthoflavone-treated male rats with the substrate rac 7-D and the amount of deuterium retained was reported after reincubation followed by normal workup,,,CHEMBL626847,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13465,,8649,Intermediate,10116.0,,1,Compound incubated with microsomal preparations from beta-naphthoflavone-treated male rats with the substrate rac 7-D and the amount of deuterium retained was reported after reincubation followed by normal workup,,,CHEMBL628677,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13466,,8649,Intermediate,10116.0,,1,Compound incubated with microsomal preparations from phenobarbital treated male rats with the substrate rac 8-D and the amount of deuterium retained was reported after normal workup,,,CHEMBL628678,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13467,,9659,Autocuration,,,1,Compound was subjected to electrochemical oxidation,,,CHEMBL628679,,22224,,,,U,0,BAO_0000019,
13468,,9659,Autocuration,,,1,Compound was subjected to photochemical oxidation,,,CHEMBL628680,,22224,,,,U,0,BAO_0000019,
13469,,9659,Autocuration,,,1,Oxidation of compound by Chloroperoxidase in presence of ethylperoxide,,,CHEMBL628681,,22224,,,,U,0,BAO_0000019,
13470,,9659,Autocuration,,,1,Oxidation of compound by horseradish peroxidase in presence of hydroperoxide,,,CHEMBL628682,,22224,,,,U,0,BAO_0000019,
13471,,9659,Autocuration,,,1,Oxidation of compound by methemoglobin in presence of hydroperoxide,,,CHEMBL628683,,22224,,,,U,0,BAO_0000019,
13472,,9607,Intermediate,10116.0,,1,Percent diffusion through fuzzy rat skin after 48 h of incubation,,,CHEMBL628684,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13473,,7057,Autocuration,,,1,Dissociation constant (pKa),,,CHEMBL877501,,22229,,,,U,0,BAO_0000100,
13474,,7057,Autocuration,,,1,Dissociation constant value of the compound; ND means not determined.,,,CHEMBL628685,,22224,,,,U,0,BAO_0000100,
13475,,7911,Intermediate,10116.0,,1,% distribution of the radioiron in blood of rat followed by intravenous injection of chelating agent,,,CHEMBL628686,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
13476,,7911,Intermediate,10116.0,,1,% distribution of the radioiron in blood of rats followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,,,CHEMBL628687,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
13477,,7911,Intermediate,10116.0,,1,% distribution of the radioiron in rat kidney followed by intravenous injection of chelating agent,,,CHEMBL628688,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13478,,7911,Intermediate,10116.0,,1,% distribution of the radioiron in rat kidney followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,,,CHEMBL628689,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13479,,7911,Intermediate,10116.0,,1,% distribution of the radioiron in rat liver followed by intravenous injection of chelating agent,,,CHEMBL628690,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
13480,,7911,Intermediate,10116.0,,1,% distribution of the radioiron in rat liver followed by intravenous injection of transferrin preincubated with 10 mg of chelating agent,,,CHEMBL629363,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
13481,,7911,Intermediate,10116.0,,1,% distribution of the radioiron in rat spleen followed by intravenous injection of chelating agent,,,CHEMBL629364,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2106.0
13482,,7911,Intermediate,10116.0,,1,% distribution of the radioiron in rat spleen followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,,,CHEMBL629365,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2106.0
13483,,7911,Intermediate,10116.0,,1,% excretion of ferritin determined in faces of rat followed by intravenous injection of chelating agent,,,CHEMBL629366,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13484,,7911,Intermediate,10116.0,,1,% excretion of ferritin determined in urine of rat followed by intravenous injection of chelating agent,,,CHEMBL629367,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
13485,,7911,Intermediate,10116.0,,1,% excretion of radioiron determined in feces of rat followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,,,CHEMBL629368,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1988.0
13486,,7911,Intermediate,10116.0,,1,% excretion of radioiron determined in urine of rat followed by intravenous injection of transferrin preincubated with 10 mg of chelating agent,,,CHEMBL877502,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
13487,,13792,Intermediate,10090.0,,1,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into cerebellum,,,CHEMBL629369,,50594,Mus musculus,,,N,1,BAO_0000218,2037.0
13488,,13792,Intermediate,10090.0,,1,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into cortex,,,CHEMBL629370,,50594,Mus musculus,,,N,1,BAO_0000218,955.0
13489,,8133,Autocuration,314293.0,,1,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded monkey at 10 mg/kg, po",,,CHEMBL629371,,22224,Simiiformes,,,U,0,BAO_0000218,1088.0
13490,,8133,Autocuration,314293.0,,1,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 1 mg/kg, po",,,CHEMBL626276,,22224,Simiiformes,,,U,0,BAO_0000218,1088.0
13491,,8133,Autocuration,314293.0,,1,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 30mg/kg, po",,,CHEMBL626277,,22224,Simiiformes,,,U,0,BAO_0000218,1088.0
13492,,8133,Autocuration,314293.0,,1,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 3mg/kg, po",,,CHEMBL631250,,22224,Simiiformes,,,U,0,BAO_0000218,1088.0
13493,,8133,Intermediate,10116.0,,1,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 0.1 mg/kg, po",,,CHEMBL631251,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
13494,,8133,Intermediate,10116.0,,1,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 0.3mg/kg, po",,,CHEMBL631252,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
13495,,8133,Intermediate,10116.0,,1,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 1.0 mg/kg, po",,,CHEMBL631253,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
13496,,8133,Intermediate,10116.0,,1,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 10.0mg/kg, po",,,CHEMBL631254,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
13497,,8133,Intermediate,10116.0,,1,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 100.0 mg/kg, po",,,CHEMBL631255,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
13498,,8133,Intermediate,10116.0,,1,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 2.1 mg/kg, po",,,CHEMBL631256,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
13499,,8133,Intermediate,10116.0,,1,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 20.8mg/kg, po",,,CHEMBL631257,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
13500,,8133,Intermediate,10116.0,,1,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 207.6 mg/kg, po",,,CHEMBL628009,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
13501,,8133,Intermediate,10116.0,,1,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 3.0mg/kg, po",,,CHEMBL628010,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
13502,,8133,Intermediate,10116.0,,1,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 30.0mg/kg, po",,,CHEMBL628011,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
13503,,8133,Intermediate,10116.0,,1,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 6.9 mg/kg, po",,,CHEMBL628012,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
13504,,8133,Intermediate,10116.0,,1,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 69.2mg/kg, po",,,CHEMBL628013,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
13505,,8133,Intermediate,10116.0,,1,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 691.9mg/kg, po",,,CHEMBL628014,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
13506,,8133,Intermediate,9615.0,,1,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 0.03 mg/kg, po",,,CHEMBL628015,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,1088.0
13507,,8133,Intermediate,9615.0,,1,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.1 mg/kg, po",,,CHEMBL628016,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,1088.0
13508,,8133,Intermediate,9615.0,,1,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 0.3 mg/kg, po",,,CHEMBL874461,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,1088.0
13509,,8133,Intermediate,9615.0,,1,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 1.0 mg/kg, po",,,CHEMBL628017,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,1088.0
13510,,8133,Intermediate,9615.0,,1,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 10.0mg/kg, po",,,CHEMBL628018,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,1088.0
13511,,8133,Intermediate,9615.0,,1,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 10mg/kg, po",,,CHEMBL628019,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,1088.0
13512,,8133,Intermediate,9615.0,,1,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 1 mg/kg, po",,,CHEMBL628020,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,1088.0
13513,,8133,Intermediate,9615.0,,1,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 30 mg/kg, po",,,CHEMBL628021,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,1088.0
13514,,8133,Intermediate,9615.0,,1,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 3mg/kg, po",,,CHEMBL628022,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,1088.0
13515,,8133,Intermediate,9615.0,,1,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 3.0mg/kg, po",,,CHEMBL628023,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,1088.0
13516,,8133,Autocuration,314293.0,,1,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 100 mg/kg, po",,,CHEMBL628024,,22224,Simiiformes,,,U,0,BAO_0000218,1088.0
13517,,8133,Autocuration,314293.0,,1,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 10mg/kg, po",,,CHEMBL628025,,22224,Simiiformes,,,U,0,BAO_0000218,1088.0
13518,,8133,Autocuration,314293.0,,1,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 1 mg/kg, po",,,CHEMBL628026,,22224,Simiiformes,,,U,0,BAO_0000218,1088.0
13519,,8133,Autocuration,314293.0,,1,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 30mg/kg, po",,,CHEMBL628027,,22224,Simiiformes,,,U,0,BAO_0000218,1088.0
13520,,8133,Autocuration,314293.0,,1,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 3mg/kg, po",,,CHEMBL628028,,22224,Simiiformes,,,U,0,BAO_0000218,1088.0
13521,,8133,Intermediate,10116.0,,1,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 0.1 mg/kg, po",,,CHEMBL628029,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
13522,,8133,Intermediate,10116.0,,1,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 0.3 mg/kg, po",,,CHEMBL628030,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
13523,,8133,Intermediate,10116.0,,1,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 1.0mg/kg, po",,,CHEMBL628031,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
13524,,8133,Intermediate,10116.0,,1,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 10.0 mg/kg, po",,,CHEMBL628032,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
13525,,8133,Intermediate,10116.0,,1,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 100.0 mg/kg, po",,,CHEMBL628033,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
13526,,8133,Intermediate,10116.0,,1,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 2.08 mg/kg, po",,,CHEMBL628034,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
13527,,8133,Intermediate,10116.0,,1,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 207.6mg/kg, po",,,CHEMBL628035,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
13528,,8133,Intermediate,10116.0,,1,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 3.0 mg/kg, po",,,CHEMBL628036,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
13529,,8133,Intermediate,10116.0,,1,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 30.0mg/kg, po",,,CHEMBL874462,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
13530,In vivo,9025,Intermediate,9615.0,,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -8/-38,,,CHEMBL628037,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
13531,In vivo,9025,Intermediate,9615.0,,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); 13/-25,,,CHEMBL628123,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
13532,In vivo,9025,Intermediate,9615.0,,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); 27/-15,,,CHEMBL628124,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
13533,In vivo,9025,Intermediate,9615.0,,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -2/-19,,,CHEMBL628125,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
13534,In vivo,9025,Intermediate,9615.0,,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/60 range (low/high); -3/-4,,,CHEMBL628126,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
13535,In vivo,9025,Intermediate,9615.0,,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 3 range (low/high),,,CHEMBL628127,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
13536,In vivo,9025,Intermediate,9615.0,,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 3/10 range (low/high); -9/24,,,CHEMBL628128,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
13537,In vivo,9025,Intermediate,9615.0,,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 3/10 range (low/high); 3/-1,,,CHEMBL628129,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
13538,In vivo,9025,Intermediate,9615.0,,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/030 range (low/high); 12/23,,,CHEMBL628130,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
13539,In vivo,9025,Intermediate,9615.0,,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3 range (low/high); 1/3,,,CHEMBL628131,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
13540,In vivo,9025,Intermediate,9615.0,,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3 range (low/high); 6/16,,,CHEMBL628132,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
13541,In vivo,9025,Intermediate,9615.0,,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3 range (low/high); 7/14,,,CHEMBL628133,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
13542,In vivo,9025,Intermediate,9615.0,,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3/10 range (low/high); 4/4/23,,,CHEMBL628134,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
13543,In vivo,9025,Intermediate,9615.0,,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 10/14,,,CHEMBL628135,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
13544,In vivo,9025,Intermediate,9615.0,,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 11/15,,,CHEMBL628136,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
13545,In vivo,9025,Intermediate,9615.0,,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 11/44,,,CHEMBL628137,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
13546,In vivo,9025,Intermediate,9615.0,,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 14/28,,,CHEMBL628138,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
13547,In vivo,9025,Intermediate,9615.0,,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 15-28,,,CHEMBL628139,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
13548,In vivo,9025,Intermediate,9615.0,,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 2/3,,,CHEMBL628140,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
13549,In vivo,9025,Intermediate,9615.0,,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 26/32,,,CHEMBL628141,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
13550,In vivo,9025,Intermediate,9615.0,,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 5/1,,,CHEMBL628142,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
13551,In vivo,9025,Intermediate,9615.0,,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 5/12,,,CHEMBL628143,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
13552,In vivo,9025,Intermediate,9615.0,,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 6/7,,,CHEMBL628144,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
13553,In vivo,9025,Intermediate,9615.0,,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 7/6,,,CHEMBL628145,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
13554,In vivo,9025,Intermediate,9615.0,,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 8/12,,,CHEMBL628146,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
13555,In vivo,9025,Intermediate,9615.0,,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 8/27,,,CHEMBL625355,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
13556,In vivo,9025,Intermediate,9615.0,,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 9/14,,,CHEMBL625356,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
13557,In vivo,9025,Intermediate,9615.0,,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 9/16,,,CHEMBL625357,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
13558,In vivo,9025,Intermediate,9615.0,,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/60 range (low/high); 12/23,,,CHEMBL625527,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
13559,In vivo,9025,Intermediate,9615.0,,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 3 range (low/high),,,CHEMBL875473,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
13560,In vivo,9025,Intermediate,9615.0,,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 3/10 range (low/high); 10/22,,,CHEMBL625528,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
13561,In vivo,9025,Intermediate,10116.0,,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 3/10 range (low/high); 4/12,,,CHEMBL626304,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13562,In vivo,9025,Intermediate,9615.0,,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a 10/30 dose range; 11/-11,,,CHEMBL624138,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,1637.0
13563,,6448,Autocuration,,,1,Calculated partition coefficient (clogP),,,CHEMBL624139,,22229,,,,U,0,BAO_0000100,
13564,,17221,Autocuration,,,1,Calculated partition coefficient (clogP),,,CHEMBL624140,,22229,,,,U,0,BAO_0000100,
13565,,6545,Autocuration,,,1,Calculated partition coefficient (clogP),,,CHEMBL624141,,22229,,,,U,0,BAO_0000100,
13566,,577,Autocuration,,,1,Calculated partition coefficient (clogP),,,CHEMBL624142,,22229,,,,U,0,BAO_0000100,
13567,,6285,Autocuration,,,1,Calculated partition coefficient (clogP),,,CHEMBL624143,,22229,,,,U,0,BAO_0000100,
13568,,6500,Autocuration,,,1,Calculated partition coefficient (clogP),,,CHEMBL624144,,22229,,,,U,0,BAO_0000100,
13569,,6716,Autocuration,,,1,Calculated partition coefficient (clogP),,,CHEMBL624145,,22229,,,,U,0,BAO_0000100,
13570,,13658,Autocuration,,,1,Calculated partition coefficient (clogP),,,CHEMBL624146,,22229,,,,U,0,BAO_0000100,
13571,,6549,Autocuration,,,1,Calculated partition coefficient (clogP),,,CHEMBL624147,,22229,,,,U,0,BAO_0000100,
13572,,14685,Autocuration,,,1,Calculated partition coefficient (clogP) (MacLogP),,,CHEMBL883123,,22229,,,,U,0,BAO_0000100,
13573,,6893,Autocuration,,,1,Partition coefficient (logP),,,CHEMBL624148,,22224,,,,U,0,BAO_0000019,
13574,,3687,Autocuration,,,1,Kinetic parameter was determined,,,CHEMBL874416,,22224,,,,U,0,BAO_0000019,
13575,,4207,Autocuration,,,1,Calculated partition coefficient (clogP),,,CHEMBL624149,,22229,,,,U,0,BAO_0000100,
13576,,4626,Autocuration,,,1,Calculated partition coefficient (clogP),,,CHEMBL624150,,22229,,,,U,0,BAO_0000100,
13577,,1021,Autocuration,,,1,Lipophilicity was determined,,,CHEMBL624151,,22224,,,,U,0,BAO_0000100,
13578,,3777,Autocuration,,,1,Lipophilicity was determined,,,CHEMBL624152,,22224,,,,U,0,BAO_0000100,
13579,,17533,Autocuration,,,1,Lipophilicity was determined,,,CHEMBL622139,,22224,,,,U,0,BAO_0000100,
13580,,6524,Autocuration,,,1,Calculated partition coefficient (clogP),,,CHEMBL622140,,22229,,,,U,0,BAO_0000100,
13581,,17533,Autocuration,,,1,Lipophilicity was determined,,,CHEMBL622141,,22224,,,,U,0,BAO_0000100,
13582,,6480,Autocuration,,,1,Lipophilicity in octanol-water,,,CHEMBL622142,,22224,,,,U,0,BAO_0000100,
13583,,17606,Autocuration,,,1,Calculated partition coefficient (clogP),,,CHEMBL622143,,22229,,,,U,0,BAO_0000100,
13584,,6863,Autocuration,,,1,Octanol-water partition coefficient was determined,,,CHEMBL622144,,22229,,,,U,0,BAO_0000100,
13585,,1356,Autocuration,,,1,Partition coefficient (logP),,,CHEMBL877473,,22224,,,,U,0,BAO_0000019,
13586,,3326,Autocuration,,,1,Calculated partition coefficient (clogP),,,CHEMBL622145,,22229,,,,U,0,BAO_0000100,
13587,,1356,Autocuration,,,1,Partition coefficient was determined; ND means not determined,,,CHEMBL622146,,22224,,,,U,0,BAO_0000019,
13588,,12984,Autocuration,,,1,Calculated partition coefficient (clogP),,,CHEMBL622147,,22229,,,,U,0,BAO_0000100,
13589,,17363,Autocuration,,,1,Partition coefficient of the compound,,,CHEMBL622148,,22224,,,,U,0,BAO_0000019,
13590,,6827,Autocuration,,,1,Permeability was determined,,,CHEMBL883124,,22224,,,,U,0,BAO_0000019,
13591,,261,Autocuration,,,1,The compound was evaluated for the partition coefficient,,,CHEMBL622149,,22229,,,,U,0,BAO_0000100,
13592,,2685,Autocuration,,,1,Partition coefficient (logP),,,CHEMBL622150,,22224,,,,U,0,BAO_0000019,
13593,,414,Autocuration,,,1,The lipophilicity was reported,,,CHEMBL622151,,22224,,,,U,0,BAO_0000100,
13594,,15769,Autocuration,,,1,logarithm of the octanol-water partition coefficient for the compound,,,CHEMBL622152,,22229,,,,U,0,BAO_0000100,
13595,,17248,Autocuration,,,1,Clogp value was determined,,,CHEMBL622153,,22224,,,,U,0,BAO_0000019,
13596,In vivo,16935,Autocuration,,,1,Clp at a dose of 1.5 mg/kg,,,CHEMBL877474,,22224,,,,U,0,BAO_0000218,
13597,In vivo,16935,Autocuration,,,1,Clp at a dose of 2.0 mg/kg,,,CHEMBL622154,,22224,,,,U,0,BAO_0000218,
13598,In vivo,14832,Autocuration,,,1,"Clp, plasma clearance at a dose of 10 mg/kg",,,CHEMBL622155,,22224,,,,U,0,BAO_0000218,1969.0
13599,In vivo,14832,Autocuration,,,1,"Clp, plasma clearance at a dose of 50 mg/kg",,,CHEMBL622156,,22224,,,,U,0,BAO_0000218,1969.0
13600,In vivo,2399,Intermediate,10116.0,,1,Compound was tested for plasma clearance in rat,,,CHEMBL622157,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
13601,In vivo,2399,Intermediate,10116.0,,1,Compound was tested for plasma clearance in rat; Not determined,,,CHEMBL622158,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
13602,In vivo,6227,Intermediate,10116.0,,1,Plasma clearance (pharmacokinetic parameter) in rat (in vivo) at a dose of 10 mg/kg,,,CHEMBL622807,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13603,In vivo,6227,Intermediate,9544.0,,1,Plasma clearance (pharmacokinetic parameter) in rhesus (in vivo) at a dose of 5 mg/kg,,,CHEMBL622808,,50797,Macaca mulatta,,,N,1,BAO_0000218,
13604,In vivo,5623,Autocuration,,,1,Plasma clearance by iv administration at a dose 0.003 ug/mL,,,CHEMBL622809,,22224,,,,U,0,BAO_0000218,
13605,In vivo,4854,Autocuration,,,1,Plasma clearance determined,,,CHEMBL622810,,22224,,,,U,0,BAO_0000218,
13606,In vivo,4493,Intermediate,10026.0,,1,Plasma clearance after iv administration at 3 mg/kg in hamster,,,CHEMBL876653,,100712,Cricetinae,,,N,1,BAO_0000218,
13607,In vivo,4493,Intermediate,10026.0,,1,Plasma clearance after iv administration at 4 mg/kg in hamster,,,CHEMBL622811,,100712,Cricetinae,,,N,1,BAO_0000218,
13608,In vivo,14956,Intermediate,10116.0,,1,Rate of clearance in rat was determined,,,CHEMBL622986,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13609,In vivo,15372,Intermediate,10116.0,,1,Total plasma clearance Clp was determined for the compound after iv dose of 5.06 mg/kg in rats,,,CHEMBL622987,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
13610,In vivo,15372,Intermediate,10116.0,,1,Total plasma clearance after iv dose of 5.10 mg/kg in rats,,,CHEMBL622988,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
13611,In vivo,15372,Intermediate,10116.0,,1,Total plasma clearance was determined for the compound after iv dose of 4.74 mg/kg in rats,,,CHEMBL622989,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
13612,In vivo,15372,Intermediate,10116.0,,1,Total plasma clearance was determined for the compound after iv dose of 4.97 mg/kg in rats,,,CHEMBL622990,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
13613,In vivo,15604,Autocuration,314293.0,,1,plasma clearance in preclinical species was measured after Intravenous administration at the given dose (0.01 mg/kg) in monkey,,,CHEMBL622991,,22224,Simiiformes,,,U,0,BAO_0000218,1969.0
13614,In vivo,15604,Intermediate,10116.0,,1,plasma clearance in preclinical species was measured after Intravenous administration at the given dose (0.05 mg/kg) in rat,,,CHEMBL622227,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
13615,In vivo,15604,Intermediate,9615.0,,1,plasma clearance in preclinical species was measured after Intravenous administration at the given dose (0.1 mg/kg) in dog,,,CHEMBL622228,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,1969.0
13616,In vivo,14964,Intermediate,10116.0,,1,Clpl value in rat,,,CHEMBL622229,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13617,In vivo,15240,Intermediate,10141.0,,1,Cmax (ng /mL) value after oral administration of 10 mg/kg in guinea pig.,,,CHEMBL622230,,50512,Cavia porcellus,,,N,1,BAO_0000218,
13618,In vivo,16449,Intermediate,10116.0,,1,Cmax after an oral dose of 10 uM/Kg in male Sprague-Dawley rats,,,CHEMBL622231,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13619,In vivo,16449,Intermediate,9541.0,,1,Cmax after an oral dose of 10 uM/Kg in male cynomolgus monkeys,,,CHEMBL622232,,100710,Macaca fascicularis,,,N,1,BAO_0000218,
13620,In vivo,12902,Autocuration,,,1,Cmax in minutes at a iv dose of 1.0(pmol/g/h).,,,CHEMBL622233,,22224,,,,U,0,BAO_0000218,
13621,In vivo,12902,Autocuration,,,1,Cmax in minutes at a iv dose of 2.0(pmol/g/h).,,,CHEMBL622234,,22224,,,,U,0,BAO_0000218,
13622,In vivo,12902,Autocuration,,,1,Cmax in minutes at a iv dose of 4.0(pmol/g/h).,,,CHEMBL622235,,22224,,,,U,0,BAO_0000218,
13623,In vivo,12902,Autocuration,,,1,Cmax in minutes at a iv dose of 5.0(pmol/g/h).,,,CHEMBL622236,,22224,,,,U,0,BAO_0000218,
13624,In vivo,12902,Autocuration,,,1,Cmax in minutes at a iv dose of 54.0(pmol/g/h).,,,CHEMBL622237,,22224,,,,U,0,BAO_0000218,
13625,In vivo,12902,Autocuration,,,1,Cmax in minutes at a po dose of 10.0(pmol/g/h).,,,CHEMBL877482,,22224,,,,U,0,BAO_0000218,
13626,In vivo,12902,Autocuration,,,1,Cmax in minutes at a po dose of 20.0(pmol/g/h).,,,CHEMBL622238,,22224,,,,U,0,BAO_0000218,
13627,In vivo,12902,Autocuration,,,1,Cmax in minutes at a po dose of 40.0(pmol/g/h).,,,CHEMBL622239,,22224,,,,U,0,BAO_0000218,
13628,In vivo,11149,Autocuration,,,1,Cmax was calculated as maximum concentration reached in the blood,,,CHEMBL622240,,22224,,,,U,0,BAO_0000218,178.0
13629,In vivo,11149,Autocuration,,,1,Cmax was calculated as maximum concentration reached in the blood in air pouch exudate,,,CHEMBL622241,,22224,,,,U,0,BAO_0000218,178.0
13630,In vivo,5669,Intermediate,10116.0,,1,Cmax was determine after peroral administration at 10 mpk in Rat,,,CHEMBL631013,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13631,In vivo,5669,Intermediate,9544.0,,1,Cmax was determine after peroral administration at 10 mpk in Rhesus,,,CHEMBL631014,,50797,Macaca mulatta,,,N,1,BAO_0000218,
13632,In vivo,5669,Intermediate,9615.0,,1,Cmax was determine after peroral administration at 10 mpk in dog,,,CHEMBL631015,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
13633,In vivo,5669,Intermediate,10116.0,,1,Cmax was determine after peroral administration at 160 mpk in Rat,,,CHEMBL631016,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13634,In vivo,5669,Intermediate,10116.0,,1,Cmax was determine after peroral administration at 20 mpk in Rat,,,CHEMBL631017,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13635,In vivo,5669,Intermediate,10116.0,,1,Cmax was determine after peroral administration at 50 mpk in Rat,,,CHEMBL631018,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13636,In vivo,4236,Autocuration,,,1,Cmax was determined,,,CHEMBL631019,,22224,,,,U,0,BAO_0000218,
13637,,13792,Intermediate,10090.0,,1,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into hippocampus,,,CHEMBL875761,,50594,Mus musculus,,,N,1,BAO_0000218,955.0
13638,,13792,Intermediate,10090.0,,1,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into hypothalamus,,,CHEMBL631020,,50594,Mus musculus,,,N,1,BAO_0000218,955.0
13639,,13792,Intermediate,10090.0,,1,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into pons and medulla,,,CHEMBL631669,,50594,Mus musculus,,,N,1,BAO_0000218,955.0
13640,,13792,Intermediate,10090.0,,1,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into rest of the brain,,,CHEMBL631670,,50594,Mus musculus,,,N,1,BAO_0000218,955.0
13641,,13792,Intermediate,10090.0,,1,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into striatum,,,CHEMBL631671,,50594,Mus musculus,,,N,1,BAO_0000218,2435.0
13642,,8418,Intermediate,10116.0,,1,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.31-0.4,,,CHEMBL631672,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
13643,,8418,Intermediate,10116.0,,1,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.97-1.12,,,CHEMBL631673,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
13644,,8418,Intermediate,10116.0,,1,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.35-0.37,,,CHEMBL631856,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
13645,,8418,Intermediate,10116.0,,1,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.72-1.03,,,CHEMBL631857,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
13646,,8418,Intermediate,10116.0,,1,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.95-1.06,,,CHEMBL631858,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
13647,,8418,Intermediate,10116.0,,1,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.35-0.4,,,CHEMBL631859,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
13648,,8418,Intermediate,10116.0,,1,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.73-0.85,,,CHEMBL631860,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
13649,,8418,Intermediate,10116.0,,1,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.65-0.83,,,CHEMBL631861,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
13650,,8418,Intermediate,10116.0,,1,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.69-0.84,,,CHEMBL631862,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
13651,,8418,Intermediate,10116.0,,1,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 0.28-0.46,,,CHEMBL631863,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
13652,,8418,Intermediate,10116.0,,1,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.38-1.5,,,CHEMBL631864,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
13653,,8418,Intermediate,10116.0,,1,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.34-0.48,,,CHEMBL631865,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
13654,,8418,Intermediate,10116.0,,1,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.58-1.17,,,CHEMBL631866,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
13655,,8418,Intermediate,10116.0,,1,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 1.0-1.24,,,CHEMBL629360,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
13656,,8418,Intermediate,10116.0,,1,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.28-0.37,,,CHEMBL629361,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
13657,,8418,Intermediate,10116.0,,1,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.54-0.63,,,CHEMBL629362,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
13658,,8418,Intermediate,10116.0,,1,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.25-0.32,,,CHEMBL630740,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
13659,,8418,Intermediate,10116.0,,1,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.49-0.58,,,CHEMBL630741,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
13660,,8418,Intermediate,10116.0,,1,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.58-0.77,,,CHEMBL630742,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
13661,,8418,Intermediate,10116.0,,1,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.20-0.25,,,CHEMBL630743,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13662,,8418,Intermediate,10116.0,,1,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.05-1.25,,,CHEMBL630744,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13663,,8418,Intermediate,10116.0,,1,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.03-0.03,,,CHEMBL630745,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13664,,8418,Intermediate,10116.0,,1,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.03-0.06,,,CHEMBL630746,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13665,,8418,Intermediate,10116.0,,1,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.34-0.5,,,CHEMBL630747,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13666,,8418,Intermediate,10116.0,,1,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.17-0.20,,,CHEMBL630748,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13667,,8418,Intermediate,10116.0,,1,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.81-1.26,,,CHEMBL632056,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13668,,8418,Intermediate,10116.0,,1,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.03-0.06,,,CHEMBL632057,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13669,,8418,Intermediate,10116.0,,1,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.18-0.36,,,CHEMBL632058,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13670,,8418,Intermediate,10116.0,,1,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 0.28-0.37,,,CHEMBL632059,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13671,,8418,Intermediate,10116.0,,1,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 0.97-2.17,,,CHEMBL632060,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13672,,8418,Intermediate,10116.0,,1,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.02-0.03,,,CHEMBL632061,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13673,,8418,Intermediate,10116.0,,1,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.05-0.07,,,CHEMBL629207,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13674,,8418,Intermediate,10116.0,,1,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.35-0.72,,,CHEMBL629208,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13675,,8418,Intermediate,10116.0,,1,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.15-0.19,,,CHEMBL629209,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13676,,8418,Intermediate,10116.0,,1,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.76-1.42,,,CHEMBL629210,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13677,,8418,Intermediate,10116.0,,1,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.02-0.03,,,CHEMBL629211,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13678,,8418,Intermediate,10116.0,,1,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.03-0.06,,,CHEMBL629212,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13679,,8418,Intermediate,10116.0,,1,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.05-0.06,,,CHEMBL629213,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13680,,8133,Intermediate,10116.0,,1,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 6.9mg/kg, po",,,CHEMBL629214,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
13681,,8133,Intermediate,10116.0,,1,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 69.2 mg/kg, po",,,CHEMBL629215,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
13682,,8133,Intermediate,10116.0,,1,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 691.9 mg/kg, po",,,CHEMBL635154,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
13683,,6996,Intermediate,10116.0,,1,Oral diuretic activity measured by Na+ excretion in Rat at 9 mg/kg after ip administration (0-5 hr),,,CHEMBL629216,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13684,,6996,Intermediate,10116.0,,1,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration,,,CHEMBL629217,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13685,,6996,Intermediate,10116.0,,1,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),,,CHEMBL629218,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13686,,6996,Intermediate,10116.0,,1,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration (0-5 hr),,,CHEMBL629219,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13687,,6996,Intermediate,10116.0,,1,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0 - 5 hr),,,CHEMBL629220,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13688,,6996,Intermediate,10116.0,,1,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr ),,,CHEMBL629221,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13689,,6996,Intermediate,10116.0,,1,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),,,CHEMBL631127,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13690,,6996,Intermediate,10116.0,,1,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration,,,CHEMBL631128,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13691,,6996,Intermediate,10116.0,,1,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),,,CHEMBL631129,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13692,,6996,Intermediate,10116.0,,1,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration (0-5 hr),,,CHEMBL631130,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13693,,6996,Intermediate,10116.0,,1,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0 - 5 hr),,,CHEMBL631131,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13694,,6996,Intermediate,10116.0,,1,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr ),,,CHEMBL631132,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13695,,6996,Intermediate,10116.0,,1,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),,,CHEMBL631133,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13696,,6996,Intermediate,10116.0,,1,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration,,,CHEMBL631134,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13697,,6996,Intermediate,10116.0,,1,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),,,CHEMBL875120,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13698,,6996,Intermediate,10116.0,,1,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration (0-5 hr),,,CHEMBL631135,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13699,,6996,Intermediate,10116.0,,1,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0 - 5 hr),,,CHEMBL631136,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13700,,6996,Intermediate,10116.0,,1,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr ),,,CHEMBL631137,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13701,,6996,Intermediate,10116.0,,1,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),,,CHEMBL631138,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13702,,6996,Intermediate,10116.0,,1,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration,,,CHEMBL631139,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13703,,6996,Intermediate,10116.0,,1,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),,,CHEMBL631140,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13704,,6996,Intermediate,10116.0,,1,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration (0-5 hr),,,CHEMBL631141,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13705,,6996,Intermediate,10116.0,,1,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0 - 5 hr),,,CHEMBL631142,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13706,,6996,Intermediate,10116.0,,1,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr ),,,CHEMBL631143,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13707,,6996,Intermediate,10116.0,,1,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),,,CHEMBL631144,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13708,,6996,Intermediate,9615.0,,1,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.312 mg/kg after ip administration,,,CHEMBL631145,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
13709,,6996,Intermediate,9615.0,,1,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.3 mg/kg after ip administration (0-6 hr),,,CHEMBL631146,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
13710,,6996,Intermediate,9615.0,,1,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.625 mg/kg after ip administration,,,CHEMBL631147,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
13711,,6996,Intermediate,9615.0,,1,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.6 mg/kg after ip administration ( 0-6 hr),,,CHEMBL631148,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
13712,,6996,Intermediate,9615.0,,1,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1.8 mg/kg after ip administration ( 0-6 hr),,,CHEMBL631149,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
13713,,6996,Intermediate,9615.0,,1,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 10 mg/kg after ip administration (0-6 hr),,,CHEMBL631150,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
13714,,6996,Intermediate,9615.0,,1,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 10 mg/kg after ip administration ( 0-6 hr),,,CHEMBL631151,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
13715,,6996,Intermediate,9615.0,,1,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 16.2 mg/kg after ip administration ( 0-6 hr),,,CHEMBL631152,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
13716,,6996,Intermediate,9615.0,,1,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration ( 0-6 hr),,,CHEMBL631443,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
13717,,6996,Intermediate,9615.0,,1,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration (0-6 hr),,,CHEMBL631444,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
13718,,6996,Intermediate,9615.0,,1,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration ( 0 - 6 hr),,,CHEMBL631445,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
13719,,6996,Intermediate,9615.0,,1,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration ( 0-6 hr ),,,CHEMBL631446,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
13720,,6996,Intermediate,9615.0,,1,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg g after ip administration (0-6 hr),,,CHEMBL631447,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
13721,,6996,Intermediate,9615.0,,1,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 20 mg/kg after ip administration ( 0-6 hr),,,CHEMBL631448,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
13722,,6996,Intermediate,9615.0,,1,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 2 mg/kg after ip administration,,,CHEMBL631449,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
13723,,6996,Intermediate,9615.0,,1,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 2 mg/kg after ip administration (0-6 hr),,,CHEMBL631450,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
13724,,6996,Intermediate,9615.0,,1,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 2 mg/kg after ip administration ( 0 - 6 hr),,,CHEMBL629724,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
13725,In vivo,9716,Intermediate,10090.0,,1,"Biodistribution in mice skin, after 24 hr of intravenous aadministration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,,CHEMBL629725,,50594,Mus musculus,,,N,1,BAO_0000218,14.0
13726,In vivo,9716,Intermediate,10090.0,,1,"Biodistribution in mice skin, after 48 hr of intravenous administration of 1-2 ug ofcompound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,,CHEMBL629726,,50594,Mus musculus,,,N,1,BAO_0000218,14.0
13727,In vivo,9716,Intermediate,10090.0,,1,"Biodistribution in mice spleen, after 12 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,,CHEMBL629727,,50594,Mus musculus,,,N,1,BAO_0000218,2106.0
13728,In vivo,9716,Intermediate,10090.0,,1,"Biodistribution in mice spleen, after 1 hr of intravenous aadministration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,,CHEMBL630404,,50594,Mus musculus,,,N,1,BAO_0000218,2106.0
13729,In vivo,9716,Intermediate,10090.0,,1,"Biodistribution in mice spleen, after 24 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,,CHEMBL630405,,50594,Mus musculus,,,N,1,BAO_0000218,2106.0
13730,In vivo,9716,Intermediate,10090.0,,1,"Biodistribution in mice spleen, after 48 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,,CHEMBL630406,,50594,Mus musculus,,,N,1,BAO_0000218,2106.0
13731,In vivo,9716,Intermediate,10090.0,,1,"Biodistribution in mice stomach, after 12 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,,CHEMBL630407,,50594,Mus musculus,,,N,1,BAO_0000218,945.0
13732,In vivo,9716,Intermediate,10090.0,,1,"Biodistribution in mice stomach, after 1 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,,CHEMBL630573,,50594,Mus musculus,,,N,1,BAO_0000218,945.0
13733,In vivo,9716,Intermediate,10090.0,,1,"Biodistribution in mice stomach, after 24 hr of intravenous administration of 1-2 ug of ofcompound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,,CHEMBL630574,,50594,Mus musculus,,,N,1,BAO_0000218,945.0
13734,In vivo,9716,Intermediate,10090.0,,1,"Biodistribution in mice stomach, after 48 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,,CHEMBL630575,,50594,Mus musculus,,,N,1,BAO_0000218,945.0
13735,In vivo,9716,Intermediate,10090.0,,1,"Biodistribution in mice tail, after 12 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,,CHEMBL630576,,50594,Mus musculus,,,N,1,BAO_0000218,
13736,In vivo,9716,Intermediate,10090.0,,1,"Biodistribution in mice tail, after 1 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,,CHEMBL630577,,50594,Mus musculus,,,N,1,BAO_0000218,
13737,In vivo,9716,Intermediate,10090.0,,1,"Biodistribution in mice tail, after 24 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,,CHEMBL630578,,50594,Mus musculus,,,N,1,BAO_0000218,
13738,In vivo,9716,Intermediate,10090.0,,1,"Biodistribution in mice tail, after 48 hr of intravenous administration of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,,CHEMBL630579,,50594,Mus musculus,,,N,1,BAO_0000218,
13739,,12192,Intermediate,10090.0,,1,Percent of injected 238-Plutonium(IV) in mice kidney at 24 hr (orally administered),,,CHEMBL630580,,50594,Mus musculus,,,N,1,BAO_0000218,2113.0
13740,,12192,Intermediate,10090.0,,1,Percent of injected 238-Plutonium(IV) in mice kidneys at 24 h,,,CHEMBL630581,,50594,Mus musculus,,,N,1,BAO_0000218,2113.0
13741,,12192,Intermediate,10090.0,,1,Percent of injected 238-Plutonium(IV) in mice kidneys at 24 hr (orally administered),,,CHEMBL630582,,50594,Mus musculus,,,N,1,BAO_0000218,2113.0
13742,,12192,Intermediate,10090.0,,1,Percent of injected 238-Plutonium(IV) in mice liver at 24 h,,,CHEMBL630583,,50594,Mus musculus,,,N,1,BAO_0000218,
13743,,12192,Intermediate,10090.0,,1,Percent of injected 238-Plutonium(IV) in mice liver at 24 hr (orally administered),,,CHEMBL630584,,50594,Mus musculus,,,N,1,BAO_0000218,
13744,,12192,Intermediate,10090.0,,1,Percent of injected 238-Plutonium(IV) in mice skeleton at 24 h,,,CHEMBL630585,,50594,Mus musculus,,,N,1,BAO_0000218,
13745,,12192,Intermediate,10090.0,,1,Percent of injected 238-Plutonium(IV) in mice skeleton at 24 hr (orally administered),,,CHEMBL630586,,50594,Mus musculus,,,N,1,BAO_0000218,
13746,,12192,Intermediate,10090.0,,1,Percent of injected 238-Plutonium(IV) in mice soft tissue at 24 h,,,CHEMBL630587,,50594,Mus musculus,,,N,1,BAO_0000218,
13747,,12192,Intermediate,10090.0,,1,Percent of injected 238-Plutonium(IV) in mice soft tissue at 24 hr (orally administered),,,CHEMBL630588,,50594,Mus musculus,,,N,1,BAO_0000218,
13748,,12192,Intermediate,10090.0,,1,Percent of injected 238-Plutonium(IV) in mice whole body at 24 h,,,CHEMBL630589,,50594,Mus musculus,,,N,1,BAO_0000218,
13749,,12192,Intermediate,10090.0,,1,Percent of injected 238-Plutonium(IV) in mice whole body at 24 hr (orally administered),,,CHEMBL630590,,50594,Mus musculus,,,N,1,BAO_0000218,
13750,,12192,Autocuration,,,1,Removal of 238-Plutonium(IV) in feces at 24 h,,,CHEMBL630591,,22224,,,,U,0,BAO_0000019,1988.0
13751,,12192,Autocuration,,,1,Removal of 238-Plutonium(IV) in feces at 24 hr (orally administered),,,CHEMBL630592,,22224,,,,U,0,BAO_0000019,1988.0
13752,,12192,Autocuration,,,1,Removal of 238-Plutonium(IV) in gastrointestinal (GI) contents at 24 h,,,CHEMBL630593,,22224,,,,U,0,BAO_0000019,
13753,,12192,Autocuration,,,1,Removal of 238-Plutonium(IV) in gastrointestinal (GI) contents at 24 hr (orally administered),,,CHEMBL630594,,22224,,,,U,0,BAO_0000019,
13754,,12192,Autocuration,,,1,Removal of 238-Plutonium(IV) in urine 0-4 h (orally administered),,,CHEMBL630595,,22224,,,,U,0,BAO_0000019,1088.0
13755,,12192,Autocuration,,,1,Removal of 238-Plutonium(IV) in urine 4-24 hr (orally administered),,,CHEMBL630596,,22224,,,,U,0,BAO_0000019,1088.0
13756,,12192,Autocuration,,,1,Removal of 238-Plutonium(IV) in urine after 0-24 h,,,CHEMBL630597,,22224,,,,U,0,BAO_0000019,1088.0
13757,,12192,Autocuration,,,1,Removal of 238-Plutonium(IV) in urine after 0-24 hr (orally administered),,,CHEMBL630598,,22224,,,,U,0,BAO_0000019,1088.0
13758,,12192,Autocuration,,,1,Removal of 238-Plutonium(IV) in urine after 0-4 h,,,CHEMBL630599,,22224,,,,U,0,BAO_0000019,1088.0
13759,,12192,Autocuration,,,1,Removal of 238-Plutonium(IV) in urine after 0-4 hr (orally administered),,,CHEMBL630600,,22224,,,,U,0,BAO_0000019,1088.0
13760,,12192,Autocuration,,,1,Removal of 238-Plutonium(IV) in urine after 4-24 h,,,CHEMBL630601,,22224,,,,U,0,BAO_0000019,1088.0
13761,,12192,Autocuration,,,1,Removal of 238-Plutonium(IV) in urine after 4-24 hr (orally administered),,,CHEMBL630602,,22224,,,,U,0,BAO_0000019,1088.0
13762,,12192,Autocuration,,,1,Removal of 238-Plutonium(IV) in urine at 0-4 hr (orally administered),,,CHEMBL630603,,22224,,,,U,0,BAO_0000019,1088.0
13763,,12192,Autocuration,,,1,Removal of 238-Plutonium(IV) in urine at 4-24 hr (orally administered),,,CHEMBL630604,,22224,,,,U,0,BAO_0000019,1088.0
13764,In vivo,12017,Intermediate,10116.0,,1,Biodistribution in blood of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,CHEMBL624869,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
13765,In vivo,12017,Intermediate,10116.0,,1,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,CHEMBL624870,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
13766,In vivo,12017,Intermediate,10116.0,,1,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,,CHEMBL623189,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
13767,In vivo,12017,Intermediate,10116.0,,1,Biodistribution in blood of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,CHEMBL623190,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
13768,In vivo,12017,Intermediate,10116.0,,1,Biodistribution in blood of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,CHEMBL623191,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
13769,In vivo,12017,Intermediate,10116.0,,1,Biodistribution in fat of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,CHEMBL623192,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13770,In vivo,12017,Intermediate,10116.0,,1,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,CHEMBL623193,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13771,In vivo,12017,Intermediate,10116.0,,1,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,,CHEMBL623194,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13772,In vivo,12017,Intermediate,10116.0,,1,Biodistribution in fat of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,CHEMBL623195,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13773,In vivo,12017,Intermediate,10116.0,,1,Biodistribution in fat of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,CHEMBL623196,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13774,,11836,Intermediate,10116.0,,1,Tested in vivo for the biodistribution in rat uterus/blood at 1 hour after intravenous dose of 15 microCi of the drug and 15 micro g of estradiol,,,CHEMBL623197,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13775,,11836,Intermediate,10116.0,,1,Tested in vivo for the biodistribution in rat uterus/blood at 1 hour after intravenous dose of 50 microCi of drug in 10%ethanol saline,,,CHEMBL623198,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13776,,11836,Intermediate,10116.0,,1,Tested in vivo for the biodistribution in rat uterus/blood at 1 hour after intravenous dose of 50 microCi of the drug and 15 ug of estradiol,,,CHEMBL623199,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13777,,11836,Intermediate,10116.0,,1,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 100 microCi of drug in 10%ethanol saline,,,CHEMBL623200,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2385.0
13778,,11836,Intermediate,10116.0,,1,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 120 microCi of drug in 10%ethanol saline,,,CHEMBL623201,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2385.0
13779,,11836,Intermediate,10116.0,,1,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 15 microCi of drug in 10%ethanol saline,,,CHEMBL623202,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2385.0
13780,,11836,Intermediate,10116.0,,1,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 50 microCi of drug in 10%ethanol saline,,,CHEMBL623203,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2385.0
13781,,11836,Intermediate,10116.0,,1,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 100 microCi of drug in 10%ethanol saline,,,CHEMBL623204,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2385.0
13782,,11836,Intermediate,10116.0,,1,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 100 microCi of the drug and 15 ug of estradiol,,,CHEMBL623205,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2385.0
13783,,11836,Intermediate,10116.0,,1,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 120 microCi of drug in 10%ethanol saline,,,CHEMBL623206,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2385.0
13784,,11836,Intermediate,10116.0,,1,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 120 microCi of the drug and 15 micro g of estradiol,,,CHEMBL623207,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2385.0
13785,,11836,Intermediate,10116.0,,1,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 15 microCi of the drug and 15 ug of estradiol,,,CHEMBL623208,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2385.0
13786,,11836,Intermediate,10116.0,,1,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 50 microCi of drug in 10%ethanol saline,,,CHEMBL623209,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2385.0
13787,,11836,Intermediate,10116.0,,1,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 50 microCi of the drug and 15 ug of estradiol,,,CHEMBL623210,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2385.0
13788,,11836,Intermediate,10116.0,,1,Tested in vivo for the biodistribution in rat fat at 1 hour after intravenous dose of 50 microCi of drug in 10%ethanol saline,,,CHEMBL623211,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13789,,11836,Intermediate,10116.0,,1,Tested in vivo for the biodistribution in rat uterus at 1 hour after intravenous dose of 120 microCi of drug in 10%ethanol saline,,,CHEMBL623212,,50597,Rattus norvegicus,,,N,1,BAO_0000218,995.0
13790,,12640,Autocuration,,,1,Tested in vitro for intrinsic activity relative to quinpirole,,,CHEMBL623213,,22224,,,,U,0,BAO_0000019,
13791,,14218,Autocuration,,,1,"Relative ion enhancement, determined in pulsed ultrafiltration",,,CHEMBL623214,,22224,,,,U,0,BAO_0000019,
13792,,11296,Autocuration,,,1,% ionization at the pH 7.4 at 37 degree Centigrade,,,CHEMBL623215,,22224,,,,U,0,BAO_0000019,
13793,,10929,Autocuration,,,1,Percentage ionization was measured,,,CHEMBL623216,,22224,,,,U,0,BAO_0000019,
13794,,13841,Intermediate,9913.0,,1,Association constant of binding of compound with calf thymus DNA was determined by using equilibrium dialysis.,,,CHEMBL623217,,50591,Bos taurus,,,N,1,BAO_0000218,
13795,,10431,Autocuration,,,1,Compound was autooxidized for 2 hour at 37 degree Celsius in pH 7.4 Pseudo-first-order rate constant,,,CHEMBL623218,,22224,,,,U,0,BAO_0000019,
13796,,10431,Autocuration,,,1,Compound was autooxidized for 2 hour at 37 degree Celsius in pH 7.4 phosphate buffer Pseudo-first-order rate constant,,,CHEMBL623913,,22224,,,,U,0,BAO_0000019,
13797,,10431,Autocuration,,,1,Compound was autooxidized for 2 hour at 37 degree Celsius in pH 7.4 phosphate buffer pseudo-first-order rate constant 0.1 mM EDTA,,,CHEMBL623914,,22224,,,,U,0,BAO_0000019,
13798,,8826,Autocuration,,,1,Compound was evaluated for the partition coefficient in octanol/water,,,CHEMBL623915,,22229,,,,U,0,BAO_0000100,
13799,,8826,Autocuration,,,1,Compound was evaluated for the partition coefficient in octanol/water (1-octanol / 10 mM phosphate buffer at pH 7.4),,,CHEMBL624080,,22229,,,,U,0,BAO_0000100,
13800,,9884,Autocuration,,,1,Equilibrium constant measured by the pulse radiolysis at pH 7,,,CHEMBL624081,,22224,,,,U,0,BAO_0000019,
13801,,9827,Intermediate,9606.0,,1,In vitro hydrolytic rate constant determined in human blood,,,CHEMBL624082,,50587,Homo sapiens,,,N,1,BAO_0000218,
13802,,10009,Intermediate,9606.0,,1,In vitro oxidation of compound to its pyridinium salt (3) in presence of human plasma,,,CHEMBL625054,,50587,Homo sapiens,,,N,1,BAO_0000218,
13803,,10009,Autocuration,,,1,In vitro oxidation of compound to its pyridinium salt (3) in presence of hydrogen peroxide,,,CHEMBL877485,,22224,,,,U,0,BAO_0000019,
13804,,10009,Intermediate,10090.0,,1,In vitro oxidation of compound to its pyridinium salt (3) in presence of mouse brain homogenate,,,CHEMBL625055,,50594,Mus musculus,,,N,1,BAO_0000218,
13805,,10009,Intermediate,10090.0,,1,In vitro oxidation of compound to its pyridinium salt (3) in presence of mouse liver homogenate,,,CHEMBL625056,,50594,Mus musculus,,,N,1,BAO_0000218,
13806,,10009,Intermediate,9606.0,,1,In vitro oxidation of compound in presence of human plasma,,,CHEMBL625057,,50587,Homo sapiens,,,N,1,BAO_0000218,
13807,,10009,Autocuration,,,1,In vitro oxidation of compound in presence of hydrogen peroxide,,,CHEMBL625058,,22224,,,,U,0,BAO_0000019,
13808,,10009,Intermediate,10090.0,,1,In vitro oxidation of compound in presence of mouse brain homogenate,,,CHEMBL625059,,50594,Mus musculus,,,N,1,BAO_0000218,
13809,,10009,Intermediate,10090.0,,1,In vitro oxidation of compound in presence of mouse liver homogenate,,,CHEMBL629536,,50594,Mus musculus,,,N,1,BAO_0000218,
13810,,11510,Intermediate,10116.0,,1,Mean potassium excretion in rats when compound administered at 0 mg/kg po and vehicle dosed at 0 umol/kg,,,CHEMBL629537,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13811,,11510,Intermediate,10116.0,,1,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 30.23 umol/kg,,,CHEMBL629538,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13812,,11510,Intermediate,10116.0,,1,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 33.59 umol/kg,,,CHEMBL629539,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13813,,11510,Intermediate,10116.0,,1,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 37.13 umol/kg,,,CHEMBL874445,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13814,,11510,Intermediate,10116.0,,1,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 39.48 umol/kg,,,CHEMBL629540,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13815,,11510,Intermediate,10116.0,,1,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 483.72 umol/kg,,,CHEMBL629541,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13816,,11510,Intermediate,10116.0,,1,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg,,,CHEMBL629542,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13817,,11510,Intermediate,10116.0,,1,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg; Not determined,,,CHEMBL630243,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13818,,11510,Intermediate,10116.0,,1,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 631.76 umol/kg,,,CHEMBL630244,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13819,,11510,Intermediate,10116.0,,1,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 7.56 umol/kg,,,CHEMBL630245,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13820,,11510,Intermediate,10116.0,,1,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 8.4 umol/kg,,,CHEMBL630246,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13821,,11510,Intermediate,10116.0,,1,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.28 umol/kg,,,CHEMBL630247,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13822,,11510,Intermediate,10116.0,,1,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.87 umol/kg,,,CHEMBL630248,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13823,In vivo,13100,Intermediate,10116.0,,1,Biodistribution in rat blood at 240 minutes after dose administration.,,,CHEMBL630249,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
13824,In vivo,13100,Intermediate,10116.0,,1,Biodistribution in rat blood at 30 minutes after dose administration.,,,CHEMBL630250,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
13825,In vivo,13100,Intermediate,10116.0,,1,Biodistribution in rat blood at 360 minutes after dose administration.,,,CHEMBL630251,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
13826,In vivo,13100,Intermediate,10116.0,,1,Biodistribution in rat blood at 3 hr after dose administration.,,,CHEMBL630252,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
13827,In vivo,13100,Intermediate,10116.0,,1,Biodistribution in rat blood at 60 minutes after dose administration.,,,CHEMBL630408,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
13828,In vivo,13100,Intermediate,10116.0,,1,Biodistribution in rat cerebellum at 120 minutes after dose administration.,,,CHEMBL630409,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2037.0
13829,In vivo,13100,Intermediate,10116.0,,1,Biodistribution in rat cerebellum at 1440 minutes after dose administration.,,,CHEMBL874446,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2037.0
13830,In vivo,13100,Intermediate,10116.0,,1,Biodistribution in rat cerebellum at 15 minutes after dose administration.,,,CHEMBL630410,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2037.0
13831,In vivo,13100,Intermediate,10116.0,,1,Biodistribution in rat cerebellum at 240 minutes after dose administration.,,,CHEMBL630411,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2037.0
13832,In vivo,13100,Intermediate,10116.0,,1,Biodistribution in rat cerebellum at 30 minutes after dose administration.,,,CHEMBL630412,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2037.0
13833,In vivo,13100,Intermediate,10116.0,,1,Biodistribution in rat cerebellum at 360 minutes after dose administration.,,,CHEMBL630413,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2037.0
13834,In vivo,13100,Intermediate,10116.0,,1,Biodistribution in rat cerebellum at 3 hr after dose administration.,,,CHEMBL630414,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2037.0
13835,In vivo,13100,Intermediate,10116.0,,1,Biodistribution in rat cerebellum at 60 minutes after dose administration.,,,CHEMBL630415,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2037.0
13836,In vivo,13100,Intermediate,10116.0,,1,Biodistribution in rat cortex at 120 minutes after dose administration.,,,CHEMBL630416,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13837,In vivo,13100,Intermediate,10116.0,,1,Biodistribution in rat cortex at 1440 minutes after dose administration.,,,CHEMBL630417,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13838,In vivo,13100,Intermediate,10116.0,,1,Biodistribution in rat cortex at 15 minutes after dose administration.,,,CHEMBL630418,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13839,In vivo,13100,Intermediate,10116.0,,1,Biodistribution in rat cortex at 240 minutes after dose administration.,,,CHEMBL630419,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13840,In vivo,13100,Intermediate,10116.0,,1,Biodistribution in rat cortex at 30 minutes after dose administration.,,,CHEMBL630420,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13841,In vivo,13100,Intermediate,10116.0,,1,Biodistribution in rat cortex at 360 minutes after dose administration.,,,CHEMBL630421,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13842,In vivo,13100,Intermediate,10116.0,,1,Biodistribution in rat cortex at 3 hr after dose administration.,,,CHEMBL630422,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13843,In vivo,13100,Intermediate,10116.0,,1,Biodistribution in rat cortex at 60 minutes after dose administration.,,,CHEMBL630423,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13844,In vivo,13100,Intermediate,10116.0,,1,Biodistribution in rat heart at 120 minutes after dose administration.,,,CHEMBL630424,,50597,Rattus norvegicus,,,N,1,BAO_0000218,948.0
13845,In vivo,13100,Intermediate,10116.0,,1,Biodistribution in rat heart at 15 minutes after dose administration.,,,CHEMBL630425,,50597,Rattus norvegicus,,,N,1,BAO_0000218,948.0
13846,In vivo,13100,Intermediate,10116.0,,1,Biodistribution in rat heart at 240 minutes after dose administration.,,,CHEMBL629462,,50597,Rattus norvegicus,,,N,1,BAO_0000218,948.0
13847,In vivo,13100,Intermediate,10116.0,,1,Biodistribution in rat heart at 30 minutes after dose administration.,,,CHEMBL630426,,50597,Rattus norvegicus,,,N,1,BAO_0000218,948.0
13848,In vivo,13100,Intermediate,10116.0,,1,Biodistribution in rat heart at 360 minutes after dose administration.,,,CHEMBL630427,,50597,Rattus norvegicus,,,N,1,BAO_0000218,948.0
13849,In vivo,13100,Intermediate,10116.0,,1,Biodistribution in rat heart at 3 hr after dose administration.,,,CHEMBL625877,,50597,Rattus norvegicus,,,N,1,BAO_0000218,948.0
13850,In vivo,13100,Intermediate,10116.0,,1,Biodistribution in rat heart at 60 minutes after dose administration.,,,CHEMBL625878,,50597,Rattus norvegicus,,,N,1,BAO_0000218,948.0
13851,In vivo,13100,Intermediate,10116.0,,1,Biodistribution in rat hippocampus at 1440 minutes after dose administration.,,,CHEMBL625879,,50597,Rattus norvegicus,,,N,1,BAO_0000218,10000000.0
13852,In vivo,13100,Intermediate,10116.0,,1,Biodistribution in rat hippocampus at 240 minutes after dose administration.,,,CHEMBL625880,,50597,Rattus norvegicus,,,N,1,BAO_0000218,10000000.0
13853,In vivo,13100,Intermediate,10116.0,,1,Biodistribution in rat hippocampus at 30 minutes after dose administration.,,,CHEMBL625881,,50597,Rattus norvegicus,,,N,1,BAO_0000218,10000000.0
13854,In vivo,13100,Intermediate,10116.0,,1,Biodistribution in rat hippocampus at 360 minutes after dose administration.,,,CHEMBL625882,,50597,Rattus norvegicus,,,N,1,BAO_0000218,10000000.0
13855,In vivo,13100,Intermediate,10116.0,,1,Biodistribution in rat hippocampus at 15 minutes after dose administration.,,,CHEMBL625883,,50597,Rattus norvegicus,,,N,1,BAO_0000218,10000000.0
13856,In vivo,13100,Intermediate,10116.0,,1,Biodistribution in rat kidney at 120 minutes after dose administration.,,,CHEMBL625884,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2113.0
13857,In vivo,13100,Intermediate,10116.0,,1,Biodistribution in rat kidney at 1440 minutes after dose administration.,,,CHEMBL625885,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2113.0
13858,In vivo,13100,Intermediate,10116.0,,1,Biodistribution in rat kidney at 15 minutes after dose administration.,,,CHEMBL628649,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2113.0
13859,In vivo,13100,Intermediate,10116.0,,1,Biodistribution in rat kidney at 240 minutes after dose administration.,,,CHEMBL628650,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2113.0
13860,In vivo,13100,Intermediate,10116.0,,1,Biodistribution in rat kidney at 30 minutes after dose administration.,,,CHEMBL628651,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2113.0
13861,In vivo,13100,Intermediate,10116.0,,1,Biodistribution in rat kidney at 360 minutes after dose administration.,,,CHEMBL628652,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2113.0
13862,In vivo,13100,Intermediate,10116.0,,1,Biodistribution in rat kidney at 60 minutes after dose administration.,,,CHEMBL628653,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2113.0
13863,In vivo,13100,Intermediate,10116.0,,1,Biodistribution in rat liver at 120 minutes after dose administration.,,,CHEMBL628654,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
13864,In vivo,13100,Intermediate,10116.0,,1,Biodistribution in rat liver at 1440 minutes after dose administration.,,,CHEMBL628655,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
13865,In vivo,13100,Intermediate,10116.0,,1,Biodistribution in rat liver at 15 minutes after dose administration.,,,CHEMBL625238,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
13866,In vivo,13100,Intermediate,10116.0,,1,Biodistribution in rat liver at 240 minutes after dose administration.,,,CHEMBL625239,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
13867,In vivo,13100,Intermediate,10116.0,,1,Biodistribution in rat liver at 30 minutes after dose administration.,,,CHEMBL625240,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
13868,In vivo,13100,Intermediate,10116.0,,1,Biodistribution in rat liver at 360 minutes after dose administration.,,,CHEMBL625241,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
13869,In vivo,13100,Intermediate,10116.0,,1,Biodistribution in rat liver at 60 minutes after dose administration.,,,CHEMBL625242,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
13870,In vivo,13100,Intermediate,10116.0,,1,Biodistribution in rat lung at 120 minutes after dose administration.,,,CHEMBL874587,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2048.0
13871,In vivo,13100,Intermediate,10116.0,,1,Biodistribution in rat lung at 1440 minutes after dose administration.,,,CHEMBL625405,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2048.0
13872,In vivo,13100,Intermediate,10116.0,,1,Biodistribution in rat lung at 15 minutes after dose administration.,,,CHEMBL625406,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2048.0
13873,In vivo,13100,Intermediate,10116.0,,1,Biodistribution in rat lung at 240 minutes after dose administration.,,,CHEMBL625407,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2048.0
13874,In vivo,13100,Intermediate,10116.0,,1,Biodistribution in rat lung at 30 minutes after dose administration.,,,CHEMBL625408,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2048.0
13875,In vivo,13100,Intermediate,10116.0,,1,Biodistribution in rat lung at 360 minutes after dose administration.,,,CHEMBL625409,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2048.0
13876,,12361,Intermediate,10116.0,,1,Percent of maximal contractile response to compound in rat thoracic aorta strips in the presence of calcium deficient buffer,,,CHEMBL625410,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1515.0
13877,,12361,Intermediate,10116.0,,1,Percent of maximal contractile response to compound in rat thoracic aorta strips in the presence of nifedipine,,,CHEMBL625411,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1515.0
13878,,12361,Intermediate,10116.0,,1,Percent of maximal contractile response to compound in rat thoracic aorta strips in the presence of verapamil,,,CHEMBL625412,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1515.0
13879,,12361,Intermediate,10116.0,,1,Percent of maximal contractile response to compound in rat thoracic aorta strips presence of PBZ and CIR,,,CHEMBL625413,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1515.0
13880,,12361,Intermediate,10116.0,,1,Percent of maximal contractile response to compound in rat thoracic aorta strips v,,,CHEMBL625414,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1515.0
13881,,12361,Intermediate,10116.0,,1,Percent of maximal contractile response to compound with phenoxybenzamine pretreatment on rat thoracic aorta strips,,,CHEMBL625415,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1515.0
13882,,12361,Intermediate,10116.0,,1,Percent of maximal contractile response to compound without phenoxybenzamine pretreatment on rat thoracic aorta strips,,,CHEMBL625416,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1515.0
13883,,12712,Intermediate,10116.0,,1,% of the total radioactive dose of compound present in the 0-24 hour urine after a single 5 mg/kg dose administered intravenously in rats,,,CHEMBL625417,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
13884,,7415,Intermediate,10116.0,,1,Compound at the dose 10 mg/kg administered intraperitoneally was evaluated for the excretion rate in rats in 7 days through feces,,,CHEMBL625418,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1988.0
13885,,7415,Intermediate,10116.0,,1,Compound at the dose 10 mg/kg administered intraperitoneally was evaluated for the excretion rate in rats in 7 days through urine,,,CHEMBL625419,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
13886,,7415,Intermediate,10116.0,,1,Compound was evaluated for the biliary excretion in the anesthetized rats in 6 hours after intravenous doses 1 mg/kg,,,CHEMBL625420,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13887,,7415,Intermediate,10116.0,,1,Compound was evaluated for the biliary excretion in the anesthetized rats in 6 hours after intravenous doses 10 mg/kg,,,CHEMBL626996,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13888,,7415,Intermediate,10116.0,,1,"Compound was evaluated for the cumulative excretion rate in rats at the dose 10 mg/kg, intraperitoneally for 18 days through feces",,,CHEMBL626997,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1988.0
13889,,7415,Intermediate,10116.0,,1,"Compound was evaluated for the cumulative excretion rate in rats at the dose 10 mg/kg, intraperitoneally for 18 days through urine",,,CHEMBL626998,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
13890,,7415,Intermediate,10116.0,,1,"Compound was evaluated for the in rats after the dose of 5 mg/kg intravenously, at the dose 4 hour biliary excretion",,,CHEMBL626999,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13891,,8050,Intermediate,10090.0,,1,faecal levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 0-30h,,,CHEMBL627000,,50594,Mus musculus,,,N,1,BAO_0000218,
13892,,8050,Intermediate,10090.0,,1,fecal levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 0-30h,,,CHEMBL627001,,50594,Mus musculus,,,N,1,BAO_0000218,
13893,,8050,Intermediate,10090.0,,1,fecal levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 0-30h,,,CHEMBL627002,,50594,Mus musculus,,,N,1,BAO_0000218,
13894,,8050,Intermediate,10090.0,,1,fecal levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 0-30h,,,CHEMBL627003,,50594,Mus musculus,,,N,1,BAO_0000218,
13895,,8050,Intermediate,10090.0,,1,urine levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 0-24 hr,,,CHEMBL627004,,50594,Mus musculus,,,N,1,BAO_0000218,1088.0
13896,,8050,Intermediate,10090.0,,1,urine levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 0-6 hr,,,CHEMBL627005,,50594,Mus musculus,,,N,1,BAO_0000218,1088.0
13897,,8050,Intermediate,10090.0,,1,urine levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 24-30 hr,,,CHEMBL874594,,50594,Mus musculus,,,N,1,BAO_0000218,1088.0
13898,,8050,Intermediate,10090.0,,1,urine levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 0-24 hr,,,CHEMBL627006,,50594,Mus musculus,,,N,1,BAO_0000218,1088.0
13899,,8050,Intermediate,10090.0,,1,urine levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 0-6 hr,,,CHEMBL627007,,50594,Mus musculus,,,N,1,BAO_0000218,1088.0
13900,,8050,Intermediate,10090.0,,1,urine levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 24-30 hr,,,CHEMBL627884,,50594,Mus musculus,,,N,1,BAO_0000218,1088.0
13901,,8050,Intermediate,10090.0,,1,urine levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 0-24 hr,,,CHEMBL627885,,50594,Mus musculus,,,N,1,BAO_0000218,1088.0
13902,,8050,Intermediate,10090.0,,1,urine levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 0-6 hr,,,CHEMBL627886,,50594,Mus musculus,,,N,1,BAO_0000218,1088.0
13903,,8050,Intermediate,10090.0,,1,urine levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 24-30 hr,,,CHEMBL627887,,50594,Mus musculus,,,N,1,BAO_0000218,1088.0
13904,,8050,Intermediate,10090.0,,1,urine levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 0-24 hr,,,CHEMBL627888,,50594,Mus musculus,,,N,1,BAO_0000218,1088.0
13905,,8050,Intermediate,10090.0,,1,urine levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 0-6 hr,,,CHEMBL628057,,50594,Mus musculus,,,N,1,BAO_0000218,1088.0
13906,,8050,Intermediate,10090.0,,1,urine levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 24-30 hr,,,CHEMBL627405,,50594,Mus musculus,,,N,1,BAO_0000218,1088.0
13907,,12582,Intermediate,9615.0,,1,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 11.9 uM/Kg of drug,,,CHEMBL627406,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,1088.0
13908,,12582,Intermediate,9615.0,,1,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 2.49 uM/Kg of drug,,,CHEMBL627407,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,1088.0
13909,,12582,Intermediate,9615.0,,1,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 26.2 uM/Kg of drug,,,CHEMBL627408,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,1088.0
13910,,12582,Intermediate,9615.0,,1,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 3.03 uM/Kg of drug,,,CHEMBL627409,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,1088.0
13911,,12582,Intermediate,9615.0,,1,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 30.3 uM/Kg of drug,,,CHEMBL875486,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,1088.0
13912,,12582,Intermediate,9615.0,,1,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 34.1 uM/Kg of drug,,,CHEMBL627410,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,1088.0
13913,,12582,Intermediate,9615.0,,1,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 52.4 uM/Kg of drug,,,CHEMBL627411,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,1088.0
13914,,12582,Intermediate,9615.0,,1,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 7.85 uM/Kg of drug,,,CHEMBL627412,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,1088.0
13915,,12582,Intermediate,9615.0,,1,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 8.47 uM/Kg of drug,,,CHEMBL627413,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,1088.0
13916,,12582,Intermediate,9615.0,,1,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 9.09 uM/Kg of drug,,,CHEMBL627414,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,1088.0
13917,,12582,Intermediate,9615.0,,1,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 10.1 uM/Kg of drug,,,CHEMBL627415,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,1088.0
13918,,12582,Intermediate,9615.0,,1,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 102 uM/Kg of drug,,,CHEMBL627416,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,1088.0
13919,,12582,Intermediate,9615.0,,1,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 3.40 uM/Kg of drug,,,CHEMBL627417,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,1088.0
13920,,12582,Intermediate,9615.0,,1,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 3.76 uM/Kg of drug,,,CHEMBL627418,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,1088.0
13921,,12582,Intermediate,9615.0,,1,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 34.1 uM/Kg of drug,,,CHEMBL627419,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,1088.0
13922,,12582,Intermediate,9615.0,,1,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 50.8 uM/Kg of drug,,,CHEMBL627320,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,1088.0
13923,,12582,Intermediate,9615.0,,1,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 68.1 uM/Kg of drug,,,CHEMBL627321,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,1088.0
13924,In vivo,12017,Intermediate,10116.0,,1,Biodistribution in kidney of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,CHEMBL627322,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2113.0
13925,In vivo,12017,Intermediate,10116.0,,1,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,CHEMBL627323,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2113.0
13926,In vivo,12017,Intermediate,10116.0,,1,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,,CHEMBL627491,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2113.0
13927,In vivo,12017,Intermediate,10116.0,,1,Biodistribution in kidney of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,CHEMBL627492,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2113.0
13928,In vivo,12017,Intermediate,10116.0,,1,Biodistribution in kidney of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,CHEMBL627493,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2113.0
13929,In vivo,12017,Intermediate,10116.0,,1,Biodistribution in liver of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,CHEMBL627494,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
13930,In vivo,12017,Intermediate,10116.0,,1,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,CHEMBL627495,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
13931,In vivo,12017,Intermediate,10116.0,,1,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,,CHEMBL627496,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
13932,In vivo,12017,Intermediate,10116.0,,1,Biodistribution in liver of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,CHEMBL627497,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
13933,In vivo,12017,Intermediate,10116.0,,1,Biodistribution in liver of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,CHEMBL627498,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
13934,In vivo,12017,Intermediate,10116.0,,1,Biodistribution in lungs of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,CHEMBL627499,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2048.0
13935,In vivo,12017,Intermediate,10116.0,,1,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,CHEMBL627500,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2048.0
13936,In vivo,12017,Intermediate,10116.0,,1,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,,CHEMBL627501,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2048.0
13937,In vivo,12017,Intermediate,10116.0,,1,Biodistribution in lungs of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,CHEMBL625616,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2048.0
13938,In vivo,12017,Intermediate,10116.0,,1,Biodistribution in lungs of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,CHEMBL625617,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2048.0
13939,In vivo,12017,Intermediate,10116.0,,1,Biodistribution in muscle of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,CHEMBL625618,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2385.0
13940,In vivo,12017,Intermediate,10116.0,,1,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,CHEMBL625619,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2385.0
13941,In vivo,12017,Intermediate,10116.0,,1,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,,CHEMBL625620,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2385.0
13942,In vivo,12017,Intermediate,10116.0,,1,Biodistribution in muscle of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,CHEMBL625621,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2385.0
13943,In vivo,12017,Intermediate,10116.0,,1,Biodistribution in muscle of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,CHEMBL625622,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2385.0
13944,In vivo,12017,Intermediate,10116.0,,1,Biodistribution in spleen of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,CHEMBL625788,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2106.0
13945,In vivo,12017,Intermediate,10116.0,,1,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,CHEMBL625789,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2106.0
13946,In vivo,12017,Intermediate,10116.0,,1,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,,CHEMBL625790,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2106.0
13947,In vivo,12017,Intermediate,10116.0,,1,Biodistribution in spleen of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,CHEMBL625791,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2106.0
13948,In vivo,12017,Intermediate,10116.0,,1,Biodistribution in spleen of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,CHEMBL622334,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2106.0
13949,In vivo,12017,Intermediate,10116.0,,1,Biodistribution in thyroid of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,CHEMBL622335,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2046.0
13950,In vivo,12017,Intermediate,10116.0,,1,Biodistribution in thyroid of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,CHEMBL622336,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2046.0
13951,In vivo,12017,Intermediate,10116.0,,1,Biodistribution in thyroid of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,,CHEMBL622337,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2046.0
13952,In vivo,12017,Intermediate,10116.0,,1,Biodistribution in thyroid of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,CHEMBL622338,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2046.0
13953,In vivo,12017,Intermediate,10116.0,,1,Biodistribution in thyroid of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,CHEMBL622339,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2046.0
13954,In vivo,12017,Intermediate,10116.0,,1,Biodistribution in uterus / blood of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,CHEMBL624153,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13955,In vivo,12017,Intermediate,10116.0,,1,Biodistribution in uterus / blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,CHEMBL628430,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13956,In vivo,12017,Intermediate,10116.0,,1,Biodistribution in uterus / blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,,CHEMBL628431,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13957,In vivo,12017,Intermediate,10116.0,,1,Biodistribution in uterus / blood of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,CHEMBL628432,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13958,In vivo,12017,Intermediate,10116.0,,1,Biodistribution in uterus / blood of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,CHEMBL628433,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13959,In vivo,12017,Intermediate,10116.0,,1,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",,,CHEMBL628434,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2106.0
13960,In vivo,12017,Intermediate,10116.0,,1,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",,,CHEMBL626789,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2106.0
13961,In vivo,12017,Intermediate,10116.0,,1,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2)",,,CHEMBL626790,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2106.0
13962,In vivo,12017,Intermediate,10116.0,,1,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",,,CHEMBL626791,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2106.0
13963,In vivo,12017,Intermediate,10116.0,,1,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",,,CHEMBL626792,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2106.0
13964,In vivo,12017,Intermediate,10116.0,,1,"Biodistribution in uterus / spleen, muscle, lungs of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",,,CHEMBL626793,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2106.0
13965,,11510,Intermediate,10116.0,,1,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 60.46 umol/kg,,,CHEMBL627436,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13966,,11510,Intermediate,10116.0,,1,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 67.18 umol/kg,,,CHEMBL627437,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13967,,11510,Intermediate,10116.0,,1,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 74.26 umol/kg,,,CHEMBL627438,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13968,,11510,Intermediate,10116.0,,1,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 78.97 umol/kg,,,CHEMBL627439,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13969,,11510,Intermediate,10116.0,,1,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 120.93 umol/kg,,,CHEMBL627440,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13970,,11510,Intermediate,10116.0,,1,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 134.35 umol/kg,,,CHEMBL627602,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13971,,11510,Intermediate,10116.0,,1,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 148.52 umol/kg,,,CHEMBL627603,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13972,,11510,Intermediate,10116.0,,1,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 157.94 umol/kg,,,CHEMBL627604,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13973,,11510,Intermediate,10116.0,,1,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 15.12 umol/kg,,,CHEMBL627605,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13974,,11510,Intermediate,10116.0,,1,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 16.79 umol/kg,,,CHEMBL627606,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13975,,11510,Intermediate,10116.0,,1,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 18.56 umol/kg,,,CHEMBL627607,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13976,,11510,Intermediate,10116.0,,1,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 19.74 umol/kg,,,CHEMBL627608,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13977,,11510,Intermediate,10116.0,,1,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 241.86 umol/kg,,,CHEMBL627609,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13978,,11510,Intermediate,10116.0,,1,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 268.71 umol/kg,,,CHEMBL627610,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13979,,11510,Intermediate,10116.0,,1,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 297.03 umol/kg,,,CHEMBL627611,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13980,,11510,Intermediate,10116.0,,1,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 315.88 umol/kg,,,CHEMBL627612,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
13981,,8362,Autocuration,,,1,Octanol:water partition coefficient is evaluated,,,CHEMBL627613,,22229,,,,U,0,BAO_0000100,
13982,,8257,Autocuration,,,1,Partition coefficient in 1-octanol/water system,,,CHEMBL627614,,22224,,,,U,0,BAO_0000100,
13983,,8257,Autocuration,,,1,Partition coefficient in 1-octanol/water system measured using radio active compounds,,,CHEMBL627615,,22224,,,,U,0,BAO_0000100,
13984,,9468,Autocuration,,,1,Partition coefficient in octanol/water system was determined,,,CHEMBL627616,,22224,,,,U,0,BAO_0000100,
13985,,9468,Autocuration,,,1,Partition coefficient in octanol/water system was determined using [14C]-labeled compounds.,,,CHEMBL627617,,22224,,,,U,0,BAO_0000100,
13986,,10568,Autocuration,,,1,Pseudo-first-order rate constant at pH 10 and 35 degrees Centigrade,,,CHEMBL627618,,22224,,,,U,0,BAO_0000019,
13987,,10568,Autocuration,,,1,"Pseudo-first-order rate constant at pH 10, micro=0.5, 35 degrees Centigrade",,,CHEMBL627619,,22224,,,,U,0,BAO_0000019,
13988,,15359,Autocuration,,,1,Pseudo-first-order rate constant of the compound,,,CHEMBL627620,,22224,,,,U,0,BAO_0000019,
13989,,15359,Autocuration,,,1,Pseudo-first-order rate constant with 1-min time point,,,CHEMBL627621,,22224,,,,U,0,BAO_0000019,
13990,,15359,Autocuration,,,1,Pseudo-first-order rate constant without 1-min time point,,,CHEMBL627622,,22224,,,,U,0,BAO_0000019,
13991,,10431,Autocuration,,,1,Pseudo-first-order rate constant was determined in pH 7.4 phosphate buffer in presence 0.5 mM EDTA,,,CHEMBL627623,,22224,,,,U,0,BAO_0000019,
13992,,10431,Autocuration,,,1,Pseudo-first-order rate constant was determined in pH 7.4 phosphate buffer in presence 50 mM EDTA,,,CHEMBL627624,,22224,,,,U,0,BAO_0000019,
13993,,10431,Autocuration,,,1,Pseudo-first-order rate constant was determined in pH 7.4 phosphate buffer in presence 70 mM EDTA,,,CHEMBL627625,,22224,,,,U,0,BAO_0000019,
13994,,15704,Autocuration,,,1,Rate constants determined using 31P NMR Kinetics experiments at 37 degrees Centigrade,,,CHEMBL628523,,22224,,,,U,0,BAO_0000019,
13995,,15287,Autocuration,,,1,The alkaline hydrolysis second order rate constant(K OH) of the compound,,,CHEMBL628524,,22224,,,,U,0,BAO_0000019,
13996,,7516,Autocuration,,,1,The efflux rate constant of the compound,,,CHEMBL628525,,22224,,,,U,0,BAO_0000019,
13997,,12973,Autocuration,,,1,The reaction rate constant (K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine,,,CHEMBL625732,,22224,,,,U,0,BAO_0000019,
13998,,12973,Autocuration,,,1,The reaction rate constant(K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine,,,CHEMBL625733,,22224,,,,U,0,BAO_0000019,
13999,,12973,Autocuration,,,1,The reaction rate constant(K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine,,,CHEMBL625734,,22224,,,,U,0,BAO_0000019,
14000,,12973,Autocuration,,,1,The reaction rate constant(K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine; ND= not determined,,,CHEMBL625913,,22224,,,,U,0,BAO_0000019,
14001,,8696,Autocuration,,,1,Association constant was evaluated towards synthetic peptidoglycan analogue Ac2-Lys-D-Ala-D-Ala,,,CHEMBL625914,,22224,,,,U,0,BAO_0000019,
14002,,15052,Autocuration,,,1,Equilibrium association (binding) constant interacting with Unilamellar Vesicles of electroneutral DMPC in PBSbuffer at pH 7.4 and 37 C,,,CHEMBL625915,,22224,,,,U,0,BAO_0000019,
14003,,15052,Autocuration,,,1,Equilibrium association (binding) constant interacting with Unilamellar Vesicles of negatively charged DMPG in PBS buffer at pH 7.4 and 37 C,,,CHEMBL625916,,22224,,,,U,0,BAO_0000019,
14004,,10503,Autocuration,,,1,Evaluated for the mustard reactivity by determining rate constant for hydrolysis of mustard in aqueous acetone (K H),,,CHEMBL625917,,22224,,,,U,0,BAO_0000019,
14005,,8354,Autocuration,,,1,"Effective biomolecular rate constant at the concentration 0.500 mM [HOX] in the conditions of 25degreeC,pH 7.6",,,CHEMBL625918,,22224,,,,U,0,BAO_0000019,
14006,,8354,Autocuration,,,1,"Effective biomolecular rate constant at the concentration 0.767 mM [HOX] in the conditions of 25degreeC,pH 7.6",,,CHEMBL625919,,22224,,,,U,0,BAO_0000019,
14007,,8354,Autocuration,,,1,"Effective biomolecular rate constant at the concentration 0.790 mM [HOX] in the conditions of 25degreeC,pH 7.6",,,CHEMBL625920,,22224,,,,U,0,BAO_0000019,
14008,,8354,Autocuration,,,1,"Effective biomolecular rate constant at the concentration 1.00 mM [HOX] in the conditions of 25degreeC,pH 7.6",,,CHEMBL874453,,22224,,,,U,0,BAO_0000019,
14009,,8354,Autocuration,,,1,"Effective biomolecular rate constant in the conditions of 25degreeC,pH 7.6",,,CHEMBL625921,,22224,,,,U,0,BAO_0000019,
14010,,10503,Autocuration,,,1,Evaluated for the mustard reactivity by determining rate constant for alkylation of 4-(4-nitrobenzyl)pyridine using NBP alkylation assay,,,CHEMBL625922,,22224,,,,U,0,BAO_0000019,
14011,,8354,Autocuration,,,1,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 0.500 mM [HOX] in the conditions of 25degreeC,pH 7.6",,,CHEMBL625923,,22224,,,,U,0,BAO_0000019,
14012,,8354,Autocuration,,,1,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 0.767 mM [HOX] in the conditions of 25degreeC,pH 7.6",,,CHEMBL625924,,22224,,,,U,0,BAO_0000019,
14013,,8354,Autocuration,,,1,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 0.790 mM [HOX] in the conditions of 25degreeC,pH 7.6",,,CHEMBL625925,,22224,,,,U,0,BAO_0000019,
14014,,8354,Autocuration,,,1,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 1.00 mM [HOX] in the conditions of 25degreeC,pH 7.6",,,CHEMBL625926,,22224,,,,U,0,BAO_0000019,
14015,In vivo,13100,Intermediate,10116.0,,1,Biodistribution in rat lung at 60 minutes after dose administration.,,,CHEMBL627704,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2048.0
14016,In vivo,13100,Intermediate,10116.0,,1,Biodistribution in rat pons/medulla at 120 minutes after dose administration.,,,CHEMBL627705,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
14017,In vivo,13100,Intermediate,10116.0,,1,Biodistribution in rat pons/medulla at 15 minutes after dose administration.,,,CHEMBL627706,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
14018,In vivo,13100,Intermediate,10116.0,,1,Biodistribution in rat pons/medulla at 240 minutes after dose administration.,,,CHEMBL627707,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
14019,In vivo,13100,Intermediate,10116.0,,1,Biodistribution in rat pons/medulla at 30 minutes after dose administration.,,,CHEMBL627708,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
14020,In vivo,13100,Intermediate,10116.0,,1,Biodistribution in rat pons/medulla at 360 minutes after dose administration.,,,CHEMBL628361,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
14021,In vivo,13100,Intermediate,10116.0,,1,Biodistribution in rat pons/medulla at 60 minutes after dose administration.,,,CHEMBL628362,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
14022,In vivo,13100,Intermediate,10116.0,,1,Biodistribution in rat striatum at 120 minutes after dose administration.,,,CHEMBL628363,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2435.0
14023,In vivo,13100,Intermediate,10116.0,,1,Biodistribution in rat striatum at 1440 minutes after dose administration.,,,CHEMBL628364,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2435.0
14024,In vivo,13100,Intermediate,10116.0,,1,Biodistribution in rat striatum at 15 minutes after dose administration.,,,CHEMBL628365,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2435.0
14025,In vivo,13100,Intermediate,10116.0,,1,Biodistribution in rat striatum at 240 minutes after dose administration.,,,CHEMBL874454,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2435.0
14026,In vivo,13100,Intermediate,10116.0,,1,Biodistribution in rat striatum at 30 minutes after dose administration.,,,CHEMBL628531,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2435.0
14027,In vivo,13100,Intermediate,10116.0,,1,Biodistribution in rat striatum at 360 minutes after dose administration.,,,CHEMBL628532,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2435.0
14028,In vivo,13100,Intermediate,10116.0,,1,Biodistribution in rat striatum at 3 hr after dose administration.,,,CHEMBL628533,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2435.0
14029,In vivo,13100,Intermediate,10116.0,,1,Biodistribution in rat striatum at 60 minutes after dose administration.,,,CHEMBL628534,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2435.0
14030,In vivo,13100,Intermediate,10116.0,,1,Biodistribution in rat thyroid at 120 minutes after dose administration.,,,CHEMBL628535,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2046.0
14031,In vivo,13100,Intermediate,10116.0,,1,Biodistribution in rat thyroid at 1440 minutes after dose administration.,,,CHEMBL628536,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2046.0
14032,In vivo,13100,Intermediate,10116.0,,1,Biodistribution in rat thyroid at 15 minutes after dose administration.,,,CHEMBL628537,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2046.0
14033,In vivo,13100,Intermediate,10116.0,,1,Biodistribution in rat thyroid at 240 minutes after dose administration.,,,CHEMBL628538,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2046.0
14034,In vivo,13100,Intermediate,10116.0,,1,Biodistribution in rat thyroid at 30 minutes after dose administration.,,,CHEMBL628539,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2046.0
14035,In vivo,13100,Intermediate,10116.0,,1,Biodistribution in rat thyroid at 360 minutes after dose administration.,,,CHEMBL630297,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2046.0
14036,In vivo,13100,Intermediate,10116.0,,1,Biodistribution in rat thyroid at 60 minutes after dose administration.,,,CHEMBL630298,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2046.0
14037,In vivo,13100,Intermediate,10116.0,,1,Biodistribution in rest of brain of rat 120 minutes after dose administration.,,,CHEMBL630299,,50597,Rattus norvegicus,,,N,1,BAO_0000218,955.0
14038,In vivo,13100,Intermediate,10116.0,,1,Biodistribution in rest of brain of rat at 1440 minutes after dose administration.,,,CHEMBL628094,,50597,Rattus norvegicus,,,N,1,BAO_0000218,955.0
14039,In vivo,13100,Intermediate,10116.0,,1,Biodistribution in rest of brain of rat at 15 minutes after dose administration.,,,CHEMBL628095,,50597,Rattus norvegicus,,,N,1,BAO_0000218,955.0
14040,In vivo,13100,Intermediate,10116.0,,1,Biodistribution in rest of brain of rat at 240 minutes after dose administration.,,,CHEMBL874648,,50597,Rattus norvegicus,,,N,1,BAO_0000218,955.0
14041,In vivo,13100,Intermediate,10116.0,,1,Biodistribution in rest of brain of rat at 30 minutes after dose administration.,,,CHEMBL628096,,50597,Rattus norvegicus,,,N,1,BAO_0000218,955.0
14042,In vivo,13100,Intermediate,10116.0,,1,Biodistribution in rest of brain of rat at 360 minutes after dose administration.,,,CHEMBL628097,,50597,Rattus norvegicus,,,N,1,BAO_0000218,955.0
14043,In vivo,13100,Intermediate,10116.0,,1,Biodistribution in rest of brain of rat at 60 minutes after dose administration.,,,CHEMBL628098,,50597,Rattus norvegicus,,,N,1,BAO_0000218,955.0
14044,,13331,Autocuration,,,1,"Mean rate constant for the hydrolysis of compound in buffers at pH 6.5, at 37 degrees Celsius in incubation mixture - d(A)-d(T) (10:1)",,,CHEMBL628099,,22224,,,,U,0,BAO_0000019,
14045,,13331,Autocuration,,,1,"Mean rate constant for the hydrolysis of compound in buffers at pH 6.5, at 37 degrees Celsius in incubation mixture - d(G)-d(C) (10:1)",,,CHEMBL628100,,22224,,,,U,0,BAO_0000019,
14046,,13331,Autocuration,,,1,Mean rate constant for the hydrolysis of compound in buffers at pH 7.4 at 37 degrees Centigrade in incubation mixture - d(A)-d(T) (10:!),,,CHEMBL628101,,22224,,,,U,0,BAO_0000019,
14047,,13331,Autocuration,,,1,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - 5'-GMP/5'-CMP (1:1)",,,CHEMBL628102,,22224,,,,U,0,BAO_0000019,
14048,,13331,Autocuration,,,1,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(A)-d(T) (1:1)",,,CHEMBL628103,,22224,,,,U,0,BAO_0000019,
14049,,13331,Autocuration,,,1,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(G)-d(C) (10:1)",,,CHEMBL628104,,22224,,,,U,0,BAO_0000019,
14050,,13331,Autocuration,,,1,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(G)-d(C) (1:1)",,,CHEMBL628105,,22224,,,,U,0,BAO_0000019,
14051,,13331,Autocuration,,,1,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(G)-d(T) (10:1)",,,CHEMBL628106,,22224,,,,U,0,BAO_0000019,
14052,,10086,Intermediate,10116.0,,1,Mean urine volume excretion in conscious rats at a dose of 0.3 mg/kg given orally,,,CHEMBL628107,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14053,,10086,Autocuration,,,1,Mean urine volume excretion in conscious rats at a dose of 0.3 mg/kg given orally,,,CHEMBL628108,,22224,,,,U,0,BAO_0000218,1088.0
14054,,10086,Intermediate,10116.0,,1,Mean urine volume excretion in conscious rats at a dose of 1.0 mg/kg given orally,,,CHEMBL628109,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14055,,10086,Autocuration,,,1,Mean urine volume excretion in conscious rats at a dose of 1.0 mg/kg given orally,,,CHEMBL625299,,22224,,,,U,0,BAO_0000218,1088.0
14056,,10086,Intermediate,10116.0,,1,Mean urine volume excretion in conscious rats at a dose of 10 mg/kg given orally,,,CHEMBL625300,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14057,,10086,Intermediate,10116.0,,1,Mean urine volume excretion in conscious rats at a dose of 100 mg/kg given orally,,,CHEMBL625301,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14058,,10086,Intermediate,10116.0,,1,Mean urine volume excretion in conscious rats at a dose of 3.0 mg/kg given orally,,,CHEMBL625302,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14059,,10086,Intermediate,10116.0,,1,Mean urine volume excretion in conscious rats at a dose of 30 mg/kg given orally,,,CHEMBL874649,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14060,,13248,Intermediate,10116.0,,1,In vitro metabolic stability of the test compound was evaluated after incubation in the presence of freshly isolated rat hepatocytes,,,CHEMBL625303,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
14061,,13248,Intermediate,10116.0,,1,In vitro metabolic stability of the test compound was evaluated after incubation in the presence of freshly isolated rat hepatocytes; NA= Not tested,,,CHEMBL625463,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
14062,,14527,Intermediate,9606.0,,1,In vitro metabolism in human liver microsomes,,,CHEMBL625464,,50587,Homo sapiens,,,N,1,BAO_0000218,2107.0
14063,,3008,Intermediate,9606.0,,1,Metabolism (NADH oxidation) by recombinant human NAD(P)H: quinone oxidoreductase (NQO1) is evaluated.,,,CHEMBL625465,,50587,Homo sapiens,,,N,1,BAO_0000218,
14064,,12582,Intermediate,9615.0,,1,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 9.06 uM/Kg of drug,,,CHEMBL625466,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,1088.0
14065,,12582,Intermediate,9615.0,,1,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 9.6 uM/Kg of drug,,,CHEMBL625467,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,1088.0
14066,,12582,Intermediate,10116.0,,1,Total electrolytic excretion of chlorine in urine of rats after intravenous administration of 7.94 uM/Kg of drug,,,CHEMBL625468,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14067,,12582,Intermediate,10116.0,,1,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 0 uM/Kg of drug,,,CHEMBL625469,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14068,,12582,Intermediate,10116.0,,1,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 1.01 uM/Kg of drug,,,CHEMBL625470,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14069,,12582,Intermediate,10116.0,,1,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 1.13 uM/Kg of drug,,,CHEMBL632418,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14070,,12582,Intermediate,10116.0,,1,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 10.1 uM/Kg of drug,,,CHEMBL627250,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14071,,12582,Intermediate,10116.0,,1,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 102 uM/Kg of drug,,,CHEMBL627251,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14072,,12582,Intermediate,10116.0,,1,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 105 uM/Kg of drug,,,CHEMBL627252,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14073,,12582,Intermediate,10116.0,,1,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 11.3 uM/Kg of drug,,,CHEMBL627253,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14074,,12582,Intermediate,10116.0,,1,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 113 uM/Kg of drug,,,CHEMBL627254,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14075,,12582,Intermediate,10116.0,,1,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 19.5 uM/Kg of drug,,,CHEMBL875471,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14076,,12582,Intermediate,10116.0,,1,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 195 uM/Kg of drug,,,CHEMBL627255,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14077,,12582,Intermediate,10116.0,,1,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 21.7 uM/Kg of drug,,,CHEMBL627256,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14078,,12582,Intermediate,10116.0,,1,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 217 uM/Kg of drug,,,CHEMBL627257,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14079,,12582,Intermediate,10116.0,,1,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 23.9 uM/Kg of drug,,,CHEMBL627258,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14080,,12582,Intermediate,10116.0,,1,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 239 uM/Kg of drug,,,CHEMBL627259,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14081,,12582,Intermediate,10116.0,,1,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 24.9 uM/Kg of drug,,,CHEMBL627260,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14082,,12582,Intermediate,10116.0,,1,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 249 uM/Kg of drug,,,CHEMBL623256,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14083,,12582,Intermediate,10116.0,,1,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 25.9 uM/Kg of drug,,,CHEMBL874413,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14084,,12582,Intermediate,10116.0,,1,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 259 uM/Kg of drug,,,CHEMBL623257,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14085,,12582,Intermediate,10116.0,,1,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 26.5 uM/Kg of drug,,,CHEMBL623258,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14086,,12582,Intermediate,10116.0,,1,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 265 uM/Kg of drug,,,CHEMBL623259,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14087,,12582,Intermediate,10116.0,,1,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 27 uM/Kg of drug,,,CHEMBL623260,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14088,,12582,Intermediate,10116.0,,1,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 27.9 uM/Kg of drug,,,CHEMBL623261,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14089,,12582,Intermediate,10116.0,,1,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 270 uM/Kg of drug,,,CHEMBL623262,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14090,,12582,Intermediate,10116.0,,1,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 279 uM/Kg of drug,,,CHEMBL623263,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14091,,12582,Intermediate,10116.0,,1,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 28.2 uM/Kg of drug,,,CHEMBL623264,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14092,,12582,Intermediate,10116.0,,1,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 28.22 uM/Kg of drug,,,CHEMBL623265,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14093,,12582,Intermediate,10116.0,,1,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 28.9 uM/Kg of drug,,,CHEMBL623266,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14094,,12582,Intermediate,10116.0,,1,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 282 uM/Kg of drug,,,CHEMBL623267,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14095,,12582,Intermediate,10116.0,,1,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 289 uM/Kg of drug,,,CHEMBL623268,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14096,,12582,Intermediate,10116.0,,1,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 3.40 uM/Kg of drug,,,CHEMBL623269,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14097,,12582,Intermediate,10116.0,,1,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 3.76 uM/Kg of drug,,,CHEMBL623270,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14098,,12582,Intermediate,10116.0,,1,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 30.2 uM/Kg of drug,,,CHEMBL623271,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14099,,12582,Intermediate,10116.0,,1,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 302 uM/Kg of drug,,,CHEMBL623272,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14100,,12582,Intermediate,10116.0,,1,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 31.6 uM/Kg of drug,,,CHEMBL623273,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14101,,12582,Intermediate,10116.0,,1,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 316 uM/Kg of drug,,,CHEMBL623274,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14102,,12582,Intermediate,10116.0,,1,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 32.4 uM/Kg of drug,,,CHEMBL874414,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14103,,12582,Intermediate,10116.0,,1,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 324 uM/Kg of drug,,,CHEMBL623275,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14104,,12582,Intermediate,10116.0,,1,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 34.0 uM/Kg of drug,,,CHEMBL629150,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14105,,12582,Intermediate,10116.0,,1,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 34.1 uM/Kg of drug,,,CHEMBL623276,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14106,,12582,Intermediate,10116.0,,1,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 34.8 uM/Kg of drug,,,CHEMBL623277,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14107,,12582,Intermediate,10116.0,,1,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 341 uM/Kg of drug,,,CHEMBL623112,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14108,,12582,Intermediate,10116.0,,1,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 348 uM/Kg of drug,,,CHEMBL623113,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14109,,12582,Intermediate,10116.0,,1,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 37.6 uM/Kg of drug,,,CHEMBL623800,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14110,,12582,Intermediate,10116.0,,1,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 58.4 uM/Kg of drug,,,CHEMBL623801,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14111,In vivo,12017,Intermediate,10116.0,,1,"Biodistribution in uterus / spleen, muscle, lungs of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",,,CHEMBL623802,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2106.0
14112,In vivo,12017,Intermediate,10116.0,,1,Biodistribution in uterus of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,CHEMBL623803,,50597,Rattus norvegicus,,,N,1,BAO_0000218,995.0
14113,In vivo,12017,Intermediate,10116.0,,1,Biodistribution in uterus of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,CHEMBL623970,,50597,Rattus norvegicus,,,N,1,BAO_0000218,995.0
14114,In vivo,12017,Intermediate,10116.0,,1,Biodistribution in uterus of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,CHEMBL623971,,50597,Rattus norvegicus,,,N,1,BAO_0000218,995.0
14115,In vivo,14045,Intermediate,10116.0,,1,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 10 min post injection (Average of three to five animals),,,CHEMBL623972,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
14116,In vivo,14045,Intermediate,10116.0,,1,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 30 min post injection (Average of three to five animals),,,CHEMBL623973,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
14117,In vivo,14045,Intermediate,10116.0,,1,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 5 min post injection (Average of three to five animals),,,CHEMBL623974,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
14118,In vivo,14045,Intermediate,10116.0,,1,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 60 min post injection (Average of three to five animals),,,CHEMBL623975,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
14119,In vivo,14045,Intermediate,10116.0,,1,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 10 min post injection (Average of three to five animals),,,CHEMBL623976,,50597,Rattus norvegicus,,,N,1,BAO_0000218,955.0
14120,In vivo,14045,Intermediate,10116.0,,1,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 30 min post injection (Average of three to five animals),,,CHEMBL623977,,50597,Rattus norvegicus,,,N,1,BAO_0000218,955.0
14121,In vivo,14045,Intermediate,10116.0,,1,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 5 min post injection (Average of three to five animals),,,CHEMBL623978,,50597,Rattus norvegicus,,,N,1,BAO_0000218,955.0
14122,In vivo,14045,Intermediate,10116.0,,1,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 60 min post injection (Average of three to five animals),,,CHEMBL623979,,50597,Rattus norvegicus,,,N,1,BAO_0000218,955.0
14123,In vivo,14045,Intermediate,10116.0,,1,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 10 min post injection (Average of three to five animals),,,CHEMBL623980,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
14124,In vivo,14045,Intermediate,10116.0,,1,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 30 min post injection (Average of three to five animals),,,CHEMBL623981,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
14125,In vivo,14045,Intermediate,10116.0,,1,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 5 min post injection (Average of three to five animals),,,CHEMBL626278,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
14126,In vivo,14045,Intermediate,10116.0,,1,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 60 min post injection (Average of three to five animals),,,CHEMBL626279,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
14127,In vivo,14045,Intermediate,10090.0,,1,Biodistribution in mice bladder plus excreted urine was determined,,,CHEMBL626280,,50594,Mus musculus,,,N,1,BAO_0000218,
14128,,14045,Intermediate,10090.0,,1,"Percentage biodistribution in mouse blood, 10 minutes post injection",,,CHEMBL626281,,50594,Mus musculus,,,N,1,BAO_0000218,
14129,,14045,Intermediate,10090.0,,1,"Percentage biodistribution in mouse blood, 30 minutes post injection",,,CHEMBL626282,,50594,Mus musculus,,,N,1,BAO_0000218,
14130,,14045,Intermediate,10090.0,,1,"Percentage biodistribution in mouse blood, 5 minutes post injection",,,CHEMBL626283,,50594,Mus musculus,,,N,1,BAO_0000218,
14131,,14045,Intermediate,10090.0,,1,"Percentage biodistribution in mouse blood, 60 minutes post injection",,,CHEMBL626284,,50594,Mus musculus,,,N,1,BAO_0000218,
14132,,14045,Intermediate,10090.0,,1,"Percentage biodistribution in mouse brain, 10 minutes post injection",,,CHEMBL626285,,50594,Mus musculus,,,N,1,BAO_0000218,955.0
14133,,14045,Intermediate,10090.0,,1,"Percentage biodistribution in mouse brain, 30 minutes post injection",,,CHEMBL626286,,50594,Mus musculus,,,N,1,BAO_0000218,955.0
14134,,14045,Intermediate,10090.0,,1,"Percentage biodistribution in mouse brain, 5 minutes post injection",,,CHEMBL626287,,50594,Mus musculus,,,N,1,BAO_0000218,955.0
14135,,14045,Intermediate,10090.0,,1,"Percentage biodistribution in mouse brain, 60 minutes post injection",,,CHEMBL626288,,50594,Mus musculus,,,N,1,BAO_0000218,955.0
14136,,14045,Intermediate,10090.0,,1,"Percentage biodistribution in mouse heart, 10 minutes post injection",,,CHEMBL626289,,50594,Mus musculus,,,N,1,BAO_0000218,
14137,,14045,Intermediate,10090.0,,1,"Percentage biodistribution in mouse heart, 30 minutes post injection",,,CHEMBL626290,,50594,Mus musculus,,,N,1,BAO_0000218,
14138,,14045,Intermediate,10090.0,,1,"Percentage biodistribution in mouse heart, 5 minutes post injection",,,CHEMBL626291,,50594,Mus musculus,,,N,1,BAO_0000218,
14139,,14045,Intermediate,10090.0,,1,"Percentage biodistribution in mouse heart, 60 minutes post injection",,,CHEMBL839888,,50594,Mus musculus,,,N,1,BAO_0000218,
14140,,14045,Intermediate,10090.0,,1,"Percentage biodistribution in mouse intestine, 10 minutes post injection",,,CHEMBL626292,,50594,Mus musculus,,,N,1,BAO_0000218,160.0
14141,,14045,Intermediate,10090.0,,1,"Percentage biodistribution in mouse intestine, 30 minutes post injection",,,CHEMBL626293,,50594,Mus musculus,,,N,1,BAO_0000218,160.0
14142,,14045,Intermediate,10090.0,,1,"Percentage biodistribution in mouse intestine, 5 minutes post injection",,,CHEMBL626294,,50594,Mus musculus,,,N,1,BAO_0000218,160.0
14143,,14045,Intermediate,10090.0,,1,"Percentage biodistribution in mouse intestine, 60 minutes post injection",,,CHEMBL626295,,50594,Mus musculus,,,N,1,BAO_0000218,160.0
14144,,14045,Intermediate,10090.0,,1,"Percentage biodistribution in mouse liver, 10 minutes post injection",,,CHEMBL627659,,50594,Mus musculus,,,N,1,BAO_0000218,2107.0
14145,,14045,Intermediate,10090.0,,1,"Percentage biodistribution in mouse liver, 30 minutes of post injection",,,CHEMBL627660,,50594,Mus musculus,,,N,1,BAO_0000218,2107.0
14146,,14045,Intermediate,10090.0,,1,"Percentage biodistribution in mouse liver, 5 minutes post injection",,,CHEMBL627661,,50594,Mus musculus,,,N,1,BAO_0000218,2107.0
14147,In vivo,14045,Intermediate,10090.0,,1,Biodistribution in mice liver at 60 minutes of post injection,,,CHEMBL627662,,50594,Mus musculus,,,N,1,BAO_0000218,2107.0
14148,In vivo,14045,Intermediate,10090.0,,1,Biodistribution in mice lungs at 10 min of post injection,,,CHEMBL627663,,50594,Mus musculus,,,N,1,BAO_0000218,2048.0
14149,,14045,Intermediate,10090.0,,1,"Percentage biodistribution in mouse lung, 30 minutes post injection",,,CHEMBL627664,,50594,Mus musculus,,,N,1,BAO_0000218,
14150,,14045,Intermediate,10090.0,,1,"Percentage biodistribution in mousee lung, 5 minutes post injection",,,CHEMBL627665,,50594,Mus musculus,,,N,1,BAO_0000218,
14151,In vivo,14045,Intermediate,10090.0,,1,Biodistribution in mice lungs at 60 min of post injection,,,CHEMBL627666,,50594,Mus musculus,,,N,1,BAO_0000218,2048.0
14152,,14045,Intermediate,10090.0,,1,Percentage biodistribution in mouse spleen,,,CHEMBL627667,,50594,Mus musculus,,,N,1,BAO_0000218,2106.0
14153,,14045,Intermediate,10090.0,,1,Percentage biodistribution in mouse stomach,,,CHEMBL627668,,50594,Mus musculus,,,N,1,BAO_0000218,945.0
14154,,11745,Intermediate,10090.0,,1,Mean biodistribution and elimination data in urine was reported 24 h after administering compound intravenously in tumor-bearing female BALB-C mice.,,,CHEMBL627669,,50594,Mus musculus,,,N,1,BAO_0000218,1088.0
14155,In vivo,13257,Autocuration,,,1,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in bladder,,,CHEMBL627670,,22224,,,,U,0,BAO_0000218,1255.0
14156,In vivo,13257,Autocuration,,,1,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in blood,,,CHEMBL627671,,22224,,,,U,0,BAO_0000218,178.0
14157,In vivo,13257,Autocuration,,,1,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in bone,,,CHEMBL627672,,22224,,,,U,0,BAO_0000218,1474.0
14158,In vivo,13257,Autocuration,,,1,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in fat,,,CHEMBL627673,,22224,,,,U,0,BAO_0000218,
14159,In vivo,13257,Autocuration,,,1,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in kidney,,,CHEMBL627674,,22224,,,,U,0,BAO_0000218,2113.0
14160,In vivo,13257,Autocuration,,,1,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in liver,,,CHEMBL627675,,22224,,,,U,0,BAO_0000218,2107.0
14161,In vivo,13257,Autocuration,,,1,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in lung,,,CHEMBL627676,,22224,,,,U,0,BAO_0000218,2048.0
14162,In vivo,13257,Autocuration,,,1,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in muscle,,,CHEMBL627677,,22224,,,,U,0,BAO_0000218,2385.0
14163,,8354,Autocuration,,,1,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator in the conditions of 25degreeC,pH 7.6",,,CHEMBL627678,,22224,,,,U,0,BAO_0000019,
14164,,7095,Intermediate,10116.0,,1,Affinity for protein binding expressed as association constant in fresh rat serum,,,CHEMBL627679,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1977.0
14165,,12185,Autocuration,,,1,Kinetic constant (Kcat) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation,,,CHEMBL627680,,22224,,,,U,0,BAO_0000019,
14166,,12185,Autocuration,,,1,Kinetic constant (Kcat) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation; Inactive,,,CHEMBL627681,,22224,,,,U,0,BAO_0000019,
14167,,12185,Autocuration,,,1,Inactivation constant (Kinact) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation,,,CHEMBL627682,,22224,,,,U,0,BAO_0000019,
14168,,12185,Autocuration,,,1,Inactivation constant (Kinact) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation; Inactive,,,CHEMBL627683,,22224,,,,U,0,BAO_0000019,
14169,,12686,Autocuration,,,1,The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 2.4,,,CHEMBL627684,,22224,,,,U,0,BAO_0000019,
14170,,12686,Autocuration,,,1,"The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 2.4; Significant cyclization occurred during nitro reduction, precluding isolation of the pure amine and determination of rate constants",,,CHEMBL874441,,22224,,,,U,0,BAO_0000019,
14171,,12686,Autocuration,,,1,The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 6.8; No cyclization detected over 4 h,,,CHEMBL627685,,22224,,,,U,0,BAO_0000019,
14172,,12686,Autocuration,,,1,"The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 6.8; Significant cyclization occurred during nitro reduction, precluding isolation of the pure amine and determination of rate constants",,,CHEMBL627686,,22224,,,,U,0,BAO_0000019,
14173,,8057,Autocuration,,,1,Apparent rate constant Koff for inactivation of dTMP synthase.,,,CHEMBL627687,,22224,,,,U,0,BAO_0000019,
14174,,15778,Autocuration,,,1,The irreversible inhibitor activity by second order rate equation.,,,CHEMBL627688,,22224,,,,U,0,BAO_0000019,
14175,,12375,Intermediate,10116.0,,1,Compound was tested for oral diuretic effect on spontaneously hypertensive rats by measuring the potassium excretion at 1 mg/kg concentration,,,CHEMBL628038,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
14176,,12375,Intermediate,10116.0,,1,Compound was tested for oral diuretic effect on spontaneously hypertensive rats by measuring the potassium excretion at 5 mg/kg concentration,,,CHEMBL628039,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
14177,,12375,Intermediate,10116.0,,1,Compound was tested for oral diuretic effect on spontaneously hypertensive rats by measuring the potassium excretion at vehicle concentration,,,CHEMBL628040,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
14178,,13588,Autocuration,,,1,Dissociation rate calculated from the first-order equation using t1/2 value,,,CHEMBL628041,,22224,,,,U,0,BAO_0000019,
14179,,15039,Autocuration,,,1,The compound was tested for Binding constant against DNA,,,CHEMBL630226,,22224,,,,U,0,BAO_0000019,
14180,,9500,Autocuration,,,1,First order rate constant for cyclization of the compound,,,CHEMBL628042,,22224,,,,U,0,BAO_0000019,
14181,,10014,Autocuration,,,1,First order rate constant of compound was determined in 50 mM phosphate buffer (pH 7.4) at 24 degree celsius,,,CHEMBL625232,,22224,,,,U,0,BAO_0000019,
14182,,10014,Autocuration,,,1,First order rate constant of compound was determined in 50 mM phosphate buffer (pH 7.4) at 37 degree celsius,,,CHEMBL625233,,22224,,,,U,0,BAO_0000019,
14183,,568,Autocuration,,,1,Hydrolysis rate constant was determined,,,CHEMBL625979,,22224,,,,U,0,BAO_0000019,
14184,,10026,Autocuration,,,1,Observed first order rate constant,,,CHEMBL625980,,22224,,,,U,0,BAO_0000019,
14185,,10281,Autocuration,,,1,Rate constant (cyclization rate) in CD3CN-deuterated phosphate buffer at pH 7.4,,,CHEMBL625981,,22224,,,,U,0,BAO_0000019,
14186,,10281,Autocuration,,,1,Rate constant (cyclization rate) in CD3CN-deuterated phosphate buffer at pH 7.4,,,CHEMBL625982,,22224,,,,U,0,BAO_0000019,
14187,,9680,Autocuration,,,1,Second-order rate constant for attack on PNPA at 25 degree Centigrade,,,CHEMBL625983,,22224,,,,U,0,BAO_0000019,
14188,,13028,Autocuration,,,1,Kinetic parameter of epimerization at a salt concentration (0.01 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,,CHEMBL625984,,22224,,,,U,0,BAO_0000019,
14189,,13028,Autocuration,,,1,Kinetic parameter of epimerization at a salt concentration (0.1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,,CHEMBL625985,,22224,,,,U,0,BAO_0000019,
14190,,13028,Autocuration,,,1,Kinetic parameter of epimerization at a salt concentration (1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,,CHEMBL625986,,22224,,,,U,0,BAO_0000019,
14191,,13028,Autocuration,,,1,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,,CHEMBL625987,,22224,,,,U,0,BAO_0000019,
14192,,13028,Autocuration,,,1,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,,,CHEMBL625988,,22224,,,,U,0,BAO_0000019,
14193,,13028,Autocuration,,,1,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 11.3 (or )in RMPI 1640 cell culture medium containing 10%FCS,,,CHEMBL625989,,22224,,,,U,0,BAO_0000019,
14194,,13028,Autocuration,,,1,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 7.5 (or )in RMPI 1640 cell culture medium containing 10%FCS,,,CHEMBL625990,,22224,,,,U,0,BAO_0000019,
14195,,13028,Autocuration,,,1,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 8.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,,CHEMBL625991,,22224,,,,U,0,BAO_0000019,
14196,,13028,Autocuration,,,1,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,,CHEMBL625992,,22224,,,,U,0,BAO_0000019,
14197,,13028,Autocuration,,,1,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,,,CHEMBL625993,,22224,,,,U,0,BAO_0000019,
14198,,13028,Autocuration,,,1,Kinetic parameter of epimerization at a salt concentration (0.01 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,,CHEMBL631973,,22224,,,,U,0,BAO_0000019,
14199,,13028,Autocuration,,,1,Kinetic parameter of epimerization at a salt concentration (0.1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,,CHEMBL632143,,22224,,,,U,0,BAO_0000019,
14200,,13028,Autocuration,,,1,Kinetic parameter of epimerization at a salt concentration (1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,,CHEMBL632144,,22224,,,,U,0,BAO_0000019,
14201,,13028,Autocuration,,,1,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,,CHEMBL632145,,22224,,,,U,0,BAO_0000019,
14202,,13028,Autocuration,,,1,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,,,CHEMBL632146,,22224,,,,U,0,BAO_0000019,
14203,,13028,Autocuration,,,1,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 11.3 (or )in RMPI 1640 cell culture medium containing 10%FCS,,,CHEMBL632147,,22224,,,,U,0,BAO_0000019,
14204,,13028,Autocuration,,,1,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 7.5 (or )in RMPI 1640 cell culture medium containing 10%FCS,,,CHEMBL632148,,22224,,,,U,0,BAO_0000019,
14205,,13028,Autocuration,,,1,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 8.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,,CHEMBL632149,,22224,,,,U,0,BAO_0000019,
14206,,13028,Autocuration,,,1,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,,CHEMBL632150,,22224,,,,U,0,BAO_0000019,
14207,,13028,Autocuration,,,1,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,,,CHEMBL632151,,22224,,,,U,0,BAO_0000019,
14208,,3008,Intermediate,9606.0,,1,Metabolism (NADH oxidation) by recombinant human NAD(P)H: quinone oxidoreductase (NQO1) is evaluated; not detected,,,CHEMBL632152,,50587,Homo sapiens,,,N,1,BAO_0000218,
14209,,4509,Intermediate,9606.0,,1,Metabolism after 30 min of incubation with human liver microsomes in the absence of cofactor NADH (2.0 mM) at a concentration of 25 uM,,,CHEMBL632153,,50587,Homo sapiens,,,N,1,BAO_0000218,
14210,,4509,Intermediate,9606.0,,1,Metabolism after 30 min of incubation with human liver microsomes in the presence of cofactor NADH (2.0 mM) at a concentration of 25 uM,,,CHEMBL632154,,50587,Homo sapiens,,,N,1,BAO_0000218,
14211,,8613,Intermediate,10298.0,,1,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 12.5 mg/kg per day; Tested mice 10,,,CHEMBL632155,,50602,Human herpesvirus 1,,,N,1,BAO_0000218,
14212,,8613,Intermediate,10298.0,,1,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 12.5 mg/kg per day; Total mice tested 10,,,CHEMBL632156,,50602,Human herpesvirus 1,,,N,1,BAO_0000218,
14213,,8613,Intermediate,10298.0,,1,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 3.1 mg/kg per day; Tested mice 10,,,CHEMBL632157,,50602,Human herpesvirus 1,,,N,1,BAO_0000218,
14214,,8613,Intermediate,10298.0,,1,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day; Tested mice 10,,,CHEMBL632158,,50602,Human herpesvirus 1,,,N,1,BAO_0000218,
14215,,8613,Intermediate,10298.0,,1,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day; Total mice tested 10,,,CHEMBL632159,,50602,Human herpesvirus 1,,,N,1,BAO_0000218,
14216,,8613,Intermediate,10298.0,,1,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at dose 0.8 mg/kg per day; Tested mice 10,,,CHEMBL626305,,50602,Human herpesvirus 1,,,N,1,BAO_0000218,
14217,,8613,Intermediate,10298.0,,1,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at dose 3.1 mg/kg per day; Total mice tested 10,,,CHEMBL626306,,50602,Human herpesvirus 1,,,N,1,BAO_0000218,
14218,,8613,Intermediate,10298.0,,1,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.02 mg/kg per day; Tested mice 10,,,CHEMBL626307,,50602,Human herpesvirus 1,,,N,1,BAO_0000218,
14219,,8613,Intermediate,10298.0,,1,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.06 mg/kg per day; Tested mice 10,,,CHEMBL626308,,50602,Human herpesvirus 1,,,N,1,BAO_0000218,
14220,,8613,Intermediate,10298.0,,1,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.25 mg/kg per day; Tested mice 10,,,CHEMBL626479,,50602,Human herpesvirus 1,,,N,1,BAO_0000218,
14221,,8613,Intermediate,10298.0,,1,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 1 mg/kg per day; Tested mice 10,,,CHEMBL626480,,50602,Human herpesvirus 1,,,N,1,BAO_0000218,
14222,,6021,Autocuration,,,1,Calculated partition coefficient (clogP) (MlogP),,,CHEMBL626481,,22229,,,,U,0,BAO_0000100,
14223,,9348,Autocuration,,,1,Equipotent potent ratio relative to carbachol (nicotinic activity),,,CHEMBL626482,,22224,,,,U,0,BAO_0000019,
14224,,15592,Intermediate,9615.0,,1,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 ); NA denotes not available",,,CHEMBL626483,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
14225,,15592,Intermediate,9615.0,,1,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 );NA denotes not available",,,CHEMBL626484,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
14226,,15592,Autocuration,,,1,Solubility at pH 7.4 in micro g/mL;NA denotes available,,,CHEMBL626485,,22229,,,,U,0,BAO_0000100,
14227,,15592,Autocuration,,,1,Solubility at pH 7.4 in micro g/mL;NA denotes not available,,,CHEMBL626486,,22229,,,,U,0,BAO_0000100,
14228,,15592,Autocuration,,,1,Solubility at pH 7.4 in ug/mL;NA denotes not available,,,CHEMBL626487,,22229,,,,U,0,BAO_0000100,
14229,In vivo,15592,Intermediate,9615.0,,1,Maximal plasma concentration in dogs at 10mg/kg oral dose 0.05M citric acid,,,CHEMBL626488,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,1969.0
14230,,7095,Intermediate,10116.0,,1,Affinity for protein binding expressed as association constant in fresh rat serum; ND is Not Determined.,,,CHEMBL626489,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1977.0
14231,,16618,Autocuration,,,1,Area under the MAP curve measured over 5 min; ND means Not determined,,,CHEMBL626490,,22224,,,,U,0,BAO_0000019,
14232,,16835,Autocuration,,,1,Lipophilicity expressed as the negative logarithm of the equilibrium constant; ND denotes no data.,,,CHEMBL626491,,22224,,,,U,0,BAO_0000100,
14233,,15284,Autocuration,,,1,The apparent partition coefficient(D) in cyclohexane-0.05 M phosphate buffer (pH 7.4) at 21 degree celsius; not determined,,,CHEMBL626492,,22229,,,,U,0,BAO_0000100,
14234,,15750,Autocuration,,,1,Half-life was measured in the presence of NADPH at 20 uM; No inhibition,,,CHEMBL626493,,22224,,,,U,0,BAO_0000019,
14235,In vivo,16618,Intermediate,10116.0,,1,Half life after oral administration to Sprague-Dawley rats; NT is Not tested,,,CHEMBL626494,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
14236,In vivo,16618,Autocuration,,,1,Half life after oral tested,,,CHEMBL626495,,22224,,,,U,0,BAO_0000218,
14237,,15812,Intermediate,10116.0,,1,Half life was determined in plasma of rat; NT indicates not tested,,,CHEMBL626496,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
14238,In vivo,16618,Intermediate,10116.0,,1,Oral bioavailability after oral administration to Sprague-Dawley rats; NT is Not tested,,,CHEMBL626497,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
14239,In vivo,16618,Autocuration,,,1,Oral bioavailability after oral tested,,,CHEMBL626498,,22224,,,,U,0,BAO_0000218,
14240,,13098,Intermediate,10116.0,,1,The bioavailability in rats at 15.9 uM/Kg after intravenous administration; NT=Not tested (F),,,CHEMBL626499,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
14241,,13098,Intermediate,10116.0,,1,The compound was tested for volume of distribution in rat at 15.9 uM/Kg after peroral administration; NT=Not tested (Vd L/Kg),,,CHEMBL626500,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
14242,,15812,Intermediate,10116.0,,1,half life was determined in plasma of rat; NT indicates not tested,,,CHEMBL626501,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
14243,,15812,Intermediate,10116.0,,1,half life was determined in plasma of rat; NT means not tested,,,CHEMBL626502,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1969.0
14244,,11510,Intermediate,10116.0,,1,Mean sodium excretion in rats (Control/Drug treatment value); Value 0.41/2.32,,,CHEMBL626503,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
14245,,11510,Intermediate,10116.0,,1,Mean sodium excretion in rats (Control/Drug treatment value); inactive,,,CHEMBL626504,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
14246,,11510,Intermediate,10116.0,,1,Mean sodium excretion in rats (Control/Drug treatment value); value 0.17/0.43,,,CHEMBL626505,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
14247,,11510,Intermediate,10116.0,,1,Mean sodium excretion in rats (Control/Drug treatment value); value 0.2/0.38,,,CHEMBL626506,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
14248,,11510,Intermediate,10116.0,,1,Mean sodium excretion in rats (Control/Drug treatment value); value 0.26/0.23,,,CHEMBL626507,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
14249,,11510,Intermediate,10116.0,,1,Mean sodium excretion in rats (Control/Drug treatment value); value 0.28/0.26,,,CHEMBL626508,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
14250,,11510,Intermediate,10116.0,,1,Mean sodium excretion in rats (Control/Drug treatment value); value 0.31/0.35,,,CHEMBL626509,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
14251,,11510,Intermediate,10116.0,,1,Mean sodium excretion in rats (Control/Drug treatment value); value 0.35/2.88,,,CHEMBL875480,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
14252,,11510,Intermediate,10116.0,,1,Mean sodium excretion in rats (Control/Drug treatment value); value 0.36/0.29,,,CHEMBL626510,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
14253,,11510,Intermediate,10116.0,,1,Mean sodium excretion in rats (Control/Drug treatment value); value 0.36/0.47,,,CHEMBL626511,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
14254,,11510,Intermediate,10116.0,,1,Mean sodium excretion in rats (Control/Drug treatment value); value 0.36/0.49,,,CHEMBL626512,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
14255,,11510,Intermediate,10116.0,,1,Mean sodium excretion in rats (Control/Drug treatment value); value 0.38/0.23,,,CHEMBL628208,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
14256,,11510,Intermediate,10116.0,,1,Mean sodium excretion in rats (Control/Drug treatment value); value 0.39/0.22,,,CHEMBL628209,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
14257,,11510,Intermediate,10116.0,,1,Mean sodium excretion in rats (Control/Drug treatment value); value 0.41/0.48,,,CHEMBL628210,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
14258,,11510,Intermediate,10116.0,,1,Mean sodium excretion in rats (Control/Drug treatment value); value 0.41/1.49,,,CHEMBL628211,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
14259,,11510,Intermediate,10116.0,,1,Mean sodium excretion in rats (Control/Drug treatment value); value 0.41/2.06,,,CHEMBL628212,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
14260,,11510,Intermediate,10116.0,,1,Mean sodium excretion in rats (Control/Drug treatment value); value 0.42/0.65,,,CHEMBL628213,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
14261,,12582,Intermediate,10116.0,,1,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 65.2 uM/Kg of drug,,,CHEMBL628214,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14262,,12582,Intermediate,10116.0,,1,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 71.6 uM/Kg of drug,,,CHEMBL628215,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14263,,12582,Intermediate,10116.0,,1,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 71.8 uM/Kg of drug,,,CHEMBL628216,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14264,,12582,Intermediate,10116.0,,1,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 74.8 uM/Kg of drug,,,CHEMBL626595,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14265,,12582,Intermediate,10116.0,,1,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 77.5 uM/Kg of drug,,,CHEMBL626596,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14266,,12582,Intermediate,10116.0,,1,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 79.4 uM/Kg of drug,,,CHEMBL626597,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14267,,12582,Intermediate,10116.0,,1,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 80.9 uM/Kg of drug,,,CHEMBL626598,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14268,,12582,Intermediate,10116.0,,1,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 83.8 uM/Kg of drug,,,CHEMBL622242,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14269,,12582,Intermediate,10116.0,,1,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 84.5 uM/Kg of drug,,,CHEMBL622243,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14270,,12582,Intermediate,10116.0,,1,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 84.7 uM/Kg of drug,,,CHEMBL622244,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14271,,12582,Intermediate,10116.0,,1,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 86.7 uM/Kg of drug,,,CHEMBL622245,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14272,,12582,Intermediate,10116.0,,1,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 86.9 uM/Kg of drug,,,CHEMBL622246,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14273,,12582,Intermediate,10116.0,,1,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 9.06 uM/Kg of drug,,,CHEMBL622247,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14274,,12582,Intermediate,10116.0,,1,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 90.6 uM/Kg of drug,,,CHEMBL622248,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14275,,12582,Intermediate,10116.0,,1,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 94.9 uM/Kg of drug,,,CHEMBL877483,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14276,,12582,Intermediate,10116.0,,1,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 97.1 uM/Kg of drug,,,CHEMBL622249,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14277,,12582,Intermediate,9615.0,,1,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 11.9 uM/Kg of drug,,,CHEMBL622250,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,1088.0
14278,,12582,Intermediate,9615.0,,1,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 2.49 uM/Kg of drug,,,CHEMBL622251,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,1088.0
14279,,12582,Intermediate,9615.0,,1,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 26.2 uM/Kg of drug,,,CHEMBL622252,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,1088.0
14280,,12582,Intermediate,9615.0,,1,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 3.03 uM/Kg of drug,,,CHEMBL622253,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,1088.0
14281,,12582,Intermediate,9615.0,,1,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 30.3 uM/Kg of drug,,,CHEMBL622254,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,1088.0
14282,,12582,Intermediate,9615.0,,1,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 34.1 uM/Kg of drug,,,CHEMBL622255,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,1088.0
14283,,12582,Intermediate,9615.0,,1,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 52.4 uM/Kg of drug,,,CHEMBL622256,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,1088.0
14284,,12582,Intermediate,9615.0,,1,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 7.85 uM/Kg of drug,,,CHEMBL622257,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,1088.0
14285,,12582,Intermediate,9615.0,,1,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 8.47 uM/Kg of drug,,,CHEMBL622258,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,1088.0
14286,,12582,Intermediate,9615.0,,1,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 9.09 uM/Kg of drug,,,CHEMBL622259,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,1088.0
14287,,12582,Intermediate,9615.0,,1,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 10.1 uM/Kg of drug,,,CHEMBL622927,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,1088.0
14288,,12582,Intermediate,9615.0,,1,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 3.40 uM/Kg of drug,,,CHEMBL622928,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,1088.0
14289,,12582,Intermediate,9615.0,,1,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 3.76 uM/Kg of drug,,,CHEMBL622929,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,1088.0
14290,,12582,Intermediate,9615.0,,1,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 9.06 uM/Kg of drug,,,CHEMBL623182,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,1088.0
14291,,12582,Intermediate,9615.0,,1,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 9.6 uM/Kg of drug,,,CHEMBL623183,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,1088.0
14292,,12582,Intermediate,10116.0,,1,Total electrolytic excretion of potassium in urine of rats after peroral administration of 0 uM/Kg of drug,,,CHEMBL623184,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14293,,12582,Intermediate,10116.0,,1,Total electrolytic excretion of potassium in urine of rats after peroral administration of 1.01 uM/Kg of drug,,,CHEMBL623185,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14294,,12582,Intermediate,10116.0,,1,Total electrolytic excretion of potassium in urine of rats after peroral administration of 1.13 uM/Kg of drug,,,CHEMBL877484,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14295,,12582,Intermediate,10116.0,,1,Total electrolytic excretion of potassium in urine of rats after peroral administration of 10.1 uM/Kg of drug,,,CHEMBL627274,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14296,,12582,Intermediate,10116.0,,1,Total electrolytic excretion of potassium in urine of rats after peroral administration of 102 uM/Kg of drug,,,CHEMBL623186,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14297,,12582,Intermediate,10116.0,,1,Total electrolytic excretion of potassium in urine of rats after peroral administration of 105 uM/Kg of drug,,,CHEMBL623187,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14298,,12582,Intermediate,10116.0,,1,Total electrolytic excretion of potassium in urine of rats after peroral administration of 11.3 uM/Kg of drug,,,CHEMBL623188,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14299,,12582,Intermediate,10116.0,,1,Total electrolytic excretion of potassium in urine of rats after peroral administration of 113 uM/Kg of drug,,,CHEMBL628055,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14300,,12582,Intermediate,10116.0,,1,Total electrolytic excretion of potassium in urine of rats after peroral administration of 19.5 uM/Kg of drug,,,CHEMBL628056,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14301,,12582,Intermediate,10116.0,,1,Total electrolytic excretion of potassium in urine of rats after peroral administration of 195 uM/Kg of drug,,,CHEMBL628200,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14302,,12582,Intermediate,10116.0,,1,Total electrolytic excretion of potassium in urine of rats after peroral administration of 21.7 uM/Kg of drug,,,CHEMBL628201,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14303,,12582,Intermediate,10116.0,,1,Total electrolytic excretion of potassium in urine of rats after peroral administration of 217 uM/Kg of drug,,,CHEMBL628202,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14304,,12582,Intermediate,10116.0,,1,Total electrolytic excretion of potassium in urine of rats after peroral administration of 23.9 uM/Kg of drug,,,CHEMBL628203,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14305,,12582,Intermediate,10116.0,,1,Total electrolytic excretion of potassium in urine of rats after peroral administration of 239 uM/Kg of drug,,,CHEMBL628204,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14306,,12582,Intermediate,10116.0,,1,Total electrolytic excretion of potassium in urine of rats after peroral administration of 24.9 uM/Kg of drug,,,CHEMBL628205,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14307,,12582,Intermediate,10116.0,,1,Total electrolytic excretion of potassium in urine of rats after peroral administration of 249 uM/Kg of drug,,,CHEMBL628206,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14308,In vivo,13257,Autocuration,,,1,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (d),,,CHEMBL628207,,22224,,,,U,0,BAO_0000218,2367.0
14309,In vivo,13257,Autocuration,,,1,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (d)/biood,,,CHEMBL627220,,22224,,,,U,0,BAO_0000218,2367.0
14310,In vivo,13257,Autocuration,,,1,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (d)/muscle,,,CHEMBL627221,,22224,,,,U,0,BAO_0000218,2385.0
14311,In vivo,13257,Autocuration,,,1,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (v),,,CHEMBL627222,,22224,,,,U,0,BAO_0000218,2367.0
14312,In vivo,13257,Autocuration,,,1,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (v)/blood,,,CHEMBL627223,,22224,,,,U,0,BAO_0000218,
14313,In vivo,13257,Autocuration,,,1,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (v)/muscle,,,CHEMBL632062,,22224,,,,U,0,BAO_0000218,2385.0
14314,In vivo,13257,Autocuration,,,1,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in spleen,,,CHEMBL632063,,22224,,,,U,0,BAO_0000218,2106.0
14315,In vivo,13257,Autocuration,,,1,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in bladder,,,CHEMBL632064,,22224,,,,U,0,BAO_0000218,1255.0
14316,In vivo,13257,Autocuration,,,1,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in blood,,,CHEMBL632065,,22224,,,,U,0,BAO_0000218,178.0
14317,In vivo,13257,Autocuration,,,1,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in bone,,,CHEMBL632066,,22224,,,,U,0,BAO_0000218,1474.0
14318,In vivo,13257,Autocuration,,,1,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in fat,,,CHEMBL632067,,22224,,,,U,0,BAO_0000218,
14319,In vivo,13257,Autocuration,,,1,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in kidney,,,CHEMBL629188,,22224,,,,U,0,BAO_0000218,2113.0
14320,In vivo,13257,Autocuration,,,1,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in liver,,,CHEMBL629189,,22224,,,,U,0,BAO_0000218,2107.0
14321,In vivo,13257,Autocuration,,,1,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in lung,,,CHEMBL629190,,22224,,,,U,0,BAO_0000218,2048.0
14322,In vivo,13257,Autocuration,,,1,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in muscle,,,CHEMBL629191,,22224,,,,U,0,BAO_0000218,2385.0
14323,In vivo,13257,Autocuration,,,1,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (d),,,CHEMBL629192,,22224,,,,U,0,BAO_0000218,2367.0
14324,In vivo,13257,Autocuration,,,1,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (d)/muscle,,,CHEMBL629193,,22224,,,,U,0,BAO_0000218,2385.0
14325,In vivo,13257,Autocuration,,,1,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (v),,,CHEMBL629194,,22224,,,,U,0,BAO_0000218,2367.0
14326,In vivo,13257,Autocuration,,,1,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (v)/blood,,,CHEMBL629195,,22224,,,,U,0,BAO_0000218,
14327,In vivo,13257,Autocuration,,,1,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (v)/muscle,,,CHEMBL629373,,22224,,,,U,0,BAO_0000218,2385.0
14328,In vivo,13257,Autocuration,,,1,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in spleen,,,CHEMBL629374,,22224,,,,U,0,BAO_0000218,2106.0
14329,In vivo,13257,Autocuration,,,1,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked)i n prostate (d)/biood,,,CHEMBL629375,,22224,,,,U,0,BAO_0000218,2367.0
14330,In vivo,13257,Autocuration,,,1,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in bladder,,,CHEMBL629376,,22224,,,,U,0,BAO_0000218,1255.0
14331,In vivo,13257,Autocuration,,,1,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in blood,,,CHEMBL629377,,22224,,,,U,0,BAO_0000218,178.0
14332,In vivo,13257,Autocuration,,,1,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in bone,,,CHEMBL629378,,22224,,,,U,0,BAO_0000218,1474.0
14333,In vivo,13257,Autocuration,,,1,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in fat,,,CHEMBL629379,,22224,,,,U,0,BAO_0000218,
14334,In vivo,13257,Autocuration,,,1,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in kidney,,,CHEMBL629151,,22224,,,,U,0,BAO_0000218,2113.0
14335,In vivo,13257,Autocuration,,,1,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in liver,,,CHEMBL629152,,22224,,,,U,0,BAO_0000218,2107.0
14336,In vivo,13257,Autocuration,,,1,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in lung,,,CHEMBL629153,,22224,,,,U,0,BAO_0000218,2048.0
14337,In vivo,13257,Autocuration,,,1,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in muscle,,,CHEMBL629154,,22224,,,,U,0,BAO_0000218,2385.0
14338,In vivo,13257,Autocuration,,,1,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (d),,,CHEMBL629155,,22224,,,,U,0,BAO_0000218,2367.0
14339,In vivo,13257,Autocuration,,,1,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (d)/biood,,,CHEMBL629156,,22224,,,,U,0,BAO_0000218,2367.0
14340,In vivo,13257,Autocuration,,,1,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (d)/muscle,,,CHEMBL629157,,22224,,,,U,0,BAO_0000218,2385.0
14341,In vivo,13257,Autocuration,,,1,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (v),,,CHEMBL629158,,22224,,,,U,0,BAO_0000218,2367.0
14342,In vivo,13257,Autocuration,,,1,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (v)/blood,,,CHEMBL629159,,22224,,,,U,0,BAO_0000218,
14343,In vivo,13257,Autocuration,,,1,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (v)/muscle,,,CHEMBL629160,,22224,,,,U,0,BAO_0000218,2385.0
14344,In vivo,13257,Autocuration,,,1,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in spleen,,,CHEMBL629161,,22224,,,,U,0,BAO_0000218,2106.0
14345,In vivo,13257,Autocuration,,,1,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in bladder,,,CHEMBL629162,,22224,,,,U,0,BAO_0000218,1255.0
14346,In vivo,13257,Autocuration,,,1,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in blood,,,CHEMBL629163,,22224,,,,U,0,BAO_0000218,178.0
14347,In vivo,13257,Autocuration,,,1,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in bone,,,CHEMBL629164,,22224,,,,U,0,BAO_0000218,1474.0
14348,In vivo,13257,Autocuration,,,1,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in fat,,,CHEMBL629165,,22224,,,,U,0,BAO_0000218,
14349,In vivo,13257,Autocuration,,,1,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in liver,,,CHEMBL629166,,22224,,,,U,0,BAO_0000218,2107.0
14350,In vivo,13257,Autocuration,,,1,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in lung,,,CHEMBL629167,,22224,,,,U,0,BAO_0000218,2048.0
14351,In vivo,13257,Autocuration,,,1,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in muscle,,,CHEMBL629168,,22224,,,,U,0,BAO_0000218,2385.0
14352,,2193,Autocuration,,,1,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 100 uM,,,CHEMBL629169,,22224,,,,U,0,BAO_0000019,
14353,,2193,Autocuration,,,1,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 100 uM; no inhibition is observed at this concentration,,,CHEMBL629170,,22224,,,,U,0,BAO_0000019,
14354,,2193,Autocuration,,,1,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 10 uM,,,CHEMBL631153,,22224,,,,U,0,BAO_0000019,
14355,,2193,Autocuration,,,1,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 10 uM; too active and complete inhibition is observed,,,CHEMBL875121,,22224,,,,U,0,BAO_0000019,
14356,,2193,Autocuration,,,1,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 1 uM,,,CHEMBL631154,,22224,,,,U,0,BAO_0000019,
14357,,2193,Autocuration,,,1,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 1 uM; too active and complete inhibition is observed,,,CHEMBL631155,,22224,,,,U,0,BAO_0000019,
14358,,568,Autocuration,,,1,Hydrolysis rate constant was determined,,,CHEMBL631156,,22224,,,,U,0,BAO_0000019,
14359,,9680,Autocuration,,,1,"K2, The intrinsic biomolecular reactivation rate constant on VX at 25 degree Centigrade",,,CHEMBL631157,,22224,,,,U,0,BAO_0000019,
14360,,9680,Autocuration,,,1,"K2, The intrinsic biomolecular reactivation rate constant on paraxon at 25 degree Centigrade",,,CHEMBL631158,,22224,,,,U,0,BAO_0000019,
14361,,9680,Autocuration,,,1,"K2, The intrinsic biomolecular reactivation rate constant on sarin at 25 degree Centigrade",,,CHEMBL631159,,22224,,,,U,0,BAO_0000019,
14362,,10026,Autocuration,,,1,Observed second order rate constant,,,CHEMBL631160,,22224,,,,U,0,BAO_0000019,
14363,,10281,Autocuration,,,1,Rate constant (cyclization rate) in CD3CN-deuterated phosphate buffer at pH 7.4,,,CHEMBL631161,,22224,,,,U,0,BAO_0000019,
14364,,10014,Autocuration,,,1,Rate constant for decay of compound was determined in 50 mM phosphate buffer (pH 7.4) at 24 degree celsius,,,CHEMBL631162,,22224,,,,U,0,BAO_0000019,
14365,,10014,Autocuration,,,1,Rate constant for decay of compound was determined in 50 mM phosphate buffer (pH 7.4) at 37 degree celsius,,,CHEMBL630313,,22224,,,,U,0,BAO_0000019,
14366,,9680,Autocuration,,,1,"k2, The intrinsic biomolecular reactivation rate constant on paraxon at 25 degree Centigrade",,,CHEMBL630314,,22224,,,,U,0,BAO_0000019,
14367,,9680,Autocuration,,,1,"k2, The intrinsic biomolecular reactivation rate constant on sarin at 25 degree Centigrade",,,CHEMBL630315,,22224,,,,U,0,BAO_0000019,
14368,,13028,Autocuration,,,1,Kinetic parameter of epimerization at a salt concentration (0.01 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,,CHEMBL630316,,22224,,,,U,0,BAO_0000019,
14369,,13028,Autocuration,,,1,Kinetic parameter of epimerization at a salt concentration (0.1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,,CHEMBL630986,,22224,,,,U,0,BAO_0000019,
14370,,13028,Autocuration,,,1,Kinetic parameter of epimerization at a salt concentration (1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,,CHEMBL630987,,22224,,,,U,0,BAO_0000019,
14371,,13028,Autocuration,,,1,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.0(or )in RMPI 1640 cell culture medium containing 10%FCS,,,CHEMBL630988,,22224,,,,U,0,BAO_0000019,
14372,,13028,Autocuration,,,1,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,,,CHEMBL630989,,22224,,,,U,0,BAO_0000019,
14373,,13028,Autocuration,,,1,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 11.3 (or )in RMPI 1640 cell culture medium containing 10%FCS,,,CHEMBL630990,,22224,,,,U,0,BAO_0000019,
14374,,13028,Autocuration,,,1,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 7.5 (or )in RMPI 1640 cell culture medium containing 10%FCS,,,CHEMBL630991,,22224,,,,U,0,BAO_0000019,
14375,,13028,Autocuration,,,1,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 8.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,,CHEMBL630992,,22224,,,,U,0,BAO_0000019,
14376,,13028,Autocuration,,,1,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,,CHEMBL630993,,22224,,,,U,0,BAO_0000019,
14377,,13028,Autocuration,,,1,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,,,CHEMBL630994,,22224,,,,U,0,BAO_0000019,
14378,,10014,Intermediate,10116.0,,1,Rate constants of compound was determined at muscarinic receptor in the rat cerebral cortex,,,CHEMBL630995,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
14379,,9962,Autocuration,,,1,Association constant for compound at 31 degree C was determined,,,CHEMBL629252,,22224,,,,U,0,BAO_0000019,
14380,,12029,Autocuration,,,1,Calculated antagonist equilibrium dissociation constant of the compound,,,CHEMBL629253,,22224,,,,U,0,BAO_0000019,
14381,,12029,Autocuration,,,1,Calculated antagonist equilibrium dissociation constant of the compound; No statistically significant antagonism observed,,,CHEMBL629944,,22224,,,,U,0,BAO_0000019,
14382,,10583,Intermediate,10141.0,,1,Dissociation constants vs LTE4 on guinea pig trachea,,,CHEMBL629945,,50512,Cavia porcellus,,,N,1,BAO_0000218,3126.0
14383,,568,Autocuration,,,1,"Tested for hydrolysis in presence of boric acid by UV spectrophotometry, dissociation constant was evaluated at the pH < 8",,,CHEMBL629946,,22224,,,,U,0,BAO_0000019,
14384,,568,Autocuration,,,1,"Tested for hydrolysis in presence of boric acid, rate constant was evaluated at the pH 8.5",,,CHEMBL629947,,22224,,,,U,0,BAO_0000019,
14385,,568,Autocuration,,,1,"Tested for hydrolysis in presence of boric acid, rate constant was evaluated at the pH 9.5",,,CHEMBL629948,,22224,,,,U,0,BAO_0000019,
14386,,568,Autocuration,,,1,"Tested for hydrolysis in presence of phenylboronic acid, rate constant was evaluated at the pH 9.5",,,CHEMBL856024,,22224,,,,U,0,BAO_0000019,
14387,,7493,Autocuration,,,1,Affinity constant KD value was derived from TMP,,,CHEMBL629949,,22224,,,,U,0,BAO_0000019,
14388,,8371,Autocuration,,,1,Apparent dissociation (binding) rate constant was evaluated,,,CHEMBL629950,,22224,,,,U,0,BAO_0000019,
14389,,13114,Autocuration,,,1,Dissociation constant (KD) of the compound,,,CHEMBL630127,,22224,,,,U,0,BAO_0000100,
14390,,15515,Autocuration,,,1,Dissociation constant determined by heteronuclear 1H/15N correlation NMR spectroscopy,,,CHEMBL630128,,22224,,,,U,0,BAO_0000100,
14391,,522,Autocuration,,,1,Dissociation constant from ESR titration experiments,,,CHEMBL630129,,22224,,,,U,0,BAO_0000100,
14392,,13888,Autocuration,,,1,Dissociation constant was evaluated which is similar to Ki (inhibitory constant),,,CHEMBL630130,,22224,,,,U,0,BAO_0000019,
14393,,2616,Autocuration,,,1,Dissociation constant was evaluated.,,,CHEMBL875234,,22224,,,,U,0,BAO_0000100,
14394,,3798,Autocuration,,,1,Dissociation constant was reported,,,CHEMBL630131,,22224,,,,U,0,BAO_0000100,
14395,,8731,Intermediate,10116.0,,1,Dissociation constant was determined in rat pituitary cells.,,,CHEMBL630132,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
14396,,11892,Autocuration,,,1,Equilibrium dissociation constant of CA complex for enantiomer 1 of compound,,,CHEMBL630133,,22224,,,,U,0,BAO_0000019,
14397,,11892,Autocuration,,,1,Equilibrium dissociation constant of CA complex for enantiomer 2 of compound,,,CHEMBL630134,,22224,,,,U,0,BAO_0000019,
14398,,2582,Autocuration,,,1,Equilibrium dissociation constant of the compound,,,CHEMBL630135,,22224,,,,U,0,BAO_0000019,
14399,,11892,Autocuration,,,1,Equilibrium dissociation constant was determined,,,CHEMBL630136,,22224,,,,U,0,BAO_0000019,
14400,,13396,Autocuration,,,1,Kinetic constant KD was evaluated,,,CHEMBL630137,,22224,,,,U,0,BAO_0000019,
14401,,603,Autocuration,,,1,Tested for dissociation constant of the compound; Value ranges from 0.1-0.3,,,CHEMBL630138,,22224,,,,U,0,BAO_0000019,
14402,,15673,Autocuration,,,1,Equilibrium association constant interacting with unilamellar vesicles of electroneutral in PBS buffer at pH 7.4,,,CHEMBL630139,,22224,,,,U,0,BAO_0000019,
14403,,10368,Autocuration,,,1,Rate constant for hydrolysis in aqueous acetone.,,,CHEMBL630140,,22224,,,,U,0,BAO_0000019,
14404,,14228,Autocuration,,,1,Disassociation constant (KI) was obtained from Cheng and Prusoff equation for quercetin trypsin complex,,,CHEMBL875235,,22224,,,,U,0,BAO_0000019,
14405,,11510,Intermediate,10116.0,,1,Mean sodium excretion in rats (Control/Drug treatment value); value 0.43/2.86,,,CHEMBL876439,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
14406,,11510,Intermediate,10116.0,,1,Mean sodium excretion in rats (Control/Drug treatment value); value 0.44/2.68,,,CHEMBL630605,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
14407,,11510,Intermediate,10116.0,,1,Mean sodium excretion in rats (Control/Drug treatment value); value 0.45/1.55,,,CHEMBL630606,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
14408,,11510,Intermediate,10116.0,,1,Mean sodium excretion in rats (Control/Drug treatment value); value 0.48/0.95,,,CHEMBL630607,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
14409,,11510,Intermediate,10116.0,,1,Mean sodium excretion in rats (Control/Drug treatment value); value 0.5/1.79,,,CHEMBL630608,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
14410,,11510,Intermediate,10116.0,,1,Mean sodium excretion in rats (Control/Drug treatment value); value 0.51/0.66,,,CHEMBL630609,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
14411,,11510,Intermediate,10116.0,,1,Mean sodium excretion in rats (Control/Drug treatment value); value 0.52/2.02,,,CHEMBL630610,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
14412,,11510,Intermediate,10116.0,,1,Mean sodium excretion in rats (Control/Drug treatment value); value 0.61//0.37,,,CHEMBL630611,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
14413,,11510,Intermediate,10116.0,,1,Mean sodium excretion in rats (Control/Drug treatment value); value 0.71/0.36,,,CHEMBL629552,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
14414,,11510,Intermediate,10116.0,,1,Mean sodium excretion in rats when compound administered at 0 mg/kg po and vehicle dosed at 0 umol/kg,,,CHEMBL629733,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
14415,,11510,Intermediate,10116.0,,1,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 30.23 umol/kg,,,CHEMBL629734,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
14416,,11510,Intermediate,10116.0,,1,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 33.59 umol/kg,,,CHEMBL629735,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
14417,,11510,Intermediate,10116.0,,1,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 37.13 umol/kg,,,CHEMBL629736,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
14418,,11510,Intermediate,10116.0,,1,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 39.48 umol/kg,,,CHEMBL629737,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
14419,,11510,Intermediate,10116.0,,1,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 483.72 umol/kg,,,CHEMBL629738,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
14420,,11510,Intermediate,10116.0,,1,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg,,,CHEMBL629739,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
14421,,11510,Intermediate,10116.0,,1,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg; Not determined,,,CHEMBL629740,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
14422,,11510,Intermediate,10116.0,,1,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 631.76 umol/kg,,,CHEMBL629741,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
14423,,11510,Intermediate,10116.0,,1,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 7.56 umol/kg,,,CHEMBL629742,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
14424,,11510,Intermediate,10116.0,,1,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 8.4 umol/kg,,,CHEMBL629743,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
14425,,11510,Intermediate,10116.0,,1,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.28 umol/kg,,,CHEMBL629744,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
14426,,11510,Intermediate,10116.0,,1,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.87 umol/kg,,,CHEMBL629745,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
14427,,11510,Intermediate,10116.0,,1,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 60.46 umol/kg,,,CHEMBL629746,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
14428,,11510,Intermediate,10116.0,,1,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 67.18 umol/kg,,,CHEMBL629747,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
14429,,11510,Intermediate,10116.0,,1,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 74.26 umol/kg,,,CHEMBL629748,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
14430,,11510,Intermediate,10116.0,,1,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 78.97 umol/kg,,,CHEMBL629749,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
14431,,11510,Intermediate,10116.0,,1,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 120.93 umol/kg,,,CHEMBL629750,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
14432,,11510,Intermediate,10116.0,,1,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 134.35 umol/kg,,,CHEMBL629751,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
14433,,11510,Intermediate,10116.0,,1,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 148.52 umol/kg,,,CHEMBL629752,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
14434,,11510,Intermediate,10116.0,,1,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 157.94 umol/kg,,,CHEMBL629753,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
14435,,11510,Intermediate,10116.0,,1,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 15.12 umol/kg,,,CHEMBL629754,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
14436,,11510,Intermediate,10116.0,,1,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 16.79 umol/kg,,,CHEMBL629755,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
14437,,11510,Intermediate,10116.0,,1,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 18.56 umol/kg,,,CHEMBL629756,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
14438,,11510,Intermediate,10116.0,,1,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 19.74 umol/kg,,,CHEMBL629757,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
14439,,11510,Intermediate,10116.0,,1,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 241.86 umol/kg,,,CHEMBL629758,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
14440,,11510,Intermediate,10116.0,,1,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 268.71 umol/kg,,,CHEMBL629759,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
14441,,11510,Intermediate,10116.0,,1,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 297.03 umol/kg,,,CHEMBL629760,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
14442,,11510,Intermediate,10116.0,,1,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 315.88 umol/kg,,,CHEMBL876443,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
14443,,8310,Intermediate,9615.0,,1,Na+ excretion mequiv /kg in 6 conscious female dogs administered perorally during 0-6 hr,,,CHEMBL629761,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
14444,,8310,Intermediate,9615.0,,1,Na+ excretion mequiv /kg in conscious female dogs administered perorally during 0-6 hr,,,CHEMBL629762,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
14445,,8310,Intermediate,10090.0,,1,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 10 ml/kg perorally,,,CHEMBL629763,,50594,Mus musculus,,,N,1,BAO_0000218,
14446,,8310,Intermediate,10090.0,,1,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 2 ml/kg perorally,,,CHEMBL629764,,50594,Mus musculus,,,N,1,BAO_0000218,
14447,,8310,Intermediate,10090.0,,1,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 2 ml/kg perorally,,,CHEMBL629765,,50594,Mus musculus,,,N,1,BAO_0000218,
14448,,8310,Intermediate,10090.0,,1,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 50 ml/kg perorally,,,CHEMBL629766,,50594,Mus musculus,,,N,1,BAO_0000218,
14449,,8310,Intermediate,10090.0,,1,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 10 ml/kg perorally,,,CHEMBL629767,,50594,Mus musculus,,,N,1,BAO_0000218,
14450,,8310,Intermediate,9615.0,,1,Na+ excretion mequiv/kg in 4 conscious female dogs administered perorally during 0-6 hr,,,CHEMBL629768,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
14451,,8310,Intermediate,10090.0,,1,Na+ excretion mequiv/kg in 4 saline-loaded mice administered at a dose 50 ml/kg perorally,,,CHEMBL629769,,50594,Mus musculus,,,N,1,BAO_0000218,
14452,,8310,Intermediate,9615.0,,1,Na+ excretion mequiv/kg in 6 conscious female dogs administered perorally during 0-6 hr,,,CHEMBL629770,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
14453,,8310,Intermediate,9615.0,,1,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 0.3 ml/kg perorally,,,CHEMBL629771,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,
14454,,8310,Intermediate,10090.0,,1,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 10 ml/kg perorally,,,CHEMBL629772,,50594,Mus musculus,,,N,1,BAO_0000218,
14455,,8310,Intermediate,10090.0,,1,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 10 ml/kg perorally,,,CHEMBL629773,,50594,Mus musculus,,,N,1,BAO_0000218,
14456,,8310,Intermediate,10090.0,,1,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 2 ml/kg perorally,,,CHEMBL625455,,50594,Mus musculus,,,N,1,BAO_0000218,
14457,,8310,Intermediate,10090.0,,1,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 250 ml/kg perorally,,,CHEMBL625456,,50594,Mus musculus,,,N,1,BAO_0000218,
14458,,8310,Intermediate,10090.0,,1,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 3 ml/kg perorally,,,CHEMBL625457,,50594,Mus musculus,,,N,1,BAO_0000218,
14459,,12582,Intermediate,10116.0,,1,Total electrolytic excretion of potassium in urine of rats after peroral administration of 25.9 uM/Kg of drug,,,CHEMBL625458,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14460,,12582,Intermediate,10116.0,,1,Total electrolytic excretion of potassium in urine of rats after peroral administration of 259 uM/Kg of drug,,,CHEMBL625459,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14461,,12582,Intermediate,10116.0,,1,Total electrolytic excretion of potassium in urine of rats after peroral administration of 26.5 uM/Kg of drug,,,CHEMBL875483,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14462,,12582,Intermediate,10116.0,,1,Total electrolytic excretion of potassium in urine of rats after peroral administration of 265 uM/Kg of drug,,,CHEMBL634779,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14463,,12582,Intermediate,10116.0,,1,Total electrolytic excretion of potassium in urine of rats after peroral administration of 27 uM/Kg of drug,,,CHEMBL625460,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14464,,12582,Intermediate,10116.0,,1,Total electrolytic excretion of potassium in urine of rats after peroral administration of 27.9 uM/Kg of drug,,,CHEMBL626117,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14465,,12582,Intermediate,10116.0,,1,Total electrolytic excretion of potassium in urine of rats after peroral administration of 270 uM/Kg of drug,,,CHEMBL626118,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14466,,12582,Intermediate,10116.0,,1,Total electrolytic excretion of potassium in urine of rats after peroral administration of 279 uM/Kg of drug,,,CHEMBL628342,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14467,,12582,Intermediate,10116.0,,1,Total electrolytic excretion of potassium in urine of rats after peroral administration of 28.2 uM/Kg of drug,,,CHEMBL628343,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14468,,12582,Intermediate,10116.0,,1,Total electrolytic excretion of potassium in urine of rats after peroral administration of 28.22 uM/Kg of drug,,,CHEMBL628344,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14469,,12582,Intermediate,10116.0,,1,Total electrolytic excretion of potassium in urine of rats after peroral administration of 28.9 uM/Kg of drug,,,CHEMBL628345,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14470,,12582,Intermediate,10116.0,,1,Total electrolytic excretion of potassium in urine of rats after peroral administration of 282 uM/Kg of drug,,,CHEMBL628346,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14471,,12582,Intermediate,10116.0,,1,Total electrolytic excretion of potassium in urine of rats after peroral administration of 289 uM/Kg of drug,,,CHEMBL628347,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14472,,12582,Intermediate,10116.0,,1,Total electrolytic excretion of potassium in urine of rats after peroral administration of 3.40 uM/Kg of drug,,,CHEMBL628348,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14473,,12582,Intermediate,10116.0,,1,Total electrolytic excretion of potassium in urine of rats after peroral administration of 3.76 uM/Kg of drug,,,CHEMBL628349,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14474,,12582,Intermediate,10116.0,,1,Total electrolytic excretion of potassium in urine of rats after peroral administration of 30.2 uM/Kg of drug,,,CHEMBL875611,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14475,,12582,Intermediate,10116.0,,1,Total electrolytic excretion of potassium in urine of rats after peroral administration of 302 uM/Kg of drug,,,CHEMBL628350,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14476,,12582,Intermediate,10116.0,,1,Total electrolytic excretion of potassium in urine of rats after peroral administration of 31.6 uM/Kg of drug,,,CHEMBL628351,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14477,,12582,Intermediate,10116.0,,1,Total electrolytic excretion of potassium in urine of rats after peroral administration of 316 uM/Kg of drug,,,CHEMBL628352,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14478,,12582,Intermediate,10116.0,,1,Total electrolytic excretion of potassium in urine of rats after peroral administration of 32.4 uM/Kg of drug,,,CHEMBL628353,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14479,,12582,Intermediate,10116.0,,1,Total electrolytic excretion of potassium in urine of rats after peroral administration of 324 uM/Kg of drug,,,CHEMBL628354,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14480,,12582,Intermediate,10116.0,,1,Total electrolytic excretion of potassium in urine of rats after peroral administration of 34.0 uM/Kg of drug,,,CHEMBL626667,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14481,,12582,Intermediate,10116.0,,1,Total electrolytic excretion of potassium in urine of rats after peroral administration of 34.1 uM/Kg of drug,,,CHEMBL626668,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14482,,12582,Intermediate,10116.0,,1,Total electrolytic excretion of potassium in urine of rats after peroral administration of 34.8 uM/Kg of drug,,,CHEMBL626669,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14483,,12582,Intermediate,10116.0,,1,Total electrolytic excretion of potassium in urine of rats after peroral administration of 341 uM/Kg of drug,,,CHEMBL626670,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14484,,12582,Intermediate,10116.0,,1,Total electrolytic excretion of potassium in urine of rats after peroral administration of 348 uM/Kg of drug,,,CHEMBL626671,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14485,,12582,Intermediate,10116.0,,1,Total electrolytic excretion of potassium in urine of rats after peroral administration of 37.6 uM/Kg of drug,,,CHEMBL626672,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14486,,12582,Intermediate,10116.0,,1,Total electrolytic excretion of potassium in urine of rats after peroral administration of 50.8 uM/Kg of drug,,,CHEMBL626673,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14487,,12582,Intermediate,10116.0,,1,Total electrolytic excretion of potassium in urine of rats after peroral administration of 58.4 uM/Kg of drug,,,CHEMBL626674,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14488,,12582,Intermediate,10116.0,,1,Total electrolytic excretion of potassium in urine of rats after peroral administration of 65.2 uM/Kg of drug,,,CHEMBL626675,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14489,,12582,Intermediate,10116.0,,1,Total electrolytic excretion of potassium in urine of rats after peroral administration of 68.1 uM/Kg of drug,,,CHEMBL626676,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14490,,12582,Intermediate,10116.0,,1,Total electrolytic excretion of potassium in urine of rats after peroral administration of 7.94 uM/Kg of drug,,,CHEMBL626677,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14491,,12582,Intermediate,10116.0,,1,Total electrolytic excretion of potassium in urine of rats after peroral administration of 71.6 uM/Kg of drug,,,CHEMBL626678,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14492,,12582,Intermediate,10116.0,,1,Total electrolytic excretion of potassium in urine of rats after peroral administration of 71.8 uM/Kg of drug,,,CHEMBL626679,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14493,,12582,Intermediate,10116.0,,1,Total electrolytic excretion of potassium in urine of rats after peroral administration of 74.8 uM/Kg of drug,,,CHEMBL875612,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14494,,12582,Intermediate,10116.0,,1,Total electrolytic excretion of potassium in urine of rats after peroral administration of 77.5 uM/Kg of drug,,,CHEMBL626680,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14495,,12582,Intermediate,10116.0,,1,Total electrolytic excretion of potassium in urine of rats after peroral administration of 79.4 uM/Kg of drug,,,CHEMBL626681,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14496,,12582,Intermediate,10116.0,,1,Total electrolytic excretion of potassium in urine of rats after peroral administration of 80.9 uM/Kg of drug,,,CHEMBL626682,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14497,,12582,Intermediate,10116.0,,1,Total electrolytic excretion of potassium in urine of rats after peroral administration of 83.8 uM/Kg of drug,,,CHEMBL626683,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14498,,12582,Intermediate,10116.0,,1,Total electrolytic excretion of potassium in urine of rats after peroral administration of 84.5 uM/Kg of drug,,,CHEMBL626684,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14499,,12582,Intermediate,10116.0,,1,Total electrolytic excretion of potassium in urine of rats after peroral administration of 84.7 uM/Kg of drug,,,CHEMBL626685,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14500,,12582,Intermediate,10116.0,,1,Total electrolytic excretion of potassium in urine of rats after peroral administration of 86.7 uM/Kg of drug,,,CHEMBL626686,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14501,,12582,Intermediate,10116.0,,1,Total electrolytic excretion of potassium in urine of rats after peroral administration of 86.9 uM/Kg of drug,,,CHEMBL626687,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14502,,12582,Intermediate,10116.0,,1,Total electrolytic excretion of potassium in urine of rats after peroral administration of 9.06 uM/Kg of drug,,,CHEMBL624978,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14503,,12582,Intermediate,10116.0,,1,Total electrolytic excretion of potassium in urine of rats after peroral administration of 90.6 uM/Kg of drug,,,CHEMBL624979,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14504,,12582,Intermediate,10116.0,,1,Total electrolytic excretion of potassium in urine of rats after peroral administration of 94.9 uM/Kg of drug,,,CHEMBL624980,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14505,,12582,Intermediate,10116.0,,1,Total electrolytic excretion of potassium in urine of rats after peroral administration of 97.1 uM/Kg of drug,,,CHEMBL624981,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14506,,12582,Intermediate,9615.0,,1,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 52.4 uM/Kg of drug,,,CHEMBL624982,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,1088.0
14507,In vivo,13257,Autocuration,,,1,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (d),,,CHEMBL627564,,22224,,,,U,0,BAO_0000218,2367.0
14508,In vivo,13257,Autocuration,,,1,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (v),,,CHEMBL627565,,22224,,,,U,0,BAO_0000218,2367.0
14509,In vivo,13257,Autocuration,,,1,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (v)/blood,,,CHEMBL627566,,22224,,,,U,0,BAO_0000218,
14510,In vivo,13257,Autocuration,,,1,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (v)/muscle,,,CHEMBL627567,,22224,,,,U,0,BAO_0000218,2385.0
14511,In vivo,13257,Autocuration,,,1,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in spleen,,,CHEMBL627568,,22224,,,,U,0,BAO_0000218,2106.0
14512,In vivo,13257,Autocuration,,,1,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hr in kidney,,,CHEMBL627569,,22224,,,,U,0,BAO_0000218,2113.0
14513,In vivo,13257,Autocuration,,,1,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in bladder,,,CHEMBL627570,,22224,,,,U,0,BAO_0000218,1255.0
14514,In vivo,13257,Autocuration,,,1,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in blood,,,CHEMBL627571,,22224,,,,U,0,BAO_0000218,178.0
14515,In vivo,13257,Autocuration,,,1,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in bone,,,CHEMBL627572,,22224,,,,U,0,BAO_0000218,1474.0
14516,In vivo,13257,Autocuration,,,1,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in fat,,,CHEMBL627573,,22224,,,,U,0,BAO_0000218,
14517,In vivo,13257,Autocuration,,,1,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in kidney,,,CHEMBL627574,,22224,,,,U,0,BAO_0000218,2113.0
14518,In vivo,13257,Autocuration,,,1,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in liver,,,CHEMBL627575,,22224,,,,U,0,BAO_0000218,2107.0
14519,In vivo,13257,Autocuration,,,1,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in lung,,,CHEMBL627576,,22224,,,,U,0,BAO_0000218,2048.0
14520,In vivo,13257,Autocuration,,,1,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in muscle,,,CHEMBL627577,,22224,,,,U,0,BAO_0000218,2385.0
14521,In vivo,13257,Autocuration,,,1,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (d),,,CHEMBL627578,,22224,,,,U,0,BAO_0000218,2367.0
14522,In vivo,13257,Autocuration,,,1,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (d)/biood,,,CHEMBL627579,,22224,,,,U,0,BAO_0000218,2367.0
14523,In vivo,13257,Autocuration,,,1,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (d)/muscle,,,CHEMBL627580,,22224,,,,U,0,BAO_0000218,2385.0
14524,In vivo,13257,Autocuration,,,1,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (v),,,CHEMBL627581,,22224,,,,U,0,BAO_0000218,2367.0
14525,In vivo,13257,Autocuration,,,1,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (v)/blood,,,CHEMBL627582,,22224,,,,U,0,BAO_0000218,
14526,In vivo,13257,Autocuration,,,1,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (v)/muscle,,,CHEMBL627583,,22224,,,,U,0,BAO_0000218,2385.0
14527,In vivo,13257,Autocuration,,,1,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in spleen,,,CHEMBL627584,,22224,,,,U,0,BAO_0000218,2106.0
14528,In vivo,13257,Autocuration,,,1,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (d)/biood,,,CHEMBL627585,,22224,,,,U,0,BAO_0000218,2367.0
14529,In vivo,13257,Autocuration,,,1,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (d)/muscle,,,CHEMBL627586,,22224,,,,U,0,BAO_0000218,2385.0
14530,In vivo,15413,Intermediate,10116.0,,1,Biodistribution of the Radiolabeled FBWAY compound in rat Cerebellum at 30 min co-injected with 200 nmol of WAY 100635,,,CHEMBL627587,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
14531,In vivo,15413,Intermediate,10116.0,,1,Biodistribution of the Radiolabeled FBWAY compound in rat Cerebellum at 30 min co-injected with 50 nmol of WAY 100635,,,CHEMBL627588,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
14532,In vivo,15413,Intermediate,10116.0,,1,Biodistribution of the Radiolabeled FBWAY compound in rat cortex at 30 min co-injected with 200 nmol of WAY 100635,,,CHEMBL628250,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
14533,In vivo,15413,Intermediate,10116.0,,1,Biodistribution of the Radiolabeled FBWAY compound in rat cortex at 30 min co-injected with 50 nmol of WAY 100635,,,CHEMBL628251,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
14534,In vivo,15413,Intermediate,10116.0,,1,Biodistribution of the Radiolabeled FBWAY compound in rat hippocampus at 30 min co-injected with 200 nmol of WAY 100635,,,CHEMBL628252,,50597,Rattus norvegicus,,,N,1,BAO_0000218,10000000.0
14535,In vivo,15413,Intermediate,10116.0,,1,Biodistribution of the Radiolabeled FBWAY compound in rat hippocampus at 30 min co-injected with 50 nmol of WAY 100635,,,CHEMBL628253,,50597,Rattus norvegicus,,,N,1,BAO_0000218,10000000.0
14536,In vivo,15413,Intermediate,10116.0,,1,Biodistribution of the Radiolabeled FBWAY compound in rat hypothalamus at 30 min co-injected with 200 nmol of WAY 100635,,,CHEMBL628254,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1898.0
14537,In vivo,15413,Intermediate,10116.0,,1,Biodistribution of the Radiolabeled FBWAY compound in rat hypothalamus at 30 min co-injected with 50 nmol of WAY 100635,,,CHEMBL877493,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1898.0
14538,In vivo,15413,Intermediate,10116.0,,1,Biodistribution of the Radiolabeled FCWAY compound in rat Cerebellum at 30 min co-injected with 50 nmol of WAY 100635,,,CHEMBL628255,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
14539,In vivo,15413,Intermediate,10116.0,,1,Biodistribution of the Radiolabeled FCWAY compound in rat cortex at 30 min co-injected with 50 nmol of WAY 100635,,,CHEMBL628256,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
14540,In vivo,15413,Intermediate,10116.0,,1,Biodistribution of the Radiolabeled FCWAY compound in rat hippocampus at 30 min co-injected with 50 nmol of WAY 100635,,,CHEMBL628257,,50597,Rattus norvegicus,,,N,1,BAO_0000218,10000000.0
14541,In vivo,15413,Intermediate,10116.0,,1,Biodistribution of the Radiolabeled FCWAY compound in rat hypothalamus at 30 min co-injected with 50 nmol of WAY 100635,,,CHEMBL628258,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1898.0
14542,In vivo,15413,Intermediate,10116.0,,1,Biodistribution of the Radiolabeled MeFBWAY compound in rat Cerebellum at 30 min co-injected with 50 nmol of WAY 100635,,,CHEMBL628259,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
14543,In vivo,15413,Intermediate,10116.0,,1,Biodistribution of the Radiolabeled MeFBWAY compound in rat cortex at 30 min co-injected with 50 nmol of WAY 100635,,,CHEMBL628429,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
14544,In vivo,15413,Intermediate,10116.0,,1,Biodistribution of the Radiolabeled MeFBWAY compound in rat hippocampus at 30 min co-injected with 50 nmol of WAY 100635,,,CHEMBL626862,,50597,Rattus norvegicus,,,N,1,BAO_0000218,10000000.0
14545,In vivo,15413,Intermediate,10116.0,,1,Biodistribution of the Radiolabeled MeFBWAY compound in rat hypothalamus at 30 min co-injected with 50 nmol of WAY 100635; Not determined,,,CHEMBL626863,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1898.0
14546,In vivo,15413,Intermediate,10116.0,,1,Biodistribution of the [11C]-radiolabeled compound in rat cerebellum,,,CHEMBL625886,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2037.0
14547,In vivo,15413,Intermediate,10116.0,,1,Biodistribution of the [11C]-radiolabeled compound in rat cerebellum co-injected with 50 nM of WAY 100635.,,,CHEMBL625887,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2037.0
14548,In vivo,15413,Intermediate,10116.0,,1,Biodistribution of the [11C]-radiolabeled compound in rat cortex,,,CHEMBL625888,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
14549,In vivo,15413,Intermediate,10116.0,,1,Biodistribution of the [11C]-radiolabeled compound in rat cortex co-injected with 50 nM of WAY 100635.,,,CHEMBL625889,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
14550,In vivo,15413,Intermediate,10116.0,,1,Biodistribution of the [11C]-radiolabeled compound in rat hippocampus,,,CHEMBL625890,,50597,Rattus norvegicus,,,N,1,BAO_0000218,10000000.0
14551,In vivo,15413,Intermediate,10116.0,,1,Biodistribution of the [11C]-radiolabeled compound in rat hippocampus co-injected with 50 nM of WAY 100635.,,,CHEMBL625891,,50597,Rattus norvegicus,,,N,1,BAO_0000218,10000000.0
14552,In vivo,15413,Intermediate,10116.0,,1,Biodistribution of the [11C]-radiolabeled compound in rat hypothalamus,,,CHEMBL625892,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1898.0
14553,In vivo,15413,Intermediate,10116.0,,1,Biodistribution of the [11C]-radiolabeled compound in rat hypothalamus co-injected with 50 nM of WAY 100635.,,,CHEMBL625893,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1898.0
14554,In vivo,15413,Intermediate,10116.0,,1,Biodistribution of the [18F]-radiolabeled compound in rat cerebellum,,,CHEMBL625894,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2037.0
14555,In vivo,15413,Intermediate,10116.0,,1,Biodistribution of the [18F]-radiolabeled compound in rat cortex,,,CHEMBL625895,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
14556,,12404,Autocuration,,,1,Reaction rate parameter value for phosphate with transfer with respect to ATP,,,CHEMBL625896,,22224,,,,U,0,BAO_0000019,
14557,,568,Autocuration,,,1,"Tested for hydrolysis in presence of boric acid, dissociation constant was evaluated at the pH 8.5(Apparent inhibition constant)",,,CHEMBL625897,,22224,,,,U,0,BAO_0000019,
14558,,568,Autocuration,,,1,"Tested for hydrolysis in presence of boric acid, dissociation constant was evaluated at the pH 9.5(Apparent inhibition constant)",,,CHEMBL625898,,22224,,,,U,0,BAO_0000019,
14559,,568,Autocuration,,,1,"Tested for hydrolysis in presence of phenylboronic acid, dissociation constant was evaluated at the pH 9.5(Apparent inhibition constant)",,,CHEMBL625899,,22224,,,,U,0,BAO_0000019,
14560,,12404,Autocuration,,,1,Reaction rate parameter value for phosphate with transfer with respect to ATP,,,CHEMBL626124,,22224,,,,U,0,BAO_0000019,
14561,,7624,Intermediate,562.0,,1,Ability to inhibit Escherichia coli adenylate kinase II activity expressed as half maximal velocity,,,CHEMBL628500,,50212,Escherichia coli,,,N,1,BAO_0000218,
14562,,7624,Intermediate,10116.0,,1,"Ability to inhibit rat adenylate kinase II, activity expressed as half-maximal velocity",,,CHEMBL857856,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
14563,,7624,Intermediate,10116.0,,1,"Ability to inhibit rat adenylate kinase III, activity expressed as half-maximal velocity",,,CHEMBL628501,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
14564,,4643,Autocuration,,,1,"Compound was evaluated for the Michaelis-Menten constant, Km in a generic protein phosphatase stopped assay system",,,CHEMBL628502,,22224,,,,U,0,BAO_0000019,
14565,,11532,Autocuration,,,1,Kinetic parameter KM (nM) for the MAO-B catalyzed oxidation of the compound.,,,CHEMBL628503,,22224,,,,U,0,BAO_0000019,
14566,,11018,Autocuration,,,1,Kinetic parameter KM at pH 7.4 and 37 degree Centigrade,,,CHEMBL628504,,22224,,,,U,0,BAO_0000019,
14567,,2276,Autocuration,,,1,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 0.25% acetonitrile and 4B2 as catalyst was expressed as KM; Not determined",,,CHEMBL628505,,22224,,,,U,0,BAO_0000019,
14568,,2276,Autocuration,,,1,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as KM",,,CHEMBL874452,,22224,,,,U,0,BAO_0000019,
14569,,2276,Autocuration,,,1,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 6C2 as catalyst was expressed as KM; Not determined",,,CHEMBL628506,,22224,,,,U,0,BAO_0000019,
14570,,2276,Autocuration,,,1,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 10% acetonitrile and 4B2 as catalyst was expressed as KM; Not determined",,,CHEMBL628507,,22224,,,,U,0,BAO_0000019,
14571,,2276,Autocuration,,,1,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as KM",,,CHEMBL628508,,22224,,,,U,0,BAO_0000019,
14572,,8949,Autocuration,,,1,Michaelis constant (KM) was evaluated,,,CHEMBL628509,,22224,,,,U,0,BAO_0000019,
14573,,12404,Autocuration,,,1,Reaction rate parameter value for phosphate with transfer with respect to ATP,,,CHEMBL628510,,22224,,,,U,0,BAO_0000019,
14574,,7625,Autocuration,,,1,Substrate concentration for half maximal velocity was reported for rat hexokinase I,,,CHEMBL628511,,22224,,,,U,0,BAO_0000019,
14575,,7625,Autocuration,,,1,Substrate concentration for half maximal velocity was reported for rat hexokinase II,,,CHEMBL628512,,22224,,,,U,0,BAO_0000019,
14576,,7625,Autocuration,,,1,Substrate concentration for half maximal velocity was reported for rat hexokinase III,,,CHEMBL628513,,22224,,,,U,0,BAO_0000019,
14577,,7625,Autocuration,,,1,Substrate concentration for half maximal velocity was reported for yeast hexokinase,,,CHEMBL628514,,22224,,,,U,0,BAO_0000019,
14578,,12908,Autocuration,,,1,Pseudo-first-order rate constant for alkylation of NBP in 50% aqueous acetone at 66 degrees celsius with 50 uM and 25 uM of NBP.,,,CHEMBL628515,,22224,,,,U,0,BAO_0000019,
14579,,10368,Autocuration,,,1,Rate constant for alkylation of 4-(4-nitrobenzyl)pyridine,,,CHEMBL628516,,22224,,,,U,0,BAO_0000019,
14580,,13108,Autocuration,,,1,Bimolecular rate constant (KOH) at 25 degree C (m = 0.5),,,CHEMBL628517,,22224,,,,U,0,BAO_0000019,
14581,,13108,Autocuration,,,1,its bimolecular rate constant (KOH) at 25 degree C (m = 0.5),,,CHEMBL628518,,22224,,,,U,0,BAO_0000019,
14582,,15217,Autocuration,,,1,Acid dissociation constant evaluated towards Hematin mu-oxo dimer,,,CHEMBL628519,,22224,,,,U,0,BAO_0000019,
14583,,15217,Autocuration,,,1,Acid dissociation constant evaluated towards Hematin mu-oxo dimer; Not available,,,CHEMBL628520,,22224,,,,U,0,BAO_0000019,
14584,,10933,Autocuration,,,1,Binding constant was determined,,,CHEMBL628521,,22224,,,,U,0,BAO_0000019,
14585,,2363,Autocuration,,,1,Alkylation of 4-(4-nitrobenzyl)pyridine (NBP) by the compound at a temperature of 66 degree Centigrade,,,CHEMBL630443,,22224,,,,U,0,BAO_0000019,
14586,,2363,Autocuration,,,1,Alkylation of 4-(4-nitrobenzyl)pyridine (NBP) by the compound at a temperature of 66 degree centigrade; Not determined,,,CHEMBL630444,,22224,,,,U,0,BAO_0000019,
14587,,2276,Autocuration,,,1,Rate constant with triethylamine at 30 degree C in 0.1 M potassium chloride was expressed as Kamine,,,CHEMBL857732,,22224,,,,U,0,BAO_0000019,
14588,,14915,Autocuration,,,1,Octanol-water apparent distribution coefficient measured in TRIS buffer at a pH 7.4.,,,CHEMBL630445,,22224,,,,U,0,BAO_0000100,
14589,,8847,Autocuration,,,1,Catalytic rate constant of the compound,,,CHEMBL630446,,22224,,,,U,0,BAO_0000019,
14590,,15357,Autocuration,,,1,inactivation rate constant calculated from experimental IC50 value for dipeptidyl peptidase IV inhibition,,,CHEMBL630447,,22224,,,,U,0,BAO_0000019,
14591,,2869,Autocuration,,,1,Catalytic constant expressed as Kinetic behavior of enzyme (PicK/6-His),,,CHEMBL630448,,22224,,,,U,0,BAO_0000019,
14592,,3484,Autocuration,,,1,Catalytic rate constant against phospholipase A2 was determined,,,CHEMBL630449,,22224,,,,U,0,BAO_0000019,
14593,,1373,Autocuration,,,1,"Compound was evaluated for catalytic constant, Kcat",,,CHEMBL630450,,22224,,,,U,0,BAO_0000019,
14594,,8142,Autocuration,,,1,Compound was tested for hydrolysis by acetylcholinesterase and the kinetic constant (kcat) which is a first-order rate constant was determined,,,CHEMBL630451,,22224,,,,U,0,BAO_0000019,
14595,,14131,Autocuration,,,1,Kcat calculated from 0.693/T1/2,,,CHEMBL630452,,22224,,,,U,0,BAO_0000019,
14596,,17269,Autocuration,,,1,Kcat was determined,,,CHEMBL630453,,22224,,,,U,0,BAO_0000019,
14597,,3485,Autocuration,,,1,Kcat against class A PCI beta-lactamase catalyzed lactone hydrolysis,,,CHEMBL630454,,22224,,,,U,0,BAO_0000019,
14598,,3485,Autocuration,,,1,Kcat against class A TEM beta-lactamase catalyzed lactone hydrolysis,,,CHEMBL630455,,22224,,,,U,0,BAO_0000019,
14599,,3485,Autocuration,,,1,Kcat against class C P99 beta-lactamase catalyzed lactone hydrolysis,,,CHEMBL631487,,22224,,,,U,0,BAO_0000019,
14600,,5962,Autocuration,,,1,Kcat value was determined,,,CHEMBL631488,,22224,,,,U,0,BAO_0000019,
14601,,3133,Autocuration,,,1,Kinetic constant for the hydrolysis by the catalyst CPA was evaluated,,,CHEMBL876440,,22224,,,,U,0,BAO_0000019,
14602,,3133,Autocuration,,,1,Kinetic constant for the hydrolysis by the catalyst McAbIIF9D8 was evaluated,,,CHEMBL631489,,22224,,,,U,0,BAO_0000019,
14603,,2276,Autocuration,,,1,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 0.25% acetonitrile and 4B2 as catalyst was expressed as Kcat; Not determined",,,CHEMBL857742,,22224,,,,U,0,BAO_0000019,
14604,,2276,Autocuration,,,1,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as Kcat",,,CHEMBL631490,,22224,,,,U,0,BAO_0000019,
14605,,2276,Autocuration,,,1,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 6C2 as catalyst was expressed as Kcat; Not determined",,,CHEMBL631491,,22224,,,,U,0,BAO_0000019,
14606,,2276,Autocuration,,,1,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 10% acetonitrile and 4B2 as catalyst was expressed as Kcat; Not determined",,,CHEMBL631492,,22224,,,,U,0,BAO_0000019,
14607,,2276,Autocuration,,,1,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as Kcat",,,CHEMBL631493,,22224,,,,U,0,BAO_0000019,
14608,,4892,Autocuration,,,1,Kinetic parameter for rate of conversion to PABA was determined,,,CHEMBL631494,,22224,,,,U,0,BAO_0000019,
14609,,3133,Autocuration,,,1,Rate acceleration expressed as ratio of Kcat to Kuncat was evaluated,,,CHEMBL631495,,22224,,,,U,0,BAO_0000019,
14610,,11488,Intermediate,10116.0,,1,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 48-72 hr",,,CHEMBL631496,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1988.0
14611,,11488,Intermediate,10116.0,,1,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 0-24 hr",,,CHEMBL631497,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14612,,11488,Intermediate,10116.0,,1,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 24-48 hr",,,CHEMBL631498,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14613,,11488,Intermediate,10116.0,,1,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 0-24 hr",,,CHEMBL629776,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14614,,11488,Intermediate,10116.0,,1,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 24-48 hr",,,CHEMBL629777,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14615,,11488,Intermediate,10116.0,,1,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 48-72 hr",,,CHEMBL629778,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14616,,11488,Intermediate,10116.0,,1,Cumulative dose excreted after intraduodenal administration at 0-0.5 hours in rats,,,CHEMBL630456,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
14617,,11488,Intermediate,10116.0,,1,Cumulative dose excreted after intraduodenal administration at 0.5-1.0 hours in rats,,,CHEMBL630457,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
14618,,11488,Intermediate,10116.0,,1,Cumulative dose excreted after intraduodenal administration at 1.0-1.5 hours in rats,,,CHEMBL630458,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
14619,,11488,Intermediate,10116.0,,1,Cumulative dose excreted after intraduodenal administration at 1.5-2.0 hours in rats,,,CHEMBL630459,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
14620,,11488,Intermediate,10116.0,,1,Cumulative dose excreted after intraduodenal administration at 2-3 hours in rats,,,CHEMBL630460,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
14621,,11488,Intermediate,10116.0,,1,Cumulative dose excreted after intraduodenal administration at 3-4 hours in rats,,,CHEMBL876550,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
14622,,11488,Intermediate,10116.0,,1,Cumulative dose excreted after intraduodenal administration at 4-6 hours in rats,,,CHEMBL630461,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
14623,,11488,Intermediate,10116.0,,1,Cumulative dose excreted after intraduodenal administration at 6-8 hours in rats,,,CHEMBL630462,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
14624,,11488,Intermediate,10116.0,,1,Cumulative dose excreted after intraduodenal administration at 8-24 hours in rats,,,CHEMBL630463,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
14625,,11488,Intermediate,10116.0,,1,Cumulative dose excreted after intravenous administration at 0-0.5 hours in rats,,,CHEMBL630464,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
14626,,11488,Intermediate,10116.0,,1,Cumulative dose excreted after intravenous administration at 0.5-1 hours in rats,,,CHEMBL630465,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
14627,,11488,Intermediate,10116.0,,1,Cumulative dose excreted after intravenous administration at 1.0-1.5 hours in rats,,,CHEMBL630466,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
14628,,11488,Intermediate,10116.0,,1,Cumulative dose excreted after intravenous administration at 1.5-2 hours in rats,,,CHEMBL630467,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
14629,,11488,Intermediate,10116.0,,1,Cumulative dose excreted after intravenous administration at 2-3 hours in rats,,,CHEMBL630633,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
14630,,11488,Intermediate,10116.0,,1,Cumulative dose excreted after intravenous administration at 3-4 hours in rats,,,CHEMBL630634,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
14631,,11488,Intermediate,10116.0,,1,Cumulative dose excreted after intravenous administration at 4-6 hours in rats,,,CHEMBL630635,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
14632,,11488,Intermediate,10116.0,,1,Cumulative dose excreted after intravenous administration at 6-8 hours in rats,,,CHEMBL630636,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
14633,,11488,Intermediate,10116.0,,1,Cumulative dose excreted after intravenous administration at 8-24 hours in rats,,,CHEMBL630637,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
14634,,7132,Intermediate,9986.0,,1,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated (total)",,,CHEMBL630638,,50592,Oryctolagus cuniculus,,,N,1,BAO_0000218,1988.0
14635,,7132,Intermediate,9986.0,,1,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated at 0-24 h",,,CHEMBL630639,,50592,Oryctolagus cuniculus,,,N,1,BAO_0000218,1988.0
14636,,7132,Intermediate,9986.0,,1,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated at 24-48 h",,,CHEMBL630640,,50592,Oryctolagus cuniculus,,,N,1,BAO_0000218,1988.0
14637,,7132,Intermediate,9986.0,,1,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated at 48-72 h",,,CHEMBL876551,,50592,Oryctolagus cuniculus,,,N,1,BAO_0000218,1988.0
14638,,7132,Intermediate,9986.0,,1,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated (total)",,,CHEMBL630641,,50592,Oryctolagus cuniculus,,,N,1,BAO_0000218,1088.0
14639,,7132,Intermediate,9986.0,,1,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 0-6 h",,,CHEMBL630642,,50592,Oryctolagus cuniculus,,,N,1,BAO_0000218,1088.0
14640,,7132,Intermediate,9986.0,,1,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 24-48 h",,,CHEMBL630643,,50592,Oryctolagus cuniculus,,,N,1,BAO_0000218,1088.0
14641,,7132,Intermediate,9986.0,,1,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 48-72 h",,,CHEMBL630644,,50592,Oryctolagus cuniculus,,,N,1,BAO_0000218,1088.0
14642,,7132,Intermediate,9986.0,,1,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 6-24 h",,,CHEMBL630645,,50592,Oryctolagus cuniculus,,,N,1,BAO_0000218,1088.0
14643,,7132,Intermediate,9986.0,,1,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated (total)",,,CHEMBL625599,,50592,Oryctolagus cuniculus,,,N,1,BAO_0000218,1988.0
14644,,7132,Intermediate,9986.0,,1,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated at 0-24 h",,,CHEMBL625600,,50592,Oryctolagus cuniculus,,,N,1,BAO_0000218,1988.0
14645,,7132,Intermediate,9986.0,,1,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated at 24-48 h",,,CHEMBL625601,,50592,Oryctolagus cuniculus,,,N,1,BAO_0000218,1988.0
14646,,7132,Intermediate,9986.0,,1,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated at 48-72 h",,,CHEMBL625602,,50592,Oryctolagus cuniculus,,,N,1,BAO_0000218,1988.0
14647,,7132,Intermediate,9986.0,,1,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated (total)",,,CHEMBL627470,,50592,Oryctolagus cuniculus,,,N,1,BAO_0000218,1088.0
14648,,7132,Intermediate,9986.0,,1,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 0-6 h",,,CHEMBL627471,,50592,Oryctolagus cuniculus,,,N,1,BAO_0000218,1088.0
14649,,7132,Intermediate,9986.0,,1,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 24-48 h",,,CHEMBL627472,,50592,Oryctolagus cuniculus,,,N,1,BAO_0000218,1088.0
14650,,7132,Intermediate,9986.0,,1,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 48-72 h",,,CHEMBL627473,,50592,Oryctolagus cuniculus,,,N,1,BAO_0000218,1088.0
14651,,7132,Intermediate,9986.0,,1,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 6-24 h",,,CHEMBL627474,,50592,Oryctolagus cuniculus,,,N,1,BAO_0000218,1088.0
14652,In vivo,13925,Intermediate,10116.0,,1,Biodistribution in rat blood post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,,CHEMBL627475,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
14653,In vivo,13925,Intermediate,10116.0,,1,Biodistribution in rat blood post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,,CHEMBL627476,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
14654,,12582,Intermediate,9615.0,,1,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 11.9 uM/Kg of drug,,,CHEMBL627477,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,1088.0
14655,,12582,Intermediate,9615.0,,1,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 2.49 uM/Kg of drug,,,CHEMBL627478,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,1088.0
14656,,12582,Intermediate,9615.0,,1,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 26.2 uM/Kg of drug,,,CHEMBL627479,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,1088.0
14657,,12582,Intermediate,9615.0,,1,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 3.03 uM/Kg of drug,,,CHEMBL627480,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,1088.0
14658,,12582,Intermediate,9615.0,,1,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 30.3 uM/Kg of drug,,,CHEMBL627481,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,1088.0
14659,,12582,Intermediate,9615.0,,1,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 34.1 uM/Kg of drug,,,CHEMBL627482,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,1088.0
14660,,12582,Intermediate,9615.0,,1,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 7.85 uM/Kg of drug,,,CHEMBL627483,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,1088.0
14661,,12582,Intermediate,9615.0,,1,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 8.47 uM/Kg of drug,,,CHEMBL875636,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,1088.0
14662,,12582,Intermediate,9615.0,,1,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 9.09 uM/Kg of drug,,,CHEMBL625764,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,1088.0
14663,,12582,Intermediate,9615.0,,1,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 10.1 uM/Kg of drug,,,CHEMBL625765,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,1088.0
14664,,12582,Intermediate,9615.0,,1,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 102 uM/Kg of drug,,,CHEMBL625766,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,1088.0
14665,,12582,Intermediate,9615.0,,1,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 3.40 uM/Kg of drug,,,CHEMBL625767,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,1088.0
14666,,12582,Intermediate,9615.0,,1,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 3.76 uM/Kg of drug,,,CHEMBL625768,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,1088.0
14667,,12582,Intermediate,9615.0,,1,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 34.1 uM/Kg of drug,,,CHEMBL625769,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,1088.0
14668,,12582,Intermediate,9615.0,,1,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 50.8 uM/Kg of drug,,,CHEMBL625770,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,1088.0
14669,,12582,Intermediate,9615.0,,1,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 68.1 uM/Kg of drug,,,CHEMBL625771,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,1088.0
14670,,12582,Intermediate,9615.0,,1,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 9.060 uM/Kg of drug,,,CHEMBL625772,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,1088.0
14671,,12582,Intermediate,9615.0,,1,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 9.6 uM/Kg of drug,,,CHEMBL625773,,50588,Canis lupus familiaris,,,N,1,BAO_0000218,1088.0
14672,,12582,Intermediate,10116.0,,1,Total electrolytic excretion of sodium in urine of rats after intravenous administration of 7.94 uM/Kg of drug,,,CHEMBL625774,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14673,,12582,Intermediate,10116.0,,1,Total electrolytic excretion of sodium in urine of rats after peroral administration of 0 uM/Kg of drug,,,CHEMBL625775,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14674,,12582,Intermediate,10116.0,,1,Total electrolytic excretion of sodium in urine of rats after peroral administration of 1.01 uM/Kg of drug,,,CHEMBL625776,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14675,,12582,Intermediate,10116.0,,1,Total electrolytic excretion of sodium in urine of rats after peroral administration of 1.13 uM/Kg of drug,,,CHEMBL625777,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14676,,12582,Intermediate,10116.0,,1,Total electrolytic excretion of sodium in urine of rats after peroral administration of 10.1 uM/Kg of drug,,,CHEMBL625778,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14677,,12582,Intermediate,10116.0,,1,Total electrolytic excretion of sodium in urine of rats after peroral administration of 102 uM/Kg of drug,,,CHEMBL625779,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14678,,12582,Intermediate,10116.0,,1,Total electrolytic excretion of sodium in urine of rats after peroral administration of 105 uM/Kg of drug,,,CHEMBL625780,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14679,,12582,Intermediate,10116.0,,1,Total electrolytic excretion of sodium in urine of rats after peroral administration of 11.3 uM/Kg of drug,,,CHEMBL625781,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14680,,12582,Intermediate,10116.0,,1,Total electrolytic excretion of sodium in urine of rats after peroral administration of 113 uM/Kg of drug,,,CHEMBL875637,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14681,,12582,Intermediate,10116.0,,1,Total electrolytic excretion of sodium in urine of rats after peroral administration of 19.5 uM/Kg of drug,,,CHEMBL626473,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14682,,12582,Intermediate,10116.0,,1,Total electrolytic excretion of sodium in urine of rats after peroral administration of 195 uM/Kg of drug,,,CHEMBL626474,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14683,,12582,Intermediate,10116.0,,1,Total electrolytic excretion of sodium in urine of rats after peroral administration of 21.7 uM/Kg of drug,,,CHEMBL626475,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14684,,12582,Intermediate,10116.0,,1,Total electrolytic excretion of sodium in urine of rats after peroral administration of 217 uM/Kg of drug,,,CHEMBL626476,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14685,,12582,Intermediate,10116.0,,1,Total electrolytic excretion of sodium in urine of rats after peroral administration of 23.9 uM/Kg of drug,,,CHEMBL634397,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14686,,12582,Intermediate,10116.0,,1,Total electrolytic excretion of sodium in urine of rats after peroral administration of 239 uM/Kg of drug,,,CHEMBL626477,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14687,,12582,Intermediate,10116.0,,1,Total electrolytic excretion of sodium in urine of rats after peroral administration of 24.9 uM/Kg of drug,,,CHEMBL631069,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14688,,12582,Intermediate,10116.0,,1,Total electrolytic excretion of sodium in urine of rats after peroral administration of 249 uM/Kg of drug,,,CHEMBL631070,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14689,,12582,Intermediate,10116.0,,1,Total electrolytic excretion of sodium in urine of rats after peroral administration of 25.9 uM/Kg of drug,,,CHEMBL631071,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14690,,12582,Intermediate,10116.0,,1,Total electrolytic excretion of sodium in urine of rats after peroral administration of 259 uM/Kg of drug,,,CHEMBL631072,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14691,,12582,Intermediate,10116.0,,1,Total electrolytic excretion of sodium in urine of rats after peroral administration of 26.5 uM/Kg of drug,,,CHEMBL631073,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14692,,12582,Intermediate,10116.0,,1,Total electrolytic excretion of sodium in urine of rats after peroral administration of 265 uM/Kg of drug,,,CHEMBL631074,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14693,,12582,Intermediate,10116.0,,1,Total electrolytic excretion of sodium in urine of rats after peroral administration of 27 uM/Kg of drug,,,CHEMBL631075,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14694,,12582,Intermediate,10116.0,,1,Total electrolytic excretion of sodium in urine of rats after peroral administration of 27.9 uM/Kg of drug,,,CHEMBL631725,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14695,,12582,Intermediate,10116.0,,1,Total electrolytic excretion of sodium in urine of rats after peroral administration of 270 uM/Kg of drug,,,CHEMBL631726,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14696,,12582,Intermediate,10116.0,,1,Total electrolytic excretion of sodium in urine of rats after peroral administration of 279 uM/Kg of drug,,,CHEMBL631727,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14697,,12582,Intermediate,10116.0,,1,Total electrolytic excretion of sodium in urine of rats after peroral administration of 28.2 uM/Kg of drug,,,CHEMBL631728,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14698,,12582,Intermediate,10116.0,,1,Total electrolytic excretion of sodium in urine of rats after peroral administration of 28.9 uM/Kg of drug,,,CHEMBL631729,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14699,,12582,Intermediate,10116.0,,1,Total electrolytic excretion of sodium in urine of rats after peroral administration of 282 uM/Kg of drug,,,CHEMBL631730,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14700,,12582,Intermediate,10116.0,,1,Total electrolytic excretion of sodium in urine of rats after peroral administration of 289 uM/Kg of drug,,,CHEMBL631731,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14701,,12582,Intermediate,10116.0,,1,Total electrolytic excretion of sodium in urine of rats after peroral administration of 3.40 uM/Kg of drug,,,CHEMBL631910,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14702,In vivo,15413,Intermediate,10116.0,,1,Biodistribution of the [18F]-radiolabeled compound in rat hippocampus,,,CHEMBL631911,,50597,Rattus norvegicus,,,N,1,BAO_0000218,10000000.0
14703,In vivo,15413,Intermediate,10116.0,,1,Biodistribution of the [18F]-radiolabeled compound in rat hypothalamus,,,CHEMBL631912,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1898.0
14704,In vivo,15413,Intermediate,10116.0,,1,Biodistribution of the [18F]-radiolabeled compound in rat hypothalamus; Not determined,,,CHEMBL631913,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1898.0
14705,In vivo,12017,Intermediate,10116.0,,1,Biodistribution in blood of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,CHEMBL631914,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
14706,In vivo,12017,Intermediate,10116.0,,1,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,CHEMBL631915,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
14707,In vivo,12017,Intermediate,10116.0,,1,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,,CHEMBL875778,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
14708,In vivo,12017,Intermediate,10116.0,,1,Biodistribution in blood of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,CHEMBL631916,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
14709,In vivo,12017,Intermediate,10116.0,,1,Biodistribution in blood of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,CHEMBL631917,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
14710,In vivo,12017,Intermediate,10116.0,,1,Biodistribution in blood of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,CHEMBL631918,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
14711,In vivo,12017,Intermediate,10116.0,,1,Biodistribution in blood of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,CHEMBL631919,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
14712,In vivo,12017,Intermediate,10116.0,,1,Biodistribution in blood of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,,CHEMBL631920,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
14713,In vivo,12017,Intermediate,10116.0,,1,Biodistribution in blood of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,CHEMBL631921,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
14714,In vivo,12017,Intermediate,10116.0,,1,Biodistribution in blood of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,CHEMBL631922,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
14715,In vivo,12017,Intermediate,10116.0,,1,Biodistribution in blood of immature femalee rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,,CHEMBL631923,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
14716,In vivo,12017,Intermediate,10116.0,,1,Biodistribution in fat of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,CHEMBL631924,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
14717,In vivo,12017,Intermediate,10116.0,,1,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,CHEMBL630234,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
14718,In vivo,12017,Intermediate,10116.0,,1,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,,CHEMBL630235,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
14719,In vivo,12017,Intermediate,10116.0,,1,Biodistribution in fat of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,CHEMBL630236,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
14720,In vivo,12017,Intermediate,10116.0,,1,Biodistribution in fat of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,CHEMBL630237,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
14721,In vivo,12017,Intermediate,10116.0,,1,Biodistribution in fat of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,CHEMBL630238,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
14722,In vivo,12017,Intermediate,10116.0,,1,Biodistribution in fat of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,CHEMBL630239,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
14723,In vivo,12017,Intermediate,10116.0,,1,Biodistribution in fat of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,,CHEMBL630303,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
14724,In vivo,12017,Intermediate,10116.0,,1,Biodistribution in fat of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,CHEMBL630304,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
14725,In vivo,12017,Intermediate,10116.0,,1,Biodistribution in fat of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,CHEMBL630305,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
14726,In vivo,12017,Intermediate,10116.0,,1,Biodistribution in kidney of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,CHEMBL630306,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2113.0
14727,In vivo,12017,Intermediate,10116.0,,1,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,CHEMBL630307,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2113.0
14728,In vivo,12017,Intermediate,10116.0,,1,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,,CHEMBL630308,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2113.0
14729,In vivo,12017,Intermediate,10116.0,,1,Biodistribution in kidney of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,CHEMBL630309,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2113.0
14730,In vivo,12017,Intermediate,10116.0,,1,Biodistribution in kidney of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,CHEMBL629309,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2113.0
14731,In vivo,12017,Intermediate,10116.0,,1,Biodistribution in kidney of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,CHEMBL629993,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2113.0
14732,In vivo,12017,Intermediate,10116.0,,1,Biodistribution in kidney of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,CHEMBL629994,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2113.0
14733,In vivo,12017,Intermediate,10116.0,,1,Biodistribution in kidney of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,,CHEMBL629995,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2113.0
14734,In vivo,12017,Intermediate,10116.0,,1,Biodistribution in kidney of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,CHEMBL631993,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2113.0
14735,In vivo,12017,Intermediate,10116.0,,1,Biodistribution in kidney of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,CHEMBL631994,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2113.0
14736,In vivo,12017,Intermediate,10116.0,,1,Biodistribution in kidney of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,CHEMBL631995,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2113.0
14737,In vivo,12017,Intermediate,10116.0,,1,Biodistribution in liver of Iimmature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,,CHEMBL631996,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
14738,In vivo,12017,Intermediate,10116.0,,1,Biodistribution in liver of Iimmature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,CHEMBL631997,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
14739,In vivo,12017,Intermediate,10116.0,,1,Biodistribution in liver of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,CHEMBL631998,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
14740,In vivo,12017,Intermediate,10116.0,,1,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,CHEMBL631999,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
14741,In vivo,12017,Intermediate,10116.0,,1,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,,CHEMBL632000,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
14742,In vivo,12017,Intermediate,10116.0,,1,Biodistribution in liver of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,CHEMBL632001,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
14743,In vivo,12017,Intermediate,10116.0,,1,Biodistribution in liver of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,CHEMBL874424,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
14744,In vivo,12017,Intermediate,10116.0,,1,Biodistribution in liver of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,CHEMBL632002,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
14745,In vivo,12017,Intermediate,10116.0,,1,Biodistribution in liver of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,CHEMBL632003,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
14746,,3133,Autocuration,,,1,Rate acceleration expressed as ratio of Kcat to Kuncat was evaluated,,,CHEMBL632004,,22224,,,,U,0,BAO_0000019,
14747,,2742,Autocuration,,,1,Compound was tested for amidase rate in the presence of N62C fully characterised enzyme,,,CHEMBL632005,,22224,,,,U,0,BAO_0000019,
14748,,2742,Autocuration,,,1,Compound was tested for amidase rate in the presence of N62C screen enzyme,,,CHEMBL632006,,22224,,,,U,0,BAO_0000019,
14749,,2742,Autocuration,,,1,Compound was tested for amidase rate in the presence of S166C fully characterised enzyme,,,CHEMBL632007,,22224,,,,U,0,BAO_0000019,
14750,,2742,Autocuration,,,1,Compound was tested for amidase rate in the presence of S166C screen enzyme,,,CHEMBL632008,,22224,,,,U,0,BAO_0000019,
14751,,2742,Autocuration,,,1,Compound was tested for esterase rate in the presence of N62C fully characterised enzyme,,,CHEMBL632009,,22224,,,,U,0,BAO_0000019,
14752,,2742,Autocuration,,,1,Compound was tested for esterase rate in the presence of N62C screen enzyme,,,CHEMBL632010,,22224,,,,U,0,BAO_0000019,
14753,,2742,Autocuration,,,1,Compound was tested for esterase rate in the presence of S166C fully characterised enzyme,,,CHEMBL857750,,22224,,,,U,0,BAO_0000019,
14754,,2742,Autocuration,,,1,Compound was tested for esterase rate in the presence of S166C screen enzyme,,,CHEMBL632011,,22224,,,,U,0,BAO_0000019,
14755,,2276,Autocuration,,,1,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 0.25% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",,,CHEMBL632012,,22224,,,,U,0,BAO_0000019,
14756,,2276,Autocuration,,,1,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",,,CHEMBL632013,,22224,,,,U,0,BAO_0000019,
14757,,2276,Autocuration,,,1,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 6C2 as catalyst was expressed as Kcat/KM",,,CHEMBL632014,,22224,,,,U,0,BAO_0000019,
14758,,2276,Autocuration,,,1,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 10% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",,,CHEMBL629622,,22224,,,,U,0,BAO_0000019,
14759,,2276,Autocuration,,,1,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",,,CHEMBL629623,,22224,,,,U,0,BAO_0000019,
14760,,2276,Autocuration,,,1,"Rate constant at 30 degree C in phosphate buffer pH 7.1, 0.5 % acetonitrile was expressed as Kcat/KM",,,CHEMBL629624,,22224,,,,U,0,BAO_0000019,
14761,,17269,Autocuration,,,1,Ratio of Kcat to that of Km was determined,,,CHEMBL629625,,22224,,,,U,0,BAO_0000019,
14762,,2276,Autocuration,,,1,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as Kcat/Kuncat",,,CHEMBL629626,,22224,,,,U,0,BAO_0000019,
14763,,2276,Autocuration,,,1,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as Kcat/Kuncat",,,CHEMBL629627,,22224,,,,U,0,BAO_0000019,
14764,,15917,Autocuration,,,1,"Compound was evaluated for constant, Kd",,,CHEMBL629628,,22224,,,,U,0,BAO_0000019,
14765,,10933,Autocuration,,,1,Deacylation rate constant(Kd fast) was determined by proflavin displacement assay,,,CHEMBL629629,,22224,,,,U,0,BAO_0000019,
14766,,10933,Autocuration,,,1,Deacylation rate constant(Kd slow) was determined by proflavin displacement assay,,,CHEMBL629630,,22224,,,,U,0,BAO_0000019,
14767,,14293,Autocuration,,,1,Dissociation Constant of compound determined,,,CHEMBL856030,,22224,,,,U,0,BAO_0000019,
14768,,6698,Autocuration,,,1,Dissociation constant for the binding of compound to PDZ3 from PSD-95 was determined,,,CHEMBL629631,,22224,,,,U,0,BAO_0000019,
14769,,6698,Autocuration,,,1,Dissociation constant for the binding of compound to PDZ3 from PSD-95 was determined; No data,,,CHEMBL629632,,22224,,,,U,0,BAO_0000019,
14770,,4318,Autocuration,,,1,Dissociation constant of compound with Fructose was determined,,,CHEMBL629633,,22224,,,,U,0,BAO_0000100,
14771,,4318,Autocuration,,,1,Dissociation constant of compound with Fructose was determined; Not determined,,,CHEMBL629634,,22224,,,,U,0,BAO_0000100,
14772,,4318,Autocuration,,,1,Dissociation constant of compound with Lactulose was determined,,,CHEMBL629635,,22224,,,,U,0,BAO_0000100,
14773,,4318,Autocuration,,,1,Dissociation constant of compound with Lactulose was determined; Not determined,,,CHEMBL629636,,22224,,,,U,0,BAO_0000100,
14774,,14959,Autocuration,,,1,Dissociation constant of the Compound,,,CHEMBL629637,,22224,,,,U,0,BAO_0000100,
14775,,5913,Autocuration,,,1,Dissociation constant by non-linear regression analysis,,,CHEMBL629638,,22224,,,,U,0,BAO_0000100,
14776,,14218,Autocuration,,,1,Dissociation constant was determined,,,CHEMBL629639,,22224,,,,U,0,BAO_0000100,
14777,,10689,Autocuration,,,1,Dissociation constant of the compound; value ranges from 0.81-1.2 nM,,,CHEMBL629640,,22224,,,,U,0,BAO_0000100,
14778,,13925,Autocuration,,,1,Dissociation constant was determined,,,CHEMBL629641,,22224,,,,U,0,BAO_0000100,
14779,,16359,Autocuration,,,1,Dissociation constant was determined,,,CHEMBL631344,,22224,,,,U,0,BAO_0000100,
14780,,10944,Intermediate,10116.0,,1,Equilibrium dissociation constant based on membrane concentration in rat smooth muscle,,,CHEMBL631345,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2385.0
14781,,11080,Autocuration,,,1,The dissociation constant determined by fluorescence displacement assay,,,CHEMBL631346,,22224,,,,U,0,BAO_0000019,
14782,,17805,Autocuration,,,1,kd value surface plasmon resonance (SPR) method,,,CHEMBL631524,,22224,,,,U,0,BAO_0000019,
14783,,10944,Intermediate,10116.0,,1,Equilibrium dissociation constant based on aqueous concentration in rat smooth muscle,,,CHEMBL631525,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2385.0
14784,,16645,Autocuration,,,1,First dissociation constant of the binding of compound to V30M TTR,,,CHEMBL631526,,22224,,,,U,0,BAO_0000019,
14785,,16645,Autocuration,,,1,Second dissociation constant of the binding of compound to V30M TTR,,,CHEMBL631527,,22224,,,,U,0,BAO_0000019,
14786,,7793,Autocuration,,,1,"Compound was evaluated for equilibrium constant, Ke",,,CHEMBL631528,,22224,,,,U,0,BAO_0000019,
14787,,12199,Autocuration,,,1,Equilibrium constant from the dorsal raphe and the ventromedial hypothalamus,,,CHEMBL631529,,22224,,,,U,0,BAO_0000019,1898.0
14788,,12199,Autocuration,,,1,Equilibrium constant from the dorsal raphe and the ventromedial hypothalamus; inactive,,,CHEMBL631530,,22224,,,,U,0,BAO_0000019,1898.0
14789,,9680,Autocuration,,,1,Keff is the effective biomolecular rate constant on VX for reactivation at pH 7.8 at 25 degree Centigrade,,,CHEMBL631531,,22224,,,,U,0,BAO_0000019,
14790,,9680,Autocuration,,,1,Keff is the effective biomolecular rate constant on paraxon for reactivation at pH 7.8 at 25 degree Centigrade,,,CHEMBL631532,,22224,,,,U,0,BAO_0000019,
14791,,9680,Autocuration,,,1,Keff is the effective biomolecular rate constant on sarin for reactivation at pH 7.8 at 25 degree Centigrade,,,CHEMBL631533,,22224,,,,U,0,BAO_0000019,
14792,,13758,Intermediate,10090.0,,1,In vitro biotransformation of compound along with coformycin in mice liver homogenate 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,,,CHEMBL876552,,50594,Mus musculus,,,N,1,BAO_0000218,
14793,,13758,Intermediate,10090.0,,1,In vitro biotransformation of compound along with coformycin in mice liver homogenate 9-(beta-D-arabinifuranosyl)adenine(ara-A) analyte,,,CHEMBL631534,,50594,Mus musculus,,,N,1,BAO_0000218,
14794,,13758,Intermediate,10090.0,,1,In vitro biotransformation of compound in mice brain homogenate 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,,,CHEMBL631535,,50594,Mus musculus,,,N,1,BAO_0000218,
14795,,13758,Intermediate,10090.0,,1,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,,,CHEMBL631536,,50594,Mus musculus,,,N,1,BAO_0000218,
14796,,13758,Intermediate,10090.0,,1,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)-6-hypoxanthine(ara-H) analyte,,,CHEMBL631537,,50594,Mus musculus,,,N,1,BAO_0000218,
14797,,13758,Intermediate,10090.0,,1,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)adenine(ara-A) analyte,,,CHEMBL631538,,50594,Mus musculus,,,N,1,BAO_0000218,
14798,,13758,Intermediate,10090.0,,1,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)adenine(ara-H) analyte,,,CHEMBL631539,,50594,Mus musculus,,,N,1,BAO_0000218,
14799,,13758,Intermediate,10090.0,,1,In vitro biotransformation of compound in mice serum 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,,,CHEMBL631540,,50594,Mus musculus,,,N,1,BAO_0000218,
14800,,14393,Intermediate,10116.0,,1,Pharmacokinetic Parameter [Kel(1/h)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,,,CHEMBL625637,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
14801,,14393,Intermediate,10116.0,,1,Pharmacokinetic parameter [Kel(1/h)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,,,CHEMBL625638,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
14802,,15078,Intermediate,10116.0,,1,"The Kel value in female wistar rat at 100 mg/kg, p.o. dose",,,CHEMBL625639,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
14803,In vivo,13925,Intermediate,10116.0,,1,Biodistribution in rat brain post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,,CHEMBL625640,,50597,Rattus norvegicus,,,N,1,BAO_0000218,955.0
14804,In vivo,13925,Intermediate,10116.0,,1,Biodistribution in rat brain post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,,CHEMBL625641,,50597,Rattus norvegicus,,,N,1,BAO_0000218,955.0
14805,In vivo,13925,Intermediate,10116.0,,1,Biodistribution in rat heart post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,,CHEMBL625642,,50597,Rattus norvegicus,,,N,1,BAO_0000218,948.0
14806,In vivo,13925,Intermediate,10116.0,,1,Biodistribution in rat heart post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,,CHEMBL625643,,50597,Rattus norvegicus,,,N,1,BAO_0000218,948.0
14807,In vivo,13925,Intermediate,10116.0,,1,Biodistribution in rat kidney post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,,CHEMBL625644,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2113.0
14808,In vivo,13925,Intermediate,10116.0,,1,Biodistribution in rat kidney post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,,CHEMBL625645,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2113.0
14809,In vivo,13925,Intermediate,10116.0,,1,Biodistribution in rat liver post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,,CHEMBL625646,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
14810,In vivo,13925,Intermediate,10116.0,,1,Biodistribution in rat liver post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,,CHEMBL625647,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
14811,In vivo,13925,Intermediate,10116.0,,1,Biodistribution in rat lung post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,,CHEMBL625648,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2048.0
14812,In vivo,13925,Intermediate,10116.0,,1,Biodistribution in rat lung post intravenous injection for 60 min of [99mTc]-TRODAT ligand expressed as percent dose per organ,,,CHEMBL625649,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2048.0
14813,In vivo,13925,Intermediate,10116.0,,1,Biodistribution in rat muscle post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,,CHEMBL625650,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2385.0
14814,In vivo,13925,Intermediate,10116.0,,1,Biodistribution in rat muscle post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,,CHEMBL625651,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2385.0
14815,In vivo,13925,Intermediate,10116.0,,1,Biodistribution in rat skin post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,,CHEMBL625652,,50597,Rattus norvegicus,,,N,1,BAO_0000218,14.0
14816,In vivo,13925,Intermediate,10116.0,,1,Biodistribution in rat skin post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,,CHEMBL625653,,50597,Rattus norvegicus,,,N,1,BAO_0000218,14.0
14817,In vivo,13925,Intermediate,10116.0,,1,Biodistribution in rat spleen post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,,CHEMBL625654,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2106.0
14818,In vivo,13925,Intermediate,10116.0,,1,Biodistribution in rat spleen post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,,CHEMBL625655,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2106.0
14819,In vivo,9712,Intermediate,10116.0,,1,Biodistribution of Compound in rat blood after 15 minutes of administration,,,CHEMBL625656,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
14820,In vivo,9712,Intermediate,10116.0,,1,Biodistribution of Compound in rat blood after 2 minutes of administration,,,CHEMBL625657,,50597,Rattus norvegicus,,,N,1,BAO_0000218,178.0
14821,In vivo,9712,Intermediate,10116.0,,1,Biodistribution of Compound in rat brain after 15 minutes of administration,,,CHEMBL625658,,50597,Rattus norvegicus,,,N,1,BAO_0000218,955.0
14822,In vivo,9712,Intermediate,10116.0,,1,Biodistribution of Compound in rat brain after 2 minutes of administration,,,CHEMBL625659,,50597,Rattus norvegicus,,,N,1,BAO_0000218,955.0
14823,In vivo,9712,Intermediate,10116.0,,1,Biodistribution of Compound in rat heart after 15 minutes of administration,,,CHEMBL625660,,50597,Rattus norvegicus,,,N,1,BAO_0000218,948.0
14824,In vivo,9712,Intermediate,10116.0,,1,Biodistribution of Compound in rat heart after 2 minutes of administration,,,CHEMBL625661,,50597,Rattus norvegicus,,,N,1,BAO_0000218,948.0
14825,In vivo,9712,Intermediate,10116.0,,1,Biodistribution of Compound in rat liver after 15 minutes of administration,,,CHEMBL625662,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
14826,In vivo,9712,Intermediate,10116.0,,1,Biodistribution of Compound in rat liver after 2 minutes of administration,,,CHEMBL625663,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
14827,In vivo,9712,Intermediate,10116.0,,1,Biodistribution of Compound in rat lung after 15 minutes of administration,,,CHEMBL875621,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2048.0
14828,In vivo,9712,Intermediate,10116.0,,1,Biodistribution of Compound in rat lung after 2 minutes of administration,,,CHEMBL628382,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2048.0
14829,In vivo,9712,Intermediate,10116.0,,1,Biodistribution of Compound in rat muscle after 15 minutes of administration,,,CHEMBL628383,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2385.0
14830,In vivo,9712,Intermediate,10116.0,,1,Biodistribution of Compound in rat muscle after 2 minutes of administration,,,CHEMBL628384,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2385.0
14831,,13925,Intermediate,10116.0,,1,Brain uptake of [99mTc]TRODAT in rat expressed as percent dose per organ at time of 2 mins,,,CHEMBL628385,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
14832,,13925,Intermediate,10116.0,,1,Brain uptake of [99mTc]TRODAT in rat expressed as percent dose per organ at time of 30 mins,,,CHEMBL875753,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
14833,,13925,Intermediate,10116.0,,1,Brain uptake of [99mTc]TRODAT in rat expressed as percent dose per organ at time of 60 mins,,,CHEMBL628386,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
14834,,6941,Intermediate,10116.0,,1,Organ distribution in rat blood 2 minutes after intravenous injection,,,CHEMBL628387,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
14835,,6941,Intermediate,10116.0,,1,Organ distribution in rat blood 2 hr after intravenous injection,,,CHEMBL628388,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
14836,,6941,Intermediate,10116.0,,1,Organ distribution in rat blood 30 minutes after intravenous injection,,,CHEMBL628389,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
14837,,6941,Intermediate,10116.0,,1,Organ distribution in rat blood 30 min after intravenous injection,,,CHEMBL632756,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
14838,,6941,Intermediate,10116.0,,1,Organ distribution in rat brain 2 minutes after intravenous injection,,,CHEMBL628390,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
14839,,6941,Intermediate,10116.0,,1,Organ distribution in rat brain 2 hr after intravenous injection,,,CHEMBL631811,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
14840,,6941,Intermediate,10116.0,,1,Organ distribution in rat brain 30 minutes after intravenous injection,,,CHEMBL631812,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
14841,,6941,Intermediate,10116.0,,1,Organ distribution in rat heart 2 minutes after intravenous injection,,,CHEMBL631813,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
14842,,6941,Intermediate,10116.0,,1,Organ distribution in rat heart 2 hr after intravenous injection,,,CHEMBL631814,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
14843,,6941,Intermediate,10116.0,,1,Organ distribution in rat heart 30 minutes after intravenous injection,,,CHEMBL631815,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
14844,,6941,Intermediate,10116.0,,1,Organ distribution in rat kidney 2 minutes after intravenous injection,,,CHEMBL631816,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
14845,,6941,Intermediate,10116.0,,1,Organ distribution in rat kidney 2 hr after intravenous injection,,,CHEMBL875758,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
14846,,6941,Intermediate,10116.0,,1,Organ distribution in rat kidney 30 minutes after intravenous injection,,,CHEMBL631817,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
14847,,6941,Intermediate,10116.0,,1,Organ distribution in rat liver 2 minutes after intravenous injection,,,CHEMBL631818,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
14848,,6941,Intermediate,10116.0,,1,Organ distribution in rat liver 2 hr after intravenous injection,,,CHEMBL631819,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
14849,,6941,Intermediate,10116.0,,1,Organ distribution in rat liver 30 minutes after intravenous injection,,,CHEMBL631820,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
14850,,6941,Intermediate,10116.0,,1,Organ distribution in rat lung 2 minutes after intravenous injection,,,CHEMBL631821,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
14851,,6941,Intermediate,10116.0,,1,Organ distribution in rat lung 2 hr after intravenous injection,,,CHEMBL631822,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
14852,,6941,Intermediate,10116.0,,1,Organ distribution in rat lung 30 minutes after intravenous injection,,,CHEMBL631823,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
14853,,6941,Intermediate,10116.0,,1,Organ distribution in rat muscle 2 minutes after intravenous injection,,,CHEMBL631824,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2385.0
14854,,6941,Intermediate,10116.0,,1,Organ distribution in rat muscle 2 hr after intravenous injection,,,CHEMBL631825,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2385.0
14855,,6941,Intermediate,10116.0,,1,Organ distribution in rat muscle 30 minutes after intravenous injection,,,CHEMBL631826,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2385.0
14856,In vivo,14439,Intermediate,10090.0,,1,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Blood (B),,,CHEMBL631827,,50594,Mus musculus,,,N,1,BAO_0000218,
14857,In vivo,14439,Intermediate,10090.0,,1,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Heart (H),,,CHEMBL631828,,50594,Mus musculus,,,N,1,BAO_0000218,
14858,In vivo,14439,Intermediate,10090.0,,1,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Lung (L),,,CHEMBL631829,,50594,Mus musculus,,,N,1,BAO_0000218,
14859,,12582,Intermediate,10116.0,,1,Total electrolytic excretion of sodium in urine of rats after peroral administration of 3.76 uM/Kg of drug,,,CHEMBL875759,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14860,,12582,Intermediate,10116.0,,1,Total electrolytic excretion of sodium in urine of rats after peroral administration of 30.20 uM/Kg of drug,,,CHEMBL631830,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14861,,12582,Intermediate,10116.0,,1,Total electrolytic excretion of sodium in urine of rats after peroral administration of 302 uM/Kg of drug,,,CHEMBL631831,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14862,,12582,Intermediate,10116.0,,1,Total electrolytic excretion of sodium in urine of rats after peroral administration of 31.6 uM/Kg of drug,,,CHEMBL631832,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14863,,12582,Intermediate,10116.0,,1,Total electrolytic excretion of sodium in urine of rats after peroral administration of 316 uM/Kg of drug,,,CHEMBL631833,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14864,,12582,Intermediate,10116.0,,1,Total electrolytic excretion of sodium in urine of rats after peroral administration of 32.4 uM/Kg of drug,,,CHEMBL631834,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14865,,12582,Intermediate,10116.0,,1,Total electrolytic excretion of sodium in urine of rats after peroral administration of 324 uM/Kg of drug,,,CHEMBL631835,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14866,,12582,Intermediate,10116.0,,1,Total electrolytic excretion of sodium in urine of rats after peroral administration of 34.0 uM/Kg of drug,,,CHEMBL631836,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14867,,12582,Intermediate,10116.0,,1,Total electrolytic excretion of sodium in urine of rats after peroral administration of 34.1 uM/Kg of drug,,,CHEMBL631837,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14868,,12582,Intermediate,10116.0,,1,Total electrolytic excretion of sodium in urine of rats after peroral administration of 34.8 uM/Kg of drug,,,CHEMBL631838,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14869,,12582,Intermediate,10116.0,,1,Total electrolytic excretion of sodium in urine of rats after peroral administration of 341 uM/Kg of drug,,,CHEMBL631839,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14870,,12582,Intermediate,10116.0,,1,Total electrolytic excretion of sodium in urine of rats after peroral administration of 348 uM/Kg of drug,,,CHEMBL631840,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14871,,12582,Intermediate,10116.0,,1,Total electrolytic excretion of sodium in urine of rats after peroral administration of 37.6 uM/Kg of drug,,,CHEMBL631841,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14872,,12582,Intermediate,10116.0,,1,Total electrolytic excretion of sodium in urine of rats after peroral administration of 58.4 uM/Kg of drug,,,CHEMBL631842,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14873,,12582,Intermediate,10116.0,,1,Total electrolytic excretion of sodium in urine of rats after peroral administration of 65.2 uM/Kg of drug,,,CHEMBL631843,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14874,,12582,Intermediate,10116.0,,1,Total electrolytic excretion of sodium in urine of rats after peroral administration of 71.6 uM/Kg of drug,,,CHEMBL631844,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14875,,12582,Intermediate,10116.0,,1,Total electrolytic excretion of sodium in urine of rats after peroral administration of 71.8 uM/Kg of drug,,,CHEMBL631845,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14876,,12582,Intermediate,10116.0,,1,Total electrolytic excretion of sodium in urine of rats after peroral administration of 74.8 uM/Kg of drug,,,CHEMBL631846,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14877,,12582,Intermediate,10116.0,,1,Total electrolytic excretion of sodium in urine of rats after peroral administration of 77.5 uM/Kg of drug,,,CHEMBL875760,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14878,,12582,Intermediate,10116.0,,1,Total electrolytic excretion of sodium in urine of rats after peroral administration of 79.4 uM/Kg of drug,,,CHEMBL632199,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14879,,12582,Intermediate,10116.0,,1,Total electrolytic excretion of sodium in urine of rats after peroral administration of 80.9 uM/Kg of drug,,,CHEMBL631847,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14880,,12582,Intermediate,10116.0,,1,Total electrolytic excretion of sodium in urine of rats after peroral administration of 83.8 uM/Kg of drug,,,CHEMBL631848,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14881,,12582,Intermediate,10116.0,,1,Total electrolytic excretion of sodium in urine of rats after peroral administration of 84.5 uM/Kg of drug,,,CHEMBL628707,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14882,,12582,Intermediate,10116.0,,1,Total electrolytic excretion of sodium in urine of rats after peroral administration of 84.7 uM/Kg of drug,,,CHEMBL628708,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14883,,12582,Intermediate,10116.0,,1,Total electrolytic excretion of sodium in urine of rats after peroral administration of 86.7 uM/Kg of drug,,,CHEMBL628709,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14884,,12582,Intermediate,10116.0,,1,Total electrolytic excretion of sodium in urine of rats after peroral administration of 86.9 uM/Kg of drug,,,CHEMBL628710,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14885,,12582,Intermediate,10116.0,,1,Total electrolytic excretion of sodium in urine of rats after peroral administration of 9.06 uM/Kg of drug,,,CHEMBL628711,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14886,,12582,Intermediate,10116.0,,1,Total electrolytic excretion of sodium in urine of rats after peroral administration of 90.6 uM/Kg of drug,,,CHEMBL628712,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14887,,12582,Intermediate,10116.0,,1,Total electrolytic excretion of sodium in urine of rats after peroral administration of 94.9 uM/Kg of drug,,,CHEMBL628713,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14888,,12582,Intermediate,10116.0,,1,Total electrolytic excretion of sodium in urine of rats after peroral administration of 97.1 uM/Kg of drug,,,CHEMBL628714,,50597,Rattus norvegicus,,,N,1,BAO_0000218,1088.0
14889,,7415,Intermediate,10116.0,,1,"excretion rate in rats after the dose of 5 mg/kg intravenously, at the dose 4 hour Rate of biliary excretion; 0.06-0.15%/h",,,CHEMBL628715,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
14890,,7313,Autocuration,,,1,Extent rates of formation of metabolic intermediate Cytochrome P-450 at compound concentration of 3.75-120 uM,,,CHEMBL629179,,22224,,,,U,0,BAO_0000019,
14891,,7313,Autocuration,,,1,Extent rates of formation of metabolic intermediate Cytochrome P-450 at compound concentration of 30 uM,,,CHEMBL629180,,22224,,,,U,0,BAO_0000019,
14892,,7313,Autocuration,,,1,Extent rates of formation of metabolic intermediate Cytochrome P-450 at compound concentration of 7.5-120 uM,,,CHEMBL875108,,22224,,,,U,0,BAO_0000019,
14893,,7570,Autocuration,,,1,Percent lipid extracted at 0.5 hr from adrenal cortex liver using CHCl3/CH3OH.,,,CHEMBL629181,,22224,,,,U,0,BAO_0000019,1235.0
14894,,7570,Autocuration,,,1,Percent lipid extracted at 0.5 hr from adrenal cortex liver using CHCl3/CH3OH.,,,CHEMBL629182,,22224,,,,U,0,BAO_0000019,1235.0
14895,,7570,Autocuration,,,1,Percent lipid extracted at 0.5 hr from liver plasma using CHCl3/CH3OH.,,,CHEMBL629183,,22224,,,,U,0,BAO_0000019,
14896,,7570,Autocuration,,,1,Percent lipid extracted at 0.5 hr from liver using CHCl3/CH3OH.,,,CHEMBL629184,,22224,,,,U,0,BAO_0000019,
14897,,7570,Autocuration,,,1,Percent lipid extracted at 24 hours from adrenal cortex using CHCl3/CH3OH.,,,CHEMBL629185,,22224,,,,U,0,BAO_0000019,1235.0
14898,,7570,Autocuration,,,1,Percent lipid extracted at 24 hours from adrenal cortex liver using CHCl3/CH3OH.,,,CHEMBL629186,,22224,,,,U,0,BAO_0000019,1235.0
14899,,7570,Autocuration,,,1,Percent lipid extracted at 24 hours from liverliver using CHCl3/CH3OH.,,,CHEMBL629187,,22224,,,,U,0,BAO_0000019,
14900,,7570,Autocuration,,,1,Percent lipid extracted at 24 hours from plasma using CHCl3/CH3OH.,,,CHEMBL629887,,22224,,,,U,0,BAO_0000019,
14901,,7570,Autocuration,,,1,Percent lipid extracted at 24 hours from plasmaliver using CHCl3/CH3OH.,,,CHEMBL629888,,22224,,,,U,0,BAO_0000019,
14902,,7570,Autocuration,,,1,Percent lipid extracted at 24 hr from liver using CHCl3/CH3OH.,,,CHEMBL629889,,22224,,,,U,0,BAO_0000019,
14903,,7570,Autocuration,,,1,Percent parent compound extracted at 0.5 hr from adrenal cortex using CHCl3/CH3OH.,,,CHEMBL629890,,22224,,,,U,0,BAO_0000019,1235.0
14904,,7570,Autocuration,,,1,Percent parent compound extracted at 0.5 hr from liver using CHCl3/CH3OH.,,,CHEMBL629891,,22224,,,,U,0,BAO_0000019,
14905,,7570,Autocuration,,,1,Percent parent compound extracted at 0.5 hr from plasma using CHCl3/CH3OH.,,,CHEMBL629892,,22224,,,,U,0,BAO_0000019,
14906,,7570,Autocuration,,,1,Percent parent compound extracted at 24 hours from adrenal cortex using CHCl3/CH3OH.,,,CHEMBL629893,,22224,,,,U,0,BAO_0000019,1235.0
14907,,7570,Autocuration,,,1,Percent parent compound extracted at 24 hours from liver using CHCl3/CH3OH.,,,CHEMBL629894,,22224,,,,U,0,BAO_0000019,
14908,,7570,Autocuration,,,1,Percent parent compound extracted at 24 hours from plasma using CHCl3/CH3OH.,,,CHEMBL629895,,22224,,,,U,0,BAO_0000019,
14909,In vivo,14122,Autocuration,9615.0,,1,"+Ratio of intravenous to oral integrated area under the concentration vs time curve, for compound in dog plasma",,,CHEMBL875109,,22224,Canis lupus familiaris,,,U,0,BAO_0000218,
14910,In vivo,16449,Autocuration,9541.0,,1,Absolute bioavailability in male cynomolgus monkeys,,,CHEMBL629896,,22224,Macaca fascicularis,,,U,0,BAO_0000218,
14911,In vivo,16449,Autocuration,10116.0,,1,Absolute bioavailability in maleSprague-Dawley rats,,,CHEMBL629897,,22224,Rattus norvegicus,,,U,0,BAO_0000218,
14912,In vivo,12017,Intermediate,10116.0,,1,Biodistribution in liver of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,,CHEMBL629898,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
14913,In vivo,12017,Intermediate,10116.0,,1,Biodistribution in liver of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,CHEMBL630057,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
14914,In vivo,12017,Intermediate,10116.0,,1,Biodistribution in liver of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,CHEMBL630058,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2107.0
14915,In vivo,12017,Intermediate,10116.0,,1,Biodistribution in lungs of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,CHEMBL630059,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2048.0
14916,In vivo,12017,Intermediate,10116.0,,1,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,CHEMBL630060,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2048.0
14917,In vivo,12017,Intermediate,10116.0,,1,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,,CHEMBL630061,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2048.0
14918,In vivo,12017,Intermediate,10116.0,,1,Biodistribution in lungs of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,CHEMBL630062,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2048.0
14919,In vivo,12017,Intermediate,10116.0,,1,Biodistribution in lungs of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,CHEMBL630063,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2048.0
14920,In vivo,12017,Intermediate,10116.0,,1,Biodistribution in lungs of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,CHEMBL630064,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2048.0
14921,In vivo,12017,Intermediate,10116.0,,1,Biodistribution in lungs of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,CHEMBL630065,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2048.0
14922,In vivo,12017,Intermediate,10116.0,,1,Biodistribution in lungs of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,,CHEMBL630066,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2048.0
14923,In vivo,12017,Intermediate,10116.0,,1,Biodistribution in lungs of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,CHEMBL630067,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2048.0
14924,In vivo,12017,Intermediate,10116.0,,1,Biodistribution in lungs of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,CHEMBL630068,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2048.0
14925,In vivo,12017,Intermediate,10116.0,,1,Biodistribution in muscle of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,CHEMBL631113,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2385.0
14926,In vivo,12017,Intermediate,10116.0,,1,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,CHEMBL631114,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2385.0
14927,In vivo,12017,Intermediate,10116.0,,1,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,,CHEMBL631115,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2385.0
14928,In vivo,12017,Intermediate,10116.0,,1,Biodistribution in muscle of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,CHEMBL631116,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2385.0
14929,In vivo,12017,Intermediate,10116.0,,1,Biodistribution in muscle of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,CHEMBL630528,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2385.0
14930,In vivo,12017,Intermediate,10116.0,,1,Biodistribution in muscle of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,CHEMBL630529,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2385.0
14931,In vivo,12017,Intermediate,10116.0,,1,Biodistribution in muscle of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,CHEMBL630530,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2385.0
14932,In vivo,12017,Intermediate,10116.0,,1,Biodistribution in muscle of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,,CHEMBL630531,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2385.0
14933,In vivo,12017,Intermediate,10116.0,,1,Biodistribution in muscle of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,CHEMBL630532,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2385.0
14934,In vivo,12017,Intermediate,10116.0,,1,Biodistribution in muscle of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,CHEMBL630533,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2385.0
14935,In vivo,15045,Intermediate,10090.0,,1,Biodistribution in normal mice blood after 120 hr,,,CHEMBL630534,,50594,Mus musculus,,,N,1,BAO_0000218,178.0
14936,In vivo,15045,Intermediate,10090.0,,1,Biodistribution in normal mice blood after 24 hr,,,CHEMBL630535,,50594,Mus musculus,,,N,1,BAO_0000218,178.0
14937,In vivo,15045,Intermediate,10090.0,,1,Biodistribution in normal mice blood after 4 hr,,,CHEMBL630536,,50594,Mus musculus,,,N,1,BAO_0000218,178.0
14938,In vivo,15045,Intermediate,10090.0,,1,Biodistribution in normal mice bone after 120 hr,,,CHEMBL630537,,50594,Mus musculus,,,N,1,BAO_0000218,10000001.0
14939,In vivo,15045,Intermediate,10090.0,,1,Biodistribution in normal mice bone after 24 hr,,,CHEMBL630538,,50594,Mus musculus,,,N,1,BAO_0000218,10000001.0
14940,In vivo,15045,Intermediate,10090.0,,1,Biodistribution in normal mice bone after 4 hr,,,CHEMBL630539,,50594,Mus musculus,,,N,1,BAO_0000218,10000001.0
14941,In vivo,15045,Intermediate,10090.0,,1,Biodistribution in normal mice heart after 120 hr,,,CHEMBL630540,,50594,Mus musculus,,,N,1,BAO_0000218,948.0
14942,In vivo,15045,Intermediate,10090.0,,1,Biodistribution in normal mice heart after 24 hr,,,CHEMBL630541,,50594,Mus musculus,,,N,1,BAO_0000218,948.0
14943,In vivo,15045,Intermediate,10090.0,,1,Biodistribution in normal mice heart after 4 hr,,,CHEMBL630542,,50594,Mus musculus,,,N,1,BAO_0000218,948.0
14944,In vivo,15045,Intermediate,10090.0,,1,Biodistribution in normal mice kidney after 120 hr,,,CHEMBL630543,,50594,Mus musculus,,,N,1,BAO_0000218,2113.0
14945,In vivo,15045,Intermediate,10090.0,,1,Biodistribution in normal mice kidney after 24 hr,,,CHEMBL630544,,50594,Mus musculus,,,N,1,BAO_0000218,2113.0
14946,In vivo,15045,Intermediate,10090.0,,1,Biodistribution in normal mice kidney after 4 hr,,,CHEMBL630545,,50594,Mus musculus,,,N,1,BAO_0000218,2113.0
14947,In vivo,15045,Intermediate,10090.0,,1,Biodistribution in normal mice liver after 120 hr,,,CHEMBL630546,,50594,Mus musculus,,,N,1,BAO_0000218,2107.0
14948,In vivo,15045,Intermediate,10090.0,,1,Biodistribution in normal mice liver after 24 hr,,,CHEMBL630547,,50594,Mus musculus,,,N,1,BAO_0000218,2107.0
14949,In vivo,15045,Intermediate,10090.0,,1,Biodistribution in normal mice liver after 4 hr,,,CHEMBL630548,,50594,Mus musculus,,,N,1,BAO_0000218,2107.0
14950,In vivo,15045,Intermediate,10090.0,,1,Biodistribution in normal mice spleen after 120 hr,,,CHEMBL630549,,50594,Mus musculus,,,N,1,BAO_0000218,2106.0
14951,In vivo,15045,Intermediate,10090.0,,1,Biodistribution in normal mice spleen after 24 hr,,,CHEMBL630550,,50594,Mus musculus,,,N,1,BAO_0000218,2106.0
14952,In vivo,15045,Intermediate,10090.0,,1,Biodistribution in normal mice spleen after 4 hr,,,CHEMBL876426,,50594,Mus musculus,,,N,1,BAO_0000218,2106.0
14953,In vivo,12017,Intermediate,10116.0,,1,Biodistribution in spleen of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,CHEMBL630551,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2106.0
14954,In vivo,12017,Intermediate,10116.0,,1,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,CHEMBL630552,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2106.0
14955,In vivo,12017,Intermediate,10116.0,,1,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,,CHEMBL630553,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2106.0
14956,In vivo,12017,Intermediate,10116.0,,1,Biodistribution in spleen of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,CHEMBL630554,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2106.0
14957,In vivo,12017,Intermediate,10116.0,,1,Biodistribution in spleen of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,CHEMBL630555,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2106.0
14958,In vivo,12017,Intermediate,10116.0,,1,Biodistribution in spleen of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,CHEMBL630556,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2106.0
14959,In vivo,12017,Intermediate,10116.0,,1,Biodistribution in spleen of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,CHEMBL630557,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2106.0
14960,In vivo,12017,Intermediate,10116.0,,1,Biodistribution in spleen of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,,CHEMBL630558,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2106.0
14961,In vivo,12017,Intermediate,10116.0,,1,Biodistribution in spleen of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,CHEMBL630559,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2106.0
14962,In vivo,12017,Intermediate,10116.0,,1,Biodistribution in spleen of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,CHEMBL630560,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2106.0
14963,In vivo,12017,Intermediate,10116.0,,1,Biodistribution in thyroid of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,CHEMBL876427,,50597,Rattus norvegicus,,,N,1,BAO_0000218,2046.0
14964,,14941,Intermediate,10116.0,,1,The Kel values in female wistar rats.,,,CHEMBL630561,,50597,Rattus norvegicus,,,N,1,BAO_0000218,
14965,,4646,Autocuration,,,1,The equilibrium constant pair at a pH of 7.0 and temperature of 25 degree Centigrade,,,CHEMBL630562,,22224,,,,U,0,BAO_0000019,
14966,,8847,Autocuration,,,1,Hydrolysis rate constant of the compound,,,CHEMBL630563,,22224,,,,U,0,BAO_0000019,
14967,,11778,Autocuration,,,1,Headecane/water partition coefficient expressed as the equilibrium ratio of the molar concentration in n-hexadecane to that in the buffer,,,CHEMBL629673,,22229,,,,U,0,BAO_0000100,
14968,,2363,Autocuration,,,1,"Hydrolysis in acetone/water (50:50) at a pH of 8.0, T=66 degree Centigrade",,,CHEMBL629674,,22224,,,,U,0,BAO_0000019,
14969,,2363,Autocuration,,,1,"Hydrolysis in acetone/water (50:50) at a pH of 8.0,T =66 degree Centigrade",,,CHEMBL629675,,22224,,,,U,0,BAO_0000019,
14970,,2363,Autocuration,,,1,"Hydrolysis in acetone/water (50:50) at a pH of 8.0,T =66 degree centigrade; No data",,,CHEMBL629676,,22224,,,,U,0,BAO_0000019,
14971,,2363,Autocuration,,,1,"Hydrolysis in acetone/water (50:50) at a pH of 8.0,T =66 degree centigrade; Not determined",,,CHEMBL629677,,22224,,,,U,0,BAO_0000019,
14972,,8371,Autocuration,,,1,Apparent inactivation rate constant was evaluated,,,CHEMBL629678,,22224,,,,U,0,BAO_0000019,
14973,,14883,Autocuration,,,1,Compound was evaluated for equilibrium constant K obtained from the ratio of reverse rate constants at 25 degree Centigrade.,,,CHEMBL629679,,22224,,,,U,0,BAO_0000019,
14974,,14883,Autocuration,,,1,Compound was evaluated for equilibrium constant K obtained from the ratio of reverse rate constants at 37 degree Centigrade,,,CHEMBL629680,,22224,,,,U,0,BAO_0000019,
14975,,4643,Autocuration,,,1,Compound was evaluated for the Ki value for peptide alcohol for competitive inhibition in the presence of Mn2+ ions at pH 7.5,,,CHEMBL629681,,22224,,,,U,0,BAO_0000019,
14976,,3519,Autocuration,,,1,Compound was tested for the inhibition of antibody-catalyzed hydrolysis.,,,CHEMBL629682,,22224,,,,U,0,BAO_0000019,
14977,,10600,Autocuration,,,1,DBH (dopamine beta-hydroxylase) activity expressed as Ki value determined by degree to which compound inhibited conversion of tyramine to octopamine,,,CHEMBL629683,,22224,,,,U,0,BAO_0000019,
14978,,8501,Autocuration,,,1,Dissociation constant against constrictor response to the compound blocked competitively by phentolamine for alpha-mediated events,,,CHEMBL629684,,22224,,,,U,0,BAO_0000019,
14979,,8505,Autocuration,,,1,Dissociation constant was determined,,,CHEMBL629685,,22224,,,,U,0,BAO_0000100,
14980,,9778,Autocuration,,,1,Dissociation constant was determined,,,CHEMBL629686,,22224,,,,U,0,BAO_0000100,
14981,,9778,Autocuration,,,1,Dissociation constant at pH 7.4,,,CHEMBL872932,,22224,,,,U,0,BAO_0000100,
14982,,9778,Autocuration,,,1,Dissociation constant in presence of 1 mM dithiothreitol,,,CHEMBL629687,,22224,,,,U,0,BAO_0000100,
14983,,13007,Autocuration,,,1,Kinetic Parameter Ki for Inhibition of Type 1 5-alpha-reductase,,,CHEMBL872931,,22224,,,,U,0,BAO_0000019,
14984,,13007,Autocuration,,,1,Kinetic Parameter Ki for Inhibition of Type 1 5-alpha-reductase,,,CHEMBL628151,,22224,,,,U,0,BAO_0000019,
14985,,13007,Autocuration,,,1,Kinetic Parameter Ki for Inhibition of Type-2 5-alpha-reductase,,,CHEMBL628152,,22224,,,,U,0,BAO_0000019,
14986,,13007,Autocuration,,,1,Kinetic Parameter Ki for Inhibition of Type-2 5-alpha-reductase,,,CHEMBL628153,,22224,,,,U,0,BAO_0000019,
14987,,11482,Autocuration,,,1,Kinetic constant for aromatization of androstenedione,,,CHEMBL628154,,22224,,,,U,0,BAO_0000019,
14988,,11482,Autocuration,,,1,Kinetic constant for aromatization of testosterone,,,CHEMBL628155,,22224,,,,U,0,BAO_0000019,
14989,,2303,Autocuration,,,1,Kinetic parameter for hydrolysis of 1 by Antibody 2D10 after addition of compound 12,,,CHEMBL628156,,22224,,,,U,0,BAO_0000019,
14990,,11964,Autocuration,,,1,Local inhibition constant was determined,,,CHEMBL628157,,22224,,,,U,0,BAO_0000019,
14991,,3140,Intermediate,4932.0,,1,Rate of inactivation of sterol methyl transferase from Saccharomyces cerevisiae using mechanism based inhibitor,,,CHEMBL857533,,50347,Saccharomyces cerevisiae,,,N,1,BAO_0000218,
14992,,10650,Autocuration,,,1,Dissociation constant value of the compound,,,CHEMBL628158,,22224,,,,U,0,BAO_0000100,
14993,,4667,Autocuration,,,1,In vitro permeability through cornea without epithelium,,,CHEMBL628159,,22224,,,,U,0,BAO_0000019,964.0
14994,,4667,Autocuration,,,1,In vitro permeability through intact cornea,,,CHEMBL875616,,22224,,,,U,0,BAO_0000019,964.0
14995,,9199,Intermediate,9986.0,,1,Evaluated for first order rate constant (Kin) for transcorneal penetration in anesthetized rabbits,,,CHEMBL628160,,50592,Oryctolagus cuniculus,,,N,1,BAO_0000218,964.0
14996,,11966,Autocuration,,,1,Rate of enzyme inactivation for the compound was determined,,,CHEMBL628161,,22224,,,,U,0,BAO_0000019,
14997,,4667,Autocuration,,,1,In vitro permeability through cornea without epithelium,,,CHEMBL628162,,22224,,,,U,0,BAO_0000019,964.0
14998,,4667,Autocuration,,,1,In vitro permeability through intact cornea,,,CHEMBL628163,,22224,,,,U,0,BAO_0000019,964.0
14999,,8354,Autocuration,,,1,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0300 mM [HOX] in the conditions of 25degreeC,pH 7.6",,,CHEMBL628164,,22224,,,,U,0,BAO_0000019,
15000,,8354,Autocuration,,,1,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0384 mM [HOX] in the conditions of 25degreeC,pH 7.6",,,CHEMBL628165,,22224,,,,U,0,BAO_0000019,
15001,,8354,Autocuration,,,1,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0395 mM [HOX] in the conditions of 25degreeC,pH 7.6",,,CHEMBL628166,,22224,,,,U,0,BAO_0000019,
15002,,8354,Autocuration,,,1,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0500 mM [HOX] in the conditions of 25degreeC,pH 7.6",,,CHEMBL628167,,22224,,,,U,0,BAO_0000019,
15003,,8354,Autocuration,,,1,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.050 mM [HOX] in the conditions of 25degreeC,pH 7.6",,,CHEMBL628168,,22224,,,,U,0,BAO_0000019,
15004,,8354,Autocuration,,,1,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0767 mM [HOX] in the conditions of 25degreeC,pH 7.6",,,CHEMBL628169,,22224,,,,U,0,BAO_0000019,
15005,,8354,Autocuration,,,1,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0790 mM [HOX] in the conditions of 25degreeC,pH 7.6",,,CHEMBL628170,,22224,,,,U,0,BAO_0000019,
15006,,8354,Autocuration,,,1,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0800 mM [HOX] in the conditions of 25degreeC,pH 7.6",,,CHEMBL628171,,22224,,,,U,0,BAO_0000019,
15007,,8354,Autocuration,,,1,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.100 mM [HOX] in the conditions of 25degreeC,pH 7.6",,,CHEMBL627434,,22224,,,,U,0,BAO_0000019,
15008,,8354,Autocuration,,,1,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.200 mM [HOX] in the conditions of 25degreeC,pH 7.6",,,CHEMBL627435,,22224,,,,U,0,BAO_0000019,
15009,,8354,Autocuration,,,1,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.300 mM [HOX] in the conditions of 25degreeC,pH 7.6",,,CHEMBL628110,,22224,,,,U,0,BAO_0000019,
15010,,8354,Autocuration,,,1,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.384 mM [HOX] in the conditions of 25degreeC,pH 7.6",,,CHEMBL628111,,22224,,,,U,0,BAO_0000019,
15011,,8354,Autocuration,,,1,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.395 mM [HOX] in the conditions of 25degreeC,pH 7.6",,,CHEMBL628112,,22224,,,,U,0,BAO_0000019,
15012,,8354,Autocuration,,,1,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.500 mM [HOX] in the conditions of 25degreeC,pH 7.6",,,CHEMBL628260,,22224,,,,U,0,BAO_0000019,
15013,,8354,Autocuration,,,1,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.767 mM [HOX] in the conditions of 25degreeC,pH 7.6",,,CHEMBL628261,,22224,,,,U,0,BAO_0000019,
15014,In vivo,14439,Intermediate,10090.0,,1,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Muscle (M),,,CHEMBL628262,,50594,Mus musculus,,,N,1,BAO_0000218,
15015,In vivo,14439,Intermediate,9606.0,,1,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Tumor (T) cells,,,CHEMBL628263,,50587,Homo sapiens,,,N,1,BAO_0000218,
15016,In vivo,14439,Intermediate,10090.0,,1,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Blood (B),,,CHEMBL628264,,50594,Mus musculus,,,N,1,BAO_0000218,
15017,In vivo,14439,Intermediate,10090.0,,1,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Heart (H),,,CHEMBL628265,,50594,Mus musculus,,,N,1,BAO_0000218,
15018,In vivo,14439,Intermediate,10090.0,,1,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Lung (L),,,CHEMBL628266,,50594,Mus musculus,,,N,1,BAO_0000218,
15019,In vivo,14439,Intermediate,10090.0,,1,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Muscle (M),,,CHEMBL628267,,50594,Mus musculus,,,N,1,BAO_0000218,
15020,In vivo,14439,Intermediate,10090.0,,1,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Tumor (T) cells,,,CHEMBL628268,,50594,Mus musculus,,,N,1,BAO_0000218,
15021,In vivo,14439,Intermediate,10090.0,,1,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Blood (B),,,CHEMBL628269,,50594,Mus musculus,,,N,1,BAO_0000218,
15022,In vivo,14439,Intermediate,10090.0,,1,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Heart (H),,,CHEMBL628270,,50594,Mus musculus,,,N,1,BAO_0000218,
15023,In vivo,14439,Intermediate,10090.0,,1,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Lung (L),,,CHEMBL628271,,50594,Mus musculus,,,N,1,BAO_0000218,
15024,In vivo,14439,Intermediate,10090.0,,1,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Muscle (M),,,CHEMBL628272,,50594,Mus musculus,,,N,1,BAO_0000218,
1,,11087,Autocuration,,,1,The compound was tested for the in vitro inhibition of platelet 12-lipoxygenase at a concentration of 30 uM,,,CHEMBL615117,,12052,,,,H,8,BAO_0000019,
2,,684,Autocuration,,,1,Compound was evaluated for its ability to mobilize calcium in 1321NI cells,,,CHEMBL615118,,22226,,,,U,0,BAO_0000219,
3,,15453,Autocuration,,,1,,,,CHEMBL615119,,22226,,,,U,0,BAO_0000019,
4,,17841,Autocuration,9913.0,,1,Binding affinity against A2 adenosine receptor in bovine striatal membranes using [3H]CGS-21680,,,CHEMBL615120,,104729,Bos taurus,,,H,4,BAO_0000249,
5,,17430,Intermediate,9606.0,,1,In vitro cell cytotoxicity against 143-B cell lines (Human osteosarcoma cell line),163.0,,CHEMBL615121,,80001,Homo sapiens,143B,,N,1,BAO_0000219,
6,,17430,Intermediate,9606.0,,1,In vitro cell cytotoxicity against 143-B cell lines (Human osteosarcoma cell line),163.0,,CHEMBL615122,,80001,Homo sapiens,143B,,N,1,BAO_0000219,
7,,13799,Intermediate,10090.0,,1,Cytotoxic Activity was evaluated against 143B (TK-) tumor cells,163.0,,CHEMBL615123,,80001,Mus musculus,143B,,N,1,BAO_0000219,
8,,17774,Expert,9606.0,,1,In vitro cell cytotoxicity was determined against 143B cell line,163.0,,CHEMBL615124,,80001,Homo sapiens,143B,,N,1,BAO_0000219,
9,,3801,Intermediate,9606.0,,1,Inhibitory activity against tumor osteosarcoma cell line 143B after 72 hr continuous exposure to compound,163.0,,CHEMBL615125,,80001,Homo sapiens,143B,,N,1,BAO_0000219,
10,,17430,Intermediate,9606.0,,1,In vitro cell cytotoxicity against 143B-LTK cell lines expressed in HSV-1 TK,163.0,,CHEMBL615126,,80001,Homo sapiens,143B,,N,1,BAO_0000219,
11,,17430,Intermediate,9606.0,,1,In vitro cell cytotoxicity against 143B-LTK cell lines expressed in HSV-1 TK,163.0,,CHEMBL615127,,80001,Homo sapiens,143B,,N,1,BAO_0000219,
12,,17774,Expert,9606.0,,1,In vitro cell cytotoxicity was determined against 143B-LTK cell line,163.0,,CHEMBL615128,,80001,Homo sapiens,143B,,N,1,BAO_0000219,
13,,11324,Intermediate,1280.0,,1,"The compound was tested for minimum inhibitory concentration in Staphylococcus aureus,147N penicillin sensitive Staphylococcus aureus",,,CHEMBL857900,,50185,Staphylococcus aureus,,,N,1,BAO_0000218,
14,,11324,Intermediate,1280.0,,1,"The compound was tested for minimum inhibitory concentration in Staphylococcus aureus,147N penicillin sensitive Staphylococcus aureus",,,CHEMBL615129,,50185,Staphylococcus aureus,,,N,1,BAO_0000218,
15,,11324,Intermediate,1280.0,,1,"The compound was tested for minimum inhibitory concentration in Staphylococcus aureus,147N penicillin sensitive Staphylococcus aureus",,,CHEMBL615130,,50185,Staphylococcus aureus,,,N,1,BAO_0000218,
16,,11324,Intermediate,1280.0,,1,"The compound was tested for minimum inhibitory concentration in Staphylococcus aureus,147N penicillin sensitive Staphylococcus aureus",,,CHEMBL615131,,50185,Staphylococcus aureus,,,N,1,BAO_0000218,
17,,11347,Expert,10116.0,,1,Inhibition of cytochrome P450 progesterone 15-alpha hydroxylase,,,CHEMBL884521,,100122,Rattus norvegicus,,,D,9,BAO_0000357,
18,,16474,Autocuration,,,1,Concentration that cause 50% activation of human reticulocyte 15-lipoxygenase (15-HLO),,,CHEMBL615132,,12054,,,,H,8,BAO_0000357,
19,,10091,Autocuration,,,1,Inhibition of partially purified 15-lipoxygenase from human leukocytes,,,CHEMBL615133,,12054,,,,H,8,BAO_0000019,
20,,16474,Autocuration,,,1,Inhibitory activity against human reticulocyte 15-lipoxygenase (15-HLO),,,CHEMBL615134,,12054,,,,H,8,BAO_0000357,
21,,16474,Autocuration,,,1,Compound was evaluated for the percent increase in activation concentration of human reticulocyte 15-lipoxygenase (15-HLO),,,CHEMBL615135,,12054,,,,H,8,BAO_0000357,
22,,16474,Autocuration,,,1,Inhibitory activity against human reticulocyte 15-lipoxygenase (15-HLO),,,CHEMBL615136,,12054,,,,H,8,BAO_0000357,
23,,16474,Autocuration,,,1,Inhibitory activity against human reticulocyte 15-lipoxygenase (15-HLO); NI is no inhibition,,,CHEMBL615137,,12054,,,,H,8,BAO_0000357,
24,,16474,Autocuration,,,1,Inhibitory activity against human reticulocyte 15-lipoxygenase (15-HLO); NI is no inhibition,,,CHEMBL615138,,12054,,,,H,8,BAO_0000357,
25,,14352,Autocuration,,,1,"Inhibitory concentration against 15-lipoxygenase, by inhibiting 15-HETE production by human umbilical vein endothelial cells (HUVEC) stimulated by calcium ionophore A 23187 at concentration of 10e-5 M.",,,CHEMBL836324,,22226,,,,U,0,BAO_0000219,
26,,5646,Autocuration,9986.0,,1,In vitro inhibitory activity of compound on rabbit reticulocyte 15-lipoxygenase,,,CHEMBL615139,,12054,Oryctolagus cuniculus,,,H,8,BAO_0000357,
27,,5646,Autocuration,9986.0,,1,Inhibition of rabbit reticulocyte 15-lipoxygenase by compound (30 uM),,,CHEMBL615140,,12054,Oryctolagus cuniculus,,,H,8,BAO_0000357,
28,,10997,Autocuration,,,1,Inhibitory activity against 15-lipoxygenase in rat polymorphonuclear leukocytes,,,CHEMBL615141,,12426,,,,H,8,BAO_0000219,
29,,6309,Autocuration,3847.0,,1,Inhibitory activity against 15-lipoxygenase was determined obtained from soya bean,,,CHEMBL615142,,12054,soya bean,,,H,8,BAO_0000357,
30,,167,Autocuration,3847.0,,1,Inhibitory activity against soybean 15-lipoxygenase was evaluated,,,CHEMBL615143,,12054,Glycine max,,,H,8,BAO_0000357,
31,,167,Autocuration,3847.0,,1,Inhibitory activity against soybean 15-lipoxygenase was evaluated at 100 uM,,,CHEMBL615144,,12054,Glycine max,,,H,8,BAO_0000357,
32,,11087,Autocuration,3847.0,,1,The compound was tested for the in vitro inhibition of 15-lipoxygenase of soybean at a concentration of 10 uM,,,CHEMBL872867,,12054,Glycine max,,,H,8,BAO_0000357,
33,,11087,Autocuration,3847.0,,1,The compound was tested for the in vitro inhibition of 15-lipoxygenase of soybean at a concentration of 100 uM,,,CHEMBL615145,,12054,Glycine max,,,H,8,BAO_0000357,
34,,13622,Autocuration,3847.0,,1,Compound was tested in vitro for inhibition of 15-lipoxygenase soybean,,,CHEMBL615146,,12054,Glycine max,,,H,8,BAO_0000357,
35,,13622,Autocuration,3847.0,,1,Compound at 100 uM was tested in vitro for inhibition of 15-lipoxygenase soybean,,,CHEMBL615147,,12054,Glycine max,,,H,8,BAO_0000357,
36,,11347,Autocuration,10116.0,,1,Inhibition of cytochrome P450 progesterone 16-alpha hydroxylase,,,CHEMBL615148,,22226,Rattus norvegicus,,,U,0,BAO_0000019,
37,,5926,Autocuration,562.0,,1,Binding affinity against bacterial 16S rRNA using mass spectrometry based assay,,,CHEMBL615149,,22226,Escherichia coli,,,U,0,BAO_0000019,
38,,4567,Autocuration,,,1,Dissociation constant with dimeric 16S rRNA RNA construct B,,,CHEMBL615150,,22226,,,,U,0,BAO_0000019,
39,,3782,Intermediate,,,1,Dissociation constant towards 16S rRNA construct A,,,CHEMBL615151,,22222,,,,M,3,BAO_0000225,
40,,3782,Intermediate,,,1,Dissociation constant towards 16S rRNA construct B,,,CHEMBL615152,,22222,,,,M,3,BAO_0000225,
41,,4466,Expert,562.0,,1,Binding affinity of aminoglycoside to 16S ribosomal RNA A-site in Escherichia coli,,,CHEMBL615153,,100263,Escherichia coli,,,M,3,BAO_0000225,
42,,6592,Expert,562.0,,1,Binding affinity for the 16S ribosomal RNA A-site of Escherichia coli,,,CHEMBL615154,,100263,Escherichia coli,,,M,3,BAO_0000225,
43,,898,Autocuration,,,1,Inhibitory activity against human placenta 17-beta-hydroxysteroid dehydrogenase type 2 (17-beta-HSD type 2),,,CHEMBL615155,,13053,,,,H,8,BAO_0000019,
44,,898,Autocuration,,,1,Inhibitory constant against human placenta 17-beta-hydroxysteroid dehydrogenase type 2 (17-beta-HSD type 2),,,CHEMBL615156,,13053,,,,H,8,BAO_0000019,
45,,13163,Autocuration,9606.0,,1,The compound was tested at a concentration of 1 uM for inhibitory activity against 17 beta-hydroxysteroid dehydrogenase from human placental microsomes,,,CHEMBL615157,,20001,Homo sapiens,,,H,8,BAO_0000019,
46,,13163,Autocuration,9606.0,,1,The compound was tested at a concentration of 1 uM for inhibitory activity against 17 beta-hydroxysteroid dehydrogenase from human placental microsomes,,,CHEMBL615158,,20001,Homo sapiens,,,H,8,BAO_0000019,
47,,10691,Expert,10116.0,,1,"Inhibition of 17-alpha-hydroxylase/17,20 lyase from rat testes microsomal preparation",,,CHEMBL615159,,12971,Rattus norvegicus,,,D,9,BAO_0000019,
48,,10691,Expert,10116.0,,1,"Inhibition of 17-alpha-hydroxylase/17,20 lyase from rat testes microsomal preparation",,,CHEMBL615172,,12971,Rattus norvegicus,,,D,9,BAO_0000019,
49,,10691,Expert,10116.0,,1,"Percent inhibition of 17-alpha-hydroxylase/17,20 lyase of rat testes microsomes at 100 uM",,,CHEMBL615173,,12971,Rattus norvegicus,,,D,9,BAO_0000019,
50,,10691,Expert,10116.0,,1,"Percent inhibition of Steroid 17-alpha-hydroxylase/17,20 lyase of rat testes microsomes at 100 uM",,,CHEMBL615174,,12971,Rattus norvegicus,,,D,9,BAO_0000019,
51,,898,Autocuration,,,1,Inhibitory activity against human placenta 17-beta-hydroxysteroid dehydrogenase type 2 (17-beta-HSD type 2),,,CHEMBL884518,,13053,,,,H,8,BAO_0000019,
52,,912,Autocuration,,,1,Compound was tested for the inhibition of 17-beta-hydroxysteroid dehydrogenase type 1(17-beta-HSD type 1),,,CHEMBL615175,,11512,,,,H,8,BAO_0000357,
53,,912,Autocuration,,,1,Compound was tested for the inhibition of 17-beta-hydroxysteroid dehydrogenase type 1(17-beta-HSD type 1) at 1 uM concentration,,,CHEMBL615176,,11512,,,,H,8,BAO_0000357,
54,,912,Autocuration,,,1,Compound was tested for the inhibition of 17-beta-hydroxysteroid dehydrogenase type 1(17-beta-HSD type 1) at 10 uM concentration,,,CHEMBL615177,,11512,,,,H,8,BAO_0000357,
55,,15103,Autocuration,10116.0,,1,Selectivity ratio of binding affinity towards mu to delta receptors of rat brain membranes,,,CHEMBL615178,Membranes,104740,Rattus norvegicus,,,D,5,BAO_0000249,
56,,5116,Intermediate,9606.0,,1,Cytotoxicity against ovarian cancer cell line (1A-9) of humans was determined,506.0,,CHEMBL615179,,80002,Homo sapiens,1A9,,N,1,BAO_0000219,
57,,14578,Autocuration,10116.0,,1,Functional antagonism by electrical assays in Xenopus oocytes expressing 1A/2A NMDA receptor subtype,,,CHEMBL615180,,104835,Rattus norvegicus,Oocytes,,D,7,BAO_0000219,
58,,14578,Autocuration,10116.0,,1,Functional antagonism by electrical assays in Xenopus oocytes expressing the 1A/2B NMDA receptor,,,CHEMBL615181,,104821,Rattus norvegicus,Oocytes,,D,7,BAO_0000219,
59,,14578,Autocuration,10116.0,,1,Functional antagonism by electrical assays in Xenopus oocytes expressing the 1A/2C NMDA receptor,,,CHEMBL615182,,104848,Rattus norvegicus,Oocytes,,D,7,BAO_0000219,
60,,4787,Expert,9606.0,,1,In vitro effective concentration required to reduce the number of human ovarian cancer (1A9) after 3-day incubation,506.0,,CHEMBL615183,,80002,Homo sapiens,1A9,,N,1,BAO_0000219,
61,,4787,Intermediate,9606.0,,1,In vitro effective concentration required to reduce the number of human ovarian cancer cells (1A9) after 3-day incubation,506.0,,CHEMBL615184,,80002,Homo sapiens,1A9,,N,1,BAO_0000219,
62,,3547,Intermediate,9606.0,,1,Cytotoxic activity against human ovarian cancer (1A9) cell line,506.0,,CHEMBL615185,,80002,Homo sapiens,1A9,,N,1,BAO_0000219,
63,,3547,Intermediate,9606.0,,1,Cytotoxic activity against human ovarian cancer (1A9) cell line; ND=Not determined,506.0,,CHEMBL615186,,80002,Homo sapiens,1A9,,N,1,BAO_0000219,
64,,6726,Intermediate,9606.0,,1,Effective dose of compound against replication of 1A9 cell line was evaluated,506.0,,CHEMBL615187,,80002,Homo sapiens,1A9,,N,1,BAO_0000219,
65,,3455,Expert,9606.0,,1,In vitro cytotoxic activity was determined against ovarian cancer (1A9) cell line,506.0,,CHEMBL885343,,80002,Homo sapiens,1A9,,N,1,BAO_0000219,
66,,5726,Intermediate,9606.0,,1,In vitro cytotoxicity evaluated against human ovarian cancer (1A9 cell line),506.0,,CHEMBL615188,,80002,Homo sapiens,1A9,,N,1,BAO_0000219,
67,,5726,Intermediate,9606.0,,1,In vitro cytotoxicity evaluated against human ovarian cancer (1A9 cell line); NA is not active,506.0,,CHEMBL615189,,80002,Homo sapiens,1A9,,N,1,BAO_0000219,
68,,5726,Intermediate,9606.0,,1,In vitro percent inhibition evaluated against human ovarian cancer (1A9 cell line) at >20 ug/mL,506.0,,CHEMBL615190,,80002,Homo sapiens,1A9,,N,1,BAO_0000219,
69,,3395,Intermediate,9606.0,,1,Inhibitory activity against Taxol resistant 1A9 cell lines,506.0,,CHEMBL615191,,80002,Homo sapiens,1A9,,N,1,BAO_0000219,
70,,3415,Expert,9606.0,,1,Cytotoxicity against human ovarian cancer (1A9) cell lines.,506.0,,CHEMBL615192,,80002,Homo sapiens,1A9,,N,1,BAO_0000219,
71,,3415,Expert,9606.0,,1,Percentage inhibition of human ovarian cancer (1A9) cell lines.,506.0,,CHEMBL827083,,80002,Homo sapiens,1A9,,N,1,BAO_0000219,
72,,17099,Expert,9606.0,,1,Effective dose required for inhibitory activity against 1A9 human tumor cell line.,506.0,,CHEMBL615193,,80002,Homo sapiens,1A9,,N,1,BAO_0000219,
73,,17099,Intermediate,9606.0,,1,Percent inhibition against 1A9 human tumor cell line at 0.10 ug/mL,506.0,,CHEMBL615194,,80002,Homo sapiens,1A9,,N,1,BAO_0000219,
74,,17099,Intermediate,9606.0,,1,Percent inhibition against 1A9 human tumor cell line at <0.00008 ug/mL,506.0,,CHEMBL615195,,80002,Homo sapiens,1A9,,N,1,BAO_0000219,
75,,17099,Intermediate,9606.0,,1,Percent inhibition against 1A9 human tumor cell line at >10 ug/mL,506.0,,CHEMBL615196,,80002,Homo sapiens,1A9,,N,1,BAO_0000219,
76,,17721,Intermediate,9606.0,,1,Inhibitory concentration against Jurkat cells,503.0,,CHEMBL615197,,81072,Homo sapiens,Jurkat,,N,1,BAO_0000219,
77,,1229,Intermediate,,,1,In vitro anticancer activity against 2 NCI SCLC cell lines; inactive,,,CHEMBL615198,,22226,,,,U,0,BAO_0000019,
78,,11347,Expert,10116.0,,1,Inhibition of cytochrome P450 progesterone 2-alpha-hydroxylase,,,CHEMBL615199,,100121,Rattus norvegicus,,,D,9,BAO_0000357,
79,,17117,Expert,,,1,"In vitro inhibition of human 2,3-oxidosqualene cyclase.",,,CHEMBL615200,,11231,,,,H,8,BAO_0000357,
80,,17117,Expert,,,1,"In vitro inhibition of human 2,3-oxidosqualene cyclase.",,,CHEMBL615201,,11231,,,,H,8,BAO_0000357,
81,,17117,Expert,,,1,"In vitro inhibition of human 2,3-oxidosqualene cyclase at 100 nM.",,,CHEMBL615202,,11231,,,,H,8,BAO_0000357,
82,,11375,Autocuration,5476.0,,1,"Compound was evaluated for the inhibition of microsomal 2,3-oxidosqualene cyclase in Candida albicans microsomes",,,CHEMBL615203,Microsomes,11231,Candida albicans,,,H,8,BAO_0000251,
83,,11375,Autocuration,5476.0,,1,"Compound was evaluated for the inhibition of microsomal 2,3-oxidosqualene-lanosterol cyclase in Candida albicans microsomes",,,CHEMBL615204,Microsomes,11231,Candida albicans,,,H,8,BAO_0000251,
84,,11375,Autocuration,4932.0,,1,"Compound was evaluated for the inhibition of microsomal 2,3-oxidosqualene cyclase in Saccharomyces cerevisiae microsomes",,,CHEMBL615205,Microsomes,11231,Saccharomyces cerevisiae,,,H,8,BAO_0000251,
85,,11375,Autocuration,4932.0,,1,"Compound was evaluated for the inhibition of microsomal 2,3-oxidosqualene-lanosterol cyclase in Saccharomyces cerevisiae microsomes",,,CHEMBL615206,Microsomes,11231,Saccharomyces cerevisiae,,,H,8,BAO_0000251,
86,,11375,Autocuration,9823.0,,1,"Compound was evaluated for the inhibition of microsomal 2,3-oxidosqualene-lanosterol cyclase in pig liver microsomes",,,CHEMBL615207,Microsomes,12083,Sus scrofa,,,H,8,BAO_0000251,2107.0
87,,791,Autocuration,10116.0,,1,"Concentration required to inhibit rat liver 2,3-oxidosqualene-lanosterol cyclase",,,CHEMBL827084,,11231,Rattus norvegicus,,,H,8,BAO_0000019,
88,,791,Autocuration,10116.0,,1,"Concentration required to inhibit rat liver 2,3-oxidosqualene-lanosterol cyclase (OSC)",,,CHEMBL615208,,11231,Rattus norvegicus,,,H,8,BAO_0000019,
89,,791,Autocuration,10116.0,,1,"Evaluated for its activity to inhibit rat liver 2,3-oxidosqualene-lanosterol cyclase, activity expressed as Ki",,,CHEMBL615209,,11231,Rattus norvegicus,,,H,8,BAO_0000019,
90,,11375,Autocuration,10116.0,,1,"Compound was evaluated for the inhibition of microsomal 2,3-oxidosqualene cyclase in rat liver microsomes",,,CHEMBL615210,Microsomes,12083,Rattus norvegicus,,,D,9,BAO_0000251,2107.0
91,,11375,Autocuration,10116.0,,1,"Compound was evaluated for the inhibition of microsomal 2,3-oxidosqualene-lanosterol cyclase in rat liver microsomes",,,CHEMBL615211,Microsomes,12083,Rattus norvegicus,,,D,9,BAO_0000251,2107.0
92,,153,Autocuration,10116.0,,1,"Compound was evaluated for inhibitory activity against 2,3-oxidosqualene-lanosterol cyclase in rat liver microsomes",,,CHEMBL615212,Microsomes,12083,Rattus norvegicus,,,D,9,BAO_0000251,2107.0
93,,8269,Expert,,,1,Molar concentration needed to give 50% prevention of 2-5A (Adenosine dependent endoribonuclease),,,CHEMBL615213,,11377,,,,H,8,BAO_0000357,
94,,8269,Expert,,,1,Molar concentration required to displace 50% of the radiolabeled probe from 2-5A (Adenosine dependent endoribonuclease) in endonuclease-nitrocellulose complex,,,CHEMBL615273,,11377,,,,H,8,BAO_0000357,
95,,17653,Expert,9606.0,,1,In vitro cytotoxic concentration required to inhibit hepatitisB virus (HBV) replication in 2.2.15 cell line,726.0,,CHEMBL615274,,81020,Homo sapiens,HepG2,,N,1,BAO_0000219,
96,,14277,Intermediate,9606.0,,1,50% Effective concentration of compound required for inhibiting intracellular viral replicative intermediate DNA in HBV-transfected 2.2.15 cell line.,726.0,,CHEMBL615275,,81020,Homo sapiens,HepG2,,N,1,BAO_0000219,
97,,1717,Intermediate,9606.0,,1,Antiviral activity against Hepatitis B virus in 2.2.15 cell line,726.0,,CHEMBL615276,,81020,Homo sapiens,HepG2,,N,1,BAO_0000219,
98,,14091,Intermediate,9606.0,,1,In vitro effective concentration against hepatitis B virus was determined in 2.2.15 cells,726.0,,CHEMBL615277,,81020,Homo sapiens,HepG2,,N,1,BAO_0000219,
99,,14091,Intermediate,9606.0,,1,In vitro effective concentration against hepatitis B virus was determined in 2.2.15 cells; Not determined,726.0,,CHEMBL615326,,81020,Homo sapiens,HepG2,,N,1,BAO_0000219,
100,,17653,Expert,10407.0,,1,In vitro effective concentration required to inhibit hepatitisB virus (HBV) replication in 2.2.15 cell line,,,CHEMBL883130,,50606,Hepatitis B virus,,,N,1,BAO_0000218,
101,,13105,Intermediate,9606.0,,1,Ability to inhibit the episomal HBV-DNA in 2.2.15 cells.,726.0,,CHEMBL884519,,81020,Homo sapiens,HepG2,,N,1,BAO_0000219,
102,,1717,Intermediate,9606.0,,1,Concentration required to inhibit 50% of 2.2.15 cell line,726.0,,CHEMBL615327,,81020,Homo sapiens,HepG2,,N,1,BAO_0000219,
103,,13105,Intermediate,9606.0,,1,Anti viral activity against 2.2.15 cells (concentration required to reduce the log phase cell growth by 50%).,726.0,,CHEMBL615328,,81020,Homo sapiens,HepG2,,N,1,BAO_0000219,
104,,13600,Intermediate,9606.0,,1,Cytotoxic activity of compound against uninfected 2.2.15 cells.,,,CHEMBL615329,,50587,Homo sapiens,2.2.15,,N,1,BAO_0000218,
105,,13467,Intermediate,9606.0,,1,Anti hepatitis-B virus activity was evaluated in 2.2.15 cells.,,,CHEMBL615330,,50587,Homo sapiens,2.2.15,,N,1,BAO_0000218,
106,,17477,Expert,10407.0,,1,"Inhibition of the replication of HBV in 2.2.15 cells, by DNA hybridization assay",,,CHEMBL615331,,50606,Hepatitis B virus,2.2.15,,N,1,BAO_0000218,
107,,1593,Intermediate,9606.0,,1,In vitro anti-HBV activity in 2.2.15 cells,,,CHEMBL615332,,50587,Homo sapiens,2.2.15,,N,1,BAO_0000218,
108,,1593,Intermediate,9606.0,,1,In vitro anti-HBV activity in 2.2.15 cells; Not determined,,,CHEMBL615333,,50587,Homo sapiens,2.2.15,,N,1,BAO_0000218,
109,,15089,Intermediate,9606.0,,1,The compound was tested in vitro for the anti-HBV activity against 2.2.15 cells,,,CHEMBL615334,,50587,Homo sapiens,2.2.15,,N,1,BAO_0000218,
110,,15089,Intermediate,9606.0,,1,The compound was tested in vitro for the anti-HBV activity in 2.2.15 cells,,,CHEMBL615335,,50587,Homo sapiens,2.2.15,,N,1,BAO_0000218,
111,,1593,Intermediate,9606.0,,1,Cytotoxicity in 2.2.15 cells,,,CHEMBL615336,,50587,Homo sapiens,2.2.15,,N,1,BAO_0000218,
112,,1593,Intermediate,9606.0,,1,Cytotoxicity in 2.2.15 cells; Not determined,,,CHEMBL615337,,50587,Homo sapiens,2.2.15,,N,1,BAO_0000218,
113,,13600,Intermediate,9606.0,,1,Inhibitory activity of compound against hepatitis B virus (HBV) in growing cultures of 2.2.15 cells,,,CHEMBL615338,,50587,Homo sapiens,2.2.15,,N,1,BAO_0000218,
114,,13467,Intermediate,9606.0,,1,The growth inhibition activity for the compound was evaluated in 2.2.15 cells.,,,CHEMBL615339,,50587,Homo sapiens,2.2.15,,N,1,BAO_0000218,
115,,13467,Intermediate,9606.0,,1,Selectivity index was determined from the ratio of IC50 to the EC50 values evaluated in 2.2.15 cells.,,,CHEMBL615340,,50587,Homo sapiens,2.2.15,,N,1,BAO_0000218,
116,,14764,Intermediate,9606.0,,1,Antiviral activity against HBV was determined in 2.215 cell line,726.0,,CHEMBL615341,,81020,Homo sapiens,HepG2,,N,1,BAO_0000219,
117,,6531,Autocuration,9606.0,,1,Inhibition of 20-HETE synthesis in human renal microsomes,,,CHEMBL615342,Microsomes,22226,Homo sapiens,,,U,0,BAO_0000251,
118,,17322,Autocuration,,,1,Inhibitory activity against 20-HETE production from arachidonic acid using human renal microsome 20-HETE synthase.,,,CHEMBL615343,,22226,,,,U,0,BAO_0000019,
119,,17072,Intermediate,9606.0,,1,Inhibitory concentration against 2008 (ovarian) cells,388.0,,CHEMBL615344,,80612,Homo sapiens,2008,,N,1,BAO_0000219,
120,,16936,Intermediate,9606.0,,1,50% Growth inhibitory concentration( GI 50 ) by using 2008 human ovarian carcinoma cell lines.,388.0,,CHEMBL615345,,80612,Homo sapiens,2008,,N,1,BAO_0000219,
121,,16936,Intermediate,9606.0,,1,Compound was tested for 50% growth inhibitory concentration by using human ovarian carcinoma cell lines (2008),388.0,,CHEMBL615346,,80612,Homo sapiens,2008,,N,1,BAO_0000219,
122,,17146,Intermediate,9606.0,,1,Direct cytotoxicity against the selected tumor cell line 2008 was determined especially on ovarian adenocarcinoma derived cells,388.0,,CHEMBL615347,,80612,Homo sapiens,2008,,N,1,BAO_0000219,
123,,17146,Intermediate,9606.0,,1,Direct cytotoxicity against the selected tumor cell line 2008 was determined especially on ovarian adenocarcinoma derived cells; not detected,388.0,,CHEMBL615348,,80612,Homo sapiens,2008,,N,1,BAO_0000219,
124,,10797,Intermediate,9606.0,,1,In vitro inhibition of 2008/R ovarian cancer cell line,561.0,,CHEMBL827085,,80613,Homo sapiens,2008/R,,N,1,BAO_0000219,
125,,10797,Intermediate,9606.0,,1,In vitro inhibition of 2008/R ovarian cancer cell line; NA= Not achievable,561.0,,CHEMBL615349,,80613,Homo sapiens,2008/R,,N,1,BAO_0000219,
126,,10797,Intermediate,9606.0,,1,In vitro inhibition of 2008/S ovarian cancer cell line,389.0,,CHEMBL615350,,80614,Homo sapiens,2008/S,,N,1,BAO_0000219,
127,,10797,Intermediate,9606.0,,1,In vitro inhibition of 2008/S ovarian cancer cell line; NA= Not achievable,389.0,,CHEMBL615351,,80614,Homo sapiens,2008/S,,N,1,BAO_0000219,
128,,4823,Expert,9606.0,,1,Tested in vitro for inhibition of chymotrypsin like activity of purified human 20S proteasome,,,CHEMBL615352,,100256,Homo sapiens,,,S,2,BAO_0000220,
129,,12912,Intermediate,9606.0,,1,Compound was evaluated for inhibitory activity against 20S proteasome from human liver and brain,,,CHEMBL615353,,100256,Homo sapiens,,,S,2,BAO_0000220,
130,,2957,Expert,,,1,Inhibition of chymotrypsin-like activity of 20S proteasome,,,CHEMBL615354,,100256,,,,S,2,BAO_0000220,
131,,2957,Expert,,,1,Inhibition of chymotrypsin-like activity of 20S proteasome; value ranges from 10-20 uM,,,CHEMBL615355,,100256,,,,S,2,BAO_0000220,
132,,3260,Intermediate,,,1,Inhibitory activity against 20S proteosome,,,CHEMBL615356,,100256,,,,S,2,BAO_0000220,
133,,3451,Autocuration,9606.0,,1,Compound was tested for inhibitory activity against tryptase,,,CHEMBL615357,,22226,Homo sapiens,,,U,0,BAO_0000019,
134,,13885,Intermediate,9606.0,,1,Concentration required to inhibit 50% of extracellular circular replication of HBV DNA using 2215 cell line,726.0,,CHEMBL615358,,81020,Homo sapiens,HepG2,,N,1,BAO_0000219,
135,,13885,Intermediate,9606.0,,1,Concentration required to inhibit 50% of intracellular circular replication of HBV DNA using 2215 cell line,726.0,,CHEMBL827086,,81020,Homo sapiens,HepG2,,N,1,BAO_0000219,
136,,3676,Autocuration,,,1,Compound was tested for the inhibition of Alpha-glucosidase,,,CHEMBL615359,,22226,,,,U,0,BAO_0000019,
137,,6043,Autocuration,,,1,Inhibitory concentration against human neutrophil elastase (HNE),,,CHEMBL615360,,235,,,,H,8,BAO_0000357,
138,,11140,Autocuration,10116.0,,1,Change in heart rate was expressed in percent at at a dose 0.002 mg/kg iv in anesthetized rat,,,CHEMBL615361,,22226,Rattus norvegicus,,,U,0,BAO_0000218,948.0
139,,10543,Autocuration,,,1,90% inhibition of the 20 Mycobacterium avium complex (MAC) clinical isolates,,,CHEMBL615362,,19640,,,,H,8,BAO_0000019,
140,,10543,Expert,,,1,Minimum inhibitory concentration of compound against 20 Mycobacterium avium complex (MAC) clinical isolates,,,CHEMBL615363,,19640,,,,H,8,BAO_0000019,
141,,10543,Autocuration,,,1,Minimum inhibitory concentration of compound against 20 Mycobacterium avium complex (MAC) clinical isolates,,,CHEMBL615364,,19640,,,,H,8,BAO_0000357,
142,,10543,Expert,,,1,90% inhibition of the 20 Mycobacterium avium complex (MAC) clinical isolates,,,CHEMBL615365,,19640,,,,H,8,BAO_0000019,
143,,11365,Intermediate,10090.0,,1,In Vitro evaluation for the growth inhibition of Subline (P388/AMSA) Leukemia cell lines,524.0,,CHEMBL615366,,80360,Mus musculus,P338,,N,1,BAO_0000219,
144,,11365,Intermediate,10090.0,,1,In Vitro evaluation for the growth inhibition of Subline (P388/CP) Leukemia cell lines,524.0,,CHEMBL615367,,80360,Mus musculus,P338,,N,1,BAO_0000219,
145,,11803,Intermediate,9606.0,,1,Compound was evaluated for the inhibition of cell replication human peripheral blood lymphocytes (PBL's).,554.0,,CHEMBL615368,,80384,Homo sapiens,PBL,,N,1,BAO_0000219,
146,,11803,Autocuration,9940.0,,1,Compound was evaluated for the inhibition of cell replication sheep choroid plexus (SCP) cells,,,CHEMBL615369,,22226,Ovis aries,,,U,0,BAO_0000019,
147,,11803,Autocuration,9940.0,,1,Compound was evaluated for the inhibition of cell replication sheep choroid plexus (SCP) cells.,,,CHEMBL615370,,22226,Ovis aries,,,U,0,BAO_0000019,
148,,12278,Autocuration,,,1,Compound is evaluated in vitro for the inhibition single mutant of HIV-1 RT (Y181C),,,CHEMBL615673,,191,,,,H,8,BAO_0000357,
149,,8249,Autocuration,9606.0,,1,Compound was evaluated for its inhibitory effect on thymidine [3H]dThd) incorporation into DNA of CEM/MTX cells in culture at conc. 10e-5,,,CHEMBL615674,,22226,Homo sapiens,,,U,0,BAO_0000019,
150,,8249,Autocuration,9606.0,,1,Compound was evaluated for its inhibitory effect on thymidine [3H]-dThd) incorporation into DNA of CEM/MTX cells in culture at conc. 10e-6,,,CHEMBL615675,,22226,Homo sapiens,,,U,0,BAO_0000019,
151,,8249,Autocuration,9606.0,,1,Compound was evaluated for its inhibitory effect on thymidine ([3H]dThd) incorporation into DNA of CEM cells in at conc. 10e-7,635.0,,CHEMBL615676,,22226,Homo sapiens,CCRF-CEM,,U,0,BAO_0000219,
152,,8249,Autocuration,9606.0,,1,Compound was evaluated for its inhibitory effect on thymidine ([3H]-dThd) incorporation into DNA of CEM cells in culture at conc. 10e-4,635.0,,CHEMBL615677,,22226,Homo sapiens,CCRF-CEM,,U,0,BAO_0000219,
153,,8249,Autocuration,9606.0,,1,Compound was evaluated for its inhibitory effect on thymidine ([3H]dThd) incorporation into DNA of CEM cells in culture at conc. 10e-5,635.0,,CHEMBL615678,,22226,Homo sapiens,CCRF-CEM,,U,0,BAO_0000219,
154,,8249,Autocuration,9606.0,,1,Compound was evaluated for its inhibitory effect on thymidine ([3H]dThd) incorporation into DNA of CEM cells in culture at conc. 10e-6,635.0,,CHEMBL615679,,22226,Homo sapiens,CCRF-CEM,,U,0,BAO_0000219,
155,,8249,Autocuration,9606.0,,1,Compound was evaluated for its inhibitory effect on thymidine ([3H]-dThd) incorporation into DNA of CEM/MTX cells in at conc. 10e-7.,,,CHEMBL615680,,22226,Homo sapiens,,,U,0,BAO_0000019,
156,,8249,Autocuration,9606.0,,1,Compound was evaluated for its inhibitory effect on thymidine ([3H]dThd) incorporation into DNA of CEM/MTX cells in culture at conc. 10e-4,,,CHEMBL615681,,22226,Homo sapiens,,,U,0,BAO_0000019,
157,,16992,Autocuration,,,1,In vitro binding affinity towards (alpha-4)2(beta-2)3 neuronal nicotinic acetylcholine receptor in P2 membrane fractions of rat forebrain,,,CHEMBL857972,,104290,,,,H,6,BAO_0000249,
158,,10543,Intermediate,1314.0,,1,Minimum inhibitory concentration of compound against Streptococcus pyogenus septicemia in the mouse,,,CHEMBL857899,,50264,Streptococcus pyogenes,,,N,1,BAO_0000218,
159,,17833,Intermediate,10335.0,,1,Antiviral activity against 07/1 strain of thymidine kinase negative (TK-) Varicella-Zoster Virus (VZV),,,CHEMBL615371,,50527,Human herpesvirus 3,,,N,1,BAO_0000218,
160,,17290,Expert,10335.0,,1,Antiviral activity against 07/1 strain of VZV in HEL (human erythroleukemia) cells.,468.0,,CHEMBL615372,,50527,vericilla zoster virus,HEL,,N,1,BAO_0000218,
161,,17290,Intermediate,10335.0,,1,Antiviral activity against 07/1 strain of VZV; ND: No data,,,CHEMBL615373,,50527,vericilla zoster virus,,,N,1,BAO_0000218,
162,,17290,Intermediate,10335.0,,1,Antiviral activity against 07/1 strain of VZV; ND=No data,,,CHEMBL615374,,50527,vericilla zoster virus,,,N,1,BAO_0000218,
163,,10932,Intermediate,561.0,,1,"Antibacterial activity was determined against gram negative organism, Enterobacter cloacae (MA2646)",,,CHEMBL615375,,50145,escherichia cloac,,,N,1,BAO_0000218,
164,,9707,Autocuration,,,1,Ratio of Ki at A2 to Ki at A1 receptors,,,CHEMBL615376,,22226,,,,U,0,BAO_0000019,
165,,2346,Expert,5476.0,,1,"In vitro inhibition of 1,3-beta-glucan synthase in Candida albicans membrane assay.",,,CHEMBL615377,,11143,Candida albicans,,,H,8,BAO_0000249,
166,,2205,Expert,284593.0,,1,"Inhibition of 1,3-beta-glucan synthase",,,CHEMBL615378,,18077,Candida glabrata CBS 138,,,H,8,BAO_0000357,
167,,11900,Intermediate,9606.0,,1,Inhibition of growth of 1-87 human tumor cell line,832.0,,CHEMBL615379,,80609,Homo sapiens,1-87 tumor cell line,,N,1,BAO_0000219,
168,,14864,Expert,10116.0,,1,Inhibition of 1-lipoxygenase (LOX)in RBL cells,,,CHEMBL615380,,12166,Rattus norvegicus,,,D,9,BAO_0000219,
169,,16474,Autocuration,3847.0,,1,Inhibitory activity against soybean 1-lipoxygenase (SLO),,,CHEMBL615381,,100171,Glycine max,,,D,9,BAO_0000357,
170,,16474,Autocuration,3847.0,,1,Inhibitory activity against soybean 1-lipoxygenase (SLO); no effect,,,CHEMBL615382,,100171,Glycine max,,,D,9,BAO_0000357,
171,,16474,Autocuration,3847.0,,1,% inhibition against soybean 1-lipoxygenase (SLO),,,CHEMBL615383,,100171,Glycine max,,,D,9,BAO_0000357,
172,,16474,Autocuration,3847.0,,1,percent inhibition against soybean 1-lipoxygenase (SLO);NI is no inhibition,,,CHEMBL615384,,100171,Glycine max,,,D,9,BAO_0000357,
173,,3094,Autocuration,3847.0,,1,Ratio of proximal to distal region oxidation by 1-lipoxygenase isolated from soybean; Ratio of proximal and distal was 10:90,,,CHEMBL615385,,100171,Glycine max,,,D,9,BAO_0000357,
174,,3094,Autocuration,3847.0,,1,Ratio of proximal to distal region oxidation by 1-lipoxygenase isolated from soybean; Ratio of proximal and distal was 1:99,,,CHEMBL615386,,100171,Glycine max,,,D,9,BAO_0000357,
175,,3094,Autocuration,3847.0,,1,Ratio of proximal to distal region oxidation by 1-lipoxygenase isolated from soybean; Ratio of proximal and distal was 25:75,,,CHEMBL615387,,100171,Glycine max,,,D,9,BAO_0000357,
176,,3094,Autocuration,3847.0,,1,Ratio of proximal to distal region oxidation by 1-lipoxygenase isolated from soybean; Ratio of proximal and distal was 35:65,,,CHEMBL615388,,100171,Glycine max,,,D,9,BAO_0000357,
177,,3094,Autocuration,3847.0,,1,Ratio of proximal to distal region oxidation by 1-lipoxygenase isolated from soybean; Ratio of proximal and distal was 50:50,,,CHEMBL615214,,100171,Glycine max,,,D,9,BAO_0000357,
178,,3094,Autocuration,3847.0,,1,Ratio of proximal to distal region oxidation by 1-lipoxygenase isolated from soybean; Ratio of proximal and distal was 76:24,,,CHEMBL827087,,100171,Glycine max,,,D,9,BAO_0000357,
179,,3094,Autocuration,3847.0,,1,Ratio of proximal to distal region oxidation by 1-lipoxygenase isolated from soybean; Ratio of proximal and distal was 87:13,,,CHEMBL615215,,100171,Glycine max,,,D,9,BAO_0000357,
180,,3094,Autocuration,3847.0,,1,Ratio of proximal to distal region oxidation by 1-lipoxygenase isolated from soybean; Ratio of proximal and distal was 89:11,,,CHEMBL615216,,100171,Glycine max,,,D,9,BAO_0000357,
181,,3094,Autocuration,3847.0,,1,Ratio of proximal to distal region oxidation by 1-lipoxygenase isolated from soybean; Ratio of proximal and distal was 95:5,,,CHEMBL615217,,100171,Glycine max,,,D,9,BAO_0000357,
182,,3094,Autocuration,3847.0,,1,Ratio of proximal to distal region oxidation by 1-lipoxygenase isolated from soybean; Ratio of proximal and distal was 97:3,,,CHEMBL615218,,100171,Glycine max,,,D,9,BAO_0000357,
183,,3094,Autocuration,3847.0,,1,Ratio of proximal to distal region oxidation by 1-lipoxygenase isolated from soybean; Ratio of proximal and distal was 99:1,,,CHEMBL615219,,100171,Glycine max,,,D,9,BAO_0000357,
184,,10413,Autocuration,10090.0,,1,Evaluated for inhibitory activity on 10-formyltetrahydrofolate synthetase(L cell) at folate substrate concentration of 100 uM,,,CHEMBL615220,,22226,Mus musculus,,,U,0,BAO_0000019,
185,,16929,Intermediate,10090.0,,1,Cells were harvested and were assayed for luciferase and -galactosidase activities (Transcriptional activity),294.0,,CHEMBL615221,,80049,Mus musculus,C3H 10T1/2,,N,1,BAO_0000219,
186,,1229,Intermediate,,,1,In vitro anticancer activity against 11 NCI NSCLC cell lines; inactive,,,CHEMBL615222,,22226,,,,U,0,BAO_0000019,
187,,16587,Autocuration,,,1,In vitro inhibitory activity against human 11 beta hydroxysteroid dehydrogenase type 1 using scintillation proximity assay (SPA),,,CHEMBL615223,,11489,,,,H,8,BAO_0000357,
188,,16587,Autocuration,,,1,In vitro inhibitory activity against mouse 11 beta hydroxysteroid dehydrogenase type 1 using scintillation proximity assay (SPA),,,CHEMBL615224,,11862,,,,H,8,BAO_0000357,
189,,16587,Autocuration,,,1,In vitro inhibitory activity against mouse 11 beta hydroxysteroid dehydrogenase type 1 using scintillation proximity assay (SPA).,,,CHEMBL615225,,11862,,,,H,8,BAO_0000357,
190,,16587,Autocuration,,,1,Ability to convert [3H]cortisol to the tritium labeled cortisone in the presence of human 11 beta hydroxysteroid dehydrogenase type 2,,,CHEMBL615226,,11489,,,,H,8,BAO_0000357,
191,,16587,Autocuration,,,1,Inhibitory activity against mouse 11 beta hydroxysteroid dehydrogenase type 2 at a concentration of 0.2 mM; NI means no inhibition,,,CHEMBL615227,,11862,,,,H,8,BAO_0000357,
192,,8058,Expert,9913.0,,1,Evaluated for inhibition of bovine adrenal cortical mitochondrial 11 beta-hydroxylase,,,CHEMBL615228,,12347,Bos taurus,,,D,9,BAO_0000019,
193,,9065,Expert,10116.0,,1,Effect on adrenal 11-beta-hydroxylase activity at 10e-4 M; No significant effect,,,CHEMBL615229,,100120,Rattus norvegicus,,,D,9,BAO_0000357,
194,,8865,Expert,10116.0,,1,Inhibition of 11 beta-hydroxylase from rat adrenal gland,,,CHEMBL615230,,100120,Rattus norvegicus,,,D,9,BAO_0000357,2369.0
195,,9066,Expert,10116.0,,1,Inhibition of rat adrenal 11-beta-hydroxylase,,,CHEMBL615231,,100120,Rattus norvegicus,,,D,9,BAO_0000357,
196,,8394,Expert,10116.0,,1,Inhibition of rat adrenal 11-beta-hydroxylase,,,CHEMBL884520,,100120,Rattus norvegicus,,,D,9,BAO_0000357,
197,,8394,Expert,10116.0,,1,Inhibition of rat adrenal 11-beta-hydroxylase at 10e-5 M,,,CHEMBL615232,,100120,Rattus norvegicus,,,D,9,BAO_0000357,
198,,6431,Autocuration,,,1,Percent inhibition against 11-beta-hydroxysteroid dehydrogenase 1 of wistar rat liver cytosol at 10 uM was determined using [3H]cortisone,,,CHEMBL615233,,10328,,,,H,8,BAO_0000019,
199,,6431,Autocuration,,,1,Percent inhibition against 11-beta-hydroxysteroid dehydrogenase 2 of wistar rat kidney at 10 uM was determined using [3H]cortisol,,,CHEMBL827088,,11490,,,,H,8,BAO_0000357,
200,,6431,Autocuration,,,1,Percent inhibition against 11-beta-hydroxysteroid dehydrogenase 2 of wistar rat kidney at 10 uM was determined using [3H]cortisol,,,CHEMBL615234,,11490,,,,H,8,BAO_0000357,
201,,9295,Autocuration,,,1,Compound was tested for the percent of inhibition against 12-LO at 10 uM,,,CHEMBL615235,,11134,,,,H,8,BAO_0000019,
202,,10193,Autocuration,,,1,In vitro inhibitory activity against rat platelet 12-lipoxygenase at 10 uM,,,CHEMBL615236,,12052,,,,H,8,BAO_0000019,
203,,13622,Autocuration,,,1,Compound was tested in vitro for inhibition of 12-LO human platelet,,,CHEMBL615237,,11134,,,,H,8,BAO_0000019,
204,,12079,Autocuration,,,1,Inhibitory concentration against human platelet 12-lipoxygenase,,,CHEMBL615238,,11134,,,,H,8,BAO_0000019,
205,,13622,Autocuration,,,1,Compound at 100 uM was tested in vitro for inhibition of 12-LO human platelet,,,CHEMBL615239,,11134,,,,H,8,BAO_0000019,
206,,12079,Autocuration,9606.0,,1,Inhibitory concentration against human platelet 12-lipoxygenase,,,CHEMBL615240,,11134,Homo sapiens,,,D,9,BAO_0000019,
207,,13500,Expert,,,1,Tested for inhibition of 12-LO (12-lipoxygenase) as an inhibitor of 12(S)-HETE biosynthesis in mouse epidermal homogenates,,,CHEMBL615241,,11835,,,,H,8,BAO_0000019,
208,,13723,Expert,,,1,Inhibitory activity against conversion of [1-14C]arachidonic acid to 12-HPETE and its reduction product 12-HETE by porcine leukocyte type 12-lipoxygenase,,,CHEMBL615242,,11601,,,,H,8,BAO_0000357,
209,,16474,Autocuration,,,1,Inhibitory activity against human platelet 12-lipoxygenase (12-HLO),,,CHEMBL615243,,11134,,,,H,8,BAO_0000019,
210,,1630,Autocuration,,,1,Inhibitory activity against human platelet 12-lipoxygenase,,,CHEMBL615244,,11134,,,,H,8,BAO_0000019,
211,,167,Autocuration,,,1,Inhibitory activity against human platelet 12-lipoxygenase was evaluated,,,CHEMBL615245,,11134,,,,H,8,BAO_0000019,
212,,16474,Autocuration,,,1,% inhibition against human platelet 12-lipoxygenase (12-HLO),,,CHEMBL615246,,11134,,,,H,8,BAO_0000019,
213,,167,Autocuration,,,1,Inhibitory activity against human platelet 12-lipoxygenase was evaluated at 100 uM,,,CHEMBL615247,,11134,,,,H,8,BAO_0000019,
214,,16474,Autocuration,,,1,percent inhibition against human platelet 12-lipoxygenase (12-HLO); NI is no inhibition,,,CHEMBL615248,,11134,,,,H,8,BAO_0000019,
215,,10091,Autocuration,,,1,Inhibitory activity towards porcine 12-lipoxygenase,,,CHEMBL615249,,11601,,,,H,8,BAO_0000357,
216,,11966,Autocuration,,,1,Tested for inhibition against porcine 12-LO,,,CHEMBL615250,,11601,,,,H,8,BAO_0000357,
217,,951,Autocuration,,,1,Inhibition of 12-lipoxygenase was evaluated in rat platelets stimulated by thrombin up to a concentration of 10 uM; NE means No effect,,,CHEMBL615251,,12052,,,,H,8,BAO_0000019,
218,,10997,Autocuration,,,1,Inhibitory activity against 12-lipoxygenase in rat platelet rich plasma,,,CHEMBL615252,,12052,,,,H,8,BAO_0000019,
219,,10193,Expert,,,1,In vitro inhibition of rat platelet 12-lipoxygenase,,,CHEMBL828340,,12052,,,,H,8,BAO_0000019,
220,,10193,Autocuration,,,1,In vitro inhibitory activity against rat platelet 12-lipoxygenase at 10 uM,,,CHEMBL615253,,12052,,,,H,8,BAO_0000019,
221,,10193,Autocuration,,,1,In vitro inhibitory activity against rat platelet 12-lipoxygenase at 100 uM,,,CHEMBL615254,,12052,,,,H,8,BAO_0000019,
222,,10193,Autocuration,,,1,In vitro inhibitory activity against rat platelet 12-lipoxygenase at 30 uM,,,CHEMBL615255,,12052,,,,H,8,BAO_0000019,
223,,10193,Autocuration,,,1,In vitro inhibitory activity against rat platelet 12-lipoxygenase at 10 uM,,,CHEMBL615256,,12052,,,,H,8,BAO_0000019,
224,,10193,Autocuration,,,1,In vitro inhibitory activity against rat platelet 12-lipoxygenase,,,CHEMBL615257,,12052,,,,H,8,BAO_0000019,
225,,11087,Autocuration,,,1,The compound was tested for the in vitro inhibition of platelet 12-lipoxygenase at a concentration of 100 uM,,,CHEMBL615258,,12052,,,,H,8,BAO_0000019,
226,,15569,Intermediate,9606.0,,1,Cytotoxic activity in a panel of Human ovarian tumor 41M cell line after 96h of drug exposure,621.0,,CHEMBL615259,,80007,Homo sapiens,41M,,N,1,BAO_0000219,
227,,12989,Expert,9606.0,,1,In vitro antitumor activity against 41M cell line.,621.0,,CHEMBL615260,,80007,Homo sapiens,41M,,N,1,BAO_0000219,
228,,16745,Intermediate,9606.0,,1,cytotoxicity against 41M cells incubated for 24 hr in MTT assay.,621.0,,CHEMBL615261,,80007,Homo sapiens,41M,,N,1,BAO_0000219,
229,,15569,Intermediate,9606.0,,1,Cytotoxic activity in a panel of Human ovarian tumor 41M/CDDP cell line after 96h of drug exposure,621.0,,CHEMBL615262,,80007,Homo sapiens,41M,,N,1,BAO_0000219,
230,,12989,Expert,9606.0,,1,In vitro antitumor activity against 41McisR cell line.,621.0,,CHEMBL615263,,80007,Homo sapiens,41M,,N,1,BAO_0000219,
231,,12989,Expert,9606.0,,1,Resistant factor was determined between IC50 of cisplatin-resistant human tumor cell lines to that of 41McisR cell line,621.0,,CHEMBL838393,,80007,Homo sapiens,41M,,N,1,BAO_0000219,
232,,16745,Intermediate,9606.0,,1,cytotoxicity against 41McisR cells incubated for 24 hr in MTT assay,621.0,,CHEMBL615264,,80007,Homo sapiens,41M,,N,1,BAO_0000219,
233,,6210,Expert,9606.0,,1,Inhibition of 5'-inosine monophosphate dehydrogenase type I (IMPDH I),,,CHEMBL615265,,84,Homo sapiens,,,D,9,BAO_0000357,
234,,6210,Expert,9606.0,,1,Inhibition of 5'-inosine monophosphate dehydrogenase type II (IMPDH II),,,CHEMBL615266,,68,Homo sapiens,,,D,9,BAO_0000357,
235,,6226,Expert,,,1,Inhibitory activity against inosine 5'-inosine monophosphate dehydrogenase type II (IMPDH II),,,CHEMBL615267,,68,,,,H,8,BAO_0000357,
236,,17855,Expert,,,1,Equilibrium dissociation constant towards human 5'-methylthioadenosine phosphorylase,,,CHEMBL615268,,10201,,,,H,8,BAO_0000357,
237,,17855,Expert,,,1,Equilibrium dissociation constant towards human 5'-methylthioadenosine phosphorylase; nd = Not determined,,,CHEMBL615269,,10201,,,,H,8,BAO_0000357,
238,,17855,Expert,,,1,Initial dissociation constant towards human 5'-methylthioadenosine phosphorylase,,,CHEMBL615270,,10201,,,,H,8,BAO_0000357,
239,,10413,Autocuration,,,1,"Evaluated for inhibitory activity on 5,10-Methenyl Tetrahydrofolate Cyclohydrolase(L cell) at folate substrate concentration of 100 uM",,,CHEMBL615271,,12220,,,,H,8,BAO_0000357,
240,,10413,Autocuration,562.0,,1,"Inhibitory activity against 5,10-methylenetetrahydrofolate dehydrogenase from Escherichia coli at a concentration of 0.1 mM; NT=Not tested",,,CHEMBL615272,,11303,Escherichia coli,,,H,8,BAO_0000357,
241,,10413,Autocuration,562.0,,1,"Inhibitory activity against 5,10-Methylene Tetrahydrofolate Cyclohydrolase from Escherichia coli at a concentration of 0.1 mM; NT=Not tested",,,CHEMBL615103,,11303,Escherichia coli,,,H,8,BAO_0000357,
242,,10413,Autocuration,562.0,,1,"Inhibitory activity against 5,10-Methylene Tetrahydrofolate Cyclohydrolase from Escherichia coli at a concentration of 0.1 mM;NT=Not tested",,,CHEMBL615104,,11303,Escherichia coli,,,H,8,BAO_0000357,
243,,10413,Autocuration,,,1,"Evaluated for inhibitory activity on 5,10-Methylene Tetrahydrofolate Cyclohydrolase(L cell) at folate substrate concentration of 100 uM",,,CHEMBL615105,,12220,,,,H,8,BAO_0000357,
244,,10413,Autocuration,,,1,"Evaluated for inhibitory activity on 5,10-methylenetetrahydrofolate dehydrogenase(L cell) at folate substrate concentration of 100 uM",,,CHEMBL872866,,12220,,,,H,8,BAO_0000357,
245,,7587,Autocuration,9823.0,,1,"Percent inhibition was measured against 5,10-Methylene Tetrahydrofolate Cyclohydrolase (L1210 tumor tissue) enzyme at 10E-6 M inhibitory concentration",,,CHEMBL615106,,11303,Sus scrofa,,,H,8,BAO_0000357,
246,,7587,Autocuration,9823.0,,1,"Percent inhibition was measured against 5,10-Methylene Tetrahydrofolate Cyclohydrolase (A,porcine liver) enzyme.",,,CHEMBL615107,,11303,Sus scrofa,,,H,8,BAO_0000019,
247,,7587,Autocuration,9823.0,,1,"Percent inhibition was measured against 5,10-Methylene Tetrahydrofolate Cyclohydrolase (L1210 tumor tissue) enzyme at 10E-4 M inhibitory concentration",,,CHEMBL615108,,11303,Sus scrofa,,,H,8,BAO_0000357,
248,,7587,Autocuration,9823.0,,1,"Percent inhibition was measured against 5,10-Methylene Tetrahydrofolate Cyclohydrolase (L1210 tumor tissue) enzyme at 10E-5 M inhibitory concentration",,,CHEMBL615109,,11303,Sus scrofa,,,H,8,BAO_0000357,
249,,7587,Autocuration,9823.0,,1,"Percent inhibition was measured against 5,10-Methylene Tetrahydrofolate Cyclohydrolase (L1210 tumor tissue) enzyme at 10E-6 M inhibitory concentration",,,CHEMBL615110,,11303,Sus scrofa,,,H,8,BAO_0000357,
250,,7587,Autocuration,9823.0,,1,"Percent inhibition was measured against 5,10-Methylene Tetrahydrofolate Cyclohydrolase (porcine liver) enzyme at 10E-4 M inhibitory concentration",,,CHEMBL840105,,11303,Sus scrofa,,,H,8,BAO_0000019,
251,,7587,Autocuration,9823.0,,1,"Percent inhibition was measured against 5,10-Methylene Tetrahydrofolate Cyclohydrolase (porcine liver) enzyme at 10E-5 M inhibitory concentration",,,CHEMBL615111,,11303,Sus scrofa,,,H,8,BAO_0000019,
252,,7587,Autocuration,9823.0,,1,"Percent inhibition was measured against 5,10-Methylene Tetrahydrofolate Cyclohydrolase (porcine liver) enzyme at 10E-6 M inhibitory concentration",,,CHEMBL615112,,11303,Sus scrofa,,,H,8,BAO_0000019,
253,,7587,Autocuration,9823.0,,1,"Percent inhibition was measured against 5,10-Methylene Tetrahydrofolate Cyclohydrolase (porcine liver) enzyme at 10E-7 M inhibitory concentration",,,CHEMBL615113,,11303,Sus scrofa,,,H,8,BAO_0000019,
254,,7587,Autocuration,9823.0,,1,"Percent inhibition was measured against 5,10-Methylene Tetrahydrofolate Cyclohydrolase (porcine liver) enzyme.",,,CHEMBL615114,,11303,Sus scrofa,,,H,8,BAO_0000019,
255,,7587,Autocuration,9823.0,,1,"Percent inhibition was measured against 5,10-Methylene Tetrahydrofolate Cyclohydrolase (L1210 tumor tissue) enzyme at 10E-6 M inhibitory concentration",,,CHEMBL615115,,11303,Sus scrofa,,,H,8,BAO_0000357,
256,,7587,Autocuration,9823.0,,1,"Percent inhibition was measured against 5,10-Methylene Tetrahydrofolate Cyclohydrolase (porcine liver) enzyme at 10E-4 M inhibitory concentration",,,CHEMBL615116,,11303,Sus scrofa,,,H,8,BAO_0000019,
257,,7323,Autocuration,,,1,"Compound was tested for in vitro inhibition of 5,10-Methylene Tetrahydrofolate Cyclohydrolase, competitive against (+)-L-5,10-methenyltetrahydrofolate",,,CHEMBL615698,,11303,,,,H,8,BAO_0000357,
258,,7587,Autocuration,9823.0,,1,"Percent inhibition was measured against 5,10-Methylene Tetrahydrofolate Reductase (porcine kidney) enzyme at 10E-4 M inhibitory concentration",,,CHEMBL615699,,22226,Sus scrofa,,,U,0,BAO_0000019,
259,,7587,Autocuration,9823.0,,1,"Percent inhibition was measured against 5,10-Methylene Tetrahydrofolate Reductase (porcine kidney) enzyme.",,,CHEMBL615700,,22226,Sus scrofa,,,U,0,BAO_0000019,
260,,13750,Expert,4932.0,,1,Inhibition of 5-Desaturase involved in ergosterol biosynthesis,,,CHEMBL615701,,100249,Saccharomyces cerevisiae,,,H,8,BAO_0000357,
261,,7662,Autocuration,10116.0,,1,Ability for reversible inhibition of Walker 256 5-Fluoro-2'-deoxyuridine Phosphorylase,,,CHEMBL615702,,22226,Rattus norvegicus,,,U,0,BAO_0000019,
262,,7662,Autocuration,10116.0,,1,Ability for reversible inhibition of Walker 256 5-Fluoro-2'-deoxyuridine Phosphorylase,,,CHEMBL615703,,22226,Rattus norvegicus,,,U,0,BAO_0000019,
263,,7662,Autocuration,10116.0,,1,"Irreversible inhibition of Walker 256 FUDR phosphorylase; expressed as Vo/Vi, velocity without inhibitor to that of velocity with inhibitor",,,CHEMBL615704,,22226,Rattus norvegicus,,,U,0,BAO_0000019,
264,,12211,Autocuration,,,1,"Tested for 5-HT 3 receptor antagonist potency by ability to inhibit the reflex bradycardia, the Bezold-Jarisch reflex in the rat",,,CHEMBL615705,,104698,,,,H,6,BAO_0000019,
265,,12211,Autocuration,,,1,"Compound was tested for its 5-HT 3 receptor antagonist potency by their ability to inhibit the reflex bradycardia, the Bezold-Jarisch reflex in the rat",,,CHEMBL615706,,104698,,,,H,6,BAO_0000019,
266,,12211,Intermediate,10141.0,,1,Relative ability to increase cholinergically mediated contractions in isolated ileum of guinea pig,,,CHEMBL615707,,20033,Cavia porcellus,,,D,9,BAO_0000221,2116.0
267,,12211,Expert,,,1,Stimulatory activity of intragastric pressure was tested in the rat,,,CHEMBL615708,,10623,,,,H,8,BAO_0000019,
268,,15453,Autocuration,,,1,% Decrease of 5-HT carrier-receptor -bound radioactivity using paroxetine as a radioligand.,,,CHEMBL615709,,121,,,,H,8,BAO_0000357,
269,,11884,Autocuration,10116.0,,1,Dose to reduce neuronal firing against 5-HT cells in rats (iv),,,CHEMBL615710,,22226,Rattus norvegicus,,,U,0,BAO_0000218,
270,,7185,Autocuration,,,1,Antagonistic activity of corresponding methoxy compound against serotonin 5-HT receptor,,,CHEMBL615711,,12688,,,,H,8,BAO_0000019,
271,,6876,Expert,9606.0,,1,Binding affinity at 5-HT reuptake site labeled with [3H]paroxetine,,,CHEMBL615712,,121,Homo sapiens,,,D,9,BAO_0000357,
272,,6876,Expert,9606.0,,1,Binding affinity at 5-HT reuptake site labeled with [3H]paroxetine; No data,,,CHEMBL836325,,121,Homo sapiens,,,D,9,BAO_0000357,
273,,11863,Autocuration,,,1,Inhibition of high affinity 5-HT uptake at concentration of 1 uM,,,CHEMBL615713,,12198,,,,H,8,BAO_0000019,
274,,11863,Autocuration,,,1,Inhibition constant of high-affinity 5-HT uptake,,,CHEMBL615714,,12198,,,,H,8,BAO_0000357,
275,,11863,Autocuration,,,1,Michaelis-Menten constant was reported for high affinity transport of 5-HT,,,CHEMBL615715,,12198,,,,H,8,BAO_0000019,
276,,11863,Autocuration,,,1,Maximum rate was determined for high affinity transport of 5-HT,,,CHEMBL615716,,12198,,,,H,8,BAO_0000019,
277,,4639,Autocuration,,,1,Compound was tested for agonistic activity against 5-HT uptake,,,CHEMBL615717,,104714,,,,H,4,BAO_0000019,
278,,15796,Expert,,,1,Inhibition affinity against 5-HT-1B receptor in rat frontal cortex using radio binding assay,,,CHEMBL881818,,10577,,,,H,8,BAO_0000019,
279,,15796,Expert,9913.0,,1,Inhibition affinity against 5-HT-1D receptor in bovine caudate nucleus using radio binding assay,,,CHEMBL884540,,105,Bos taurus,,,H,8,BAO_0000357,
280,,12801,Autocuration,10116.0,,1,Binding affinity towards 5-hydroxytryptamine 1 receptor using [3H]5-HT as radioligand,,,CHEMBL615718,,104744,Rattus norvegicus,,,D,5,BAO_0000224,
281,,12801,Autocuration,,,1,The compound was evaluated for the binding affinity towards 5-hydroxytryptamine 1 using [3H]5-HT as radioligand,,,CHEMBL615719,,104744,,,,H,4,BAO_0000224,
282,,12120,Autocuration,,,1,Percent inhibition of binding of 3.0 nM [3H]5-HT to 5-hydroxytryptamine 1 receptor in rat caudate membranes at 10 e -5 M,,,CHEMBL615720,Membranes,104744,,,,H,4,BAO_0000249,
283,,12120,Autocuration,,,1,Percent inhibition of binding of 3.0 nM [3H]5-HT to 5-hydroxytryptamine 1 receptor in rat caudate membranes at 10 e -5 M.,,,CHEMBL615721,Membranes,104744,,,,H,4,BAO_0000249,
284,,11963,Autocuration,,,1,Displacement of binding of [3H]-5-HT to 5-hydroxytryptamine 1 receptor in rat cerebral cortex,,,CHEMBL615722,,104744,,,,H,4,BAO_0000019,
285,,11701,Autocuration,,,1,Dose required to reduce neuronal firing of 5-HT1A cells by 50%,,,CHEMBL615723,,51,,,,H,8,BAO_0000019,
286,,9995,Autocuration,,,1,In vitro inhibition of [3H]5-HT (2 nM) binding to 5-hydroxytryptamine 1A receptor from bovine hippocampus,,,CHEMBL615724,,51,,,,H,8,BAO_0000221,10000000.0
287,,9995,Autocuration,,,1,In vitro inhibition of [3H]DPAT (1 nM) binding to 5-HT1A receptor from bovine hippocampus,,,CHEMBL615725,,51,,,,H,8,BAO_0000221,10000000.0
288,,9995,Autocuration,,,1,In vitro inhibition of [3H]DPAT (1 nM) binding to 5-hydroxytryptamine 1A receptor from bovine hippocampus,,,CHEMBL615726,,51,,,,H,8,BAO_0000221,10000000.0
289,In vivo,16394,Autocuration,,,1,Antagonistic activity at postsynaptic 5-HT1A receptor was measured by its ability to inhibit hypothermia elicited by s.c. administration of 8-OH-DPAT in rat;ranges from (.26-3.52),,,CHEMBL615727,,10576,,,,H,8,BAO_0000218,
290,,11574,Intermediate,10141.0,,1,Effect on forskolin stimulated adenylate cyclase activity at 5-HT1D receptor of guinea pig substantia nigra.,,,CHEMBL615728,,105570,Cavia porcellus,,,D,9,BAO_0000019,
291,,15779,Autocuration,,,1,Binding affinity towards 5-HT1F (human cloned receptor) in CHO cells using [3H]5-HT as radioligand.,449.0,,CHEMBL857971,,279,,CHO,,H,8,BAO_0000219,
292,,15363,Autocuration,,,1,Compound was tested for the displacement of [125I]DOI from clone human 5-hydroxytryptamine 2A receptor,,,CHEMBL615729,,107,,,,H,8,BAO_0000357,
293,,15363,Expert,10116.0,,1,Efficacy against 5-hydroxytryptamine 2A receptor,,,CHEMBL615730,,12687,Rattus norvegicus,,,D,9,BAO_0000019,
294,,15329,Expert,,,1,Intrinsic activity towards 5-HT2A receptor of rat tail artery,,,CHEMBL615731,,12687,,,,H,8,BAO_0000019,
295,,15329,Expert,,,1,Relative potency towards 5-HT2A receptor of rat tail artery,,,CHEMBL615732,,12687,,,,H,8,BAO_0000019,
296,,15329,Expert,,,1,Blocking 5-HT2A receptor-mediated contractions of rat tail artery,,,CHEMBL615733,,12687,,,,H,8,BAO_0000019,
297,,15329,Expert,,,1,Partial agonism at 5-HT2A receptor was evaluated in presence of ketanserin (3-10 nM) in isolated rat tail artery,,,CHEMBL615734,,12687,,,,H,8,BAO_0000019,
298,,15329,Autocuration,,,1,Compound was tested for the intrinsic activity against 5-HT2A receptors of rat tail artery.,,,CHEMBL615735,,12687,,,,H,8,BAO_0000019,
299,,15329,Expert,,,1,Effectiveness in blocking 5-HT2A receptor-mediated contractions of rat tail artery,,,CHEMBL615736,,12687,,,,H,8,BAO_0000019,
300,,273,Intermediate,10141.0,,1,Evaluated for the agonistic activity against 5-HT4 receptor in non-electrically stimulated guinea-pig ileum.,,,CHEMBL615737,,20033,Cavia porcellus,,,D,9,BAO_0000221,2116.0
301,,273,Intermediate,10141.0,,1,Agonistic activity against Serotonin 5-HT4 receptor in low frequency field stimulation of guinea-pig ileum (FSGPI),,,CHEMBL615738,,20033,Cavia porcellus,,,D,9,BAO_0000221,2116.0
302,,273,Intermediate,10141.0,,1,Evaluated for the agonistic activity against Serotonin 5-HT4 receptor in non-electrically stimulated guinea-pig ileum.,,,CHEMBL615739,,20033,Cavia porcellus,,,D,9,BAO_0000221,2116.0
303,,12092,Autocuration,,,1,The binding affinity was measured on 5-hydroxytryptamine 4 receptor using [3H]- GR-113808 as radioligand.,,,CHEMBL615278,,10623,,,,H,8,BAO_0000357,
304,,1317,Expert,10116.0,,1,Antagonist activity against 5-HT4 receptor mediated relaxation of rat carbachol contracted esophageal muscularis mucosae,,,CHEMBL615279,,10623,Rattus norvegicus,,,D,9,BAO_0000019,
305,,12409,Expert,,,1,Binding affinity against 5-hydroxytryptamine 4 receptor,,,CHEMBL615280,,168,,,,H,8,BAO_0000357,
306,,11126,Autocuration,9031.0,,1,Relative competitive index values for binding to 25-OH-D3-1-hydroxylase of chick intestine,,,CHEMBL615281,,22226,Gallus gallus,,,U,0,BAO_0000019,
307,,11126,Autocuration,9606.0,,1,Inhibitory effect (10e-6 M) on the 25-OH-D3-1-hydroxylase activity,,,CHEMBL615282,,22226,Homo sapiens,,,U,0,BAO_0000019,
308,,11126,Autocuration,9606.0,,1,25-OH-D3-1-hydroxylase activity (10e-6 M) was measured as %control,,,CHEMBL615283,,22226,Homo sapiens,,,U,0,BAO_0000019,
309,,11126,Autocuration,9606.0,,1,Relative competitive index values for binding to 25-OH-D3-1-hydroxylase of human HL-60 cells,649.0,,CHEMBL615284,,80156,Homo sapiens,HL-60,,N,1,BAO_0000219,
310,,11126,Autocuration,9606.0,,1,Inhibitory effect (10e-6 M) on the 25-hydroxyvitamin D3-1-hydroxylase activity,,,CHEMBL615285,,22226,Homo sapiens,,,U,0,BAO_0000019,
311,,11126,Autocuration,9606.0,,1,25-hydroxyvitamin D3-1-hydroxylase activity (10e-6 M) was measured as %control,,,CHEMBL615286,,22226,Homo sapiens,,,U,0,BAO_0000019,
312,,17807,Autocuration,9606.0,,1,Displacement of [3H]-Ro- 15-1788 from human GABA-A alpha-1-beta-3-gamma-2 receptor subunits expressed in Xenopus oocytes,,,CHEMBL615287,,104703,Homo sapiens,Oocytes,,D,7,BAO_0000219,
313,,16575,Intermediate,,,1,Chymotryptic inhibitory activity against 26S proteasome,,,CHEMBL615288,,100256,,,,S,2,BAO_0000220,
314,,15407,Intermediate,,,1,Inhibitory activity against 26S proteasome degradation of IkB,,,CHEMBL615289,,100256,,,,S,2,BAO_0000220,
315,,10797,Intermediate,9606.0,,1,In vitro inhibition of 2780/DOX ovarian cancer cell line,478.0,,CHEMBL615290,,81034,Homo sapiens,A2780,,N,1,BAO_0000219,
316,,10797,Intermediate,9606.0,,1,In vitro inhibition of 2780/S ovarian cancer cell line,478.0,,CHEMBL884522,,81034,Homo sapiens,A2780,,N,1,BAO_0000219,
317,,3469,Autocuration,9606.0,,1,Relative activity on the cellular accumulation of vincristine in multidrug-resistant (MDR) human ovarian cancer 2780AD cells,,,CHEMBL615291,,22226,Homo sapiens,,,U,0,BAO_0000019,
318,,16037,Intermediate,,,1,Association constant for binding to AATT 28-mer AATT hairpin,,,CHEMBL615292,,22222,,,,M,3,BAO_0000225,
319,,16037,Intermediate,,,1,Kinetically Defined Association Constant for 28-mer AATT hairpin.,,,CHEMBL615293,,22222,,,,M,3,BAO_0000225,
320,,16037,Intermediate,,,1,Reaction Rate Parameter for 28-mer AATT hairpin,,,CHEMBL615294,,22222,,,,M,3,BAO_0000225,
321,,16037,Intermediate,,,1,Reaction Rate Parameter for 28-mer AATT hairpin,,,CHEMBL615295,,22222,,,,M,3,BAO_0000225,
322,,16524,Autocuration,9606.0,,1,Antiviral activity against envelope deficient HIV-1 in a single cycle replication assay (experiment 1),,,CHEMBL825021,,22226,Homo sapiens,,,U,0,BAO_0000019,
323,,16524,Autocuration,9606.0,,1,Antiviral activity against envelope deficient HIV-1 in a single cycle replication assay (experiment 2),,,CHEMBL615296,,22226,Homo sapiens,,,U,0,BAO_0000019,
324,,16524,Autocuration,9606.0,,1,Inhibitory concentration by single cycle replication assay using envelope deficient HIV-1,,,CHEMBL615297,,22226,Homo sapiens,,,U,0,BAO_0000019,
325,,16758,Autocuration,10029.0,,1,Cytotoxicity against cell line 2SC/20 determined by MTT test,,,CHEMBL615298,,22226,Cricetulus griseus,,,U,0,BAO_0000019,
326,,16758,Autocuration,10029.0,,1,Cytotoxicity against cell line 2SC/20 of hamster determined by MTT test,,,CHEMBL615299,,22226,Cricetulus griseus,,,U,0,BAO_0000019,
327,,16758,Autocuration,10029.0,,1,Inhibitory concentration against the growth of 2SC/20 cell line after 72 hr of drug exposure by MTT test,,,CHEMBL615300,,22226,Cricetulus griseus,,,U,0,BAO_0000019,
328,,14360,Autocuration,,,1,Binding affinity on 3 beta-hydroxysteroid dehydrogenase,,,CHEMBL615301,,241,,,,H,8,BAO_0000357,
329,,14360,Expert,9606.0,,1,Binding affinity for 3-beta-hydroxysteroid dehydrogenase,,,CHEMBL615302,,241,Homo sapiens,,,D,9,BAO_0000357,
330,,9964,Autocuration,10116.0,,1,Selectivity ratio of ID50 in liver and heart,,,CHEMBL615303,,22226,Rattus norvegicus,,,U,0,BAO_0000019,
331,,9964,Autocuration,,,1,"Selectivity, ratio of relative ID50 in liver and heart",,,CHEMBL615304,,12132,,,,H,8,BAO_0000019,
332,,9964,Autocuration,,,1,Binding affinity to the receptor was determined in isolated nuclei of heart(In vitro) relative to T3,,,CHEMBL615305,,12132,,,,H,8,BAO_0000019,
333,,9964,Autocuration,,,1,"Binding affinity to the receptor was determined in nuclei of heart In vivo 1 hour after intravenous administration relative to 3,5,3' triiodothyronine receptor",,,CHEMBL615306,,12132,,,,H,8,BAO_0000218,
334,,9964,Autocuration,,,1,"Binding affinity to the receptor was determined in nuclei of liver In vivo 1 hour after intravenous administration relative to 3,5,3' triiodothyronine receptor",,,CHEMBL615307,,12132,,,,H,8,BAO_0000218,
335,In vivo,9964,Autocuration,,,1,"Binding affinity to the receptor was determined in nuclei of liver in vivo 1 hour after intravenous administration relative to 3,5,3' triiodothyronine receptor",,,CHEMBL615308,,12132,,,,H,8,BAO_0000218,
336,In vivo,9964,Autocuration,,,1,"Binding affinity to the receptor was determined in nuclei of liver in vivo 1 hour after intravenous administration relative to 3,5,3' triiodothyronine receptor",,,CHEMBL615309,,12132,,,,H,8,BAO_0000218,
337,,9964,Autocuration,,,1,"Binding affinity to the thyroid hormone receptor was determined in vitro in isolated nuclei of rat liver relative to 3,5,3' triiodothyronine",,,CHEMBL615310,,22226,,,,U,0,BAO_0000019,
338,,9964,Autocuration,,,1,Binding affinity to the receptor was determined in vitro in isolated nuclei of rat liver relative to T3,,,CHEMBL615311,,12132,,,,H,8,BAO_0000019,
339,,9964,Autocuration,9606.0,,1,"Binding affinity to thyroid hormone receptor beta, relative to 3,5,3' triiodothyronine receptor, in isolated nuclei of heart",,,CHEMBL615312,,22226,Homo sapiens,,,U,0,BAO_0000019,
340,,9964,Autocuration,,,1,In vitro binding affinity to the receptor was determined in isolated nuclei of heart relative to T3,,,CHEMBL615313,,12132,,,,H,8,BAO_0000019,
341,,9964,Autocuration,,,1,In vitro binding affinity to the receptor was determined in isolated nuclei of heart relative to T3,,,CHEMBL615314,,12132,,,,H,8,BAO_0000019,
342,,9964,Autocuration,,,1,"Binding affinity to the receptor was determined in isolated nuclei of heart(In vitro) relative to 3,5,3' triiodothyronine receptor",,,CHEMBL615315,,12132,,,,H,8,BAO_0000019,
343,,9964,Autocuration,10116.0,,1,"In vivo binding affinity for 3,5,3'' triiodothyronine receptor of heart nuclei 1 hr after intravenous administration",,,CHEMBL615316,,22226,Rattus norvegicus,,,U,0,BAO_0000218,
344,In vivo,9964,Autocuration,,,1,Binding affinity to the receptor was determined in nuclei of heart in vivo 1 hour after intravenous administration relative to T3,,,CHEMBL615317,,12132,,,,H,8,BAO_0000218,
345,,9964,Autocuration,,,1,"Binding affinity to the receptor was determined in nuclei of liver In vivo 1 hour after intravenous administration relative to 3,5,3' triiodothyronine receptor",,,CHEMBL615318,,12132,,,,H,8,BAO_0000218,
346,,9964,Autocuration,10116.0,,1,"In vivo binding affinity for 3,5,3' triiodothyronine receptor of liver nuclei 1 hour after intravenous administration",,,CHEMBL615319,,22226,Rattus norvegicus,,,U,0,BAO_0000218,
347,,9964,Autocuration,,,1,"In vitro binding affinity to the receptor was determined in isolated nuclei of heart relative to 3,5,3' triiodothyronine receptor",,,CHEMBL615320,,12132,,,,H,8,BAO_0000019,
348,,9964,Autocuration,,,1,"In vitro binding affinity to the receptor was determined in isolated nuclei of heart relative to 3,5,3' triiodothyronine receptor",,,CHEMBL615321,,12132,,,,H,8,BAO_0000019,
349,,3796,Autocuration,10116.0,,1,"Inhibition of [125I]L-T3 binding to rat hepatic 3,5,3''-triiodo-L-thyronine receptor",,,CHEMBL615322,,22226,Rattus norvegicus,,,U,0,BAO_0000019,
350,,4251,Autocuration,562.0,,1,Inhibition constant for binding to Co2+ form of 3-dehydroquinate synthase (DHQ) purified from Escherichia coli,,,CHEMBL615323,,19690,Escherichia coli,,,H,8,BAO_0000357,
351,,4251,Autocuration,562.0,,1,Inhibition constant for binding to Zn2+ form of 3-dehydroquinate synthase (DHQ) purified from Escherichia coli,,,CHEMBL615407,,19690,Escherichia coli,,,H,8,BAO_0000357,
352,,4251,Autocuration,562.0,,1,Kinetics expressed as Michaelis-Menten constant against Co2+ form of 3-dehydroquinate synthase purified from Escherichia coli,,,CHEMBL857267,,19690,Escherichia coli,,,H,8,BAO_0000357,
353,,4251,Autocuration,562.0,,1,Kinetics expressed as Michaelis-Menten constant against Zn2+ form of 3-dehydroquinate synthase purified from Escherichia coli,,,CHEMBL615408,,19690,Escherichia coli,,,H,8,BAO_0000357,
354,,166,Autocuration,,,1,Type of inhibition of 3-dehydroquinate synthase was determined; R - Slowly reversible,,,CHEMBL615409,,19690,,,,H,8,BAO_0000357,
355,,17861,Autocuration,,,1,Compound was evaluated for its inhibitory constant against 3-dehydroquinate synthase,,,CHEMBL615410,,19690,,,,H,8,BAO_0000357,
356,,166,Autocuration,,,1,Inhibition constant against 3-dehydroquinate synthase,,,CHEMBL615411,,19690,,,,H,8,BAO_0000357,
357,,166,Autocuration,,,1,Association rate constant against 3-dehydroquinate synthase,,,CHEMBL615412,,19690,,,,H,8,BAO_0000357,
358,,166,Autocuration,,,1,Rate constant against 3-dehydroquinate synthase,,,CHEMBL615413,,19690,,,,H,8,BAO_0000357,
359,,3548,Autocuration,,,1,Inhibitory activity against fuc-TVII,,,CHEMBL615414,,22226,,,,U,0,BAO_0000019,
360,,9877,Autocuration,10116.0,,1,Ability of compound (2.5 uM) to inhibit the activity of 3-hydroxy -3- methyl glutanyl coenzyme A reductase(HMGR) using [14C]mevalonate in rat liver microsomes,,,CHEMBL615415,Microsomes,12236,Rattus norvegicus,,,D,9,BAO_0000251,2107.0
361,,9877,Autocuration,10116.0,,1,Ability of compound (2500 uM) to inhibit the activity of 3-hydroxy -3- methyl glutanyl coenzyme A reductase(HMGR) using [14C]mevalonate in rat liver microsomes,,,CHEMBL615416,Microsomes,12236,Rattus norvegicus,,,D,9,BAO_0000251,2107.0
362,,9877,Autocuration,10116.0,,1,Ability of compound (250 uM) to inhibit the activity of 3-hydroxy -3- methyl glutanyl coenzyme A reductase(HMGR) using [14C]mevalonate in rat liver microsomes,,,CHEMBL615417,Microsomes,12236,Rattus norvegicus,,,D,9,BAO_0000251,2107.0
363,,9877,Autocuration,10116.0,,1,Ability of compound (25 uM) to inhibit the activity of 3-hydroxy -3- methyl glutanyl coenzyme A reductase(HMGR) using [14C]mevalonate in rat liver microsomes,,,CHEMBL615418,Microsomes,12236,Rattus norvegicus,,,D,9,BAO_0000251,2107.0
364,,9877,Autocuration,10116.0,,1,Ability of compound at 0 uM to inhibit the activity of 3-hydroxy -3- methyl glutanyl coenzyme A reductase(HMGR) using [14C]mevalonate in rat liver microsomes,,,CHEMBL615419,Microsomes,12236,Rattus norvegicus,,,D,9,BAO_0000251,2107.0
365,,9877,Autocuration,10116.0,,1,Ability of compound to inhibit the activity of 3-hydroxy-3-methylglutarylcoenzyme A(HMGR) reductase in rat liver microsomes,,,CHEMBL615420,Microsomes,12236,Rattus norvegicus,,,D,9,BAO_0000251,2107.0
366,,9877,Autocuration,10116.0,,1,Percentage inhibition of 3-hydroxy-3-methyl glutaryl coenzyme A reductase in rat liver microsomes at 250 uM,,,CHEMBL615421,Microsomes,12236,Rattus norvegicus,,,D,9,BAO_0000251,2107.0
367,,9877,Autocuration,10116.0,,1,Percentage inhibition of 3-hydroxy -3- methyl glutanyl coenzyme A reductase(HMGR) in rat liver microsomes at 0 uM,,,CHEMBL615422,Microsomes,12236,Rattus norvegicus,,,D,9,BAO_0000251,2107.0
368,,9877,Autocuration,10116.0,,1,Percentage inhibition of 3-hydroxy -3- methyl glutanyl coenzyme A reductase(HMGR) in rat liver microsomes at 2.5 uM,,,CHEMBL615423,Microsomes,12236,Rattus norvegicus,,,D,9,BAO_0000251,2107.0
369,,9877,Autocuration,10116.0,,1,Percentage inhibition of 3-hydroxy -3- methyl glutanyl coenzyme A reductase(HMGR) in rat liver microsomes at 2500 uM,,,CHEMBL872868,Microsomes,12236,Rattus norvegicus,,,D,9,BAO_0000251,2107.0
370,,9877,Autocuration,10116.0,,1,Percentage inhibition of 3-hydroxy -3- methyl glutanyl coenzyme A reductase(HMGR) in rat liver microsomes at 25 uM,,,CHEMBL615424,Microsomes,12236,Rattus norvegicus,,,D,9,BAO_0000251,2107.0
371,,3003,Autocuration,,,1,Inhibitory activity against 3-phosphoglycerate kinase.,,,CHEMBL825022,,104832,,,,H,4,BAO_0000224,
372,,3003,Autocuration,,,1,Binding affinity was evaluated towards 3-phosphoglycerate kinase at 37 degrees Celsius in 0.1 m NaCl pH 7.1,,,CHEMBL615425,,104832,,,,H,4,BAO_0000224,
373,,3003,Autocuration,,,1,"Michaelis-Menten constant with 1,3-bisphosphoglyceric acid (1,3-BPG) against 3-phosphoglycerate kinase",,,CHEMBL615426,,104832,,,,H,4,BAO_0000224,
374,,17185,Expert,9606.0,,1,Inhibition of human 3-phosphoinositide-dependent protein kinase 1 at 10 uM,,,CHEMBL615427,,10612,Homo sapiens,,,D,9,BAO_0000357,
375,,6072,Intermediate,9606.0,,1,Cytotoxicity on 3677 melanoma cells,844.0,,CHEMBL615428,,80616,Homo sapiens,3677 melanoma cell line,,N,1,BAO_0000219,
376,,6072,Intermediate,9606.0,,1,Cytotoxicity on 3677 melanoma cells in combination with L-49-sFv-bL,844.0,,CHEMBL615429,,80616,Homo sapiens,3677 melanoma cell line,,N,1,BAO_0000219,
377,,5018,Intermediate,10090.0,,1,Antitumor activity against Mouse colon 38 at 500 ug/disk in disk diffusion assay,700.0,,CHEMBL615430,,80617,Mus musculus,MC-38,,N,1,BAO_0000219,
378,,2852,Intermediate,9606.0,,1,Compound was evaluated for inhibition of tumor cell growth using sulforhodamine-B assay in 38 human cell lines,,,CHEMBL615431,,22226,Homo sapiens,,,U,0,BAO_0000019,
379,,8663,Autocuration,,,1,In vivo antitumor activity against 3B131 intraperitoneally implanted B16 melanoma cells; NT= Not tested,798.0,,CHEMBL615432,,22226,,B16,,U,0,BAO_0000218,
380,,8663,Autocuration,,,1,In vivo antitumor activity against 3B131 intraperitoneally implanted B16 melanoma cells; reproducible significant activity.,798.0,,CHEMBL615433,,22226,,B16,,U,0,BAO_0000218,
381,,3245,Expert,12131.0,,1,Inhibitory activity against Human RhinoVirus serotype-14 3C Protease,,,CHEMBL615434,,12464,Human rhinovirus 14,,,D,9,BAO_0000019,
382,,3245,Intermediate,169066.0,,1,Inhibitory activity against Human RhinoVirus serotype-14 3C Protease; NI means No inhibition to 50 uM,,,CHEMBL615435,,50085,Human rhinovirus sp.,,,N,1,BAO_0000218,
383,,3877,Intermediate,169066.0,,1,Compound was evaluated for the inactivation of HRV 14 3C protease activity expressed as KI,,,CHEMBL615436,,50679,human rhinovirus type 14,,,N,1,BAO_0000218,
384,,3877,Intermediate,169066.0,,1,Compound was evaluated for the inactivation of HRV 14 3C protease activity expressed as kinact,,,CHEMBL615437,,50679,human rhinovirus type 14,,,N,1,BAO_0000218,
385,,5861,Expert,12131.0,,1,Antiviral activity against human rhinovirus-14 (HRV-14) 3C protease using enzyme assay,,,CHEMBL615438,,12464,Human rhinovirus 14,,,D,9,BAO_0000019,
386,,5861,Expert,12131.0,,1,Antiviral activity against human rhinovirus-14 (HRV-14) 3C protease using enzyme assay,,,CHEMBL615439,,12464,Human rhinovirus 14,,,D,9,BAO_0000019,
387,,5861,Expert,12131.0,,1,Antiviral activity against human rhinovirus-14 (HRV-14) 3C protease using enzyme assay,,,CHEMBL615440,,12464,Human rhinovirus 14,,,D,9,BAO_0000019,
388,,5861,Expert,12131.0,,1,Antiviral activity against human rhinovirus-14 (HRV-14) 3C protease using enzyme assay; inactive,,,CHEMBL615441,,12464,Human rhinovirus 14,,,D,9,BAO_0000019,
389,,13748,Intermediate,12059.0,,1,Compound was tested for the inhibitory activity of compound towards human rhinovirus 3C protease,,,CHEMBL615641,,50665,Enterovirus,,,N,1,BAO_0000218,
390,,13748,Intermediate,12059.0,,1,Compound was tested for the inhibitory activity of compound towards human rhinovirus-16 3C protease,,,CHEMBL872065,,50665,Enterovirus,,,N,1,BAO_0000218,
391,,13748,Intermediate,12059.0,,1,Compound was tested for the inhibitory activity of compound towards human rhinovirus-2 3C protease,,,CHEMBL825023,,50665,Enterovirus,,,N,1,BAO_0000218,
392,,13748,Intermediate,12059.0,,1,Compound was tested for the inhibitory activity of compound towards human rhinovirus-89 3C protease,,,CHEMBL615642,,50665,Enterovirus,,,N,1,BAO_0000218,
393,,13748,Expert,147712.0,,1,Inhibition of human rhinovirus 3C protease,,,CHEMBL615643,,12464,Human rhinovirus B,,,H,8,BAO_0000357,
394,,17699,Autocuration,9606.0,,1,Compound was tested for inhibition of a proteinase 3CL pro of human coronavirus; Inhibited,,,CHEMBL615644,,22226,Homo sapiens,,,U,0,BAO_0000019,
395,,7145,Intermediate,10090.0,,1,Compound tested for activity against 3EM 37 mouse ependymoblastoma after single ip injection on day 1 at optimal dose of 100 mg/kg (Dose range 200-12.5),833.0,,CHEMBL615645,,80619,Mus musculus,3EM 37,,N,1,BAO_0000218,
396,,7145,Intermediate,10090.0,,1,Compound tested for activity against 3EM 37 mouse ependymoblastoma after single ip injection on day 1 at optimal dose of 128 mg/kg (Dose range 256-16),833.0,,CHEMBL615646,,80619,Mus musculus,3EM 37,,N,1,BAO_0000218,
397,,7145,Intermediate,10090.0,,1,Compound tested for toxicity against 3EM 37 Mouse Ependymoblastoma after single ip injection on day 1 at optimal dose (OD) of 100 mg/kg on the 5th day after the injection of the compound; (10/10),833.0,,CHEMBL615647,,80619,Mus musculus,3EM 37,,N,1,BAO_0000218,
398,,7145,Intermediate,10090.0,,1,Compound tested for toxicity against 3EM 37 mouse ependymoblastoma after single ip injection on day 1 at optimal dose (OD) of 100 mg/kg on the 5th day after the injection of the compound; (6/6),833.0,,CHEMBL615648,,80619,Mus musculus,3EM 37,,N,1,BAO_0000218,
399,,7145,Intermediate,10090.0,,1,Effect of compound on 3EM 37 mouse ependymoblastoma after single ip injection on day 1 recorded as animal weight difference of the treated and the control (T-C) at OD of 100 mg/kg,833.0,,CHEMBL615649,,80619,Mus musculus,3EM 37,,N,1,BAO_0000218,
400,,7145,Intermediate,10090.0,,1,Effect of compound on 3EM 37 mouse ependymoblastoma after single ip injection on day 1 recorded as percentage of cured animals at OD of 100 mg/kg,833.0,,CHEMBL615650,,80619,Mus musculus,3EM 37,,N,1,BAO_0000218,
401,,5325,Intermediate,10090.0,,1,In vivo anti-tumor and anti-metastatic activity was measured after oral dosing 15 mg/kg b.i.d. to B6D2F1 mice bearing metastatic 3LL Lewis lung tumor,847.0,,CHEMBL615651,,80620,Mus musculus,3LL cell line,,N,1,BAO_0000218,
402,,5325,Intermediate,10090.0,,1,In vivo anti-tumor and anti-metastatic activity was measured after oral dosing b.i.d. to B6D2F1 mice bearing metastatic 3LL Lewis lung tumor,847.0,,CHEMBL615652,,80620,Mus musculus,3LL cell line,,N,1,BAO_0000218,
403,,5325,Expert,10090.0,,1,In vivo anti-tumor and anti-metastatic activity following p.o. administration b.i.d. to B6D2F1 mice bearing metastatic 3LL Lewis lung tumor; Not tested.,847.0,,CHEMBL615653,,80620,Mus musculus,3LL cell line,,N,1,BAO_0000218,
404,,16169,Intermediate,10090.0,,1,accumulation of compound in 3LL cells was measured with DFMO by HPLC at 1 uM dose,847.0,,CHEMBL615654,,80620,Mus musculus,3LL cell line,,N,1,BAO_0000219,
405,,16169,Intermediate,10090.0,,1,accumulation of compound in 3LL cells was measured with DFMO by HPLC at 10 uM dose,847.0,,CHEMBL615655,,80620,Mus musculus,3LL cell line,,N,1,BAO_0000219,
406,,16169,Intermediate,10090.0,,1,accumulation of compound in 3LL cells was measured with DFMO by HPLC at 250 uM dose,847.0,,CHEMBL825024,,80620,Mus musculus,3LL cell line,,N,1,BAO_0000219,
407,,16169,Intermediate,10090.0,,1,accumulation of compound in 3LL cells was measured with DFMO by HPLC at 50 uM dose,847.0,,CHEMBL615656,,80620,Mus musculus,3LL cell line,,N,1,BAO_0000219,
408,,16169,Intermediate,10090.0,,1,accumulation of compound in 3LL cells was measured with DFMO by ICP-AES at 50 uM dose,847.0,,CHEMBL615657,,80620,Mus musculus,3LL cell line,,N,1,BAO_0000219,
409,,16169,Intermediate,10090.0,,1,accumulation of compound in 3LL cells was measured without DFMO by HPLC at 1 uM dose,847.0,,CHEMBL615658,,80620,Mus musculus,3LL cell line,,N,1,BAO_0000219,
410,,16169,Intermediate,10090.0,,1,accumulation of compound in 3LL cells was measured without DFMO by HPLC at 10 uM dose,847.0,,CHEMBL615659,,80620,Mus musculus,3LL cell line,,N,1,BAO_0000219,
411,,16169,Intermediate,10090.0,,1,accumulation of compound in 3LL cells was measured without DFMO by HPLC at 250 uM dose,847.0,,CHEMBL615660,,80620,Mus musculus,3LL cell line,,N,1,BAO_0000219,
412,,16169,Intermediate,10090.0,,1,accumulation of compound in 3LL cells was measured without DFMO by HPLC at 50 uM dose,847.0,,CHEMBL615661,,80620,Mus musculus,3LL cell line,,N,1,BAO_0000219,
413,,16169,Intermediate,10090.0,,1,accumulation of compound in 3LL cells was measured without DFMO by ICP-AES at 50 uM dose,847.0,,CHEMBL615662,,80620,Mus musculus,3LL cell line,,N,1,BAO_0000219,
414,,16169,Intermediate,10090.0,,1,Effect on the growth of 3LL cells by DFMO pretreatment at 48 hr incubation,847.0,,CHEMBL615663,,80620,Mus musculus,3LL cell line,,N,1,BAO_0000219,
415,,16169,Intermediate,10090.0,,1,Effect on the growth of 3LL cells was evaluated using an MTT assay at 48 hour incubation,847.0,,CHEMBL615664,,80620,Mus musculus,3LL cell line,,N,1,BAO_0000219,
416,,16169,Intermediate,10090.0,,1,Effect on the growth of 3LL cells was evaluated using an MTT assay at 72 hour incubation,847.0,,CHEMBL615665,,80620,Mus musculus,3LL cell line,,N,1,BAO_0000219,
417,,16169,Intermediate,10090.0,,1,accumulation of compound in 3LL cells was measured without DFMO by HPLC at 50 uM dose,847.0,,CHEMBL615666,,80620,Mus musculus,3LL cell line,,N,1,BAO_0000219,
418,,16169,Intermediate,10090.0,,1,putrescine levels in 3LL cells after the treatment of 1 uM of Compound,847.0,,CHEMBL615667,,80620,Mus musculus,3LL cell line,,N,1,BAO_0000219,
419,,16169,Intermediate,10090.0,,1,putrescine levels in 3LL cells after the treatment of 10 uM of Compound,847.0,,CHEMBL615668,,80620,Mus musculus,3LL cell line,,N,1,BAO_0000219,
420,,16169,Intermediate,10090.0,,1,putrescine levels in 3LL cells after the treatment of 250 uM of Compound,847.0,,CHEMBL615669,,80620,Mus musculus,3LL cell line,,N,1,BAO_0000219,
421,,16169,Intermediate,10090.0,,1,putrescine levels in 3LL cells after the treatment of 50 uM of Compound,847.0,,CHEMBL615670,,80620,Mus musculus,3LL cell line,,N,1,BAO_0000219,
422,,16169,Intermediate,10090.0,,1,spermidine levels in 3LL cells after the treatment of 1 uM of Compound,847.0,,CHEMBL836739,,80620,Mus musculus,3LL cell line,,N,1,BAO_0000219,
423,,16169,Intermediate,10090.0,,1,spermidine levels in 3LL cells after the treatment of 10 uM of Compound,847.0,,CHEMBL615671,,80620,Mus musculus,3LL cell line,,N,1,BAO_0000219,
424,,16169,Intermediate,10090.0,,1,spermidine levels in 3LL cells after the treatment of 250 uM of Compound,847.0,,CHEMBL615672,,80620,Mus musculus,3LL cell line,,N,1,BAO_0000219,
425,,16169,Intermediate,10090.0,,1,spermidine levels in 3LL cells after the treatment of 50 uM of Compound,847.0,,CHEMBL615791,,80620,Mus musculus,3LL cell line,,N,1,BAO_0000219,
426,,16169,Intermediate,10090.0,,1,spermine levels in 3LL cells after the treatment of 1 uM of Compound,847.0,,CHEMBL615792,,80620,Mus musculus,3LL cell line,,N,1,BAO_0000219,
427,,16169,Intermediate,10090.0,,1,spermine levels in 3LL cells after the treatment of 10 uM of Compound,847.0,,CHEMBL615793,,80620,Mus musculus,3LL cell line,,N,1,BAO_0000219,
428,,16169,Intermediate,10090.0,,1,spermine levels in 3LL cells after the treatment of 250 uM of Compound,847.0,,CHEMBL615794,,80620,Mus musculus,3LL cell line,,N,1,BAO_0000219,
429,,16169,Intermediate,10090.0,,1,spermine levels in 3LL cells after the treatment of 50 uM of Compound,847.0,,CHEMBL615795,,80620,Mus musculus,3LL cell line,,N,1,BAO_0000219,
430,,15547,Intermediate,9606.0,,1,Concentration required to inhibit the colony formation of lung carcinoma (3LLD122) cell lines by 50%,971.0,,CHEMBL615590,,80621,Homo sapiens,3LLD122,,N,1,BAO_0000219,
431,,8663,Autocuration,,,1,In vivo antitumor activity against 3M531 is the sarcoma M5076; reproducible minimal activity,,,CHEMBL615591,,22226,,,,U,0,BAO_0000218,
432,,8663,Autocuration,,,1,In vivo antitumor activity against 3M531 is the sarcoma M5076; reproducible significant activity.,,,CHEMBL615592,,22226,,,,U,0,BAO_0000218,
433,,8663,Autocuration,,,1,In vivo antitumor activity against 3MBG5 subrenal capsule mammary carcinoma MX-1 xenograft; NT= Not tested,,,CHEMBL615593,,22226,,,,U,0,BAO_0000218,
434,,8663,Autocuration,,,1,In vivo antitumor activity against 3MBG5 subrenal capsule mammary carcinoma MX-1 xenograft; reproducible significant activity.,,,CHEMBL615594,,22226,,,,U,0,BAO_0000218,
435,,4504,Intermediate,10090.0,,1,Effective dose required against Trypanosoma cruzi amastigotes in 3T3 Fibroblasts,723.0,,CHEMBL615595,,80951,Mus musculus,NIH3T3,,N,1,BAO_0000219,
436,,4504,Intermediate,10090.0,,1,Effective dose required against Trypanosoma cruzi amastigotes in 3T3 Fibroblasts,723.0,,CHEMBL615596,,80951,Mus musculus,NIH3T3,,N,1,BAO_0000219,
437,,12695,Expert,,,1,Inhibition of 6 nM bombesin induced [3H]thymidine incorporation measured in swiss 3T3 cells using a mitogenicity assay,723.0,,CHEMBL615597,,11169,,NIH3T3,,H,8,BAO_0000219,
438,,12695,Intermediate,10090.0,,1,Ability of the peptide to inhibit 6 nM bombesin induced [3H]thymidine incorporation was measured in swiss 3T3 cells using mitogenicity assay; na=Not active,723.0,,CHEMBL615598,,80951,Mus musculus,NIH3T3,,N,1,BAO_0000219,
439,,12695,Intermediate,10090.0,,1,Ability of the peptide to inhibit 6 nM bombesin induced [3H]thymidine incorporation was measured in swiss 3T3 cells using mitogenicity assay; nt=Not tested,723.0,,CHEMBL615599,,80951,Mus musculus,NIH3T3,,N,1,BAO_0000219,
440,,17642,Expert,10090.0,,1,Effective dose against murine 3T3 fibroblasts cells,723.0,,CHEMBL615600,,80951,Mus musculus,NIH3T3,,N,1,BAO_0000219,
441,,17642,Expert,10090.0,,1,Dose required against murine 3T3 fibroblasts cells; 1-10 uM,723.0,,CHEMBL615601,,80951,Mus musculus,NIH3T3,,N,1,BAO_0000219,
442,,12340,Expert,10090.0,,1,Cytotoxic effect on 3T3 cells,723.0,,CHEMBL615602,,80951,Mus musculus,NIH3T3,,N,1,BAO_0000219,
443,,12340,Expert,10090.0,,1,Cytotoxic effect on 3T3 cells,723.0,,CHEMBL615603,,80951,Mus musculus,NIH3T3,,N,1,BAO_0000219,
444,,12716,Intermediate,10090.0,,1,Compound was tested for the concentration necessary to inhibit swiss 3T3 Mouse Fibroblast cell growth rate by 50%.,723.0,,CHEMBL615604,,80951,Mus musculus,NIH3T3,,N,1,BAO_0000219,
445,,6277,Intermediate,10090.0,,1,Concentration of NO in supernatant generated by mouse fibroblasts (3T3) cell line in the presence of compound was determined using NR coloration,723.0,,CHEMBL615605,,80951,Mus musculus,NIH3T3,,N,1,BAO_0000219,
446,,6277,Intermediate,10090.0,,1,Concentration of NO in supernatant generated by mouse fibroblasts (3T3) cell line in the presence of compound was determined using NR coloration; nd=No data,723.0,,CHEMBL615606,,80951,Mus musculus,NIH3T3,,N,1,BAO_0000219,
447,,6277,Expert,10090.0,,1,In vitro cytotoxic concentration against mouse fibroblasts (3T3) cell line using MTT coloration,723.0,,CHEMBL884526,,80951,Mus musculus,NIH3T3,,N,1,BAO_0000219,
448,,6277,Expert,10090.0,,1,In vitro cytotoxic concentration against mouse fibroblasts (3T3) cell line using MTT coloration; n.d.=no data,723.0,,CHEMBL615607,,80951,Mus musculus,NIH3T3,,N,1,BAO_0000219,
449,,6277,Intermediate,10090.0,,1,In vitro cytotoxic concentration against mouse fibroblasts (3T3) cell line using MTT coloration; n.t.=not tested,723.0,,CHEMBL615608,,80951,Mus musculus,NIH3T3,,N,1,BAO_0000219,
450,,6277,Expert,10090.0,,1,In vitro inhibitory activity against mouse fibroblasts (3T3) cell line using CV coloration,723.0,,CHEMBL615609,,80951,Mus musculus,NIH3T3,,N,1,BAO_0000219,
451,,6277,Expert,10090.0,,1,In vitro inhibitory activity against mouse fibroblasts (3T3) cell line using CV coloration; n.d.=no data,723.0,,CHEMBL615682,,80951,Mus musculus,NIH3T3,,N,1,BAO_0000219,
452,,6277,Intermediate,10090.0,,1,In vitro inhibitory activity against mouse fibroblasts (3T3) cell line using CV coloration; n.t.=not tested,723.0,,CHEMBL615683,,80951,Mus musculus,NIH3T3,,N,1,BAO_0000219,
453,,17780,Expert,10090.0,,1,In vivo inhibition of H-ras-transformed 3T3 fibroblasts in nude mouse tumor models,723.0,,CHEMBL615684,,80951,Mus musculus,NIH3T3,,N,1,BAO_0000218,
454,,12751,Autocuration,10090.0,,1,Inhibition of PDGF-dependent autophosphorylation of PDGF-R in mouse BALB/c3T3 cells,,,CHEMBL615685,,104860,Mus musculus,,,D,7,BAO_0000219,
455,,12380,Expert,10090.0,,1,Inhibition of Swiss 3T3 Mouse fibroblast proliferation,723.0,,CHEMBL615686,,80951,Mus musculus,NIH3T3,,N,1,BAO_0000219,
456,,14892,Intermediate,10090.0,,1,Inhibitory activity against 3T3 cell line,723.0,,CHEMBL615687,,80951,Mus musculus,NIH3T3,,N,1,BAO_0000219,
457,,12695,Intermediate,10090.0,,1,The ability of the peptide to inhibit the binding of 10 pM [125I]gastrin releasing peptide to S-3T3 cell membrane was measured,723.0,,CHEMBL884523,,80951,Mus musculus,NIH3T3,,N,1,BAO_0000219,
458,,12695,Expert,,,1,Ability of peptide to inhibit binding of 10 pM [125I]gastrin releasing peptide to S-3T3 cell membrane.,,,CHEMBL615688,,11169,,,,H,8,BAO_0000019,
459,,12695,Intermediate,10090.0,,1,The ability of the peptide to inhibit the binding of 10 pM [125I]gastrin releasing peptide to S-3T3 cell membrane was measured; nt=Not tested,723.0,,CHEMBL615689,,80951,Mus musculus,NIH3T3,,N,1,BAO_0000219,
460,,12695,Intermediate,10090.0,,1,The ability of the peptide to inhibit the binding of 50 pM [125I]gastrin releasing peptide to intact S-3T3 cells was measured,723.0,,CHEMBL615690,,80951,Mus musculus,NIH3T3,,N,1,BAO_0000219,
461,,12695,Expert,,,1,The ability of the peptide to inhibit the binding of 50 pM [125I]gastrin releasing peptide to intact S-3T3 cells,,,CHEMBL615691,,11169,,,,H,8,BAO_0000019,
462,,12695,Expert,,,1,The ability of the peptide to inhibit the binding of 50 pM [125I]gastrin releasing peptide to intact S-3T3 cells; nt=Not tested,,,CHEMBL615692,,11169,,,,H,8,BAO_0000019,
463,,6277,Intermediate,10090.0,,1,Concentration of NO in supernatant generated by mouse fibroblasts (3T3) cell line in the presence of compound was determined using NR coloration,723.0,,CHEMBL615693,,80951,Mus musculus,NIH3T3,,N,1,BAO_0000219,
464,,6277,Expert,10090.0,,1,Concentration of NO in supernatant generated by mouse fibroblasts (3T3) cell line was determined using NR coloration; n.d.=no data,723.0,,CHEMBL615324,,80951,Mus musculus,NIH3T3,,N,1,BAO_0000219,
465,,4959,Expert,9606.0,,1,Inhibition of ligand-induced proliferation in human EGF-R Kinase expressing 3T3 cells,723.0,,CHEMBL615325,,9,Homo sapiens,NIH3T3,,D,9,BAO_0000219,
466,,4959,Expert,9606.0,,1,Inhibition of ligand-induced proliferation in human EGF-R Kinase expressing 3T3 cells (Not tested),723.0,,CHEMBL615490,,9,Homo sapiens,NIH3T3,,D,9,BAO_0000219,
467,,4959,Expert,9606.0,,1,Inhibition of ligand induced proliferation in human Her-2 (p185erbB) tyrosine kinase expressing 3T3 cells,723.0,,CHEMBL615491,,188,Homo sapiens,NIH3T3,,D,9,BAO_0000219,
468,,4959,Expert,9606.0,,1,Inhibition of ligand-induced proliferation in human Her-2 (p185erbB) tyrosine kinase expressing 3T3 cells (Not tested),723.0,,CHEMBL615492,,188,Homo sapiens,NIH3T3,,D,9,BAO_0000219,
469,,12082,Intermediate,10090.0,,1,Inhibitory concentration of compound rwas calculated on 3T3 cells by [3H]Thd incorporation,723.0,,CHEMBL615493,,80951,Mus musculus,NIH3T3,,N,1,BAO_0000219,
470,,12082,Intermediate,10090.0,,1,Inhibitory concentration of compound was calculated on 3T3 cells by [14C]Leu incorporation,723.0,,CHEMBL615494,,80951,Mus musculus,NIH3T3,,N,1,BAO_0000219,
471,,12082,Intermediate,10090.0,,1,Inhibitory concentration of compound was calculated on 3T3 cells by using clonal assay,723.0,,CHEMBL615495,,80951,Mus musculus,NIH3T3,,N,1,BAO_0000219,
472,,12082,Intermediate,10090.0,,1,Inhibitory concentration was calculated on 3T3 cells by using growth assay,723.0,,CHEMBL615496,,80951,Mus musculus,NIH3T3,,N,1,BAO_0000219,
473,,2643,Intermediate,10090.0,,1,In vitro cytotoxicity was evaluated in mouse embryo BALB/c 3T3 cells,723.0,,CHEMBL615497,,80951,Mus musculus,NIH3T3,,N,1,BAO_0000219,
474,,11926,Expert,10090.0,,1,Inhibition of Swiss 3T3 mouse fibroblast proliferation,723.0,,CHEMBL615498,,80951,Mus musculus,NIH3T3,,N,1,BAO_0000219,
475,,15204,Intermediate,10090.0,,1,The compound was tested for cytotoxicity against 3T3 fibroblast murine cell line.,723.0,,CHEMBL615499,,80951,Mus musculus,NIH3T3,,N,1,BAO_0000219,
476,,15992,Expert,10090.0,,1,Effective concentration required to inhibit the growth of murine 3T3 fibroblasts,723.0,,CHEMBL835522,,80951,Mus musculus,NIH3T3,,N,1,BAO_0000219,
477,,16279,Intermediate,10090.0,,1,Cytotoxicity on 3T3 fibroblasts (3T3F) murine cell line (O.D.=0.131+/-0.014); Not tested,723.0,,CHEMBL615500,,80951,Mus musculus,NIH3T3,,N,1,BAO_0000219,
478,,16279,Intermediate,10090.0,,1,Cytotoxicity against 3T3 fibroblasts (3T3F) murine cell line (O.D.=0.131+/-0.014),723.0,,CHEMBL615501,,80951,Mus musculus,NIH3T3,,N,1,BAO_0000219,
479,,16279,Intermediate,10090.0,,1,Cytotoxicity on 3T3 fibroblasts (3T3F) murine cell line (O.D.=0.131+/-0.014),723.0,,CHEMBL615502,,80951,Mus musculus,NIH3T3,,N,1,BAO_0000219,
480,,16279,Intermediate,10090.0,,1,cytotoxicity on 3T3 fibroblasts (3T3F) murine cell line (O.D.=0.131+/-0.014),723.0,,CHEMBL615503,,80951,Mus musculus,NIH3T3,,N,1,BAO_0000219,
481,,16279,Intermediate,10090.0,,1,Cytotoxicity on 3T3 fibroblasts (3T3F) murine cell line (O.D.=0.131+/-0.014),723.0,,CHEMBL615504,,80951,Mus musculus,NIH3T3,,N,1,BAO_0000219,
482,,16279,Intermediate,10090.0,,1,Cytotoxicity against 3T3 fibroblasts (3T3F) murine cell line (O.D.=0.131+/-0.014),723.0,,CHEMBL615505,,80951,Mus musculus,NIH3T3,,N,1,BAO_0000219,
483,,12831,Expert,10090.0,,1,Inhibition of swiss 3T3 mouse fibroblast proliferation,723.0,,CHEMBL615506,,80951,Mus musculus,NIH3T3,,N,1,BAO_0000219,
484,,13497,Intermediate,10090.0,,1,Compound was tested for sublethal concentrations in 3T3 mouse fibroblast lysis.,723.0,,CHEMBL615507,,80951,Mus musculus,NIH3T3,,N,1,BAO_0000219,
485,,13715,Intermediate,,,1,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at 30 uM dose.,620.0,,CHEMBL615508,,80006,,3T3-L1,,N,1,BAO_0000218,
486,,13618,Intermediate,10090.0,,1,Concentration required to stimulate glucose uptake in 3T3-L1 adipocytes after 48 hr incubation,620.0,,CHEMBL615509,,80006,Mus musculus,3T3-L1,,N,1,BAO_0000219,
487,,11902,Intermediate,10090.0,,1,Effect on GLUT 1 glucose transporter expression in 3T3-L1 adipocytes at dose of 0.3 uM,620.0,,CHEMBL615510,,80006,Mus musculus,3T3-L1,,N,1,BAO_0000219,
488,,11902,Intermediate,10090.0,,1,Effect on GLUT 1 glucose transporter expression in 3T3-L1 adipocytes at dose of 3 uM,620.0,,CHEMBL615511,,80006,Mus musculus,3T3-L1,,N,1,BAO_0000219,
489,,11902,Intermediate,10090.0,,1,Effect on GLUT 1 glucose transporter expression in 3T3-L1 adipocytes at dose of 30 uM,620.0,,CHEMBL615512,,80006,Mus musculus,3T3-L1,,N,1,BAO_0000219,
490,,14840,Intermediate,10090.0,,1,"In vitro ability to stimulate glucose transport in 3T3-L1 adipocytes, given at 100 mg/kg in mouse, after 24 hr",620.0,,CHEMBL615513,,80006,Mus musculus,3T3-L1,,N,1,BAO_0000218,
491,,14840,Intermediate,10090.0,,1,"In vitro ability to stimulate glucose transport in 3T3-L1 adipocytes, given at 100 mg/kg in mouse, after 3 hr",620.0,,CHEMBL615514,,80006,Mus musculus,3T3-L1,,N,1,BAO_0000218,
492,,13715,Intermediate,,,1,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes,620.0,,CHEMBL615515,,80006,,3T3-L1,,N,1,BAO_0000219,
493,,13715,Intermediate,,,1,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at concentration of 10 micro M,620.0,,CHEMBL615516,,80006,,3T3-L1,,N,1,BAO_0000219,
494,,13715,Intermediate,,,1,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at concentration of 3 micro M,620.0,,CHEMBL615517,,80006,,3T3-L1,,N,1,BAO_0000219,
495,,13715,Intermediate,,,1,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at concentration of 30 micro M,620.0,,CHEMBL615518,,80006,,3T3-L1,,N,1,BAO_0000219,
496,,13715,Intermediate,,,1,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at concentration of 3 micro M,620.0,,CHEMBL615519,,80006,,3T3-L1,,N,1,BAO_0000219,
497,,13715,Intermediate,,,1,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at 0.3 uM dose.,620.0,,CHEMBL615520,,80006,,3T3-L1,,N,1,BAO_0000218,
498,,13715,Intermediate,,,1,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at 0.5 uM dose.,620.0,,CHEMBL615521,,80006,,3T3-L1,,N,1,BAO_0000218,
499,,13715,Intermediate,,,1,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at 1 uM dose.,620.0,,CHEMBL615522,,80006,,3T3-L1,,N,1,BAO_0000218,
500,,13715,Intermediate,,,1,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at 10 uM dose.,620.0,,CHEMBL615523,,80006,,3T3-L1,,N,1,BAO_0000218,
501,,13715,Expert,,,1,In vitro measurements 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at 100 uM dose.,620.0,,CHEMBL615524,,80006,,3T3-L1,,N,1,BAO_0000218,
502,,13715,Expert,,,1,Acute effects in vitro by measuring 2-deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at 10 uM dose.,620.0,,CHEMBL615525,,80006,,3T3-L1,,N,1,BAO_0000218,
503,,13715,Intermediate,,,1,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at 1 uM dose.,620.0,,CHEMBL615526,,80006,,3T3-L1,,N,1,BAO_0000218,
504,,13715,Intermediate,,,1,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at 3 uM dose.,620.0,,CHEMBL615527,,80006,,3T3-L1,,N,1,BAO_0000218,
505,,13715,Intermediate,,,1,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at 300 uM dose.,620.0,,CHEMBL615528,,80006,,3T3-L1,,N,1,BAO_0000218,
506,,13715,Expert,,,1,Acute effects in vitro by measuring 2-deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at 30 uM dose.,620.0,,CHEMBL615529,,80006,,3T3-L1,,N,1,BAO_0000218,
507,,13715,Expert,,,1,In vitro by measurements of 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at 3 uM dose.,620.0,,CHEMBL615530,,80006,,3T3-L1,,N,1,BAO_0000218,
508,,13715,Expert,,,1,In vitro measurements of 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at 60 uM dose.,620.0,,CHEMBL615531,,80006,,3T3-L1,,N,1,BAO_0000218,
509,,13715,Intermediate,,,1,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at concentration of 10 micro M,620.0,,CHEMBL615532,,80006,,3T3-L1,,N,1,BAO_0000219,
510,,13715,Intermediate,,,1,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at concentration of 3 micro M,620.0,,CHEMBL615533,,80006,,3T3-L1,,N,1,BAO_0000219,
511,,13715,Intermediate,,,1,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at concentration of 30 micro M,620.0,,CHEMBL615534,,80006,,3T3-L1,,N,1,BAO_0000219,
512,,13715,Intermediate,,,1,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at 100 uM dose.,620.0,,CHEMBL615535,,80006,,3T3-L1,,N,1,BAO_0000218,
513,,13715,Intermediate,,,1,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at 10 uM dose.,620.0,,CHEMBL615536,,80006,,3T3-L1,,N,1,BAO_0000218,
514,,13715,Intermediate,,,1,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at 30 uM dose.,620.0,,CHEMBL615537,,80006,,3T3-L1,,N,1,BAO_0000218,
515,,13715,Intermediate,,,1,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at 3 uM dose.,620.0,,CHEMBL615538,,80006,,3T3-L1,,N,1,BAO_0000218,
516,,13715,Intermediate,,,1,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at 60 uM dose.,620.0,,CHEMBL836166,,80006,,3T3-L1,,N,1,BAO_0000218,
517,,6411,Expert,,,1,Inhibition of forskolin-stimulated lipolysis in differentiated 3T3-L1 cells,620.0,,CHEMBL615539,,11214,,3T3-L1,,H,8,BAO_0000219,
518,,6411,Intermediate,10090.0,,1,Evaluated for the inhibition of forskolin-stimulated lipolysis in differentiated 3T3-L1 cells; ND = No data,620.0,,CHEMBL615540,,80006,Mus musculus,3T3-L1,,N,1,BAO_0000219,
519,,6411,Expert,,,1,Evaluated for the inhibition of forskolin-stimulated lipolysis in differentiated 3T3-L1 cells; Na = Not active,620.0,,CHEMBL615541,,11214,,3T3-L1,,H,8,BAO_0000219,
520,,3966,Expert,10090.0,,1,Insulin-sensitizing activity; triglyceride accumulation from insulin regulated differentiation of 3T3-L1 cells at 1 uM expressed as percent activity of pioglitazone,620.0,,CHEMBL615542,,80006,Mus musculus,3T3-L1,,N,1,BAO_0000219,
521,,3966,Intermediate,10090.0,,1,Compound was tested for insulin-sensitizing activity by measuring triglyceride accumulation from insulin regulated differentiation of 3T3-L1 cells at 10 uM expressed as percent activity of pioglitazone,620.0,,CHEMBL615543,,80006,Mus musculus,3T3-L1,,N,1,BAO_0000219,
522,,15556,Expert,10090.0,,1,Stimulation of adipogenesis in 3T3-L1 cells is expressed as concentration equivalent to the [ 1-14C] uptake counts after treatment with 0.2 ug/mL troglitazone,620.0,,CHEMBL615544,,80006,Mus musculus,3T3-L1,,N,1,BAO_0000219,
523,,5845,Expert,10090.0,,1,Effective concentration for enhancement of insulin-induced triglyceride accumulation in 3T3-L1 cells,620.0,,CHEMBL615545,,80006,Mus musculus,3T3-L1,,N,1,BAO_0000219,
524,,14422,Expert,10090.0,,1,Effective concentration for 50% enhancement of insulin-induced triglyceride accumulation in 3T3-L1 cells,620.0,,CHEMBL615546,,80006,Mus musculus,3T3-L1,,N,1,BAO_0000219,
525,,5845,Expert,10090.0,,1,Percentage of rosiglitazone response for insulin-sensitizing activity at 1 uM concentration in 3T3-L1 cells,620.0,,CHEMBL615547,,80006,Mus musculus,3T3-L1,,N,1,BAO_0000219,
526,,14508,Expert,10090.0,,1,In vitro glucose transport activity in 3T3-LI adipocytes at 10 uM concentration.,620.0,,CHEMBL615548,,80006,Mus musculus,3T3-L1,,N,1,BAO_0000219,
527,,14508,Expert,10090.0,,1,In vitro glucose transport activity in 3T3-LI adipocytes at 3 uM concentration.,620.0,,CHEMBL615549,,80006,Mus musculus,3T3-L1,,N,1,BAO_0000219,
528,,14508,Expert,10090.0,,1,In vitro glucose transport activity in 3T3-LI adipocytes at 30 uM concentration.,620.0,,CHEMBL615550,,80006,Mus musculus,3T3-L1,,N,1,BAO_0000219,
529,,6349,Intermediate,10116.0,,1,Inhibitory activity against rat fibroblast (3Y1) cell line,1118.0,,CHEMBL615551,,80622,Rattus norvegicus,3Y1 cell line,,N,1,BAO_0000219,
530,,15899,Expert,10116.0,,1,Mean concentration causing inhibition of cell growth in 3Y1 cells.,1118.0,,CHEMBL615552,,80622,Rattus norvegicus,3Y1 cell line,,N,1,BAO_0000219,
531,,15899,Expert,10116.0,,1,Cytotoxicity in 3Y1 cells.,1118.0,,CHEMBL615553,,80622,Rattus norvegicus,3Y1 cell line,,N,1,BAO_0000219,
532,,15899,Expert,10116.0,,1,Cytostatic effect in 3Y1 cells.,1118.0,,CHEMBL615554,,80622,Rattus norvegicus,3Y1 cell line,,N,1,BAO_0000219,
533,,15899,Intermediate,10116.0,,1,"Mean averaged concentration for total growth inhibition, which signifies cytostatic effect",1118.0,,CHEMBL615555,,80622,Rattus norvegicus,3Y1 cell line,,N,1,BAO_0000219,
534,,17038,Expert,10116.0,,1,Concentration to inhibit growth of normal rat fibroblast cells (3Y1-B cells) after 72 h exposure,1118.0,,CHEMBL615556,,80622,Rattus norvegicus,3Y1 cell line,,N,1,BAO_0000219,
535,,12421,Autocuration,,,1,In vitro inhibitory activity against human adrenal 3-beta hydroxy-delta 5-teroid isomerase,,,CHEMBL615557,,22226,,,,U,0,BAO_0000019,
536,,12947,Autocuration,,,1,Inhibition of recombinant human adrenal 3-beta-hydroxy-delta-5-steroid dehydrogenase,,,CHEMBL615558,,22226,,,,U,0,BAO_0000019,
537,,12947,Autocuration,,,1,Inhibition of recombinant rat adrenal 3-beta-hydroxy-delta-5-steroid dehydrogenase,,,CHEMBL872066,,22226,,,,U,0,BAO_0000019,
538,,4896,Expert,9823.0,,1,In vitro inhibition against of 4-Hydroxyphenylpyruvate dioxygenase (4-HPPD) from pig liver by the enol borate method,,,CHEMBL615559,,11607,Sus scrofa,,,D,9,BAO_0000019,
539,,6148,Autocuration,,,1,In vitro inhibitory concentration required against 4-hydroxyphenylpyruvate dioxygenase (4-HPPD) taken from pig liver,,,CHEMBL615560,,11607,,,,H,8,BAO_0000019,
540,,16432,Autocuration,,,1,Inhibition of pig liver 4-Hydroxyphenylpyruvate dioxygenase (4-HPPD) enzyme,,,CHEMBL615561,,11607,,,,H,8,BAO_0000019,
541,,4978,Expert,,,1,Concentration required to achieve 50% inhibition against 4-Hydroxyphenylpyruvate dioxygenase (HPPD) from pig liver,,,CHEMBL857062,,11607,,,,H,8,BAO_0000019,
542,,4978,Expert,,,1,Concentration required to achieve 50% inhibition against 4-Hydroxyphenylpyruvate dioxygenase (HPPD) from pig liver; (observed value),,,CHEMBL615562,,11607,,,,H,8,BAO_0000019,
543,,3723,Autocuration,,,1,In vitro inhibitory activity against HPPD(4-hydroxyphenylpyruvate Dioxygenase) from pig liver using enol borate assay method,,,CHEMBL615563,,11607,,,,H,8,BAO_0000019,
544,,3518,Autocuration,,,1,Compound was evaluated for complete competitive inhibition of 4-hydroxyphenylpyruvate dioxygenase (HPPD),,,CHEMBL615564,,11607,,,,H,8,BAO_0000357,
545,,4164,Autocuration,,,1,In vitro inhibition of 4-hydroxyphenylpyruvate dioxygenase obtained from purified pig liver by enol-borate method,,,CHEMBL615565,,11607,,,,H,8,BAO_0000019,
546,,3518,Autocuration,,,1,Inhibitory activity on pig liver 4-hydroxyphenylpyruvate dioxygenase (HPPD) was evaluated,,,CHEMBL615566,,11607,,,,H,8,BAO_0000019,
547,,4164,Expert,9823.0,,1,Inhibition of 4-hydroxyphenylpyruvate dioxygenase of purified pig liver by enol-borate method,,,CHEMBL615567,,11607,Sus scrofa,,,D,9,BAO_0000019,
548,,3518,Autocuration,,,1,The inhibitory activity on pig liver 4-hydroxyphenylpyruvate dioxygenase (HPPD) was evaluated.,,,CHEMBL615568,,11607,,,,H,8,BAO_0000019,
549,,3518,Autocuration,,,1,Compound was evaluated for competitive inhibition of 4-hydroxyphenylpyruvate dioxygenase (HPPD) (complete inhibition was observed at a concentration of 0.5-1.0 mM),,,CHEMBL615569,,11607,,,,H,8,BAO_0000357,
550,,4978,Autocuration,,,1,Concentration required to achieve 50% inhibition against 4-hydroxyphenylpyruvate dioxygenase from pig liver,,,CHEMBL615570,,11607,,,,H,8,BAO_0000019,
551,,4978,Autocuration,,,1,Concentration required to achieve 50% inhibition against 4-hydroxyphenylpyruvate dioxygenase from pig liver; (observed value),,,CHEMBL615571,,11607,,,,H,8,BAO_0000019,
552,,6455,Autocuration,,,1,Binding affinity against melatonin (MT1) receptor (pC1),,,CHEMBL615572,,104733,,,,H,4,BAO_0000224,
553,,2222,Autocuration,,,1,Compound was tested for inhibitory activity against 5-hydroxytryptamine 1 receptor,,,CHEMBL615573,,22226,,,,U,0,BAO_0000019,
554,,13020,Autocuration,,,1,Inhibition of [3H]- 5-HT binding to 5-hydroxytryptamine 1 receptor at 10e-5 M,,,CHEMBL615574,,22226,,,,U,0,BAO_0000019,
555,,13021,Autocuration,,,1,Inhibition of [3H]5-HT binding to 5-hydroxytryptamine 1 receptor of central nervous system,,,CHEMBL615575,,22226,,,,U,0,BAO_0000019,
556,,14532,Autocuration,,,1,Inhibitory activity against 5-hydroxytryptamine 1 receptor using [3H]5-HT as radioligand at 10e-5 M concentration,,,CHEMBL615576,,10619,,,,H,8,BAO_0000357,
557,,14118,Autocuration,,,1,Binding affinity against 5-hydroxytryptamine 1 receptor using [3H]5-HT as radioligand,,,CHEMBL615577,,10619,,,,H,8,BAO_0000357,
558,,11884,Autocuration,,,1,Binding affinity at 5-hydroxytryptamine 1A receptor in bovine hippocampal preparation using [3H]8-OH-DPAT,,,CHEMBL615578,,51,,,,H,8,BAO_0000221,10000000.0
559,,13969,Expert,,,1,Binding affinity against 5-hydroxytryptamine 1A receptor was measured using [3H]8-OH-DPAT as radioligand,,,CHEMBL615579,,51,,,,H,8,BAO_0000357,
560,,13392,Expert,,,1,Binding affinity for 5-hydroxytryptamine 1A receptor,,,CHEMBL615580,,51,,,,H,8,BAO_0000357,
561,,14430,Expert,,,1,Affinity towards 5-hydroxytryptamine 1A receptor in membranes from bovine hippocampus using [3H]OH-DPAT,,,CHEMBL615581,,51,,,,H,8,BAO_0000019,
562,,12248,Autocuration,,,1,Compound was evaluated for the binding affinity against [3H]8-OH-DPAT-labeled 5-hydroxytryptamine 1A receptor sites in bovine hippocampus,,,CHEMBL615582,,51,,,,H,8,BAO_0000221,10000000.0
563,,12249,Autocuration,,,1,Compound was evaluated for the binding affinity against [3H]8-OH-DPAT-labeled 5-hydroxytryptamine 1A receptor sites in bovine hippocampus,,,CHEMBL615583,,51,,,,H,8,BAO_0000221,10000000.0
564,,9995,Autocuration,,,1,In vitro inhibition of [3H]5-HT (2 nM) binding to 5-HT1A receptor from bovine hippocampus,,,CHEMBL615584,,51,,,,H,8,BAO_0000221,10000000.0
565,,9995,Autocuration,,,1,In vitro inhibition of [3H]5-HT (2 nM) binding to 5-hydroxytryptamine 1A receptor from bovine hippocampus,,,CHEMBL833691,,51,,,,H,8,BAO_0000221,10000000.0
566,,9995,Autocuration,,,1,In vitro inhibition of azido-[125I]-IPAPP (0.25 nM) binding to 5-HT1A receptor from bovine hippocampus,,,CHEMBL615585,,51,,,,H,8,BAO_0000221,10000000.0
567,,9995,Autocuration,,,1,In vitro inhibition of [125I]IPAPP (0.25 nM) binding to 5-HT1A receptor from bovine hippocampus,,,CHEMBL615586,,51,,,,H,8,BAO_0000221,10000000.0
568,,9995,Autocuration,,,1,In vitro inhibition of [125I]IPAPP (2.5 nM) binding to 5-hydroxytryptamine 1A receptor from bovine hippocampus,,,CHEMBL884524,,51,,,,H,8,BAO_0000221,10000000.0
569,,12249,Autocuration,,,1,Inhibitory concentration against [3H]8-OH-DPAT-labeled 5-hydroxytryptamine 1A receptor sites in bovine hippocampus,,,CHEMBL615587,,51,,,,H,8,BAO_0000221,10000000.0
570,,11799,Autocuration,,,1,"Compound was tested for binding affinity against 5-hydroxytryptamine 1A receptor from bovine hippocampus, used [3H]8-OH-DPAT as radioligand",,,CHEMBL615588,,51,,,,H,8,BAO_0000221,10000000.0
571,,14331,Expert,10116.0,,1,Displacement of [3H]8-OH-DPAT from 5-hydroxytryptamine 1A receptor of rat hippocampal membranes,,,CHEMBL615589,Membranes,10576,Rattus norvegicus,,,D,9,BAO_0000249,
572,,11884,Expert,9913.0,,1,Displacement of [3H]8-OH-DPAT from 5-hydroxytryptamine 1A receptor of bovine hippocampus.,,,CHEMBL615442,,51,Bos taurus,,,H,8,BAO_0000221,10000000.0
573,,14331,Autocuration,,,1,Binding affinity of compound towards 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT (0.5 nM) ligand in hippocampus + frontal bovine was determined,,,CHEMBL615443,,51,,,,H,8,BAO_0000221,10000000.0
574,,11701,Autocuration,,,1,Compound was evaluated for its ability to displace [3H]DPAT from 5-HT1A receptor in homogenates of bovine hippocampus,,,CHEMBL615444,,51,,,,H,8,BAO_0000221,10000000.0
575,,11701,Expert,,,1,Ability to displace [3H]-DPAT from 5-hydroxytryptamine 1A receptor in homogenates of bovine hippocampus.,,,CHEMBL615445,,51,,,,H,8,BAO_0000221,10000000.0
576,,12248,Autocuration,,,1,Compound was evaluated for the binding affinity against [3H]8-OH-DPAT-labeled 5-hydroxytryptamine 1A receptor in bovine hippocampus,,,CHEMBL615446,,51,,,,H,8,BAO_0000221,10000000.0
577,,12248,Autocuration,,,1,Compound was evaluated for the binding affinity against [3H]8-OH-DPAT-labeled 5-hydroxytryptamine 1A receptor sites in CHO cells,449.0,,CHEMBL615447,,51,,CHO,,H,8,BAO_0000219,
578,,12248,Expert,,,1,Binding affinity against [3H]8-OH-DPAT-labeled 5-hydroxytryptamine 1A receptor sites in bovine hippocampus,,,CHEMBL615448,,51,,,,H,8,BAO_0000221,10000000.0
579,,12249,Expert,,,1,Binding affinity against [3H]8-OH-DPAT-labeled 5-hydroxytryptamine 1A receptor sites in bovine hippocampus,,,CHEMBL615449,,51,,,,H,8,BAO_0000221,10000000.0
580,,12248,Autocuration,,,1,Compound was evaluated for the binding affinity against [3H]8-OH-DPAT-labeled 5-hydroxytryptamine 1A receptor sites in cloned CHO cells,449.0,,CHEMBL615450,,51,,CHO,,H,8,BAO_0000219,
581,,11799,Expert,,,1,"Binding affinity against 5-hydroxytryptamine 1A receptor from bovine hippocampus, used [3H]8-OH-DPAT as radioligand",,,CHEMBL615451,,51,,,,H,8,BAO_0000221,10000000.0
582,,634,Autocuration,,,1,Compound was tested for its binding affinity against 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT radioligand,,,CHEMBL615452,,51,,,,H,8,BAO_0000357,
583,,9995,Autocuration,,,1,In vitro inhibition of [3H]5-HT (2 nM) binding to 5-HT1A receptor from bovine hippocampus,,,CHEMBL615453,,51,,,,H,8,BAO_0000221,10000000.0
584,,9995,Autocuration,,,1,In vitro inhibition of [3H]5-HT (2 nM) binding to 5-hydroxytryptamine 1A receptor from bovine hippocampus,,,CHEMBL615454,,51,,,,H,8,BAO_0000221,10000000.0
585,,9995,Autocuration,,,1,In vitro inhibition of [3H]DPAT (1 nM) binding to 5-HT1A receptor from bovine hippocampus,,,CHEMBL615455,,51,,,,H,8,BAO_0000221,10000000.0
586,,9995,Autocuration,,,1,In vitro inhibition of [3H]DPAT (1 nM) binding to 5-hydroxytryptamine 1A receptor from bovine hippocampus,,,CHEMBL615456,,51,,,,H,8,BAO_0000221,10000000.0
587,,9995,Autocuration,,,1,In vitro inhibition of [3H]DPAT (1 nM) binding to 5-HT1A receptor from bovine hippocampus,,,CHEMBL615457,,51,,,,H,8,BAO_0000221,10000000.0
588,,12210,Expert,,,1,In vivo binding affinity towards [3H]8-OH-DPAT-labeled 5-hydroxytryptamine 1A receptor sites in bovine hippocampus.,,,CHEMBL615458,,51,,,,H,8,BAO_0000218,10000000.0
589,,13311,Expert,,,1,Tested for activity against 5-hydroxytryptamine 1A receptor from bovine hippocampus,,,CHEMBL615459,,51,,,,H,8,BAO_0000221,10000000.0
590,,2331,Expert,9606.0,,1,"Tested in vitro for the inhibition of [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor, expressed in cloned CHO cells.",449.0,,CHEMBL615460,,51,Homo sapiens,CHO,,D,9,BAO_0000219,
591,,1375,Autocuration,10141.0,,1,Compound was tested for the inhibition of forskolin-stimulated adenylate cyclase at 5-hydroxytryptamine 1A receptor in guinea pig,,,CHEMBL615461,,51,Cavia porcellus,,,H,8,BAO_0000019,
592,,1375,Autocuration,10141.0,,1,Compound was tested for the inhibition of forskolin-stimulated adenylate cyclase at 5-hydroxytryptamine 1A receptor in guinea pig; NT means not tested,,,CHEMBL615462,,51,Cavia porcellus,,,H,8,BAO_0000019,
593,,11574,Autocuration,10141.0,,1,Effect on forskolin stimulated adenylate cyclase activity at 5-hydroxytryptamine 1A receptor of guinea pig hippocampus.,,,CHEMBL615463,,51,Cavia porcellus,,,H,8,BAO_0000221,10000000.0
594,,12867,Autocuration,10141.0,,1,Ability to antagonize Acetylcholine induced contractile responses in Guinea pig ileum for 5-HT1A receptor.,,,CHEMBL615464,,51,Cavia porcellus,,,H,8,BAO_0000221,2116.0
595,,12867,Autocuration,10141.0,,1,Ability to antagonize Acetylcholine induced contractile responses in Guinea pig ileum for 5-HT1A receptor. Inactive at dose level of 1.0 uM,,,CHEMBL615465,,51,Cavia porcellus,,,H,8,BAO_0000221,2116.0
596,,12867,Autocuration,10141.0,,1,Ability to antagonize electrical induced contractile responses in Guinea pig ileum for 5-HT1A receptor.,,,CHEMBL615466,,51,Cavia porcellus,,,H,8,BAO_0000221,2116.0
597,,12867,Autocuration,10141.0,,1,Ability to antagonize electrical induced contractile responses in Guinea pig ileum for 5-HT1A receptor. Inactive at dose level of 1.0 uM,,,CHEMBL615467,,51,Cavia porcellus,,,H,8,BAO_0000221,2116.0
598,,12867,Autocuration,10141.0,,1,Ability to antagonize electrical induced contractile responses in Guinea pig ileum for 5-HT1A receptor. Inactive at dose level of 1.0 uM,,,CHEMBL615468,,51,Cavia porcellus,,,H,8,BAO_0000221,2116.0
599,,12867,Autocuration,10141.0,,1,Ability to antagonize electrical induced contractile responses in Guinea pig ileum for 5-HT1A receptor; Inactive at dose level of 1.0 uM,,,CHEMBL615469,,51,Cavia porcellus,,,H,8,BAO_0000221,2116.0
600,,11574,Autocuration,10141.0,,1,Binding affinity against 5-hydroxytryptamine 1A receptor,,,CHEMBL615470,,51,Cavia porcellus,,,H,8,BAO_0000357,
601,,13114,Autocuration,10141.0,,1,Compound is evaluated for in vitro receptor binding affinity against 5-hydroxytryptamine 1A receptor,,,CHEMBL615471,,51,Cavia porcellus,,,H,8,BAO_0000357,
602,,13181,Autocuration,10141.0,,1,Binding affinity was determined against 5-hydroxytryptamine 1A receptor,,,CHEMBL615472,,51,Cavia porcellus,,,H,8,BAO_0000357,
603,,10639,Autocuration,10141.0,,1,Inhibition of Forskolin-stimulated adenylate cyclase activity against 5-hydroxytryptamine 1A receptor of guinea pig hippocampus,,,CHEMBL883242,,106,Cavia porcellus,,,H,8,BAO_0000221,10000000.0
604,,10639,Autocuration,10141.0,,1,Inhibition of Forskolin-stimulated adenylate cyclase activity against 5-hydroxytryptamine 1A receptor of guinea pig hippocampus,,,CHEMBL615473,,106,Cavia porcellus,,,H,8,BAO_0000221,10000000.0
605,,11883,Autocuration,10029.0,,1,In vitro binding affinity against 5-hydroxytryptamine 1A receptor using [3H]-8-OH-DPAT as radioligand in CHO cells (sc),449.0,,CHEMBL615474,,11863,Cricetulus griseus,CHO,,H,8,BAO_0000218,
606,,17785,Autocuration,,,1,Fraction involved in salt bridge interactions with Asp3:11 part of the 5-hydroxytryptamine 1A receptor,,,CHEMBL615475,,51,,,,H,8,BAO_0000357,
607,,1558,Autocuration,,,1,Compound was tested for its ability to inhibit forskolin-stimulated activity of adenylate cyclase coupled to human 5-HT 1A receptor in HeLa cells; value ranges from 85-370,308.0,,CHEMBL615476,,51,,HeLa,,H,8,BAO_0000219,
608,,1558,Autocuration,,,1,Compound was tested for its ability to inhibit forskolin-stimulated activity of adenylate cyclase coupled to human 5-hydroxytryptamine 1A receptor in HeLa cells; value ranges from 95-320,308.0,,CHEMBL615477,,51,,HeLa,,H,8,BAO_0000219,
609,,15740,Autocuration,,,1,EC50 for inhibition of 50 uM forskolin-stimulated cAMP accumulation against 5-hydroxytryptamine 1A receptor,,,CHEMBL615478,,51,,,,H,8,BAO_0000019,
610,,17624,Autocuration,,,1,Effective concentration against binding of radioligand [35S]GTP-gamma-S in CHO cells expressing human 5-hydroxytryptamine 1A receptor,449.0,,CHEMBL615160,,51,,CHO,,H,8,BAO_0000219,
611,,17624,Expert,,,1,Effective concentration against binding of radioligand [35S]GTP-gamma-S in CHO cells expressing human 5-hydroxytryptamine 1A receptor,449.0,,CHEMBL615161,,51,,CHO,,H,8,BAO_0000219,
612,,17624,Autocuration,,,1,Effective concentration against binding of radioligand [35S]GTP-gamma-S in CHO cells expressing human 5-hydroxytryptamine 1A receptor; nd=Not determined,449.0,,CHEMBL615162,,51,,CHO,,H,8,BAO_0000219,
613,,17624,Autocuration,,,1,Effective concentration against binding of radioligand [35S]GTP-gamma-S in CHO cells expressing human 5-hydroxytryptamine 1A receptor; nd=not determined,449.0,,CHEMBL615163,,51,,CHO,,H,8,BAO_0000219,
614,,17624,Expert,,,1,Effective concentration against human 5-hydroxytryptamine 1A receptor using cAMP as radioligand in CHO cells,449.0,,CHEMBL615164,,51,,CHO,,H,8,BAO_0000219,
615,,17624,Expert,,,1,Effective concentration against human 5-hydroxytryptamine 1A receptor using cAMP as radioligand in CHO cells,449.0,,CHEMBL615165,,51,,CHO,,H,8,BAO_0000219,
616,,17624,Autocuration,,,1,Effective concentration against human 5-hydroxytryptamine 1A receptor using cAMP as radioligand in CHO cells; nd=not determined,449.0,,CHEMBL615166,,51,,CHO,,H,8,BAO_0000219,
617,,14256,Autocuration,,,1,In vitro potency at human 5-hydroxytryptamine 1A receptor in inhibiting forskolin-stimulated accumulation of intracellular cAMP,,,CHEMBL615167,,51,,,,H,8,BAO_0000219,
618,,3445,Expert,9606.0,,1,Stimulation of [35S]- GIPyS binding to cloned human 5-hydroxytryptamine 1A receptor stably expressed in HeLa cells,308.0,,CHEMBL615168,,51,Homo sapiens,HeLa,,D,9,BAO_0000219,
619,,3445,Expert,9606.0,,1,Stimulation of [35S]- GIPyS binding to cloned human 5-hydroxytryptamine 1A receptor stably expressed in HeLa cells; Inverse,308.0,,CHEMBL615169,,51,Homo sapiens,HeLa,,D,9,BAO_0000219,
620,,17200,Expert,9606.0,,1,Tested for functional response on CHO cells expressing cloned human 5-hydroxytryptamine 1A receptor,449.0,,CHEMBL615170,,51,Homo sapiens,CHO,,D,9,BAO_0000219,
621,,17200,Expert,9606.0,,1,Tested for functional response on CHO cells expressing cloned human 5-hydroxytryptamine 1A receptor; Not determined,449.0,,CHEMBL615171,,51,Homo sapiens,CHO,,D,9,BAO_0000219,
622,,15180,Autocuration,,,1,Eudisimic ratio(ER) is the antilog of the defference between the pKb and pD2 values against 5-hydroxytryptamine 1A receptor,,,CHEMBL615694,,51,,,,H,8,BAO_0000019,
623,,15180,Autocuration,,,1,Eudisimic ratio(ER) is the antilog of the difference between the pKb and pD2 values against 5-hydroxytryptamine 1A receptor,,,CHEMBL615695,,51,,,,H,8,BAO_0000019,
624,,16026,Autocuration,,,1,"Percent of maximum effect on binding of [35S]GTP-gamma-S, to HeLa cell membranes expressing the human 5-hydroxytryptamine 1A receptor",,,CHEMBL615696,,51,,,,H,8,BAO_0000019,
625,,2759,Autocuration,,,1,Agonistic efficacy was evaluated by adenylyl cyclase assay in CHO cells stably expressing the human 5-HT1A receptor,449.0,,CHEMBL615697,,51,,CHO,,H,8,BAO_0000219,
626,,2759,Expert,9606.0,,1,Agonistic efficacy as adenylyl cyclase assay in CHO cells expressing human 5-HT1A receptor (experiment 1),449.0,,CHEMBL859410,,51,Homo sapiens,CHO,,D,9,BAO_0000219,
627,,2759,Autocuration,,,1,Agonistic efficacy was evaluated by adenylyl cyclase assay in CHO cells stably expressing the human 5-HT1A receptor (experiment 2),449.0,,CHEMBL615841,,51,,CHO,,H,8,BAO_0000219,
628,,2759,Expert,9606.0,,1,Agonistic efficacy in adenylyl cyclase assay in CHO cells expressing human 5-HT1A receptor (experiment 2),449.0,,CHEMBL615842,,51,Homo sapiens,CHO,,D,9,BAO_0000219,
629,,2759,Autocuration,,,1,Antagonistic efficacy was evaluated by adenylyl cyclase assay in CHO cells stably expressing the human 5-HT1A receptor,449.0,,CHEMBL835003,,51,,CHO,,H,8,BAO_0000219,
630,,2759,Autocuration,,,1,Antagonistic efficacy was evaluated by adenylyl cyclase assay in CHO cells stably expressing the human 5-HT1A receptor (experiment 1),449.0,,CHEMBL615843,,51,,CHO,,H,8,BAO_0000219,
631,,2759,Expert,9606.0,,1,Antagonistic efficacy as adenylyl cyclase assay in CHO cells expressing human 5-HT1A receptor (experiment 1),449.0,,CHEMBL615979,,51,Homo sapiens,CHO,,D,9,BAO_0000219,
632,,2759,Autocuration,,,1,Antagonistic efficacy was evaluated by adenylyl cyclase assay in CHO cells stably expressing the human 5-HT1A receptor (experiment 2),449.0,,CHEMBL615980,,51,,CHO,,H,8,BAO_0000219,
633,,2759,Expert,9606.0,,1,Antagonistic efficacy as adenylyl cyclase assay in CHO cells expressing human 5-HT1A receptor (experiment 2),449.0,,CHEMBL615981,,51,Homo sapiens,CHO,,D,9,BAO_0000219,
634,,3445,Expert,9606.0,,1,Percent efficacy against cloned human 5-hydroxytryptamine 1A receptor normalized to the maximal 5-HT response,,,CHEMBL615982,,51,Homo sapiens,,,D,9,BAO_0000019,
635,,5272,Expert,9606.0,,1,"Agonist activity at the 5-hydroxytryptamine 1A receptor was determined in vitro using a [35S]GTP-gamma-S,",,,CHEMBL615983,,51,Homo sapiens,,,D,9,BAO_0000019,
636,,5272,Expert,9606.0,,1,"Agonist activity at the 5-hydroxytryptamine 1A receptor in vitro using a [35S]GTP-gamma-S, No data",,,CHEMBL615984,,51,Homo sapiens,,,D,9,BAO_0000019,
637,,5272,Expert,9606.0,,1,"Agonist activity at the 5-hydroxytryptamine 1A receptor determined in vitro using a [35S]GTP-gamma-S,",,,CHEMBL615985,,51,Homo sapiens,,,D,9,BAO_0000019,
638,,17624,Autocuration,,,1,Agonistic effect against 5-HT1A receptor using cAMP as radioligand relative to 5-HT in inhibiting forskolin-stimulated adenylate cyclase activity in CHO cells,449.0,,CHEMBL615986,,51,,CHO,,H,8,BAO_0000219,
639,,17624,Autocuration,,,1,Agonistic effect against 5-hydroxytryptamine 1A receptor using cAMP as radioligand relative to 5-HT in inhibiting forskolin-stimulated adenylate cyclase activity in CHO cells,449.0,,CHEMBL615987,,51,,CHO,,H,8,BAO_0000219,
640,,17624,Autocuration,,,1,Agonistic effect against 5-hydroxytryptamine 1A receptor using cAMP as radioligand relative to 5-HT in inhibiting forskolin-stimulated adenylate cyclase activity in CHO cells; nd=Not determined,449.0,,CHEMBL615988,,51,,CHO,,H,8,BAO_0000219,
641,,17624,Expert,,,1,Agonistic effect against 5-hydroxytryptamine 1A receptor using cAMP as radioligand relative to 5-HT in inhibiting forskolin-stimulated adenylate cyclase activity in CHO cells,449.0,,CHEMBL615989,,51,,CHO,,H,8,BAO_0000219,
642,,17624,Autocuration,,,1,Agonistic effect against 5-hydroxytryptamine 1A receptor using cAMP as radioligand relative to 5-HT in inhibiting forskolin-stimulated adenylate cyclase activity in CHO cells; nd=Not determined,449.0,,CHEMBL615990,,51,,CHO,,H,8,BAO_0000219,
643,,17624,Autocuration,,,1,Agonistic effect against 5-hydroxytryptamine 1A receptor using cAMP as radioligand relative to 5-HT in inhibiting forskolin-stimulated adenylate cyclase activity in CHO cells; nd=not determined,449.0,,CHEMBL615991,,51,,CHO,,H,8,BAO_0000219,
644,,17624,Autocuration,,,1,Agonistic effect against 5-HT 1A receptor using [35S]GTP-gamma-S as radioligand in CHO cells relative to 5-HT,449.0,,CHEMBL615992,,51,,CHO,,H,8,BAO_0000219,
645,,17624,Autocuration,,,1,Agonistic effect against 5-HT 1A receptor using [35S]GTP-gamma-S as radioligand in CHO cells relative to 5-HT; nd=Not determined,449.0,,CHEMBL615993,,51,,CHO,,H,8,BAO_0000219,
646,,17624,Expert,,,1,Agonistic effect against 5-hydroxytryptamine 1A receptor using [35S]GTP-gamma-S as radioligand in CHO cells relative to 5-HT,449.0,,CHEMBL615994,,51,,CHO,,H,8,BAO_0000219,
647,,17624,Autocuration,,,1,Agonistic effect against 5-hydroxytryptamine 1A receptor using [35S]GTP-gamma-S as radioligand in CHO cells relative to 5-HT; nd=not determined,449.0,,CHEMBL615995,,51,,CHO,,H,8,BAO_0000219,
648,,17624,Autocuration,,,1,Agonistic effect against 5-hydroxytryptamine 1A receptor using [35S]GTP-gamma-S as radioligand in CHO cells relative to 5-HT,449.0,,CHEMBL615996,,51,,CHO,,H,8,BAO_0000219,
649,,17624,Autocuration,,,1,Agonistic effect against 5-hydroxytryptamine 1A receptor using [35]GTPgammaS as radioligand in CHO cells relative to 5-HT; nd=Not determined,449.0,,CHEMBL615997,,51,,CHO,,H,8,BAO_0000219,
650,,6563,Autocuration,,,1,"Agonistic activity of compound towards 5-hydroxytryptamine 1A receptor was evaluated by [35S]GTP-gamma-S, stimulated cAMP assay",,,CHEMBL615998,,51,,,,H,8,BAO_0000019,
651,,6563,Autocuration,,,1,"Agonistic activity of compound towards 5-hydroxytryptamine 1A receptor was evaluated by [35S]GTP-gamma-S, stimulated cAMP assay",,,CHEMBL615999,,51,,,,H,8,BAO_0000019,
652,,6563,Autocuration,,,1,Agonistic activity of compound towards 5-hydroxytryptamine 1A receptor was evaluated by forskolin stimulated cAMP assay,,,CHEMBL616000,,51,,,,H,8,BAO_0000019,
653,,17296,Autocuration,,,1,Binding affinity against human 5-hydroxytryptamine 1A receptors HEK 293 cell membranes using [35S]GTP gamma-S,722.0,,CHEMBL616001,,51,,HEK293,,H,8,BAO_0000219,
654,,6876,Expert,9606.0,,1,"Evaluated for stimulation at 1 uM concentration expressed as percent of the maximal [35S]GTP-gamma-S, binding induced by 5-hydroxytryptamine",,,CHEMBL616002,,51,Homo sapiens,,,D,9,BAO_0000019,
655,,6876,Expert,,,1,"Stimulation of percent maximal [35S]GTP-gamma-S, binding induced by 5-hydroxytryptamine at 1 uM; nd = not determined",,,CHEMBL616003,,51,,,,H,8,BAO_0000019,
656,,5272,Expert,9606.0,,1,In vitro agonist activity at the 5-hydroxytryptamine 1A receptor,,,CHEMBL616004,,51,Homo sapiens,,,D,9,BAO_0000019,
657,,5272,Expert,9606.0,,1,In vitro agonist activity at the 5-hydroxytryptamine 1A receptor; No data,,,CHEMBL616005,,51,Homo sapiens,,,D,9,BAO_0000019,
658,,5548,Autocuration,,,1,"Maximal response as a result of 5-HT1A receptor-mediated stimulation of [35S]GTP-gamma-S, binding; Not determined",,,CHEMBL616006,,51,,,,H,8,BAO_0000019,
659,,5548,Expert,,,1,"Maximal response as a result of 5-hydroxytryptamine 1A receptor-mediated stimulation of [35S]GTP-gamma-S, binding",,,CHEMBL616007,,51,,,,H,8,BAO_0000019,
660,,5548,Autocuration,,,1,"Maximal response as a result of 5-hydroxytryptamine 1A receptor-mediated stimulation of [35S]GTP-gamma-S, binding; Not determined",,,CHEMBL616008,,51,,,,H,8,BAO_0000019,
661,,5548,Autocuration,,,1,"Maximal response as a result of 5-hydroxytryptamine 1A receptor-mediated stimulation of [35S]GTP-gamma-S, binding; Not determined",,,CHEMBL616009,,51,,,,H,8,BAO_0000019,
662,,5929,Expert,,,1,"Maximal stimulation of expressed human 5-hydroxytryptamine 1A receptor assayed by [35S]GTP-gamma-S, binding",,,CHEMBL616010,,51,,,,H,8,BAO_0000019,
663,,5929,Expert,9606.0,,1,"Maximal response towards 5-hydroxytryptamine 1A receptor in human using [35S]GTP-gamma-S, as radioligand; ND means not determined",,,CHEMBL616011,,51,Homo sapiens,,,D,9,BAO_0000019,
664,,5929,Expert,9606.0,,1,"Maximal response towards 5-hydroxytryptamine 1A receptor in human using [35S]GTP-gamma-S, as radioligand; ND=Not determined",,,CHEMBL615740,,51,Homo sapiens,,,D,9,BAO_0000019,
665,,16245,Autocuration,,,1,"Maximal stimulation was expressed as percentage of the maximal 5-HT response in the [35S]GTP-gamma-S, binding assay on 5-hydroxytryptamine 1A receptor",,,CHEMBL615741,,51,,,,H,8,BAO_0000019,
666,,5640,Expert,,,1,"Inhibition of 5-HT induced [35S]GTP-gamma-S, binding at human cloned 5-HT 1A receptors.",,,CHEMBL615742,,51,,,,H,8,BAO_0000019,
667,,5640,Autocuration,,,1,"5-hydroxytryptamine 1A receptor antagonism was evaluated by the ability to inhibit [35S]GTP-gamma-S, binding that was induced by 5-HT; Emin (%): not determined",,,CHEMBL615743,,51,,,,H,8,BAO_0000019,
668,,14509,Autocuration,,,1,Antagonist activity was measured against CHO cells expressing the human 5-hydroxytryptamine 1A receptor in a forskolin stimulated adenylate cyclase (FSC) assay,449.0,,CHEMBL615744,,51,,CHO,,H,8,BAO_0000219,
669,,14509,Expert,,,1,Antagonist activity against CHO cells expressing the human 5-hydroxytryptamine 1A receptor in a forskolin stimulated adenylate cyclase (FSC) assay.,449.0,,CHEMBL615745,,51,,CHO,,H,8,BAO_0000219,
670,,15331,Autocuration,,,1,Affinity of compound towards 5-hydroxytryptamine 1A receptor was evaluated using radioligand binding technique,,,CHEMBL615746,,51,,,,H,8,BAO_0000357,
671,,15331,Autocuration,,,1,Affinity of compound towards 5-hydroxytryptamine 1A receptor was evaluated using radioligand binding technique,,,CHEMBL615747,,51,,,,H,8,BAO_0000357,
672,,6563,Autocuration,,,1,"Agonistic activity of compound towards 5-hydroxytryptamine 1A receptor was evaluated by [35S]GTP-gamma-S, stimulated cAMP assay",,,CHEMBL615748,,51,,,,H,8,BAO_0000019,
673,,6563,Autocuration,,,1,"Agonistic activity of compound towards 5-hydroxytryptamine 1A receptor was evaluated by [35S]GTP-gamma-S, stimulated cAMP assay; NA indicates not available",,,CHEMBL615749,,51,,,,H,8,BAO_0000019,
674,,6563,Autocuration,,,1,Agonistic activity of compound towards 5-hydroxytryptamine 1A receptor was evaluated by forskolin stimulated cAMP assay,,,CHEMBL615750,,51,,,,H,8,BAO_0000019,
675,,6563,Expert,9606.0,,1,Forskolin stimulated cAMP assessment of agonist activity for 5-hydroxytryptamine 1A receptor,,,CHEMBL616259,,51,Homo sapiens,,,D,9,BAO_0000019,
676,,6563,Autocuration,,,1,"Agonistic activity of compound towards 5-hydroxytryptamine 1A receptor was evaluated by [35S]GTP-gamma-S, stimulated cAMP assay",,,CHEMBL616260,,51,,,,H,8,BAO_0000019,
677,,5272,Expert,9606.0,,1,Antagonism of 5-hydroxytryptamine 1A receptor determined in vitro,,,CHEMBL616261,,51,Homo sapiens,,,D,9,BAO_0000019,
678,,5272,Expert,9606.0,,1,"Antagonism of 5-hydroxytryptamine 1A receptor was determined in vitro using a [35S]GTP-gamma-S,",,,CHEMBL616262,,51,Homo sapiens,,,D,9,BAO_0000019,
679,,5272,Expert,9606.0,,1,"Antagonism at the 5-hydroxytryptamine 1A receptor determined in vitro using a [35S]GTP-gamma-S, No data",,,CHEMBL616263,,51,Homo sapiens,,,D,9,BAO_0000019,
680,,5272,Expert,9606.0,,1,Antagonism at the 5-hydroxytryptamine 1A receptor was determined in vitro; No data,,,CHEMBL616264,,51,Homo sapiens,,,D,9,BAO_0000019,
681,,5272,Expert,9606.0,,1,Antagonism at the 5-hydroxytryptamine 1A receptor in vitro,,,CHEMBL616265,,51,Homo sapiens,,,D,9,BAO_0000019,
682,,5272,Expert,9606.0,,1,"Antagonism at the 5-hydroxytryptamine 1A receptor was determined in vitro using a [35S]GTP-gamma-S,",,,CHEMBL616266,,51,Homo sapiens,,,D,9,BAO_0000019,
683,,5272,Expert,9606.0,,1,"Antagonism at the 5-hydroxytryptamine 1A receptor determined in vitro using a [35S]GTP-gamma-S, No data",,,CHEMBL616267,,51,Homo sapiens,,,D,9,BAO_0000019,
684,,5272,Expert,9606.0,,1,Antagonism at the 5-hydroxytryptamine 1A receptor determined in vitro; No data,,,CHEMBL616268,,51,Homo sapiens,,,D,9,BAO_0000019,
685,,16146,Expert,9606.0,,1,Inhibition of human 5-hydroxytryptamine 1A receptor,,,CHEMBL616269,,51,Homo sapiens,,,D,9,BAO_0000357,
686,,17624,Autocuration,,,1,Binding affinity against 5-hydroxytryptamine 1A receptor using cAMP as radioligand in CHO cells,449.0,,CHEMBL884528,,51,,CHO,,H,8,BAO_0000219,
687,,13706,Expert,,,1,Displacement of [3H]-5-HT from human 5-hydroxytryptamine 1D receptor alpha expressed in HEK 293 cells,722.0,,CHEMBL616270,,105,,HEK293,,D,9,BAO_0000219,
688,,15250,Autocuration,,,1,Compound was tested for the displacement of [3H]5-HT binding to cloned 5-hydroxytryptamine 1A receptor stably expressed in CHO cells,449.0,,CHEMBL616271,,51,,CHO,,H,8,BAO_0000219,
689,,17624,Autocuration,,,1,Effective concentration against binding of radioligand [35S]GTP-gamma-S in CHO cells expressing 5-hydroxytryptamine 1A receptor,449.0,,CHEMBL616272,,51,,CHO,,H,8,BAO_0000219,
690,,6861,Expert,,,1,In vitro binding affinity against 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT in human CYP3A4 assay,,,CHEMBL616273,,51,,,,H,8,BAO_0000357,
691,,17200,Expert,9606.0,,1,In vitro inhibitory concentration required against [3H]8-OH-DPAT binding to cloned human 5-hydroxytryptamine 1A receptor,,,CHEMBL616274,,51,Homo sapiens,,,D,9,BAO_0000357,
692,,17624,Autocuration,,,1,Inhibition concentration against 5-HT 1A receptor using cAMP as radioligand in CHO cells,449.0,,CHEMBL616275,,51,,CHO,,H,8,BAO_0000219,
693,,17624,Autocuration,,,1,Inhibition concentration against 5-hydroxytryptamine 1A receptor using cAMP as radioligand in CHO cells,449.0,,CHEMBL616276,,51,,CHO,,H,8,BAO_0000219,
694,In vivo,12058,Autocuration,10116.0,,1,Effective dose for half-maximal decrease in the accumulation of 5-hydroxytryptophan (5-HTP) in reserpinized rat brain hemispheral area by po administration,,,CHEMBL616277,,22226,Rattus norvegicus,,,U,0,BAO_0000218,
695,In vivo,12058,Autocuration,10116.0,,1,Effective dose for half-maximal decrease in the accumulation of 5-hydroxytryptophan (5-HTP) in reserpinized rat brain hemispheral area by po administration; Inactive,,,CHEMBL616278,,22226,Rattus norvegicus,,,U,0,BAO_0000218,
696,In vivo,12058,Autocuration,10116.0,,1,Effective dose for half-maximal decrease in the accumulation of 5-hydroxytryptophan (5-HTP) in reserpinized rat brain hemispheral area by sc administration,,,CHEMBL616279,,22226,Rattus norvegicus,,,U,0,BAO_0000218,
697,In vivo,12058,Autocuration,10116.0,,1,Effective dose for half-maximal decrease in the accumulation of 5-hydroxytryptophan (5-HTP) in reserpinized rat brain hemispheral area by sc administration; Inactive,,,CHEMBL616280,,22226,Rattus norvegicus,,,U,0,BAO_0000218,
698,In vivo,12058,Autocuration,10116.0,,1,Effective dose for half-maximal decrease in the accumulation of 5-hydroxytryptophan (5-HTP) in reserpinized rat brain hemispheral area by sc administration; Partial response at the highest dose tested,,,CHEMBL616281,,22226,Rattus norvegicus,,,U,0,BAO_0000218,
699,In vivo,12058,Autocuration,10116.0,,1,Effective dose for half-maximal decrease in the accumulation of 5-hydroxytryptophan (5-HTP) in reserpinized rat brain hemispheral area by sc administration; Inactive,,,CHEMBL616282,,22226,Rattus norvegicus,,,U,0,BAO_0000218,
700,In vivo,12058,Autocuration,10116.0,,1,Effective dose for half-maximal decrease in the accumulation of 5-hydroxytryptophan (5-HTP) in reserpinized rat brain limbic area by po administration,,,CHEMBL616283,,22226,Rattus norvegicus,,,U,0,BAO_0000218,
701,In vivo,12058,Autocuration,10116.0,,1,Effective dose for half-maximal decrease in the accumulation of 5-hydroxytryptophan (5-HTP) in reserpinized rat brain limbic area by po administration; Inactive,,,CHEMBL616284,,22226,Rattus norvegicus,,,U,0,BAO_0000218,
702,In vivo,12058,Autocuration,10116.0,,1,Effective dose for half-maximal decrease in the accumulation of 5-hydroxytryptophan (5-HTP) in reserpinized rat brain limbic area by sc administration,,,CHEMBL616285,,22226,Rattus norvegicus,,,U,0,BAO_0000218,
703,In vivo,12058,Autocuration,10116.0,,1,Effective dose for half-maximal decrease in the accumulation of 5-hydroxytryptophan (5-HTP) in reserpinized rat brain limbic area by sc administration; Inactive,,,CHEMBL616286,,22226,Rattus norvegicus,,,U,0,BAO_0000218,
704,In vivo,12058,Autocuration,10116.0,,1,Effective dose for half-maximal decrease in the accumulation of 5-hydroxytryptophan (5-HTP) in reserpinized rat brain limbic area by sc administration; partial response at the highest dose tested,,,CHEMBL616287,,22226,Rattus norvegicus,,,U,0,BAO_0000218,
705,In vivo,12058,Autocuration,10116.0,,1,Effective dose for half-maximal decrease in the accumulation of 5-hydroxytryptophan (5-HTP) in reserpinized rat brain striatal area by po administration,,,CHEMBL616288,,22226,Rattus norvegicus,,,U,0,BAO_0000218,
706,In vivo,12058,Autocuration,10116.0,,1,Effective dose for half-maximal decrease in the accumulation of 5-hydroxytryptophan (5-HTP) in reserpinized rat brain striatal area by po administration; Inactive,,,CHEMBL616289,,22226,Rattus norvegicus,,,U,0,BAO_0000218,
707,In vivo,12058,Autocuration,10116.0,,1,Effective dose for half-maximal decrease in the accumulation of 5-hydroxytryptophan (5-HTP) in reserpinized rat brain striatal area by po administration; Partial response at the highest dose tested,,,CHEMBL615610,,22226,Rattus norvegicus,,,U,0,BAO_0000218,
708,In vivo,12058,Autocuration,10116.0,,1,Effective dose for half-maximal decrease in the accumulation of 5-hydroxytryptophan (5-HTP) in reserpinized rat brain striatal area by sc administration,,,CHEMBL615611,,22226,Rattus norvegicus,,,U,0,BAO_0000218,
709,In vivo,12058,Autocuration,10116.0,,1,Effective dose for half-maximal decrease in the accumulation of 5-hydroxytryptophan (5-HTP) in reserpinized rat brain striatal area by sc administration; Inactive,,,CHEMBL615612,,22226,Rattus norvegicus,,,U,0,BAO_0000218,
710,In vivo,12058,Autocuration,10116.0,,1,Effective dose for half-maximal decrease in the accumulation of 5-hydroxytryptophan (5-HTP) in reserpinized rat brain striatal area by sc administration; Partial response at the highest dose tested,,,CHEMBL615613,,22226,Rattus norvegicus,,,U,0,BAO_0000218,
711,In vivo,12058,Autocuration,10116.0,,1,Effective dose for half-maximal decrease in the accumulation of 5-hydroxytryptophan (5-HTP) in reserpinized rat brain striatal area by sc administration; partial response at the highest dose tested,,,CHEMBL615614,,22226,Rattus norvegicus,,,U,0,BAO_0000218,
712,In vivo,12058,Autocuration,10116.0,,1,Effective dose for half-maximal decrease in the accumulation of 5-hydroxytryptophan (5-HTP) in reserpinized rat brain hemispheral area by po administration,,,CHEMBL615615,,22226,Rattus norvegicus,,,U,0,BAO_0000218,
713,,11440,Autocuration,,,1,Affinity in displacing [125I](R)-DOI from rat cortical homogenate 5-HT2 receptor.,,,CHEMBL615616,,105093,,,,H,4,BAO_0000019,
714,,6238,Autocuration,,,1,Binding affinity towards 5-HT 7 receptor in rat hypothalamus membranes using [3H]5-CT as radioligand,,,CHEMBL615617,,11923,,,,H,8,BAO_0000249,1898.0
715,,10046,Autocuration,,,1,Inhibitory activity against 5-HT1B receptor of rat striatal membrane homogenate using [3H]5-HT as the radioligand; nd is No Data,,,CHEMBL615618,,10577,,,,H,8,BAO_0000019,
716,,10046,Autocuration,,,1,Inhibitory activity against 5-hydroxytryptamine 1B receptor of rat striatal membrane homogenate using [3H]5-HT as the radioligand; nd is No Data.,,,CHEMBL615619,,10577,,,,H,8,BAO_0000019,
717,,10046,Expert,,,1,Inhibitory activity against 5-hydroxytryptamine 1B receptor of rat striatal membrane homogenate using [3H]5-HT as the radioligand.,,,CHEMBL615620,,10577,,,,H,8,BAO_0000019,
718,,167,Autocuration,,,1,"Inhibitory activity against human whole blood, LTB4 5-lipoxygenase was evaluated",,,CHEMBL615621,,55,,,,H,8,BAO_0000357,
719,,167,Autocuration,,,1,"Inhibitory activity against intact human PMNL, LTB4 5-lipoxygenase was evaluated",,,CHEMBL615622,,55,,,,H,8,BAO_0000357,
720,,11520,Autocuration,,,1,Compound was evaluated for the inhibition of 5-LO (lipoxygenase),,,CHEMBL615623,,12166,,,,H,8,BAO_0000019,
721,,11520,Autocuration,,,1,Compound was evaluated for the inhibition of 5-LO (5-lipoxygenase).,,,CHEMBL615624,,12166,,,,H,8,BAO_0000019,
722,,11520,Autocuration,,,1,Compound was evaluated for the inhibition of 5-LO (5-lipoxygenase).,,,CHEMBL615625,,12166,,,,H,8,BAO_0000019,
723,,11520,Autocuration,,,1,Compound was evaluated for the inhibition of 5-LO (5-lipoxygenase).,,,CHEMBL767045,,12166,,,,H,8,BAO_0000019,
724,,135,Autocuration,10141.0,,1,Inhibition of [14C]arachidonic acid conversion to 5-HETE by broken cell 5-LO isolated from guinea pig PMN,,,CHEMBL615626,,55,Cavia porcellus,,,H,8,BAO_0000019,
725,,135,Autocuration,10141.0,,1,Inhibition of [14C]arachidonic acid conversion to 5-HETE by broken cell 5-LO isolated from guinea pig PMN; not active at the highest concentration (3 ug/mL) tested; No activity,,,CHEMBL615627,,55,Cavia porcellus,,,H,8,BAO_0000019,
726,,11311,Autocuration,10141.0,,1,The compound was tested for inhibitory activity against 5-Lipoxygenase in guinea pig polymorphonuclear leukocytes,,,CHEMBL615628,,55,Cavia porcellus,,,H,8,BAO_0000019,
727,,10193,Autocuration,10141.0,,1,In vitro inhibitory activity against polymorphonuclear leukocyte 5-lipoxygenase using guinea pig supernatant at 10 uM,,,CHEMBL615629,,55,Cavia porcellus,,,H,8,BAO_0000357,
728,,12281,Expert,9606.0,,1,Inhibitory concentration against 5-lipoxygenase from human whole blood,,,CHEMBL615630,,55,Homo sapiens,,,D,9,BAO_0000357,
729,,11311,Autocuration,,,1,The compound was tested for inhibitory activity against 5-Lipoxygenase in human polymorphonuclear leukocytes[PMNS],,,CHEMBL615631,,55,,,,H,8,BAO_0000219,
730,,12576,Autocuration,,,1,In vivo inhibition of 5-lipoxygenase (LTC4) in the mouse zymosan peritonitis assay at an oral dose of 30 mg/Kg,,,CHEMBL615632,,17087,,,,H,8,BAO_0000218,
731,,12281,Autocuration,,,1,Inhibitory concentration against 5-lipoxygenase from mouse macrophage,,,CHEMBL615633,,17087,,,,H,8,BAO_0000357,
732,,12576,Autocuration,,,1,In vivo inhibition of 5-lipoxygenase (LTC4) in the mouse zymosan peritonitis assay at an oral dose of 30 mg/Kg,,,CHEMBL615634,,17087,,,,H,8,BAO_0000218,
733,,11089,Expert,9823.0,,1,Inhibition of arachidonate 5-lipoxygenase purified from porcine leukocytes.,,,CHEMBL615635,,55,Sus scrofa,,,H,8,BAO_0000019,
734,,11006,Expert,,,1,In vitro inhibition of rat 5-Lipoxygenase,,,CHEMBL615636,,12166,,,,H,8,BAO_0000357,
735,,11481,Expert,10116.0,,1,Inhibitory activity against 5-Lipoxygenase,,,CHEMBL615637,,12166,Rattus norvegicus,,,D,9,BAO_0000357,
736,,10864,Expert,,,1,Inhibitory activity against 5-lipoxygenase in rat basophilic leukemia cells,702.0,,CHEMBL615638,,12166,,RBL-1,,H,8,BAO_0000219,
737,,3595,Autocuration,,,1,Inhibitory activity against 5-lipoxygenase (5-LO) in intact rat barophilic leukemia cells (RBL-1),702.0,,CHEMBL615639,,12166,,RBL-1,,H,8,BAO_0000219,
738,,11311,Autocuration,,,1,The compound was tested for inhibitory activity against 5-Lipoxygenase in rat RBL-1,702.0,,CHEMBL615640,,12166,,RBL-1,,H,8,BAO_0000219,
739,,11311,Autocuration,,,1,The compound was tested for inhibitory activity against 5-Lipoxygenase in rat blood,,,CHEMBL615796,,12166,,,,H,8,BAO_0000019,
740,,11311,Autocuration,,,1,The compound was tested for inhibitory activity against 5-Lipoxygenase receptor in rat polymorphonuclear leukocytes[PMNS],,,CHEMBL615845,,12166,,,,H,8,BAO_0000219,
741,,11006,Autocuration,,,1,Compound was evaluated for the inhibition of 5-Lipoxygenase (5-LO) in vitro at 1 uM,,,CHEMBL615846,,12166,,,,H,8,BAO_0000357,
742,,3595,Autocuration,,,1,Inhibitory activity against 5-lipoxygenase (5-LO) using broken rat barophilic leukemia cells (RBL-1)at 10 uM,702.0,,CHEMBL615847,,12166,,RBL-1,,H,8,BAO_0000219,
743,,11311,Autocuration,,,1,The compound was tested for inhibition of isolated 5-Lipoxygenase,,,CHEMBL615848,,12166,,,,H,8,BAO_0000357,
744,,11481,Autocuration,10116.0,,1,Ratio of IC50 against 5-LO and COX,,,CHEMBL615849,,22226,Rattus norvegicus,,,U,0,BAO_0000019,
745,,11006,Autocuration,,,1,Compound was evaluated for the inhibition of 5-Lipoxygenase (5-LO) in vitro at 1 uM,,,CHEMBL615850,,12166,,,,H,8,BAO_0000357,
746,,11006,Autocuration,,,1,Compound was evaluated for the inhibition of 5-Lipoxygenase (5-LO) in vitro at 1 uM; range is 20-35%,,,CHEMBL615851,,12166,,,,H,8,BAO_0000357,
747,,11311,Autocuration,,,1,The compound was tested for inhibition against 5-Lipoxygenase in rat polymorphonuclear leukocytes at 10 uM concentration,,,CHEMBL615852,,12166,,,,H,8,BAO_0000219,
748,,11006,Autocuration,,,1,Compound was evaluated for the inhibition of 5-Lipoxygenase (5-LO) ex vivo,,,CHEMBL615853,,12166,,,,H,8,BAO_0000019,
749,,4288,Autocuration,,,1,Compound was tested for the inhibition of type 2 5-alpha-reductase of human prostates,,,CHEMBL884527,,120,,,,H,8,BAO_0000357,2367.0
750,,7587,Autocuration,8932.0,,1,Percent inhibition was measured against 5-amino-4-imidazolecarboxamide ribotide transformylase(pigeon liver) enzyme at 10E-4 M inhibitory concentration,,,CHEMBL872871,,22226,Columba livia,,,U,0,BAO_0000019,
751,,7587,Autocuration,8932.0,,1,Percent inhibition was measured against 5-amino-4-imidazolecarboxamide ribotide transformylase(pigeon liver) enzyme at 10E-5 M inhibitory concentration,,,CHEMBL615854,,22226,Columba livia,,,U,0,BAO_0000019,
752,,7587,Autocuration,8932.0,,1,Percent inhibition was measured against 5-amino-4-imidazolecarboxamide ribotide transformylase(pigeon liver) enzyme.,,,CHEMBL767046,,22226,Columba livia,,,U,0,BAO_0000019,
753,,11249,Autocuration,,,1,Compound was evaluated for the inhibition of 5-aminoimidazole-4-carboxamide ribonucleotide transformylase obtained from human at 100 uM,,,CHEMBL615855,,10732,,,,H,8,BAO_0000357,
754,,8003,Expert,10116.0,,1,Effect on synaptosomal uptake inhibition of 5-hydroxytryptamine (5-HT); NT = Not Tested,,,CHEMBL615856,,12198,Rattus norvegicus,,,D,9,BAO_0000019,
755,,8003,Expert,10116.0,,1,Effect on synaptosomal uptake inhibition of 5-hydroxytryptamine (5-HT),,,CHEMBL615857,,12198,Rattus norvegicus,,,D,9,BAO_0000019,
756,,8003,Expert,10116.0,,1,Effect on synaptosomal uptake inhibition of 5-hydroxytryptamine (5-HT),,,CHEMBL615858,,12198,Rattus norvegicus,,,D,9,BAO_0000019,
757,,12416,Expert,,,1,In vitro affinity towards 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand in hippocampus,,,CHEMBL615859,,10576,,,,H,8,BAO_0000221,10000000.0
758,,16293,Autocuration,,,1,Binding affinity towards human 5-hydroxytryptamine 1 receptor,,,CHEMBL615860,,51,,,,H,8,BAO_0000357,
759,,13047,Autocuration,9986.0,,1,Intrinsic activity against 5-hydroxytryptamine 1 receptor using rabbit saphenous vein assay.,,,CHEMBL615861,,22226,Oryctolagus cuniculus,,,U,0,BAO_0000019,
760,,13047,Autocuration,9986.0,,1,Binding affinity against 5-hydroxytryptamine 1 receptor using rabbit saphenous vein assay.,,,CHEMBL615862,,22226,Oryctolagus cuniculus,,,U,0,BAO_0000019,
761,,13047,Autocuration,9986.0,,1,Binding affinity against 5-hydroxytryptamine 1D receptor using rabbit saphenous vein assay.,,,CHEMBL615863,,22226,Oryctolagus cuniculus,,,U,0,BAO_0000019,
762,,13047,Autocuration,9986.0,,1,Binding affinity against 5-hydroxytryptamine 4 receptor using rabbit saphenous vein assay.,,,CHEMBL615864,,22226,Oryctolagus cuniculus,,,U,0,BAO_0000019,
763,,10085,Autocuration,,,1,Ability to bind at 5-hydroxytryptamine 1 receptor of rat hippocampus by displacing [3H]5-HT,,,CHEMBL615865,,104744,,,,H,4,BAO_0000221,10000000.0
764,,10085,Autocuration,,,1,Ability to bind at 5-hydroxytryptamine 1 receptor of rat hippocampus by displacing [3H]5-HT,,,CHEMBL615866,,104744,,,,H,4,BAO_0000221,10000000.0
765,,10085,Autocuration,,,1,Ability to bind at serotonin 5-hydroxytryptamine 1 receptor of rat hippocampus by displacing [3H]5-HT,,,CHEMBL615867,,104744,,,,H,4,BAO_0000221,10000000.0
766,,9841,Autocuration,,,1,Ability to inhibit binding of titreated serotonin to the 5-hydroxytryptamine 1 receptor in rat brain frontal cortex membranes,,,CHEMBL615868,Membranes,104744,,,,H,4,BAO_0000249,
767,,8822,Autocuration,10116.0,,1,Binding affinity towards 5-hydroxytryptamine 1 receptor in brain cortical membranes of rat,,,CHEMBL615869,,104744,Rattus norvegicus,,,D,5,BAO_0000249,
768,,9806,Autocuration,10116.0,,1,Binding affinity towards 5-hydroxytryptamine 1 receptor in rat frontal cortex homogenates using [3H]5-HT as a radioligand,,,CHEMBL615870,,104744,Rattus norvegicus,,,D,5,BAO_0000019,
769,,9806,Autocuration,10116.0,,1,Binding affinity towards 5-hydroxytryptamine 1 receptor using [3H]5-HT as a radioligand from rat frontal cortex homogenates,,,CHEMBL615871,,104744,Rattus norvegicus,,,D,5,BAO_0000019,
770,,8868,Autocuration,,,1,Binding affinity towards 5-hydroxytryptamine 1 receptor was measured using radioligand ([3H]5-HT) binding assay,,,CHEMBL615872,,104744,,,,H,4,BAO_0000224,
771,,9036,Autocuration,,,1,Binding affinity towards hippocampus 5-hydroxytryptamine 1 receptor was measured using radioligand [3H]5-HT,,,CHEMBL833492,,104744,,,,H,4,BAO_0000221,10000000.0
772,,11374,Autocuration,,,1,Compound was evaluated for the inhibition of [3H]5-HT (concentration of 12 nM) specific binding to rat hippocampus,,,CHEMBL615873,,104744,,,,H,4,BAO_0000221,10000000.0
773,,10881,Autocuration,,,1,Inhibitory activity against 5-hydroxytryptamine 1 receptor by 3H ligand binding experiments.,,,CHEMBL615479,,104744,,,,H,4,BAO_0000224,
774,,8822,Autocuration,,,1,Tested for its binding affinity towards 5-hydroxytryptamine 1 receptor in rat,,,CHEMBL615480,,104744,,,,H,4,BAO_0000019,
775,,9806,Autocuration,10116.0,,1,Tested for its binding affinity towards 5-hydroxytryptamine 1 receptor in rat cortical membrane homogenates using radioligand ([3H]5-HT) binding assay.,,,CHEMBL615481,,104744,Rattus norvegicus,,,D,5,BAO_0000249,
776,,15463,Autocuration,,,1,Compound at 1 uM was tested for the inhibition of radioligand [3H]5-HT binding to 5-hydroxytryptamine 1 receptor in rat cerebral cortex,,,CHEMBL872869,,104744,,,,H,4,BAO_0000019,
777,,15463,Autocuration,,,1,Compound at 1 uM was tested for the inhibition of radioligand [3H]5-HT binding to 5-hydroxytryptamine 1 receptor in rat cerebral cortex,,,CHEMBL615482,,104744,,,,H,4,BAO_0000019,
778,,14542,Autocuration,,,1,Compound is evaluated for binding affinity towards 5-hydroxytryptamine 1 receptor using [3H]5-HT in rat brain cortex at 10 uM,,,CHEMBL615483,,104744,,,,H,4,BAO_0000221,955.0
779,,14542,Autocuration,,,1,Compound is evaluated for binding affinity towards 5-hydroxytryptamine 1 receptor using [3H]5-HT in rat brain cortex at 10 uM,,,CHEMBL615484,,104744,,,,H,4,BAO_0000221,955.0
780,,8569,Autocuration,,,1,Percent inhibition of 5-hydroxytryptamine 1 receptor from rat cortex membrane using [3H]- serotonin as radioligand at 33 uM,,,CHEMBL615485,,104744,,,,H,4,BAO_0000019,
781,,10062,Autocuration,10116.0,,1,Inhibition of [3H]5-HT radioligand binding against 5-hydroxytryptamine 1 receptor,,,CHEMBL615486,,104744,Rattus norvegicus,,,D,5,BAO_0000224,
782,,4771,Autocuration,,,1,Ancillary Binding affinity towards rat 5-hydroxytryptamine 1 receptor,,,CHEMBL615487,,104744,,,,H,4,BAO_0000224,
783,,10062,Autocuration,,,1,Binding affinity determined in radioreceptor binding assay by using [3H]5-HT radioligand against 5-hydroxytryptamine 1 receptor,,,CHEMBL615488,,104744,,,,H,4,BAO_0000224,
784,,10062,Autocuration,,,1,Binding affinity in radioreceptor binding assay by using [3H]5-HT radioligand against 5-hydroxytryptamine 1 receptor,,,CHEMBL615489,,104744,,,,H,4,BAO_0000224,
785,,10062,Autocuration,,,1,Binding affinity in radioreceptor binding assay by using [3H]5-HT radioligand against 5-hydroxytryptamine 1 receptor,,,CHEMBL615389,,104744,,,,H,4,BAO_0000224,
786,,15463,Autocuration,,,1,Binding affinity towards 5-hydroxytryptamine 1 receptor was determined in rat cerebral cortex using [3H]5-HT as radioligand,,,CHEMBL615390,,104744,,,,H,4,BAO_0000019,
787,,15463,Autocuration,,,1,Binding affinity towards central 5-hydroxytryptamine 1 receptor was determined in rat cerebral cortex using [3H]5-HT as radioligand,,,CHEMBL615391,,104744,,,,H,4,BAO_0000019,
788,,9098,Autocuration,,,1,Binding affinity towards 5-hydroxytryptamine 1 receptor was determined,,,CHEMBL615392,,104744,,,,H,4,BAO_0000224,
789,,3070,Autocuration,10116.0,,1,Affinity for 5-hydroxytryptamine 1 receptor,,,CHEMBL615393,,22226,Rattus norvegicus,,,U,0,BAO_0000019,
790,,14542,Autocuration,,,1,Compound is evaluated for binding affinity towards 5-hydroxytryptamine 1 receptor using [3H]5-HT in rat brain cortex,,,CHEMBL615394,,104744,,,,H,4,BAO_0000221,955.0
791,,14542,Autocuration,,,1,Compound is evaluated for binding affinity towards 5-hydroxytryptamine 1 receptor using [3H]5-HT in rat brain cortex at 10 uM,,,CHEMBL615395,,104744,,,,H,4,BAO_0000221,955.0
792,,6398,Autocuration,,,1,Compound was evaluated for 5-hydroxytryptamine 1 receptor binding,,,CHEMBL615396,,104744,,,,H,4,BAO_0000224,
793,,1344,Autocuration,,,1,Compound was evaluated for its binding affinity to 5-hydroxytryptamine 1 receptor in rat brain using [3H]HT radioligand assay,,,CHEMBL615397,,104744,,,,H,4,BAO_0000221,955.0
794,,11963,Autocuration,,,1,Displacement of binding of [3H]5-HT to 5-hydroxytryptamine 1 receptor in rat cerebral cortex,,,CHEMBL615398,,104744,,,,H,4,BAO_0000019,
795,,8908,Autocuration,10116.0,,1,Displacement of [3H]spiperone from 5-hydroxytryptamine 1 receptor of rat cortex,,,CHEMBL615399,,22226,Rattus norvegicus,,,U,0,BAO_0000019,
796,,9098,Autocuration,,,1,Evaluated for binding affinity towards rat cortical membranes at 5-hydroxytryptamine 1 receptor binding site by using [3H]-5-HT as a radioligand.,,,CHEMBL615400,,104744,,,,H,4,BAO_0000019,
797,,8841,Autocuration,10116.0,,1,Binding affinity for 5-hydroxytryptamine 1 receptor of rat prefrontal cortex,,,CHEMBL615401,,104744,Rattus norvegicus,,,D,5,BAO_0000019,
798,,8814,Autocuration,10116.0,,1,Displacement of [3H]5-HT from 5-hydroxytryptamine 1 receptor of rat cortical membrane homogenates,,,CHEMBL615402,,22226,Rattus norvegicus,,,U,0,BAO_0000019,
799,,11752,Autocuration,,,1,The ability to inhibit [3H]5-HT binding to 5-hydroxytryptamine 1 receptor in rat cortex,,,CHEMBL615403,,104744,,,,H,4,BAO_0000019,
800,,11642,Autocuration,,,1,The binding affinity was measured on serotonin 5-hydroxytryptamine 1 receptor in rat brain tissue,,,CHEMBL615404,,104744,,,,H,4,BAO_0000221,955.0
801,,11642,Autocuration,,,1,The compound was tested for its binding affinity towards 5-hydroxytryptamine 1 receptor by displacing [3H]5-HT radioligand in rat cerebral cortex,,,CHEMBL615781,,104744,,,,H,4,BAO_0000019,
802,,9231,Autocuration,,,1,Tested for 5-hydroxytryptamine 1 receptor binding ability by displacement of [3H]5-HT from rat brain synaptosomes,,,CHEMBL615782,,104744,,,,H,4,BAO_0000220,955.0
803,,11351,Autocuration,,,1,Inhibition constant (1 uM) was measured on 5-hydroxytryptamine 1 receptor/uptake using [3H]- serotonin as radioligand in rat brain cortex.,,,CHEMBL615783,,104744,,,,H,4,BAO_0000221,955.0
804,,4639,Autocuration,,,1,Compound was tested for binding affinity against 5-HT1 receptor,,,CHEMBL873481,,22226,,,,U,0,BAO_0000019,
805,,1205,Autocuration,,,1,Inhibitory concentration against 5-hydroxytryptamine 1 receptor,,,CHEMBL615784,,22226,,,,U,0,BAO_0000019,
806,,10025,Expert,,,1,Concentration necessary to achieve half maximal inhibition of [3H]8-Hydroxy-2-(di-n-propylamino)tetralin binding to 5-hydroxytryptamine 1A receptor at 1 uM,,,CHEMBL615785,,10576,,,,H,8,BAO_0000357,
807,,13241,Autocuration,,,1,"Ability to inhibit 5-HT sensitive,forskolin-stimulated adenylyl cyclase(FSC) activity in rat hippocampal membranes mediated through 5-hydroxytryptamine 1A receptor",,,CHEMBL615786,,10576,,,,H,8,BAO_0000249,
808,In vivo,16245,Autocuration,,,1,Agonistic activity (induction of forepaw treading in rats)on postsynaptic 5-hydroxytryptamine 1A receptor while iv administration,,,CHEMBL615787,,10576,,,,H,8,BAO_0000218,
809,In vivo,16245,Autocuration,,,1,Agonistic activity (induction of forepaw treading in rats)on postsynaptic 5-hydroxytryptamine 1A receptor while subcutaneous administration,,,CHEMBL615788,,10576,,,,H,8,BAO_0000218,
810,,12438,Autocuration,,,1,Inhibition of forskolin stimulated adenylate cyclase at 5-hydroxytryptamine 1A receptor,,,CHEMBL767044,,10576,,,,H,8,BAO_0000019,
811,In vivo,16245,Autocuration,,,1,Agonistic activity (induction of forepaw treading in rats)on postsynaptic 5-hydroxytryptamine 1A receptor while iv administration,,,CHEMBL615789,,10576,,,,H,8,BAO_0000218,
812,In vivo,16245,Autocuration,,,1,Agonistic activity (induction of forepaw treading in rats)on postsynaptic 5-hydroxytryptamine 1A receptor while subcutaneous administration,,,CHEMBL615790,,10576,,,,H,8,BAO_0000218,
813,,15740,Autocuration,,,1,Evaluated for the 5-hydroxytryptamine 1A receptor agonist activity in LY-293284 trained rats,,,CHEMBL615813,,10576,,,,H,8,BAO_0000019,
814,,15535,Autocuration,,,1,Percent of maximum response by 5-HT when tested for inhibition of vasoactive intestinal polypeptide-induced (VIP-induced) cAMP formation assessed in GH4ZD10 cells at 10 uM concentration,,,CHEMBL615814,,10576,,,,H,8,BAO_0000219,
815,,15535,Expert,,,1,Percent inhibition of vasoactive intestinal polypeptide-induced (VIP-induced) cAMP formation in GH4ZD10 cells expressing 5-HT1A receptor at 50 uM relative to 5-HT,,,CHEMBL615815,,51,,,,H,8,BAO_0000219,
816,,15535,Autocuration,,,1,Percent of maximum response by 5-HT when tested for inhibition of vasoactive intestinal polypeptide-induced (VIP-induced) cAMP formation assessed in GH4ZD10 cells at 50 uM concentration; No effect,,,CHEMBL615816,,10576,,,,H,8,BAO_0000219,
817,,9888,Expert,,,1,Binding affinity at [3H]8-OH-DPAT-Labeled 5-hydroxytryptamine 1A receptor sites in rat brain hippocampal membranes expressed as Hill values,,,CHEMBL615817,,10576,,,,H,8,BAO_0000249,
818,,10085,Autocuration,,,1,Ability to bind at 5-hydroxytryptamine 1A receptor of rat hippocampus by displacing [3H]8-OH-DPAT,,,CHEMBL615818,,10576,,,,H,8,BAO_0000221,10000000.0
819,,10085,Autocuration,,,1,Ability to bind at serotonin 5-hydroxytryptamine 1A receptors of rat hippocampus by displacing [3H]8-OH-DPAT,,,CHEMBL615819,,10576,,,,H,8,BAO_0000221,10000000.0
820,,17331,Expert,,,1,Binding affinity against 5-hydroxytryptamine 1A receptor (5-HT1A) by displacement of [3H]8-OH-DPAT from rat hippocampus membranes,,,CHEMBL615820,Membranes,10576,,,,H,8,BAO_0000249,
821,,10845,Expert,10116.0,,1,Binding affinity against 5-hydroxytryptamine 1A receptor of rat hippocampal tissue with [3H]8-OH-DPAT,,,CHEMBL615821,,10576,Rattus norvegicus,,,D,9,BAO_0000221,10000000.0
822,,10845,Expert,10116.0,,1,Binding affinity against 5-hydroxytryptamine 1A receptor of rat hippocampal tissue with [3H]5-HT,,,CHEMBL615822,,10576,Rattus norvegicus,,,D,9,BAO_0000221,10000000.0
823,,10845,Expert,,,1,Binding affinity against 5-hydroxytryptamine 1A receptor using in rat hippocampal tissue using [3H]8-OH-DPAT as radioligand,,,CHEMBL615823,,10576,,,,H,8,BAO_0000221,10000000.0
824,,10845,Expert,10116.0,,1,Displacement of [3H]8-OH-DPAT from rat hippocampal 5-hydroxytryptamine 1A receptor; IA-Inactive,,,CHEMBL615824,,10576,Rattus norvegicus,,,D,9,BAO_0000221,10000000.0
825,,10845,Expert,10116.0,,1,Binding affinity against 5-hydroxytryptamine 1A receptor of rat hippocampal tissue with [3H]5-HT,,,CHEMBL615825,,10576,Rattus norvegicus,,,D,9,BAO_0000221,10000000.0
826,,13730,Expert,,,1,Binding affinity towards rat 5-hydroxytryptamine 1A receptor was evaluated using [3H]8-OH-DPAT as radioligand,,,CHEMBL615826,,10576,,,,H,8,BAO_0000357,
827,,13508,Expert,,,1,Binding affinity against 5-hydroxytryptamine 1A receptor in rat hippocampus membranes using [3H]8-OH-DPAT as radioligand,,,CHEMBL615827,,10576,,,,H,8,BAO_0000249,
828,,13508,Expert,,,1,Binding affinity against serotonin 5-hydroxytryptamine 1A receptor in rat hippocampus membrane using [3H]8-OH-DPAT as radioligand,,,CHEMBL615828,,10576,,,,H,8,BAO_0000249,10000000.0
829,,12073,Expert,,,1,Binding affinity by measuring displacement of [3H]-8-OH-DPAT from 5-hydroxytryptamine 1A receptor in rat hippocampus,,,CHEMBL615829,,10576,,,,H,8,BAO_0000221,10000000.0
830,,4671,Autocuration,,,1,Binding affinity to 5-hydroxytryptamine 1A receptor of rat hippocampus with [3H]8-OH-DPAT as radioligand,,,CHEMBL615830,,10576,,,,H,8,BAO_0000221,10000000.0
831,,13631,Expert,,,1,Binding affinity towards serotonin 5-HT1A receptor was determined in rat hippocampus using [3H]8-OH-DPAT as ligand,,,CHEMBL615831,,10576,,,,H,8,BAO_0000221,10000000.0
832,,12438,Autocuration,,,1,Binding affinity was measured against serotonin 5-hydroxytryptamine 1A receptor,,,CHEMBL615832,,10576,,,,H,8,BAO_0000357,
833,,10483,Autocuration,,,1,Binding affinity to 5-hydroxytryptamine 1A receptor in rat cortex using [3H]-8-OH- DPAT as radioligand,,,CHEMBL615833,,10576,,,,H,8,BAO_0000019,
834,,10483,Autocuration,,,1,Binding affinity to 5-hydroxytryptamine 1A receptor in rat hippocampus using [3H]-8-OH- DPAT as radioligand,,,CHEMBL615834,,10576,,,,H,8,BAO_0000221,10000000.0
835,,12352,Intermediate,,,1,Binding affinity against 5-hydroxytryptamine 1A (5-HT1A) receptor in rat hippocampus membranes,,,CHEMBL615835,,10576,,,,H,8,BAO_0000249,
836,,14732,Autocuration,,,1,Binding affinity was measured at the serotonin 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand in rat hippocampal membrane.,,,CHEMBL615836,,10576,,,,H,8,BAO_0000249,10000000.0
837,,11049,Expert,10116.0,,1,Binding affinity to 5-hydroxytryptamine 1A receptor in the rat brain using [3H]8-hydroxy-2-(di-n-propylamine)tetralin as radioligand.,,,CHEMBL615837,,10576,Rattus norvegicus,,,D,9,BAO_0000019,
838,,11049,Expert,10116.0,,1,Binding affinity to 5-hydroxytryptamine 1A receptor in the rat brain using [3H]8-hydroxy-2-(di-n-propylamine)tetralin as radioligand; ND-Not determined,,,CHEMBL615838,,10576,Rattus norvegicus,,,D,9,BAO_0000019,
839,,13657,Expert,,,1,"Binding affinity to 5-hydroxytryptamine 1A receptor in rat hippocampus membranes,3H-8-OH-DPAT and buspirone for nonspecific binding (NSB)",,,CHEMBL615839,,10576,,,,H,8,BAO_0000249,
840,,11473,Autocuration,,,1,Compound was evaluated for binding affinity towards 5-hydroxytryptamine 1A receptor in rat cortex using [3H]-8-OH-DPAT as radioligand,,,CHEMBL884525,,10576,,,,H,8,BAO_0000019,
841,,2014,Autocuration,,,1,Compound was evaluated for its ability to displace [3H]8-OH-DPAT from serotonin 5-hydroxytryptamine 1A receptor in rat cerebral cortex membranes,,,CHEMBL615840,,10576,,,,H,8,BAO_0000249,
842,,3086,Expert,,,1,Displacement of [3H]8-OH-DPAT from 5-hydroxytryptamine 1A receptor in rat hippocampus,,,CHEMBL615405,,10576,,,,H,8,BAO_0000221,10000000.0
843,,15854,Expert,,,1,Binding affinity towards 5-hydroxytryptamine 1A receptor in rat frontal cortex using [125I]iodocyanopindolol as radio-ligand.,,,CHEMBL615406,,10576,,,,H,8,BAO_0000019,
844,,10922,Expert,,,1,Affinity for 5-hydroxytryptamine 1A receptor labeled with [3H]8-OH-DPAT radioligand in hippocampus tissue,,,CHEMBL615900,,10576,,,,H,8,BAO_0000221,10000000.0
845,,13346,Expert,,,1,Inhibition of [3H]8-OH-DPAT binding at serotonin 5-hydroxytryptamine 1A receptor from rat hippocampus tissue.,,,CHEMBL615901,,10576,,,,H,8,BAO_0000221,10000000.0
846,,15311,Expert,,,1,In vitro inhibition of [3H]8-OH-DPAT binding to rat 5-HT 1a receptors.,,,CHEMBL615902,,10576,,,,H,8,BAO_0000357,
847,,10922,Autocuration,,,1,Compound was measured for affinity at 5-hydroxytryptamine 1A receptor labeled with [3H]8-OH-DPAT radioligand in hippocampus tissue,,,CHEMBL615903,,10576,,,,H,8,BAO_0000221,10000000.0
848,,10025,Autocuration,,,1,Concentration necessary to achieve half maximal inhibition of [3H]8-Hydroxy-2-(di-n-propylamino)tetralin binding to 5-hydroxytryptamine 1A receptor<br>at 1 uM,,,CHEMBL615904,,10576,,,,H,8,BAO_0000357,
849,,10025,Expert,,,1,Concentration necessary to achieve half maximal inhibition of [3H]8-Hydroxy-2-(di-n-propylamino)tetralin binding to 5-hydroxytryptamine 1A receptor at 1 uM,,,CHEMBL615905,,10576,,,,H,8,BAO_0000357,
850,,9742,Autocuration,,,1,In vitro Inhibitory activity tested at 5-hydroxytryptamine 1A receptor binding site in rat,,,CHEMBL615906,,10576,,,,H,8,BAO_0000019,
851,,9742,Autocuration,,,1,In vitro Inhibitory activity tested at 5-hydroxytryptamine 1A receptor binding site in rat,,,CHEMBL615907,,10576,,,,H,8,BAO_0000019,
852,,12304,Expert,,,1,In vitro ability to inhibit binding of radioligand [3H]8-OH-DPAT to 5-hydroxytryptamine 1A receptor in rat cerebral cortex,,,CHEMBL615908,,10576,,,,H,8,BAO_0000019,
853,,15789,Autocuration,,,1,In vitro affinity against 5-hydroxytryptamine 1A receptor using [3H]-8-OH-DPAT in rat hippocampus,,,CHEMBL615909,,10576,,,,H,8,BAO_0000221,10000000.0
854,,9912,Autocuration,,,1,"In vitro binding activity against 5-hydroxytryptamine 1A receptor from homogenized rat brain, using [3H]-8-OH-DPAT as the radioligand",,,CHEMBL615910,,10576,,,,H,8,BAO_0000019,
855,,9912,Autocuration,,,1,"In vitro binding activity against 5-hydroxytryptamine 1A receptor from homogenized rat brain, using [3H]8-OH-DPAT as the radioligand.",,,CHEMBL615911,,10576,,,,H,8,BAO_0000019,
856,,9912,Autocuration,,,1,"In vitro binding activity against 5-hydroxytryptamine 1A receptor from homogenized rat brain, using [3H]8-OH-DPAT as the radioligand",,,CHEMBL615912,,10576,,,,H,8,BAO_0000019,
857,,16693,Expert,,,1,In vitro binding affinity for serotonin 5-hydroxytryptamine 1A receptor fof rat cerebral cortex using [3H]8-OH-DPAT as radioligand,,,CHEMBL615913,,10576,,,,H,8,BAO_0000019,
858,,13276,Expert,,,1,In vitro binding affinity measured on serotonin 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand.,,,CHEMBL615914,,10576,,,,H,8,BAO_0000357,
859,,12678,Autocuration,,,1,In vitro binding affinity to 5-hydroxytryptamine 1A receptor using [125I](R)-(+)-trans-8-OH-PIPAT as radioligand in rat hippocampal homogenate,,,CHEMBL615915,,10576,,,,H,8,BAO_0000221,10000000.0
860,,11825,Autocuration,,,1,In vitro binding affinity towards the 5-hydroxytryptamine 1A receptor was evaluated,,,CHEMBL615916,,10576,,,,H,8,BAO_0000357,
861,,12443,Expert,,,1,In vitro binding affinity was measured on serotonergic 5-hydroxytryptamine 1A receptor by displacement of [3H]- tetralin,,,CHEMBL615917,,10576,,,,H,8,BAO_0000357,
862,,13830,Expert,,,1,In vitro inhibitory activity against [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor,,,CHEMBL615918,,10576,,,,H,8,BAO_0000357,
863,,14286,Expert,,,1,In vitro inhibitory concentration against radioligand [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor in rat hippocampal membrane.,,,CHEMBL615919,,10576,,,,H,8,BAO_0000249,10000000.0
864,,14356,Expert,10116.0,,1,In vitro radioligand binding assay on 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT in rat hippocampus,,,CHEMBL615920,,10576,Rattus norvegicus,,,D,9,BAO_0000221,10000000.0
865,,15306,Autocuration,,,1,Inhibition concentration against 5-hydroxytryptamine 1A receptor,,,CHEMBL615921,,10576,,,,H,8,BAO_0000357,
866,,15306,Expert,,,1,Inhibitory concentration against 5-hydroxytryptamine 1A receptor (Inactive at >1000 nM concentration),,,CHEMBL615922,,10576,,,,H,8,BAO_0000357,
867,,16616,Expert,10116.0,,1,"Inhibition of (+)-8-OH-DPAT stimulated [35S]GTP-gamma-S, binding to 5-hydroxytryptamine 1A receptor in hippocampal membranes",,,CHEMBL881290,,10576,Rattus norvegicus,,,D,9,BAO_0000249,
868,,3651,Autocuration,,,1,"Inhibition of [3H]8-hydroxy-2-dipropylamino-1,2,3,4-tetrahydronaphthalene binding to 5-hydroxytryptamine 1A receptor in hippocampus region of rat brain; Residual radioligand binding higher than 50%",,,CHEMBL615923,,10576,,,,H,8,BAO_0000221,10000000.0
869,,14331,Autocuration,,,1,Inhibition of forskolin-activated adenylate cyclase (cAMP) activity at 5-hydroxytryptamine 1A receptor in rat hippocampus,,,CHEMBL615924,,10576,,,,H,8,BAO_0000221,10000000.0
870,,14331,Autocuration,,,1,Inhibition of forskolin-activated adenylate cyclase (cAMP) activity at 5-hydroxytryptamine 1A receptor in rat hippocampus,,,CHEMBL615925,,10576,,,,H,8,BAO_0000221,10000000.0
871,,14178,Expert,10116.0,,1,Inhibition of radiolabeled [3H]-8-OH-DPAT ligand binding to 5-hydroxytryptamine 1A receptor,,,CHEMBL615926,,10576,Rattus norvegicus,,,D,9,BAO_0000357,
872,,10639,Expert,10116.0,,1,Displacement of [3H]8-OH-DPAT from rat cortex 5-hydroxytryptamine 1A receptor,,,CHEMBL615927,,10576,Rattus norvegicus,,,D,9,BAO_0000019,
873,,12306,Autocuration,,,1,Inhibitory activity against 5-hydroxytryptamine 1A receptor of rat hippocampal homogenates,,,CHEMBL615928,,10576,,,,H,8,BAO_0000221,10000000.0
874,,1348,Expert,10116.0,,1,Inhibitory activity against 5-hydroxytryptamine 1A receptor subtype,,,CHEMBL615929,,10576,Rattus norvegicus,,,D,9,BAO_0000357,
875,,13605,Autocuration,,,1,Inhibitory activity against [3H]DPAT binding to 5-HT1A receptor in rat hippocampus,,,CHEMBL615930,,10576,,,,H,8,BAO_0000221,10000000.0
876,,17624,Autocuration,,,1,Inhibition concentration against 5-hydroxytryptamine 1A receptor using cAMP as radioligand in CHO cells,449.0,,CHEMBL615931,,51,,CHO,,H,8,BAO_0000219,
877,,17624,Autocuration,,,1,Inhibition concentration against binding of radioligand [35S]GTP-gamma-S in CHO cells expressing 5-hydroxytryptamine 1A receptor,449.0,,CHEMBL615932,,51,,CHO,,H,8,BAO_0000219,
878,,17624,Autocuration,,,1,Inhibition concentration against binding of radioligand [35S]GTP-gamma-S in CHO cells expressing 5-hydroxytryptamine 1A receptor,449.0,,CHEMBL615933,,51,,CHO,,H,8,BAO_0000219,
879,,15267,Autocuration,,,1,Inhibition of [3H]- 8-OH-DAPT binding against human recombinant 5-hydroxytryptamine 1A receptor,,,CHEMBL615934,,51,,,,H,8,BAO_0000357,
880,,16532,Autocuration,,,1,The binding affinity at the 5-hydroxytryptamine 1A receptor determined using [3H]5-CT; Not tested,,,CHEMBL615935,,51,,,,H,8,BAO_0000357,
881,,6563,Autocuration,,,1,"Agonistic activity of compound towards 5-hydroxytryptamine 1A receptor was evaluated by [35S]GTP-gamma-S, stimulated cAMP assay",,,CHEMBL615936,,51,,,,H,8,BAO_0000019,
882,,4751,Autocuration,,,1,Ability to displace [3H]-8-OH-DPAT from CHO cells stably transfected with human 5-hydroxytryptamine 1A receptor at a concentration of 1 uM,449.0,,CHEMBL615937,,51,,CHO,,H,8,BAO_0000219,
883,,15463,Autocuration,,,1,Compound at 1 uM was tested for the inhibition of radioligand [3H]8-OH-DPAT binding to recombinant human 5-hydroxytryptamine 1A receptor,,,CHEMBL615938,,51,,,,H,8,BAO_0000357,
884,,3805,Autocuration,,,1,In vitro binding affinity against human 5-hydroxytryptamine 1A receptor at a concentration of 100 (nM),,,CHEMBL615797,,51,,,,H,8,BAO_0000357,
885,,5640,Autocuration,,,1,In vitro binding affinity towards 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand,,,CHEMBL615798,,51,,,,H,8,BAO_0000357,
886,,6563,Autocuration,,,1,Inhibition of [3H]8-OH-DPAT binding to human 5-hydroxytryptamine 1A receptor at 1000 nM compound concentration,,,CHEMBL872870,,51,,,,H,8,BAO_0000357,
887,,5548,Autocuration,,,1,Inhibitory activity against 5-hydroxytryptamine 1A receptor using [3H]-8-OH-DPAT as radioligand at 100 nM concentration,,,CHEMBL615799,,51,,,,H,8,BAO_0000357,
888,,6347,Autocuration,,,1,Percent binding affinity against 5-hydroxytryptamine 1A receptor,,,CHEMBL615800,,51,,,,H,8,BAO_0000357,
889,,17296,Autocuration,,,1,Intrinsic activity for human 5-hydroxytryptamine 1A receptors HEK 293 cell membranes using [35S]GTP gamma-S,722.0,,CHEMBL615801,,51,,HEK293,,H,8,BAO_0000219,
890,,13047,Autocuration,,,1,Binding affinity against 5-hydroxytryptamine 1 receptor using rabbit jugular vein assay in the absence of endothelium,,,CHEMBL615802,,51,,,,H,8,BAO_0000019,
891,,15740,Autocuration,,,1,Dissociation constant against human 5-hydroxytryptamine 1A receptor receptor,,,CHEMBL615803,,51,,,,H,8,BAO_0000357,
892,,5640,Expert,,,1,"Inhibition of 5-HT induced [35S]GTP-gamma-S, binding at human cloned 5-HT 1A receptors.",,,CHEMBL835002,,51,,,,H,8,BAO_0000019,
893,,5640,Autocuration,,,1,"5-hydroxytryptamine 1A receptor antagonism was evaluated by the ability to inhibit [35S]GTP-gamma-S, binding that was induced by 5-HT; Ki (nM): not determined",,,CHEMBL615804,,51,,,,H,8,BAO_0000019,
894,,17211,Expert,,,1,Ability to displace [3H]5-CT (2.0 nM) from HeLa cells of human 5-hydroxytryptamine 1A receptor,308.0,,CHEMBL615805,,51,,HeLa,,H,8,BAO_0000219,
895,,4751,Autocuration,,,1,Ability to displace [3H]8-OH-DPAT from CHO cells stably transfected with human 5-hydroxytryptamine 1A receptor,449.0,,CHEMBL615806,,51,,CHO,,H,8,BAO_0000219,
896,,6491,Expert,9606.0,,1,Affinity towards human 5-hydroxytryptamine 1A serotonin receptor,,,CHEMBL615807,,51,Homo sapiens,,,D,9,BAO_0000357,
897,,4707,Autocuration,,,1,Binding affinity towards human 5-hydroxytryptamine 1A receptor was determined using [3H]8-OH-DPAT-as radioligand,,,CHEMBL615808,,51,,,,H,8,BAO_0000357,
898,,13910,Expert,9606.0,,1,Binding affinity against 5-hydroxytryptamine 1A receptor,,,CHEMBL615809,,51,Homo sapiens,,,D,9,BAO_0000357,
899,,16190,Autocuration,,,1,Binding affinity against 5-hydroxytryptamine 1A receptor in HeLa cells was determined using [3H]5-HT,308.0,,CHEMBL615810,,51,,HeLa,,H,8,BAO_0000219,
900,,16633,Autocuration,,,1,Binding affinity against 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand,,,CHEMBL615811,,51,,,,H,8,BAO_0000357,
901,,11898,Autocuration,,,1,Binding affinity against [3H]- -8-OH-DPAT -labeled 5-hydroxytryptamine 1A sites in cloned CHO cells,449.0,,CHEMBL615812,,51,,CHO,,H,8,BAO_0000219,
902,,11898,Autocuration,,,1,Binding affinity against [3H]8-OH-DPAT-labeled 5-hydroxytryptamine 1A receptor sites in cloned CHO cells,449.0,,CHEMBL615751,,51,,CHO,,H,8,BAO_0000219,
903,,14331,Autocuration,,,1,Binding affinity against human 5-hydroxytryptamine 1A receptor,,,CHEMBL615752,,51,,,,H,8,BAO_0000357,
904,,17624,Expert,,,1,Binding affinity against human 5-hydroxytryptamine 1A receptor in CHO cells labeled with [3H]8-OH-DPAT radioligand,449.0,,CHEMBL615753,,51,,CHO,,H,8,BAO_0000219,
905,,17624,Autocuration,,,1,Binding affinity against human 5-hydroxytryptamine 1A receptor in CHO cells labeled with [3H]8-OH-DPAT radioligand; nd=not determined,449.0,,CHEMBL615754,,51,,CHO,,H,8,BAO_0000219,
906,,3307,Autocuration,,,1,Binding affinity of compound to human 5-hydroxytryptamine 1A receptor,,,CHEMBL615755,,51,,,,H,8,BAO_0000357,
907,,6563,Expert,9606.0,,1,Displacement of [3H]8-OH-DPAT from human 5-hydroxytryptamine 1A receptor expressed in CHO cells,449.0,,CHEMBL615756,,51,Homo sapiens,CHO,,D,9,BAO_0000219,
908,,14165,Autocuration,,,1,Binding affinity for 5-hydroxytryptamine 1A receptor in HeLa transfected cell type using [3H]8-OH-DPAT as radioligand,,,CHEMBL615757,,51,,,,H,8,BAO_0000019,
909,,5732,Autocuration,,,1,Binding affinity towards cloned human 5-hydroxytryptamine 1A receptor was determined,,,CHEMBL615758,,51,,,,H,8,BAO_0000357,
910,,13366,Expert,,,1,In vitro affinity at human cloned 5-hydroxytryptamine 1A receptor by [3H]8-OH-DPAT displacement.,,,CHEMBL615759,,51,,,,H,8,BAO_0000357,
911,,17626,Autocuration,,,1,Binding affinity towards human 5-hydroxytryptamine 1A receptor,,,CHEMBL615760,,51,,,,H,8,BAO_0000357,
912,,6588,Expert,,,1,Binding affinity towards human 5-hydroxytryptamine 1A receptor by the displacement of [3H]5-HT radioligand from the cloned receptor expressed in HeLa cells,308.0,,CHEMBL615761,,51,,HeLa,,H,8,BAO_0000219,
913,,16209,Autocuration,,,1,Binding affinity towards human 5-hydroxytryptamine 1A receptor was determined using [3H]-5-HT as radioligand,,,CHEMBL872104,,51,,,,H,8,BAO_0000357,
914,,15463,Autocuration,,,1,Binding affinity towards recombinant human 5-hydroxytryptamine 1A receptor was determined using [3H]8-OH-DPAT as radioligand,,,CHEMBL615762,,51,,,,H,8,BAO_0000357,
915,,15463,Autocuration,,,1,Binding affinity towards recombinant human Compound at 1 uM was tested for the inhibition of radioligand [3H]8-OH-DPAT binding to recombinant human 5-hydroxytryptamine 1A receptor was determined using [3H]8-OH-DPAT as radioligand,,,CHEMBL615763,,51,,,,H,8,BAO_0000357,
916,,14770,Autocuration,,,1,Binding affinity for recombinant human 5-hydroxytryptamine 1A receptor using [3H]5-HT as radioligand.,,,CHEMBL615764,,51,,,,H,8,BAO_0000357,
917,,16245,Autocuration,,,1,Binding affinity on human cloned 5-hydroxytryptamine 1A receptor transfected in human cell lines (He La),1167.0,,CHEMBL615765,,51,,Cell line,,H,8,BAO_0000219,
918,,16245,Autocuration,,,1,Binding affinity on human cloned 5-hydroxytryptamine 1A receptor transfected in human cell lines(He La),,,CHEMBL615766,,51,,,,H,8,BAO_0000019,
919,,5548,Autocuration,,,1,Binding affinity towards 5-HT1A receptor using [3H]8-OH-DPAT as radioligand,,,CHEMBL615767,,51,,,,H,8,BAO_0000357,
920,,5548,Expert,,,1,Binding affinity was determined towards 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand,,,CHEMBL615768,,51,,,,H,8,BAO_0000357,
921,,5548,Autocuration,,,1,Binding affinity towards 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand,,,CHEMBL615769,,51,,,,H,8,BAO_0000357,
922,,6876,Expert,,,1,Binding affinity was evaluated at 5-hydroxytryptamine 1A receptor labeled with [3H]-8-OH-DPAT,,,CHEMBL615770,,51,,,,H,8,BAO_0000357,
923,,2598,Autocuration,,,1,Binding affinity was evaluated at human recombinant 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand,,,CHEMBL615771,,51,,,,H,8,BAO_0000357,
924,,17785,Expert,,,1,Binding affinity to human 5-hydroxytryptamine 1A receptor was measured using [3H]-8-hydroxy-2-(di-n-propylamine) tetraline [3H]8-OH-DPAT) as radioligand,,,CHEMBL615772,,51,,,,H,8,BAO_0000357,
925,,6013,Autocuration,,,1,Binding affinity towards 5-hydroxytryptamine 1A receptor,,,CHEMBL615773,,51,,,,H,8,BAO_0000357,
926,,5929,Expert,,,1,Binding affinity towards 5-hydroxytryptamine 1A receptor in human using [3H]8-OH-DPAT as radioligand,,,CHEMBL615774,,51,,,,H,8,BAO_0000357,
927,,16633,Autocuration,,,1,Binding affinity towards 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand,,,CHEMBL615775,,51,,,,H,8,BAO_0000357,
928,,1558,Autocuration,,,1,Binding affinity towards cloned human 5-hydroxytryptamine 1A receptor was determined,,,CHEMBL615776,,51,,,,H,8,BAO_0000357,
929,,16026,Expert,,,1,Binding affinity towards human cloned 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand,,,CHEMBL615777,,51,,,,H,8,BAO_0000357,
930,,12469,Autocuration,,,1,Binding affinity was measured on 5-hydroxytryptamine 1A receptor in AK cells transfected with human 5-HT1A gene labeled with [3H]-8-OH-DPAT,,,CHEMBL615778,,51,,,,H,8,BAO_0000219,
931,,15874,Expert,9606.0,,1,Binding affinity was measured on cloned Human 5-hydroxytryptamine 1A receptor which is labeled by [3H]8-OH-DPAT,,,CHEMBL615779,,51,Homo sapiens,,,D,9,BAO_0000357,
932,,15874,Autocuration,,,1,Binding affinity was measured on cloned human 5-hydroxytryptamine 1A receptor which is labeled by [3H]8-OH-DPAT,,,CHEMBL615780,,51,,,,H,8,BAO_0000357,
933,,3935,Autocuration,,,1,Compound was evaluated for its binding affinity for human 5-hydroxytryptamine 1A receptor,,,CHEMBL616298,,51,,,,H,8,BAO_0000357,
934,,15818,Autocuration,,,1,Compound was evaluated for its binding affinity towards human 5-hydroxytryptamine 1A receptor,,,CHEMBL616299,,51,,,,H,8,BAO_0000357,
935,,13706,Autocuration,,,1,Compound was tested for binding affinity against cloned human 5-hydroxytryptamine 1A receptor expressed in CHO-K1 cells.,485.0,,CHEMBL616300,,51,,CHO-K1,,H,8,BAO_0000219,
936,,13729,Expert,,,1,Ability to inhibit the forskolin-stimulated c-AMP formation mediated by human 5-hydroxytryptamine 1A receptor in CHO-K1 cells,485.0,,CHEMBL616301,,51,,CHO-K1,,H,8,BAO_0000219,
937,,15413,Autocuration,,,1,In vitro inhibition of [3H]- 8-OH-DPAT binding to cloned cell line containing human 5-hydroxytryptamine 1A receptor,,,CHEMBL616302,,51,,,,H,8,BAO_0000019,
938,,15413,Autocuration,,,1,In vitro inhibition of [3H]- 8-OH-DPAT binding to cloned cell line containing human 5-hydroxytryptamine 1A receptor (Experiment 1),,,CHEMBL616117,,51,,,,H,8,BAO_0000019,
939,,15413,Autocuration,,,1,In vitro inhibition of [3H]- 8-OH-DPAT binding to cloned cell line containing human 5-hydroxytryptamine 1A receptor (Experiment 2),,,CHEMBL616118,,51,,,,H,8,BAO_0000019,
940,,15413,Autocuration,,,1,In vitro inhibition of [3H]- 8-OH-DPAT binding to cloned cell line containing human 5-hydroxytryptamine 1A receptor by Panlabs assay,,,CHEMBL616119,,51,,,,H,8,BAO_0000019,
941,,3445,Expert,9606.0,,1,Displacement of specific [3H]- 5-HT binding to cloned human 5-hydroxytryptamine 1A receptor stably expressed in HeLa cells,308.0,,CHEMBL616120,,51,Homo sapiens,HeLa,,D,9,BAO_0000219,
942,,15740,Autocuration,,,1,Evaluated for the binding constant at [3H]8-OH-DPAT-labeled human 5-hydroxytryptamine 1A receptor,,,CHEMBL616121,,51,,,,H,8,BAO_0000357,
943,,15740,Autocuration,,,1,Evaluated for the binding constant at [3H]8-OH-DPAT-labeled human 5-hydroxytryptamine 1A receptor receptor,,,CHEMBL616122,,51,,,,H,8,BAO_0000357,
944,,17626,Autocuration,,,1,In vitro binding affinity tested on human 5-hydroxytryptamine 1A receptor,,,CHEMBL616123,,51,,,,H,8,BAO_0000357,
945,,4234,Expert,9606.0,,1,In vitro binding affinity to human 5-hydroxytryptamine 1A receptor,,,CHEMBL616124,,51,Homo sapiens,,,D,9,BAO_0000357,
946,,5640,Expert,,,1,In vitro binding affinity at 5-hydroxytryptamine 1A receptor by [3H]8-OH-DPAT displacement.,,,CHEMBL616125,,51,,,,H,8,BAO_0000357,
947,,5272,Expert,10116.0,,1,In vitro binding affinity towards Human 5-hydroxytryptamine 1A receptor by the displacement of [3H]8-OH-DPAT,,,CHEMBL616126,,51,Rattus norvegicus,,,H,8,BAO_0000357,
948,,4622,Autocuration,,,1,In vitro binding affinity towards cloned human 5-hydroxytryptamine 1A receptor expressed in Chinese hamster ovary (CHO) cells using [3H]8-OH-DPAT as radioligand,449.0,,CHEMBL616127,,51,,CHO,,H,8,BAO_0000219,
949,,17085,Expert,,,1,In vitro binding affinity by radioligand binding assay using cell line expressing human 5-hydroxytryptamine 1A receptor,,,CHEMBL616128,,51,,,,H,8,BAO_0000019,
950,,3025,Autocuration,,,1,In vitro binding affinity was determined towards cloned human 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT radioligand,,,CHEMBL616129,,51,,,,H,8,BAO_0000357,
951,,15315,Expert,,,1,In vitro receptor binding affinity for cloned human 5-hydroxytryptamine 1A receptor,,,CHEMBL616130,,51,,,,H,8,BAO_0000357,
952,,15267,Autocuration,,,1,Inhibition of [3H]- OH-DPAT binding against 5-hydroxytryptamine 1A receptor from human recombinant,,,CHEMBL616131,,51,,,,H,8,BAO_0000357,
953,,17158,Autocuration,,,1,Inhibition of [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor serotonergic receptor in human HeLa cells,308.0,,CHEMBL616132,,51,,HeLa,,H,8,BAO_0000219,
954,,14214,Expert,9606.0,,1,Receptor binding affinity for cloned human 5-hydroxytryptamine 1A receptor in HeLa cells,308.0,,CHEMBL616133,,51,Homo sapiens,HeLa,,D,9,BAO_0000219,
955,,17133,Autocuration,,,1,Tested in vitro for its ability to bind to 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand,,,CHEMBL616134,,51,,,,H,8,BAO_0000357,
956,,16532,Autocuration,,,1,The binding affinity at the 5-hydroxytryptamine 1A receptor determined using [3H]5-CT,,,CHEMBL616135,,51,,,,H,8,BAO_0000357,
957,,2391,Expert,9606.0,,1,Affinity for 5-hydroxytryptamine 1A receptor subtype,,,CHEMBL616136,,51,Homo sapiens,,,D,9,BAO_0000357,
958,,14447,Autocuration,,,1,The compound was tested for CNS binding affinity towards 5-hydroxytryptamine 1A receptor from cloned Human membranes,,,CHEMBL616137,,51,,,,H,8,BAO_0000019,
959,,14447,Autocuration,,,1,The compound was tested for CNS binding affinity towards 5-hydroxytryptamine 1A receptor from cloned Human membranes.,,,CHEMBL872105,,51,,,,H,8,BAO_0000019,
960,,15086,Autocuration,,,1,The compound was tested for binding affinity against 5-hydroxytryptamine 1A receptor receptor,,,CHEMBL616138,,51,,,,H,8,BAO_0000357,
961,,13051,Expert,9606.0,,1,Binding affinity for cloned human 5-hydroxytryptamine 1A receptor,,,CHEMBL616139,,51,Homo sapiens,,,D,9,BAO_0000357,
962,,16026,Autocuration,,,1,"Ability to influence the binding of [35S]GTP-gamma-S, to HeLa cell membranes expressing the human 5-hydroxytryptamine 1A receptor; Not active",,,CHEMBL616140,,51,,,,H,8,BAO_0000019,
963,,17085,Expert,,,1,In vitro binding affinity was determined by radioligand binding assay using cell line expressing human 5-hydroxytryptamine 1A receptor; ND means not determined,,,CHEMBL616141,,51,,,,H,8,BAO_0000019,
964,,17133,Autocuration,,,1,Tested in vitro for its ability to bind to 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand,,,CHEMBL616142,,51,,,,H,8,BAO_0000357,
965,,17133,Autocuration,,,1,Tested in vitro for its ability to bind to 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand; ND means Not determined,,,CHEMBL616143,,51,,,,H,8,BAO_0000357,
966,,17211,Autocuration,,,1,Ability to displace [3H]5-CT (2.0 nM) from HeLa cells of human 5-hydroxytryptamine 1A receptor; NT denotes not tested,308.0,,CHEMBL616144,,51,,HeLa,,H,8,BAO_0000219,
967,,17211,Autocuration,,,1,Ability to displace [3H]5-CT (2.0 nM) from HeLa cells of human 5-hydroxytryptamine 1A receptor; NT=not tested,308.0,,CHEMBL616145,,51,,HeLa,,H,8,BAO_0000219,
968,,17211,Autocuration,,,1,Ability to displace [3H]5-CT (2.0 nM) from HeLa cells of human 5-hydroxytryptamine 1A receptor; NT denotes not tested,308.0,,CHEMBL616012,,51,,HeLa,,H,8,BAO_0000219,
969,,17211,Autocuration,,,1,Ability to displace [3H]5-CT (2.0 nM) from HeLa cells of human 5-hydroxytryptamine 1A receptor; NT denotes not tested,308.0,,CHEMBL616013,,51,,HeLa,,H,8,BAO_0000219,
970,,16394,Autocuration,,,1,"Agonist efficacy of [35S]GTP-gamma-S, binding to 5-hydroxytryptamine 1A receptor compared with 5-HT.; NT is not tested",,,CHEMBL616014,,51,,,,H,8,BAO_0000019,
971,,16394,Autocuration,,,1,"Agonist efficacy of [35S]GTP-gamma-S, binding to 5-hydroxytryptamine 1A receptor compared with 5-HT.; NT is not tested",,,CHEMBL616015,,51,,,,H,8,BAO_0000019,
972,,16394,Autocuration,,,1,"Agonist efficacy of [35S]GTP-gamma-S, binding to 5-hydroxytryptamine 1A receptor compared with 5-HT.; NT is not tested",,,CHEMBL616016,,51,,,,H,8,BAO_0000019,
973,In vivo,16394,Autocuration,,,1,Antagonist induction of hypothermia by 8-OH-DPAT in 5-hydroxytryptamine 1A receptor after subcutaneous administration; NT is not tested,,,CHEMBL616017,,51,,,,H,8,BAO_0000218,
974,,16394,Autocuration,,,1,Binding affinity at human 5-hydroxytryptamine 1A receptor by inhibition of [3H]-8-OH-DPAT binding in Chinese hamster ovary cell line; NT is not tested,,,CHEMBL616018,,51,,,,H,8,BAO_0000019,
975,,15740,Autocuration,,,1,EC50 for inhibition of 50 uM forskolin-stimulated cAMP accumulation against 5-hydroxytryptamine 1A receptor receptor; Not tested,,,CHEMBL616019,,51,,,,H,8,BAO_0000019,
976,,15740,Autocuration,,,1,EC50 for inhibition of 50 uM forskolin-stimulated cAMP accumulation against 5-hydroxytryptamine 1A receptor; Not tested,,,CHEMBL616020,,51,,,,H,8,BAO_0000019,
977,,15740,Autocuration,,,1,Evaluated for the binding constant at [3H]8-OH-DPAT-labeled human 5-hydroxytryptamine 1A receptor,,,CHEMBL858018,,51,,,,H,8,BAO_0000357,
978,,17296,Autocuration,,,1,Binding affinity against human 5-hydroxytryptamine 1A receptors HEK 293 cell membranes using [35S]GTP gamma-S,722.0,,CHEMBL616021,,51,,HEK293,,H,8,BAO_0000219,
979,,5640,Expert,,,1,"Stimulation of binding of [35S]GTP-gamma-S, to G protein mediated by human cloned 5-hydroxytryptamine 1A receptor tested in vitro at 1 uM.",,,CHEMBL616022,,51,,,,H,8,BAO_0000019,
980,,5640,Autocuration,,,1,"Stimulation of binding of [35S]GTP-gamma-S, to G protein mediated by human cloned 5-hydroxytryptamine 1A receptor tested in vitro at a concentration of 1 uM; ND means Not determined",,,CHEMBL616023,,51,,,,H,8,BAO_0000019,
981,,5640,Autocuration,,,1,"Stimulation of binding of [35S]GTP-gamma-S, to G protein mediated by human cloned 5-hydroxytryptamine 1A receptor tested in vitro at a concentration of 1 uM; ND means not determined",,,CHEMBL616024,,51,,,,H,8,BAO_0000019,
982,,5640,Autocuration,,,1,"Stimulation of binding of [35S]GTP-gamma-S, to G protein mediated by human cloned 5-hydroxytryptamine 1A receptor tested in vitro at a concentration of 1 uM; Not determined",,,CHEMBL616025,,51,,,,H,8,BAO_0000019,
983,,2759,Autocuration,,,1,Antagonistic efficacy was evaluated by adenylyl cyclase assay in CHO cells stably expressing the human 5-HT1A receptor,449.0,,CHEMBL616026,,51,,CHO,,H,8,BAO_0000219,
984,,16394,Autocuration,,,1,"Agonist efficacy of [35S]GTP-gamma-S, binding to 5-hydroxytryptamine 1A receptor compared with 5-HT",,,CHEMBL616027,,51,,,,H,8,BAO_0000019,
985,,16394,Expert,9606.0,,1,"Agonist efficacy of [35S]GTP-gamma-S, binding to 5-hydroxytryptamine 1A receptor compared to 5-HT",,,CHEMBL616028,,51,Homo sapiens,,,D,9,BAO_0000019,
986,,3445,Expert,9606.0,,1,Percent efficacy against human 5-hydroxytryptamine 1A receptor relative to maximal 5-HT response,,,CHEMBL616029,,51,Homo sapiens,,,D,9,BAO_0000019,
987,,4316,Expert,,,1,Binding affinity for 5-hydroxytryptamine 1A receptor was determined by incubating human 5-hydroxytryptamine 1A receptor transfected CHO cells with [3H]8-OH-DPAT,449.0,,CHEMBL616030,,51,,CHO,,H,8,BAO_0000219,
988,,4316,Expert,,,1,In vitro inhibition of [3H]8-OH-DPAT binding to human cloned 5-hydroxytryptamine 1A receptor on CHO cell membranes.,,,CHEMBL616031,,51,,,,H,8,BAO_0000019,
989,,15180,Expert,9606.0,,1,Agonist efficacy on 5-hydroxytryptamine 1A receptor subtype,,,CHEMBL616032,,51,Homo sapiens,,,D,9,BAO_0000019,
990,,15180,Expert,9606.0,,1,Agonist efficacy on 5-hydroxytryptamine 1A receptor subtype,,,CHEMBL616033,,51,Homo sapiens,,,D,9,BAO_0000019,
991,,15042,Autocuration,,,1,Maximum binding affinity was evaluated as ([35S]GTP binding on 5-hydroxytryptamine 1A serotonergic receptors.,,,CHEMBL616034,,51,,,,H,8,BAO_0000019,
992,,15042,Autocuration,,,1,Maximum binding affinity was evaluated as ([35S]GTP binding on 5-hydroxytryptamine 1A serotonergic receptors.,,,CHEMBL616035,,51,,,,H,8,BAO_0000019,
993,,15042,Autocuration,,,1,Maximum binding affinity was evaluated as ([35S]GTP binding on cloned human 5-hydroxytryptamine 1A receptor,,,CHEMBL616036,,51,,,,H,8,BAO_0000019,
994,,15042,Autocuration,,,1,Agonist efficacy was evaluated as ([35S]GTP binding on 5-hydroxytryptamine 1A serotonergic receptors.,,,CHEMBL616037,,51,,,,H,8,BAO_0000019,
995,,15042,Autocuration,,,1,Agonist efficacy was evaluated as ([35S]GTP binding on 5-hydroxytryptamine 1A serotonergic receptors.,,,CHEMBL616038,,51,,,,H,8,BAO_0000019,
996,,15042,Autocuration,,,1,Agonist efficacy was evaluated as ([35S]GTP binding on 5-hydroxytryptamine 1A serotonergic receptors.,,,CHEMBL616039,,51,,,,H,8,BAO_0000019,
997,,15042,Autocuration,,,1,Agonist efficacy was evaluated as [35S]GTP binding on cloned human 5-hydroxytryptamine 1A receptor,,,CHEMBL616040,,51,,,,H,8,BAO_0000019,
998,,15180,Expert,9606.0,,1,Concentration required to obtain 50% maximal stimulation of [35S]GTP gamma-S binding to human cloned 5-HT1A receptors of cell membranes from HeLa cells,308.0,,CHEMBL616041,,51,Homo sapiens,HeLa,,D,9,BAO_0000219,
999,,15180,Expert,9606.0,,1,Negative logarithm of concentration required to obtain 50% maximal stimulation of [35S]GTP gamma-S binding to human cloned 5-HT1A receptors of cell membranes from HeLa cells,308.0,,CHEMBL616042,,51,Homo sapiens,HeLa,,D,9,BAO_0000219,
1000,,15180,Expert,9606.0,,1,Negative logarithm of concentration required to obtain 50% maximal stimulation of [35S]GTP gamma-S binding to human cloned 5-HT1A receptors of cell membranes from HeLa cells,308.0,,CHEMBL616043,,51,Homo sapiens,HeLa,,D,9,BAO_0000219,
1001,,16245,Autocuration,,,1,"Potency (pD2) for the stimulation of [35S]GTP-gamma-S, binding on 5-hydroxytryptamine 1A receptor",,,CHEMBL616044,,51,,,,H,8,BAO_0000019,
1002,,16026,Autocuration,,,1,"Ability to influence the binding of [35S]GTP-gamma-S, to HeLa cell membranes expressing the human 5-hydroxytryptamine 1A receptor",,,CHEMBL616045,,51,,,,H,8,BAO_0000019,
1003,,17296,Autocuration,,,1,Binding affinity against human 5-hydroxytryptamine 1A receptors HEK 293 cell membranes using [35S]GTP gamma-S,722.0,,CHEMBL616046,,51,,HEK293,,H,8,BAO_0000219,
1004,,2759,Autocuration,,,1,Compound was tested for its potency against 5-hydroxytryptamine 1A receptor expressed in CHO cells (experiment 2),449.0,,CHEMBL616047,,51,,CHO,,H,8,BAO_0000219,
1005,,2759,Autocuration,,,1,Compound was tested for its potency against human 5-hydroxytryptamine 1A receptor expressed in CHO cells,449.0,,CHEMBL616048,,51,,CHO,,H,8,BAO_0000219,
1006,,2759,Expert,9606.0,,1,Potency against human 5-hydroxytryptamine 1A receptor expressed in CHO cells (experiment 1),449.0,,CHEMBL616049,,51,Homo sapiens,CHO,,D,9,BAO_0000219,
1007,,2759,Autocuration,,,1,Compound was tested for its potency against human 5-hydroxytryptamine 1A receptor expressed in CHO cells (experiment 2),449.0,,CHEMBL616050,,51,,CHO,,H,8,BAO_0000219,
1008,,15419,Expert,,,1,In vitro effective concentration required to inhibit forskolin-stimulated cAMP levels in HA7 cells expressing human 5-HT1A receptor,,,CHEMBL616051,,51,,,,H,8,BAO_0000219,
1009,,15419,Autocuration,,,1,In vitro effective concentration required to inhibit forskolin-stimulated cAMP levels in HA7 cells expressing human 5-HT1A receptor; Not tested,,,CHEMBL616212,,51,,,,H,8,BAO_0000219,
1010,,16026,Autocuration,,,1,"ability to influence the binding of [35S]GTP-gamma-S, to HeLa cell membranes expressing the human 5-hydroxytryptamine 1A receptor",,,CHEMBL616213,,51,,,,H,8,BAO_0000019,
1011,In vitro,1414,Expert,,,1,Ability to bind to 5-hydroxytryptamine 1A receptor from cloned human expressed in Ha7 cells,,,CHEMBL616214,,51,,,,H,8,BAO_0000219,
1012,In vitro,1414,Expert,,,1,Ability to bind to 5-hydroxytryptamine 1A receptor subtype from cloned human expressed in Ha7 cells,,,CHEMBL616215,,51,,,,H,8,BAO_0000219,
1013,,12861,Autocuration,,,1,Binding activity radioligand.,,,CHEMBL616216,,51,,,,H,8,BAO_0000357,
1014,,12861,Autocuration,,,1,Binding activity against 5-hydroxytryptamine 3 receptor from rat cortex homogenate using [3H]-Q-ICS 205-930 as radioligand.,,,CHEMBL616217,,51,,,,H,8,BAO_0000019,
1015,,5104,Autocuration,,,1,Binding affinity for human cloned 5-hydroxytryptamine 1A receptor,,,CHEMBL616218,,51,,,,H,8,BAO_0000357,
1016,,5105,Autocuration,,,1,Binding affinity for human cloned 5-hydroxytryptamine 1A receptor,,,CHEMBL616219,,51,,,,H,8,BAO_0000357,
1017,,16312,Autocuration,,,1,binding affinity towards human recombinant 5-hydroxytryptamine 1A receptor,,,CHEMBL616220,,51,,,,H,8,BAO_0000357,
1018,,15180,Expert,9606.0,,1,Displacement of [3H]8-hydroxy-2-(di-n-propylamino)tetralin from human 5-hydroxytryptamine 1A receptor,,,CHEMBL833493,,51,Homo sapiens,,,D,9,BAO_0000357,
1019,,5033,Autocuration,,,1,Ability to displace the radioligand [3H]-8-OH-DPAT from human 5-hydroxytryptamine 1A receptor,,,CHEMBL616221,,51,,,,H,8,BAO_0000357,
1020,,16909,Expert,9606.0,,1,Affinity constant on CHO cells expressing Human recombinant 5-hydroxytryptamine receptor 1A,449.0,,CHEMBL616222,,51,Homo sapiens,CHO,,D,9,BAO_0000219,
1021,,2590,Autocuration,,,1,Antagonistic affinity against cloned human 5-hydroxytryptamine 1A receptor,,,CHEMBL616223,,51,,,,H,8,BAO_0000019,
1022,,2590,Autocuration,,,1,Antagonistic affinity against cloned human 5-hydroxytryptamine 1A receptor; Not determined,,,CHEMBL616224,,51,,,,H,8,BAO_0000019,
1023,,16394,Expert,,,1,Binding affinity at human 5-hydroxytryptamine 1A receptor by inhibition of [3H]8-OH-DPAT binding in Chinese hamster ovary cell line,,,CHEMBL616225,,51,,,,H,8,BAO_0000019,
1024,,4540,Expert,9606.0,,1,Binding affinity to human cloned 5-hydroxytryptamine 1A receptor in HEK 293 cells using [3H]-8-OH- DPAT as radioligand,722.0,,CHEMBL616226,,51,Homo sapiens,HEK293,,D,9,BAO_0000219,
1025,,17296,Autocuration,,,1,Binding affinity against 5-hydroxytryptamine 1A human cloned receptors in HEK293 cells,722.0,,CHEMBL616227,,51,,HEK293,,H,8,BAO_0000219,
1026,,17296,Autocuration,,,1,Binding affinity against 5-hydroxytryptamine 1A human cloned receptors in HEK293 cells using [3H]8-OH-DPAT as radioligand,722.0,,CHEMBL616228,,51,,HEK293,,H,8,BAO_0000219,
1027,,15779,Autocuration,,,1,Binding affinity towards 5-hydroxytryptamine 1A receptor (human cloned receptor) in HEK293 cells using [3H]8-OH-DPAT as radioligand;,722.0,,CHEMBL616229,,51,,HEK293,,H,8,BAO_0000219,
1028,,15779,Autocuration,,,1,Binding affinity towards 5-hydroxytryptamine 1A receptor (human cloned receptor) in HEK293 cells using [3H]8-OH-DPAT as radioligand; ND means no data,722.0,,CHEMBL616230,,51,,HEK293,,H,8,BAO_0000219,
1029,,15779,Autocuration,,,1,Binding affinity towards 5-hydroxytryptamine 1A receptor (human cloned receptor) in HEK293 cells using [3H]8-OH-DPAT as radioligand;ND means no data.,722.0,,CHEMBL616231,,51,,HEK293,,H,8,BAO_0000219,
1030,,6166,Autocuration,,,1,Binding affinity towards 5-hydroxytryptamine 1A receptor in human using [3H]8-OH-DPAT as radioligand,,,CHEMBL616232,,51,,,,H,8,BAO_0000357,
1031,,15779,Autocuration,,,1,Binding affinity towards 5-hydroxytryptamine 1A receptor (human cloned receptor) in HEK293 cells using [3H]8-OH-DPAT as radioligand;,722.0,,CHEMBL616233,,51,,HEK293,,H,8,BAO_0000219,
1032,,4199,Autocuration,,,1,Compound was evaluated for binding affinity against human cloned 5-hydroxytryptamine 1A receptor in HEK 293 cells using [3H]8-OH-DPAT as the radioligand,722.0,,CHEMBL857973,,51,,HEK293,,H,8,BAO_0000219,
1033,,15316,Autocuration,,,1,Compound was evaluated for its ability to displace [3H]8-OH-DPAT binding from human 5-hydroxytryptamine 1A receptor in mammalian cells,,,CHEMBL616234,,51,,,,H,8,BAO_0000219,
1034,,14875,Autocuration,,,1,Compound was tested for binding affinity against human 5-hydroxytryptamine 1A receptor,,,CHEMBL616235,,51,,,,H,8,BAO_0000357,
1035,,14727,Expert,,,1,Binding affinity at human cloned 5-hydroxytryptamine 1A receptor expressed in HeLa cells by [3H]8-hydroxy-2-(di-n-propylamino)tetraline displacement.,308.0,,CHEMBL616236,,51,,HeLa,,H,8,BAO_0000219,
1036,,14727,Expert,,,1,Binding affinity at native 5-hydroxytryptamine 1A receptor in rat by [3H]8-hydroxy-2-(di-n-propylamino)tetraline displacement.,,,CHEMBL616237,,51,,,,H,8,BAO_0000019,
1037,,15146,Autocuration,,,1,Compound was tested for its binding affinity against 5-hydroxytryptamine 1A receptor in human cloned receptors in HEK 293 cells using [3H]8-OH-DPAT,722.0,,CHEMBL616238,,51,,HEK293,,H,8,BAO_0000219,
1038,,5213,Autocuration,,,1,Compound was tested for its binding affinity for human cloned 5-hydroxytryptamine 1A receptor in HEK 293 using [3H]5-CT as a radioligand,722.0,,CHEMBL616239,,51,,HEK293,,H,8,BAO_0000219,
1039,,16429,Autocuration,,,1,In vitro binding affinity at human recombinant 5-hydroxytryptamine 1A receptor in mammalian cells using 3[H]8-OH-DPAT as the radioligand,,,CHEMBL616240,,51,,,,H,8,BAO_0000219,
1040,,15042,Expert,9606.0,,1,The binding affinity was evaluated on cloned human 5-hydroxytryptamine 1A receptor expressed in HeLa cells by using DPAT as radioligand.,308.0,,CHEMBL616241,,51,Homo sapiens,HeLa,,D,9,BAO_0000219,
1041,,14818,Autocuration,,,1,The compound was tested for its binding affinity towards cloned human 5-hydroxytryptamine 1A receptor in HEK 293 cells using [3H]8-OH-DPAT.,722.0,,CHEMBL616242,,51,,HEK293,,H,8,BAO_0000219,
1042,,4829,Autocuration,,,1,"The compound was tested for the binding affinity towards human cloned 5-hydroxytryptamine 1A receptor in HEK293 cells, using [3H]8-OH-DPAT as radioligand",722.0,,CHEMBL616243,,51,,HEK293,,H,8,BAO_0000219,
1043,,17200,Expert,,,1,In vitro inhibitory concentration required against [3H]8-OH-DPAT binding to cloned human 5-hydroxytryptamine 1A receptor,,,CHEMBL616244,,51,,,,D,9,BAO_0000357,
1044,,13051,Autocuration,9606.0,,1,The compound was tested for binding affinity against cloned human 5-hydroxytryptamine 1A receptor,,,CHEMBL616245,,51,Homo sapiens,,,D,9,BAO_0000357,
1045,,5486,Autocuration,,,1,Binding affinity towards 5-HT1B receptor by the displacement of [3H]-5-CT] in human recombinant receptors in mammalian cell,,,CHEMBL616246,,106,,,,H,8,BAO_0000357,
1046,,5254,Autocuration,,,1,Binding affinity against 5-HT1D receptor,,,CHEMBL616247,,105,,,,H,8,BAO_0000357,
1047,,5254,Autocuration,,,1,Binding affinity against 5-hydroxytryptamine 1A receptor,,,CHEMBL616248,,105,,,,H,8,BAO_0000357,
1048,,15331,Autocuration,,,1,Affinity of compound towards 5-hydroxytryptamine 1A receptor was evaluated using radioligand binding technique,,,CHEMBL616249,,107,,,,H,8,BAO_0000357,
1049,,13506,Autocuration,9606.0,,1,Binding affinity against serotonin 5-hydroxytryptamine 1A receptor using radioligand [3H]8-OH-DPAT binding assay,,,CHEMBL616250,,10576,Homo sapiens,,,H,8,BAO_0000357,
1050,,15267,Autocuration,,,1,Inhibition of [3H]- 8-OH-DAPT binding against human recombinant 5-hydroxytryptamine 1A receptor,,,CHEMBL616251,,51,,,,H,8,BAO_0000357,
1051,In vivo,16616,Autocuration,,,1,Antagonist activity at 5-hydroxytryptamine 1A receptor against (+)-8-OH-DPAT induced hypothermia in mice 15 min after administration of the compound,,,CHEMBL616252,,11863,,,,H,8,BAO_0000218,
1052,In vivo,16616,Autocuration,,,1,Antagonist activity at 5-hydroxytryptamine 1A receptor against (+)-8-OH-DPAT induced hypothermia in mice 30 min after administration of the compound,,,CHEMBL616253,,11863,,,,H,8,BAO_0000218,
1053,In vivo,16616,Autocuration,,,1,Antagonist activity at 5-hydroxytryptamine 1A receptor against (+)-8-OH-DPAT induced hypothermia in mice 60 min after administration of the compound,,,CHEMBL616254,,11863,,,,H,8,BAO_0000218,
1054,,16616,Expert,10090.0,,1,Antagonist activity at 5-hydroxytryptamine 1A receptor against (+)-8-OH-DPAT induced hypothermia in mice at 10 mg/kg after 15 min,,,CHEMBL616255,,11863,Mus musculus,,,D,9,BAO_0000218,
1055,,16616,Expert,10090.0,,1,Antagonist activity at 5-hydroxytryptamine 1A receptor against (+)-8-OH-DPAT induced hypothermia in mice at 10 mg/kg after 30 min,,,CHEMBL832872,,11863,Mus musculus,,,D,9,BAO_0000218,
1056,,16616,Expert,10090.0,,1,Antagonist activity at 5-hydroxytryptamine 1A receptor against (+)-8-OH-DPAT induced hypothermia in mice at 10 mg/kg after 60 min,,,CHEMBL616256,,11863,Mus musculus,,,D,9,BAO_0000218,
1057,,16616,Expert,10090.0,,1,Antagonist activity at 5-hydroxytryptamine 1A receptor against (+)-8-OH-DPAT induced hypothermia in mice at 1 mg/kg after 15 min,,,CHEMBL616257,,11863,Mus musculus,,,D,9,BAO_0000218,
1058,,16616,Expert,10090.0,,1,Antagonist activity at 5-hydroxytryptamine 1A receptor against (+)-8-OH-DPAT induced hypothermia in mice at 1 mg/kg after 30 min,,,CHEMBL616258,,11863,Mus musculus,,,D,9,BAO_0000218,
1059,,16616,Expert,10090.0,,1,Antagonist activity at 5-hydroxytryptamine 1A receptor against (+)-8-OH-DPAT induced hypothermia in mice at 1 mg/kg after 60 min,,,CHEMBL616384,,11863,Mus musculus,,,D,9,BAO_0000218,
1060,,10297,Autocuration,,,1,Hill number was determined for inhibition of of [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor in mouse hippocampus,,,CHEMBL616385,,11863,,,,H,8,BAO_0000221,10000000.0
1061,,13704,Expert,,,1,Inhibitory activity against serotonin 5-hydroxytryptamine 1A receptor from mice.,,,CHEMBL616386,,11863,,,,H,8,BAO_0000357,
1062,,10297,Expert,10090.0,,1,Inhibitory activity towards 5-hydroxytryptamine 1A receptor by the displacement of [3H]8-OH-DPAT in mouse hippocampus,,,CHEMBL616387,,11863,Mus musculus,,,D,9,BAO_0000221,10000000.0
1063,,10297,Autocuration,,,1,Binding affinity towards 5-hydroxytryptamine 1A receptor by the displacement of [3H]8-OH-DPAT in mouse hippocampus; Not determined,,,CHEMBL616388,,11863,,,,H,8,BAO_0000221,10000000.0
1064,,10297,Expert,10090.0,,1,Binding affinity towards 5-hydroxytryptamine 1A receptor by the displacement of [3H]8-OH-DPAT in mouse hippocampus,,,CHEMBL616389,,11863,Mus musculus,,,D,9,BAO_0000221,10000000.0
1065,,10297,Autocuration,,,1,Binding affinity towards 5-hydroxytryptamine 1A receptor by the displacement of [3H]8-OH-DPAT in mouse hippocampus; Not determined,,,CHEMBL616390,,11863,,,,H,8,BAO_0000221,10000000.0
1066,,217,Autocuration,,,1,Compound was tested for binding affinity to 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as a radioligand,,,CHEMBL616391,,11863,,,,H,8,BAO_0000357,
1067,,10297,Expert,10090.0,,1,Hill number was determined for inhibition of of [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor in mouse hippocampus,,,CHEMBL616392,,11863,Mus musculus,,,D,9,BAO_0000221,10000000.0
1068,,4921,Autocuration,9823.0,,1,Ability to displace [3H]8-OH-DPAT radioligand from porcine 5-hydroxytryptamine 1A receptor,,,CHEMBL616393,,51,Sus scrofa,,,H,8,BAO_0000357,
1069,,4921,Autocuration,9823.0,,1,Ability to displace [3H]8-OH-DPAT radioligand from porcine 5-hydroxytryptamine 1A receptor; ND denotes not determined,,,CHEMBL616394,,51,Sus scrofa,,,H,8,BAO_0000357,
1070,,4996,Autocuration,9823.0,,1,Binding affinity of compound measured for 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT-labeled porcine brain homogenates,,,CHEMBL616395,,51,Sus scrofa,,,H,8,BAO_0000019,
1071,,12918,Autocuration,9823.0,,1,Compound was evaluated for the binding affinity at 5- HT1A receptor,,,CHEMBL616396,,51,Sus scrofa,,,H,8,BAO_0000357,
1072,,5333,Autocuration,9823.0,,1,Compound was tested in vitro for its ability to compete with [3H]8-OH-DPAT at 5-hydroxytryptamine 1A receptor in porcine brain homogenate,,,CHEMBL872907,,51,Sus scrofa,,,H,8,BAO_0000019,
1073,,4437,Autocuration,9823.0,,1,In vitro for its ability to displace [3H]8-OH-DPAT from 5-hydroxytryptamine 1A receptor in porcine brain homogenate,,,CHEMBL616397,,51,Sus scrofa,,,H,8,BAO_0000019,
1074,,1742,Autocuration,9823.0,,1,Compound was tested for its ability to displace [3H]8-OH-DPAT from 5-hydroxytryptamine 1A receptor in pig cortex,,,CHEMBL616398,,51,Sus scrofa,,,H,8,BAO_0000019,
1075,,16688,Expert,9823.0,,1,Displacement of [3H]- 8-OH-DPAT from porcine 5-hydroxytryptamine 1A receptor,,,CHEMBL616399,,51,Sus scrofa,,,H,8,BAO_0000357,
1076,,12861,Autocuration,9823.0,,1,Binding activity radioligand.,,,CHEMBL857065,,51,Sus scrofa,,,H,8,BAO_0000357,
1077,,12861,Expert,9823.0,,1,Binding activity against 5-hydroxytryptamine 1A receptor from pig cortex membrane using [3H]8-OH-DPAT-HT as radioligand.,,,CHEMBL616400,,51,Sus scrofa,,,H,8,BAO_0000019,
1078,,12861,Autocuration,9823.0,,1,Binding activity against 5-hydroxytryptamine 1A receptor from pig cortex membrane using [3H]8-OH-DPAT-HT as radioligand.,,,CHEMBL616401,,51,Sus scrofa,,,H,8,BAO_0000019,
1079,,12490,Expert,,,1,Displacement of [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor from pig cortex,,,CHEMBL616402,,10624,,,,H,8,BAO_0000019,
1080,,11828,Expert,9823.0,,1,Displacement of [3H]8-OH-DPAT from pig cortex 5-hydroxytryptamine 1A receptor,,,CHEMBL616403,,51,Sus scrofa,,,H,8,BAO_0000019,
1081,,11866,Autocuration,9823.0,,1,Binding affinity for 5-hydroxytryptamine 1A receptor in piglet hippocampus using [3H]8-OH-DPAT,,,CHEMBL616404,,51,Sus scrofa,,,H,8,BAO_0000221,10000000.0
1082,,12827,Autocuration,9823.0,,1,Binding affinity towards 5-hydroxytryptamine 1A receptor in pig frontal cortex membranes using [8H]-OH-DPAT,,,CHEMBL616405,,51,Sus scrofa,,,H,8,BAO_0000249,
1083,,12918,Autocuration,9823.0,,1,Binding affinity was evaluated by 5-hydroxytryptamine 1A receptor agonism in the pig cortex by displacing 8-OH-DPAT,,,CHEMBL616406,,51,Sus scrofa,,,H,8,BAO_0000019,
1084,,12919,Expert,9823.0,,1,Agonistic activity against 5-hydroxytryptamine 1A receptor in pig cortex using [3H]8-OH-DPAT,,,CHEMBL616407,,51,Sus scrofa,,,H,8,BAO_0000019,
1085,,13047,Autocuration,9986.0,,1,Binding affinity against 5-hydroxytryptamine 1 receptor using rabbit jugular vein assay in the presence of endothelium,,,CHEMBL616408,,51,Oryctolagus cuniculus,,,H,8,BAO_0000019,
1086,,15796,Expert,10116.0,,1,Inhibition activity against 5-hydroxytryptamine 1A receptor in rat hippocampus membranes using radio binding assays,,,CHEMBL616409,,10576,Rattus norvegicus,,,D,9,BAO_0000249,
1087,,3651,Expert,10116.0,,1,"Inhibition of [3H]8-hydroxy-2-dipropylamino-1,2,3,4-tetrahydronaphthalene binding to 5-hydroxytryptamine 1A receptor in hippocampus region of rat brain; Less active",,,CHEMBL616410,,10576,Rattus norvegicus,,,D,9,BAO_0000221,10000000.0
1088,,188,Autocuration,,,1,Tested for the effect on binding at 5-hydroxytryptamine 1A receptor; No activity,,,CHEMBL616411,,10576,,,,H,8,BAO_0000357,
1089,,16616,Expert,10116.0,,1,"Antagonist activity to stimulate binding of [35S]GTP-gamma-S, to 5-hydroxytryptamine 1A receptor in isolated rat hippocampal membranes",,,CHEMBL616412,Membranes,10576,Rattus norvegicus,,,D,9,BAO_0000249,
1090,,16616,Expert,10116.0,,1,"Inhibition of (+)-8-OH-DPAT stimulated [35S]GTP-gamma-S, binding in rat hippocampal membranes",,,CHEMBL616413,Membranes,10576,Rattus norvegicus,,,D,9,BAO_0000249,10000000.0
1091,,12306,Autocuration,,,1,The binding of [125I]MPPI ligand to 5-hydroxytryptamine 1A receptor of rat hippocampal homogenates,,,CHEMBL616414,,10576,,,,H,8,BAO_0000221,10000000.0
1092,,17167,Expert,10116.0,,1,Binding affinity for rat hippocampus 5-hydroxytryptamine 1A receptor by inhibition of [3H]8-OH-DPAT binding,,,CHEMBL616415,,10576,Rattus norvegicus,,,D,9,BAO_0000221,10000000.0
1093,,14776,Autocuration,,,1,Binding affinity measured at the 5-hydroxytryptamine 1A receptor by the inhibition of [3H]8-OH-DPAT binding to rat cortex using unlabeled buspirone for nonspecific binding.,,,CHEMBL616416,,10576,,,,H,8,BAO_0000019,
1094,,12158,Expert,,,1,Binding affinity of 5-hydroxytryptamine 1A receptor using [3H]-8-OH-DPAT as radioligand.,,,CHEMBL616417,,10576,,,,H,8,BAO_0000357,
1095,,13481,Autocuration,,,1,Binding affinity of [3H]- -8-OH-DPAT labelled towards Rat Hippocampal 5-hydroxytryptamine 1A receptor using radioligand binding assay,,,CHEMBL616418,,10576,,,,H,8,BAO_0000357,
1096,In vitro,13427,Autocuration,,,1,Binding affinity of [3H]-8-OH-DPAT towards 5-hydroxytryptamine 1A receptor in cloned mammalian receptor expressed in cultured cells or from rat whole brain.,,,CHEMBL616419,,10576,,,,H,8,BAO_0000219,
1097,,10210,Autocuration,,,1,Binding affinity of compound against 5-hydroxytryptamine 1A receptor binding site using radioligand [3H]8-OH-DPAT,,,CHEMBL616420,,10576,,,,H,8,BAO_0000357,
1098,,10205,Autocuration,,,1,Binding affinity of compound towards 5-HT 1A receptor by measuring ability to displace [3H]OH-DPAT from 5-hydroxytryptamine 1A receptor in rat striatal membranes,,,CHEMBL616421,Membranes,10576,,,,H,8,BAO_0000249,
1099,,10205,Autocuration,,,1,Binding affinity of compound towards 5-HT 1A receptor by measuring ability to displace [3H]OH-DPAT from 5-hydroxytryptamine 1A receptor in rat striatal membranes,,,CHEMBL616422,Membranes,10576,,,,H,8,BAO_0000249,
1100,,10205,Expert,,,1,Binding affinity of compound towards 5-hydroxytryptamine 1A receptor in rat striatal membranes by [3H]OH-DPAT displacement.,,,CHEMBL616423,Membranes,10576,,,,H,8,BAO_0000249,
1101,,12280,Expert,10116.0,,1,Binding affinity for 5-hydroxytryptamine 1A receptor with [3H]5-HT,,,CHEMBL616424,,10576,Rattus norvegicus,,,D,9,BAO_0000357,
1102,,17386,Expert,,,1,Binding affinity to the rat 5-hydroxytryptamine 1A receptor,,,CHEMBL616425,,10576,,,,H,8,BAO_0000357,
1103,,13654,Expert,,,1,Binding affinity was tested on 5-hydroxytryptamine 1A receptor using radioligand [3H]5-HT binding assay.,,,CHEMBL616426,,10576,,,,H,8,BAO_0000357,
1104,,14423,Autocuration,,,1,Binding affinity against 5-hydroxytryptamine 1A receptor from rat hippocampus using [3H]8-OH-DPAT as the radioligand.,,,CHEMBL616427,,10576,,,,H,8,BAO_0000221,10000000.0
1105,,15412,Autocuration,,,1,Binding affinity against 5-hydroxytryptamine 1A receptor of rat hippocampus tissue.,,,CHEMBL616428,,10576,,,,H,8,BAO_0000221,10000000.0
1106,,12073,Autocuration,,,1,Binding affinity by measuring displacement of [3H]8-OH-DPAT from 5-hydroxytryptamine 1A receptor in rat hippocampus,,,CHEMBL616290,,10576,,,,H,8,BAO_0000221,10000000.0
1107,,4101,Expert,10116.0,,1,Displacement of [3H]8-OH-DPAT from rat striata 5-hydroxytryptamine 1A receptor,,,CHEMBL616052,,10576,Rattus norvegicus,,,D,9,BAO_0000357,
1108,,10062,Autocuration,,,1,Binding affinity in radioreceptor binding assay by using [3H]5-HT radioligand against 5-hydroxytryptamine 1A receptor,,,CHEMBL616053,,10576,,,,H,8,BAO_0000357,
1109,,6238,Autocuration,,,1,Binding affinity towards 5-HT 1A receptor in rat cerebral cortex membranes using [3H]8-OH-DPAT as radioligand,,,CHEMBL616054,,10576,,,,H,8,BAO_0000249,
1110,,16273,Autocuration,,,1,Binding affinity towards 5-hydroxytryptamine 1A receptor,,,CHEMBL616055,,10576,,,,H,8,BAO_0000357,
1111,,11139,Autocuration,,,1,Binding affinity towards 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand in competitive binding assay,,,CHEMBL616056,,10576,,,,H,8,BAO_0000357,
1112,,16796,Expert,,,1,Binding affinity towards 5-hydroxytryptamine 1A receptor from rat hippocampal membranes,,,CHEMBL616057,,10576,,,,H,8,BAO_0000019,
1113,,9548,Expert,10116.0,,1,Binding affinity towards 5-hydroxytryptamine 1A receptor in rat brain,,,CHEMBL616058,,10576,Rattus norvegicus,,,D,9,BAO_0000221,955.0
1114,,10381,Autocuration,,,1,Binding affinity towards 5-hydroxytryptamine 1A receptor in rat brain,,,CHEMBL616059,,10576,,,,H,8,BAO_0000221,955.0
1115,,13408,Autocuration,,,1,Binding affinity towards 5-hydroxytryptamine 1A receptor in rat hypocampus membrane using [3H]8-OH-DPAT as radioligand,,,CHEMBL616060,,10576,,,,H,8,BAO_0000249,
1116,,13825,Expert,10116.0,,1,Binding affinity towards 5-hydroxytryptamine 1A receptor in the rat brain (hippocampus) using [3H]8-OH-DPAT,,,CHEMBL616061,,10576,Rattus norvegicus,,,D,9,BAO_0000221,10000000.0
1117,,11147,Expert,,,1,Binding affinity towards 5-hydroxytryptamine 1A receptor of rat hippocampus using [3H]-8-hydroxy-2-(di-n-propylamine) tetralin (8-OH-DPAT) as a radioligand,,,CHEMBL616062,,10576,,,,H,8,BAO_0000221,10000000.0
1118,,10552,Autocuration,,,1,Binding affinity towards 5-hydroxytryptamine 1A receptor sites in cortical membranes using [3H]8-OH-DPAT as radioligand,,,CHEMBL616063,,10576,,,,H,8,BAO_0000249,
1119,,10552,Autocuration,,,1,"Binding affinity towards 5-hydroxytryptamine 1A receptor sites, in rat striatum membranes using [3H]- sandoz 205-501 as radioligand",,,CHEMBL616064,,10576,,,,H,8,BAO_0000249,2435.0
1120,,17136,Expert,10116.0,,1,Displacement of [3H]8-OH-DPAT from 5-hydroxytryptamine 1A receptor of rat cortex membranes,,,CHEMBL616065,Membranes,10576,Rattus norvegicus,,,D,9,BAO_0000249,
1121,,5778,Expert,10116.0,,1,Displacement of [3H]8-OH-DPAT from 5-hydroxytryptamine 1A receptor of rat cerebral cortex membranes,,,CHEMBL616066,Membranes,10576,Rattus norvegicus,,,D,9,BAO_0000249,
1122,,13481,Autocuration,,,1,Binding affinity towards rat hippocampal 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand,,,CHEMBL616067,,10576,,,,H,8,BAO_0000221,10000000.0
1123,,13481,Autocuration,,,1,Binding affinity towards rat hippocampal 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand; Not tested,,,CHEMBL616068,,10576,,,,H,8,BAO_0000221,10000000.0
1124,,13630,Intermediate,,,1,Binding affinity against rat hippocampal 5-hydroxytryptamine 1A (5-HT1A) receptor determined using [3H]8-OH-DPAT as radioligand,,,CHEMBL616069,,10576,,,,H,8,BAO_0000221,10000000.0
1125,,16245,Expert,,,1,Binding was determined on 5-hydroxytryptamine 1A receptor in rat hippocampal membranes,,,CHEMBL616070,,10576,,,,H,8,BAO_0000249,
1126,,14509,Autocuration,,,1,Binding affinity was evaluated against 5-hydroxytryptamine 1A receptor on rat hippocampus using [3H]8-OH-DPAT as radioligand,,,CHEMBL616071,,10576,,,,H,8,BAO_0000221,10000000.0
1127,,14509,Expert,,,1,Binding affinity against 5-hydroxytryptamine 1A receptor on rat hippocampus using [3H]8-OH-DPAT as radioligand.,,,CHEMBL616072,,10576,,,,H,8,BAO_0000221,10000000.0
1128,,14509,Autocuration,,,1,Binding affinity was evaluated against 5-hydroxytryptamine 1A receptor on rat hippocampus using [3H]8-OH-DPAT as radioligand.; ND = Not determined,,,CHEMBL616073,,10576,,,,H,8,BAO_0000221,10000000.0
1129,,14509,Autocuration,,,1,Binding affinity was evaluated against 5-hydroxytryptamine 1A receptor on rat hippocampus using [3H]8-OH-DPAT as radioligand; ND = Not determined,,,CHEMBL616074,,10576,,,,H,8,BAO_0000221,10000000.0
1130,,14256,Expert,,,1,Binding affinity was evaluated by determining in vitro displacement of [3H]8-OH-DPAT from the central 5-hydroxytryptamine 1A receptor recognition site in rat frontal cortex homogenate.,,,CHEMBL616075,,10576,,,,H,8,BAO_0000019,
1131,,11139,Autocuration,,,1,Binding affinity was evaluated by using [3H]8-OH-DPAT radioligand by using competitive binding assay on 5-hydroxytryptamine 1A receptor,,,CHEMBL616076,,10576,,,,H,8,BAO_0000357,
1132,,11047,Expert,10116.0,,1,Binding affinity for 5-HT1A measured by displacing [3H]8-OH-DPAT from rat cortical membranes; Not determined,,,CHEMBL616077,,10576,Rattus norvegicus,,,D,9,BAO_0000019,
1133,,11047,Expert,10116.0,,1,Binding affinity for 5-hydroxytryptamine 1A receptor measured by displacing [3H]8-OH-DPAT from rat cortical membranes,,,CHEMBL616078,,10576,Rattus norvegicus,,,D,9,BAO_0000019,
1134,,11047,Expert,10116.0,,1,Binding affinity for 5-hydroxytryptamine 1A receptor measured by displacing [3H]8-OH-DPAT from rat cortical membranes;ND-Not determined,,,CHEMBL616079,,10576,Rattus norvegicus,,,D,9,BAO_0000019,
1135,,2395,Expert,10116.0,,1,Binding affinity against [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor expressed in CHO-K1 cells,485.0,,CHEMBL616080,,10576,Rattus norvegicus,CHO-K1,,D,9,BAO_0000219,
1136,,9699,Autocuration,,,1,Binding affinity towards 5-hydroxytryptamine 1A receptor,,,CHEMBL616081,,10576,,,,H,8,BAO_0000357,
1137,,12028,Expert,10116.0,,1,Binding affinity towards 5-hydroxytryptamine 1A receptor by the displacement of [125I]trans-8-OH-PIPAT in membrane homogenates of hippocampal tissue of rat brain,,,CHEMBL616082,,10576,Rattus norvegicus,,,D,9,BAO_0000221,10000000.0
1138,,12028,Autocuration,,,1,Binding affinity towards 5-hydroxytryptamine 1A receptor by the displacement of [3H]8-OH-DPAT in membrane homogenates of hippocampal tissue of rat brain,,,CHEMBL616083,,10576,,,,H,8,BAO_0000221,10000000.0
1139,,5815,Autocuration,,,1,Binding affinity towards 5-hydroxytryptamine 1A receptor in rat cerebral cortex,,,CHEMBL616084,,10576,,,,H,8,BAO_0000019,
1140,,16616,Expert,,,1,Binding affinity towards 5-hydroxytryptamine 1A receptor in rat frontal cortex homogenates,,,CHEMBL616085,,10576,,,,H,8,BAO_0000019,
1141,,5815,Autocuration,,,1,Binding affinity towards 5-hydroxytryptamine 1A receptor in rat cerebral cortex using [3H]-8-OH-DPAT,,,CHEMBL616086,,10576,,,,H,8,BAO_0000019,
1142,,2761,Autocuration,,,1,"Binding affinity towards 5-hydroxytryptamine 1A receptor using 0.1 nM [3H]-8-OH-DPAT (8-hydroxy-2-(di-n-propylamino)tet-ralin), from rat hippocampal homogenate",,,CHEMBL616087,,10576,,,,H,8,BAO_0000221,10000000.0
1143,,13133,Expert,,,1,Binding affinity was determined against 5-hydroxytryptamine 1A receptor using [3H]WB-4101,,,CHEMBL616088,,10576,,,,H,8,BAO_0000357,
1144,,10444,Autocuration,,,1,Binding affinity was determined against 5-hydroxytryptamine 1A receptor was determined in male Sprague-Dawley rat brain.,,,CHEMBL616089,,10576,,,,H,8,BAO_0000019,
1145,,13278,Expert,10116.0,,1,Binding affinity was measured against 5-hydroxytryptamine 1A receptor by displacement of [3H]8-OH-DPAT by lysergic acid amides,,,CHEMBL616090,,10576,Rattus norvegicus,,,D,9,BAO_0000357,
1146,,15874,Autocuration,,,1,Binding affinity was measured on cloned rat 5-hydroxytryptamine 1A receptor which is labeled by [3H]8-OH-DPAT,,,CHEMBL616091,,10576,,,,H,8,BAO_0000357,
1147,,10552,Autocuration,,,1,"Binding affinity of the compound towards 5-hydroxytryptamine 1A receptor sites, in rat striatum membranes using [3H]- sandoz 205-501 as radioligand",,,CHEMBL616092,Membranes,10576,,,,H,8,BAO_0000249,2435.0
1148,,11130,Autocuration,,,1,Binding constant against 5-hydroxytryptamine 1A receptor (in vitro),,,CHEMBL616093,,10576,,,,H,8,BAO_0000357,
1149,In vivo,11130,Autocuration,,,1,Binding constant against 5-hydroxytryptamine 1A receptor (in vivo),,,CHEMBL616094,,10576,,,,H,8,BAO_0000218,
1150,,14542,Autocuration,,,1,Compound is evaluated for binding affinity towards 5-hydroxytryptamine 1A receptor using [3H]-8-OH- -DPAT in rat brain cortex,,,CHEMBL616095,,10576,,,,H,8,BAO_0000221,955.0
1151,,13670,Expert,10116.0,,1,Inhibition of [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor,,,CHEMBL616096,,10576,Rattus norvegicus,,,D,9,BAO_0000357,
1152,,9888,Expert,,,1,Binding affinity at [3H]8-OH-DPAT-Labeled 5-hydroxytryptamine 1A receptor sites in rat brain hippocampal membranes,,,CHEMBL616097,,10576,,,,H,8,BAO_0000249,
1153,,3678,Expert,10116.0,,1,Displacement of [3H]8-OH-DPAT from 5-hydroxytryptamine 1A receptor of rat hippocampus membranes,,,CHEMBL616098,Membranes,10576,Rattus norvegicus,,,D,9,BAO_0000249,
1154,,11332,Autocuration,,,1,Compound was evaluated for in vitro binding affinity towards 5-hydroxytryptamine 1A receptor in rat hippocampus using [3H]8-OH-DPAT as radioligand,,,CHEMBL616099,,10576,,,,H,8,BAO_0000221,10000000.0
1155,,11332,Autocuration,,,1,Compound was evaluated for in vitro binding affinity towards serotonin 5-hydroxytryptamine 1A receptor receptor in rat hippocampus using [3H]8-OH-DPAT as radioligand,,,CHEMBL616100,,10576,,,,H,8,BAO_0000221,10000000.0
1156,,1185,Expert,,,1,Ability to displace [3H]-8-OH-DPAT from serotonergic 5-hydroxytryptamine 1A receptor,,,CHEMBL616101,,10576,,,,H,8,BAO_0000357,
1157,,2014,Expert,,,1,Binding affinity at 5-hydroxytryptamine 1A receptor in rat cerebral cortex membranes by [3H]8-OH-DPAT displacement.,,,CHEMBL616102,,10576,,,,H,8,BAO_0000249,
1158,,1185,Autocuration,,,1,Compound was evaluated for its ability to displace [3H]8-OH-DPAT from serotonergic 5-hydroxytryptamine 1A receptor,,,CHEMBL616103,,10576,,,,H,8,BAO_0000357,
1159,,14429,Expert,,,1,Compound was evaluated for its binding affinity against 5-hydroxytryptamine 1A receptor from rat cerebral cortex,,,CHEMBL616104,,10576,,,,H,8,BAO_0000019,
1160,,16288,Expert,,,1,"Binding affinity to 5-hydroxytryptamine 1A receptor (5-HT 1A receptor, serotonin receptor) from rat cortex using [3H]8-OH-DPAT as radioligand",,,CHEMBL616105,,10576,,,,H,8,BAO_0000019,
1161,,5432,Expert,10116.0,,1,Displacement of [3H]prazosin from rat cortex membrane 5-hydroxytryptamine 1A receptor,,,CHEMBL616106,,10576,Rattus norvegicus,,,D,9,BAO_0000019,
1162,,14429,Autocuration,,,1,Compound was evaluated for its binding affinity with 5-hydroxytryptamine 1A receptor using membranes prepared from rat cerebral cortex,,,CHEMBL616107,,10576,,,,H,8,BAO_0000019,
1163,,13672,Expert,,,1,Binding affinity towards rat 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT radioligand.,,,CHEMBL616108,,10576,,,,H,8,BAO_0000357,
1164,,11296,Expert,,,1,In vitro ability to displace [3H]8-hydroxy-2-(di-n-propylamino) tetralin binding from 5-hydroxytryptamine 1A receptor site in rat brain hippocampus,,,CHEMBL616109,,10576,,,,H,8,BAO_0000221,10000000.0
1165,,11296,Autocuration,,,1,In vitro ability to displace [3H]8-hydroxy-2-(di-n-propylamino) tetralin binding from 5-hydroxytryptamine 1A receptor site.,,,CHEMBL616110,,10576,,,,H,8,BAO_0000357,
1166,,14749,Expert,,,1,Binding affinity against rat 5-hydroxytryptamine 1A receptor in CHO cells.,449.0,,CHEMBL616111,,10576,,CHO,,H,8,BAO_0000219,
1167,,15086,Expert,,,1,Binding affinity towards 5-hydroxytryptamine 1A receptor from rat brain using [3H]-8-OH-DPAT as radioligand,,,CHEMBL616112,,10576,,,,H,8,BAO_0000019,
1168,,13462,Autocuration,,,1,Compound was tested for the Binding affinity against rat hippocampal 5-hydroxytryptamine 1A receptor by Radio ligand [3H]8-OH-DPAT binding assay.,,,CHEMBL616113,,10576,,,,H,8,BAO_0000221,10000000.0
1169,,15363,Autocuration,,,1,Compound was tested for the displacement of [3H]-8-OH- DPAT from rat brain 5-hydroxytryptamine 1A receptor,,,CHEMBL616114,,10576,,,,H,8,BAO_0000019,
1170,,15363,Autocuration,,,1,Compound was tested for the displacement of [3H]-8-OH- DPAT from rat brain 5-hydroxytryptamine 1A receptor,,,CHEMBL616115,,10576,,,,H,8,BAO_0000019,
1171,,10796,Autocuration,,,1,Compound was tested in vitro for binding affinity for 5-hydroxytryptamine 1A receptor,,,CHEMBL616116,,10576,,,,H,8,BAO_0000357,
1172,,12816,Expert,,,1,Binding affinity for 5-hydroxytryptamine 1A receptor in rat brain tissue using [3H]8-OH-DPAT as radioligand,,,CHEMBL615844,,10576,,,,H,8,BAO_0000221,955.0
1173,,13542,Expert,,,1,In vitro displacement of [3H]8-OH-DPAT binding to rat hippocampal 5-hydroxytryptamine 1A receptor,,,CHEMBL615939,,10576,,,,H,8,BAO_0000221,10000000.0
1174,,13308,Expert,,,1,In vitro ability to displace [3H]8-OH-DPAT from 5-hydroxytryptamine 1A receptor sites of rat brain cortex.,,,CHEMBL615940,,10576,,,,H,8,BAO_0000019,
1175,,13541,Expert,,,1,In vitro affinity at 5-hydroxytryptamine 1A receptor of rat hippocampus by [3H]8-OH-DPAT displacement.,,,CHEMBL615941,,10576,,,,H,8,BAO_0000221,10000000.0
1176,,10058,Autocuration,,,1,In vitro ability to inhibit [3H]8-OH-DPAT binding to 5-HT1A receptor of rat hippocampus and the value ranges from 9 - 12,,,CHEMBL615942,,10576,,,,H,8,BAO_0000221,10000000.0
1177,,10058,Autocuration,,,1,In vitro ability to inhibit [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor of rat hippocampus,,,CHEMBL615943,,10576,,,,H,8,BAO_0000221,10000000.0
1178,,10058,Autocuration,,,1,In vitro ability to inhibit [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor of rat hippocampus (94%CI) from 12 to 17,,,CHEMBL615944,,10576,,,,H,8,BAO_0000221,10000000.0
1179,,10058,Autocuration,,,1,In vitro ability to inhibit [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor of rat hippocampus (94%CI) from 391-841,,,CHEMBL615945,,10576,,,,H,8,BAO_0000221,10000000.0
1180,,10058,Autocuration,,,1,In vitro ability to inhibit [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor of rat hippocampus and the value ranges from 12 to 17.,,,CHEMBL615946,,10576,,,,H,8,BAO_0000221,10000000.0
1181,,10058,Autocuration,,,1,In vitro ability to inhibit [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor of rat hippocampus and the value ranges from 12 to 20.,,,CHEMBL615947,,10576,,,,H,8,BAO_0000221,10000000.0
1182,,10058,Autocuration,,,1,In vitro ability to inhibit [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor of rat hippocampus and the value ranges from 245 to 736,,,CHEMBL615948,,10576,,,,H,8,BAO_0000221,10000000.0
1183,,10058,Autocuration,,,1,In vitro ability to inhibit [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor of rat hippocampus and the value ranges from 25 - 84,,,CHEMBL615949,,10576,,,,H,8,BAO_0000221,10000000.0
1184,,10058,Autocuration,,,1,In vitro ability to inhibit [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor of rat hippocampus and the value ranges from 48 to 59,,,CHEMBL615950,,10576,,,,H,8,BAO_0000221,10000000.0
1185,,10058,Autocuration,,,1,In vitro ability to inhibit [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor of rat hippocampus and the value ranges from 3 -5,,,CHEMBL615951,,10576,,,,H,8,BAO_0000221,10000000.0
1186,,10058,Autocuration,,,1,In vitro ability to inhibit [3H]-8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor of rat hippocampus and value ranges from 15 - 31,,,CHEMBL615952,,10576,,,,H,8,BAO_0000221,10000000.0
1187,,10058,Autocuration,,,1,In vitro ability to inhibit [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor of rat hippocampus and value ranges from 27 - 42,,,CHEMBL615953,,10576,,,,H,8,BAO_0000221,10000000.0
1188,,10058,Autocuration,,,1,In vitro ability to inhibit [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor of rat hippocampus and value ranges from 6 - 13,,,CHEMBL615954,,10576,,,,H,8,BAO_0000221,10000000.0
1189,,10058,Expert,10116.0,,1,Inhibition of [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor of rat hippocampus,,,CHEMBL615955,,10576,Rattus norvegicus,,,D,9,BAO_0000221,10000000.0
1190,,10058,Autocuration,,,1,In vitro ability to inhibit [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor of rat hippocampus.; ND is No Data.,,,CHEMBL615956,,10576,,,,H,8,BAO_0000221,10000000.0
1191,,10058,Autocuration,,,1,In vitro ability to inhibit [3H]-8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor of rat hippocampus. and the value ranges from 16 - 27,,,CHEMBL615957,,10576,,,,H,8,BAO_0000221,10000000.0
1192,,12879,Expert,,,1,Displacement of [3H]2-(di-N-propylamino)-8-hydroxytetralin from central 5-hydroxytryptamine 1A receptor recognition sites in rat frontal cortex homogenates.,,,CHEMBL615958,,10576,,,,H,8,BAO_0000019,
1193,,11964,Expert,,,1,Displacement of radioligand [3H]2-(di-N-propylamino)-8-hydroxytetralin from 5-hydroxytryptamine 1A receptor in rat frontal cortex homogenate,,,CHEMBL615959,,10576,,,,H,8,BAO_0000019,
1194,,11964,Autocuration,,,1,Displacement of radioligand [3H]2-(di-N-propylamino)-8-hydroxytetralin from 5-hydroxytryptamine 1A receptor in rat frontal cortex homogenate (experiment 1),,,CHEMBL615960,,10576,,,,H,8,BAO_0000019,
1195,,11964,Autocuration,,,1,Displacement of radioligand [3H]2-(di-N-propylamino)-8-hydroxytetralin from 5-hydroxytryptamine 1A receptor in rat frontal cortex homogenate (experiment 2),,,CHEMBL615961,,10576,,,,H,8,BAO_0000019,
1196,,9548,Expert,,,1,Evaluated for binding affinity towards 5-hydroxytryptamine 1A receptor in rat brain,,,CHEMBL615962,,10576,,,,H,8,BAO_0000221,955.0
1197,,9098,Expert,,,1,Evaluated for the binding affinity to hippocampus striatal membranes at 5-hydroxytryptamine 1A receptor binding site by using [3H]-8-OH- DPAT as a radioligand.,,,CHEMBL615963,,10576,,,,H,8,BAO_0000019,
1198,,9098,Autocuration,,,1,Evaluated for the binding affinity to hippocampus striatal membranes at 5-hydroxytryptamine 1A receptor binding site by using [3H]-8-OH- DPAT as a radioligand; ND is no data.,,,CHEMBL615964,,10576,,,,H,8,BAO_0000019,
1199,,9098,Autocuration,,,1,Evaluated for the binding affinity to hippocampus striatal membranes at 5-hydroxytryptamine 1A receptor binding site by using [3H]-8-OH- DPAT as a radioligand;ND means no data,,,CHEMBL615965,,10576,,,,H,8,BAO_0000019,
1200,,13248,Expert,,,1,In vitro displacement of radioactively labeled ligand [3H]8-OH-DPAT from 5-hydroxytryptamine 1A receptor site in CHO cells,449.0,,CHEMBL615966,,10576,,CHO,,H,8,BAO_0000219,
1201,,3147,Expert,,,1,In vitro ability to inhibit [3H]-8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor in rat cortical membranes,,,CHEMBL615967,,10576,,,,H,8,BAO_0000249,
1202,,13949,Expert,,,1,In vitro binding affinity against 5-hydroxytryptamine 1A receptor of rat cerebral cortex using [3H]8-OH-DPAT as radioligand.,,,CHEMBL615968,,10576,,,,H,8,BAO_0000019,
1203,,11883,Autocuration,,,1,In vitro binding affinity against 5-hydroxytryptamine 1A receptor using [3H]-8-OH-DPAT as radioligand in CHO cells (sc),449.0,,CHEMBL615969,,10576,,CHO,,H,8,BAO_0000218,
1204,,11883,Autocuration,,,1,In vitro binding affinity against 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT (agonist) as radioligand (sc),,,CHEMBL615970,,10576,,,,H,8,BAO_0000218,
1205,,11883,Expert,10116.0,,1,In vitro binding affinity against 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT,,,CHEMBL615971,,10576,Rattus norvegicus,,,D,9,BAO_0000357,
1206,,15535,Expert,,,1,In vitro binding affinity at 5-HT1A receptors assayed by displacement of [3H]8-OH-DPAT from 5-hydroxytryptamine 1A receptor in rat hippocampal membranes,,,CHEMBL615972,Membranes,10576,,,,H,8,BAO_0000249,
1207,,15535,Autocuration,,,1,In vitro binding affinity at 5-HT1A receptor by measuring its ability to displace [3H]8-OH-DPAT from 5-hydroxytryptamine 1A receptor in rat hippocampal membranes + cortex,,,CHEMBL615973,,10576,,,,H,8,BAO_0000249,
1208,,15535,Autocuration,,,1,In vitro binding affinity at 5-HT1A receptor by measuring its ability to displace [3H]-8-OH-DPAT from 5-hydroxytryptamine 1A receptor in rat hippocampal membranes+cortex,,,CHEMBL615974,,10576,,,,H,8,BAO_0000249,
1209,,16372,Expert,9606.0,,1,Displacement of [3H]8-OH-DPAT from human 5-hydroxytryptamine 1A receptor expressed in CHO cells,449.0,,CHEMBL615975,,51,Homo sapiens,CHO,,D,9,BAO_0000219,
1210,,14608,Expert,,,1,In vitro binding affinity for 5-hydroxytryptamine 1A receptor in rat hippocampal membranes by [125I]-labeled agonist displacement.,,,CHEMBL615976,,10576,,,,H,8,BAO_0000249,
1211,,4795,Expert,10116.0,,1,Displacement of [3H]8-OH-DPAT from 5-hydroxytryptamine 1A receptor of rat hippocampus,,,CHEMBL872106,,10576,Rattus norvegicus,,,D,9,BAO_0000221,10000000.0
1212,,13863,Autocuration,,,1,In vitro binding affinity of compound towards 5-hydroxytryptamine 1A receptor was determined using [3H]8-OH-DPAT as radioligand,,,CHEMBL615977,,10576,,,,H,8,BAO_0000357,
1213,,13863,Autocuration,,,1,In vitro binding affinity of compound towards 5-hydroxytryptamine 1A receptor was determined using [3H]8-OH-DPAT as radioligand; range=100-230,,,CHEMBL615978,,10576,,,,H,8,BAO_0000357,
1214,,13863,Autocuration,,,1,In vitro binding affinity of compound towards 5-hydroxytryptamine 1A receptor was determined using [3H]8-OH-DPAT as radioligand; range=12-14,,,CHEMBL616166,,10576,,,,H,8,BAO_0000357,
1215,,13863,Autocuration,,,1,In vitro binding affinity of compound towards 5-hydroxytryptamine 1A receptor was determined using [3H]8-OH-DPAT as radioligand; range=16-20,,,CHEMBL616167,,10576,,,,H,8,BAO_0000357,
1216,,13863,Autocuration,,,1,In vitro binding affinity of compound towards 5-hydroxytryptamine 1A receptor was determined using [3H]8-OH-DPAT as radioligand; range=160-430,,,CHEMBL616168,,10576,,,,H,8,BAO_0000357,
1217,,13863,Autocuration,,,1,In vitro binding affinity of compound towards 5-hydroxytryptamine 1A receptor was determined using [3H]8-OH-DPAT as radioligand; range=174-224,,,CHEMBL616169,,10576,,,,H,8,BAO_0000357,
1218,,13863,Autocuration,,,1,In vitro binding affinity of compound towards 5-hydroxytryptamine 1A receptor was determined using [3H]8-OH-DPAT as radioligand; range=184-503,,,CHEMBL616170,,10576,,,,H,8,BAO_0000357,
1219,,13863,Autocuration,,,1,In vitro binding affinity of compound towards 5-hydroxytryptamine 1A receptor was determined using [3H]8-OH-DPAT as radioligand; range=19-23,,,CHEMBL616171,,10576,,,,H,8,BAO_0000357,
1220,,13863,Autocuration,,,1,In vitro binding affinity of compound towards 5-hydroxytryptamine 1A receptor was determined using [3H]-8-OH-DPAT as radioligand; range=2.2-3.2,,,CHEMBL616172,,10576,,,,H,8,BAO_0000357,
1221,,13863,Autocuration,,,1,In vitro binding affinity of compound towards 5-hydroxytryptamine 1A receptor was determined using [3H]8-OH-DPAT as radioligand; range=2.7-3.6,,,CHEMBL616173,,10576,,,,H,8,BAO_0000357,
1222,,13863,Autocuration,,,1,In vitro binding affinity of compound towards 5-hydroxytryptamine 1A receptor was determined using [3H]8-OH-DPAT as radioligand; range=20-23,,,CHEMBL616174,,10576,,,,H,8,BAO_0000357,
1223,,13863,Autocuration,,,1,In vitro binding affinity of compound towards 5-hydroxytryptamine 1A receptor was determined using [3H]-8-OH-DPAT as radioligand; range=21-28,,,CHEMBL616175,,10576,,,,H,8,BAO_0000357,
1224,,13863,Autocuration,,,1,In vitro binding affinity of compound towards 5-hydroxytryptamine 1A receptor was determined using [3H]8-OH-DPAT as radioligand; range=240-760,,,CHEMBL616176,,10576,,,,H,8,BAO_0000357,
1225,,13863,Autocuration,,,1,In vitro binding affinity of compound towards 5-hydroxytryptamine 1A receptor was determined using [3H]-8-OH-DPAT as radioligand; range=39-87,,,CHEMBL616177,,10576,,,,H,8,BAO_0000357,
1226,,13863,Autocuration,,,1,In vitro binding affinity of compound towards 5-hydroxytryptamine 1A receptor was determined using [3H]8-OH-DPAT as radioligand; range=4.6-5.2,,,CHEMBL616178,,10576,,,,H,8,BAO_0000357,
1227,,9742,Autocuration,,,1,Inhibitory activity tested in vitro at 5-hydroxytryptamine 1A receptor binding site in rat,,,CHEMBL616179,,10576,,,,H,8,BAO_0000019,
1228,,12073,Autocuration,,,1,Inhibitory concentration against 5-hydroxytryptamine 1A receptor,,,CHEMBL616180,,10576,,,,H,8,BAO_0000357,
1229,,4101,Autocuration,,,1,Inhibitory concentration against binding of 5-hydroxytryptamine 1A receptor from striata of male Wistar rats by displacement of [3H]8-OH-DPAT,,,CHEMBL616181,,10576,,,,H,8,BAO_0000357,
1230,,15360,Autocuration,,,1,Inhibitory concentration against radioligand [3H]hydroxy-2-(di-n-propylamino)-tetralin binding to 5-hydroxytryptamine 1A receptor in rat,,,CHEMBL616182,,10576,,,,H,8,BAO_0000019,
1231,,11576,Autocuration,,,1,Inhibitory concentration against radioligand [3H]8-OH-DPAT binding to rat hippocampal 5-hydroxytryptamine 1A receptor,,,CHEMBL616183,,10576,,,,H,8,BAO_0000221,10000000.0
1232,,5834,Expert,,,1,Inhibition of the 5-hydroxytryptamine 1A receptor in rat dorsal raphe,,,CHEMBL615874,,10576,,,,H,8,BAO_0000019,
1233,,2395,Expert,10116.0,,1,Inhibitory concentration against [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor expressed in CHO-K1 cells,485.0,,CHEMBL615875,,10576,Rattus norvegicus,CHO-K1,,D,9,BAO_0000219,
1234,,1375,Autocuration,,,1,Tested in vitro for receptor binding affinity to 5-hydroxytryptamine 1A receptor in rat cortex using [3H]OH-DPAT radioligand,,,CHEMBL615876,,10576,,,,H,8,BAO_0000019,
1235,,1375,Autocuration,,,1,Tested in vitro for receptor binding affinity to 5-hydroxytryptamine 1A receptor in rat cortex using [3H]OH-DPAT radioligand; NT means not tested,,,CHEMBL615877,,10576,,,,H,8,BAO_0000019,
1236,,3967,Autocuration,,,1,The compound was evaluated for the ability to displace [3H]- 8-OH -DPAT from 5-hydroxytryptamine 1A receptor ( striata of male wistar rats),,,CHEMBL615878,,10576,,,,H,8,BAO_0000357,
1237,,12884,Expert,,,1,Binding affinity towards 5-hydroxytryptamine 1A receptor binding site using [3H]8-OH-DPAT. ,,,CHEMBL615879,,10576,,,,H,8,BAO_0000357,
1238,,2343,Expert,,,1,Binding affinity towards 5-hydroxytryptamine 1A receptor using receptor binding assay,,,CHEMBL615880,,10576,,,,H,8,BAO_0000357,
1239,,11511,Autocuration,,,1,"The compound was tested in vitro for inhibitory activity against 5-HT1A receptor in rats, using [3H]8-OH-DPAT as radioligand",,,CHEMBL615881,,10576,,,,H,8,BAO_0000019,
1240,,11511,Expert,10116.0,,1,"Inhibitory activity against 5-hydroxytryptamine 1A receptor in rats, using [3H]8-OH-DPAT as radioligand",,,CHEMBL615882,,10576,Rattus norvegicus,,,D,9,BAO_0000019,
1241,In vivo,16394,Autocuration,,,1,Antagonistic activity at postsynaptic 5-hydroxytryptamine 1A receptor was measured by its ability to inhibit hypothermia elicited by s.c. administration of 8-OH-DPAT in rat,,,CHEMBL615883,,10576,,,,H,8,BAO_0000218,
1242,In vivo,16394,Autocuration,,,1,Antagonistic activity at postsynaptic 5-hydroxytryptamine 1A receptor was measured by its ability to inhibit hypothermia elicited by s.c. administration of 8-OH-DPAT in rat;ranges from (0.10-6.20),,,CHEMBL615884,,10576,,,,H,8,BAO_0000218,
1243,In vivo,16394,Autocuration,,,1,Antagonistic activity at postsynaptic 5-hydroxytryptamine 1A receptor was measured by its ability to inhibit hypothermia elicited by s.c. administration of 8-OH-DPAT in rat;ranges from (0.20-1.60),,,CHEMBL615885,,10576,,,,H,8,BAO_0000218,
1244,In vivo,16394,Autocuration,,,1,Antagonistic activity at postsynaptic 5-hydroxytryptamine 1A receptor was measured by its ability to inhibit hypothermia elicited by s.c. administration of 8-OH-DPAT in rat;ranges from (0.20-1.80),,,CHEMBL615886,,10576,,,,H,8,BAO_0000218,
1245,In vivo,16394,Autocuration,,,1,Antagonistic activity at postsynaptic 5-hydroxytryptamine 1A receptor was measured by its ability to inhibit hypothermia elicited by s.c. administration of 8-OH-DPAT in rat;ranges from (0.37-4.27),,,CHEMBL615887,,10576,,,,H,8,BAO_0000218,
1246,In vivo,16394,Autocuration,,,1,Antagonistic activity at postsynaptic 5-hydroxytryptamine 1A receptor was measured by its ability to inhibit hypothermia elicited by s.c. administration of 8-OH-DPAT in rat;ranges from (0.40-2.70),,,CHEMBL615888,,10576,,,,H,8,BAO_0000218,
1247,In vivo,16394,Autocuration,,,1,Antagonistic activity at postsynaptic 5-hydroxytryptamine 1A receptor was measured by its ability to inhibit hypothermia elicited by s.c. administration of 8-OH-DPAT in rat;ranges from (0.40-4),,,CHEMBL615889,,10576,,,,H,8,BAO_0000218,
1248,In vivo,16394,Autocuration,,,1,Antagonistic activity at postsynaptic 5-hydroxytryptamine 1A receptor was measured by its ability to inhibit hypothermia elicited by s.c. administration of 8-OH-DPAT in rat;ranges from (0.45-4.51),,,CHEMBL615890,,10576,,,,H,8,BAO_0000218,
1249,In vivo,16394,Autocuration,,,1,Antagonistic activity at postsynaptic 5-hydroxytryptamine 1A receptor was measured by its ability to inhibit hypothermia elicited by s.c. administration of 8-OH-DPAT in rat;ranges from (0.50-5.30),,,CHEMBL615891,,10576,,,,H,8,BAO_0000218,
1250,In vivo,16394,Autocuration,,,1,Antagonistic activity at postsynaptic 5-hydroxytryptamine 1A receptor was measured by its ability to inhibit hypothermia elicited by s.c. administration of 8-OH-DPAT in rat;ranges from (0.60-1.60),,,CHEMBL615892,,10576,,,,H,8,BAO_0000218,
1251,In vivo,16394,Autocuration,,,1,Antagonistic activity at postsynaptic 5-hydroxytryptamine 1A receptor was measured by its ability to inhibit hypothermia elicited by s.c. administration of 8-OH-DPAT in rat;ranges from (0.72-2.87),,,CHEMBL615893,,10576,,,,H,8,BAO_0000218,
1252,In vivo,16394,Autocuration,,,1,Antagonistic activity at postsynaptic 5-hydroxytryptamine 1A receptor was measured by its ability to inhibit hypothermia elicited by s.c. administration of 8-OH-DPAT in rat;ranges from (0.80-5.80),,,CHEMBL615894,,10576,,,,H,8,BAO_0000218,
1253,In vivo,16394,Autocuration,,,1,Antagonistic activity at postsynaptic 5-hydroxytryptamine 1A receptor was measured by its ability to inhibit hypothermia elicited by s.c. administration of 8-OH-DPAT in rat;ranges from (1.50-16.5),,,CHEMBL615895,,10576,,,,H,8,BAO_0000218,
1254,In vivo,16394,Autocuration,,,1,Antagonistic activity at postsynaptic 5-hydroxytryptamine 1A receptor was measured by its ability to inhibit hypothermia elicited by s.c. administration of 8-OH-DPAT in rat;ranges from (2.20-30.5),,,CHEMBL615896,,10576,,,,H,8,BAO_0000218,
1255,In vivo,16394,Autocuration,,,1,Antagonistic activity at postsynaptic 5-hydroxytryptamine 1A receptor was measured by its ability to inhibit hypothermia elicited by s.c. administration of 8-OH-DPAT in rat;ranges is not computable,,,CHEMBL615897,,10576,,,,H,8,BAO_0000218,
1256,,16616,Expert,10116.0,,1,"Percent increase of R(+)-8-OH-DPAT stimulated [35S]GTP-gamma-S, binding to 5-hydroxytryptamine 1A receptor in isolated rat hippocampal membranes",,,CHEMBL615898,Membranes,10576,Rattus norvegicus,,,D,9,BAO_0000249,
1257,,16796,Autocuration,,,1,% inhibition towards 5-HT1A receptor from rat hippocampal membranes,,,CHEMBL615899,,10576,,,,H,8,BAO_0000019,
1258,,16796,Autocuration,,,1,% inhibition towards 5-hydroxytryptamine 1A receptor from rat hippocampal membranes,,,CHEMBL616291,,10576,,,,H,8,BAO_0000019,
1259,,15629,Autocuration,,,1,Tested in vitro for % inhibition against (serotonin)5-HT 1A receptor.,,,CHEMBL616292,,10576,,,,H,8,BAO_0000357,
1260,,13241,Autocuration,,,1,"Ability to inhibit 5-HT sensitive,forskolin-stimulated adenylyl cyclase(FSC) activity in rat hippocampal membranes mediated through 5-hydroxytryptamine 1A receptor",,,CHEMBL616293,,10576,,,,H,8,BAO_0000249,
1261,,12073,Expert,,,1,Measurement of binding affinity by displacement of [3H]8-OH-DPAT from 5-hydroxytryptamine 1A receptor in rat hippocampus,,,CHEMBL616294,,10576,,,,H,8,BAO_0000221,10000000.0
1262,,14286,Autocuration,,,1,Compound at 10E-5 M was tested in vitro for the inhibition of radioligand [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor in rat hippocampal membrane,,,CHEMBL616295,,10576,,,,H,8,BAO_0000249,10000000.0
1263,,14542,Autocuration,,,1,Compound is evaluated for binding affinity towards 5-hydroxytryptamine 1A receptor using [3H]-8-OH- -DPAT in rat brain cortex at 10 uM,,,CHEMBL616296,,10576,,,,H,8,BAO_0000221,955.0
1264,,13630,Autocuration,,,1,Effect on 5-hydroxytryptamine 1A receptor mediated inhibition of VIP-stimulated cAMP production at dose of 0.1 uM + 10 uM 5-HT.,,,CHEMBL616297,,10576,,,,H,8,BAO_0000019,
1265,,13630,Autocuration,,,1,Effect on 5-hydroxytryptamine 1A receptor mediated inhibition of VIP-stimulated cAMP production at dose of 0+ 1 uM 5-HT.,,,CHEMBL616605,,10576,,,,H,8,BAO_0000019,
1266,,13630,Autocuration,,,1,Effect on 5-hydroxytryptamine 1A receptor mediated inhibition of VIP-stimulated cAMP production at dose of 0.01 uM+ 1 uM 5-HT.,,,CHEMBL616606,,10576,,,,H,8,BAO_0000019,
1267,,13630,Autocuration,,,1,Effect on 5-hydroxytryptamine 1A receptor mediated inhibition of VIP-stimulated cAMP production at dose of 0.05 uM,,,CHEMBL616607,,10576,,,,H,8,BAO_0000019,
1268,,13630,Expert,,,1,Effect on 5-hydroxytryptamine 1A receptor mediated inhibition of VIP-stimulated cAMP production at dose of 0.05 uM,,,CHEMBL616608,,10576,,,,H,8,BAO_0000019,
1269,,13630,Autocuration,,,1,Effect on 5-hydroxytryptamine 1A receptor mediated inhibition of VIP-stimulated cAMP production at dose of 0.05 uM+ 1 uM 5-HT.,,,CHEMBL616609,,10576,,,,H,8,BAO_0000019,
1270,,13630,Expert,10116.0,,1,Effect against 5-hydroxytryptamine 1A receptor mediated inhibition of VIP-stimulated cAMP production at 0.1 uM dose,,,CHEMBL616610,,10576,Rattus norvegicus,,,D,9,BAO_0000019,
1271,,13630,Autocuration,,,1,Effect on 5-hydroxytryptamine 1A receptor mediated inhibition of VIP-stimulated cAMP production at dose of 0.1 uM + 10 uM 5-HT.,,,CHEMBL616611,,10576,,,,H,8,BAO_0000019,
1272,,13630,Expert,,,1,Effect on 5-hydroxytryptamine 1A receptor mediated inhibition of VIP-stimulated cAMP production at dose of 0.1 uM + 1 uM 5-HT.,,,CHEMBL616612,,10576,,,,H,8,BAO_0000019,
1273,,13630,Autocuration,,,1,Effect on 5-hydroxytryptamine 1A receptor mediated inhibition of VIP-stimulated cAMP production at dose of 0.1 uM + 0.1 uM 5-HT.,,,CHEMBL616613,,10576,,,,H,8,BAO_0000019,
1274,,13630,Expert,,,1,Effect on 5-hydroxytryptamine 1A receptor mediated inhibition of VIP-stimulated cAMP production at dose of 10 uM,,,CHEMBL616614,,10576,,,,H,8,BAO_0000019,
1275,,13630,Autocuration,,,1,Effect on 5-hydroxytryptamine 1A receptor mediated inhibition of VIP-stimulated cAMP production at dose of 10 uM+ 10 uM 5-HT.,,,CHEMBL616615,,10576,,,,H,8,BAO_0000019,
1276,,13630,Expert,,,1,Effect on 5-hydroxytryptamine 1A receptor mediated inhibition of VIP-stimulated cAMP production at dose of 1 uM,,,CHEMBL616616,,10576,,,,H,8,BAO_0000019,
1277,,13630,Autocuration,,,1,Effect on 5-hydroxytryptamine 1A receptor mediated inhibition of VIP-stimulated cAMP production at dose of 1 uM+ 0.1 uM 5-HT.,,,CHEMBL616617,,10576,,,,H,8,BAO_0000019,
1278,,13630,Autocuration,,,1,Effect on 5-hydroxytryptamine 1A receptor mediated inhibition of VIP-stimulated cAMP production at dose of 1 uM+ 10 uM 5-HT.,,,CHEMBL616618,,10576,,,,H,8,BAO_0000019,
1279,,13630,Autocuration,,,1,Effect on 5-hydroxytryptamine 1A receptor mediated inhibition of VIP-stimulated cAMP production at dose of 1 uM+ 1 uM 5-HT.,,,CHEMBL616619,,10576,,,,H,8,BAO_0000019,
1280,,13630,Expert,,,1,Effect on 5-hydroxytryptamine 1A receptor mediated inhibition of VIP-stimulated cAMP production at dose of 1 uM+ 3 uM 5-HT.,,,CHEMBL616620,,10576,,,,H,8,BAO_0000019,
1281,,13630,Expert,,,1,Effect on 5-hydroxytryptamine 1A receptor mediated inhibition of VIP-stimulated cAMP production at dose of 1 uM+ 50 uM 5-HT.,,,CHEMBL616621,,10576,,,,H,8,BAO_0000019,
1282,,13630,Autocuration,,,1,Effect on 5-hydroxytryptamine 1A receptor mediated inhibition of VIP-stimulated cAMP production at dose of 30 uM,,,CHEMBL616622,,10576,,,,H,8,BAO_0000019,
1283,,13630,Expert,,,1,Effect on 5-hydroxytryptamine 1A receptor mediated inhibition of VIP-stimulated cAMP production at dose of 50 uM,,,CHEMBL616146,,10576,,,,H,8,BAO_0000019,
1284,,13630,Autocuration,,,1,Effect on 5-hydroxytryptamine 1A receptor mediated inhibition of VIP-stimulated cAMP production at dose of 50 uM+ 50 uM 5-HT.,,,CHEMBL832873,,10576,,,,H,8,BAO_0000019,
1285,,13630,Autocuration,,,1,Effect on 5-hydroxytryptamine 1A receptor-mediated inhibition of VIP-stimulated cAMP production at dose of 0.1 uM,,,CHEMBL616147,,10576,,,,H,8,BAO_0000019,
1286,,13630,Autocuration,,,1,Effect on 5-hydroxytryptamine 1A receptor-mediated inhibition of VIP-stimulated cAMP production at dose of 1 uM+ 10 uM 5-HT.,,,CHEMBL872872,,10576,,,,H,8,BAO_0000019,
1287,,13630,Autocuration,,,1,Effect on 5-hydroxytryptamine 1A receptor mediated inhibition of VIP-stimulated cAMP production at dose of 1 uM,,,CHEMBL616148,,10576,,,,H,8,BAO_0000019,
1288,,9783,Autocuration,,,1,In vitro inhibition of [3H]spiperone binding to 5-hydroxytryptamine 1A receptor from rat hippocampal tissue,,,CHEMBL616149,,10576,,,,H,8,BAO_0000221,10000000.0
1289,,9783,Expert,,,1,In vitro inhibition of [3H]spiperone binding to 5-hydroxytryptamine 1A receptor from rat hippocampal tissue at 1 uM,,,CHEMBL616150,,10576,,,,H,8,BAO_0000221,10000000.0
1290,,14331,Expert,10116.0,,1,Inhibition of [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor in rat hippocampal membranes at 10e-7 M,,,CHEMBL616151,Membranes,10576,Rattus norvegicus,,,D,9,BAO_0000249,
1291,,15260,Expert,,,1,Inhibitory activity against 5-hydroxytryptamine 1A receptor of rat hippocampal tissue at 1 uM,,,CHEMBL872873,,10576,,,,H,8,BAO_0000221,10000000.0
1292,,15260,Autocuration,,,1,Inhibitory activity against rat hippocampal tissue 5-hydroxytryptamine 1A receptor at 0.1 uM concentration,,,CHEMBL616670,,10576,,,,H,8,BAO_0000221,10000000.0
1293,,15260,Autocuration,,,1,Inhibitory activity against rat hippocampal tissue 5-hydroxytryptamine 1A receptor at 1 uM concentration,,,CHEMBL616671,,10576,,,,H,8,BAO_0000221,10000000.0
1294,,16616,Expert,10116.0,,1,"Percent inhibition of (+)-8-OH-DPAT stimulated [35S]GTP-gamma-S, binding to 5-hydroxytryptamine 1A receptor in hippocampal membranes",,,CHEMBL884861,,10576,Rattus norvegicus,,,D,9,BAO_0000249,
1295,,15629,Autocuration,,,1,Tested in vitro for % inhibition against (serotonin)5-HT 1A receptor,,,CHEMBL616672,,10576,,,,H,8,BAO_0000357,
1296,,15086,Autocuration,,,1,The compound was tested binding affinity against 5-hydroxytryptamine 1A receptor from rat brain using [3H]8-OH-DPAT as radioligand at 10e-6 M.,,,CHEMBL616673,,10576,,,,H,8,BAO_0000019,
1297,,5717,Expert,,,1,Antagonistic activity against 5-hydroxytryptamine 1A receptor in rat cerebral cortex using [3H]8-OH-DPAT as radioligand.,,,CHEMBL616674,,10576,,,,H,8,BAO_0000019,
1298,,12652,Autocuration,,,1,Binding affinity against the site labelled by the 5-hydroxytryptamine 1A receptor agonist [3H]- 8-OH-DPAT,,,CHEMBL616675,,10576,,,,H,8,BAO_0000357,
1299,,14608,Autocuration,,,1,In vitro binding affinity for 5-hydroxytryptamine 1A receptor was determined by measuring specific inhibition of [125I]-binding to rat hippocampal membrane preparations,,,CHEMBL616676,,10576,,,,H,8,BAO_0000221,10000000.0
1300,,12306,Autocuration,,,1,Inhibition of binding of [125I]-8-OH-PIPAT ligand to 5-hydroxytryptamine 1A receptor of rat hippocampal homogenates,,,CHEMBL616677,,10576,,,,H,8,BAO_0000221,10000000.0
1301,,12306,Autocuration,,,1,The binding of [125I]MPPI ligand to 5-hydroxytryptamine 1A receptor of rat hippocampal homogenates,,,CHEMBL616678,,10576,,,,H,8,BAO_0000221,10000000.0
1302,,15247,Expert,10116.0,,1,Ability to displace [3H]8-OH-DPAT from 5-hydroxytryptamine 1A receptor,,,CHEMBL616679,,10576,Rattus norvegicus,,,D,9,BAO_0000357,
1303,,17529,Expert,,,1,Ability to bind to central serotonin 5-hydroxytryptamine 1A receptor in vitro in hippocampus of the rat brain using [3H]8-OH-DPAT radioligand,,,CHEMBL616680,,10576,,,,H,8,BAO_0000221,10000000.0
1304,,14826,Autocuration,,,1,Ability to displace [3H]- -OH-DPAT bound to 5-hydroxytryptamine 1A receptor in rat hippocampus,,,CHEMBL616681,,10576,,,,H,8,BAO_0000221,10000000.0
1305,,14826,Autocuration,,,1,Ability to displace [3H]- -(OH)-DPAT bound to 5-hydroxytryptamine 1A receptor in rat hippocampus,,,CHEMBL616682,,10576,,,,H,8,BAO_0000221,10000000.0
1306,,13241,Autocuration,,,1,Ability to displace [3H]8-OH-DPAT binding to rat hippocampal 5-hydroxytryptamine 1A receptor,,,CHEMBL616683,,10576,,,,H,8,BAO_0000221,10000000.0
1307,,14093,Autocuration,,,1,Ability to displace [3H]-8-OH-DPAT from rat hippocampal homogenate 5-hydroxytryptamine 1A receptor,,,CHEMBL616684,,10576,,,,H,8,BAO_0000221,10000000.0
1308,,14093,Autocuration,,,1,Ability to displace [3H]-8-OH-DPAT from rat hippocampal homogenate 5-hydroxytryptamine 1A receptor; Not tested,,,CHEMBL616685,,10576,,,,H,8,BAO_0000221,10000000.0
1309,,14442,Autocuration,,,1,Affinity at [3H]8-OH-DPAT-labeled 5-hydroxytryptamine 1A receptor in rat brain homogenate was determined,,,CHEMBL616686,,10576,,,,H,8,BAO_0000221,955.0
1310,,9919,Autocuration,,,1,Affinity for 5-hydroxytryptamine 1A receptor site,,,CHEMBL616687,,10576,,,,H,8,BAO_0000357,
1311,,9919,Autocuration,,,1,Affinity for 5-hydroxytryptamine 1A receptor site,,,CHEMBL616688,,10576,,,,H,8,BAO_0000357,
1312,,11440,Autocuration,,,1,Affinity in displacing [3H]8-OH-DPAT from rat hippocampal 5-HT1A receptor.,,,CHEMBL616689,,10576,,,,H,8,BAO_0000221,10000000.0
1313,,11257,Autocuration,,,1,Affinity on 5-hydroxytryptamine 1A receptor labeled by [3H]8-OH-DPAT,,,CHEMBL616690,,10576,,,,H,8,BAO_0000357,
1314,,10330,Expert,,,1,Binding affinity against 5-hydroxytryptamine 1A receptor using [3H]-8-OH-DPAT as radioligand,,,CHEMBL616691,,10576,,,,H,8,BAO_0000357,
1315,,17331,Expert,10116.0,,1,Displacement of [3H]8-OH-DPAT from 5-hydroxytryptamine 1A receptor of rat hippocampus mambranes,,,CHEMBL616692,,10576,Rattus norvegicus,,,D,9,BAO_0000221,10000000.0
1316,,16567,Expert,,,1,Binding affinity against 5-hydroxytryptamine 1A receptor by displacing [3H]8-OH-DPAT radioligand in rat cortex membrane,,,CHEMBL616693,,10576,,,,H,8,BAO_0000249,
1317,,12058,Expert,10116.0,,1,"Binding affinity against 5-hydroxytryptamine 1A receptor in homogenated rat brain tissue, using by [3H]8-OH-DPAT as radioligand",,,CHEMBL616694,,10576,Rattus norvegicus,,,D,9,BAO_0000019,
1318,,9699,Autocuration,,,1,Binding affinity against 5-hydroxytryptamine 1A receptor in rat hippocampal tissue,,,CHEMBL616695,,10576,,,,H,8,BAO_0000221,10000000.0
1319,,9547,Autocuration,,,1,Binding affinity against 5-hydroxytryptamine 1A receptor of rat was determined using [3H]8-OH-DPAT in binding assay,,,CHEMBL616696,,10576,,,,H,8,BAO_0000357,
1320,,10330,Autocuration,,,1,Binding affinity against 5-hydroxytryptamine 1A receptor using [3H]DOB as radioligand,,,CHEMBL616697,,10576,,,,H,8,BAO_0000357,
1321,,14331,Autocuration,,,1,Binding affinity against rat 5-hydroxytryptamine 1A receptor,,,CHEMBL616698,,10576,,,,H,8,BAO_0000357,
1322,,14060,Expert,10116.0,,1,Binding affinity against rat brain 5-hydroxytryptamine 1A receptor,,,CHEMBL616949,,10576,Rattus norvegicus,,,D,9,BAO_0000019,
1323,,14744,Autocuration,,,1,Binding affinity against the 5-hydroxytryptamine 1A receptor labelled with [3H]8-OH-DPAT in rat hippocampal homogenates,,,CHEMBL616950,,10576,,,,H,8,BAO_0000221,10000000.0
1324,,13506,Autocuration,,,1,Binding affinity against serotonin 5-hydroxytryptamine 1A receptor using radioligand [3H]8-OH-DPAT binding assay,,,CHEMBL832875,,10576,,,,H,8,BAO_0000357,
1325,,10862,Expert,,,1,Binding affinity at 5-hydroxytryptamine 1A receptor by the displacement of [3H]8-OH-DPAT in rat brain.,,,CHEMBL616951,,10576,,,,H,8,BAO_0000221,955.0
1326,,10862,Expert,,,1,Binding affinity at 5-hydroxytryptamine 1A receptor by the displacement of [3H]8-OH-DPAT in rat brain.,,,CHEMBL616952,,10576,,,,H,8,BAO_0000221,955.0
1327,,10062,Expert,,,1,Binding affinity at rat 5-hydroxytryptamine 1A receptor by [3H]WB-4101 displacement.,,,CHEMBL616953,,10576,,,,H,8,BAO_0000357,
1328,,12073,Autocuration,,,1,Binding affinity for 5-hydroxytryptamine 1A receptor by use of [3H]8-OH-DPAT in male rat,,,CHEMBL616954,,10576,,,,H,8,BAO_0000357,
1329,,14875,Autocuration,,,1,GTPgammaS radioligand binding assay,,,CHEMBL616955,,106,,,,H,8,BAO_0000357,
1330,,2391,Autocuration,,,1,The compound was evaluated for intrinsic activity against human cloned 5-hydroxytryptamine 1B receptor; Not determined,,,CHEMBL616956,,106,,,,H,8,BAO_0000357,
1331,,2391,Autocuration,,,1,The compound was evaluated for intrinsic activity against human cloned 5-hydroxytryptamine 1B receptor; Partial agonist,,,CHEMBL616957,,106,,,,H,8,BAO_0000019,
1332,,2391,Autocuration,,,1,The compound was evaluated for intrinsic activity against human cloned 5-hydroxytryptamine 1B receptor; Slient antagonist,,,CHEMBL616958,,106,,,,H,8,BAO_0000019,
1333,,2391,Autocuration,,,1,The compound was evaluated for intrinsic activity against human cloned 5-hydroxytryptamine 1B receptor,,,CHEMBL616959,,106,,,,H,8,BAO_0000357,
1334,,2391,Autocuration,,,1,The compound was evaluated for intrinsic activity against human cloned 5-hydroxytryptamine 1B receptor; Not determined,,,CHEMBL616960,,106,,,,H,8,BAO_0000357,
1335,,2391,Autocuration,,,1,The compound was evaluated for intrinsic activity against human cloned 5-hydroxytryptamine 1B receptor; silent antagonist,,,CHEMBL616961,,106,,,,H,8,BAO_0000019,
1336,,17211,Expert,,,1,Ability to displace [3H]5-CT (1.5 nM) from HeLa cells of human 5-hydroxytryptamine 1B receptor,308.0,,CHEMBL616962,,106,,HeLa,,H,8,BAO_0000219,
1337,,17211,Autocuration,,,1,Ability to displace [3H]5-CT (1.5 nM) from HeLa cells of human 5-hydroxytryptamine 1B receptor receptor,308.0,,CHEMBL616963,,106,,HeLa,,H,8,BAO_0000219,
1338,,6491,Expert,9606.0,,1,Affinity towards human 5-hydroxytryptamine 1B serotonin receptor,,,CHEMBL616524,,106,Homo sapiens,,,D,9,BAO_0000357,
1339,,16190,Autocuration,,,1,Binding affinity against 5-hydroxytryptamine 1B receptor in CHO cells using [3H]5-HT as radioligand,449.0,,CHEMBL616525,,106,,CHO,,H,8,BAO_0000219,
1340,,14165,Autocuration,,,1,Binding affinity for 5-hydroxytryptamine 1B receptor in C6-glial transfected cell type using [3H]5-CT as radioligand,,,CHEMBL872908,,106,,,,H,8,BAO_0000019,
1341,,14165,Autocuration,,,1,Binding affinity for 5-hydroxytryptamine 1B receptor in C6-glial transfected cell type using [3H]GR-125743 as radioligand,,,CHEMBL616526,,106,,,,H,8,BAO_0000019,
1342,,4234,Expert,9606.0,,1,Binding affinity to cloned human 5-hydroxytryptamine 1B receptor,,,CHEMBL616527,,106,Homo sapiens,,,D,9,BAO_0000357,
1343,,6328,Expert,,,1,Binding affinity towards human 5-hydroxytryptamine 1B receptor in L-M(tk-) cells using [3H]GR-125743 as radioligand,,,CHEMBL616528,,106,,,,H,8,BAO_0000219,
1344,,14770,Autocuration,,,1,Binding affinity for recombinant human 5-hydroxytryptamine 1B receptor using [3H]5-HT as radioligand.,,,CHEMBL616529,,106,,,,H,8,BAO_0000357,
1345,,2598,Autocuration,,,1,Binding affinity was evaluated at human recombinant 5-hydroxytryptamine 1B receptor using [3H]5-CT as radioligand,,,CHEMBL616530,,106,,,,H,8,BAO_0000357,
1346,,6897,Expert,,,1,Binding affinity was evaluated at the cloned human 5-hydroxytryptamine 1B receptor,,,CHEMBL616531,,106,,,,H,8,BAO_0000357,
1347,,6897,Autocuration,,,1,Binding affinity was evaluated at the cloned human 5-hydroxytryptamine 1B receptor,,,CHEMBL616532,,106,,,,H,8,BAO_0000357,
1348,,6013,Autocuration,,,1,Binding affinity towards 5-hydroxytryptamine 1B receptor,,,CHEMBL616533,,106,,,,H,8,BAO_0000357,
1349,,5843,Expert,,,1,Binding affinity towards cloned human 5-hydroxytryptamine 1B receptor,,,CHEMBL616534,,106,,,,H,8,BAO_0000357,
1350,,14454,Expert,,,1,Binding affinity towards human 5-hydroxytryptamine 1B receptor using [3H]5-HT trifluoroacetate as radioligand,,,CHEMBL616535,,106,,,,H,8,BAO_0000357,
1351,,16209,Autocuration,,,1,Binding affinity towards human 5-hydroxytryptamine 1B receptor using [3H]5-HT radioligand,,,CHEMBL616536,,106,,,,H,8,BAO_0000357,
1352,,3935,Autocuration,,,1,Compound was evaluated for its binding affinity for human 5-hydroxytryptamine 1B receptor,,,CHEMBL616537,,106,,,,H,8,BAO_0000357,
1353,,13729,Expert,,,1,Ability to inhibit the forskolin-stimulated c-AMP formation mediated by human 5-hydroxytryptamine 1B receptor in CHO-K1 cells,485.0,,CHEMBL616538,,106,,CHO-K1,,H,8,BAO_0000219,
1354,,14251,Expert,,,1,Agonist activity to the human recombinant 5-hydroxytryptamine 1B receptor,,,CHEMBL616539,,106,,,,H,8,BAO_0000019,
1355,,17085,Expert,,,1,In vitro binding affinity by radioligand binding assay using cell line expressing human 5-hydroxytryptamine 1B receptor,,,CHEMBL616540,,106,,,,H,8,BAO_0000019,
1356,,3025,Autocuration,,,1,In vitro binding affinity was determined towards cloned human 5-hydroxytryptamine 1B receptor using [3H]5-CT radioligand,,,CHEMBL616429,,106,,,,H,8,BAO_0000357,
1357,,15315,Expert,,,1,In vitro receptor binding affinity for cloned human 5-hydroxytryptamine 1B receptor,,,CHEMBL616430,,106,,,,H,8,BAO_0000357,
1358,,14214,Expert,9606.0,,1,Receptor binding affinity for cloned human 5-hydroxytryptamine 1B receptor in Cos-7 cells,,,CHEMBL616431,,106,Homo sapiens,,,D,9,BAO_0000219,
1359,,3804,Expert,9606.0,,1,Binding affinity towards cloned human 5-hydroxytryptamine 1B receptor,,,CHEMBL616432,,106,Homo sapiens,,,D,9,BAO_0000357,
1360,,2391,Expert,9606.0,,1,Affinity for 5-hydroxytryptamine 1B receptor subtype,,,CHEMBL616433,,106,Homo sapiens,,,D,9,BAO_0000357,
1361,,4175,Expert,9606.0,,1,Binding affinity for human 5-hydroxytryptamine 1B receptor,,,CHEMBL616434,,106,Homo sapiens,,,D,9,BAO_0000357,
1362,,17296,Autocuration,,,1,Binding affinity against cloned human 5-hydroxytryptamine 1B receptor in CHO cells using [3H]5-CT as radioligand; Not determined,449.0,,CHEMBL616435,,106,,CHO,,H,8,BAO_0000219,
1363,,17085,Expert,,,1,In vitro binding affinity was determined by radioligand binding assay using cell line expressing human 5-hydroxytryptamine 1B receptor; ND means not determined,,,CHEMBL616436,,106,,,,H,8,BAO_0000019,
1364,,17211,Autocuration,,,1,Ability to displace [3H]5-CT (1.5 nM) from HeLa cells of human 5-hydroxytryptamine 1B receptor; NT denotes not tested,308.0,,CHEMBL616437,,106,,HeLa,,H,8,BAO_0000219,
1365,,17211,Autocuration,,,1,Ability to displace [3H]5-CT (1.5 nM) from HeLa cells of human 5-hydroxytryptamine 1B receptor; NT=not tested,308.0,,CHEMBL616438,,106,,HeLa,,H,8,BAO_0000219,
1366,,17211,Autocuration,,,1,Ability to displace [3H]-5-CT (1.5 nM) from HeLa cells of human 5-hydroxytryptamine 1B receptor; NT denotes not tested,308.0,,CHEMBL616439,,106,,HeLa,,H,8,BAO_0000219,
1367,,15926,Expert,9606.0,,1,Binding activity against human 5-hydroxytryptamine 1B receptor; NT means not tested,,,CHEMBL616440,,106,Homo sapiens,,,D,9,BAO_0000357,
1368,,16312,Autocuration,,,1,Binding affinity in CHO-K1 cells transfected with human recombinant 5-hydroxytryptamine 1B receptor; not tested,485.0,,CHEMBL616441,,106,,CHO-K1,,H,8,BAO_0000219,
1369,,5843,Expert,,,1,Selectivity ratio against cloned human 5-HT1B receptor to that of h5-HT1D receptor,,,CHEMBL616442,,106,,,,H,8,BAO_0000357,
1370,,5843,Autocuration,,,1,Selectivity ratio against cloned human 5-hydroxytryptamine 1B receptor to that of human 5-hydroxytryptamine 1D receptor,,,CHEMBL616443,,106,,,,H,8,BAO_0000357,
1371,,16312,Expert,,,1,Binding affinity in CHO-K1 cells transfected with human recombinant 5-hydroxytryptamine 1B receptor,485.0,,CHEMBL616444,,106,,CHO-K1,,H,8,BAO_0000219,
1372,,15926,Expert,9606.0,,1,Binding activity against human 5-hydroxytryptamine 1B receptor,,,CHEMBL616445,,106,Homo sapiens,,,D,9,BAO_0000357,
1373,,15926,Expert,9606.0,,1,Binding activity against human 5-hydroxytryptamine 1B receptor,,,CHEMBL616446,,106,Homo sapiens,,,D,9,BAO_0000357,
1374,,4540,Expert,9606.0,,1,Binding affinity to human cloned 5-hydroxytryptamine 1B receptor in CHO cells using [3H]5-HT as radioligand,449.0,,CHEMBL616447,,106,Homo sapiens,CHO,,D,9,BAO_0000219,
1375,,6166,Autocuration,,,1,Binding affinity towards cloned human 5-hydroxytryptamine 1B receptor was determined,,,CHEMBL616448,,106,,,,H,8,BAO_0000357,
1376,,17296,Autocuration,,,1,Binding affinity against cloned human 5-hydroxytryptamine 1B receptor in CHO cells using [3H]5-CT as radioligand,449.0,,CHEMBL616449,,106,,CHO,,H,8,BAO_0000219,
1377,,17296,Autocuration,,,1,Binding affinity against human 5-hydroxytryptamine 1B receptor cloned receptors in CHO cells,449.0,,CHEMBL616450,,106,,CHO,,H,8,BAO_0000219,
1378,,17296,Autocuration,,,1,Binding affinity against human 5-hydroxytryptamine 1B receptor cloned receptors in CHO cells using [3H]5-CT as radioligand,449.0,,CHEMBL857974,,106,,CHO,,H,8,BAO_0000219,
1379,,15779,Autocuration,,,1,Binding affinity towards 5-hydroxytryptamine 1B (human cloned receptor) in CHO cells using [3H]5-HT as radioligand,449.0,,CHEMBL616451,,106,,CHO,,H,8,BAO_0000219,
1380,,15779,Autocuration,,,1,Binding affinity towards 5-hydroxytryptamine 1B receptor (human cloned receptor) in CHO cells using [3H]5-HT as radioligand,449.0,,CHEMBL616452,,106,,CHO,,H,8,BAO_0000219,
1381,,15779,Autocuration,,,1,Binding affinity towards 5-hydroxytryptamine 1B receptor (human cloned receptor) in CHO cells using [3H]5-HT as radioligand;ND means no data.,449.0,,CHEMBL616453,,106,,CHO,,H,8,BAO_0000219,
1382,,4199,Autocuration,,,1,Compound was evaluated for binding affinity against human cloned 5-hydroxytryptamine 1B receptor in CHO cells using [3H]5-HT as the radioligand,449.0,,CHEMBL616454,,106,,CHO,,H,8,BAO_0000219,
1383,,14875,Expert,9606.0,,1,Binding affinity for human 5-hydroxytryptamine 1B receptor,,,CHEMBL616455,,106,Homo sapiens,,,D,9,BAO_0000357,
1384,,15146,Autocuration,,,1,Compound was tested for its binding affinity against human cloned 5-hydroxytryptamine 1B receptor in CHO cells using [3H]5-HT,449.0,,CHEMBL616456,,106,,CHO,,H,8,BAO_0000219,
1385,,5213,Autocuration,,,1,Compound was tested for its binding affinity for human cloned 5-hydroxytryptamine 1B receptor in CHO using [3H]5-HT as a radioligand,,,CHEMBL616457,,106,,,,H,8,BAO_0000357,
1386,,14818,Autocuration,,,1,The compound was tested for its binding affinity towards cloned human 5-hydroxytryptamine 1B receptor in CHO cells using [3H]5-HT,449.0,,CHEMBL616458,,106,,CHO,,H,8,BAO_0000219,
1387,,4829,Autocuration,,,1,"The compound was tested for the binding affinity towards human cloned 5-hydroxytryptamine 1B receptor in CHO cells, using [3H]5-HT as radioligand",449.0,,CHEMBL616459,,106,,CHO,,H,8,BAO_0000219,
1388,,14454,Expert,,,1,Adenyl cyclase activity was expressed as percent forskolin response against 5-hydroxytryptamine 1B receptor at concentration 1 uM,,,CHEMBL616460,,106,,,,H,8,BAO_0000019,
1389,,14454,Expert,,,1,Adenyl cyclase activity was expressed as percent forskolin response against 5-hydroxytryptamine 1B receptor at concentration 10 uM,,,CHEMBL616461,,106,,,,H,8,BAO_0000019,
1390,,14875,Autocuration,,,1,"Effect of compound on [35S]GTP-gamma-S, radioligand binding CHO cells expressing human 5-hydroxytryptamine 1B receptor",449.0,,CHEMBL616462,,106,,CHO,,H,8,BAO_0000219,
1391,,14875,Autocuration,,,1,"Effect of compound on [35S]GTP-gamma-S, radioligand binding in CHO cells expressing human 5-hydroxytryptamine 1B receptor",449.0,,CHEMBL616463,,106,,CHO,,H,8,BAO_0000219,
1392,,15250,Autocuration,,,1,"Compound was tested for maximum stimulation of [35S]GTP-gamma-S, binding expressed relative to the maximal effect produced by 5-HT.",,,CHEMBL616464,,105,,,,H,8,BAO_0000019,
1393,,15250,Autocuration,,,1,Compound was tested for the displacement of [3H]5-HT binding to cloned 5-hydroxytryptamine 1D receptor stably expressed in CHO cells.,449.0,,CHEMBL616465,,105,,CHO,,H,8,BAO_0000219,
1394,,15086,Autocuration,,,1,The compound was tested for binding affinity against 5-hydroxytryptamine 1B receptor,,,CHEMBL832874,,17105,,,,H,8,BAO_0000357,
1395,,3025,Autocuration,9986.0,,1,5-hydroxytryptamine 1B receptor agonist potency determined in rabbit saphenous vein contraction model,,,CHEMBL616184,,106,Oryctolagus cuniculus,,,H,8,BAO_0000019,
1396,,14998,Autocuration,9986.0,,1,The vascular 5-hydroxytryptamine 1B receptor affinity was assessed using ring preparations of rabbit saphenous vein (RbSV).,,,CHEMBL616185,,106,Oryctolagus cuniculus,,,H,8,BAO_0000019,
1397,,14998,Intermediate,9986.0,,1,"Binding affinity against vascular 5-hydroxytryptamine 1B receptor, measured using ring preparations of rabbit saphenous vein (RbSV)",,,CHEMBL616186,,106,Oryctolagus cuniculus,,,H,8,BAO_0000019,
1398,,14998,Autocuration,9986.0,,1,The vascular 5-hydroxytryptamine 1B receptor affinity was assessed using ring preparations of rabbit saphenous vein(RbSV).,,,CHEMBL616187,,106,Oryctolagus cuniculus,,,H,8,BAO_0000019,
1399,,13969,Expert,,,1,Binding affinity towards 5-hydroxytryptamine 1B receptor was measured using [3H]5-HT as radioligand,,,CHEMBL616188,,10577,,,,H,8,BAO_0000357,
1400,,13392,Intermediate,,,1,Binding affinity for 5-hydroxytryptamine 1B receptor,,,CHEMBL873475,,10577,,,,D,9,BAO_0000357,
1401,,3651,Expert,10116.0,,1,Inhibition of [3H]5-HT binding to 5-hydroxytryptamine 1B receptor in rat striatum; Less active,,,CHEMBL616189,,10577,Rattus norvegicus,,,D,9,BAO_0000019,2435.0
1402,,10025,Expert,,,1,Concentration necessary to achieve half maximal inhibition of [125I]- Iodocyanopindolol binding to 5-hydroxytryptamine 1B receptor at 1 uM,,,CHEMBL616190,,10577,,,,H,8,BAO_0000357,
1403,,13863,Autocuration,,,1,In vitro binding affinity of compound towards 5-hydroxytryptamine 1A receptor was determined using [3H]-8-OH-DPAT as radioligand; range=48-77,,,CHEMBL616191,,10576,,,,H,8,BAO_0000357,
1404,,13863,Autocuration,,,1,In vitro binding affinity of compound towards 5-hydroxytryptamine 1A receptor was determined using [3H]8-OH-DPAT as radioligand; range=63-95,,,CHEMBL616192,,10576,,,,H,8,BAO_0000357,
1405,,13863,Autocuration,,,1,In vitro binding affinity of compound towards 5-hydroxytryptamine 1A receptor was determined using [3H]8-OH-DPAT as radioligand; range=710-980,,,CHEMBL616193,,10576,,,,H,8,BAO_0000357,
1406,,13863,Autocuration,,,1,In vitro binding affinity of compound towards 5-hydroxytryptamine 1A receptor was determined using [3H]8-OH-DPAT as radioligand; range=78-140,,,CHEMBL616194,,10576,,,,H,8,BAO_0000357,
1407,,13863,Autocuration,,,1,In vitro binding affinity of compound towards 5-hydroxytryptamine 1A receptor was determined using [3H]8-OH-DPAT as radioligand; range=85-130,,,CHEMBL616195,,10576,,,,H,8,BAO_0000357,
1408,,13863,Autocuration,,,1,In vitro binding affinity of compound towards 5-hydroxytryptamine 1A receptor was determined using [3H]8-OH-DPAT as radioligand; range=89-280,,,CHEMBL616196,,10576,,,,H,8,BAO_0000357,
1409,,4622,Autocuration,,,1,In vitro binding affinity towards 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand in rat hippocampus membrane.,,,CHEMBL616197,,10576,,,,H,8,BAO_0000249,10000000.0
1410,,14911,Intermediate,,,1,Binding affinity at 5-hydroxytryptamine 1A (5-HT1A) receptor in rat cerebral cortex using [3H]8-OH-DPAT as radioligand,,,CHEMBL616198,,10576,,,,H,8,BAO_0000019,
1411,,12678,Autocuration,,,1,In vitro binding affinity to 5-hydroxytryptamine 1A receptor using [125I](R)-(+)-trans-8-OH-PIPAT as radioligand in rat hippocampal homogenate,,,CHEMBL616199,,10576,,,,H,8,BAO_0000221,10000000.0
1412,,12678,Expert,,,1,In vitro binding affinity to 5-hydroxytryptamine 1A receptor in rat hippocampal homogenate by [125I](R)-(+)-trans-8-OH-PIPAT displacement.,,,CHEMBL616200,,10576,,,,H,8,BAO_0000221,10000000.0
1413,,14235,Expert,,,1,In vitro binding affinity to rat hippocampal 5-hydroxytryptamine 1A receptor was determined using [3H]8-OH-DPAT as radioligand,,,CHEMBL616201,,10576,,,,H,8,BAO_0000221,10000000.0
1414,,14949,Expert,,,1,In vitro binding affinity towards 5-hydroxytryptamine 1A r receptor by the displacement of [3H]8-OH-DPAT radioligand in rat hippocampal homogenates,,,CHEMBL616202,,10576,,,,H,8,BAO_0000221,10000000.0
1415,,14949,Expert,,,1,In vitro binding affinity towards 5-hydroxytryptamine 1A receptor by the displacement of [3H]8-OH-DPAT radioligand in rat hippocampal homogenates,,,CHEMBL616203,,10576,,,,H,8,BAO_0000221,10000000.0
1416,,14949,Expert,,,1,In vitro binding affinity towards 5-hydroxytryptamine 1A receptor by the displacement of [3H]8-OH-DPAT radioligand in rat hippocampal homogenates; ND=not determined,,,CHEMBL616204,,10576,,,,H,8,BAO_0000221,10000000.0
1417,,14949,Expert,,,1,In vitro binding affinity towards 5-hydroxytryptamine 1A receptor by the displacement of [3H]8-OH-DPAT radioligand in rat hippocampal homogenates; Not determined,,,CHEMBL616205,,10576,,,,H,8,BAO_0000221,10000000.0
1418,,14949,Expert,,,1,In vitro binding affinity towards 5-hydroxytryptamine 1A receptor by the displacement of [3H]8-OH-DPAT radioligand in rat hippocampal homogenates; not determined,,,CHEMBL616206,,10576,,,,H,8,BAO_0000221,10000000.0
1419,,16118,Expert,,,1,In vitro binding affinity towards 5-hydroxytryptamine 1A receptor in rat cerebral cortex membranes,,,CHEMBL616207,,10576,,,,H,8,BAO_0000249,
1420,,3268,Autocuration,,,1,In vitro binding affinity towards 5-hydroxytryptamine 1A receptor was determined using [3H]8-OH-DPAT as radioligand in rat cerebral cortex membranes,,,CHEMBL616208,,10576,,,,H,8,BAO_0000249,
1421,,3268,Autocuration,,,1,In vitro binding affinity towards 5-hydroxytryptamine 1A receptor was determined using [3H]8-OH-DPAT as radioligand in rat cerebral cortex membranes; Inactive,,,CHEMBL616209,,10576,,,,H,8,BAO_0000249,
1422,,16117,Expert,,,1,In vitro binding affinity towards 5-hydroxytryptamine 1A receptor was determined using radioligand [3H]-8-OH-DPAT,,,CHEMBL616210,,10576,,,,H,8,BAO_0000357,
1423,,9783,Expert,,,1,In vitro inhibition of [3H]spiperone binding to 5-hydroxytryptamine 1A receptor from rat hippocampal tissue.,,,CHEMBL616211,,10576,,,,H,8,BAO_0000221,10000000.0
1424,,9783,Autocuration,,,1,In vitro inhibition of [3H]spiperone binding to 5-hydroxytryptamine 1A receptor from rat hippocampal tissue; NT=Not tested,,,CHEMBL616504,,10576,,,,H,8,BAO_0000221,10000000.0
1425,,14356,Expert,10116.0,,1,Displacement of [3H]8-OH-DPAT from rat hippocampal 5-hydroxytryptamine 1A receptor,,,CHEMBL616505,,10576,Rattus norvegicus,,,D,9,BAO_0000221,10000000.0
1426,,15740,Autocuration,,,1,Inhibition constant of 50 uM forskolin-stimulated cAMP accumulation against 5-hydroxytryptamine 1A receptor,,,CHEMBL616506,,10576,,,,H,8,BAO_0000019,
1427,,12306,Autocuration,,,1,Inhibition of binding of [125I]8-OH-PIPAT ligand to 5-hydroxytryptamine 1A receptor of rat hippocampal homogenates,,,CHEMBL872107,,10576,,,,H,8,BAO_0000221,10000000.0
1428,,13348,Expert,10116.0,,1,Displacement of [3H]5-HT from rat hippocampal 5-hydroxytryptamine 1A receptor with 10e-6 M ketanserin,,,CHEMBL616507,,10576,Rattus norvegicus,,,D,9,BAO_0000221,10000000.0
1429,,10394,Autocuration,,,1,Inhibitory activity against 5-hydroxytryptamine 1A receptor in rat cortical membranes using [3H]8-OH-DPAT as a radioligand,,,CHEMBL616303,,10576,,,,H,8,BAO_0000249,
1430,,15260,Autocuration,,,1,Inhibitory activity against 5-hydroxytryptamine 1A receptor of rat hippocampal tissue,,,CHEMBL616304,,10576,,,,H,8,BAO_0000221,10000000.0
1431,,10046,Expert,,,1,Inhibitory activity against 5-hydroxytryptamine 1A receptor of rat hippocampal tissue using [3H]OH-DPAT as radioligand.,,,CHEMBL616305,,10576,,,,H,8,BAO_0000221,10000000.0
1432,,15260,Intermediate,,,1,Antagonist activity against rat hippocampal tissue 5-hydroxytryptamine 1A receptor,,,CHEMBL616306,,10576,,,,H,8,BAO_0000221,10000000.0
1433,,12851,Autocuration,,,1,Inhibitory affinity constant against 5-hydroxytryptamine 1A receptor,,,CHEMBL616307,,10576,,,,H,8,BAO_0000357,
1434,,2148,Expert,10116.0,,1,Displacement of [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor of rat brain hippocampus,,,CHEMBL881829,,10576,Rattus norvegicus,,,D,9,BAO_0000221,10000000.0
1435,,13134,Expert,,,1,Affinity against the 5-hydroxytryptamine receptor 1A using [3H]WB-4101.,,,CHEMBL616308,,10576,,,,H,8,BAO_0000357,
1436,,12462,Autocuration,,,1,Tested for affinity against 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT in homogenized rat brain,,,CHEMBL616309,,10576,,,,H,8,BAO_0000019,
1437,,12462,Expert,,,1,Tested for affinity against 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT in homogenized rat brain tissue,,,CHEMBL616310,,10576,,,,H,8,BAO_0000019,
1438,,12462,Autocuration,,,1,Tested for affinity against 5-hydroxytryptamine 1A receptors using [3H]8-OH-DPAT in homogenized rat cloned CHO cells,449.0,,CHEMBL616311,,10576,,CHO,,H,8,BAO_0000219,
1439,,11933,Expert,,,1,Tested for binding affinity against 5-hydroxytryptamine 1A receptor from rat frontal cortical regions using [3H]8-OH-DPAT as radioligand,,,CHEMBL616312,,10576,,,,H,8,BAO_0000357,
1440,,11933,Autocuration,,,1,Tested for binding affinity against 5-hydroxytryptamine 1A receptor from rat frontal cortical regions using [3H]8-OH-DPAT as radioligand; ND is Not Determined,,,CHEMBL616313,,10576,,,,H,8,BAO_0000357,
1441,,403,Expert,10116.0,,1,Displacement of [3H]8-OH-DPAT from rat hippocampal 5-hydroxytryptamine 1A receptor,,,CHEMBL616314,,10576,Rattus norvegicus,,,D,9,BAO_0000221,10000000.0
1442,,15538,Autocuration,,,1,Tested for binding affinity by measuring displacement of [3H]8-OH-DPAT from rat serotonin 5-hydroxytryptamine 1A receptor in rat hippocampus,,,CHEMBL616315,,10576,,,,H,8,BAO_0000221,10000000.0
1443,,15538,Autocuration,,,1,Tested for binding affinity by measuring displacement of [3H]8-OH-DPAT from rat serotonin 5-hydroxytryptamine 1A receptor in rat hippocampus; NA means Not Active,,,CHEMBL616567,,10576,,,,H,8,BAO_0000221,10000000.0
1444,,15538,Autocuration,,,1,Tested for binding affinity by measuring displacement of [3H]-8-OH-DPAT from rat serotonin 5-hydroxytryptamine 1A receptor in rat hippocampus; ND means Not Determined,,,CHEMBL616568,,10576,,,,H,8,BAO_0000221,10000000.0
1445,,12464,Intermediate,,,1,Binding affinity to displace [3H]2-(di-N-propylamino)-8-hydroxy-tetralin from 5-hydroxytryptamine 1A (5-HT1A) receptor in rat frontal cortex homogenates,,,CHEMBL616569,,10576,,,,H,8,BAO_0000019,
1446,,1455,Expert,,,1,Binding affinity to 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT radioligand assay.,,,CHEMBL616570,,10576,,,,H,8,BAO_0000357,
1447,,12652,Autocuration,,,1,Tested for the binding affinity against the site labelled by the 5-hydroxytryptamine 1A receptor agonist [3H]- 8-OH-DPAT,,,CHEMBL616571,,10576,,,,H,8,BAO_0000357,
1448,,12639,Autocuration,,,1,Tested for the inhibitory activity against 5-hydroxytryptamine 1A receptor in rat hippocampal,,,CHEMBL616572,,10576,,,,H,8,BAO_0000221,10000000.0
1449,,13949,Expert,,,1,Tested in vitro for binding affinity by measuring its ability to inhibit [3H]8-OH-DPAT binding at 5-hydroxytryptamine 1A receptor in rat cerebral cortex membranes.,,,CHEMBL616573,,10576,,,,H,8,BAO_0000249,
1450,,12463,Expert,10116.0,,1,Tested in vitro for receptor binding affinity against 5-hydroxytryptamine 1A receptor using radioligand [3H]8-OH-DPAT,,,CHEMBL616574,,10576,Rattus norvegicus,,,D,9,BAO_0000357,
1451,,14829,Expert,,,1,The binding affinity by measuring its ability to displace [3H]8-OH-DPAT radioligand in 5-hydroxytryptamine 1A receptor on rat hippocampal preparation,,,CHEMBL616575,,10576,,,,H,8,BAO_0000221,10000000.0
1452,,14829,Autocuration,,,1,The binding affinity by measuring its ability to displace [3H]8-OH-DPAT radioligand in 5-hydroxytryptamine 1A receptor on rat hippocampal preparation; ND=not determined,,,CHEMBL872108,,10576,,,,H,8,BAO_0000221,10000000.0
1453,,12092,Autocuration,,,1,The binding affinity was measured on 5-hydroxytryptamine 1A receptor using [3H]- 8-OH-DPAT as radioligand.,,,CHEMBL616576,,10576,,,,H,8,BAO_0000357,
1454,,403,Autocuration,,,1,The compound was evaluated for binding affinity against 5-hydroxytryptamine 1A receptor in rat hippocampal membranes using [3H]8-OH-DPAT as radioligand in the presence of 1 mM of MnCl2,,,CHEMBL616577,,10576,,,,H,8,BAO_0000249,
1455,,403,Autocuration,,,1,The compound was evaluated for binding affinity against 5-hydroxytryptamine 1A receptor in rat hippocampal membranes using [3H]8-OH-DPAT as radioligand in the presence of 3*10e-5 M GTP gamma S,,,CHEMBL616578,,10576,,,,H,8,BAO_0000249,
1456,,3967,Expert,,,1,Binding affinity at 5-hydroxytryptamine 1A receptor from striata of wistar rats by [3H]- 8-OH -DPAT displacement.,,,CHEMBL616579,,10576,,,,H,8,BAO_0000357,
1457,,12771,Expert,10116.0,,1,Binding affinity towards 5-hydroxytryptamine 1A receptor of rat brain synaptosomal preparations,,,CHEMBL616580,,10576,Rattus norvegicus,,,D,9,BAO_0000019,
1458,,15086,Autocuration,,,1,The compound was tested binding affinity against 5-hydroxytryptamine 1A receptor from rat brain using [3H]8-OH-DPAT as radioligand at 10e-6 M.,,,CHEMBL616581,,10576,,,,H,8,BAO_0000019,
1459,,14909,Autocuration,,,1,The compound was tested for binding affinity on [3H]8-OH-DPAT as specific ligand on 5-hydroxytryptamine 1A receptor in rat hippocampus,,,CHEMBL616582,,10576,,,,H,8,BAO_0000221,10000000.0
1460,,14949,Expert,,,1,The compound was tested for binding affinity on [3H]8-OH-DPAT as specific ligand on 5-hydroxytryptamine 1A receptor in rat hippocampus,,,CHEMBL616583,,10576,,,,H,8,BAO_0000221,10000000.0
1461,,2309,Expert,10116.0,,1,Binding affinity against 5-hydroxytryptamine 1A receptor of rat hippocampus using [3H]8-OH-DPAT,,,CHEMBL616584,,10576,Rattus norvegicus,,,D,9,BAO_0000221,10000000.0
1462,,4170,Expert,,,1,Binding affinity towards 5-hydroxytryptamine 1A receptor,,,CHEMBL616585,,10576,,,,H,8,BAO_0000357,
1463,,11642,Expert,10116.0,,1,Binding affinity towards 5-hydroxytryptamine 1A receptor by displacing [3H]WB-4101 from rat hippocampus,,,CHEMBL616586,,10576,Rattus norvegicus,,,D,9,BAO_0000221,10000000.0
1464,,11642,Autocuration,,,1,The compound was tested for its binding affinity towards 5-hydroxytryptamine 1A receptor by displacing [3H]WB-4101 radioligand in rat hippocampus,,,CHEMBL616587,,10576,,,,H,8,BAO_0000221,10000000.0
1465,,12953,Autocuration,,,1,The compound was tested for their binding affinity towards 5-hydroxytryptamine 1A receptor from rat hippocampus using [3H]-8-OH-DPAT as radioligand,,,CHEMBL616588,,10576,,,,H,8,BAO_0000221,10000000.0
1466,,12953,Autocuration,,,1,The compound was tested for their binding affinity towards 5-hydroxytryptamine 1A receptor from rat hippocampus using [3H]8-OH-DPAT as radioligand.,,,CHEMBL616589,,10576,,,,H,8,BAO_0000221,10000000.0
1467,,12953,Expert,,,1,Binding affinity for 5-hydroxytryptamine 1A receptor from rat hippocampus using [3H]8-OH-DPAT as radioligand,,,CHEMBL616590,,10576,,,,H,8,BAO_0000221,10000000.0
1468,,12903,Expert,,,1,"In vitro binding affinity against cloned mammalian 5-hydroxytryptamine 1A receptor expressed in CHO cells, by using [3H]8-OH-DPAT as radioligand.",449.0,,CHEMBL616591,,10576,,CHO,,H,8,BAO_0000219,
1469,,12536,Expert,,,1,Displacement of the radioligand [3H]8-OH-DPAT from 5-hydroxytryptamine 1A receptor,,,CHEMBL616592,,10576,,,,H,8,BAO_0000357,
1470,,10058,Autocuration,,,1,The inhibition activity of 5-HT1A at 1 uM,,,CHEMBL616593,,10576,,,,H,8,BAO_0000357,
1471,,12902,Expert,,,1,"Binding affinity against 5-hydroxytryptamine 1A receptor from CHO-K1 cells, using [3H]8-OH-DPAT as the radioligand.",485.0,,CHEMBL616594,,10576,,CHO-K1,,H,8,BAO_0000219,
1472,,14057,Expert,,,1,Binding affinities against 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand in rat cerebral cortex membrane,,,CHEMBL616595,,10576,,,,H,8,BAO_0000249,
1473,,11296,Autocuration,,,1,Compound was evaluated for its ability to displace the protonated form of [3H]8-hydroxy-2-(di-n-propylamino)tetralin binding from labeled 5-HT 1A receptor site.,,,CHEMBL616596,,10576,,,,H,8,BAO_0000357,
1474,,11296,Autocuration,,,1,Compound was evaluated for its ability to displace the protonated form of [3H]8-hydroxy-2-(di-n-propylamino)tetralin binding from labeled 5-hydroxytryptamine 1A receptor site in rat brain hippocampus,,,CHEMBL616597,,10576,,,,H,8,BAO_0000221,10000000.0
1475,,11296,Expert,,,1,Ability to displace the protonated form of [3H]8-hydroxy-2-(di-n-propylamino)tetralin binding from labeled 5-hydroxytryptamine 1A receptor site in rat brain hippocampus,,,CHEMBL616598,,10576,,,,H,8,BAO_0000221,10000000.0
1476,,16616,Expert,10116.0,,1,Antagonist activity to stimulate binding of [35S]-GTP-gamma S binding to 5-hydroxytryptamine 1A receptor in isolated rat hippocampal membranes,,,CHEMBL616599,Membranes,10576,Rattus norvegicus,,,D,9,BAO_0000249,
1477,,16616,Expert,10116.0,,1,"Inhibition of (+)-8-OH-DPAT stimulated [35S]GTP-gamma-S, binding in rat hippocampal membranes",,,CHEMBL616600,Membranes,10576,Rattus norvegicus,,,D,9,BAO_0000249,10000000.0
1478,,16567,Autocuration,,,1,Binding affinity against 5-hydroxytryptamine 1A receptor by displacing [3H]8-OH-DPAT radioligand in rat cortex membrane;ND is defined as not -determined.,,,CHEMBL616601,,10576,,,,H,8,BAO_0000019,
1479,,16567,Autocuration,,,1,Binding affinity against 5-hydroxytryptamine 1A receptor by displacing [3H]8-OH-DPAT radioligand in rat cortex membrane;ND is defined as not defined.,,,CHEMBL616602,,10576,,,,H,8,BAO_0000019,
1480,,16567,Autocuration,,,1,Binding affinity against 5-hydroxytryptamine 1A receptor by displacing [3H]8-OH-DPAT radioligand in rat cortex membrane;ND is defined as not determined.,,,CHEMBL616603,,10576,,,,H,8,BAO_0000019,
1481,,16567,Autocuration,,,1,Binding affinity against 5-hydroxytryptamine 1A receptor by displacing [3H]8-OH-DPAT radioligand in rat cortex membrane;ND means not determined.,,,CHEMBL616604,,10576,,,,H,8,BAO_0000019,
1482,,17136,Autocuration,,,1,Binding affinity towards 5-hydroxytryptamine 1A receptor was determined in rat cortex membranes using [3H]8-OH-DPAT as radioligand; No data,,,CHEMBL616316,,10576,,,,H,8,BAO_0000249,
1483,,17136,Autocuration,,,1,Binding affinity towards 5-hydroxytryptamine 1A receptor was determined in rat cortex membranes using [3H]8-OH-DPAT as radioligand; Not determined,,,CHEMBL616317,,10576,,,,H,8,BAO_0000249,
1484,,16616,Expert,10116.0,,1,Binding affinity towards 5-hydroxytryptamine 1A receptor in rat frontal cortex homogenates; ND means No data,,,CHEMBL616318,,10576,Rattus norvegicus,,,D,9,BAO_0000019,
1485,,17331,Autocuration,,,1,Binding affinity against 5-hydroxytryptamine 1A receptor by displacement of [3H]8-OH-DPAT from rat hippocampus mambranes,,,CHEMBL616319,,10576,,,,H,8,BAO_0000221,10000000.0
1486,,17331,Autocuration,,,1,Binding affinity against 5-hydroxytryptamine 1A receptor by displacement of [3H]8-OH-DPAT from rat hippocampus mambranes; Not tested,,,CHEMBL616320,,10576,,,,H,8,BAO_0000221,10000000.0
1487,,17167,Expert,10116.0,,1,Binding affinity for rat hippocampus 5-hydroxytryptamine 1A receptor by inhibition of [3H]8-OH-DPAT binding; Not tested,,,CHEMBL616321,,10576,Rattus norvegicus,,,D,9,BAO_0000221,10000000.0
1488,,15740,Autocuration,,,1,Evaluated for the 5-hydroxytryptamine 1A receptor agonist activity in LY-293284 trained rats; Not tested,,,CHEMBL616322,,10576,,,,H,8,BAO_0000019,
1489,,15740,Autocuration,,,1,Evaluated for the 5-hydroxytryptamine 1A receptor agonist activity in LY-293284 trained rats; not tested,,,CHEMBL616323,,10576,,,,H,8,BAO_0000019,
1490,,4671,Autocuration,,,1,Ratio of binding affinity to 5-HT 1A and D2 receptor,,,CHEMBL616324,,10576,,,,H,8,BAO_0000357,
1491,,10058,Autocuration,,,1,In vitro ability to inhibit [3H]-8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor of rat hippocampus at 1 uM,,,CHEMBL616325,,10576,,,,H,8,BAO_0000221,10000000.0
1492,,10058,Autocuration,,,1,In vitro ability to inhibit [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor of rat hippocampus at 1 uM,,,CHEMBL616326,,10576,,,,H,8,BAO_0000221,10000000.0
1493,,10058,Autocuration,,,1,In vitro ability to inhibit [3H]-8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor of rat hippocampus.,,,CHEMBL616327,,10576,,,,H,8,BAO_0000221,10000000.0
1494,,12073,Autocuration,,,1,Percentage inhibition against 5-hydroxytryptamine 1A receptor,,,CHEMBL616328,,10576,,,,H,8,BAO_0000357,
1495,,2759,Autocuration,,,1,Compound was tested for its potency against 5-hydroxytryptamine 1A receptor in rat frontal cortex membranes (experiment 1),,,CHEMBL858110,,10576,,,,H,8,BAO_0000249,
1496,,2759,Autocuration,,,1,Compound was tested for its potency against 5-hydroxytryptamine 1A receptor in rat frontal cortex membranes (experiment 1),,,CHEMBL616329,,10576,,,,H,8,BAO_0000249,
1497,,2759,Autocuration,,,1,Compound was tested for its potency against 5-hydroxytryptamine 1A receptor in rat frontal cortex membranes (experiment 2),,,CHEMBL616330,,10576,,,,H,8,BAO_0000249,
1498,,2759,Autocuration,,,1,Compound was tested for its potency against 5-hydroxytryptamine 1A receptor in rat frontal cortex membranes (experiment 2),,,CHEMBL616331,,10576,,,,H,8,BAO_0000249,
1499,,2759,Autocuration,,,1,Compound was tested for its potency against 5-hydroxytryptamine 1A receptor in rat frontal cortex membranes.,,,CHEMBL616332,,10576,,,,H,8,BAO_0000249,
1500,,9737,Autocuration,,,1,Binding affinity towards 5-hydroxytryptamine 1A receptor in rat brain membrane using [3H]8-OH-DPAT as a selective ligand.,,,CHEMBL857063,,10576,,,,H,8,BAO_0000249,955.0
1501,,9737,Autocuration,,,1,Binding affinity towards 5-hydroxytryptamine 1A receptor in rat frontal cortex using [3H]8-OH-DPAT as a radioligand,,,CHEMBL616333,,10576,,,,H,8,BAO_0000019,
1502,,5717,Expert,,,1,Antagonistic activity against 5-hydroxytryptamine 1A receptor in rat cerebral cortex using [3H]-8-OH-DPAT as radioligand.,,,CHEMBL616334,,10576,,,,H,8,BAO_0000019,
1503,,12253,Autocuration,,,1,Binding affinity of 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT in rat hippocampus,,,CHEMBL616335,,10576,,,,H,8,BAO_0000221,10000000.0
1504,,14025,Autocuration,,,1,Affinity pKi for 5-hydroxytryptamine 1A receptor was measured in rat cortex homogenates.,,,CHEMBL616336,,10576,,,,H,8,BAO_0000019,
1505,,10425,Expert,,,1,Binding affinity against 5-hydroxytryptamine 1A receptor in rat cerebral cortical membrane using [3H]-8-OH-DPAT as radioligand.,,,CHEMBL616337,,10576,,,,H,8,BAO_0000249,
1506,,14998,Autocuration,,,1,Binding affinity against 5-hydroxytryptamine 1A receptor in rat cortex homogenates.,,,CHEMBL616338,,10576,,,,H,8,BAO_0000019,
1507,,13694,Autocuration,,,1,Binding affinity against native 5-HT1A-receptors from rat hippocampus using radioligand ([3H]- 8-hydri\oxy-2-(di-n-propylamino)tetraline) binding assay,,,CHEMBL616339,,10576,,,,H,8,BAO_0000221,10000000.0
1508,,13694,Autocuration,,,1,Binding affinity against native 5-HT1A-receptors from rat hippocampus using radioligand ([3H]8-hydroxy-2-(di-n-propylamino)-tetraline) binding assay,,,CHEMBL616340,,10576,,,,H,8,BAO_0000221,10000000.0
1509,,4342,Autocuration,,,1,Binding affinity of compound towards 5-hydroxytryptamine 1A receptor was determined,,,CHEMBL616341,,10576,,,,H,8,BAO_0000357,
1510,,12936,Expert,10116.0,,1,Binding affinity against rat 5-hydroxytryptamine 1A receptor,,,CHEMBL616342,,10576,Rattus norvegicus,,,D,9,BAO_0000357,
1511,,13144,Expert,10116.0,,1,Inhibition of [3H]2-(di-N-propylamino)-8-hydroxytetralin binding to 5-HT1A receptor of rat frontal cortex homogenates,,,CHEMBL616343,,10576,Rattus norvegicus,,,D,9,BAO_0000019,
1512,,13343,Expert,,,1,Binding affinity of a compound to rat brain 5-hydroxytryptamine 1A (serotonin) receptor assayed by radiolabeled [3H]-8-OH-DPAT ligand displacement,,,CHEMBL616344,,10576,,,,H,8,BAO_0000019,
1513,,12132,Expert,,,1,Binding affinity towards 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand.,,,CHEMBL616345,,10576,,,,H,8,BAO_0000357,
1514,,15419,Expert,,,1,Binding affinity towards 5-hydroxytryptamine 1A receptor in rat cortex using [3H]8-OH-DPAT as a radioligand,,,CHEMBL616346,,10576,,,,H,8,BAO_0000019,
1515,,1479,Autocuration,,,1,Binding affinity towards 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT in rat hippocampus,,,CHEMBL616347,,10576,,,,H,8,BAO_0000221,10000000.0
1516,,14287,Expert,,,1,In vitro by displacement of [3H]8-OH-DPAT from 5-hydroxytryptamine 1A receptor on rat cortical membrane,,,CHEMBL616348,,10576,,,,H,8,BAO_0000019,
1517,,13116,Expert,,,1,Binding affinity at 5-hydroxytryptamine 1A receptor,,,CHEMBL616349,,10576,,,,H,8,BAO_0000357,
1518,,2759,Expert,10116.0,,1,Inhibition of [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor of rat frontal cortex membranes,,,CHEMBL616152,Membranes,10576,Rattus norvegicus,,,D,9,BAO_0000249,
1519,,2759,Autocuration,,,1,Compound was tested for inhibition constant against 5-hydroxytryptamine 1A receptor in rat frontal cortex membranes.,,,CHEMBL616153,,10576,,,,H,8,BAO_0000249,
1520,,14748,Expert,,,1,"Binding affinity for rat cortex 5-hydroxytryptamine 1A receptor, by displacement of 0.2 nM [3H]8-OH-DPAT radioligand",,,CHEMBL616154,,10576,,,,H,8,BAO_0000019,
1521,,12304,Autocuration,,,1,In vitro ability to inhibit binding of radioligand [3H]8-OH-DPAT to 5-hydroxytryptamine 1A receptor in rat cerebral cortex,,,CHEMBL616155,,10576,,,,H,8,BAO_0000019,
1522,,12409,Expert,10116.0,,1,Binding affinity towards 5-hydroxytryptamine 1A receptor in rat hippocampus using [3H]8-OH-DPAT,,,CHEMBL616156,,10576,Rattus norvegicus,,,D,9,BAO_0000221,10000000.0
1523,,12409,Expert,10116.0,,1,Binding affinity towards 5-hydroxytryptamine 1A receptor in rat hippocampus with [3H]8-OH-DPAT,,,CHEMBL616157,,10576,Rattus norvegicus,,,D,9,BAO_0000221,10000000.0
1524,,13267,Autocuration,,,1,The binding affinity (pKi) was measured against 5-hydroxytryptamine 4 receptor of piglet hippocampus using [125I]-SB 207710 as radioligand,,,CHEMBL616158,,10576,,,,H,8,BAO_0000221,10000000.0
1525,,15194,Autocuration,,,1,The compound was tested for the binding affinity against 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand.,,,CHEMBL616159,,10576,,,,H,8,BAO_0000357,
1526,,14256,Expert,,,1,pKi value against rat 5-hydroxytryptamine 1A receptor.,,,CHEMBL616160,,10576,,,,H,8,BAO_0000357,
1527,,16567,Autocuration,,,1,Binding affinity against 5-hydroxytryptamine 1A receptor by displacing [3H]8-OH-DPAT radioligand in rat cortex membrane;ND is define as non-determined.,,,CHEMBL616161,,10576,,,,H,8,BAO_0000019,
1528,,15740,Autocuration,,,1,Evaluated for the 5-hydroxytryptamine 1A receptor agonist activity in LY-293284 trained rats; Not tested,,,CHEMBL616162,,10576,,,,H,8,BAO_0000019,
1529,,13278,Expert,10116.0,,1,Binding affinity was measured against 5-hydroxytryptamine 2A receptor by displacement of [3H]- ketanserin by lysergic acid amides,,,CHEMBL616163,,12687,Rattus norvegicus,,,D,9,BAO_0000357,
1530,,1970,Expert,,,1,Inhibition of specific [3H]OH-DPAT binding at 5-hydroxytryptamine 1A receptor in rat hippocampal membranes,,,CHEMBL616164,Membranes,10626,,,,H,8,BAO_0000249,
1531,,10034,Autocuration,,,1,Concentration of compound required to inhibit cortical 5-hydroxytryptamine 1A receptor binding sites in rat brain was evaluated,,,CHEMBL616165,,10576,,,,H,8,BAO_0000221,955.0
1532,,13348,Autocuration,10116.0,,1,Inhibitory activity against 5-hydroxytryptamine 1A receptor isolated from rat hippocampus membranes membrane using [3H]5-HT as radioligand in the presence of 10e-6 M ketanserin as 5-HT2 blocker,,,CHEMBL616355,,51,Rattus norvegicus,,,H,8,BAO_0000019,
1533,,13630,Autocuration,,,1,Effect on 5-hydroxytryptamine 1A receptor mediated inhibition of VIP-stimulated cAMP production at dose of 1 uM+ 50 uM 5-HT.,,,CHEMBL616356,,10576,,,,H,8,BAO_0000019,
1534,,10862,Autocuration,,,1,Binding affinity at 5-hydroxytryptamine 1A receptor by the displacement of [3H]8-OH-DPAT in rat brain.,,,CHEMBL616357,,10576,,,,H,8,BAO_0000221,955.0
1535,,12058,Autocuration,,,1,"Binding affinity against 5-hydroxytryptamine 1A receptor in homogenated rat brain tissue, using by [3H]8-OH-DPAT as radioligand",,,CHEMBL616358,,10576,,,,H,8,BAO_0000019,
1536,,4639,Autocuration,,,1,Compound was tested for binding affinity against 5-hydroxytryptamine 1A receptor,,,CHEMBL616359,,51,,,,H,8,BAO_0000357,
1537,,15453,Expert,,,1,Percent decrease in 5-hydroxytryptamine 1A receptor binding using 8-OH-DPAT,,,CHEMBL616360,,51,,,,H,8,BAO_0000357,
1538,,4820,Expert,,,1,Binding affinity towards 5-hydroxytryptamine 1A receptor,,,CHEMBL616361,,51,,,,H,8,BAO_0000357,
1539,,1089,Autocuration,,,1,Tested for binding affinity for 5-hydroxytryptamine 1A receptor,,,CHEMBL616362,,51,,,,H,8,BAO_0000357,
1540,,386,Autocuration,,,1,The compound was evaluated for its ability to displace [3H]-8-OH-DPAT from 5-hydroxytryptamine 1A receptor in cellular brain membranes,,,CHEMBL616363,Brain membranes,51,,,,H,8,BAO_0000249,
1541,,6011,Autocuration,,,1,Inhibition of binding towards 5-hydroxytryptamine 1A receptor at 100 nM concentration,,,CHEMBL616364,,51,,,,H,8,BAO_0000357,
1542,,5014,Autocuration,,,1,Percent inhibition (at 1 uM) against 5-hydroxytryptamine 1A receptor,,,CHEMBL616365,,51,,,,H,8,BAO_0000357,
1543,,4402,Expert,,,1,Binding affinity for 5-hydroxytryptamine 1A receptor determined using [3H]8-OH-DPAT as radioligand,,,CHEMBL616366,,51,,,,H,8,BAO_0000357,
1544,,17066,Expert,,,1,Binding affinity towards 5-hydroxytryptamine 1A receptor,,,CHEMBL872906,,51,,,,H,8,BAO_0000357,
1545,,17515,Autocuration,,,1,Binding affinity of compound towards serotonin 5-hydroxytryptamine 1A receptor; inactive at 10 uM,,,CHEMBL616367,,51,,,,H,8,BAO_0000357,
1546,,2474,Autocuration,,,1,Binding affinity against 5-hydroxytryptamine 1A receptor,,,CHEMBL616368,,51,,,,H,8,BAO_0000357,
1547,,4775,Autocuration,,,1,Binding affinity to 5-hydroxytryptamine 1A receptor was determined,,,CHEMBL616369,,51,,,,H,8,BAO_0000357,
1548,,14294,Expert,9606.0,,1,Binding affinity towards Serotonin 5-hydroxytryptamine 1A receptor by displacement of [3H]-(+)-8-OH-DPAT.,,,CHEMBL616370,,51,Homo sapiens,,,D,9,BAO_0000357,
1549,,14294,Expert,9606.0,,1,Binding affinity towards Serotonin 5-hydroxytryptamine 1A receptor by displacement of [3H](+)-8-OH-DPAT; inactive,,,CHEMBL616371,,51,Homo sapiens,,,D,9,BAO_0000357,
1550,,12249,Autocuration,,,1,Compound was evaluated for the binding affinity against [3H]8-OH-DPAT-labeled 5-hydroxytryptamine 1A receptor sites in cloned CHO cells,449.0,,CHEMBL616372,,51,,CHO,,H,8,BAO_0000219,
1551,,11376,Expert,,,1,Displacement of [3H]8-OH-DPAT from 5-hydroxytryptamine 1A receptor expressed in CHO cell membranes,,,CHEMBL616373,,51,,,,H,8,BAO_0000219,
1552,In vivo,2474,Autocuration,,,1,Compound was measured in vivo for its binding affinity at 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand,,,CHEMBL616374,,51,,,,H,8,BAO_0000218,
1553,,13311,Autocuration,,,1,Tested for activity against 5-hydroxytryptamine 1A receptor from bovine hippocampus,,,CHEMBL616375,,51,,,,H,8,BAO_0000221,10000000.0
1554,,4373,Autocuration,,,1,Binding affinity relative to indolopiperidine (compound 1) for 5-hydroxytryptamine 1A receptor was determined,,,CHEMBL616376,,51,,,,H,8,BAO_0000357,
1555,,1633,Expert,,,1,Binding affinity towards 5-hydroxytryptamine 1A receptor by displacement of [3H]8-OH-DPAT.,,,CHEMBL857064,,51,,,,H,8,BAO_0000357,
1556,,11866,Autocuration,,,1,Binding affinity for 5-hydroxytryptamine 1A receptor was determined,,,CHEMBL616377,,51,,,,H,8,BAO_0000357,
1557,,4373,Autocuration,,,1,Binding affinity for 5-hydroxytryptamine 1A receptor was determined,,,CHEMBL616378,,51,,,,H,8,BAO_0000357,
1558,,4687,Autocuration,,,1,Evaluated for the binding affinity to 5-hydroxytryptamine 1A receptor,,,CHEMBL616379,,51,,,,H,8,BAO_0000357,
1559,,16946,Autocuration,,,1,Ability to displace [3H]8-OH-DPAT from 5-hydroxytryptamine 1A receptor,,,CHEMBL616380,,11863,,,,H,8,BAO_0000357,
1560,,13291,Autocuration,,,1,Binding affinity against 5-hydroxytryptamine 1A receptor was determined using [3H]-8-OH-DPAT radioligand,,,CHEMBL616381,,11863,,,,H,8,BAO_0000357,
1561,,14159,Autocuration,,,1,Compound was evaluated for the affinity at 5-hydroxytryptamine 1A receptor,,,CHEMBL616382,,11863,,,,H,8,BAO_0000357,
1562,,10812,Autocuration,,,1,Compound was tested for the binding affinity against 5-hydroxytryptamine 1A receptor by using [3H]DPAT as radioligand,,,CHEMBL616383,,11863,,,,H,8,BAO_0000357,
1563,,3032,Expert,10090.0,,1,In vitro binding affinity against 5-hydroxytryptamine 1A receptor in CHO cells,449.0,,CHEMBL616350,,11863,Mus musculus,CHO,,D,9,BAO_0000219,
1564,,16655,Autocuration,,,1,Inhibition of 5-OH-DPAT binding to 5-hydroxytryptamine 1A receptor,,,CHEMBL616351,,11863,,,,H,8,BAO_0000357,
1565,,14532,Autocuration,,,1,Inhibitory activity against 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand at 10e-5 M concentration,,,CHEMBL616352,,11863,,,,H,8,BAO_0000357,
1566,,13944,Autocuration,,,1,Binding affinity against 5-hydroxytryptamine 1A receptor,,,CHEMBL616353,,11863,,,,H,8,BAO_0000357,
1567,,13033,Autocuration,,,1,Binding affinity against serotonergic 5-HT1a receptor,,,CHEMBL616354,,11863,,,,H,8,BAO_0000357,
1568,,10321,Autocuration,,,1,Binding affinity for 5-hydroxytryptamine 1A receptor was determined by using [3H]8-OH-DPAT as radioligand,,,CHEMBL616508,,11863,,,,H,8,BAO_0000357,
1569,,2968,Expert,10090.0,,1,Binding affinity for 5-hydroxytryptamine 1A receptor,,,CHEMBL616559,,11863,Mus musculus,,,D,9,BAO_0000357,
1570,,13964,Autocuration,,,1,Binding affinity at 5-hydroxytryptamine 1A receptor,,,CHEMBL616560,,11863,,,,H,8,BAO_0000357,
1571,,15527,Autocuration,,,1,"Binding affinity towards 5-hydroxytryptamine 1A receptor receptor, using [3H]5-HT as radioligand.",,,CHEMBL616561,,11863,,,,H,8,BAO_0000357,
1572,,12248,Autocuration,,,1,Compound was evaluated for the binding affinity against [3H]8-OH-DPAT-labeled 5-hydroxytryptamine 1A receptor sites in cloned CHO cells,449.0,,CHEMBL616562,,11863,,CHO,,H,8,BAO_0000219,
1573,,12249,Autocuration,,,1,Compound was evaluated for the binding affinity against [3H]8-OH-DPAT-labeled 5-hydroxytryptamine 1A receptor sites in cloned CHO cells,449.0,,CHEMBL616563,,11863,,CHO,,H,8,BAO_0000219,
1574,,15120,Autocuration,,,1,Compound was tested for binding affinity using [3H]8-OH-DPAT against 5-hydroxytryptamine 1A receptor,,,CHEMBL616564,,11863,,,,H,8,BAO_0000357,
1575,,13313,Autocuration,,,1,In vitro binding affinity towards 5-hydroxytryptamine 1A receptor by using [3H]-8-OH-DPAT as radioligand,,,CHEMBL616565,,11863,,,,H,8,BAO_0000357,
1576,,2613,Autocuration,,,1,In vivo binding affinity was evaluated against 5-hydroxytryptamine 1A receptor,,,CHEMBL616566,,11863,,,,H,8,BAO_0000218,
1577,,16700,Autocuration,,,1,The binding affinity towards 5-hydroxytryptamine 1A receptor; No affinity,,,CHEMBL616989,,11863,,,,H,8,BAO_0000357,
1578,,2201,Autocuration,,,1,Ability to displace [125I]iodosulpiride from 5-hydroxytryptamine 1A receptor,,,CHEMBL857975,,11863,,,,H,8,BAO_0000357,
1579,,1274,Expert,10090.0,,1,Binding affinity against 5-hydroxytryptamine 1A receptor,,,CHEMBL616990,,11863,Mus musculus,,,D,9,BAO_0000357,
1580,,1317,Autocuration,,,1,Compound was evaluated for binding affinity against 5-hydroxytryptamine 1A receptor using radioligand binding assay,,,CHEMBL616991,,11863,,,,H,8,BAO_0000357,
1581,,12146,Autocuration,,,1,Tested against 5-hydroxytryptamine 1A receptor,,,CHEMBL616992,,11863,,,,H,8,BAO_0000357,
1582,,14059,Autocuration,,,1,The compound's binding affinity against 5-hydroxytryptamine 1A receptor,,,CHEMBL616993,,11863,,,,H,8,BAO_0000357,
1583,,14025,Expert,9986.0,,1,Dissociation equilibrium constant against the vascular 5-hydroxytryptamine 1B like receptor in the rabbit saphenous vein,,,CHEMBL616994,,106,Oryctolagus cuniculus,,,H,8,BAO_0000019,
1584,,14025,Autocuration,9986.0,,1,The dissociation equilibrium constant (pKB=-log KB) of compound was determined against the vascular 5-hydroxytryptamine 1B like receptor in the rabbit saphenous vein(RbSV); NS=non surmountable,,,CHEMBL616995,,106,Oryctolagus cuniculus,,,H,8,BAO_0000019,
1585,,14447,Intermediate,9593.0,,1,The compound was tested for CNS binding affinity towards 5-hydroxytryptamine 1B receptor from cloned gorilla membranes expressed in cultured HEK 293 cells,722.0,,CHEMBL616996,,105571,Gorilla gorilla,HEK293,,D,9,BAO_0000219,
1586,In vivo,3025,Autocuration,10141.0,,1,5-HT1B agonist potency was evaluated as effective dose that induced hypothermia in the guinea-pig upon intraperitoneal administration,,,CHEMBL616997,,106,Cavia porcellus,,,H,8,BAO_0000218,
1587,In vivo,3025,Autocuration,10141.0,,1,5-hydroxytryptamine 1B receptor agonist potency was evaluated as effective dose that induced hypothermia in the guinea-pig upon intraperitoneal administration,,,CHEMBL616998,,106,Cavia porcellus,,,H,8,BAO_0000218,
1588,,15329,Autocuration,10141.0,,1,Affinity of compound towards 5-hydroxytryptamine 1B receptor in isolated guinea-pig iliac artery,,,CHEMBL616999,,106,Cavia porcellus,,,H,8,BAO_0000019,
1589,,15329,Autocuration,10141.0,,1,Affinity of compound towards 5-hydroxytryptamine 1B receptor in isolated guinea-pig iliac artery; n.d. indicates Not determined,,,CHEMBL617000,,106,Cavia porcellus,,,H,8,BAO_0000019,
1590,,15847,Autocuration,10141.0,,1,Compound was evaluated for its antagonist affinity towards 5-hydroxytryptamine 1B receptor of guinea pig,,,CHEMBL617001,,106,Cavia porcellus,,,H,8,BAO_0000019,
1591,,15847,Autocuration,10141.0,,1,Compound was evaluated for its antagonist affinity towards 5-hydroxytryptamine 1B receptor of guinea pig; ND means not done,,,CHEMBL858111,,106,Cavia porcellus,,,H,8,BAO_0000019,
1592,,14165,Autocuration,,,1,Intrinsic activity for Antagonism of 5-hydroxytryptamine 1B receptor-mediated stimulation of [35S]GTP gamma S binding,,,CHEMBL617002,,106,,,,H,8,BAO_0000019,
1593,,14214,Autocuration,,,1,Antagonism tested at 1 uM against the agonist-induced inhibitory effect of 10 nM 5-carbamoyltryptamine (5-CT),,,CHEMBL617003,,106,,,,H,8,BAO_0000019,
1594,,14214,Autocuration,,,1,Antagonism tested at 1 uM against the agonist-induced inhibitory effect of 10 nM 5-carbamoyltryptamine(5-CT),,,CHEMBL617004,,106,,,,H,8,BAO_0000019,
1595,,14214,Expert,9606.0,,1,Agonist activity at 5-hydroxytryptamine 1B receptor by measuring the inhibition of forskolin-stimulated cAMP formation,,,CHEMBL617005,,106,Homo sapiens,,,D,9,BAO_0000019,
1596,,13729,Expert,9606.0,,1,Inhibition of forskolin-stimulated c-AMP formation by human 5-hydroxytryptamine 1B receptor expressed in CHO-K1 cells,485.0,,CHEMBL616623,,106,Homo sapiens,CHO-K1,,D,9,BAO_0000219,
1597,,3025,Autocuration,,,1,Effective concentration determined by measuring inhibition of forskolin-stimulated c-AMP formation at 5-hydroxytryptamine 1B receptor stably transfected in CHO cell lines,449.0,,CHEMBL616624,,106,,CHO,,H,8,BAO_0000219,
1598,,2391,Autocuration,,,1,The compound was evaluated for intrinsic activity against human cloned 5-hydroxytryptamine 1B receptor,,,CHEMBL883243,,106,,,,H,8,BAO_0000357,
1599,,2391,Autocuration,,,1,The compound was evaluated for intrinsic activity against human cloned 5-hydroxytryptamine 1B receptor; full agonist,,,CHEMBL616625,,106,,,,H,8,BAO_0000019,
1600,,14956,Expert,,,1,"Agonist-induced [35S]GTP-gamma-S, binding in CHO cells stably transfected with human 5-hydroxytryptamine 1B receptor",449.0,,CHEMBL616626,,106,,CHO,,H,8,BAO_0000219,
1601,,2598,Autocuration,,,1,The intrinsic activity was evaluated for its ability to inhibit forskolin-stimulated c-AMP formation mediated by cloned 5-hydroxytryptamine 1B receptor in CHO cell line,449.0,,CHEMBL616627,,106,,CHO,,H,8,BAO_0000219,
1602,,2598,Autocuration,,,1,The intrinsic activity was evaluated for its ability to inhibit forskolin-stimulated c-AMP formation mediated by cloned 5-hydroxytryptamine 1B receptor in CHO cell line; Antagonist,449.0,,CHEMBL616628,,106,,CHO,,H,8,BAO_0000219,
1603,,2598,Autocuration,,,1,The intrinsic activity was evaluated for its ability to inhibit forskolin-stimulated c-AMP formation mediated by cloned 5-hydroxytryptamine 1B receptor in CHO cell line; Full Agonist,449.0,,CHEMBL616629,,106,,CHO,,H,8,BAO_0000219,
1604,,2598,Autocuration,,,1,The intrinsic activity was evaluated for its ability to inhibit forskolin-stimulated c-AMP formation mediated by cloned 5-hydroxytryptamine 1B receptor in CHO cell line; Partial Agonist,449.0,,CHEMBL616630,,106,,CHO,,H,8,BAO_0000219,
1605,,14956,Expert,,,1,"Efficacy was evaluated relative to human 5-HT1B receptor using [35S]GTP-gamma-S, as radioligand",,,CHEMBL616631,,106,,,,H,8,BAO_0000019,
1606,,14956,Autocuration,,,1,"Efficacy of compound was evaluated relative to human 5-hydroxytryptamine 1B receptor using [35S]GTP-gamma-S, as radioligand",,,CHEMBL616632,,106,,,,H,8,BAO_0000019,
1607,,14214,Expert,9606.0,,1,Percentage Maximal inhibition obtained with 1 uM 5-HT against 5-hydroxytryptamine 1B receptor,,,CHEMBL616633,,106,Homo sapiens,,,D,9,BAO_0000357,
1608,,3463,Expert,,,1,Ability to displace [3H]5-HT from recombinant human 5-hydroxytryptamine 1B receptor stably expressed in CHO cells determined in vitro,449.0,,CHEMBL616634,,106,,CHO,,H,8,BAO_0000219,
1609,,15331,Autocuration,,,1,Affinity of compound towards 5-hydroxytryptamine 1B receptor was evaluated using radioligand binding technique,,,CHEMBL616635,,106,,,,H,8,BAO_0000357,
1610,,16146,Expert,9606.0,,1,Binding affinity against 5-hydroxytryptamine 1B receptor,,,CHEMBL885358,,106,Homo sapiens,,,D,9,BAO_0000357,
1611,,14159,Expert,9606.0,,1,Displacement of [3H]5-HT from human 5-hydroxytryptamine 1B receptor expressed in CHO cells,449.0,,CHEMBL616636,,106,Homo sapiens,CHO,,D,9,BAO_0000219,
1612,,14158,Expert,,,1,Binding affinity to human cloned 5-hydroxytryptamine 1B receptor in CHO cells by [3H]5-HT binding displacement.,449.0,,CHEMBL616637,,106,,CHO,,H,8,BAO_0000219,
1613,,14159,Autocuration,,,1,Compound was evaluated for the affinity at 5-hydroxytryptamine 1B receptor,,,CHEMBL616638,,106,,,,H,8,BAO_0000357,
1614,,15250,Expert,,,1,Displacement of [3H]5-HT binding to cloned 5-hydroxytryptamine 1B receptor stably expressed in CHO cells,449.0,,CHEMBL616639,,106,,CHO,,H,8,BAO_0000219,
1615,,15250,Expert,,,1,Binding affinity at cloned human 5-hydroxytryptamine 1B receptor stably expressed in CHO cells by [3H]5-HT displacement.,449.0,,CHEMBL616640,,106,,CHO,,H,8,BAO_0000219,
1616,,15331,Expert,,,1,Displacement of [3H]5-HT binding from the cloned human 5-hydroxytryptamine 1B receptor stably expressed in CHO cells,449.0,,CHEMBL616641,,106,,CHO,,H,8,BAO_0000219,
1617,,15332,Expert,,,1,Displacement of [3H]5-HT binding from cloned human 5-hydroxytryptamine 1B receptor stably expressed in CHO cells.,449.0,,CHEMBL616642,,106,,CHO,,H,8,BAO_0000219,
1618,,14956,Expert,,,1,Displacement of specific [3H]5-HT binding to cloned human 5-hydroxytryptamine 1B receptor expressed in CHO cells,449.0,,CHEMBL616643,,106,,CHO,,H,8,BAO_0000219,
1619,,3805,Autocuration,,,1,In vitro binding affinity against human 5-hydroxytryptamine 1B receptor at a concentration of 100 (nM),,,CHEMBL616644,,106,,,,H,8,BAO_0000357,
1620,,14875,Autocuration,,,1,Intrinsic activity for each compound is calculated as a percentage of the 5-hydroxytryptamine 1B receptor response,,,CHEMBL616645,,106,,,,H,8,BAO_0000357,
1621,,14454,Autocuration,9986.0,,1,Compound was tested for 5-hydroxytryptamine 1D like receptor-mediated vascular effect in rabbit saphenous vein (RSV),,,CHEMBL616646,,105,Oryctolagus cuniculus,,,H,8,BAO_0000019,
1622,,14454,Expert,9986.0,,1,Tested for 5-hydroxytryptamine 1D like receptor-mediated vascular effect in rabbit saphenous vein (RSV),,,CHEMBL616647,,105,Oryctolagus cuniculus,,,H,8,BAO_0000019,
1623,,16288,Autocuration,,,1,Affinity at 5-hydroxytryptamine 1D receptor (For sumatriptan = Ki (nM)-12+/-1.9),,,CHEMBL616509,,105,,,,H,8,BAO_0000357,
1624,,16288,Autocuration,,,1,Affinity at 5-hydroxytryptamine 1D receptor from calf caudate using [3H]5-HT as radioligand (For sumatriptan = Ki(nM)-12+/-1.9),,,CHEMBL616510,,105,,,,H,8,BAO_0000357,
1625,,16312,Autocuration,,,1,Binding affinity against calf caudate 5-hydroxytryptamine 1D receptor,,,CHEMBL616511,,105,,,,H,8,BAO_0000357,
1626,,1348,Expert,9913.0,,1,Inhibitory activity against 5-hydroxytryptamine 1D receptor subtype,,,CHEMBL616512,,105,Bos taurus,,,H,8,BAO_0000357,
1627,,5834,Autocuration,9913.0,,1,Inhibitory concentration required against 5-hydroxytryptamine 1D receptor in bovine caudate using [3H]5-HT,,,CHEMBL616513,,105,Bos taurus,,,H,8,BAO_0000357,
1628,,13366,Autocuration,9913.0,,1,Binding affinity towards 5-hydroxytryptamine 1D receptor was determined in calf striatum homogenate,,,CHEMBL616514,,105,Bos taurus,,,H,8,BAO_0000019,2435.0
1629,,1414,Expert,9913.0,,1,Ability to bind to 5-hydroxytryptamine 1D receptor of calf substantia nigra,,,CHEMBL616515,,105,Bos taurus,,,H,8,BAO_0000357,
1630,,14998,Autocuration,9913.0,,1,Binding affinity against 5-hydroxytryptamine 1D receptor in calf caudate homogenates.,,,CHEMBL616516,,105,Bos taurus,,,H,8,BAO_0000019,
1631,,11473,Autocuration,9913.0,,1,Compound was evaluated for binding affinity towards 5-hydroxytryptamine 1D receptor in bovine caudate using [3H]- serotonin as radioligand,,,CHEMBL616517,,105,Bos taurus,,,H,8,BAO_0000357,
1632,,11473,Autocuration,9913.0,,1,Compound was evaluated for binding affinity towards 5-hydroxytryptamine 1D receptor in bovine caudate using [3H]- serotonin as radioligand,,,CHEMBL616518,,105,Bos taurus,,,H,8,BAO_0000357,
1633,,10639,Autocuration,9913.0,,1,Compound was evaluated for its inhibitory activity against 5-hydroxytryptamine 1D receptor of bovine caudate using [3H]5-HT as the radioligand,,,CHEMBL616519,,105,Bos taurus,,,H,8,BAO_0000357,
1634,,10639,Autocuration,9913.0,,1,Inhibitory activity against 5-hydroxytryptamine 1D receptor of bovine caudate using [3H]5-HT as the radioligand,,,CHEMBL616520,,105,Bos taurus,,,H,8,BAO_0000357,
1635,,1375,Autocuration,9913.0,,1,Tested in vitro for receptor binding affinity to 5-hydroxytryptamine 1D receptor in bovine caudate using [3H]5-HT radioligand,,,CHEMBL616521,,105,Bos taurus,,,H,8,BAO_0000357,
1636,,1375,Autocuration,9913.0,,1,Tested in vitro for receptor binding affinity to 5-hydroxytryptamine 1D receptor in bovine caudate using [3H]5-HT radioligand; NT means not tested,,,CHEMBL616522,,105,Bos taurus,,,H,8,BAO_0000357,
1637,,16532,Autocuration,9913.0,,1,The binding affinity at 5-hydroxytryptamine 1D receptor was determined using [3H]5-CT; Not tested,,,CHEMBL884531,,105,Bos taurus,,,H,8,BAO_0000357,
1638,,11147,Autocuration,9913.0,,1,Binding affinity towards 5-hydroxytryptamine 1D receptor using [3H]5-HT as radioligand,,,CHEMBL616523,,105,Bos taurus,,,H,8,BAO_0000357,
1639,,13366,Autocuration,9913.0,,1,Binding affinity towards 5-hydroxytryptamine 1D receptor was determined in calf striatum homogenate,,,CHEMBL616731,,105,Bos taurus,,,H,8,BAO_0000019,2435.0
1640,,10444,Autocuration,9913.0,,1,Binding affinity was determined against 5-hydroxytryptamine 1D receptor in bovine caudate homogenate,,,CHEMBL616732,,105,Bos taurus,,,H,8,BAO_0000019,
1641,,16532,Autocuration,9913.0,,1,The binding affinity at 5-hydroxytryptamine 1D receptor was determined using [3H]5-CT,,,CHEMBL616733,,105,Bos taurus,,,H,8,BAO_0000357,
1642,,16532,Autocuration,9913.0,,1,The binding affinity at 5-hydroxytryptamine 1D receptor was determined using [3H]5-CT; Not tested,,,CHEMBL616734,,105,Bos taurus,,,H,8,BAO_0000357,
1643,,12827,Autocuration,9913.0,,1,Binding affinity towards 5-hydroxytryptamine 1B receptor in rat frontal cortex membranes using [125]ICYP,,,CHEMBL616735,,105,Bos taurus,,,H,8,BAO_0000249,
1644,,12827,Autocuration,9913.0,,1,Binding affinity towards 5-hydroxytryptamine 1B receptor in rat frontal cortex membranes using [125]ICYP; Not determined,,,CHEMBL616736,,105,Bos taurus,,,H,8,BAO_0000249,
1645,,12919,Expert,9913.0,,1,Agonistic activity against 5-hydroxytryptamine 1D receptor in calf caudate using [3H]-GTI,,,CHEMBL616737,,105,Bos taurus,,,H,8,BAO_0000019,
1646,,14025,Autocuration,9913.0,,1,Affinity pKi for 5-hydroxytryptamine 1D receptor was measured in calf caudate homogenate,,,CHEMBL616738,,105,Bos taurus,,,H,8,BAO_0000019,
1647,,12919,Expert,9913.0,,1,Agonistic activity against 5-hydroxytryptamine 1D receptor in calf caudate using [3H]-GTI,,,CHEMBL616739,,105,Bos taurus,,,H,8,BAO_0000019,
1648,,12919,Expert,9913.0,,1,Agonistic activity against 5-hydroxytryptamine 1D receptor in calf caudate using [3H]-GTI,,,CHEMBL616740,,105,Bos taurus,,,H,8,BAO_0000019,
1649,,12919,Expert,9913.0,,1,Agonistic activity against 5-hydroxytryptamine 1D receptor in calf caudate using [3H]-GTI,,,CHEMBL616741,,105,Bos taurus,,,H,8,BAO_0000019,
1650,,14447,Autocuration,9593.0,,1,The compound was tested for CNS binding affinity towards 5-hydroxytryptamine 1D receptor from cloned gorilla membranes expressed in cultured HEK 293 cells,722.0,,CHEMBL616742,,105,Gorilla gorilla,HEK293,,H,8,BAO_0000219,
1651,,1375,Intermediate,10141.0,,1,Compound was tested for the inhibition of forskolin-stimulated adenylate cyclase at 5-hydroxytryptamine 1D receptor in guinea pig substantia nigra,,,CHEMBL616743,,105570,Cavia porcellus,,,D,9,BAO_0000019,
1652,,1375,Intermediate,10141.0,,1,Compound was tested for the inhibition of forskolin-stimulated adenylate cyclase at 5-hydroxytryptamine 1D receptor in guinea pig substantia nigra; NT means not tested,,,CHEMBL616744,,105570,Cavia porcellus,,,D,9,BAO_0000019,
1653,,12409,Intermediate,10141.0,,1,Oral effective dose against hypothermia in the guinea pig caused by stimulation of central 5-hydroxytryptamine 1D receptor by the agonist GR-46611,,,CHEMBL616745,,105570,Cavia porcellus,,,D,9,BAO_0000019,
1654,,12409,Intermediate,10141.0,,1,Oral effective dose against hypothermia in the guinea pig caused by stimulation of central 5-hydroxytryptamine 1D receptors by the agonist GR-46611,,,CHEMBL616746,,105570,Cavia porcellus,,,D,9,BAO_0000019,
1655,,12409,Intermediate,10141.0,,1,Oral effective dose against hypothermia in the guinea pig caused by stimulation of central 5-hydroxytryptamine 1D receptors by the agonist GR-46611; range is 2-9,,,CHEMBL616747,,105570,Cavia porcellus,,,D,9,BAO_0000019,
1656,,12409,Intermediate,10141.0,,1,Oral effective dose against hypothermia in the guinea pig caused by stimulation of central 5-hydroxytryptamine 1D receptors by the agonist GR-46611;range is 0.2-0.4,,,CHEMBL616748,,105570,Cavia porcellus,,,D,9,BAO_0000019,
1657,,12409,Intermediate,10141.0,,1,Oral effective dose against hypothermia in the guinea pig caused by stimulation of central 5-hydroxytryptamine 1D receptors by the agonist GR-46611;range is 0.2-1.2,,,CHEMBL616648,,105570,Cavia porcellus,,,D,9,BAO_0000019,
1658,,11574,Intermediate,10141.0,,1,Binding affinity against 5-hydroxytryptamine 1D receptor,,,CHEMBL616649,,105570,Cavia porcellus,,,D,9,BAO_0000357,
1659,,1558,Intermediate,10141.0,,1,Binding affinity towards guinea pig 5-hydroxytryptamine 1D receptor was determined,,,CHEMBL616650,,105570,Cavia porcellus,,,D,9,BAO_0000357,
1660,,12409,Intermediate,10141.0,,1,Compound at 3 mg/kg was tested for the inhibition of hypothermia in the guinea pig caused by stimulation of central 5-hydroxytryptamine 1D receptors by the agonist GR-46611,,,CHEMBL616651,,105570,Cavia porcellus,,,D,9,BAO_0000218,
1661,,12409,Intermediate,10141.0,,1,Compound at 45 mg/kg was tested for the inhibition of hypothermia in the guinea pig caused by stimulation of central 5-hydroxytryptamine 1D receptors by the agonist GR-46611,,,CHEMBL616652,,105570,Cavia porcellus,,,D,9,BAO_0000218,
1662,,12409,Intermediate,10141.0,,1,Compound at 50 mg/kg was tested for the inhibition of hypothermia in the guinea pig caused by stimulation of central 5-hydroxytryptamine 1D receptors by the agonist GR-46611,,,CHEMBL616653,,105570,Cavia porcellus,,,D,9,BAO_0000218,
1663,,12409,Intermediate,10141.0,,1,Compound at oral dose of 45 mg/kg was tested for percent inhibition against 5-hydroxytryptamine 1D receptor causes hypothermia in guinea pig,,,CHEMBL616654,,105570,Cavia porcellus,,,D,9,BAO_0000218,
1664,,12253,Intermediate,10141.0,,1,Binding affinity of 5-hydroxytryptamine 1D receptor using [3H]-8-HT in guinea pig cortex,,,CHEMBL616655,,105570,Cavia porcellus,,,D,9,BAO_0000019,
1665,,12936,Intermediate,10141.0,,1,Binding affinity against guinea pig 5-hydroxytryptamine 1D receptor,,,CHEMBL616656,,105570,Cavia porcellus,,,D,9,BAO_0000357,
1666,,13181,Autocuration,10141.0,,1,Binding affinity was determined against 5-hydroxytryptamine 4 receptor using [125I]SB 207710 as radioligand from piglet hippocampal membranes,,,CHEMBL616657,,105,Cavia porcellus,,,H,8,BAO_0000019,
1667,,12409,Intermediate,10141.0,,1,In vitro binding affinity towards 5-hydroxytryptamine 1D receptor in guinea-pig striatum in presence of BMY-7378 and mesulergine,,,CHEMBL616658,,105570,Cavia porcellus,,,D,9,BAO_0000357,2435.0
1668,,10639,Intermediate,10141.0,,1,Inhibition of Forskolin-stimulated adenylate cyclase activity against 5-hydroxytryptamine 1D receptor of guinea pig substantia nigra,,,CHEMBL616659,,105570,Cavia porcellus,,,D,9,BAO_0000357,
1669,,5254,Autocuration,,,1,Binding affinity against 5-hydroxytryptamine 1D receptor,,,CHEMBL616660,,51,,,,H,8,BAO_0000357,
1670,,13051,Autocuration,,,1,The compound was tested for binding affinity against cloned human 5-hydroxytryptamine 1D receptor beta,,,CHEMBL616661,,106,,,,H,8,BAO_0000357,
1671,,3463,Expert,,,1,Maximum stimulation of [35S]GTP gamma-S binding expressed relative to the maximal effect produced by 5-hydroxytryptamine 1D receptor,,,CHEMBL616662,,105,,,,H,8,BAO_0000019,
1672,,15315,Autocuration,,,1,Ability to inhibit forskolin-stimulated adenylate cyclase in a cell line expressing human 5-hydroxytryptamine 1D receptor,,,CHEMBL616663,,105,,,,H,8,BAO_0000019,
1673,,6011,Autocuration,,,1,Ability to inhibit forskolin-stimulated adenylate cyclase activity in Chinese hamster ovary (CHO) stable cell lines expressing human 5-hydroxytryptamine 1D receptor,,,CHEMBL616664,,105,,,,H,8,BAO_0000019,
1674,,14159,Expert,9606.0,,1,"Stimulation of [35S]GTP-gamma-S, binding in CHO cells expressing 5-hydroxytryptamine 1D receptor",449.0,,CHEMBL881820,,105,Homo sapiens,CHO,,D,9,BAO_0000219,
1675,,14159,Autocuration,,,1,"Compound was evaluated for the stimulation of [35S]GTP-gamma-S, binding in CHO cells expressing the 5-hydroxytryptamine 1D receptor.",449.0,,CHEMBL616665,,105,,CHO,,H,8,BAO_0000219,
1676,,15250,Expert,,,1,Agonist-induced [35S]- GTPgammaS binding in CHO cells stably transfected with 5-hydroxytryptamine 1D receptor,449.0,,CHEMBL616666,,105,,CHO,,H,8,BAO_0000219,
1677,,15250,Autocuration,,,1,Compound was tested for measuring agonist-induced [35S]- GTPgammaS binding in CHO cells stably transfected with human 5-hydroxytryptamine 1D receptor,449.0,,CHEMBL616667,,105,,CHO,,H,8,BAO_0000219,
1678,,15331,Expert,,,1,"Stimulation of [35S]GTP-gamma-S, binding in CHO cells expressing the 5-hydroxytryptamine 1D receptor",449.0,,CHEMBL616668,,105,,CHO,,H,8,BAO_0000219,
1679,,15332,Expert,9606.0,,1,"Stimulation of [35S]GTP-gamma-S, binding in CHO cells expressing the 5-hydroxytryptamine 1D receptor",449.0,,CHEMBL616669,,105,Homo sapiens,CHO,,D,9,BAO_0000219,
1680,,15332,Expert,,,1,"Stimulation of [35S]GTP-gamma-S, binding in CHO cells expressing the human 5-hydroxytryptamine 1D receptor.",449.0,,CHEMBL617040,,105,,CHO,,H,8,BAO_0000219,
1681,,3294,Autocuration,,,1,"Measurement of agonist induced [35S]GTP-gamma-S, binding in CHO cells stably transfected with 5-hydroxytryptamine 1D receptor",449.0,,CHEMBL617041,,105,,CHO,,H,8,BAO_0000219,
1682,,14158,Expert,,,1,"Measurement of agonist induced [35S]GTP-gamma-S, binding in CHO cells stably transfected with 5-hydroxytryptamine 1D receptor.",449.0,,CHEMBL617042,,105,,CHO,,H,8,BAO_0000219,
1683,,14956,Expert,,,1,"Agonist-induced [35S]GTP-gamma-S, binding in CHO cells stably transfected with human 5-hydroxytryptamine 1D receptor",449.0,,CHEMBL617043,,105,,CHO,,H,8,BAO_0000219,
1684,,12469,Autocuration,,,1,Compound was evaluated for its agonistic activity on 5-hydroxytryptamine 1D receptor,,,CHEMBL617044,,105,,,,H,8,BAO_0000019,
1685,,3463,Expert,,,1,Measurement of agonist-induced [35S]-GTP gamma-S binding in CHO cells stably transfected with 5-hydroxytryptamine 1D receptor,449.0,,CHEMBL617045,,105,,CHO,,H,8,BAO_0000219,
1686,,15250,Expert,9606.0,,1,"Maximum stimulation of [35S]GTP-gamma-S, binding in CHO cells expressing human 5-HT-1d relative to 5-HT",449.0,,CHEMBL617046,,105,Homo sapiens,CHO,,D,9,BAO_0000219,
1687,,15250,Expert,9606.0,,1,"Maximum stimulation of [35S]GTP-gamma-S, binding in CHO cells expressing human 5-HT-1d relative to 5-HT",449.0,,CHEMBL617047,,105,Homo sapiens,CHO,,D,9,BAO_0000219,
1688,,14956,Expert,,,1,"Efficacy was evaluated relative to human 5-hydroxytryptamine 1D receptor using [35S]GTP-gamma-S, as radioligand",,,CHEMBL617048,,105,,,,H,8,BAO_0000019,
1689,,14159,Autocuration,,,1,"Maximum stimulation of [35S]GTP-gamma-S, binding expressed relative to the maximal effect produced by 5-hydroxytryptamine 1D receptor.",,,CHEMBL616897,,105,,,,H,8,BAO_0000019,
1690,,14159,Expert,9606.0,,1,"Maximum stimulation of [35S]GTP-gamma-S, binding to 5-hydroxytryptamine 1D receptor relative to 5-HT",,,CHEMBL616898,,105,Homo sapiens,,,D,9,BAO_0000019,
1691,,14499,Expert,9606.0,,1,Percent efficacy relative to 5-HT treatment of CHO cells expressing 5-HT 1d receptor,449.0,,CHEMBL858201,,105,Homo sapiens,CHO,,D,9,BAO_0000219,
1692,,15315,Autocuration,,,1,Intrinsic activity for 5-hydroxytryptamine 1D receptor,,,CHEMBL616899,,105,,,,H,8,BAO_0000019,
1693,In vitro,3294,Autocuration,,,1,Ability to displace [3H]- -5-HT binding to cloned 5-hydroxytryptamine 1D receptor stably expressed in chinese hamster cells (CHO cells),,,CHEMBL616900,,105,,,,H,8,BAO_0000219,
1694,,3463,Expert,,,1,Ability to displace [3H]-5-HT from recombinant human 5-hydroxytryptamine 1D receptor stably expressed in CHO cells determined in vitro,449.0,,CHEMBL616901,,105,,CHO,,H,8,BAO_0000219,
1695,,15331,Autocuration,,,1,Affinity of compound towards 5-hydroxytryptamine 1D receptor was evaluated using radioligand binding technique,,,CHEMBL616902,,105,,,,H,8,BAO_0000357,
1696,,14159,Expert,9606.0,,1,Displacement of [3H]5-HT from human 5-hydroxytryptamine 1D receptor expressed in CHO cells,449.0,,CHEMBL616903,,105,Homo sapiens,CHO,,D,9,BAO_0000219,
1697,,14158,Expert,,,1,Binding affinity by displacement to human cloned 5-hydroxytryptamine 1D receptor in CHO cells by [3H]5-HT displacement.,449.0,,CHEMBL616904,,105,,CHO,,H,8,BAO_0000219,
1698,,14159,Autocuration,,,1,Compound was evaluated for the affinity at 5-hydroxytryptamine 1D receptor,,,CHEMBL616905,,105,,,,H,8,BAO_0000357,
1699,,15250,Expert,,,1,Binding affinity at human cloned 5-hydroxytryptamine 1D receptor stably expressed in CHO cells by [3H]5-HT displacement.,449.0,,CHEMBL616906,,105,,CHO,,H,8,BAO_0000219,
1700,,15250,Expert,,,1,Displacement of [3H]5-HT binding to cloned human 5-hydroxytryptamine 1D receptor stably expressed in CHO cells,449.0,,CHEMBL616907,,105,,CHO,,H,8,BAO_0000219,
1701,,15331,Expert,,,1,Displacement of [3H]5-HT binding from the cloned human 5-hydroxytryptamine 1D receptor stably expressed in CHO cells,449.0,,CHEMBL616908,,105,,CHO,,H,8,BAO_0000219,
1702,,15332,Expert,9606.0,,1,Displacement of [3H]5-HT binding from human 5-hydroxytryptamine 1D receptor expressed in CHO cells,449.0,,CHEMBL616909,,105,Homo sapiens,CHO,,D,9,BAO_0000219,
1703,,14499,Expert,9606.0,,1,Displacement of [3H]5-HT from human 5-hydroxytryptamine 1D receptor expressed in CHO cells,449.0,,CHEMBL616910,,105,Homo sapiens,CHO,,D,9,BAO_0000219,
1704,,15332,Expert,,,1,Displacement of [3H]5-HT binding to the cloned human 5-hydroxytryptamine 1D receptor stably expressed in CHO cells,449.0,,CHEMBL616911,,105,,CHO,,H,8,BAO_0000219,
1705,,14956,Expert,,,1,Displacement of specific [3H]5-HT binding to cloned human 5-hydroxytryptamine 1D receptor expressed in CHO cells,449.0,,CHEMBL616912,,105,,CHO,,H,8,BAO_0000219,
1706,,3805,Autocuration,,,1,In vitro binding affinity against human 5-hydroxytryptamine 1D receptor at a concentration of 100 (nM),,,CHEMBL616913,,105,,,,H,8,BAO_0000357,
1707,,6011,Expert,9606.0,,1,Inhibition of [3H]5-HT binding to human 5-hydroxytryptamine 1D receptor expressed in CHO cells at 1 uM,449.0,,CHEMBL616914,,105,Homo sapiens,CHO,,D,9,BAO_0000219,
1708,,16190,Autocuration,,,1,Binding affinity against 5-hydroxytryptamine 1D receptor in CHO cells using [3H]5-HT as radioligand,449.0,,CHEMBL616915,,105,,CHO,,H,8,BAO_0000219,
1709,,14165,Autocuration,,,1,Binding affinity for 5-hydroxytryptamine 1D receptor in Cos-7 transfected cell type using [3H]5-CT as radioligand,,,CHEMBL616916,,105,,,,H,8,BAO_0000019,
1710,,4234,Expert,9606.0,,1,Binding affinity to cloned human 5-hydroxytryptamine 1D receptor,,,CHEMBL616917,,105,Homo sapiens,,,D,9,BAO_0000357,
1711,,15527,Autocuration,,,1,"Binding affinity towards 5-HT1D receptor, using [3H]5-HT as radioligand.",,,CHEMBL616918,,105,,,,H,8,BAO_0000357,
1712,,6328,Expert,,,1,Binding affinity towards human 5-hydroxytryptamine 1D receptor in L-M(tk-) cells using [3H]GR-125743 as radioligand,,,CHEMBL616919,,105,,,,H,8,BAO_0000219,
1713,,16209,Autocuration,,,1,Binding affinity towards human 5-hydroxytryptamine 1D receptor was determined using [3H]5-HT as radioligand,,,CHEMBL616920,,105,,,,H,8,BAO_0000357,
1714,,14770,Autocuration,,,1,Binding affinity for recombinant human 5-hydroxytryptamine 1D receptor using [3H]5-HT as radioligand.,,,CHEMBL872914,,105,,,,H,8,BAO_0000357,
1715,,2598,Autocuration,,,1,Binding affinity was evaluated at human recombinant 5-hydroxytryptamine 1D receptor using [3H]-5-CT as radioligand,,,CHEMBL616921,,105,,,,H,8,BAO_0000357,
1716,,6897,Expert,,,1,Binding affinity was evaluated at the cloned human 5-hydroxytryptamine 1D receptor,,,CHEMBL616922,,105,,,,H,8,BAO_0000357,
1717,,6013,Autocuration,,,1,Binding affinity towards 5-hydroxytryptamine 1D receptor,,,CHEMBL616923,,105,,,,H,8,BAO_0000357,
1718,,5843,Expert,,,1,Binding affinity towards cloned human 5-hydroxytryptamine 1D receptor,,,CHEMBL616924,,105,,,,H,8,BAO_0000357,
1719,,14454,Expert,,,1,Binding affinity towards human 5-hydroxytryptamine 1D receptor using [3H]5-HT trifluoroacetate as radioligand,,,CHEMBL875909,,105,,,,H,8,BAO_0000357,
1720,,14454,Autocuration,,,1,Binding affinity towards human 5-hydroxytryptamine 1D receptor using [3H]5-HT trifluoroacetate as radioligand; Not determined,,,CHEMBL616925,,105,,,,H,8,BAO_0000357,
1721,,14454,Autocuration,,,1,Binding affinity towards human 5-hydroxytryptamine 1D receptor using [3H]5-HT trifluoroacetate as radioligand; not determined,,,CHEMBL616926,,105,,,,H,8,BAO_0000357,
1722,,15818,Autocuration,,,1,Compound was evaluated for its binding affinity towards human 5-hydroxytryptamine 1D receptor,,,CHEMBL616927,,105,,,,H,8,BAO_0000357,
1723,,13729,Expert,,,1,Ability to inhibit the forskolin-stimulated c-AMP formation mediated by human 5-hydroxytryptamine 1D receptor in CHO-K1 cells,485.0,,CHEMBL616928,,105,,CHO-K1,,H,8,BAO_0000219,
1724,In vitro,6011,Expert,9606.0,,1,Displacement of [3H]5-HT from human 5-hydroxytryptamine 1D receptor expressed in Chinese hamster ovary cells (CHO cells),,,CHEMBL616929,,105,Homo sapiens,,,D,9,BAO_0000219,
1725,,4234,Expert,9606.0,,1,In vitro binding affinity to human 5-hydroxytryptamine 1D receptor,,,CHEMBL616930,,105,Homo sapiens,,,D,9,BAO_0000357,
1726,,17085,Expert,,,1,In vitro binding affinity by radioligand binding assay using cell line expressing human 5-hydroxytryptamine 1D receptor,,,CHEMBL616931,,105,,,,H,8,BAO_0000019,
1727,,3025,Autocuration,,,1,In vitro binding affinity was determined towards cloned human 5-hydroxytryptamine 1D receptor using [3H]5-CT radioligand,,,CHEMBL616932,,105,,,,H,8,BAO_0000357,
1728,,15315,Expert,,,1,In vitro receptor binding affinity for cloned human 5-hydroxytryptamine 1D receptor,,,CHEMBL616933,,105,,,,H,8,BAO_0000357,
1729,,14214,Expert,9606.0,,1,Receptor binding affinity for cloned human 5-hydroxytryptamine 1D receptor in Cos-7 cells,,,CHEMBL616934,,105,Homo sapiens,,,D,9,BAO_0000219,
1730,,3804,Expert,9606.0,,1,Binding affinity for human 5-hydroxytryptamine 1D receptor,,,CHEMBL616935,,105,Homo sapiens,,,D,9,BAO_0000357,
1731,,16700,Autocuration,,,1,The binding affinity towards the 5-hydroxytryptamine 1D receptor; No affinity,,,CHEMBL616936,,105,,,,H,8,BAO_0000357,
1732,,2391,Expert,9606.0,,1,Affinity for 5-hydroxytryptamine 1D receptor subtype,,,CHEMBL616937,,105,Homo sapiens,,,D,9,BAO_0000357,
1733,,4175,Expert,9606.0,,1,Binding affinity for human 5-hydroxytryptamine 1D receptor,,,CHEMBL616938,,105,Homo sapiens,,,D,9,BAO_0000357,
1734,,17085,Autocuration,,,1,In vitro binding affinity by radioligand binding assay using cell line expressing human 5-hydroxytryptamine 1D receptor,,,CHEMBL616939,,105,,,,H,8,BAO_0000019,
1735,,17085,Expert,,,1,In vitro binding affinity was determined by radioligand binding assay using cell line expressing human 5-hydroxytryptamine 1D receptor; ND means not determined,,,CHEMBL616940,,105,,,,H,8,BAO_0000019,
1736,,15926,Expert,9606.0,,1,Binding activity against human 5-hydroxytryptamine 1D receptor; NT means not tested,,,CHEMBL616941,,105,Homo sapiens,,,D,9,BAO_0000357,
1737,,16312,Autocuration,,,1,Binding affinity in CHO-K1 cells transfected with human 5-hydroxytryptamine 1D receptor; Not tested,485.0,,CHEMBL616942,,105,,CHO-K1,,H,8,BAO_0000219,
1738,,16312,Autocuration,,,1,Binding affinity in CHO-K1 cells transfected with human 5-hydroxytryptamine 1D receptor; not tested,485.0,,CHEMBL616943,,105,,CHO-K1,,H,8,BAO_0000219,
1739,,14956,Autocuration,,,1,Selectivity towards 5-HT1D and to that of 5-HT1B in CHO cells,449.0,,CHEMBL616944,,104802,,CHO,,H,4,BAO_0000219,
1740,,3294,Autocuration,,,1,"Maximum stimulation of [35S]GTP-gamma-S, binding expressed relative to the maximal effect produced by the 5-HT",,,CHEMBL616945,,105,,,,H,8,BAO_0000019,
1741,,12861,Autocuration,,,1,Binding activity radioligand.,,,CHEMBL616946,,105,,,,H,8,BAO_0000357,
1742,,12861,Autocuration,,,1,Binding activity against 5-hydroxytryptamine 3 receptor from rat cortex homogenate using [3H]-Q-ICS 205-930 as radioligand.,,,CHEMBL616947,,105,,,,H,8,BAO_0000019,
1743,,16312,Expert,,,1,Binding affinity in CHO-K1 cells transfected with human 5-hydroxytryptamine 1D receptor,485.0,,CHEMBL616948,,105,,CHO-K1,,H,8,BAO_0000219,
1744,,5104,Autocuration,,,1,Binding affinity for human cloned 5-hydroxytryptamine 1D receptor,,,CHEMBL616851,,105,,,,H,8,BAO_0000357,
1745,,5105,Autocuration,,,1,Binding affinity for human cloned 5-hydroxytryptamine 1D receptor,,,CHEMBL616852,,105,,,,H,8,BAO_0000357,
1746,,14499,Autocuration,,,1,Measured as -log Ka on 5-hydroxytryptamine 1D receptor,,,CHEMBL616853,,105,,,,H,8,BAO_0000357,
1747,,15926,Expert,9606.0,,1,Binding activity against human 5-hydroxytryptamine 1D receptor,,,CHEMBL616854,,105,Homo sapiens,,,D,9,BAO_0000357,
1748,,4540,Expert,9606.0,,1,Binding affinity to human cloned 5-hydroxytryptamine 1D receptor in CHO cells using [3H]5-HT as radioligand,449.0,,CHEMBL616855,,105,Homo sapiens,CHO,,D,9,BAO_0000219,
1749,,15779,Autocuration,,,1,Binding affinity towards 5-hydroxytryptamine 1D (human cloned receptor) in CHO cells using [3H]-5-HT as radioligand.,449.0,,CHEMBL616856,,105,,CHO,,H,8,BAO_0000219,
1750,,15779,Autocuration,,,1,Binding affinity towards 5-hydroxytryptamine 1D (human cloned receptor) in CHO cells using [3H]5-HT as radioligand.,449.0,,CHEMBL616857,,105,,CHO,,H,8,BAO_0000219,
1751,,6166,Autocuration,,,1,Binding affinity towards cloned human 5-hydroxytryptamine 1D receptor,,,CHEMBL616858,,105,,,,H,8,BAO_0000357,
1752,,15779,Autocuration,,,1,Binding affinity towards human cloned 5-hydroxytryptamine 1D receptor in CHO cells using [3H]5-HT as radioligand.,449.0,,CHEMBL616859,,105,,CHO,,H,8,BAO_0000219,
1753,,15779,Autocuration,,,1,Binding affinity towards human cloned 5-hydroxytryptamine 1D receptor in CHO cells using [3H]-5-HT as radioligand.;ND means no data.,449.0,,CHEMBL616860,,105,,CHO,,H,8,BAO_0000219,
1754,,17451,Autocuration,,,1,Binding constant towards serotonin receptor subtype 5-hydroxytryptamine 1D receptor expressed in HEK 293 cells using [3H]LSD as radioligand,722.0,,CHEMBL616861,,105,,HEK293,,H,8,BAO_0000219,
1755,,17451,Autocuration,,,1,Binding constant towards serotonin receptor subtype 5-hydroxytryptamine 1D receptor expressed in HEK 293 cells using [3H]LSD as radioligand,722.0,,CHEMBL616541,,105,,HEK293,,H,8,BAO_0000219,
1756,,17451,Autocuration,,,1,Binding constant towards serotonin receptor subtype 5-hydroxytryptamine 1D receptor expressed in HEK 293 cells using [3H]LSD as radioligand; Not determined,722.0,,CHEMBL616542,,105,,HEK293,,H,8,BAO_0000219,
1757,,4199,Autocuration,,,1,Compound was evaluated for binding affinity against human cloned 5-hydroxytryptamine 1D receptor in CHO cells using [3H]5-HT as the radioligand,449.0,,CHEMBL616543,,105,,CHO,,H,8,BAO_0000219,
1758,,14875,Expert,9606.0,,1,Binding affinity for human 5-hydroxytryptamine 1D receptor,,,CHEMBL616544,,105,Homo sapiens,,,D,9,BAO_0000357,
1759,,15146,Autocuration,,,1,Compound was tested for its binding affinity against human cloned 5-hydroxytryptamine 1D receptor in CHO cells using [3H]5-HT,449.0,,CHEMBL616545,,105,,CHO,,H,8,BAO_0000219,
1760,,5213,Autocuration,,,1,Compound was tested for its binding affinity for human cloned 5-hydroxytryptamine 1D receptor in CHO using [3H]5-HT as a radioligand,,,CHEMBL616546,,105,,,,H,8,BAO_0000357,
1761,,14818,Autocuration,,,1,The compound was tested for its binding affinity towards cloned human 5-hydroxytryptamine 1D receptor in CHO cells using [3H]5-HT.,449.0,,CHEMBL616547,,105,,CHO,,H,8,BAO_0000219,
1762,,4829,Autocuration,,,1,"The compound was tested for the binding affinity towards human cloned 5-hydroxytryptamine 1D receptor in CHO cells, using [3H]5-HT as radioligand",449.0,,CHEMBL616548,,105,,CHO,,H,8,BAO_0000219,
1763,,14454,Expert,,,1,Adenyl cyclase activity was expressed as percent forskolin response against 5-hydroxytryptamine 1D receptor at concentration 1 uM,,,CHEMBL616549,,105,,,,H,8,BAO_0000019,
1764,,14454,Expert,,,1,Adenyl cyclase activity was expressed as percent forskolin response against 5-hydroxytryptamine 1D receptor at concentration 10 uM,,,CHEMBL616550,,105,,,,H,8,BAO_0000019,
1765,,5254,Autocuration,,,1,Binding affinity against 5-HT2C receptor,,,CHEMBL857066,,108,,,,H,8,BAO_0000357,
1766,,5254,Autocuration,,,1,Binding affinity against 5-hydroxytryptamine 1D receptor,,,CHEMBL616551,,108,,,,H,8,BAO_0000357,
1767,,10639,Autocuration,,,1,Inhibition of Forskolin-stimulated adenylate cyclase activity against 5-hydroxytryptamine 1B receptor of rat substantia nigra,,,CHEMBL616552,,10577,,,,H,8,BAO_0000357,
1768,,10639,Autocuration,,,1,Inhibition of Forskolin-stimulated adenylate cyclase activity against 5-hydroxytryptamine 1B receptor of rat substantia nigra,,,CHEMBL832876,,10577,,,,H,8,BAO_0000019,
1769,,12352,Expert,,,1,"Binding affinity for 5-hydroxytryptamine 1B receptor in rat cortex, striatum and globus pallidus",,,CHEMBL616553,,10577,,,,H,8,BAO_0000019,
1770,,9098,Autocuration,,,1,Binding affinity towards 5-HT1B was determined,,,CHEMBL616554,,10577,,,,H,8,BAO_0000357,
1771,,14430,Expert,,,1,Affinity towards 5-hydroxytryptamine 1B receptor in membranes from rat frontal cortex using [3H]5-HT,,,CHEMBL616555,,10577,,,,H,8,BAO_0000019,
1772,,13657,Expert,,,1,"Binding affinity to 5-HT1B receptors using rat cortex+striatum + globus pallidus,[3H]-5-OH-tryptamine, and serotonin for NSB",,,CHEMBL616556,,10577,,,,H,8,BAO_0000019,
1773,,13657,Autocuration,,,1,"Compound was evaluated for binding affinity on 5-HT1B receptors using rat cortex+striatum+ globus pallidus,[ 3H]-5-OH-tryptamine, and serotonin for NSB.",,,CHEMBL616557,,10577,,,,H,8,BAO_0000019,
1774,,15854,Expert,,,1,Binding affinity towards 5-hydroxytryptamine 1B receptor in rat frontal cortex using [125I]iodocyanopindolol as radio-ligand.,,,CHEMBL616558,,10577,,,,H,8,BAO_0000019,
1775,,10639,Expert,10116.0,,1,Inhibitory activity against 5-hydroxytryptamine 1B receptor of rat cortex using [3H]5-HT,,,CHEMBL616749,,10577,Rattus norvegicus,,,D,9,BAO_0000019,
1776,,10025,Autocuration,,,1,Concentration necessary to achieve half maximal inhibition of [125I]- Iodocyanopindolol binding to 5-hydroxytryptamine 1B receptor at 1 uM,,,CHEMBL616750,,10577,,,,H,8,BAO_0000357,
1777,,10025,Autocuration,,,1,"Concentration necessary to achieve half maximal inhibition of [125I]- Iodocyanopindolol, binds to 5-hydroxytryptamine 1B receptor at 1 uM",,,CHEMBL616751,,10577,,,,H,8,BAO_0000357,
1778,,14286,Autocuration,,,1,In vitro inhibitory concentration against radioligand [3H]5-HT binding to 5-hydroxytryptamine 1B receptor in rat striatal membrane,,,CHEMBL616752,,10577,,,,H,8,BAO_0000249,
1779,,3651,Autocuration,,,1,Inhibition of [3H]-5-HT binding to 5-hydroxytryptamine 1B receptor in rat striatum; Residual radioligand binding higher than 50%,,,CHEMBL616753,,10577,,,,H,8,BAO_0000019,2435.0
1780,,14178,Expert,10116.0,,1,Inhibition of radiolabeled [3H]-5-HT ligand binding to 5-hydroxytryptamine 1B receptor,,,CHEMBL616754,,10577,Rattus norvegicus,,,D,9,BAO_0000357,
1781,,10639,Autocuration,,,1,Inhibitory activity against 5-hydroxytryptamine 1B receptor of rat cortex using [3H]5-HT as the radioligand.,,,CHEMBL616755,,10577,,,,H,8,BAO_0000019,
1782,,13605,Autocuration,,,1,Inhibitory activity against [3H]5-HT binding to 5-HT1B receptor in rat striatum,,,CHEMBL616756,,10577,,,,H,8,BAO_0000019,2435.0
1783,,5834,Autocuration,,,1,Inhibitory concentration required against 5-hydroxytryptamine 1B receptor in rat striatum using [3H]5-HT,,,CHEMBL616757,,10577,,,,H,8,BAO_0000019,2435.0
1784,,10922,Autocuration,,,1,compound was measured for affinity against 5-hydroxytryptamine 1B receptor labelled with [3H]5-HT radioligand in striatum tissue,,,CHEMBL616758,,10577,,,,H,8,BAO_0000357,2435.0
1785,,14286,Autocuration,,,1,Compound at 10E-5 M was tested in vitro for the inhibition of radioligand [3H]5-HT binding to 5-hydroxytryptamine 1B receptor in rat striatal membrane,,,CHEMBL616759,,10577,,,,H,8,BAO_0000249,
1786,,11825,Autocuration,,,1,In vitro binding affinity towards the 5-hydroxytryptamine 1B receptor at 10 e-6 M,,,CHEMBL616760,,10577,,,,H,8,BAO_0000357,
1787,,14826,Autocuration,,,1,Ability to displace [3H]5-HT bound to 5-hydroxytryptamine 1B receptor in rat striatum,,,CHEMBL616761,,10577,,,,H,8,BAO_0000019,2435.0
1788,,9699,Autocuration,,,1,Binding affinity against 5-HT1B serotonin receptor in rat striatum,,,CHEMBL616762,,10577,,,,H,8,BAO_0000019,2435.0
1789,,14423,Autocuration,,,1,Binding affinity against 5-hydroxytryptamine 1B receptor in membranes of Rat cerebral cortex,,,CHEMBL616763,,10577,,,,H,8,BAO_0000019,
1790,,10062,Expert,,,1,Binding affinity at rat 5-hydroxytryptamine 1B receptor by [3H]5-HT displacement.,,,CHEMBL872909,,10577,,,,H,8,BAO_0000357,
1791,,10062,Autocuration,,,1,Binding affinity determined in radioreceptor binding assay by using [3H]5-HT radioligand against 5-hydroxytryptamine 1B receptor,,,CHEMBL616764,,10577,,,,H,8,BAO_0000357,
1792,,12280,Expert,10116.0,,1,Inhibition of [3H]5-HT binding to 5-hydroxytryptamine 1B receptor,,,CHEMBL616765,,10577,Rattus norvegicus,,,D,9,BAO_0000357,
1793,,15412,Autocuration,,,1,Binding affinity against 5-hydroxytryptamine 1B receptor of rat striatum,,,CHEMBL616766,,10577,,,,H,8,BAO_0000357,2435.0
1794,,15412,Autocuration,,,1,Binding affinity against 5-hydroxytryptamine 1B receptor of rat striatum.,,,CHEMBL616767,,10577,,,,H,8,BAO_0000357,2435.0
1795,,10062,Autocuration,,,1,Binding affinity in radioreceptor binding assay by using [3H]5-HT radioligand against 5-hydroxytryptamine 1B receptor,,,CHEMBL616768,,10577,,,,H,8,BAO_0000357,
1796,,11147,Autocuration,,,1,Binding affinity towards 5-hydroxytryptamine 1B receptor using [3H]5-HT as radioligand,,,CHEMBL616769,,10577,,,,H,8,BAO_0000357,
1797,,9547,Autocuration,,,1,Binding affinity towards 5-hydroxytryptamine 1B receptor in rat was determined using 50 uL of [125I]ICYP in binding assay,,,CHEMBL616770,,10577,,,,H,8,BAO_0000019,
1798,,10444,Autocuration,,,1,Binding affinity was determined against 5-hydroxytryptamine 1B receptor was determined in male Sprague-Dawley rat brain.,,,CHEMBL616771,,10577,,,,H,8,BAO_0000019,
1799,,12469,Autocuration,,,1,Binding affinity was measured on 5-hydroxytryptamine 1B receptor in rat striatum labeled with [3H]5-HT,,,CHEMBL616772,,10577,,,,H,8,BAO_0000019,2435.0
1800,,9098,Expert,,,1,Binding affinity (Ki) to rat cortical membranes at 5-HT1B binding site by using [125 I] ICYP as a radioligand.,,,CHEMBL616773,,10577,,,,H,8,BAO_0000019,
1801,,9098,Autocuration,,,1,Compound was evaluated for the binding affinity (Ki) to rat cortical membranes at 5-HT1B binding site by using [125 I] ICYP as a radioligand; ND is no data.,,,CHEMBL616774,,10577,,,,H,8,BAO_0000019,
1802,,9699,Autocuration,,,1,Evaluated for binding affinity towards 5-hydroxytryptamine 1B receptor,,,CHEMBL616775,,10577,,,,H,8,BAO_0000357,
1803,,10394,Autocuration,,,1,Inhibitory activity against 5-hydroxytryptamine 1B receptor in rat cortical membranes using [3H]5-HT as a radioligand,,,CHEMBL616776,,10577,,,,H,8,BAO_0000249,
1804,,12092,Autocuration,,,1,The binding affinity was measured on 5-hydroxytryptamine 1B receptor using [3H]- serotonin as radioligand.,,,CHEMBL616777,,10577,,,,H,8,BAO_0000357,
1805,,16700,Autocuration,,,1,The binding affinity towards the receptor rat 5-hydroxytryptamine 1B receptor; No affinity,,,CHEMBL616778,,10577,,,,H,8,BAO_0000357,
1806,,403,Expert,10116.0,,1,Binding affinity against 5-hydroxytryptamine 1B receptor in rat striatal membranes using [3H]5-HT as radioligand,,,CHEMBL616779,,10577,Rattus norvegicus,,,D,9,BAO_0000249,
1807,,12771,Expert,10116.0,,1,Binding affinity towards 5-hydroxytryptamine 1B receptor,,,CHEMBL616780,,10577,Rattus norvegicus,,,D,9,BAO_0000357,
1808,,11642,Autocuration,,,1,The compound was tested for its binding affinity towards 5-hydroxytryptamine 1B receptor by displacing [3H]serotonin radioligand in rat cerebral cortex,,,CHEMBL616781,,10577,,,,H,8,BAO_0000019,
1809,,12953,Autocuration,,,1,The compound was tested for their binding affinity towards 5-hydroxytryptamine 1B receptor from rat striatum using [3H]5-HT as radioligand,,,CHEMBL616782,,10577,,,,H,8,BAO_0000357,
1810,,12953,Autocuration,,,1,The compound was tested for their binding affinity towards 5-hydroxytryptamine 1B receptor from rat striatum using [3H]5-HT as radioligand.,,,CHEMBL616783,,10577,,,,H,8,BAO_0000357,
1811,,12953,Expert,,,1,Binding affinity for 5-hydroxytryptamine 1B receptor in rat striatum using [3H]5-HT as radioligand,,,CHEMBL616784,,10577,,,,H,8,BAO_0000019,2435.0
1812,,12953,Autocuration,,,1,The compound was tested for their binding affinity towards 5-hydroxytryptamine 1B receptor from rat striatum using [3H]5-HT as radioligand; Nonactive at 10 uM,,,CHEMBL616785,,10577,,,,H,8,BAO_0000357,
1813,,9737,Autocuration,,,1,Binding affinity against 5-HT1B receptor in rat brain membrane using [3H]8-OH-DPAT as a selective ligand.,,,CHEMBL857067,,10577,,,,H,8,BAO_0000249,955.0
1814,,9737,Autocuration,,,1,Binding affinity against 5-HT1B receptor in rat frontal cortex using [3H]-5-HT in presence of 0.1 uM [3H]-8-OH-DPAT as a radioligand,,,CHEMBL616786,,10577,,,,H,8,BAO_0000019,
1815,,9737,Autocuration,,,1,Binding affinity towards 5-HT1B receptor in rat brain membrane using [3H]8-OH-DPAT as a selective ligand.,,,CHEMBL616787,,10577,,,,H,8,BAO_0000249,955.0
1816,,12827,Autocuration,,,1,Binding affinity towards 5-hydroxytryptamine 2C receptor of porcine choroid plexus using [3H]mesulergine,,,CHEMBL616788,,10577,,,,H,8,BAO_0000357,
1817,,5033,Autocuration,,,1,Ability to displace the radioligand [125I](-)-iodocyanopindolol from rat striatal 5-hydroxytryptamine 1B receptor,,,CHEMBL616789,,10577,,,,H,8,BAO_0000357,
1818,,9786,Expert,10116.0,,1,Displacement of [3H]5-HT from 5-HT1B receptor of rat frontal cortex homogenate,,,CHEMBL616790,,10577,Rattus norvegicus,,,D,9,BAO_0000019,
1819,,13116,Expert,,,1,Binding affinity at 5-hydroxytryptamine 1B receptor,,,CHEMBL616791,,10577,,,,H,8,BAO_0000357,
1820,,16429,Autocuration,,,1,In vitro binding affinity at 5-hydroxytryptamine 1B receptor in rat striatal muscles using [125I](-)-iodocyanopindolol as the radioligand,,,CHEMBL616792,,10577,,,,H,8,BAO_0000019,
1821,,12409,Expert,10116.0,,1,In vitro binding affinity towards 5-hydroxytryptamine 1B receptor in rat striatal membrane with [125I]- iodocyanopindolol,,,CHEMBL616793,,10577,Rattus norvegicus,,,D,9,BAO_0000249,
1822,,15194,Autocuration,,,1,The compound was tested for the binding affinity against 5-hydroxytryptamine 1B receptor using [3H]5-HT as radioligand,,,CHEMBL616794,,10577,,,,H,8,BAO_0000357,
1823,,15194,Autocuration,,,1,The compound was tested for the binding affinity against 5-hydroxytryptamine 1B receptor using [3H]5-HT as radioligand.,,,CHEMBL616795,,10577,,,,H,8,BAO_0000357,
1824,,5486,Autocuration,,,1,Binding affinity towards 5-HT2 receptor by the displacement of [3H]-ketanserin] in rat cerebral cortex,,,CHEMBL616796,,104686,,,,H,4,BAO_0000019,
1825,,4639,Autocuration,,,1,Compound was tested for binding affinity against 5-hydroxytryptamine 1B receptor,,,CHEMBL616797,,106,,,,H,8,BAO_0000357,
1826,,386,Autocuration,,,1,The compound was evaluated for its ability to displace [3H]5-HT from 5-hydroxytryptamine 1B receptor in cellular brain membranes,,,CHEMBL616798,Brain membranes,106,,,,H,8,BAO_0000249,
1827,,2474,Autocuration,,,1,Compound was measured for its binding affinity at 5-hydroxytryptamine 1B receptor at a concentration of 100 nM using [125I]CYP as radioligand,,,CHEMBL616799,,106,,,,H,8,BAO_0000357,
1828,,6011,Autocuration,,,1,Inhibition of binding towards 5-hydroxytryptamine 1B receptor at 100 nM concentration,,,CHEMBL616800,,106,,,,H,8,BAO_0000357,
1829,,5014,Autocuration,,,1,Percent inhibition (at 1 uM) against 5-hydroxytryptamine 1B receptor,,,CHEMBL616801,,106,,,,H,8,BAO_0000357,
1830,,17515,Autocuration,,,1,Binding affinity of compound towards serotonin 5-hydroxytryptamine 1B receptor; inactive at 10 uM,,,CHEMBL616802,,106,,,,H,8,BAO_0000357,
1831,,4373,Autocuration,,,1,Binding affinity relative to indolopiperidine (compound 1) for 5-hydroxytryptamine 1B receptor was determined,,,CHEMBL616803,,106,,,,H,8,BAO_0000357,
1832,,1633,Expert,,,1,Binding affinity towards 5-hydroxytryptamine 1B receptor by displacement of [3H]5-HT.,,,CHEMBL857068,,106,,,,H,8,BAO_0000357,
1833,,1633,Autocuration,,,1,Compound was evaluated for the binding affinity towards 5-hydroxytryptamine 1B receptor by displacement of [3H]ketanserin.,,,CHEMBL616804,,106,,,,H,8,BAO_0000357,
1834,,4373,Autocuration,,,1,Binding affinity for 5-hydroxytryptamine 1B receptor was determined,,,CHEMBL616805,,106,,,,H,8,BAO_0000357,
1835,,4687,Autocuration,,,1,Evaluated for the binding affinity to 5-hydroxytryptamine 1B receptor,,,CHEMBL616806,,106,,,,H,8,BAO_0000357,
1836,,11574,Autocuration,,,1,Binding affinity against 5-hydroxytryptamine 1B receptor,,,CHEMBL616807,,106,,,,H,8,BAO_0000357,
1837,,10321,Autocuration,,,1,Binding affinity for 5-hydroxytryptamine 1B receptor was determined by using [3H]5-HT as radioligand,,,CHEMBL616808,,106,,,,H,8,BAO_0000357,
1838,,15527,Autocuration,,,1,Binding affinity towards 5-hydroxytryptamine 1B receptor using [3H]5-HT as radioligand.,,,CHEMBL616809,,106,,,,H,8,BAO_0000357,
1839,,17200,Autocuration,,,1,Inhibitory constant against 5-hydroxytryptamine 1B receptor using with [125I]- cyanopindolol radioligand,,,CHEMBL616810,,106,,,,H,8,BAO_0000357,
1840,,14423,Autocuration,,,1,Binding affinity against 5-hydroxytryptamine 1B receptor - 5-hydroxytryptamine 1D receptor using [3H]5-HT as the radioligand.,,,CHEMBL616811,,104802,,,,H,4,BAO_0000224,
1841,,5834,Autocuration,9913.0,,1,Inhibitory concentration required against 5-hydroxytryptamine 1C receptor in bovine choroid plexus using [3H]mesulergine,,,CHEMBL616812,,108,Bos taurus,,,H,8,BAO_0000357,
1842,,11473,Autocuration,9823.0,,1,Binding affinity towards 5-hydroxytryptamine 1C receptor using [3H]mesulergine as radioligand,,,CHEMBL616813,,108,Sus scrofa,,,H,8,BAO_0000357,
1843,,11473,Autocuration,9823.0,,1,Compound was evaluated for binding affinity towards 5-hydroxytryptamine 1C receptor in pig choroid plexus using [3H]mesulergine as radioligand,,,CHEMBL616814,,108,Sus scrofa,,,H,8,BAO_0000357,
1844,,10639,Autocuration,9823.0,,1,Compound was evaluated for its inhibitory activity against 5-hydroxytryptamine 1C receptor of pig choroid plexus using [3H]mesulergine as the radioligand,,,CHEMBL616815,,108,Sus scrofa,,,H,8,BAO_0000357,
1845,,10639,Autocuration,9823.0,,1,inhibitory activity against 5-hydroxytryptamine 1C receptor of pig choroid plexus using [3H]mesulergine as the radioligand,,,CHEMBL616816,,108,Sus scrofa,,,H,8,BAO_0000357,
1846,,14331,Autocuration,9823.0,,1,Binding affinity of compound towards 5-hydroxytryptamine 1C receptor using [3H]mesulergine (1.2 nM) ligand in choroid Plexus pig was determined,,,CHEMBL616817,,108,Sus scrofa,,,H,8,BAO_0000357,
1847,,10796,Autocuration,9823.0,,1,Compound was tested in vitro for binding affinity for 5-hydroxytryptamine 1C receptor,,,CHEMBL616818,,108,Sus scrofa,,,H,8,BAO_0000357,
1848,,9098,Expert,9823.0,,1,Evaluated for the binding affinity to porcine choroid plexus at 5-hydroxytryptamine 2C receptor binding site by using [3H]-MES as a radioligand.,,,CHEMBL616819,,108,Sus scrofa,,,H,8,BAO_0000357,
1849,,14331,Expert,9823.0,,1,Inhibition of [3H]mesulergine binding to 5-hydroxytryptamine 1C receptor of pig choroid Plexus,,,CHEMBL616820,,108,Sus scrofa,,,H,8,BAO_0000357,
1850,,11828,Expert,9823.0,,1,Displacement of [3H]mesulergine from pig cortex 5-hydroxytryptamine 1C receptor,,,CHEMBL616821,,108,Sus scrofa,,,H,8,BAO_0000019,
1851,,11866,Autocuration,9823.0,,1,Binding affinity for 5-hydroxytryptamine 1C receptor in piglet choroid plexus using [3H]5-HT,,,CHEMBL616822,,108,Sus scrofa,,,H,8,BAO_0000357,
1852,,13047,Autocuration,9986.0,,1,Binding affinity against 5-hydroxytryptamine 1D receptor alpha using rabbit saphenous vein assay.,,,CHEMBL616823,,108,Oryctolagus cuniculus,,,H,8,BAO_0000019,
1853,,188,Autocuration,10116.0,,1,Tested for the effect on binding at 5-hydroxytryptamine 1C receptor; No activity,,,CHEMBL616824,,12689,Rattus norvegicus,,,D,9,BAO_0000357,
1854,,11825,Autocuration,10116.0,,1,In vitro binding affinity towards the 5-hydroxytryptamine 1C receptor at 10 e-6 M,,,CHEMBL616825,,12689,Rattus norvegicus,,,D,9,BAO_0000357,
1855,,11825,Autocuration,10116.0,,1,In vitro binding affinity towards the 5-hydroxytryptamine 1C receptor at 10 e-6 M,,,CHEMBL616826,,12689,Rattus norvegicus,,,D,9,BAO_0000357,
1856,,11624,Expert,10116.0,,1,Binding affinity against 5-hydroxytryptamine 1C receptor in rat using [3H]mesulergine as radioligand,,,CHEMBL616827,,12689,Rattus norvegicus,,,D,9,BAO_0000019,
1857,,11139,Autocuration,10116.0,,1,Binding affinity towards 5-hydroxytryptamine 1C receptor using [125 I]-SCH23982 as radioligand in competitive binding assay,,,CHEMBL616828,,12689,Rattus norvegicus,,,D,9,BAO_0000357,
1858,,11147,Autocuration,10116.0,,1,Binding affinity towards 5-hydroxytryptamine 1C receptor using [3H]mesulergine as radioligand,,,CHEMBL616829,,12689,Rattus norvegicus,,,D,9,BAO_0000357,
1859,,10444,Autocuration,10116.0,,1,Binding affinity was determined against 5-hydroxytryptamine 1C receptor was determined in male Sprague-Dawley rat brain.,,,CHEMBL616830,,12689,Rattus norvegicus,,,D,9,BAO_0000019,
1860,,11624,Expert,10116.0,,1,Binding affinity against 5-hydroxytryptamine 1C receptor,,,CHEMBL616831,,12689,Rattus norvegicus,,,D,9,BAO_0000357,
1861,,11662,Autocuration,10116.0,,1,"Compound was tested for binding affinity towards 5-HT1C (5-HT1C) receptor from frontal cortical regions of male Sprague-Dawley rat homogenates, using [3H]mesulergine as radioligand",,,CHEMBL616832,,12689,Rattus norvegicus,,,D,9,BAO_0000019,
1862,,11662,Autocuration,10116.0,,1,"Compound was tested for binding affinity towards 5-hydroxytryptamine 1C receptor from frontal cortical regions of male Sprague-Dawley rat homogenates, using [3H]mesulergine as radioligand",,,CHEMBL616833,,12689,Rattus norvegicus,,,D,9,BAO_0000019,
1863,,11662,Expert,10116.0,,1,"Binding affinity towards 5-hydroxytryptamine 1C receptor from frontal cortical regions of male Sprague-Dawley rat homogenates, using [3H]mesulergine as radioligand",,,CHEMBL616834,,12689,Rattus norvegicus,,,D,9,BAO_0000019,
1864,,11662,Autocuration,10116.0,,1,"Compound was tested for binding affinity towards 5-hydroxytryptamine 1C receptor from frontal cortical regions of male Sprague-Dawley rat homogenates, using [3H]mesulergine as radioligand",,,CHEMBL829595,,12689,Rattus norvegicus,,,D,9,BAO_0000019,
1865,,9098,Autocuration,10116.0,,1,Evaluated for the binding affinity to porcine choroid plexus at 5-hydroxytryptamine 1C receptor binding site by using [3H]- MES as a radioligand.,,,CHEMBL616835,,12689,Rattus norvegicus,,,D,9,BAO_0000357,
1866,,10394,Autocuration,10116.0,,1,Inhibitory activity against 5-hydroxytryptamine 1C receptor in rat cortical membranes using [3H]mesulergine as a radioligand,,,CHEMBL872910,,12689,Rattus norvegicus,,,D,9,BAO_0000249,
1867,,11933,Expert,,,1,Tested for binding affinity against 5-hydroxytryptamine 1C receptor from rat frontal cortical regions using [3H]mesulergine as radioligand,,,CHEMBL616836,,12689,,,,H,8,BAO_0000357,
1868,,12092,Autocuration,10116.0,,1,The binding affinity was measured on 5-hydroxytryptamine 1C receptor using [3H]- serotonin as radioligand.,,,CHEMBL616837,,12689,Rattus norvegicus,,,D,9,BAO_0000357,
1869,,12253,Autocuration,10116.0,,1,Binding affinity of 5-hydroxytryptamine 1C receptor using [3H]- ketanserin in rat frontal cortex,,,CHEMBL616466,,12689,Rattus norvegicus,,,D,9,BAO_0000019,
1870,,12253,Autocuration,10116.0,,1,Binding affinity towards rat 5-hydroxytryptamine 1C receptor using [3H]mesulergine as radioligand expressed in 293 cells,722.0,,CHEMBL616467,,12689,Rattus norvegicus,HEK293,,D,9,BAO_0000219,
1871,,1558,Autocuration,,,1,Compound was tested for its affinity towards 5-hydroxytryptamine 1C receptor,,,CHEMBL616468,,108,,,,H,8,BAO_0000357,
1872,,2474,Autocuration,,,1,Compound was measured for its binding affinity at 5-hydroxytryptamine 1C receptor at a concentration of 100 nM using [3H]mesulergine as radioligand,,,CHEMBL616469,,108,,,,H,8,BAO_0000357,
1873,,2474,Autocuration,,,1,Compound was measured for its binding affinity at 5-hydroxytryptamine 1C receptor at a concentration of 100 nM using [3H]mesulergine as radioligand,,,CHEMBL616470,,108,,,,H,8,BAO_0000357,
1874,,11574,Autocuration,,,1,Binding affinity against 5-hydroxytryptamine 1C receptor,,,CHEMBL616471,,12689,,,,H,8,BAO_0000357,
1875,,1558,Autocuration,,,1,Compound was tested for its affinity towards 5-hydroxytryptamine 1C receptor,,,CHEMBL616472,,12689,,,,H,8,BAO_0000357,
1876,,13944,Autocuration,,,1,Binding affinity against 5-hydroxytryptamine 1C receptor,,,CHEMBL616473,,12689,,,,H,8,BAO_0000357,
1877,,13033,Autocuration,,,1,Binding affinity against serotonergic 5-HT1c receptor,,,CHEMBL616474,,12689,,,,H,8,BAO_0000357,
1878,,10321,Autocuration,,,1,Binding affinity for 5-hydroxytryptamine 1C receptor was determined by using [3H]- mesulergine as radioligand,,,CHEMBL616475,,12689,,,,H,8,BAO_0000357,
1879,,11866,Autocuration,,,1,Binding affinity for 5-hydroxytryptamine 1C receptor was determined,,,CHEMBL616476,,12689,,,,H,8,BAO_0000357,
1880,,14454,Autocuration,9986.0,,1,Compound was tested for 5-hydroxytryptamine 1D like receptor-mediated vascular effect in rabbit saphenous vein (RSV),,,CHEMBL616477,,105,Oryctolagus cuniculus,,,H,8,BAO_0000019,
1881,,11574,Autocuration,,,1,Binding affinity against 5-hydroxytryptamine 2 receptor using [125I]DOI as radioligand.,,,CHEMBL616478,,104686,,,,H,4,BAO_0000224,
1882,,11574,Autocuration,,,1,Binding affinity against 5-hydroxytryptamine 2 receptor using [3H]ket as radioligand.,,,CHEMBL616479,,104686,,,,H,4,BAO_0000224,
1883,,13631,Autocuration,,,1,Binding affinity towards serotonin 5-HT2 receptor was determined in rat cortex using [3H]spiperone as ligand,,,CHEMBL616480,,104686,,,,H,4,BAO_0000019,
1884,,9630,Autocuration,10116.0,,1,Binding affinity towards 5-hydroxytryptamine 2 receptor as antagonism of serotonin-induced contractions in rat jugular vein,,,CHEMBL616481,,104686,Rattus norvegicus,,,D,5,BAO_0000019,
1885,,8822,Autocuration,10116.0,,1,Binding affinity towards 5-hydroxytryptamine 2 receptor in rat brain cortical membranes,,,CHEMBL616482,,104686,Rattus norvegicus,,,D,5,BAO_0000249,
1886,,9064,Autocuration,10116.0,,1,Binding affinity towards 5-hydroxytryptamine 2 receptor in rat brain using [3H]spiroperidol,,,CHEMBL884713,,104686,Rattus norvegicus,,,D,5,BAO_0000221,955.0
1887,,8868,Autocuration,,,1,Binding affinity towards 5-hydroxytryptamine 2 receptor measured using radioligand ([3H]spiperone) binding assay,,,CHEMBL616483,,104686,,,,H,4,BAO_0000224,
1888,,9064,Autocuration,,,1,Binding affinity towards 5-hydroxytryptamine 2 receptor using [3H]- spiroperidol,,,CHEMBL616484,,104686,,,,H,4,BAO_0000224,
1889,,9806,Autocuration,,,1,Binding affinity at 5-hydroxytryptamine 2 receptor from rat frontal cortex homogenates by [3H]-spiperone displacement.,,,CHEMBL616485,,104686,,,,H,4,BAO_0000019,
1890,,9098,Autocuration,,,1,Binding affinity towards 5-hydroxytryptamine 2 receptor was determined,,,CHEMBL616486,,104686,,,,H,4,BAO_0000224,
1891,,8868,Autocuration,,,1,Binding affinity towards 5-hydroxytryptamine 2 receptor was measured using radioligand ([3H]spiperone) binding assay,,,CHEMBL616487,,104686,,,,H,4,BAO_0000224,
1892,,12765,Autocuration,,,1,Binding affinity at serotonin 5-hydroxytryptamine 2 receptor by [3H]ketanserin displacement.,,,CHEMBL616488,,104686,,,,H,4,BAO_0000224,
1893,,11049,Autocuration,,,1,Compound was evaluated In vitro for its activity by binding to 5-hydroxytryptamine 2 receptor in the rat brain using [3H]ketanserin as radioligand.,,,CHEMBL616489,,104686,,,,H,4,BAO_0000019,
1894,,11049,Autocuration,,,1,Compound was evaluated In vitro for its activity by binding to 5-hydroxytryptamine 2 receptor in the rat brain using [3H]ketanserin as radioligand.,,,CHEMBL616490,,104686,,,,H,4,BAO_0000019,
1895,,11049,Autocuration,,,1,Compound was evaluated In vitro for its activity by binding to 5-hydroxytryptamine 2 receptor in the rat brain using [3H]-Ketanserin as radioligand; not determined,,,CHEMBL616491,,104686,,,,H,4,BAO_0000019,
1896,,11049,Autocuration,,,1,Compound was evaluated In vitro for its activity by binding to 5-hydroxytryptamine 2 receptor in the rat brain using [3H]ketanserin as radioligand; ND-Not determined,,,CHEMBL616492,,104686,,,,H,4,BAO_0000019,
1897,,11049,Autocuration,,,1,Compound was evaluated In vitro for its activity by binding to 5-hydroxytryptamine 2 receptor in the rat brain using [3H]ketanserin as radioligand.,,,CHEMBL616493,,104686,,,,H,4,BAO_0000019,
1898,,11473,Autocuration,,,1,Compound was evaluated for binding affinity towards 5-hydroxytryptamine 2 receptor in rat anterior cortex using [125I]DOI as radioligand,,,CHEMBL616494,,104686,,,,H,4,BAO_0000019,
1899,,11473,Autocuration,,,1,Compound was evaluated for binding affinity towards 5-hydroxytryptamine 2 receptor in rat anterior cortex using [3H]ketanserin as radioligand,,,CHEMBL616495,,104686,,,,H,4,BAO_0000019,
1900,,3086,Autocuration,,,1,Displacement of [3H]ketanserin from 5-hydroxytryptamine 2 receptor in rat pre frontal cortex,,,CHEMBL616496,,104686,,,,H,4,BAO_0000019,
1901,,11049,Autocuration,,,1,Compound was evaluated for its activity by binding to 5-hydroxytryptamine 2 receptor in the rat brain using [3H]ketanserin as radioligand.,,,CHEMBL616497,,104686,,,,H,4,BAO_0000019,
1902,,11049,Autocuration,,,1,Compound was evaluated for its activity by binding to 5-hydroxytryptamine 2 receptor in the rat brain using [3H]ketanserin as radioligand.,,,CHEMBL616498,,104686,,,,H,4,BAO_0000019,
1903,,10639,Autocuration,,,1,Compound was evaluated for its inhibitory activity against 5-hydroxytryptamine 2 receptor of rat anterior cortex using [3H]ketanserin as the radioligand,,,CHEMBL616499,,104686,,,,H,4,BAO_0000019,
1904,,10922,Autocuration,,,1,Compound was measured for affinity at 5-hydroxytryptamine 2 receptor in rat cortical by [3H]spiroperidol displacement.,,,CHEMBL616500,,104686,,,,H,4,BAO_0000019,
1905,,9064,Autocuration,10116.0,,1,Binding affinity against serotonin-2 receptor in rat brain using [3H]spiroperidol,,,CHEMBL616501,,104686,Rattus norvegicus,,,D,5,BAO_0000221,955.0
1906,,10748,Autocuration,,,1,Compound was tested for its inhibitory effect on the binding profile in 5-hydroxytryptamine 2 receptor using [3H]spiroperidol in rat brain.,,,CHEMBL616502,,104686,,,,H,4,BAO_0000221,955.0
1907,,11614,Autocuration,,,1,Displacement of [3H]ketanserin from 5-hydroxytryptamine 2 receptor from rat cortical membranes.,,,CHEMBL884529,Membranes,104686,,,,H,4,BAO_0000249,
1908,,11615,Autocuration,,,1,Displacement of [3H]ketanserin from 5-hydroxytryptamine 2 receptor in rat cortical membranes,,,CHEMBL616503,Membranes,104686,,,,H,4,BAO_0000249,
1909,,11615,Autocuration,,,1,Compound was tested for the displacement of [3H]ketanserin from serotonin 5-hydroxytryptamine 2 receptor,,,CHEMBL616964,,104686,,,,H,4,BAO_0000224,
1910,,11614,Autocuration,,,1,Compound was tested for the displacement of [3H]ketanserin from serotonin 5-hydroxytryptamine 2 receptor from rat cortical membranes.,,,CHEMBL616965,Membranes,104686,,,,H,4,BAO_0000249,
1911,,11702,Autocuration,,,1,Inhibition of [3H]ketanserin binding to rat 5-hydroxytryptamine 2 receptors.,,,CHEMBL616966,,104686,,,,H,4,BAO_0000224,
1912,,11702,Autocuration,,,1,Compound was tested for the inhibition of [3H]ketanserin binding to 5-hydroxytryptamine 2 receptor; NT=Not tested,,,CHEMBL616967,,104686,,,,H,4,BAO_0000224,
1913,,11702,Autocuration,10116.0,,1,Inhibition of [3H]ketanserin binding to dopamine 5-hydroxytryptamine 2 receptor,,,CHEMBL616968,,104686,Rattus norvegicus,,,D,5,BAO_0000224,
1914,,11702,Autocuration,,,1,Compound was tested for the inhibition of [3H]ketanserin binding to dopamine 5-hydroxytryptamine 2 receptor; NT=Not tested,,,CHEMBL616969,,104686,,,,H,4,BAO_0000224,
1915,,13346,Autocuration,,,1,Inhibition of [3H]ketanserin binding at 5-hydroxytryptamine 2 receptor from rat frontal cortex.,,,CHEMBL884530,,104686,,,,H,4,BAO_0000019,
1916,,10025,Autocuration,,,1,Concentration necessary to achieve half maximal inhibition of [3H]-ketanserin binding to 5-hydroxytryptamine 2 receptor,,,CHEMBL616970,,104686,,,,H,4,BAO_0000224,
1917,,10025,Autocuration,,,1,Concentration necessary to achieve half maximal inhibition of [3H]ketanserin binding to 5-hydroxytryptamine 2 receptor at 1 uM,,,CHEMBL616971,,104686,,,,H,4,BAO_0000224,
1918,,10025,Autocuration,,,1,"Concentration necessary to achieve half maximal inhibition of [3H]ketanserin, binds to 5-hydroxytryptamine 2 receptor at 1 uM",,,CHEMBL616972,,104686,,,,H,4,BAO_0000224,
1919,,9036,Autocuration,,,1,Evaluated for binding affinity towards 5-hydroxytryptamine 2 receptor using radioligand [3H]-spiperone,,,CHEMBL616973,,104686,,,,H,4,BAO_0000224,
1920,,9036,Autocuration,,,1,Evaluated for binding affinity towards 5-hydroxytryptamine 2 receptor using radioligand [3H]spiperone; IA=Inactive,,,CHEMBL616974,,104686,,,,H,4,BAO_0000224,
1921,,9161,Autocuration,,,1,In vitro 5-hydroxytryptamine 2 receptor affinity by using [3H]spiperone as the radioligand in rat cortical tissue.,,,CHEMBL616975,,104686,,,,H,4,BAO_0000019,
1922,,12304,Autocuration,,,1,Inhibition of binding of radioligand [3H]ketanserin to 5-hydroxytryptamine 2 receptor in rat cerebral cortex,,,CHEMBL616976,,104686,,,,H,4,BAO_0000019,
1923,,13276,Autocuration,,,1,In vitro binding affinity measured on serotonin 5-hydroxytryptamine 2 receptor using [3H]ketanserin as radioligand.,,,CHEMBL616977,,104686,,,,H,4,BAO_0000224,
1924,,11825,Autocuration,,,1,In vitro binding affinity towards the 5-hydroxytryptamine 2 receptor at 10 e-6 M,,,CHEMBL616978,,104686,,,,H,4,BAO_0000224,
1925,,12443,Autocuration,,,1,In vitro binding affinity was measured on serotonergic 5-hydroxytryptamine 2 receptor by displacement of [3H]- ketanserin,,,CHEMBL616979,,104686,,,,H,4,BAO_0000224,
1926,,13830,Autocuration,,,1,In vitro inhibitory activity against [3H]ketanserin binding to 5-hydroxytryptamine 2 receptor,,,CHEMBL616980,,104686,,,,H,4,BAO_0000224,
1927,,9592,Autocuration,,,1,Inhibition of [3H]spiperone binding to 5-hydroxytryptamine 2 receptor from rat cortical membranes,,,CHEMBL616981,Membranes,104686,,,,H,4,BAO_0000249,
1928,,9592,Autocuration,,,1,Inhibition of [3H]spiperone binding to 5-hydroxytryptamine 2 receptor from rat cortical membranes; Not tested,,,CHEMBL616982,Membranes,104686,,,,H,4,BAO_0000249,
1929,,10881,Autocuration,,,1,Inhibitory activity against 5-hydroxytryptamine 2 receptor by 3H ligand binding experiments.,,,CHEMBL616983,,104686,,,,H,4,BAO_0000224,
1930,,13605,Autocuration,,,1,Inhibitory activity against [3H]spiroperidol binding to 5-HT2 receptor in rat cortex,,,CHEMBL616984,,104686,,,,H,4,BAO_0000019,
1931,,11624,Autocuration,10116.0,,1,Inhibitory activity against 5-hydroxytryptamine 2 receptor,,,CHEMBL616985,,104686,Rattus norvegicus,,,D,5,BAO_0000224,
1932,,4101,Autocuration,,,1,Inhibitory concentration against 5-hydroxytryptamine 2 receptor from striata of male Wistar rats by displacement of [3H]-ketanserin,,,CHEMBL616986,,104686,,,,H,4,BAO_0000224,
1933,,4101,Autocuration,,,1,Inhibitory concentration against binding of 5-hydroxytryptamine 2 receptor from striata of male Wistar rats by displacement of [3H]-ketanserin,,,CHEMBL616987,,104686,,,,H,4,BAO_0000224,
1934,,15360,Autocuration,,,1,Inhibitory concentration against radioligand [3H]ketanserin binding to 5-hydroxytryptamine 2 receptor in rat,,,CHEMBL616988,,104686,,,,H,4,BAO_0000019,
1935,,11576,Autocuration,,,1,Inhibitory concentration against radioligand [3H]spiperone binding to 5-hydroxytryptamine 2 receptor in rat cortex,,,CHEMBL617243,,104686,,,,H,4,BAO_0000019,
1936,,5834,Autocuration,,,1,Inhibitory concentration required against 5-hydroxytryptamine 2 receptor in rat cortex using [3H]spiperone,,,CHEMBL617244,,104686,,,,H,4,BAO_0000019,
1937,,2395,Autocuration,10116.0,,1,Inhibitory concentration against [3H]ketanserin binding to 5-hydroxytryptamine 2 receptor expressed in CHO-K1 cells,485.0,,CHEMBL617245,,104686,Rattus norvegicus,CHO-K1,,D,5,BAO_0000219,
1938,,11965,Autocuration,,,1,Displacement of [3H]ketanserin from 5-hydroxytryptamine 2 receptor in rat cortical membranes,,,CHEMBL617246,Membranes,104686,,,,H,4,BAO_0000249,
1939,,3967,Autocuration,,,1,The compound was evaluated for the ability to displace [3H]ketanserin from 5-hydroxytryptamine 2 receptor ( striata of male wistar rats),,,CHEMBL617546,,104686,,,,H,4,BAO_0000224,
1940,,11130,Autocuration,,,1,The concentration required to inhibit [3H]ketanserin binding to 5-hydroxytryptamine 2 receptor in rat brain membranes (in vitro),,,CHEMBL617547,Brain membranes,104686,,,,H,4,BAO_0000249,
1941,In vitro,13427,Autocuration,,,1,Binding affinity of [3H]ketanserin towards 5-hydroxytryptamine 2 receptor in cloned mammalian receptor expressed in cultured cells or from rat whole brain.,,,CHEMBL617548,,104686,,,,H,4,BAO_0000219,
1942,,9443,Autocuration,,,1,Binding affinity towards 5-hydroxytryptamine 2 receptor,,,CHEMBL617549,,104686,,,,H,4,BAO_0000224,
1943,,9443,Autocuration,,,1,Binding affinity towards 5-hydroxytryptamine 2 receptor at 1.0 uM concentration,,,CHEMBL617550,,104686,,,,H,4,BAO_0000224,
1944,,11825,Autocuration,,,1,In vitro binding affinity towards the 5-hydroxytryptamine 2 receptor at 10 e-6 M,,,CHEMBL617551,,104686,,,,H,4,BAO_0000224,
1945,,12120,Autocuration,,,1,Percent inhibition of binding of 1.0 nM [3H]ketanserin to 5-hydroxytryptamine 2 receptor in rat cortical membranes at 10 e -5 M,,,CHEMBL617552,Membranes,104686,,,,H,4,BAO_0000249,
1946,,12120,Autocuration,,,1,Percent inhibition of binding of 1.0 nM [3H]-ketanserin to 5-hydroxytryptamine 2 receptor in rat cortical membranes at 10 e-5 M.,,,CHEMBL617553,Membranes,104686,,,,H,4,BAO_0000249,
1947,,11963,Autocuration,,,1,Tested for antagonistic activity against 5-hydroxytryptamine 2 receptor from rat thoracic aorta,,,CHEMBL617554,,104686,,,,H,4,BAO_0000019,1515.0
1948,,9069,Autocuration,,,1,Binding affinity for membrane-bound 5-hydroxytryptamine 2 receptor,,,CHEMBL617555,,104686,,,,H,4,BAO_0000019,
1949,,8868,Autocuration,,,1,Compound was tested for its effect on 5-hydroxytryptamine 2 receptor saturation analysis,,,CHEMBL617556,,104686,,,,H,4,BAO_0000224,
1950,,17200,Autocuration,,,1,Inhibitory constant against human 5-hydroxytryptamine 1B receptor using [3H]5-CT radioligand,,,CHEMBL617557,,10624,,,,H,8,BAO_0000357,
1951,,17200,Autocuration,,,1,Inhibitory constant against human 5-hydroxytryptamine 1D receptor using [3H]5-CT radioligand,,,CHEMBL617558,,10624,,,,H,8,BAO_0000357,
1952,,13969,Expert,,,1,Binding affinity against 5-hydroxytryptamine 1D receptor was measured using [3H]5-HT as radioligand,,,CHEMBL617559,,17106,,,,H,8,BAO_0000357,
1953,,13392,Expert,,,1,Binding affinity for 5-hydroxytryptamine 1D receptor,,,CHEMBL617560,,17106,,,,D,9,BAO_0000357,
1954,,1742,Autocuration,,,1,Compound was tested for its ability to displace [125I]GTI binding to 5-hydroxytryptamine 1D receptor recognition sites in pig caudate membranes,,,CHEMBL617561,,17106,,,,H,8,BAO_0000249,
1955,,1742,Autocuration,,,1,Compound was tested for its ability to displace [3H]-5-HT binding to 5-hydroxytryptamine 1D receptor recognition sites in pig caudate membranes,,,CHEMBL617562,,17106,,,,H,8,BAO_0000249,
1956,,14331,Autocuration,,,1,Binding affinity against 5-hydroxytryptamine 1D receptor using [3H]5-HT in pig striatum + frontalCortex,,,CHEMBL617563,,17106,,,,H,8,BAO_0000357,2435.0
1957,,12861,Autocuration,,,1,Relative agonist efficacy against 1 uM 5-hydroxytryptamine 1D receptor,,,CHEMBL617564,,17106,,,,H,8,BAO_0000019,
1958,,12861,Expert,,,1,Binding activity against 5-hydroxytryptamine 1D receptor from pig caudate membrane using [3H]5-HT as radioligand,,,CHEMBL617565,,17106,,,,H,8,BAO_0000019,
1959,,12861,Autocuration,,,1,Binding activity radioligand.,,,CHEMBL856076,,17106,,,,H,8,BAO_0000357,
1960,,12861,Autocuration,,,1,Binding activity against 5-hydroxytryptamine 2C receptor from human brain cortex using [3H]mesulergine as radioligand.,,,CHEMBL617566,,17106,,,,H,8,BAO_0000019,
1961,,12861,Expert,,,1,Binding activity against 5-hydroxytryptamine 3 receptor from rat cortex homogenate using [3H]-Q-ICS 205-930 as radioligand.,,,CHEMBL875911,,17106,,,,H,8,BAO_0000019,
1962,,12861,Autocuration,,,1,Binding activity against 5-hydroxytryptamine 3 receptor from rat cortex homogenate using [3H]-Q-ICS 205-930 as radioligand; NA Not Available,,,CHEMBL617567,,17106,,,,H,8,BAO_0000019,
1963,,675,Autocuration,,,1,Compound was tested for the displacement of [3H]-5-HT to 5-hydroxytryptamine 1D receptor recognition sites in pig caudate membranes,,,CHEMBL617568,,17106,,,,H,8,BAO_0000249,
1964,,12490,Expert,,,1,Displacement of [3H]5-HT binding to 5-hydroxytryptamine 1D receptor from pig caudate membrane,,,CHEMBL617569,,17106,,,,H,8,BAO_0000019,
1965,,11828,Expert,,,1,Displacement of radioligand [3H]5-HT binding to 5-hydroxytryptamine 1D receptor in pig caudate membrane,,,CHEMBL617570,,17106,,,,H,8,BAO_0000249,
1966,,11866,Autocuration,,,1,Binding affinity for 5-hydroxytryptamine 1D receptor in piglet caudate using [3H]5-HT,,,CHEMBL617571,,17106,,,,H,8,BAO_0000357,
1967,,773,Autocuration,9823.0,,1,In Vitro Binding affinity againist 5-hydroxytryptamine 1D receptor by displacing [125I]GTI from pig caudate,,,CHEMBL617572,,105,Sus scrofa,,,H,8,BAO_0000357,
1968,,13047,Expert,9986.0,,1,The compound was tested for intrinsic activity against 5-HT1D receptor,,,CHEMBL617573,,105,Oryctolagus cuniculus,,,H,8,BAO_0000357,
1969,,13047,Autocuration,9986.0,,1,Intrinsic activity against 5-hydroxytryptamine 1 receptor using rabbit saphenous vein assay.,,,CHEMBL617574,,105,Oryctolagus cuniculus,,,H,8,BAO_0000019,
1970,,13047,Expert,9986.0,,1,The compound was tested for binding affinity against 5-HT1D receptor,,,CHEMBL617575,,105,Oryctolagus cuniculus,,,H,8,BAO_0000357,
1971,,188,Autocuration,,,1,Tested for the effect on binding at 5-hydroxytryptamine 1D receptor; No activity,,,CHEMBL617576,,10578,,,,H,8,BAO_0000357,
1972,,10639,Autocuration,,,1,Inhibition of Forskolin-stimulated adenylate cyclase activity against 5-hydroxytryptamine 1D receptor of rat substantia nigra,,,CHEMBL617577,,10578,,,,H,8,BAO_0000019,
1973,,12438,Autocuration,,,1,Inhibition of forskolin stimulated adenylate cyclase at 5-hydroxytryptamine 1D receptor,,,CHEMBL617578,,10578,,,,H,8,BAO_0000019,
1974,,12438,Autocuration,,,1,Binding affinity was measured against serotonin 5-hydroxytryptamine 1D receptor,,,CHEMBL617579,,10578,,,,H,8,BAO_0000357,
1975,,15854,Expert,,,1,Binding affinity towards 5-hydroxytryptamine 1D receptor in rat frontal cortex using [125I]iodocyanopindolol as radio-ligand.,,,CHEMBL617580,,10578,,,,H,8,BAO_0000019,
1976,,10394,Autocuration,,,1,Inhibitory activity against 5-hydroxytryptamine 1D receptor in rat cortical membranes using [3H]5-HT as a radioligand,,,CHEMBL617581,,10578,,,,H,8,BAO_0000249,
1977,,12092,Autocuration,,,1,The binding affinity was measured on 5-hydroxytryptamine 1D receptor using [3H]- serotonin as radioligand.,,,CHEMBL617582,,10578,,,,H,8,BAO_0000357,
1978,,3389,Expert,,,1,Binding affinity to 5-hydroxytryptamine 1D receptor in the rat forebrain by [3H]- SB-204269 displacement.,,,CHEMBL617583,,10578,,,,H,8,BAO_0000019,
1979,,6011,Autocuration,,,1,Inhibition of binding towards 5-hydroxytryptamine 1D receptor at 100 nM concentration,,,CHEMBL617584,,105,,,,H,8,BAO_0000357,
1980,,4639,Autocuration,,,1,Compound was tested for binding affinity against 5-hydroxytryptamine 1D receptor,,,CHEMBL617585,,105,,,,H,8,BAO_0000357,
1981,,2474,Autocuration,,,1,Compound was measured for its binding affinity at 5-hydroxytryptamine 1D receptor at a concentration of 10 uM using [3H]5-HT as radioligand,,,CHEMBL875912,,105,,,,H,8,BAO_0000357,
1982,,5014,Autocuration,,,1,Percent inhibition (at 1 uM) against 5-hydroxytryptamine 1D receptor,,,CHEMBL617586,,105,,,,H,8,BAO_0000357,
1983,,17515,Autocuration,,,1,Binding affinity of compound towards serotonin 5-hydroxytryptamine 1D receptor; inactive at 10 uM,,,CHEMBL617587,,105,,,,H,8,BAO_0000357,
1984,,11866,Autocuration,,,1,Binding affinity for 5-hydroxytryptamine 1D receptor was determined,,,CHEMBL617588,,105,,,,H,8,BAO_0000357,
1985,,4687,Autocuration,,,1,Evaluated for the binding affinity against 5-hydroxytryptamine 1D receptor,,,CHEMBL857980,,105,,,,H,8,BAO_0000357,
1986,,12146,Autocuration,,,1,Tested against 5-hydroxytryptamine 1D receptor,,,CHEMBL617589,,105,,,,H,8,BAO_0000357,
1987,,10321,Autocuration,,,1,Binding affinity for 5-hydroxytryptamine 1D receptor was determined by using [3H]5-HT as radioligand,,,CHEMBL617590,,105,,,,H,8,BAO_0000357,
1988,,13267,Autocuration,,,1,Antagonistic binding affinity measured against 5-hydroxytryptamine 2A receptor (human clone expressed in 293 cells) using [3H]ketanserin as radioligand,722.0,,CHEMBL617591,,105,,HEK293,,H,8,BAO_0000219,
1989,,1274,Expert,9606.0,,1,Binding affinity against 5-Hydroxytryptamine 1D receptor,,,CHEMBL617592,,105,Homo sapiens,,,D,9,BAO_0000357,
1990,,15250,Autocuration,,,1,,,,CHEMBL617593,,105,,,,H,8,BAO_0000357,
1991,,13706,Autocuration,,,1,Compound was tested for binding affinity against cloned human 5-hydroxytryptamine 1D receptor alpha expressed in CHO-K1 cells.,485.0,,CHEMBL617594,,106,,CHO-K1,,H,8,BAO_0000219,
1992,,13706,Autocuration,,,1,Compound was tested for binding affinity against cloned human 5-hydroxytryptamine 1D receptor alpha expressed in CHO-K1 cells.,485.0,,CHEMBL617595,,105,,CHO-K1,,H,8,BAO_0000219,
1993,,13706,Autocuration,,,1,Compound was tested for binding affinity against human 5-hydroxytryptamine 1D receptor alpha clones expressed in human embryonic kidney (HEK 293) cells line.,722.0,,CHEMBL617596,,105,,HEK293,,H,8,BAO_0000219,
1994,,13706,Autocuration,,,1,Compound was tested for binding affinity against human 5-hydroxytryptamine 1D receptor alpha clones expressed in human embryonic kidney (HEK 293) cells line; NT= not tested,722.0,,CHEMBL617597,,105,,HEK293,,H,8,BAO_0000219,
1995,,13047,Autocuration,,,1,Binding affinity against 5-hydroxytryptamine 1D receptor beta using rabbit saphenous vein assay.,,,CHEMBL617598,,105,,,,H,8,BAO_0000019,
1996,,13366,Autocuration,,,1,Binding affinity of compound against 5-HT1Dalpha Binding affinity of compound against 5-HT1D alpha receptors in human,,,CHEMBL872916,,105,,,,H,8,BAO_0000357,
1997,,13366,Expert,,,1,In vitro affinity human cloned 5-hydroxytryptamine 1D receptor alpha by [3H]5-HT displacement.,,,CHEMBL617599,,105,,,,H,8,BAO_0000357,
1998,,1558,Autocuration,,,1,Binding affinity towards cloned human 5-hydroxytryptamine 1D receptor alpha was determined,,,CHEMBL617091,,105,,,,H,8,BAO_0000357,
1999,,12902,Expert,,,1,"Binding affinity against 5-hydroxytryptamine 1D receptor alpha expressed in CHO-K1 cells, using [3H]-5-HT as the radioligand.",485.0,,CHEMBL617092,,105,,CHO-K1,,H,8,BAO_0000219,
2000,,13706,Autocuration,,,1,Compound was tested for binding affinity against cloned human 5-hydroxytryptamine 1D receptor alpha expressed in CHO-K1 cells.,485.0,,CHEMBL617093,,105,,CHO-K1,,H,8,BAO_0000219,
2001,,13706,Autocuration,,,1,Compound was tested for intrinsic efficacy against human 5-hydroxytryptamine 1D receptor alpha measured as the reduction of forskolin-stimulated cAMP.,,,CHEMBL617094,,105,,,,H,8,BAO_0000019,
2002,,13706,Autocuration,,,1,Compound was tested for intrinsic efficacy against human 5-hydroxytryptamine 1D receptor beta measured as the reduction of forskolin-stimulated cAMP.,,,CHEMBL617095,,105,,,,H,8,BAO_0000019,
2003,,14251,Autocuration,,,1,Compound was tested for its agonist activity against human 5-hydroxytryptamine 1D receptor alpha for comparison purpose.,,,CHEMBL617096,,105,,,,H,8,BAO_0000019,
2004,,14251,Autocuration,,,1,Compound was tested for its agonist activity against human recombinant 5-hydroxytryptamine 1D receptor alpha for comparison purpose.,,,CHEMBL617097,,105,,,,H,8,BAO_0000019,
2005,,14251,Autocuration,,,1,Compound was tested for its agonist activity against human recombinant 5-hydroxytryptamine 1D receptor alpha for comparison purpose.,,,CHEMBL617098,,105,,,,H,8,BAO_0000019,
2006,,13313,Autocuration,,,1,In vitro binding affinity towards 5-HT1D alpha receptor by using [3H]5-HT as radioligand,,,CHEMBL617301,,105,,,,H,8,BAO_0000357,
2007,,13313,Autocuration,,,1,In vitro binding affinity towards 5-hydroxytryptamine 1D receptor alpha by using [3H]5-HT as radioligand,,,CHEMBL617302,,105,,,,H,8,BAO_0000357,
2008,,13366,Autocuration,,,1,Selectivity towards 5-hydroxytryptamine 1D receptor beta to that of 5-hydroxytryptamine 1D receptor alpha,,,CHEMBL617303,,105,,,,H,8,BAO_0000357,
2009,,13051,Expert,,,1,Binding affinity to recombinant human 5-hydroxytryptamine 1D receptor alpha,,,CHEMBL617304,,105,,,,H,8,BAO_0000357,
2010,,12903,Expert,,,1,"In vitro binding affinity against cloned mammalian 5-hydroxytryptamine 1D receptor alpha expressed in CHO cells, by using [3H]5-HT as radioligand",449.0,,CHEMBL617305,,105,,CHO,,H,8,BAO_0000219,
2011,,12469,Autocuration,9606.0,,1,Binding affinity was measured on 5-hydroxytryptamine 1D receptor alpha in COS cells transfected with human 5-HT1D alpha gene labeled with [3H]5-HT,,,CHEMBL617306,,105,Homo sapiens,,,D,9,BAO_0000219,
2012,,5619,Autocuration,,,1,Binding affinity (in vitro) against 5-hydroxytryptamine 1D receptor alpha using radio-ligand binding assay,,,CHEMBL617307,,17106,,,,H,8,BAO_0000357,
2013,,13047,Autocuration,9986.0,,1,Binding affinity against 5-hydroxytryptamine 4 receptor using rabbit saphenous vein assay.,,,CHEMBL617308,,105,Oryctolagus cuniculus,,,H,8,BAO_0000019,
2014,,16633,Autocuration,,,1,Binding affinities against 5-hydroxytryptamine 1D receptor alpha,,,CHEMBL617309,,105,,,,H,8,BAO_0000357,
2015,,16633,Autocuration,,,1,Binding affinities towards 5-hydroxytryptamine 1D receptor alpha,,,CHEMBL617310,,105,,,,H,8,BAO_0000357,
2016,,16633,Autocuration,,,1,Binding affinities towards 5-hydroxytryptamine 1D receptor alpha,,,CHEMBL617311,,105,,,,H,8,BAO_0000357,
2017,,16633,Autocuration,,,1,Binding affinity towards 5-hydroxytryptamine 1D receptor alpha using [3H]8-OH-DPAT as radioligand,,,CHEMBL617312,,105,,,,H,8,BAO_0000357,
2018,,3269,Autocuration,,,1,Affinity against 5-hydroxytryptamine 1D receptor alpha,,,CHEMBL617313,,105,,,,H,8,BAO_0000357,
2019,,12409,Expert,,,1,Binding affinity against 5-hydroxytryptamine 1D receptor alpha,,,CHEMBL617314,,105,,,,H,8,BAO_0000357,
2020,,13706,Autocuration,,,1,Compound was tested for intrinsic efficacy against human 5-hydroxytryptamine 1D receptor beta measured as the reduction of forskolin-stimulated cAMP.,,,CHEMBL617315,,106,,,,H,8,BAO_0000019,
2021,,13706,Autocuration,,,1,Compound was tested for binding affinity against human 5-hydroxytryptamine 1D receptor beta clones expressed in human embryonic kidney (HEK 293) cells line.,722.0,,CHEMBL617316,,106,,HEK293,,H,8,BAO_0000219,
2022,,13706,Autocuration,,,1,Compound was tested for binding affinity against human 5-hydroxytryptamine 1D receptor beta clones expressed in human embryonic kidney (HEK 293) cells line; NT= not tested,722.0,,CHEMBL617317,,106,,HEK293,,H,8,BAO_0000219,
2023,,12903,Autocuration,,,1,"The compound was tested in vitro for binding affinity against cloned mammalian 5-hydroxytryptamine 1D receptor beta expressed in CHO cells, by using [3H]5-HT as radioligand",449.0,,CHEMBL617318,,106,,CHO,,H,8,BAO_0000219,
2024,,13047,Autocuration,,,1,Binding affinity against 5-hydroxytryptamine 1D receptor beta using rabbit saphenous vein assay.,,,CHEMBL617319,,106,,,,H,8,BAO_0000019,
2025,,13366,Expert,,,1,Displacement of [3H]-5-HT from human 5-hydroxytryptamine 1D receptor beta,,,CHEMBL617320,,106,,,,D,9,BAO_0000357,
2026,,13366,Expert,,,1,Displacement of [3H]-5-HT from human 5-hydroxytryptamine 1D receptor beta,,,CHEMBL617321,,106,,,,D,9,BAO_0000357,
2027,,13366,Expert,,,1,Displacement of [3H]-5-HT from human 5-hydroxytryptamine 1D receptor beta,,,CHEMBL617322,,106,,,,D,9,BAO_0000357,
2028,,13366,Autocuration,,,1,Binding affinity towards cloned human 5-hydroxytryptamine 1D receptor beta was determined using [3H]8-OH-DPAT as radioligand,,,CHEMBL616862,,106,,,,H,8,BAO_0000357,
2029,,13366,Autocuration,,,1,Binding affinity towards cloned human 5-hydroxytryptamine 1D receptor was determined using [3H]8-OH-DPAT as radioligand,,,CHEMBL616863,,106,,,,H,8,BAO_0000357,
2030,,12469,Autocuration,,,1,Binding affinity was measured on 5-hydroxytryptamine 1D receptor beta in CHO cells transfected with human 5-HT1D beta gene labeled with [3H]5-HT,449.0,,CHEMBL616864,,106,,CHO,,H,8,BAO_0000219,
2031,,13706,Autocuration,,,1,Compound was tested for binding affinity against cloned human 5-HT1D beta receptor expressed in CHO-K1 cells.,485.0,,CHEMBL616865,,106,,CHO-K1,,H,8,BAO_0000219,
2032,,13706,Autocuration,,,1,Compound was tested for binding affinity against cloned human 5-hydroxytryptamine 1D receptor beta expressed in CHO-K1 cells.,485.0,,CHEMBL616866,,106,,CHO-K1,,H,8,BAO_0000219,
2033,,13706,Autocuration,,,1,Compound was tested for intrinsic efficacy against human 5-hydroxytryptamine 1D receptor beta measured as the reduction of forskolin-stimulated cAMP.,,,CHEMBL616867,,106,,,,H,8,BAO_0000019,
2034,,12902,Expert,,,1,"Binding affinity against 5-hydroxytryptamine 1D receptor beta expressed in CHO-K1 cells, using [3H]5-HT as the radioligand.",485.0,,CHEMBL616868,,106,,CHO-K1,,H,8,BAO_0000219,
2035,,13051,Expert,,,1,Binding affinity for cloned human 5-hydroxytryptamine 1D receptor beta,,,CHEMBL616869,,105,,,,H,8,BAO_0000357,
2036,,12903,Expert,,,1,"In vitro binding affinity against cloned mammalian 5-hydroxytryptamine 1D receptor beta expressed in CHO cells, by using [3H]5-HT as radioligand",449.0,,CHEMBL616870,,106,,CHO,,H,8,BAO_0000219,
2037,,1558,Autocuration,,,1,Compound was tested for its ability inhibit forskolin-stimulated activity of adenylate cyclase coupled to human 5-hydroxytryptamine 1D receptor beta in CHO-K1 cells; value ranges from 0.24-0.55,485.0,,CHEMBL616871,,105,,CHO-K1,,H,8,BAO_0000219,
2038,,1558,Autocuration,,,1,Compound was tested for its ability inhibit forskolin-stimulated activity of adenylate cyclase coupled to human 5-hydroxytryptamine 1D receptor beta in CHO-K1 cells; value ranges from 0.6-2.0,485.0,,CHEMBL616872,,105,,CHO-K1,,H,8,BAO_0000219,
2039,,1558,Autocuration,,,1,Compound was tested for its ability inhibit forskolin-stimulated activity of adenylate cyclase coupled to human 5-hydroxytryptamine 1D receptor beta in CHO-K1 cells; value ranges from 2.8-6.5,485.0,,CHEMBL616873,,105,,CHO-K1,,H,8,BAO_0000219,
2040,,1558,Autocuration,,,1,Compound was tested for its ability inhibit forskolin-stimulated activity of adenylate cyclase coupled to human 5-hydroxytryptamine 1D receptor beta in CHO-K1 cells; value ranges from 30-70,485.0,,CHEMBL616838,,105,,CHO-K1,,H,8,BAO_0000219,
2041,,1558,Autocuration,,,1,Binding affinity towards cloned human 5-hydroxytryptamine 1D receptor beta was determined,,,CHEMBL616839,,105,,,,H,8,BAO_0000357,
2042,,13047,Autocuration,9986.0,,1,Binding affinity against 5-hydroxytryptamine 3 receptor using rabbit saphenous vein assay.,,,CHEMBL616840,,106,Oryctolagus cuniculus,,,H,8,BAO_0000019,
2043,,13313,Autocuration,,,1,In vitro binding affinity towards 5-hydroxytryptamine 1D receptor alpha by using [3H]-5-HT as radioligand,,,CHEMBL616841,,105,,,,H,8,BAO_0000357,
2044,,13313,Autocuration,,,1,In vitro binding affinity towards 5-hydroxytryptamine 1D receptor beta by using [3H]5-HT as radioligand,,,CHEMBL616842,,105,,,,H,8,BAO_0000357,
2045,,12409,Expert,,,1,Binding affinity against 5-hydroxytryptamine 1D receptor beta,,,CHEMBL857976,,105,,,,H,8,BAO_0000357,
2046,,15250,Autocuration,,,1,Compound was tested for the displacement of [3H]5-HT binding to cloned human 5-hydroxytryptamine 1E receptor stably expressed in CHO cells,449.0,,CHEMBL616843,,10618,,CHO,,H,8,BAO_0000219,
2047,,1348,Expert,9606.0,,1,Inhibitory activity against 5-hydroxytryptamine 1E receptor subtype,,,CHEMBL616844,,10618,Homo sapiens,,,D,9,BAO_0000357,
2048,,1348,Autocuration,,,1,Inhibitory activity against 5-hydroxytryptamine 1E receptor subtype; NA denotes data not available,,,CHEMBL616845,,10618,,,,H,8,BAO_0000357,
2049,,4234,Expert,9606.0,,1,Binding affinity to cloned human 5-hydroxytryptamine 1E receptor,,,CHEMBL616846,,10618,Homo sapiens,,,D,9,BAO_0000357,
2050,,16209,Autocuration,,,1,Binding affinity towards human 5-hydroxytryptamine 1E receptor was determined using [3H]5-HT as radioligand,,,CHEMBL616847,,10618,,,,H,8,BAO_0000357,
2051,,10444,Autocuration,,,1,Binding affinity was determined against 5-hydroxytryptamine 1E receptor in human cortical homogenate,,,CHEMBL616848,,10618,,,,H,8,BAO_0000019,
2052,,3935,Autocuration,,,1,Compound was evaluated for its binding affinity for human 5-hydroxytryptamine 1E receptor,,,CHEMBL616849,,10618,,,,H,8,BAO_0000357,
2053,,15818,Autocuration,,,1,Compound was evaluated for its binding affinity towards human 5-hydroxytryptamine 1E receptor,,,CHEMBL872911,,10618,,,,H,8,BAO_0000357,
2054,,17085,Autocuration,,,1,In vitro binding affinity by radioligand binding assay using cell line expressing human 5-hydroxytryptamine 1E receptor,,,CHEMBL616850,,10618,,,,H,8,BAO_0000019,
2055,,12936,Expert,9606.0,,1,Binding affinity against human 5-hydroxytryptamine 1E receptor expressed in CHO cells,449.0,,CHEMBL616699,,10618,Homo sapiens,CHO,,D,9,BAO_0000219,
2056,,6166,Autocuration,,,1,Binding affinity towards cloned human 5-hydroxytryptamine 1E receptor was determined,,,CHEMBL616700,,10618,,,,H,8,BAO_0000357,
2057,,15779,Autocuration,,,1,Binding affinity towards 5-hydroxytryptamine 1E receptor (human cloned receptor) in CHO cells using [3H]5-HT as radioligand.,449.0,,CHEMBL616701,,10618,,CHO,,H,8,BAO_0000219,
2058,,15779,Autocuration,,,1,Binding affinity towards human cloned 5-hydroxytryptamine 1E receptor in CHO cells using [3H]5-HT as radioligand.,449.0,,CHEMBL616702,,10618,,CHO,,H,8,BAO_0000219,
2059,,15779,Autocuration,,,1,Binding affinity towards human cloned 5-hydroxytryptamine 1E receptor in CHO cells using [3H]5-HT as radioligand;ND means no data.,449.0,,CHEMBL616703,,10618,,CHO,,H,8,BAO_0000219,
2060,,13181,Autocuration,,,1,Binding affinity was determined against 5-hydroxytryptamine 1D receptor,,,CHEMBL616704,,10618,,,,H,8,BAO_0000357,
2061,,4199,Autocuration,,,1,Compound was evaluated for binding affinity against human cloned 5-hydroxytryptamine 1E receptor in CHO cells using [3H]5-HT as the radioligand,449.0,,CHEMBL616705,,10618,,CHO,,H,8,BAO_0000219,
2062,,14875,Autocuration,,,1,Compound was tested for binding affinity against human 5-hydroxytryptamine 1E receptor,,,CHEMBL616706,,10618,,,,H,8,BAO_0000357,
2063,,15146,Autocuration,,,1,Compound was tested for its binding affinity against cloned human 5-hydroxytryptamine 1E receptor in CHO cells using [3H]-5-HT,449.0,,CHEMBL616707,,10618,,CHO,,H,8,BAO_0000219,
2064,,5213,Autocuration,,,1,Compound was tested for its binding affinity for human cloned 5-hydroxytryptamine 1E receptor in CHO using [3H]5-HT as a radioligand,,,CHEMBL616708,,10618,,,,H,8,BAO_0000357,
2065,,12146,Autocuration,,,1,Tested for binding affinity towards cloned human 5-hydroxytryptamine 1E receptor using [3H]5-HT as radioligand,,,CHEMBL616709,,10618,,,,H,8,BAO_0000357,
2066,,13267,Autocuration,,,1,The binding affinity (pKi) measured against 5-hydroxytryptamine 1E receptor (cloned human receptors in CHO cells) using [3H]5-HT1E as radioligand,449.0,,CHEMBL616710,,10618,,CHO,,H,8,BAO_0000219,
2067,,14818,Autocuration,,,1,The compound was tested for its binding affinity towards cloned human 5-hydroxytryptamine 1E receptor in CHO cells using [3H]5-HT.,449.0,,CHEMBL616711,,10618,,CHO,,H,8,BAO_0000219,
2068,,4829,Autocuration,,,1,"The compound was tested for the binding affinity towards human cloned 5-hydroxytryptamine 1E receptor in CHO cells, using [3H]5-HT as radioligand",449.0,,CHEMBL616712,,10618,,CHO,,H,8,BAO_0000219,
2069,,4373,Autocuration,,,1,Binding affinity relative to indolopiperidine (compound 1) for 5-hydroxytryptamine 1E receptor was determined,,,CHEMBL616713,,10618,,,,H,8,BAO_0000357,
2070,,4373,Autocuration,,,1,Binding affinity for 5-hydroxytryptamine 1E receptor was determined,,,CHEMBL616714,,10618,,,,H,8,BAO_0000357,
2071,,14159,Autocuration,,,1,Compound was evaluated for the affinity at 5-hydroxytryptamine 1E receptor,,,CHEMBL616715,,10618,,,,H,8,BAO_0000357,
2072,,16633,Autocuration,,,1,Binding affinity towards 5-hydroxytryptamine 1E receptor,,,CHEMBL616716,,10618,,,,H,8,BAO_0000357,
2073,,17085,Autocuration,,,1,"In vitro effective concentration for stimulation of [35S]GTP-gamma-S, binding in mouse LM(tk-)cells expressing the human 5-HT1F receptor",,,CHEMBL616717,,279,,,,H,8,BAO_0000019,
2074,,17085,Expert,,,1,"In vitro effective concentration for stimulation of [35S]GTP-gamma-S, binding in mouse LM(tk-)cells expressing the human 5-hydroxytryptamine 1F receptor",,,CHEMBL616718,,279,,,,H,8,BAO_0000019,
2075,,16209,Autocuration,,,1,In vitro effective concentration for inhibition of skolin-stimulated adenylate cyclase in cell line expressing human 5-hydroxytryptamine 1F receptor,,,CHEMBL875905,,279,,,,H,8,BAO_0000019,
2076,,16209,Autocuration,,,1,In vitro agonist potency against human 5-hydroxytryptamine 1F receptor,,,CHEMBL616719,,279,,,,H,8,BAO_0000019,
2077,,17085,Expert,,,1,"Maximum stimulation of of [35S]GTP-gamma-S, binding expressed relative to the maximal effect of 5-hydroxytryptamine 1F receptor",,,CHEMBL616720,,279,,,,H,8,BAO_0000019,
2078,,14159,Autocuration,,,1,Compound was evaluated for the affinity at 5-hydroxytryptamine 1F receptor,,,CHEMBL616721,,279,,,,H,8,BAO_0000357,
2079,,15250,Autocuration,,,1,Compound was tested for the displacement of [3H]5-HT binding to cloned human 5-hydroxytryptamine 1F receptor stably expressed in CHO cells,449.0,,CHEMBL616722,,279,,CHO,,H,8,BAO_0000219,
2080,,3805,Autocuration,,,1,In vitro binding affinity against human 5-hydroxytryptamine 1F receptor at a concentration of 100 (nM),,,CHEMBL616723,,279,,,,H,8,BAO_0000357,
2081,,16190,Autocuration,,,1,Binding affinity against 5-hydroxytryptamine 1F receptor in CHO cells using [3H]5-HT radioligand,449.0,,CHEMBL616724,,279,,CHO,,H,8,BAO_0000219,
2082,,16190,Autocuration,,,1,Binding affinity against 5-hydroxytryptamine 1F receptor in CHO using [3H]5-HT radioligand,,,CHEMBL616725,,279,,,,H,8,BAO_0000357,
2083,,16209,Autocuration,,,1,Binding affinity towards human 5-hydroxytryptamine 1F receptor,,,CHEMBL616726,,279,,,,H,8,BAO_0000357,
2084,,16209,Autocuration,,,1,Binding affinity towards human 5-hydroxytryptamine 1F receptor was determined,,,CHEMBL616727,,279,,,,H,8,BAO_0000357,
2085,,16209,Autocuration,,,1,Binding affinity towards human 5-hydroxytryptamine 1F receptor using [3H]-5-HT radioligand,,,CHEMBL616728,,279,,,,H,8,BAO_0000357,
2086,,6866,Autocuration,,,1,In vitro binding affinity for human 5-hydroxytryptamine 1F receptor,,,CHEMBL616729,,279,,,,H,8,BAO_0000357,
2087,,17085,Expert,,,1,In vitro binding affinity was determined by radioligand binding assay using cell line expressing human 5-hydroxytryptamine 1F receptor,,,CHEMBL616730,,279,,,,H,8,BAO_0000019,
2088,,16312,Autocuration,,,1,Binding affinity towards human recombinant 5-hydroxytryptamine 1F receptor,,,CHEMBL617125,,279,,,,H,8,BAO_0000357,
2089,,6166,Autocuration,,,1,Binding affinity towards cloned human 5-hydroxytryptamine 1F receptor was determined,,,CHEMBL857977,,279,,,,H,8,BAO_0000357,
2090,,15779,Autocuration,,,1,Binding affinity towards 5-hydroxytryptamine 1F receptor (human cloned receptor) in CHO cells using [3H]5-HT as radioligand.,449.0,,CHEMBL617126,,279,,CHO,,H,8,BAO_0000219,
2091,,4199,Autocuration,,,1,Compound was evaluated for binding affinity against human cloned 5-hydroxytryptamine 1F receptor in CHO cells using [3H]-5-HT as the radioligand,449.0,,CHEMBL617127,,279,,CHO,,H,8,BAO_0000219,
2092,,14875,Autocuration,,,1,Compound was tested for binding affinity against human 5-hydroxytryptamine 1F receptor,,,CHEMBL617128,,279,,,,H,8,BAO_0000357,
2093,,15146,Autocuration,,,1,Compound was tested for its binding affinity against 5-hydroxytryptamine 1F receptor in human cloned receptors in CHO cells using [3H]5-HT,449.0,,CHEMBL617129,,279,,CHO,,H,8,BAO_0000219,
2094,,5213,Autocuration,,,1,Compound was tested for its binding affinity for human cloned 5-hydroxytryptamine 1F receptor in CHO using [3H]5-HT as a radioligand,,,CHEMBL617130,,279,,,,H,8,BAO_0000357,
2095,,14818,Autocuration,,,1,The compound was tested for its binding affinity towards cloned human 5-hydroxytryptamine 1F receptor in CHO cells using [3H]5-HT.,449.0,,CHEMBL617131,,279,,CHO,,H,8,BAO_0000219,
2096,,4829,Autocuration,,,1,"The compound was tested for the binding affinity towards human cloned 5-hydroxytryptamine 1F receptor in CHO cells, using [3H]5-HT as radioligand",449.0,,CHEMBL617132,,279,,CHO,,H,8,BAO_0000219,
2097,,4829,Autocuration,,,1,"The compound was tested for the binding affinity towards human cloned 5-hydroxytryptamine 1F receptor in CHO cells, using [3H]5-HT as radioligand",449.0,,CHEMBL617133,,279,,CHO,,H,8,BAO_0000219,
2098,,4373,Autocuration,,,1,Binding affinity relative to indolopiperidine (compound 1) for 5-hydroxytryptamine 1F receptor was determined,,,CHEMBL617134,,279,,,,H,8,BAO_0000357,
2099,,4373,Autocuration,,,1,Binding affinity for 5-hydroxytryptamine 1F receptor was determined,,,CHEMBL617135,,279,,,,H,8,BAO_0000357,
2100,,5014,Autocuration,,,1,Percent inhibition (at 1 uM) against 5-hydroxytryptamine 1F receptor,,,CHEMBL617136,,279,,,,H,8,BAO_0000357,
2101,,11662,Autocuration,,,1,"Compound was tested for binding affinity towards 5-hydroxytryptamine 2 (5-hydroxytryptamine-2) receptor from frontal cortical regions of male Sprague-Dawley rat homogenates, using [3H]-ketanserin as radioligand",,,CHEMBL617137,,104686,,,,H,4,BAO_0000019,
2102,,11662,Autocuration,,,1,"Compound was tested for binding affinity towards 5-hydroxytryptamine 2 receptor from frontal cortical regions of male Sprague-Dawley rat homogenates, using [3H]ketanserin as radioligand",,,CHEMBL617138,,104686,,,,H,4,BAO_0000019,
2103,,11662,Autocuration,,,1,"Compound was tested for binding affinity towards 5-hydroxytryptamine 2 (5-hydroxytryptamine-2) receptor from frontal cortical regions of male Sprague-Dawley rat homogenates, using [3H]ketanserin as radioligand; Not Determined",,,CHEMBL617139,,104686,,,,H,4,BAO_0000019,
2104,,14093,Autocuration,,,1,Ability to displace [3H]ketanserin from rat cortical homogenate 5-hydroxytryptamine 2A receptor,,,CHEMBL617140,,12687,,,,H,8,BAO_0000019,
2105,In vivo,11200,Autocuration,,,1,"In vivo inhibitory activity of 10 mg/kg compound in rats against elevation of BP caused by 5-HT (300 ug/kg, iv) through 5-HT2 receptor 1 hr after oral administration",,,CHEMBL617141,,104686,,,,H,4,BAO_0000218,
2106,,11200,Autocuration,,,1,In vitro antagonistic activity against the contraction induced by 5-HT through 5-hydroxytryptamine 2 receptor in rat thoracic aortic strips,,,CHEMBL858112,,104686,,,,H,4,BAO_0000019,
2107,,12352,Intermediate,,,1,Binding affinity towards 5-hydroxytryptamine 2 receptor in calf frontal cortex,,,CHEMBL617142,,17005,,,,H,8,BAO_0000019,
2108,,13657,Autocuration,9913.0,,1,"Binding affinity to 5-hydroxytryptamine 2 receptor using calf frontal cortex, [3H]- ketanserin, and spiperone for NSB",,,CHEMBL617143,,22226,Bos taurus,,,U,0,BAO_0000019,
2109,,14331,Autocuration,9913.0,,1,Inhibition of [3H]ketanserin binding to 5-hydroxytryptamine 2 receptor of bovine frontal cortex at 10e-7 M,,,CHEMBL617144,,22226,Bos taurus,,,U,0,BAO_0000019,
2110,,14331,Autocuration,9913.0,,1,Inhibition of [3H]ketanserin binding to 5-hydroxytryptamine 2 receptor of bovine frontal cortex,,,CHEMBL617145,,22226,Bos taurus,,,U,0,BAO_0000019,
2111,,14331,Autocuration,,,1,Binding affinity of compound towards 5-hydroxytryptamine 2 receptor using [3H]ketanserin (0.8 nM) ligand in frontal cortex bovine was determined,,,CHEMBL617146,,22226,,,,U,0,BAO_0000019,
2112,,12685,Autocuration,10141.0,,1,Binding affinity for serotonin 5-hydroxytryptamine 2 receptor using [3H]ketanserin in guinea pig frontal cortex,,,CHEMBL617147,,104784,Cavia porcellus,,,H,4,BAO_0000019,
2113,,14389,Autocuration,10141.0,,1,Inhibition of [3H]ketanserin binding to 5-hydroxytryptamine 2 receptor of guinea pig frontal cortex membranes,,,CHEMBL617148,,104784,Cavia porcellus,,,H,4,BAO_0000019,
2114,,14386,Autocuration,10141.0,,1,Compound was tested for its binding affinity towards 5-hydroxytryptamine 2 receptor using [3H]ketanserin from guinea pig frontal cortex,,,CHEMBL617149,,104784,Cavia porcellus,,,H,4,BAO_0000019,
2115,,5732,Autocuration,,,1,Binding affinity towards cloned human 5-hydroxytryptamine 2 receptor was determined,,,CHEMBL617150,,104784,,,,H,4,BAO_0000224,
2116,,16293,Autocuration,,,1,Binding affinity towards 5-hydroxytryptamine 2 receptor was determined,,,CHEMBL617151,,104784,,,,H,4,BAO_0000224,
2117,,2078,Autocuration,,,1,In vitro binding affinity of compound against neuronal 5-hydroxytryptamine 2 receptor,,,CHEMBL617201,,104784,,,,H,4,BAO_0000224,
2118,,5486,Autocuration,,,1,Binding affinity towards 5-HT7 receptor by the displacement of [3H]-5-CT] in human recombinant receptors in mammalian cell,,,CHEMBL617202,,10209,,,,H,8,BAO_0000357,
2119,In vivo,11820,Autocuration,,,1,Effective dose through peroral route for in vivo inhibition against 5-hydroxytryptamine 2 receptor in male CF-1 mice by using radioligand [3H]ketanserin,,,CHEMBL617203,,104826,,,,H,4,BAO_0000218,
2120,,10297,Autocuration,,,1,Hill number was determined for inhibition of [3H]ketanserin binding to 5-hydroxytryptamine 2 receptor in mouse cerebral cortex,,,CHEMBL617204,,104826,,,,H,4,BAO_0000019,
2121,,13704,Autocuration,,,1,Inhibitory activity against serotonin 5-hydroxytryptamine 2 receptor from mice.,,,CHEMBL617205,,104826,,,,H,4,BAO_0000224,
2122,,10297,Autocuration,10090.0,,1,Inhibitory activity towards 5-hydroxytryptamine 2 receptor by the displacement of [3H]ketanserin in mouse cerebral cortex,,,CHEMBL617206,,104826,Mus musculus,,,D,5,BAO_0000019,
2123,In vivo,11820,Autocuration,,,1,Effective dose through peroral route for in vivo inhibition against 5-hydroxytryptamine 2 receptor in male CF-1 mice by using radioligand [3H]ketanserin,,,CHEMBL617207,,104826,,,,H,4,BAO_0000218,
2124,,10297,Autocuration,10090.0,,1,Binding affinity towards 5-hydroxytryptamine 2 receptor by the displacement of [3H]-ketanserin in mouse cerebral cortex,,,CHEMBL617208,,104826,Mus musculus,,,D,5,BAO_0000019,
2125,,11555,Autocuration,,,1,The compound was tested in vitro for its binding affinity towards 5-hydroxytryptamine 2 receptor,,,CHEMBL617209,,104826,,,,H,4,BAO_0000224,
2126,,11555,Autocuration,,,1,In vitro binding affinity for serotonin 5-hydroxytryptamine (5-HT) 2 receptors,,,CHEMBL617210,,104826,,,,H,4,BAO_0000224,
2127,,11555,Autocuration,,,1,The compound was tested in vitro for its binding affinity towards serotonin 5-hydroxytryptamine 2 receptor; nd = no data,,,CHEMBL617211,,104826,,,,H,4,BAO_0000224,
2128,,10297,Autocuration,10090.0,,1,Hill number was determined for inhibition of [3H]ketanserin binding to 5-hydroxytryptamine 2 receptor in mouse cerebral cortex,,,CHEMBL617212,,104826,Mus musculus,,,D,5,BAO_0000019,
2129,,16688,Autocuration,9823.0,,1,Binding affinity for porcine 5-hydroxytryptamine 2 receptor using [3H]- ketanserin,,,CHEMBL617213,,104784,Sus scrofa,,,H,4,BAO_0000224,
2130,,16688,Autocuration,9823.0,,1,Binding affinity for porcine 5-hydroxytryptamine 2 receptor using [3H]- ketanserin with 10 uM prazosin,,,CHEMBL617214,,104784,Sus scrofa,,,H,4,BAO_0000224,
2131,,5333,Autocuration,,,1,Compound was tested in vitro for its ability to compete with [3H]-ketanserin at 5-hydroxytryptamine 2 receptor in porcine brain homogenate,,,CHEMBL617215,,22226,,,,U,0,BAO_0000221,
2132,,4437,Autocuration,,,1,In vitro for its ability to displace [3H]- ketanserin from 5-hydroxytryptamine 2 receptor in porcine brain homogenate,,,CHEMBL617216,,22226,,,,U,0,BAO_0000221,
2133,,5033,Autocuration,9823.0,,1,Ability to displace the radioligand [3H]mesulergine from pig choroid plexus 5-hydroxytryptamine 2 receptor,,,CHEMBL617217,,17005,Sus scrofa,,,H,8,BAO_0000357,
2134,,15267,Autocuration,,,1,Inhibition of [3H]- Ketanserin binding against rat brain 5-hydroxytryptamine 2 receptor,,,CHEMBL617218,,104686,,,,H,4,BAO_0000019,
2135,,15267,Autocuration,,,1,Inhibition of [3H]- Ketanserin binding against rat brain 5-hydroxytryptamine 2 receptor,,,CHEMBL872913,,104686,,,,H,4,BAO_0000019,
2136,,11820,Autocuration,,,1,Binding affinity against 5-hydroxytryptamine 2 receptor from rat cortical synaptosomal membrane using radioligand [3H]ketanserin.,,,CHEMBL617219,,104826,,,,H,4,BAO_0000019,
2137,,9069,Autocuration,,,1,Evaluated for binding activity against [3H]ketanserin as radioligand for 5-hydroxytryptamine 2 receptor,,,CHEMBL873482,,104686,,,,H,4,BAO_0000224,
2138,,9162,Autocuration,10116.0,,1,Affinity towards 5-hydroxytryptamine 2 receptor by measuring its ability to antagonize serotonin-induced contractions in the rat jugular vein; ND means no data,,,CHEMBL617220,,104686,Rattus norvegicus,,,D,5,BAO_0000019,
2139,,9162,Autocuration,,,1,Affinity towards 5-hydroxytryptamine 2 receptor by measuring its ability to antagonize serotonin-induced contractions in the rat jugular vein.,,,CHEMBL617221,,104686,,,,H,4,BAO_0000019,
2140,,9162,Autocuration,,,1,Affinity towards 5-hydroxytryptamine 2 receptor by measuring its ability to antagonize serotonin-induced contractions in the rat jugular vein; no appreciable 5-HT2 receptor affinity,,,CHEMBL617222,,104686,,,,H,4,BAO_0000019,
2141,,10428,Autocuration,,,1,Antagonistic activity against (5-hydroxytryptamine 2 receptor) serotonin-induced contractions in the rat jugular vein,,,CHEMBL875906,,104686,,,,H,4,BAO_0000019,
2142,,9628,Autocuration,,,1,Binding affinity to the 5-hydroxytryptamine 2 receptor assayed by antagonism of serotonin-induced contractions in the rat jugular vein,,,CHEMBL617223,,104686,,,,H,4,BAO_0000019,
2143,,12704,Autocuration,,,1,Binding affinity against serotonin 5-hydroxytryptamine 2 receptor,,,CHEMBL617224,,104686,,,,H,4,BAO_0000224,
2144,,15453,Autocuration,10116.0,,1,Percent decrease in 5-hydroxytryptamine 2 receptor binding using ketanserin,,,CHEMBL617225,,104686,Rattus norvegicus,,,D,5,BAO_0000224,
2145,,188,Autocuration,,,1,Tested for the effect on binding at 5-hydroxytryptamine 2 receptor; No activity,,,CHEMBL617226,,104686,,,,H,4,BAO_0000224,
2146,,10349,Autocuration,,,1,Effect of 2 week administration of compound on 5-hydroxytryptamine 2 receptor binding by using 0.4 nM dose of [3H]- spiperone as a radioligand.,,,CHEMBL617227,,104686,,,,H,4,BAO_0000224,
2147,,10349,Autocuration,,,1,Effect of 2 week administration of compound on 5-hydroxytryptamine 2 receptor binding by using 0.6 nM dose of [3H]- spiperone as a radioligand.,,,CHEMBL617228,,104686,,,,H,4,BAO_0000224,
2148,,8868,Autocuration,,,1,Compound was tested for its effect on 5-hydroxytryptamine 2 receptor saturation analysis,,,CHEMBL617229,,104686,,,,H,4,BAO_0000224,
2149,,10025,Autocuration,,,1,Concentration necessary to achieve half maximal inhibition of [3H]ketanserin binding to 5-hydroxytryptamine 2 receptor at 1 uM,,,CHEMBL617230,,104686,,,,H,4,BAO_0000224,
2150,,10025,Autocuration,,,1,"Concentration necessary to achieve half maximal inhibition of [3H]ketanserin, binds to 5-hydroxytryptamine 2 receptor at 1 uM",,,CHEMBL617231,,104686,,,,H,4,BAO_0000224,
2151,,11702,Autocuration,,,1,Compound was tested for the inhibition of quipazine binding at 5-HT2 receptor,,,CHEMBL617232,,104686,,,,H,4,BAO_0000224,
2152,,11702,Autocuration,,,1,Compound was tested for the inhibition of quipazine binding at 5-hydroxytryptamine 2 receptor,,,CHEMBL617233,,104686,,,,H,4,BAO_0000224,
2153,,11702,Autocuration,,,1,Compound was tested for the inhibition of quipazine binding at 5-hydroxytryptamine 2 receptor; NT=Not tested,,,CHEMBL617234,,104686,,,,H,4,BAO_0000224,
2154,,11702,Autocuration,,,1,Compound was tested for the inhibition of quipazine induced head twitches in rats,,,CHEMBL617235,,104686,,,,H,4,BAO_0000019,
2155,,11702,Autocuration,,,1,Compound was tested for the inhibition of quipazine induced head twitches in rats; NT=Not tested,,,CHEMBL617236,,104686,,,,H,4,BAO_0000019,
2156,,10085,Autocuration,,,1,Ability to bind at 5-hydroxytryptamine 2 receptor of rat hippocampus by displacing [3H]spiperone,,,CHEMBL617237,,104686,,,,H,4,BAO_0000221,10000000.0
2157,,10085,Autocuration,,,1,Ability to bind at serotonin 5-hydroxytryptamine 2 receptors of rat hippocampus by displacing [3H]spiperone,,,CHEMBL617238,,104686,,,,H,4,BAO_0000221,10000000.0
2158,,9630,Autocuration,10116.0,,1,Displacement of [3H]spiroperidol from 5-hydroxytryptamine 2 receptor in rat brain,,,CHEMBL617239,,104686,Rattus norvegicus,,,D,5,BAO_0000221,955.0
2159,,11070,Autocuration,,,1,Ability to inhibit binding of [3H]KET to 5-hydroxytryptamine 2 receptor in rat cortex,,,CHEMBL617240,,104686,,,,H,4,BAO_0000019,
2160,,9841,Autocuration,,,1,Ability to inhibit binding of titreated spiperone to 5-hydroxytryptamine 2 receptor in rat brain frontal cortex membranes,,,CHEMBL617241,Membranes,104686,,,,H,4,BAO_0000249,
2161,,9841,Autocuration,,,1,Ability to inhibit binding of titreated spiperone to the 5-hydroxytryptamine 2 receptor in rat brain frontal cortex membranes,,,CHEMBL875907,Membranes,104686,,,,H,4,BAO_0000249,
2162,,13291,Autocuration,,,1,Affinity for 5-hydroxytryptamine 2 receptor binding sites by its ability to displace [3H]spiperone from rat frontal cortex.,,,CHEMBL617242,,104686,,,,H,4,BAO_0000019,
2163,,10590,Autocuration,,,1,Antagonistic activity against 5-hydroxytryptamine 2 receptor on rat frontal cortex membrane.,,,CHEMBL617152,,104686,,,,H,4,BAO_0000019,
2164,,9064,Autocuration,10116.0,,1,Binding affinity against serotonin-2 receptor in rat brain using [3H]spiroperidol,,,CHEMBL617153,,104686,Rattus norvegicus,,,D,5,BAO_0000221,955.0
2165,,12268,Autocuration,10116.0,,1,Binding affinity at 5-hydroxytryptamine 2 receptor by the inhibition of binding to [3H]ketanserin in rat cortical membranes,,,CHEMBL617154,Membranes,104686,Rattus norvegicus,,,D,5,BAO_0000249,
2166,,13508,Autocuration,,,1,Binding affinity against 5-hydroxytryptamine 2 receptor in rat brain using [3H]ketanserin as radioligand,,,CHEMBL617155,,104686,,,,H,4,BAO_0000221,955.0
2167,,11279,Autocuration,,,1,5-hydroxytryptamine 2 receptor antagonistic activity on the rat tail artery determined by Schild plot.,,,CHEMBL617156,,104686,,,,H,4,BAO_0000019,
2168,,11200,Autocuration,,,1,In vitro antagonistic activity against the contraction induced by 5-HT through 5-HT2 receptor in rat thoracic aortic strips,,,CHEMBL617157,,104686,,,,H,4,BAO_0000019,
2169,,11200,Autocuration,,,1,In vitro antagonistic activity tested against the contraction induced by 5-HT through 5-hydroxytryptamine 2 receptor in rat thoracic aortic strips,,,CHEMBL617158,,104686,,,,H,4,BAO_0000019,
2170,,11200,Autocuration,,,1,In vitro antagonistic activity against the contraction induced by 5-HT through 5-hydroxytryptamine 2 receptor in rat thoracic aortic strips; NC=non competitive antagonism,,,CHEMBL617159,,104686,,,,H,4,BAO_0000019,
2171,,11200,Autocuration,,,1,In vitro antagonistic activity against the contraction induced by 5-HT through 5-hydroxytryptamine 2 receptor in rat thoracic aortic strips; NC=non competitive antagonism,,,CHEMBL617160,,104686,,,,H,4,BAO_0000019,
2172,,11200,Autocuration,,,1,In vitro antagonistic activity against the contraction induced by 5-HT through 5-hydroxytryptamine 2 receptor in rat thoracic aortic strips,,,CHEMBL858113,,104686,,,,H,4,BAO_0000019,
2173,,9231,Autocuration,,,1,Tested for 5-hydroxytryptamine 2 receptor binding ability by displacement of [3H]spiperone from rat brain frontal cortex synaptosomes,,,CHEMBL617247,,104686,,,,H,4,BAO_0000220,955.0
2174,,9737,Autocuration,,,1,Binding affinity towards 5-hydroxytryptamine 2 receptor in rat frontal cortex using [3H]ketanserin as radioligand,,,CHEMBL617248,,104686,,,,H,4,BAO_0000019,
2175,,9737,Autocuration,,,1,Binding affinity towards 5-hydroxytryptamine 2 receptor in rat brain membrane using [3H]8-OH-DPAT as a selective ligand.,,,CHEMBL617249,,104686,,,,H,4,BAO_0000249,955.0
2176,,9737,Autocuration,,,1,Binding affinity towards 5-hydroxytryptamine 2 receptor in rat frontal cortex,,,CHEMBL617250,,104686,,,,H,4,BAO_0000019,
2177,,9737,Autocuration,,,1,Binding affinity towards 5-hydroxytryptamine 2 receptor in rat frontal cortex using [3H]ketanserin as radioligand,,,CHEMBL617251,,104686,,,,H,4,BAO_0000019,
2178,,11828,Autocuration,10116.0,,1,isplacement of [3H]DOB from rat cortex homogenate 5-hydroxytryptamine 2 receptor,,,CHEMBL617252,,104686,Rattus norvegicus,,,D,5,BAO_0000019,
2179,,12253,Autocuration,,,1,Binding affinity of 5-hydroxytryptamine 2 receptor using [3H]- ketanserin in rat frontal cortex,,,CHEMBL617006,,104686,,,,H,4,BAO_0000019,
2180,,12253,Autocuration,,,1,Binding affinity against 5-hydroxytryptamine 2 receptor using [3H]ketanserin in rat frontal cortex,,,CHEMBL617007,,104686,,,,H,4,BAO_0000019,
2181,,11279,Autocuration,,,1,"5-hydroxytryptamine 2 receptor antagonistic activity at concentrations of<br>3,10 and 30 uM on the rat tail artery.",,,CHEMBL617008,,104686,,,,H,4,BAO_0000019,
2182,,11866,Autocuration,,,1,Binding affinity for 5-hydroxytryptamine 2 receptor in rat cortex using [3H]- ketanserin,,,CHEMBL617009,,104686,,,,H,4,BAO_0000019,
2183,,14424,Autocuration,10116.0,,1,Binding affinity against 5-hydroxytryptamine 2 receptor in serotonin-induced contraction of the rat aorta,,,CHEMBL617010,,104686,Rattus norvegicus,,,D,5,BAO_0000224,
2184,,15180,Autocuration,10116.0,,1,Displacement of [3H]ketanserin from rat brain 5-hydroxytryptamine 2 receptor,,,CHEMBL857978,,104686,Rattus norvegicus,,,D,5,BAO_0000019,
2185,,15180,Autocuration,10116.0,,1,Displacement of [3H]ketanserin from rat brain 5-hydroxytryptamine 2 receptor,,,CHEMBL617011,,104686,Rattus norvegicus,,,D,5,BAO_0000019,
2186,,9786,Autocuration,10116.0,,1,Displacement of [3H]ketanserin from 5-hydroxytryptamine 2 receptor of rat frontal cortex homogenate,,,CHEMBL617012,,104686,Rattus norvegicus,,,D,5,BAO_0000019,
2187,,12132,Autocuration,,,1,Binding affinity towards 5-hydroxytryptamine 2 receptor using [3H]-ketanserin as radioligand.,,,CHEMBL617013,,104686,,,,H,4,BAO_0000224,
2188,,5486,Autocuration,,,1,Binding affinity towards 5-hydroxytryptamine 2 receptor by the displacement of [3H]ketanserin in rat cerebral cortex membrane,,,CHEMBL617014,,104686,,,,H,4,BAO_0000249,
2189,,15316,Autocuration,,,1,Compound was evaluated for its ability to displace [3H]ketanserin binding from cloned rat cerebral cortex membranes 5-hydroxytryptamine 2 receptor,,,CHEMBL617015,,104686,,,,H,4,BAO_0000019,
2190,,16429,Autocuration,,,1,In vitro binding affinity to 5-hydroxytryptamine 2 receptor of rat cerebral cortex membranes using [3H]ketanserin as the radioligand,,,CHEMBL617016,,104686,,,,H,4,BAO_0000019,
2191,,14617,Autocuration,,,1,pKi value for 5-hydroxytryptamine 2 receptor binding site,,,CHEMBL617017,,104686,,,,H,4,BAO_0000224,
2192,,11351,Autocuration,,,1,Inhibitory constant (1 uM) was measured on 5-hydroxytryptamine 2 receptor/uptake using [3H]- ketanserin as radioligand in rat brain cortex.,,,CHEMBL617018,,104686,,,,H,4,BAO_0000221,955.0
2193,,11279,Autocuration,,,1,5-hydroxytryptamine 2 receptor antagonistic activity on the rat tail artery determined by Schild plot.,,,CHEMBL617019,,104686,,,,H,4,BAO_0000019,
2194,,9523,Autocuration,,,1,Binding affinity at 5-hydroxytryptamine 2 receptor determined using [125I]- DOI as radioligand in rat frontal cortex,,,CHEMBL617020,,105075,,,,H,4,BAO_0000019,
2195,,9523,Autocuration,,,1,Binding affinity at 5-hydroxytryptamine 2 receptor was determined using [125I]- DOI as radioligand in rat frontal cortex,,,CHEMBL617021,,105075,,,,H,4,BAO_0000019,
2196,,9523,Autocuration,,,1,Binding affinity at [3H]DOB labeled sites of 5-hydroxytryptamine 2 receptor determined using [125I]- DOI as radioligand in rat frontal cortex,,,CHEMBL617022,,105075,,,,H,4,BAO_0000019,
2197,,9523,Autocuration,,,1,Binding affinity at [3H]DOB labeled sites of 5-hydroxytryptamine 2 receptor was determined using [125I]- DOI as radioligand in rat frontal cortex,,,CHEMBL617023,,105075,,,,H,4,BAO_0000019,
2198,,9523,Autocuration,,,1,Binding affinity at [3H]KET labeled sites of 5-hydroxytryptamine 2 receptor determined using [125I]- DOI as radioligand in rat frontal cortex,,,CHEMBL617024,,105075,,,,H,4,BAO_0000019,
2199,,9523,Autocuration,,,1,Binding affinity at [3H]KET labeled sites of 5-hydroxytryptamine 2 receptor was determined using [125I]- DOI as radioligand in rat frontal cortex,,,CHEMBL617025,,105075,,,,H,4,BAO_0000019,
2200,,9523,Autocuration,,,1,Hill coefficient of compound was determined,,,CHEMBL617026,,105075,,,,H,4,BAO_0000224,
2201,,4771,Autocuration,,,1,Ancillary Binding affinity towards rat 5-hydroxytryptamine 2 receptor,,,CHEMBL617027,,22226,,,,U,0,BAO_0000019,
2202,,5033,Autocuration,10116.0,,1,Ability to displace the radioligand [3H]5-carboximidotryptamine ([3H]-ketanserin) from 5-hydroxytryptamine 2 receptor of rat cerebral cortex membrane,,,CHEMBL617028,,104686,Rattus norvegicus,,,D,5,BAO_0000019,
2203,,10845,Expert,,,1,Binding affinity against rat 5-hydroxytryptamine 2 receptor in rat cerebral cortex tissue using [3H]spiperone as radioligand,,,CHEMBL617029,,12687,,,,H,8,BAO_0000019,
2204,,10845,Expert,,,1,Binding affinity against rat 5-hydroxytryptamine 2 receptor in rat cerebral cortex tissue using [3H]spiperone as radioligand; IA-Inactive,,,CHEMBL875908,,12687,,,,H,8,BAO_0000019,
2205,,16288,Autocuration,,,1,Affinity at 5-hydroxytryptamine 2 receptor (For ketanserin = Ki(nM)= 0.7+/-0.09),,,CHEMBL617030,,12687,,,,H,8,BAO_0000357,
2206,,16288,Autocuration,,,1,Affinity at 5-hydroxytryptamine 2 receptor from rat frontal cortex using [3H]ketanserin as radioligand (For ketanserin = Ki(nM)=0.7+/-0.09),,,CHEMBL617031,,12687,,,,H,8,BAO_0000019,
2207,,16190,Autocuration,,,1,Binding affinity for 5-hydroxytryptamine 2 receptor of rat cortical membrane using [3H]DOB radioligand,,,CHEMBL617032,,12687,,,,H,8,BAO_0000019,
2208,,12463,Autocuration,10116.0,,1,Tested in vitro for receptor binding affinity against 5-hydroxytryptamine 2 receptor using radioligand [3H]ketanserin,,,CHEMBL617033,,104686,Rattus norvegicus,,,D,5,BAO_0000224,
2209,,9699,Autocuration,,,1,"Binding affinity towards 5-hydroxytryptamine 2 receptor using [3H]- 1-(4-bromo-2,5-dimethoxy-phenyl)-2-aminopropane (D) as radioligand",,,CHEMBL617034,,104686,,,,H,4,BAO_0000224,
2210,,9699,Autocuration,,,1,Binding affinity towards 5-hydroxytryptamine 2 receptor using [3H]- ketanserin as radioligand,,,CHEMBL617035,,104686,,,,H,4,BAO_0000224,
2211,,11662,Autocuration,,,1,"Compound was tested for binding affinity towards 5-hydroxytryptamine 2 receptor from frontal cortical regions of male Sprague-Dawley rat homogenates, using [3H]ketanserin as radioligand; Not Determined",,,CHEMBL617036,,104686,,,,H,4,BAO_0000019,
2212,,1205,Autocuration,,,1,Inhibitory concentration against 5-hydroxytryptamine 2 receptor,,,CHEMBL617037,,104784,,,,H,4,BAO_0000224,
2213,,11376,Autocuration,,,1,Compound was evaluated for the binding affinity towards 5-hydroxytryptamine 2 receptor from mammalian clones expressed in CHO cell membranes using [3H]-ketanserin as radioligand,,,CHEMBL617038,,22226,,,,U,0,BAO_0000219,
2214,,11376,Autocuration,,,1,"Binding affinity towards 5-hydroxytryptamine 2 receptor expressed in CHO cell membranes using [3H]ketanserin (60 Ci/mmol, 1 nM)",,,CHEMBL617039,,104784,,,,H,4,BAO_0000219,
2215,,4639,Autocuration,,,1,Compound was tested for binding affinity against 5-hydroxytryptamine 2 receptor,,,CHEMBL617161,,104784,,,,H,4,BAO_0000224,
2216,,2222,Autocuration,,,1,Compound was tested for inhibitory activity against 5-hydroxytryptamine 2 receptor,,,CHEMBL617162,,104784,,,,H,4,BAO_0000224,
2217,,1558,Autocuration,,,1,Compound was tested for its affinity towards 5-hydroxytryptamine 2 receptor,,,CHEMBL617163,,104784,,,,H,4,BAO_0000224,
2218,,1089,Autocuration,,,1,Tested for binding affinity for 5-hydroxytryptamine 2 receptor,,,CHEMBL617164,,104784,,,,H,4,BAO_0000224,
2219,,386,Autocuration,,,1,The compound was evaluated for its ability to displace [3H]ketanserin from 5-hydroxytryptamine 2 receptor in cellular brain membranes,,,CHEMBL617165,Brain membranes,104784,,,,H,4,BAO_0000249,
2220,,2474,Autocuration,,,1,Compound was measured for its binding affinity at 5-hydroxytryptamine 2 receptor at a concentration of 10 uM using [3H]ketanserin as radioligand,,,CHEMBL617166,,104784,,,,H,4,BAO_0000224,
2221,,17066,Autocuration,,,1,Binding affinity towards 5-HT2 receptor,,,CHEMBL617167,,104784,,,,H,4,BAO_0000224,
2222,,959,Autocuration,,,1,Displacement of [3H]ketanserin from 5-hydroxytryptamine 2 receptor,,,CHEMBL872912,,104784,,,,H,4,BAO_0000224,
2223,,6398,Autocuration,,,1,Compound was evaluated for 5-hydroxytryptamine 2 receptor binding,,,CHEMBL617168,,104784,,,,H,4,BAO_0000224,
2224,,11889,Autocuration,,,1,In vitro binding affinity against rat 5-hydroxytryptamine 2 receptor.,,,CHEMBL617169,,104686,,,,H,4,BAO_0000224,
2225,,4221,Autocuration,,,1,In vitro binding affinity for 5-hydroxytryptamine 2 receptor,,,CHEMBL617170,,104784,,,,H,4,BAO_0000224,
2226,,11026,Autocuration,,,1,The compound was tested for binding affinity against 5-hydroxytryptamine 2 receptor using ketanserin as radioligand,,,CHEMBL617171,,104784,,,,H,4,BAO_0000224,
2227,,11866,Autocuration,,,1,Binding affinity for 5-hydroxytryptamine 2 receptor was determined,,,CHEMBL617172,,104784,,,,H,4,BAO_0000224,
2228,,4221,Autocuration,,,1,In vitro binding affinity for 5-hydroxytryptamine 2 receptor,,,CHEMBL617173,,104784,,,,H,4,BAO_0000224,
2229,,13950,Autocuration,,,1,In Vitro binding affinity for 5-hydroxytryptamine 2 receptor,,,CHEMBL617174,,22226,,,,U,0,BAO_0000019,
2230,,1263,Autocuration,,,1,5-hydroxytryptamine 2 receptor binding affinity,,,CHEMBL617175,,104784,,,,H,4,BAO_0000224,
2231,,13291,Autocuration,,,1,Binding affinity against 5-hydroxytryptamine 2 receptor was determined using [ [3H]spiperone radioligand,,,CHEMBL617176,,17005,,,,H,8,BAO_0000357,
2232,,10812,Autocuration,,,1,Compound was tested for the binding affinity against 5-hydroxytryptamine 2 receptor by using [3H]ketanserin as radioligand,,,CHEMBL617177,,17005,,,,H,8,BAO_0000357,
2233,,13020,Autocuration,,,1,Inhibition of [3H]ketanserin binding to 5-hydroxytryptamine 2 receptor at 10e-5 M,,,CHEMBL617178,,104784,,,,H,4,BAO_0000224,
2234,,13021,Autocuration,,,1,Inhibition of [3H]ketanserin binding to 5-hydroxytryptamine 2 receptor of central nervous system,,,CHEMBL617179,,104784,,,,H,4,BAO_0000224,
2235,,13020,Autocuration,,,1,Ketanserin binding to 5-hydroxytryptamine 2 receptor at 10e-5 M,,,CHEMBL617180,,104784,,,,H,4,BAO_0000224,
2236,,14532,Autocuration,,,1,Inhibitory activity against 5-hydroxytryptamine 2 receptor using [3H]-ketanserin as radioligand at 10e-5 M concentration,,,CHEMBL617181,,17005,,,,H,8,BAO_0000357,
2237,,13944,Autocuration,,,1,Binding affinity against 5-hydroxytryptamine 2 receptor,,,CHEMBL617182,,17005,,,,H,8,BAO_0000357,
2238,,14331,Autocuration,,,1,Binding affinity against 5-hydroxytryptamine 2 receptor,,,CHEMBL617183,,17005,,,,H,8,BAO_0000357,
2239,,14118,Autocuration,,,1,Binding affinity against 5-hydroxytryptamine 2 receptor using [3H]ketanserin as radioligand,,,CHEMBL617184,,17005,,,,H,8,BAO_0000357,
2240,,13033,Autocuration,,,1,Binding affinity against serotonergic 5-HT2 receptor,,,CHEMBL617185,,17005,,,,H,8,BAO_0000357,
2241,,10321,Autocuration,,,1,Binding affinity for 5-hydroxytryptamine 2 receptor was determined by using [3H]ketanserin as radioligand,,,CHEMBL617186,,17005,,,,H,8,BAO_0000357,
2242,,12918,Autocuration,,,1,Compound was evaluated for the binding affinity at 5- HT2 receptor,,,CHEMBL617187,,17005,,,,H,8,BAO_0000357,
2243,,15120,Autocuration,,,1,Compound was tested for binding affinity using [3H]ketanserin against 5-hydroxytryptamine 2 receptor,,,CHEMBL617188,,17005,,,,H,8,BAO_0000357,
2244,,2613,Autocuration,,,1,In vivo binding affinity was evaluated against 5-hydroxytryptamine 2 receptor,,,CHEMBL617189,,17005,,,,H,8,BAO_0000218,
2245,,13378,Autocuration,9606.0,,1,Inhibitory activity against cloned human 5-HT2 receptor,,,CHEMBL617190,,104784,Homo sapiens,,,D,5,BAO_0000224,
2246,,2331,Autocuration,9606.0,,1,"Tested in vitro for the inhibition of [3H]ketanserin binding to 5-hydroxytryptamine 2 receptor, expressed in cloned CHO cells",449.0,,CHEMBL617191,,104784,Homo sapiens,CHO,,D,5,BAO_0000219,
2247,,2331,Autocuration,9606.0,,1,"Tested in vitro for the inhibition of [3H]ketanserin binding to 5-hydroxytryptamine 2 receptor, expressed in cloned CHO cells.",449.0,,CHEMBL617192,,104784,Homo sapiens,CHO,,D,5,BAO_0000219,
2248,,2331,Autocuration,9606.0,,1,"Tested in vitro for the inhibition of [3H]-ketanserin binding to 5-hydroxytryptamine 2 receptor, expressed in cloned CHO cells; Inactive",449.0,,CHEMBL617193,,104784,Homo sapiens,CHO,,D,5,BAO_0000219,
2249,,2331,Autocuration,9606.0,,1,"Tested in vitro for the inhibition of [3H]ketanserin binding to 5-hydroxytryptamine 2 receptor, expressed in cloned CHO cells; not tested",449.0,,CHEMBL617194,,104784,Homo sapiens,CHO,,D,5,BAO_0000219,
2250,,4170,Autocuration,,,1,Binding affinity towards 5-hydroxytryptamine 2 receptor,,,CHEMBL617195,,104784,,,,H,4,BAO_0000224,
2251,,15453,Autocuration,,,1,Percent decrease in 5-hydroxytryptamine 2 receptor binding using ketanserin,,,CHEMBL881830,,104784,,,,H,4,BAO_0000224,
2252,,1479,Autocuration,,,1,Binding affinity towards 5-hydroxytryptamine 2 receptor,,,CHEMBL617196,,17005,,,,H,8,BAO_0000357,
2253,,11139,Autocuration,,,1,Binding affinity towards 5-hydroxytryptamine 2- receptor using [3H]ketanserin as radioligand in competitive binding assay,,,CHEMBL617197,,104686,,,,H,4,BAO_0000224,
2254,,13969,Expert,,,1,Binding affinity against 5-hydroxytryptamine 2A receptor was measured using [3H]ketanserin as radioligand,,,CHEMBL617198,,17005,,,,H,8,BAO_0000357,
2255,,13392,Expert,,,1,Binding affinity towards 5-hydroxytryptamine 2A receptor,,,CHEMBL873476,,17005,,,,H,8,BAO_0000357,
2256,,14430,Expert,,,1,Affinity towards 5-hydroxytryptamine 2A receptor in membranes from bovine frontal cortex using [3H]ketanserin,,,CHEMBL617199,,17005,,,,H,8,BAO_0000019,
2257,,13181,Autocuration,10141.0,,1,Binding affinity was determined against 5-hydroxytryptamine 2A receptor,,,CHEMBL617200,,107,Cavia porcellus,,,H,8,BAO_0000357,
2258,,17200,Autocuration,,,1,Inhibitory constant against cloned human 5-hydroxytryptamine 2A receptor using with [125I]- DOI radioligand,,,CHEMBL617484,,51,,,,H,8,BAO_0000357,
2259,,17200,Autocuration,,,1,Inhibitory constant against cloned human 5-hydroxytryptamine 2A receptor using with [125I]- DOI radioligand,,,CHEMBL617485,,107,,,,H,8,BAO_0000357,
2260,,17200,Autocuration,,,1,Inhibitory constant against cloned human 5-hydroxytryptamine 2A receptor using with [125I]- DOI radioligand,,,CHEMBL617486,,51,,,,H,8,BAO_0000357,
2261,,13463,Autocuration,,,1,Binding affinity analysed on 5-HT 2A human clone using [3H]ketanserin as radioligand,,,CHEMBL858022,,107,,,,H,8,BAO_0000357,
2262,,6347,Autocuration,,,1,Effective concentration against human 5-hydroxytryptamine 2A receptor in CHO cells using 8-OH-DPA radioligand,449.0,,CHEMBL617049,,107,,CHO,,H,8,BAO_0000219,
2263,,6857,Expert,9606.0,,1,Functional activity against human 5-hydroxytryptamine 2A receptor expressed in CHO cells using fluorometric imaging plate reader,449.0,,CHEMBL617050,,107,Homo sapiens,CHO,,D,9,BAO_0000219,
2264,,4176,Autocuration,,,1,Functional agonist activity of compound was determined by fluorescence-based assay measuring intracellular calcium mobilization for 5-HT2a receptor cell line,,,CHEMBL617051,,107,,,,H,8,BAO_0000219,
2265,,4176,Autocuration,,,1,Functional agonist activity of compound was determined by fluorescence-based assay measuring intracellular calcium mobilization for 5-HT2a receptor cell line; no data,,,CHEMBL617052,,107,,,,H,8,BAO_0000219,
2266,,4176,Autocuration,,,1,Functional antagonist activity of compound was determined by fluorescence-based assay measuring intracellular calcium mobilization for 5-HT2a receptor cell line,,,CHEMBL617053,,107,,,,H,8,BAO_0000219,
2267,,6347,Autocuration,,,1,"Agonistic binding affinity against human 5-hydroxytryptamine 2A receptor in CHO cells using 8-OH-DPA radioligand, expressed as Emax",449.0,,CHEMBL617054,,107,,CHO,,H,8,BAO_0000219,
2268,,6347,Autocuration,,,1,"Agonistic binding affinity against human 5-hydroxytryptamine 2A receptor in CHO cells, expressed as Emax",449.0,,CHEMBL617055,,107,,CHO,,H,8,BAO_0000219,
2269,,15331,Autocuration,,,1,Affinity of compound towards human 5-hydroxytryptamine 2A receptor was evaluated using radioligand binding technique,,,CHEMBL882924,,107,,,,H,8,BAO_0000357,
2270,,16146,Expert,9606.0,,1,Inhibition of human 5-hydroxytryptamine 2A receptor,,,CHEMBL617056,,107,Homo sapiens,,,D,9,BAO_0000357,
2271,,15250,Autocuration,,,1,Compound was tested for the displacement of [3H]5-HT binding to cloned human 5-hydroxytryptamine 2A receptor stably expressed in CHO cells,449.0,,CHEMBL617057,,107,,CHO,,H,8,BAO_0000219,
2272,,13631,Expert,,,1,Inhibitory concentration against human 5-HT2A receptor in BEK cells,,,CHEMBL617058,,107,,,,H,8,BAO_0000219,
2273,,3805,Autocuration,,,1,In vitro binding affinity against human 5-hydroxytryptamine 2A receptor at a concentration of 100 (nM),,,CHEMBL617059,,107,,,,H,8,BAO_0000357,
2274,,4011,Autocuration,,,1,Ability to displace [3H]ketanserin from CHO cells expressing human 5-hydroxytryptamine 2A receptor was determined,449.0,,CHEMBL617060,,107,,CHO,,H,8,BAO_0000219,
2275,,4012,Expert,,,1,Displacement of [3H]ketanserin from CHO cells expressing human 5-hydroxytryptamine 2A receptor.,449.0,,CHEMBL617061,,107,,CHO,,H,8,BAO_0000219,
2276,,6366,Expert,,,1,Ability to displace [125I]R91150 from human cloned 5-hydroxytryptamine 2A receptor expressed in L929 cells,307.0,,CHEMBL617062,,107,,L929,,H,8,BAO_0000219,
2277,,15949,Expert,,,1,Ability to displace [3H]ketanserin binding to human 5-hydroxytryptamine 2A receptor stably expressed in CHO cells,449.0,,CHEMBL617063,,107,,CHO,,H,8,BAO_0000219,
2278,,14093,Autocuration,,,1,Agonist activity at cloned human 5-hydroxytryptamine 2A receptor using [125I]DOI radioligand,,,CHEMBL617064,,107,,,,H,8,BAO_0000019,
2279,,13481,Autocuration,,,1,Agonistic activity at cloned human 5-hydroxytryptamine 2A receptor using [125I]DOI as radioligand,,,CHEMBL617065,,107,,,,H,8,BAO_0000019,
2280,,6347,Autocuration,,,1,Agonistic binding affinity against human 5-hydroxytryptamine 2A receptor in CHO cells using 8-OH-DPA radioligand,449.0,,CHEMBL617066,,107,,CHO,,H,8,BAO_0000219,
2281,,6347,Autocuration,,,1,Agonistic binding affinity against human 5-hydroxytryptamine 2A receptor in CHO cells using 8-OH-DPA radioligand; Nd means not done,449.0,,CHEMBL617067,,107,,CHO,,H,8,BAO_0000219,
2282,,14093,Autocuration,,,1,Antagonist activity at cloned human 5-hydroxytryptamine 2A receptor using [3H]-Ketanserin radioligand,,,CHEMBL617068,,107,,,,H,8,BAO_0000019,
2283,,14093,Autocuration,,,1,Antagonist activity at cloned human 5-hydroxytryptamine 2A receptor using [3H]ketanserin radioligand; Not tested,,,CHEMBL617069,,107,,,,H,8,BAO_0000019,
2284,,13481,Autocuration,,,1,Antagonistic activity at cloned human 5-hydroxytryptamine 2A receptor using [3H]ketanserin as radioligand,,,CHEMBL617070,,107,,,,H,8,BAO_0000019,
2285,,14442,Autocuration,,,1,Binding ability of compound at cloned human 5-hydroxytryptamine 2A receptor using [125 I]DOI as radioligand,,,CHEMBL617071,,107,,,,H,8,BAO_0000357,
2286,,14442,Autocuration,,,1,Binding ability of compound at cloned human 5-hydroxytryptamine 2A receptor using [3H]ketanserin as radioligand,,,CHEMBL872915,,107,,,,H,8,BAO_0000357,
2287,,14755,Autocuration,,,1,Binding activity against cloned human 5-hydroxytryptamine 2A receptor using [125I]DOI as the radioligand.,,,CHEMBL617072,,107,,,,H,8,BAO_0000357,
2288,,16441,Autocuration,,,1,Binding affinity against 5-hydroxytryptamine 2A receptor in humans,,,CHEMBL617073,,107,,,,H,8,BAO_0000357,
2289,,14744,Autocuration,,,1,Binding affinity against the cloned human 5-hydroxytryptamine 2A receptor using [125I]DOI as the radioligand,,,CHEMBL617074,,107,,,,H,8,BAO_0000357,
2290,,16659,Expert,,,1,Binding affinity for displacement of [3H]ketanserin to human 5-hydroxytryptamine 2A receptor stably expressed in CHO cells,449.0,,CHEMBL617075,,107,,CHO,,H,8,BAO_0000219,
2291,,3307,Autocuration,,,1,Binding affinity of compound to human 5-hydroxytryptamine 2A receptor,,,CHEMBL617076,,107,,,,H,8,BAO_0000357,
2292,,6857,Expert,9606.0,,1,Affinity for human 5-hydroxytryptamine 2A receptor expressed in mammalian cell line,,,CHEMBL617077,,107,Homo sapiens,,,D,9,BAO_0000019,
2293,,5635,Expert,,,1,Binding affinity against 5-hydroxytryptamine 2A receptor using [125I]DOI radioligand.,,,CHEMBL617078,,107,,,,H,8,BAO_0000357,
2294,,4234,Expert,9606.0,,1,Binding affinity to cloned human 5-hydroxytryptamine 2A receptor,,,CHEMBL617079,,107,Homo sapiens,,,D,9,BAO_0000357,
2295,,15527,Autocuration,,,1,Binding affinity towards 5-hydroxytryptamine 2A receptor using [3H]5-HT as radioligand.,,,CHEMBL617080,,107,,,,H,8,BAO_0000357,
2296,,6588,Expert,,,1,Binding affinity towards human 5-hydroxytryptamine 2A receptor by the displacement of [3H]ketanserin radioligand from the cloned receptor expressed in CHO cells,449.0,,CHEMBL617081,,107,,CHO,,H,8,BAO_0000219,
2297,,13631,Expert,,,1,Binding affinity towards human 5-HT2A receptor in BEK cells,,,CHEMBL617082,,107,,,,H,8,BAO_0000219,
2298,,17723,Autocuration,,,1,Binding affinity towards human serotonin 5-hydroxytryptamine 2A receptor,,,CHEMBL617083,,107,,,,H,8,BAO_0000357,
2299,,14770,Autocuration,,,1,Binding affinity for recombinant human 5-hydroxytryptamine 2A receptor using [3H]5-HT as radioligand.,,,CHEMBL617084,,107,,,,H,8,BAO_0000357,
2300,,16293,Expert,9606.0,,1,Binding affinity for human 5-hydroxytryptamine 2A receptor,,,CHEMBL617085,,107,Homo sapiens,,,D,9,BAO_0000357,
2301,,16209,Autocuration,,,1,Binding affinity towards human 5-hydroxytryptamine 2A receptor using [125I]DOI as radioligand,,,CHEMBL617086,,107,,,,H,8,BAO_0000357,
2302,,12469,Autocuration,,,1,Binding affinity was measured on 5-hydroxytryptamine 2A receptor in GF6 cells transfected with human 5-HT2A gene labeled with [3H]ketanserin,,,CHEMBL617087,,107,,,,H,8,BAO_0000219,
2303,,15363,Autocuration,,,1,Compound was tested for the displacement of [125I]-DOI from clone human 5-hydroxytryptamine 2A receptor,,,CHEMBL617088,,107,,,,H,8,BAO_0000357,
2304,,15363,Autocuration,,,1,Compound was tested for the displacement of [125I]DOI from cloned human 5-hydroxytryptamine 2A receptor,,,CHEMBL617089,,107,,,,H,8,BAO_0000357,
2305,,16441,Expert,,,1,"Tested on genetically transfected COS7 cell membranes selectively expressing human 5-hydroxytryptamine 2A receptor, using [3H]ketanserin as radioligand",,,CHEMBL617090,,107,,,,H,8,BAO_0000019,
2306,,8,Autocuration,,,1,In vitro binding affinity towards 5-hydroxytryptamine 2A receptor in human using [3H]ketanserin as radioligand,,,CHEMBL617513,,107,,,,H,8,BAO_0000357,
2307,,4176,Autocuration,,,1,In vitro binding affinity towards human 5-hydroxytryptamine 2A receptor expressed in HEK293 cells was determined using [3H]ketanserin as radioligand,722.0,,CHEMBL617514,,107,,HEK293,,H,8,BAO_0000219,
2308,,17085,Autocuration,,,1,In vitro binding affinity by radioligand binding assay using cell line expressing human 5-hydroxytryptamine 2A receptor,,,CHEMBL617515,,107,,,,H,8,BAO_0000019,
2309,,17200,Autocuration,,,1,Inhibitory constant against cloned human 5-hydroxytryptamine 2A receptor using with [125I]- DOI radioligand,,,CHEMBL617516,,107,,,,H,8,BAO_0000357,
2310,,17200,Expert,9606.0,,1,Inhibitory constant determined against cloned human 5-hydroxytryptamine 2A receptor using with [125I]- DOI radioligand,,,CHEMBL617517,,107,Homo sapiens,,,D,9,BAO_0000357,
2311,,4013,Expert,9606.0,,1,Displacement of [3H]ketanserin from human 5-hydroxytryptamine 2A receptor expressed in CHO cells,449.0,,CHEMBL617518,,107,Homo sapiens,CHO,,D,9,BAO_0000219,
2312,,5088,Autocuration,,,1,Tested for binding affinity towards 5-hydroxytryptamine 2A receptor,,,CHEMBL617519,,107,,,,H,8,BAO_0000357,
2313,,5088,Expert,9606.0,,1,Displacement of [3H]DOB from human 5-hydroxytryptamine 2A receptor,,,CHEMBL617520,,107,Homo sapiens,,,D,9,BAO_0000357,
2314,,5088,Autocuration,,,1,Tested for binding affinity towards 5-hydroxytryptamine 2A receptor using [3H]DOB as labeled ligand; binding data not obtained,,,CHEMBL617521,,107,,,,H,8,BAO_0000357,
2315,,5088,Expert,9606.0,,1,Displacement of [3H]ketanserin from human 5-hydroxytryptamine 2A receptor,,,CHEMBL617522,,107,Homo sapiens,,,D,9,BAO_0000357,
2316,,5088,Autocuration,,,1,Tested for binding affinity towards human 5-hydroxytryptamine 2A receptor using [3H]5-HT as radioligand,,,CHEMBL617523,,107,,,,H,8,BAO_0000357,
2317,,5088,Autocuration,,,1,Tested for binding affinity towards human 5-hydroxytryptamine 2A receptor using [3H]DOB as radioligand,,,CHEMBL617524,,107,,,,H,8,BAO_0000357,
2318,,9786,Autocuration,,,1,Ability to displace 0.75 nM [3H]ketanserin in 5-hydroxytryptamine 2 receptor from rat frontal cortex homogenate,,,CHEMBL617525,,104686,,,,H,4,BAO_0000019,
2319,,9205,Autocuration,10116.0,,1,Ability to inhibit [3H]spiperone binding to 5-hydroxytryptamine 2 receptor determined in rat,,,CHEMBL617526,,104686,Rattus norvegicus,,,D,5,BAO_0000019,
2320,,11257,Autocuration,,,1,Affinity on 5-hydroxytryptamine 2 receptor labeled by [125I]DOI,,,CHEMBL617527,,104686,,,,H,4,BAO_0000224,
2321,,9362,Autocuration,,,1,Affinity towards [3H]- DOB -labeled 5-hydroxytryptamine 2 receptor sites in rat cortical homogenates,,,CHEMBL617528,,104686,,,,H,4,BAO_0000019,
2322,,9362,Autocuration,,,1,Affinity towards [3H]- ketanserin-labeled 5-hydroxytryptamine 2 receptor sites in rat cortical homogenates,,,CHEMBL617529,,104686,,,,H,4,BAO_0000019,
2323,,10590,Autocuration,,,1,Inhibition of 5-hydroxytryptamine 2 induced vasoconstriction of rat caudal artery.,,,CHEMBL617530,,104686,,,,H,4,BAO_0000224,
2324,,10468,Autocuration,,,1,Binding affinity against 5-hydroxytryptamine 2 receptor of rat frontal cortex using [3H]ketanserin radioligand,,,CHEMBL617531,,104686,,,,H,4,BAO_0000019,
2325,,13050,Autocuration,,,1,Binding affinity against 5-hydroxytryptamine 2 receptor from rat frontal cortex using [125]-(R)-DOI as radioligand,,,CHEMBL617532,,104686,,,,H,4,BAO_0000019,
2326,,11624,Autocuration,,,1,Binding affinity against 5-hydroxytryptamine 2 receptor in rat using [3H]ketanserin as radioligand,,,CHEMBL617533,,104686,,,,H,4,BAO_0000019,
2327,,10468,Autocuration,,,1,Binding affinity against 5-hydroxytryptamine 2 receptor of rat frontal cortex using [3H]ketanserin radioligand,,,CHEMBL617534,,104686,,,,H,4,BAO_0000019,
2328,,10330,Autocuration,,,1,Binding affinity against 5-hydroxytryptamine 2 receptor using [3H]ketanserin as radioligand,,,CHEMBL617535,,104686,,,,H,4,BAO_0000224,
2329,,10062,Autocuration,,,1,Binding affinity at rat 5-hydroxytryptamine 2 receptor by [3H]ketanserin displacement.,,,CHEMBL617536,,104686,,,,H,4,BAO_0000224,
2330,,11642,Autocuration,,,1,Binding affinity determined in radioreceptor binding assay by using [3H]ketanserin radioligand against 5-hydroxytryptamine 2 receptor,,,CHEMBL617537,,104686,,,,H,4,BAO_0000224,
2331,,10062,Autocuration,,,1,Binding affinity determined in radioreceptor binding assay by using [3H]ketanserin radioligand against 5-hydroxytryptamine 2 receptor,,,CHEMBL617538,,104686,,,,H,4,BAO_0000224,
2332,In vitro,13427,Autocuration,,,1,Binding affinity of [3H]ketanserin towards 5-hydroxytryptamine 2 receptor in cloned mammalian receptor expressed in cultured cells or from rat whole brain.,,,CHEMBL617539,,104686,,,,H,4,BAO_0000219,
2333,,12280,Autocuration,10116.0,,1,Displacement of [3H]ketanserin from 5-hydroxytryptamine 2 receptor,,,CHEMBL617540,,104686,Rattus norvegicus,,,D,5,BAO_0000224,
2334,,4101,Autocuration,10116.0,,1,Binding affinity for 5-hydroxytryptamine 2 receptor from striata of male Wistar rats by displacement of [3H]ketanserin,,,CHEMBL617541,,104686,Rattus norvegicus,,,D,5,BAO_0000224,
2335,,10062,Autocuration,,,1,Binding affinity in radioreceptor binding assay by using [3H]5-HT radioligand against 5-hydroxytryptamine 2 receptor,,,CHEMBL617542,,104686,,,,H,4,BAO_0000224,
2336,,11147,Autocuration,,,1,Binding affinity towards 5-hydroxytryptamine 2 receptor using [3H]DOB as,,,CHEMBL617543,,104686,,,,H,4,BAO_0000224,
2337,,2395,Autocuration,10116.0,,1,Binding affinity against [3H]ketanserin binding to 5-hydroxytryptamine 2 receptor expressed in CHO-K1 cells,485.0,,CHEMBL617544,,104686,Rattus norvegicus,CHO-K1,,D,5,BAO_0000219,
2338,,2395,Autocuration,10116.0,,1,Binding affinity against [3H]ketanserin binding to 5-hydroxytryptamine 2 receptor expressed in CHO-K1 cells,485.0,,CHEMBL617545,,104686,Rattus norvegicus,CHO-K1,,D,5,BAO_0000219,
2339,,9098,Autocuration,10116.0,,1,Binding affinity to rat cortical membranes at 5-hydroxytryptamine 2 receptor binding site by using [3H]- DOB as a radioligand,,,CHEMBL617413,,104686,Rattus norvegicus,,,D,5,BAO_0000019,
2340,,9098,Autocuration,,,1,Binding affinity to rat cortical membranes at 5-hydroxytryptamine 2 receptor binding site by using [3H]- DOB as a radioligand.,,,CHEMBL617414,,104686,,,,H,4,BAO_0000019,
2341,,9098,Autocuration,10116.0,,1,Binding affinity to 5-hydroxytryptamine 2 receptor of rat cortical membranes using [3H]- DOB; ND means no data.,,,CHEMBL617415,,104686,Rattus norvegicus,,,D,5,BAO_0000019,
2342,,9443,Autocuration,,,1,Binding affinity towards 5-hydroxytryptamine 2 receptor,,,CHEMBL617416,,104686,,,,H,4,BAO_0000224,
2343,,9443,Autocuration,,,1,Binding affinity towards 5-hydroxytryptamine 2 receptor at 1.0 uM concentration,,,CHEMBL617417,,104686,,,,H,4,BAO_0000224,
2344,,9699,Autocuration,,,1,"Binding affinity towards 5-hydroxytryptamine 2 receptor using [3H]- 1-(4-bromo-2,5-dimethoxy-phenyl)-2-aminopropane (D) as radioligand in rat frontal cortex",,,CHEMBL617418,,104686,,,,H,4,BAO_0000019,
2345,,9699,Autocuration,,,1,Binding affinity towards 5-hydroxytryptamine 2 receptor using [3H]- ketanserin as radioligand in rat frontal cortex,,,CHEMBL617419,,104686,,,,H,4,BAO_0000019,
2346,,9098,Autocuration,,,1,Binding affinity towards 5-hydroxytryptamine 2 receptor was determined,,,CHEMBL617420,,104686,,,,H,4,BAO_0000224,
2347,,3070,Autocuration,10116.0,,1,Affinity for 5-hydroxytryptamine 2 receptor,,,CHEMBL617421,,104686,Rattus norvegicus,,,D,5,BAO_0000224,
2348,,9547,Autocuration,,,1,Binding affinity towards serotonin 5-hydroxytryptamine 2 receptor of rat determined using 0.5 nM of [3H]ketanserin in binding assay,,,CHEMBL617422,,104686,,,,H,4,BAO_0000224,
2349,,10444,Autocuration,,,1,Binding affinity was determined against 5-hydroxytryptamine 2 receptor from male Sprague-Dawley rat brain.,,,CHEMBL617423,,104686,,,,H,4,BAO_0000019,
2350,,14617,Autocuration,,,1,Binding affinity which represents concentration giving half-maximal inhibition of [3H]ketanserin binding to 5-hydroxytryptamine 2 receptor from rat tissue homogenate,,,CHEMBL617424,,104686,,,,H,4,BAO_0000019,
2351,,14617,Autocuration,,,1,Binding affinity which represents concentration giving half-maximal inhibition of [3H]ketanserin binding to 5-hydroxytryptamine 2 receptor rat tissue homogenate,,,CHEMBL617425,,104686,,,,H,4,BAO_0000019,
2352,,11130,Autocuration,,,1,Binding constant against 5-hydroxytryptamine 2 receptor (in vitro),,,CHEMBL617426,,104686,,,,H,4,BAO_0000224,
2353,In vivo,11130,Autocuration,,,1,Binding constant against 5-hydroxytryptamine 2 receptor (in vivo),,,CHEMBL617427,,104686,,,,H,4,BAO_0000218,
2354,,14542,Autocuration,,,1,Compound is evaluated for binding affinity towards 5-hydroxytryptamine 2 receptor using [3H]ketanserin in rat brain,,,CHEMBL617428,,104686,,,,H,4,BAO_0000221,955.0
2355,,2797,Autocuration,,,1,Compound was evaluated for binding affinity against 5-hydroxytryptamine 2 receptor from rat,,,CHEMBL617429,,104686,,,,H,4,BAO_0000224,
2356,,11332,Autocuration,,,1,Compound was evaluated for in vitro binding affinity towards 5-hydroxytryptamine 2 receptor in rat cortex using [3H]- spiperone as radioligand,,,CHEMBL617430,,104686,,,,H,4,BAO_0000019,
2357,,11332,Autocuration,,,1,Compound was evaluated for in vitro binding affinity towards serotonin 5-hydroxytryptamine 2 receptor in rat cortex using [3H]- spiperone as radioligand,,,CHEMBL617431,,104686,,,,H,4,BAO_0000019,
2358,,10752,Autocuration,,,1,Compound was evaluated for its ability to displace 0.25 nM [125I](R)-DOI from binding sites in rat frontal cortex.,,,CHEMBL617432,,104686,,,,H,4,BAO_0000019,1870.0
2359,,1185,Autocuration,,,1,Ability to displace [3H]ketanserin from serotonergic 5-hydroxytryptamine 2 receptor,,,CHEMBL617433,,104686,,,,H,4,BAO_0000224,
2360,,1185,Autocuration,,,1,Compound was evaluated for its ability to displace [3H]ketanserin from serotonergic 5-hydroxytryptamine 2 receptor,,,CHEMBL617434,,104686,,,,H,4,BAO_0000224,
2361,,11624,Autocuration,10116.0,,1,Binding affinity against 5-Hydroxy tryptamine 2 (5-hydroxytryptamine 2)receptor,,,CHEMBL617435,,104686,Rattus norvegicus,,,D,5,BAO_0000224,
2362,,1344,Autocuration,,,1,Compound was evaluated for its binding affinity to 5-hydroxytryptamine 2 receptor in rat cortex using [3H]ketanserin radioligand assay,,,CHEMBL617436,,104686,,,,H,4,BAO_0000019,
2363,,15453,Autocuration,10116.0,,1,Binding affinity against 5-hydroxytryptamine 2 receptor in rat striatum using [3H]-RP62203,,,CHEMBL617437,,104686,Rattus norvegicus,,,D,5,BAO_0000019,2435.0
2364,,11662,Autocuration,,,1,"Binding affinity towards 5-hydroxytryptamine 2 receptor from frontal cortical regions of male Sprague-Dawley rat homogenates, using [3H]ketanserin as radioligand",,,CHEMBL617438,,104686,,,,H,4,BAO_0000019,
2365,,11662,Autocuration,,,1,"Compound was tested for binding affinity towards 5-hydroxytryptamine 2 receptor from frontal cortical regions of male Sprague-Dawley rat homogenates, using [3H]ketanserin as radioligand; Not Determined",,,CHEMBL617439,,104686,,,,H,4,BAO_0000019,
2366,,10796,Autocuration,,,1,Compound was tested in vitro for binding affinity for 5-hydroxytryptamine 2 receptor,,,CHEMBL617440,,104686,,,,H,4,BAO_0000224,
2367,,9069,Autocuration,,,1,Evaluated for binding activity against [3H]ketanserin as radioligand for 5-hydroxytryptamine 2 receptor,,,CHEMBL617441,,104686,,,,H,4,BAO_0000224,
2368,,8814,Autocuration,10116.0,,1,Displacement of [3H]ketanserin from 5-hydroxytryptamine 2 receptor of rat cortical membrane homogenates,,,CHEMBL872918,,104686,Rattus norvegicus,,,D,5,BAO_0000019,
2369,,8908,Autocuration,10116.0,,1,Displacement of [3H]ketanserin from 5-hydroxytryptamine 2 receptor of rat cortex,,,CHEMBL617442,,104686,Rattus norvegicus,,,D,5,BAO_0000019,
2370,,9098,Autocuration,,,1,Evaluated for the binding affinity to rat cortical membranes at 5-hydroxytryptamine 2 receptor binding site by using [3H]- KET as a radioligand; ND means no data.,,,CHEMBL617443,,104686,,,,H,4,BAO_0000019,
2371,,9098,Autocuration,,,1,Binding affinity to rat cortical membranes at 5-hydroxytryptamine 2 (5-HT2) receptor using [3H]KET as a radioligand,,,CHEMBL617444,,104686,,,,H,4,BAO_0000019,
2372,,9098,Autocuration,,,1,Evaluated for the binding affinity to rat cortical membranes at 5-hydroxytryptamine 2 receptor binding site by using [3H]- KET as a radioligand; ND means no data.,,,CHEMBL617445,,104686,,,,H,4,BAO_0000019,
2373,,9098,Autocuration,,,1,Evaluated for the binding affinity to rat cortical membranes at 5-hydroxytryptamine 2 receptor binding site by using [3H]- KET as a radioligand.,,,CHEMBL617446,,104686,,,,H,4,BAO_0000019,
2374,,9098,Autocuration,,,1,Binding affinity to 5-hydroxytryptamine 2 receptor in rat frontal cortical membranes by [3H]- KET displacement.,,,CHEMBL617447,,104686,,,,H,4,BAO_0000249,
2375,,9098,Autocuration,,,1,Evaluated for the binding affinity to rat frontal cortical membranes at 5-hydroxytryptamine 2 receptor binding site by using [3H]- KET as a radioligand.;ND is not determined,,,CHEMBL617448,,104686,,,,H,4,BAO_0000019,
2376,,9098,Autocuration,,,1,Evaluated for the binding affinity to rat frontal cortical membranes at 5-hydroxytryptamine 2 receptor binding site by using [3H]- KET as a radioligand;ND means no data,,,CHEMBL617449,,104686,,,,H,4,BAO_0000019,
2377,,9161,Autocuration,,,1,In vitro binding affinity at 5-hydroxytryptamine 2 receptor in rat cortical tissue by [3H]spiperone displacement; No data.,,,CHEMBL617450,,104686,,,,H,4,BAO_0000019,
2378,,9161,Autocuration,,,1,In vitro 5-hydroxytryptamine 2 receptor affinity by using [3H]spiperone as the radioligand in rat cortical tissue; value may range from 165 to 263,,,CHEMBL617451,,104686,,,,H,4,BAO_0000019,
2379,,9161,Autocuration,,,1,In vitro 5-hydroxytryptamine 2 receptor affinity by using [3H]spiperone as the radioligand in rat cortical tissue; value may range from 2.4 to 5.3,,,CHEMBL617452,,104686,,,,H,4,BAO_0000019,
2380,,9161,Autocuration,,,1,In vitro 5-hydroxytryptamine 2 receptor affinity by using [3H]-Spiperone as the radioligand in rat cortical tissue.,,,CHEMBL617453,,104686,,,,H,4,BAO_0000019,
2381,,9161,Autocuration,,,1,In vitro 5-hydroxytryptamine 2 receptor affinity by using [3H]spiperone as the radioligand in rat cortical tissue.; value may range from 140 to 980,,,CHEMBL617660,,104686,,,,H,4,BAO_0000019,
2382,,9161,Autocuration,,,1,In vitro 5-hydroxytryptamine 2 receptor affinity by using [3H]spiperone as the radioligand in rat cortical tissue.; value may range from 76 to 299,,,CHEMBL617661,,104686,,,,H,4,BAO_0000019,
2383,,9161,Autocuration,,,1,In vitro 5-hydroxytryptamine 2 receptor affinity by using [3H]-Spiperone as the radioligand in rat cortical tissue; value may range from 12 to 66,,,CHEMBL617662,,104686,,,,H,4,BAO_0000019,
2384,,9161,Autocuration,,,1,In vitro 5-hydroxytryptamine 2 receptor affinity by using [3H]spiperone as the radioligand in rat cortical tissue; value may range from 136 to 220,,,CHEMBL872919,,104686,,,,H,4,BAO_0000019,
2385,,9161,Autocuration,,,1,In vitro 5-hydroxytryptamine 2 receptor affinity by using [3H]spiperone as the radioligand in rat cortical tissue; value may range from 197 to 341,,,CHEMBL617663,,104686,,,,H,4,BAO_0000019,
2386,,9161,Autocuration,,,1,In vitro 5-hydroxytryptamine 2 receptor affinity by using [3H]spiperone as the radioligand in rat cortical tissue; value may range from 23 to 187,,,CHEMBL617664,,104686,,,,H,4,BAO_0000019,
2387,,9161,Autocuration,,,1,In vitro 5-hydroxytryptamine 2 receptor affinity by using [3H]spiperone as the radioligand in rat cortical tissue; value may range from 29 to 132,,,CHEMBL617665,,104686,,,,H,4,BAO_0000019,
2388,,9161,Autocuration,,,1,In vitro 5-hydroxytryptamine 2 receptor affinity by using [3H]spiperone as the radioligand in rat cortical tissue; value may range from 6 to 75,,,CHEMBL617666,,104686,,,,H,4,BAO_0000019,
2389,,12094,Autocuration,,,1,In vitro binding affinity on 5-hydroxytryptamine 2 receptor is inhibition of binding of [125I]- I-LSD to P11 cells,,,CHEMBL617667,,104686,,,,H,4,BAO_0000019,
2390,,12018,Autocuration,,,1,In vitro binding affinity towards 5-hydroxytryptamine 2 receptor in rat striatal membranes by [3H]ketanserin displacement.,,,CHEMBL617668,,104686,,,,H,4,BAO_0000249,
2391,,10394,Autocuration,,,1,Inhibitory activity against 5-hydroxytryptamine 2 receptor in rat cortical membranes using [3H]ketanserin as a radioligand,,,CHEMBL617669,,104686,,,,H,4,BAO_0000249,
2392,,15260,Autocuration,,,1,Inhibitory activity against rat cortical 5-hydroxytryptamine 2 receptor,,,CHEMBL617670,,104686,,,,H,4,BAO_0000224,
2393,,11624,Autocuration,10116.0,,1,Inhibitory constant against 5-hydroxytryptamine 2 receptor,,,CHEMBL617671,,104686,Rattus norvegicus,,,D,5,BAO_0000224,
2394,,13654,Autocuration,,,1,Percentage specific displacement of radioligand [3H]-ketanserin from 5-hydroxytryptamine 2 receptor,,,CHEMBL617672,,104686,,,,H,4,BAO_0000224,
2395,,9541,Autocuration,,,1,Potency to displace [3H]- Spiperone from 5-hydroxytryptamine 2 receptor in rat striatum,,,CHEMBL617673,,104686,,,,H,4,BAO_0000019,
2396,,11933,Autocuration,,,1,Tested for binding affinity against 5-hydroxytryptamine 2 receptor from rat frontal cortical regions using [3H]ketanserin as radioligand,,,CHEMBL617674,,104686,,,,H,4,BAO_0000224,
2397,,15538,Autocuration,,,1,Tested for binding affinity by measuring displacement of [3H]ketanserin from rat serotonin 5-hydroxytryptamine 2 receptor in rat cortex,,,CHEMBL617675,,104686,,,,H,4,BAO_0000019,
2398,,15538,Autocuration,,,1,Tested for binding affinity by measuring displacement of [3H]ketanserin from rat serotonin 5-hydroxytryptamine 2 receptor in rat cortex; NA means Not Active,,,CHEMBL617676,,104686,,,,H,4,BAO_0000019,
2399,,15538,Autocuration,,,1,Tested for binding affinity by measuring displacement of [3H]ketanserin from rat serotonin 5-hydroxytryptamine 2 receptor in rat cortex; not determined,,,CHEMBL617677,,104686,,,,H,4,BAO_0000019,
2400,,8841,Autocuration,,,1,Displacement of [3H]ketanserin from rat prefrontal cortex 5-hydroxytryptamine 2 receptor,,,CHEMBL617678,,104686,,,,D,5,BAO_0000019,
2401,,1455,Autocuration,,,1,Binding affinity to 5-hydroxytryptamine 2 receptor using [3H]ketanserin radioligand assay.,,,CHEMBL617679,,104686,,,,H,4,BAO_0000224,
2402,,1455,Autocuration,,,1,Tested for its binding affinity to Tested for its binding affinity to 5-hydroxytryptamine 2 receptor using [3H]-ketanserin radioligand assay using [3H]-ketanserin radioligand assay,,,CHEMBL617680,,104686,,,,H,4,BAO_0000224,
2403,,11752,Autocuration,,,1,The ability to inhibit [3H]ketanserin binding to 5-hydroxytryptamine 2 receptor in rat whole brain,,,CHEMBL617681,,104686,,,,H,4,BAO_0000019,
2404,,11642,Autocuration,,,1,The binding affinity was measured on 5-hydroxytryptamine 2 receptor in rat brain tissue,,,CHEMBL617682,,104686,,,,H,4,BAO_0000221,955.0
2405,,12092,Autocuration,,,1,The binding affinity was measured on 5-hydroxytryptamine 2 receptor using [3H]- spiperone as radioligand.,,,CHEMBL617683,,104686,,,,H,4,BAO_0000224,
2406,,3967,Autocuration,,,1,Binding affinity at 5-hydroxytryptamine 2 receptor from striata wistar rats by [3H]ketanserin displacement.,,,CHEMBL617684,,104686,,,,H,4,BAO_0000224,
2407,,12771,Autocuration,10116.0,,1,Binding affinity towards 5-hydroxytryptamine 2 receptor,,,CHEMBL617685,,104686,Rattus norvegicus,,,D,5,BAO_0000224,
2408,,11642,Autocuration,,,1,The compound was tested for its binding affinity towards 5-hydroxytryptamine 2 receptor by displacing [3H]ketanserin radioligand in rat cerebral cortex,,,CHEMBL617686,,104686,,,,H,4,BAO_0000019,
2409,,11628,Autocuration,,,1,The compound was tested in vitro for binding affinity towards 5-hydroxytryptamine 2 receptor by displacing [125]I-LSD radioligand,,,CHEMBL617687,,104686,,,,H,4,BAO_0000224,
2410,,13654,Autocuration,,,1,Percentage specific displacement of radioligand [3H]ketanserin from 5-hydroxytryptamine 2 receptor,,,CHEMBL617688,,104686,,,,H,4,BAO_0000224,
2411,,11200,Autocuration,,,1,In vitro antagonistic activity against the contraction induced by 5-HT through 5-hydroxytryptamine 2 receptor in rat thoracic aortic strips,,,CHEMBL617689,,104686,,,,H,4,BAO_0000019,
2412,,11200,Autocuration,,,1,In vitro antagonistic activity against the contraction induced by 5-HT through 5-hydroxytryptamine 2 receptor in rat thoracic aortic strips,,,CHEMBL617690,,104686,,,,H,4,BAO_0000019,
2413,In vivo,11200,Autocuration,,,1,"In vivo inhibitory activity of 10 mg/kg compound in rats against elevation of BP caused by 5-HT (300 ug/kg, iv) through 5-hydroxytryptamine 2 receptor 1 hr after oral administration",,,CHEMBL617691,,104686,,,,H,4,BAO_0000218,
2414,In vivo,11200,Autocuration,,,1,"In vivo inhibitory activity of 10 mg/kg compound in rats against elevation of BP caused by 5-HT (300 ug/kg, iv) through 5-hydroxytryptamine 2 receptor 3h after oral administration",,,CHEMBL617692,,104686,,,,H,4,BAO_0000218,
2415,In vivo,11200,Autocuration,,,1,"In vivo inhibitory activity of 3 mg/kg compound in rats against elevation of BP caused by 5-HT (300 ug/kg, iv) through 5-hydroxytryptamine 2 receptor 1 hr after oral administration",,,CHEMBL617693,,104686,,,,H,4,BAO_0000218,
2416,In vivo,11200,Autocuration,,,1,"In vivo inhibitory activity of 3 mg/kg compound in rats against elevation of BP caused by 5-HT (300 ug/kg, iv) through 5-hydroxytryptamine 2 receptor 3h after oral administration",,,CHEMBL617694,,104686,,,,H,4,BAO_0000218,
2417,,15436,Expert,,,1,Affinity for 5-hydroxytryptamine 2A receptor in rat brain cortex by ability to displace [3H]ketanserin,,,CHEMBL857985,,12687,,,,H,8,BAO_0000221,955.0
2418,,15436,Expert,10116.0,,1,Affinity at 5-hydroxytryptamine 2A receptor of the rat brain cortex was assessed on the basis of their ability to displace [3H]ketanserin,,,CHEMBL617695,,12687,Rattus norvegicus,,,D,9,BAO_0000019,
2419,,14025,Autocuration,,,1,Affinity pKi for 5-hydroxytryptamine 2A receptor was measured in rat cortex homogenates,,,CHEMBL617696,,12687,,,,H,8,BAO_0000019,
2420,,4342,Autocuration,,,1,Binding affinity of compound towards serotonin 5-hydroxytryptamine 2A receptor was determined,,,CHEMBL617697,,12687,,,,H,8,BAO_0000357,
2421,,13735,Expert,10116.0,,1,Displacement of [3H]ketanserin from 5-HT2A receptor of rat frontal cortex,,,CHEMBL617257,,12687,Rattus norvegicus,,,D,9,BAO_0000019,
2422,,5816,Expert,10116.0,,1,Binding affinity towards 5-hydroxytryptamine 2A receptor using [3H]ketanserin,,,CHEMBL617258,,12687,Rattus norvegicus,,,D,9,BAO_0000357,
2423,,14287,Expert,,,1,Binding affinity was evaluated in vitro by displacement of [3H]ketanserin from 5-hydroxytryptamine 2A receptor on rat cortical membrane,,,CHEMBL617259,,12687,,,,H,8,BAO_0000019,
2424,,15738,Autocuration,,,1,In vitro affinity against serotonin ( 5-hydroxytryptamine 2A receptor ) receptor,,,CHEMBL617260,,12687,,,,H,8,BAO_0000357,
2425,,15738,Expert,10116.0,,1,In vitro affinity against serotonin 5-hydroxytryptamine 2A receptor,,,CHEMBL617261,,12687,Rattus norvegicus,,,D,9,BAO_0000357,
2426,,15026,Autocuration,,,1,Compound was tested in vitro for its binding affinity towards 5-hydroxytryptamine 2A receptor from rat frontal cortex using [3H]-ketanserin as radioligand,,,CHEMBL617262,,12687,,,,H,8,BAO_0000019,
2427,,16647,Expert,,,1,Half-maximal inhibition of [3H]- Ketanserin binding to 5-hydroxytryptamine 2A receptor in rat cerebral cortex homogenate,,,CHEMBL617263,,12687,,,,H,8,BAO_0000019,
2428,,16647,Autocuration,,,1,Half-maximal inhibition of [3H]ketanserin binding to 5-hydroxytryptamine 2A receptor in rat tissue homogenate,,,CHEMBL617264,,12687,,,,H,8,BAO_0000019,
2429,,13345,Expert,10116.0,,1,Displacement of [3H]-ketanserin from rat brain 5-hydroxytryptamine 2A receptor,,,CHEMBL617265,,12687,Rattus norvegicus,,,D,9,BAO_0000019,
2430,,1543,Autocuration,,,1,Inhibition constant for in vitro inhibition of [3H]ketanserin binding to rat frontal cortex membranes 5-hydroxytryptamine 2A receptor,,,CHEMBL617266,Membranes,12687,,,,H,8,BAO_0000249,
2431,,12444,Autocuration,,,1,Inhibition of [3H]ketanserin binding to 5-hydroxytryptamine 2A receptor rat frontal cortex membrane,,,CHEMBL617267,,12687,,,,H,8,BAO_0000019,
2432,,16404,Expert,,,1,Inhibitory constant on 5-hydroxytryptamine 2A receptor of Rat frontal cortex,,,CHEMBL617268,,12687,,,,H,8,BAO_0000019,
2433,,16404,Autocuration,,,1,Inhibitory constant on human 5-hydroxytryptamine 2A receptor transfected in to CHO cells,449.0,,CHEMBL617269,,12687,,CHO,,H,8,BAO_0000219,
2434,,15577,Expert,,,1,Kinetic inhibition constant evaluated by measuring serotonergic activity,,,CHEMBL617323,,12687,,,,H,8,BAO_0000357,
2435,,15577,Autocuration,,,1,Serotonergic activity of the compound.,,,CHEMBL617324,,12687,,,,H,8,BAO_0000357,
2436,,2495,Autocuration,,,1,Tested in vitro for its ability to inhibit [3H]ketanserin binding to 5-hydroxytryptamine 2A receptor in rat frontal cortex membranes,,,CHEMBL617325,,12687,,,,H,8,BAO_0000249,
2437,,15042,Expert,10116.0,,1,The binding affinity was evaluated on 5-hydroxytryptamine 2A receptor expressed in rat cortex by using [3H]ketanserin as radioligand.,,,CHEMBL617326,,12687,Rattus norvegicus,,,D,9,BAO_0000019,
2438,,15026,Expert,,,1,In vitro ability to displace [3H]ketanserin binding from 5-hydroxytryptamine 2A receptor in rat striatal membrane.,,,CHEMBL617327,,12687,,,,H,8,BAO_0000249,
2439,,12919,Expert,10116.0,,1,Agonistic activity against 5-hydroxytryptamine 2A receptor in rat cortex using [3H]ketanserin,,,CHEMBL617328,,12687,Rattus norvegicus,,,D,9,BAO_0000019,
2440,,12919,Expert,10116.0,,1,Agonistic activity against 5-hydroxytryptamine 2A receptor in rat cortex using [3H]ketanserin,,,CHEMBL617329,,12687,Rattus norvegicus,,,D,9,BAO_0000019,
2441,,12919,Expert,10116.0,,1,Agonistic activity against 5-hydroxytryptamine 2A receptor in rat cortex using [3H]ketanserin,,,CHEMBL617330,,12687,Rattus norvegicus,,,D,9,BAO_0000019,
2442,,15194,Autocuration,,,1,The compound was tested for the binding affinity against 5-hydroxytryptamine 2A receptor using [3H]ketanserin as radioligand,,,CHEMBL617331,,12687,,,,H,8,BAO_0000357,
2443,,15194,Autocuration,,,1,The compound was tested for the binding affinity against 5-hydroxytryptamine 2A receptor using [3H]ketanserin as radioligand.,,,CHEMBL617332,,12687,,,,H,8,BAO_0000357,
2444,,4820,Expert,,,1,Binding affinity towards 5-hydroxytryptamine 2A receptor,,,CHEMBL617333,,107,,,,H,8,BAO_0000357,
2445,,6736,Autocuration,,,1,Binding affinity against serotonin 5-hydroxytryptamine 2A receptor was determined using human [125I]-eotaxin,,,CHEMBL617334,,107,,,,H,8,BAO_0000357,
2446,,5163,Autocuration,,,1,Binding affinity towards 5-hydroxytryptamine 2A receptor was determined at a concentration of 0.000001 mol/L,,,CHEMBL617335,,107,,,,H,8,BAO_0000357,
2447,,5163,Autocuration,,,1,Binding affinity towards 5-hydroxytryptamine 2A receptor was determined at a concentration of 0.00001 mol/L,,,CHEMBL617336,,107,,,,H,8,BAO_0000357,
2448,,6011,Autocuration,,,1,Inhibition of binding towards 5-hydroxytryptamine 2A receptor at 100 nM concentration,,,CHEMBL617337,,107,,,,H,8,BAO_0000357,
2449,,14294,Expert,9606.0,,1,Percent inhibition against 5-hydroxytryptamine 2A receptor using [3H]ketanserin at 1 uM,,,CHEMBL617338,,107,Homo sapiens,,,D,9,BAO_0000357,
2450,,5014,Autocuration,,,1,Percent inhibition (at 1 uM) against 5-hydroxytryptamine 2A receptor,,,CHEMBL617339,,107,,,,H,8,BAO_0000357,
2451,,17066,Expert,,,1,Binding affinity towards 5-hydroxytryptamine 2A receptor,,,CHEMBL617340,,107,,,,H,8,BAO_0000357,
2452,,17515,Autocuration,,,1,Binding affinity of compound towards serotonin 5-hydroxytryptamine 2A receptor; inactive at 10 uM,,,CHEMBL617341,,107,,,,H,8,BAO_0000357,
2453,,6736,Expert,,,1,Inhibition of [125I]-eotaxin binding to serotonin 5-hydroxytryptamine 2A receptor,,,CHEMBL617342,,107,,,,H,8,BAO_0000357,
2454,,5163,Expert,,,1,Affinity for 5-hydroxytryptamine 2A receptor,,,CHEMBL617343,,107,,,,H,8,BAO_0000357,
2455,,16911,Expert,,,1,Binding affinity was performed using [3H]ketanserin as the radioligand and stably transfected NIH3T3 cells expressing the 5-hydroxytryptamine 2A receptor (GF-62 cells).,723.0,,CHEMBL617344,,107,,NIH3T3,,H,8,BAO_0000219,
2456,,6841,Expert,,,1,Binding affinity towards 5-hydroxytryptamine 2A receptor using [3H]ketanserin,,,CHEMBL617345,,107,,,,H,8,BAO_0000357,
2457,,6119,Expert,,,1,Binding affinity towards 5-hydroxytryptamine 2A receptor using [125I]DOI as radioligand.,,,CHEMBL617346,,107,,,,H,8,BAO_0000357,
2458,,3962,Autocuration,,,1,Compound was evaluated for its binding against 5-hydroxytryptamine 2A receptor,,,CHEMBL617347,,107,,,,H,8,BAO_0000357,
2459,,4373,Autocuration,,,1,Binding affinity relative to indolopiperidine (compound 1) for 5-hydroxytryptamine 2A receptor was determined,,,CHEMBL617348,,107,,,,H,8,BAO_0000357,
2460,,4373,Autocuration,,,1,Binding affinity relative to indolopiperidine (compound 1)for 5-hydroxytryptamine 2A receptor was determined,,,CHEMBL617349,,107,,,,H,8,BAO_0000357,
2461,,3962,Autocuration,,,1,Compound was evaluated for its inverse agonist activity against 5-hydroxytryptamine 2A receptor,,,CHEMBL617350,,107,,,,H,8,BAO_0000019,
2462,,1633,Expert,,,1,Binding affinity towards 5-hydroxytryptamine 2A receptor by displacement of [3H]ketanserin,,,CHEMBL872339,,107,,,,H,8,BAO_0000357,
2463,,4373,Autocuration,,,1,Binding affinity for 5-hydroxytryptamine 2A receptor was determined,,,CHEMBL617351,,107,,,,H,8,BAO_0000357,
2464,,6576,Expert,,,1,Binding affinity towards serotonin 5-hydroxytryptamine 2A receptor,,,CHEMBL617352,,107,,,,H,8,BAO_0000357,
2465,,4687,Autocuration,,,1,Evaluated for the binding affinity towards 5-hydroxytryptamine 2A receptor,,,CHEMBL617353,,107,,,,H,8,BAO_0000357,
2466,,16946,Autocuration,,,1,Ability to displace [3H]-ketanserin from 5-hydroxytryptamine 2A receptor,,,CHEMBL617354,,107,,,,H,8,BAO_0000357,
2467,,14159,Autocuration,,,1,Compound was evaluated for the affinity at 5-hydroxytryptamine 2A receptor,,,CHEMBL617355,,107,,,,H,8,BAO_0000357,
2468,,3032,Expert,10090.0,,1,In vitro binding affinity against 5-hydroxytryptamine 2A receptor in CHO cells,449.0,,CHEMBL617356,,107,Mus musculus,CHO,,H,8,BAO_0000219,
2469,,16655,Autocuration,,,1,Inhibition of ketanserin binding to 5-hydroxytryptamine 2A receptor,,,CHEMBL617357,,107,,,,H,8,BAO_0000357,
2470,,13964,Autocuration,,,1,Binding affinity at 5-hydroxytryptamine 2A receptor,,,CHEMBL617358,,107,,,,H,8,BAO_0000357,
2471,,16989,Expert,,,1,Binding affinity towards Serotonin 5-hydroxytryptamine 2A receptor,,,CHEMBL617359,,107,,,,H,8,BAO_0000357,
2472,,16117,Autocuration,,,1,In vitro binding affinity towards 5-hydroxytryptamine 2A receptor was determined,,,CHEMBL617360,,107,,,,H,8,BAO_0000357,
2473,,16700,Autocuration,,,1,The binding affinity towards 5-hydroxytryptamine 2A receptor; No affinity,,,CHEMBL875913,,107,,,,H,8,BAO_0000357,
2474,,3269,Autocuration,,,1,Affinity against 5-hydroxytryptamine 2A receptor,,,CHEMBL617361,,107,,,,H,8,BAO_0000357,
2475,,1274,Expert,9606.0,,1,Binding affinity against 5-Hydroxytryptamine 2A receptor,,,CHEMBL617362,,107,Homo sapiens,,,D,9,BAO_0000357,
2476,,1317,Autocuration,,,1,Compound was evaluated for binding affinity against 5-hydroxytryptamine 2A receptor using radioligand binding assay,,,CHEMBL617363,,107,,,,H,8,BAO_0000357,
2477,,12146,Autocuration,,,1,Tested against 5-hydroxytryptamine 2A receptor,,,CHEMBL617364,,107,,,,H,8,BAO_0000357,
2478,,12652,Autocuration,,,1,Binding affinity against the site labelled by the 5-hydroxytryptamine 2A receptor - 5-hydroxytryptamine 2C receptor antagonist [3H]- ketanserin,,,CHEMBL617365,,105075,,,,H,4,BAO_0000224,
2479,,12652,Autocuration,,,1,Tested for the binding affinity against the site labelled by the 5-hydroxytryptamine 2A receptor - 5-hydroxytryptamine 2C receptor antagonist [3H] ketanserin,,,CHEMBL617366,,105075,,,,H,4,BAO_0000224,
2480,,12652,Autocuration,,,1,Tested for the binding affinity against the site labelled by the 5-hydroxytryptamine 2A receptor - 5-hydroxytryptamine 2C receptor agonist [125I]- - (+/-)DOI,,,CHEMBL617367,,105075,,,,H,4,BAO_0000224,
2481,,12652,Autocuration,,,1,Tested for the binding affinity against the site labelled by the 5-hydroxytryptamine 2A receptor - 5-hydroxytryptamine 2C receptor antagonist [3H]- ketanserin,,,CHEMBL617368,,105075,,,,H,4,BAO_0000224,
2482,,16647,Autocuration,,,1,Selectivity ratio towards 5-hydroxytryptamine 2A receptor to Dopamine receptor D2 (5-HT2A/D2 ),,,CHEMBL617369,,107,,,,H,8,BAO_0000357,
2483,,15851,Expert,9606.0,,1,Displacement of [3H]ketanserin from human 5-hydroxytryptamine 2B receptor expressed in HEK293 cells; ND means no data,722.0,,CHEMBL617370,,227,Homo sapiens,HEK293,,D,9,BAO_0000219,
2484,,6857,Expert,9606.0,,1,Functional activity against human 5-hydroxytryptamine 2B receptor expressed in CHO cells using fluorometric imaging plate reader,449.0,,CHEMBL617371,,227,Homo sapiens,CHO,,D,9,BAO_0000219,
2485,,3805,Autocuration,,,1,In vitro binding affinity against human 5-HT2B receptor at a concentration of 100 (nM),,,CHEMBL617372,,227,,,,H,8,BAO_0000357,
2486,,6491,Expert,9606.0,,1,Affinity towards human 5-hydroxytryptamine 2B serotonin receptor,,,CHEMBL617373,,227,Homo sapiens,,,D,9,BAO_0000357,
2487,,14093,Autocuration,,,1,Agonist activity at cloned human 5-hydroxytryptamine 2B receptor using [3H]5-HT radioligand,,,CHEMBL617374,,227,,,,H,8,BAO_0000019,
2488,,13481,Autocuration,,,1,Agonistic activity at cloned human 5-hydroxytryptamine 2B receptor using [3H]-5-HT as radioligand,,,CHEMBL617375,,227,,,,H,8,BAO_0000019,
2489,,14093,Autocuration,,,1,Antagonist activity at cloned human 5-hydroxytryptamine 2B receptor using [3H]- rauwolscine radioligand,,,CHEMBL617376,,227,,,,H,8,BAO_0000019,
2490,,14093,Autocuration,,,1,Antagonist activity at cloned human 5-hydroxytryptamine 2B receptor using [3H]- rauwolscine radioligand; Not tested,,,CHEMBL617377,,227,,,,H,8,BAO_0000019,
2491,,14093,Autocuration,,,1,Antagonist activity at cloned human 5-hydroxytryptamine 2B receptor using [3H]rauwolscine radioligand,,,CHEMBL617378,,227,,,,H,8,BAO_0000019,
2492,,13481,Autocuration,,,1,Antagonistic activity at cloned human 5-hydroxytryptamine 2B receptor using [3H]rauwolscine as radioligand,,,CHEMBL617379,,227,,,,H,8,BAO_0000019,
2493,,14442,Autocuration,,,1,Binding ability of compound at cloned human 5-hydroxytryptamine 2B receptor using [3H]- rauwolscine as radioligand,,,CHEMBL617380,,227,,,,H,8,BAO_0000357,
2494,,14442,Autocuration,,,1,Binding ability of compound at cloned human 5-hydroxytryptamine 2B receptor using [3H]5-HT 2B as radioligand,,,CHEMBL617381,,227,,,,H,8,BAO_0000357,
2495,,14442,Autocuration,,,1,Binding ability of compound at cloned human 5-hydroxytryptamine 2B receptor using [3H]rauwolscine as radioligand,,,CHEMBL617382,,227,,,,H,8,BAO_0000357,
2496,,12369,Autocuration,,,1,The compound evaluated for its affinity against 5-hydroxytryptamine 2A receptor,,,CHEMBL617383,,107,,,,H,8,BAO_0000357,
2497,,12369,Expert,,,1,Affinity against 5-hydroxytryptamine 2A receptor (D) labeled with [125I]DOI.,,,CHEMBL617384,,107,,,,H,8,BAO_0000357,
2498,,12369,Expert,,,1,Affinity against 5-hydroxytryptamine 2A receptor (K) labeled with [3H]ketanserin.,,,CHEMBL617385,,107,,,,H,8,BAO_0000357,
2499,,14447,Autocuration,,,1,The compound was tested for CNS binding affinity towards 5-hydroxytryptamine 2A receptor from cloned Human membranes,,,CHEMBL617386,,107,,,,H,8,BAO_0000019,
2500,,14447,Autocuration,,,1,The compound was tested for CNS binding affinity towards 5-hydroxytryptamine 2A receptor from cloned Human membranes.,,,CHEMBL617387,,107,,,,H,8,BAO_0000019,
2501,,17451,Autocuration,,,1,Binding constant towards serotonin receptor subtype 5-hydroxytryptamine 2A receptor expressed in 3T3 cells using [3H]5-HT as radioligand; Not determined,723.0,,CHEMBL617388,,107,,NIH3T3,,H,8,BAO_0000219,
2502,,6857,Autocuration,,,1,Relative efficacy against human 5-hydroxytryptamine 2A receptor expressed in CHO cells using fluorometric imaging plate reader relative to 10 uM 5-HT,449.0,,CHEMBL617389,,107,,CHO,,H,8,BAO_0000219,
2503,,6857,Expert,9606.0,,1,Relative efficacy against human 5-hydroxytryptamine 2A receptor expressed in CHO cells using fluorometric imaging plate reader relative to 10 uM 5-HT,449.0,,CHEMBL617390,,107,Homo sapiens,CHO,,D,9,BAO_0000219,
2504,,5635,Autocuration,,,1,Selectivity ratio of binding affinity of 5-hydroxytryptamine 2A receptor to that of 5-hydroxytryptamine 2C receptor.,,,CHEMBL617391,,104817,,,,H,4,BAO_0000224,
2505,,12861,Autocuration,,,1,Binding activity radioligand.,,,CHEMBL617392,,107,,,,H,8,BAO_0000357,
2506,,12861,Autocuration,,,1,Binding activity against 5-hydroxytryptamine 2C receptor from human brain cortex using [3H]mesulergine as radioligand.,,,CHEMBL617393,,107,,,,H,8,BAO_0000019,
2507,,5105,Autocuration,,,1,Binding affinity for human cloned 5-HT2A receptor expressed in L929 cells using [125I]R91150 as radioligand,307.0,,CHEMBL617394,,107,,L929,,H,8,BAO_0000219,
2508,,5104,Expert,,,1,Binding affinity for human cloned 5-hydroxytryptamine 2A receptor expressed in L929 cells using [125I]R91150 as radioligand,307.0,,CHEMBL617395,,107,,L929,,H,8,BAO_0000219,
2509,,5105,Expert,,,1,Binding affinity at human cloned 5-hydroxytryptamine 2A receptor expressed in L929 cells by [125I]R91150 displacement.,307.0,,CHEMBL617396,,107,,L929,,H,8,BAO_0000219,
2510,,5105,Autocuration,,,1,Binding affinity for human cloned 5-hydroxytryptamine 2A receptor expressed in L929 cells using [125I]R91150 as radioligand; Not tested,307.0,,CHEMBL617397,,107,,L929,,H,8,BAO_0000219,
2511,,5254,Autocuration,,,1,Binding affinity against 5-HT2A receptor,,,CHEMBL617398,,107,,,,H,8,BAO_0000357,
2512,,5254,Autocuration,,,1,Binding affinity against 5-hydroxytryptamine 2A receptor,,,CHEMBL617399,,107,,,,H,8,BAO_0000357,
2513,,13267,Autocuration,,,1,Antagonistic binding affinity measured against 5-hydroxytryptamine 2A receptor (human clone expressed in 293 cells) using [3H]ketanserin as radioligand,722.0,,CHEMBL617400,,107,,HEK293,,H,8,BAO_0000219,
2514,,13267,Autocuration,,,1,Antagonistic binding affinity measured against 5-hydroxytryptamine 2C receptor (human clone expressed in 293 cells) using [3H]mesulergine as radioligand,722.0,,CHEMBL617401,,107,,HEK293,,H,8,BAO_0000219,
2515,,14157,Expert,9606.0,,1,Displacement of [3H]ketanserin from 5-hydroxytryptamine 2A receptor expressed in HEK 293 cells,722.0,,CHEMBL617402,,107,Homo sapiens,HEK293,,D,9,BAO_0000219,
2516,,12936,Expert,9606.0,,1,Binding affinity against human 5-hydroxytryptamine 2A receptor expressed in 293 cells using [3H]ketanserin,722.0,,CHEMBL617403,,107,Homo sapiens,HEK293,,D,9,BAO_0000219,
2517,,14068,Expert,,,1,Binding affinity against human 5-hydroxytryptamine 2A receptor using displacement of [3H]5-HT,,,CHEMBL617404,,107,,,,H,8,BAO_0000357,
2518,,12936,Expert,9606.0,,1,Binding affinity against human 5-hydroxytryptamine 2A receptor expressed in 293 cells using [3H]ketanserin,722.0,,CHEMBL857981,,107,Homo sapiens,HEK293,,D,9,BAO_0000219,
2519,,12936,Expert,9606.0,,1,Binding affinity against human 5-hydroxytryptamine 2A receptor expressed in 293 cells using [3H]ketanserin,722.0,,CHEMBL617405,,107,Homo sapiens,HEK293,,D,9,BAO_0000219,
2520,,4540,Expert,9606.0,,1,Binding affinity to human cloned 5-hydroxytryptamine 2A receptor in HEK 293 cells using [3H]- ketanserin as radioligand,722.0,,CHEMBL617253,,107,Homo sapiens,HEK293,,D,9,BAO_0000219,
2521,,6166,Expert,,,1,Binding affinity at human cloned 5-hydroxytryptamine 2A receptor.,,,CHEMBL617254,,107,,,,H,8,BAO_0000357,
2522,,17296,Autocuration,,,1,Binding affinity against 5-hydroxytryptamine 2A receptor human cloned receptors in HEK 293 cells using [3H]ketanserin as radioligand,722.0,,CHEMBL617255,,107,,HEK293,,H,8,BAO_0000219,
2523,,17296,Autocuration,,,1,Binding affinity against 5-hydroxytryptamine 2A receptor human cloned receptors in HEK 293 cells using [3H]ketanserin as radioligand,722.0,,CHEMBL617256,,107,,HEK293,,H,8,BAO_0000219,
2524,,17296,Autocuration,,,1,Binding affinity against 5-hydroxytryptamine 2A receptor human cloned receptorswithouteffect in HEK 293 cells using [3H]ketanserin as radioligand,722.0,,CHEMBL616874,,107,,HEK293,,H,8,BAO_0000219,
2525,,15779,Expert,9606.0,,1,Binding affinity towards 5-hydroxytryptamine 2A receptor (human cloned receptor) in HEK 293 cells using [3H]ketanserin as radioligand.,722.0,,CHEMBL616875,,107,Homo sapiens,HEK293,,D,9,BAO_0000219,
2526,,14391,Expert,,,1,Binding affinity towards human 5-hydroxytryptamine 2A receptor expressed in HEK 293 cells using [3H]ketanserin as radioligand,722.0,,CHEMBL616876,,107,,HEK293,,H,8,BAO_0000219,
2527,,15851,Expert,,,1,"Binding affinity towards human cloned 5-hydroxytryptamine receptor 2A in HEK293 cells, using [3H]ketanserin as radioligand.",722.0,,CHEMBL616877,,107,,HEK293,,H,8,BAO_0000219,
2528,,15851,Expert,9606.0,,1,Displacement of [3H]ketanserin from human 5-hydroxytryptamine 2A receptor expressed in HEK293 cells; compound is insoluble,722.0,,CHEMBL616878,,107,Homo sapiens,HEK293,,D,9,BAO_0000219,
2529,,3832,Expert,,,1,Binding affinity towards human cloned 5-hydroxytryptamine 2A receptor of HEK293 cells by displacement of [3H]ketanserin,722.0,,CHEMBL616879,,107,,HEK293,,H,8,BAO_0000219,
2530,,3833,Expert,,,1,In vitro binding affinity at human cloned 5-hydroxytryptamine 2A receptor of HEK293 cells by [3H]ketanserin displacement.,722.0,,CHEMBL616880,,107,,HEK293,,H,8,BAO_0000219,
2531,,12936,Expert,9606.0,,1,Binding affinity against human 5-hydroxytryptamine 2A receptor expressed in 293 cells using [3H]ketanserin,722.0,,CHEMBL616881,,107,Homo sapiens,HEK293,,D,9,BAO_0000219,
2532,,17451,Autocuration,,,1,Binding constant towards serotonin receptor subtype 5-hydroxytryptamine 2A receptor expressed in 3T3 cells using [3H]5-HT as radioligand,723.0,,CHEMBL616882,,107,,NIH3T3,,H,8,BAO_0000219,
2533,,17451,Autocuration,,,1,Binding constant towards serotonin receptor subtype 5-hydroxytryptamine 2A receptor expressed in 3T3 cells using [3H]5-HT as radioligand; Not determined,723.0,,CHEMBL616883,,107,,NIH3T3,,H,8,BAO_0000219,
2534,,17451,Autocuration,,,1,Binding constant towards serotonin receptor subtype 5-hydroxytryptamine 2A receptor expressed in 3T3 cells using [3H]5-HT as radioligand; Not determined,723.0,,CHEMBL616884,,107,,NIH3T3,,H,8,BAO_0000219,
2535,,4199,Autocuration,,,1,Compound was evaluated for binding affinity against human cloned 5-hydroxytryptamine 2A receptor in HEK 293 cells using [3H]ketanserin as the radioligand,722.0,,CHEMBL616885,,107,,HEK293,,H,8,BAO_0000219,
2536,,1883,Autocuration,,,1,Compound was evaluated for displacement of [3H]ketanserin from human cloned 5-hydroxytryptamine 2A receptor in transfected CHO-K1 cells,485.0,,CHEMBL616886,,107,,CHO-K1,,H,8,BAO_0000219,
2537,,1883,Expert,,,1,Displacement of [3H]-ketanserin from human cloned 5-hydroxytryptamine 2A receptor expressed in CHO-K1 cells.,485.0,,CHEMBL616887,,107,,CHO-K1,,H,8,BAO_0000219,
2538,,14875,Expert,9606.0,,1,Binding affinity for human 5-hydroxytryptamine 2A receptor,,,CHEMBL616888,,107,Homo sapiens,,,D,9,BAO_0000357,
2539,,15146,Autocuration,,,1,Compound was tested for its binding affinity against 5-hydroxytryptamine 2A receptor in human cloned receptors in HEK 293 cells using [3H]ketanserin,722.0,,CHEMBL616889,,107,,HEK293,,H,8,BAO_0000219,
2540,,5213,Autocuration,,,1,Compound was tested for its binding affinity for human cloned 5-hydroxytryptamine 2A receptor in HEK 293 using [3H]ketanserin as a radioligand,722.0,,CHEMBL616890,,107,,HEK293,,H,8,BAO_0000219,
2541,,16404,Expert,9606.0,,1,Inhibitory constant for human 5-hydroxytryptamine 2A receptor transfected in to CHO cells,449.0,,CHEMBL616891,,107,Homo sapiens,CHO,,D,9,BAO_0000219,
2542,,14818,Autocuration,,,1,The compound was tested for its binding affinity towards cloned human 5-hydroxytryptamine 2A receptor in HEK293 cells using [3H]-ketanserin.,722.0,,CHEMBL616892,,107,,HEK293,,H,8,BAO_0000219,
2543,,4829,Autocuration,,,1,"The compound was tested for the binding affinity towards human cloned 5-hydroxytryptamine 2A receptor in HEK293 cells, using [3H]ketanserin as radioligand",722.0,,CHEMBL616893,,107,,HEK293,,H,8,BAO_0000219,
2544,,12652,Autocuration,,,1,Percent of maximum stimulation of phosphatidylinositol turnover at cloned 5-hydroxytryptamine 2A receptor in 3T3 cells,723.0,,CHEMBL616894,,10620,,NIH3T3,,H,8,BAO_0000219,
2545,,4682,Expert,,,1,Displacement of [3H]ketanserin from 5-hydroxytryptamine 2A receptor expressed NIH3T3 cells,723.0,,CHEMBL616895,,107,,NIH3T3,,H,8,BAO_0000219,
2546,,12652,Autocuration,,,1,The maximum responses of [3H]- inositol monophosphate accumulation in cells expressing the 5-hydroxytryptamine 2A receptor,,,CHEMBL616896,,10620,,,,H,8,BAO_0000019,
2547,,4921,Autocuration,,,1,Ability to displace [3H]-Ketanserin radioligand from porcine 5-hydroxytryptamine 2A receptor,,,CHEMBL617099,,10621,,,,H,8,BAO_0000357,
2548,,4921,Autocuration,,,1,Ability to displace [3H]ketanserin radioligand from porcine 5-hydroxytryptamine 2A receptor; ND denotes not determined,,,CHEMBL617100,,10621,,,,H,8,BAO_0000357,
2549,,16312,Autocuration,9986.0,,1,Binding affinity against rabbit aorta 5-HT2A receptor,,,CHEMBL884532,,107,Oryctolagus cuniculus,,,H,8,BAO_0000357,
2550,,14998,Expert,9986.0,,1,Binding affinity for 5-hydroxytryptamine 2A receptor of rabbit aorta ring preparations,,,CHEMBL617101,,107,Oryctolagus cuniculus,,,H,8,BAO_0000357,
2551,,14025,Expert,9986.0,,1,Dissociation equilibrium constant against the vascular 5-hydroxytryptamine 2A receptor in the rabbit saphenous aorta,,,CHEMBL617102,,107,Oryctolagus cuniculus,,,H,8,BAO_0000357,
2552,,13047,Autocuration,9986.0,,1,Binding affinity against 5-hydroxytryptamine 1D receptor alpha using rabbit saphenous vein assay.,,,CHEMBL617103,,107,Oryctolagus cuniculus,,,H,8,BAO_0000019,
2553,,13047,Expert,9986.0,,1,The compound was tested for binding affinity against 5-HT2A receptor,,,CHEMBL617104,,107,Oryctolagus cuniculus,,,H,8,BAO_0000357,
2554,,1883,Autocuration,,,1,Compound was evaluated for displacement of [3H]ketanserin from cloned rat 5-hydroxytryptamine 2A receptor in transfected CHO-K1 cells.,485.0,,CHEMBL857979,,10576,,CHO-K1,,H,8,BAO_0000219,
2555,,13463,Autocuration,,,1,Binding affinity analysed towards 5-HT 2A in rat jugular vein,,,CHEMBL857502,,12687,,,,H,8,BAO_0000019,
2556,,13463,Autocuration,,,1,Binding affinity analysed towards 5-HT 2A in rat jugular vein.,,,CHEMBL617105,,12687,,,,H,8,BAO_0000019,
2557,,13463,Autocuration,,,1,Binding affinity analysed on 5-HT 2A in rat stomach fundus.,,,CHEMBL858021,,12687,,,,H,8,BAO_0000019,945.0
2558,,13463,Expert,10116.0,,1,Binding affinity for 5-HT 2A in rat stomach fundus,,,CHEMBL875910,,12687,Rattus norvegicus,,,D,9,BAO_0000019,945.0
2559,,13463,Autocuration,,,1,Binding affinity analysed towards 5-HT 2A in rat jugular vein.,,,CHEMBL617106,,12687,,,,H,8,BAO_0000019,
2560,,16326,Expert,,,1,Ability to stimulate phosphoinositide hydrolysis in NIH3T3 cells expressing the 5-hydroxytryptamine 2A receptor,723.0,,CHEMBL617107,,12687,,NIH3T3,,H,8,BAO_0000219,
2561,,14093,Autocuration,,,1,Effect on phosphoinositide hydrolysis in NIH 3T3 fibroblast 5-hydroxytryptamine 2A receptor,,,CHEMBL617108,,12687,,,,H,8,BAO_0000019,
2562,,14093,Autocuration,,,1,Effect on phosphoinositide hydrolysis in NIH 3T3 fibroblast expressing 5-hydroxytryptamine 2A receptor,,,CHEMBL617109,,12687,,,,H,8,BAO_0000019,
2563,,15740,Autocuration,,,1,Evaluated for the effective concentration at [125I]-DOI-labeled rat 5-hydroxytryptamine 2A receptor,,,CHEMBL617110,,12687,,,,H,8,BAO_0000357,
2564,,16633,Autocuration,,,1,Functional potency at the rat 5-hydroxytryptamine 2A receptor as effective concentration EC50 for stimulating Phosphoinositide accumulation,,,CHEMBL617111,,12687,,,,H,8,BAO_0000357,
2565,,17200,Expert,10116.0,,1,In vitro relative agonist activity against 5-hydroxytryptamine 2A using PI assay in rat vascular smooth muscle cells,,,CHEMBL617112,,12687,Rattus norvegicus,,,D,9,BAO_0000019,
2566,,17133,Autocuration,,,1,Tested for its ability to activate phospholipase C by quantification of IP3 at cloned rat 5-hydroxytryptamine 2A receptor,,,CHEMBL617113,,12687,,,,H,8,BAO_0000357,
2567,,17133,Autocuration,,,1,Tested for its ability to activate phospholipase C by quantification of IP3 at cloned rat 5-hydroxytryptamine 2A receptor,,,CHEMBL617114,,12687,,,,H,8,BAO_0000357,
2568,,17133,Autocuration,,,1,Tested for its ability to activate phospholipase c by quantification of IP3 at cloned rat 5-hydroxytryptamine 2A receptor,,,CHEMBL617115,,12687,,,,H,8,BAO_0000357,
2569,,17200,Autocuration,,,1,The receptor (5-hydroxytryptamine 2A ) mediated mobilization of intracellular calcium [Ca2+] was studied in rat smooth muscle cells,,,CHEMBL617116,,12687,,,,H,8,BAO_0000219,
2570,,15363,Autocuration,,,1,Efficacy at 5-hydroxytryptamine 2A receptor,,,CHEMBL617117,,12687,,,,H,8,BAO_0000019,
2571,,17200,Autocuration,,,1,In vitro efficacy against rat 5-hydroxytryptamine 2A receptor was determined by using CA+ assay (Emax),,,CHEMBL617118,,12687,,,,H,8,BAO_0000357,
2572,,17200,Expert,10116.0,,1,In vitro efficacy against rat 5-hydroxytryptamine 2A receptor was determined by using CA+ assay (Emax),,,CHEMBL617119,,12687,Rattus norvegicus,,,D,9,BAO_0000357,
2573,,17200,Expert,10116.0,,1,In vitro efficacy against rat 5-hydroxytryptamine 2A receptor determined by using PI assay (Emax),,,CHEMBL617120,,12687,Rattus norvegicus,,,D,9,BAO_0000357,
2574,,17200,Expert,10116.0,,1,The receptor (5-hydroxytryptamine 2A ) mediated mobilization of intracellular calcium [Ca2+] was studied in rat smooth muscle cells,,,CHEMBL617121,,12687,Rattus norvegicus,,,D,9,BAO_0000219,
2575,,17200,Autocuration,,,1,The receptor (5-hydroxytryptamine 2A) mediated mobilization of intracellular calcium [Ca2+] was studied in rat smooth muscle cells,,,CHEMBL617122,,12687,,,,H,8,BAO_0000219,
2576,,17211,Autocuration,,,1,Ability to displace [3H]ketanserin (0.5 nM) from cerebral cortex of rat 5-hydroxytryptamine 2A receptor,,,CHEMBL617123,,12687,,,,H,8,BAO_0000019,
2577,,17331,Expert,,,1,Binding affinity against 5-hydroxytryptamine 2A receptor by displacement of [3H]-ketanserin from rat prefrontal cerebral cortex mambranes,,,CHEMBL617124,,12687,,,,H,8,BAO_0000019,
2578,,13565,Expert,,,1,Binding affinity to serotonin 5-hydroxytryptamine 2A receptors using a radioligand [3H]ketanserin binding assay in rat cortical membranes,,,CHEMBL617600,,12687,,,,H,8,BAO_0000249,
2579,,13730,Expert,,,1,Binding affinity towards rat 5-hydroxytryptamine 2A receptor was evaluated using [3H]- ketanserin as radioligand,,,CHEMBL617601,,12687,,,,H,8,BAO_0000357,
2580,,12416,Expert,,,1,In vitro affinity towards 5-hydroxytryptamine 2A receptor using [3H]spiroperidol as radioligand in cortex,,,CHEMBL882923,,12687,,,,H,8,BAO_0000019,
2581,,15295,Autocuration,,,1,Compound was tested for it's binding affinity towards 5-hydroxytryptamine 2A receptor,,,CHEMBL617602,,12687,,,,H,8,BAO_0000357,
2582,,1742,Autocuration,,,1,Compound was tested for its ability to displace [3H]DOB from 5-hydroxytryptamine 2A receptor in rat cortex homogenates,,,CHEMBL617603,,12687,,,,H,8,BAO_0000019,
2583,,15295,Autocuration,,,1,Compound was tested for the inhibition of [3H]ketanserin binding to 5-hydroxytryptamine 2A receptor,,,CHEMBL617604,,12687,,,,H,8,BAO_0000357,
2584,,14970,Expert,,,1,Binding affinity towards 5-hydroxytryptamine 2A receptor from rat frontal cortex using [3H]ketanserin as radioligand,,,CHEMBL617605,,12687,,,,H,8,BAO_0000019,
2585,,16693,Expert,,,1,In vitro binding affinity for serotonin 5-hydroxytryptamine 2A receptor of rat cerebral cortex using [3H]ketanserin as radioligand,,,CHEMBL617606,,12687,,,,H,8,BAO_0000019,
2586,,14776,Expert,10116.0,,1,Inhibition of [3H]ketanserin binding to rat frontal cortex membrane 5-hydroxytryptamine 2A receptor,,,CHEMBL617607,,12687,Rattus norvegicus,,,D,9,BAO_0000019,
2587,,14286,Autocuration,,,1,In vitro inhibitory concentration against radioligand [3H]ketanserin binding to 5-hydroxytryptamine 2A receptor in rat cortical membrane,,,CHEMBL617455,,12687,,,,H,8,BAO_0000249,
2588,,17200,Expert,10116.0,,1,In vitro inhibition of [125I]DOI binding to 5-hydroxytryptamine 2A receptor in rat cerebral cortex,,,CHEMBL617456,,12687,Rattus norvegicus,,,D,9,BAO_0000019,
2589,,15306,Expert,,,1,Inhibitory concentration against 5-hydroxytryptamine 2A receptor (Inactive at >1000 nM concentration),,,CHEMBL617457,,12687,,,,H,8,BAO_0000357,
2590,,14178,Expert,10116.0,,1,Inhibition of radiolabeled [3H]-Ketanserin ligand binding to 5-hydroxytryptamine 2A receptor,,,CHEMBL617458,,12687,Rattus norvegicus,,,D,9,BAO_0000357,
2591,,14229,Expert,10116.0,,1,Inhibition of [3H]ketanserin binding to 5-hydroxytryptamine 2A receptor from rat brain,,,CHEMBL617459,,12687,Rattus norvegicus,,,D,9,BAO_0000019,
2592,,12884,Expert,,,1,Binding affinity towards 5-hydroxytryptamine 2A receptor binding site using [3H]ketanserin. ,,,CHEMBL617460,,12687,,,,H,8,BAO_0000357,
2593,,13149,Expert,,,1,"Binding affinity for 5-hydroxytryptamine 2A receptor, activity is expressed as IC50 values.",,,CHEMBL617461,,12687,,,,H,8,BAO_0000357,
2594,,15295,Expert,10116.0,,1,Displacement of [3H]ketanserin from rat cortical membrane 5-hydroxytryptamine 2A receptor at 10e-7 M,,,CHEMBL617462,,12687,Rattus norvegicus,,,D,9,BAO_0000019,
2595,,15740,Autocuration,,,1,Intrinsic activity was determined at 5-hydroxytryptamine 2A receptor which is percentage response given compared with the response produced by 10 uM serotonin.,,,CHEMBL617463,,12687,,,,H,8,BAO_0000357,
2596,,15185,Autocuration,,,1,"Compound was tested for binding affinity at 5-hydroxytryptamine 2A receptor sites in rat cortical homogenate using [125I]-2,5-Dimethoxy -4-iodoamphetamine (DOI).",,,CHEMBL617464,,12687,,,,H,8,BAO_0000019,
2597,,15185,Autocuration,,,1,"Compound was tested for binding affinity using [3H]MDL-100,907 at 5-hydroxytryptamine 2A receptor sites in rat cortical homogenate.",,,CHEMBL617465,,12687,,,,H,8,BAO_0000019,
2598,,17529,Expert,,,1,Ability to bind to central serotonin 5-hydroxytryptamine 2A receptor in vitro in cortex of the rat brain using [3H]ketanserin radioligand,,,CHEMBL617466,,12687,,,,H,8,BAO_0000019,
2599,,14826,Autocuration,,,1,Ability to displace [3H]- ketanserin bound to 5-hydroxytryptamine 2A receptor in rat pre-frontal cortex,,,CHEMBL617467,,12687,,,,H,8,BAO_0000019,
2600,,17211,Expert,,,1,Displacement of [3H]ketanserin (0.5 nM) from rat cerebral cortex 5-hydroxytryptamine 2A receptors,,,CHEMBL617468,,12687,,,,H,8,BAO_0000019,
2601,,14826,Autocuration,,,1,Ability to displace [3H]ketanserin bound to 5-hydroxytryptamine 2A receptor in rat pre-frontal cortex,,,CHEMBL617469,,12687,,,,H,8,BAO_0000019,
2602,,14093,Autocuration,,,1,Ability to displace [3H]ketanserin from rat cortical homogenate 5-hydroxytryptamine 2A receptor,,,CHEMBL617470,,12687,,,,H,8,BAO_0000019,
2603,,14093,Autocuration,,,1,Ability to displace [3H]ketanserin from rat cortical homogenate 5-hydroxytryptamine 2A receptor; Not tested,,,CHEMBL617471,,12687,,,,H,8,BAO_0000019,
2604,,13246,Expert,,,1,Ability to inhibit the binding of iodine-125-labelled lysergic acid diethylamide([125I]-LSD) to the S-2A serotonin receptor in NIH3T3 cell line membranes,723.0,,CHEMBL617472,,12687,,NIH3T3,,H,8,BAO_0000219,
2605,,13246,Expert,,,1,Ability to inhibit the binding of iodine-125-labelled lysergic acid diethylamide([125I]-LSD) to the S-2A serotonin receptor.,,,CHEMBL617473,,12687,,,,H,8,BAO_0000357,
2606,,15436,Expert,10116.0,,1,Affinity 5-hydroxytryptamine 2A receptor of the rat brain cortex was assessed on the basis of their ability to displace [3H]ketanserin,,,CHEMBL617474,,12687,Rattus norvegicus,,,D,9,BAO_0000019,
2607,,15436,Expert,10116.0,,1,Affinity at 5-hydroxytryptamine 2A receptor of the rat brain cortex was assessed on the basis of their ability to displace [3H]ketanserin,,,CHEMBL617475,,12687,Rattus norvegicus,,,D,9,BAO_0000019,
2608,,14442,Autocuration,,,1,Affinity at [3H]ketanserin-labeled 5-hydroxytryptamine 2A receptor in rat brain homogenate was determined,,,CHEMBL617476,,12687,,,,H,8,BAO_0000221,955.0
2609,,12457,Expert,,,1,Affinity was evaluated as inhibition constant for serotonin 5-hydroxytryptamine 2A receptor,,,CHEMBL617477,,12687,,,,H,8,BAO_0000357,
2610,,12457,Expert,,,1,Affinity was evaluated by inhibition of [125I]LSD binding to NIH 3T3 cells transfected with cloned rat 5-hydroxytryptamine 2A receptor,723.0,,CHEMBL617478,,12687,,NIH3T3,,H,8,BAO_0000219,
2611,,14755,Autocuration,,,1,"Antagonistic activity measured for 5-hydroxytryptamine 2A receptor using [3H]-MDL- 100,907 as radioligand in rat cortical homogenates.",,,CHEMBL617479,,12687,,,,H,8,BAO_0000221,
2612,,4707,Autocuration,,,1,Binding affinity towards rat 5-hydroxytryptamine 2A receptor was determined using [125I]- DOI as radioligand,,,CHEMBL617480,,12687,,,,H,8,BAO_0000357,
2613,,13297,Expert,,,1,Binding affinity against 5-hydroxytryptamine 2A receptor,,,CHEMBL617481,,12687,,,,H,8,BAO_0000357,
2614,,17331,Expert,,,1,Binding affinity against 5-hydroxytryptamine 2A receptor by displacement of [3H]ketanserin from rat prefrontal cerebral cortex mambranes,,,CHEMBL617482,,12687,,,,H,8,BAO_0000019,
2615,,4664,Autocuration,,,1,Binding affinity against 5-hydroxytryptamine 2A receptor from rat forebrain using [3H]ketanserin as radioligand,,,CHEMBL617483,,12687,,,,H,8,BAO_0000019,
2616,,16633,Autocuration,,,1,Binding affinity against 5-hydroxytryptamine 2A receptor using [125I]DOI as radioligand,,,CHEMBL621528,,12687,,,,H,8,BAO_0000357,
2617,,4664,Expert,10116.0,,1,Binding affinity against 5-hydroxytryptamine 2A receptor expressed NIH3T3 cells using [3H]ketanserin,723.0,,CHEMBL621529,,12687,Rattus norvegicus,NIH3T3,,D,9,BAO_0000219,
2618,,16133,Expert,,,1,Binding affinity against rat 5-hydroxytryptamine 2A receptor using [3H]DOB as radioligand,,,CHEMBL621530,,12687,,,,H,8,BAO_0000357,
2619,,16133,Expert,,,1,Binding affinity against rat 5-hydroxytryptamine 2A receptor using [3H]ketanserin as radioligand,,,CHEMBL621531,,12687,,,,H,8,BAO_0000357,
2620,,14060,Expert,10116.0,,1,Binding affinity against rat brain 5-hydroxytryptamine 2A receptor,,,CHEMBL621532,,12687,Rattus norvegicus,,,D,9,BAO_0000019,
2621,,16326,Expert,,,1,Binding affinity at cloned rat 5-hydroxytryptamine 2A receptor using [3H]DOB as radioligand,,,CHEMBL621533,,12687,,,,H,8,BAO_0000357,
2622,,16659,Expert,,,1,Binding affinity for displacement of [3H]ketanserin to rat 5-hydroxytryptamine 2A receptor stably expressed in CHO cells,449.0,,CHEMBL621534,,12687,,CHO,,H,8,BAO_0000219,
2623,,14776,Autocuration,,,1,Binding affinity measured at the 5-hydroxytryptamine 2A receptor by the inhibition of [3H]ketanserin binding to rat cortex using unlabeled mianserin for nonspecific binding.,,,CHEMBL621535,,12687,,,,H,8,BAO_0000019,
2624,,13481,Autocuration,,,1,Binding affinity of [3H]- ketanserin labelled towards Rat cortical 5-hydroxytryptamine 2A receptor using radioligand binding assay,,,CHEMBL621536,,12687,,,,H,8,BAO_0000357,
2625,,17386,Autocuration,,,1,Binding affinity of compound was tested for 5-hydroxytryptamine 2A receptor,,,CHEMBL621537,,12687,,,,H,8,BAO_0000357,
2626,,6611,Expert,10116.0,,1,Binding affinity for 5-hydroxytryptamine 2A receptor,,,CHEMBL621538,,12687,Rattus norvegicus,,,D,9,BAO_0000357,
2627,,14423,Autocuration,,,1,Binding affinity against 5-hydroxytryptamine 2A receptor from rat cortex using [3H]ketanserin as the radioligand.,,,CHEMBL621539,,12687,,,,H,8,BAO_0000019,
2628,,15412,Autocuration,,,1,Binding affinity against 5-hydroxytryptamine 2A receptor of rat pre-frontal cortex,,,CHEMBL621540,,12687,,,,H,8,BAO_0000019,
2629,,15412,Autocuration,,,1,Binding affinity against 5-hydroxytryptamine 2A receptor of rat pre-frontal cortex.,,,CHEMBL621541,,12687,,,,H,8,BAO_0000019,
2630,,6238,Autocuration,,,1,Binding affinity towards 5-HT 2A receptor in rat cerebral frontal cortex membranes using [3H]ketanserin as radioligand,,,CHEMBL621542,,12687,,,,H,8,BAO_0000019,
2631,,6648,Expert,,,1,Binding affinity at 5-hydroxytryptamine 2A receptor of rat.,,,CHEMBL621543,,12687,,,,H,8,BAO_0000357,
2632,,5667,Expert,,,1,Binding affinity towards 5-hydroxytryptamine 2A receptor sites by using [3H]ketanserin as radioligand,,,CHEMBL621544,,12687,,,,H,8,BAO_0000357,
2633,,6611,Expert,10116.0,,1,Binding affinity for 5-hydroxytryptamine 2A serotonin receptor,,,CHEMBL621545,,12687,Rattus norvegicus,,,D,9,BAO_0000357,
2634,,13481,Autocuration,,,1,Binding affinity towards rat cortical 5-hydroxytryptamine 2A receptor using [3H]ketanserin as radioligand,,,CHEMBL621546,,12687,,,,H,8,BAO_0000357,
2635,,13481,Autocuration,,,1,Binding affinity towards rat cortical 5-hydroxytryptamine 2A receptor using [3H]ketanserin as radioligand; Not tested,,,CHEMBL621547,,12687,,,,H,8,BAO_0000357,
2636,,15558,Expert,,,1,Displacement of [3H]ketanserin from NIH3T3 cells stably expressing rat 5-hydroxytryptamine 2A receptor,723.0,,CHEMBL618692,,12687,,NIH3T3,,H,8,BAO_0000219,
2637,,6013,Autocuration,,,1,Binding affinity towards 5-hydroxytryptamine 2A receptor,,,CHEMBL618693,,12687,,,,H,8,BAO_0000357,
2638,,16633,Autocuration,,,1,Binding affinity towards 5-hydroxytryptamine 2A receptor using [125I]DOI as radioligand,,,CHEMBL872922,,12687,,,,H,8,BAO_0000357,
2639,,6013,Autocuration,,,1,Binding affinity towards cloned rat 5-hydroxytryptamine 2A receptor from fundus tissue was determined using [3H]mesulergine as radioligand,,,CHEMBL618694,,12687,,,,H,8,BAO_0000357,
2640,,6013,Expert,10116.0,,1,Binding affinity for rat 5-hydroxytryptamine 2A receptor using [3H]DOB,,,CHEMBL618695,,12687,Rattus norvegicus,,,D,9,BAO_0000357,
2641,,6013,Autocuration,,,1,Binding affinity towards cloned rat 5-hydroxytryptamine 2A receptor was determined using [3H]DOB as radioligand; ND=No data,,,CHEMBL618696,,12687,,,,H,8,BAO_0000357,
2642,,6013,Expert,,,1,Binding affinity towards cloned rat 5-hydroxytryptamine 2A receptor by [3H]ketanserin displacement.,,,CHEMBL618697,,12687,,,,H,8,BAO_0000357,
2643,,6013,Autocuration,,,1,Binding affinity towards cloned rat Inhibition of binding towards 5-hydroxytryptamine 2A receptor at 100 nM concentration was determined using [3H]DOB as radioligand,,,CHEMBL618892,,12687,,,,H,8,BAO_0000357,
2644,,6013,Autocuration,,,1,Binding affinity towards cloned rat Inhibition of binding towards 5-hydroxytryptamine 2A receptor at 100 nM concentration was determined using [3H]ketanserin as radioligand,,,CHEMBL618893,,12687,,,,H,8,BAO_0000357,
2645,,16293,Autocuration,,,1,Binding affinity towards rat 5-hydroxytryptamine 2A receptor,,,CHEMBL618894,,12687,,,,H,8,BAO_0000357,
2646,,17175,Expert,,,1,Binding affinity towards rat 5-hydroxytryptamine 2A receptor expressed in NIH3T3 cells using [3H]ketanserin as radioligand,723.0,,CHEMBL618895,,12687,,NIH3T3,,H,8,BAO_0000219,
2647,,13278,Expert,10116.0,,1,Binding affinity was measured against 5-hydroxytryptamine 2A receptor by displacement of [3H]- ketanserin by lysergic acid amides,,,CHEMBL618896,,12687,Rattus norvegicus,,,D,9,BAO_0000357,
2648,,3682,Autocuration,,,1,Compound was evaluated for affinity towards cerebral 5-hydroxytryptamine 2A receptor in homogenate of caudate putamen tissue from rat brain,,,CHEMBL618897,,12687,,,,H,8,BAO_0000019,5383.0
2649,,2014,Autocuration,,,1,Compound was evaluated for binding affinity against 5-hydroxytryptamine 2A receptor using [3H]ketanserin as a radioligand,,,CHEMBL618898,,12687,,,,H,8,BAO_0000357,
2650,,2014,Autocuration,,,1,Compound was evaluated for binding affinity against 5-hydroxytryptamine 2A receptor using [3H]ketanserin as a radioligand; Not determined,,,CHEMBL618899,,12687,,,,H,8,BAO_0000357,
2651,,4932,Autocuration,,,1,Compound was evaluated for its ability to displace (+/-)[125I]-DOI from 5-hydroxytryptamine 2A receptor in cloned rat cell culture,,,CHEMBL618900,,12687,,,,H,8,BAO_0000357,
2652,,4932,Autocuration,,,1,Compound was evaluated for its ability to displace [125I](R)-DOI from 5-hydroxytryptamine 2A receptor in cloned rat prefrontal cortex homogenate,,,CHEMBL618901,,12687,,,,H,8,BAO_0000019,
2653,,3935,Autocuration,,,1,Compound was evaluated for its binding affinity for rat 5-hydroxytryptamine 2A receptor,,,CHEMBL618902,,12687,,,,H,8,BAO_0000357,
2654,,5432,Expert,10116.0,,1,Displacement of [3H]8-OH-DPAT from rat hippocampus membrane 5-hydroxytryptamine 2A receptor,,,CHEMBL618903,,12687,Rattus norvegicus,,,D,9,BAO_0000221,10000000.0
2655,,15818,Autocuration,,,1,Compound was evaluated for its binding affinity towards rat 5-hydroxytryptamine 2A receptor,,,CHEMBL618904,,12687,,,,H,8,BAO_0000357,
2656,,13672,Autocuration,,,1,Compound was evaluated for the binding affinity towards 5-hydroxytryptamine 2A receptor using [3H]ketanserin radioligand.,,,CHEMBL618905,,12687,,,,H,8,BAO_0000357,
2657,,13672,Autocuration,,,1,Compound was evaluated for the binding affinity towards 5-hydroxytryptamine 2A receptor using [3H]-ketanserin radioligand.,,,CHEMBL618906,,12687,,,,H,8,BAO_0000357,
2658,,14749,Expert,,,1,Binding affinity against rat 5-hydroxytryptamine 2A receptor in NIH3T3 cells.,723.0,,CHEMBL618907,,12687,,NIH3T3,,H,8,BAO_0000219,
2659,,13462,Autocuration,,,1,Compound was tested for the Binding affinity against rat frontal cortex 5-hydroxytryptamine 2A receptor by Radio ligand [3H]ketanserin binding assay.,,,CHEMBL618908,,12687,,,,H,8,BAO_0000019,
2660,,15740,Autocuration,,,1,Evaluated for the binding constant at [125I]-DOI-labeled rat 5-hydroxytryptamine 2A receptor,,,CHEMBL617909,,12687,,,,H,8,BAO_0000357,
2661,,16647,Expert,,,1,Half-maximal inhibition of [3H]ketanserin binding to 5-hydroxytryptamine 2A receptor in rat cerebral cortex homogenate,,,CHEMBL617910,,12687,,,,H,8,BAO_0000019,
2662,,13345,Autocuration,,,1,In vitro ability to displace [3H]ketanserin from 5-hydroxytryptamine 2A receptor in rat brain.,,,CHEMBL617911,,12687,,,,H,8,BAO_0000221,955.0
2663,,16740,Autocuration,,,1,In vitro binding affinity at 5-hydroxytryptamine 2A receptor in rat cortical membrane,,,CHEMBL872923,,12687,,,,H,8,BAO_0000249,
2664,,16740,Autocuration,,,1,In vitro binding affinity at 5-hydroxytryptamine 2A receptor in rat cortical membrane,,,CHEMBL617912,,12687,,,,H,8,BAO_0000249,
2665,,15535,Expert,10116.0,,1,In vitro binding affinity at 5-hydroxytryptamine 2A receptor by displacement of [3H]ketanserin from rat cortex,,,CHEMBL617913,,12687,Rattus norvegicus,,,D,9,BAO_0000019,
2666,,16740,Expert,,,1,In vitro binding affinity at 5-hydroxytryptamine 2A receptor in rat cortical membrane,,,CHEMBL617914,,12687,,,,H,8,BAO_0000249,
2667,,16740,Autocuration,,,1,In vitro binding affinity at 5-hydroxytryptamine 2A receptor in rat cortical membrane,,,CHEMBL617915,,12687,,,,H,8,BAO_0000249,
2668,,16740,Autocuration,,,1,In vitro binding affinity at serotonin 5-hydroxytryptamine 2A receptor in rat cortical membrane,,,CHEMBL617916,,12687,,,,H,8,BAO_0000249,
2669,,4795,Expert,10116.0,,1,Displacement of [3H]- Ketanserin from rat cortex 5-hydroxytryptamine 2A receptor,,,CHEMBL617917,,12687,Rattus norvegicus,,,D,9,BAO_0000019,
2670,,8,Expert,,,1,In vitro binding affinity towards 5-hydroxytryptamine 2A receptor in rat tissue homogenate using [3H]ketanserin as radioligand,,,CHEMBL617918,,12687,,,,H,8,BAO_0000019,
2671,,8,Autocuration,,,1,In vitro binding affinity towards 5-hydroxytryptamine 2A receptor in rat tissue homogenate using [3H]ketanserin as radioligand; Not active at 10-5 M,,,CHEMBL617919,,12687,,,,H,8,BAO_0000019,
2672,,17200,Expert,10116.0,,1,In vitro inhibitory constant against [125I]DOI binding to 5-hydroxytryptamine 2A receptor in rat cerebral cortex,,,CHEMBL617920,,12687,Rattus norvegicus,,,D,9,BAO_0000019,
2673,,2148,Expert,10116.0,,1,Displacement of [3H]ketanserin from 5-hydroxytryptamine 2A receptor of rat brain cortex,,,CHEMBL617921,,12687,Rattus norvegicus,,,D,9,BAO_0000019,
2674,,13345,Expert,10116.0,,1,"Relative binding affinity for D2 receptor and 5-hydroxytryptamine 2A receptor, ratio of Ki",,,CHEMBL617922,,105102,Rattus norvegicus,,,D,5,BAO_0000224,
2675,,5088,Autocuration,,,1,Tested for binding affinity towards rat 5-hydroxytryptamine 2A receptor using [3H]DOB as radioligand,,,CHEMBL617923,,12687,,,,H,8,BAO_0000357,
2676,,5088,Autocuration,,,1,Tested for binding affinity towards rat 5-hydroxytryptamine 2A receptor using [3H]ketanserin as radioligand,,,CHEMBL617924,,12687,,,,H,8,BAO_0000357,
2677,,17133,Autocuration,,,1,Tested in vitro for its ability to bind to 5-hydroxytryptamine 2A receptor using [125 I]-DOI as radioligand,,,CHEMBL617925,,12687,,,,H,8,BAO_0000357,
2678,,17133,Expert,10116.0,,1,In vitro binding to 5-hydroxytryptamine 2A receptor using [125 I]-DOI,,,CHEMBL617926,,12687,Rattus norvegicus,,,D,9,BAO_0000357,
2679,,16532,Autocuration,,,1,The binding affinity at 5-hydroxytryptamine 2A receptor was determined using [3H]ketanserin,,,CHEMBL617927,,12687,,,,H,8,BAO_0000357,
2680,,15086,Autocuration,,,1,The compound was tested for binding affinity against 5-hydroxytryptamine 2A receptor,,,CHEMBL617928,,12687,,,,H,8,BAO_0000357,
2681,,2309,Expert,10116.0,,1,Binding affinity for 5-hydroxytryptamine 2A receptor in rat cortex using [3H]ketanserin,,,CHEMBL617929,,12687,Rattus norvegicus,,,D,9,BAO_0000019,
2682,,12953,Expert,,,1,Binding affinity to 5-hydroxytryptamine 2A receptor from rat cortex assayed using [3H]ketanserin as radioligand.,,,CHEMBL617930,,12687,,,,H,8,BAO_0000019,
2683,,12953,Autocuration,,,1,The compound was tested for its binding affinity towards 5-hydroxytryptamine 2A receptor from rat cortex using [3H]ketanserin as radioligand.; Nonactive at 10 uM,,,CHEMBL617931,,12687,,,,H,8,BAO_0000019,
2684,,12953,Autocuration,,,1,The compound was tested for its binding affinity towards 5-hydroxytryptamine 2A receptor from rat cortex using [3H]-ketanserin as radioligand; Nonactive at 10 uM,,,CHEMBL617932,,12687,,,,H,8,BAO_0000019,
2685,,16659,Autocuration,,,1,Binding affinity for displacement of [3H]ketanserin to rat 5-hydroxytryptamine 2A receptor stably expressed in CHO cells; ND is No Data,449.0,,CHEMBL617933,,12687,,CHO,,H,8,BAO_0000219,
2686,,16740,Autocuration,,,1,In vitro binding affinity at 5-hydroxytryptamine 2A receptor in rat cortical membrane; ND means no data,,,CHEMBL617934,,12687,,,,H,8,BAO_0000019,
2687,,16740,Autocuration,,,1,In vitro binding affinity at serotonin 5-hydroxytryptamine 2A receptor in rat cortical membrane; ND means no data,,,CHEMBL617935,,12687,,,,H,8,BAO_0000019,
2688,,17133,Autocuration,,,1,Tested for its ability to activate phospholipase C by quantification of IP3 at cloned rat 5-hydroxytryptamine 2A receptor; Not determined,,,CHEMBL617936,,12687,,,,H,8,BAO_0000357,
2689,,17211,Autocuration,,,1,Ability to displace [3H]ketanserin (0.5 nM) from cerebral cortex of rat 5-hydroxytryptamine 2A receptor; NT=not tested,,,CHEMBL617937,,12687,,,,H,8,BAO_0000019,
2690,,17331,Autocuration,,,1,Binding affinity against 5-hydroxytryptamine 2A receptor by displacement of [3H]-ketanserin from rat prefrontal cerebral cortex mambranes; Not tested,,,CHEMBL617938,,12687,,,,H,8,BAO_0000019,
2691,,16633,Autocuration,,,1,Compound was evaluated for effective dose measured in nmol/kg following a dose of 0.04 mg/kg and 0.093 uM/kg (95%CI); range 32-63,,,CHEMBL617939,,12687,,,,H,8,BAO_0000218,
2692,,16633,Autocuration,,,1,Compound was evaluated for the percentage of rats disrupted following a dose of 0.04 mg/kg and 0.097 uM/kg,,,CHEMBL617940,,12687,,,,H,8,BAO_0000218,
2693,,16633,Autocuration,,,1,Compound was evaluated for the percentage of rats disrupted following a dose of 0.08 mg/kg and 0.194 uM/kg,,,CHEMBL617941,,12687,,,,H,8,BAO_0000218,
2694,,15026,Expert,,,1,Ratio of pKi of 5-HT2A to that of 5-HT2C receptor,,,CHEMBL617942,,12687,,,,H,8,BAO_0000357,
2695,,15026,Expert,,,1,Ratio of pKi of 5-HT2A to that of D2 receptor,,,CHEMBL617943,,12687,,,,H,8,BAO_0000357,
2696,,16404,Expert,,,1,Selectivity ratio towards KB of 5-hydroxytryptamine 2A receptor to 5-hydroxytryptamine 2B receptor,,,CHEMBL617944,,105093,,,,H,4,BAO_0000224,
2697,,16404,Expert,,,1,Selectivity ratio towards KB of 5-hydroxytryptamine 2A receptor to 5-hydroxytryptamine 2B receptor,,,CHEMBL617945,,105093,,,,H,4,BAO_0000224,
2698,,16404,Expert,,,1,Selectivity ratio towards Ki of 5-hydroxytryptamine 2A receptor to 5-hydroxytryptamine 2C receptor,,,CHEMBL617946,,105075,,,,H,4,BAO_0000224,
2699,,16404,Autocuration,,,1,Selectivity ratio towards Ki of 5-hydroxytryptamine 2A receptor to 5-hydroxytryptamine 2C receptor; ND is no data,,,CHEMBL617947,,12687,,,,H,8,BAO_0000357,
2700,,16326,Expert,,,1,Percent maximal 5-HT stimulation at cloned rat 5-hydroxytryptamine 2A receptor (phosphoinositide hydrolysis study) at a conc of 100 uM,,,CHEMBL617948,,12687,,,,H,8,BAO_0000357,
2701,,15847,Autocuration,,,1,Compound was evaluated for its antagonist affinity towards 5-hydroxytryptamine 2A receptor of rat,,,CHEMBL858116,,12687,,,,H,8,BAO_0000019,
2702,,15847,Autocuration,,,1,Compound was evaluated for its antagonist affinity towards 5-hydroxytryptamine 2A receptor of rat; ND means not done,,,CHEMBL617949,,12687,,,,H,8,BAO_0000019,
2703,,15329,Autocuration,,,1,Effectiveness of compound in blocking 5-hydroxytryptamine 2A receptor-mediated contractions of rat tail artery,,,CHEMBL617950,,12687,,,,H,8,BAO_0000019,
2704,,16404,Expert,,,1,Negative log concentration of antagonist on 5-hydroxytryptamine 2A receptor in rat thoracic aorta,,,CHEMBL617951,,12687,,,,H,8,BAO_0000019,1515.0
2705,,16404,Expert,,,1,Negative log concentration of antagonistic compound was determined on 5-hydroxytryptamine 2A receptor of Rat thoracic aorta,,,CHEMBL617952,,12687,,,,H,8,BAO_0000019,1515.0
2706,,16404,Autocuration,,,1,Negative log concentration of antagonistic compound was determined on 5-hydroxytryptamine 2A receptor of Rat thoracic aorta; ND is not determined.,,,CHEMBL617953,,12687,,,,H,8,BAO_0000019,1515.0
2707,,12861,Autocuration,,,1,Binding activity radioligand.,,,CHEMBL617954,,12687,,,,H,8,BAO_0000357,
2708,,12861,Expert,,,1,Binding activity against 5-hydroxytryptamine 2C receptor from pig cortex membrane using [3H]mesulergine as radioligand.,,,CHEMBL617955,,12687,,,,H,8,BAO_0000019,
2709,,12861,Autocuration,,,1,Binding activity against 5-hydroxytryptamine 2C receptor from pig cortex membrane using [3H]mesulergine as radioligand; NA Not Available,,,CHEMBL857071,,12687,,,,H,8,BAO_0000019,
2710,,12490,Expert,,,1,Displacement of [3H]DOB binding to 5-hydroxytryptamine 2A receptor from rat cortex homogenate,,,CHEMBL617270,,12687,,,,H,8,BAO_0000019,
2711,,12827,Autocuration,,,1,Binding affinity towards 5-hydroxytryptamine 3 receptor in membranes of N1E-115 neuroblastoma cells using [3H]-ICS 205-930,339.0,,CHEMBL617271,,12687,,N1E-115,,H,8,BAO_0000219,
2712,,12827,Autocuration,,,1,Binding affinity towards 5-hydroxytryptamine 3 receptor in membranes of N1E-115 neuroblastoma cells using [3H]-ICS 205-930; Not determined,339.0,,CHEMBL617272,,12687,,N1E-115,,H,8,BAO_0000219,
2713,,12918,Autocuration,,,1,Binding affinity was evaluated by 5-hydroxytryptamine 2A receptor agonism in the rat cortex by displacing ketanserin,,,CHEMBL617273,,12687,,,,H,8,BAO_0000019,
2714,,12919,Expert,10116.0,,1,Agonistic activity against 5-hydroxytryptamine 2A receptor in rat cortex using [3H]-ketanserin,,,CHEMBL617274,,12687,Rattus norvegicus,,,D,9,BAO_0000019,
2715,,17723,Autocuration,,,1,Binding affinity towards human serotonin 5-hydroxytryptamine 2C receptor,,,CHEMBL617275,,108,,,,H,8,BAO_0000357,
2716,,6013,Autocuration,,,1,Binding affinity towards 5-hydroxytryptamine 2C receptor,,,CHEMBL617276,,108,,,,H,8,BAO_0000357,
2717,,16293,Autocuration,,,1,Binding affinity towards human 5-hydroxytryptamine 2C receptor,,,CHEMBL617277,,108,,,,H,8,BAO_0000357,
2718,,3857,Expert,,,1,Binding affinity using [125I]DOI as radioligand with membranes isolated from a CHO-k cell line expressing the human 5-hydroxytryptamine 2C receptor,,,CHEMBL617278,,108,,,,H,8,BAO_0000019,
2719,,3857,Expert,,,1,Binding affinity using [125I]DOI as radioligand with membranes isolated from a CHO-k cell line expressing the human 5-hydroxytryptamine 2C receptor; Not determined,,,CHEMBL617279,,108,,,,H,8,BAO_0000019,
2720,,3857,Expert,,,1,Binding affinity using [3H]mesulergine as radioligand with receptor membranes isolated from a CHO-k cell line expressing the human 5-hydroxytryptamine 2C receptor,,,CHEMBL617280,,108,,,,H,8,BAO_0000019,
2721,,15363,Autocuration,,,1,Compound was tested for the displacement of [125I]DOI from cloned human 5-hydroxytryptamine 2C receptor,,,CHEMBL617281,,108,,,,H,8,BAO_0000357,
2722,,15363,Autocuration,,,1,Compound was tested for the displacement of [125I]DOI from cloned human 5-hydroxytryptamine 2C receptor,,,CHEMBL617282,,108,,,,H,8,BAO_0000357,
2723,,16441,Expert,,,1,Tested on transfected cell membranes selectively expressing human 5-hydroxytryptamine 2C receptor using [3H]mesulergine,,,CHEMBL617283,,108,,,,H,8,BAO_0000019,
2724,,16441,Expert,,,1,Tested on transfected cell membranes selectively expressing human 5-hydroxytryptamine 2C receptor using [3H]-mesulergine; ND is No Data.,,,CHEMBL617284,,108,,,,H,8,BAO_0000019,
2725,,4176,Autocuration,,,1,In vitro binding affinity towards human 5-hydroxytryptamine 2C receptor expressed in HEK293 cells was determined using [3H]mesulergine as radioligand,722.0,,CHEMBL617285,,108,,HEK293,,H,8,BAO_0000219,
2726,,17085,Autocuration,,,1,In vitro binding affinity by radioligand binding assay using cell line expressing human 5-hydroxytryptamine 2C receptor,,,CHEMBL617286,,108,,,,H,8,BAO_0000019,
2727,,17200,Expert,9606.0,,1,Inhibitory constant against cloned human 5-hydroxytryptamine 2C receptor using with [125I]- DOI radioligand,,,CHEMBL617287,,108,Homo sapiens,,,D,9,BAO_0000357,
2728,,5088,Expert,,,1,Binding affinity towards human 5-hydroxytryptamine 2C receptor.,,,CHEMBL617288,,108,,,,H,8,BAO_0000357,
2729,,5088,Autocuration,,,1,Tested for binding affinity towards human 5-hydroxytryptamine 2C receptor using [3H]DOB as radioligand,,,CHEMBL617289,,108,,,,H,8,BAO_0000357,
2730,,5088,Autocuration,,,1,Tested for binding affinity towards human 5-hydroxytryptamine 2C receptor using [3H]mesulergine as radioligand,,,CHEMBL872917,,108,,,,H,8,BAO_0000357,
2731,,5088,Autocuration,,,1,Tested for binding affinity towards human 5-hydroxytryptamine 2C receptor using [3H]5-HT as radioligand,,,CHEMBL617290,,108,,,,H,8,BAO_0000357,
2732,,16659,Autocuration,,,1,Binding affinity for displacement of [3H]mesulergine to human 5-hydroxytryptamine 2C receptor stably expressed in CHO cells,449.0,,CHEMBL617291,,108,,CHO,,H,8,BAO_0000219,
2733,,16659,Autocuration,,,1,Binding affinity for displacement of [3H]mesulergine to human 5-hydroxytryptamine 2C receptor stably expressed in CHO cells; ND is no data,449.0,,CHEMBL617292,,108,,CHO,,H,8,BAO_0000219,
2734,,17451,Autocuration,,,1,Binding constant towards serotonin receptor subtype 5-hydroxytryptamine 2C receptor expressed in 3T3 cells using [3H]5-HT as radioligand; Not determined,723.0,,CHEMBL617293,,108,,NIH3T3,,H,8,BAO_0000219,
2735,,6857,Expert,9606.0,,1,Relative efficacy against human 5-hydroxytryptamine 2B receptor expressed in CHO cells using fluorometric imaging plate reader relative to 10 uM 5-HT,449.0,,CHEMBL617294,,108,Homo sapiens,CHO,,D,9,BAO_0000219,
2736,,3857,Expert,,,1,Inhibitory activity using [3H]mesulergine as radioligand with receptor membranes isolated from a CHO-k cell line expressing the human 5-hydroxytryptamine 2C receptor at a concentration of 1 uM,,,CHEMBL617295,,108,,,,H,8,BAO_0000019,
2737,,12861,Autocuration,,,1,Binding activity radioligand.,,,CHEMBL617296,,108,,,,H,8,BAO_0000357,
2738,,12861,Autocuration,,,1,Binding activity against 5-hydroxytryptamine 2C receptor from human brain cortex using [3H]mesulergine as radioligand.,,,CHEMBL617297,,108,,,,H,8,BAO_0000019,
2739,,5104,Expert,,,1,Binding affinity for human cloned 5-hydroxytryptamine 2C receptor expressed in CHO cells using [3H]mesulergine as radioligand,449.0,,CHEMBL617298,,108,,CHO,,H,8,BAO_0000219,
2740,,5105,Expert,,,1,Binding affinity at human cloned 5-hydroxytryptamine 2C receptor expressed in CHO cells by [3H]mesulergine displacement.,449.0,,CHEMBL617299,,108,,CHO,,H,8,BAO_0000219,
2741,,5105,Autocuration,,,1,Binding affinity for human cloned 5-hydroxytryptamine 2C receptor expressed in CHO cells using [3H]mesulergine as radioligand; NT means not tested,449.0,,CHEMBL617300,,108,,CHO,,H,8,BAO_0000219,
2742,,5254,Autocuration,,,1,Binding affinity against 5-HT2C receptor,,,CHEMBL617454,,108,,,,H,8,BAO_0000357,
2743,,13267,Autocuration,,,1,Antagonistic binding affinity measured against 5-hydroxytryptamine 2C receptor (human clone expressed in 293 cells) using [3H]mesulergine as radioligand,722.0,,CHEMBL617505,,108,,HEK293,,H,8,BAO_0000219,
2744,,14157,Expert,9606.0,,1,Displacement of [3H]mesulergine from 5-hydroxytryptamine 2C receptor expressed in HEK 293 cells,722.0,,CHEMBL617506,,108,Homo sapiens,HEK293,,D,9,BAO_0000219,
2745,,12936,Expert,9606.0,,1,Binding affinity against human 5-hydroxytryptamine 2C receptor expressed in 293 cells using [3H]mesulergine,722.0,,CHEMBL617507,,108,Homo sapiens,HEK293,,D,9,BAO_0000219,
2746,,14068,Expert,,,1,Binding affinity against human 5-hydroxytryptamine 2C receptor using displacement of [3H]DOB,,,CHEMBL617508,,108,,,,H,8,BAO_0000357,
2747,,12936,Expert,9606.0,,1,Binding affinity against human 5-hydroxytryptamine 2C receptor expressed in 293 cells using [3H]mesulergine,722.0,,CHEMBL857982,,108,Homo sapiens,HEK293,,D,9,BAO_0000219,
2748,,4540,Expert,9606.0,,1,Binding affinity to human cloned 5-hydroxytryptamine 2C receptor in HEK 293 cells using [3H]- mesulergine as radioligand,722.0,,CHEMBL617509,,108,Homo sapiens,HEK293,,D,9,BAO_0000219,
2749,,4540,Expert,9606.0,,1,Binding affinity to human cloned 5-hydroxytryptamine 2C receptor in HEK 293 cells using [3H]- mesulergine as radioligand; Nd means not determined,722.0,,CHEMBL617510,,108,Homo sapiens,HEK293,,D,9,BAO_0000219,
2750,,6166,Autocuration,,,1,Binding affinity towards cloned human 5-hydroxytryptamine 2C receptor was determined,,,CHEMBL617511,,108,,,,H,8,BAO_0000357,
2751,,17296,Autocuration,,,1,Binding affinity against 5-hydroxytryptamine 2C receptor human cloned receptors in HEK 293 cells using [3H]mesulergine as radioligand,722.0,,CHEMBL617512,,108,,HEK293,,H,8,BAO_0000219,
2752,,17296,Autocuration,,,1,Binding affinity against 5-hydroxytryptamine 2C receptor human cloned receptorswithouteffect in HEK 293 cells using [3H]mesulergine as radioligand,722.0,,CHEMBL617749,,108,,HEK293,,H,8,BAO_0000219,
2753,,15779,Autocuration,,,1,Binding affinity towards 5-HT2C (human cloned receptor) in HEK 293 cells using [3H]mesulergine as radioligand.,722.0,,CHEMBL617750,,108,,HEK293,,H,8,BAO_0000219,
2754,,15779,Autocuration,,,1,Binding affinity towards 5-hydroxytryptamine 2C receptor (human cloned receptor) in HEK 293 cells using [3H]mesulergine as radioligand.,722.0,,CHEMBL617751,,108,,HEK293,,H,8,BAO_0000219,
2755,,14391,Expert,,,1,Binding affinity towards cloned human 5-hydroxytryptamine 2C receptor expressed in HEK 293 cells using [3H]mesulergine as radioligand,722.0,,CHEMBL617752,,108,,HEK293,,H,8,BAO_0000219,
2756,,15779,Autocuration,,,1,"Binding affinity towards human cloned 5-hydroxytryptamine 2C receptor in HEK293 cells, using [3H]mesulergine as radioligand",722.0,,CHEMBL617753,,108,,HEK293,,H,8,BAO_0000219,
2757,,15851,Expert,,,1,"Binding affinity towards human cloned 5-hydroxytryptamine receptor 2C in HEK293 cells, using [3H]mesulergine as radioligand.",722.0,,CHEMBL617754,,108,,HEK293,,H,8,BAO_0000219,
2758,,15851,Expert,9606.0,,1,Displacement of [3H]mesulergine from human 5-hydroxytryptamine 2C receptor expressed in HEK293 cells; compound insoluble,722.0,,CHEMBL617755,,108,Homo sapiens,HEK293,,D,9,BAO_0000219,
2759,,15779,Autocuration,,,1,"Binding affinity towards human cloned 5-hydroxytryptamine 2C receptor in HEK293 cells, using [3H]mesulergine as radioligand; no data",722.0,,CHEMBL617756,,108,,HEK293,,H,8,BAO_0000219,
2760,,3832,Expert,,,1,Binding affinity towards human cloned 5-hydroxytryptamine 2C receptor of HEK293 cells by displacement of [3H]mesulergine,722.0,,CHEMBL617757,,108,,HEK293,,H,8,BAO_0000219,
2761,,3833,Expert,,,1,In vitro binding affinity at human cloned 5-hydroxytryptamine 2C receptor of HEK293 cells by [3H]mesulergine displacement.,722.0,,CHEMBL617758,,108,,HEK293,,H,8,BAO_0000219,
2762,,17451,Autocuration,,,1,Binding constant towards serotonin receptor subtype 5-hydroxytryptamine 2C receptor expressed in 3T3 cells using [3H]5-HT as radioligand,723.0,,CHEMBL617759,,108,,NIH3T3,,H,8,BAO_0000219,
2763,,4199,Autocuration,,,1,Compound was evaluated for binding affinity against human cloned 5-hydroxytryptamine 2C receptor in HEK 293 cells using [3H]mesulergine as the radioligand,722.0,,CHEMBL617760,,108,,HEK293,,H,8,BAO_0000219,
2764,,1883,Expert,,,1,Displacement of [3H]mesulergine from human cloned 5-hydroxytryptamine 2C receptor expressed in CHO-K1 cells,485.0,,CHEMBL617761,,108,,CHO-K1,,H,8,BAO_0000219,
2765,,4321,Expert,9606.0,,1,Binding affinity against 5-hydroxytryptamine 2C receptor,,,CHEMBL617762,,108,Homo sapiens,,,D,9,BAO_0000357,
2766,,14875,Autocuration,,,1,Compound was tested for binding affinity against human 5-hydroxytryptamine 2C receptor,,,CHEMBL617763,,108,,,,H,8,BAO_0000357,
2767,,15146,Autocuration,,,1,Compound was tested for its binding affinity against human cloned 5-hydroxytryptamine 2C receptor in HEK 293 cells using [3H]mesulergine,722.0,,CHEMBL857983,,108,,HEK293,,H,8,BAO_0000219,
2768,,5213,Autocuration,,,1,Compound was tested for its binding affinity for human cloned 5-hydroxytryptamine 2C receptor in HEK 293 using [3H]mesulergine as a radioligand,722.0,,CHEMBL617764,,108,,HEK293,,H,8,BAO_0000219,
2769,,16404,Autocuration,,,1,Inhibitory constant on human 5-hydroxytryptamine 2C receptor transfected in to HeLa cells,308.0,,CHEMBL617765,,108,,HeLa,,H,8,BAO_0000219,
2770,,13267,Autocuration,,,1,Selectivity as the ratio of Ki value towards 5-hydroxytryptamine 2C receptor to that of pA2 value towards 5-hydroxytryptamine 2B receptor,,,CHEMBL617766,,108,,,,H,8,BAO_0000019,
2771,,13267,Autocuration,,,1,The binding affinity (pKi) measured against 5-hydroxytryptamine 3 receptor of rat hippocampus and entorhinal cortex using [3H]granisetron as radioligand,,,CHEMBL617767,,108,,,,H,8,BAO_0000221,10000000.0
2772,,14818,Autocuration,,,1,The compound was tested for its binding affinity towards cloned human 5-hydroxytryptamine 2C receptor in HEK293 cells using [3H]mesulergine.,722.0,,CHEMBL617768,,108,,HEK293,,H,8,BAO_0000219,
2773,,4829,Autocuration,,,1,"The compound was tested for the binding affinity towards human cloned 5-hydroxytryptamine 2C receptor in HEK293 cells, using [3H]5-mesulergine as radioligand",722.0,,CHEMBL617769,,108,,HEK293,,H,8,BAO_0000219,
2774,,13463,Autocuration,,,1,Binding affinity analysed on 5-HT 2C in human clone using [3H]mesulergine as radioligand,,,CHEMBL858023,,11864,,,,H,8,BAO_0000357,
2775,,13463,Autocuration,,,1,Binding affinity analysed on 5-HT 2C in rat stomach fundus,,,CHEMBL617770,,11864,,,,H,8,BAO_0000019,945.0
2776,,13463,Autocuration,,,1,Binding affinity analysed towards 5-HT 2C in rat stomach fundus,,,CHEMBL617771,,11864,,,,H,8,BAO_0000019,945.0
2777,,12652,Autocuration,,,1,Percent of maximum stimulation of phosphatidylinositol turnover at cloned 5-hydroxytryptamine 2C receptor in A9 cells,625.0,,CHEMBL617772,,11864,,A9,,H,8,BAO_0000219,
2778,,4682,Autocuration,,,1,Binding affinity to 5-hydroxytryptamine 2C receptor using [3H]Mesulergine as radioligand in stably transfected NIH3T3 cells,723.0,,CHEMBL617773,,11864,,NIH3T3,,H,8,BAO_0000219,
2779,,4682,Autocuration,,,1,Binding affinity to 5-hydroxytryptamine 2C receptor measured using radioligand [3H]Mesulergine in stably transfected NIH3T3 cells,723.0,,CHEMBL617850,,11864,,NIH3T3,,H,8,BAO_0000219,
2780,,4682,Autocuration,,,1,Binding affinity to 5-hydroxytryptamine 2C receptor using [3H]Mesulergine as radioligand in stably transfected NIH3T3 cells,723.0,,CHEMBL617851,,11864,,NIH3T3,,H,8,BAO_0000219,
2781,,12652,Autocuration,,,1,The maximum responses of [3H]- inositol monophosphate accumulation in cells expressing the 5-hydroxytryptamine 2C receptor,,,CHEMBL617852,,11864,,,,H,8,BAO_0000019,
2782,,13463,Autocuration,10090.0,,1,Binding affinity analysed on 5-HT 2C in rat stomach fundus.,,,CHEMBL858024,,12689,Mus musculus,,,H,8,BAO_0000019,945.0
2783,,13463,Expert,10116.0,,1,Binding affinity towards 5-HT 2C receptor in rat stomach fundus,,,CHEMBL617853,,12689,Rattus norvegicus,,,D,9,BAO_0000019,945.0
2784,,13969,Expert,,,1,Binding affinity against 5-Hydroxytryptamine 2C Receptor was measured using [3H]N-methyl-mesulergine as radioligand,,,CHEMBL617854,,108,,,,H,8,BAO_0000357,
2785,,13392,Expert,9823.0,,1,Binding affinity for 5-hydroxytryptamine 2C receptor,,,CHEMBL873477,,108,Sus scrofa,,,H,8,BAO_0000357,
2786,,13392,Expert,,,1,Binding affinity towards 5-hydroxytryptamine 2C receptor,,,CHEMBL617855,,108,,,,H,8,BAO_0000357,
2787,,14430,Expert,,,1,Affinity towards 5-hydroxytryptamine 2C receptor in membranes from pig choroid plexus using [3H]N-methyl-mesulergine,,,CHEMBL617856,,108,,,,H,8,BAO_0000019,
2788,,1742,Autocuration,,,1,Compound was tested for its ability to displace [3H]mesulergine from 5-hydroxytryptamine 2C receptor in pig cortex,,,CHEMBL617857,,108,,,,H,8,BAO_0000019,
2789,,14286,Autocuration,,,1,In vitro inhibitory concentration against radioligand [3H]mesulergine binding to 5-hydroxytryptamine 2C receptor in pig cortical membrane,,,CHEMBL617858,,108,,,,H,8,BAO_0000249,
2790,,5619,Autocuration,,,1,Binding affinity towards pig 5-hydroxytryptamine 2C receptor,,,CHEMBL617859,,108,,,,H,8,BAO_0000357,
2791,,15086,Autocuration,,,1,The compound was tested for binding affinity against 5-hydroxytryptamine 2C receptor,,,CHEMBL617860,,108,,,,H,8,BAO_0000357,
2792,,12861,Autocuration,,,1,Binding activity radioligand.,,,CHEMBL617861,,108,,,,H,8,BAO_0000357,
2793,,12861,Expert,,,1,Binding activity against 5-hydroxytryptamine 2C receptor from pig cortex membrane using [3H]mesulergine as radioligand.,,,CHEMBL617862,,108,,,,H,8,BAO_0000019,
2794,,12861,Autocuration,,,1,Binding activity against 5-hydroxytryptamine 3 receptor from pig cortex membrane using [3H]mesulergine as radioligand; NA Not Available,,,CHEMBL617863,,108,,,,H,8,BAO_0000019,
2795,,12827,Autocuration,,,1,Binding affinity towards 5-hydroxytryptamine 1D receptor in calf caudate membranes using [3H]5-HT,,,CHEMBL617864,,108,,,,H,8,BAO_0000249,
2796,,12827,Autocuration,,,1,Binding affinity towards 5-hydroxytryptamine 1D receptor in calf caudate membranes using [3H]5-HT; Not determined,,,CHEMBL617649,,108,,,,H,8,BAO_0000249,
2797,,12919,Expert,9823.0,,1,Agonistic activity against 5-hydroxytryptamine 2C receptor in pig choroid plexus using [3H]mesulergine,,,CHEMBL617650,,108,Sus scrofa,,,H,8,BAO_0000019,
2798,,12919,Expert,9823.0,,1,Agonistic activity against 5-hydroxytryptamine 2C receptor in pig choroid plexus using [3H]mesulergine,,,CHEMBL617651,,108,Sus scrofa,,,H,8,BAO_0000019,
2799,,16429,Autocuration,9823.0,,1,In vitro binding affinity at 5-hydroxytryptamine 2C receptor in pig choroid plexus using 3[H]mesulergine as the radioligand,,,CHEMBL617652,,108,Sus scrofa,,,H,8,BAO_0000357,
2800,,773,Autocuration,9823.0,,1,In Vitro Binding affinity againist 5-hydroxytryptamine 2C receptor by displacing [3H]mesulergine from pig cortex,,,CHEMBL857072,,108,Sus scrofa,,,H,8,BAO_0000019,
2801,,5033,Autocuration,9823.0,,1,Ability to displace the radioligand [3H]mesulergine from pig choroid plexus 5-hydroxytryptamine 2C receptor,,,CHEMBL617653,,108,Sus scrofa,,,H,8,BAO_0000357,
2802,,12861,Autocuration,,,1,Binding activity against 5-hydroxytryptamine 2C receptor from pig cortex membrane using [3H]mesulergine as radioligand.,,,CHEMBL617654,,12687,,,,H,8,BAO_0000019,
2803,,14093,Autocuration,,,1,Effect on phosphoinositide hydrolysis in NIH 3T3 fibroblast 5-hydroxytryptamine 2C receptor,,,CHEMBL617655,,12689,,,,H,8,BAO_0000019,
2804,,14970,Expert,,,1,Binding affinity towards 5-HT2C receptor from rat using [3H]mesulergine as radioligand,,,CHEMBL617656,,12689,,,,H,8,BAO_0000357,
2805,,14970,Autocuration,,,1,Compound was tested in vitro for its binding affinity towards 5-hydroxytryptamine 2C receptor from rat using [3H]mesulergine as radioligand,,,CHEMBL617657,,12689,,,,H,8,BAO_0000357,
2806,,14970,Autocuration,,,1,Compound was tested in vitro for its binding affinity towards 5-hydroxytryptamine 2C receptor from rat using [3H]mesulergine as radioligand; Not tested,,,CHEMBL617658,,12689,,,,H,8,BAO_0000357,
2807,,14178,Expert,10116.0,,1,Inhibition of radiolabeled [3H]-Ketanserin ligand binding to 5-hydroxytryptamine 2C receptor,,,CHEMBL617659,,12689,Rattus norvegicus,,,D,9,BAO_0000357,
2808,,14178,Expert,10116.0,,1,Inhibition of radiolabeled [3H]mesulergine ligand binding to 5-hydroxytryptamine 2C receptor,,,CHEMBL617838,,12689,Rattus norvegicus,,,D,9,BAO_0000357,
2809,,14229,Expert,10116.0,,1,Inhibition of [3H]mesulergine binding to 5-hydroxytryptamine 2C receptor in rat brain membranes,,,CHEMBL617839,Brain membranes,12689,Rattus norvegicus,,,D,9,BAO_0000249,
2810,,16532,Autocuration,,,1,The binding affinity at 5-hydroxytryptamine 2C receptor was determined using [3H]mesulergine; Not tested,,,CHEMBL617840,,12689,,,,H,8,BAO_0000357,
2811,,14826,Autocuration,,,1,Ability to displace [3H]mesulergine bound to 5-hydroxytryptamine 2C receptor in rat cortex,,,CHEMBL617841,,12689,,,,H,8,BAO_0000019,
2812,,17211,Autocuration,,,1,Ability to displace [3H]mesulergine (0.5 nM) from SR-3T3 cells of rat 5-HT2C receptor,,,CHEMBL875915,,12689,,,,H,8,BAO_0000019,
2813,In vitro,17211,Expert,,,1,Displacement of [3H]mesulergine (0.5 nM) from rat 5-hydroxytryptamine 2C receptor expressed in SR-3T3 cells,,,CHEMBL617842,,12689,,,,H,8,BAO_0000219,
2814,,13246,Expert,,,1,Ability to inhibit the binding of iodine-125-labelled lysergic acid diethylamide([125I]-LSD) to the S-2C serotonin receptor in NIH3T3 cell line membranes,723.0,,CHEMBL617843,,12689,,NIH3T3,,H,8,BAO_0000219,
2815,,13246,Expert,,,1,Ability to inhibit the binding of iodine-125-labelled lysergic acid diethylamide([125I]-LSD) to the S-2C serotonin receptor.,,,CHEMBL617844,,12689,,,,H,8,BAO_0000357,
2816,,12457,Expert,,,1,Affinity was evaluated as inhibition constant for serotonin 5-hydroxytryptamine 2C receptor,,,CHEMBL617845,,12689,,,,H,8,BAO_0000357,
2817,,12457,Expert,,,1,Affinity was evaluated by inhibition of [125I]LSD binding to NIH 3T3 cells transfected with cloned rat 5-hydroxytryptamine 2C receptor,723.0,,CHEMBL617846,,12689,,NIH3T3,,H,8,BAO_0000219,
2818,,4707,Autocuration,,,1,Binding affinity towards rat 5-hydroxytryptamine 2C receptor was determined using [125I]- DOI as radioligand,,,CHEMBL617847,,12689,,,,H,8,BAO_0000357,
2819,,13297,Expert,,,1,Binding affinity against 5-hydroxytryptamine 2C receptor,,,CHEMBL617848,,12689,,,,H,8,BAO_0000357,
2820,,16633,Autocuration,,,1,Binding affinity against 5-hydroxytryptamine 2C receptor using [125I]DOI as radioligand,,,CHEMBL617849,,12689,,,,H,8,BAO_0000357,
2821,,16133,Expert,,,1,Binding affinity against rat 5-hydroxytryptamine 2C receptor using [3H]mesulergine as radioligand,,,CHEMBL621507,,12689,,,,H,8,BAO_0000357,
2822,,16326,Expert,,,1,Binding affinity at cloned rat 5-hydroxytryptamine 2C receptor using [3H]DOI as radioligand,,,CHEMBL621508,,12689,,,,H,8,BAO_0000357,
2823,,14423,Autocuration,,,1,Binding affinity against 5-hydroxytryptamine 2C receptor from rat cortex using [3H]mesulergine as the radioligand.,,,CHEMBL621509,,12689,,,,H,8,BAO_0000019,
2824,,15412,Autocuration,,,1,Binding affinity against 5-hydroxytryptamine 2C receptor of rat cortex,,,CHEMBL621510,,12689,,,,H,8,BAO_0000019,
2825,,15412,Autocuration,,,1,Binding affinity against 5-hydroxytryptamine 2C receptor of rat cortex.,,,CHEMBL621511,,12689,,,,H,8,BAO_0000019,
2826,,15558,Expert,,,1,Displacement of [3H]mesulergine from A9 cells stably expressing rat 5-hydroxytryptamine 2C receptor,625.0,,CHEMBL621512,,12689,,A9,,H,8,BAO_0000219,
2827,,16633,Autocuration,,,1,Binding affinity towards 5-hydroxytryptamine 2C receptor using [125I]DOI as radioligand,,,CHEMBL621513,,12689,,,,H,8,BAO_0000357,
2828,,6013,Expert,,,1,Binding affinity towards cloned rat 5-hydroxytryptamine 2C receptor from fundus tissue by [3H]mesulergine displacement.,,,CHEMBL621514,,12689,,,,H,8,BAO_0000357,
2829,In vitro,17175,Expert,,,1,Binding affinity towards rat 5-hydroxytryptamine 2C receptor expressed in A-9 cells using [3H]mesulergine as radioligand,,,CHEMBL621515,,12689,,,,H,8,BAO_0000219,
2830,,12469,Autocuration,,,1,Binding affinity was measured on 5-hydroxytryptamine 2C receptor in J1 cells transfected with rat 5-HT2C gene labeled with [3H]mesulergine,,,CHEMBL621516,,12689,,,,H,8,BAO_0000219,
2831,,3682,Autocuration,,,1,Compound was evaluated for affinity towards cerebral 5-hydroxytryptamine 2C receptor in homogenate of caudate putamen tissue from rat brain,,,CHEMBL621517,,12689,,,,H,8,BAO_0000019,5383.0
2832,,4932,Autocuration,,,1,Compound was evaluated for its ability to displace (+/-)[125I]-DOI from 5-hydroxytryptamine 2C receptor in cloned rat cell culture,,,CHEMBL621518,,12689,,,,H,8,BAO_0000357,
2833,,4932,Autocuration,,,1,Compound was evaluated for its ability to displace [125I](R)-DOI from 5-hydroxytryptamine 2C receptor in cloned rat prefrontal cortex homogenate; ND denotes no data,,,CHEMBL621519,,12689,,,,H,8,BAO_0000019,
2834,,3935,Autocuration,,,1,Compound was evaluated for its binding affinity for rat 5-hydroxytryptamine 2C receptor,,,CHEMBL621520,,12689,,,,H,8,BAO_0000357,
2835,,15818,Autocuration,,,1,Compound was evaluated for its binding affinity towards rat 5-hydroxytryptamine 2C receptor,,,CHEMBL621521,,12689,,,,H,8,BAO_0000357,
2836,,15818,Autocuration,,,1,Compound was evaluated for its binding affinity towards rat r5-hydroxytryptamine 2C receptor,,,CHEMBL621522,,12689,,,,H,8,BAO_0000357,
2837,,14749,Expert,,,1,Binding affinity against rat 5-hydroxytryptamine 2C receptor in A-9 cells.,,,CHEMBL621523,,12689,,,,H,8,BAO_0000219,
2838,,15740,Autocuration,,,1,Evaluated for the binding constant at [125I]-DOI-labeled rat 5-hydroxytryptamine 2C receptor,,,CHEMBL621524,,12689,,,,H,8,BAO_0000357,
2839,,17133,Expert,10116.0,,1,In vitro binding to 5-hydroxytryptamine 2C receptor using [125 I]-DOI,,,CHEMBL621525,,12689,Rattus norvegicus,,,D,9,BAO_0000357,
2840,,16532,Autocuration,,,1,The binding affinity at 5-hydroxytryptamine 2C receptor was determined using [3H]mesulergine,,,CHEMBL872921,,12689,,,,H,8,BAO_0000357,
2841,,12369,Autocuration,,,1,The compound evaluated for its affinity against 5-hydroxytryptamine 2C receptor,,,CHEMBL621526,,12689,,,,H,8,BAO_0000357,
2842,,12369,Expert,,,1,Affinity against 5-hydroxytryptamine 2C receptor in J1 cells transfected with the rat 5-HT2C gene labeled with [3H]mesulergine.,,,CHEMBL621527,,12689,,,,H,8,BAO_0000219,
2843,,2309,Expert,10116.0,,1,Binding affinity against 5-hydroxytryptamine 2C receptor in rat choroid plexus using [3H]N-methyl-mesulergine,,,CHEMBL617865,,12689,Rattus norvegicus,,,D,9,BAO_0000019,
2844,,12953,Autocuration,,,1,The compound was tested for their binding affinity towards 5-hydroxytryptamine 2C receptor,,,CHEMBL617866,,12689,,,,H,8,BAO_0000357,
2845,,12953,Autocuration,,,1,The compound was tested for their binding affinity towards 5-hydroxytryptamine 2C receptor from rat cortex using [3H]-citalopram as radioligand; Nonactive at 10 uM,,,CHEMBL617867,,12689,,,,H,8,BAO_0000019,
2846,,12953,Autocuration,,,1,The compound was tested for their binding affinity towards 5-hydroxytryptamine 2C receptor using [3H]mesulergine as radioligand; Nonactive at 10 uM,,,CHEMBL617487,,12689,,,,H,8,BAO_0000357,
2847,,12953,Expert,,,1,Binding affinity for 5-hydroxytryptamine 2C receptor,,,CHEMBL617488,,12689,,,,H,8,BAO_0000357,
2848,,17133,Autocuration,,,1,Tested in vitro for its ability to bind to 5-hydroxytryptamine 2C receptor using [125 I]-DOI as radioligand; Not determined,,,CHEMBL617489,,12689,,,,H,8,BAO_0000357,
2849,,17211,Autocuration,,,1,Ability to displace [3H]mesulergine (0.5 nM) from SR-3T3 cells of rat 5-hydroxytryptamine 2C receptor; NT denotes not tested,,,CHEMBL617490,,12689,,,,H,8,BAO_0000019,
2850,,17211,Autocuration,,,1,Ability to displace [3H]mesulergine (0.5 nM) from SR-3T3 cells of rat 5-hydroxytryptamine 2C receptor; NT=not tested,,,CHEMBL617491,,12689,,,,H,8,BAO_0000019,
2851,,14025,Autocuration,,,1,Affinity pKi for 5-hydroxytryptamine 2C receptor was measured in rat cortex homogenates.,,,CHEMBL617492,,12689,,,,H,8,BAO_0000019,
2852,,14998,Autocuration,,,1,Binding affinity against 5-hydroxytryptamine 2C receptor in rat cortex homogenates.,,,CHEMBL617493,,12689,,,,H,8,BAO_0000019,
2853,,4342,Autocuration,,,1,Binding affinity of compound towards serotonin 5-hydroxytryptamine 2C receptor was determined,,,CHEMBL617494,,12689,,,,H,8,BAO_0000357,
2854,,13735,Expert,10116.0,,1,Displacement of [3H]mesulergine from rat 5-HT2C receptor expressed in HEK293,,,CHEMBL617495,,12689,Rattus norvegicus,,,D,9,BAO_0000019,
2855,,13181,Autocuration,,,1,Binding affinity was determined against cloned human 5-hydroxytryptamine 2C receptor using [3H]5-HT as radioligand,,,CHEMBL617496,,12689,,,,H,8,BAO_0000357,
2856,,1883,Autocuration,,,1,Compound was evaluated for displacement of [3H]mesulergine from cloned rat 5-hydroxytryptamine 2C receptor in transfected CHO-K1 cells.,485.0,,CHEMBL617497,,12689,,CHO-K1,,H,8,BAO_0000219,
2857,,15194,Autocuration,,,1,The compound was tested for the binding affinity against 5-hydroxytryptamine 2C receptor using [3H]mesulergine as radioligand,,,CHEMBL617498,,12689,,,,H,8,BAO_0000357,
2858,,15194,Autocuration,,,1,The compound was tested for the binding affinity against 5-hydroxytryptamine 2C receptor using [3H]Mesulergine as radioligand.,,,CHEMBL617499,,12689,,,,H,8,BAO_0000357,
2859,,14579,Autocuration,,,1,Compound tested for relative response using 0.1 uM 5-HT as agonist against 5-hydroxytryptamine 2C receptor,,,CHEMBL617500,,12689,,,,H,8,BAO_0000019,
2860,,4639,Autocuration,,,1,Compound was tested for binding affinity against 5-hydroxytryptamine 2C receptor,,,CHEMBL617501,,108,,,,H,8,BAO_0000357,
2861,,4820,Expert,,,1,Binding affinity towards 5-hydroxytryptamine 2C receptor,,,CHEMBL617502,,108,,,,H,8,BAO_0000357,
2862,,14442,Autocuration,,,1,Binding ability of compound at cloned human 5-hydroxytryptamine 2B receptor using [3H]rauwolscine as radioligand; Not Tested,,,CHEMBL617503,,227,,,,H,8,BAO_0000357,
2863,,14755,Autocuration,,,1,Binding activity against cloned human 5-hydroxytryptamine 2B receptor using [3H]5-HT as the radioligand.,,,CHEMBL617504,,227,,,,H,8,BAO_0000357,
2864,,14744,Autocuration,,,1,Binding affinity against the cloned human 5-hydroxytryptamine 2B receptor using [3H]5-HT as the radioligand,,,CHEMBL617406,,227,,,,H,8,BAO_0000357,
2865,,6857,Expert,9606.0,,1,Affinity for human 5-hydroxytryptamine 2B receptor expressed in mammalian cell line,,,CHEMBL617407,,227,Homo sapiens,,,D,9,BAO_0000019,
2866,,16209,Autocuration,,,1,Binding affinity towards human 5-hydroxytryptamine 2B receptor using [3H]5-HT as radioligand,,,CHEMBL617408,,227,,,,H,8,BAO_0000357,
2867,,15363,Autocuration,,,1,Compound was tested for the displacement of [3H]5-HT from clone human 5-hydroxytryptamine 2B receptor,,,CHEMBL617409,,227,,,,H,8,BAO_0000357,
2868,,15363,Autocuration,,,1,Compound was tested for the displacement of [3H]5-HT from clone human 5-hydroxytryptamine 2B receptor,,,CHEMBL617410,,227,,,,H,8,BAO_0000357,
2869,,15363,Autocuration,,,1,Compound was tested for the displacement of [3H]5-HT from cloned human 5-hydroxytryptamine 2B receptor,,,CHEMBL617411,,227,,,,H,8,BAO_0000357,
2870,,17085,Autocuration,,,1,In vitro binding affinity by radioligand binding assay using cell line expressing human 5-hydroxytryptamine 2B receptor,,,CHEMBL617412,,227,,,,H,8,BAO_0000019,
2871,,17200,Expert,9606.0,,1,Inhibitory constant against cloned human 5-hydroxytryptamine 2B receptor using with [125I]- DOI radioligand,,,CHEMBL617774,,227,Homo sapiens,,,D,9,BAO_0000357,
2872,,15851,Expert,9606.0,,1,Displacement of [3H]5-HT from human 5-hydroxytryptamine 2B receptor expressed in HEK293 cells; ND = no data,722.0,,CHEMBL617775,,227,Homo sapiens,HEK293,,D,9,BAO_0000219,
2873,,15851,Expert,9606.0,,1,Displacement of [3H]ketanserin from human 5-hydroxytryptamine 2B receptor expressed in HEK293 cells; ND = no data,722.0,,CHEMBL617776,,227,Homo sapiens,HEK293,,D,9,BAO_0000219,
2874,,6857,Expert,9606.0,,1,Relative efficacy against human 5-hydroxytryptamine 2B receptor expressed in CHO cells using fluorometric imaging plate reader relative to 10 uM 5-HT,449.0,,CHEMBL617777,,227,Homo sapiens,CHO,,D,9,BAO_0000219,
2875,,6857,Expert,9606.0,,1,Rleative efficacy against human 5-hydroxytryptamine 2B receptor expressed in CHO cells using fluorometric imaging plate reader relative to 10 uM 5-HT,449.0,,CHEMBL617778,,227,Homo sapiens,CHO,,D,9,BAO_0000219,
2876,,15779,Autocuration,,,1,"Binding affinities towards human cloned 5-hydroxytryptamine 2B receptor in HEK293 cells, using [3H]5-HT as radioligand",722.0,,CHEMBL617779,,227,,HEK293,,H,8,BAO_0000219,
2877,,15851,Expert,,,1,Binding affinities towards human cloned 5-hydroxytryptamine 2B receptor in HEK293 cells using [3H]5-HT as radioligand.,722.0,,CHEMBL617780,,227,,HEK293,,H,8,BAO_0000219,
2878,,15779,Autocuration,,,1,"Binding affinities towards human cloned 5-hydroxytryptamine 2B receptor in HEK293 cells, using [3H]5-HT as radioligand; no data",722.0,,CHEMBL617781,,227,,HEK293,,H,8,BAO_0000219,
2879,,14157,Expert,9606.0,,1,Displacement of [3H]5-HT from 5-hydroxytryptamine 2B receptor expressed in HEK 293 cells,722.0,,CHEMBL617782,,227,Homo sapiens,HEK293,,D,9,BAO_0000219,
2880,,4540,Expert,9606.0,,1,Binding affinity to human cloned 5-HT2B receptor in HEK 293 cells using [3H]- -5-HT as radioligand,722.0,,CHEMBL617783,,227,Homo sapiens,HEK293,,D,9,BAO_0000219,
2881,,6166,Autocuration,,,1,Binding affinity towards cloned human 5-hydroxytryptamine 2B receptor was determined,,,CHEMBL617784,,227,,,,H,8,BAO_0000357,
2882,,15779,Autocuration,,,1,Binding affinity towards 5-hydroxytryptamine 2B receptor (human cloned receptor) in HEK 293 cells using [3H]5-HT as radioligand.,722.0,,CHEMBL617785,,227,,HEK293,,H,8,BAO_0000219,
2883,,14391,Expert,,,1,Binding affinity towards cloned human 5-hydroxytryptamine 2B receptor expressed in HEK 293 cells using [3H]5-HT as radioligand,722.0,,CHEMBL857984,,227,,HEK293,,H,8,BAO_0000219,
2884,,3832,Expert,,,1,Binding affinity towards human cloned 5-HT2B receptor of HEK293 cells by displacement of [3H]5-HT,722.0,,CHEMBL617786,,227,,HEK293,,H,8,BAO_0000219,
2885,,3833,Expert,,,1,In vitro binding affinity at human cloned 5-hydroxytryptamine 2B receptor of HEK293 cells by [3H]5-HT displacement.,722.0,,CHEMBL617787,,227,,HEK293,,H,8,BAO_0000219,
2886,,15851,Expert,9606.0,,1,Displacement of [3H]5-HT from human 5-hydroxytryptamine 2B receptor expressed in HEK293 cells,722.0,,CHEMBL617788,,227,Homo sapiens,HEK293,,D,9,BAO_0000219,
2887,,15851,Expert,9606.0,,1,Displacement of [3H]5-HT from human 5-hydroxytryptamine 2B receptor expressed in HEK293 cells; compound is insoluble,722.0,,CHEMBL617789,,227,Homo sapiens,HEK293,,D,9,BAO_0000219,
2888,,4199,Autocuration,,,1,Compound was evaluated for binding affinity against human cloned 5-HT2B receptor in HEK 293 cells using [3H]5-HT as the radioligand,722.0,,CHEMBL617790,,227,,HEK293,,H,8,BAO_0000219,
2889,,1883,Expert,,,1,Displacement of [3H]-5-5HT from human cloned 5-hydroxytryptamine 2B receptor expressed in CHO-K1 cells,485.0,,CHEMBL617791,,227,,CHO-K1,,H,8,BAO_0000219,
2890,,4321,Expert,,,1,Binding affinity against 5-hydroxytryptamine 2B receptor,,,CHEMBL617608,,227,,,,H,8,BAO_0000357,
2891,,15146,Autocuration,,,1,Compound was tested for its binding affinity against cloned human 5-hydroxytryptamine 2B receptor in HEK 293 cells using [3H]5-HT,722.0,,CHEMBL617609,,227,,HEK293,,H,8,BAO_0000219,
2892,,5213,Autocuration,,,1,Compound was tested for its binding affinity for human cloned 5-hydroxytryptamine 2B receptor in HEK 293 using [3H]ketanserin as a radioligand,722.0,,CHEMBL617610,,227,,HEK293,,H,8,BAO_0000219,
2893,,14818,Autocuration,,,1,The compound was tested for its binding affinity towards cloned human 5-hydroxytryptamine 2B receptors in HEK293 cells using [3H]5-HT.,722.0,,CHEMBL617611,,227,,HEK293,,H,8,BAO_0000219,
2894,,4829,Autocuration,,,1,"The compound was tested for the binding affinity towards human cloned 5-hydroxytryptamine 2B receptor in HEK293 cells, using [3H]5-HT as radioligand",722.0,,CHEMBL617612,,227,,HEK293,,H,8,BAO_0000219,
2895,,4829,Autocuration,,,1,"The compound was tested for the binding affinity towards human cloned 5-hydroxytryptamine 2B receptor in HEK293 cells, using [3H]5-HT as radioligand",722.0,,CHEMBL617613,,227,,HEK293,,H,8,BAO_0000219,
2896,,14025,Autocuration,9986.0,,1,The dissociation equilibrium constant (pKB=-log KB) of compound was determined against the vascular 5-hydroxytryptamine 2B receptor in the endothelium intact rabbit jugular vein.,,,CHEMBL617614,,227,Oryctolagus cuniculus,,,H,8,BAO_0000019,
2897,,13463,Expert,,,1,Binding affinity analysed for 5-HT 2B receptor in rat stomach fundus,,,CHEMBL617615,,12688,,,,H,8,BAO_0000019,945.0
2898,,7259,Expert,,,1,Affinity against 5-hydroxytryptamine 2B receptor in the isolated rat stomach fundus,,,CHEMBL858114,,12688,,,,H,8,BAO_0000357,945.0
2899,,7259,Autocuration,,,1,Affinity against serotonergic receptor in the isolated rat stomach fundus,,,CHEMBL617616,,12688,,,,H,8,BAO_0000357,945.0
2900,,7185,Expert,10116.0,,1,Antagonistic activity against 5-hydroxytryptamine 2B receptor obtained from rat stomach fundus preparation,,,CHEMBL617617,,12688,Rattus norvegicus,,,D,9,BAO_0000019,945.0
2901,,7185,Expert,10116.0,,1,Antagonistic against 5-hydroxytryptamine 2B receptor,,,CHEMBL875914,,12688,Rattus norvegicus,,,D,9,BAO_0000019,
2902,,13267,Autocuration,,,1,Antagonistic affinity measured as pA2 value on 5-hydroxytryptamine 2B receptor of the rat stomach fundus,,,CHEMBL617618,,12688,,,,H,8,BAO_0000019,945.0
2903,,13735,Expert,10116.0,,1,Inhibition of 5-HT binding to 5-HT2B receptor of Rat stomach fundus,,,CHEMBL617619,,12688,Rattus norvegicus,,,D,9,BAO_0000357,945.0
2904,,15738,Autocuration,,,1,Compound was evaluated for antagonism against serotonin (5-hydroxytryptamine 2B receptor ) receptor,,,CHEMBL617620,,12688,,,,H,8,BAO_0000019,
2905,,15738,Autocuration,,,1,Compound was evaluated for antagonism against serotonin (5-hydroxytryptamine 2B receptor ) receptor; No data,,,CHEMBL617621,,12688,,,,H,8,BAO_0000019,
2906,,15738,Autocuration,,,1,Compound was evaluated for antagonism against serotonin (5-hydroxytryptamine 2B) receptor,,,CHEMBL617622,,12688,,,,H,8,BAO_0000019,
2907,,12936,Expert,10116.0,,1,Inhibitory potency against rat stomach fundus 5-hydroxytryptamine 2B receptor,,,CHEMBL617623,,12688,Rattus norvegicus,,,D,9,BAO_0000357,945.0
2908,,12936,Expert,10116.0,,1,Inhibitory potency against rat stomach fundus 5-hydroxytryptamine 2B receptor,,,CHEMBL617624,,12688,Rattus norvegicus,,,D,9,BAO_0000357,945.0
2909,,12936,Expert,10116.0,,1,Inhibitory potency against rat stomach fundus 5-hydroxytryptamine 2B receptor,,,CHEMBL617625,,12688,Rattus norvegicus,,,D,9,BAO_0000357,945.0
2910,,12936,Expert,10116.0,,1,Inhibitory potency against rat stomach fundus 5-hydroxytryptamine 2B receptor,,,CHEMBL617626,,12688,Rattus norvegicus,,,D,9,BAO_0000357,945.0
2911,,16404,Autocuration,,,1,Negative log concentration of antagonistic compound was determined on 5-hydroxytryptamine 2B receptor of Rat stomach fundus,,,CHEMBL617627,,12688,,,,H,8,BAO_0000019,945.0
2912,,16404,Expert,,,1,Negative log concentration of antagonist was determined on 5-hydroxytryptamine 2B receptor of Rat stomach fundus,,,CHEMBL617628,,12688,,,,H,8,BAO_0000019,945.0
2913,,16404,Autocuration,,,1,Negative log concentration of antagonistic compound was determined on 5-hydroxytryptamine 2B receptor of Rat stomach fundus; ND is No Data.,,,CHEMBL617629,,12688,,,,H,8,BAO_0000019,945.0
2914,,16404,Autocuration,,,1,Negative log concentration of antagonistic compound was determined on 5-hydroxytryptamine 2B receptor of Rat stomach fundus; ND is not determined.,,,CHEMBL858115,,12688,,,,H,8,BAO_0000019,945.0
2915,,16404,Expert,10116.0,,1,Antagonistic activity on 5-hydroxytryptamine 2B receptor of Rat stomach fundus;ND is not determined,,,CHEMBL617630,,12688,Rattus norvegicus,,,D,9,BAO_0000019,945.0
2916,,16404,Autocuration,,,1,Negative log concentration of antagonistic compound was determined on 5-hydroxytryptamine 2B receptor of Rat thoracic aorta; ND is not determined,,,CHEMBL617631,,12688,,,,H,8,BAO_0000019,1515.0
2917,,7483,Autocuration,,,1,The binding affinity of compound to 5-HT receptor of rat fundus was expressed as pA2 value; Unable to determine valid PA2 value due to slope of Schild plot,,,CHEMBL617632,,12688,,,,H,8,BAO_0000357,
2918,,7483,Expert,,,1,The binding affinity to 5-hydroxytryptamine 2B receptor of rat fundus,,,CHEMBL617633,,12688,,,,H,8,BAO_0000357,
2919,,7483,Autocuration,,,1,The binding affinity of compound to 5-hydroxytryptamine 2B receptor of rat fundus was expressed as pA2 value; Unable to determine valid PA2 value due to slope of Schild plot,,,CHEMBL617634,,12688,,,,H,8,BAO_0000357,
2920,,7483,Autocuration,,,1,The binding affinity of compound to 5-hydroxytryptamine 2B receptor of rat fundus; Unable to determine valid PA2 value due to slope of Schild plot,,,CHEMBL617635,,12688,,,,H,8,BAO_0000357,
2922,,16404,Autocuration,10116.0,,1,Negative log concentration of antagonistic compound was determined on 5-hydroxytryptamine 2B receptor of Rat stomach fundus,,,CHEMBL617637,,12688,Rattus norvegicus,,,D,9,BAO_0000019,945.0
2923,,6347,Autocuration,,,1,Binding affinity against 5-hydroxytryptamine 1A receptor,,,CHEMBL617638,,227,,,,H,8,BAO_0000357,
2924,,4373,Autocuration,,,1,Binding affinity relative to indolopiperidine (compound 1) for 5-hydroxytryptamine 2B receptor was determined,,,CHEMBL617639,,227,,,,H,8,BAO_0000357,
2925,,4373,Autocuration,,,1,Binding affinity for 5-hydroxytryptamine 2B receptor was determined,,,CHEMBL617640,,227,,,,H,8,BAO_0000357,
2926,,4687,Autocuration,,,1,Evaluated for the binding affinity to 5-HT 2B receptor,,,CHEMBL617641,,227,,,,H,8,BAO_0000357,
2927,,16946,Autocuration,,,1,Ability to displace [3H]5-HT from 5-hydroxytryptamine 2B receptor,,,CHEMBL617642,,227,,,,H,8,BAO_0000357,
2928,,16633,Autocuration,,,1,Binding affinities against 5-hydroxytryptamine 2B receptor,,,CHEMBL617643,,227,,,,H,8,BAO_0000357,
2929,,16633,Autocuration,,,1,Binding affinities towards 5-hydroxytryptamine 2B receptor,,,CHEMBL617644,,227,,,,H,8,BAO_0000357,
2930,,16633,Autocuration,,,1,Binding affinity towards 5-hydroxytryptamine 2B receptor using [125I]DOI as radioligand,,,CHEMBL617645,,227,,,,H,8,BAO_0000357,
2931,,15026,Expert,,,1,In vitro ability to displace [3H]mesulergine binding from 5-hydroxytryptamine 2C receptor from bovine choroid plexus.,,,CHEMBL617646,,108,,,,H,8,BAO_0000357,
2932,,15738,Autocuration,9913.0,,1,In vitro affinity against serotonin (5-hydroxytryptamine 2C) receptor,,,CHEMBL617647,,108,Bos taurus,,,H,8,BAO_0000357,
2933,,15738,Autocuration,9913.0,,1,In vitro affinity against serotonin (5-hydroxytryptamine 2C) receptor at a concentration of 10E-6 M,,,CHEMBL617648,,108,Bos taurus,,,H,8,BAO_0000357,
2934,,15738,Autocuration,9913.0,,1,In vitro affinity against serotonin (5-hydroxytryptamine 2C) receptor at a concentration of 10e-6 M,,,CHEMBL617875,,108,Bos taurus,,,H,8,BAO_0000357,
2935,,15738,Autocuration,9913.0,,1,In vitro affinity against serotonin (5-hydroxytryptamine 2C) receptor at concentration of 10e-6 M,,,CHEMBL617876,,108,Bos taurus,,,H,8,BAO_0000357,
2936,,16404,Expert,9913.0,,1,Inhibitory constant was determined on 5-hydroxytryptamine 2C receptor of Bovine choroid plexus,,,CHEMBL617877,,108,Bos taurus,,,H,8,BAO_0000357,
2937,,15026,Expert,9913.0,,1,In vitro ability to displace [3H]mesulergine binding from 5-hydroxytryptamine 2C receptor from bovine choroid plexus.,,,CHEMBL617878,,108,Bos taurus,,,H,8,BAO_0000357,
2938,,15738,Autocuration,9913.0,,1,In vitro affinity against serotonin (5-hydroxytryptamine 2C) receptor,,,CHEMBL617879,,108,Bos taurus,,,H,8,BAO_0000357,
2939,,16312,Autocuration,10141.0,,1,Binding affinity against guinea pig cortex 5-HT2C receptor in the presence of [3H]mesulergine,,,CHEMBL617880,,108,Cavia porcellus,,,H,8,BAO_0000019,
2940,,5486,Intermediate,10141.0,,1,Binding affinity towards 5-HT4 receptor by the displacement of [3H]GR-113808 in guinea-pig striatum,,,CHEMBL617881,,20033,Cavia porcellus,,,D,9,BAO_0000357,2435.0
2941,,5254,Autocuration,,,1,Binding affinity against 5-HT1A receptor,,,CHEMBL857073,,51,,,,H,8,BAO_0000357,
2942,,3857,Expert,,,1,Agonistic activity for 5-HT2c (5-HT2C) by measuring [3H]inositol monophosphate fromation in CHO cells in which the human 5-HT2C receptor subtype was stably expressed,449.0,,CHEMBL617882,,108,,CHO,,H,8,BAO_0000219,
2943,,6857,Expert,9606.0,,1,Functional activity against human 5-hydroxytryptamine 2C receptor expressed in CHO cells using fluorometric imaging plate reader,449.0,,CHEMBL617883,,108,Homo sapiens,CHO,,D,9,BAO_0000219,
2944,,4176,Autocuration,,,1,Functional agonist activity of compound was determined by fluorescence-based assay measuring intracellular calcium mobilization for 5-HT2c receptor cell line,,,CHEMBL617884,,108,,,,H,8,BAO_0000219,
2945,,6347,Autocuration,,,1,Agonistic binding efficacy against human 5-hydroxytryptamine 2C receptor in CHO cells using [125I]- DOI radioligand,449.0,,CHEMBL617885,,108,,CHO,,H,8,BAO_0000219,
2946,,6347,Autocuration,,,1,"Agonistic binding affinity against human 5-hydroxytryptamine 2C receptor in CHO cells using [125I]- DOI radioligand, expressed as Emax",449.0,,CHEMBL617886,,108,,CHO,,H,8,BAO_0000219,
2947,,16146,Expert,9606.0,,1,Inhibition of human 5-hydroxytryptamine 2C receptor,,,CHEMBL617887,,108,Homo sapiens,,,D,9,BAO_0000357,
2948,,3805,Autocuration,,,1,In vitro binding affinity against human 5-hydroxytryptamine 2C receptor at a concentration of 100 (nM),,,CHEMBL617888,,108,,,,H,8,BAO_0000357,
2949,,3857,Autocuration,,,1,Inhibitory activity using [3H]mesulergine as radioligand with receptor membranes isolated from a CHO-k cell line expressing the human 5-hydroxytryptamine 2C receptor at a concentration of 1 uM,,,CHEMBL617889,,108,,,,H,8,BAO_0000019,
2950,,5635,Autocuration,,,1,Intrinsic efficacy against 5-hydroxytryptamine 2C receptor,,,CHEMBL617890,,108,,,,H,8,BAO_0000357,
2951,,5635,Autocuration,,,1,Intrinsic efficacy against 5-hydroxytryptamine 2C receptor Intrinsic efficacy against 5-hydroxytryptamine 2C receptor; Intrinsic efficacy (%) not determined,,,CHEMBL617891,,108,,,,H,8,BAO_0000357,
2952,,5635,Autocuration,,,1,Intrinsic efficacy against 5-hydroxytryptamine 2C receptor; Intrinsic efficacy (%) not determined,,,CHEMBL617892,,108,,,,H,8,BAO_0000357,
2953,,4012,Expert,,,1,Displacement of [H]-mesulergine from CHO cells expressing human 5-hydroxytryptamine 2C receptor.,449.0,,CHEMBL617893,,108,,CHO,,H,8,BAO_0000219,
2954,,6366,Expert,,,1,Ability to displace [3H]- mesulergine from human cloned 5-hydroxytryptamine 2C receptor expressed in CHO cells,449.0,,CHEMBL617894,,108,,CHO,,H,8,BAO_0000219,
2955,,15949,Expert,,,1,Ability to displace [3H]mesulergine binding to human 5-hydroxytryptamine 2C receptor stably expressed in CHO cells,449.0,,CHEMBL617895,,108,,CHO,,H,8,BAO_0000219,
2956,,17211,Autocuration,,,1,Ability to displace [3H]mesulergine (0.5 nM) from CHO cells of human 5-hydroxytryptamine 2C receptor,449.0,,CHEMBL617896,,108,,CHO,,H,8,BAO_0000219,
2957,,6491,Expert,9606.0,,1,Affinity towards human 5-hydroxytryptamine 2C serotonin receptor,,,CHEMBL617897,,108,Homo sapiens,,,D,9,BAO_0000357,
2958,,14093,Autocuration,,,1,Agonist activity at cloned human 5-hydroxytryptamine 2C receptor using [125I]DOI radioligand,,,CHEMBL617898,,108,,,,H,8,BAO_0000019,
2959,,13481,Autocuration,,,1,Agonistic activity at cloned human 5-hydroxytryptamine 2C receptor using [125I]DOI as radioligand,,,CHEMBL617899,,108,,,,H,8,BAO_0000019,
2960,,6347,Expert,10116.0,,1,Agonistic binding affinity against human 5-hydroxytryptamine 2C receptor in CHO cells using [125I]- DOI ,449.0,,CHEMBL617900,,108,Rattus norvegicus,CHO,,H,8,BAO_0000219,
2961,,14093,Autocuration,,,1,Antagonist activity at cloned human 5-hydroxytryptamine 2C receptor using [3H]mesulergine radioligand,,,CHEMBL617901,,108,,,,H,8,BAO_0000019,
2962,,14093,Autocuration,,,1,Antagonist activity at cloned human 5-hydroxytryptamine 2C receptor using [3H]mesulergine radioligand; Not tested,,,CHEMBL617902,,108,,,,H,8,BAO_0000019,
2963,,13481,Autocuration,,,1,Antagonistic activity at cloned human 5-hydroxytryptamine 2C receptor using [3H]mesulergine as radioligand,,,CHEMBL617903,,108,,,,H,8,BAO_0000019,
2964,,14442,Autocuration,,,1,Binding ability of compound at cloned human 5-hydroxytryptamine 2C receptor using [125 I]DOI as radioligand,,,CHEMBL617904,,108,,,,H,8,BAO_0000357,
2965,,14442,Autocuration,,,1,Binding ability of compound at cloned human 5-hydroxytryptamine 2C receptor using [3H]- mesulergine as radioligand,,,CHEMBL617905,,108,,,,H,8,BAO_0000357,
2966,,14442,Autocuration,,,1,Binding ability of compound at cloned human 5-hydroxytryptamine 2C receptor using [3H]- mesulergine as radioligand;not tested,,,CHEMBL617906,,108,,,,H,8,BAO_0000357,
2967,,14755,Autocuration,,,1,Binding activity against cloned human 5-hydroxytryptamine 2C receptor using [125I]DOI as the radioligand.,,,CHEMBL617907,,108,,,,H,8,BAO_0000357,
2968,,14744,Autocuration,,,1,Binding affinity against the cloned human 5-hydroxytryptamine 2C receptor using [125I]DOI as the radioligand,,,CHEMBL617908,,108,,,,H,8,BAO_0000357,
2969,,16659,Expert,,,1,Binding affinity for displacement of [3H]mesulergine to human 5-hydroxytryptamine 2C receptor stably expressed in CHO cells,449.0,,CHEMBL620617,,108,,CHO,,H,8,BAO_0000219,
2970,,6857,Expert,9606.0,,1,Affinity for human 5-hydroxytryptamine 2C receptor expressed in mammalian cell line,,,CHEMBL620618,,108,Homo sapiens,,,D,9,BAO_0000019,
2971,,5635,Expert,,,1,Binding affinity against 5-hydroxytryptamine 2C receptor using [125I]DOI radioligand.,,,CHEMBL620619,,108,,,,H,8,BAO_0000357,
2972,,4234,Expert,9606.0,,1,Binding affinity to cloned human 5-hydroxytryptamine 2C receptor,,,CHEMBL620620,,108,Homo sapiens,,,D,9,BAO_0000357,
2973,,16209,Autocuration,,,1,Binding affinity towards human 5-HT2C receptor was determined using [125I]- DOI as radioligand,,,CHEMBL620621,,108,,,,H,8,BAO_0000357,
2974,,5778,Autocuration,10116.0,,1,Binding affinity for 5-HT3 receptor by displacement of [3H]-LY 278584 in rat cerebral cortex membranes,,,CHEMBL872920,Membranes,104698,Rattus norvegicus,,,D,7,BAO_0000249,
2975,,5094,Autocuration,,,1,Binding affinity towards rat 5-hydroxytryptamine 3 receptor was evaluated,,,CHEMBL620622,,104698,,,,H,6,BAO_0000223,
2976,,809,Autocuration,10116.0,,1,Binding affinity against 5-hydroxytryptamine 3 receptor using [3H]BRL-43694 in rat posterior cortex,,,CHEMBL620623,,104698,Rattus norvegicus,,,D,7,BAO_0000019,
2977,,1578,Autocuration,,,1,Binding affinity against 5-hydroxytryptamine 3 receptor using [3H]BRL-43694 as radioligand in rat posterior cortex,,,CHEMBL620624,,104698,,,,H,6,BAO_0000019,
2978,,809,Autocuration,,,1,Binding affinity against 5-hydroxytryptamine 3 receptor using [3H]BRL-43694 as radioligand in rat posterior cortex; Not tested,,,CHEMBL620625,,104698,,,,H,6,BAO_0000019,
2979,,12469,Autocuration,,,1,Binding affinity was measured on 5-hydroxytryptamine 3 receptor in NG-108 cells labeled with [3H]GR-65630,,,CHEMBL620626,,104698,,,,H,6,BAO_0000219,
2980,,14290,Autocuration,,,1,Binding affinity was measured on 5-hydroxytryptamine 3 receptor using [3H]-BRL 43694 as radioligand in rat posterior cortex,,,CHEMBL621307,,104698,,,,H,6,BAO_0000019,
2981,,14290,Autocuration,,,1,Binding affinity was measured on 5-hydroxytryptamine 3 receptor using [3H]-BRL 43694 as radioligand in rat posterior cortex.,,,CHEMBL621308,,104698,,,,H,6,BAO_0000019,
2982,,10609,Autocuration,,,1,Binding affinity for central 5-hydroxytryptamine 3 receptor was determined by displacement of [3H]-5-HT,,,CHEMBL621309,,104698,,,,H,6,BAO_0000223,
2983,,10609,Autocuration,,,1,Binding affinity for central 5-hydroxytryptamine 3 receptor was determined by displacement of [3H]GR-65630,,,CHEMBL621310,,104698,,,,H,6,BAO_0000223,
2984,,10609,Autocuration,,,1,Binding affinity for central 5-hydroxytryptamine 3 receptor was determined by displacement of [3H]-ketanserin,,,CHEMBL621311,,104698,,,,H,6,BAO_0000223,
2985,,15253,Autocuration,,,1,"Compound was evaluated for its in vitro affinity at serotonergic 5-hydroxytryptamine 3 receptor by radioligand binding assay, using [3H]-LY 278584 in rat cerebral cortex membranes.",,,CHEMBL621502,,104698,,,,H,6,BAO_0000249,
2986,,15253,Autocuration,,,1,"In vitro affinity at serotonergic 5-hydroxytryptamine 3 receptor by radioligand binding assay, using [3H]-LY 278584 in rat cerebral cortex membranes.",,,CHEMBL621503,,104698,,,,H,6,BAO_0000249,
2987,,11683,Autocuration,,,1,Displacement of the 5-hydroxytryptamine 3 receptor ligand [3H]GR-65630 from rat brain cortical membranes.,,,CHEMBL621504,Membranes,104698,,,,H,6,BAO_0000249,
2988,,12092,Autocuration,,,1,Compound was evaluated for binding affinity against 5-hydroxytryptamine 3 receptor,,,CHEMBL621505,,104698,,,,H,6,BAO_0000223,
2989,,1946,Autocuration,,,1,Binding affinity at 5-hydroxytryptamine 3 receptor in rat entorhinal cortex by [3H]BRL-43694 displacement.,,,CHEMBL621506,,104698,,,,H,6,BAO_0000019,
2990,,11623,Autocuration,,,1,Ability to displace [3H]quipazine binding to 5-hydroxytryptamine 3 receptor sites in NG 108-15.,,,CHEMBL619781,,104698,,,,H,6,BAO_0000223,
2991,,11623,Autocuration,,,1,Compound was evaluated for its ability to displace [3H]quipazine binding to 5-hydroxytryptamine 3 receptor sites in NG 108-15. ,,,CHEMBL619782,,104698,,,,H,6,BAO_0000223,
2992,,14788,Autocuration,,,1,Compound was evaluated for its binding affinity for 5-hydroxytryptamine 3 receptor by measuring displacement [3H]GR-65630 in rat cerebral cortex,,,CHEMBL619783,,104698,,,,H,6,BAO_0000019,
2993,,5432,Autocuration,10116.0,,1,Displacement of [3H]ketanserin from rat cortex 5-HT3 receptor,,,CHEMBL619784,,104698,Rattus norvegicus,,,D,7,BAO_0000019,
2994,,14826,Autocuration,,,1,Ability to displace [3H]granisetron specifically bound to 5-hydroxytryptamine 3 receptor in rat cortical membrane,,,CHEMBL619785,,104698,,,,H,6,BAO_0000249,
2995,,2222,Autocuration,,,1,Compound was tested for its binding affinity for the 5-hydroxytryptamine 3 receptor,,,CHEMBL619786,,104698,,,,H,6,BAO_0000223,
2996,,11963,Autocuration,,,1,Displacement of binding of [3H]-BRL 43694 to 5-hydroxytryptamine 3 receptor in rat cerebral cortex,,,CHEMBL619787,,104698,,,,H,6,BAO_0000019,
2997,,14145,Autocuration,,,1,In vitro affinity for 5-hydroxytryptamine 3 (5-HT3) receptor by displacement of [3H]BRL-43694 from rat entorhinal cortex,,,CHEMBL872925,,104698,,,,H,6,BAO_0000019,
2998,,17819,Autocuration,,,1,In vitro binding affinity at serotonin 5-hydroxytryptamine 3 receptor in rat cortex by [3H]granisetron displacement.,,,CHEMBL619788,,104698,,,,H,6,BAO_0000019,
2999,,10394,Autocuration,,,1,Inhibitory activity against 5-hydroxytryptamine 3 receptor in rat cortical membranes using [3H]- 1-Methyl-1H-indazole-3-carboxylic acid (8-methyl-8-aza-bicyclo[3.2.1]oct-3-yl)-amide as a radioligand,,,CHEMBL619789,,104698,,,,H,6,BAO_0000249,
3000,,10394,Autocuration,,,1,Inhibitory activity against 5-hydroxytryptamine 3 receptor in rat cortical membranes using [3H]-1-Methyl-1H-indazole-3-carboxylic acid (8-methyl-8-aza-bicyclo[3.2.1]oct-3-yl)-amide as a radioligand,,,CHEMBL619790,,104698,,,,H,6,BAO_0000249,
3001,,15034,Autocuration,,,1,Inhibitory concentration against 5-hydroxytryptamine 3 receptor in rat entorhinal cortex using [3H]-LY 278584 as radioligand,,,CHEMBL619791,,104698,,,,H,6,BAO_0000019,
3002,,691,Autocuration,,,1,Binding affinity at 5-hydroxytryptamine 3 receptor in rat entorhinal cortex by [3H]BRL-43694 displacement.,,,CHEMBL619792,,104698,,,,H,6,BAO_0000019,
3003,,12092,Autocuration,,,1,Displacement of [3H]GR-65630 binding to 5-hydroxytryptamine 3 receptor in rat brain cortical membranes,,,CHEMBL619793,Membranes,104698,,,,H,6,BAO_0000249,
3004,,11752,Autocuration,10116.0,,1,Inhibition of [3H]GR-65630 binding to 5-hydroxytryptamine 3 receptor,,,CHEMBL619794,,104698,Rattus norvegicus,,,D,7,BAO_0000223,
3005,,11752,Autocuration,,,1,The ability to inhibit [3H]GR-65630 binding to 5-hydroxytryptamine 3 receptor in rat brain cortices,,,CHEMBL619795,,104698,,,,H,6,BAO_0000221,955.0
3006,,301,Autocuration,,,1,Binding affinity at 5-hydroxytryptamine 3 receptor in rat posterior cortex by [3H]-BRL 43694 displacement.,,,CHEMBL619796,,104698,,,,H,6,BAO_0000019,
3007,,16532,Autocuration,,,1,The binding affinity at 5-hydroxytryptamine 3 receptor was determined using [3H]LY-278584,,,CHEMBL620448,,104698,,,,H,6,BAO_0000223,
3008,,16532,Autocuration,,,1,The binding affinity at 5-hydroxytryptamine 3 receptor was determined using [3H]LY-278584; Not tested,,,CHEMBL620449,,104698,,,,H,6,BAO_0000223,
3009,,12092,Autocuration,,,1,The binding affinity was measured on 5-hydroxytryptamine 3 receptor using [3H]GR-65630 as radioligand.,,,CHEMBL620450,,104698,,,,H,6,BAO_0000223,
3010,,11684,Autocuration,,,1,The compound was evaluated for the binding affinity towards 5-hydroxytryptamine 3 receptor by displacement of radioligand [3H]GR-65630,,,CHEMBL620451,,104698,,,,H,6,BAO_0000223,
3011,,11684,Autocuration,,,1,Binding affinity towards 5-hydroxytryptamine 3 receptor by displacement of radioligand [3H]GR-65630.,,,CHEMBL620631,,104698,,,,H,6,BAO_0000223,
3012,,12953,Autocuration,,,1,Binding affinity for 5-hydroxytryptamine 3 receptor from rat cortex using [3H]BRL-43694 as radioligand,,,CHEMBL620632,,104698,,,,H,6,BAO_0000019,
3013,,12953,Autocuration,,,1,The compound was tested for its binding affinity towards 5-hydroxytryptamine 3 receptor from rat cortex using [3H]BRL-43694 as radioligand; NA means Not active,,,CHEMBL620633,,104698,,,,H,6,BAO_0000019,
3014,,12953,Autocuration,,,1,The compound was tested for their binding affinity towards 5-hydroxytryptamine 3 receptor; Nonactive at 10 uM,,,CHEMBL620634,,104698,,,,H,6,BAO_0000223,
3015,,12861,Autocuration,,,1,Binding activity against 5-hydroxytryptamine 3 receptor from rat cortex homogenate using [3H]-Q-ICS 205-930 as radioligand; NA Not Available,,,CHEMBL620635,,104698,,,,H,6,BAO_0000019,
3016,In vivo,11454,Autocuration,,,1,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 0.03 mg/kg at 0.5 hours in urethane-anesthetized rats,,,CHEMBL620636,,104698,,,,H,6,BAO_0000218,
3017,In vivo,11454,Autocuration,,,1,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 0.03 mg/kg at 1 hour in urethane-anesthetized rats,,,CHEMBL620637,,104698,,,,H,6,BAO_0000218,
3018,In vivo,11454,Autocuration,,,1,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 0.03 mg/kg at 3 hours in urethane-anesthetized rats,,,CHEMBL620638,,104698,,,,H,6,BAO_0000218,
3019,In vivo,11454,Autocuration,,,1,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 0.03 mg/kg at 6 hours in urethane-anesthetized rats,,,CHEMBL620639,,104698,,,,H,6,BAO_0000218,
3020,In vivo,11454,Autocuration,,,1,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 0.1 mg/kg at 0.5 hours in urethane-anesthetized rats,,,CHEMBL620640,,104698,,,,H,6,BAO_0000218,
3021,In vivo,11454,Autocuration,,,1,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 0.1 mg/kg at 1 hour in urethane-anesthetized rats,,,CHEMBL620641,,104698,,,,H,6,BAO_0000218,
3022,In vivo,11454,Autocuration,,,1,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 0.1 mg/kg at 16 hours in urethane-anesthetized rats,,,CHEMBL620642,,104698,,,,H,6,BAO_0000218,
3023,In vivo,11454,Autocuration,,,1,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 0.1 mg/kg at 3 hours in urethane-anesthetized rats,,,CHEMBL620643,,104698,,,,H,6,BAO_0000218,
3024,In vivo,11454,Autocuration,,,1,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 0.1 mg/kg at 6 hours in urethane-anesthetized rats,,,CHEMBL620644,,104698,,,,H,6,BAO_0000218,
3025,In vivo,11454,Autocuration,,,1,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 0.3 mg/kg at 0.5 hours in urethane-anesthetized rats,,,CHEMBL620645,,104698,,,,H,6,BAO_0000218,
3026,In vivo,11454,Autocuration,,,1,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 0.3 mg/kg at 1 hour in urethane-anesthetized rats,,,CHEMBL620646,,104698,,,,H,6,BAO_0000218,
3027,In vivo,11454,Autocuration,,,1,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 0.3 mg/kg at 3 hours in urethane-anesthetized rats,,,CHEMBL620647,,104698,,,,H,6,BAO_0000218,
3028,In vivo,11454,Autocuration,,,1,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 0.3 mg/kg at 6 hours in urethane-anesthetized rats,,,CHEMBL620648,,104698,,,,H,6,BAO_0000218,
3029,In vivo,11454,Autocuration,,,1,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 1 mg/kg at 0.5 hours in urethane-anesthetized rats,,,CHEMBL620649,,104698,,,,H,6,BAO_0000218,
3030,In vivo,11454,Autocuration,,,1,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 1 mg/kg at 3 hours in urethane-anesthetized rats,,,CHEMBL620650,,104698,,,,H,6,BAO_0000218,
3031,In vivo,11454,Autocuration,,,1,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 10 mg/kg at 1 hour in urethane-anesthetized rats,,,CHEMBL620651,,104698,,,,H,6,BAO_0000218,
3032,In vivo,11454,Autocuration,,,1,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 10 mg/kg at 3 hours in urethane-anesthetized rats,,,CHEMBL872875,,104698,,,,H,6,BAO_0000218,
3033,In vivo,11454,Autocuration,,,1,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 1 mg/kg at 1 hour in urethane-anesthetized rats,,,CHEMBL620652,,104698,,,,H,6,BAO_0000218,
3034,,10609,Autocuration,,,1,5-hydroxytryptamine 3 receptor antagonist activity was confirmed by its ability to antagonize 5-HT evoked tachycardia of rabbit isolated heart,,,CHEMBL620653,,104698,,,,H,6,BAO_0000019,
3035,,12861,Autocuration,,,1,Binding activity against 5-hydroxytryptamine 2A receptor from rat cortex homogenates using [3H]DOB as radioligand.,,,CHEMBL857076,,104698,,,,H,6,BAO_0000019,
3036,,12861,Autocuration,10116.0,,1,Inhibition of [3H]-Q-ICS 205-930 binding to rat cortex homogenate 5-hydroxytryptamine 3 receptor,,,CHEMBL620654,,104698,Rattus norvegicus,,,D,7,BAO_0000019,
3037,,12861,Autocuration,,,1,Binding activity radioligand.,,,CHEMBL620655,,104698,,,,H,6,BAO_0000223,
3038,,10728,Autocuration,,,1,Compound was evaluated for the displacement of [3H]-Q-ICS 205-930 binding to 5-hydroxytryptamine 3 receptor in rat brain membranes,,,CHEMBL620656,Brain membranes,104698,,,,H,6,BAO_0000249,
3039,,10728,Autocuration,,,1,Displacement of [3H]-Q-ICS 205-930 binding to 5-hydroxytryptamine 3 receptor recognition sites in rat brain membranes.,,,CHEMBL620657,Brain membranes,104698,,,,H,6,BAO_0000249,
3040,,5163,Autocuration,,,1,Binding affinity towards 5-hydroxytryptamine 2C receptor was determined at a concentration of 0.000001 mol/L,,,CHEMBL620658,,108,,,,H,8,BAO_0000357,
3041,,5163,Autocuration,,,1,Binding affinity towards 5-hydroxytryptamine 2C receptor was determined at a concentration of 0.00001 mol/L,,,CHEMBL620659,,108,,,,H,8,BAO_0000357,
3042,,6011,Autocuration,,,1,Inhibition of binding towards 5-hydroxytryptamine 2C receptor at 100 nM concentration,,,CHEMBL620660,,108,,,,H,8,BAO_0000357,
3043,,5014,Autocuration,,,1,Percent inhibition (at 1 uM) against 5-hydroxytryptamine 2C receptor,,,CHEMBL620661,,108,,,,H,8,BAO_0000357,
3044,,5635,Autocuration,,,1,Binding affinity of compound towards 5-hydroxytryptamine 2C receptor,,,CHEMBL620662,,108,,,,H,8,BAO_0000357,
3045,,5163,Expert,,,1,Affinity for 5-hydroxytryptamine 2C receptor,,,CHEMBL620663,,108,,,,H,8,BAO_0000357,
3046,,6841,Autocuration,,,1,Binding affinity towards 5-hydroxytryptamine 2C receptor using [3H]mesulergine as radioligand,,,CHEMBL620664,,108,,,,H,8,BAO_0000357,
3047,,6119,Expert,,,1,Binding affinity towards 5-hydroxytryptamine 2C receptor using [125I]DOI as radioligand.,,,CHEMBL620665,,108,,,,H,8,BAO_0000357,
3048,,4373,Autocuration,,,1,Binding affinity relative to indolopiperidine (compound 1) for 5-hydroxytryptamine 2C receptor was determined,,,CHEMBL620666,,108,,,,H,8,BAO_0000357,
3049,,1633,Autocuration,,,1,Compound was evaluated for the binding affinity towards 5-hydroxytryptamine 2C receptor by displacement of [3H]-Ketanserin,,,CHEMBL620667,,108,,,,H,8,BAO_0000357,
3050,,1633,Expert,,,1,Binding affinity towards 5-hydroxytryptamine 2C receptor by displacement of [3H]N-methyl-mesulergine,,,CHEMBL620668,,108,,,,H,8,BAO_0000357,
3051,,4373,Autocuration,,,1,Binding affinity for 5-hydroxytryptamine 2C receptor was determined,,,CHEMBL620669,,108,,,,H,8,BAO_0000357,
3052,,6576,Expert,,,1,Binding affinity towards serotonin 5-hydroxytryptamine 2C receptor,,,CHEMBL620670,,108,,,,H,8,BAO_0000357,
3053,,4687,Autocuration,,,1,Evaluated for the binding affinity to 5-hydroxytryptamine 2C receptor,,,CHEMBL620671,,108,,,,H,8,BAO_0000357,
3054,,12146,Autocuration,,,1,Tested agains t5-hydroxytryptamine 2C receptor in experiment 1,,,CHEMBL620672,,108,,,,H,8,BAO_0000357,
3055,,12146,Autocuration,,,1,Tested against 5-hydroxytryptamine 2C receptor in experiment 2,,,CHEMBL620673,,108,,,,H,8,BAO_0000357,
3056,,16946,Autocuration,,,1,Ability to displace [3H]mesulergine from 5-hydroxytryptamine 2C receptor,,,CHEMBL620674,,108,,,,H,8,BAO_0000357,
3057,,14159,Autocuration,,,1,Compound was evaluated for the affinity at 5-hydroxytryptamine 2C receptor,,,CHEMBL620675,,108,,,,H,8,BAO_0000357,
3058,,16700,Autocuration,,,1,The binding affinity towards 5-hydroxytryptamine 2C receptor; No affinity,,,CHEMBL620676,,108,,,,H,8,BAO_0000357,
3059,,3269,Autocuration,,,1,Affinity against 5-hydroxytryptamine 2C receptor,,,CHEMBL621382,,108,,,,H,8,BAO_0000357,
3060,,1274,Expert,9606.0,,1,Binding affinity against 5-hydroxytryptamine 2C receptor,,,CHEMBL621383,,108,Homo sapiens,,,D,9,BAO_0000357,
3061,,1317,Autocuration,,,1,Compound was evaluated for binding affinity against 5-hydroxytryptamine 2C receptor using radioligand binding assay,,,CHEMBL621384,,108,,,,H,8,BAO_0000357,
3062,,5834,Autocuration,9913.0,,1,Inhibitory concentration required against 5-HT3 receptor in bovine area postrema using [3H]GR-65630,,,CHEMBL621385,,144,Bos taurus,,,H,8,BAO_0000357,
3063,,11147,Autocuration,9913.0,,1,Binding affinity towards 5-hydroxytryptamine 3 receptor using [3H]GR-65630 as radioligand,,,CHEMBL617989,,144,Bos taurus,,,H,8,BAO_0000357,
3064,,14145,Expert,10141.0,,1,Antagonistic potency against serotonin 5-hydroxytryptamine 3 receptor in GPI assay,,,CHEMBL617990,,104714,Cavia porcellus,,,H,4,BAO_0000019,
3065,,10561,Autocuration,10141.0,,1,Binding affinity to 5-hydroxytryptamine 3 receptor entirely in guinea pig ileum,,,CHEMBL875085,,104714,Cavia porcellus,,,H,4,BAO_0000221,2116.0
3066,,15847,Autocuration,10141.0,,1,Compound was evaluated for its antagonist affinity towards 5-hydroxytryptamine 3 receptor of guinea pig,,,CHEMBL617991,,104714,Cavia porcellus,,,H,4,BAO_0000019,
3067,,15847,Autocuration,10141.0,,1,Compound was evaluated for its antagonist affinity towards 5-hydroxytryptamine 3 receptor of guinea pig; ND means not done,,,CHEMBL617992,,104714,Cavia porcellus,,,H,4,BAO_0000019,
3068,,10561,Autocuration,10141.0,,1,Potency to 5-hydroxytryptamine 3 receptor entirely in guinea pig ileum,,,CHEMBL617993,,104714,Cavia porcellus,,,H,4,BAO_0000221,2116.0
3069,,11454,Autocuration,10141.0,,1,In vitro binding affinity was measured for 5-hydroxytryptamine 3 receptor in the guinea pig ileum.,,,CHEMBL617994,,104714,Cavia porcellus,,,H,4,BAO_0000221,2116.0
3070,,4639,Autocuration,10141.0,,1,Compound was tested for agonistic activity against 5-hydroxytryptamine 3 receptor on guinea colon at a concentration 0.01 uM,,,CHEMBL617995,,104714,Cavia porcellus,,,H,4,BAO_0000019,
3071,,4639,Autocuration,10141.0,,1,Percent of control response to 5-HT3 agonistic activity on guinea colon at a concentration 0.1 uM,,,CHEMBL617996,,104714,Cavia porcellus,,,H,4,BAO_0000019,
3072,,4639,Autocuration,10141.0,,1,Percent of control response to 5-HT3 agonistic activity on guinea colon at a concentration 1 uM,,,CHEMBL617997,,104714,Cavia porcellus,,,H,4,BAO_0000019,
3073,,4639,Autocuration,10141.0,,1,Percent of control response to 5-HT3 agonistic activity on guinea colon at a concentration 1 uM in the presence of 30 uM MDL 72222,,,CHEMBL617998,,104714,Cavia porcellus,,,H,4,BAO_0000019,
3074,,4639,Autocuration,10141.0,,1,Percent of control response to 5-HT3 antagonistic activity on guinea colon at a concentration 0.01 uM,,,CHEMBL617999,,104714,Cavia porcellus,,,H,4,BAO_0000019,
3075,,4639,Autocuration,10141.0,,1,Percent of control response to 5-HT3 antagonistic activity on guinea colon at a concentration 1 uM,,,CHEMBL618000,,104714,Cavia porcellus,,,H,4,BAO_0000019,
3076,,15253,Autocuration,10141.0,,1,"Concentration required to produce 50% of maximal contraction induced by 5-HT through 5-HT3 receptors in the presence of the compound, in isolated guinea pig ileum",,,CHEMBL617815,,104714,Cavia porcellus,,,H,4,BAO_0000221,2116.0
3077,,15253,Autocuration,10141.0,,1,"Concentration required to produce 50% of maximal contraction induced by 5-HT through 5-HT3 receptors in the presence of the compound, in isolated guinea pig ileum.",,,CHEMBL617816,,104714,Cavia porcellus,,,H,4,BAO_0000221,2116.0
3078,,11963,Autocuration,10141.0,,1,Tested for the antagonistic activity against 5-hydroxytryptamine 3 receptor from guinea pig ileum,,,CHEMBL617817,,104714,Cavia porcellus,,,H,4,BAO_0000221,2116.0
3079,,1946,Autocuration,10141.0,,1,In vitro 5-hydroxytryptamine 3 receptor activity in guinea pig ileum,,,CHEMBL617818,,104714,Cavia porcellus,,,H,4,BAO_0000221,2116.0
3080,,1946,Autocuration,10141.0,,1,In vitro 5-hydroxytryptamine 3 receptor activity in guinea pig ileum; Not tested,,,CHEMBL617819,,104714,Cavia porcellus,,,H,4,BAO_0000221,2116.0
3081,,12045,Autocuration,10141.0,,1,Binding affinity towards [3H]quipazine labeled 5-hydroxytryptamine 3 receptor sites in HG108-15,,,CHEMBL617820,,104714,Cavia porcellus,,,H,4,BAO_0000223,
3082,,1559,Autocuration,10141.0,,1,Binding affinity against 5-hydroxytryptamine 3 receptor of guinea pig ileum,,,CHEMBL617821,,104714,Cavia porcellus,,,H,4,BAO_0000221,2116.0
3083,,273,Autocuration,10141.0,,1,Evaluated for the antagonistic activity against 5-hydroxytryptamine 3 receptor in isolated guinea pig ileum (GPI),,,CHEMBL617822,,104714,Cavia porcellus,,,H,4,BAO_0000221,2116.0
3084,,273,Autocuration,10141.0,,1,Antagonistic activity against Serotonin 5-hydroxytryptamine 3 receptor of isolated guinea pig ileum (GPI),,,CHEMBL617823,,104714,Cavia porcellus,,,H,4,BAO_0000221,2116.0
3085,,188,Autocuration,10141.0,,1,Tested for antagonistic activity on 5-hydroxytryptamine 3 receptor mediated effects of 5-HT in guinea pig isolated ileum,,,CHEMBL617824,,104714,Cavia porcellus,,,H,4,BAO_0000221,2116.0
3086,,12919,Autocuration,10141.0,,1,Agonistic activity against 5-hydroxytryptamine 3 receptor in guinea pig ileum assay,,,CHEMBL617825,,104714,Cavia porcellus,,,H,4,BAO_0000221,2116.0
3087,,12918,Autocuration,10141.0,,1,5-hydroxytryptamine 3 receptor agonism in the guinea pig ileum by functional 5-HT3 receptor assay,,,CHEMBL617826,,104714,Cavia porcellus,,,H,4,BAO_0000221,2116.0
3088,,1559,Autocuration,10141.0,,1,Binding affinity against 5-hydroxytryptamine 3 receptor of guinea pig ileum,,,CHEMBL617827,,104714,Cavia porcellus,,,H,4,BAO_0000221,2116.0
3089,,273,Autocuration,10141.0,,1,Evaluated for the antagonistic activity against Serotonin 5-hydroxytryptamine 3 receptor in isolated guinea pig ileum (GPI),,,CHEMBL617828,,104714,Cavia porcellus,,,H,4,BAO_0000221,2116.0
3090,,1559,Autocuration,10141.0,,1,Binding affinity against 5-hydroxytryptamine 3 receptor of guinea pig ileum,,,CHEMBL617829,,104714,Cavia porcellus,,,H,4,BAO_0000221,2116.0
3091,,1559,Autocuration,10141.0,,1,Binding affinity against 5-hydroxytryptamine 3 receptor of guinea pig ileum; Not determined,,,CHEMBL617830,,104714,Cavia porcellus,,,H,4,BAO_0000221,2116.0
3092,,1559,Autocuration,10141.0,,1,Binding affinity towards 5-hydroxytryptamine 3 receptor of guinea pig ileum; not determined,,,CHEMBL617831,,104714,Cavia porcellus,,,H,4,BAO_0000221,2116.0
3093,,14424,Autocuration,10141.0,,1,The compound was tested for binding affinity against 5-hydroxytryptamine 3 receptor in guinea pig ileum.,,,CHEMBL617832,,104714,Cavia porcellus,,,H,4,BAO_0000221,2116.0
3094,,13181,Autocuration,10141.0,,1,Binding affinity was determined against 5-hydroxytryptamine 2A receptor,,,CHEMBL617833,,22226,Cavia porcellus,,,U,0,BAO_0000019,
3095,,5486,Autocuration,,,1,Binding affinity towards 5-HT1A receptor by the displacement of [3H]-8-OH-DPAT] in human recombinant receptors in mammalian cell,,,CHEMBL617834,,51,,,,H,8,BAO_0000357,
3096,,6491,Expert,9606.0,,1,Affinity towards human 5-hydroxytryptamine 3 serotonin receptor,,,CHEMBL617835,,104714,Homo sapiens,,,D,5,BAO_0000223,
3097,,6013,Autocuration,,,1,Binding affinity towards 5-HT3 receptor,,,CHEMBL617836,,104714,,,,H,4,BAO_0000223,
3098,,12861,Autocuration,,,1,Binding activity radioligand.,,,CHEMBL617837,,104714,,,,H,4,BAO_0000223,
3099,,12861,Autocuration,,,1,Binding activity against 5-hydroxytryptamine 1A receptor from human brain cortex using [3H]8-OH-DPAT-HT as radioligand.,,,CHEMBL620392,,104714,,,,H,4,BAO_0000019,
3100,,5104,Autocuration,,,1,Binding affinity for human cloned 5-hydroxytryptamine 3 receptor,,,CHEMBL620393,,104714,,,,H,4,BAO_0000223,
3101,,5105,Autocuration,,,1,Binding affinity for human cloned 5-hydroxytryptamine 3 receptor,,,CHEMBL620394,,104714,,,,H,4,BAO_0000223,
3102,,5104,Autocuration,,,1,Binding affinity for human cloned 5-hydroxytryptamine 3 receptor; NT means Not tested,,,CHEMBL620395,,104714,,,,H,4,BAO_0000223,
3103,,3935,Autocuration,,,1,Compound was evaluated for its binding affinity for human 5-hydroxytryptamine 3 receptor,,,CHEMBL620396,,22226,,,,U,0,BAO_0000019,
3104,,13657,Expert,,,1,Displacement of [3H]-BRC 36694 from 5-hydroxytryptamine 3 receptor in NG108-15 cells,433.0,,CHEMBL620582,,105030,,NG108-15,,H,4,BAO_0000219,
3105,In vivo,10369,Autocuration,,,1,"Percent inhibition of [3H]5 binding to 5-hydroxytryptamine 3 receptor was evaluated by injection of compound (75 microCi/kg, 1.32 ug/kg) into the tail vein of mice (in vivo)",,,CHEMBL620583,,105030,,,,H,4,BAO_0000218,
3106,,10369,Autocuration,,,1,The binding affinity was measured for 5-hydroxytryptamine 3 receptor on NG 108-15 cell line of mouse neuroblastoma-glioma cells in presence of [3H]5 radioligand (in vitro),,,CHEMBL620584,,105030,,,,H,4,BAO_0000019,
3107,,12918,Autocuration,,,1,Compound was evaluated for the binding affinity at 5- HT3 receptor subtype,,,CHEMBL620585,,105030,,,,H,4,BAO_0000224,
3108,,12918,Autocuration,,,1,Compound was evaluated for the binding affinity at 5- HT3 receptor,,,CHEMBL620586,,105030,,,,H,4,BAO_0000224,
3109,,10369,Autocuration,,,1,The binding affinity was measured for 5-hydroxytryptamine 3 receptor on NG 108-15 cell line of mouse neuroblastoma-glioma cells in presence of [3H]5 radioligand (in vitro),,,CHEMBL620587,,105030,,,,H,4,BAO_0000019,
3110,,773,Autocuration,,,1,In Vitro Binding affinity againist 5-hydroxytryptamine 3 receptor by displacing [3H]-Q-ICS 205-930 from rat cortex homogenates,,,CHEMBL620588,,105030,,,,H,4,BAO_0000019,
3111,,12918,Autocuration,,,1,5-hydroxytryptamine 3 receptor agonism in mouse,,,CHEMBL620589,,105030,,,,H,4,BAO_0000218,
3112,,10561,Autocuration,,,1,Binding affinity towards 5-hydroxytryptamine 3 receptor was determined by using [3H]-ICS 205-930 as radioligand in mouse N1E 115 cells,,,CHEMBL620590,,105030,,,,H,4,BAO_0000219,
3113,,12827,Autocuration,,,1,Binding affinity towards 5-hydroxytryptamine 2A receptor in rat cortex preparations using [3H]ketanserin,,,CHEMBL617956,,105030,,,,H,4,BAO_0000019,
3114,,12827,Autocuration,,,1,Binding affinity towards 5-hydroxytryptamine 2A receptor in rat cortex preparations using [3H]ketanserin,,,CHEMBL617957,,105030,,,,H,4,BAO_0000019,
3115,,12918,Autocuration,,,1,Binding affinity was evaluated by 5-hydroxytryptamine 3 receptor agonism in the mouse NIE-115 by displacing tropisetron,,,CHEMBL617958,,105030,,,,H,4,BAO_0000224,
3116,,273,Autocuration,,,1,Compound was evaluated for binding to 5-hydroxytryptamine 3 receptor in N1E cells using [3H]- -Tropisetron as radioligand,,,CHEMBL617959,,105030,,,,H,4,BAO_0000219,
3117,,273,Autocuration,,,1,Compound was evaluated for binding to Serotonin 5-hydroxytryptamine 3 receptor in N1E cells using [3H]- -Tropisetron as radioligand,,,CHEMBL617960,,105030,,,,H,4,BAO_0000219,
3118,,10561,Autocuration,,,1,Potency at neuronal 5-hydroxytryptamine 3 receptor in the rabbit heart,,,CHEMBL617961,,105030,,,,H,4,BAO_0000224,
3119,In vitro,5033,Autocuration,,,1,Ability to displace the radioligand [3H]GR-65630 from 5-hydroxytryptamine 3 receptor expressed in NIE-115 cells,,,CHEMBL617962,,105030,,,,H,4,BAO_0000219,
3120,,16429,Autocuration,,,1,In vitro binding affinity at 5-hydroxytryptamine 3 receptor in N1E-115 cells using 3[H]GR-65630 as the radioligand,339.0,,CHEMBL617963,,105030,,N1E-115,,H,4,BAO_0000219,
3121,,10322,Autocuration,,,1,In vitro binding affinity for the 5-hydroxytryptamine 3 receptor was determined with NG-108-15 mouse neuroblastoma-glioma cells,,,CHEMBL617964,,11765,,,,H,8,BAO_0000019,
3122,,14331,Autocuration,,,1,Inhibition of [3H]BRL-43694 binding to 5-hydroxytryptamine 3 receptor in NG cells 108-15,,,CHEMBL617965,,11765,,,,H,8,BAO_0000219,
3123,,13462,Autocuration,10090.0,,1,Compound was tested for the Binding affinity against N1e-115 neuroblastoma 5-hydroxytryptamine 3 receptor by Radio ligand [3H]GR-65630 binding assay.,,,CHEMBL617966,,10630,Mus musculus,,,D,9,BAO_0000357,
3124,,12861,Autocuration,,,1,Binding activity against 5-hydroxytryptamine 3 receptor from rat cortex homogenate using [3H]-Q-ICS 205-930 as radioligand.,,,CHEMBL857074,,17106,,,,H,8,BAO_0000019,
3125,,15086,Autocuration,9823.0,,1,The compound was tested for binding affinity against 5-hydroxytryptamine 3 receptor,,,CHEMBL617967,,144,Sus scrofa,,,H,8,BAO_0000357,
3126,,12861,Autocuration,9823.0,,1,Binding activity radioligand.,,,CHEMBL617968,,144,Sus scrofa,,,H,8,BAO_0000357,
3127,,10561,Autocuration,9986.0,,1,Binding affinity to 5-hydroxytryptamine 3 receptor of neuronal in the afferent rabbit vagus,,,CHEMBL617969,,104714,Oryctolagus cuniculus,,,H,4,BAO_0000223,
3128,,10561,Autocuration,9986.0,,1,Potency at neuronal 5-hydroxytryptamine 3 receptor in the rabbit heart,,,CHEMBL617970,,104714,Oryctolagus cuniculus,,,H,4,BAO_0000223,
3129,,10561,Autocuration,9986.0,,1,Potency at neuronal 5-hydroxytryptamine 3 receptors in the rabbit heart,,,CHEMBL617971,,104714,Oryctolagus cuniculus,,,H,4,BAO_0000223,
3130,,10561,Autocuration,9986.0,,1,Potency to 5-hydroxytryptamine 3 receptor using [3H]GR-65630 as radioligand in rat cortex,,,CHEMBL617972,,104714,Oryctolagus cuniculus,,,H,4,BAO_0000019,
3131,,273,Autocuration,9986.0,,1,Evaluated for the antagonistic activity against 5-hydroxytryptamine 3 receptor in isolated perfused rabbit heart (RH),,,CHEMBL617973,,104714,Oryctolagus cuniculus,,,H,4,BAO_0000019,
3132,,273,Autocuration,9986.0,,1,Evaluated for the antagonistic activity against 5-hydroxytryptamine 3 receptor in isolated rabbit vagus nerve (RVN),,,CHEMBL617974,,104714,Oryctolagus cuniculus,,,H,4,BAO_0000019,
3133,,273,Autocuration,9986.0,,1,Evaluated for the antagonistic activity against Serotonin 5-hydroxytryptamine 3 receptor in isolated guinea pig ileum (GPI),,,CHEMBL617975,,104714,Oryctolagus cuniculus,,,H,4,BAO_0000221,2116.0
3134,,273,Autocuration,9986.0,,1,Evaluated for the antagonistic activity against Serotonin 5-hydroxytryptamine 3 receptor in isolated perfused rabbit heart (RH),,,CHEMBL617976,,104714,Oryctolagus cuniculus,,,H,4,BAO_0000019,
3135,,273,Autocuration,9986.0,,1,Antagonistic activity against Serotonin 5-hydroxytryptamine 3 receptor in isolated rabbit vagus nerve (RVN),,,CHEMBL617977,,104714,Oryctolagus cuniculus,,,H,4,BAO_0000019,
3136,,273,Autocuration,9986.0,,1,Evaluated for the antagonistic activity against Serotonin 5-hydroxytryptamine 3 receptor in isolated perfused rabbit heart (RH),,,CHEMBL617978,,104714,Oryctolagus cuniculus,,,H,4,BAO_0000019,
3137,,273,Autocuration,9986.0,,1,Evaluated for the antagonistic activity against Serotonin 5-hydroxytryptamine 3 receptor in isolated rabbit vagus nerve (RVN),,,CHEMBL617979,,104714,Oryctolagus cuniculus,,,H,4,BAO_0000019,
3138,,13047,Autocuration,9986.0,,1,Binding affinity against 5-hydroxytryptamine 3 receptor in CHO cells using [3H]5-HT as radioligand,449.0,,CHEMBL617980,,104714,Oryctolagus cuniculus,CHO,,H,4,BAO_0000219,
3139,,1650,Autocuration,10116.0,,1,In vitro displacement of [3H]-LY 278584 from rat cerebral cortex 5-hydroxytryptamine 3 receptor,,,CHEMBL617981,,104698,Rattus norvegicus,,,D,7,BAO_0000019,
3140,,16288,Autocuration,,,1,Affinity at 5-hydroxytryptamine 3 receptor from rat frontal cortex using [3H]granisetron as radioligand (For granisetron = Ki(nM)=0.3+/-0.01),,,CHEMBL617982,,12020,,,,H,8,BAO_0000019,
3141,,16288,Autocuration,,,1,Affinity at 5-hydroxytryptamine 3 receptor (For granisetron = Ki (nM)=0.3+/-0.01),,,CHEMBL617983,,12020,,,,H,8,BAO_0000357,
3142,,10254,Autocuration,10116.0,,1,In vitro displacement of [3H]ICS-205-930 from 5-hydroxytryptamine 3 receptor in cultured NG-108-15 rat glioma cells,,,CHEMBL617984,,104698,Rattus norvegicus,,,D,7,BAO_0000019,
3143,,14532,Autocuration,,,1,"Binding affinity for 5-hydroxytryptamine 3 receptor in rat cerebral cortex, determined by displacement of [3H]GR-65630",,,CHEMBL617985,,104698,,,,H,6,BAO_0000019,
3144,In vivo,13392,Autocuration,,,1,"5-Hydroxy tryptamine 3 receptor showing agonist activity (in vivo) in Von Bezold-Jarisch Reflex in rats at 120 (ug/kg), evaluated as change in heart rate",,,CHEMBL617986,,104698,,,,H,6,BAO_0000218,948.0
3145,,13392,Autocuration,,,1,"Agonistic activity of compound towards 5-hydroxytryptamine 3 receptor in Von Bezold-Jarisch Reflex in rats at 100 (ug/kg), evaluated as change in heart rate",,,CHEMBL617987,,104698,,,,H,6,BAO_0000019,948.0
3146,,13392,Autocuration,,,1,"Agonistic activity of compound towards 5-hydroxytryptamine 3 receptor in Von Bezold-Jarisch Reflex in rats at 120 (ug/kg), evaluated as change in heart rate",,,CHEMBL617988,,104698,,,,H,6,BAO_0000019,948.0
3147,,13392,Autocuration,,,1,"Agonistic activity of compound towards 5-hydroxytryptamine 3 receptor in Von Bezold-Jarisch Reflex in rats at 60 (ug/kg), evaluated as change in heart rate",,,CHEMBL617792,,104698,,,,H,6,BAO_0000019,948.0
3148,,13392,Autocuration,,,1,"Agonistic activity of compound towards 5-hydroxytryptamine 3 receptorr in Von Bezold-Jarisch Reflex in rats at 100 (ug/kg), evaluated as change in heart rate",,,CHEMBL617793,,104698,,,,H,6,BAO_0000019,948.0
3149,,13392,Autocuration,,,1,"Antagonistic activity of compound towards 5-hydroxytryptamine 3 receptor in Von Bezold-Jarisch Reflex in rats at 100(ug/kg), evaluated as percent inhibition of bradycardia",,,CHEMBL617794,,104698,,,,H,6,BAO_0000019,
3150,,13392,Autocuration,,,1,"Antagonistic activity of compound towards 5-hydroxytryptamine 3 receptor in Von Bezold-Jarisch Reflex in rats at 60 (ug/kg), evaluated as percent inhibition of bradycardia",,,CHEMBL617795,,104698,,,,H,6,BAO_0000019,
3151,,13392,Autocuration,,,1,"Antagonistic activity of compound towards 5-hydroxytryptamine 3 receptor in Von Bezold-Jarisch reflex in rats at 60 (ug/kg), evaluated as percent inhibition of bradycardia",,,CHEMBL617796,,104698,,,,H,6,BAO_0000019,
3152,,13392,Autocuration,,,1,"Antagonistic activity of compound towards 5-hydroxytryptamine 3 receptor in Von Bezold-Jarisch reflex in rats at 60(ug/kg), evaluated as percent inhibition of bradycardia",,,CHEMBL617797,,104698,,,,H,6,BAO_0000019,
3153,In vivo,1089,Autocuration,10116.0,,1,Antagonism of 5-HT-induced Von Bezold-Jarisch reflex in rat after intravenous administration of 30 ug/kg of HT (5-hydroxytryptamine 3 receptor antagonism),,,CHEMBL617798,,104698,Rattus norvegicus,,,D,7,BAO_0000218,
3154,In vivo,1089,Autocuration,,,1,Ability to antagonise the 5-HT- induced Von Bezold-Jarisch reflex in the rat after intravenous administration of 30 ug/kg of HT (5-hydroxytryptamine 3 receptor),,,CHEMBL617799,,104698,,,,H,6,BAO_0000218,
3155,In vivo,11454,Autocuration,10116.0,,1,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 1000 ug/kg dose in urethane-anesthetized rats,,,CHEMBL617800,,104698,Rattus norvegicus,,,D,7,BAO_0000218,
3156,,11454,Autocuration,10116.0,,1,Inhibition of 5-HT-induced bradycardia by 5-hydroxytryptamine 3+,,,CHEMBL617801,,104698,Rattus norvegicus,,,D,7,BAO_0000019,
3157,In vivo,12205,Autocuration,10116.0,,1,In vivo inhibitory concentration after 5 minutes against 5-hydroxytryptamine 3 receptor induced bradycardia [bezold-jarisch (B-J) reflex test] in rat by intravenous administration,,,CHEMBL617802,,104698,Rattus norvegicus,,,D,7,BAO_0000218,
3158,,1089,Autocuration,10116.0,,1,Inhibition of 5-HT (1 ug/mL) induced depolarization in rat vagus nerve (5-hydroxytryptamine 3 receptor antagonism),,,CHEMBL617803,,104698,Rattus norvegicus,,,D,7,BAO_0000019,
3159,,5094,Autocuration,,,1,Binding affinity towards 5-HT3 receptor in rat was evaluated,,,CHEMBL617804,,104698,,,,H,6,BAO_0000019,
3160,,2622,Autocuration,10116.0,,1,Inhibition of [3H]GR-65630 binding to rat cortical membrane 5-hydroxytryptamine 3 receptor,,,CHEMBL617805,,104698,Rattus norvegicus,,,D,7,BAO_0000019,
3161,,245,Autocuration,,,1,Binding affinity was evaluated in vitro by displacement of [3H]zacopride radioligand from 5-hydroxytryptamine 3 receptor,,,CHEMBL617806,,104698,,,,H,6,BAO_0000223,
3162,,14788,Autocuration,,,1,Compound was evaluated for its binding affinity for 5-hydroxytryptamine 3 receptor by measuring displacement [3H]GR-65630 in rat cerebral cortex.,,,CHEMBL617807,,104698,,,,H,6,BAO_0000019,
3163,,14788,Autocuration,,,1,Compound was evaluated for its binding affinity for 5-hydroxytryptamine 3 receptor by measuring displacement of [3H]granisetron from rat cerebral cortex,,,CHEMBL617808,,104698,,,,H,6,BAO_0000019,
3164,,3020,Autocuration,,,1,Binding affinity against 5-hydroxytryptamine 3 receptor in rat cortical membrane using [3H]GR-65630 as radioligand,,,CHEMBL617809,,104698,,,,H,6,BAO_0000249,
3165,,1742,Autocuration,,,1,Compound was tested for its ability to displace [3H]-Q-ICS 205-930 from 5-hydroxytryptamine 3 receptor in rat cortex homogenates,,,CHEMBL617810,,104698,,,,H,6,BAO_0000019,
3166,,17394,Autocuration,,,1,Concentration of compound required to inhibit the binding of radioligand [3H]GR-65630 to 5-hydroxytryptamine 3 receptor in rat brain cortical membrane,,,CHEMBL617811,,104698,,,,H,6,BAO_0000249,955.0
3167,,17394,Autocuration,,,1,Concentration required to inhibit the binding of radioligand [3H]GR-65630 to serotonin 5-hydroxytryptamine-3 receptor (5-HT 3 receptor)in rat brain cortical membrane,,,CHEMBL617812,,104698,,,,H,6,BAO_0000221,955.0
3168,,17394,Autocuration,,,1,Concentration of compound required to inhibit the binding of radioligand [3H]GR-65630 to serotonin 5-hydroxytryptamine 3 receptor in rat cortical membrane,,,CHEMBL617813,,104698,,,,H,6,BAO_0000249,
3169,,14286,Autocuration,,,1,In vitro inhibitory concentration against radioligand [3H]BRL-43694 binding to 5-hydroxytryptamine 3 receptor in rat cortical membrane,,,CHEMBL617814,,104698,,,,H,6,BAO_0000249,
3170,,14178,Autocuration,,,1,Inhibition of [3H]BRL-43694 binding to 5-hydroxytryptamine 3 receptor of rat cortical homogenate.,,,CHEMBL617698,,104698,,,,H,6,BAO_0000019,
3171,,14178,Autocuration,10116.0,,1,Inhibition of [3H]BRL-43694 binding to 5-hydroxytryptamine 3 receptor of rat cortical homogenate; Not active at 10000 nm,,,CHEMBL617699,,104698,Rattus norvegicus,,,D,7,BAO_0000019,
3172,,14178,Autocuration,10116.0,,1,Inhibition of [3H]BRL-43694 binding to 5-hydroxytryptamine 3 receptor of rat cortical homogenate; not active at 10000 nM,,,CHEMBL617700,,104698,Rattus norvegicus,,,D,7,BAO_0000019,
3173,,14178,Autocuration,10116.0,,1,Inhibition of radiolabeled [3H]-Zacopride ligand binding to 5-hydroxytryptamine 3 receptor,,,CHEMBL617701,,104698,Rattus norvegicus,,,D,7,BAO_0000223,
3174,,15034,Autocuration,,,1,Inhibitory concentration against 5-hydroxytryptamine 3 receptor in rat entorhinal cortex using [3H]-LY 278584 as radioligand,,,CHEMBL617702,,104698,,,,H,6,BAO_0000019,
3175,,1089,Autocuration,,,1,"Tested for inhibition of binding of [3H]GR-65630 to rat cortical membranes, expressed as IC50",,,CHEMBL617703,Membranes,104698,,,,H,6,BAO_0000249,
3176,,1089,Autocuration,10116.0,,1,Inhibition of [3H]GR-65630 binding to rat cortical membrane serotonin 3 receptor,,,CHEMBL617704,,104698,Rattus norvegicus,,,D,7,BAO_0000019,
3177,,16532,Autocuration,,,1,The binding affinity at 5-hydroxytryptamine 3 receptor was determined using [3H]LY-278584; Not tested,,,CHEMBL617705,,104698,,,,H,6,BAO_0000223,
3178,,12801,Autocuration,10116.0,,1,Inhibition of [3H]BRL-43694 binding to rat 5-hydroxytryptamine 3 receptor,,,CHEMBL617706,,104698,Rattus norvegicus,,,D,7,BAO_0000223,
3179,,15194,Autocuration,,,1,The compound was tested for binding affinity against 5-hydroxytryptamine 3 receptor from NG108-15 cells (using [3H]zacopride as radioligand),433.0,,CHEMBL617707,,104698,,NG108-15,,H,6,BAO_0000219,
3180,,15194,Autocuration,,,1,The compound was tested for binding affinity against 5-hydroxytryptamine 3 receptor from NG108-15 cells using [3H]zacopride as radioligand,433.0,,CHEMBL617708,,104698,,NG108-15,,H,6,BAO_0000219,
3181,,15194,Autocuration,,,1,Binding affinity against 5-hydroxytryptamine 3 (5-HT3) receptor from rat cortical homogenate using [3H]zacopride as radioligand,,,CHEMBL617709,,104698,,,,H,6,BAO_0000019,
3182,,15194,Autocuration,,,1,The compound was tested for binding affinity against 5-hydroxytryptamine 3 receptor from rat cortical homogenate using [3H]zacopride as radioligand; NA= Not active,,,CHEMBL617710,,104698,,,,H,6,BAO_0000019,
3183,,15194,Autocuration,,,1,The compound was tested for binding affinity against 5-hydroxytryptamine 3 receptor from rat cortical homogenate using [3H]zacopride as radioligand; NA=Not active,,,CHEMBL882925,,104698,,,,H,6,BAO_0000019,
3184,,15194,Autocuration,,,1,The compound was tested for binding affinity against 5-hydroxytryptamine 3 receptor from rat cortical homogenate using [3H]zacopride as radioligand; not active,,,CHEMBL617711,,104698,,,,H,6,BAO_0000019,
3185,,10610,Autocuration,,,1,Antagonist potency to 5-hydroxytryptamine 3 receptor was assayed by antagonism of the 5-HT-evoked reflex bradycardia [Bezold-Jarisch(BJ) reflex] in rats,,,CHEMBL617712,,104698,,,,H,6,BAO_0000019,
3186,,10355,Autocuration,10116.0,,1,Antagonistic activity against 5-hydroxytryptamine 3 receptor as inhibition of 5-HT-induced bradycardia (von Bezold-jarisch reflex) in anesthetized rat,,,CHEMBL617713,,104698,Rattus norvegicus,,,D,7,BAO_0000019,
3187,,691,Autocuration,,,1,"Compound was tested as a 5-hydroxytryptamine 3 receptor antagonist in the rat by assessment of the inhibition of the Bezold-Jarisch effect, when administered intravenously",,,CHEMBL617714,,104698,,,,H,6,BAO_0000019,
3188,,10611,Autocuration,,,1,In vivo 5-hydroxytryptamine 3 receptor (5-HT 3 receptor) antagonistic activity expressed as ability to inhibit Bezold-Jarich reflex evoked by 5-HT in rats,,,CHEMBL617715,,104698,,,,H,6,BAO_0000218,
3189,In vivo,12801,Autocuration,,,1,Inhibition dose for 50 percent antagonism for 5-hydroxytryptamine 3 receptor in vivo in rats,,,CHEMBL617716,,104698,,,,H,6,BAO_0000218,
3190,,10609,Autocuration,,,1,Inhibition of 5-HT evoked reflex bradycardia in rat.,,,CHEMBL617717,,104698,,,,H,6,BAO_0000218,
3191,In vivo,11454,Autocuration,,,1,5-HT3 receptor antagonistic activity was measured by the inhibition of 5-HT-induced bradycardia after iv administration of 1000 ug/kg dose in urethane-anesthetized rats,,,CHEMBL617718,,104698,,,,H,6,BAO_0000218,
3192,In vivo,11454,Autocuration,,,1,5-hydroxytryptamine 3 receptor antagonistic activity was measured by the inhibition of 5H+ T-induced bradycardia after iv administration of 1 ug/kg dose in urethane-anesthetized rats,,,CHEMBL617719,,104698,,,,H,6,BAO_0000218,
3193,In vivo,11454,Autocuration,,,1,5-hydroxytryptamine 3 receptor antagonistic activity measured by inhibition of 5-HT-induced bradycardia (iv administration 10 ug/kg dose in urethane-anesthetized rats),,,CHEMBL617720,,104698,,,,H,6,BAO_0000218,
3194,In vivo,11454,Autocuration,10116.0,,1,5-hydroxytryptamine 3 receptor antagonistic activity as inhibition of 5-HT-induced bradycardia after iv administration of 100 ug/kg dose in urethane-anesthetized rats,,,CHEMBL617721,,104698,Rattus norvegicus,,,D,7,BAO_0000218,
3195,In vivo,11454,Autocuration,,,1,5-hydroxytryptamine 3 receptor antagonistic activity was measured by the inhibition of 5H+ T-induced bradycardia after iv administration of 1000 ug/kg dose in urethane-anesthetized rats,,,CHEMBL617722,,104698,,,,H,6,BAO_0000218,
3196,In vivo,11454,Autocuration,,,1,5-hydroxytryptamine 3 receptor antagonistic activity was measured by the inhibition of 5H+ T-induced bradycardia after iv administration of 1000 ug/kgetized rats,,,CHEMBL617723,,104698,,,,H,6,BAO_0000218,
3197,In vivo,11454,Autocuration,,,1,5-hydroxytryptamine 3 receptor antagonistic activity was measured by the inhibition of 5H+ T-induced bradycardia after iv administration of 3 ug/kg dose in urethane-anesthetized rats,,,CHEMBL617724,,104698,,,,H,6,BAO_0000218,
3198,In vivo,11454,Autocuration,,,1,5-hydroxytryptamine 3 receptor antagonistic activity was measured by the inhibition of 5H+ T-induced bradycardia after po administration of 10 ug/kg dose in urethane-anesthetized rats,,,CHEMBL617725,,104698,,,,H,6,BAO_0000218,
3199,In vivo,11454,Autocuration,,,1,5-hydroxytryptamine 3 receptor antagonistic activity was measured by the inhibition of 5H+ T-induced bradycardia after po administration of 100 ug/kg dose in urethane-anesthetized rats,,,CHEMBL617726,,104698,,,,H,6,BAO_0000218,
3200,In vivo,11454,Autocuration,,,1,5-hydroxytryptamine 3 receptor antagonistic activity was measured by the inhibition of 5H+ T-induced bradycardia after po administration of 1000 ug/kg dose in urethane-anesthetized rats,,,CHEMBL617727,,104698,,,,H,6,BAO_0000218,
3201,In vivo,11454,Autocuration,,,1,5-hydroxytryptamine 3 receptor antagonistic activity was measured by the inhibition of 5H+ T-induced bradycardia after po administration of 30 ug/kg dose in urethane-anesthetized rats,,,CHEMBL617728,,104698,,,,H,6,BAO_0000218,
3202,In vivo,11454,Autocuration,,,1,5-hydroxytryptamine 3 receptor antagonistic activity was measured by the inhibition of 5H+ T-induced bradycardia after po administration of 300 ug/kg dose in urethane-anesthetized rats,,,CHEMBL617729,,104698,,,,H,6,BAO_0000218,
3203,In vivo,11454,Autocuration,,,1,5-hydroxytryptamine 3 receptor antagonistic activity was measured by the inhibition of 5H+ T-induced bradycardia after po administration of 3ug/kg dose in urethane-anesthetized rats,,,CHEMBL617730,,104698,,,,H,6,BAO_0000218,
3204,In vivo,11454,Autocuration,,,1,5-hydroxytryptamine 3 receptor antagonistic activity was measured by the inhibition of 5-HT-induced bradycardia after iv administration of 1000 ug/kg dose in urethane-anesthetized rats,,,CHEMBL617731,,104698,,,,H,6,BAO_0000218,
3205,In vivo,11454,Autocuration,,,1,Compound was tested for the inhibition of 5-HT-induced bradycardia after intravenous administration of 0.3 ug/kg dose in urethane-anesthetized rats,,,CHEMBL617732,,104698,,,,H,6,BAO_0000218,
3206,In vivo,11454,Autocuration,,,1,Compound was tested for the inhibition of 5-HT-induced bradycardia after intravenous administration of 1 ug/kg dose in urethane-anesthetized rats,,,CHEMBL617733,,104698,,,,H,6,BAO_0000218,
3207,In vivo,11454,Autocuration,,,1,Compound was tested for the inhibition of 5-HT-induced bradycardia after intravenous administration of 30 ug/kg dose in urethane-anesthetized rats,,,CHEMBL617734,,104698,,,,H,6,BAO_0000218,
3208,In vivo,11454,Autocuration,,,1,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 0.03 mg/kg dose in urethane-anesthetized rats at 0.05 hour,,,CHEMBL872874,,104698,,,,H,6,BAO_0000218,
3209,In vivo,11454,Autocuration,,,1,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 0.03 mg/kg dose in urethane-anesthetized rats at 1 hour,,,CHEMBL617735,,104698,,,,H,6,BAO_0000218,
3210,In vivo,11454,Autocuration,,,1,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 0.03 mg/kg dose in urethane-anesthetized rats at 16 hour,,,CHEMBL617736,,104698,,,,H,6,BAO_0000218,
3211,In vivo,11454,Autocuration,,,1,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 0.03 mg/kg dose in urethane-anesthetized rats at 3 hour,,,CHEMBL617737,,104698,,,,H,6,BAO_0000218,
3212,In vivo,11454,Autocuration,,,1,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 0.03 mg/kg dose in urethane-anesthetized rats at 6 hour,,,CHEMBL617738,,104698,,,,H,6,BAO_0000218,
3213,In vivo,11454,Autocuration,,,1,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 10 ug/kg dose in urethane-anesthetized rats,,,CHEMBL617739,,104698,,,,H,6,BAO_0000218,
3214,In vivo,11454,Autocuration,,,1,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 100 ug/kg dose in urethane-anesthetized rats,,,CHEMBL617740,,104698,,,,H,6,BAO_0000218,
3215,In vivo,11454,Autocuration,,,1,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 1000 ug/kg dose in urethane-anesthetized rats,,,CHEMBL617741,,104698,,,,H,6,BAO_0000218,
3216,In vivo,11454,Autocuration,,,1,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 10 ug/kg dose in urethane-anesthetized rats,,,CHEMBL617742,,104698,,,,H,6,BAO_0000218,
3217,In vivo,11454,Autocuration,,,1,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 3 ug/kg dose in urethane-anesthetized rats,,,CHEMBL617743,,104698,,,,H,6,BAO_0000218,
3218,In vivo,11454,Autocuration,,,1,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 30 ug/kg dose in urethane-anesthetized rats,,,CHEMBL617744,,104698,,,,H,6,BAO_0000218,
3219,In vivo,11454,Autocuration,,,1,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 300 ug/kg dose in urethane-anesthetized rats,,,CHEMBL617745,,104698,,,,H,6,BAO_0000218,
3220,,670,Autocuration,,,1,"In vivo 5-hydroxytryptamine 3 receptor antagonist activity by antagonism of the von Bezold-Jarisch (B-J) reflex in anesthetized rats, (i.v.)",,,CHEMBL617746,,104698,,,,H,6,BAO_0000218,
3221,,670,Autocuration,,,1,"In vivo 5-hydroxytryptamine 3 receptor antagonist activity by antagonism of the von Bezold-Jarisch (B-J) reflex in anesthetized rats, (i.v.); Not tested",,,CHEMBL617747,,104698,,,,H,6,BAO_0000218,
3222,In vivo,10321,Autocuration,,,1,Serotonin receptor antagonist activity was measured as ability to block the serotonin-induced Bezold-Jarisch reflex in rats after iv administration of 10 ug/Kg,,,CHEMBL617748,,104698,,,,H,6,BAO_0000218,
3223,In vivo,10321,Autocuration,,,1,Serotonin receptor antagonist activity was measured as ability to block the serotonin-induced Bezold-Jarisch reflex in rats after iv administration of 100 ug/Kg,,,CHEMBL618909,,104698,,,,H,6,BAO_0000218,
3224,In vivo,10321,Autocuration,,,1,Serotonin receptor antagonist activity was measured as ability to block the serotonin-induced Bezold-Jarisch reflex in rats after iv administration of 2 ug/Kg,,,CHEMBL618910,,104698,,,,H,6,BAO_0000218,
3225,In vivo,10321,Autocuration,,,1,Serotonin receptor antagonist activity was measured as ability to block the serotonin-induced Bezold-Jarisch reflex in rats after iv administration of 20 ug/Kg,,,CHEMBL618911,,104698,,,,H,6,BAO_0000218,
3226,In vivo,10321,Autocuration,,,1,Serotonin receptor antagonist activity was measured as ability to block the serotonin-induced Bezold-Jarisch reflex in rats after iv administration of 5 ug/Kg,,,CHEMBL618912,,104698,,,,H,6,BAO_0000218,
3227,In vivo,10322,Autocuration,,,1,Tested for inhibition of Bezold-Jarisch (B-J) reflex mediated by 5-hydroxytryptamine 3 receptor in rats after intravenous administration (2.0 ug/kg),,,CHEMBL618913,,104698,,,,H,6,BAO_0000218,
3228,,15412,Autocuration,,,1,Intrinsic efficacy against 5-hydroxytryptamine 3 receptor; A means pure agonist,,,CHEMBL618914,,104698,,,,H,6,BAO_0000019,
3229,,15412,Autocuration,,,1,Intrinsic efficacy against 5-hydroxytryptamine 3 receptor; A means pure agonist,,,CHEMBL618915,,104698,,,,H,6,BAO_0000019,
3230,,15412,Autocuration,10116.0,,1,Intrinsic efficacy for rat 5-hydroxytryptamine 3 receptor,,,CHEMBL618916,,104698,Rattus norvegicus,,,D,7,BAO_0000223,
3231,,15412,Autocuration,,,1,Intrinsic efficacy against 5-hydroxytryptamine 3 receptor; PA means partial agonist,,,CHEMBL618917,,104698,,,,H,6,BAO_0000019,
3232,,15412,Intermediate,,,1,Inhibition of [3H]granisetron binding to 5-hydroxytryptamine 3 receptor (5-HT 3 receptor) of rat cortex and hippocampus tissue,,,CHEMBL618918,,104698,,,,D,7,BAO_0000221,10000000.0
3233,,15412,Autocuration,10116.0,,1,Inhibition of [3H]granisetron binding to 5-hydroxytryptamine 3 receptor of rat cortical membrane,,,CHEMBL618919,,104698,Rattus norvegicus,,,D,7,BAO_0000019,
3234,,17394,Autocuration,10116.0,,1,Inhibition of [3H]GR-65630 binding to rat cortical membrane serotonin 5-hydroxytryptamine 3 receptor,,,CHEMBL618920,,104698,Rattus norvegicus,,,D,7,BAO_0000019,
3235,,12457,Autocuration,,,1,Affinity was evaluated as inhibition constant for serotonin 5-hydroxytryptamine 3 receptor,,,CHEMBL618921,,104698,,,,H,6,BAO_0000223,
3236,,12457,Autocuration,,,1,Affinity was evaluated by inhibition of [3H]GR-65630 binding to NG108-15 cell transfected with cloned rat 5-hydroxytryptamine 3 receptor,,,CHEMBL618922,,104698,,,,H,6,BAO_0000019,
3237,,12205,Autocuration,,,1,Binding affinity against radioligand [3H]quipazine labeled 5-hydroxytryptamine 3 receptor sites in neuroblastoma-glioma (NG108-15) cells.,,,CHEMBL618923,,104698,,,,H,6,BAO_0000019,
3238,,14532,Autocuration,,,1,Binding affinity for 5-hydroxytryptamine 3 receptor was determined by measuring displacement of [3H]GR-65630 from rat brain cortices,,,CHEMBL618924,,104698,,,,H,6,BAO_0000019,
3239,,1122,Autocuration,,,1,Binding affinity to 5-hydroxytryptamine 3 receptor in rat entorhinal cortex using [3H]-BRL 43694 as radioligand,,,CHEMBL618925,,104698,,,,H,6,BAO_0000019,
3240,,5094,Autocuration,,,1,Binding affinity towards 5-HT3 receptor in rat was evaluated,,,CHEMBL618926,,104698,,,,H,6,BAO_0000019,
3241,,809,Intermediate,10141.0,,1,5-hydroxytryptamine 4 receptor agonist activity as increased response to electrical stimulation in guinea pig ileum,,,CHEMBL618927,,20033,Cavia porcellus,,,D,9,BAO_0000221,2116.0
3242,,809,Intermediate,10141.0,,1,5-hydroxytryptamine 4 receptor agonist activity expressed as the concentration which gave a 50% increase in the response to the electrical stimulation in male guinea pig ileum; Not tested,,,CHEMBL618928,,20033,Cavia porcellus,,,D,9,BAO_0000221,2116.0
3243,,14290,Intermediate,10141.0,,1,"5-hydroxytryptamine 4 receptor agonist activity, concentration which gave 50% increase in the response to electrically-stimulated myenteric plexus and longitudinal muscle of the guinea pig ileum",,,CHEMBL618929,,20033,Cavia porcellus,,,D,9,BAO_0000221,2116.0
3244,,14290,Intermediate,10141.0,,1,"5-hydroxytryptamine 4 receptor agonist activity, concentration which gave 50% increase in the response to electrically-stimulated myenteric plexus and longitudinal muscle of the guinea pig ileum; Inactive up to 10E-5 M",,,CHEMBL618930,,20033,Cavia porcellus,,,D,9,BAO_0000221,2116.0
3245,,14290,Intermediate,10141.0,,1,"5-hydroxytryptamine 4 receptor agonist activity, concentration which gave 50% increase in the response to electrically-stimulated myenteric plexus and longitudinal muscle of the guinea pig ileum; Not tested",,,CHEMBL618931,,20033,Cavia porcellus,,,D,9,BAO_0000221,2116.0
3246,,14290,Intermediate,10141.0,,1,"5-hydroxytryptamine 4 receptor agonist activity, concentration which gave 50% increase in the response to electrically-stimulated myenteric plexus and longitudinal muscle of the guinea pig ileum; Not tested",,,CHEMBL619594,,20033,Cavia porcellus,,,D,9,BAO_0000221,2116.0
3247,,14290,Intermediate,10141.0,,1,"5-hydroxytryptamine 4 receptor antagonist activity, concentration which gave 50% reduction of the 5-HT-induced contractions in the guinea pig ileum; Not capable of evaluation",,,CHEMBL619595,,20033,Cavia porcellus,,,D,9,BAO_0000221,2116.0
3248,,13961,Intermediate,10141.0,,1,concentration which gave a 50% increase in the response to electrical stimulation against 5-hydroxytryptamine 4 receptor in the guinea pig ileum.,,,CHEMBL619596,,20033,Cavia porcellus,,,D,9,BAO_0000221,2116.0
3249,,13961,Intermediate,10141.0,,1,concentration which gave a 50% increase in the response to electrical stimulation against 5-hydroxytryptamine 4 receptor in the guinea pig ileum. Activity expressed as percent of the maximum 5-HT response given in brackets.,,,CHEMBL619755,,20033,Cavia porcellus,,,D,9,BAO_0000221,2116.0
3250,,809,Intermediate,10141.0,,1,5-hydroxytryptamine 4 receptor antagonist activity expressed as the concentration which produced a 50% reduction of 5-HT induced contraction in guinea pig ileum,,,CHEMBL619756,,20033,Cavia porcellus,,,D,9,BAO_0000221,2116.0
3251,,809,Intermediate,10141.0,,1,5-hydroxytryptamine 4 receptor antagonist activity expressed as the concentration which produced a 50% reduction of 5-HT induced contraction in guinea pig ileum; Not evaluable,,,CHEMBL619757,,20033,Cavia porcellus,,,D,9,BAO_0000221,2116.0
3252,,809,Intermediate,10141.0,,1,5-hydroxytryptamine 4 receptor antagonist activity expressed as the concentration which produced a 50% reduction of 5-HT induced contraction in guinea pig ileum; Not tested,,,CHEMBL619758,,20033,Cavia porcellus,,,D,9,BAO_0000221,2116.0
3253,,14290,Intermediate,10141.0,,1,"5-hydroxytryptamine 4 receptor antagonist activity, concentration which gave 50% reduction of the 5-HT-induced contractions in the guinea pig ileum",,,CHEMBL619759,,20033,Cavia porcellus,,,D,9,BAO_0000221,2116.0
3254,,14290,Intermediate,10141.0,,1,"5-hydroxytryptamine 4 receptor antagonist activity, concentration which gave 50% reduction of the 5-HT-induced contractions in the guinea pig ileum; Inactive up to 10-5 M",,,CHEMBL619760,,20033,Cavia porcellus,,,D,9,BAO_0000221,2116.0
3255,,14290,Intermediate,10141.0,,1,"5-hydroxytryptamine 4 receptor antagonist activity, concentration which gave 50% reduction of the 5-HT-induced contractions in the guinea pig ileum; Inactive up to 10E-5 M",,,CHEMBL619761,,20033,Cavia porcellus,,,D,9,BAO_0000221,2116.0
3256,,14290,Intermediate,10141.0,,1,5-hydroxytryptamine 4 receptor antagonist activity as inhibition of 5-HT-induced contractions in guinea pig ileum; Not capable of evaluation.,,,CHEMBL619762,,20033,Cavia porcellus,,,D,9,BAO_0000221,2116.0
3257,,14290,Intermediate,10141.0,,1,"5-hydroxytryptamine 4 receptor antagonist activity, concentration which gave 50% reduction of the 5-HT-induced contractions in the guinea pig ileum; Not tested",,,CHEMBL619763,,20033,Cavia porcellus,,,D,9,BAO_0000221,2116.0
3258,,14290,Intermediate,10141.0,,1,"5-hydroxytryptamine 4 receptor antagonist activity, concentration which gave 50% reduction of the 5-HT-induced contractions in the guinea pig ileum; Not tested",,,CHEMBL617868,,20033,Cavia porcellus,,,D,9,BAO_0000221,2116.0
3259,,15034,Intermediate,10141.0,,1,Displacement of [3H]GR-113808 from 5-hydroxytryptamine 4 receptor in guinea pig striatum,,,CHEMBL617869,,20033,Cavia porcellus,,,D,9,BAO_0000357,
3260,,5094,Intermediate,10141.0,,1,Binding affinity towards 5-HT4 receptor in striatum membranes of guinea-pig brain was evaluated,,,CHEMBL882926,,20033,Cavia porcellus,,,D,9,BAO_0000249,2435.0
3261,,5094,Intermediate,10141.0,,1,Binding affinity towards 5-hydroxytryptamine 4 receptor in striatum membranes of guinea-pig brain was evaluated,,,CHEMBL617870,,20033,Cavia porcellus,,,D,9,BAO_0000249,2435.0
3262,,5399,Intermediate,10141.0,,1,Inhibitory activity against 5-hydroxytryptamine 4 receptor of guinea pig striatum using [3H]GR-113808 as radioligand,,,CHEMBL617871,,20033,Cavia porcellus,,,D,9,BAO_0000357,2435.0
3263,,17394,Intermediate,10141.0,,1,Concentration of compound required to inhibit the binding of radioligand [3H]GR-113808 to 5-hydroxytryptamine 4 receptor in guinea pig striatum,,,CHEMBL617872,,20033,Cavia porcellus,,,D,9,BAO_0000357,2435.0
3264,,17394,Intermediate,10141.0,,1,Concentration of compound required to inhibit the binding of radioligand [3H]GR-113808 to 5-hydroxytryptamine 4 receptor in guinea-pig striatum,,,CHEMBL617873,,20033,Cavia porcellus,,,D,9,BAO_0000357,2435.0
3265,,17394,Intermediate,10141.0,,1,Concentration of compound required to inhibit the binding of radioligand [3H]GR-113808 to serotonin 5-hydroxytryptamine 4 receptor in guinea-pig striatum,,,CHEMBL617874,,20033,Cavia porcellus,,,D,9,BAO_0000357,2435.0
3266,,13961,Intermediate,10141.0,,1,The antagonist activity was calculated as the concentration which produced a 50% reduction against 5-hydroxytryptamine 4 receptor in guinea pig ileum.,,,CHEMBL619067,,20033,Cavia porcellus,,,D,9,BAO_0000221,2116.0
3267,,13961,Intermediate,10141.0,,1,The antagonist activity was calculated as the concentration which produced a 50% reduction against 5-hydroxytryptamine 4 receptor in guinea pig ileum. 95% confidence limits are in brackets.,,,CHEMBL619068,,20033,Cavia porcellus,,,D,9,BAO_0000221,2116.0
3268,,13961,Intermediate,10141.0,,1,The antagonist activity was calculated as the concentration which produced a 50% reduction against 5-hydroxytryptamine 4 receptor in guinea pig ileum;ne=not capable of evaluation.,,,CHEMBL619069,,20033,Cavia porcellus,,,D,9,BAO_0000221,2116.0
3269,,16946,Intermediate,10141.0,,1,Ability to displace [3H]GR-113808 from 5-hydroxytryptamine 4 receptor at concentration of 10e-6 M in guinea pig,,,CHEMBL619070,,20033,Cavia porcellus,,,D,9,BAO_0000357,
3270,,16946,Intermediate,10141.0,,1,Ability to displace [3H]GR-113808 from 5-hydroxytryptamine 4 receptor at concentration of 10e-8 M in guinea pig,,,CHEMBL619071,,20033,Cavia porcellus,,,D,9,BAO_0000357,
3271,,15034,Intermediate,10141.0,,1,Agonistic activity against 5-hydroxytryptamine 4 receptor,,,CHEMBL619072,,20033,Cavia porcellus,,,D,9,BAO_0000019,
3272,,15034,Intermediate,10141.0,,1,Agonistic activity against 5-hydroxytryptamine 4 receptor; not tested,,,CHEMBL619073,,20033,Cavia porcellus,,,D,9,BAO_0000019,
3273,,12918,Intermediate,10141.0,,1,Compound was evaluated for the relative potency with respect to serotonin against 5-hydroxytryptamine 4 receptor,,,CHEMBL619074,,20033,Cavia porcellus,,,D,9,BAO_0000019,
3274,,16946,Intermediate,10141.0,,1,Ability to displace [3H]GR-113808 from 5-hydroxytryptamine 4 receptor,,,CHEMBL619075,,20033,Cavia porcellus,,,D,9,BAO_0000357,
3275,,17394,Intermediate,10141.0,,1,Inhibition of [3H]GR-113808 binding to guinea pig striatum 5-hydroxytryptamine 4 receptor,,,CHEMBL619076,,20033,Cavia porcellus,,,D,9,BAO_0000357,2435.0
3276,,15034,Intermediate,10141.0,,1,Binding affinity against 5-hydroxytryptamine 4 receptor in guinea pig striatum using [3H]GR-113808 as radioligand,,,CHEMBL619077,,20033,Cavia porcellus,,,D,9,BAO_0000357,2435.0
3277,,5094,Intermediate,10141.0,,1,Binding affinity towards 5-HT4 receptor in striatum membranes of guinea-pig brain was evaluated,,,CHEMBL619078,,20033,Cavia porcellus,,,D,9,BAO_0000249,2435.0
3278,,5094,Intermediate,10141.0,,1,Binding affinity towards 5-hydroxytryptamine 4 receptor in striatum membranes of guinea-pig brain was evaluated,,,CHEMBL619079,,20033,Cavia porcellus,,,D,9,BAO_0000249,2435.0
3279,,17358,Intermediate,10141.0,,1,Tested for affinity against 5-hydroxytryptamine 4 receptor in the myenteric plexus of the guinea pig ileum.,,,CHEMBL619080,,20033,Cavia porcellus,,,D,9,BAO_0000221,2116.0
3280,,12953,Expert,10141.0,,1,Displacement of [3H]-GR113808 from 5-HT4 receptor of guinea pig striatum,,,CHEMBL619081,,20033,Cavia porcellus,,,D,9,BAO_0000357,
3281,,12953,Intermediate,10141.0,,1,The compound was tested for their binding affinity towards 5-HT4 receptor from guinea pig striatum using [3H]GR-113808 as radioligand; Nonactive at 10 uM,,,CHEMBL619082,,20033,Cavia porcellus,,,D,9,BAO_0000357,
3282,,12953,Intermediate,10141.0,,1,The compound was tested for their binding affinity towards 5-hydroxytryptamine 4 receptor from guinea pig striatum using [3H]GR-113808 as radioligand.,,,CHEMBL619083,,20033,Cavia porcellus,,,D,9,BAO_0000357,
3283,,12953,Intermediate,10141.0,,1,The compound was tested for their binding affinity towards 5-hydroxytryptamine 4 receptor from guinea pig striatum using [3H]GR-113808 as radioligand; Nonactive at 10 uM,,,CHEMBL619084,,20033,Cavia porcellus,,,D,9,BAO_0000357,
3284,,273,Intermediate,10141.0,,1,Evaluated for the antagonistic activity against Serotonin 5-hydroxytryptamine 4 receptor in non-electrically stimulated guinea-pig ileum.,,,CHEMBL859397,,20033,Cavia porcellus,,,D,9,BAO_0000221,2116.0
3285,,12918,Intermediate,10141.0,,1,5-hydroxytryptamine 4 receptor agonist activity in the guinea pig ileum assay,,,CHEMBL619085,,20033,Cavia porcellus,,,D,9,BAO_0000221,2116.0
3286,,12919,Intermediate,10141.0,,1,5-hydroxytryptamine 4 receptor agonistic activity was measured by twitch response enhancing activity in electrically stimulated guinea pig ileum preparation,,,CHEMBL619086,,20033,Cavia porcellus,,,D,9,BAO_0000221,2116.0
3287,,273,Intermediate,10141.0,,1,Agonistic activity against Serotonin 5-hydroxytryptamine 4 receptor in low frequency field stimulation of guinea-pig ileum (FSGPI).,,,CHEMBL619087,,20033,Cavia porcellus,,,D,9,BAO_0000221,2116.0
3288,,273,Intermediate,10141.0,,1,Agonistic activity against Serotonin 5-hydroxytryptamine 4 receptor in non-electrically stimulated guinea-pig ileum.,,,CHEMBL619088,,20033,Cavia porcellus,,,D,9,BAO_0000221,2116.0
3289,,13181,Intermediate,10141.0,,1,Ability to antagonize 5-HT-evoked contractions mediated through 5-hydroxytryptamine 4 receptor activation in the guinea pig distal colon LMMP,,,CHEMBL619089,,20033,Cavia porcellus,,,D,9,BAO_0000357,
3290,,13181,Autocuration,10141.0,,1,Binding affinity was determined against 5-hydroxytryptamine 3 receptor,,,CHEMBL619090,,168,Cavia porcellus,,,H,8,BAO_0000357,
3291,,15034,Intermediate,10141.0,,1,Antagonistic activity against 5-hydroxytryptamine 4 receptor,,,CHEMBL619091,,20033,Cavia porcellus,,,D,9,BAO_0000019,
3292,,5033,Intermediate,10141.0,,1,Ability to displace the radioligand [3H]GR-113808 from guinea pig striatum 5-hydroxytryptamine 4 receptor,,,CHEMBL619092,,20033,Cavia porcellus,,,D,9,BAO_0000357,
3293,,1980,Intermediate,10141.0,,1,Binding affinity for 5-hydroxytryptamine 4 receptor by displacement of [3H]GR-113808 from guinea pig brain striatum.,,,CHEMBL619093,,20033,Cavia porcellus,,,D,9,BAO_0000019,
3294,,13181,Autocuration,10141.0,,1,Binding affinity was determined against 5-hydroxytryptamine 2C receptor using cloned rat receptors expressed in 293 cells radiolabeled with [3H]mesulergine,722.0,,CHEMBL619094,,168,Cavia porcellus,HEK293,,H,8,BAO_0000219,
3295,,14287,Intermediate,10141.0,,1,In vitro by displacement of [3H]GR-113808 from 5-hydroxytryptamine 4 receptor on guinea pig striatal membrane,,,CHEMBL619095,,20033,Cavia porcellus,,,D,9,BAO_0000019,
3296,,1317,Intermediate,10141.0,,1,Compound was evaluated for binding affinity against 5-hydroxytryptamine 4 receptor using radioligand binding assay using [3H]GR as radioligand,,,CHEMBL857988,,20033,Cavia porcellus,,,D,9,BAO_0000357,
3297,,15316,Intermediate,10141.0,,1,Compound was evaluated for its ability to displace [3H]GR-113808 binding from 5-hydroxytryptamine 4 receptor in guinea pig striatum.,,,CHEMBL619096,,20033,Cavia porcellus,,,D,9,BAO_0000357,
3298,,16429,Intermediate,10141.0,,1,In vitro binding affinity at 5-hydroxytryptamine 4 receptor in guinea pig striatum using 3[H]GR-113808 as the radioligand,,,CHEMBL619097,,20033,Cavia porcellus,,,D,9,BAO_0000357,2435.0
3299,,14818,Intermediate,10141.0,,1,The compound was tested for its binding affinity towards 5-hydroxytryptamine 4 receptor in guinea pig hippocampus using [125I]SB-207710.,,,CHEMBL619098,,20033,Cavia porcellus,,,D,9,BAO_0000221,10000000.0
3300,,15194,Intermediate,10141.0,,1,The compound was tested for the binding affinity against 5-hydroxytryptamine 4 receptor using [3H]GR-113808 as radioligand,,,CHEMBL619751,,20033,Cavia porcellus,,,D,9,BAO_0000357,
3301,,15194,Intermediate,10141.0,,1,The compound was tested for the binding affinity against 5-hydroxytryptamine 4 receptor using [3H]GR-113808 as radioligand.,,,CHEMBL619752,,20033,Cavia porcellus,,,D,9,BAO_0000357,
3302,,13961,Intermediate,10141.0,,1,The antagonist activity was calculated as the concentration which produced a 50% reduction against 5-hydroxytryptamine 4 receptor in guinea pig ileum;ne=not capable of evaluation.,,,CHEMBL875096,,20033,Cavia porcellus,,,D,9,BAO_0000221,2116.0
3303,,5486,Autocuration,,,1,Binding affinity towards 5-HT2C receptor by the displacement of [3H]mesulergine] in human recombinant receptors in mammalian cell,,,CHEMBL619004,,108,,,,H,8,BAO_0000357,
3304,,16209,Autocuration,,,1,Binding affinity towards human 5-hydroxytryptamine 4 receptor using [3H]5-HT as radioligand,,,CHEMBL619005,,168,,,,H,8,BAO_0000357,
3305,,17085,Autocuration,,,1,In vitro binding affinity by radioligand binding assay using cell line expressing human 5-hydroxytryptamine 4 receptor,,,CHEMBL619006,,168,,,,H,8,BAO_0000019,
3306,,4199,Autocuration,,,1,Compound was evaluated for the binding affinity against human cloned 5-hydroxytryptamine 4 receptor in HeLa cells using [3H]-LSD as the radioligand,308.0,,CHEMBL619007,,168,,HeLa,,H,8,BAO_0000219,
3307,,15146,Autocuration,,,1,Compound was tested for its binding affinity against 5-hydroxytryptamine 4 receptor,,,CHEMBL619008,,168,,,,H,8,BAO_0000357,
3308,,5213,Autocuration,,,1,Compound was tested for its binding affinity for 5-hydroxytryptamine 4 receptor,,,CHEMBL619009,,168,,,,H,8,BAO_0000357,
3309,,4829,Autocuration,,,1,"The compound was tested for the binding affinity towards human cloned 5-hydroxytryptamine 4 receptor in HeLa cells, using [3H]LSD as radioligand",308.0,,CHEMBL619010,,168,,HeLa,,H,8,BAO_0000219,
3310,,17358,Autocuration,,,1,Tested for ability to stimulate production of cAMP mediated by 5-hydroxytryptamine 4 receptor in mouse Coliculi neurons,,,CHEMBL619011,,10622,,,,H,8,BAO_0000357,
3311,,17358,Autocuration,,,1,Tested for ability to stimulate production of cAMP mediated by 5-hydroxytryptamine 4 receptor in mouse Coliculi neurons; IA means inactive,,,CHEMBL619012,,10622,,,,H,8,BAO_0000357,
3312,,16946,Autocuration,,,1,Ability to displace [3H]GR-113808 from mouse 5-hydroxytryptamine 4 receptor in COS7 cells,,,CHEMBL619013,,10622,,,,H,8,BAO_0000219,
3313,,17358,Autocuration,,,1,Tested for ability to stimulate 5-hydroxytryptamine 4 receptors in mouse Coliculi neurons,,,CHEMBL619014,,10622,,,,H,8,BAO_0000357,
3314,,268,Autocuration,,,1,Evaluated for the 5-hydroxytryptamine 4 receptor antagonistic activity in piglet atrium model,,,CHEMBL857503,,11249,,,,H,8,BAO_0000019,2081.0
3315,,268,Autocuration,,,1,Evaluated for the 5-hydroxytryptamine 4 receptor antagonistic activity in piglet atrium model; compound found inactive at 1 uM,,,CHEMBL619015,,11249,,,,H,8,BAO_0000019,2081.0
3316,,15086,Autocuration,,,1,The compound was tested for binding affinity against 5-hydroxytryptamine 4 receptor,,,CHEMBL619016,,11249,,,,H,8,BAO_0000357,
3317,,14875,Autocuration,,,1,Compound was tested for binding affinity against piglet hippocampus 5-hydroxytryptamine 4 receptor,,,CHEMBL619017,,11249,,,,H,8,BAO_0000221,10000000.0
3318,,13267,Autocuration,9823.0,,1,The binding affinity (pKi) was measured against 5-hydroxytryptamine 4 receptor of piglet hippocampus using [125I]SB 207710 as radioligand,,,CHEMBL619018,,168,Sus scrofa,,,H,8,BAO_0000221,10000000.0
3319,,13047,Autocuration,9986.0,,1,Binding affinity against 5-hydroxytryptamine 2A receptor using rabbit saphenous vein assay.,,,CHEMBL619019,,168,Oryctolagus cuniculus,,,H,8,BAO_0000019,
3320,,1650,Expert,10116.0,,1,Displacement of [3H]GR-113808 from rat striatum 5-hydroxytryptamine 4 receptor,,,CHEMBL619020,,10623,Rattus norvegicus,,,D,9,BAO_0000357,
3321,,567,Autocuration,,,1,Tested for its agonist potency against the 5-hydroxytryptamine 4 receptor located in the rat esophageal tunica muscularis mucosae,,,CHEMBL619021,,10623,,,,H,8,BAO_0000019,
3322,,17358,Autocuration,,,1,Tested for affinity towards 5-hydroxytryptamine 4 receptor in relaxation of rat oesophagus,,,CHEMBL619022,,10623,,,,H,8,BAO_0000357,
3323,,188,Autocuration,,,1,Tested for the effect on binding at 5-hydroxytryptamine 4 receptor; No activity,,,CHEMBL619023,,10623,,,,H,8,BAO_0000357,
3324,,670,Autocuration,,,1,lntrinsic activity relative to 5-HT receptor,,,CHEMBL619024,,10623,,,,H,8,BAO_0000019,
3325,,204,Autocuration,,,1,Compound was evaluated for the agonistic activity towards 5-hydroxytryptamine 4 receptor using the rat tunica muscularis mucosae (TMM) esophagus strip assay,,,CHEMBL619025,,10623,,,,H,8,BAO_0000019,
3326,,1946,Expert,,,1,In vitro relaxation of carbachol pre-contracted rat oesophageal TMM.,,,CHEMBL619026,,10623,,,,H,8,BAO_0000019,
3327,,6398,Autocuration,,,1,Compound was tested for agonist activity at the 5-hydroxytryptamine 4 receptor in the rat tunica muscularis mucosae (TMM) assay,,,CHEMBL619027,,10623,,,,H,8,BAO_0000019,
3328,,6398,Autocuration,,,1,Compound was tested for agonist activity at the 5-hydroxytryptamine 4 receptor in the rat tunica muscularis mucosae (TMM) assay; IN = Inactive,,,CHEMBL619028,,10623,,,,H,8,BAO_0000019,
3329,,17358,Autocuration,,,1,Efficient 5-hydroxytryptamine 4 agonist in the rat tunica muscularis mucosae,,,CHEMBL619029,,10623,,,,H,8,BAO_0000019,
3330,,6398,Autocuration,,,1,Tested for agonist activity at the 5-hydroxytryptamine 4 receptor in the rat tunica muscularis mucosae (TMM) assay of racemate mixture,,,CHEMBL619030,,10623,,,,H,8,BAO_0000019,
3331,,11752,Expert,,,1,Relaxation of carbachol induced contractions of rat tunica muscularis mucosae,,,CHEMBL619031,,10623,,,,H,8,BAO_0000357,
3332,,809,Autocuration,,,1,5-hydroxytryptamine 4 receptor agonist activity was determined by the relaxation of the carbachol-contracted rat esophageal tunica muscularis mucosae,,,CHEMBL619032,,10623,,,,H,8,BAO_0000019,
3333,,14178,Expert,10116.0,,1,Inhibition of radiolabeled [3H]GR-113808 ligand binding to 5-hydroxytryptamine 4 receptor,,,CHEMBL619033,,10623,Rattus norvegicus,,,D,9,BAO_0000357,
3334,,567,Autocuration,,,1,Tested for its efficacy against the 5-hydroxytryptamine 4 receptor located in the rat esophageal tunica muscularis mucosae,,,CHEMBL619034,,10623,,,,H,8,BAO_0000357,
3335,,1946,Autocuration,,,1,In vitro 5-hydroxytryptamine 4 receptor activity by using carbachol-precontracted esophageal tunica muscularis mucosae.,,,CHEMBL619035,,10623,,,,H,8,BAO_0000357,
3336,,1946,Autocuration,,,1,In vitro 5-hydroxytryptamine 4 receptor activity by using carbachol-precontracted esophageal tunica muscularis mucosae; No activity up to 104M concentration,,,CHEMBL619036,,10623,,,,H,8,BAO_0000357,
3337,,13961,Expert,10116.0,,1,Binding affinity (Ki+/-SEM) against 5-hydroxytryptamine 4 receptor from cheng Prusoff equation by using [3H]GR-113808 in rat striatum,,,CHEMBL619037,,10623,Rattus norvegicus,,,D,9,BAO_0000019,
3338,,6238,Autocuration,,,1,Binding affinity towards 5-HT 4 receptor in rat striatum membranes using [3H]GR-113808 as radioligand,,,CHEMBL619038,,10623,,,,H,8,BAO_0000249,2435.0
3339,,14290,Autocuration,,,1,Binding affinity towards 5-HT4 receptor was determined in rat striatal membranes using [3H]GR-113808 as radioligand; Not tested,,,CHEMBL619039,,10623,,,,H,8,BAO_0000249,
3340,,14290,Expert,,,1,Binding affinity towards 5-hydroxytryptamine 4 receptor was determined in rat striatal membranes using [3H]GR-113808 as radioligand,,,CHEMBL619040,,10623,,,,H,8,BAO_0000249,
3341,,809,Expert,10116.0,,1,Binding affinity against 5-hydroxytryptamine 4 receptor using [3H]GR-113808 as radioligand in rat striatum,,,CHEMBL619041,,10623,Rattus norvegicus,,,D,9,BAO_0000019,2435.0
3342,,1578,Autocuration,,,1,Binding affinity against 5-hydroxytryptamine 4 receptor using [3H]GR-113808 as radioligand in rat striatum,,,CHEMBL619042,,10623,,,,H,8,BAO_0000019,2435.0
3343,,16709,Expert,,,1,Binding affinity to 5-hydroxytryptamine 4 receptor using [3H]GR-113808 as radioligand in rat striatum membrane,,,CHEMBL619043,,10623,,,,H,8,BAO_0000249,2435.0
3344,,1946,Expert,,,1,Binding affinity at 5-hydroxytryptamine 4 receptor in rat striatum by [3H]GR-113808 displacement.,,,CHEMBL619044,,10623,,,,H,8,BAO_0000019,2435.0
3345,,15253,Expert,,,1,In vitro affinity at serotonergic 5-hydroxytryptamine 4 receptor by radioligand binding assay using [3H]GR-113808 in rat striatum membranes.,,,CHEMBL619045,,10623,,,,H,8,BAO_0000249,2435.0
3346,,4535,Expert,,,1,In vitro binding affinity to 5-hydroxytryptamine 4 receptor in rat striatum membrane,,,CHEMBL619046,,10623,,,,H,8,BAO_0000249,2435.0
3347,,13961,Expert,,,1,Binding affinity at 5-hydroxytryptamine 4 receptor in rat striatal membranes by [3H]GR-113808 displacement.,,,CHEMBL619047,,10623,,,,H,8,BAO_0000249,
3348,,17358,Autocuration,,,1,Tested for potency against 5-hydroxytryptamine 4 receptor agonist in rat brain,,,CHEMBL619048,,10623,,,,H,8,BAO_0000221,955.0
3349,,15847,Autocuration,,,1,Compound was evaluated for its antagonist affinity towards 5-hydroxytryptamine 4 receptor of rat,,,CHEMBL859398,,10623,,,,H,8,BAO_0000019,
3350,,15847,Autocuration,,,1,Compound was evaluated for its antagonist affinity towards 5-hydroxytryptamine 4 receptor of rat; ND means not done,,,CHEMBL619049,,10623,,,,H,8,BAO_0000019,
3351,,670,Autocuration,,,1,5-hydroxytryptamine 4 receptor agonist activity in the rat esophageal muscularis mucosae,,,CHEMBL857886,,10623,,,,H,8,BAO_0000019,
3352,,670,Autocuration,,,1,5-hydroxytryptamine 4 receptor agonist activity in the rat esophageal muscularis mucosae; Not tested,,,CHEMBL619050,,10623,,,,H,8,BAO_0000019,
3353,,1317,Autocuration,,,1,Antagonist activity against 5-hydroxytryptamine 4 receptor mediated relaxation of rat carbachol contracted esophageal muscularis mucosae,,,CHEMBL620591,,10623,,,,H,8,BAO_0000019,
3354,,12936,Expert,10116.0,,1,Binding affinity against rat 5-hydroxytryptamine 4 receptor,,,CHEMBL620592,,10623,Rattus norvegicus,,,D,9,BAO_0000357,
3355,,4535,Expert,,,1,pKi against 5-hydroxytryptamine 4 receptor in rat striatum membrane,,,CHEMBL620593,,10623,,,,H,8,BAO_0000249,2435.0
3356,,14424,Expert,10116.0,,1,Antagonistic activity evaluated by ability to block serotonin induced relaxation (mediated by activation of 5-hydroxytryptamine 4 receptor) in carbamylcholine (10e-6 M) contracted esophagus at a concentration of 10e-5 M.,,,CHEMBL620594,,10623,Rattus norvegicus,,,D,9,BAO_0000019,
3357,,14424,Expert,,,1,Antagonistic activity by ability to block serotonin induced relaxation (mediated by activation of 5-hydroxytryptamine 4 receptor) in carbamylcholine (10e-6 M) contracted esophagus at a concentration of 10e-6 M.,,,CHEMBL875079,,10623,,,,H,8,BAO_0000019,
3358,,14424,Expert,,,1,Antagonistic activity by ability to block serotonin induced relaxation (mediated by activation of 5-hydroxytryptamine 4 receptor) in carbamylcholine (10e-6 M) contracted esophagus at a concentration of 10e-7 M.,,,CHEMBL620595,,10623,,,,H,8,BAO_0000019,
3359,,14424,Expert,10116.0,,1,Antagonistic activity evaluated by ability to block serotonin induced relaxation (mediated by activation of 5-hydroxytryptamine 4 receptor) in carbamylcholine (10e-6 M) contracted esophagus at a concentration of 10e-8 M.,,,CHEMBL620596,,10623,Rattus norvegicus,,,D,9,BAO_0000019,
3360,,14424,Autocuration,,,1,Antagonistic activity of compound was evaluated by ability to block serotonin induced relaxation (mediated by activation of 5-hydroxytryptamine 4 receptor) in carbamylcholine (10e-6 M) contracted esophagus at a concentration of 3*10e-7 M.,,,CHEMBL620597,,10623,,,,H,8,BAO_0000019,
3361,,14424,Expert,,,1,Antagonistic activity evaluated by ability to block serotonin induced relaxation (via 5-hydroxytryptamine 4 receptor) in carbamylcholine (10e-6 M) contracted esophagus at a concentration of 3*10e-8 M.,,,CHEMBL620598,,10623,,,,H,8,BAO_0000019,
3362,,14424,Expert,,,1,Antagonistic activity evaluated by ability to block serotonin induced relaxation via 5-hydroxytryptamine 4 receptor) in carbamylcholine (10e-6 M) contracted esophagus at a concentration of 0.1 mg/kg (p.o.),,,CHEMBL620599,,10623,,,,H,8,BAO_0000218,
3363,,14424,Autocuration,,,1,Antagonistic activity of compound was evaluated by ability to block serotonin induced relaxation (mediated by activation of 5-hydroxytryptamine 4 receptor) in carbamylcholine (10e-6 M) contracted esophagus at a concentration of 10e-7 M.,,,CHEMBL620600,,10623,,,,H,8,BAO_0000019,
3364,,1980,Autocuration,10116.0,,1,Estimate from relaxation of carbachol-contracted rat esophageal muscularis mucosae,,,CHEMBL620601,,168,Rattus norvegicus,,,H,8,BAO_0000019,
3365,,4639,Autocuration,,,1,Compound was tested for agonistic activity against 5-hydroxytryptamine 4 receptor on guinea colon at a concentration 0.1 uM,,,CHEMBL620602,,168,,,,H,8,BAO_0000019,
3366,,17358,Autocuration,,,1,Tested for affinity towards 5-hydroxytryptamine 4 receptor,,,CHEMBL620603,,168,,,,H,8,BAO_0000357,
3367,,17358,Autocuration,,,1,Tested for affinity towards 5-hydroxytryptamine 4 receptor.,,,CHEMBL620604,,168,,,,H,8,BAO_0000357,
3368,,17358,Autocuration,,,1,Compound was tested for 5-hydroxytryptamine 4 binding affinity,,,CHEMBL620605,,168,,,,H,8,BAO_0000357,
3369,,1558,Autocuration,,,1,Compound was tested for its affinity towards 5-hydroxytryptamine 4 receptor,,,CHEMBL620606,,168,,,,H,8,BAO_0000357,
3370,,17358,Autocuration,,,1,Tested for 5-hydroxytryptamine 4 receptor antagonist activity,,,CHEMBL620607,,168,,,,H,8,BAO_0000019,
3371,,16117,Autocuration,,,1,In vitro binding affinity towards 5-HT4 receptor was determined,,,CHEMBL620608,,168,,,,H,8,BAO_0000357,
3372,,17358,Autocuration,,,1,Tested for 5-hydroxytryptamine 4 receptor antagonist activity,,,CHEMBL620609,,168,,,,H,8,BAO_0000019,
3373,,17358,Autocuration,,,1,Tested for agonist activity against 5-hydroxytryptamine 4 receptor,,,CHEMBL620610,,168,,,,H,8,BAO_0000019,
3374,,17358,Autocuration,,,1,Tested for selectivity for 5-hydroxytryptamine 4 receptor,,,CHEMBL620611,,168,,,,H,8,BAO_0000357,
3375,,17358,Autocuration,,,1,Tested for 5-hydroxytryptamine 4 binding affinity against cisapride,,,CHEMBL620612,,168,,,,H,8,BAO_0000357,
3376,,17358,Autocuration,,,1,Tested for 5-hydroxytryptamine 4 binding affinity against renzapride,,,CHEMBL620613,,168,,,,H,8,BAO_0000357,
3377,,17358,Autocuration,,,1,Tested for 5-hydroxytryptamine 4 binding affinity against zacopride,,,CHEMBL620614,,168,,,,H,8,BAO_0000357,
3378,,1274,Expert,,,1,Binding affinity against 5-Hydroxytryptamine 4 receptor,,,CHEMBL620615,,168,,,,H,8,BAO_0000357,
3379,,10728,Autocuration,,,1,Compound was evaluated for the displacement of [3H]-Q-ICS 205-930 binding to 5-hydroxytryptamine 3 recognition sites in rat brain membranes,,,CHEMBL857075,Brain membranes,104698,,,,H,6,BAO_0000249,
3380,,11695,Autocuration,,,1,Compound was evaluated for the displacement of [3H]Q-ICS-205-930 from 5-HT3 recognition sites in rat brain membranes,,,CHEMBL620616,Brain membranes,104698,,,,H,6,BAO_0000249,
3381,,11695,Autocuration,,,1,Displacement of [3H]Q-ICS-205-930 from 5-hydroxytryptamine 3 receptor recognition sites in rat brain membranes,,,CHEMBL619411,Brain membranes,104698,,,,H,6,BAO_0000249,
3382,,12490,Autocuration,,,1,Displacement of [3H]-Q-ICS 205-930 binding to 5-hydroxytryptamine 3 receptor from rat cortex homogenate,,,CHEMBL619412,,104698,,,,H,6,BAO_0000019,
3383,,11828,Autocuration,10116.0,,1,Displacement of [3H]-Q-ICS 205-930 from rat cortex homogenate 5-hydroxytryptamine 3 receptor,,,CHEMBL619413,,104698,Rattus norvegicus,,,D,7,BAO_0000019,
3384,,12253,Autocuration,,,1,Binding affinity of 5-hydroxytryptamine 3 receptor using [3H]granisetron in rat hippocampus and entorhinal cortex,,,CHEMBL619414,,104698,,,,H,6,BAO_0000221,10000000.0
3385,,10561,Autocuration,,,1,Binding affinity to 5-hydroxytryptamine 3 receptor using [3H]GR-65630 as radioligand in rat cortex,,,CHEMBL619415,,104698,,,,H,6,BAO_0000019,
3386,,10561,Autocuration,,,1,Binding affinity to 5-hydroxytryptamine 3 receptor using [3H]quipazine as radioligand in rat cortex,,,CHEMBL619416,,104698,,,,H,6,BAO_0000019,
3387,,14432,Autocuration,,,1,Rat 5-hydroxytryptamine 3 receptor (5-HT3) antagonist,,,CHEMBL619417,,104698,,,,H,6,BAO_0000019,
3388,,12936,Autocuration,10116.0,,1,Binding affinity against rat 5-hydroxytryptamine 3 receptor,,,CHEMBL619418,,104698,Rattus norvegicus,,,D,7,BAO_0000223,
3389,,1274,Autocuration,10116.0,,1,Binding affinity against 5-Hydroxytryptamine 3 receptor,,,CHEMBL619419,,104698,Rattus norvegicus,,,D,7,BAO_0000223,
3390,,1980,Autocuration,,,1,Binding affinity for 5-hydroxytryptamine 3 receptor by displacement of racemic [3H]zacopride from rat cortex,,,CHEMBL619420,,104698,,,,H,6,BAO_0000019,
3391,,670,Autocuration,,,1,Binding affinity to 5-hydroxytryptamine 3 receptor was determined in rat cerebro cortical membranes using [3H]quipazine.,,,CHEMBL619421,,104698,,,,H,6,BAO_0000249,
3392,,968,Autocuration,10116.0,,1,Displacement of [3H]granisetron from 5-hydroxytryptamine 3 receptor of rat cortex,,,CHEMBL619422,,104698,Rattus norvegicus,,,D,7,BAO_0000019,
3393,,14287,Autocuration,,,1,In vitro by displacement of [3H]LY-278584 from 5-hydroxytryptamine 3 receptor on rat entorhinal cortex,,,CHEMBL619423,,104698,,,,H,6,BAO_0000019,
3394,,567,Autocuration,,,1,Tested for its binding affinity by measuring its ability to displace [3H]granisetron from 5-hydroxytryptamine 3 receptor in rat cortex,,,CHEMBL875080,,104698,,,,H,6,BAO_0000019,
3395,,13267,Autocuration,,,1,The binding affinity (pKi) measured against 5-hydroxytryptamine 1A receptor of rat cortex using [3H]8-OH-DPAT as radioligand,,,CHEMBL619424,,104698,,,,H,6,BAO_0000019,
3396,,14826,Autocuration,,,1,Binding affinity at 5-hydroxytryptamine 3 receptor in rat cortical membrane by [3H]graniestron displacement.,,,CHEMBL619425,,104698,,,,H,6,BAO_0000249,
3397,,15194,Autocuration,,,1,The compound was tested for the binding affinity against 5-hydroxytryptamine 3 receptor using [3H]zacopride as radioligand,,,CHEMBL619426,,104698,,,,H,6,BAO_0000223,
3398,,15194,Autocuration,,,1,The compound was tested for the binding affinity against 5-hydroxytryptamine 3 receptor using [3H]zacopride as radioligand.,,,CHEMBL619427,,104698,,,,H,6,BAO_0000223,
3399,,10394,Autocuration,10116.0,,1,pKi value for inhibition of [3H]LY-278584 binding to 5-hydroxytryptamine 3 receptor,,,CHEMBL619645,,104698,Rattus norvegicus,,,D,7,BAO_0000223,
3400,,13657,Expert,,,1,"Compound was evaluated for binding affinity on 5-hydroxytryptamine 1A receptor in rat hippocampus membranes,3H-8-OH-DPAT and buspirone for nonspecific binding",,,CHEMBL619646,,10576,,,,D,9,BAO_0000249,
3401,,1879,Autocuration,,,1,Compound was tested for its antagonistic activity against 5-hydroxytryptamine 3 receptor in rat brain using [3H]zacopride as the radioligand.,,,CHEMBL619647,,12020,,,,H,8,BAO_0000221,955.0
3402,,1879,Autocuration,,,1,Compound was tested in vitro for its antagonistic activity against 5-hydroxytryptamine 3 receptor,,,CHEMBL619648,,12020,,,,H,8,BAO_0000019,
3403,,1879,Autocuration,,,1,Compound was tested in vitro for its antagonistic activity against 5-hydroxytryptamine 3 receptor in rat CNS.,,,CHEMBL619165,,12020,,,,H,8,BAO_0000019,
3404,In vivo,204,Autocuration,,,1,Compound was evaluated in vivo for the antagonistic activity towards 5-hydroxytryptamine 3 receptor,,,CHEMBL620719,,12020,,,,H,8,BAO_0000218,
3405,,1879,Autocuration,,,1,Compound was tested for its binding affinity towards 5-HT-3 receptor in whole rat brain using (S)-[125I]-zacopride as the radioligand.,,,CHEMBL872924,,12020,,,,H,8,BAO_0000019,
3406,,1879,Autocuration,,,1,Compound was tested for its binding affinity towards 5-hydroxytryptamine 3 receptor,,,CHEMBL620720,,12020,,,,H,8,BAO_0000357,
3407,,1879,Autocuration,,,1,Compound was tested for its binding affinity towards 5-hydroxytryptamine 3 receptor in whole rat brain using (S)-[125I]-zacopride as the radioligand.,,,CHEMBL620721,,12020,,,,H,8,BAO_0000019,
3408,,1879,Autocuration,,,1,Compound was tested for its binding affinity towards 5-hydroxytryptamine 3 receptor in whole rat brain using [125I]DAIZAC as the radioligand.,,,CHEMBL620722,,12020,,,,H,8,BAO_0000019,
3409,,10641,Autocuration,,,1,"Concentration that inhibits the binding of radioligand, [3H]-ICS 205930, to 5-hydroxytryptamine 3 receptor from rat cortex",,,CHEMBL620723,,104698,,,,H,6,BAO_0000019,
3410,,773,Autocuration,,,1,In Vitro Binding affinity againist 5-hydroxytryptamine 3 receptor by displacing [3H]-Q-ICS 205-930 from rat cortex homogenates,,,CHEMBL620724,,12020,,,,H,8,BAO_0000019,
3411,,11952,Autocuration,,,1,Binding affinity against 5-hydroxytryptamine 3 (5-HT3) receptor in rat brain cortical membranes using radioligand [3H]quipazine,,,CHEMBL620725,,104698,,,,H,6,BAO_0000249,
3412,,14145,Autocuration,10116.0,,1,Antagonist activity (100 ug/kg) for the Bezold Jarisch reflex evoked by 30 (ug/Kg) of 5-hydroxytryptamine 3 receptor in ethylurethane anesthetized rats i.v.,,,CHEMBL620726,,12020,Rattus norvegicus,,,D,9,BAO_0000019,
3413,,17066,Expert,,,1,Binding affinity towards 5-hydroxytryptamine 3 receptor,,,CHEMBL620727,,144,,,,H,8,BAO_0000357,
3414,,6398,Autocuration,,,1,Compound was evaluated for 5-hydroxytryptamine 3 receptor binding,,,CHEMBL620728,,104714,,,,H,4,BAO_0000223,
3415,,10321,Autocuration,,,1,Binding affinity towards 5-hydroxytryptamine 3 receptor by displacement of [3H]2 in Neuroblastoma-Glioma NG-108-15 cells,,,CHEMBL620729,,22226,,,,U,0,BAO_0000019,
3416,,511,Autocuration,,,1,Tested for 5-hydroxytryptamine 3 receptor antagonist activity by inhibiting the 5-HT evoked Bezold-Jarisch reflex,,,CHEMBL858288,,104714,,,,H,4,BAO_0000019,
3417,,4639,Autocuration,,,1,Compound was tested for binding affinity towards 5-hydroxytryptamine 3 receptor,,,CHEMBL620730,,104714,,,,H,4,BAO_0000223,
3418,,4639,Autocuration,,,1,Binding affinity towards 5-hydroxytryptamine 3 receptor,,,CHEMBL620731,,104714,,,,H,4,BAO_0000223,
3419,,4639,Autocuration,10141.0,,1,Compound was tested for antagonistic activity against 5-hydroxytryptamine 3 receptor on guinea pig colon at a concentration of 0.3 uM,,,CHEMBL620732,,104714,Cavia porcellus,,,H,4,BAO_0000019,
3420,,4639,Autocuration,10141.0,,1,Compound was tested for antagonistic activity against 5-hydroxytryptamine 3 receptor on guinea pig colon at a concentration of 3 uM,,,CHEMBL618042,,104714,Cavia porcellus,,,H,4,BAO_0000019,
3421,,4639,Autocuration,10141.0,,1,Compound was tested for antagonistic activity against 5-hydroxytryptamine 3 receptor on guinea pig colon at a concentration of 30 uM,,,CHEMBL618043,,104714,Cavia porcellus,,,H,4,BAO_0000019,
3422,,1558,Autocuration,,,1,Compound was tested for its affinity towards 5-hydroxytryptamine 3 receptor,,,CHEMBL618044,,104714,,,,H,4,BAO_0000223,
3423,,268,Autocuration,,,1,Evaluated for the 5-hydroxytryptamine 3 receptor antagonistic activity in Bezold-Jarisch model expressed as inhibition of the reflex bradycardia induced by an intravenous injection,,,CHEMBL618045,,104714,,,,H,4,BAO_0000019,
3424,,2474,Autocuration,,,1,Compound was measured for its binding affinity at 5-hydroxytryptamine 3 receptor at a concentration of 10 uM using [3H]BRL-43694 as radioligand,,,CHEMBL618046,,104714,,,,H,4,BAO_0000223,
3425,,5067,Autocuration,,,1,Intrinsic activity towards 5-hydroxytryptamine 3 receptor was determined by Benzold-Jarisch reflex (peripheral assay); A: agonist,,,CHEMBL618047,,104714,,,,H,4,BAO_0000019,
3426,,5067,Autocuration,,,1,Intrinsic activity towards 5-hydroxytryptamine 3 receptor was determined by Benzold-Jarisch reflex (peripheral assay); ANT: agonist,,,CHEMBL875084,,104714,,,,H,4,BAO_0000019,
3427,,5067,Autocuration,,,1,Intrinsic activity towards 5-hydroxytryptamine 3 receptor was determined by Benzold-Jarisch reflex (peripheral assay); ANT: antagonist,,,CHEMBL618048,,104714,,,,H,4,BAO_0000019,
3428,,5067,Autocuration,,,1,Intrinsic activity towards 5-hydroxytryptamine 3 receptor was determined by Benzold-Jarisch reflex (peripheral assay); NA means data not available,,,CHEMBL618049,,104714,,,,H,4,BAO_0000223,
3429,,5067,Autocuration,,,1,Intrinsic activity towards 5-hydroxytryptamine 3 receptor was determined by Benzold-Jarisch reflex (peripheral assay); PA: Partial agonist,,,CHEMBL619764,,104714,,,,H,4,BAO_0000019,
3430,,5067,Autocuration,,,1,Intrinsic activity towards CNS 5-hydroxytryptamine 3 receptor was determined; A: agonist,,,CHEMBL619765,,104714,,,,H,4,BAO_0000019,
3431,,5067,Autocuration,,,1,Intrinsic activity towards CNS 5-hydroxytryptamine 3 receptor was determined; ANT: Antagonist,,,CHEMBL619766,,104714,,,,H,4,BAO_0000019,
3432,,5067,Autocuration,,,1,Intrinsic activity towards CNS 5-hydroxytryptamine 3 receptor was determined; NA: not active,,,CHEMBL619767,,104714,,,,H,4,BAO_0000223,
3433,,5067,Autocuration,,,1,Intrinsic activity towards CNS 5-hydroxytryptamine 3 receptor was determined; NA means data not available,,,CHEMBL619768,,104714,,,,H,4,BAO_0000223,
3434,,5067,Autocuration,,,1,Intrinsic activity towards CNS 5-hydroxytryptamine 3 receptor was determined; PA: Partial agonist,,,CHEMBL619769,,104714,,,,H,4,BAO_0000019,
3435,,5067,Autocuration,,,1,Intrinsic activity towards CNS 5-hydroxytryptamine 3 receptor was determined; na means data not available,,,CHEMBL619770,,104714,,,,H,4,BAO_0000223,
3436,,5067,Autocuration,,,1,Binding affinity towards 5-hydroxytryptamine 3 receptor,,,CHEMBL619771,,104714,,,,H,4,BAO_0000223,
3437,,14331,Autocuration,,,1,Binding affinity of compound towards 5-hydroxytryptamine 3 receptor using [3H]-BRL-43694 (1 nM) ligand in NG cells 108-15 was determined,,,CHEMBL619772,,104714,,,,H,4,BAO_0000219,
3438,,5067,Autocuration,,,1,Binding affinity of compound towards 5-hydroxytryptamine 3 receptor; NA: not active,,,CHEMBL619773,,104714,,,,H,4,BAO_0000223,
3439,,6179,Autocuration,,,1,Binding affinity for 5-HT3 receptor of NG108-15 cells using [3H]GR-65630,433.0,,CHEMBL619774,,104714,,NG108-15,,H,4,BAO_0000219,
3440,,4265,Autocuration,,,1,Binding affinity to 5-HT3 serotonin receptor in NG 108-15 neuroblastoma glioma cells using [3H]GR-65630 radioligand.,,,CHEMBL875083,,104714,,,,H,4,BAO_0000019,
3441,,4265,Autocuration,,,1,Binding affinity to 5-HT3 serotonin receptor in NG108-15 neuroblastoma glioma cells using [3H]GR-65630 radioligand,433.0,,CHEMBL620718,,104714,,NG108-15,,H,4,BAO_0000219,
3442,,17358,Autocuration,,,1,Compound was tested for 5-hydroxytryptamine 3 receptor binding affinity,,,CHEMBL618127,,104714,,,,H,4,BAO_0000223,
3443,,17358,Autocuration,,,1,Compound was tested for selectivity against 5-hydroxytryptamine 3 receptor binding affinity,,,CHEMBL618128,,104714,,,,H,4,BAO_0000223,
3444,In vitro,13628,Autocuration,,,1,Compound was tested for the inhibition of [3H]GR-65630 binding to 5-hydroxytryptamine 3 receptor expressed in NG 108-15 cells,,,CHEMBL618129,,104714,,,,H,4,BAO_0000219,
3445,,4612,Autocuration,,,1,In vitro Binding affinity towards 5-hydroxytryptamine 3 receptor was determined,,,CHEMBL618130,,104714,,,,H,4,BAO_0000223,
3446,,17358,Autocuration,,,1,Tested for 5-hydroxytryptamine 3 receptor antagonist activity,,,CHEMBL618131,,104714,,,,H,4,BAO_0000019,
3447,,4639,Autocuration,10141.0,,1,Compound was tested for agonistic activity against 5-hydroxytryptamine 3 receptor on guinea pig colon at a concentration of 1 uM,,,CHEMBL618132,,104714,Cavia porcellus,,,H,4,BAO_0000019,
3448,,4639,Autocuration,10141.0,,1,Compound was tested for agonistic activity against 5-hydroxytryptamine 3 receptor on guinea pig colon at a concentration of 10 uM,,,CHEMBL618133,,104714,Cavia porcellus,,,H,4,BAO_0000019,
3449,,4639,Autocuration,10141.0,,1,Compound was tested for agonistic activity against 5-hydroxytryptamine 3 receptor on guinea pig colon at a concentration of 10 uM in the presence of 30 uM MDL 72222,,,CHEMBL618134,,104714,Cavia porcellus,,,H,4,BAO_0000019,
3450,,4639,Autocuration,10141.0,,1,Compound was tested for agonistic activity against 5-hydroxytryptamine 3 receptor on guinea pig colon at a concentration of 3 uM,,,CHEMBL618135,,104714,Cavia porcellus,,,H,4,BAO_0000019,
3451,,511,Autocuration,,,1,Binding affinity for the 5-hydroxytryptamine 3 receptor was evaluated in vitro by examining its ability to displace [3H]-BRL 43694.,,,CHEMBL618136,,104714,,,,H,4,BAO_0000223,
3452,,1479,Autocuration,,,1,Binding affinity towards 5-hydroxytryptamine 3 receptor,,,CHEMBL618137,,104714,,,,H,4,BAO_0000223,
3453,,1317,Autocuration,,,1,Compound was evaluated for binding affinity against 5-hydroxytryptamine 3 receptor using radioligand binding assay,,,CHEMBL618138,,104714,,,,H,4,BAO_0000223,
3454,,12146,Autocuration,,,1,Tested against 5-hydroxytryptamine 3 receptor in experiment 1,,,CHEMBL618139,,104714,,,,H,4,BAO_0000223,
3455,,12146,Autocuration,,,1,Tested against 5-hydroxytryptamine 3 receptor in experiment 2,,,CHEMBL618140,,104714,,,,H,4,BAO_0000223,
3456,,13969,Autocuration,,,1,Binding affinity against 5-hydroxytryptamine 3 receptor was measured using [3H]granisetron as radioligand,,,CHEMBL618141,,104714,,,,H,4,BAO_0000223,
3457,,13392,Expert,,,1,Binding affinity for 5-hydroxytryptamine 2C receptor,,,CHEMBL873478,,108,,,,H,8,BAO_0000357,
3458,,13392,Autocuration,,,1,Binding affinity towards 5-hydroxytryptamine 3 receptor,,,CHEMBL618142,,104698,,,,H,6,BAO_0000223,
3459,,14159,Autocuration,,,1,Compound was evaluated for the affinity at 5-hydroxytryptamine 3 receptor,,,CHEMBL618143,,144,,,,H,8,BAO_0000357,
3460,,1558,Autocuration,,,1,Compound was tested for its affinity towards 5-hydroxytryptamine 3 receptor,,,CHEMBL618144,,144,,,,H,8,BAO_0000357,
3461,,16655,Autocuration,,,1,Inhibition of GR-65630 binding to 5-hydroxytryptamine 3 receptor,,,CHEMBL618145,,144,,,,H,8,BAO_0000357,
3462,,13020,Autocuration,,,1,Inhibition of [3H]- BRL 43 694 binding to 5-hydroxytryptamine 3 receptor at 10e-5 M,,,CHEMBL618146,,104714,,,,H,4,BAO_0000223,
3463,,13021,Autocuration,,,1,Inhibition of [3H]-BRL 43 694 binding to 5-hydroxytryptamine 3 receptor of central nervous system,,,CHEMBL618147,,104714,,,,H,4,BAO_0000223,
3464,,13020,Autocuration,,,1,Inhibition of [3H]- BRL 43 694 binding to 5-hydroxytryptamine 3 receptor at 10e-5 M,,,CHEMBL618148,,104714,,,,H,4,BAO_0000223,
3465,,10321,Autocuration,,,1,Binding affinity towards 5-hydroxytryptamine 3 receptor by displacement of [3H]2 in Neuroblastoma-Glioma NG-108-15 cells,,,CHEMBL618149,,144,,,,H,8,BAO_0000019,
3466,,15818,Autocuration,,,1,Compound was evaluated for its binding affinity towards 5-hydroxytryptamine 3 receptor,,,CHEMBL872927,,144,,,,H,8,BAO_0000357,
3467,,15818,Autocuration,,,1,Compound was evaluated for its binding affinity towards 5-hydroxytryptamine 3 receptor,,,CHEMBL618150,,144,,,,H,8,BAO_0000357,
3468,,17358,Autocuration,,,1,Compound was tested for 5-hydroxytryptamine 3 receptor binding affinity,,,CHEMBL618151,,144,,,,H,8,BAO_0000357,
3469,,2222,Autocuration,,,1,Compound was tested for its binding affinity for the 5-hydroxytryptamine 3 receptor,,,CHEMBL875094,,144,,,,H,8,BAO_0000357,
3470,,10322,Autocuration,,,1,In vitro binding affinity for the 5-hydroxytryptamine 3 receptor was determined with NG-108-15 mouse neuroblastoma-glioma cells,,,CHEMBL618152,,144,,,,H,8,BAO_0000019,
3471,,16117,Autocuration,,,1,In vitro binding affinity towards 5-hydroxytryptamine 3 receptor was determined,,,CHEMBL618153,,144,,,,H,8,BAO_0000357,
3472,,17200,Autocuration,,,1,Inhibitory constant against 5-hydroxytryptamine 3 receptor using [3H]GR-65630 radioligand,,,CHEMBL618888,,144,,,,H,8,BAO_0000357,
3473,,17358,Autocuration,,,1,Tested for 5-hydroxytryptamine 3 receptor agonist activity,,,CHEMBL618889,,144,,,,H,8,BAO_0000019,
3474,,16700,Autocuration,,,1,The binding affinity towards 5-hydroxytryptamine 3 receptor; No affinity,,,CHEMBL618890,,144,,,,H,8,BAO_0000357,
3475,,1980,Autocuration,,,1,Binding affinity for 5-hydroxytryptamine 3 receptor by displacement of [3H](R)-zacopride from ondansetron-treated NG-108-15 cell membranes,,,CHEMBL618891,,144,,,,H,8,BAO_0000019,
3476,,1980,Autocuration,,,1,Binding affinity for 5-hydroxytryptamine 3 receptor by displacement of [3H]-BRL 43694 from NG-108-15 cell membranes,,,CHEMBL619054,,144,,,,H,8,BAO_0000019,
3477,,12409,Autocuration,,,1,Binding affinity against the 5-hydroxytryptamine 3 receptor,,,CHEMBL619055,,104714,,,,H,4,BAO_0000223,
3478,,4365,Autocuration,,,1,Binding affinity against human 5-hydroxytryptamine 3A receptor,,,CHEMBL619056,,144,,,,H,8,BAO_0000357,
3479,,4365,Autocuration,,,1,Percent efficacy against 5-hydroxytryptamine 3A receptor,,,CHEMBL619057,,144,,,,H,8,BAO_0000019,
3480,,4365,Autocuration,,,1,Binding affinity against human 5-hydroxytryptamine 3A receptor,,,CHEMBL619058,,144,,,,H,8,BAO_0000357,
3481,,6769,Expert,10116.0,,1,Response at rat 5-hydroxytryptamine 3a receptor expressed in xenopus oocytes,,,CHEMBL619059,,12020,Rattus norvegicus,Oocytes,,D,9,BAO_0000219,
3482,,6769,Expert,10116.0,,1,Ability to block serotonin (30 uM)-evoked responses at rat 5HT3-alpha receptor expressed in xenopus oocytes,,,CHEMBL619060,,12020,Rattus norvegicus,Oocytes,,D,9,BAO_0000219,
3483,,6769,Expert,10116.0,,1,Effect on rat 5-hydroxytryptamine 3a receptor expressed in xenopus oocytes at concentration up to 100 uM,,,CHEMBL875095,,12020,Rattus norvegicus,Oocytes,,D,9,BAO_0000219,
3484,,809,Intermediate,10141.0,,1,5-hydroxytryptamine 4 receptor agonist activity as percent maximum 5-HT effect in response to electrical stimulation in male guinea pig ileum,,,CHEMBL619061,,20033,Cavia porcellus,,,D,9,BAO_0000221,2116.0
3485,,809,Intermediate,10141.0,,1,5-hydroxytryptamine 4 receptor agonist activity expressed as the concentration which gave a 50% increase in the response to the electrical stimulation in male guinea pig ileum,,,CHEMBL619062,,20033,Cavia porcellus,,,D,9,BAO_0000221,2116.0
3486,,14290,Intermediate,10141.0,,1,5-hydroxytryptamine 4 receptor agonist activity is expressed as percent of the maximum 5-HT response,,,CHEMBL619063,,20033,Cavia porcellus,,,D,9,BAO_0000019,
3487,,17358,Intermediate,10141.0,,1,Tested for affinity towards 5-hydroxytryptamine 4 receptor in electrically stimulated longitudinal muscle preparation of guinea pig ileum,,,CHEMBL619064,,20033,Cavia porcellus,,,D,9,BAO_0000221,2116.0
3488,,17358,Intermediate,10141.0,,1,Tested for affinity towards 5-hydroxytryptamine 4 receptor in guinea pig distal colon preparation,,,CHEMBL619065,,20033,Cavia porcellus,,,D,9,BAO_0000357,
3489,,17358,Intermediate,10141.0,,1,Tested for affinity towards 5-hydroxytryptamine 4 receptor in isolated guinea pig ileum longitudinal muscle preparation,,,CHEMBL619066,,20033,Cavia porcellus,,,D,9,BAO_0000221,2116.0
3490,,17386,Autocuration,,,1,Maximal relaxation effect induced by 3 uM compound on substance P stimulated guinea pig ileum with 5-hydroxytryptamine 7 receptor nondesensitization,,,CHEMBL619775,,10209,,,,H,8,BAO_0000221,2116.0
3491,,3269,Autocuration,,,1,Affinity against 5-hydroxytryptamine 7 receptor,,,CHEMBL619776,,10209,,,,H,8,BAO_0000357,
3492,,7721,Autocuration,10141.0,,1,Ability to displace [3H]5-HT binding from 5-hydroxytryptamine receptor site using 1 uM LSD as masking ligand,,,CHEMBL619777,,104841,Cavia porcellus,,,H,4,BAO_0000224,
3493,,7721,Autocuration,10141.0,,1,Ability to displace [3H]5-HT binding to 5-hydroxytryptamine receptor site using 1 uM LSD as masking ligand,,,CHEMBL619778,,104841,Cavia porcellus,,,H,4,BAO_0000224,
3494,,9117,Autocuration,10141.0,,1,Evaluated for inhibition of 5-hydroxytryptamine receptor on guinea pig ileum at 10 uM; No effect,,,CHEMBL619779,,104841,Cavia porcellus,,,H,4,BAO_0000221,2116.0
3495,,7721,Autocuration,10141.0,,1,"Ability to displace [3H]5-HT binding to 5-hydroxytryptamine receptor site using 1 uM LSD as masking ligand, activity is expressed as Kd.",,,CHEMBL619780,,104841,Cavia porcellus,,,H,4,BAO_0000224,
3496,,7721,Autocuration,10141.0,,1,"Ability to displace [3H]5-HT binding to 5-hydroxytryptamine receptor using 1 uM LSD as masking ligand, activity is expressed as Kd.",,,CHEMBL619166,,104841,Cavia porcellus,,,H,4,BAO_0000224,
3497,,15796,Autocuration,10141.0,,1,5-HT level in K+ induced 5-hydroxytryptamine release in guinea pig cortex.,,,CHEMBL619167,,104841,Cavia porcellus,,,H,4,BAO_0000019,
3498,,15796,Autocuration,10141.0,,1,5-hydroxytryptamine level in K+ induced 5-hydroxytryptamine release in guinea pig cortex.,,,CHEMBL619168,,104841,Cavia porcellus,,,H,4,BAO_0000019,
3499,,15650,Expert,9606.0,,1,Concentration required to produce half-maximal response against 5-hydroxytryptamine receptor in the presence of 10 nM compound in isolated human atrial myocytes,,,CHEMBL619169,,168,Homo sapiens,,,D,9,BAO_0000219,2081.0
3500,,15650,Expert,9606.0,,1,Concentration required to produce half-maximal response against 5-hydroxytryptamine receptor on the L-type calcium current (I Ca) in isolated human atrial myocytes,,,CHEMBL619170,,168,Homo sapiens,,,D,9,BAO_0000219,2081.0
3501,,6866,Autocuration,9606.0,,1,"Maximum stimulation of [35S]GTP-gamma-S, binding expressed relative to the maximal effect of 5-hydroxytryptamine",,,CHEMBL619171,,104841,Homo sapiens,,,D,5,BAO_0000019,
3502,,15650,Expert,9606.0,,1,",Antagonism of stimulation of 5-hydroxytryptamine receptor on the L-type calcium current (I Ca) in isolated human atrial myocytes",,,CHEMBL619172,,168,Homo sapiens,,,D,9,BAO_0000219,2081.0
3503,,10063,Autocuration,10090.0,,1,Ability (10 ug/kg) to inhibit binding of [125I]iododexetimide to 5-hydroxytryptamine receptor in mice,,,CHEMBL619173,,22226,Mus musculus,,,U,0,BAO_0000019,
3504,,12665,Autocuration,10090.0,,1,Percent inhibition of radioligand [3H]-LSD binding to 5-HT receptor at 10 uM concentration,,,CHEMBL619174,,22226,Mus musculus,,,U,0,BAO_0000019,
3505,,7504,Autocuration,,,1,5-hydroxytryptamine receptor binding affinity was determined in rats,,,CHEMBL619175,,104705,,,,H,4,BAO_0000019,
3506,,7504,Autocuration,,,1,Binding affinity at rat 5-hydroxytryptamine receptor.,,,CHEMBL619176,,104705,,,,H,4,BAO_0000224,
3507,,7038,Autocuration,,,1,Affinity against 5-hydroxytryptamine receptors in rat fundus model,,,CHEMBL619177,,104705,,,,H,4,BAO_0000019,
3508,,7626,Autocuration,,,1,Affinity for 5-hydroxytryptamine receptor was determined using male Dawley rat fundus preparation,,,CHEMBL619178,,104705,,,,H,4,BAO_0000224,
3509,,7626,Autocuration,,,1,Affinity for 5-hydroxytryptamine receptor was determined using male Dawley rat fundus preparation; Not determined,,,CHEMBL619179,,104705,,,,H,4,BAO_0000224,
3510,,7185,Autocuration,,,1,Antagonistic activity against serotonin 5-HT receptor obtained from rat stomach fundus preparation,,,CHEMBL619180,,104705,,,,H,4,BAO_0000019,945.0
3511,,7185,Autocuration,,,1,Antagonistic activity against serotonin 5-HT receptor obtained from rat stomach fundus preparation (resulted in discoloration in the oxygenated muscle bath to give varying results).,,,CHEMBL619181,,104705,,,,H,4,BAO_0000019,945.0
3512,,7185,Autocuration,,,1,Antagonistic activity of corresponding methoxy compound against serotonin 5-HT receptor,,,CHEMBL619182,,104705,,,,H,4,BAO_0000019,
3513,,6960,Autocuration,,,1,Compound was evaluated for binding affinity towards 5-hydroxytryptamine receptor in isolated rat fundus preparation measured as pA2,,,CHEMBL619183,,104705,,,,H,4,BAO_0000224,
3514,,6960,Autocuration,,,1,"Compound was evaluated for binding affinity towards 5-hydroxytryptamine receptor in isolated rat fundus preparation measured as pA2; Valid pA2, can not be determined because of slope of Schild plot.",,,CHEMBL619184,,104705,,,,H,4,BAO_0000224,
3515,,12416,Autocuration,,,1,In vitro affinity towards 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand in hippocampus,,,CHEMBL619185,,10576,,,,H,8,BAO_0000221,10000000.0
3516,,15753,Expert,,,1,Binding affinity for rat 5-hydroxytryptamine transporter.,,,CHEMBL619186,,12198,,,,H,8,BAO_0000357,
3517,,8062,Autocuration,,,1,Evaluated for inhibition of specific [3H]5-HT receptor binding in rat cortex.,,,CHEMBL619187,,104705,,,,H,4,BAO_0000019,
3518,,9036,Autocuration,10116.0,,1,Binding affinity at serotonin 5-HT1-type site receptor in rat cortex by displacing [3H]5-HT,,,CHEMBL619188,,104705,Rattus norvegicus,,,D,5,BAO_0000019,
3519,,15067,Autocuration,10116.0,,1,Compound was tested for its inhibitory activity against 5-hydroxytryptamine receptor,,,CHEMBL619189,,104705,Rattus norvegicus,,,D,5,BAO_0000224,
3520,,15753,Expert,10116.0,,1,Inhibitory activity against [3H]- 5-hydroxytryptamine reuptake in whole rat brain minus cerebellum,,,CHEMBL619190,,12198,Rattus norvegicus,,,D,9,BAO_0000019,955.0
3521,,15753,Expert,10116.0,,1,Inhibition of [3H]5-HT reuptake in whole rat brain (minus cerebellum) homogenate.,,,CHEMBL619191,,12198,Rattus norvegicus,,,D,9,BAO_0000221,2037.0
3522,,15295,Autocuration,10116.0,,1,Displacement of [3H]-citalopram from rat forebrain membrane 5-hydroxytryptamine receptor at 10e-7 M,,,CHEMBL619192,,104705,Rattus norvegicus,,,D,5,BAO_0000019,
3523,,6347,Autocuration,10116.0,,1,Percent binding affinity against 5-hydroxytryptamine receptor,,,CHEMBL619193,,104705,Rattus norvegicus,,,D,5,BAO_0000224,
3524,,6763,Autocuration,,,1,Ability to displace 0.4 nM [3H]paroxetine binding to 5-hydroxytryptamine receptor in rat frontal cortex,,,CHEMBL619194,,22226,,,,U,0,BAO_0000019,
3525,,12092,Autocuration,10116.0,,1,The binding affinity was measured on 5-hydroxytryptamine receptor uptake receptor using [3H]- paroxetine as radioligand.,,,CHEMBL619195,,104705,Rattus norvegicus,,,D,5,BAO_0000224,
3526,,1579,Autocuration,10116.0,,1,Affinity against 5-hydroxytryptamine receptor was determined,,,CHEMBL619196,,104705,Rattus norvegicus,,,D,5,BAO_0000224,
3527,,1579,Autocuration,10116.0,,1,Affinity against 5-hydroxytryptamine receptor was determined in rat stomach fundus strip,,,CHEMBL619197,,104705,Rattus norvegicus,,,D,5,BAO_0000019,945.0
3528,In vitro,5963,Expert,9606.0,,1,Inhibition of [3H]5-HT uptake in HEK cells expressing human SERT,,,CHEMBL619198,,121,Homo sapiens,,,D,9,BAO_0000219,
3529,In vitro,5963,Expert,9606.0,,1,Inhibition of [3H]5-HT uptake in HEK cells expressing human SERT,,,CHEMBL875081,,121,Homo sapiens,,,D,9,BAO_0000219,
3530,,5030,Autocuration,,,1,Ability to compete with radioactive ligands specific to the Serotonergic 5-HT receptor at 10 uM; NA means compound failed to compete,,,CHEMBL884712,,18065,,,,H,8,BAO_0000357,
3531,,15796,Expert,,,1,Inhibition of 5-hydroxytryptamine reuptake,,,CHEMBL884710,,121,,,,H,8,BAO_0000357,
3532,,15413,Autocuration,,,1,"Receptor-linked G protein activation at 5-hydroxytryptamine receptor was determined by measuring the stimulation of [35S]GTP-gamma-S, binding",,,CHEMBL619199,,18065,,,,H,8,BAO_0000019,
3533,,15413,Autocuration,,,1,"Receptor-linked G protein activation at 5-hydroxytryptamine receptor was determined by measuring the stimulation of [35S]GTP-gamma-S, binding (Experiment 1)",,,CHEMBL619200,,18065,,,,H,8,BAO_0000019,
3534,,15413,Autocuration,,,1,"Receptor-linked G protein activation at 5-hydroxytryptamine receptor was determined by measuring the stimulation of [35S]GTP-gamma-S, binding (Experiment 2)",,,CHEMBL619201,,18065,,,,H,8,BAO_0000019,
3535,,12409,Autocuration,,,1,Tested for 5-hydroxytryptamine receptor uptake,,,CHEMBL619202,,18065,,,,H,8,BAO_0000019,
3536,,16909,Expert,9606.0,,1,Affinity constant on CHO cells expressing Human recombinant 5-hydroxytryptamine receptor 1A,449.0,,CHEMBL619203,,51,Homo sapiens,CHO,,D,9,BAO_0000219,
3537,,16909,Expert,9606.0,,1,Antagonistic affinity tested against isolated human cloned alpha-1d adrenoceptor subtype,,,CHEMBL619204,,51,Homo sapiens,,,D,9,BAO_0000019,
3538,,15629,Autocuration,9606.0,,1,In vitro binding affinity towards 5-hydroxytryptamine receptor 1A receptor by using [3H]8-OH-DPAT in rat hippocampal membranes.,,,CHEMBL619205,,10576,Homo sapiens,,,H,8,BAO_0000249,
3539,,15629,Autocuration,,,1,Tested in vitro for % inhibition against 5-hydroxytryptamine receptor 1A,,,CHEMBL619206,,10576,,,,H,8,BAO_0000357,
3540,,15629,Expert,,,1,In vitro binding affinity at 5-hydroxytryptamine receptor 1A receptor in rat hippocampal membranes by [3H]8-OH-DPAT displacement.,,,CHEMBL619207,,10576,,,,H,8,BAO_0000249,
3541,,10034,Autocuration,,,1,Compound was tested for its effect on NSD 1015 induced accumulation of 5-HTP in rats corpus striatum at a dosage of 0.10 umol/kg,,,CHEMBL619208,,10825,,,,H,8,BAO_0000019,2435.0
3542,,10034,Autocuration,,,1,Compound was tested for its effect on NSD 1015 induced accumulation of 5-HTP in rats corpus striatum at a dosage of 10 umol/kg,,,CHEMBL619209,,10825,,,,H,8,BAO_0000019,2435.0
3543,,10034,Autocuration,,,1,Compound was tested for its effect on NSD 1015 induced accumulation of 5-HTP in rats in corpus striatum at a dosage of 0.32 umol/kg,,,CHEMBL619210,,10825,,,,H,8,BAO_0000019,2435.0
3544,,10034,Autocuration,,,1,Compound was tested for its effect on NSD 1015 induced accumulation of 5-HTP in rats in corpus striatum at a dosage of 3.2 umol/kg,,,CHEMBL619211,,10825,,,,H,8,BAO_0000019,2435.0
3545,,10034,Autocuration,,,1,Compound was tested for its effect on NSD 1015 induced accumulation of 5-HTP in rats in corpus striatum at a dosage of 32 umol/kg,,,CHEMBL619212,,10825,,,,H,8,BAO_0000019,2435.0
3546,,10034,Autocuration,,,1,Compound was tested for its effect on NSD 1015 induced accumulation of 5-HTP(ng/g) in rats in corpus striatum at a dosage of 0.032 umol/kg,,,CHEMBL620681,,10825,,,,H,8,BAO_0000019,2435.0
3547,,10034,Autocuration,,,1,Compound was tested for its effect on NSD 1015 induced accumulation of 5-HTP(ng/g) in rats in corpus striatum at a dosage of 1.0 umol/kg,,,CHEMBL620682,,10825,,,,H,8,BAO_0000019,2435.0
3548,,10034,Autocuration,,,1,Compound was tested for its effect on NSD 1015 induced accumulation of 5-HTP(ng/g) in rats in corpus striatum at a dosage of 10 umol/kg,,,CHEMBL620683,,10825,,,,H,8,BAO_0000019,2435.0
3549,,10034,Autocuration,,,1,Compound was tested for its effect on NSD 1015 induced accumulation of 5-HTP(ng/g) in rats in corpus striatum at a dosage of 100 umol/kg,,,CHEMBL620684,,10825,,,,H,8,BAO_0000019,2435.0
3550,,10034,Autocuration,,,1,Compound was tested for its effect on NSD 1015 induced accumulation of 5-HTP(ng/g) in rats in corpus striatum at a dosage of 3.2 umol/kg,,,CHEMBL620685,,10825,,,,H,8,BAO_0000019,2435.0
3551,,10034,Autocuration,,,1,Compound was tested for its effect on NSD 1015 induced accumulation of 5-HTP(ng/g) in rats in corpus striatum at a dosage of 32 umol/kg,,,CHEMBL620686,,10825,,,,H,8,BAO_0000019,2435.0
3552,,10034,Autocuration,,,1,Compound was tested for its effect on NSD 1015 induced accumulation of 5-HTP(ng/g) in rats in limbic system at a dosage of 0.032 umol/kg,,,CHEMBL620687,,10825,,,,H,8,BAO_0000019,349.0
3553,,10034,Autocuration,,,1,Compound was tested for its effect on NSD 1015 induced accumulation of 5-HTP(ng/g) in rats in limbic system at a dosage of 0.10 umol/kg,,,CHEMBL620688,,10825,,,,H,8,BAO_0000019,349.0
3554,,10034,Autocuration,,,1,Compound was tested for its effect on NSD 1015 induced accumulation of 5-HTP(ng/g) in rats in limbic system at a dosage of 0.32 umol/kg,,,CHEMBL620689,,10825,,,,H,8,BAO_0000019,349.0
3555,,10034,Autocuration,,,1,Compound was tested for its effect on NSD 1015 induced accumulation of 5-HTP(ng/g) in rats in limbic system at a dosage of 1.0 umol/kg,,,CHEMBL620690,,10825,,,,H,8,BAO_0000019,349.0
3556,,10034,Autocuration,,,1,Compound was tested for its effect on NSD 1015 induced accumulation of 5-HTP(ng/g) in rats in limbic system at a dosage of 10 umol/kg,,,CHEMBL620691,,10825,,,,H,8,BAO_0000019,349.0
3557,,10034,Autocuration,,,1,Compound was tested for its effect on NSD 1015 induced accumulation of 5-HTP(ng/g) in rats in limbic system at a dosage of 100 umol/kg,,,CHEMBL620692,,10825,,,,H,8,BAO_0000019,349.0
3558,,10034,Autocuration,,,1,Compound was tested for its effect on NSD 1015 induced accumulation of 5-HTP(ng/g) in rats in limbic system at a dosage of 3.2 umol/kg,,,CHEMBL620693,,10825,,,,H,8,BAO_0000019,349.0
3559,,1274,Expert,,,1,Binding affinity against 5-hydroxytryptamine 4 receptor,,,CHEMBL620694,,168,,,,H,8,BAO_0000357,
3560,,17358,Autocuration,,,1,Tested for 5-hydroxytryptamine 4 receptor antagonist activity,,,CHEMBL857986,,168,,,,H,8,BAO_0000019,
3561,,14532,Autocuration,,,1,Inhibitory activity against 5-hydroxytryptamine 4 receptor using [3H]GR-113808 as radioligand at 10e-5 M concentration,,,CHEMBL620695,,168,,,,H,8,BAO_0000357,
3562,,16989,Expert,,,1,Binding affinity towards Serotonin 5-hydroxytryptamine 4 receptor,,,CHEMBL620696,,168,,,,H,8,BAO_0000357,
3563,,17200,Autocuration,,,1,Inhibitory constant against 5-hydroxytryptamine 4 receptor using [3H]GR-113808 radioligand,,,CHEMBL620697,,168,,,,H,8,BAO_0000357,
3564,,15779,Autocuration,,,1,Binding affinity towards 5-hydroxytryptamine 4 receptor,,,CHEMBL620698,,168,,,,H,8,BAO_0000357,
3565,,15779,Autocuration,,,1,Binding affinity towards 5-hydroxytryptamine 4 receptor; ND means no data.,,,CHEMBL620699,,168,,,,H,8,BAO_0000357,
3566,,15779,Autocuration,,,1,Binding affinity towards 5-hydroxytryptamine 4 receptor; ND means no data.,,,CHEMBL620700,,168,,,,H,8,BAO_0000357,
3567,,15650,Autocuration,,,1,Binding affinity was determined against cloned 5-hydroxytryptamine 4A receptor isoform expressed in COS-7 cells,643.0,,CHEMBL620701,,168,,COS-7,,H,8,BAO_0000219,
3568,,15650,Autocuration,,,1,Binding affinity was determined against cloned 5-hydroxytryptamine 4B receptor isoform expressed in COS-7 cells,643.0,,CHEMBL875082,,168,,COS-7,,H,8,BAO_0000219,
3569,,15650,Autocuration,,,1,Binding affinity was determined against cloned 5-hydroxytryptamine 4C receptor isoform expressed in COS-7 cells,643.0,,CHEMBL620702,,168,,COS-7,,H,8,BAO_0000219,
3570,,15650,Autocuration,,,1,Binding affinity was determined against cloned 5-hydroxytryptamine 4D receptor isoform expressed in COS-7 cells,643.0,,CHEMBL620703,,168,,COS-7,,H,8,BAO_0000219,
3571,,17046,Autocuration,,,1,Binding affinity of compound towards cloned human 5-hydroxytryptamine 4E receptor expressed in C6 glial cells using [3H]GR-113808 as radioligand,673.0,,CHEMBL620704,,168,,C6,,H,8,BAO_0000219,
3572,,17046,Expert,,,1,Binding affinity towards cloned human 5-hydroxytryptamine 4E receptor expressed in C6 glial cells using [3H]GR-113808 as radioligand,673.0,,CHEMBL620705,,168,,C6,,H,8,BAO_0000219,
3573,,15650,Expert,,,1,Binding affinity was determined against cloned 5-hydroxytryptamine 4E receptor isoform expressed in C6 glial cells incubated with 0.2 nM [3H]GR-113808,673.0,,CHEMBL620706,,168,,C6,,H,8,BAO_0000219,
3574,,17046,Expert,,,1,Binding affinity towards cloned human 5-hydroxytryptamine 4E receptor expressed in C6 glial cells using [3H]GR-113808 as radioligand; Not determined,673.0,,CHEMBL620707,,168,,C6,,H,8,BAO_0000219,
3575,,17066,Expert,,,1,Binding affinity towards 5-hydroxytryptamine 5 receptor,,,CHEMBL620708,,10624,,,,H,8,BAO_0000357,
3576,,17200,Autocuration,,,1,Inhibitory constant against human 5-hydroxytryptamine 5A receptor using [3H]LSD radioligand,,,CHEMBL620709,,105,,,,H,8,BAO_0000357,
3577,,16146,Expert,9606.0,,1,Binding affinity against 5-hydroxytryptamine 5A receptor,,,CHEMBL620710,,10624,Homo sapiens,,,D,9,BAO_0000357,
3578,,15250,Autocuration,,,1,Compound was tested for the displacement of [3H]5-HT binding to cloned human 5-hydroxytryptamine 5A receptor stably expressed in CHO cells,449.0,,CHEMBL620711,,10624,,CHO,,H,8,BAO_0000219,
3579,,6491,Expert,9606.0,,1,Affinity towards human 5-hydroxytryptamine 5A serotonin receptor,,,CHEMBL620712,,10624,Homo sapiens,,,D,9,BAO_0000357,
3580,,17066,Expert,9606.0,,1,Binding affinity towards human 5-hydroxytryptamine 5A receptor,,,CHEMBL620713,,10624,Homo sapiens,,,D,9,BAO_0000357,
3581,,17066,Expert,9606.0,,1,Binding affinity towards human 5-hydroxytryptamine 5A receptor was evaluated using [3H]-5-CT as radioligand,,,CHEMBL620714,,10624,Homo sapiens,,,D,9,BAO_0000357,
3582,,4234,Expert,9606.0,,1,Binding affinity to cloned human 5-hydroxytryptamine 5A receptor,,,CHEMBL620715,,10624,Homo sapiens,,,D,9,BAO_0000357,
3583,,6013,Autocuration,,,1,Binding affinity towards 5-HT5A receptor,,,CHEMBL620716,,10624,,,,H,8,BAO_0000357,
3584,,17175,Expert,,,1,Binding affinity towards human 5-hydroxytryptamine 5A receptor using LSD as radioligand,,,CHEMBL620717,,10624,,,,H,8,BAO_0000357,
3585,,15818,Autocuration,,,1,Compound was evaluated for its binding affinity towards human 5-hydroxytryptamine 5A receptor,,,CHEMBL618072,,10624,,,,H,8,BAO_0000357,
3586,,6166,Autocuration,,,1,Binding affinity towards cloned human 5-HT5A receptor was determined,,,CHEMBL857987,,10624,,,,H,8,BAO_0000357,
3587,,15779,Autocuration,,,1,Binding affinity towards 5-hydroxytryptamine 5A receptor (human cloned receptor) in HEK 293 cells using [3H]mesulergine as radioligand.,722.0,,CHEMBL618073,,10624,,HEK293,,H,8,BAO_0000219,
3588,,15779,Autocuration,,,1,Binding affinity towards 5-hydroxytryptamine 5A receptor (human cloned receptor) in HEK 293 cells using [3H]mesulergine as radioligand;ND means no data.,722.0,,CHEMBL618074,,10624,,HEK293,,H,8,BAO_0000219,
3589,,5213,Autocuration,,,1,Compound was tested for its binding affinity in 5-hydroxytryptamine 5A receptor (using human cloned receptors in HEK 293 and [3H]5-CTas a radioligand ),722.0,,CHEMBL618075,,10624,,HEK293,,H,8,BAO_0000219,
3590,,17066,Expert,10090.0,,1,Binding affinity towards mouse 5-hydroxytryptamine 5A receptor,,,CHEMBL618076,,10625,Mus musculus,,,D,9,BAO_0000357,
3591,,17066,Expert,10090.0,,1,Binding affinity towards mouse 5-hydroxytryptamine 5A receptor was evaluated using [125I]-2-iodo LSD as radioligand,,,CHEMBL618077,,10625,Mus musculus,,,D,9,BAO_0000357,
3592,,17066,Expert,10090.0,,1,Binding affinity towards mouse 5-hydroxytryptamine 5A receptor was evaluated using [3H]- LSD as radioligand,,,CHEMBL618078,,10625,Mus musculus,,,D,9,BAO_0000357,
3593,,17066,Expert,10090.0,,1,Binding affinity towards mouse 5-hydroxytryptamine 5A receptor was evaluated using [3H]LSD as radioligand,,,CHEMBL881821,,10625,Mus musculus,,,D,9,BAO_0000357,
3594,,17066,Expert,10090.0,,1,Binding affinity towards murine 5-hydroxytryptamine 5A receptor,,,CHEMBL618079,,10625,Mus musculus,,,D,9,BAO_0000357,
3595,,17175,Expert,,,1,Binding affinity towards mouse 5-hydroxytryptamine 5A receptor using LSD as radioligand,,,CHEMBL618080,,10625,,,,H,8,BAO_0000357,
3596,,16190,Autocuration,,,1,Binding affinity against 5-hydroxytryptamine 5A receptor in HEK 293 cells was determined using [3H]LSD as radioligand,722.0,,CHEMBL618081,,10576,,HEK293,,H,8,BAO_0000219,
3597,,16190,Autocuration,,,1,Binding affinity against 5-hydroxytryptamine 5A receptor in HEK 293 cells was determined using [3H]LSD as radioligand,722.0,,CHEMBL618082,,10626,,HEK293,,H,8,BAO_0000219,
3598,,4820,Expert,,,1,Binding affinity towards 5-HT5a receptor,,,CHEMBL618083,,10624,,,,H,8,BAO_0000357,
3599,,17066,Expert,9606.0,,1,Binding affinity towards 5-hydroxytryptamine 5A receptor,,,CHEMBL618084,,10624,Homo sapiens,,,D,9,BAO_0000357,
3600,,17066,Expert,,,1,Binding affinity for rodent 5-hydroxytryptamine 5A receptor,,,CHEMBL618085,,10624,,,,H,8,BAO_0000357,
3601,,17175,Expert,,,1,Binding affinity towards 5-hydroxytryptamine 5A receptor using lysergic acid diethylamide (LSD) as radioligand,,,CHEMBL618086,,10624,,,,H,8,BAO_0000357,
3602,,16633,Autocuration,,,1,Binding affinities against 5-hydroxytryptamine 5A receptor,,,CHEMBL875092,,10624,,,,H,8,BAO_0000357,
3603,,16633,Autocuration,,,1,Binding affinities towards 5-hydroxytryptamine 5A receptor,,,CHEMBL618087,,10624,,,,H,8,BAO_0000357,
3604,,16700,Autocuration,,,1,The binding affinity towards 5-hydroxytryptamine 5A receptor; No affinity,,,CHEMBL872926,,10624,,,,H,8,BAO_0000357,
3605,,4639,Autocuration,10141.0,,1,Percent of control response to 5-HT3 agonistic activity on guinea colon at a concentration 0.01 uM,,,CHEMBL618088,,104714,Cavia porcellus,,,H,4,BAO_0000019,
3606,,5486,Autocuration,,,1,Binding affinity towards 5-HT3 receptor by the displacement of [3H]GR-65630] in human recombinant receptors in mammalian cell,,,CHEMBL618089,,104714,,,,H,4,BAO_0000223,
3607,,16146,Expert,9606.0,,1,Inhibition of human 5-hydroxytryptamine 6 receptor,,,CHEMBL618090,,10627,Homo sapiens,,,D,9,BAO_0000357,
3608,,17273,Expert,9606.0,,1,Binding affinity towards 5-hydroxytryptamine 6 receptor using [3H]- LSD as radioligand,,,CHEMBL618091,,10627,Homo sapiens,,,D,9,BAO_0000357,
3609,,17687,Autocuration,,,1,Inhibition against human 5-hydroxytryptamine 6 receptor,,,CHEMBL618092,,10627,,,,H,8,BAO_0000357,
3610,,6491,Expert,9606.0,,1,Affinity towards human 5-hydroxytryptamine 6 serotonin receptor,,,CHEMBL618093,,10627,Homo sapiens,,,D,9,BAO_0000357,
3611,,16190,Expert,,,1,Binding affinity as displacement of [3H]5-HT binding to 5-hydroxytryptamine 6 receptor in HeLa cells.,308.0,,CHEMBL618094,,10627,,HeLa,,H,8,BAO_0000219,
3612,,17066,Expert,9606.0,,1,Binding affinity towards [3H]LSD-labeled human 5-hydroxytryptamine 6 receptor,,,CHEMBL618095,,10627,Homo sapiens,,,D,9,BAO_0000357,
3613,,17066,Expert,9606.0,,1,Binding affinity towards human 5-hydroxytryptamine 6 receptor,,,CHEMBL875093,,10627,Homo sapiens,,,D,9,BAO_0000357,
3614,,17066,Expert,9606.0,,1,Binding affinity towards human 5-hydroxytryptamine 6 receptor was evaluated using [125I]-2-iodo LSD as radioligand,,,CHEMBL618096,,10627,Homo sapiens,,,D,9,BAO_0000357,
3615,,17066,Expert,9606.0,,1,Binding affinity towards human 5-hydroxytryptamine 6 receptor was evaluated using [3H]-LSD as radioligand,,,CHEMBL618118,,10627,Homo sapiens,,,D,9,BAO_0000357,
3616,,3555,Expert,9606.0,,1,Binding affinity against 5-hydroxytryptamine 6 receptor,,,CHEMBL618119,,10627,Homo sapiens,,,D,9,BAO_0000357,
3617,,5808,Expert,,,1,Binding affinity towards human 5-hydroxytryptamine 6 receptor,,,CHEMBL618120,,10627,,,,H,8,BAO_0000357,
3618,,6013,Autocuration,,,1,Binding affinity towards human 5-hydroxytryptamine 6 receptor,,,CHEMBL618121,,10627,,,,H,8,BAO_0000357,
3619,,15818,Expert,,,1,"Binding affinity for human 5-hydroxytryptamine 6 receptor expressed in HEK 293 human embryonic kidney cells, [3H]-lysergic acid diethylamide as radioligand",722.0,,CHEMBL618122,,10627,,HEK293,,H,8,BAO_0000219,
3620,,16209,Autocuration,,,1,Binding affinity towards human 5-hydroxytryptamine 6 receptor using [3H]LSD as radioligand,,,CHEMBL618123,,10627,,,,H,8,BAO_0000357,
3621,,3935,Expert,,,1,Binding affinity against human 5-hydroxytryptamine 6 receptor stably transfected to HEK 293 human embryonic kidney cells using [3H]-lysergic acid diethylamide as radioligand,722.0,,CHEMBL618124,,10627,,HEK293,,H,8,BAO_0000219,
3622,,15818,Autocuration,,,1,Compound was evaluated for its binding affinity towards human 5-hydroxytryptamine 6 receptor,,,CHEMBL618125,,10627,,,,H,8,BAO_0000357,
3623,,3805,Expert,9606.0,,1,Displacement of [3H]LSD from human 5-hydroxytryptamine 6 receptor expressed in HEK 293 cells,722.0,,CHEMBL618126,,10627,Homo sapiens,HEK293,,D,9,BAO_0000219,
3624,,16441,Expert,,,1,Tested on cell membranes from transfected cells selectively expressing human 5-hydroxytryptamine 6 receptor incubated with 1 nM [3H]LSD,,,CHEMBL618236,,10627,,,,H,8,BAO_0000019,
3625,,16441,Expert,,,1,Tested on cell membranes from transfected cells selectively expressing human 5-hydroxytryptamine 6 receptor incubated with 1 nM [3H]LSD; ND is No Data.,,,CHEMBL618237,,10627,,,,H,8,BAO_0000019,
3626,,6786,Expert,,,1,Ability to displace [3H]LSD from human 5-hydroxytryptamine 6 receptor transiently expressed in COS-7 cells,643.0,,CHEMBL618238,,10627,,COS-7,,H,8,BAO_0000219,
3627,,4234,Expert,9606.0,,1,In vitro binding affinity to human 5-hydroxytryptamine 6 receptor,,,CHEMBL618239,,10627,Homo sapiens,,,D,9,BAO_0000357,
3628,,17085,Autocuration,,,1,In vitro binding affinity by radioligand binding assay using cell line expressing human 5-hydroxytryptamine 6 receptor,,,CHEMBL618240,,10627,,,,H,8,BAO_0000019,
3629,,17200,Autocuration,,,1,Inhibitory constant against human 5-hydroxytryptamine 6 receptor using [3H]LSD radioligand,,,CHEMBL618241,,10627,,,,H,8,BAO_0000357,
3630,,17451,Autocuration,,,1,Antagonism assessed in a functional cAMP binding assay using 5-CT to stimulate human 5-hydroxytryptamine 6 receptor expressed in HEK 293 cells,722.0,,CHEMBL859399,,10627,,HEK293,,H,8,BAO_0000219,
3631,,3935,Autocuration,,,1,The compound was tested for antagonist activity by inhibition of human 5-HT6 stimulated adenylate cyclase,,,CHEMBL618242,,10627,,,,H,8,BAO_0000019,
3632,,5033,Autocuration,,,1,Ability to displace the radioligand [3H]LSD from human 5-hydroxytryptamine 6 receptor,,,CHEMBL857991,,10627,,,,H,8,BAO_0000357,
3633,,4540,Expert,,,1,Binding affinity against human 5-hydroxytryptamine 6 receptor,,,CHEMBL619951,,10627,,,,H,8,BAO_0000357,
3634,,4540,Expert,9606.0,,1,Binding affinity to human cloned 5-HT6 receptor in HeLa cells using [3H]- LSD as radioligand,308.0,,CHEMBL619952,,10627,Homo sapiens,HeLa,,D,9,BAO_0000219,
3635,,4540,Expert,9606.0,,1,Binding affinity to human cloned 5-hydroxytryptamine 6 receptor in HeLa cells using [3H]- LSD as radioligand,308.0,,CHEMBL619953,,10627,Homo sapiens,HeLa,,D,9,BAO_0000219,
3636,,17296,Autocuration,,,1,Binding affinity against 5-hydroxytryptamine 6 human cloned receptors in HeLa cells,308.0,,CHEMBL619954,,10627,,HeLa,,H,8,BAO_0000219,
3637,,17296,Autocuration,,,1,Binding affinity against 5-hydroxytryptamine 6 human cloned receptors in HeLa cells using [3H]LSD as radioligand,308.0,,CHEMBL619955,,10627,,HeLa,,H,8,BAO_0000219,
3638,,17296,Autocuration,,,1,Binding affinity against 5-hydroxytryptamine 6 human cloned receptors in HeLa cells using [3H]LSD as radioligand,308.0,,CHEMBL619956,,10627,,HeLa,,H,8,BAO_0000219,
3639,,15779,Autocuration,,,1,Binding affinity towards 5-hydroxytryptamine 6 receptor (human cloned receptor) in CHO cells using [3H]5-HT as radioligand,449.0,,CHEMBL619957,,10627,,CHO,,H,8,BAO_0000219,
3640,,15779,Autocuration,,,1,Binding affinity towards 5-hydroxytryptamine 6 receptor (human cloned receptor) in HEK 293 cells using [3H]mesulergine as radioligand.,722.0,,CHEMBL619958,,10627,,HEK293,,H,8,BAO_0000219,
3641,,15779,Autocuration,,,1,Binding affinity towards 5-hydroxytryptamine 6 receptor (human cloned receptor) in HEK 293 cells using [3H]mesulergine as radioligand; ND means no data.,722.0,,CHEMBL620627,,10627,,HEK293,,H,8,BAO_0000219,
3642,,15779,Autocuration,,,1,Binding affinity towards 5-hydroxytryptamine 6 receptor (human cloned receptor) in HEK 293 cells using [3H]mesulergine as radioligand;ND means no data.,722.0,,CHEMBL620628,,10627,,HEK293,,H,8,BAO_0000219,
3643,,15779,Autocuration,,,1,Binding affinity towards 5-hydroxytryptamine 6 receptor (human cloned receptor) in HeLa cells using [3H]LSD as radioligand;ND means no data.,308.0,,CHEMBL620629,,10627,,HeLa,,H,8,BAO_0000219,
3644,,6166,Autocuration,,,1,Binding affinity towards human 5-hydroxytryptamine 6 receptor,,,CHEMBL620630,,10627,,,,H,8,BAO_0000357,
3645,,17451,Autocuration,,,1,Binding constant towards serotonin receptor subtype 5-hydroxytryptamine 6 receptor expressed in HeLa cells using [3H]LSD as radioligand,308.0,,CHEMBL620782,,10627,,HeLa,,H,8,BAO_0000219,
3646,,15316,Autocuration,,,1,Compound was evaluated for its ability to displace [3H]LSD binding from human recombinant 5-hydroxytryptamine 6 receptor,,,CHEMBL620783,,10627,,,,H,8,BAO_0000357,
3647,,4199,Expert,,,1,Binding affinity against human 5-hydroxytryptamine 6 receptor,,,CHEMBL620784,,10627,,,,H,8,BAO_0000357,
3648,,15146,Expert,,,1,Binding affinity against human cloned 5-hydroxytryptamine 6 receptor in HeLa cells using [3H]LSD,308.0,,CHEMBL620785,,10627,,HeLa,,H,8,BAO_0000219,
3649,,5213,Autocuration,,,1,Compound was tested for its binding affinity in 5-hydroxytryptamine 6 receptor (using human cloned receptors in HeLa and [3H]LSD as a radioligand ),,,CHEMBL857992,,10627,,,,H,8,BAO_0000357,
3650,,16429,Autocuration,,,1,In vitro binding affinity at human recombinant 5-hydroxytryptamine 6 receptor in mammalian cells using 3[H]LSD as the radioligand,,,CHEMBL620786,,10627,,,,H,8,BAO_0000219,
3651,,14818,Autocuration,,,1,The compound was tested for its binding affinity towards cloned human 5-hydroxytryptamine 6 receptor in HeLa cells using [3H]5-LSD.,308.0,,CHEMBL620787,,10627,,HeLa,,H,8,BAO_0000219,
3652,,4829,Autocuration,,,1,"The compound was tested for the binding affinity towards human cloned 5-hydroxytryptamine 6 receptor in HeLa cells, using [3H]5-LSD as radioligand; n=3",308.0,,CHEMBL620788,,10627,,HeLa,,H,8,BAO_0000219,
3653,,4829,Autocuration,,,1,"The compound was tested for the binding affinity towards human cloned 5-hydroxytryptamine 6 receptor in HeLa cells, using [3H]5-LSD as radioligand; n=9",308.0,,CHEMBL620789,,10627,,HeLa,,H,8,BAO_0000219,
3654,,4829,Autocuration,,,1,"The compound was tested for the binding affinity towards human cloned 5-hydroxytryptamine 6 receptor in HeLa cells, using [3H]LSD as radioligand; n=3",308.0,,CHEMBL620790,,10627,,HeLa,,H,8,BAO_0000219,
3655,,15250,Autocuration,,,1,Compound was tested for the displacement of [3H]5-HT binding to cloned rat 5-hydroxytryptamine 6 receptor stably expressed in CHO cells,449.0,,CHEMBL620791,,10628,,CHO,,H,8,BAO_0000219,
3656,,14423,Autocuration,,,1,Binding affinity against 5-hydroxytryptamine 6 receptor from CHO cell membranes using [3H]5-HT as the radioligand.,,,CHEMBL620792,,10628,,,,H,8,BAO_0000019,
3657,,15086,Autocuration,,,1,The compound was tested for binding affinity against 5-hydroxytryptamine 6 receptor,,,CHEMBL620793,,10628,,,,H,8,BAO_0000357,
3658,,4342,Autocuration,,,1,Binding affinity of compound towards serotonin 5-hydroxytryptamine 6 receptor was determined,,,CHEMBL620794,,10628,,,,H,8,BAO_0000357,
3659,,16190,Autocuration,9606.0,,1,Binding affinity as displacement of [3H]5-HT binding to 5-hydroxytryptamine 6 receptor in HeLa cells,308.0,,CHEMBL620795,,10627,Homo sapiens,HeLa,,D,9,BAO_0000219,
3660,,4820,Expert,,,1,Binding affinity towards human 5-hydroxytryptamine 6 receptor,,,CHEMBL620796,,10627,,,,H,8,BAO_0000357,
3661,,4639,Autocuration,,,1,Percentage of displacement at 5-hydroxytryptamine 6 receptor at 10e-8 M,,,CHEMBL620797,,10627,,,,H,8,BAO_0000357,
3662,,17066,Expert,9606.0,,1,Antagonistic activity towards 5-hydroxytryptamine 6 receptor was evaluated in cAMP assay,,,CHEMBL620798,,10627,Homo sapiens,,,D,9,BAO_0000019,
3663,,6011,Autocuration,,,1,Inhibition of binding towards 5-hydroxytryptamine 6 receptor at 100 nM concentration,,,CHEMBL620799,,10627,,,,H,8,BAO_0000357,
3664,,17066,Expert,,,1,Binding affinity towards human 5-hydroxytryptamine 6 receptor,,,CHEMBL620800,,10627,,,,H,8,BAO_0000357,
3665,,17515,Autocuration,,,1,Binding affinity of compound towards serotonin 5-hydroxytryptamine 6 receptor; inactive at 10 uM,,,CHEMBL620801,,10627,,,,H,8,BAO_0000357,
3666,,5014,Autocuration,,,1,Compound was tested for its binding affinity towards 5-hydroxytryptamine 6 receptor,,,CHEMBL875100,,10627,,,,H,8,BAO_0000357,
3667,,4373,Autocuration,,,1,Binding affinity relative to indolopiperidine (compound 1) for 5-hydroxytryptamine 6 receptor was determined,,,CHEMBL620802,,10627,,,,H,8,BAO_0000357,
3668,,17066,Expert,,,1,Antagonistic activity towards 5-hydroxytryptamine 6 receptor,,,CHEMBL620803,,10627,,,,H,8,BAO_0000019,
3669,,17066,Expert,,,1,Antagonistic activity towards 5-hydroxytryptamine 6 receptor was evaluated in cAMP assay,,,CHEMBL620804,,10627,,,,H,8,BAO_0000019,
3670,,4373,Autocuration,,,1,Binding affinity for 5-hydroxytryptamine 6 receptor was determined,,,CHEMBL620805,,10627,,,,H,8,BAO_0000357,
3671,,4687,Autocuration,,,1,Evaluated for the binding affinity towards 5-hydroxytryptamine 6 receptor,,,CHEMBL620806,,10627,,,,H,8,BAO_0000357,
3672,,16946,Autocuration,,,1,Ability to displace [125I]LSD 113808 from 5-hydroxytryptamine 6 receptor at concentration of 10e-6 M,,,CHEMBL620807,,10627,,,,H,8,BAO_0000357,
3673,,16946,Autocuration,,,1,Ability to displace [125I]LSD 113808 from 5-hydroxytryptamine 6 receptor at concentration of 10e-8 M,,,CHEMBL620808,,10627,,,,H,8,BAO_0000357,
3674,,16633,Autocuration,,,1,Binding affinities against 5-hydroxytryptamine 6 receptor,,,CHEMBL620809,,10627,,,,H,8,BAO_0000357,
3675,,16633,Autocuration,,,1,Binding affinities towards 5-hydroxytryptamine 6 receptor,,,CHEMBL620810,,10627,,,,H,8,BAO_0000357,
3676,,17066,Expert,9606.0,,1,Binding affinity towards 5-hydroxytryptamine 6 receptor,,,CHEMBL620811,,10627,Homo sapiens,,,D,9,BAO_0000357,
3677,,16700,Autocuration,,,1,The binding affinity towards 5-hydroxytryptamine 6 receptor; No affinity,,,CHEMBL620812,,10627,,,,H,8,BAO_0000357,
3678,,3269,Autocuration,,,1,Affinity against 5-hydroxytryptamine 6 receptor,,,CHEMBL620813,,10627,,,,H,8,BAO_0000357,
3679,,5486,Autocuration,,,1,Binding affinity towards human recombinant 5-hydroxytryptamine 7 receptor by the displacement of [3H]-5-CT],,,CHEMBL620814,,10627,,,,H,8,BAO_0000357,
3680,,16146,Expert,9606.0,,1,Inhibition of human 5-hydroxytryptamine 7 receptor,,,CHEMBL620815,,10209,Homo sapiens,,,D,9,BAO_0000357,
3681,,5014,Autocuration,,,1,Compound was tested for its binding affinity towards human 5-hydroxytryptamine 7 receptor from HEK293 cells using radioligand [3H]LSD,722.0,,CHEMBL620816,,10209,,HEK293,,H,8,BAO_0000219,
3682,,15463,Autocuration,,,1,Compound at 1 uM was tested for the inhibition of radioligand [3H]LSD binding to recombinant human 5-hydroxytryptamine 7 receptor,,,CHEMBL620817,,10209,,,,H,8,BAO_0000357,
3683,,3805,Autocuration,,,1,In vitro binding affinity against human 5-hydroxytryptamine 7 receptor at a concentration of 100 (nM),,,CHEMBL620818,,10209,,,,H,8,BAO_0000357,
3684,,5014,Expert,,,1,Inhibition (at 1 uM) of radioligand [3H]LSD binding to human 5-hydroxytryptamine 7 receptor on HEK293 cells,722.0,,CHEMBL620819,,10209,,HEK293,,H,8,BAO_0000219,
3685,,6491,Expert,9606.0,,1,Affinity towards human 5-hydroxytryptamine 7 serotonin receptor,,,CHEMBL620820,,10209,Homo sapiens,,,D,9,BAO_0000357,
3686,,16190,Autocuration,,,1,Binding affinity for 5-hydroxytryptamine 7 receptor human cloned receptors in CHO cells using [3H]5-HT,449.0,,CHEMBL620821,,10209,,CHO,,H,8,BAO_0000219,
3687,,17066,Expert,9606.0,,1,Binding affinity towards human 5-hydroxytryptamine 7 receptor,,,CHEMBL620822,,10209,Homo sapiens,,,D,9,BAO_0000357,
3688,,17066,Expert,9606.0,,1,Displacement of [3H]5-HT from human 5-hydroxytryptamine 7 receptor,,,CHEMBL620823,,10209,Homo sapiens,,,D,9,BAO_0000357,
3689,,3555,Expert,9606.0,,1,Binding affinity against 5-hydroxytryptamine 7 receptor,,,CHEMBL620824,,10209,Homo sapiens,,,D,9,BAO_0000357,
3690,,6588,Expert,,,1,Binding affinity towards human 5-hydroxytryptamine 7 receptor by the displacement of [3H]-5-HT radioligand from the cloned receptor expressed in CHO cells,449.0,,CHEMBL620825,,10209,,CHO,,H,8,BAO_0000219,
3691,,15463,Autocuration,,,1,Binding affinity towards recombinant human 5-hydroxytryptamine 7 receptor was determined using [3H]LSD as radioligand,,,CHEMBL872930,,10209,,,,H,8,BAO_0000357,
3692,,6013,Autocuration,,,1,Binding affinity towards 5-hydroxytryptamine 7 receptor,,,CHEMBL620826,,10209,,,,H,8,BAO_0000357,
3693,,16209,Autocuration,,,1,Binding affinity towards human 5-hydroxytryptamine 7 receptor using [3H]5-HT as radioligand,,,CHEMBL620827,,10209,,,,H,8,BAO_0000357,
3694,,3935,Autocuration,,,1,Compound was evaluated for its binding affinity for human 5-hydroxytryptamine 7 receptor,,,CHEMBL620828,,10209,,,,H,8,BAO_0000357,
3695,,15818,Autocuration,,,1,Compound was evaluated for its binding affinity towards human 5-hydroxytryptamine 7 receptor,,,CHEMBL620829,,10209,,,,H,8,BAO_0000357,
3696,,5014,Expert,,,1,Binding affinity towards human 5-hydroxytryptamine 7 receptor on HEK293 cells using radioligand [3H]LSD,722.0,,CHEMBL620830,,10209,,HEK293,,H,8,BAO_0000219,
3697,,16441,Expert,,,1,Tested on cell membranes from transfected cells selectively expressing human 5-hydroxytryptamine 7 receptor incubated with 1 nM [3H]LSD,,,CHEMBL620831,,10209,,,,H,8,BAO_0000019,
3698,,16441,Expert,,,1,Tested on cell membranes from transfected cells selectively expressing human 5-hydroxytryptamine 7 receptor incubated with 1 nM [3H]LSD; ND is No Data.,,,CHEMBL620832,,10209,,,,H,8,BAO_0000019,
3699,,4234,Expert,9606.0,,1,In vitro binding affinity to human 5-hydroxytryptamine 7 receptor,,,CHEMBL621548,,10209,Homo sapiens,,,D,9,BAO_0000357,
3700,,17085,Autocuration,,,1,In vitro binding affinity by radioligand binding assay using cell line expressing human 5-hydroxytryptamine 7 receptor,,,CHEMBL621549,,10209,,,,H,8,BAO_0000019,
3701,,17200,Autocuration,,,1,Inhibitory constant against human 5-hydroxytryptamine 7 receptor using [3H]LSD radioligand,,,CHEMBL621550,,10209,,,,H,8,BAO_0000357,
3702,,17451,Autocuration,,,1,Binding constant towards serotonin receptor subtype 5-hydroxytryptamine 7 receptor expressed in CHO cells using [3H]-LSD as radioligand; Not determined,449.0,,CHEMBL621551,,10209,,CHO,,H,8,BAO_0000219,
3703,,17085,Autocuration,,,1,In vitro binding affinity by radioligand binding assay using cell line expressing human 5-hydroxytryptamine 7 receptor; ND means not determined,,,CHEMBL621552,,10209,,,,H,8,BAO_0000019,
3704,,5104,Autocuration,,,1,Binding affinity for human cloned 5-hydroxytryptamine 7 receptor,,,CHEMBL857077,,10209,,,,H,8,BAO_0000357,
3705,,5104,Autocuration,,,1,Binding affinity for human cloned 5-hydroxytryptamine 7 receptor; Not tested,,,CHEMBL618158,,10209,,,,H,8,BAO_0000357,
3706,,5033,Expert,9606.0,,1,Ability to displace the radioligand [3H]5-carboxyamidotryptamine ([3H]5-CT) from human 5-hydroxytryptamine 7 receptor expressed in COS-7 cells,643.0,,CHEMBL618159,,10209,Homo sapiens,COS-7,,D,9,BAO_0000219,
3707,,5486,Autocuration,,,1,Ability to displace the radioligand [3H]5-carboximidotryptamine ([3H]-5-CT) from cloned human 5-hydroxytryptamine 7 receptor expressed in COS-7 cells,643.0,,CHEMBL875101,,10209,,COS-7,,H,8,BAO_0000219,
3708,,4540,Expert,9606.0,,1,Binding affinity to human cloned 5-hydroxytryptamine 7 receptor in HEK 293 cells using [3H]-5-CT as radioligand,722.0,,CHEMBL618160,,10209,Homo sapiens,HEK293,,D,9,BAO_0000219,
3709,,6166,Expert,,,1,Binding affinity at human cloned 5-hydroxytryptamine 7 receptor.,,,CHEMBL618161,,10209,,,,H,8,BAO_0000357,
3710,,17342,Expert,,,1,Binding affinity towards cloned human 5-hydroxytryptamine 7 receptor was determined in HEK293 cells using [3H]5-CT as radioligand,722.0,,CHEMBL618162,,10209,,HEK293,,H,8,BAO_0000219,
3711,,17342,Expert,,,1,Binding affinity towards human recombinant 5-hydroxytryptamine 7 receptor was determined using [3H]5-CT as radioligand,,,CHEMBL618163,,10209,,,,H,8,BAO_0000357,
3712,,17296,Autocuration,,,1,Binding affinity against 5-hydroxytryptamine 7 human receptors,,,CHEMBL618164,,10209,,,,H,8,BAO_0000357,
3713,,16429,Expert,,,1,Binding affinity to human recombinant 5-hydroxytryptamine 7 receptor in mammalian cells using [3H]5-CT as radioligand,,,CHEMBL618165,,10209,,,,H,8,BAO_0000219,
3714,,15779,Autocuration,,,1,Binding affinity toward 5-hydroxytryptamine 7 receptor (human cloned receptor) in HEK 293 cells using [3H]-5-CT as radioligand.,722.0,,CHEMBL618166,,10209,,HEK293,,H,8,BAO_0000219,
3715,,15779,Autocuration,,,1,Binding affinity towards 5-hydroxytryptamine 7 receptor (a) (human cloned receptor) in HEK 293 cells using [3H]5-CT as radioligand.,722.0,,CHEMBL857989,,10209,,HEK293,,H,8,BAO_0000219,
3716,,15779,Autocuration,,,1,Binding affinity towards 5-hydroxytryptamine 7 receptor (human cloned receptor) in HEK 293 cells using [3H]5-CT as radioligand.,722.0,,CHEMBL619888,,10209,,HEK293,,H,8,BAO_0000219,
3717,,15779,Autocuration,,,1,Binding affinity towards 5-hydroxytryptamine 7 receptor (human cloned receptor) in HEK 293 cells using [3H]5-CT as radioligand.,722.0,,CHEMBL619889,,10209,,HEK293,,H,8,BAO_0000219,
3718,,15779,Autocuration,,,1,Binding affinity towards 5-hydroxytryptamine 7 receptor 7(a) (human cloned receptor in HEK 293 cells using [3H]5-CT as radioligand.,722.0,,CHEMBL619890,,10209,,HEK293,,H,8,BAO_0000219,
3719,,17451,Autocuration,,,1,Binding constant towards serotonin receptor subtype 5-hydroxytryptamine 7 receptor expressed in CHO cells using [3H]LSD as radioligand,449.0,,CHEMBL619891,,10209,,CHO,,H,8,BAO_0000219,
3720,,4199,Autocuration,,,1,Compound was evaluated for binding affinity against human cloned 5-hydroxytryptamine 7 receptor in HEK 293 cells using [3H]5-CT as the radioligand (n=3),722.0,,CHEMBL619892,,10209,,HEK293,,H,8,BAO_0000219,
3721,,4199,Expert,,,1,Displacement of [3H]-5-CT from human 5-hydroxytryptamine 7 receptor expressed in HEK-293 cells,722.0,,CHEMBL619893,,10209,,HEK293,,D,9,BAO_0000219,
3722,,4199,Autocuration,,,1,Compound was evaluated for binding affinity against human cloned 5-hydroxytryptamine 7 receptor in HEK 293 cells using [3H]5-CT as the radioligand(n=6),722.0,,CHEMBL619894,,10209,,HEK293,,H,8,BAO_0000219,
3723,,3680,Intermediate,,,1,Binding affinity towards cloned human 5-hydroxytryptamine 7 receptor in HEK 293 cells,722.0,,CHEMBL619895,,10209,,HEK293,,D,9,BAO_0000219,
3724,,3680,Intermediate,,,1,Binding affinity towards human recombinant 5-hydroxytryptamine 7 receptor using [3H]5-CT as radioligand,,,CHEMBL619896,,10209,,,,D,9,BAO_0000357,
3725,,15316,Autocuration,,,1,Compound was evaluated for its ability to displace [3H]5-CT binding from cloned human 5-hydroxytryptamine 7 receptor expressed in COS-7 cells.,643.0,,CHEMBL619897,,10209,,COS-7,,H,8,BAO_0000219,
3726,,15146,Autocuration,,,1,Compound was tested for its binding affinity against human cloned 5-hydroxytryptamine 7 receptor in HEK 293 cells using [3H]5-CT,722.0,,CHEMBL619898,,10209,,HEK293,,H,8,BAO_0000219,
3727,,5213,Expert,,,1,Binding affinity for human cloned 5-hydroxytryptamine 7 receptor in HEK 293 using [3H]5-CT as a radioligand,722.0,,CHEMBL619899,,10209,,HEK293,,H,8,BAO_0000219,
3728,,5213,Autocuration,,,1,Compound was tested for its binding affinity in 5-hydroxytryptamine 7 receptor (using human cloned receptors in HEK 293 and [3H]5-CT as a radioligand ),722.0,,CHEMBL619900,,10209,,HEK293,,H,8,BAO_0000219,
3729,,14818,Expert,9606.0,,1,Binding affinity towards cloned human 5-hydroxytryptamine 7 receptor expressed in HEK 293 cells using [3H]5-CT,722.0,,CHEMBL619901,,10209,Homo sapiens,HEK293,,D,9,BAO_0000219,
3730,,14818,Autocuration,,,1,The compound was tested for its binding affinity towards cloned human 5-hydroxytryptamine 7 receptor expressed in HEK 293 cells using [3H]5-CT. ,722.0,,CHEMBL620580,,10209,,HEK293,,H,8,BAO_0000219,
3731,,14818,Autocuration,,,1,The compound was tested for its binding affinity towards cloned human 5-hydroxytryptamine 7 receptor in HEK 293 cells using [3H]5-CT.,722.0,,CHEMBL620581,,10209,,HEK293,,H,8,BAO_0000219,
3732,,4829,Autocuration,,,1,"The compound was tested for the binding affinity towards human cloned 5-hydroxytryptamine 7 receptor in HEK293 cells, using [3H]5-CT as radioligand",722.0,,CHEMBL620733,,10209,,HEK293,,H,8,BAO_0000219,
3733,,17200,Autocuration,9606.0,,1,Inhibitory constant against human 5-hydroxytryptamine 7 receptor using [3H]-LSD radioligand; Not determined,,,CHEMBL620734,,10209,Homo sapiens,,,D,9,BAO_0000357,
3734,,17066,Expert,10090.0,,1,Binding affinity towards mouse 5-hydroxytryptamine 7 receptor was evaluated using [3H]5-HT as radioligand,,,CHEMBL620735,,10022,Mus musculus,,,D,9,BAO_0000357,
3735,,14025,Autocuration,9986.0,,1,The dissociation equilibrium constant (pKB=-log KB) of compound was determined against the vascular 5-hydroxytryptamine 7 receptor in the endothelium denuded rabbit jugular vein.,,,CHEMBL620736,,10209,Oryctolagus cuniculus,,,H,8,BAO_0000019,
3736,,15250,Autocuration,,,1,Compound was tested for the displacement of [3H]5-HT binding to cloned rat 5-hydroxytryptamine 7 receptor stably expressed in CHO cells,449.0,,CHEMBL620737,,11923,,CHO,,H,8,BAO_0000219,
3737,,16372,Autocuration,,,1,Percent inhibition of 5-HT7-induced stimulation of cAMP production in CHO cells expressing rat 5-HT 7 receptors at a concentration of 10000 nM,449.0,,CHEMBL620738,,11923,,CHO,,H,8,BAO_0000219,
3738,,16372,Autocuration,,,1,Percent inhibition of 5-HT7-induced stimulation of cAMP production in CHO cells expressing rat 5-HT 7 receptors at a concentration of 100 nM,449.0,,CHEMBL620739,,11923,,CHO,,H,8,BAO_0000219,
3739,,16372,Autocuration,,,1,Percent inhibition of 5-HT7-induced stimulation of cAMP production in CHO cells expressing rat 5-HT 7 receptors at a concentration of 1 nM,449.0,,CHEMBL620740,,11923,,CHO,,H,8,BAO_0000219,
3740,,16372,Autocuration,,,1,Percent inhibition of 5-HT7-induced stimulation of cAMP production in CHO cells expressing rat 5-HT 7 receptors by 10000 nM 5-HT.,449.0,,CHEMBL620741,,11923,,CHO,,H,8,BAO_0000219,
3741,,16372,Autocuration,,,1,Percent inhibition of 5-HT7-induced stimulation of cAMP production in CHO cells expressing rat 5-HT 7 receptors by 100 nM 5-HT.,449.0,,CHEMBL620742,,11923,,CHO,,H,8,BAO_0000219,
3742,,16372,Autocuration,,,1,Percent inhibition of 5-HT7-induced stimulation of cAMP production in CHO cells expressing rat 5-HT 7 receptors by 1 nM 5-HT,449.0,,CHEMBL620743,,11923,,CHO,,H,8,BAO_0000219,
3743,,16372,Autocuration,,,1,Percent inhibition of 5-HT7-induced stimulation of cAMP production in CHO cells expressing rat 5-HT receptors at a concentration of 10000 nM,449.0,,CHEMBL620744,,11923,,CHO,,H,8,BAO_0000219,
3744,,16372,Autocuration,,,1,Percent inhibition of 5-HT7-induced stimulation of cAMP production in CHO cells expressing rat 5-HT receptors at a concentration of 100 nM,449.0,,CHEMBL620745,,11923,,CHO,,H,8,BAO_0000219,
3745,,16372,Autocuration,,,1,Percent inhibition of 5-HT7-induced stimulation of cAMP production in CHO cells expressing rat 5-HT receptors at a concentration of 1 nM,449.0,,CHEMBL620746,,11923,,CHO,,H,8,BAO_0000219,
3746,,16372,Autocuration,,,1,Percent inhibition of 5-HT7-induced stimulation of cAMP production in CHO cells expressing rat 5-HT receptors by 10000 nM 5-HT.,449.0,,CHEMBL620747,,11923,,CHO,,H,8,BAO_0000219,
3747,,16372,Autocuration,,,1,Percent inhibition of 5-HT7-induced stimulation of cAMP production in CHO cells expressing rat 5-HT receptors by 100 nM 5-HT.,449.0,,CHEMBL620748,,11923,,CHO,,H,8,BAO_0000219,
3748,,16372,Autocuration,,,1,Percent inhibition of 5-HT7-induced stimulation of cAMP production in CHO cells expressing rat 5-HT receptors by 1 nM 5-HT.,449.0,,CHEMBL620749,,11923,,CHO,,H,8,BAO_0000219,
3749,,17066,Expert,,,1,Binding affinity towards rat 5-hydroxytryptamine 7 receptor,,,CHEMBL620750,,11923,,,,H,8,BAO_0000357,
3750,,17066,Expert,10116.0,,1,Binding affinity towards rat 5-hydroxytryptamine 7 receptor was evaluated using [3H]5-HT as radioligand,,,CHEMBL620751,,11923,Rattus norvegicus,,,D,9,BAO_0000357,
3751,,17386,Expert,,,1,Binding affinity to the rat 5-hydroxytryptamine 7 receptor,,,CHEMBL620752,,11923,,,,H,8,BAO_0000357,
